#Chr	Start	End	Ref	Alt	Ref.Gene	Func.refGene	ExonicFunc.refGene	Gene.ensGene	avsnp150	AAChange.ensGene	AAChange.refGene	clinvar: Clinvar 	 CancerVar: CancerVar and Evidence 	Freq_ExAC_ALL	Freq_esp6500siv2_all	Freq_1000g2015aug_all	Freq_gnomAD_genome_ALL	CADD_raw	CADD_phred	SIFT_score	GERP++_RS	phastCons20way_mammalian	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	AAChange.knownGene	MetaSVM_score	Freq_gnomAD_genome_POPs	OMIM	Phenotype_MIM	OrphaNumber	Orpha	Pathway	Therap_list	Diag_list	Prog_list	Polyphen2_HDIV_score	FATHMM_score	MetaLR_score	MutationAssessor_score	cosmic91	icgc28	Otherinfo
1	2160304	2160304	C	G	SKI	exonic	synonymous SNV	ENSG00000157933	rs200019352	ENSG00000157933:ENST00000378536:exon1:c.C99G:p.G33G	SKI:NM_003036:exon1:c.C99G:p.G33G	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0189	0.0045	0.0071885	0.0130	.	.	.	.	.	.	.	.	SKI:uc001aja.4:exon1:c.C99G:p.G33G	.	AFR:0.0043,AMR:0.0159,EAS:0,FIN:0.0142,NFE:0.0197,OTH:0.0069,ASJ:0.0118	164780	182212;	2462;	2462|Marfanoid craniosynostosis syndrome<br>SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182212 ~	.	.	.	.	.	.	.	.	1	.	het
1	2160390	2160390	C	G	SKI	exonic	nonsynonymous SNV	ENSG00000157933	rs28384811	ENSG00000157933:ENST00000378536:exon1:c.C185G:p.A62G	SKI:NM_003036:exon1:c.C185G:p.A62G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0920	.	0.0457268	0.0474	1.378	12.67	0.017	2.3	0.990	.	.	.	SKI:uc001aja.4:exon1:c.C185G:p.A62G	-0.302	AFR:0.0296,AMR:0.0584,EAS:0.0043,FIN:0.0372,NFE:0.0636,OTH:0.0451,ASJ:0.0720	164780	182212;	2462;	2462|Marfanoid craniosynostosis syndrome<br>SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182212 ~	.	.	.	.	0.981	-3.82	0.147	0	1	MU4554004	het
1	2488153	2488153	A	G	TNFRSF14	exonic	nonsynonymous SNV	ENSG00000157873	rs4870	ENSG00000157873:ENST00000355716:exon1:c.A50G:p.K17R,ENSG00000157873:ENST00000409119:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000426449:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000434817:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000435221:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000451778:exon2:c.A50G:p.K17R	TNFRSF14:NM_001297605:exon1:c.A50G:p.K17R,TNFRSF14:NM_003820:exon1:c.A50G:p.K17R	clinvar: not_provided 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5443	0.5580	0.614816	MU4560918	-0.182	1.198	0.471	-1.09	0.000	.	.	.	TNFRSF14:uc001ajr.3:exon1:c.A50G:p.K17R,TNFRSF14:uc009vlf.1:exon1:c.A50G:p.K17R,TNFRSF14:uc010nzc.1:exon1:c.A50G:p.K17R	-0.931	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.5446,EAS:0.5143,FIN:0.4467,NFE:0.4609,OTH:0.4842,ASJ:0.7156	602746	.	.	.	.	.	.	.	0.61	-2.37	0.000	1.175	1	1(pancreas)	0.4735
1	2490898	2490898	C	A	TNFRSF14	intronic	.	ENSG00000157873	rs2257763	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5899	.	0.640775	0.5671	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C450A:p.C150X	.	AFR:0.7517,AMR:0.5358,EAS:0.5143,FIN:0.5020,NFE:0.4867,OTH:0.5307,ASJ:0.4603	602746	.	.	.	.	.	.	.	.	.	.	.	1	MU15519966	hom
1	2490942	2490942	C	A	TNFRSF14	intronic	.	ENSG00000157873	rs2281852	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5713	.	0.597843	ESAD-UK|2|409|0.00488998,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C494A:p.A165E	.	AFR:0.5331,AMR:0.6520,EAS:0.4570,FIN:0.4611,NFE:0.4991,OTH:0.4821,ASJ:0.5251	602746	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.5256
1	2491205	2491205	C	T	TNFRSF14	intronic	.	ENSG00000157873	rs2234161	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6596	.	0.64397	12(central_nervous_system)	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C757T:p.R253C	.	AFR:MU15520040,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.7639,FIN:0.5358,NFE:0.4603,OTH:0.5130,ASJ:0.5704	602746	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.5006
1	3301721	3301721	C	T	PRDM16	exonic	synonymous SNV	ENSG00000142611	rs2282198	ENSG00000142611:ENST00000463591:exon2:c.C12T:p.S4S,ENSG00000142611:ENST00000270722:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000378391:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000378398:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000441472:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000442529:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000511072:exon4:c.C447T:p.S149S,ENSG00000142611:ENST00000514189:exon4:c.C447T:p.S149S	PRDM16:NM_022114:exon4:c.C444T:p.S148S,PRDM16:NM_199454:exon4:c.C444T:p.S148S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3295	0.2049	0.340455	1(lung)	.	.	.	.	.	.	.	.	PRDM16:uc001akc.3:exon4:c.C444T:p.S148S,PRDM16:uc001ake.3:exon4:c.C444T:p.S148S,PRDM16:uc001akf.3:exon4:c.C444T:p.S148S	.	AFR:1(thyroid),AMR:MU4547297,EAS:0.2446,FIN:0.0786,NFE:0.3816,OTH:0.2649,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	1(liver)	0.6075
1	3328358	3328358	T	C	PRDM16	exonic	nonsynonymous SNV	ENSG00000142611	rs870124	ENSG00000142611:ENST00000509860:exon5:c.T1024C:p.S342P,ENSG00000142611:ENST00000270722:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000378391:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000441472:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000442529:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000511072:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000514189:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000378398:exon10:c.T1600C:p.S534P	PRDM16:NM_022114:exon9:c.T1597C:p.S533P,PRDM16:NM_199454:exon9:c.T1597C:p.S533P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8897	0.8777	0.945088	0.9008	-0.543	0.172	0.651	5.33	0.826	.	.	.	PRDM16:uc001akc.3:exon9:c.T1597C:p.S533P,PRDM16:uc001ake.3:exon9:c.T1597C:p.S533P,PRDM16:uc001akf.3:exon9:c.T1597C:p.S533P,PRDM16:uc009vlh.3:exon9:c.T700C:p.S234P	-0.955	AFR:0.9696,AMR:0.9332,EAS:0.9994,FIN:0.9196,NFE:0.8459,OTH:0.8794,ASJ:0.86	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	0.0	3.38	0.000	-1.7	1	MU113190	hom
1	6528589	6528589	C	T	PLEKHG5	exonic	synonymous SNV	ENSG00000171680	rs3138150	ENSG00000171680:ENST00000340850:exon20:c.G2307A:p.T769T,ENSG00000171680:ENST00000377725:exon20:c.G2307A:p.T769T,ENSG00000171680:ENST00000377728:exon20:c.G2307A:p.T769T,ENSG00000171680:ENST00000377732:exon20:c.G2418A:p.T806T,ENSG00000171680:ENST00000400913:exon20:c.G2307A:p.T769T,ENSG00000171680:ENST00000535355:exon20:c.G2514A:p.T838T,ENSG00000171680:ENST00000377737:exon21:c.G2307A:p.T769T,ENSG00000171680:ENST00000377748:exon21:c.G2538A:p.T846T,ENSG00000171680:ENST00000400915:exon21:c.G2475A:p.T825T,ENSG00000171680:ENST00000537245:exon21:c.G2544A:p.T848T,ENSG00000171680:ENST00000544978:exon21:c.G2307A:p.T769T	PLEKHG5:NM_001042664:exon20:c.G2307A:p.T769T,PLEKHG5:NM_001042665:exon20:c.G2307A:p.T769T,PLEKHG5:NM_001265593:exon20:c.G2514A:p.T838T,PLEKHG5:NM_001265594:exon20:c.G2307A:p.T769T,PLEKHG5:NM_020631:exon20:c.G2307A:p.T769T,PLEKHG5:NM_001042663:exon21:c.G2475A:p.T825T,PLEKHG5:NM_001265592:exon21:c.G2544A:p.T848T,PLEKHG5:NM_198681:exon21:c.G2538A:p.T846T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0535	0.0626	0.0557109	.	.	.	.	.	.	.	.	.	PLEKHG5:uc001anj.1:exon8:c.G990A:p.T330T,PLEKHG5:uc009vma.1:exon18:c.G1827A:p.T609T,PLEKHG5:uc001ank.1:exon20:c.G2307A:p.T769T,PLEKHG5:uc001anl.2:exon20:c.G2307A:p.T769T,PLEKHG5:uc001anm.2:exon20:c.G2307A:p.T769T,PLEKHG5:uc001ann.1:exon20:c.G2418A:p.T806T,PLEKHG5:uc009vmb.2:exon20:c.G2307A:p.T769T,PLEKHG5:uc010nzr.1:exon20:c.G2514A:p.T838T,PLEKHG5:uc001ano.1:exon21:c.G2475A:p.T825T,PLEKHG5:uc001anp.2:exon21:c.G2538A:p.T846T,PLEKHG5:uc031plb.1:exon21:c.G2544A:p.T848T	.	AFR:0.0535,AMR:0.0691,EAS:0.0861,FIN:0,NFE:0.0232,OTH:0.0557,ASJ:0.0573	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	1(urinary_tract)	0.0634
1	6529183	6529185	TCC	-	PLEKHG5	exonic	nonframeshift deletion	ENSG00000171680	rs113541584	ENSG00000171680:ENST00000340850:exon19:c.2166_2168del:p.722_723del,ENSG00000171680:ENST00000377725:exon19:c.2166_2168del:p.722_723del,ENSG00000171680:ENST00000377728:exon19:c.2166_2168del:p.722_723del,ENSG00000171680:ENST00000377732:exon19:c.2277_2279del:p.759_760del,ENSG00000171680:ENST00000400913:exon19:c.2166_2168del:p.722_723del,ENSG00000171680:ENST00000535355:exon19:c.2373_2375del:p.791_792del,ENSG00000171680:ENST00000377737:exon20:c.2166_2168del:p.722_723del,ENSG00000171680:ENST00000377740:exon20:c.2397_2399del:p.799_800del,ENSG00000171680:ENST00000377748:exon20:c.2397_2399del:p.799_800del,ENSG00000171680:ENST00000400915:exon20:c.2334_2336del:p.778_779del,ENSG00000171680:ENST00000537245:exon20:c.2403_2405del:p.801_802del,ENSG00000171680:ENST00000544978:exon20:c.2166_2168del:p.722_723del	PLEKHG5:NM_001042664:exon19:c.2166_2168del:p.722_723del,PLEKHG5:NM_001042665:exon19:c.2166_2168del:p.722_723del,PLEKHG5:NM_001265593:exon19:c.2373_2375del:p.791_792del,PLEKHG5:NM_001265594:exon19:c.2166_2168del:p.722_723del,PLEKHG5:NM_020631:exon19:c.2166_2168del:p.722_723del,PLEKHG5:NM_001042663:exon20:c.2334_2336del:p.778_779del,PLEKHG5:NM_001265592:exon20:c.2403_2405del:p.801_802del,PLEKHG5:NM_198681:exon20:c.2397_2399del:p.799_800del	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1130	0.1704	0.0972444	0.0841	.	.	.	.	.	.	.	.	PLEKHG5:uc001anj.1:exon7:c.849_851del:p.283_284del,PLEKHG5:uc009vma.1:exon17:c.1686_1688del:p.562_563del,PLEKHG5:uc001ank.1:exon19:c.2166_2168del:p.722_723del,PLEKHG5:uc001anl.2:exon19:c.2166_2168del:p.722_723del,PLEKHG5:uc001anm.2:exon19:c.2166_2168del:p.722_723del,PLEKHG5:uc001ann.1:exon19:c.2277_2279del:p.759_760del,PLEKHG5:uc009vmb.2:exon19:c.2166_2168del:p.722_723del,PLEKHG5:uc010nzr.1:exon19:c.2373_2375del:p.791_792del,PLEKHG5:uc001ano.1:exon20:c.2334_2336del:p.778_779del,PLEKHG5:uc001anp.2:exon20:c.2397_2399del:p.799_800del,PLEKHG5:uc001anq.2:exon20:c.2397_2399del:p.799_800del,PLEKHG5:uc031plb.1:exon20:c.2403_2405del:p.801_802del	.	AFR:0.1846,AMR:0.0647,EAS:0.0080,FIN:0.0252,NFE:0.0569,OTH:0.0767,ASJ:0.0884	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6529443	6529443	A	G	PLEKHG5	exonic	synonymous SNV	ENSG00000171680	rs730600	ENSG00000171680:ENST00000340850:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000377725:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000377728:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000377732:exon18:c.T2112C:p.S704S,ENSG00000171680:ENST00000400913:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000535355:exon18:c.T2208C:p.S736S,ENSG00000171680:ENST00000377737:exon19:c.T2001C:p.S667S,ENSG00000171680:ENST00000377740:exon19:c.T2232C:p.S744S,ENSG00000171680:ENST00000377748:exon19:c.T2232C:p.S744S,ENSG00000171680:ENST00000400915:exon19:c.T2169C:p.S723S,ENSG00000171680:ENST00000537245:exon19:c.T2238C:p.S746S,ENSG00000171680:ENST00000544978:exon19:c.T2001C:p.S667S	PLEKHG5:NM_001042664:exon18:c.T2001C:p.S667S,PLEKHG5:NM_001042665:exon18:c.T2001C:p.S667S,PLEKHG5:NM_001265593:exon18:c.T2208C:p.S736S,PLEKHG5:NM_001265594:exon18:c.T2001C:p.S667S,PLEKHG5:NM_020631:exon18:c.T2001C:p.S667S,PLEKHG5:NM_001042663:exon19:c.T2169C:p.S723S,PLEKHG5:NM_001265592:exon19:c.T2238C:p.S746S,PLEKHG5:NM_198681:exon19:c.T2232C:p.S744S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1723	0.2872	0.269569	0.2653	.	.	.	.	.	.	.	.	PLEKHG5:uc001anj.1:exon6:c.T684C:p.S228S,PLEKHG5:uc009vma.1:exon16:c.T1521C:p.S507S,PLEKHG5:uc001ank.1:exon18:c.T2001C:p.S667S,PLEKHG5:uc001anl.2:exon18:c.T2001C:p.S667S,PLEKHG5:uc001anm.2:exon18:c.T2001C:p.S667S,PLEKHG5:uc001ann.1:exon18:c.T2112C:p.S704S,PLEKHG5:uc009vmb.2:exon18:c.T2001C:p.S667S,PLEKHG5:uc010nzr.1:exon18:c.T2208C:p.S736S,PLEKHG5:uc001ano.1:exon19:c.T2169C:p.S723S,PLEKHG5:uc001anp.2:exon19:c.T2232C:p.S744S,PLEKHG5:uc001anq.2:exon19:c.T2232C:p.S744S,PLEKHG5:uc031plb.1:exon19:c.T2238C:p.S746S	.	AFR:0.5904,AMR:0.1169,EAS:0,FIN:0.1584,NFE:0.1460,OTH:0.1833,ASJ:0.1424	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6530435	6530435	A	G	PLEKHG5	intronic	.	ENSG00000171680	rs2986753	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1355	0.1971	0.171725	0.1807	.	.	.	.	.	.	.	.	.	.	AFR:0.3435,AMR:0.1026,EAS:0,FIN:0.0997,NFE:0.1327,OTH:0.1418,ASJ:0.1233	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6531589	6531589	C	T	PLEKHG5	exonic	nonsynonymous SNV	ENSG00000171680	rs74809741	ENSG00000171680:ENST00000340850:exon12:c.G1240A:p.A414T,ENSG00000171680:ENST00000377725:exon12:c.G1240A:p.A414T,ENSG00000171680:ENST00000377728:exon12:c.G1240A:p.A414T,ENSG00000171680:ENST00000377732:exon12:c.G1351A:p.A451T,ENSG00000171680:ENST00000400913:exon12:c.G1240A:p.A414T,ENSG00000171680:ENST00000535355:exon12:c.G1447A:p.A483T,ENSG00000171680:ENST00000377737:exon13:c.G1240A:p.A414T,ENSG00000171680:ENST00000377740:exon13:c.G1471A:p.A491T,ENSG00000171680:ENST00000377748:exon13:c.G1471A:p.A491T,ENSG00000171680:ENST00000400915:exon13:c.G1408A:p.A470T,ENSG00000171680:ENST00000537245:exon13:c.G1477A:p.A493T,ENSG00000171680:ENST00000544978:exon13:c.G1240A:p.A414T	PLEKHG5:NM_001042664:exon12:c.G1240A:p.A414T,PLEKHG5:NM_001042665:exon12:c.G1240A:p.A414T,PLEKHG5:NM_001265593:exon12:c.G1447A:p.A483T,PLEKHG5:NM_001265594:exon12:c.G1240A:p.A414T,PLEKHG5:NM_020631:exon12:c.G1240A:p.A414T,PLEKHG5:NM_001042663:exon13:c.G1408A:p.A470T,PLEKHG5:NM_001265592:exon13:c.G1477A:p.A493T,PLEKHG5:NM_198681:exon13:c.G1471A:p.A491T	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0629	0.0677	0.0553115	.	1.373	12.65	0.491	3.21	0.988	.	.	Dbl homology (DH) domain	PLEKHG5:uc009vma.1:exon10:c.G760A:p.A254T,PLEKHG5:uc001ank.1:exon12:c.G1240A:p.A414T,PLEKHG5:uc001anl.2:exon12:c.G1240A:p.A414T,PLEKHG5:uc001anm.2:exon12:c.G1240A:p.A414T,PLEKHG5:uc001ann.1:exon12:c.G1351A:p.A451T,PLEKHG5:uc009vmb.2:exon12:c.G1240A:p.A414T,PLEKHG5:uc010nzr.1:exon12:c.G1447A:p.A483T,PLEKHG5:uc001ano.1:exon13:c.G1408A:p.A470T,PLEKHG5:uc001anp.2:exon13:c.G1471A:p.A491T,PLEKHG5:uc001anq.2:exon13:c.G1471A:p.A491T,PLEKHG5:uc031plb.1:exon13:c.G1477A:p.A493T	-1.099	AFR:0.0573,AMR:0.0833,EAS:0.0861,FIN:0,NFE:0.0224,OTH:0.0556,ASJ:0.0573	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	0.0	-0.3	0.004	0.295	1	1(pancreas)	0.0622
1	6533393	6533393	G	C	PLEKHG5	exonic	nonsynonymous SNV	ENSG00000171680	rs61741379	ENSG00000171680:ENST00000340850:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000377725:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000377728:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000377732:exon8:c.C824G:p.T275S,ENSG00000171680:ENST00000400913:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000535355:exon8:c.C920G:p.T307S,ENSG00000171680:ENST00000377737:exon9:c.C713G:p.T238S,ENSG00000171680:ENST00000377740:exon9:c.C944G:p.T315S,ENSG00000171680:ENST00000377748:exon9:c.C944G:p.T315S,ENSG00000171680:ENST00000400915:exon9:c.C881G:p.T294S,ENSG00000171680:ENST00000537245:exon9:c.C950G:p.T317S,ENSG00000171680:ENST00000544978:exon9:c.C713G:p.T238S	PLEKHG5:NM_001042664:exon8:c.C713G:p.T238S,PLEKHG5:NM_001042665:exon8:c.C713G:p.T238S,PLEKHG5:NM_001265593:exon8:c.C920G:p.T307S,PLEKHG5:NM_001265594:exon8:c.C713G:p.T238S,PLEKHG5:NM_020631:exon8:c.C713G:p.T238S,PLEKHG5:NM_001042663:exon9:c.C881G:p.T294S,PLEKHG5:NM_001265592:exon9:c.C950G:p.T317S,PLEKHG5:NM_198681:exon9:c.C944G:p.T315S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2212	0.2727	0.285743	.	-1.995	0.001	1.0	0.976	0.000	.	.	.	PLEKHG5:uc009vma.1:exon6:c.C233G:p.T78S,PLEKHG5:uc001ank.1:exon8:c.C713G:p.T238S,PLEKHG5:uc001anl.2:exon8:c.C713G:p.T238S,PLEKHG5:uc001anm.2:exon8:c.C713G:p.T238S,PLEKHG5:uc001ann.1:exon8:c.C824G:p.T275S,PLEKHG5:uc009vmb.2:exon8:c.C713G:p.T238S,PLEKHG5:uc010nzr.1:exon8:c.C920G:p.T307S,PLEKHG5:uc001ano.1:exon9:c.C881G:p.T294S,PLEKHG5:uc001anp.2:exon9:c.C944G:p.T315S,PLEKHG5:uc001anq.2:exon9:c.C944G:p.T315S,PLEKHG5:uc031plb.1:exon9:c.C950G:p.T317S	-0.968	AFR:0.2792,AMR:0.6409,EAS:0.1391,FIN:0.0019,NFE:0.1577,OTH:0.1454,ASJ:0.1205	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	0.0	-0.09	0.000	0	1	2(thyroid)	0.1816
1	6545390	6545390	A	T	PLEKHG5	exonic	nonsynonymous SNV	ENSG00000171680	rs75490131	ENSG00000171680:ENST00000535355:exon1:c.T114A:p.D38E	PLEKHG5:NM_001265593:exon1:c.T114A:p.D38E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3451	.	0.292133	0.2549	0.610	8.222	1.0	-3.7	0.074	.	.	.	PLEKHG5:uc010nzr.1:exon1:c.T114A:p.D38E	-0.964	AFR:0.5401,AMR:0.1199,EAS:0.2673,FIN:0.1461,NFE:0.1291,OTH:0.1694,ASJ:0.1093	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	0.0	1.06	0.000	.	1	MU81690117	hom
1	6696319	6696319	A	G	DNAJC11	intronic	.	ENSG00000007923	rs560641884	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0024	.	0.00539137	3.232e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	614827	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	6704635	6704635	A	G	DNAJC11	exonic	synonymous SNV	ENSG00000007923	rs200458	ENSG00000007923:ENST00000377573:exon9:c.T810C:p.G270G,ENSG00000007923:ENST00000294401:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000377577:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000542246:exon10:c.T966C:p.G322G	DNAJC11:NM_018198:exon10:c.T1080C:p.G360G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8836	0.9000	0.833067	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	DNAJC11:uc010nzu.1:exon9:c.T810C:p.G270G,DNAJC11:uc001aof.2:exon10:c.T1080C:p.G360G,DNAJC11:uc001aog.2:exon10:c.T1080C:p.G360G	.	AFR:0.8748,AMR:0.8724,EAS:0.8841,FIN:0.5730,NFE:0.8712,OTH:0.9033,ASJ:0.9499	614827	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.9041
1	7430266	7430266	C	T	CAMTA1	intronic	.	ENSG00000237402	rs3752542	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.29393	0.1749	.	.	.	.	.	.	.	.	.	.	AFR:0.1209,AMR:0.3186,EAS:0.5284,FIN:0.1766,NFE:0.1603,OTH:0.1772,ASJ:0.1424	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	MU15700596	hom
1	7723957	7723957	G	A	CAMTA1	exonic	synonymous SNV	ENSG00000171735	rs12128526	ENSG00000171735:ENST00000303635:exon9:c.G1350A:p.S450S,ENSG00000171735:ENST00000439411:exon9:c.G1350A:p.S450S	CAMTA1:NM_001349608:exon8:c.G1260A:p.S420S,CAMTA1:NM_001349612:exon8:c.G1260A:p.S420S,CAMTA1:NM_001349609:exon9:c.G1350A:p.S450S,CAMTA1:NM_001349610:exon9:c.G1350A:p.S450S,CAMTA1:NM_015215:exon9:c.G1350A:p.S450S	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4450	0.4300	0.40016	1(large_intestine)	.	.	.	.	.	.	.	.	CAMTA1:uc001aoi.3:exon9:c.G1350A:p.S450S	.	AFR:MU110401,AMR:LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3886,FIN:0.4964,NFE:0.4333,OTH:0.3456,ASJ:0.4396	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	2(lung)	0.4891
1	7737799	7737799	A	G	CAMTA1	intronic	.	ENSG00000171735	rs3011926	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5498	0.5563	0.591653	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5458,AMR:0.5805,EAS:0.6093,FIN:0.6447,NFE:0.4857,OTH:0.5329,ASJ:0.4773	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	1(biliary_tract)	0.5236
1	11169420	11169420	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs41274506	ENSG00000198793:ENST00000455339:exon6:c.C423T:p.D141D,ENSG00000198793:ENST00000376838:exon18:c.C2070T:p.D690D,ENSG00000198793:ENST00000361445:exon56:c.C7455T:p.D2485D	MTOR:NM_004958:exon56:c.C7455T:p.D2485D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0033	0.0043	0.00259585	0.0028	.	.	.	.	.	.	.	.	MTOR:uc001asc.3:exon18:c.C2070T:p.D690D,MTOR:uc001asd.3:exon56:c.C7455T:p.D2485D	.	AFR:0.0017,AMR:0.0012,EAS:0,FIN:0.0006,NFE:0.0045,OTH:0.0010,ASJ:0.0033	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	.	het
1	11181327	11181327	C	T	MTOR	exonic	synonymous SNV	ENSG00000198793	rs11121691	ENSG00000198793:ENST00000376838:exon11:c.G1524A:p.L508L,ENSG00000198793:ENST00000361445:exon49:c.G6909A:p.L2303L	MTOR:NM_004958:exon49:c.G6909A:p.L2303L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2184	0.3021	0.220647	23(meninges)	.	.	.	.	.	.	.	.	MTOR:uc001asc.3:exon11:c.G1524A:p.L508L,MTOR:uc001asd.3:exon49:c.G6909A:p.L2303L	.	AFR:.,AMR:.,EAS:0.4310,FIN:0.1337,NFE:0.3633,OTH:0.0593,ASJ:0.2797	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	1(stomach)	0.2270
1	11190646	11190646	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs2275527	ENSG00000198793:ENST00000376838:exon1:c.C168T:p.S56S,ENSG00000198793:ENST00000361445:exon39:c.C5553T:p.S1851S	MTOR:NM_004958:exon39:c.C5553T:p.S1851S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2215	0.3059	0.228634	3(lung)	.	.	.	.	.	.	.	.	MTOR:uc001asc.3:exon1:c.C168T:p.S56S,MTOR:uc001asd.3:exon39:c.C5553T:p.S1851S	.	AFR:24(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,FIN:0.2823,NFE:0.4400,OTH:0.1360,ASJ:MU668989	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	1(thyroid)	0.3642
1	11205058	11205058	C	T	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1057079	ENSG00000198793:ENST00000361445:exon33:c.G4731A:p.A1577A	MTOR:NM_004958:exon33:c.G4731A:p.A1577A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6779	0.5459	0.547524	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon33:c.G4731A:p.A1577A	.	AFR:0.5689,AMR:0.1535,EAS:0.5530,FIN:0.8004,NFE:0.7093,OTH:0.7379,ASJ:0.7124	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	2(breast)	0.6735
1	11259404	11259404	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs747404142	ENSG00000198793:ENST00000361445:exon28:c.C4164T:p.A1388A	MTOR:NM_004958:exon28:c.C4164T:p.A1388A	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	9.061e-05	.	.	6.455e-05	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon28:c.C4164T:p.A1388A	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:6.66e-05,OTH:0,ASJ:0	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	.	het
1	11288758	11288758	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1064261	ENSG00000198793:ENST00000361445:exon19:c.C2997T:p.N999N	MTOR:NM_004958:exon19:c.C2997T:p.N999N	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7429	0.6176	0.700479	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon19:c.C2997T:p.N999N	.	AFR:0.6449,AMR:0.3858,EAS:0.6126,FIN:0.9283,NFE:0.7467,OTH:0.7263,ASJ:0.8365	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	1(breast)	0.7157
1	11301714	11301714	A	G	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1135172	ENSG00000198793:ENST00000361445:exon10:c.T1437C:p.D479D	MTOR:NM_004958:exon10:c.T1437C:p.D479D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7170	0.5853	0.639577	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon10:c.T1437C:p.D479D	.	AFR:0.6129,AMR:0.2871,EAS:0.6126,FIN:0.8837,NFE:0.7487,OTH:0.7263,ASJ:0.7751	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7625,7629	.	,7626	.	.	.	.	1	1(breast)	0.7070
1	11735245	11735245	A	C	MAD2L2	intronic	.	ENSG00000116670	rs878778	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1009	0.0338	0.149561	0.0652	.	.	.	.	.	.	.	.	.	.	AFR:0.0106,AMR:0.1110,EAS:0.4963,FIN:0.0542,NFE:0.0511,OTH:0.0726,ASJ:0.0232	604094	.	.	.	.	.	.	.	.	.	.	.	1	MU580078	hom
1	11854457	11854457	G	A	MTHFR	exonic	synonymous SNV	ENSG00000177000	rs4846051	ENSG00000177000:ENST00000376592:exon7:c.C1305T:p.F435F,ENSG00000177000:ENST00000376583:exon8:c.C1428T:p.F476F,ENSG00000177000:ENST00000376590:exon8:c.C1305T:p.F435F,ENSG00000177000:ENST00000376585:exon9:c.C1428T:p.F476F	MTHFR:NM_001330358:exon8:c.C1428T:p.F476F,MTHFR:NM_005957:exon8:c.C1305T:p.F435F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9697	0.8905	0.902955	0.9091	.	.	.	.	.	.	.	.	MTHFR:uc031plg.1:exon4:c.C570T:p.F190F,MTHFR:uc001atb.1:exon7:c.C1374T:p.F458F,MTHFR:uc001atc.2:exon8:c.C1305T:p.F435F	.	AFR:0.6825,AMR:0.9809,EAS:0.9988,FIN:1,NFE:0.9992,OTH:0.9867,ASJ:0.9768	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	.	.	.	.	1	MU81691184	hom
1	11856378	11856378	G	A	MTHFR	exonic	nonsynonymous SNV	ENSG00000177000	rs1801133	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	MTHFR:NM_001330358:exon5:c.C788T:p.A263V,MTHFR:NM_005957:exon5:c.C665T:p.A222V	clinvar: drug_response 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, 2, 0, 1] 	0.3037	0.2706	0.245407	1(lung)	4.914	25.0	0.002	5.08	0.530	.	.	FAD-linked oxidoreductase-like	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	-1.455	AFR:1(urinary_tract),AMR:2(stomach),EAS:MU580088,FIN:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,NFE:0.2572,OTH:0.1131,ASJ:3(haematopoietic_and_lymphoid_tissue)	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	,7605,7604	.	,7603	0.998	-4.03	0.000	2.965	1	24(soft_tissue)	0.4845
1	14059395	14059395	T	C	PRDM2	intronic	.	ENSG00000116731	rs33969518	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2312	0.1649	0.167133	0.1654	.	.	.	.	.	.	.	.	.	.	AFR:0.0383,AMR:0.2978,EAS:0.1918,FIN:0.1832,NFE:0.2219,OTH:0.2169,ASJ:0.1523	601196	.	.	.	.	.	.	.	.	.	.	.	1	MU642855	het
1	14105139	14105139	T	A	PRDM2	exonic	nonsynonymous SNV	ENSG00000116731	rs2076324	ENSG00000116731:ENST00000413440:exon3:c.T246A:p.D82E,ENSG00000116731:ENST00000343137:exon4:c.T246A:p.D82E,ENSG00000116731:ENST00000235372:exon8:c.T849A:p.D283E,ENSG00000116731:ENST00000311066:exon8:c.T849A:p.D283E	PRDM2:NM_001007257:exon3:c.T246A:p.D82E,PRDM2:NM_012231:exon8:c.T849A:p.D283E,PRDM2:NM_015866:exon8:c.T849A:p.D283E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3563	0.3206	0.371206	0.3255	-1.966	0.001	1.0	-3.62	0.313	.	.	SET domain	PRDM2:uc001avk.3:exon4:c.T246A:p.D82E,PRDM2:uc021ogk.1:exon4:c.T138A:p.D46E,PRDM2:uc001avh.3:exon8:c.T849A:p.D283E,PRDM2:uc001avi.3:exon8:c.T849A:p.D283E	-1.058	AFR:0.2430,AMR:0.5269,EAS:0.3429,FIN:0.3495,NFE:0.3530,OTH:0.3623,ASJ:0.3067	601196	.	.	.	.	.	.	.	0.003	4.98	0.000	0	1	MU19318037	het
1	14106394	14106394	-	CTC	PRDM2	exonic	nonframeshift insertion	ENSG00000116731	rs2308040	ENSG00000116731:ENST00000413440:exon3:c.1501_1502insCTC:p.T501delinsTP,ENSG00000116731:ENST00000343137:exon4:c.1501_1502insCTC:p.T501delinsTP,ENSG00000116731:ENST00000235372:exon8:c.2104_2105insCTC:p.T702delinsTP,ENSG00000116731:ENST00000311066:exon8:c.2104_2105insCTC:p.T702delinsTP	PRDM2:NM_001007257:exon3:c.1501_1502insCTC:p.T501delinsTP,PRDM2:NM_012231:exon8:c.2104_2105insCTC:p.T702delinsTP,PRDM2:NM_015866:exon8:c.2104_2105insCTC:p.T702delinsTP	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4687	0.4698	.	0.4693	.	.	.	.	.	.	.	.	PRDM2:uc001avk.3:exon4:c.1501_1502insCTC:p.T501delinsTP,PRDM2:uc021ogk.1:exon4:c.1393_1394insCTC:p.T465delinsTP,PRDM2:uc001avh.3:exon8:c.2104_2105insCTC:p.T702delinsTP,PRDM2:uc001avi.3:exon8:c.2104_2105insCTC:p.T702delinsTP	.	AFR:0.5742,AMR:0.6065,EAS:0.5768,FIN:0.4068,NFE:0.4075,OTH:0.4427,ASJ:0.3758	601196	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	14109114	14109114	A	G	PRDM2	exonic	synonymous SNV	ENSG00000116731	rs1203651	ENSG00000116731:ENST00000413440:exon3:c.A4221G:p.S1407S,ENSG00000116731:ENST00000343137:exon4:c.A4221G:p.S1407S,ENSG00000116731:ENST00000235372:exon8:c.A4824G:p.S1608S,ENSG00000116731:ENST00000311066:exon8:c.A4824G:p.S1608S	PRDM2:NM_001007257:exon3:c.A4221G:p.S1407S,PRDM2:NM_012231:exon8:c.A4824G:p.S1608S,PRDM2:NM_015866:exon8:c.A4824G:p.S1608S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3881	0.3308	0.365016	0.3377	.	.	.	.	.	.	.	.	PRDM2:uc001avk.3:exon4:c.A4221G:p.S1407S,PRDM2:uc001avh.3:exon8:c.A4824G:p.S1608S,PRDM2:uc001avi.3:exon8:c.A4824G:p.S1608S	.	AFR:0.2576,AMR:0.5513,EAS:0.3469,FIN:0.3631,NFE:0.3631,OTH:0.3776,ASJ:0.3212	601196	.	.	.	.	.	.	.	.	.	.	.	1	MU147799	het
1	14143003	14143003	A	G	PRDM2	exonic	nonsynonymous SNV	ENSG00000116731	rs1046331	ENSG00000116731:ENST00000505823:exon3:c.A101G:p.Q34R,ENSG00000116731:ENST00000503842:exon4:c.A101G:p.Q34R,ENSG00000116731:ENST00000376048:exon7:c.A593G:p.Q198R	PRDM2:NM_001135610:exon7:c.A593G:p.Q198R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8256	0.8744	0.821286	0.8594	0.129	3.917	0.0	-4.33	0.332	.	.	.	PRDM2:uc001avg.3:exon7:c.A593G:p.Q198R	-1.038	AFR:0.9377,AMR:0.8067,EAS:0.6968,FIN:0.8144,NFE:0.8477,OTH:0.8388,ASJ:0.7748	601196	.	.	.	.	.	.	.	0.0	0.56	0.000	.	1	MU20384874	hom
1	15772155	15772155	G	A	CTRC	exonic	nonsynonymous SNV	ENSG00000162438	rs140993290	ENSG00000162438:ENST00000375949:exon7:c.G703A:p.V235I	CTRC:NM_007272:exon7:c.G703A:p.V235I	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 1, 2, 1, 0, 0] 	0.0012	7.7e-05	0.00119808	1(endometrium)	5.859	27.3	0.006	4.38	0.991	.	.	Peptidase S1, PA clan|Serine proteases, trypsin domain	CTRC:uc001awj.1:exon6:c.G557A:p.R186H,CTRC:uc001awi.1:exon7:c.G703A:p.V235I	0.983	AFR:MU21769476,AMR:ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526,PBCA-DE|1|499|0.00200401,UCEC-US|1|531|0.00188324,EAS:0.0003,FIN:0,NFE:0,OTH:0,ASJ:0.0002	601405	167800;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	0.996	-3.46	0.897	1.1	1	1(prostate)	0
1	16256007	16256007	T	C	SPEN	exonic	nonsynonymous SNV	ENSG00000065526	rs848209	ENSG00000065526:ENST00000375759:exon11:c.T3272C:p.L1091P	SPEN:NM_015001:exon11:c.T3272C:p.L1091P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6154	0.6878	0.648962	1(lung)	-0.797	0.043	0.846	3.51	0.197	.	.	.	SPEN:uc010obp.1:exon10:c.T3149C:p.L1050P,SPEN:uc001axk.1:exon11:c.T3272C:p.L1091P	-1.030	AFR:1(urinary_tract),AMR:MU4550099,EAS:0.6713,FIN:0.9243,NFE:0.7584,OTH:0.61,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,COCA-CN|3|321|0.00934579	613484	.	.	.	.	.	.	.	0.0	3.2	0.000	-0.895	1	1(thyroid)	0.2983
1	16259813	16259813	A	G	SPEN	exonic	nonsynonymous SNV	ENSG00000065526	rs848210	ENSG00000065526:ENST00000375759:exon11:c.A7078G:p.N2360D	SPEN:NM_015001:exon11:c.A7078G:p.N2360D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6146	0.6896	0.648962	MU4549778	-1.105	0.010	0.853	3.1	0.006	.	.	.	SPEN:uc010obp.1:exon10:c.A6955G:p.N2319D,SPEN:uc001axk.1:exon11:c.A7078G:p.N2360D	-1.042	AFR:LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6706,EAS:0.7590,FIN:0.6033,NFE:0.2976,OTH:0.6101,ASJ:0.9239	613484	.	.	.	.	.	.	.	0.0	3.13	0.000	-0.625	1	3(haematopoietic_and_lymphoid_tissue)	0.5793
1	16451767	16451767	G	A	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs3754334	ENSG00000142627:ENST00000358432:exon17:c.C2874T:p.I958I	EPHA2:NM_001329090:exon16:c.C2712T:p.I904I,EPHA2:NM_004431:exon17:c.C2874T:p.I958I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2751	0.2279	0.236621	0.2237	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon17:c.C2874T:p.I958I	.	AFR:0.1269,AMR:0.3337,EAS:0.1429,FIN:0.2669,NFE:0.2687,OTH:0.2649,ASJ:0.2848	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	MU699553	het
1	16464673	16464673	G	A	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs2230597	ENSG00000142627:ENST00000358432:exon5:c.C987T:p.P329P	EPHA2:NM_001329090:exon4:c.C825T:p.P275P,EPHA2:NM_004431:exon5:c.C987T:p.P329P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3787	0.3888	0.349441	0.3666	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon5:c.C987T:p.P329P,EPHA2:uc010oca.2:exon5:c.C987T:p.P329P	.	AFR:0.3567,AMR:0.3753,EAS:0.1239,FIN:0.3430,NFE:0.3990,OTH:0.4059,ASJ:0.4669	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	MU65392	hom
1	16474982	16474982	C	G	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs36037949	ENSG00000142627:ENST00000358432:exon3:c.G714C:p.P238P	EPHA2:NM_001329090:exon2:c.G552C:p.P184P,EPHA2:NM_004431:exon3:c.G714C:p.P238P	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 0, 0] 	0.0017	7.7e-05	0.00179712	0.0004	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon3:c.G714C:p.P238P,EPHA2:uc010oca.2:exon3:c.G714C:p.P238P	.	AFR:0,AMR:0.0036,EAS:0,FIN:0,NFE:0.0005,OTH:0.0010,ASJ:0	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	.	het
1	16475123	16475123	C	T	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs6678616	ENSG00000142627:ENST00000358432:exon3:c.G573A:p.L191L	EPHA2:NM_001329090:exon2:c.G411A:p.L137L,EPHA2:NM_004431:exon3:c.G573A:p.L191L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2900	0.2849	0.226438	0.2598	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon3:c.G573A:p.L191L,EPHA2:uc010oca.2:exon3:c.G573A:p.L191L	.	AFR:0.1617,AMR:0.3233,EAS:0.0179,FIN:0.2786,NFE:0.3281,OTH:0.3180,ASJ:0.4371	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	.	unknown
1	16475126	16475126	C	T	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs6678618	ENSG00000142627:ENST00000358432:exon3:c.G570A:p.A190A	EPHA2:NM_001329090:exon2:c.G408A:p.A136A,EPHA2:NM_004431:exon3:c.G570A:p.A190A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2900	0.2849	0.226637	0.2598	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon3:c.G570A:p.A190A,EPHA2:uc010oca.2:exon3:c.G570A:p.A190A	.	AFR:0.1612,AMR:0.3241,EAS:0.0179,FIN:0.2788,NFE:0.3282,OTH:0.3186,ASJ:0.4371	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	.	unknown
1	17380497	17380497	G	T	SDHB	exonic	synonymous SNV	ENSG00000117118	rs2746462	ENSG00000117118:ENST00000375499:exon1:c.C18A:p.A6A	SDHB:NM_003000:exon1:c.C18A:p.A6A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9721	0.9515	0.957069	0.9577	.	.	.	.	.	.	.	.	SDHB:uc001bae.3:exon1:c.C18A:p.A6A	.	AFR:0.9069,AMR:0.9690,EAS:0.9994,FIN:0.9823,NFE:0.9755,OTH:0.9785,ASJ:0.9371	185470	115310;171300;606764;606864;612359;	201;97286;44890;29072;29072;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	MU81693539	hom
1	19027239	19027239	A	G	PAX7	exonic	synonymous SNV	ENSG00000009709	rs2743201	ENSG00000009709:ENST00000375375:exon6:c.A879G:p.P293P,ENSG00000009709:ENST00000400661:exon6:c.A873G:p.P291P,ENSG00000009709:ENST00000420770:exon6:c.A879G:p.P293P	PAX7:NM_001135254:exon6:c.A879G:p.P293P,PAX7:NM_002584:exon6:c.A879G:p.P293P,PAX7:NM_013945:exon6:c.A873G:p.P291P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3747	0.3721	0.488618	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PAX7:uc001bay.3:exon6:c.A879G:p.P293P,PAX7:uc001baz.3:exon6:c.A873G:p.P291P,PAX7:uc010oct.2:exon6:c.A879G:p.P293P	.	AFR:MU760649,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5991,FIN:0.4414,NFE:0.3767,OTH:0.5857,ASJ:0.3923	167410	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	 ~	.	.	.	.	.	.	.	1	2(liver)	0.3289
1	20980880	20980880	G	A	DDOST	intronic	.	ENSG00000244038	rs607254	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3878	0.3863	0.357228	ESAD-UK|2|409|0.00488998,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.3787,AMR:0.3687,EAS:0.4338,FIN:0.2736,NFE:0.3759,OTH:0.3940,ASJ:0.4007	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.3814
1	20982631	20982631	G	A	DDOST	exonic	synonymous SNV	ENSG00000244038	rs4704	ENSG00000244038:ENST00000415136:exon2:c.C255T:p.G85G,ENSG00000244038:ENST00000375048:exon3:c.C366T:p.G122G,ENSG00000244038:ENST00000602624:exon3:c.C315T:p.G105G	DDOST:NM_005216:exon3:c.C366T:p.G122G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5844	0.6502	0.58726	1(oesophagus)	.	.	.	.	.	.	.	.	DDOST:uc010ode.1:exon2:c.C255T:p.G85G,DDOST:uc001bdo.1:exon3:c.C366T:p.G122G	.	AFR:MU4553462,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,EAS:0.7344,FIN:0.5573,NFE:0.59,OTH:0.3861,ASJ:0.6286	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.6179
1	23885498	23885498	T	C	ID3	exonic	nonsynonymous SNV	ENSG00000117318	rs11574	ENSG00000117318:ENST00000374561:exon2:c.A313G:p.T105A	ID3:NM_002167:exon2:c.A313G:p.T105A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8037	0.8219	0.890375	0.8086	-2.559	0.001	0.865	-2.76	0.145	.	.	.	ID3:uc001bhh.4:exon2:c.A313G:p.T105A	-0.986	AFR:0.9543,AMR:0.7303,EAS:0.9746,FIN:0.6847,NFE:0.7405,OTH:0.7541,ASJ:0.9040	600277	.	.	.	.	.	.	.	0.0	-0.56	0.000	-0.205	1	MU81695702	hom
1	23885599	23885599	T	C	ID3	intronic	.	ENSG00000117318	rs2067053	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3787	0.4114	0.463658	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:4(large_intestine),AMR:MU762893,EAS:0.4032,FIN:0.5970,NFE:0.3161,OTH:0.3633,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	600277	.	.	.	.	.	.	.	.	.	.	.	1	2(lung)	0.3548
1	36937059	36937059	A	G	CSF3R	exonic	synonymous SNV	ENSG00000119535	rs3917981	ENSG00000119535:ENST00000331941:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000338937:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000418048:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000440588:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000361632:exon9:c.T1260C:p.T420T,ENSG00000119535:ENST00000373103:exon10:c.T1260C:p.T420T,ENSG00000119535:ENST00000373104:exon10:c.T1260C:p.T420T,ENSG00000119535:ENST00000373106:exon10:c.T1260C:p.T420T	CSF3R:NM_000760:exon10:c.T1260C:p.T420T,CSF3R:NM_156039:exon10:c.T1260C:p.T420T,CSF3R:NM_172313:exon10:c.T1260C:p.T420T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5648	0.6086	0.592452	2(lung)	.	.	.	.	.	.	.	.	CSF3R:uc001cav.2:exon10:c.T1260C:p.T420T,CSF3R:uc001caw.2:exon10:c.T1260C:p.T420T,CSF3R:uc001cax.2:exon10:c.T1260C:p.T420T	.	AFR:MU767632,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,EAS:0.7304,FIN:0.4165,NFE:0.5397,OTH:0.4061,ASJ:0.5927	138971	617014;	420702;	420702|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|617014 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer ~	.	2077,,2078	.	.	.	.	.	1	1(urinary_tract)	0.6111
1	36937065	36937065	A	G	CSF3R	exonic	synonymous SNV	ENSG00000119535	rs3917980	ENSG00000119535:ENST00000331941:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000338937:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000418048:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000440588:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000361632:exon9:c.T1254C:p.R418R,ENSG00000119535:ENST00000373103:exon10:c.T1254C:p.R418R,ENSG00000119535:ENST00000373104:exon10:c.T1254C:p.R418R,ENSG00000119535:ENST00000373106:exon10:c.T1254C:p.R418R	CSF3R:NM_000760:exon10:c.T1254C:p.R418R,CSF3R:NM_156039:exon10:c.T1254C:p.R418R,CSF3R:NM_172313:exon10:c.T1254C:p.R418R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3156	0.2997	0.246406	0.2815	.	.	.	.	.	.	.	.	CSF3R:uc001cav.2:exon10:c.T1254C:p.R418R,CSF3R:uc001caw.2:exon10:c.T1254C:p.R418R,CSF3R:uc001cax.2:exon10:c.T1254C:p.R418R	.	AFR:0.2036,AMR:0.2404,EAS:0.1168,FIN:0.3480,NFE:0.3277,OTH:0.3190,ASJ:0.3543	138971	617014;	420702;	420702|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|617014 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer ~	.	2077,,2078	.	.	.	.	.	1	MU4568824	unknown
1	40363054	40363054	G	C	MYCL	exonic	nonsynonymous SNV	ENSG00000116990	rs3134614	ENSG00000116990:ENST00000372816:exon2:c.C1085G:p.T362S,ENSG00000116990:ENST00000397332:exon3:c.C1175G:p.T392S	MYCL:NM_001033081:exon2:c.C1085G:p.T362S,MYCL:NM_001033082:exon3:c.C1175G:p.T392S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8865	0.9037	0.935703	0.9116	0.145	4.091	1.0	4.53	0.999	.	.	.	MYCL1:uc001ces.2:exon2:c.C1085G:p.T362S,MYCL1:uc001cer.2:exon3:c.C1175G:p.T392S	-0.955	AFR:0.9750,AMR:0.8568,EAS:0.9975,FIN:0.8808,NFE:0.8796,OTH:0.8707,ASJ:0.8477	164850	.	.	.	.	.	.	.	0.0	-0.9	0.000	-0.77	1	MU3888723	hom
1	40980731	40980731	G	T	EXO5	exonic	nonsynonymous SNV	ENSG00000164002	rs11208299	ENSG00000164002:ENST00000372703:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000418186:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000419161:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000420209:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000296380:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000443729:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000358527:exon4:c.G515T:p.G172V	EXO5:NM_001346948:exon2:c.G515T:p.G172V,EXO5:NM_001346954:exon2:c.G515T:p.G172V,EXO5:NM_001346956:exon2:c.G515T:p.G172V,EXO5:NM_001346946:exon3:c.G515T:p.G172V,EXO5:NM_001346951:exon3:c.G515T:p.G172V,EXO5:NM_001346952:exon3:c.G515T:p.G172V,EXO5:NM_001346955:exon3:c.G515T:p.G172V,EXO5:NM_022774:exon3:c.G515T:p.G172V,EXO5:NM_001346947:exon4:c.G515T:p.G172V,EXO5:NM_001346949:exon4:c.G515T:p.G172V,EXO5:NM_001346950:exon4:c.G515T:p.G172V,EXO5:NM_001346953:exon4:c.G515T:p.G172V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4444	0.4619	0.542133	LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	1.360	12.58	1.0	3.96	0.998	.	.	.	EXO5:uc021omb.1:exon1:c.G515T:p.G172V,EXO5:uc001cfr.3:exon2:c.G515T:p.G172V,EXO5:uc001cfp.3:exon3:c.G515T:p.G172V,EXO5:uc001cfq.3:exon4:c.G515T:p.G172V	-0.951	AFR:0.4570,AMR:0.6495,EAS:0.4967,FIN:0.4858,NFE:0.3426,OTH:0.3644,ASJ:0.5550	.	.	.	.	.	.	.	.	0.0	1.83	0.000	-3.005	1	1(large_intestine)	0.4286
1	41466803	41466803	G	A	CTPS1	intronic	.	ENSG00000171793	rs12718433	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4048	0.3332	0.333067	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.3440,AMR:0.1552,EAS:0.4106,FIN:0.4190,NFE:0.4217,OTH:0.4105,ASJ:0.5395	123860	615897;	420573;	420573|SCID due to CTPS1 deficiency|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|615897 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.4192
1	43408966	43408966	G	A	SLC2A1	exonic	synonymous SNV	ENSG00000117394	rs1385129	ENSG00000117394:ENST00000372500:exon2:c.C45T:p.A15A,ENSG00000117394:ENST00000415851:exon2:c.C45T:p.A15A,ENSG00000117394:ENST00000426263:exon2:c.C45T:p.A15A	SLC2A1:NM_006516:exon2:c.C45T:p.A15A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2446	0.2018	0.240415	1(lung)	.	.	.	.	.	.	.	.	SLC2A1:uc001cik.2:exon2:c.C45T:p.A15A	.	AFR:1(stomach),AMR:MU159330,EAS:0.2145,FIN:0.1775,NFE:0.2883,OTH:0.2067,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	143090	.	.	.	~ko04066 HIF-1 signaling pathway~ko04911 Insulin secretion~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04931 Insulin resistance~ko04976 Bile secretion~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	1(large_intestine)	0.2937
1	43805240	43805240	A	G	MPL	exonic	synonymous SNV	ENSG00000117400	rs16830693	ENSG00000117400:ENST00000372470:exon4:c.A690G:p.E230E,ENSG00000117400:ENST00000413998:exon4:c.A690G:p.E230E	MPL:NM_005373:exon4:c.A690G:p.E230E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0375	0.0544	0.0591054	MU113465428	.	.	.	.	.	0.0005	0.072	.	MPL:uc001civ.3:exon4:c.A690G:p.E230E,MPL:uc001ciw.3:exon4:c.A690G:p.E230E,MPL:uc009vwr.3:exon4:c.A669G:p.E223E	.	AFR:LAML-KR|1|205|0.00487805,AMR:0.0475,EAS:0.0204,FIN:0.0099,NFE:0.0234,OTH:0.0392,ASJ:0.0943	159530	254450;601977;604498;	3319;3318;71493;824;	3319|CAMT<br>Congenital amegakaryocytic thrombocytopenic purpura|Unknown|Autosomal recessive|Neonatal|604498 ~3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.0272
1	45292866	45292866	G	A	PTCH2	exonic	synonymous SNV	ENSG00000117425	rs2295996	ENSG00000117425:ENST00000372192:exon16:c.C2487T:p.D829D,ENSG00000117425:ENST00000447098:exon16:c.C2487T:p.D829D	PTCH2:NM_001166292:exon16:c.C2487T:p.D829D,PTCH2:NM_003738:exon16:c.C2487T:p.D829D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1608	0.1395	0.147764	2(breast)	.	.	.	.	.	.	.	.	PTCH2:uc010olg.2:exon15:c.C1581T:p.D527D,PTCH2:uc010olf.2:exon16:c.C2487T:p.D829D,PTCH2:uc021omv.1:exon16:c.C2487T:p.D829D	.	AFR:1(large_intestine),AMR:MU133781,EAS:0.1426,FIN:0.0773,NFE:0.1770,OTH:0.1556,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	603673	109400;155255;605462;	251858;251863;251867;616;377;	251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	1	5(meninges)	0.2048
1	45293518	45293518	A	G	PTCH2	exonic	synonymous SNV	ENSG00000117425	rs7525308	ENSG00000117425:ENST00000372192:exon14:c.T2055C:p.A685A,ENSG00000117425:ENST00000447098:exon14:c.T2055C:p.A685A	PTCH2:NM_001166292:exon14:c.T2055C:p.A685A,PTCH2:NM_003738:exon14:c.T2055C:p.A685A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3846	0.4244	0.445487	1(large_intestine)	.	.	.	.	.	.	.	.	PTCH2:uc010olg.2:exon13:c.T1149C:p.A383A,PTCH2:uc010olf.2:exon14:c.T2055C:p.A685A,PTCH2:uc021omv.1:exon14:c.T2055C:p.A685A	.	AFR:2(thyroid),AMR:1(breast),EAS:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,FIN:0.4351,NFE:0.5915,OTH:0.4260,ASJ:MU133802	603673	109400;155255;605462;	251858;251863;251867;616;377;	251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	1	2(lung)	0.3179
1	45307506	45307506	G	A	PTCH2	intronic	.	ENSG00000117425	rs3795720	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3675	0.3391	0.372005	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:1(liver),AMR:MU27918046,EAS:0.3554,FIN:0.3245,NFE:0.4881,OTH:0.3233,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	603673	109400;155255;605462;	251858;251863;251867;616;377;	251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	1	1(lung)	0.4314
1	45479709	45479709	A	G	UROD	exonic	synonymous SNV	ENSG00000126088	rs2228084	ENSG00000126088:ENST00000434478:exon5:c.A540G:p.P180P,ENSG00000126088:ENST00000246337:exon6:c.A603G:p.P201P	UROD:NM_000374:exon6:c.A603G:p.P201P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0748	0.0855	0.0954473	MU146487	.	.	.	.	.	.	.	.	UROD:uc010olj.1:exon4:c.A435G:p.P145P,UROD:uc001cna.2:exon6:c.A603G:p.P201P,UROD:uc001cnb.2:exon6:c.A498G:p.P166P	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.0871,EAS:0.1050,FIN:0.0199,NFE:0.1239,OTH:0.0664,ASJ:0.1411	613521	176100;	101330;443062;95159;	101330|PCT|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|176090 176100 ~443062|Porphyria cutanea tarda type II|-|Autosomal dominant|-|176100 ~95159|HEP|<1 / 1 000 000|Autosomal recessive|-|176100 ~	.	.	.	.	.	.	.	.	1	1(liver)	0.0580
1	45797505	45797505	C	G	MUTYH	exonic	nonsynonymous SNV	ENSG00000132781	rs3219489	ENSG00000132781:ENST00000467459:exon4:c.G347C:p.S116T,ENSG00000132781:ENST00000412971:exon7:c.G546C:p.Q182H,ENSG00000132781:ENST00000354383:exon12:c.G933C:p.Q311H,ENSG00000132781:ENST00000355498:exon12:c.G930C:p.Q310H,ENSG00000132781:ENST00000372098:exon12:c.G1005C:p.Q335H,ENSG00000132781:ENST00000372100:exon12:c.G963C:p.Q321H,ENSG00000132781:ENST00000372110:exon12:c.G975C:p.Q325H,ENSG00000132781:ENST00000372115:exon12:c.G972C:p.Q324H,ENSG00000132781:ENST00000448481:exon12:c.G963C:p.Q321H,ENSG00000132781:ENST00000450313:exon12:c.G1014C:p.Q338H,ENSG00000132781:ENST00000456914:exon12:c.G930C:p.Q310H,ENSG00000132781:ENST00000528013:exon12:c.G972C:p.Q324H,ENSG00000132781:ENST00000372104:exon13:c.G930C:p.Q310H	MUTYH:NM_001350650:exon11:c.G585C:p.Q195H,MUTYH:NM_001350651:exon11:c.G585C:p.Q195H,MUTYH:NM_001048171:exon12:c.G972C:p.Q324H,MUTYH:NM_001048172:exon12:c.G933C:p.Q311H,MUTYH:NM_001048173:exon12:c.G930C:p.Q310H,MUTYH:NM_001048174:exon12:c.G930C:p.Q310H,MUTYH:NM_001128425:exon12:c.G1014C:p.Q338H,MUTYH:NM_001293190:exon12:c.G975C:p.Q325H,MUTYH:NM_001293191:exon12:c.G963C:p.Q321H,MUTYH:NM_001293192:exon12:c.G654C:p.Q218H,MUTYH:NM_001293196:exon12:c.G654C:p.Q218H,MUTYH:NM_012222:exon12:c.G1005C:p.Q335H,MUTYH:NM_001293195:exon13:c.G930C:p.Q310H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2967	0.2541	0.313498	1(large_intestine)	0.336	6.039	0.168	1.26	0.732	.	.	DNA glycosylase|Helix-turn-helix, base-excision DNA repair, C-terminal	MUTYH:uc001cnf.3:exon12:c.G930C:p.Q310H,MUTYH:uc001cng.3:exon12:c.G963C:p.Q321H,MUTYH:uc001cnh.3:exon12:c.G933C:p.Q311H,MUTYH:uc001cni.3:exon12:c.G930C:p.Q310H,MUTYH:uc001cnj.3:exon12:c.G654C:p.Q218H,MUTYH:uc001cnl.3:exon12:c.G972C:p.Q324H,MUTYH:uc001cnm.3:exon12:c.G1005C:p.Q335H,MUTYH:uc001cnn.3:exon12:c.G975C:p.Q325H,MUTYH:uc001cno.3:exon12:c.G654C:p.Q218H,MUTYH:uc009vxp.3:exon12:c.G1014C:p.Q338H,MUTYH:uc009vxo.3:exon13:c.G930C:p.Q310H	-0.933	AFR:MU120737,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.2696,FIN:0.4353,NFE:0.3013,OTH:0.4143,ASJ:0.2584	604933	132600;608456;613659;	220460;247798;91414;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247798|MUTYH-related AFAP<br>MUTYH-related attenuated FAP<br>MUTYH-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|608456 ~91414|Epithelioma calcificans of Malherbe<br>Pilomatricoma|Unknown|Not applicable|Childhood<br>Adolescent<br>Adult|132600 ~	.	.	.	.	0.343	3.23	0.000	2.665	1	19(soft_tissue)	0.2278
1	46521517	46521517	G	A	LOC110117498-PIK3R3;PIK3R3	exonic	synonymous SNV	ENSG00000117461	rs785468	ENSG00000117461:ENST00000262741:exon7:c.C891T:p.S297S,ENSG00000117461:ENST00000540385:exon7:c.C1029T:p.S343S,ENSG00000117461:ENST00000372006:exon8:c.C891T:p.S297S,ENSG00000117461:ENST00000420542:exon8:c.C891T:p.S297S	PIK3R3:NM_001328654:exon5:c.C423T:p.S141S,PIK3R3:NM_001328653:exon6:c.C648T:p.S216S,LOC110117498-PIK3R3:NM_001303427:exon7:c.C1029T:p.S343S,PIK3R3:NM_001328648:exon7:c.C759T:p.S253S,PIK3R3:NM_001328649:exon7:c.C759T:p.S253S,PIK3R3:NM_001328650:exon7:c.C759T:p.S253S,PIK3R3:NM_001328651:exon7:c.C759T:p.S253S,PIK3R3:NM_001328652:exon7:c.C891T:p.S297S,PIK3R3:NM_003629:exon7:c.C891T:p.S297S,PIK3R3:NM_001114172:exon8:c.C891T:p.S297S,PIK3R3:NM_001303428:exon8:c.C942T:p.S314S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6810	0.6715	0.637979	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PIK3R3:uc010olv.2:exon2:c.C261T:p.S87S,PIK3R3:uc001cpb.4:exon7:c.C891T:p.S297S,PIK3R3:uc010olw.2:exon7:c.C1029T:p.S343S,PIK3R3:uc001cpc.4:exon8:c.C891T:p.S297S,PIK3R3:uc009vyc.3:exon8:c.C942T:p.S314S	.	AFR:0.6766,AMR:0.5981,EAS:0.7086,FIN:0.645,NFE:0.7415,OTH:0.7094,ASJ:0.6487	.	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.7047
1	46521559	46521559	A	T	LOC110117498-PIK3R3;PIK3R3	exonic	nonsynonymous SNV	ENSG00000117461	rs785467	ENSG00000117461:ENST00000262741:exon7:c.T849A:p.N283K,ENSG00000117461:ENST00000540385:exon7:c.T987A:p.N329K,ENSG00000117461:ENST00000372006:exon8:c.T849A:p.N283K,ENSG00000117461:ENST00000420542:exon8:c.T849A:p.N283K	PIK3R3:NM_001328654:exon5:c.T381A:p.N127K,PIK3R3:NM_001328653:exon6:c.T606A:p.N202K,LOC110117498-PIK3R3:NM_001303427:exon7:c.T987A:p.N329K,PIK3R3:NM_001328648:exon7:c.T717A:p.N239K,PIK3R3:NM_001328649:exon7:c.T717A:p.N239K,PIK3R3:NM_001328650:exon7:c.T717A:p.N239K,PIK3R3:NM_001328651:exon7:c.T717A:p.N239K,PIK3R3:NM_001328652:exon7:c.T849A:p.N283K,PIK3R3:NM_003629:exon7:c.T849A:p.N283K,PIK3R3:NM_001114172:exon8:c.T849A:p.N283K,PIK3R3:NM_001303428:exon8:c.T900A:p.N300K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6940	0.7183	0.682109	MU81700272	0.729	9.016	1.0	3.95	0.999	.	.	PI3K p85 subunit, inter-SH2 domain	PIK3R3:uc010olv.2:exon2:c.T219A:p.N73K,PIK3R3:uc001cpb.4:exon7:c.T849A:p.N283K,PIK3R3:uc010olw.2:exon7:c.T987A:p.N329K,PIK3R3:uc001cpc.4:exon8:c.T849A:p.N283K,PIK3R3:uc009vyc.3:exon8:c.T900A:p.N300K	-0.960	AFR:COCA-CN|5|321|0.0155763,AMR:0.7188,EAS:0.6599,FIN:0.7086,NFE:0.6461,OTH:0.7414,ASJ:0.7464	.	.	.	.	.	.	.	.	0.0	1.75	0.000	-1.725	1	1(skin)	0.7095
1	47685455	47685455	T	C	TAL1	exonic	synonymous SNV	ENSG00000162367	rs927462	ENSG00000162367:ENST00000294339:exon4:c.A933G:p.K311K,ENSG00000162367:ENST00000371883:exon4:c.A939G:p.K313K,ENSG00000162367:ENST00000371884:exon5:c.A933G:p.K311K	TAL1:NM_001290406:exon3:c.A456G:p.K152K,TAL1:NM_001287347:exon5:c.A933G:p.K311K,TAL1:NM_001290403:exon5:c.A933G:p.K311K,TAL1:NM_001290405:exon5:c.A933G:p.K311K,TAL1:NM_001290404:exon6:c.A933G:p.K311K,TAL1:NM_003189:exon6:c.A933G:p.K311K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TAL1:uc009vyq.2:exon3:c.A203G:p.N68S	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	187040	613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	1
1	47717189	47717189	A	G	STIL	exonic	synonymous SNV	ENSG00000123473	rs2758735	ENSG00000123473:ENST00000243182:exon17:c.T3483C:p.P1161P,ENSG00000123473:ENST00000337817:exon17:c.T3483C:p.P1161P,ENSG00000123473:ENST00000371877:exon17:c.T3486C:p.P1162P,ENSG00000123473:ENST00000396221:exon17:c.T3432C:p.P1144P,ENSG00000123473:ENST00000360380:exon18:c.T3483C:p.P1161P	STIL:NM_001048166:exon17:c.T3486C:p.P1162P,STIL:NM_003035:exon17:c.T3483C:p.P1161P,STIL:NM_001282936:exon18:c.T3483C:p.P1161P,STIL:NM_001282937:exon18:c.T3432C:p.P1144P,STIL:NM_001282938:exon19:c.T3345C:p.P1115P,STIL:NM_001282939:exon19:c.T3291C:p.P1097P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4979	0.4085	0.393371	0.4384	.	.	.	.	.	.	.	.	STIL:uc001crc.1:exon17:c.T3483C:p.P1161P,STIL:uc001crd.1:exon17:c.T3486C:p.P1162P,STIL:uc010omo.1:exon17:c.T3432C:p.P1144P,STIL:uc001cre.1:exon18:c.T3483C:p.P1161P,STIL:uc010omn.1:exon18:c.T3345C:p.P1115P	.	AFR:0.1619,AMR:0.4426,EAS:0.4621,FIN:0.6309,NFE:0.5404,OTH:0.5510,ASJ:0.6358	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU15861869	hom
1	47735551	47735551	T	C	STIL	intronic	.	ENSG00000123473	rs140975915	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0] 	0.0049	0.0006	0.00878594	0.0064	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0284,FIN:0.0292,NFE:0.0027,OTH:0.0102,ASJ:0	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU27918274	het
1	47737930	47737930	C	T	STIL	intronic	.	ENSG00000123473	rs2758741	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0353	0.0121	0.0702875	0.0255	.	.	.	.	.	.	.	.	.	.	AFR:0.0249,AMR:0.0132,EAS:0.2083,FIN:0.0321,NFE:0.0055,OTH:0.0256,ASJ:0.0166	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU804488	hom
1	51873951	51873951	G	A	EPS15	exonic	synonymous SNV	ENSG00000085832	rs1065754	ENSG00000085832:ENST00000396122:exon4:c.C360T:p.Y120Y,ENSG00000085832:ENST00000371733:exon15:c.C1329T:p.Y443Y	EPS15:NM_001159969:exon3:c.C387T:p.Y129Y,EPS15:NM_001981:exon15:c.C1329T:p.Y443Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7347	0.7293	0.822684	0.7522	.	.	.	.	.	.	.	.	EPS15:uc001csp.3:exon3:c.C387T:p.Y129Y,EPS15:uc001csq.1:exon15:c.C1329T:p.Y443Y	.	AFR:0.8763,AMR:0.7840,EAS:0.9975,FIN:0.7030,NFE:0.6682,OTH:0.7290,ASJ:0.5728	600051	.	.	.	.	.	.	.	.	.	.	.	1	MU81700903	hom
1	55505732	55505732	A	G	PCSK9	intronic	.	ENSG00000169174	rs2495482	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9370	0.9116	0.908546	0.9128	.	.	.	.	.	.	.	.	.	.	AFR:0.8318,AMR:0.8389,EAS:0.9353,FIN:0.9691,NFE:0.9459,OTH:0.9440,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701675	hom
1	55518316	55518316	C	T	PCSK9	intronic	.	ENSG00000169174	rs2483205	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4276	0.4582	0.394169	0.4467	.	.	.	.	.	0	0	.	.	.	AFR:0.4925,AMR:0.3413,EAS:0.2305,FIN:0.4622,NFE:0.4467,OTH:0.4240,ASJ:0.4733	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU806780	het
1	55518467	55518467	A	G	PCSK9	intronic	.	ENSG00000169174	rs2495477	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4311	0.5042	0.466254	0.4935	.	.	.	.	.	0.0012	0.014	.	.	.	AFR:0.7191,AMR:0.3218,EAS:0.2649,FIN:0.4432,NFE:0.4139,OTH:0.4216,ASJ:0.4396	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU17742898	het
1	55523033	55523033	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs509504	ENSG00000169174:ENST00000543384:exon5:c.A426G:p.Q142Q,ENSG00000169174:ENST00000302118:exon7:c.A1026G:p.Q342Q	PCSK9:NM_174936:exon7:c.A1026G:p.Q342Q	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9945	0.9797	0.981829	0.9829	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon7:c.A1026G:p.Q342Q	.	AFR:0.9397,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701677	hom
1	55524197	55524197	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs540796	ENSG00000169174:ENST00000543384:exon7:c.A728G:p.Y243C	PCSK9:NM_174936:exon9:c.A1380G:p.V460V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8544	0.8178	0.869209	0.8316	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon9:c.A1380G:p.V460V	.	AFR:0.7927,AMR:0.9069,EAS:0.9988,FIN:0.8171,NFE:0.8337,OTH:0.8582,ASJ:0.8245	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU9830779	hom
1	55524237	55524237	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs562556	ENSG00000169174:ENST00000302118:exon9:c.G1420A:p.V474I	PCSK9:NM_174936:exon9:c.G1420A:p.V474I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8544	0.8178	0.86901	COCA-CN|5|321|0.0155763	-1.303	0.004	0.412	-8.95	0.000	.	.	.	PCSK9:uc001cyf.2:exon9:c.G1420A:p.V474I	-0.970	AFR:0.8315,AMR:0.7928,EAS:0.8245,FIN:0.9988,NFE:0.8170,OTH:0.8334,ASJ:0.9069	607786	603776;	.	.	.	.	.	.	0.013	-0.52	0.000	1.555	1	1(thyroid)	0.8571
1	55524342	55524355	GTGTGTGTGTGTGT	-	PCSK9	intronic	.	ENSG00000169174	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	.	unknown
1	55529187	55529187	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs505151	ENSG00000169174:ENST00000302118:exon12:c.G2009A:p.G670E	PCSK9:NM_174936:exon12:c.G2009A:p.G670E	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9433	0.8894	0.898962	0.8930	-1.402	0.003	1.0	0.348	0.001	.	.	.	PCSK9:uc001cyf.2:exon12:c.G2009A:p.G670E	-0.976	AFR:0.7349,AMR:0.9761,EAS:0.9427,FIN:0.9485,NFE:0.9569,OTH:0.9532,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	0.0	-0.35	0.000	-2.34	1	MU26731505	hom
1	65311262	65311262	G	A	JAK1	exonic	synonymous SNV	ENSG00000162434	rs2230587	ENSG00000162434:ENST00000342505:exon15:c.C2049T:p.S683S	JAK1:NM_001321852:exon15:c.C2049T:p.S683S,JAK1:NM_001321856:exon15:c.C2049T:p.S683S,JAK1:NM_001321857:exon15:c.C2046T:p.S682S,JAK1:NM_002227:exon15:c.C2049T:p.S683S,JAK1:NM_001320923:exon16:c.C2049T:p.S683S,JAK1:NM_001321854:exon16:c.C2049T:p.S683S,JAK1:NM_001321855:exon16:c.C2049T:p.S683S,JAK1:NM_001321853:exon17:c.C2049T:p.S683S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1507	0.1356	0.198283	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	JAK1:uc001dbu.1:exon15:c.C2049T:p.S683S,JAK1:uc009wam.1:exon16:c.C2049T:p.S683S	.	AFR:0.1514,AMR:0.1953,EAS:0.1225,FIN:0.3181,NFE:0.1246,OTH:0.1155,ASJ:0.1599	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6191,6193,6192	.	.	.	.	.	.	1	2(soft_tissue)	0.1316
1	66036441	66036441	A	G	LEPR	exonic	nonsynonymous SNV	ENSG00000116678	rs1137100	ENSG00000116678:ENST00000371058:exon2:c.A326G:p.K109R,ENSG00000116678:ENST00000344610:exon4:c.A326G:p.K109R,ENSG00000116678:ENST00000349533:exon4:c.A326G:p.K109R,ENSG00000116678:ENST00000371059:exon4:c.A326G:p.K109R,ENSG00000116678:ENST00000371060:exon4:c.A326G:p.K109R	LEPR:NM_001198687:exon3:c.A326G:p.K109R,LEPR:NM_001198688:exon3:c.A326G:p.K109R,LEPR:NM_001198689:exon3:c.A326G:p.K109R,LEPR:NM_001003679:exon4:c.A326G:p.K109R,LEPR:NM_001003680:exon4:c.A326G:p.K109R,LEPR:NM_002303:exon4:c.A326G:p.K109R	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2942	0.2334	0.320288	0.2857	1.636	14.05	0.321	4.55	0.996	.	.	.	LEPR:uc001dcj.3:exon3:c.A326G:p.K109R,LEPR:uc001dck.3:exon3:c.A326G:p.K109R,LEPR:uc021ool.1:exon3:c.A326G:p.K109R,LEPR:uc001dcg.3:exon4:c.A326G:p.K109R,LEPR:uc001dch.3:exon4:c.A326G:p.K109R,LEPR:uc001dci.3:exon4:c.A326G:p.K109R,LEPR:uc009waq.3:exon4:c.A326G:p.K109R	-0.885	AFR:0.1680,AMR:0.3002,EAS:0.8224,FIN:0.3564,NFE:0.2827,OTH:0.2914,ASJ:0.0960	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	0.971	0.23	0.160	2.255	1	MU26019590	het
1	66036501	66036501	G	T	LEPR	intronic	.	ENSG00000116678	rs2186248	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9995	1	0.9996	.	.	.	.	.	.	.	.	.	.	AFR:0.9987,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	.	.	.	.	1	MU81702628	hom
1	66058513	66058513	A	G	LEPR	exonic	nonsynonymous SNV	ENSG00000116678	rs1137101	ENSG00000116678:ENST00000371058:exon4:c.A668G:p.Q223R,ENSG00000116678:ENST00000344610:exon6:c.A668G:p.Q223R,ENSG00000116678:ENST00000349533:exon6:c.A668G:p.Q223R,ENSG00000116678:ENST00000371059:exon6:c.A668G:p.Q223R,ENSG00000116678:ENST00000371060:exon6:c.A668G:p.Q223R	LEPR:NM_001198687:exon5:c.A668G:p.Q223R,LEPR:NM_001198688:exon5:c.A668G:p.Q223R,LEPR:NM_001198689:exon5:c.A668G:p.Q223R,LEPR:NM_001003679:exon6:c.A668G:p.Q223R,LEPR:NM_001003680:exon6:c.A668G:p.Q223R,LEPR:NM_002303:exon6:c.A668G:p.Q223R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5103	0.4903	0.584265	MU114597	1.483	13.22	0.22	3.66	0.966	.	.	Immunoglobulin-like fold	LEPR:uc001dcj.3:exon5:c.A668G:p.Q223R,LEPR:uc001dck.3:exon5:c.A668G:p.Q223R,LEPR:uc021ool.1:exon5:c.A668G:p.Q223R,LEPR:uc001dcg.3:exon6:c.A668G:p.Q223R,LEPR:uc001dch.3:exon6:c.A668G:p.Q223R,LEPR:uc001dci.3:exon6:c.A668G:p.Q223R	-1.102	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AMR:0.5338,EAS:0.4494,FIN:0.3775,NFE:0.875,OTH:0.6017,ASJ:0.5530	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	0.282	0.56	0.050	1.935	1	1(large_intestine)	0.4783
1	66067109	66067109	T	C	LEPR	exonic	synonymous SNV	ENSG00000116678	rs1805134	ENSG00000116678:ENST00000371058:exon7:c.T1029C:p.S343S,ENSG00000116678:ENST00000344610:exon9:c.T1029C:p.S343S,ENSG00000116678:ENST00000349533:exon9:c.T1029C:p.S343S,ENSG00000116678:ENST00000371059:exon9:c.T1029C:p.S343S,ENSG00000116678:ENST00000371060:exon9:c.T1029C:p.S343S	LEPR:NM_001198687:exon8:c.T1029C:p.S343S,LEPR:NM_001198688:exon8:c.T1029C:p.S343S,LEPR:NM_001198689:exon8:c.T1029C:p.S343S,LEPR:NM_001003679:exon9:c.T1029C:p.S343S,LEPR:NM_001003680:exon9:c.T1029C:p.S343S,LEPR:NM_002303:exon9:c.T1029C:p.S343S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2287	0.2437	0.253994	0.2404	.	.	.	.	.	.	.	.	LEPR:uc001dcj.3:exon8:c.T1029C:p.S343S,LEPR:uc001dck.3:exon8:c.T1029C:p.S343S,LEPR:uc021ool.1:exon8:c.T1029C:p.S343S,LEPR:uc001dcg.3:exon9:c.T1029C:p.S343S,LEPR:uc001dch.3:exon9:c.T1029C:p.S343S,LEPR:uc001dci.3:exon9:c.T1029C:p.S343S	.	AFR:0.3252,AMR:0.1447,EAS:0.0563,FIN:0.2427,NFE:0.2141,OTH:0.2347,ASJ:0.34	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	.	.	.	.	1	MU114613	het
1	66102257	66102257	G	A	LEPR	exonic	synonymous SNV	ENSG00000116678	rs1805096	ENSG00000116678:ENST00000406510:exon6:c.G258A:p.P86P,ENSG00000116678:ENST00000349533:exon20:c.G3057A:p.P1019P	LEPR:NM_002303:exon20:c.G3057A:p.P1019P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4526	0.4075	0.529752	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LEPR:uc001dci.3:exon20:c.G3057A:p.P1019P	.	AFR:0.4440,AMR:0.4501,EAS:0.35,FIN:0.8680,NFE:0.4638,OTH:0.3892,ASJ:0.5084	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	.	.	.	.	1	1(liver)	0.4321
1	76272837	76272837	A	G	MSH4	intronic	.	ENSG00000057468	rs3737574	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3315	0.2249	0.330272	0.2571	.	.	.	.	.	.	.	.	.	.	AFR:0.0743,AMR:0.2572,EAS:0.7135,FIN:0.2787,NFE:0.3070,OTH:0.2908,ASJ:0.2583	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU13888352	hom
1	76344011	76344011	C	A	MSH4	intronic	.	ENSG00000057468	rs1493367	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7967	0.7411	0.792732	0.7763	.	.	.	.	.	0	0.006	.	.	.	AFR:0.7152,AMR:0.8218,EAS:0.9845,FIN:0.8051,NFE:0.7779,OTH:0.7912,ASJ:0.8377	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU81703300	hom
1	76344705	76344705	T	C	MSH4	exonic	synonymous SNV	ENSG00000057468	rs5745448	ENSG00000057468:ENST00000263187:exon12:c.T1569C:p.Y523Y	MSH4:NM_002440:exon12:c.T1569C:p.Y523Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3450	0.2433	0.33746	0.2719	.	.	.	.	.	.	.	.	MSH4:uc001dhd.2:exon12:c.T1569C:p.Y523Y	.	AFR:0.0799,AMR:0.2667,EAS:0.7197,FIN:0.2944,NFE:0.3281,OTH:0.3112,ASJ:0.2649	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU9965201	unknown
1	76344711	76344711	A	T	MSH4	exonic	synonymous SNV	ENSG00000057468	rs5745449	ENSG00000057468:ENST00000263187:exon12:c.A1575T:p.L525L	MSH4:NM_002440:exon12:c.A1575T:p.L525L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7963	0.7415	0.792732	0.7759	.	.	.	.	.	.	.	.	MSH4:uc001dhd.2:exon12:c.A1575T:p.L525L	.	AFR:0.7147,AMR:0.8234,EAS:0.9833,FIN:0.8055,NFE:0.7774,OTH:0.7898,ASJ:0.8377	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU81703331	unknown
1	76346920	76346920	-	AT	MSH4	intronic	.	ENSG00000057468	rs5745466	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9880	0.9555	0.956669	0.9644	.	.	.	.	.	.	.	.	.	.	AFR:0.8755,AMR:0.9952,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	602105	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	76378361	76378361	T	A	MSH4	intronic	.	ENSG00000057468	rs5020911	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4851	.	0.392173	0.4691	.	.	.	.	.	.	.	.	.	.	AFR:0.2766,AMR:0.4447,EAS:0.7278,FIN:0.4959,NFE:0.5372,OTH:0.5113,ASJ:0.4890	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU21151650	hom
1	85741968	85741968	G	C	BCL10	intronic	.	ENSG00000142867	rs12562182	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0928	0.0610	0.0834665	0.0628	.	.	.	.	.	.	.	.	.	.	AFR:0.0172,AMR:0.0933,EAS:0.1388,FIN:0.0725,NFE:0.0771,OTH:0.0663,ASJ:0.0563	603517	137245;156240;605027;616098;	547;50251;52417;	547|NHL|1-5 / 10 000|-|Adult|605027 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~52417|Extranodal marginal zone B-cell lymphoma<br>MALToma<br>Mucosa-associated lymphatic tissue lymphoma<br>Mucosa-associated lymphoid tissue lymphoma|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|137245 ~	.	.	.	.	.	.	.	.	1	MU10026866	het
1	91728053	91728053	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs585898	ENSG00000162669:ENST00000370424:exon33:c.C3108T:p.A1036A,ENSG00000162669:ENST00000370425:exon37:c.C4071T:p.A1357A	HFM1:NM_001017975:exon37:c.C4071T:p.A1357A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon18:c.C1635T:p.A545A,HFM1:uc010osu.2:exon33:c.C3108T:p.A1036A,HFM1:uc001doa.4:exon37:c.C4071T:p.A1357A	.	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704389	hom
1	91781413	91781413	T	G	HFM1	exonic	synonymous SNV	ENSG00000162669	rs281992	ENSG00000162669:ENST00000370424:exon24:c.A2136C:p.I712I,ENSG00000162669:ENST00000294696:exon28:c.A795C:p.I265I,ENSG00000162669:ENST00000370425:exon28:c.A3099C:p.I1033I	HFM1:NM_001017975:exon28:c.A3099C:p.I1033I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7059	0.6881	0.762979	0.6920	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon9:c.A663C:p.I221I,HFM1:uc010osv.1:exon22:c.A2151C:p.I717I,HFM1:uc010osu.2:exon24:c.A2136C:p.I712I,HFM1:uc001doa.4:exon28:c.A3099C:p.I1033I	.	AFR:0.7378,AMR:0.7105,EAS:0.8246,FIN:0.6821,NFE:0.6500,OTH:0.6875,ASJ:0.8212	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU19378877	het
1	91782011	91782011	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs74843031	ENSG00000162669:ENST00000370424:exon22:c.C1872T:p.I624I,ENSG00000162669:ENST00000294696:exon26:c.C531T:p.I177I,ENSG00000162669:ENST00000370425:exon26:c.C2835T:p.I945I	HFM1:NM_001017975:exon26:c.C2835T:p.I945I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0950	0.0879	0.105631	ESAD-UK|1|409|0.00244499,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon7:c.C399T:p.I133I,HFM1:uc010osv.1:exon20:c.C1887T:p.I629I,HFM1:uc010osu.2:exon22:c.C1872T:p.I624I,HFM1:uc001doa.4:exon26:c.C2835T:p.I945I	.	AFR:0.0984,AMR:0.1046,EAS:0.0662,FIN:0.1729,NFE:0.1006,OTH:0.0858,ASJ:0.1280	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	2(stomach)	0.0898
1	91784887	91784887	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs10493845	ENSG00000162669:ENST00000370424:exon20:c.C1680T:p.T560T,ENSG00000162669:ENST00000294696:exon24:c.C339T:p.T113T,ENSG00000162669:ENST00000370425:exon24:c.C2643T:p.T881T	HFM1:NM_001017975:exon24:c.C2643T:p.T881T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2951	0.3117	0.236422	MU580750	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon6:c.C339T:p.T113T,HFM1:uc010osv.1:exon18:c.C1695T:p.T565T,HFM1:uc010osu.2:exon20:c.C1680T:p.T560T,HFM1:uc001doa.4:exon24:c.C2643T:p.T881T	.	AFR:COCA-CN|2|321|0.00623053,AMR:0.3070,EAS:0.2895,FIN:0.1921,NFE:0.1743,OTH:0.3188,ASJ:0.2576	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	1(liver)	0.3504
1	91841301	91841301	T	C	HFM1	intronic	.	ENSG00000162669	rs282036	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9991	0.999201	0.9987	.	.	.	.	.	.	.	.	.	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704472	hom
1	91851253	91851253	T	C	HFM1	exonic	synonymous SNV	ENSG00000162669	rs282026	ENSG00000162669:ENST00000448819:exon3:c.A210G:p.Q70Q,ENSG00000162669:ENST00000427444:exon4:c.A507G:p.Q169Q,ENSG00000162669:ENST00000370425:exon5:c.A633G:p.Q211Q	HFM1:NM_001017975:exon5:c.A633G:p.Q211Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001doc.1:exon4:c.A633G:p.Q211Q,HFM1:uc001doa.4:exon5:c.A633G:p.Q211Q	.	AFR:0.9955,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704499	hom
1	91859795	91859795	T	C	HFM1	exonic	nonsynonymous SNV	ENSG00000162669	rs282009	ENSG00000162669:ENST00000427444:exon3:c.A223G:p.I75V,ENSG00000162669:ENST00000370425:exon4:c.A349G:p.I117V,ENSG00000162669:ENST00000455133:exon4:c.A349G:p.I117V	HFM1:NM_001017975:exon4:c.A349G:p.I117V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9997	0.9991	0.999201	0.9987	-2.189	0.001	1.0	1.52	0.304	.	.	.	HFM1:uc001doc.1:exon3:c.A349G:p.I117V,HFM1:uc001doa.4:exon4:c.A349G:p.I117V	-0.972	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	0.0	0.49	0.015	-2.24	1	MU81704512	hom
1	92174260	92174260	A	G	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs284878	ENSG00000069702:ENST00000525962:exon13:c.T2247C:p.T749T,ENSG00000069702:ENST00000212355:exon14:c.T2247C:p.T749T,ENSG00000069702:ENST00000465892:exon14:c.T2244C:p.T748T,ENSG00000069702:ENST00000370399:exon15:c.T2244C:p.T748T	TGFBR3:NM_001195683:exon14:c.T2244C:p.T748T,TGFBR3:NM_003243:exon14:c.T2247C:p.T749T,TGFBR3:NM_001195684:exon15:c.T2244C:p.T748T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9337	0.9394	0.906749	0.9356	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon14:c.T2247C:p.T749T,TGFBR3:uc001doi.3:exon14:c.T2244C:p.T748T,TGFBR3:uc001doj.3:exon15:c.T2244C:p.T748T,TGFBR3:uc010osy.2:exon15:c.T2121C:p.T707T,TGFBR3:uc009wde.3:exon17:c.T1332C:p.T444T	.	AFR:0.9334,AMR:0.9582,EAS:0.7531,FIN:0.9699,NFE:0.9472,OTH:0.9491,ASJ:0.9007	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU81704562	hom
1	92177938	92177938	A	G	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs1805113	ENSG00000069702:ENST00000525962:exon12:c.T2028C:p.F676F,ENSG00000069702:ENST00000212355:exon13:c.T2028C:p.F676F,ENSG00000069702:ENST00000465892:exon13:c.T2025C:p.F675F,ENSG00000069702:ENST00000370399:exon14:c.T2025C:p.F675F	TGFBR3:NM_001195683:exon13:c.T2025C:p.F675F,TGFBR3:NM_003243:exon13:c.T2028C:p.F676F,TGFBR3:NM_001195684:exon14:c.T2025C:p.F675F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3660	0.4048	0.279752	1(liver)	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon13:c.T2028C:p.F676F,TGFBR3:uc001doi.3:exon13:c.T2025C:p.F675F,TGFBR3:uc001doj.3:exon14:c.T2025C:p.F675F,TGFBR3:uc010osy.2:exon14:c.T1902C:p.F634F	.	AFR:MU749628,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.3425,FIN:0.2876,NFE:0.4040,OTH:0.0912,ASJ:0.3765	600742	.	.	.	.	.	.	.	.	.	.	.	1	2(lung)	0.3693
1	92262874	92262874	T	C	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs2810904	ENSG00000069702:ENST00000525962:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000533089:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000212355:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000465892:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000370399:exon4:c.A216G:p.A72A	TGFBR3:NM_001195683:exon3:c.A216G:p.A72A,TGFBR3:NM_003243:exon3:c.A216G:p.A72A,TGFBR3:NM_001195684:exon4:c.A216G:p.A72A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6631	0.6786	0.715256	0.6616	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doi.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doj.3:exon4:c.A216G:p.A72A,TGFBR3:uc010osy.2:exon4:c.A90G:p.A30A	.	AFR:0.7388,AMR:0.6730,EAS:0.7667,FIN:0.5975,NFE:0.6226,OTH:0.6375,ASJ:0.5867	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU143026	hom
1	92327045	92327045	G	A	TGFBR3	exonic	nonsynonymous SNV	ENSG00000069702	rs1805110	ENSG00000069702:ENST00000525962:exon1:c.C44T:p.S15F,ENSG00000069702:ENST00000533089:exon1:c.C44T:p.S15F,ENSG00000069702:ENST00000212355:exon2:c.C44T:p.S15F,ENSG00000069702:ENST00000465892:exon2:c.C44T:p.S15F,ENSG00000069702:ENST00000532540:exon2:c.C44T:p.S15F,ENSG00000069702:ENST00000370399:exon3:c.C44T:p.S15F,ENSG00000069702:ENST00000417833:exon3:c.C44T:p.S15F	TGFBR3:NM_001195683:exon2:c.C44T:p.S15F,TGFBR3:NM_003243:exon2:c.C44T:p.S15F,TGFBR3:NM_001195684:exon3:c.C44T:p.S15F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1308	0.1153	0.185903	1(soft_tissue)	0.927	10.24	0.166	3.18	0.841	.	.	.	TGFBR3:uc001doh.3:exon2:c.C44T:p.S15F,TGFBR3:uc001doi.3:exon2:c.C44T:p.S15F,TGFBR3:uc001doj.3:exon3:c.C44T:p.S15F	-1.065	AFR:1(large_intestine),AMR:MU580752,EAS:0.1310,FIN:0.1777,NFE:0.1337,OTH:0.1258,ASJ:ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	600742	.	.	.	.	.	.	.	0.4	1.47	0.027	1.24	1	1(stomach)	0.3813
1	92944315	92944316	AG	-	GFI1	intronic	.	ENSG00000162676	rs768494519	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	0.1379	.	.	0.1424	.	.	.	.	.	.	.	.	.	.	AFR:0.1430,AMR:0.0990,EAS:0.0357,FIN:0.1576,NFE:0.1515,OTH:0.1471,ASJ:0.1295	600871	607847;613107;	486;2688;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2688|-|-|-|-|607847 ~	.	.	.	.	.	.	.	.	1	.	unknown
1	92946479	92946479	G	A	GFI1	exonic	synonymous SNV	ENSG00000162676	rs11164605	ENSG00000162676:ENST00000294702:exon4:c.C465T:p.C155C,ENSG00000162676:ENST00000370332:exon4:c.C465T:p.C155C,ENSG00000162676:ENST00000427103:exon4:c.C465T:p.C155C	GFI1:NM_001127215:exon4:c.C465T:p.C155C,GFI1:NM_001127216:exon4:c.C465T:p.C155C,GFI1:NM_005263:exon4:c.C465T:p.C155C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8883	0.8519	0.91893	0.8503	.	.	.	.	.	.	.	.	GFI1:uc001dou.4:exon4:c.C465T:p.C155C,GFI1:uc001dov.4:exon4:c.C465T:p.C155C,GFI1:uc001dow.4:exon4:c.C465T:p.C155C	.	AFR:0.9214,AMR:0.9076,EAS:0.9667,FIN:0.7807,NFE:0.8087,OTH:0.8330,ASJ:0.9139	600871	607847;613107;	486;2688;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2688|-|-|-|-|607847 ~	.	.	.	.	.	.	.	.	1	MU81704682	het
1	98348885	98348885	G	A	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801265	ENSG00000188641:ENST00000306031:exon2:c.C85T:p.R29C,ENSG00000188641:ENST00000370192:exon2:c.C85T:p.R29C	DPYD:NM_000110:exon2:c.C85T:p.R29C,DPYD:NM_001160301:exon2:c.C85T:p.R29C	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7652	0.7159	0.739816	0.7199	.	.	.	.	.	.	.	.	DPYD:uc001drv.3:exon2:c.C85T:p.R29C,DPYD:uc001drw.3:exon2:c.C85T:p.R29C	.	AFR:0.5991,AMR:0.7769,EAS:0.9284,FIN:0.7140,NFE:0.7626,OTH:0.7352,ASJ:0.8642	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	MU4134499	hom
1	104076462	104076462	C	T	RNPC3	exonic	synonymous SNV	ENSG00000185946	rs6697444	ENSG00000185946:ENST00000423855:exon3:c.C342T:p.G114G,ENSG00000185946:ENST00000524631:exon3:c.C342T:p.G114G,ENSG00000185946:ENST00000531883:exon4:c.C342T:p.G114G,ENSG00000185946:ENST00000533099:exon4:c.C342T:p.G114G	RNPC3:NM_017619:exon3:c.C342T:p.G114G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6387	0.6468	0.602037	0.6343	.	.	.	.	.	.	.	.	RNPC3:uc010oul.1:exon3:c.C342T:p.G114G,RNPC3:uc010oum.1:exon3:c.C342T:p.G114G,RNPC3:uc010oun.2:exon3:c.C342T:p.G114G	.	AFR:0.7232,AMR:0.5846,EAS:0.3890,FIN:0.5876,NFE:0.6228,OTH:0.6074,ASJ:0.6443	.	.	.	.	.	.	.	.	.	.	.	.	1	MU26035144	hom
1	104076495	104076495	A	G	RNPC3	intronic	.	ENSG00000185946	rs6702220	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6556	.	0.644169	0.6617	.	.	.	.	.	.	.	.	.	.	AFR:0.8362,AMR:0.5978,EAS:0.3862,FIN:0.5725,NFE:0.6176,OTH:0.6072,ASJ:0.6358	.	.	.	.	.	.	.	.	.	.	.	.	1	MU26035183	hom
1	109465166	109465168	CTT	-	GPSM2	exonic	nonframeshift deletion	ENSG00000121957	rs35029887	ENSG00000121957:ENST00000264126:exon13:c.1568_1570del:p.523_524del,ENSG00000121957:ENST00000406462:exon14:c.1568_1570del:p.523_524del	GPSM2:NM_001321038:exon13:c.1568_1570del:p.523_524del,GPSM2:NM_001321039:exon13:c.1568_1570del:p.523_524del,GPSM2:NM_013296:exon13:c.1568_1570del:p.523_524del	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2907	0.3786	.	0.3574	.	.	.	.	.	.	.	.	GPSM2:uc010ovc.2:exon13:c.1568_1570del:p.523_524del,GPSM2:uc010ovd.2:exon13:c.1568_1570del:p.523_524del,GPSM2:uc010ove.1:exon13:c.1568_1570del:p.523_524del	.	AFR:0.5663,AMR:0.2584,EAS:0.0448,FIN:0.3131,NFE:0.2903,OTH:0.2982,ASJ:0.3267	609245	604213;	314597;	314597|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|604213 ~	.	.	.	.	.	.	.	.	1	MU85980	het
1	113456546	113456546	A	T	SLC16A1	exonic	nonsynonymous SNV	ENSG00000155380	rs1049434	ENSG00000155380:ENST00000369626:exon5:c.T1470A:p.D490E,ENSG00000155380:ENST00000538576:exon5:c.T1470A:p.D490E	SLC16A1:NM_001166496:exon5:c.T1470A:p.D490E,SLC16A1:NM_003051:exon5:c.T1470A:p.D490E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6662	0.676717	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	-0.947	0.020	1.0	2.74	0.095	.	.	.	SLC16A1:uc001ecx.3:exon5:c.T1470A:p.D490E,SLC16A1:uc001ecy.3:exon5:c.T1470A:p.D490E	-0.939	AFR:0.6639,AMR:0.8573,EAS:0.6358,FIN:0.6710,NFE:0.5837,OTH:0.5817,ASJ:0.5431	600682	245340;610021;616095;	438075;165991;171690;	438075|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Childhood|616095 ~165991|EIHI<br>Exercise-induced hyperinsulinemic hypoglycemia<br>Hyperinsulinism due to SLC16A1 deficiency<br>Hyperinsulinism due to monocarboxylate transporter 1 deficiency|-|Autosomal dominant|-|610021 ~171690|Erythrocyte lactate transporter defect|-|-|-|245340 ~	.	.	.	.	0.0	2.08	0.005	-0.345	1	1(pancreas)	0.5825
1	113460683	113460683	T	G	SLC16A1	intronic	.	ENSG00000155380	rs1344429	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5386	0.2844	0.356829	0.0838	.	.	.	.	.	.	.	.	.	.	AFR:0.1086,AMR:0.0925,EAS:0.2941,FIN:0.0435,NFE:0.0539,OTH:0.0579,ASJ:0	600682	245340;610021;616095;	438075;165991;171690;	438075|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Childhood|616095 ~165991|EIHI<br>Exercise-induced hyperinsulinemic hypoglycemia<br>Hyperinsulinism due to SLC16A1 deficiency<br>Hyperinsulinism due to monocarboxylate transporter 1 deficiency|-|Autosomal dominant|-|610021 ~171690|Erythrocyte lactate transporter defect|-|-|-|245340 ~	.	.	.	.	.	.	.	.	1	.	hom
1	114680540	114680540	C	T	SYT6	exonic	synonymous SNV	ENSG00000134207	rs17032441	ENSG00000134207:ENST00000369547:exon3:c.G393A:p.S131S,ENSG00000134207:ENST00000393296:exon3:c.G648A:p.S216S,ENSG00000134207:ENST00000607941:exon3:c.G393A:p.S131S,ENSG00000134207:ENST00000608203:exon3:c.G393A:p.S131S,ENSG00000134207:ENST00000609117:exon3:c.G393A:p.S131S,ENSG00000134207:ENST00000610222:exon3:c.G648A:p.S216S	SYT6:NM_001253772:exon3:c.G648A:p.S216S,SYT6:NM_001270805:exon3:c.G393A:p.S131S,SYT6:NM_001366223:exon3:c.G393A:p.S131S,SYT6:NM_001366224:exon3:c.G648A:p.S216S,SYT6:NM_001366225:exon3:c.G648A:p.S216S,SYT6:NM_001366226:exon3:c.G393A:p.S131S,SYT6:NM_205848:exon3:c.G393A:p.S131S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1919	0.2040	0.207668	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	SYT6:uc001eev.3:exon3:c.G393A:p.S131S,SYT6:uc021orz.1:exon3:c.G393A:p.S131S	.	AFR:MU580836,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1996,FIN:0.1914,NFE:0.1767,OTH:0.2397,ASJ:0.1821	607718	.	.	.	.	.	.	.	.	.	.	.	1	1(stomach)	0.1111
1	114940633	114940633	A	-	TRIM33	intronic	.	ENSG00000197323	rs397981357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5981	.	0.696685	0.8236	.	.	.	.	.	.	.	.	.	.	AFR:0.8736,AMR:0.8254,EAS:0.9741,FIN:0.7737,NFE:0.7888,OTH:0.7803,ASJ:0.7243	605769	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	114948281	114948281	A	G	TRIM33	exonic	nonsynonymous SNV	ENSG00000197323	rs6537825	ENSG00000197323:ENST00000450349:exon14:c.T1415C:p.I472T,ENSG00000197323:ENST00000358465:exon15:c.T2519C:p.I840T,ENSG00000197323:ENST00000369543:exon15:c.T2519C:p.I840T	TRIM33:NM_015906:exon15:c.T2519C:p.I840T,TRIM33:NM_033020:exon15:c.T2519C:p.I840T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8921	0.9423	0.85643	MU807108	0.726	8.995	1.0	4.35	0.993	.	.	.	TRIM33:uc001eey.1:exon2:c.T104C:p.I35T,TRIM33:uc010owr.2:exon10:c.T1361C:p.I454T,TRIM33:uc010ows.2:exon14:c.T1415C:p.I472T,TRIM33:uc001eew.3:exon15:c.T2519C:p.I840T,TRIM33:uc001eex.3:exon15:c.T2519C:p.I840T	-1.066	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.9250,EAS:0.8266,FIN:0.87,NFE:0.5813,OTH:0.9674,ASJ:0.9707	605769	.	.	.	.	.	.	.	0.0	-0.55	0.039	-1.955	1	86(lung)	0.9320
1	114969926	114969926	A	-	TRIM33	intronic	.	ENSG00000197323	rs36115645	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1512	0.1518	0.104233	0.1480	.	.	.	.	.	.	.	.	.	.	AFR:0.0735,AMR:0.1259,EAS:0.0241,FIN:0.1649,NFE:0.1972,OTH:0.1901,ASJ:0.2649	605769	.	.	.	.	.	.	.	.	.	.	.	1	MU30870579	het
1	114973429	114973429	T	C	TRIM33	exonic	synonymous SNV	ENSG00000197323	rs12083584	ENSG00000197323:ENST00000358465:exon6:c.A1146G:p.Q382Q,ENSG00000197323:ENST00000369543:exon6:c.A1146G:p.Q382Q	TRIM33:NM_015906:exon6:c.A1146G:p.Q382Q,TRIM33:NM_033020:exon6:c.A1146G:p.Q382Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3076	0.3677	0.295727	1(breast)	.	.	.	.	.	.	.	.	TRIM33:uc001eew.3:exon6:c.A1146G:p.Q382Q,TRIM33:uc001eex.3:exon6:c.A1146G:p.Q382Q	.	AFR:MU125994,AMR:LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.4661,FIN:0.2309,NFE:0.47,OTH:0.0414,ASJ:0.3583	605769	.	.	.	.	.	.	.	.	.	.	.	1	11(soft_tissue)	0.3218
1	118165691	118165691	C	T	TENT5C	exonic	synonymous SNV	ENSG00000183508	rs1630312	ENSG00000183508:ENST00000369448:exon2:c.C201T:p.H67H	TENT5C:NM_017709:exon2:c.C201T:p.H67H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2641	0.3063	0.207069	0.2835	.	.	.	.	.	.	.	.	FAM46C:uc021osq.1:exon1:c.C201T:p.H67H,FAM46C:uc001ehe.3:exon2:c.C201T:p.H67H	.	AFR:0.2237,AMR:0.2470,EAS:0.0927,FIN:0.3663,NFE:0.3202,OTH:0.3190,ASJ:0.2384	613952	.	.	.	.	.	.	.	.	.	.	.	1	MU152136	het
1	118165973	118165973	C	T	TENT5C	exonic	synonymous SNV	ENSG00000183508	rs1627787	ENSG00000183508:ENST00000369448:exon2:c.C483T:p.N161N	TENT5C:NM_017709:exon2:c.C483T:p.N161N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2556	0.2575	0.279752	0.2518	.	.	.	.	.	.	.	.	FAM46C:uc021osq.1:exon1:c.C483T:p.N161N,FAM46C:uc001ehe.3:exon2:c.C483T:p.N161N	.	AFR:0.3195,AMR:0.2792,EAS:0.2088,FIN:0.2218,NFE:0.2220,OTH:0.2531,ASJ:0.2748	613952	.	.	.	.	.	.	.	.	.	.	.	1	MU11265200	het
1	118166096	118166096	C	T	TENT5C	exonic	synonymous SNV	ENSG00000183508	rs2884587	ENSG00000183508:ENST00000369448:exon2:c.C606T:p.I202I	TENT5C:NM_017709:exon2:c.C606T:p.I202I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1704	0.1256	0.134385	0.1255	.	.	.	.	.	.	.	.	FAM46C:uc021osq.1:exon1:c.C606T:p.I202I,FAM46C:uc001ehe.3:exon2:c.C606T:p.I202I	.	AFR:0.0389,AMR:0.2064,EAS:0.0888,FIN:0.1590,NFE:0.1635,OTH:0.1680,ASJ:0.1921	613952	.	.	.	.	.	.	.	.	.	.	.	1	MU11265204	het
1	120057158	120057158	C	T	HSD3B1	exonic	synonymous SNV	ENSG00000203857	rs6203	ENSG00000203857:ENST00000528909:exon3:c.C1012T:p.L338L,ENSG00000203857:ENST00000235547:exon4:c.C1018T:p.L340L,ENSG00000203857:ENST00000369413:exon4:c.C1012T:p.L338L	HSD3B1:NM_000862:exon4:c.C1012T:p.L338L,HSD3B1:NM_001328615:exon4:c.C1012T:p.L338L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4388	0.3219	0.366813	1(liver)	.	.	.	.	.	.	.	.	HSD3B1:uc031pnt.1:exon3:c.C1012T:p.L338L,HSD3B1:uc001ehv.1:exon4:c.C1012T:p.L338L	.	AFR:MU89685,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.0963,FIN:0.5431,NFE:0.3841,OTH:0.6566,ASJ:0.3701	109715	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.5444
1	120057246	120057246	C	A	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs1047303	ENSG00000203857:ENST00000528909:exon3:c.C1100A:p.T367N,ENSG00000203857:ENST00000235547:exon4:c.C1106A:p.T369N,ENSG00000203857:ENST00000369413:exon4:c.C1100A:p.T367N	HSD3B1:NM_000862:exon4:c.C1100A:p.T367N,HSD3B1:NM_001328615:exon4:c.C1100A:p.T367N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7554	0.7492	0.833466	COCA-CN|5|321|0.0155763	-1.422	0.003	0.303	-0.043	0.000	.	.	.	HSD3B1:uc031pnt.1:exon3:c.C1100A:p.T367N,HSD3B1:uc001ehv.1:exon4:c.C1100A:p.T367N	-1.061	AFR:0.7697,AMR:0.8843,EAS:0.6887,FIN:0.9312,NFE:0.7460,OTH:0.6915,ASJ:0.8141	109715	.	.	.	.	.	.	.	0.01	-0.58	0.151	2.52	1	1(large_intestine)	0.7485
1	120458004	120458004	A	T	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs6685892	ENSG00000134250:ENST00000256646:exon34:c.T7341A:p.G2447G	NOTCH2:NM_024408:exon34:c.T7341A:p.G2447G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.1293	0.1785	0.192492	0.1687	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon34:c.T7341A:p.G2447G	.	AFR:0.3249,AMR:0.0993,EAS:0.0284,FIN:0.1294,NFE:0.1107,OTH:0.1214,ASJ:0.0960	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	.	.	.	.	1	.	het
1	120572547	120572547	T	C	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs61788900	ENSG00000134250:ENST00000256646:exon2:c.A137G:p.N46S,ENSG00000134250:ENST00000602566:exon3:c.A20G:p.N7S	NOTCH2:NM_001200001:exon2:c.A137G:p.N46S,NOTCH2:NM_024408:exon2:c.A137G:p.N46S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4736	.	.	4(penis)	2.196	17.48	0.129	5.05	1.000	.	.	EGF-like domain	NOTCH2:uc001eik.3:exon2:c.A137G:p.N46S,NOTCH2:uc001eil.3:exon2:c.A137G:p.N46S,NOTCH2:uc021osy.1:exon2:c.A20G:p.N7S	-0.943	AFR:4(thyroid),AMR:2(large_intestine),EAS:1(biliary_tract),FIN:MU617194,NFE:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,THCA-CN|1|50|0.02,OTH:0.3958,ASJ:1(kidney)	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.01	-0.03	0.124	0.885	1	4(haematopoietic_and_lymphoid_tissue)	0.2468
1	120572572	120572572	C	T	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs61788901	ENSG00000134250:ENST00000256646:exon2:c.G112A:p.E38K	NOTCH2:NM_001200001:exon2:c.G112A:p.E38K,NOTCH2:NM_024408:exon2:c.G112A:p.E38K	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4699	.	.	2(haematopoietic_and_lymphoid_tissue)	2.535	19.69	0.058	2.14	0.988	.	.	EGF-like domain	NOTCH2:uc001eik.3:exon2:c.G112A:p.E38K,NOTCH2:uc001eil.3:exon2:c.G112A:p.E38K	-1.097	AFR:1(central_nervous_system),AMR:18(upper_aerodigestive_tract),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,FIN:0.3980,NFE:0.2513,OTH:0.4313,ASJ:MU4547029	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.044	0.13	0.049	0.02	1	1(thyroid)	0.4424
1	120611964	120611964	G	C	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs11810554	ENSG00000134250:ENST00000256646:exon1:c.C57G:p.C19W	NOTCH2:NM_001200001:exon1:c.C57G:p.C19W,NOTCH2:NM_024408:exon1:c.C57G:p.C19W	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4493	.	.	0.3877	2.208	17.56	0.185	2.04	0.868	.	.	.	NOTCH2:uc001eik.3:exon1:c.C57G:p.C19W,NOTCH2:uc001eil.3:exon1:c.C57G:p.C19W	-1.048	AFR:0.2278,AMR:0.4293,EAS:0.4526,FIN:0.4558,NFE:0.4469,OTH:0.4300,ASJ:0.4312	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.001	0.4	0.036	1.04	1	MU815514	het
1	120612006	120612006	G	A	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs4021006	ENSG00000134250:ENST00000256646:exon1:c.C15T:p.R5R	NOTCH2:NM_001200001:exon1:c.C15T:p.R5R,NOTCH2:NM_024408:exon1:c.C15T:p.R5R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4638	.	0.39397	0.3802	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon1:c.C15T:p.R5R,NOTCH2:uc001eil.3:exon1:c.C15T:p.R5R	.	AFR:0.2426,AMR:0.4346,EAS:0.4369,FIN:0.4496,NFE:0.4286,OTH:0.4243,ASJ:0.4070	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	.	.	.	.	1	MU657255	het
1	120612038	120612046	CCTCCGCCG	-	NOTCH2NLR	ncRNA_exonic	.	ENSG00000134250	rs59571254	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0131	0.0432	.	0.0719	.	.	.	.	.	.	.	.	.	.	AFR:0.1955,AMR:0.0389,EAS:0.0054,FIN:0.0217,NFE:0.0429,OTH:0.0367,ASJ:0.0215	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	.	.	.	.	.	.	.	.	1	.	het
1	120612040	120612040	-	CCTCCGCCG	NOTCH2NLR	ncRNA_exonic	.	ENSG00000134250	rs782658834	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0833	0.0187	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	.	.	.	.	.	.	.	.	1	.	het
1	147087721	147087721	T	A	BCL9;NBPF19	intronic	.	ENSG00000116128	rs3737843	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4461	0.3704	0.316693	0.4042	.	.	.	.	.	.	.	.	.	.	AFR:0.0906,AMR:0.3397,EAS:0.4359,FIN:0.6025,NFE:0.5327,OTH:0.5133,ASJ:0.4503	602597	.	.	.	.	.	.	.	.	.	.	.	1	MU790640	het
1	147091972	147091972	C	T	BCL9	exonic	nonsynonymous SNV	ENSG00000116128	rs3820129	ENSG00000116128:ENST00000234739:exon8:c.C2011T:p.P671S	BCL9:NM_004326:exon8:c.C2011T:p.P671S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3143	0.2961	0.181909	0.3084	3.160	22.6	0.02	3.92	1.000	.	.	.	BCL9:uc010ozr.1:exon5:c.C1789T:p.P597S,BCL9:uc001epq.3:exon8:c.C2011T:p.P671S	-1.031	AFR:0.0747,AMR:0.2231,EAS:0.0812,FIN:0.4587,NFE:0.4336,OTH:0.3814,ASJ:0.3411	602597	.	.	.	.	.	.	.	0.079	0.53	0.065	1.555	1	MU21284346	het
1	147092112	147092112	G	A	BCL9	exonic	synonymous SNV	ENSG00000116128	rs61754125	ENSG00000116128:ENST00000234739:exon8:c.G2151A:p.K717K	BCL9:NM_004326:exon8:c.G2151A:p.K717K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0271	0.0263	0.0181709	0.0233	.	.	.	.	.	.	.	.	BCL9:uc010ozr.1:exon5:c.G1929A:p.K643K,BCL9:uc001epq.3:exon8:c.G2151A:p.K717K	.	AFR:0.0069,AMR:0.0382,EAS:0.0006,FIN:0.0226,NFE:0.0342,OTH:0.0327,ASJ:0.0132	602597	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	154557685	154557685	C	T	ADAR	intronic	.	ENSG00000160710	rs9427094	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4630	0.4032	0.388778	0.4128	.	.	.	.	.	0.0004	0.01	.	.	.	AFR:0.2448,AMR:0.4797,EAS:0.5392,FIN:0.4581,NFE:0.4804,OTH:0.4324,ASJ:0.4636	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU20489329	hom
1	154573967	154573967	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs2229857	ENSG00000160710:ENST00000529168:exon1:c.A1136G:p.K379R,ENSG00000160710:ENST00000292205:exon2:c.A1280G:p.K427R,ENSG00000160710:ENST00000368471:exon2:c.A266G:p.K89R,ENSG00000160710:ENST00000368474:exon2:c.A1151G:p.K384R	ADAR:NM_001025107:exon2:c.A266G:p.K89R,ADAR:NM_001111:exon2:c.A1151G:p.K384R,ADAR:NM_001193495:exon2:c.A266G:p.K89R,ADAR:NM_001365045:exon2:c.A1178G:p.K393R,ADAR:NM_001365048:exon2:c.A266G:p.K89R,ADAR:NM_015840:exon2:c.A1151G:p.K384R,ADAR:NM_015841:exon2:c.A1151G:p.K384R,ADAR:NM_001365046:exon3:c.A266G:p.K89R,ADAR:NM_001365047:exon3:c.A266G:p.K89R,ADAR:NM_001365049:exon3:c.A266G:p.K89R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6956	0.6079	0.622604	0.6279	-1.245	0.005	0.381	-0.812	0.003	.	.	.	ADAR:uc001ffh.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffi.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffj.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffk.3:exon2:c.A266G:p.K89R,ADAR:uc001ffl.1:exon2:c.A266G:p.K89R,ADAR:uc021pag.1:exon2:c.A266G:p.K89R	-0.976	AFR:0.4283,AMR:0.7673,EAS:0.7093,FIN:0.6791,NFE:0.7098,OTH:0.6994,ASJ:0.6689	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.73	0.009	2.015	1	MU20489500	hom
1	154574820	154574820	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs1466731	ENSG00000160710:ENST00000529168:exon1:c.A283G:p.R95G,ENSG00000160710:ENST00000292205:exon2:c.A427G:p.R143G,ENSG00000160710:ENST00000368474:exon2:c.A298G:p.R100G	ADAR:NM_001111:exon2:c.A298G:p.R100G,ADAR:NM_001365045:exon2:c.A325G:p.R109G,ADAR:NM_015840:exon2:c.A298G:p.R100G,ADAR:NM_015841:exon2:c.A298G:p.R100G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9988	0.9957	0.996206	0.9969	-1.562	0.002	0.807	-2.82	0.000	.	.	.	ADAR:uc001ffh.3:exon2:c.A298G:p.R100G,ADAR:uc001ffi.3:exon2:c.A298G:p.R100G,ADAR:uc001ffj.3:exon2:c.A298G:p.R100G	-1.015	AFR:0.9892,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.45	0.009	-0.205	1	MU81711582	hom
1	154575040	154575040	C	T	ADAR	exonic	synonymous SNV	ENSG00000160710	rs1802645	ENSG00000160710:ENST00000529168:exon1:c.G63A:p.R21R,ENSG00000160710:ENST00000292205:exon2:c.G207A:p.R69R,ENSG00000160710:ENST00000368474:exon2:c.G78A:p.R26R	ADAR:NM_001111:exon2:c.G78A:p.R26R,ADAR:NM_001365045:exon2:c.G105A:p.R35R,ADAR:NM_015840:exon2:c.G78A:p.R26R,ADAR:NM_015841:exon2:c.G78A:p.R26R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9992	0.9972	0.997005	0.9978	.	.	.	.	.	.	.	.	ADAR:uc001ffh.3:exon2:c.G78A:p.R26R,ADAR:uc001ffi.3:exon2:c.G78A:p.R26R,ADAR:uc001ffj.3:exon2:c.G78A:p.R26R,ADAR:uc001ffn.2:exon2:c.G78A:p.R26R	.	AFR:0.9924,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU81711590	hom
1	155870416	155870416	G	A	RIT1	intronic	.	ENSG00000143622	rs1749409	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8772	0.7934	0.779752	0.8171	.	.	.	.	.	0	0	.	.	.	AFR:0.5463,AMR:0.9356,EAS:0.9377,FIN:0.9035,NFE:0.9284,OTH:0.8921,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	.	.	.	.	.	.	.	1	MU26075081	hom
1	155880573	155880573	C	G	RIT1	exonic	nonsynonymous SNV	ENSG00000143622	rs493446	ENSG00000143622:ENST00000368322:exon2:c.G31C:p.E11Q	RIT1:NM_001256821:exon2:c.G31C:p.E11Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.8775	0.7952	0.779952	0.8174	-0.532	0.183	0.43	-0.379	0.012	.	.	.	RIT1:uc031pqc.1:exon2:c.G31C:p.E11Q	-1.065	AFR:0.5470,AMR:0.9356,EAS:0.9382,FIN:0.9038,NFE:0.9286,OTH:0.8918,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	9550,,9551	.	.	.	-0.21	0.078	.	1	MU26075246	hom
1	156785617	156785617	G	A	NTRK1	UTR5	.	ENSG00000198400	rs1800601	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6674	0.6177	0.636981	0.6243	.	.	.	.	.	.	.	.	.	.	AFR:0.5074,AMR:0.6926,EAS:0.8288,FIN:0.6437,NFE:0.6591,OTH:0.6449,ASJ:0.6887	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	MU718802	het
1	156846233	156846233	G	A	NTRK1	exonic	synonymous SNV	ENSG00000198400	rs6334	ENSG00000198400:ENST00000358660:exon13:c.G1665A:p.Q555Q,ENSG00000198400:ENST00000368196:exon13:c.G1656A:p.Q552Q,ENSG00000198400:ENST00000392302:exon14:c.G1566A:p.Q522Q,ENSG00000198400:ENST00000524377:exon14:c.G1674A:p.Q558Q	NTRK1:NM_001012331:exon13:c.G1656A:p.Q552Q,NTRK1:NM_001007792:exon14:c.G1566A:p.Q522Q,NTRK1:NM_002529:exon14:c.G1674A:p.Q558Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2203	0.1936	0.212859	1(large_intestine)	.	.	.	.	.	.	.	.	NTRK1:uc001fqi.1:exon13:c.G1656A:p.Q552Q,NTRK1:uc009wsi.1:exon13:c.G771A:p.Q257Q,NTRK1:uc009wsk.1:exon13:c.G1665A:p.Q555Q,NTRK1:uc001fqf.1:exon14:c.G1566A:p.Q522Q,NTRK1:uc001fqh.1:exon14:c.G1674A:p.Q558Q	.	AFR:MU124466,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.1354,FIN:0.2076,NFE:0.2167,OTH:0.3626,ASJ:0.1995	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	1(lung)	0.2084
1	156848995	156848995	C	T	NTRK1	exonic	synonymous SNV	ENSG00000198400	rs6337	ENSG00000198400:ENST00000358660:exon14:c.C1878T:p.A626A,ENSG00000198400:ENST00000368196:exon14:c.C1869T:p.A623A,ENSG00000198400:ENST00000392302:exon15:c.C1779T:p.A593A,ENSG00000198400:ENST00000524377:exon15:c.C1887T:p.A629A	NTRK1:NM_001012331:exon14:c.C1869T:p.A623A,NTRK1:NM_001007792:exon15:c.C1779T:p.A593A,NTRK1:NM_002529:exon15:c.C1887T:p.A629A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5724	0.5568	0.334065	MU687507	.	.	.	.	.	.	.	.	NTRK1:uc001fqi.1:exon14:c.C1869T:p.A623A,NTRK1:uc009wsi.1:exon14:c.C984T:p.A328A,NTRK1:uc009wsk.1:exon14:c.C1878T:p.A626A,NTRK1:uc001fqf.1:exon15:c.C1779T:p.A593A,NTRK1:uc001fqh.1:exon15:c.C1887T:p.A629A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,BRCA-KR|1|50|0.02,AMR:0.5379,EAS:0.5919,FIN:0.7351,NFE:0.0433,OTH:0.7278,ASJ:0.2079	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	2(thyroid)	0.7271
1	161645259	161645259	T	G	FCGR2B	intronic	.	ENSG00000072694	rs1674759	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.792532	0.8326	.	.	.	.	.	.	.	.	.	.	AFR:0.7640,AMR:0.8604,EAS:0.8306,FIN:0.8873,NFE:0.8578,OTH:0.8535,ASJ:0.7919	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	1	MU113392205	hom
1	162740327	162740327	T	C	DDR2	intronic	.	ENSG00000162733	rs1780003	ENSG00000162733:ENST00000458105:exon2:c.T359C:p.V120A	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9855	0.9476	0.945487	0.9541	-0.266	0.793	0.0	-10.1	0.000	.	.	.	.	-1.062	AFR:0.8402,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9867,ASJ:1	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	.	.	.	.	1.39	0.010	.	1	MU81714571	hom
1	164529120	164529120	G	A	PBX1	exonic	nonsynonymous SNV	ENSG00000185630	rs2275558	ENSG00000185630:ENST00000367897:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000401534:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000420696:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000540236:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000559240:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000340699:exon2:c.G61A:p.G21S,ENSG00000185630:ENST00000485769:exon2:c.G61A:p.G21S	PBX1:NM_001204961:exon1:c.G61A:p.G21S,PBX1:NM_001204963:exon1:c.G61A:p.G21S,PBX1:NM_001353131:exon1:c.G61A:p.G21S,PBX1:NM_002585:exon1:c.G61A:p.G21S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2977	0.1381	0.307308	MU21780744	2.102	16.87	0.118	5.18	1.000	.	.	.	PBX1:uc001gcs.3:exon1:c.G61A:p.G21S,PBX1:uc001gct.3:exon1:c.G61A:p.G21S,PBX1:uc010pku.2:exon1:c.G61A:p.G21S	-0.502	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|2|50|0.04,AMR:0.2004,EAS:0.4354,FIN:0.2649,NFE:0.6461,OTH:0.2045,ASJ:0.0390	176310	.	.	.	~ko04927 Cortisol synthesis and secretion~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.054	0.79	0.329	1.04	1	2(lung)	0.2274
1	170501385	170501385	A	C	GORAB	exonic	synonymous SNV	ENSG00000120370	rs7531125	ENSG00000120370:ENST00000367762:exon1:c.A96C:p.G32G,ENSG00000120370:ENST00000367763:exon1:c.A96C:p.G32G	GORAB:NM_001146039:exon1:c.A96C:p.G32G,GORAB:NM_152281:exon1:c.A96C:p.G32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9797	0.9355	0.927516	0.9418	.	.	.	.	.	.	.	.	GORAB:uc001ggz.4:exon1:c.A96C:p.G32G,GORAB:uc001gha.2:exon1:c.A96C:p.G32G,GORAB:uc009wvw.2:exon1:c.A96C:p.G32G	.	AFR:0.7985,AMR:0.9821,EAS:0.9994,FIN:1,NFE:0.9987,OTH:0.9919,ASJ:0.9834	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	.	.	.	.	1	MU4568428	hom
1	173878832	173878832	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5878	ENSG00000117601:ENST00000367698:exon5:c.A1011G:p.Q337Q	SERPINC1:NM_000488:exon5:c.A1011G:p.Q337Q,SERPINC1:NM_001365052:exon6:c.A867G:p.Q289Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4029	0.4882	0.535743	0.4717	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A1011G:p.Q337Q	.	AFR:0.7680,AMR:0.2632,EAS:0.6539,FIN:0.2885,NFE:0.3395,OTH:0.3706,ASJ:0.53	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158486	het
1	173878862	173878862	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5877	ENSG00000117601:ENST00000367698:exon5:c.A981G:p.V327V	SERPINC1:NM_000488:exon5:c.A981G:p.V327V,SERPINC1:NM_001365052:exon6:c.A837G:p.V279V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4079	0.4836	0.545327	0.4688	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A981G:p.V327V	.	AFR:0.7612,AMR:0.3353,EAS:0.6751,FIN:0.2736,NFE:0.3346,OTH:0.3673,ASJ:0.5265	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158492	het
1	180243524	180243524	A	G	LHX4	exonic	nonsynonymous SNV	ENSG00000121454	rs7536561	ENSG00000121454:ENST00000263726:exon6:c.A983G:p.N328S	LHX4:NM_033343:exon6:c.A983G:p.N328S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4850	0.4107	0.426318	0.4295	-0.369	0.458	1.0	3.27	1.000	.	.	.	LHX4:uc001goe.2:exon6:c.A983G:p.N328S	-0.956	AFR:0.1917,AMR:0.2840,EAS:0.6141,FIN:0.5750,NFE:0.5128,OTH:0.5297,ASJ:0.5878	602146	262700;	85442;	85442|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|262700 ~	.	.	.	.	0.0	-2.24	0.000	-0.03	1	MU114774	hom
1	183155482	183155482	C	A	LAMC2	UTR5	.	ENSG00000058085	rs684527	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3799	0.2218	0.27476	0.2627	.	.	.	.	.	.	.	.	.	.	AFR:0.1074,AMR:0.3222,EAS:0.4437,FIN:0.4118,NFE:0.2915,OTH:0.3194,ASJ:0.2649	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU82068436	het
1	183177218	183177218	A	G	LAMC2	intronic	.	ENSG00000058085	rs647347	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4739	0.4475	0.496206	0.4515	.	.	.	.	.	.	.	.	.	.	AFR:0.4648,AMR:0.5120,EAS:0.5694,FIN:0.4966,NFE:0.4171,OTH:0.4662,ASJ:0.4073	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU11323905	hom
1	183184616	183184616	C	T	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs2274980	ENSG00000058085:ENST00000264144:exon3:c.C297T:p.S99S,ENSG00000058085:ENST00000493293:exon3:c.C297T:p.S99S	LAMC2:NM_005562:exon3:c.C297T:p.S99S,LAMC2:NM_018891:exon3:c.C297T:p.S99S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2460	0.2461	0.313698	0.2528	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon3:c.C297T:p.S99S,LAMC2:uc001gqa.2:exon3:c.C297T:p.S99S	.	AFR:0.3893,AMR:0.3556,EAS:0.3401,FIN:0.1934,NFE:0.1766,OTH:0.2189,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU59731	hom
1	183187603	183187603	C	T	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1129723	ENSG00000058085:ENST00000264144:exon4:c.C483T:p.V161V,ENSG00000058085:ENST00000493293:exon4:c.C483T:p.V161V	LAMC2:NM_005562:exon4:c.C483T:p.V161V,LAMC2:NM_018891:exon4:c.C483T:p.V161V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2566	0.2461	0.313898	0.2528	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon4:c.C483T:p.V161V,LAMC2:uc001gqa.2:exon4:c.C483T:p.V161V	.	AFR:0.3887,AMR:0.3529,EAS:0.3375,FIN:0.1935,NFE:0.1772,OTH:0.2189,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU81716861	hom
1	183192304	183192304	T	G	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1047980	ENSG00000058085:ENST00000264144:exon7:c.T798G:p.G266G,ENSG00000058085:ENST00000493293:exon7:c.T798G:p.G266G	LAMC2:NM_005562:exon7:c.T798G:p.G266G,LAMC2:NM_018891:exon7:c.T798G:p.G266G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2589	0.2871	0.355032	0.2881	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon7:c.T798G:p.G266G,LAMC2:uc001gqa.2:exon7:c.T798G:p.G266G	.	AFR:0.5103,AMR:0.3687,EAS:0.3410,FIN:0.1934,NFE:0.1782,OTH:0.2223,ASJ:0.1433	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU581268	hom
1	183206573	183206573	G	A	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1047981	ENSG00000058085:ENST00000264144:exon18:c.G2688A:p.Q896Q,ENSG00000058085:ENST00000493293:exon18:c.G2688A:p.Q896Q	LAMC2:NM_005562:exon18:c.G2688A:p.Q896Q,LAMC2:NM_018891:exon18:c.G2688A:p.Q896Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2579	0.2864	0.352436	0.2871	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon18:c.G2688A:p.Q896Q,LAMC2:uc001gqa.2:exon18:c.G2688A:p.Q896Q,LAMC2:uc010poa.2:exon18:c.G1788A:p.Q596Q	.	AFR:0.5071,AMR:0.3648,EAS:0.3428,FIN:0.1929,NFE:0.1780,OTH:0.2254,ASJ:0.1433	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU21003025	hom
1	183212548	183212548	T	G	LAMC2	UTR3	.	ENSG00000058085	rs3768593	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2372	0.2296	0.310903	0.2352	.	.	.	.	.	.	.	.	.	.	AFR:0.3540,AMR:0.3484,EAS:0.3623,FIN:0.1626,NFE:0.1668,OTH:0.2067,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU21936644	hom
1	183542387	183542387	T	C	NCF2	exonic	nonsynonymous SNV	ENSG00000116701	rs2274064	ENSG00000116701:ENST00000413720:exon4:c.A407G:p.K136R,ENSG00000116701:ENST00000367535:exon5:c.A542G:p.K181R,ENSG00000116701:ENST00000367536:exon6:c.A542G:p.K181R	NCF2:NM_001190794:exon4:c.A407G:p.K136R,NCF2:NM_000433:exon5:c.A542G:p.K181R,NCF2:NM_001127651:exon6:c.A542G:p.K181R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4895	0.4300	0.491613	1(breast)	0.553	7.827	0.909	1.27	0.983	.	.	Tetratricopeptide-like helical domain	NCF2:uc010pod.2:exon4:c.A407G:p.K136R,NCF2:uc001gqj.4:exon5:c.A542G:p.K181R,NCF2:uc001gqk.4:exon6:c.A542G:p.K181R	-0.933	AFR:1(lung),AMR:3(urinary_tract),EAS:SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,FIN:0.4535,NFE:0.3690,OTH:0.6005,ASJ:MU117998	608515	233710;	379;	379|CGD<br>Chronic septic granulomatosis|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|233670 233690 233700 233710 306400 613960 ~	.	.	.	.	0.0	-0.17	0.000	0	1	2(thyroid)	0.4238
1	196642969	196642969	-	TT	CFH	intronic	.	ENSG00000000971	rs35507625	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2568	.	0.305711	0.2361	.	.	.	.	.	.	.	.	.	.	AFR:0.1806,AMR:0.2958,EAS:0.5019,FIN:0.2693,NFE:0.2270,OTH:0.2716,ASJ:0.2252	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	.	het
1	196654324	196654324	A	C	CFH	exonic	synonymous SNV	ENSG00000000971	rs1061147	ENSG00000000971:ENST00000359637:exon6:c.A729C:p.A243A,ENSG00000000971:ENST00000367429:exon7:c.A921C:p.A307A,ENSG00000000971:ENST00000439155:exon7:c.A921C:p.A307A	CFH:NM_000186:exon7:c.A921C:p.A307A,CFH:NM_001014975:exon7:c.A921C:p.A307A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6666	0.6081	0.713059	0.6188	.	.	.	.	.	.	.	.	CFH:uc009wyx.3:exon6:c.A729C:p.A243A,CFH:uc001gti.4:exon7:c.A921C:p.A307A,CFH:uc001gtj.4:exon7:c.A921C:p.A307A,CFH:uc009wyw.3:exon7:c.A921C:p.A307A	.	AFR:0.5773,AMR:0.7830,EAS:0.9559,FIN:0.5500,NFE:0.6138,OTH:0.6071,ASJ:0.6689	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	MU155913	hom
1	196659237	196659237	C	T	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs1061170	ENSG00000000971:ENST00000359637:exon8:c.C1012T:p.H338Y,ENSG00000000971:ENST00000367429:exon9:c.C1204T:p.H402Y,ENSG00000000971:ENST00000439155:exon9:c.C1204T:p.H402Y	CFH:NM_000186:exon9:c.C1204T:p.H402Y,CFH:NM_001014975:exon9:c.C1204T:p.H402Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6721	0.6243	0.733427	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-3.918	0.001	1.0	-9.09	0.000	.	.	Sushi/SCR/CCP domain	CFH:uc009wyx.3:exon8:c.C1012T:p.H338Y,CFH:uc001gti.4:exon9:c.C1204T:p.H402Y,CFH:uc001gtj.4:exon9:c.C1204T:p.H402Y,CFH:uc009wyw.3:exon9:c.C1129T:p.H377Y	-1.007	AFR:0.6336,AMR:0.6282,EAS:0.6689,FIN:0.9557,NFE:0.55,OTH:0.6144,ASJ:0.7885	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.03	0.000	.	1	1(large_intestine)	0.6104
1	196661505	196661505	G	C	CFH	intronic	.	ENSG00000000971	rs10922094	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.733227	0.6325	.	.	.	.	.	.	.	.	.	.	AFR:0.6290,AMR:0.7862,EAS:0.9554,FIN:0.5514,NFE:0.6109,OTH:0.6076,ASJ:0.6689	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	MU115452194	hom
1	196682947	196682947	G	A	CFH	exonic	synonymous SNV	ENSG00000000971	rs2274700	ENSG00000000971:ENST00000367429:exon10:c.G1419A:p.A473A	CFH:NM_000186:exon10:c.G1419A:p.A473A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4431	0.4262	0.479034	LAML-KR|4|205|0.0195122,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon10:c.G1419A:p.A473A	.	AFR:0.4239,AMR:0.4696,EAS:0.51,FIN:0.4261,NFE:0.3805,OTH:0.4042,ASJ:0.4412	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	5(haematopoietic_and_lymphoid_tissue)	0.4274
1	196712577	196712577	T	C	CFH	intronic	.	ENSG00000000971	rs513699	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2585	.	.	1(pancreas)	.	.	.	.	.	0	0.028	.	.	.	AFR:MU11352223,AMR:SKCA-BR|1|100|0.01,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|7|205|0.0341463,COCA-CN|4|321|0.0124611,NKTL-SG|1|50|0.02,ESCA-CN|1|332|0.00301205,EAS:0.0245,FIN:0.0230,NFE:0.0144,OTH:0.0716,ASJ:0.0246	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	8(haematopoietic_and_lymphoid_tissue)	0.0147
1	196712586	196712586	C	T	CFH	exonic	synonymous SNV	ENSG00000000971	rs61822181	ENSG00000000971:ENST00000367429:exon20:c.C3138T:p.T1046T	CFH:NM_000186:exon20:c.C3138T:p.T1046T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2657	.	.	2(thyroid)	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon20:c.C3138T:p.T1046T	.	AFR:1(pancreas),AMR:MU4550049,EAS:0.0505,FIN:0.0457,NFE:0.0428,OTH:0.0510,ASJ:SKCA-BR|1|100|0.01,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|6|205|0.0292683,COCA-CN|3|321|0.00934579,NKTL-SG|1|50|0.02	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	6(lung)	0.1337
1	197055925	197055925	T	C	ASPM	intronic	.	ENSG00000066279	rs10754213	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8786	0.7551	0.782748	0.7908	.	.	.	.	.	0	0	.	.	.	AFR:0.4511,AMR:0.9079,EAS:1,FIN:0.9407,NFE:0.9131,OTH:0.9192,ASJ:0.9238	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717435	hom
1	197070776	197070776	C	T	ASPM	exonic	synonymous SNV	ENSG00000066279	rs10922162	ENSG00000066279:ENST00000367409:exon18:c.G7605A:p.V2535V	ASPM:NM_018136:exon18:c.G7605A:p.V2535V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2396	0.1149	0.294928	0.1742	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.G1149A:p.V383V,ASPM:uc001gtu.3:exon18:c.G7605A:p.V2535V	.	AFR:0.0399,AMR:0.4067,EAS:0.7106,FIN:0.2460,NFE:0.1641,OTH:0.2255,ASJ:0.1656	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU698269	hom
1	197070815	197070815	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs1412640	ENSG00000066279:ENST00000367409:exon18:c.A7566G:p.L2522L	ASPM:NM_018136:exon18:c.A7566G:p.L2522L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8876	0.7869	0.815895	0.8174	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.A1110G:p.L370L,ASPM:uc001gtu.3:exon18:c.A7566G:p.L2522L	.	AFR:0.5454,AMR:0.9163,EAS:1,FIN:0.9410,NFE:0.9131,OTH:0.9254,ASJ:0.9272	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717480	hom
1	197070901	197070901	A	G	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs964201	ENSG00000066279:ENST00000367409:exon18:c.T7480C:p.Y2494H	ASPM:NM_018136:exon18:c.T7480C:p.Y2494H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9956	0.9957	0.997404	0.9962	0.626	8.336	1.0	4.83	0.900	.	.	IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.T1024C:p.Y342H,ASPM:uc001gtu.3:exon18:c.T7480C:p.Y2494H	-0.934	AFR:0.9994,AMR:0.9988,EAS:1,FIN:1,NFE:0.9927,OTH:0.9980,ASJ:1	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.001	-0.74	0.000	-2.065	1	MU81717489	hom
1	197091537	197091537	A	T	ASPM	exonic	synonymous SNV	ENSG00000066279	rs4915337	ENSG00000066279:ENST00000367408:exon10:c.T1329A:p.S443S,ENSG00000066279:ENST00000294732:exon14:c.T3579A:p.S1193S,ENSG00000066279:ENST00000367409:exon14:c.T3579A:p.S1193S	ASPM:NM_001206846:exon14:c.T3579A:p.S1193S,ASPM:NM_018136:exon14:c.T3579A:p.S1193S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8779	0.7547	0.782548	0.7906	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon14:c.T3579A:p.S1193S,ASPM:uc001gtv.3:exon14:c.T3579A:p.S1193S	.	AFR:0.4511,AMR:0.9079,EAS:0.9988,FIN:0.9408,NFE:0.9126,OTH:0.9194,ASJ:0.92	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717511	hom
1	197102745	197102745	A	G	ASPM	intronic	.	ENSG00000066279	rs4915344	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2416	0.1140	0.29972	MU795121	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.1757,EAS:0.4029,FIN:0.1656,NFE:0.7078,OTH:0.2457,ASJ:0.0428	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.1640
1	197112533	197112533	G	A	ASPM	exonic	synonymous SNV	ENSG00000066279	rs6677082	ENSG00000066279:ENST00000294732:exon3:c.C849T:p.S283S,ENSG00000066279:ENST00000367409:exon3:c.C849T:p.S283S	ASPM:NM_001206846:exon3:c.C849T:p.S283S,ASPM:NM_018136:exon3:c.C849T:p.S283S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8698	0.7308	0.755591	0.7690	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon3:c.C849T:p.S283S,ASPM:uc001gtv.3:exon3:c.C849T:p.S283S	.	AFR:0.3794,AMR:0.9043,EAS:0.9808,FIN:0.9408,NFE:0.9125,OTH:0.9129,ASJ:0.9205	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU17987338	hom
1	197113073	197113073	G	A	ASPM	intronic	.	ENSG00000066279	rs1571964	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8704	0.7302	0.755591	0.7694	.	.	.	.	.	.	.	.	.	.	AFR:0.3798,AMR:0.9043,EAS:0.9802,FIN:0.9408,NFE:0.9125,OTH:0.9131,ASJ:0.9205	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU17987498	hom
1	198671653	198671653	A	G	PTPRC	exonic	nonsynonymous SNV	ENSG00000081237	rs4915154	ENSG00000081237:ENST00000367367:exon5:c.A379G:p.T127A,ENSG00000081237:ENST00000367376:exon6:c.A571G:p.T191A,ENSG00000081237:ENST00000442510:exon6:c.A577G:p.T193A	PTPRC:NM_002838:exon6:c.A577G:p.T193A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0393	0.0067	0.0563099	MU11357389	-2.273	0.001	.	-11.7	0.049	.	.	.	PTPRC:uc010ppg.2:exon5:c.A379G:p.T127A,PTPRC:uc001gur.2:exon6:c.A577G:p.T193A,PTPRC:uc001guu.1:exon6:c.A700G:p.T234A	-1.092	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.0214,EAS:0.1229,FIN:0.0099,NFE:0.2019,OTH:0.0006,ASJ:0.0057	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	0.008	4.31	0.000	0.55	1	1(lung)	0.0105
1	198703306	198703306	C	T	PTPRC	intronic	.	ENSG00000081237	rs6683595	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1938	0.2212	0.278754	0.2181	.	.	.	.	.	.	.	.	.	.	AFR:0.3838,AMR:0.3165,EAS:0.2680,FIN:0.1180,NFE:0.1410,OTH:0.1373,ASJ:0.1325	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	MU11357414	het
1	198704294	198704294	C	T	PTPRC	exonic	synonymous SNV	ENSG00000081237	rs7540378	ENSG00000081237:ENST00000348564:exon20:c.C1833T:p.G611G,ENSG00000081237:ENST00000594404:exon20:c.C1827T:p.G609G,ENSG00000081237:ENST00000352140:exon22:c.C2166T:p.G722G,ENSG00000081237:ENST00000367367:exon22:c.C2118T:p.G706G,ENSG00000081237:ENST00000529828:exon22:c.C2172T:p.G724G,ENSG00000081237:ENST00000367376:exon23:c.C2310T:p.G770G,ENSG00000081237:ENST00000442510:exon23:c.C2316T:p.G772G	PTPRC:NM_080921:exon20:c.C1833T:p.G611G,PTPRC:NM_002838:exon23:c.C2316T:p.G772G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1683	0.1639	0.226238	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PTPRC:uc001gut.2:exon20:c.C1833T:p.G611G,PTPRC:uc010ppg.2:exon22:c.C2118T:p.G706G,PTPRC:uc021pgy.2:exon22:c.C2172T:p.G724G,PTPRC:uc001gur.2:exon23:c.C2316T:p.G772G	.	AFR:0.1624,AMR:0.2423,EAS:0.1291,FIN:0.2645,NFE:0.0688,OTH:0.1234,ASJ:0.2940	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	0.1150
1	198717219	198717220	TT	-	PTPRC	intronic	.	ENSG00000081237	rs546749152	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2059	.	0.279553	0.1991	.	.	.	.	.	.	.	.	.	.	AFR:0.3068,AMR:0.3094,EAS:0.2757,FIN:0.0693,NFE:0.1311,OTH:0.1295,ASJ:0.1445	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	.	unknown
1	200522566	200522566	G	C	KIF14	exonic	nonsynonymous SNV	ENSG00000118193	rs12120084	ENSG00000118193:ENST00000367350:exon30:c.C4897G:p.P1633A	KIF14:NM_001305792:exon28:c.C3424G:p.P1142A,KIF14:NM_014875:exon30:c.C4897G:p.P1633A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3203	0.3058	0.219649	0.2696	-0.976	0.018	0.091	0.605	0.017	.	.	.	KIF14:uc010ppj.1:exon28:c.C3424G:p.P1142A,KIF14:uc010ppk.1:exon30:c.C4897G:p.P1633A	-1.020	AFR:0.0894,AMR:0.2093,EAS:0.2261,FIN:0.2695,NFE:0.3773,OTH:0.3020,ASJ:0.4272	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	0.307	-0.77	0.000	1.195	1	MU102596	het
1	200534248	200534248	C	T	KIF14	exonic	synonymous SNV	ENSG00000118193	rs7543730	ENSG00000118193:ENST00000367350:exon25:c.G4020A:p.E1340E	KIF14:NM_001305792:exon23:c.G2547A:p.E849E,KIF14:NM_014875:exon25:c.G4020A:p.E1340E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5717	0.5359	0.563498	0.5250	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon23:c.G2547A:p.E849E,KIF14:uc010ppk.1:exon25:c.G4020A:p.E1340E	.	AFR:0.4177,AMR:0.4868,EAS:0.6865,FIN:0.5287,NFE:0.5686,OTH:0.5400,ASJ:0.6093	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU708297	het
1	200558363	200558363	T	C	KIF14	exonic	synonymous SNV	ENSG00000118193	rs6665951	ENSG00000118193:ENST00000367350:exon18:c.A3096G:p.E1032E	KIF14:NM_001305792:exon16:c.A1623G:p.E541E,KIF14:NM_014875:exon18:c.A3096G:p.E1032E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7515	0.8067	0.766573	0.7926	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon16:c.A1623G:p.E541E,KIF14:uc010ppk.1:exon18:c.A3096G:p.E1032E	.	AFR:0.8873,AMR:0.6100,EAS:0.6856,FIN:0.7478,NFE:0.7711,OTH:0.7556,ASJ:0.8411	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU9422538	het
1	200584735	200584735	T	C	KIF14	exonic	nonsynonymous SNV	ENSG00000118193	rs766030658	ENSG00000118193:ENST00000367350:exon3:c.A1115G:p.E372G	KIF14:NM_014875:exon3:c.A1115G:p.E372G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	5.958e-05	.	.	.	6.367	29.4	0.006	5.64	0.998	.	.	Kinesin motor domain|P-loop containing nucleoside triphosphate hydrolase	KIF14:uc010ppk.1:exon3:c.A1115G:p.E372G	0.729	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	1.0	-1.07	0.736	3.385	1	.	het
1	201016296	201016296	G	A	CACNA1S	exonic	nonsynonymous SNV	ENSG00000081248	rs3850625	ENSG00000081248:ENST00000367338:exon37:c.C4558T:p.R1520C,ENSG00000081248:ENST00000362061:exon38:c.C4615T:p.R1539C	CACNA1S:NM_000069:exon38:c.C4615T:p.R1539C	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1172	0.0893	0.0840655	1(skin)	7.420	34	0.008	5.17	1.000	.	.	Voltage-dependent calcium channel, alpha-1 subunit, IQ domain	CACNA1S:uc001gvv.3:exon38:c.C4615T:p.R1539C	-0.915	AFR:MU154669,AMR:COCA-CN|1|321|0.00311526,EOPC-DE|1|202|0.0049505,GACA-JP|1|585|0.0017094,EAS:0.0235,FIN:0.1086,NFE:0.1026,OTH:0.0304,ASJ:0.0947	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	0.736	-0.47	0.006	2.02	1	1(urinary_tract)	0.1557
1	201020105	201020105	A	G	CACNA1S	intronic	.	ENSG00000081248	rs6702590	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7705	0.7548	0.880391	0.7864	.	.	.	.	.	0	0	.	.	.	AFR:0.9291,AMR:0.8532,EAS:0.9975,FIN:0.7546,NFE:0.6883,OTH:0.7332,ASJ:0.7450	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU32834473	hom
1	201044748	201044748	A	G	CACNA1S	intronic	.	ENSG00000081248	rs1998721	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7814	0.7033	0.759585	0.7224	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5560,AMR:0.7148,EAS:0.9470,FIN:0.7916,NFE:0.7745,OTH:0.7827,ASJ:0.7583	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU81717919	hom
1	201060865	201060865	G	A	CACNA1S	exonic	synonymous SNV	ENSG00000081248	rs2296383	ENSG00000081248:ENST00000362061:exon5:c.C597T:p.I199I,ENSG00000081248:ENST00000367338:exon5:c.C597T:p.I199I	CACNA1S:NM_000069:exon5:c.C597T:p.I199I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3887	0.3298	0.305112	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	CACNA1S:uc001gvv.3:exon5:c.C597T:p.I199I	.	AFR:0.3251,AMR:0.1063,EAS:0.4503,FIN:0.3453,NFE:0.3780,OTH:0.4281,ASJ:0.3421	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	1(bone)	0.4236
1	201334382	201334382	G	A	TNNT2	exonic	synonymous SNV	ENSG00000118194	rs3729547	ENSG00000118194:ENST00000360372:exon7:c.C303T:p.I101I,ENSG00000118194:ENST00000236918:exon8:c.C333T:p.I111I,ENSG00000118194:ENST00000367315:exon8:c.C318T:p.I106I,ENSG00000118194:ENST00000367317:exon8:c.C318T:p.I106I,ENSG00000118194:ENST00000438742:exon8:c.C303T:p.I101I,ENSG00000118194:ENST00000367318:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000367322:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000421663:exon9:c.C324T:p.I108I,ENSG00000118194:ENST00000422165:exon9:c.C333T:p.I111I,ENSG00000118194:ENST00000509001:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000455702:exon10:c.C348T:p.I116I,ENSG00000118194:ENST00000458432:exon10:c.C354T:p.I118I	TNNT2:NM_001001432:exon8:c.C303T:p.I101I,TNNT2:NM_001001430:exon9:c.C318T:p.I106I,TNNT2:NM_001001431:exon9:c.C318T:p.I106I,TNNT2:NM_001276347:exon9:c.C318T:p.I106I,TNNT2:NM_000364:exon10:c.C348T:p.I116I,TNNT2:NM_001276345:exon10:c.C348T:p.I116I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7194	0.6828	0.695088	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TNNT2:uc009wzs.1:exon3:c.C243T:p.I81I,TNNT2:uc001gwk.1:exon7:c.C141T:p.I47I,TNNT2:uc009wzr.4:exon7:c.C141T:p.I47I,TNNT2:uc001gwh.4:exon8:c.C291T:p.I97I,TNNT2:uc021phc.2:exon8:c.C318T:p.I106I,TNNT2:uc001gwg.4:exon9:c.C318T:p.I106I,TNNT2:uc009wzt.2:exon9:c.C318T:p.I106I,TNNT2:uc001gwf.4:exon10:c.C348T:p.I116I	.	AFR:MU109570,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6157,FIN:0.7685,NFE:0.7682,OTH:0.5336,ASJ:0.6921	191045	115195;601494;612422;	75249;154;54260;	75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	1(thyroid)	0.7944
1	201341176	201341180	AGAAG	-	TNNT2	intronic	.	ENSG00000118194	rs45533739	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5919	.	0.520367	0.5292	.	.	.	.	.	.	.	.	.	.	AFR:0.3040,AMR:0.6776,EAS:0.4630,FIN:0.6784,NFE:0.6170,OTH:0.6173,ASJ:0.6333	191045	115195;601494;612422;	75249;154;54260;	75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	.	het
1	202304868	202304868	T	C	UBE2T	exonic	synonymous SNV	ENSG00000077152	rs14451	ENSG00000077152:ENST00000367274:exon2:c.A15G:p.S5S	UBE2T:NM_014176:exon2:c.A15G:p.S5S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4584	0.4882	0.390575	0.4724	.	.	.	.	.	.	.	.	UBE2T:uc001gxx.4:exon2:c.A15G:p.S5S	.	AFR:0.4281,AMR:0.3254,EAS:0.3290,FIN:0.5312,NFE:0.5025,OTH:0.4990,ASJ:0.6656	610538	616435;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	1	MU145935	hom
1	204400783	204400783	A	G	PIK3C2B	intronic	.	ENSG00000226330	rs2271421	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1404	0.0741	0.191294	1(lung)	.	.	.	.	.	.	.	.	.	.	AFR:4(soft_tissue),AMR:MU11367805,EAS:0.1021,FIN:0.0370,NFE:0.0990,OTH:0.0795,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	602838	.	.	.	.	.	.	.	.	.	.	.	1	18(meninges)	0.4553
1	204413297	204413297	C	T	PIK3C2B	intronic	.	ENSG00000133056	rs2292459	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7286	0.7105	0.610823	MU813473	.	.	.	.	.	0.0004	0.054	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6782,EAS:0.7578,FIN:0.8433,NFE:0.4751,OTH:0.7230,ASJ:0.4977	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7839
1	204413299	204413299	G	A	PIK3C2B	intronic	.	ENSG00000133056	rs2292460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7081	0.6927	0.561502	MU731753	.	.	.	.	.	0	0.006	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6541,EAS:0.7458,FIN:0.8267,NFE:0.3269,OTH:0.7226,ASJ:0.4457	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7821
1	204416111	204416111	A	G	PIK3C2B	intronic	.	ENSG00000133056	rs3106365	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.865815	0.9020	.	.	.	.	.	.	.	.	.	.	AFR:0.6910,AMR:0.9618,EAS:0.8517,FIN:0.9997,NFE:0.9969,OTH:0.9816,ASJ:0.9801	602838	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	204438334	204438334	C	T	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs1124777	ENSG00000133056:ENST00000367187:exon3:c.G597A:p.P199P,ENSG00000133056:ENST00000424712:exon3:c.G597A:p.P199P	PIK3C2B:NM_002646:exon3:c.G597A:p.P199P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8916	0.7767	0.728035	0.7878	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon2:c.G597A:p.P199P,PIK3C2B:uc001haw.3:exon3:c.G597A:p.P199P,PIK3C2B:uc010pqv.2:exon3:c.G597A:p.P199P	.	AFR:0.3585,AMR:0.8413,EAS:0.7540,FIN:0.9648,NFE:0.9841,OTH:0.9265,ASJ:0.9636	602838	.	.	.	.	.	.	.	.	.	.	.	1	MU17996773	hom
1	204438643	204438643	G	T	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs1553921	ENSG00000133056:ENST00000415899:exon2:c.C288A:p.L96L,ENSG00000133056:ENST00000367187:exon3:c.C288A:p.L96L,ENSG00000133056:ENST00000424712:exon3:c.C288A:p.L96L	PIK3C2B:NM_002646:exon3:c.C288A:p.L96L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8903	0.7763	0.727236	0.7869	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon2:c.C288A:p.L96L,PIK3C2B:uc001haw.3:exon3:c.C288A:p.L96L,PIK3C2B:uc010pqv.2:exon3:c.C288A:p.L96L	.	AFR:0.3551,AMR:0.8405,EAS:0.7531,FIN:0.9645,NFE:0.9840,OTH:0.9264,ASJ:0.9636	602838	.	.	.	.	.	.	.	.	.	.	.	1	MU17996820	hom
1	204494436	204494436	C	T	MDM4	intronic	.	ENSG00000198625	rs3789051	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.307708	0.3891	.	.	.	.	.	.	.	.	.	.	AFR:0.1278,AMR:0.4988,EAS:0.2761,FIN:0.5705,NFE:0.4991,OTH:0.4673,ASJ:0.4267	602704	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	204516025	204516025	A	G	MDM4	intronic	.	ENSG00000198625	rs2290854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6451	0.5536	0.539337	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6003,AMR:0.2930,EAS:0.6324,FIN:0.6473,NFE:0.7944,OTH:0.7221,ASJ:0.5993	602704	.	.	.	.	.	.	.	.	.	.	.	1	4(soft_tissue)	0.6908
1	206647742	206647742	A	G	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539242	ENSG00000143466:ENST00000367120:exon4:c.A156G:p.Q52Q	IKBKE:NM_001193322:exon4:c.A156G:p.Q52Q,IKBKE:NM_014002:exon4:c.A156G:p.Q52Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9984	0.999401	0.9985	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbu.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbv.2:exon4:c.A156G:p.Q52Q	.	AFR:0.9998,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9974,OTH:0.9980,ASJ:1	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU4564045	hom
1	206647787	206647787	T	C	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539243	ENSG00000143466:ENST00000367120:exon4:c.T201C:p.I67I	IKBKE:NM_001193322:exon4:c.T201C:p.I67I,IKBKE:NM_014002:exon4:c.T201C:p.I67I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8591	0.8459	0.899161	0.8525	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbu.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbv.2:exon4:c.T201C:p.I67I	.	AFR:0.8711,AMR:0.9129,EAS:0.9846,FIN:0.8333,NFE:0.8311,OTH:0.8299,ASJ:0.7947	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU81719582	hom
1	206651107	206651107	G	A	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs2297545	ENSG00000143466:ENST00000537984:exon7:c.G462A:p.T154T,ENSG00000143466:ENST00000367120:exon8:c.G717A:p.T239T	IKBKE:NM_001193321:exon7:c.G462A:p.T154T,IKBKE:NM_001193322:exon8:c.G717A:p.T239T,IKBKE:NM_014002:exon8:c.G717A:p.T239T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3248	0.1942	0.315495	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	IKBKE:uc001hea.2:exon7:c.G462A:p.T154T,IKBKE:uc001hdz.2:exon8:c.G717A:p.T239T,IKBKE:uc009xbu.2:exon8:c.G717A:p.T239T,IKBKE:uc009xbv.2:exon8:c.G717A:p.T239T	.	AFR:0.2324,AMR:0.1714,EAS:0.2252,FIN:0.6378,NFE:0.2370,OTH:0.2155,ASJ:0.3493	605048	.	.	.	.	.	.	.	.	.	.	.	1	1(thyroid)	0.2480
1	206658354	206658354	C	T	IKBKE	exonic	nonsynonymous SNV	ENSG00000143466	rs52817862	ENSG00000143466:ENST00000537984:exon13:c.C1193T:p.T398M,ENSG00000143466:ENST00000367120:exon14:c.C1448T:p.T483M	IKBKE:NM_001193321:exon13:c.C1193T:p.T398M,IKBKE:NM_001193322:exon14:c.C1448T:p.T483M,IKBKE:NM_014002:exon14:c.C1448T:p.T483M	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	0.0012	7.7e-05	0.00259585	0.0010	-0.479	0.248	.	-8.84	0.001	.	.	.	IKBKE:uc001hea.2:exon13:c.C1193T:p.T398M,IKBKE:uc001hdz.2:exon14:c.C1448T:p.T483M,IKBKE:uc009xbv.2:exon14:c.C1448T:p.T483M	-1.022	AFR:0.0003,AMR:0.0012,EAS:0.0173,FIN:0,NFE:0,OTH:0,ASJ:0	605048	.	.	.	.	.	.	.	0.004	-0.07	0.034	0.29	1	.	het
1	206669465	206669465	C	T	IKBKE	exonic	nonsynonymous SNV	ENSG00000143466	rs3748022	ENSG00000143466:ENST00000537984:exon21:c.C1883T:p.P628L,ENSG00000143466:ENST00000367120:exon22:c.C2138T:p.P713L	IKBKE:NM_001193321:exon21:c.C1883T:p.P628L,IKBKE:NM_014002:exon22:c.C2138T:p.P713L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1930	0.1592	0.148163	1(haematopoietic_and_lymphoid_tissue)	2.072	16.67	.	3.45	0.437	.	.	.	IKBKE:uc001hea.2:exon21:c.C1883T:p.P628L,IKBKE:uc001hdz.2:exon22:c.C2138T:p.P713L	-1.059	AFR:1(large_intestine),AMR:MU91278,EAS:0.1675,FIN:0.0406,NFE:0.2602,OTH:0.1821,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579	605048	.	.	.	.	.	.	.	0.03	0.16	0.000	1.1	1	7(soft_tissue)	0.2042
1	209968684	209968684	C	A	IRF6	exonic	synonymous SNV	ENSG00000117595	rs2013162	ENSG00000117595:ENST00000542854:exon3:c.G174T:p.S58S,ENSG00000117595:ENST00000456314:exon4:c.G459T:p.S153S,ENSG00000117595:ENST00000367021:exon5:c.G459T:p.S153S	IRF6:NM_001206696:exon3:c.G174T:p.S58S,IRF6:NM_006147:exon5:c.G459T:p.S153S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4020	0.3424	0.403754	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	IRF6:uc010psm.2:exon3:c.G174T:p.S58S,IRF6:uc001hhq.2:exon5:c.G459T:p.S153S	.	AFR:0.3578,AMR:0.2733,EAS:0.3221,FIN:0.5602,NFE:0.3787,OTH:0.3706,ASJ:0.5119	607199	119300;119500;608864;	199306;1300;888;	199306|Alveolar cleft lip and palate<br>Cleft lip and palate<br>Cleft lip-alveolus-palate syndrome<br>FLP|1-5 / 10 000|Multigenic/multifactorial|Infancy<br>Neonatal|119530 129400 225060 600625 600757 602966 608371 608864 608874 610361 612858 613705 616788 ~1300|Facio-genito-popliteal syndrome<br>Popliteal web syndrome|1-9 / 1 000 000|Autosomal dominant|Neonatal|119500 ~888|Cleft lip/palate with mucous cysts of lower lip<br>Lip-pit syndrome<br>VWS|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|119300 604547 606713 ~	.	.	.	.	.	.	.	.	1	1(thyroid)	0.3845
1	209969902	209969902	G	C	IRF6	intronic	.	ENSG00000117595	rs7552506	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3260	0.3305	0.270966	0.3190	.	.	.	.	.	0.0021	0.074	.	.	.	AFR:0.2673,AMR:0.3074,EAS:0.1422,FIN:0.3629,NFE:0.3574,OTH:0.3442,ASJ:0.2967	607199	119300;119500;608864;	199306;1300;888;	199306|Alveolar cleft lip and palate<br>Cleft lip and palate<br>Cleft lip-alveolus-palate syndrome<br>FLP|1-5 / 10 000|Multigenic/multifactorial|Infancy<br>Neonatal|119530 129400 225060 600625 600757 602966 608371 608864 608874 610361 612858 613705 616788 ~1300|Facio-genito-popliteal syndrome<br>Popliteal web syndrome|1-9 / 1 000 000|Autosomal dominant|Neonatal|119500 ~888|Cleft lip/palate with mucous cysts of lower lip<br>Lip-pit syndrome<br>VWS|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|119300 604547 606713 ~	.	.	.	.	.	.	.	.	1	MU82172777	het
1	226016633	226016633	G	A	EPHX1	intronic	.	ENSG00000143819	rs3738047	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1361	0.0613	0.120607	0.0760	.	.	.	.	.	.	.	.	.	.	AFR:0.0159,AMR:0.1838,EAS:0.2153,FIN:0.0926,NFE:0.0824,OTH:0.1133,ASJ:0.1325	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	1	MU18510300	het
1	226027068	226027069	GT	-	EPHX1	intronic	.	ENSG00000143819	rs878921666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	1	.	het
1	226259113	226259113	C	G	H3F3A	exonic	nonsynonymous SNV	ENSG00000163041	rs749423281	ENSG00000163041:ENST00000366813:exon3:c.C344G:p.A115G,ENSG00000163041:ENST00000366815:exon4:c.C344G:p.A115G,ENSG00000163041:ENST00000366816:exon5:c.C344G:p.A115G	H3F3A:NM_002107:exon4:c.C344G:p.A115G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0105	.	.	5(upper_aerodigestive_tract)	6.237	28.8	.	5.83	1.000	.	.	Histone H2A/H2B/H3|Histone-fold	H3F3AP4:uc021pjv.1:exon3:c.C344G:p.A115G,H3F3A:uc001hpw.3:exon4:c.C344G:p.A115G	-0.983	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:2(liver),EAS:LICA-CN|1|402|0.00248756,GACA-CN|1|123|0.00813008,BLCA-CN|1|103|0.00970874,FIN:0.0002,NFE:0.0004,OTH:0,ASJ:MU4603415	601128	.	.	.	~ko05034 Alcoholism~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	0.015	0.64	0.141	2.9	1	1(stomach)	0
1	226570840	226570840	T	C	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805415	ENSG00000143799:ENST00000366794:exon8:c.A1056G:p.K352K	PARP1:NM_001618:exon8:c.A1056G:p.K352K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7939	0.8601	0.789337	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon8:c.A1056G:p.K352K	.	AFR:MU4559844,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.8962,FIN:0.6388,NFE:0.8411,OTH:0.5603,ASJ:0.8228	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(liver)	0.7643
1	226573364	226573364	A	G	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805414	ENSG00000143799:ENST00000366794:exon7:c.T852C:p.A284A	PARP1:NM_001618:exon7:c.T852C:p.A284A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4228	0.4077	0.516573	MU4559841	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon7:c.T852C:p.A284A	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AMR:0.4306,EAS:0.5060,FIN:0.33,NFE:0.8154,OTH:0.3971,ASJ:0.5477	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.3312
1	226578099	226578099	T	C	PARP1	intronic	.	ENSG00000143799	rs1805403	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8059	0.8233	0.857628	0.8477	.	.	.	.	.	.	.	.	.	.	AFR:0.9384,AMR:0.8246,EAS:0.9481,FIN:0.8815,NFE:0.7819,OTH:0.8255,ASJ:0.6933	173870	.	.	.	.	.	.	.	.	.	.	.	1	MU18520760	hom
1	226580021	226580021	G	T	PARP1	intronic	.	ENSG00000143799	rs1805405	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1944	0.2417	0.255791	0.2283	.	.	.	.	.	0.0304	0.08	.	.	.	AFR:0.3709,AMR:0.1352,EAS:0.3451,FIN:0.1585,NFE:0.1620,OTH:0.1342,ASJ:0.1457	173870	.	.	.	.	.	.	.	.	.	.	.	1	MU737447	het
1	231488524	231488524	C	T	SPRTN	exonic	nonsynonymous SNV	ENSG00000010072	rs2437150	ENSG00000010072:ENST00000295050:exon5:c.C887T:p.P296L	SPRTN:NM_032018:exon5:c.C887T:p.P296L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5988	0.5793	0.532947	0.5920	0.053	3.111	0.293	1.26	0.001	.	.	.	SPRTN:uc001hur.4:exon5:c.C887T:p.P296L	-0.903	AFR:0.4543,AMR:0.5227,EAS:0.5725,FIN:0.6947,NFE:0.6493,OTH:0.6478,ASJ:0.6490	616086	616200;	435953;	435953|Ruijs-Aalfs syndrome|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|616200 ~	.	.	.	.	0.0	0.99	0.000	0.73	1	MU21239736	hom
1	231557634	231557634	-	GGCGGC	EGLN1	UTR5	.	ENSG00000135766	rs574288484	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	4.522e-05	.	.	9.874e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0,ASJ:0	606425	609070;609820;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko04066 HIF-1 signaling pathway~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	1	.	het
1	237551376	237551376	T	A	RYR2	intronic	.	ENSG00000198626	rs10754602	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5751	0.5273	0.55651	0.5325	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.4675,AMR:0.7446,EAS:0.6148,FIN:0.5416,NFE:0.5458,OTH:0.5662,ASJ:0.5033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU24513954	het
1	237617757	237617757	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs3765097	ENSG00000198626:ENST00000542537:exon14:c.C1311T:p.S437S,ENSG00000198626:ENST00000366574:exon15:c.C1359T:p.S453S,ENSG00000198626:ENST00000360064:exon16:c.C1353T:p.S451S	RYR2:NM_001035:exon15:c.C1359T:p.S453S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5755	0.5119	0.535743	0.5238	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon15:c.C1359T:p.S453S	.	AFR:0.3184,AMR:0.5897,EAS:0.7073,FIN:0.5894,NFE:0.5988,OTH:0.5867,ASJ:0.6033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU18032197	het
1	237620049	237620049	T	C	RYR2	intronic	.	ENSG00000198626	rs2045955	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5514	0.4634	0.53115	0.4984	.	.	.	.	.	.	.	.	.	.	AFR:0.3107,AMR:0.5624,EAS:0.7823,FIN:0.5657,NFE:0.5521,OTH:0.5643,ASJ:0.57	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU786721	het
1	237711797	237711797	A	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2253273	ENSG00000198626:ENST00000542537:exon25:c.A2925G:p.S975S,ENSG00000198626:ENST00000366574:exon26:c.A2973G:p.S991S,ENSG00000198626:ENST00000360064:exon27:c.A2967G:p.S989S	RYR2:NM_001035:exon26:c.A2973G:p.S991S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9262	0.8511	0.830272	0.8540	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon26:c.A2973G:p.S991S	.	AFR:0.6002,AMR:0.9414,EAS:0.8838,FIN:0.9762,NFE:0.9567,OTH:0.9450,ASJ:0.9603	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU4558519	hom
1	237753075	237753075	T	-	RYR2	intronic	.	ENSG00000198626	rs11331089	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4622	0.3469	0.285144	0.3537	.	.	.	.	.	.	.	.	.	.	AFR:0.1250,AMR:0.5570,EAS:0.2506,FIN:0.4796,NFE:0.4511,OTH:0.4165,ASJ:0.4467	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	.	het
1	237801770	237801770	T	C	RYR2	exonic	synonymous SNV	ENSG00000198626	rs707189	ENSG00000198626:ENST00000542537:exon44:c.T6858C:p.L2286L,ENSG00000198626:ENST00000366574:exon45:c.T6906C:p.L2302L,ENSG00000198626:ENST00000360064:exon46:c.T6900C:p.L2300L	RYR2:NM_001035:exon45:c.T6906C:p.L2302L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9884	0.9592	0.954872	0.9641	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon45:c.T6906C:p.L2302L	.	AFR:0.8753,AMR:0.9881,EAS:1,FIN:0.9994,NFE:0.9999,OTH:0.9898,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724737	hom
1	237814783	237814783	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs684923	ENSG00000198626:ENST00000542537:exon50:c.C7758T:p.H2586H,ENSG00000198626:ENST00000366574:exon51:c.C7806T:p.H2602H,ENSG00000198626:ENST00000360064:exon52:c.C7800T:p.H2600H	RYR2:NM_001035:exon51:c.C7806T:p.H2602H	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5198	0.4507	0.554912	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon51:c.C7806T:p.H2602H	.	AFR:0.4881,AMR:0.5021,EAS:0.2947,FIN:0.8125,NFE:0.4991,OTH:0.4477,ASJ:0.4940	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.4603
1	237841390	237841390	A	G	RYR2	exonic	nonsynonymous SNV	ENSG00000198626	rs34967813	ENSG00000198626:ENST00000542537:exon60:c.A8825G:p.Q2942R,ENSG00000198626:ENST00000366574:exon61:c.A8873G:p.Q2958R,ENSG00000198626:ENST00000360064:exon62:c.A8867G:p.Q2956R	RYR2:NM_001035:exon61:c.A8873G:p.Q2958R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2533	0.2249	0.0992412	LUSC-KR|1|170|0.00588235	2.365	18.59	0.473	5.67	0.988	.	.	.	RYR2:uc001hyl.1:exon61:c.A8873G:p.Q2958R	-1.093	AFR:0.2111,AMR:0.0510,EAS:0.2285,FIN:0.0006,NFE:0.2433,OTH:0.3170,ASJ:0.1827	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.287	-0.29	0.000	0.725	1	1(large_intestine)	0.2715
1	237863718	237863718	T	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797436	ENSG00000198626:ENST00000542537:exon64:c.T9270G:p.S3090S,ENSG00000198626:ENST00000366574:exon65:c.T9318G:p.S3106S,ENSG00000198626:ENST00000360064:exon66:c.T9312G:p.S3104S	RYR2:NM_001035:exon65:c.T9318G:p.S3106S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9917	0.9718	0.969249	0.9715	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon4:c.T183G:p.S61S,RYR2:uc001hyl.1:exon65:c.T9318G:p.S3106S	.	AFR:0.9005,AMR:0.9964,EAS:1,FIN:1,NFE:0.9993,OTH:0.9969,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724751	hom
1	237881770	237881770	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797441	ENSG00000198626:ENST00000542537:exon72:c.C10455T:p.T3485T,ENSG00000198626:ENST00000366574:exon73:c.C10503T:p.T3501T,ENSG00000198626:ENST00000360064:exon74:c.C10497T:p.T3499T	RYR2:NM_001035:exon73:c.C10503T:p.T3501T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9886	0.9616	0.960463	0.9623	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon12:c.C1368T:p.T456T,RYR2:uc001hyl.1:exon73:c.C10503T:p.T3501T	.	AFR:0.8678,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724767	hom
1	237890437	237890437	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2685301	ENSG00000198626:ENST00000542537:exon75:c.C10728T:p.S3576S,ENSG00000198626:ENST00000366574:exon76:c.C10776T:p.S3592S,ENSG00000198626:ENST00000360064:exon77:c.C10770T:p.S3590S	RYR2:NM_001035:exon76:c.C10776T:p.S3592S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9885	0.9608	0.960264	0.9625	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon76:c.C10776T:p.S3592S	.	AFR:0.8687,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724775	hom
1	237893674	237893674	C	T	RYR2	intronic	.	ENSG00000198626	rs2797445	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9954	0.9854	0.985224	0.9853	.	.	.	.	.	.	.	.	.	.	AFR:0.9485,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724780	hom
1	237951451	237951451	A	G	RYR2	intronic	.	ENSG00000198626	rs2256242	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5750	0.6176	0.636581	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.6090,AMR:0.7662,EAS:0.6258,FIN:0.6894,NFE:0.5272,OTH:0.5375,ASJ:0.4749	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.5723
1	237957161	237957161	A	G	RYR2	intronic	.	ENSG00000198626	rs790901	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7399	0.6514	0.757588	0.6830	.	.	.	.	.	0	0	.	.	.	AFR:0.5929,AMR:0.8091,EAS:0.9580,FIN:0.6922,NFE:0.6941,OTH:0.7182,ASJ:0.6821	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU13920819	hom
1	237957309	237957309	A	C	RYR2	intronic	.	ENSG00000198626	rs790900	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7273	0.6478	0.750799	0.6803	.	.	.	.	.	.	.	.	.	.	AFR:0.6020,AMR:0.7995,EAS:0.9579,FIN:0.6896,NFE:0.6851,OTH:0.7122,ASJ:0.6755	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU13920863	hom
1	241663902	241663902	-	GAGAGAGA	FH	intronic	.	ENSG00000091483	rs144131869	.	.	clinvar: Uncertain_significance 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.0823	.	.	.	.	.	.	.	.	.	.	AFR:0.1492,AMR:0.0655,EAS:0.0865,FIN:0.0661,NFE:0.0535,OTH:0.0589,ASJ:0.0714	136850	150800;606812;	24;523;	24|Fumarase deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|606812 ~523|Familial leiomyomatosis and renal cell cancer<br>Familial leiomyomatosis cutis et uteri<br>Familial leiomyomatosis with renal carcinoma<br>Familial multiple cutaneous leiomyomas<br>HLRCC<br>Hereditary leiomyomatosis<br>Hereditary leiomyomatosis with renal carcinoma<br>Hereditary multiple cutaneous leiomyomas<br>MCUL<br>Multiple cutaneous and uterine leiomyomas<br>Reed syndrome|Unknown|Autosomal dominant|Adolescent<br>Adult<br>Elderly|150800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04934 Cushing syndrome~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00011 Citrate cycle, second carbon oxidation, 2-oxoglutarate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00376 3-Hydroxypropionate bi-cycle ~	.	.	.	.	.	.	.	1	MU111726801	unknown
1	242030151	242030151	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs735943	ENSG00000174371:ENST00000348581:exon9:c.A1061G:p.H354R,ENSG00000174371:ENST00000518483:exon9:c.A1061G:p.H354R,ENSG00000174371:ENST00000366548:exon11:c.A1061G:p.H354R	EXO1:NM_003686:exon9:c.A1061G:p.H354R,EXO1:NM_006027:exon9:c.A1061G:p.H354R,EXO1:NM_001319224:exon10:c.A1061G:p.H354R,EXO1:NM_130398:exon11:c.A1061G:p.H354R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5930	0.5674	0.636981	0.6067	-0.879	0.029	0.997	-0.821	0.933	.	.	.	EXO1:uc021plj.1:exon9:c.A1061G:p.H354R,EXO1:uc021plk.1:exon9:c.A1061G:p.H354R,EXO1:uc009xgq.3:exon10:c.A1061G:p.H354R,EXO1:uc001hzh.3:exon11:c.A1061G:p.H354R	-0.990	AFR:0.6181,AMR:0.6770,EAS:0.7866,FIN:0.6154,NFE:0.5774,OTH:0.5922,ASJ:0.5232	606063	.	.	.	.	.	.	.	0.0	1.41	0.000	1.025	1	MU16150612	het
1	242042301	242042301	G	A	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1047840	ENSG00000174371:ENST00000348581:exon11:c.G1765A:p.E589K,ENSG00000174371:ENST00000518483:exon11:c.G1765A:p.E589K,ENSG00000174371:ENST00000366548:exon13:c.G1765A:p.E589K	EXO1:NM_003686:exon11:c.G1765A:p.E589K,EXO1:NM_006027:exon11:c.G1765A:p.E589K,EXO1:NM_001319224:exon12:c.G1762A:p.E588K,EXO1:NM_130398:exon13:c.G1765A:p.E589K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3610	0.4087	0.351637	1(haematopoietic_and_lymphoid_tissue)	-0.283	0.727	1.0	-3.34	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.G1765A:p.E589K,EXO1:uc021plk.1:exon11:c.G1765A:p.E589K,EXO1:uc009xgq.3:exon12:c.G1762A:p.E588K,EXO1:uc001hzh.3:exon13:c.G1765A:p.E589K	-0.938	AFR:1(skin),AMR:MU581675,EAS:0.4007,FIN:0.4647,NFE:0.3720,OTH:0.3808,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|4|205|0.0195122,COCA-CN|2|321|0.00623053	606063	.	.	.	.	.	.	.	0.0	1.24	0.000	-0.6	1	1(prostate)	0.1951
1	242042545	242042545	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1776148	ENSG00000174371:ENST00000348581:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000518483:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000366548:exon13:c.A2009G:p.E670G	EXO1:NM_003686:exon11:c.A2009G:p.E670G,EXO1:NM_006027:exon11:c.A2009G:p.E670G,EXO1:NM_001319224:exon12:c.A2006G:p.E669G,EXO1:NM_130398:exon13:c.A2009G:p.E670G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6573	0.6550	0.681909	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.519	0.197	0.382	-5.51	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.A2009G:p.E670G,EXO1:uc021plk.1:exon11:c.A2009G:p.E670G,EXO1:uc009xgq.3:exon12:c.A2006G:p.E669G,EXO1:uc001hzh.3:exon13:c.A2009G:p.E670G	-1.000	AFR:0.6669,AMR:0.6913,EAS:0.6722,FIN:0.8226,NFE:0.6128,OTH:0.6491,ASJ:0.6885	606063	.	.	.	.	.	.	.	0.0	1.44	0.000	0.41	1	1(thyroid)	0.6373
1	242045275	242045275	C	T	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1635498	ENSG00000174371:ENST00000348581:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000518483:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000366548:exon14:c.C2167T:p.R723C	EXO1:NM_003686:exon12:c.C2167T:p.R723C,EXO1:NM_006027:exon12:c.C2167T:p.R723C,EXO1:NM_001319224:exon13:c.C2164T:p.R722C,EXO1:NM_130398:exon14:c.C2167T:p.R723C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9564	0.9452	0.915335	0.9462	3.117	22.6	0.188	1.84	0.565	.	.	.	EXO1:uc021plj.1:exon12:c.C2167T:p.R723C,EXO1:uc021plk.1:exon12:c.C2167T:p.R723C,EXO1:uc009xgq.3:exon13:c.C2164T:p.R722C,EXO1:uc001hzh.3:exon14:c.C2167T:p.R723C	-0.976	AFR:0.8801,AMR:0.9712,EAS:0.8691,FIN:0.9954,NFE:0.9780,OTH:0.9744,ASJ:0.9669	606063	.	.	.	.	.	.	.	0.85	1.35	0.000	0.345	1	MU18036633	unknown
1	242045283	242045283	T	A	EXO1	exonic	synonymous SNV	ENSG00000174371	rs4149984	ENSG00000174371:ENST00000348581:exon12:c.T2175A:p.S725S,ENSG00000174371:ENST00000518483:exon12:c.T2175A:p.S725S,ENSG00000174371:ENST00000366548:exon14:c.T2175A:p.S725S	EXO1:NM_003686:exon12:c.T2175A:p.S725S,EXO1:NM_006027:exon12:c.T2175A:p.S725S,EXO1:NM_001319224:exon13:c.T2172A:p.S724S,EXO1:NM_130398:exon14:c.T2175A:p.S725S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0333	0.0189	0.0499201	0.0220	.	.	.	.	.	.	.	.	EXO1:uc021plj.1:exon12:c.T2175A:p.S725S,EXO1:uc021plk.1:exon12:c.T2175A:p.S725S,EXO1:uc009xgq.3:exon13:c.T2172A:p.S724S,EXO1:uc001hzh.3:exon14:c.T2175A:p.S725S	.	AFR:0.0097,AMR:0.0191,EAS:0.1306,FIN:0.0055,NFE:0.0213,OTH:0.0215,ASJ:0.0331	606063	.	.	.	.	.	.	.	.	.	.	.	1	MU810734	unknown
1	242048674	242048674	C	T	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs9350	ENSG00000174371:ENST00000348581:exon13:c.C2270T:p.P757L,ENSG00000174371:ENST00000518483:exon13:c.C2270T:p.P757L,ENSG00000174371:ENST00000366548:exon15:c.C2270T:p.P757L	EXO1:NM_003686:exon13:c.C2270T:p.P757L,EXO1:NM_006027:exon13:c.C2270T:p.P757L,EXO1:NM_001319224:exon14:c.C2267T:p.P756L,EXO1:NM_130398:exon15:c.C2270T:p.P757L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2036	0.1674	0.251597	0.1896	6.327	29.3	0.021	6.0	0.611	.	.	.	EXO1:uc021plj.1:exon13:c.C2270T:p.P757L,EXO1:uc021plk.1:exon13:c.C2270T:p.P757L,EXO1:uc009xgq.3:exon14:c.C2267T:p.P756L,EXO1:uc001hzh.3:exon15:c.C2270T:p.P757L	-0.995	AFR:0.1853,AMR:0.3185,EAS:0.4456,FIN:0.1565,NFE:0.1668,OTH:0.1865,ASJ:0.1060	606063	.	.	.	.	.	.	.	0.827	-0.12	0.000	2.43	1	MU151457	het
1	243777040	243777040	G	T	AKT3	exonic	nonsynonymous SNV	ENSG00000117020	.	ENSG00000117020:ENST00000263826:exon7:c.C629A:p.S210Y,ENSG00000117020:ENST00000336199:exon7:c.C629A:p.S210Y,ENSG00000117020:ENST00000366539:exon8:c.C629A:p.S210Y,ENSG00000117020:ENST00000366540:exon8:c.C629A:p.S210Y	AKT3:NM_181690:exon7:c.C629A:p.S210Y,AKT3:NM_001206729:exon8:c.C629A:p.S210Y,AKT3:NM_001370074:exon8:c.C629A:p.S210Y,AKT3:NM_005465:exon8:c.C629A:p.S210Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	5.518	26.3	0.035	5.67	1.000	0.9974	0.872	Protein kinase B gamma, catalytic domain|Protein kinase domain|Protein kinase-like domain	AKT3:uc001hzz.1:exon7:c.C629A:p.S210Y,AKT3:uc001iab.2:exon7:c.C629A:p.S210Y,AKT3:uc021plu.1:exon8:c.C629A:p.S210Y	-1.107	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611223	615937;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.003	1.75	0.082	1.53	1	.	unknown
1	243777041	243777041	A	C	AKT3	exonic	nonsynonymous SNV	ENSG00000117020	.	ENSG00000117020:ENST00000263826:exon7:c.T628G:p.S210A,ENSG00000117020:ENST00000336199:exon7:c.T628G:p.S210A,ENSG00000117020:ENST00000366539:exon8:c.T628G:p.S210A,ENSG00000117020:ENST00000366540:exon8:c.T628G:p.S210A	AKT3:NM_181690:exon7:c.T628G:p.S210A,AKT3:NM_001206729:exon8:c.T628G:p.S210A,AKT3:NM_001370074:exon8:c.T628G:p.S210A,AKT3:NM_005465:exon8:c.T628G:p.S210A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	1.303	12.28	0.987	5.67	0.999	0.0008	0.1	Protein kinase B gamma, catalytic domain|Protein kinase domain|Protein kinase-like domain	AKT3:uc001hzz.1:exon7:c.T628G:p.S210A,AKT3:uc001iab.2:exon7:c.T628G:p.S210A,AKT3:uc021plu.1:exon8:c.T628G:p.S210A	-1.089	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611223	615937;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	1.81	0.038	0.96	1	.	unknown
1	243777050	243777050	-	TTCCTTCCAGAC	AKT3	intronic	.	ENSG00000117020	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611223	615937;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	1	.	unknown
1	247587531	247587531	A	G	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs4925543	ENSG00000162711:ENST00000336119:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000348069:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366496:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000391827:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366497:exon4:c.A786G:p.R262R,ENSG00000162711:ENST00000391828:exon5:c.A786G:p.R262R	NLRP3:NM_001127462:exon3:c.A786G:p.R262R,NLRP3:NM_001243133:exon3:c.A780G:p.R260R,NLRP3:NM_004895:exon3:c.A786G:p.R262R,NLRP3:NM_183395:exon3:c.A786G:p.R262R,NLRP3:NM_001127461:exon4:c.A786G:p.R262R,NLRP3:NM_001079821:exon5:c.A786G:p.R262R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.9188	0.919928	0.9332	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.A780G:p.R260R,NLRP3:uc001icu.3:exon3:c.A786G:p.R262R,NLRP3:uc001icv.3:exon3:c.A786G:p.R262R,NLRP3:uc001icw.3:exon3:c.A786G:p.R262R,NLRP3:uc010pyw.2:exon3:c.A780G:p.R260R,NLRP3:uc001ics.3:exon4:c.A786G:p.R262R,NLRP3:uc001icr.3:exon5:c.A786G:p.R262R	.	AFR:0.8519,AMR:0.9737,EAS:0.9975,FIN:0.9522,NFE:0.9645,OTH:0.9562,ASJ:0.9735	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	MU81725544	hom
1	247588858	247588858	C	A	NLRP3	exonic	nonsynonymous SNV	ENSG00000162711	rs35829419	ENSG00000162711:ENST00000336119:exon3:c.C2113A:p.Q705K,ENSG00000162711:ENST00000348069:exon3:c.C2113A:p.Q705K,ENSG00000162711:ENST00000366496:exon3:c.C2113A:p.Q705K,ENSG00000162711:ENST00000391827:exon3:c.C2113A:p.Q705K,ENSG00000162711:ENST00000366497:exon4:c.C2113A:p.Q705K,ENSG00000162711:ENST00000391828:exon5:c.C2113A:p.Q705K	NLRP3:NM_001127462:exon3:c.C2113A:p.Q705K,NLRP3:NM_001243133:exon3:c.C2107A:p.Q703K,NLRP3:NM_004895:exon3:c.C2113A:p.Q705K,NLRP3:NM_183395:exon3:c.C2113A:p.Q705K,NLRP3:NM_001127461:exon4:c.C2113A:p.Q705K,NLRP3:NM_001079821:exon5:c.C2113A:p.Q705K	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 0] 	0.0409	0.0348	0.0223642	0.0325	-1.102	0.010	0.22	-0.977	0.008	.	.	.	NLRP3:uc001ict.1:exon3:c.C2107A:p.Q703K,NLRP3:uc001icu.3:exon3:c.C2113A:p.Q705K,NLRP3:uc001icv.3:exon3:c.C2113A:p.Q705K,NLRP3:uc001icw.3:exon3:c.C2113A:p.Q705K,NLRP3:uc010pyw.2:exon3:c.C2107A:p.Q703K,NLRP3:uc001ics.3:exon4:c.C2113A:p.Q705K,NLRP3:uc001icr.3:exon5:c.C2113A:p.Q705K	-0.731	AFR:0.0087,AMR:0.0274,EAS:0,FIN:0.0495,NFE:0.0449,OTH:0.0367,ASJ:0.0795	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	0.008	-2.37	0.119	0.695	1	MU115889099	het
2	17884495	17884495	C	T	SMC6	exonic	nonsynonymous SNV	ENSG00000163029	rs1065381	ENSG00000163029:ENST00000351948:exon18:c.G2071A:p.A691T,ENSG00000163029:ENST00000448223:exon19:c.G2071A:p.A691T,ENSG00000163029:ENST00000381272:exon20:c.G2149A:p.A717T,ENSG00000163029:ENST00000446852:exon20:c.G2149A:p.A717T,ENSG00000163029:ENST00000402989:exon21:c.G2071A:p.A691T	SMC6:NM_024624:exon18:c.G2071A:p.A691T,SMC6:NM_001142286:exon19:c.G2071A:p.A691T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2702	0.3278	0.20647	0.3173	1.434	12.96	0.225	1.55	0.949	.	.	.	SMC6:uc002rcn.3:exon18:c.G2071A:p.A691T,SMC6:uc002rcp.1:exon18:c.G2149A:p.A717T,SMC6:uc002rco.3:exon19:c.G2071A:p.A691T,SMC6:uc002rcq.2:exon20:c.G2149A:p.A717T,SMC6:uc010exo.3:exon21:c.G2071A:p.A691T	-0.916	AFR:0.3178,AMR:0.2005,EAS:0.0180,FIN:0.3924,NFE:0.3378,OTH:0.3197,ASJ:0.3377	609387	.	.	.	.	.	.	.	0.0	1.57	0.000	0.205	2	MU22910347	het
2	17897488	17897488	T	C	SMC6	exonic	nonsynonymous SNV	ENSG00000163029	rs35195207	ENSG00000163029:ENST00000351948:exon14:c.A1390G:p.R464G,ENSG00000163029:ENST00000448223:exon15:c.A1390G:p.R464G,ENSG00000163029:ENST00000381272:exon16:c.A1468G:p.R490G,ENSG00000163029:ENST00000446852:exon16:c.A1468G:p.R490G,ENSG00000163029:ENST00000402989:exon17:c.A1390G:p.R464G	SMC6:NM_024624:exon14:c.A1390G:p.R464G,SMC6:NM_001142286:exon15:c.A1390G:p.R464G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1908	0.2025	0.101238	MU139772	3.141	22.6	0.031	4.42	0.994	.	.	.	SMC6:uc002rcn.3:exon14:c.A1390G:p.R464G,SMC6:uc002rcp.1:exon14:c.A1468G:p.R490G,SMC6:uc002rco.3:exon15:c.A1390G:p.R464G,SMC6:uc002rcq.2:exon16:c.A1468G:p.R490G,SMC6:uc010exo.3:exon17:c.A1390G:p.R464G	-0.997	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,AMR:0.1925,EAS:0.1543,FIN:0.2649,NFE:0.0204,OTH:0.2497,ASJ:0.0776	609387	.	.	.	.	.	.	.	0.246	1.56	0.000	1.87	2	1(haematopoietic_and_lymphoid_tissue)	0.2634
2	17954027	17954027	G	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300175	ENSG00000178295:ENST00000528873:exon3:c.G242A:p.S81N,ENSG00000178295:ENST00000317402:exon8:c.G929A:p.S310N,ENSG00000178295:ENST00000381254:exon8:c.G929A:p.S310N	GEN1:NM_001130009:exon8:c.G929A:p.S310N,GEN1:NM_182625:exon8:c.G929A:p.S310N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9932	0.9835	0.977037	0.9882	-3.164	0.001	0.706	-11.3	0.001	.	.	.	GEN1:uc002rct.2:exon8:c.G929A:p.S310N,GEN1:uc002rcu.2:exon8:c.G929A:p.S310N,GEN1:uc010yjs.1:exon8:c.G929A:p.S310N	-0.973	AFR:0.9588,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	612449	.	.	.	.	.	.	.	0.001	0.81	0.000	-0.66	2	MU81728351	hom
2	21225281	21225281	C	T	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs1042034	ENSG00000084674:ENST00000233242:exon29:c.G13013A:p.S4338N	APOB:NM_000384:exon29:c.G13013A:p.S4338N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7057	0.8030	0.629593	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	-1.281	0.005	1.0	1.61	0.002	.	.	Armadillo-type fold	APOB:uc002red.3:exon29:c.G13013A:p.S4338N	-0.975	AFR:0.7647,AMR:0.8537,EAS:0.8576,FIN:0.2640,NFE:0.7441,OTH:0.7720,ASJ:0.7835	107730	144010;615558;	.	.	.	.	.	.	0.0	1.25	0.000	-2.005	2	3(haematopoietic_and_lymphoid_tissue)	0.7118
2	21231524	21231524	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs676210	ENSG00000084674:ENST00000233242:exon26:c.C8216T:p.P2739L	APOB:NM_000384:exon26:c.C8216T:p.P2739L	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2928	0.1965	0.366214	MU156045	5.787	27.1	0.0	5.22	1.000	.	.	.	APOB:uc002red.3:exon26:c.C8216T:p.P2739L	-1.071	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.2347,EAS:0.2153,FIN:0.1424,NFE:0.7298,OTH:0.2563,ASJ:0.1459	107730	144010;615558;	.	.	.	.	.	.	1.0	5.21	0.000	2.785	2	1(large_intestine)	0.2276
2	21232195	21232195	G	A	APOB	exonic	synonymous SNV	ENSG00000084674	rs693	ENSG00000084674:ENST00000233242:exon26:c.C7545T:p.T2515T	APOB:NM_000384:exon26:c.C7545T:p.T2515T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3899	0.4139	0.250998	MU4566531	.	.	.	.	.	.	.	.	APOB:uc002red.3:exon26:c.C7545T:p.T2515T	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.3797,EAS:0.3911,FIN:0.42,NFE:0.0484,OTH:0.4109,ASJ:0.2297	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.4908
2	21232803	21232803	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs584542	ENSG00000084674:ENST00000233242:exon26:c.A6937G:p.I2313V	APOB:NM_000384:exon26:c.A6937G:p.I2313V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9950	0.9816	0.986222	0.9842	-4.107	0.001	0.626	-3.8	0.005	.	.	.	APOB:uc002red.3:exon26:c.A6937G:p.I2313V	-0.985	AFR:0.9457,AMR:0.9976,EAS:0.9981,FIN:1,NFE:0.9996,OTH:0.9969,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	0.002	5.78	0.000	1.465	2	MU81728574	unknown
2	21232804	21232804	G	A	APOB	exonic	synonymous SNV	ENSG00000084674	rs1041968	ENSG00000084674:ENST00000233242:exon26:c.C6936T:p.D2312D	APOB:NM_000384:exon26:c.C6936T:p.D2312D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3891	0.3960	0.249201	LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	APOB:uc002red.3:exon26:c.C6936T:p.D2312D	.	AFR:0.3800,AMR:0.2301,EAS:0.4238,FIN:0.0484,NFE:0.4110,OTH:0.4909,ASJ:0.3909	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	1(urinary_tract)	0.4283
2	21235475	21235475	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs568413	ENSG00000084674:ENST00000233242:exon26:c.A4265G:p.Y1422C	APOB:NM_000384:exon26:c.A4265G:p.Y1422C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9997	1	0.9997	.	.	.	.	.	.	.	.	APOB:uc002red.3:exon26:c.A4265G:p.Y1422C	.	AFR:0.9997,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	MU81728579	hom
2	21250914	21250914	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs679899	ENSG00000084674:ENST00000233242:exon14:c.C1853T:p.A618V,ENSG00000084674:ENST00000399256:exon14:c.C1853T:p.A618V	APOB:NM_000384:exon14:c.C1853T:p.A618V	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4857	0.3655	0.485024	0.4190	5.620	26.6	0.005	5.73	0.712	.	.	Lipid transport protein, N-terminal|Vitellinogen, superhelical	APOB:uc002red.3:exon14:c.C1853T:p.A618V	-0.928	AFR:0.1710,AMR:0.3926,EAS:0.8424,FIN:0.5479,NFE:0.4846,OTH:0.5061,ASJ:0.3576	107730	144010;615558;	.	.	.	.	.	.	1.0	-0.62	0.000	2.695	2	MU4129271	het
2	24905927	24905927	G	C	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125744	ENSG00000084676:ENST00000288599:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000348332:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000395856:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000407230:exon6:c.G9C:p.T3T,ENSG00000084676:ENST00000538539:exon7:c.G462C:p.T154T,ENSG00000084676:ENST00000406961:exon8:c.G462C:p.T154T,ENSG00000084676:ENST00000405141:exon9:c.G462C:p.T154T	NCOA1:NM_147233:exon6:c.G462C:p.T154T,NCOA1:NM_147223:exon7:c.G462C:p.T154T,NCOA1:NM_001362950:exon8:c.G462C:p.T154T,NCOA1:NM_001362952:exon8:c.G462C:p.T154T,NCOA1:NM_001362954:exon8:c.G462C:p.T154T,NCOA1:NM_001362955:exon8:c.G462C:p.T154T,NCOA1:NM_003743:exon8:c.G462C:p.T154T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8689	0.7864	0.80651	0.8160	.	.	.	.	.	.	.	.	NCOA1:uc002rfi.3:exon6:c.G9C:p.T3T,NCOA1:uc002rfj.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfk.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfl.3:exon6:c.G462C:p.T154T,NCOA1:uc010eye.3:exon7:c.G462C:p.T154T	.	AFR:0.5729,AMR:0.9306,EAS:0.9957,FIN:0.9123,NFE:0.9034,OTH:0.8724,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU4558267	hom
2	24974945	24974945	T	G	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125763	ENSG00000084676:ENST00000288599:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000348332:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000395856:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000407230:exon18:c.T3348G:p.L1116L,ENSG00000084676:ENST00000538539:exon19:c.T3801G:p.L1267L,ENSG00000084676:ENST00000406961:exon20:c.T3801G:p.L1267L,ENSG00000084676:ENST00000405141:exon21:c.T3801G:p.L1267L	NCOA1:NM_147233:exon18:c.T3801G:p.L1267L,NCOA1:NM_147223:exon19:c.T3801G:p.L1267L,NCOA1:NM_001362950:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362952:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362954:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362955:exon20:c.T3801G:p.L1267L,NCOA1:NM_003743:exon20:c.T3801G:p.L1267L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8784	0.8189	0.836062	0.8444	.	.	.	.	.	.	.	.	NCOA1:uc010eyf.3:exon2:c.T480G:p.L160L,NCOA1:uc002rfi.3:exon18:c.T3348G:p.L1116L,NCOA1:uc002rfj.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfk.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfl.3:exon18:c.T3801G:p.L1267L,NCOA1:uc010eye.3:exon19:c.T3801G:p.L1267L	.	AFR:0.6732,AMR:0.9368,EAS:0.9957,FIN:0.9118,NFE:0.9033,OTH:0.8763,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU81728834	hom
2	25469502	25469502	C	T	DNMT3A	exonic	synonymous SNV	ENSG00000119772	rs2276598	ENSG00000119772:ENST00000402667:exon5:c.G597A:p.L199L,ENSG00000119772:ENST00000380746:exon6:c.G699A:p.L233L,ENSG00000119772:ENST00000264709:exon10:c.G1266A:p.L422L,ENSG00000119772:ENST00000321117:exon10:c.G1266A:p.L422L,ENSG00000119772:ENST00000380756:exon10:c.G1266A:p.L422L	DNMT3A:NM_001320893:exon5:c.G810A:p.L270L,DNMT3A:NM_153759:exon6:c.G699A:p.L233L,DNMT3A:NM_022552:exon10:c.G1266A:p.L422L,DNMT3A:NM_175629:exon10:c.G1266A:p.L422L	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1913	0.2049	0.223842	1(large_intestine)	.	.	.	.	.	.	.	.	DNMT3A:uc002rgb.4:exon6:c.G699A:p.L233L,DNMT3A:uc002rgc.4:exon10:c.G1266A:p.L422L,DNMT3A:uc002rgd.4:exon10:c.G1266A:p.L422L	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:2(lung),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02,FIN:0.2202,NFE:0.2884,OTH:0.2124,ASJ:MU778215	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	2233,2226,,2236,2225,2229,2228	.	,2227,2231,2234,2232,2235,2230	.	.	.	.	2	1(liver)	0.1921
2	25469913	25469913	C	T	DNMT3A	intronic	.	ENSG00000119772	rs2276599	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7167	0.6863	0.614018	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	.	.	.	.	.	0	0	.	.	.	AFR:0.7006,AMR:0.5654,EAS:0.6656,FIN:0.6001,NFE:0.8238,OTH:0.7565,ASJ:0.7363	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7525
2	25474851	25474851	G	A	DNMT3A	exonic	nonsynonymous SNV	ENSG00000119772	.	.	DNMT3A:NM_001320893:exon1:c.C113T:p.P38L	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	2233,2226,,2236,2225,2229,2228	.	,2227,2231,2234,2232,2235,2230	.	.	.	.	2	.	het
2	25994412	25994412	-	G	ASXL2	intronic	.	ENSG00000143970	rs35322542	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2454	0.2736	0.213458	0.2501	.	.	.	.	.	.	.	.	.	.	AFR:0.2521,AMR:0.1651,EAS:0.0888,FIN:0.2064,NFE:0.2829,OTH:0.2342,ASJ:0.2219	612991	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	27440785	27440785	C	T	CAD	exonic	synonymous SNV	ENSG00000084774	rs1275536	ENSG00000084774:ENST00000264705:exon2:c.C123T:p.T41T,ENSG00000084774:ENST00000403525:exon2:c.C123T:p.T41T	CAD:NM_001306079:exon2:c.C123T:p.T41T,CAD:NM_004341:exon2:c.C123T:p.T41T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9958	0.995807	0.9947	.	.	.	.	.	.	.	.	CAD:uc002rji.3:exon2:c.C123T:p.T41T,CAD:uc010eyw.3:exon2:c.C123T:p.T41T	.	AFR:0.9815,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	MU81729819	hom
2	27460968	27460968	A	G	CAD	exonic	synonymous SNV	ENSG00000084774	rs1141313	ENSG00000084774:ENST00000403525:exon29:c.A4584G:p.A1528A,ENSG00000084774:ENST00000264705:exon30:c.A4773G:p.A1591A	CAD:NM_001306079:exon29:c.A4584G:p.A1528A,CAD:NM_004341:exon30:c.A4773G:p.A1591A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3653	0.4499	0.454673	0.4209	.	.	.	.	.	.	.	.	CAD:uc010eyw.3:exon29:c.A4584G:p.A1528A,CAD:uc002rji.3:exon30:c.A4773G:p.A1591A	.	AFR:0.7635,AMR:0.5552,EAS:0.1469,FIN:0.2536,NFE:0.2903,OTH:0.3265,ASJ:0.3411	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	MU67341713	het
2	27462076	27462076	C	T	CAD	exonic	synonymous SNV	ENSG00000084774	rs3739092	ENSG00000084774:ENST00000403525:exon31:c.C5040T:p.P1680P,ENSG00000084774:ENST00000264705:exon32:c.C5229T:p.P1743P	CAD:NM_001306079:exon31:c.C5040T:p.P1680P,CAD:NM_004341:exon32:c.C5229T:p.P1743P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2681	0.2340	0.265575	MU72482	.	.	.	.	.	.	.	.	CAD:uc010eyw.3:exon31:c.C5040T:p.P1680P,CAD:uc002rji.3:exon32:c.C5229T:p.P1743P	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,AMR:0.2303,EAS:0.4773,FIN:0.2914,NFE:0.1465,OTH:0.2115,ASJ:0.2366	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	1(large_intestine)	0.2242
2	29416572	29416572	T	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs1670283	ENSG00000171094:ENST00000431873:exon4:c.A871G:p.I291V,ENSG00000171094:ENST00000389048:exon29:c.A4381G:p.I1461V	ALK:NM_001353765:exon10:c.A1177G:p.I393V,ALK:NM_004304:exon29:c.A4381G:p.I1461V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.9972	0.9903	0.992212	COCA-CN|5|321|0.0155763	-2.014	0.001	1.0	-0.134	0.001	.	.	.	ALK:uc010ymo.3:exon10:c.A1177G:p.I393V,ALK:uc031rnw.1:exon11:c.A1177G:p.I393V,ALK:uc002rmy.3:exon29:c.A4381G:p.I1461V	-0.987	AFR:0.9907,AMR:0.9680,EAS:0.9934,FIN:1,NFE:1,OTH:0.9999,ASJ:0.9940	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,623,617,624,620,622,621,619,618,616	.	.	0.0	-0.89	0.000	-1.1	2	30(lung)	0.9990
2	29444095	29444095	C	T	ALK	intronic	.	ENSG00000171094	rs1569156	ENSG00000171094:ENST00000453137:exon4:c.G218A:p.W73X	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9757	.	0.914736	0.9329	0.034	2.916	.	-1.17	0.003	.	.	.	.	.	AFR:0.7762,AMR:0.9833,EAS:0.9414,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU23036355	het
2	29445798	29445798	T	C	ALK	intronic	.	ENSG00000171094	rs4666182	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.922923	0.9371	.	.	.	.	.	.	.	.	.	.	AFR:0.7909,AMR:0.9868,EAS:0.9426,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29446701	29446701	T	C	ALK	UTR5	.	ENSG00000171094	rs12619049	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.305711	0.3932	.	.	.	.	.	.	.	.	.	.	AFR:0.4174,AMR:0.2649,EAS:0.1656,FIN:0.3302,NFE:0.4251,OTH:0.3939,ASJ:0.4205	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU22244114	unknown
2	29446721	29446721	A	G	ALK	UTR5	.	ENSG00000171094	rs4665447	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.854633	0.8794	.	.	.	.	.	.	.	.	.	.	AFR:0.6369,AMR:0.9617,EAS:0.9340,FIN:0.9759,NFE:0.9801,OTH:0.9622,ASJ:0.9669	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29447253	29447253	A	G	ALK	intronic	.	ENSG00000171094	rs6723311	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.629393	0.5322	.	.	.	.	.	.	.	.	.	.	AFR:0.4892,AMR:0.7375,EAS:0.8872,FIN:0.5295,NFE:0.5070,OTH:0.5439,ASJ:0.5364	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449345	29449345	A	-	ALK	intronic	.	ENSG00000171094	rs3028223	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.0344	.	.	.	.	.	.	.	.	.	.	AFR:0.1101,AMR:0.0053,EAS:0.0159,FIN:0,NFE:0.0015,OTH:0,ASJ:0	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449526	29449526	C	T	ALK	intronic	.	ENSG00000171094	rs1881419	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.388778	0.3004	.	.	.	.	.	.	.	.	.	.	AFR:0.1990,AMR:0.5,EAS:0.6807,FIN:0.3245,NFE:0.2992,OTH:0.3480,ASJ:0.2649	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29543663	29543663	T	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs2293564	ENSG00000171094:ENST00000389048:exon7:c.A1500G:p.Q500Q	ALK:NM_004304:exon7:c.A1500G:p.Q500Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8716	0.7909	0.776558	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon7:c.A1500G:p.Q500Q	.	AFR:0.8023,AMR:0.5071,EAS:0.8808,FIN:0.9086,NFE:0.9241,OTH:0.9216,ASJ:0.8771	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,623,617,624,620,622,621,619,618,616	.	.	.	.	.	.	2	18(meninges)	0.8939
2	29940529	29940529	A	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs2246745	ENSG00000171094:ENST00000389048:exon2:c.T702A:p.P234P,ENSG00000171094:ENST00000431873:exon2:c.T702A:p.P234P	ALK:NM_004304:exon2:c.T702A:p.P234P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7335	0.6270	0.589257	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon2:c.T702A:p.P234P	.	AFR:0.6361,AMR:0.2397,EAS:0.7881,FIN:0.7342,NFE:0.7362,OTH:0.8163,ASJ:0.7224	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,623,617,624,620,622,621,619,618,616	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7633
2	30143499	30143499	G	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs4358080	ENSG00000171094:ENST00000389048:exon1:c.C27G:p.L9L,ENSG00000171094:ENST00000431873:exon1:c.C27G:p.L9L	ALK:NM_004304:exon1:c.C27G:p.L9L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8949	0.9093	0.89377	0.8892	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon1:c.C27G:p.L9L	.	AFR:0.8349,AMR:0.9459,EAS:1,FIN:0.8627,NFE:0.9123,OTH:0.9002,ASJ:0.8245	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,623,617,624,620,622,621,619,618,616	.	.	.	.	.	.	2	MU84195	hom
2	31178818	31178818	C	T	GALNT14	exonic	synonymous SNV	ENSG00000158089	rs2288100	ENSG00000158089:ENST00000356174:exon4:c.G393A:p.K131K,ENSG00000158089:ENST00000430167:exon4:c.G393A:p.K131K,ENSG00000158089:ENST00000349752:exon5:c.G492A:p.K164K,ENSG00000158089:ENST00000324589:exon6:c.G507A:p.K169K,ENSG00000158089:ENST00000420311:exon6:c.G387A:p.K129K,ENSG00000158089:ENST00000406653:exon7:c.G432A:p.K144K	GALNT14:NM_001329097:exon5:c.G492A:p.K164K,GALNT14:NM_024572:exon5:c.G492A:p.K164K,GALNT14:NM_001253826:exon6:c.G507A:p.K169K,GALNT14:NM_001329095:exon6:c.G387A:p.K129K,GALNT14:NM_001253827:exon7:c.G432A:p.K144K,GALNT14:NM_001329096:exon7:c.G432A:p.K144K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1541	0.1322	0.127995	MU82738	.	.	.	.	.	.	.	.	GALNT14:uc010ezo.2:exon4:c.G393A:p.K131K,GALNT14:uc002rnr.3:exon5:c.G492A:p.K164K,GALNT14:uc002rns.3:exon6:c.G507A:p.K169K,GALNT14:uc010ymr.2:exon6:c.G387A:p.K129K,GALNT14:uc002rnq.3:exon7:c.G432A:p.K144K,GALNT14:uc010ezp.1:exon7:c.G405A:p.K135K	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.1358,EAS:0.0800,FIN:0.3013,NFE:0.1837,OTH:0.1787,ASJ:0.0640	608225	.	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.1599
2	44123759	44123759	G	A	LRPPRC	intronic	.	ENSG00000138095	rs3795859	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1599	0.0823	0.205072	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1099,AMR:0.0266,EAS:0.1325,FIN:0.4553,NFE:0.1376,OTH:0.1069,ASJ:0.2029	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	3(haematopoietic_and_lymphoid_tissue)	0.1469
2	44201376	44201376	T	C	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs4953042	ENSG00000138095:ENST00000260665:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000409659:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000409946:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000447246:exon9:c.A990G:p.Q330Q	LRPPRC:NM_133259:exon9:c.A1068G:p.Q356Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2099	0.1152	0.255791	MU733051	.	.	.	.	.	.	.	.	LRPPRC:uc010yob.1:exon8:c.A768G:p.Q256Q,LRPPRC:uc002rtr.2:exon9:c.A1068G:p.Q356Q,LRPPRC:uc010faw.1:exon9:c.A990G:p.Q330Q	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.1504,EAS:0.2847,FIN:0.1689,NFE:0.5044,OTH:0.1844,ASJ:0.0500	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.1521
2	44209477	44209477	C	T	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs6741066	ENSG00000138095:ENST00000260665:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409659:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409946:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000447246:exon2:c.G168A:p.Q56Q	LRPPRC:NM_133259:exon2:c.G246A:p.Q82Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6240	0.7243	0.503994	2(large_intestine)	.	.	.	.	.	.	.	.	LRPPRC:uc002rtr.2:exon2:c.G246A:p.Q82Q,LRPPRC:uc010faw.1:exon2:c.G168A:p.Q56Q	.	AFR:MU108002,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,EAS:0.7029,FIN:0.5347,NFE:0.7550,OTH:0.0222,ASJ:0.6781	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.7353
2	46583278	46583278	-	G	EPAS1	intronic	.	ENSG00000116016	rs61586942	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3480	.	.	0.4475	.	.	.	.	.	.	.	.	.	.	AFR:0.4979,AMR:0.4742,EAS:0.7933,FIN:0.3989,NFE:0.3877,OTH:0.4149,ASJ:0.3803	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	MU113958442	het
2	46583279	46583279	-	T	EPAS1	intronic	.	ENSG00000116016	rs142684263	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3680	.	.	0.4466	.	.	.	.	.	.	.	.	.	.	AFR:0.4990,AMR:0.4729,EAS:0.7943,FIN:0.3948,NFE:0.3871,OTH:0.4122,ASJ:0.3761	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	.	het
2	46583281	46583281	C	T	EPAS1	intronic	.	ENSG00000116016	rs75984373	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4037	.	0.0662939	0.4737	.	.	.	.	.	0	0.002	.	.	.	AFR:0.6060,AMR:0.4570,EAS:0.7878,FIN:0.3895,NFE:0.3844,OTH:0.4065,ASJ:0.3976	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	MU24543271	het
2	46603671	46603671	C	G	EPAS1	intronic	.	ENSG00000116016	rs7557402	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4104	0.4291	0.3125	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0217	0.11	.	.	.	AFR:0.3909,AMR:0.2780,EAS:0.47,FIN:0.1968,NFE:0.4450,OTH:0.4659,ASJ:0.2703	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.4539
2	47641560	47641561	AA	-	MSH2	intronic	.	ENSG00000095002	rs1057519254	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.1442	.	.	.	.	.	.	.	.	.	.	AFR:0.1563,AMR:0.1711,EAS:0.1911,FIN:0.1333,NFE:0.1294,OTH:0.1507,ASJ:0.1848	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	.	hom
2	48010488	48010488	G	A	MSH6	exonic	nonsynonymous SNV	ENSG00000116062	rs1042821	ENSG00000116062:ENST00000234420:exon1:c.G116A:p.G39E,ENSG00000116062:ENST00000445503:exon1:c.G116A:p.G39E,ENSG00000116062:ENST00000456246:exon1:c.G116A:p.G39E,ENSG00000116062:ENST00000540021:exon1:c.G116A:p.G39E	MSH6:NM_000179:exon1:c.G116A:p.G39E,MSH6:NM_001281492:exon1:c.G116A:p.G39E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2141	0.1796	0.200879	MU113418	-0.457	0.281	0.212	2.63	0.250	.	.	.	MSH6:uc002rwc.2:exon1:c.G116A:p.G39E,MSH6:uc002rwd.4:exon1:c.G116A:p.G39E	-1.097	AFR:LUSC-KR|7|170|0.0411765,COCA-CN|4|321|0.0124611,AMR:0.1903,EAS:0.1214,FIN:0.2583,NFE:0.2398,OTH:0.1368,ASJ:0.2229	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	7600,	.	0.0	-1.77	0.000	0.695	2	3(meninges)	0.1813
2	48032740	48032740	-	T	MSH6	intronic	.	ENSG00000116062;ENSG00000138081	rs267608104	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2300	0.1640	.	0.1525	.	.	.	.	.	.	.	.	.	.	AFR:0.0795,AMR:0.1715,EAS:0.0356,FIN:0.2422,NFE:0.1923,OTH:0.1995,ASJ:0.2444	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	MU112127565	het
2	48033551	48033551	C	G	MSH6	intronic	.	ENSG00000116062;ENSG00000138081	rs3136367	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7426	0.7872	0.809105	MU18078954	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,AMR:0.7725,EAS:0.6214,FIN:0.7351,NFE:0.8835,OTH:0.6606,ASJ:0.9177	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	1(liver)	0.7160
2	55872538	55872538	T	C	PNPT1	exonic	nonsynonymous SNV	ENSG00000138035	rs7594497	ENSG00000138035:ENST00000415374:exon22:c.A1768G:p.N590D,ENSG00000138035:ENST00000447944:exon22:c.A1768G:p.N590D	PNPT1:NM_033109:exon22:c.A1768G:p.N590D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0828	0.1571	0.147564	0.1408	2.651	20.5	0.396	5.66	1.000	.	.	Exoribonuclease, phosphorolytic domain 2|PNPase/RNase PH domain	PNPT1:uc002rzf.3:exon22:c.A1768G:p.N590D	-0.954	AFR:0.3677,AMR:0.0490,EAS:0.0562,FIN:0.0347,NFE:0.0546,OTH:0.0631,ASJ:0.0633	610316	614932;614934;	90636;319514;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~319514|COXPD13|<1 / 1 000 000|-|Infancy|614932 ~	.	.	.	.	0.0	0.97	0.000	1.54	2	MU23446201	het
2	55873385	55873385	C	G	PNPT1	intronic	.	ENSG00000138035	rs7584120	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1298	0.2032	0.198482	0.1801	.	.	.	.	.	.	.	.	.	.	AFR:0.4087,AMR:0.0668,EAS:0.1059,FIN:0.0536,NFE:0.0965,OTH:0.0927,ASJ:0.1921	610316	614932;614934;	90636;319514;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~319514|COXPD13|<1 / 1 000 000|-|Infancy|614932 ~	.	.	.	.	.	.	.	.	2	MU773618	het
2	58388696	58388696	A	G	FANCL	exonic	synonymous SNV	ENSG00000115392	rs848291	ENSG00000115392:ENST00000403676:exon8:c.T630C:p.S210S,ENSG00000115392:ENST00000449070:exon9:c.T804C:p.S268S,ENSG00000115392:ENST00000403295:exon11:c.T897C:p.S299S,ENSG00000115392:ENST00000233741:exon12:c.T981C:p.S327S,ENSG00000115392:ENST00000402135:exon12:c.T996C:p.S332S	FANCL:NM_001114636:exon12:c.T996C:p.S332S,FANCL:NM_018062:exon12:c.T981C:p.S327S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6487	0.7041	0.70647	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FANCL:uc010fcf.1:exon9:c.T804C:p.S268S,FANCL:uc010fce.3:exon11:c.T897C:p.S299S,FANCL:uc002rzw.4:exon12:c.T981C:p.S327S,FANCL:uc002rzx.4:exon12:c.T996C:p.S332S	.	AFR:0.6976,AMR:0.8947,EAS:0.5430,FIN:0.5789,NFE:0.6272,OTH:0.6195,ASJ:0.6751	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	4922,	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.6442
2	58453843	58453843	-	A	FANCL	intronic	.	ENSG00000115392	rs372101290	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3679	0.2509	0.259585	0.2920	.	.	.	.	.	.	.	.	.	.	AFR:0.0835,AMR:0.4194,EAS:0.3209,FIN:0.4288,NFE:0.3730,OTH:0.3878,ASJ:0.3333	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	2	MU112120040	het
2	60687959	60687959	A	G	BCL11A	exonic	synonymous SNV	ENSG00000119866	rs7569946	ENSG00000119866:ENST00000358510:exon3:c.T1986C:p.S662S,ENSG00000119866:ENST00000538214:exon3:c.T1986C:p.S662S,ENSG00000119866:ENST00000335712:exon4:c.T2088C:p.S696S,ENSG00000119866:ENST00000356842:exon4:c.T2088C:p.S696S,ENSG00000119866:ENST00000537768:exon6:c.T1095C:p.S365S	BCL11A:NM_001363864:exon3:c.T1986C:p.S662S,BCL11A:NM_001365609:exon3:c.T1986C:p.S662S,BCL11A:NM_018014:exon4:c.T2088C:p.S696S,BCL11A:NM_022893:exon4:c.T2088C:p.S696S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6977	0.7125	0.830072	0.7089	.	.	.	.	.	.	.	.	BCL11A:uc002sad.1:exon3:c.T1632C:p.S544S,BCL11A:uc002saf.1:exon3:c.T1986C:p.S662S,BCL11A:uc010ypj.2:exon3:c.T1986C:p.S662S,BCL11A:uc002sab.3:exon4:c.T2088C:p.S696S,BCL11A:uc002sae.1:exon4:c.T2088C:p.S696S,BCL11A:uc010ypi.2:exon6:c.T1095C:p.S365S	.	AFR:0.9088,AMR:0.8118,EAS:0.9994,FIN:0.5992,NFE:0.5886,OTH:0.6311,ASJ:0.5530	606557	617101;	.	.	.	.	.	.	.	.	.	.	2	MU68453	hom
2	74128433	74128433	C	T	ACTG2	UTR5	.	ENSG00000163017	rs1050146	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7697	0.7628	0.707867	0.7708	.	.	.	.	.	.	.	.	.	.	AFR:0.7010,AMR:0.8795,EAS:0.5767,FIN:0.8539,NFE:0.8053,OTH:0.8014,ASJ:0.7517	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	MU753936	het
2	74129474	74129474	T	C	ACTG2	intronic	.	ENSG00000163017	rs1726025	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5897	0.5568	0.562899	MU753938	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.5948,EAS:0.7440,FIN:0.4733,NFE:0.4856,OTH:0.6981,ASJ:0.5271	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.6150
2	74135797	74135797	T	C	ACTG2	intronic	.	ENSG00000163017	rs702461	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6476	0.5947	0.575879	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.048	.	.	.	AFR:0.6214,AMR:0.4490,EAS:0.5662,FIN:0.4907,NFE:0.7430,OTH:0.6957,ASJ:0.7883	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.6728
2	74135898	74135898	A	G	ACTG2	exonic	synonymous SNV	ENSG00000163017	rs756128	ENSG00000163017:ENST00000409731:exon3:c.A225G:p.E75E,ENSG00000163017:ENST00000345517:exon4:c.A354G:p.E118E,ENSG00000163017:ENST00000442912:exon4:c.A354G:p.E118E,ENSG00000163017:ENST00000409624:exon5:c.A354G:p.E118E	ACTG2:NM_001199893:exon3:c.A225G:p.E75E,ACTG2:NM_001615:exon4:c.A354G:p.E118E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6403	0.5900	0.571885	0.6143	.	.	.	.	.	.	.	.	ACTG2:uc010yrn.2:exon3:c.A225G:p.E75E,ACTG2:uc002sjw.3:exon4:c.A354G:p.E118E,ACTG2:uc010fey.3:exon5:c.A354G:p.E118E	.	AFR:0.4483,AMR:0.7892,EAS:0.4901,FIN:0.7384,NFE:0.6839,OTH:0.6578,ASJ:0.5497	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	MU753952	het
2	74140789	74140789	T	C	ACTG2	intronic	.	ENSG00000163017	rs891698	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6494	0.6196	0.60004	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.6377,AMR:0.5326,EAS:0.5533,FIN:0.4914,NFE:0.7378,OTH:0.6827,ASJ:0.7950	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.6619
2	75185856	75185856	G	T	POLE4	exonic	nonsynonymous SNV	ENSG00000115350	rs12366	ENSG00000115350:ENST00000483063:exon1:c.G50T:p.G17V	POLE4:NM_019896:exon1:c.G50T:p.G17V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4146	0.3250	0.341653	1(upper_aerodigestive_tract)	3.708	23.3	0.226	3.58	0.046	.	.	.	POLE4:uc002snf.3:exon1:c.G50T:p.G17V	-0.919	AFR:MU93397,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.3261,FIN:0.3173,NFE:0.5232,OTH:0.4248,ASJ:0.3517	607269	.	.	.	.	.	.	.	0.468	1.51	0.000	0.895	2	1(liver)	0.2697
2	85360829	85360831	GGC	-	TCF7L1	exonic	nonframeshift deletion	ENSG00000152284	rs566806913	ENSG00000152284:ENST00000282111:exon1:c.22_24del:p.8_8del	TCF7L1:NM_031283:exon1:c.22_24del:p.8_8del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.75	.	0.382588	0.4514	.	.	.	.	.	.	.	.	TCF7L1:uc002soy.3:exon1:c.22_24del:p.8_8del	.	AFR:0.5374,AMR:0.3534,EAS:0.1810,FIN:0.5503,NFE:0.4306,OTH:0.4443,ASJ:0.3649	604652	.	.	.	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04916 Melanogenesis~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	2	.	het
2	88874891	88874891	C	A	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs1805165	ENSG00000172071:ENST00000415570:exon12:c.G1747T:p.A583S,ENSG00000172071:ENST00000303236:exon13:c.G2110T:p.A704S,ENSG00000172071:ENST00000419748:exon13:c.G1657T:p.A553S	EIF2AK3:NM_001313915:exon13:c.G1657T:p.A553S,EIF2AK3:NM_004836:exon13:c.G2110T:p.A704S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7021	0.8017	0.720647	0.7688	1.963	15.98	1.0	4.91	0.998	.	.	Protein kinase domain	EIF2AK3:uc002stc.4:exon13:c.G2110T:p.A704S	-0.930	AFR:0.9445,AMR:0.7088,EAS:0.5186,FIN:0.6582,NFE:0.7264,OTH:0.7051,ASJ:0.7815	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.003	-0.43	0.000	-0.09	2	MU815303	hom
2	88879131	88879131	T	C	EIF2AK3	exonic	synonymous SNV	ENSG00000172071	rs1805164	ENSG00000172071:ENST00000415570:exon10:c.A1428G:p.Q476Q,ENSG00000172071:ENST00000303236:exon11:c.A1791G:p.Q597Q,ENSG00000172071:ENST00000419748:exon11:c.A1338G:p.Q446Q	EIF2AK3:NM_001313915:exon11:c.A1338G:p.Q446Q,EIF2AK3:NM_004836:exon11:c.A1791G:p.Q597Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2854	0.2731	0.258187	0.2903	.	.	.	.	.	.	.	.	EIF2AK3:uc002stc.4:exon11:c.A1791G:p.Q597Q	.	AFR:0.2258,AMR:0.3735,EAS:0.3240,FIN:0.3397,NFE:0.3066,OTH:0.3173,ASJ:0.2748	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	.	.	.	.	2	MU2427107	hom
2	88895123	88895123	T	C	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs13045	ENSG00000172071:ENST00000415570:exon2:c.A134G:p.Q45R,ENSG00000172071:ENST00000303236:exon3:c.A497G:p.Q166R,ENSG00000172071:ENST00000419748:exon3:c.A44G:p.Q15R	EIF2AK3:NM_001313915:exon3:c.A44G:p.Q15R,EIF2AK3:NM_004836:exon3:c.A497G:p.Q166R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6379	0.7347	0.648962	0.7040	1.089	11.15	0.924	6.16	0.989	.	.	Quinoprotein alcohol dehydrogenase-like superfamily	EIF2AK3:uc002stc.4:exon3:c.A497G:p.Q166R	-0.950	AFR:0.8633,AMR:0.6091,EAS:0.4832,FIN:0.6032,NFE:0.6675,OTH:0.6391,ASJ:0.7285	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.0	1.63	0.000	-2.045	2	MU13566225	hom
2	88991391	88991391	A	G	RPIA	exonic	nonsynonymous SNV	ENSG00000153574	rs1025721878	ENSG00000153574:ENST00000283646:exon1:c.A175G:p.S59G	RPIA:NM_144563:exon1:c.A175G:p.S59G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	-0.746	0.057	0.41	-1.29	0.009	.	.	.	RPIA:uc002ste.3:exon1:c.A175G:p.S59G	-0.951	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180430	608611;	440706;	440706|-|<1 / 1 000 000|Autosomal recessive|Childhood|608611 ~	.	.	.	.	0.0	-1.12	0.192	0.09	2	.	het
2	96918871	96918871	-	G	TMEM127	UTR3	.	ENSG00000135956	rs201871634	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	0.0117812	0.0394	.	.	.	.	.	.	.	.	.	.	AFR:0.0070,AMR:0.0179,EAS:0,FIN:0.0694,NFE:0.0565,OTH:0.0418,ASJ:0.0397	613403	171300;	29072;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	2	.	het
2	100019496	100019496	A	G	REV1	exonic	synonymous SNV	ENSG00000135945	rs2305354	ENSG00000135945:ENST00000258428:exon20:c.T3240C:p.I1080I,ENSG00000135945:ENST00000393445:exon20:c.T3237C:p.I1079I	REV1:NM_001037872:exon20:c.T3237C:p.I1079I,REV1:NM_016316:exon20:c.T3240C:p.I1080I,REV1:NM_001321454:exon21:c.T3348C:p.I1116I,REV1:NM_001321455:exon21:c.T3027C:p.I1009I,REV1:NM_001321458:exon21:c.T1770C:p.I590I,REV1:NM_001321459:exon21:c.T1671C:p.I557I,REV1:NM_001321460:exon21:c.T1671C:p.I557I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5797	0.6132	0.588658	1(breast)	.	.	.	.	.	.	.	.	REV1:uc002tac.3:exon20:c.T3237C:p.I1079I,REV1:uc002tad.3:exon20:c.T3240C:p.I1080I	.	AFR:MU13237564,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.7456,FIN:0.6885,NFE:0.5066,OTH:0.3393,ASJ:0.6129	606134	.	.	.	.	.	.	.	.	.	.	.	2	1(stomach)	0.6567
2	100055158	100055158	T	C	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087399	ENSG00000135945:ENST00000450415:exon1:c.A32G:p.N11S,ENSG00000135945:ENST00000258428:exon6:c.A1118G:p.N373S,ENSG00000135945:ENST00000393445:exon6:c.A1118G:p.N373S	REV1:NM_001037872:exon6:c.A1118G:p.N373S,REV1:NM_001321454:exon6:c.A1118G:p.N373S,REV1:NM_016316:exon6:c.A1118G:p.N373S,REV1:NM_001321455:exon7:c.A908G:p.N303S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1384	0.1655	0.167931	0.1742	0.043	3.016	0.194	-0.648	0.997	.	.	.	REV1:uc002tae.1:exon4:c.A1055G:p.N352S,REV1:uc002tac.3:exon6:c.A1118G:p.N373S,REV1:uc002tad.3:exon6:c.A1118G:p.N373S	-0.984	AFR:0.2740,AMR:0.0525,EAS:0.0314,FIN:0.1968,NFE:0.1352,OTH:0.1796,ASJ:0.0530	606134	.	.	.	.	.	.	.	0.069	1.55	0.000	2.395	2	MU135349	het
2	100055506	100055506	A	G	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087386	ENSG00000135945:ENST00000258428:exon6:c.T770C:p.F257S,ENSG00000135945:ENST00000393445:exon6:c.T770C:p.F257S	REV1:NM_001037872:exon6:c.T770C:p.F257S,REV1:NM_001321454:exon6:c.T770C:p.F257S,REV1:NM_016316:exon6:c.T770C:p.F257S,REV1:NM_001321455:exon7:c.T560C:p.F187S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5755	0.6015	0.580272	1(stomach)	-1.561	0.002	0.465	-0.027	0.333	.	.	.	REV1:uc002tae.1:exon4:c.T707C:p.F236S,REV1:uc002tac.3:exon6:c.T770C:p.F257S,REV1:uc002tad.3:exon6:c.T770C:p.F257S	-0.979	AFR:1(breast),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:MU754754,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,NFE:0.6019,OTH:0.7121,ASJ:1(oesophagus)	606134	.	.	.	.	.	.	.	0.0	1.8	0.000	-2.045	2	1(thyroid)	0.6874
2	100096371	100096371	T	C	REV1	intronic	.	ENSG00000135945	rs13430962	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.167133	0.1756	.	.	.	.	.	.	.	.	.	.	AFR:0.2769,AMR:0.0526,EAS:0.0335,FIN:0.1976,NFE:0.1358,OTH:0.1816,ASJ:0.0533	606134	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	100210074	100210074	G	C	AFF3	exonic	synonymous SNV	ENSG00000144218	rs1047281	ENSG00000144218:ENST00000409236:exon13:c.C2049G:p.S683S,ENSG00000144218:ENST00000317233:exon14:c.C2049G:p.S683S,ENSG00000144218:ENST00000356421:exon14:c.C2124G:p.S708S,ENSG00000144218:ENST00000409579:exon15:c.C2124G:p.S708S	AFF3:NM_001025108:exon14:c.C2124G:p.S708S,AFF3:NM_002285:exon14:c.C2049G:p.S683S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1851	0.1708	0.146765	1(thyroid)	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon13:c.C2049G:p.S683S,AFF3:uc002taf.3:exon14:c.C2124G:p.S708S,AFF3:uc002tag.3:exon14:c.C2049G:p.S683S,AFF3:uc002tah.1:exon15:c.C2124G:p.S708S,AFF3:uc010yvr.1:exon15:c.C2508G:p.S836S	.	AFR:MU4549462,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.1105,FIN:0.1184,NFE:0.2318,OTH:0.0996,ASJ:0.1689	601464	.	.	.	.	.	.	.	.	.	.	.	2	2(lung)	0.1883
2	100210642	100210642	T	C	AFF3	exonic	nonsynonymous SNV	ENSG00000144218	rs1047265	ENSG00000144218:ENST00000409236:exon13:c.A1481G:p.N494S,ENSG00000144218:ENST00000317233:exon14:c.A1481G:p.N494S,ENSG00000144218:ENST00000356421:exon14:c.A1556G:p.N519S,ENSG00000144218:ENST00000409579:exon15:c.A1556G:p.N519S	AFF3:NM_001025108:exon14:c.A1556G:p.N519S,AFF3:NM_002285:exon14:c.A1481G:p.N494S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1833	0.1734	0.147764	MU156907	-2.861	0.001	0.469	-11.7	0.989	.	.	.	AFF3:uc010fiq.1:exon13:c.A1481G:p.N494S,AFF3:uc002taf.3:exon14:c.A1556G:p.N519S,AFF3:uc002tag.3:exon14:c.A1481G:p.N494S,AFF3:uc002tah.1:exon15:c.A1556G:p.N519S,AFF3:uc010yvr.1:exon15:c.A1940G:p.N647S	-1.143	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1688,EAS:0.1175,FIN:0.2318,NFE:0.0999,OTH:0.1876,ASJ:0.1106	601464	.	.	.	.	.	.	.	0.001	-0.01	0.000	-1.23	2	9(soft_tissue)	0.2059
2	100343557	100343557	C	T	AFF3	exonic	nonsynonymous SNV	ENSG00000144218	rs4851223	ENSG00000144218:ENST00000409236:exon9:c.G1073A:p.S358N,ENSG00000144218:ENST00000317233:exon10:c.G1073A:p.S358N,ENSG00000144218:ENST00000356421:exon10:c.G1148A:p.S383N,ENSG00000144218:ENST00000409579:exon11:c.G1148A:p.S383N	AFF3:NM_001025108:exon10:c.G1148A:p.S383N,AFF3:NM_002285:exon10:c.G1073A:p.S358N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon9:c.G1073A:p.S358N,AFF3:uc002taf.3:exon10:c.G1148A:p.S383N,AFF3:uc002tag.3:exon10:c.G1073A:p.S358N,AFF3:uc002tah.1:exon11:c.G1148A:p.S383N,AFF3:uc010fir.1:exon11:c.G1304A:p.S435N,AFF3:uc010yvr.1:exon11:c.G1535A:p.S512N	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601464	.	.	.	.	.	.	.	.	.	.	.	2	MU81737770	hom
2	100722024	100722024	G	T	AFF3	UTR5	.	ENSG00000144218	rs551658918	ENSG00000144218:ENST00000415384:exon2:c.C265A:p.P89T,ENSG00000144218:ENST00000440445:exon2:c.C34A:p.P12T	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0003	.	0.000998403	0.0005	0.715	8.926	0.0	2.37	0.129	.	.	.	AFF3:uc010fir.1:exon2:c.C34A:p.P12T,AFF3:uc010yvr.1:exon2:c.C265A:p.P89T	-1.001	AFR:0,AMR:0,EAS:0.0105,FIN:0,NFE:0,OTH:0,ASJ:0	601464	.	.	.	.	.	.	.	0.067	.	0.082	.	2	MU82074461	het
2	109389463	109389463	G	A	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs826580	ENSG00000153201:ENST00000283195:exon23:c.G8253A:p.E2751E	RANBP2:NM_006267:exon23:c.G8253A:p.E2751E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9959	0.9842	0.98722	0.9884	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon23:c.G8253A:p.E2751E	.	AFR:0.9595,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	MU81738486	hom
2	112686988	112686988	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs13027171	ENSG00000153208:ENST00000295408:exon2:c.G353A:p.S118N,ENSG00000153208:ENST00000421804:exon2:c.G353A:p.S118N	MERTK:NM_006343:exon2:c.G353A:p.S118N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2313	0.2219	0.168131	MU13261932	-1.221	0.006	0.714	-3.98	0.569	.	.	Immunoglobulin|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	MERTK:uc002thk.1:exon2:c.G353A:p.S118N	-1.025	AFR:COCA-CN|1|321|0.00311526,AMR:0.1977,EAS:0.1791,FIN:0.3212,NFE:0.1420,OTH:0.2009,ASJ:0.0645	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.34	0.000	0.495	2	1(urinary_tract)	0.2780
2	112702647	112702647	C	T	MERTK	intronic	.	ENSG00000153208	rs11683694	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2395	0.2487	0.190695	0.2196	.	.	.	.	.	.	.	.	.	.	AFR:0.1381,AMR:0.1885,EAS:0.1418,FIN:0.2022,NFE:0.2795,OTH:0.2133,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	MU755137	het
2	112705157	112705157	T	C	MERTK	intronic	.	ENSG00000153208	rs3761701	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5845	0.5847	0.514776	1(bone)	.	.	.	.	.	.	.	.	.	.	AFR:MU13261954,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,GACA-CN|1|123|0.00813008,COCA-CN|2|321|0.00623053,EAS:0.5057,FIN:0.6244,NFE:0.6887,OTH:0.2478,ASJ:0.5774	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.6613
2	112751928	112751928	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs7604639	ENSG00000153208:ENST00000409780:exon8:c.G869A:p.R290K,ENSG00000153208:ENST00000295408:exon9:c.G1397A:p.R466K,ENSG00000153208:ENST00000421804:exon9:c.G1397A:p.R466K	MERTK:NM_006343:exon9:c.G1397A:p.R466K	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6340	0.561502	73(lung)	-1.256	0.005	1.0	-3.17	0.328	.	.	Fibronectin type III|Immunoglobulin-like fold	MERTK:uc002thk.1:exon9:c.G1397A:p.R466K,MERTK:uc002thl.1:exon9:c.G869A:p.R290K	-0.967	AFR:MU755143,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6596,FIN:0.6340,NFE:0.6887,OTH:0.2466,ASJ:0.6217	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.0	0.65	0.000	-1.685	2	5(haematopoietic_and_lymphoid_tissue)	0.6623
2	112754880	112754880	G	A	MERTK	intronic	.	ENSG00000153208	rs3811633	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2384	0.2495	0.190096	MU755152	.	.	.	.	.	.	.	.	.	.	AFR:COCA-CN|2|321|0.00623053,AMR:0.2197,EAS:0.1874,FIN:0.3278,NFE:0.1409,OTH:0.2021,ASJ:0.1392	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2791
2	112754943	112754943	C	T	MERTK	exonic	synonymous SNV	ENSG00000153208	rs3811634	ENSG00000153208:ENST00000409780:exon9:c.C966T:p.N322N,ENSG00000153208:ENST00000295408:exon10:c.C1494T:p.N498N,ENSG00000153208:ENST00000421804:exon10:c.C1494T:p.N498N	MERTK:NM_006343:exon10:c.C1494T:p.N498N	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2385	0.2497	0.190495	0.2198	1.865	15.37	.	1.35	0.913	.	.	.	MERTK:uc002thk.1:exon10:c.C1494T:p.N498N,MERTK:uc002thl.1:exon10:c.C966T:p.N322N	-1.042	AFR:0.1394,AMR:0.1878,EAS:0.1413,FIN:0.2022,NFE:0.2791,OTH:0.2153,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	0.000	.	2	MU755155	het
2	112755001	112755001	A	G	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs2230515	ENSG00000153208:ENST00000409780:exon9:c.A1024G:p.I342V,ENSG00000153208:ENST00000295408:exon10:c.A1552G:p.I518V,ENSG00000153208:ENST00000421804:exon10:c.A1552G:p.I518V	MERTK:NM_006343:exon10:c.A1552G:p.I518V	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5973	0.6339	0.561502	73(lung)	-1.806	0.002	0.795	-2.03	0.431	.	.	.	MERTK:uc002thk.1:exon10:c.A1552G:p.I518V,MERTK:uc002thl.1:exon10:c.A1024G:p.I342V	-0.960	AFR:1(large_intestine),AMR:MU755158,EAS:0.6218,FIN:0.6603,NFE:0.6340,OTH:0.6887,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.81	0.000	-0.085	2	4(haematopoietic_and_lymphoid_tissue)	0.2469
2	112765973	112765973	A	G	MERTK	exonic	synonymous SNV	ENSG00000153208	rs1131244	ENSG00000153208:ENST00000409780:exon13:c.A1353G:p.S451S,ENSG00000153208:ENST00000295408:exon14:c.A1881G:p.S627S,ENSG00000153208:ENST00000421804:exon14:c.A1881G:p.S627S	MERTK:NM_006343:exon14:c.A1881G:p.S627S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5825	0.5878	0.515176	LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MERTK:uc002thk.1:exon14:c.A1881G:p.S627S,MERTK:uc002thl.1:exon14:c.A1353G:p.S451S	.	AFR:0.5805,AMR:0.5181,EAS:0.6887,FIN:0.2469,NFE:0.6615,OTH:0.6273,ASJ:0.6223	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	2(lung)	0.6090
2	121713022	121713022	C	G	GLI2	intronic	.	ENSG00000074047	rs6718382	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9999	.	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU81739801	unknown
2	121726447	121726447	G	A	GLI2	exonic	synonymous SNV	ENSG00000074047	rs2592595	ENSG00000074047:ENST00000360874:exon3:c.G388A:p.G130S	GLI2:NM_001371271:exon6:c.G801A:p.S267S,GLI2:NM_005270:exon6:c.G801A:p.S267S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9401	0.8092	0.827276	0.8415	0.628	8.346	0.994	-9.82	0.535	.	.	.	GLI2:uc002tmv.1:exon3:c.G412A:p.G138S	-0.987	AFR:0.4716,AMR:0.9582,EAS:0.9988,FIN:0.9954,NFE:0.9864,OTH:0.9633,ASJ:0.9570	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.006	.	0.000	.	2	MU81739854	hom
2	121746956	121746956	G	T	GLI2	exonic	nonsynonymous SNV	ENSG00000074047	rs3738880	ENSG00000074047:ENST00000361492:exon13:c.G3466T:p.A1156S,ENSG00000074047:ENST00000452319:exon14:c.G3466T:p.A1156S	GLI2:NM_001371271:exon14:c.G3466T:p.A1156S,GLI2:NM_005270:exon14:c.G3466T:p.A1156S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6296	0.6234	0.508986	0.6086	-0.059	2.058	0.515	0.039	0.049	.	.	.	GLI2:uc002tmt.4:exon10:c.G2482T:p.A828S,GLI2:uc002tmu.4:exon10:c.G2431T:p.A811S,GLI2:uc010flp.3:exon13:c.G3466T:p.A1156S	-1.041	AFR:0.4041,AMR:0.5730,EAS:0.4901,FIN:0.6738,NFE:0.7230,OTH:0.6582,ASJ:0.6589	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.156	2.53	0.000	1.65	2	MU22958533	het
2	121747406	121747406	G	A	GLI2	exonic	nonsynonymous SNV	ENSG00000074047	rs12711538	ENSG00000074047:ENST00000361492:exon13:c.G3916A:p.D1306N,ENSG00000074047:ENST00000452319:exon14:c.G3916A:p.D1306N	GLI2:NM_001371271:exon14:c.G3916A:p.D1306N,GLI2:NM_005270:exon14:c.G3916A:p.D1306N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6464	0.6769	0.567093	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	-0.401	0.385	1.0	2.13	0.005	.	.	.	GLI2:uc002tmt.4:exon10:c.G2932A:p.D978N,GLI2:uc002tmu.4:exon10:c.G2881A:p.D961N,GLI2:uc010flp.3:exon13:c.G3916A:p.D1306N	-1.028	AFR:0.6592,AMR:0.5805,EAS:0.6623,FIN:0.4870,NFE:0.6745,OTH:0.7234,ASJ:0.5883	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.0	2.6	0.000	-1.545	2	1(large_intestine)	0.6701
2	121747429	121747429	A	G	GLI2	exonic	synonymous SNV	ENSG00000074047	rs10167980	ENSG00000074047:ENST00000361492:exon13:c.A3939G:p.P1313P,ENSG00000074047:ENST00000452319:exon14:c.A3939G:p.P1313P	GLI2:NM_001371271:exon14:c.A3939G:p.P1313P,GLI2:NM_005270:exon14:c.A3939G:p.P1313P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6344	0.6241	0.51238	0.6130	.	.	.	.	.	.	.	.	GLI2:uc002tmt.4:exon10:c.A2955G:p.P985P,GLI2:uc002tmu.4:exon10:c.A2904G:p.P968P,GLI2:uc010flp.3:exon13:c.A3939G:p.P1313P	.	AFR:0.4068,AMR:0.5728,EAS:0.4981,FIN:0.6808,NFE:0.7277,OTH:0.6615,ASJ:0.6623	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU634692	het
2	127819777	127819777	C	T	BIN1	intronic	.	ENSG00000136717	rs61748157	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1580	0.1055	0.0972444	0.1035	.	.	.	.	.	0	0.004	.	.	.	AFR:0.0617,AMR:0.0823,EAS:0.0210,FIN:0.1219,NFE:0.1306,OTH:0.1306,ASJ:0.1656	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	.	het
2	127821499	127821499	T	C	BIN1	intronic	.	ENSG00000136717	rs72481904	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3704	0.2872	0.345248	MU755367	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.3079,EAS:0.4081,FIN:0.4067,NFE:0.4042,OTH:0.3790,ASJ:0.1669	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.3546
2	128046899	128046899	G	A	ERCC3	intronic	.	ENSG00000163161	rs200833462	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0012	0.0013	0.000798722	0.0007	.	.	.	.	.	.	.	.	.	.	AFR:0.0006,AMR:0.0036,EAS:0,FIN:0.0006,NFE:0.0009,OTH:0,ASJ:0	133510	610651;616390;	33364;220295;910;	33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	2	.	het
2	136873084	136873084	G	A	CXCR4	exonic	synonymous SNV	ENSG00000121966	rs2228014	ENSG00000121966:ENST00000409817:exon1:c.C426T:p.I142I,ENSG00000121966:ENST00000241393:exon2:c.C414T:p.I138I	CXCR4:NM_001008540:exon1:c.C426T:p.I142I,CXCR4:NM_001348060:exon2:c.C369T:p.I123I,CXCR4:NM_003467:exon2:c.C414T:p.I138I,CXCR4:NM_001348056:exon3:c.C627T:p.I209I,CXCR4:NM_001348059:exon3:c.C513T:p.I171I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0460	0.0370	0.0628994	3(pituitary)	.	.	.	.	.	.	.	.	CXCR4:uc002tuy.3:exon1:c.C426T:p.I142I,CXCR4:uc002tuz.3:exon2:c.C414T:p.I138I,CXCR4:uc010fnk.3:exon2:c.C369T:p.I123I	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU134858,EAS:0.0353,FIN:0.0157,NFE:0.0215,OTH:0.1026,ASJ:LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	162643	193670;	51636;	51636|WILM<br>Warts-hypogammaglobulinemia-infections-myelokathexis syndrome<br>Warts-infections-leukopenia-myelokatexis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|193670 ~	~ko04020 Calcium signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04062 Chemokine signaling pathway~ko04144 Endocytosis~ko04360 Axon guidance~ko04670 Leukocyte transendothelial migration~ko04672 Intestinal immune network for IgA production~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	,2168	.	.	.	.	.	.	2	1(breast)	0.1222
2	140992337	140992337	C	A	LRP1B	intronic	.	ENSG00000168702	rs13387241	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5495	0.5303	0.467452	0.5345	.	.	.	.	.	.	.	.	.	.	AFR:0.3965,AMR:0.4940,EAS:0.5443,FIN:0.6355,NFE:0.5916,OTH:0.5849,ASJ:0.4106	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU735230	hom
2	141027926	141027926	A	G	LRP1B	intronic	.	ENSG00000168702	rs3748865	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1767	0.1296	0.167732	0.1411	.	.	.	.	.	0.0003	0.018	.	.	.	AFR:0.0346,AMR:0.1918,EAS:0.3342,FIN:0.1777,NFE:0.1706,OTH:0.1636,ASJ:0.1258	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU13320520	het
2	141032088	141032088	C	T	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs1386356	ENSG00000168702:ENST00000389484:exon85:c.G13047A:p.T4349T	LRP1B:NM_018557:exon85:c.G13047A:p.T4349T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6037	0.5320	0.486222	0.5412	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon85:c.G13047A:p.T4349T	.	AFR:0.2389,AMR:0.5469,EAS:0.7081,FIN:0.6794,NFE:0.6628,OTH:0.6222,ASJ:0.4967	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU26066624	hom
2	141259283	141259283	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs35296183	ENSG00000168702:ENST00000389484:exon55:c.C8823T:p.D2941D	LRP1B:NM_018557:exon55:c.C8823T:p.D2941D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1741	0.1715	0.104433	0.1568	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon55:c.C8823T:p.D2941D	.	AFR:0.0628,AMR:0.1358,EAS:0.0130,FIN:0.1996,NFE:0.2148,OTH:0.2049,ASJ:0.1788	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU115423	het
2	141259376	141259376	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs35164907	ENSG00000168702:ENST00000389484:exon55:c.C8730T:p.C2910C	LRP1B:NM_018557:exon55:c.C8730T:p.C2910C	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2154	0.2067	0.126198	0.2063	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon55:c.C8730T:p.C2910C	.	AFR:0.0852,AMR:0.1583,EAS:0.0136,FIN:0.2952,NFE:0.2750,OTH:0.2740,ASJ:0.2252	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU115441	het
2	141260668	141260668	A	G	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs4444457	ENSG00000168702:ENST00000389484:exon54:c.T8526C:p.Y2842Y	LRP1B:NM_018557:exon54:c.T8526C:p.Y2842Y	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5490	0.5328	0.543131	0.5463	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon54:c.T8526C:p.Y2842Y	.	AFR:0.4917,AMR:0.4580,EAS:0.7593,FIN:0.5842,NFE:0.5528,OTH:0.5647,ASJ:0.4040	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU115465	het
2	141274576	141274576	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs4954672	ENSG00000168702:ENST00000389484:exon50:c.A8031G:p.Q2677Q	LRP1B:NM_018557:exon50:c.A8031G:p.Q2677Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7150	0.7467	0.642372	0.7137	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon50:c.A8031G:p.Q2677Q	.	AFR:0.6961,AMR:0.7542,EAS:0.3999,FIN:0.6857,NFE:0.7578,OTH:0.7296,ASJ:0.8543	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU800510	hom
2	141298674	141298674	T	C	LRP1B	intronic	.	ENSG00000168702	rs13013854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3911	0.3490	0.329473	0.3494	.	.	.	.	.	0	0	.	.	.	AFR:0.1858,AMR:0.3621,EAS:0.3510,FIN:0.4485,NFE:0.4165,OTH:0.4083,ASJ:0.3742	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU585211	unknown
2	141298682	141298682	G	C	LRP1B	intronic	.	ENSG00000168702	rs11694934	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5084	0.4952	0.504792	0.4973	.	.	.	.	.	.	.	.	.	.	AFR:0.4414,AMR:0.4233,EAS:0.5985,FIN:0.5407,NFE:0.5137,OTH:0.5092,ASJ:0.4338	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU13320946	unknown
2	141474402	141474402	-	A	LRP1B	intronic	.	ENSG00000168702	rs398104769	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5608	0.5631	0.46246	0.5477	.	.	.	.	.	.	.	.	.	.	AFR:0.3869,AMR:0.4498,EAS:0.3916,FIN:0.5835,NFE:0.6495,OTH:0.5813,ASJ:0.7318	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	141571329	141571329	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs3749010	ENSG00000168702:ENST00000389484:exon32:c.A5256G:p.S1752S	LRP1B:NM_018557:exon32:c.A5256G:p.S1752S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8708	0.8370	0.845248	0.8491	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon32:c.A5256G:p.S1752S	.	AFR:0.7260,AMR:0.8098,EAS:0.9932,FIN:0.8967,NFE:0.8937,OTH:0.8809,ASJ:0.8642	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU4547566	het
2	141598473	141598473	-	T	LRP1B	intronic	.	ENSG00000168702	rs35745624	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9923	8e-05	0.977636	0.9811	.	.	.	.	.	.	.	.	.	.	AFR:0.9375,AMR:0.9880,EAS:1,FIN:1,NFE:0.9987,OTH:0.9888,ASJ:1	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	141598681	141598681	A	C	LRP1B	intronic	.	ENSG00000168702	rs74787922	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0573	0.0554	0.0385383	0.0436	.	.	.	.	.	.	.	.	.	.	AFR:0.0191,AMR:0.0502,EAS:0,FIN:0.0381,NFE:0.0628,OTH:0.05,ASJ:0.0629	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU116598588	het
2	141625834	141625834	-	A	LRP1B	splicing	.	ENSG00000168702	rs758437148	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0317	.	.	0.0875	.	.	.	.	.	.	.	.	.	.	AFR:0.1463,AMR:0.0429,EAS:0.0054,FIN:0.0838,NFE:0.0626,OTH:0.0870,ASJ:0.0484	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	141707868	141707868	G	T	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs6748626	ENSG00000168702:ENST00000434794:exon5:c.C507A:p.A169A,ENSG00000168702:ENST00000389484:exon20:c.C3072A:p.A1024A	LRP1B:NM_018557:exon20:c.C3072A:p.A1024A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1761	0.2232	0.275759	0.2011	.	.	.	.	.	.	.	.	LRP1B:uc010fnl.1:exon5:c.C618A:p.A206A,LRP1B:uc002tvj.1:exon20:c.C3072A:p.A1024A	.	AFR:0.4066,AMR:0.2470,EAS:0.2220,FIN:0.0639,NFE:0.1141,OTH:0.1263,ASJ:0.1954	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU107809	hom
2	141751592	141751592	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs13007735	ENSG00000168702:ENST00000389484:exon16:c.C2616T:p.D872D	LRP1B:NM_018557:exon16:c.C2616T:p.D872D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3880	0.3987	0.509585	0.3874	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon16:c.C2616T:p.D872D	.	AFR:0.5551,AMR:0.3553,EAS:0.5853,FIN:0.2413,NFE:0.3080,OTH:0.3145,ASJ:0.4834	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU26807821	hom
2	141773397	141773397	C	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs78806080	ENSG00000168702:ENST00000389484:exon13:c.G2058T:p.R686R	LRP1B:NM_018557:exon13:c.G2058T:p.R686R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0528	0.0461	0.0339457	0.0382	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon13:c.G2058T:p.R686R	.	AFR:0.0115,AMR:0.0514,EAS:0.0006,FIN:0.0301,NFE:0.0574,OTH:0.0519,ASJ:0.0662	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU87743534	het
2	141816621	141816621	A	G	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs1525579	ENSG00000168702:ENST00000389484:exon9:c.T1239C:p.V413V	LRP1B:NM_018557:exon9:c.T1239C:p.V413V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9843	0.9405	0.945288	0.9499	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon9:c.T1239C:p.V413V	.	AFR:0.8252,AMR:0.9916,EAS:1,FIN:1,NFE:0.9996,OTH:0.9918,ASJ:1	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU81741570	hom
2	152402516	152402516	A	-	NEB	intronic	.	ENSG00000183091	rs779970363	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1554	.	.	0.0346	.	.	.	.	.	.	.	.	.	.	AFR:0.0935,AMR:0.0135,EAS:0.0040,FIN:0.0120,NFE:0.0069,OTH:0.015,ASJ:0.0238	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	het
2	152432311	152432311	T	C	NEB	exonic	synonymous SNV	ENSG00000183091	rs33988153	ENSG00000183091:ENST00000413693:exon7:c.A1101G:p.P367P,ENSG00000183091:ENST00000172853:exon79:c.A11808G:p.P3936P,ENSG00000183091:ENST00000409198:exon80:c.A11808G:p.P3936P,ENSG00000183091:ENST00000603639:exon105:c.A16911G:p.P5637P,ENSG00000183091:ENST00000604864:exon105:c.A16911G:p.P5637P,ENSG00000183091:ENST00000397345:exon107:c.A16911G:p.P5637P,ENSG00000183091:ENST00000427231:exon107:c.A16911G:p.P5637P	NEB:NM_004543:exon80:c.A11808G:p.P3936P,NEB:NM_001164507:exon107:c.A16911G:p.P5637P,NEB:NM_001164508:exon107:c.A16911G:p.P5637P,NEB:NM_001271208:exon107:c.A16911G:p.P5637P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1984	0.1894	0.110224	.	.	.	.	.	.	.	.	.	NEB:uc002txr.3:exon7:c.A1206G:p.P402P,NEB:uc021vrb.1:exon78:c.A11808G:p.P3936P,NEB:uc010fnx.3:exon79:c.A11772G:p.P3924P,NEB:uc021vrd.1:exon80:c.A11808G:p.P3936P,NEB:uc002txu.3:exon107:c.A16911G:p.P5637P,NEB:uc021vrc.1:exon107:c.A16911G:p.P5637P,NEB:uc031rpp.1:exon107:c.A16911G:p.P5637P	.	AFR:0.1751,AMR:0.0473,EAS:0.2748,FIN:0.0012,NFE:0.2520,OTH:0.2476,ASJ:0.1283	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2290
2	152438012	152438012	G	A	NEB	exonic	synonymous SNV	ENSG00000183091	rs542916866	ENSG00000183091:ENST00000413693:exon3:c.C459T:p.A153A,ENSG00000183091:ENST00000603639:exon101:c.C16269T:p.A5423A,ENSG00000183091:ENST00000604864:exon101:c.C16269T:p.A5423A,ENSG00000183091:ENST00000397345:exon103:c.C16269T:p.A5423A,ENSG00000183091:ENST00000427231:exon103:c.C16269T:p.A5423A	NEB:NM_001164507:exon103:c.C16269T:p.A5423A,NEB:NM_001164508:exon103:c.C16269T:p.A5423A,NEB:NM_001271208:exon103:c.C16269T:p.A5423A	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0127	.	0.00319489	0.0002	.	.	.	.	.	.	.	.	NEB:uc002txr.3:exon3:c.C564T:p.A188A,NEB:uc002txu.3:exon103:c.C16269T:p.A5423A,NEB:uc021vrc.1:exon103:c.C16269T:p.A5423A,NEB:uc031rpp.1:exon103:c.C16269T:p.A5423A	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0002,OTH:0.0025,ASJ:0	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	het
2	152449688	152449688	A	G	NEB	exonic	synonymous SNV	ENSG00000183091	rs2288217	ENSG00000183091:ENST00000603639:exon92:c.T14563C:p.L4855L,ENSG00000183091:ENST00000604864:exon92:c.T14563C:p.L4855L,ENSG00000183091:ENST00000397345:exon94:c.T14563C:p.L4855L,ENSG00000183091:ENST00000427231:exon94:c.T14563C:p.L4855L	NEB:NM_001164507:exon94:c.T14563C:p.L4855L,NEB:NM_001164508:exon94:c.T14563C:p.L4855L,NEB:NM_001271208:exon94:c.T14563C:p.L4855L	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	.	.	.	0.6786	.	.	.	.	.	.	.	.	NEB:uc002txu.3:exon94:c.T14563C:p.L4855L,NEB:uc021vrc.1:exon94:c.T14563C:p.L4855L,NEB:uc031rpp.1:exon94:c.T14563C:p.L4855L	.	AFR:0.5,AMR:.,EAS:.,FIN:0.5,NFE:1,OTH:1,ASJ:.	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	hom
2	152490458	152490458	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6710212	ENSG00000183091:ENST00000603639:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000604864:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000397345:exon65:c.T9124C:p.C3042R,ENSG00000183091:ENST00000427231:exon65:c.T9124C:p.C3042R	NEB:NM_001164507:exon65:c.T9124C:p.C3042R,NEB:NM_001164508:exon65:c.T9124C:p.C3042R,NEB:NM_001271208:exon65:c.T9124C:p.C3042R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9928	0.9757	0.972045	0.9771	0.806	9.498	0.971	6.02	0.994	.	.	.	NEB:uc002txu.3:exon65:c.T9124C:p.C3042R,NEB:uc021vrc.1:exon65:c.T9124C:p.C3042R,NEB:uc031rpp.1:exon65:c.T9124C:p.C3042R	-0.915	AFR:0.9192,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	3.85	0.000	.	2	MU81742117	hom
2	152496526	152496526	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6713162	ENSG00000183091:ENST00000603639:exon60:c.T8734C:p.S2912P,ENSG00000183091:ENST00000604864:exon60:c.T8734C:p.S2912P,ENSG00000183091:ENST00000172853:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000397345:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000409198:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000427231:exon62:c.T8734C:p.S2912P	NEB:NM_001164507:exon62:c.T8734C:p.S2912P,NEB:NM_001164508:exon62:c.T8734C:p.S2912P,NEB:NM_001271208:exon62:c.T8734C:p.S2912P,NEB:NM_004543:exon62:c.T8734C:p.S2912P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2540	0.3010	0.445288	MU119575	2.013	16.29	1.0	5.46	0.985	.	.	.	NEB:uc021vrb.1:exon60:c.T8734C:p.S2912P,NEB:uc002txu.3:exon62:c.T8734C:p.S2912P,NEB:uc010fnx.3:exon62:c.T8734C:p.S2912P,NEB:uc021vrc.1:exon62:c.T8734C:p.S2912P,NEB:uc021vrd.1:exon62:c.T8734C:p.S2912P,NEB:uc031rpp.1:exon62:c.T8734C:p.S2912P	-0.974	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3143,EAS:0.1376,FIN:0.2417,NFE:0.5910,OTH:0.1398,ASJ:0.6350	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.73	0.000	-2.8	2	1(large_intestine)	0.1572
2	152500449	152500449	C	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs13013209	ENSG00000183091:ENST00000603639:exon55:c.G7839C:p.K2613N,ENSG00000183091:ENST00000604864:exon55:c.G7839C:p.K2613N,ENSG00000183091:ENST00000172853:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000397345:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000409198:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000427231:exon57:c.G7839C:p.K2613N	NEB:NM_001164507:exon57:c.G7839C:p.K2613N,NEB:NM_001164508:exon57:c.G7839C:p.K2613N,NEB:NM_001271208:exon57:c.G7839C:p.K2613N,NEB:NM_004543:exon57:c.G7839C:p.K2613N	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4150	0.3498	0.293331	1(urinary_tract)	6.495	31	0.026	5.77	1.000	.	.	.	NEB:uc021vrb.1:exon55:c.G7839C:p.K2613N,NEB:uc002txu.3:exon57:c.G7839C:p.K2613N,NEB:uc010fnx.3:exon57:c.G7839C:p.K2613N,NEB:uc021vrc.1:exon57:c.G7839C:p.K2613N,NEB:uc021vrd.1:exon57:c.G7839C:p.K2613N,NEB:uc031rpp.1:exon57:c.G7839C:p.K2613N	-0.977	AFR:MU4546905,AMR:COCA-CN|3|321|0.00934579,EAS:0.0874,FIN:0.4448,NFE:0.4007,OTH:0.2562,ASJ:0.3553	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.999	1.13	0.000	3.455	2	1(bone)	0.4464
2	152511778	152511778	A	C	NEB	intronic	.	ENSG00000183091	rs10930723	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3411	0.2905	0.430911	0.3008	.	.	.	.	.	0.0001	0.064	.	.	.	AFR:0.5887,AMR:0.1316,EAS:0.5946,FIN:0.1401,NFE:0.1569,OTH:0.1980,ASJ:0.2483	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU17371938	het
2	152515683	152515683	G	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs75807392	ENSG00000183091:ENST00000603639:exon45:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000604864:exon45:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000172853:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000397345:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000409198:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000427231:exon47:c.C5971T:p.H1991Y	NEB:NM_001164507:exon47:c.C5971T:p.H1991Y,NEB:NM_001164508:exon47:c.C5971T:p.H1991Y,NEB:NM_001271208:exon47:c.C5971T:p.H1991Y,NEB:NM_004543:exon47:c.C5971T:p.H1991Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0774	0.0422	0.0920527	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	-0.057	2.073	1.0	4.38	0.474	0.0002	0.046	.	NEB:uc021vrb.1:exon45:c.C5971T:p.H1991Y,NEB:uc002txu.3:exon47:c.C5971T:p.H1991Y,NEB:uc010fnx.3:exon47:c.C5971T:p.H1991Y,NEB:uc021vrc.1:exon47:c.C5971T:p.H1991Y,NEB:uc021vrd.1:exon47:c.C5971T:p.H1991Y,NEB:uc031rpp.1:exon47:c.C5971T:p.H1991Y	-1.006	AFR:0.0621,AMR:0.0224,EAS:0.0298,FIN:0.2491,NFE:0.0930,OTH:0.0587,ASJ:0.0489	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.677	0.92	0.000	1.59	2	1(lung)	0.0723
2	152521096	152521096	C	T	NEB	exonic	synonymous SNV	ENSG00000183091	rs10170273	ENSG00000183091:ENST00000603639:exon42:c.G5370A:p.E1790E,ENSG00000183091:ENST00000604864:exon42:c.G5370A:p.E1790E,ENSG00000183091:ENST00000172853:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000397345:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000409198:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000427231:exon44:c.G5370A:p.E1790E	NEB:NM_001164507:exon44:c.G5370A:p.E1790E,NEB:NM_001164508:exon44:c.G5370A:p.E1790E,NEB:NM_001271208:exon44:c.G5370A:p.E1790E,NEB:NM_004543:exon44:c.G5370A:p.E1790E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3018	0.2951	0.434904	MU119622	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon42:c.G5370A:p.E1790E,NEB:uc002txu.3:exon44:c.G5370A:p.E1790E,NEB:uc010fnx.3:exon44:c.G5370A:p.E1790E,NEB:uc021vrc.1:exon44:c.G5370A:p.E1790E,NEB:uc021vrd.1:exon44:c.G5370A:p.E1790E,NEB:uc031rpp.1:exon44:c.G5370A:p.E1790E	.	AFR:MELA-AU|1|183|0.00546448,COCA-CN|5|321|0.0155763,AMR:0.3056,EAS:0.1325,FIN:0.2533,NFE:0.5882,OTH:0.1394,ASJ:0.6058	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(skin)	0.1569
2	152527572	152527572	C	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs7426114	ENSG00000183091:ENST00000603639:exon36:c.G4471A:p.V1491M,ENSG00000183091:ENST00000604864:exon36:c.G4471A:p.V1491M,ENSG00000183091:ENST00000172853:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000397345:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000409198:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000427231:exon38:c.G4471A:p.V1491M	NEB:NM_001164507:exon38:c.G4471A:p.V1491M,NEB:NM_001164508:exon38:c.G4471A:p.V1491M,NEB:NM_001271208:exon38:c.G4471A:p.V1491M,NEB:NM_004543:exon38:c.G4471A:p.V1491M	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.7386	0.6615	0.533147	MU761016	5.308	25.8	0.03	5.42	0.996	.	.	.	NEB:uc021vrb.1:exon36:c.G4471A:p.V1491M,NEB:uc002txu.3:exon38:c.G4471A:p.V1491M,NEB:uc010fnx.3:exon38:c.G4471A:p.V1491M,NEB:uc021vrc.1:exon38:c.G4471A:p.V1491M,NEB:uc021vrd.1:exon38:c.G4471A:p.V1491M,NEB:uc031rpp.1:exon38:c.G4471A:p.V1491M	-1.161	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6642,EAS:0.8609,FIN:0.7450,NFE:0.4091,OTH:0.8606,ASJ:0.2882	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.82	3.22	0.000	2.325	2	1(large_intestine)	0.8429
2	152527608	152527608	C	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs34577613	ENSG00000183091:ENST00000603639:exon36:c.G4435A:p.V1479I,ENSG00000183091:ENST00000604864:exon36:c.G4435A:p.V1479I,ENSG00000183091:ENST00000172853:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000397345:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000409198:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000427231:exon38:c.G4435A:p.V1479I	NEB:NM_001164507:exon38:c.G4435A:p.V1479I,NEB:NM_001164508:exon38:c.G4435A:p.V1479I,NEB:NM_001271208:exon38:c.G4435A:p.V1479I,NEB:NM_004543:exon38:c.G4435A:p.V1479I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1899	0.1914	0.335264	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	1.430	12.95	0.597	4.25	0.998	.	.	.	NEB:uc021vrb.1:exon36:c.G4435A:p.V1479I,NEB:uc002txu.3:exon38:c.G4435A:p.V1479I,NEB:uc010fnx.3:exon38:c.G4435A:p.V1479I,NEB:uc021vrc.1:exon38:c.G4435A:p.V1479I,NEB:uc021vrd.1:exon38:c.G4435A:p.V1479I,NEB:uc031rpp.1:exon38:c.G4435A:p.V1479I	-1.009	AFR:0.2132,AMR:0.3921,EAS:0.1490,FIN:0.5405,NFE:0.1216,OTH:0.1069,ASJ:0.1017	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.5	0.000	-1.78	2	1(large_intestine)	0.1544
2	152531077	152531077	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6711382	ENSG00000183091:ENST00000603639:exon34:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000604864:exon34:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000172853:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000397345:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000409198:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000427231:exon36:c.T3901C:p.Y1301H	NEB:NM_001164507:exon36:c.T3901C:p.Y1301H,NEB:NM_001164508:exon36:c.T3901C:p.Y1301H,NEB:NM_001271208:exon36:c.T3901C:p.Y1301H,NEB:NM_004543:exon36:c.T3901C:p.Y1301H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8265	0.8178	0.716054	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	1.671	14.24	0.456	5.52	0.994	.	.	.	NEB:uc021vrb.1:exon34:c.T3901C:p.Y1301H,NEB:uc002txu.3:exon36:c.T3901C:p.Y1301H,NEB:uc010fnx.3:exon36:c.T3901C:p.Y1301H,NEB:uc021vrc.1:exon36:c.T3901C:p.Y1301H,NEB:uc021vrd.1:exon36:c.T3901C:p.Y1301H,NEB:uc031rpp.1:exon36:c.T3901C:p.Y1301H	-0.984	AFR:0.8055,AMR:0.6410,EAS:0.8510,FIN:0.5892,NFE:0.8883,OTH:0.8950,ASJ:0.9055	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	0.91	0.000	-1.385	2	1(haematopoietic_and_lymphoid_tissue)	0.8605
2	152531781	152531781	C	A	NEB	intronic	.	ENSG00000183091	rs12618063	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2548	0.1643	0.28774	0.1840	.	.	.	.	.	.	.	.	.	.	AFR:0.3115,AMR:0.0897,EAS:0.4639,FIN:0.1117,NFE:0.1057,OTH:0.1393,ASJ:0.1490	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU761022	het
2	152536498	152536498	T	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6735208	ENSG00000183091:ENST00000603639:exon29:c.A3081T:p.K1027N,ENSG00000183091:ENST00000604864:exon29:c.A3081T:p.K1027N,ENSG00000183091:ENST00000172853:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000397345:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000409198:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000427231:exon31:c.A3081T:p.K1027N	NEB:NM_001164507:exon31:c.A3081T:p.K1027N,NEB:NM_001164508:exon31:c.A3081T:p.K1027N,NEB:NM_001271208:exon31:c.A3081T:p.K1027N,NEB:NM_004543:exon31:c.A3081T:p.K1027N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7499	0.6986	0.583466	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	3.606	23.2	0.131	-1.62	0.997	.	.	.	NEB:uc021vrb.1:exon29:c.A3081T:p.K1027N,NEB:uc002txu.3:exon31:c.A3081T:p.K1027N,NEB:uc010fnx.3:exon31:c.A3081T:p.K1027N,NEB:uc021vrc.1:exon31:c.A3081T:p.K1027N,NEB:uc021vrd.1:exon31:c.A3081T:p.K1027N,NEB:uc031rpp.1:exon31:c.A3081T:p.K1027N	-1.010	AFR:0.6939,AMR:0.3867,EAS:0.7318,FIN:0.4932,NFE:0.8647,OTH:0.8361,ASJ:0.8711	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.982	3.22	0.000	1.65	2	1(breast)	0.8043
2	152573981	152573981	A	G	NEB	exonic	synonymous SNV	ENSG00000183091	rs4611637	ENSG00000183091:ENST00000603639:exon8:c.T771C:p.A257A,ENSG00000183091:ENST00000604864:exon8:c.T771C:p.A257A,ENSG00000183091:ENST00000172853:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000397345:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000409198:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000427231:exon10:c.T771C:p.A257A	NEB:NM_001164507:exon10:c.T771C:p.A257A,NEB:NM_001164508:exon10:c.T771C:p.A257A,NEB:NM_001271208:exon10:c.T771C:p.A257A,NEB:NM_004543:exon10:c.T771C:p.A257A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7438	0.6861	0.569289	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon8:c.T771C:p.A257A,NEB:uc002txu.3:exon10:c.T771C:p.A257A,NEB:uc010fnx.3:exon10:c.T771C:p.A257A,NEB:uc021vrc.1:exon10:c.T771C:p.A257A,NEB:uc021vrd.1:exon10:c.T771C:p.A257A,NEB:uc031rpp.1:exon10:c.T771C:p.A257A	.	AFR:0.6784,AMR:0.3451,EAS:0.7351,FIN:0.4548,NFE:0.8545,OTH:0.8362,ASJ:0.8604	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.7965
2	169789016	169789016	T	C	ABCB11	exonic	synonymous SNV	ENSG00000073734	rs497692	ENSG00000073734:ENST00000263817:exon24:c.A3084G:p.A1028A	ABCB11:NM_003742:exon24:c.A3084G:p.A1028A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5557	0.4546	0.496805	0.4676	.	.	.	.	.	.	.	.	ABCB11:uc010zda.1:exon11:c.A1410G:p.A470A,ABCB11:uc010zdb.1:exon11:c.A1512G:p.A504A,ABCB11:uc002ueo.1:exon24:c.A3084G:p.A1028A	.	AFR:0.2680,AMR:0.5859,EAS:0.6359,FIN:0.5378,NFE:0.5353,OTH:0.5337,ASJ:0.6126	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU585262	het
2	169801488	169801488	A	G	ABCB11	intronic	.	ENSG00000073734	rs853789	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7663	0.7523	0.855232	0.7491	.	.	.	.	.	.	.	.	.	.	AFR:0.9016,AMR:0.8433,EAS:0.9806,FIN:0.6540,NFE:0.6558,OTH:0.7090,ASJ:0.7517	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU81743974	hom
2	169814655	169814655	G	T	ABCB11	intronic	.	ENSG00000073734	rs853772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5399	0.4506	0.497604	0.4537	.	.	.	.	.	.	.	.	.	.	AFR:0.2681,AMR:0.5815,EAS:0.6344,FIN:0.5161,NFE:0.5150,OTH:0.5163,ASJ:0.5828	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU18167943	het
2	169826573	169826573	C	A	ABCB11	exonic	synonymous SNV	ENSG00000073734	rs11568371	ENSG00000073734:ENST00000263817:exon15:c.G1791T:p.V597V	ABCB11:NM_003742:exon15:c.G1791T:p.V597V	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0159	0.0012	0.0311502	0.0017	.	.	.	.	.	.	.	.	ABCB11:uc010zda.1:exon2:c.G117T:p.V39V,ABCB11:uc010zdb.1:exon2:c.G219T:p.V73V,ABCB11:uc002ueo.1:exon15:c.G1791T:p.V597V	.	AFR:0.0046,AMR:0,EAS:0.0006,FIN:0,NFE:0.0001,OTH:0.0092,ASJ:0	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	.	unknown
2	169826592	169826592	T	C	ABCB11	exonic	nonsynonymous SNV	ENSG00000073734	rs11568367	ENSG00000073734:ENST00000263817:exon15:c.A1772G:p.N591S	ABCB11:NM_003742:exon15:c.A1772G:p.N591S	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0158	0.0005	0.0309505	0.0006	5.373	25.9	0.135	5.2	0.999	.	.	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	ABCB11:uc010zda.1:exon2:c.A98G:p.N33S,ABCB11:uc010zdb.1:exon2:c.A200G:p.N67S,ABCB11:uc002ueo.1:exon15:c.A1772G:p.N591S	-0.430	AFR:0.0009,AMR:0,EAS:0.0006,FIN:0,NFE:0.0001,OTH:0.0092,ASJ:0	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	0.989	-0.6	0.228	-0.67	2	.	unknown
2	169830328	169830328	A	G	ABCB11	exonic	nonsynonymous SNV	ENSG00000073734	rs2287622	ENSG00000073734:ENST00000263817:exon13:c.T1331C:p.V444A	ABCB11:NM_003742:exon13:c.T1331C:p.V444A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5794	0.5958	0.588658	MU13370497	1.830	15.16	0.25	4.62	0.998	.	.	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	ABCB11:uc002ueo.1:exon13:c.T1331C:p.V444A	-0.896	AFR:COCA-CN|5|321|0.0155763,AMR:0.5706,EAS:0.4185,FIN:0.5497,NFE:0.7126,OTH:0.5115,ASJ:0.5576	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	0.001	-3.2	0.000	0.145	2	1(haematopoietic_and_lymphoid_tissue)	0.5895
2	169842809	169842809	T	C	ABCB11	intronic	.	ENSG00000073734	rs2287618	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7053	0.7396	0.774161	0.7312	.	.	.	.	.	.	.	.	.	.	AFR:0.8273,AMR:0.5203,EAS:0.7994,FIN:0.6964,NFE:0.6929,OTH:0.6701,ASJ:0.6887	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU23484908	hom
2	173292709	173292709	A	G	ITGA6	intronic	.	ENSG00000226963	rs6744873	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3560	0.3208	0.500599	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505	.	.	.	.	.	.	.	.	.	.	AFR:0.3607,AMR:0.4865,EAS:0.2416,FIN:0.8855,NFE:0.3204,OTH:0.2360,ASJ:0.4988	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.3509
2	173292713	173292713	C	T	ITGA6	intronic	.	ENSG00000226963	rs6716540	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3463	0.3175	0.489018	0.3521	.	.	.	.	.	.	.	.	.	.	AFR:0.4824,AMR:0.4730,EAS:0.8664,FIN:0.2892,NFE:0.2327,OTH:0.3306,ASJ:0.2384	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	MU16475346	unknown
2	173337495	173337495	C	T	ITGA6	intronic	.	ENSG00000091409	rs16860497	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1919	0.0879	0.270367	0.1454	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.0577,AMR:0.2410,EAS:0.7315,FIN:0.2364,NFE:0.1067,OTH:0.1714,ASJ:0.0530	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	MU16475466	het
2	173352103	173352103	C	T	ITGA6	exonic	synonymous SNV	ENSG00000091409	rs2293649	ENSG00000091409:ENST00000264107:exon15:c.C2082T:p.D694D,ENSG00000091409:ENST00000343713:exon15:c.C2067T:p.D689D,ENSG00000091409:ENST00000409080:exon15:c.C2082T:p.D694D,ENSG00000091409:ENST00000409532:exon15:c.C1725T:p.D575D,ENSG00000091409:ENST00000458358:exon15:c.C2067T:p.D689D,ENSG00000091409:ENST00000264106:exon16:c.C2199T:p.D733D,ENSG00000091409:ENST00000375221:exon16:c.C2199T:p.D733D,ENSG00000091409:ENST00000442250:exon16:c.C2199T:p.D733D	ITGA6:NM_000210:exon15:c.C2082T:p.D694D,ITGA6:NM_001079818:exon15:c.C2082T:p.D694D,ITGA6:NM_001316306:exon15:c.C1725T:p.D575D,ITGA6:NM_001365529:exon15:c.C2082T:p.D694D,ITGA6:NM_001365530:exon15:c.C2082T:p.D694D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2974	0.2128	0.346645	MU109819	.	.	.	.	.	.	.	.	ITGA6:uc010fqm.1:exon9:c.C1020T:p.D340D,ITGA6:uc002uho.1:exon15:c.C2082T:p.D694D,ITGA6:uc002uhp.1:exon15:c.C2082T:p.D694D,ITGA6:uc010zdy.1:exon15:c.C1725T:p.D575D	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.2531,EAS:0.4069,FIN:0.2715,NFE:0.5333,OTH:0.3467,ASJ:0.2088	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(urinary_tract)	0.2136
2	175677022	175677022	C	T	CHN1	intronic	.	ENSG00000128656	rs12613075	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4335	0.3596	0.336861	0.3693	.	.	.	.	.	.	.	.	.	.	AFR:0.1096,AMR:0.2967,EAS:0.4411,FIN:0.4768,NFE:0.4856,OTH:0.4550,ASJ:0.3907	118423	604356;	233;	233|DRS<br>DURS<br>Duane syndrome<br>Stilling-Turk-Duane syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|126800 604356 616219 617041 ~	.	.	.	.	.	.	.	.	2	MU82176465	het
2	187487160	187487160	G	A	ITGAV	intronic	.	ENSG00000138448	rs9333288	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7458	0.7575	0.76258	0.7530	.	.	.	.	.	0	0.004	.	.	.	AFR:0.7741,AMR:0.7291,EAS:0.8623,FIN:0.7467,NFE:0.7342,OTH:0.7295,ASJ:0.7119	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	2	MU26816650	hom
2	187498107	187498107	T	C	ITGAV	intronic	.	ENSG00000138448	rs9333289	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2493	0.2051	0.179513	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647	.	.	.	.	.	0.3053	0.424	.	.	.	AFR:0.2113,AMR:0.0525,EAS:0.31,FIN:0.1346,NFE:0.2320,OTH:0.2992,ASJ:0.2863	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.2495
2	187532417	187532417	G	A	ITGAV	exonic	nonsynonymous SNV	ENSG00000138448	rs2230616	ENSG00000138448:ENST00000374907:exon22:c.G2239A:p.V747I,ENSG00000138448:ENST00000261023:exon24:c.G2347A:p.V783I,ENSG00000138448:ENST00000433736:exon24:c.G2209A:p.V737I	ITGAV:NM_001145000:exon22:c.G2239A:p.V747I,ITGAV:NM_001144999:exon24:c.G2209A:p.V737I,ITGAV:NM_002210:exon24:c.G2347A:p.V783I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9978	0.9909	0.992212	0.9923	2.394	18.78	0.694	3.39	1.000	.	.	Integrin alpha-2|Integrin domain	ITGAV:uc010frs.4:exon22:c.G2239A:p.V747I,ITGAV:uc002upq.4:exon24:c.G2347A:p.V783I,ITGAV:uc010zfv.3:exon24:c.G2209A:p.V737I	-0.948	AFR:0.9732,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.002	0.62	0.000	0.39	2	MU81747102	hom
2	189862048	189862048	G	C	COL3A1	intronic	.	ENSG00000168542	rs7579815	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1263	0.1667	0.128994	0.1453	.	.	.	.	.	.	.	.	.	.	AFR:0.2106,AMR:0.0981,EAS:0.0019,FIN:0.0954,NFE:0.1375,OTH:0.1408,ASJ:0.1457	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	.	het
2	189862097	189862097	G	A	COL3A1	exonic	synonymous SNV	ENSG00000168542	rs7579903	ENSG00000168542:ENST00000304636:exon26:c.G1851A:p.Q617Q,ENSG00000168542:ENST00000317840:exon26:c.G1851A:p.Q617Q	COL3A1:NM_000090:exon26:c.G1851A:p.Q617Q	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1260	0.1645	0.128994	0.1452	.	.	.	.	.	.	.	.	COL3A1:uc002uqj.1:exon26:c.G1851A:p.Q617Q	.	AFR:0.2112,AMR:0.0981,EAS:0.0018,FIN:0.0954,NFE:0.1371,OTH:0.1395,ASJ:0.1457	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	.	het
2	189863389	189863389	C	T	COL3A1	intronic	.	ENSG00000168542	rs13306272	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2641	0.2436	0.246805	0.2350	.	.	.	.	.	0	0	.	.	.	AFR:0.1949,AMR:0.2434,EAS:0.2144,FIN:0.2589,NFE:0.2504,OTH:0.2587,ASJ:0.3609	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	MU13400799	het
2	189864080	189864080	G	A	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1800255	ENSG00000168542:ENST00000304636:exon30:c.G2092A:p.A698T,ENSG00000168542:ENST00000317840:exon30:c.G2092A:p.A698T	COL3A1:NM_000090:exon30:c.G2092A:p.A698T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3204	0.2139	0.21845	0.2118	3.334	22.9	0.231	0.873	0.906	.	.	.	COL3A1:uc002uqj.1:exon30:c.G2092A:p.A698T	-1.057	AFR:0.1219,AMR:0.2368,EAS:0.2178,FIN:0.2579,NFE:0.2463,OTH:0.2485,ASJ:0.3411	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	-3.23	0.000	0.975	2	MU121280	het
2	189864582	189864582	T	C	COL3A1	exonic	synonymous SNV	ENSG00000168542	rs1801184	ENSG00000168542:ENST00000304636:exon32:c.T2244C:p.G748G,ENSG00000168542:ENST00000317840:exon32:c.T2244C:p.G748G	COL3A1:NM_000090:exon32:c.T2244C:p.G748G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3138	0.2850	0.212061	0.2518	.	.	.	.	.	.	.	.	COL3A1:uc002uqj.1:exon32:c.T2244C:p.G748G	.	AFR:0.2929,AMR:0.2026,EAS:0.0637,FIN:0.1812,NFE:0.2668,OTH:0.2439,ASJ:0.3079	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	MU4568253	het
2	189875421	189875421	T	G	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1516446	ENSG00000168542:ENST00000317840:exon41:c.T3150G:p.H1050Q,ENSG00000168542:ENST00000304636:exon50:c.T4059G:p.H1353Q	COL3A1:NM_000090:exon50:c.T4059G:p.H1353Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9985	0.9949	0.996605	0.9958	0.421	6.799	1.0	1.42	0.979	.	.	Fibrillar collagen, C-terminal|Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1	COL3A1:uc002uqj.1:exon50:c.T4059G:p.H1353Q	-0.950	AFR:0.9852,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:0.9967	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	0.36	0.000	-3.715	2	MU81747200	hom
2	191922841	191922841	G	A	STAT4	intronic	.	ENSG00000138378	rs3024866	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6415	0.5701	0.496406	0.5778	.	.	.	.	.	0.0006	0.06	.	.	.	AFR:0.2175,AMR:0.5168,EAS:0.5229,FIN:0.7042,NFE:0.7574,OTH:0.6857,ASJ:0.7185	600558	612253;	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	2	MU13402894	hom
2	198257795	198257795	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs4685	ENSG00000115524:ENST00000335508:exon24:c.A3657G:p.V1219V	SF3B1:NM_012433:exon24:c.A3657G:p.V1219V	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6717	0.7360	0.71845	0.6804	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon24:c.A3657G:p.V1219V	.	AFR:0.8292,AMR:0.5299,EAS:0.5310,FIN:0.5539,NFE:0.6499,OTH:0.6245,ASJ:0.7517	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9683,9684,9685	.	,9681,9677,9676,9675,9680,9678,9679	.	.	.	.	2	MU137937	hom
2	198264904	198264906	AAT	-	SF3B1	intronic	.	ENSG00000115524	rs140740106	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1733	0.1584	0.144569	0.1530	.	.	.	.	.	.	.	.	.	.	AFR:0.0746,AMR:0.1878,EAS:0.2519,FIN:0.1799,NFE:0.1775,OTH:0.1626,ASJ:0.2351	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	.	het
2	198265173	198265173	T	A	SF3B1	intronic	.	ENSG00000115524	rs788017	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6669	.	0.717851	0.6813	.	.	.	.	.	.	.	.	.	.	AFR:0.8299,AMR:0.5255,EAS:0.5281,FIN:0.5566,NFE:0.6509,OTH:0.6255,ASJ:0.7433	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	MU13407940	hom
2	198265526	198265526	A	G	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788018	ENSG00000115524:ENST00000335508:exon18:c.T2631C:p.G877G	SF3B1:NM_012433:exon18:c.T2631C:p.G877G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6708	0.7351	0.716653	0.6806	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon18:c.T2631C:p.G877G	.	AFR:0.8284,AMR:0.5310,EAS:0.5255,FIN:0.5545,NFE:0.6510,OTH:0.6301,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9683,9684,9685	.	,9681,9677,9676,9675,9680,9678,9679	.	.	.	.	2	MU137951	hom
2	198267770	198267770	-	AA	SF3B1	intronic	.	ENSG00000115524	rs3217350	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6743	0.7355	0.717452	0.6793	.	.	.	.	.	.	.	.	.	.	AFR:0.8259,AMR:0.5323,EAS:0.5323,FIN:0.5537,NFE:0.6492,OTH:0.6268,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	.	hom
2	198283305	198283305	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788023	ENSG00000115524:ENST00000335508:exon5:c.A423G:p.K141K	SF3B1:NM_012433:exon5:c.A423G:p.K141K	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6725	0.7394	0.720647	0.6838	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon5:c.A423G:p.K141K	.	AFR:0.8395,AMR:0.5311,EAS:0.5273,FIN:0.5554,NFE:0.6508,OTH:0.6281,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9683,9684,9685	.	,9681,9677,9676,9675,9680,9678,9679	.	.	.	.	2	MU137962	hom
2	202122995	202122995	A	G	CASP8	exonic	nonsynonymous SNV	ENSG00000064012	rs3769823	ENSG00000064012:ENST00000358485:exon1:c.A41G:p.K14R,ENSG00000064012:ENST00000437283:exon1:c.A41G:p.K14R	CASP8:NM_001080125:exon1:c.A41G:p.K14R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6673	0.6695	0.646366	LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916	-0.732	0.061	1.0	2.78	0.001	.	.	Death effector domain|Death-like domain	CASP8:uc002uxt.1:exon1:c.A41G:p.K14R	-0.995	AFR:0.6618,AMR:0.5774,EAS:0.6167,FIN:0.7326,NFE:0.6444,OTH:0.7127,ASJ:0.5658	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	0.008	4.26	0.000	.	2	1(thyroid)	0.6714
2	202151163	202151163	A	G	CASP8	intronic	.	ENSG00000064012	rs3769818	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7151	0.7429	0.745208	MU18189875	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.7305,EAS:0.5670,FIN:0.6424,NFE:0.7249,OTH:0.6720,ASJ:0.7850	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	2	2(upper_aerodigestive_tract)	0.7251
2	203421199	203421199	G	A	BMPR2	exonic	synonymous SNV	ENSG00000204217	rs1061157	ENSG00000204217:ENST00000374580:exon12:c.G2811A:p.R937R	BMPR2:NM_001204:exon12:c.G2811A:p.R937R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1203	0.0917	0.116414	BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	BMPR2:uc002uzf.4:exon12:c.G2811A:p.R937R	.	AFR:0.0915,AMR:0.0218,EAS:0.0667,FIN:0.0980,NFE:0.1231,OTH:0.1239,ASJ:0.0931	600799	178600;265450;	31837;422;	31837|-|-|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265450 ~422|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable<br>or&nbsp;Autosomal recessive|All ages|178600 265400 615342 615343 615344 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.0980
2	209101906	209101906	A	-	IDH1	intronic	.	ENSG00000138413	rs57383668	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9898	.	0.982628	0.9861	.	.	.	.	.	.	.	.	.	.	AFR:0.9526,AMR:0.9964,EAS:1,FIN:1,NFE:0.9994,OTH:0.9938,ASJ:1	147700	137800;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00480 Glutathione metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko01210 2-Oxocarboxylic acid metabolism~ko01230 Biosynthesis of amino acids~ko04146 Peroxisome~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00010 Citrate cycle, first carbon oxidation, oxaloacetate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00740 Methylaspartate cycle ~	.	.	.	.	.	.	.	2	.	hom
2	211527828	211527828	T	-	CPS1	intronic	.	ENSG00000021826	rs397703682	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.7547	.	0.77476	0.8552	.	.	.	.	.	.	.	.	.	.	AFR:0.7533,AMR:0.8290,EAS:0.9375,FIN:0.9002,NFE:0.8987,OTH:0.9048,ASJ:0.9190	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	.	hom
2	212251864	212251864	T	C	ERBB4	exonic	synonymous SNV	ENSG00000178568	rs3748962	ENSG00000178568:ENST00000436443:exon26:c.A3147G:p.V1049V,ENSG00000178568:ENST00000342788:exon27:c.A3195G:p.V1065V,ENSG00000178568:ENST00000402597:exon27:c.A3165G:p.V1055V	ERBB4:NM_001042599:exon26:c.A3147G:p.V1049V,ERBB4:NM_005235:exon27:c.A3195G:p.V1065V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2954	0.2527	0.223043	1(breast)	.	.	.	.	.	.	.	.	ERBB4:uc002veh.1:exon26:c.A3147G:p.V1049V,ERBB4:uc010zjj.1:exon26:c.A3117G:p.V1039V,ERBB4:uc002veg.1:exon27:c.A3195G:p.V1065V,ERBB4:uc010zji.1:exon27:c.A3165G:p.V1055V	.	AFR:1(urinary_tract),AMR:1(lung),EAS:MU159309,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,NFE:0.2698,OTH:0.0988,ASJ:1(haematopoietic_and_lymphoid_tissue)	600543	615515;	803;	803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer ~	,4763,4764	.	.	.	.	.	.	2	5(large_intestine)	0.2530
2	212578380	212578380	A	-	ERBB4	intronic	.	ENSG00000178568	rs397987661	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4628	.	0.442891	0.3497	.	.	.	.	.	.	.	.	.	.	AFR:0.3398,AMR:0.3713,EAS:0.2683,FIN:0.4472,NFE:0.3540,OTH:0.3663,ASJ:0.236	600543	615515;	803;	803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	2	.	het
2	215603804	215603804	T	A	BARD1	intronic	.	ENSG00000138376	rs2034250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.297724	0.2956	.	.	.	.	.	.	.	.	.	.	AFR:0.2751,AMR:0.2721,EAS:0.3973,FIN:0.3766,NFE:0.2762,OTH:0.3258,ASJ:0.3377	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	.	het
2	215632192	215632192	G	A	BARD1	intronic	.	ENSG00000138376	rs5031011	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3614	0.3353	0.352236	0.3655	.	.	.	.	.	.	.	.	.	.	AFR:0.3481,AMR:0.2938,EAS:0.3850,FIN:0.4501,NFE:0.3537,OTH:0.4131,ASJ:0.4073	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU757044	het
2	215632255	215632255	C	T	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2070094	ENSG00000138376:ENST00000449967:exon5:c.G1087A:p.V363M,ENSG00000138376:ENST00000260947:exon6:c.G1519A:p.V507M	BARD1:NM_001282543:exon5:c.G1462A:p.V488M,BARD1:NM_000465:exon6:c.G1519A:p.V507M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3783	0.2806	0.366214	0.3845	0.209	4.771	0.269	-11.3	0.313	.	.	Ankyrin repeat-containing domain	BARD1:uc021vwf.1:exon4:c.G1228A:p.V410M,BARD1:uc010zjm.1:exon5:c.G1087A:p.V363M,BARD1:uc021vwd.1:exon5:c.G217A:p.V73M,BARD1:uc021vwe.1:exon5:c.G1462A:p.V488M,BARD1:uc002veu.2:exon6:c.G1519A:p.V507M,BARD1:uc021vwj.1:exon6:c.G1111A:p.V371M	-1.097	AFR:0.3705,AMR:0.3103,EAS:0.3806,FIN:0.4676,NFE:0.3741,OTH:0.4286,ASJ:0.4238	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.001	-0.17	0.000	1.23	2	MU152802	unknown
2	215632256	215632256	A	G	BARD1	exonic	synonymous SNV	ENSG00000138376	rs2070093	ENSG00000138376:ENST00000449967:exon5:c.T1086C:p.H362H,ENSG00000138376:ENST00000260947:exon6:c.T1518C:p.H506H	BARD1:NM_001282543:exon5:c.T1461C:p.H487H,BARD1:NM_000465:exon6:c.T1518C:p.H506H	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8134	0.7138	0.770567	0.7658	.	.	.	.	.	.	.	.	BARD1:uc021vwf.1:exon4:c.T1227C:p.H409H,BARD1:uc010zjm.1:exon5:c.T1086C:p.H362H,BARD1:uc021vwd.1:exon5:c.T216C:p.H72H,BARD1:uc021vwe.1:exon5:c.T1461C:p.H487H,BARD1:uc002veu.2:exon6:c.T1518C:p.H506H,BARD1:uc021vwj.1:exon6:c.T1110C:p.H370H	.	AFR:0.6055,AMR:0.7883,EAS:0.9543,FIN:0.8947,NFE:0.8028,OTH:0.8286,ASJ:0.7848	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU31491380	unknown
2	215634055	215634055	C	T	BARD1	intronic	.	ENSG00000138376	rs6704780	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3818	0.3595	0.365216	0.3855	.	.	.	.	.	.	.	.	.	.	AFR:0.3717,AMR:0.3110,EAS:0.3835,FIN:0.4670,NFE:0.3754,OTH:0.4284,ASJ:0.4267	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU757049	het
2	215645464	215645464	C	G	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2229571	ENSG00000138376:ENST00000449967:exon3:c.G702C:p.R234S,ENSG00000138376:ENST00000260947:exon4:c.G1134C:p.R378S	BARD1:NM_001282543:exon3:c.G1077C:p.R359S,BARD1:NM_000465:exon4:c.G1134C:p.R378S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5487	0.5318	0.459265	0.5519	0.673	8.652	0.174	-1.03	0.050	.	.	.	BARD1:uc021vwf.1:exon2:c.G843C:p.R281S,BARD1:uc010zjm.1:exon3:c.G702C:p.R234S,BARD1:uc021vwe.1:exon3:c.G1077C:p.R359S,BARD1:uc002veu.2:exon4:c.G1134C:p.R378S	-0.921	AFR:0.4006,AMR:0.4376,EAS:0.3851,FIN:0.6827,NFE:0.6283,OTH:0.6214,ASJ:0.5894	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.024	-0.67	0.000	1.67	2	MU152809	hom
2	215657183	215657183	A	-	BARD1	intronic	.	ENSG00000138376	rs56130510	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.4384	.	0.444888	0.3164	.	.	.	.	.	.	.	.	.	.	AFR:0.3335,AMR:0.3605,EAS:0.2098,FIN:0.2949,NFE:0.3181,OTH:0.3190,ASJ:0.3130	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	.	het
2	215674224	215674224	G	A	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs1048108	ENSG00000138376:ENST00000260947:exon1:c.C70T:p.P24S,ENSG00000138376:ENST00000421162:exon1:c.C70T:p.P24S,ENSG00000138376:ENST00000455743:exon1:c.C70T:p.P24S	BARD1:NM_000465:exon1:c.C70T:p.P24S,BARD1:NM_001282543:exon1:c.C70T:p.P24S,BARD1:NM_001282545:exon1:c.C70T:p.P24S,BARD1:NM_001282548:exon1:c.C70T:p.P24S,BARD1:NM_001282549:exon1:c.C70T:p.P24S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4377	0.3031	0.33127	0.3408	1.242	11.97	0.184	3.1	0.116	.	.	.	BARD1:uc002veu.2:exon1:c.C70T:p.P24S,BARD1:uc021vwe.1:exon1:c.C70T:p.P24S,BARD1:uc021vwg.1:exon1:c.C70T:p.P24S,BARD1:uc021vwh.1:exon1:c.C70T:p.P24S,BARD1:uc021vwi.1:exon1:c.C70T:p.P24S,BARD1:uc021vwj.1:exon1:c.C70T:p.P24S	-1.043	AFR:0.2121,AMR:0.4141,EAS:0.3779,FIN:0.4177,NFE:0.3819,OTH:0.4378,ASJ:0.41	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.002	-0.72	0.000	1.195	2	MU152818	het
2	216229692	216229692	A	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs11651	ENSG00000115414:ENST00000456923:exon19:c.T3039C:p.Y1013Y,ENSG00000115414:ENST00000345488:exon41:c.T6282C:p.Y2094Y,ENSG00000115414:ENST00000346544:exon42:c.T6363C:p.Y2121Y,ENSG00000115414:ENST00000356005:exon42:c.T6618C:p.Y2206Y,ENSG00000115414:ENST00000357867:exon42:c.T6258C:p.Y2086Y,ENSG00000115414:ENST00000359671:exon43:c.T6888C:p.Y2296Y,ENSG00000115414:ENST00000421182:exon43:c.T6450C:p.Y2150Y,ENSG00000115414:ENST00000432072:exon43:c.T6531C:p.Y2177Y,ENSG00000115414:ENST00000443816:exon43:c.T6525C:p.Y2175Y,ENSG00000115414:ENST00000336916:exon44:c.T6795C:p.Y2265Y,ENSG00000115414:ENST00000354785:exon44:c.T7161C:p.Y2387Y,ENSG00000115414:ENST00000446046:exon44:c.T6720C:p.Y2240Y,ENSG00000115414:ENST00000323926:exon45:c.T7068C:p.Y2356Y	FN1:NM_001365523:exon42:c.T6543C:p.Y2181Y,FN1:NM_212474:exon42:c.T6258C:p.Y2086Y,FN1:NM_212476:exon42:c.T6618C:p.Y2206Y,FN1:NM_001306130:exon43:c.T6531C:p.Y2177Y,FN1:NM_001306131:exon43:c.T6525C:p.Y2175Y,FN1:NM_001306132:exon43:c.T6450C:p.Y2150Y,FN1:NM_001365517:exon43:c.T6891C:p.Y2297Y,FN1:NM_001365518:exon43:c.T6888C:p.Y2296Y,FN1:NM_001365519:exon43:c.T6816C:p.Y2272Y,FN1:NM_001365520:exon43:c.T6813C:p.Y2271Y,FN1:NM_001365524:exon43:c.T6528C:p.Y2176Y,FN1:NM_001365521:exon44:c.T6798C:p.Y2266Y,FN1:NM_001365522:exon44:c.T6723C:p.Y2241Y,FN1:NM_002026:exon44:c.T6795C:p.Y2265Y,FN1:NM_212478:exon44:c.T6720C:p.Y2240Y,FN1:NM_212482:exon44:c.T7161C:p.Y2387Y,FN1:NM_001306129:exon45:c.T7068C:p.Y2356Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4079	0.2481	0.282748	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	FN1:uc002vez.3:exon17:c.T1650C:p.Y550Y,FN1:uc010zjp.2:exon19:c.T2772C:p.Y924Y,FN1:uc002vfg.3:exon42:c.T6618C:p.Y2206Y,FN1:uc002vfh.3:exon42:c.T6258C:p.Y2086Y,FN1:uc002vfb.3:exon43:c.T6525C:p.Y2175Y,FN1:uc002vfc.3:exon43:c.T6450C:p.Y2150Y,FN1:uc002vfj.3:exon43:c.T6531C:p.Y2177Y,FN1:uc002vfa.3:exon44:c.T7161C:p.Y2387Y,FN1:uc002vfe.3:exon44:c.T6795C:p.Y2265Y,FN1:uc002vff.3:exon44:c.T6720C:p.Y2240Y,FN1:uc002vfi.3:exon45:c.T7068C:p.Y2356Y	.	AFR:0.2534,AMR:0.0982,EAS:0.3940,FIN:0.2816,NFE:0.2758,OTH:0.3266,ASJ:0.3369	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	1(large_intestine)	0.2751
2	216235089	216235089	C	T	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250209	ENSG00000115414:ENST00000456923:exon16:c.G2659A:p.V887I,ENSG00000115414:ENST00000356005:exon39:c.G6238A:p.V2080I,ENSG00000115414:ENST00000357867:exon39:c.G5878A:p.V1960I,ENSG00000115414:ENST00000346544:exon40:c.G6148A:p.V2050I,ENSG00000115414:ENST00000359671:exon40:c.G6508A:p.V2170I,ENSG00000115414:ENST00000421182:exon40:c.G6070A:p.V2024I,ENSG00000115414:ENST00000432072:exon40:c.G6151A:p.V2051I,ENSG00000115414:ENST00000443816:exon40:c.G6145A:p.V2049I,ENSG00000115414:ENST00000336916:exon41:c.G6415A:p.V2139I,ENSG00000115414:ENST00000354785:exon41:c.G6781A:p.V2261I,ENSG00000115414:ENST00000446046:exon41:c.G6340A:p.V2114I,ENSG00000115414:ENST00000323926:exon42:c.G6688A:p.V2230I	FN1:NM_001365523:exon39:c.G6163A:p.V2055I,FN1:NM_212474:exon39:c.G5878A:p.V1960I,FN1:NM_212476:exon39:c.G6238A:p.V2080I,FN1:NM_001306130:exon40:c.G6151A:p.V2051I,FN1:NM_001306131:exon40:c.G6145A:p.V2049I,FN1:NM_001306132:exon40:c.G6070A:p.V2024I,FN1:NM_001365517:exon40:c.G6511A:p.V2171I,FN1:NM_001365518:exon40:c.G6508A:p.V2170I,FN1:NM_001365519:exon40:c.G6436A:p.V2146I,FN1:NM_001365520:exon40:c.G6433A:p.V2145I,FN1:NM_001365524:exon40:c.G6148A:p.V2050I,FN1:NM_001365521:exon41:c.G6418A:p.V2140I,FN1:NM_001365522:exon41:c.G6343A:p.V2115I,FN1:NM_002026:exon41:c.G6415A:p.V2139I,FN1:NM_212478:exon41:c.G6340A:p.V2114I,FN1:NM_212482:exon41:c.G6781A:p.V2261I,FN1:NM_001306129:exon42:c.G6688A:p.V2230I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9998	0.9998	0.9998	3.072	22.4	1.0	5.6	0.999	.	.	Fibronectin type III|Immunoglobulin-like fold;Fibronectin, type I	FN1:uc010fvd.1:exon7:c.G961A:p.V321I,FN1:uc010fvc.1:exon11:c.G1507A:p.V503I,FN1:uc002vez.3:exon14:c.G1270A:p.V424I,FN1:uc010zjp.2:exon16:c.G2392A:p.V798I,FN1:uc002vfg.3:exon39:c.G6238A:p.V2080I,FN1:uc002vfh.3:exon39:c.G5878A:p.V1960I,FN1:uc002vfb.3:exon40:c.G6145A:p.V2049I,FN1:uc002vfc.3:exon40:c.G6070A:p.V2024I,FN1:uc002vfj.3:exon40:c.G6151A:p.V2051I,FN1:uc002vfa.3:exon41:c.G6781A:p.V2261I,FN1:uc002vfe.3:exon41:c.G6415A:p.V2139I,FN1:uc002vff.3:exon41:c.G6340A:p.V2114I,FN1:uc002vfi.3:exon42:c.G6688A:p.V2230I	-0.928	AFR:0.9994,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.29	0.000	-0.455	2	MU81750207	hom
2	216240127	216240128	AC	-	FN1	intronic	.	ENSG00000115414	rs3214672	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3189	0.2450	0.379593	0.2731	.	.	.	.	.	.	.	.	.	.	AFR:0.2521,AMR:0.3873,EAS:0.7909,FIN:0.2484,NFE:0.2268,OTH:0.2771,ASJ:0.39	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU114604750	het
2	216242917	216242917	T	A	FN1	exonic	synonymous SNV	ENSG00000115414	rs1132741	ENSG00000115414:ENST00000456923:exon10:c.A1569T:p.G523G,ENSG00000115414:ENST00000356005:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000357867:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000421182:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000443816:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000336916:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000345488:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000346544:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000357009:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000359671:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000432072:exon34:c.A5421T:p.G1807G,ENSG00000115414:ENST00000446046:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000323926:exon35:c.A5691T:p.G1897G,ENSG00000115414:ENST00000354785:exon35:c.A5691T:p.G1897G	FN1:NM_001306131:exon33:c.A5148T:p.G1716G,FN1:NM_001306132:exon33:c.A5148T:p.G1716G,FN1:NM_001365523:exon33:c.A5148T:p.G1716G,FN1:NM_212474:exon33:c.A5148T:p.G1716G,FN1:NM_212476:exon33:c.A5148T:p.G1716G,FN1:NM_001306130:exon34:c.A5421T:p.G1807G,FN1:NM_001365517:exon34:c.A5421T:p.G1807G,FN1:NM_001365518:exon34:c.A5418T:p.G1806G,FN1:NM_001365519:exon34:c.A5421T:p.G1807G,FN1:NM_001365520:exon34:c.A5418T:p.G1806G,FN1:NM_001365521:exon34:c.A5421T:p.G1807G,FN1:NM_001365522:exon34:c.A5421T:p.G1807G,FN1:NM_001365524:exon34:c.A5418T:p.G1806G,FN1:NM_002026:exon34:c.A5418T:p.G1806G,FN1:NM_212478:exon34:c.A5418T:p.G1806G,FN1:NM_001306129:exon35:c.A5691T:p.G1897G,FN1:NM_212482:exon35:c.A5691T:p.G1897G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2868	0.1899	0.324681	LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	FN1:uc010fvc.1:exon5:c.A777T:p.G259G,FN1:uc002vez.3:exon7:c.A273T:p.G91G,FN1:uc010zjp.2:exon10:c.A1302T:p.G434G,FN1:uc002vfb.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfc.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfg.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfh.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfe.3:exon34:c.A5418T:p.G1806G,FN1:uc002vff.3:exon34:c.A5418T:p.G1806G,FN1:uc002vfj.3:exon34:c.A5421T:p.G1807G,FN1:uc002vfa.3:exon35:c.A5691T:p.G1897G,FN1:uc002vfi.3:exon35:c.A5691T:p.G1897G	.	AFR:0.2265,AMR:0.0876,EAS:0.39,FIN:0.7924,NFE:0.2491,OTH:0.2271,ASJ:0.3726	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2684
2	216249587	216249587	C	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs13652	ENSG00000115414:ENST00000456923:exon5:c.G873A:p.E291E,ENSG00000115414:ENST00000336916:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000345488:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000346544:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000356005:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357009:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357867:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000359671:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000421182:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000443816:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000446046:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000323926:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000354785:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000432072:exon29:c.G4725A:p.E1575E	FN1:NM_001306131:exon28:c.G4452A:p.E1484E,FN1:NM_001306132:exon28:c.G4452A:p.E1484E,FN1:NM_001365518:exon28:c.G4452A:p.E1484E,FN1:NM_001365520:exon28:c.G4452A:p.E1484E,FN1:NM_001365523:exon28:c.G4452A:p.E1484E,FN1:NM_001365524:exon28:c.G4452A:p.E1484E,FN1:NM_002026:exon28:c.G4452A:p.E1484E,FN1:NM_212474:exon28:c.G4452A:p.E1484E,FN1:NM_212476:exon28:c.G4452A:p.E1484E,FN1:NM_212478:exon28:c.G4452A:p.E1484E,FN1:NM_001306129:exon29:c.G4725A:p.E1575E,FN1:NM_001306130:exon29:c.G4725A:p.E1575E,FN1:NM_001365517:exon29:c.G4725A:p.E1575E,FN1:NM_001365519:exon29:c.G4725A:p.E1575E,FN1:NM_001365521:exon29:c.G4725A:p.E1575E,FN1:NM_001365522:exon29:c.G4725A:p.E1575E,FN1:NM_212482:exon29:c.G4725A:p.E1575E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8752	0.8493	0.86861	0.8734	.	.	.	.	.	.	.	.	FN1:uc010zjp.2:exon5:c.G606A:p.E202E,FN1:uc002vfb.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfc.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfe.3:exon28:c.G4452A:p.E1484E,FN1:uc002vff.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfg.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfh.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfa.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfi.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfj.3:exon29:c.G4725A:p.E1575E	.	AFR:0.8131,AMR:0.8890,EAS:1,FIN:0.9270,NFE:0.8818,OTH:0.8890,ASJ:0.8046	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU81750265	hom
2	216251697	216251697	G	A	FN1	intronic	.	ENSG00000115414	rs35343655	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3241	0.2398	0.373602	0.2721	.	.	.	.	.	.	.	.	.	.	AFR:0.2433,AMR:0.3888,EAS:0.7932,FIN:0.2484,NFE:0.2270,OTH:0.2780,ASJ:0.3885	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU21425088	het
2	216253039	216253039	G	C	FN1	intronic	.	ENSG00000115414	rs1250215	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5491	0.5241	0.411741	0.5267	.	.	.	.	.	.	.	.	.	.	AFR:0.3086,AMR:0.4880,EAS:0.2151,FIN:0.6778,NFE:0.6522,OTH:0.5939,ASJ:0.4073	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU25472968	het
2	216256344	216256344	C	G	FN1	intronic	.	ENSG00000115414	rs10498038	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0371	0.0415	0.0177716	0.0355	.	.	.	.	.	.	.	.	.	.	AFR:0.0102,AMR:0.0191,EAS:0,FIN:0.0280,NFE:0.0569,OTH:0.0336,ASJ:0.0298	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU116714168	het
2	216259399	216259399	C	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs751943840	ENSG00000115414:ENST00000323926:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000336916:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000345488:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000346544:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000354785:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000356005:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000357009:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000357867:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000359671:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000421182:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000432072:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000443816:exon24:c.G3648A:p.Q1216Q,ENSG00000115414:ENST00000446046:exon24:c.G3648A:p.Q1216Q	FN1:NM_001306129:exon24:c.G3648A:p.Q1216Q,FN1:NM_001306130:exon24:c.G3648A:p.Q1216Q,FN1:NM_001306131:exon24:c.G3648A:p.Q1216Q,FN1:NM_001306132:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365517:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365518:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365519:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365520:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365521:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365522:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365523:exon24:c.G3648A:p.Q1216Q,FN1:NM_001365524:exon24:c.G3648A:p.Q1216Q,FN1:NM_002026:exon24:c.G3648A:p.Q1216Q,FN1:NM_212474:exon24:c.G3648A:p.Q1216Q,FN1:NM_212476:exon24:c.G3648A:p.Q1216Q,FN1:NM_212478:exon24:c.G3648A:p.Q1216Q,FN1:NM_212482:exon24:c.G3648A:p.Q1216Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	2.472e-05	.	.	.	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfb.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfc.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfe.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vff.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfg.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfh.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfi.3:exon24:c.G3648A:p.Q1216Q,FN1:uc002vfj.3:exon24:c.G3648A:p.Q1216Q	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	.	het
2	216269095	216269095	C	T	FN1	intronic	.	ENSG00000115414	rs13306359	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3648	0.3458	0.286941	0.3347	.	.	.	.	.	.	.	.	.	.	AFR:0.2350,AMR:0.3041,EAS:0.0686,FIN:0.3869,NFE:0.4101,OTH:0.3727,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177168	het
2	216269209	216269209	T	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs1053238	ENSG00000115414:ENST00000323926:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000336916:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000345488:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000346544:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000354785:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000356005:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000357009:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000357867:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000359671:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000421182:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000432072:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000443816:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000446046:exon20:c.A3156C:p.P1052P	FN1:NM_001306129:exon20:c.A3156C:p.P1052P,FN1:NM_001306130:exon20:c.A3156C:p.P1052P,FN1:NM_001306131:exon20:c.A3156C:p.P1052P,FN1:NM_001306132:exon20:c.A3156C:p.P1052P,FN1:NM_001365517:exon20:c.A3156C:p.P1052P,FN1:NM_001365518:exon20:c.A3156C:p.P1052P,FN1:NM_001365519:exon20:c.A3156C:p.P1052P,FN1:NM_001365520:exon20:c.A3156C:p.P1052P,FN1:NM_001365521:exon20:c.A3156C:p.P1052P,FN1:NM_001365522:exon20:c.A3156C:p.P1052P,FN1:NM_001365523:exon20:c.A3156C:p.P1052P,FN1:NM_001365524:exon20:c.A3156C:p.P1052P,FN1:NM_002026:exon20:c.A3156C:p.P1052P,FN1:NM_212474:exon20:c.A3156C:p.P1052P,FN1:NM_212476:exon20:c.A3156C:p.P1052P,FN1:NM_212478:exon20:c.A3156C:p.P1052P,FN1:NM_212482:exon20:c.A3156C:p.P1052P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3643	0.3462	0.286741	0.3376	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfb.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfc.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfe.3:exon20:c.A3156C:p.P1052P,FN1:uc002vff.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfg.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfh.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfi.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfj.3:exon20:c.A3156C:p.P1052P	.	AFR:0.2361,AMR:0.3062,EAS:0.0698,FIN:0.3954,NFE:0.4123,OTH:0.3724,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177191	het
2	216269254	216269254	T	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs7589580	ENSG00000115414:ENST00000323926:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000336916:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000345488:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000346544:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000354785:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000356005:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000357009:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000357867:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000359671:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000421182:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000432072:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000443816:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000446046:exon20:c.A3111C:p.G1037G	FN1:NM_001306129:exon20:c.A3111C:p.G1037G,FN1:NM_001306130:exon20:c.A3111C:p.G1037G,FN1:NM_001306131:exon20:c.A3111C:p.G1037G,FN1:NM_001306132:exon20:c.A3111C:p.G1037G,FN1:NM_001365517:exon20:c.A3111C:p.G1037G,FN1:NM_001365518:exon20:c.A3111C:p.G1037G,FN1:NM_001365519:exon20:c.A3111C:p.G1037G,FN1:NM_001365520:exon20:c.A3111C:p.G1037G,FN1:NM_001365521:exon20:c.A3111C:p.G1037G,FN1:NM_001365522:exon20:c.A3111C:p.G1037G,FN1:NM_001365523:exon20:c.A3111C:p.G1037G,FN1:NM_001365524:exon20:c.A3111C:p.G1037G,FN1:NM_002026:exon20:c.A3111C:p.G1037G,FN1:NM_212474:exon20:c.A3111C:p.G1037G,FN1:NM_212476:exon20:c.A3111C:p.G1037G,FN1:NM_212478:exon20:c.A3111C:p.G1037G,FN1:NM_212482:exon20:c.A3111C:p.G1037G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3644	0.3462	0.286941	0.3384	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfb.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfc.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfe.3:exon20:c.A3111C:p.G1037G,FN1:uc002vff.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfg.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfh.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfi.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfj.3:exon20:c.A3111C:p.G1037G	.	AFR:0.237,AMR:0.3079,EAS:0.0699,FIN:0.3945,NFE:0.4131,OTH:0.3760,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177210	het
2	216272819	216272819	C	G	FN1	intronic	.	ENSG00000115414	rs7570208	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6051	0.6068	0.665935	0.6195	.	.	.	.	.	.	.	.	.	.	AFR:0.6739,AMR:0.6504,EAS:0.9277,FIN:0.5985,NFE:0.5594,OTH:0.5930,ASJ:0.6133	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084458	het
2	216272900	216272900	T	G	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs2577301	ENSG00000115414:ENST00000323926:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000336916:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000345488:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000346544:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000354785:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000356005:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357009:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357867:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000359671:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000421182:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000432072:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000443816:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000446046:exon17:c.A2449C:p.T817P	FN1:NM_001306129:exon17:c.A2449C:p.T817P,FN1:NM_001306130:exon17:c.A2449C:p.T817P,FN1:NM_001306131:exon17:c.A2449C:p.T817P,FN1:NM_001306132:exon17:c.A2449C:p.T817P,FN1:NM_001365517:exon17:c.A2449C:p.T817P,FN1:NM_001365518:exon17:c.A2449C:p.T817P,FN1:NM_001365519:exon17:c.A2449C:p.T817P,FN1:NM_001365520:exon17:c.A2449C:p.T817P,FN1:NM_001365521:exon17:c.A2449C:p.T817P,FN1:NM_001365522:exon17:c.A2449C:p.T817P,FN1:NM_001365523:exon17:c.A2449C:p.T817P,FN1:NM_001365524:exon17:c.A2449C:p.T817P,FN1:NM_002026:exon17:c.A2449C:p.T817P,FN1:NM_212474:exon17:c.A2449C:p.T817P,FN1:NM_212476:exon17:c.A2449C:p.T817P,FN1:NM_212478:exon17:c.A2449C:p.T817P,FN1:NM_212482:exon17:c.A2449C:p.T817P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9999	0.9998	0.9998	1.626	14.00	0.314	5.93	0.070	.	.	Fibronectin type III|Immunoglobulin-like fold	FN1:uc002vfa.3:exon17:c.A2449C:p.T817P,FN1:uc002vfb.3:exon17:c.A2449C:p.T817P,FN1:uc002vfc.3:exon17:c.A2449C:p.T817P,FN1:uc002vfe.3:exon17:c.A2449C:p.T817P,FN1:uc002vff.3:exon17:c.A2449C:p.T817P,FN1:uc002vfg.3:exon17:c.A2449C:p.T817P,FN1:uc002vfh.3:exon17:c.A2449C:p.T817P,FN1:uc002vfi.3:exon17:c.A2449C:p.T817P,FN1:uc002vfj.3:exon17:c.A2449C:p.T817P	-0.957	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.51	0.000	-0.69	2	MU81750388	hom
2	216272907	216272907	A	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs7596677	ENSG00000115414:ENST00000323926:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000336916:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000345488:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000346544:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000354785:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000356005:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000357009:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000357867:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000359671:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000421182:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000432072:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000443816:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000446046:exon17:c.T2442A:p.P814P	FN1:NM_001306129:exon17:c.T2442A:p.P814P,FN1:NM_001306130:exon17:c.T2442A:p.P814P,FN1:NM_001306131:exon17:c.T2442A:p.P814P,FN1:NM_001306132:exon17:c.T2442A:p.P814P,FN1:NM_001365517:exon17:c.T2442A:p.P814P,FN1:NM_001365518:exon17:c.T2442A:p.P814P,FN1:NM_001365519:exon17:c.T2442A:p.P814P,FN1:NM_001365520:exon17:c.T2442A:p.P814P,FN1:NM_001365521:exon17:c.T2442A:p.P814P,FN1:NM_001365522:exon17:c.T2442A:p.P814P,FN1:NM_001365523:exon17:c.T2442A:p.P814P,FN1:NM_001365524:exon17:c.T2442A:p.P814P,FN1:NM_002026:exon17:c.T2442A:p.P814P,FN1:NM_212474:exon17:c.T2442A:p.P814P,FN1:NM_212476:exon17:c.T2442A:p.P814P,FN1:NM_212478:exon17:c.T2442A:p.P814P,FN1:NM_212482:exon17:c.T2442A:p.P814P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3394	0.2522	0.421526	0.2924	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon17:c.T2442A:p.P814P,FN1:uc002vfb.3:exon17:c.T2442A:p.P814P,FN1:uc002vfc.3:exon17:c.T2442A:p.P814P,FN1:uc002vfe.3:exon17:c.T2442A:p.P814P,FN1:uc002vff.3:exon17:c.T2442A:p.P814P,FN1:uc002vfg.3:exon17:c.T2442A:p.P814P,FN1:uc002vfh.3:exon17:c.T2442A:p.P814P,FN1:uc002vfi.3:exon17:c.T2442A:p.P814P,FN1:uc002vfj.3:exon17:c.T2442A:p.P814P	.	AFR:0.2128,AMR:0.4557,EAS:0.9243,FIN:0.3105,NFE:0.2552,OTH:0.3014,ASJ:0.3675	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU25473493	het
2	216274854	216274855	AC	-	FN1	intronic	.	ENSG00000115414	rs397987770	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3020	.	0.39397	0.2624	.	.	.	.	.	.	.	.	.	.	AFR:0.1430,AMR:0.4381,EAS:0.9171,FIN:0.3021,NFE:0.2392,OTH:0.2831,ASJ:0.3576	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	216283958	216283958	T	A	FN1	intronic	.	ENSG00000115414	rs3796123	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3206	0.2354	0.411542	0.2791	.	.	.	.	.	0.0005	0.006	.	.	.	AFR:0.2161,AMR:0.4594,EAS:0.9247,FIN:0.2898,NFE:0.2310,OTH:0.2867,ASJ:0.3742	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084546	het
2	216299550	216299550	G	A	FN1	intronic	.	ENSG00000115414	rs2577290	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3196	0.1445	0.422324	0.3007	.	.	.	.	.	0.0132	0.174	.	.	.	AFR:0.2916,AMR:0.4555,EAS:0.9251,FIN:0.2948,NFE:0.2287,OTH:0.2945,ASJ:0.3691	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084633	het
2	216299551	216299551	C	A	FN1	intronic	.	ENSG00000115414	rs2692234	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3196	0.1314	0.422324	0.3011	.	.	.	.	.	0.0002	0.022	.	.	.	AFR:0.2921,AMR:0.4577,EAS:0.9251,FIN:0.2952,NFE:0.2290,OTH:0.2945,ASJ:0.3667	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084672	het
2	216300482	216300482	T	A	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250259	ENSG00000115414:ENST00000323926:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000336916:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000345488:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000346544:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000354785:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000356005:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000357009:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000357867:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000359671:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000421182:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000426059:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000432072:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000443816:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000446046:exon1:c.A44T:p.Q15L	FN1:NM_001306129:exon1:c.A44T:p.Q15L,FN1:NM_001306130:exon1:c.A44T:p.Q15L,FN1:NM_001306131:exon1:c.A44T:p.Q15L,FN1:NM_001306132:exon1:c.A44T:p.Q15L,FN1:NM_001365517:exon1:c.A44T:p.Q15L,FN1:NM_001365518:exon1:c.A44T:p.Q15L,FN1:NM_001365519:exon1:c.A44T:p.Q15L,FN1:NM_001365520:exon1:c.A44T:p.Q15L,FN1:NM_001365521:exon1:c.A44T:p.Q15L,FN1:NM_001365522:exon1:c.A44T:p.Q15L,FN1:NM_001365523:exon1:c.A44T:p.Q15L,FN1:NM_001365524:exon1:c.A44T:p.Q15L,FN1:NM_002026:exon1:c.A44T:p.Q15L,FN1:NM_054034:exon1:c.A44T:p.Q15L,FN1:NM_212474:exon1:c.A44T:p.Q15L,FN1:NM_212476:exon1:c.A44T:p.Q15L,FN1:NM_212478:exon1:c.A44T:p.Q15L,FN1:NM_212482:exon1:c.A44T:p.Q15L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7691	0.7885	0.795128	COCA-CN|5|321|0.0155763	1.570	13.69	1.0	5.35	0.947	.	.	.	FN1:uc002vfa.3:exon1:c.A44T:p.Q15L,FN1:uc002vfb.3:exon1:c.A44T:p.Q15L,FN1:uc002vfc.3:exon1:c.A44T:p.Q15L,FN1:uc002vfe.3:exon1:c.A44T:p.Q15L,FN1:uc002vff.3:exon1:c.A44T:p.Q15L,FN1:uc002vfg.3:exon1:c.A44T:p.Q15L,FN1:uc002vfh.3:exon1:c.A44T:p.Q15L,FN1:uc002vfi.3:exon1:c.A44T:p.Q15L,FN1:uc002vfj.3:exon1:c.A44T:p.Q15L,FN1:uc002vfl.3:exon1:c.A44T:p.Q15L	-0.961	AFR:0.7912,AMR:0.8614,EAS:0.8013,FIN:0.9302,NFE:0.7946,OTH:0.7365,ASJ:0.7613	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	1.28	0.000	-0.895	2	1(thyroid)	0.7811
2	217012901	217012901	A	G	XRCC5	exonic	synonymous SNV	ENSG00000079246	rs207906	ENSG00000079246:ENST00000392132:exon14:c.A1572G:p.T524T,ENSG00000079246:ENST00000392133:exon16:c.A1572G:p.T524T	XRCC5:NM_021141:exon14:c.A1572G:p.T524T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8710	0.8732	0.882788	0.8815	.	.	.	.	.	.	.	.	XRCC5:uc002vfz.3:exon11:c.A1230G:p.T410T,XRCC5:uc002vfy.3:exon14:c.A1572G:p.T524T	.	AFR:0.8683,AMR:0.9093,EAS:0.9220,FIN:0.9187,NFE:0.8729,OTH:0.9083,ASJ:0.8742	194364	.	.	.	.	.	.	.	.	.	.	.	2	MU26214825	het
2	219288484	219288484	C	T	VIL1	intronic	.	ENSG00000127831	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0	0	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	193040	.	.	.	.	.	.	.	.	.	.	.	2	MU60376436	hom
2	220022176	220022176	C	T	NHEJ1	intronic	.	ENSG00000187736;ENSG00000213901	rs6436120	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9646	0.9163	0.902356	0.9324	.	.	.	.	.	.	.	.	.	.	AFR:0.7672,AMR:0.9785,EAS:1,FIN:1,NFE:0.9984,OTH:0.9827,ASJ:0.9868	611290	611291;	169079;	169079|Cernunnos XLFD<br>Cernunnos deficiency<br>Combined immunodeficiency-microcephaly-growth retardation-sensitivity to ionizing radiation syndrome<br>NHEJ1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|611291 ~	.	.	.	.	.	.	.	.	2	MU81751416	hom
2	220466344	220466344	-	T	STK11IP	intronic	.	ENSG00000144589	rs397735129	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5384	.	0.591653	0.8052	.	.	.	.	.	.	.	.	.	.	AFR:0.5218,AMR:0.8675,EAS:0.9961,FIN:0.7952,NFE:0.9438,OTH:0.9109,ASJ:0.8881	607172	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	220476443	220476443	C	T	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	rs627530	ENSG00000144589:ENST00000295641:exon18:c.C2255T:p.S752F,ENSG00000144589:ENST00000456909:exon18:c.C2222T:p.S741F	STK11IP:NM_052902:exon18:c.C2222T:p.S741F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9376	0.8398	0.839058	0.8456	1.670	14.24	0.054	1.31	0.000	.	.	.	STK11IP:uc002vml.3:exon18:c.C2255T:p.S752F	-1.018	AFR:0.5283,AMR:0.9642,EAS:0.9975,FIN:0.9547,NFE:0.9720,OTH:0.9517,ASJ:0.9570	607172	.	.	.	.	.	.	.	0.004	3.48	0.000	1.6	2	MU81752072	hom
2	223085029	223085029	G	A	PAX3	exonic	nonsynonymous SNV	ENSG00000135903	rs151199924	ENSG00000135903:ENST00000336840:exon7:c.C1003T:p.P335S,ENSG00000135903:ENST00000344493:exon7:c.C1003T:p.P335S,ENSG00000135903:ENST00000350526:exon7:c.C1003T:p.P335S,ENSG00000135903:ENST00000392069:exon7:c.C1003T:p.P335S,ENSG00000135903:ENST00000392070:exon7:c.C1003T:p.P335S,ENSG00000135903:ENST00000409551:exon7:c.C1000T:p.P334S	PAX3:NM_001127366:exon7:c.C1000T:p.P334S,PAX3:NM_181457:exon7:c.C1003T:p.P335S,PAX3:NM_181458:exon7:c.C1003T:p.P335S,PAX3:NM_181459:exon7:c.C1003T:p.P335S,PAX3:NM_181460:exon7:c.C1003T:p.P335S,PAX3:NM_181461:exon7:c.C1003T:p.P335S	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, -1, 1, 2, 1, 0] 	0.0015	7.7e-05	0.00539137	0.0001	4.414	24.1	0.017	5.68	0.998	.	.	.	PAX3:uc002vmt.2:exon7:c.C1003T:p.P335S,PAX3:uc002vmv.2:exon7:c.C1003T:p.P335S,PAX3:uc002vmw.2:exon7:c.C1003T:p.P335S,PAX3:uc002vmx.2:exon7:c.C1003T:p.P335S,PAX3:uc002vmy.2:exon7:c.C1000T:p.P334S,PAX3:uc010fwo.3:exon7:c.C1003T:p.P335S	0.747	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0.0031,ASJ:0	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	0.999	-3.55	0.883	2.07	2	.	het
2	223161862	223161862	G	C	PAX3	exonic	synonymous SNV	ENSG00000135903	rs28945092	ENSG00000135903:ENST00000258387:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000336840:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000344493:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000350526:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000392069:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000392070:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000409551:exon2:c.C156G:p.P52P,ENSG00000135903:ENST00000409828:exon2:c.C156G:p.P52P	PAX3:NM_000438:exon2:c.C156G:p.P52P,PAX3:NM_001127366:exon2:c.C156G:p.P52P,PAX3:NM_013942:exon2:c.C156G:p.P52P,PAX3:NM_181457:exon2:c.C156G:p.P52P,PAX3:NM_181458:exon2:c.C156G:p.P52P,PAX3:NM_181459:exon2:c.C156G:p.P52P,PAX3:NM_181460:exon2:c.C156G:p.P52P,PAX3:NM_181461:exon2:c.C156G:p.P52P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0045	0.0094	0.0151757	0.0089	.	.	.	.	.	.	.	.	PAX3:uc002vmt.2:exon2:c.C156G:p.P52P,PAX3:uc002vmv.2:exon2:c.C156G:p.P52P,PAX3:uc002vmw.2:exon2:c.C156G:p.P52P,PAX3:uc002vmx.2:exon2:c.C156G:p.P52P,PAX3:uc002vmy.2:exon2:c.C156G:p.P52P,PAX3:uc002vmz.2:exon2:c.C156G:p.P52P,PAX3:uc002vna.2:exon2:c.C156G:p.P52P,PAX3:uc010fwo.3:exon2:c.C156G:p.P52P	.	AFR:0.0305,AMR:0,EAS:0.0006,FIN:0.0003,NFE:0.0005,OTH:0.0010,ASJ:0	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	.	.	.	.	2	.	het
2	223161889	223161889	A	G	PAX3	exonic	synonymous SNV	ENSG00000135903	rs12623857	ENSG00000135903:ENST00000258387:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000336840:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000344493:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000350526:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392069:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392070:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409551:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409828:exon2:c.T129C:p.G43G	PAX3:NM_000438:exon2:c.T129C:p.G43G,PAX3:NM_001127366:exon2:c.T129C:p.G43G,PAX3:NM_013942:exon2:c.T129C:p.G43G,PAX3:NM_181457:exon2:c.T129C:p.G43G,PAX3:NM_181458:exon2:c.T129C:p.G43G,PAX3:NM_181459:exon2:c.T129C:p.G43G,PAX3:NM_181460:exon2:c.T129C:p.G43G,PAX3:NM_181461:exon2:c.T129C:p.G43G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8872	0.8465	0.904353	0.8514	.	.	.	.	.	.	.	.	PAX3:uc002vmt.2:exon2:c.T129C:p.G43G,PAX3:uc002vmv.2:exon2:c.T129C:p.G43G,PAX3:uc002vmw.2:exon2:c.T129C:p.G43G,PAX3:uc002vmx.2:exon2:c.T129C:p.G43G,PAX3:uc002vmy.2:exon2:c.T129C:p.G43G,PAX3:uc002vmz.2:exon2:c.T129C:p.G43G,PAX3:uc002vna.2:exon2:c.T129C:p.G43G,PAX3:uc010fwo.3:exon2:c.T129C:p.G43G	.	AFR:0.8433,AMR:0.9165,EAS:1,FIN:0.8283,NFE:0.8402,OTH:0.8523,ASJ:0.9305	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	.	.	.	.	2	MU81752201	hom
2	223161892	223161892	G	T	PAX3	exonic	synonymous SNV	ENSG00000135903	rs369680052	ENSG00000135903:ENST00000258387:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000336840:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000344493:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000350526:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000392069:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000392070:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000409551:exon2:c.C126A:p.G42G,ENSG00000135903:ENST00000409828:exon2:c.C126A:p.G42G	PAX3:NM_000438:exon2:c.C126A:p.G42G,PAX3:NM_001127366:exon2:c.C126A:p.G42G,PAX3:NM_013942:exon2:c.C126A:p.G42G,PAX3:NM_181457:exon2:c.C126A:p.G42G,PAX3:NM_181458:exon2:c.C126A:p.G42G,PAX3:NM_181459:exon2:c.C126A:p.G42G,PAX3:NM_181460:exon2:c.C126A:p.G42G,PAX3:NM_181461:exon2:c.C126A:p.G42G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0018	0.0003	0.00219649	0.0002	.	.	.	.	.	.	.	.	PAX3:uc002vmt.2:exon2:c.C126A:p.G42G,PAX3:uc002vmv.2:exon2:c.C126A:p.G42G,PAX3:uc002vmw.2:exon2:c.C126A:p.G42G,PAX3:uc002vmx.2:exon2:c.C126A:p.G42G,PAX3:uc002vmy.2:exon2:c.C126A:p.G42G,PAX3:uc002vmz.2:exon2:c.C126A:p.G42G,PAX3:uc002vna.2:exon2:c.C126A:p.G42G,PAX3:uc010fwo.3:exon2:c.C126A:p.G42G	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:0.0003,OTH:0,ASJ:0	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	.	.	.	.	2	.	het
2	225434445	225434445	A	G	CUL3	exonic	synonymous SNV	ENSG00000036257	rs10498163	.	CUL3:NM_001257198:exon1:c.T45C:p.H15H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2999	.	0.28095	0.2821	.	.	.	.	.	.	.	.	CUL3:uc010fwy.2:exon1:c.T45C:p.H15H	.	AFR:0.1706,AMR:0.3594,EAS:0.3046,FIN:0.2849,NFE:0.3338,OTH:0.3476,ASJ:0.3709	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	MU24815200	het
2	228102723	228102723	G	C	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs13424243	ENSG00000169031:ENST00000396578:exon2:c.G127C:p.G43R	COL4A3:NM_000091:exon2:c.G127C:p.G43R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 0] 	0.2884	0.3511	0.230232	0.3127	4.616	24.5	0.013	4.31	0.001	.	.	.	COL4A3:uc002vom.2:exon2:c.G127C:p.G43R	-1.817	AFR:0.3182,AMR:0.2380,EAS:0.0278,FIN:0.3427,NFE:0.3384,OTH:0.2889,ASJ:0.3477	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	1.0	-4.63	0.000	4.08	2	MU121352	het
2	228102752	228102752	C	A	LOC654841	ncRNA_intronic	.	ENSG00000236432	rs1882435	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3078	0.2848	0.305112	0.2982	.	.	.	.	.	.	.	.	.	.	AFR:0.2605,AMR:0.2995,EAS:0.4509,FIN:0.2605,NFE:0.3118,OTH:0.3074,ASJ:0.3013	.	.	.	.	.	.	.	.	.	.	.	.	2	MU585375	het
2	228111435	228111435	T	C	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs10178458	ENSG00000169031:ENST00000396578:exon7:c.T422C:p.L141P	COL4A3:NM_000091:exon7:c.T422C:p.L141P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8302	0.7704	0.796725	0.7805	-0.830	0.037	1.0	3.62	0.029	.	.	.	COL4A3:uc002vom.2:exon7:c.T422C:p.L141P	-0.919	AFR:0.6284,AMR:0.8720,EAS:0.9280,FIN:0.8270,NFE:0.8347,OTH:0.8180,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.004	-3.4	0.000	-1.39	2	MU18207837	hom
2	228113175	228113175	A	G	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs6436669	ENSG00000169031:ENST00000396578:exon9:c.A485G:p.E162G	COL4A3:NM_000091:exon9:c.A485G:p.E162G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8304	0.7701	0.796326	0.7808	0.832	9.659	0.828	1.24	0.181	.	.	.	COL4A3:uc002vom.2:exon9:c.A485G:p.E162G	-0.962	AFR:0.6290,AMR:0.8723,EAS:0.9284,FIN:0.8286,NFE:0.8343,OTH:0.8184,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.001	-3.17	0.000	1.355	2	MU18208095	hom
2	228128540	228128540	C	T	COL4A3	exonic	synonymous SNV	ENSG00000169031	rs10205042	ENSG00000169031:ENST00000396578:exon21:c.C1195T:p.L399L	COL4A3:NM_000091:exon21:c.C1195T:p.L399L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7667	0.7180	0.767572	0.7419	.	.	.	.	.	.	.	.	COL4A3:uc002vom.2:exon21:c.C1195T:p.L399L	.	AFR:0.6775,AMR:0.8242,EAS:0.8912,FIN:0.8013,NFE:0.7453,OTH:0.7597,ASJ:0.6589	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU18208390	hom
2	228128568	228128568	G	A	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs34505188	ENSG00000169031:ENST00000396578:exon21:c.G1223A:p.R408H	COL4A3:NM_000091:exon21:c.G1223A:p.R408H	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.0910	0.0633	0.100639	0.0616	2.610	20.3	0.555	2.07	0.003	.	.	.	COL4A3:uc002vom.2:exon21:c.G1223A:p.R408H	-0.722	AFR:0.0331,AMR:0.1647,EAS:0.1512,FIN:0.0358,NFE:0.0678,OTH:0.0662,ASJ:0.0894	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.998	-3.33	0.010	0.95	2	MU19525888	het
2	228131169	228131169	A	G	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs11677877	ENSG00000169031:ENST00000396578:exon22:c.A1352G:p.H451R	COL4A3:NM_000091:exon22:c.A1352G:p.H451R	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0944	0.0735	0.111422	0.0723	-2.340	0.001	0.621	-4.09	0.000	.	.	.	COL4A3:uc002vom.2:exon22:c.A1352G:p.H451R	-0.661	AFR:0.0704,AMR:0.1706,EAS:0.1510,FIN:0.0358,NFE:0.0680,OTH:0.0662,ASJ:0.0894	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.015	-4.07	0.003	-0.215	2	MU16159958	het
2	228131752	228131752	G	A	COL4A3	exonic	synonymous SNV	ENSG00000169031	rs34019152	ENSG00000169031:ENST00000396578:exon23:c.G1452A:p.G484G	COL4A3:NM_000091:exon23:c.G1452A:p.G484G	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0923	0.0681	0.105232	0.0667	.	.	.	.	.	.	.	.	COL4A3:uc002vom.2:exon23:c.G1452A:p.G484G	.	AFR:0.0504,AMR:0.1695,EAS:0.1510,FIN:0.0358,NFE:0.0681,OTH:0.0654,ASJ:0.0894	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU81752801	het
2	228135631	228135631	C	T	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs28381984	ENSG00000169031:ENST00000396578:exon25:c.C1721T:p.P574L	COL4A3:NM_000091:exon25:c.C1721T:p.P574L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 0] 	0.4694	0.3890	0.39996	0.3967	5.446	26.1	0.005	5.8	0.226	.	.	.	COL4A3:uc002vom.2:exon25:c.C1721T:p.P574L	-1.332	AFR:0.1974,AMR:0.4474,EAS:0.4578,FIN:0.4653,NFE:0.4817,OTH:0.4559,ASJ:0.4702	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.999	-3.16	0.000	3.25	2	MU121370	het
2	228159661	228159661	T	-	LOC654841	ncRNA_intronic	.	ENSG00000236432	rs35803812	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4894	.	0.536941	0.6519	.	.	.	.	.	.	.	.	.	.	AFR:0.5499,AMR:0.6095,EAS:0.596,FIN:0.6067,NFE:0.7267,OTH:0.6856,ASJ:0.6944	.	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	232952286	232952286	A	G	DIS3L2	exonic	synonymous SNV	ENSG00000144535	rs11887184	ENSG00000144535:ENST00000409307:exon5:c.A456G:p.Q152Q,ENSG00000144535:ENST00000433430:exon5:c.A456G:p.Q152Q,ENSG00000144535:ENST00000273009:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000325385:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000360410:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000390005:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000409401:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000445090:exon6:c.A456G:p.Q152Q	DIS3L2:NM_001257281:exon6:c.A456G:p.Q152Q,DIS3L2:NM_001257282:exon6:c.A456G:p.Q152Q,DIS3L2:NM_152383:exon6:c.A456G:p.Q152Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0961	0.1047	0.11242	0.1046	.	.	.	.	.	.	.	.	DIS3L2:uc010fxz.3:exon6:c.A456G:p.Q152Q,DIS3L2:uc031rrt.1:exon6:c.A456G:p.Q152Q	.	AFR:0.1882,AMR:0.1471,EAS:0.0389,FIN:0.0685,NFE:0.0699,OTH:0.0988,ASJ:0.0894	614184	267000;	2849;	2849|Nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267000 ~	.	.	.	.	.	.	.	.	2	.	het
2	233201328	233201328	A	G	DIS3L2	exonic	synonymous SNV	ENSG00000144535	rs3811578	ENSG00000144535:ENST00000409307:exon20:c.A2646G:p.S882S,ENSG00000144535:ENST00000325385:exon21:c.A2646G:p.S882S	DIS3L2:NM_152383:exon21:c.A2646G:p.S882S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1425	0.0995	0.202077	ESAD-UK|1|409|0.00244499,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	DIS3L2:uc010fxz.3:exon21:c.A2646G:p.S882S	.	AFR:0.1334,AMR:0.1472,EAS:0.0695,FIN:0.4664,NFE:0.0880,OTH:0.0967,ASJ:0.2386	614184	267000;	2849;	2849|Nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267000 ~	.	.	.	.	.	.	.	.	2	1(thyroid)	0.1135
2	240003870	240003870	G	A	HDAC4	exonic	synonymous SNV	ENSG00000068024	rs1063639	ENSG00000068024:ENST00000543185:exon15:c.C1317T:p.P439P,ENSG00000068024:ENST00000345617:exon21:c.C2565T:p.P855P	HDAC4:NM_006037:exon21:c.C2565T:p.P855P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5333	0.5061	0.595248	0.5092	.	.	.	.	.	.	.	.	HDAC4:uc010fyy.3:exon18:c.C2436T:p.P812P,HDAC4:uc002vyk.4:exon21:c.C2565T:p.P855P	.	AFR:0.5783,AMR:0.6277,EAS:0.7295,FIN:0.4685,NFE:0.4490,OTH:0.5092,ASJ:0.4667	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU792285	het
2	240029736	240029736	T	C	HDAC4	intronic	.	ENSG00000068024	rs7585225	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8336	0.7889	0.838658	0.8060	.	.	.	.	.	.	.	.	.	.	AFR:0.7561,AMR:0.9045,EAS:0.8403,FIN:0.8229,NFE:0.8207,OTH:0.8347,ASJ:0.7767	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU26830207	het
2	240033280	240033280	C	T	HDAC4	exonic	synonymous SNV	ENSG00000068024	rs533357140	ENSG00000068024:ENST00000543185:exon8:c.G657A:p.A219A,ENSG00000068024:ENST00000541256:exon12:c.G1827A:p.A609A,ENSG00000068024:ENST00000345617:exon14:c.G1905A:p.A635A	HDAC4:NM_006037:exon14:c.G1905A:p.A635A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0002	.	0.000599042	.	.	.	.	.	.	.	.	.	HDAC4:uc010znz.1:exon10:c.G1554A:p.A518A,HDAC4:uc010fyy.3:exon11:c.G1776A:p.A592A,HDAC4:uc010fyz.1:exon13:c.G1890A:p.A630A,HDAC4:uc010zoa.1:exon13:c.G1905A:p.A635A,HDAC4:uc002vyk.4:exon14:c.G1905A:p.A635A,HDAC4:uc010fza.2:exon14:c.G1920A:p.A640A	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	.	het
2	240066417	240066417	A	G	HDAC4	intronic	.	ENSG00000068024	rs2290087	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8616	0.8947	0.88778	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0001	0.048	.	.	.	AFR:0.8949,AMR:0.9678,EAS:0.7980,FIN:0.8407,NFE:0.9032,OTH:0.8698,ASJ:0.6914	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.8931
2	242793273	242793273	A	G	PDCD1	exonic	synonymous SNV	ENSG00000188389	rs2227981	ENSG00000188389:ENST00000334409:exon5:c.T804C:p.A268A	PDCD1:NM_005018:exon5:c.T804C:p.A268A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6284	0.5864	0.647963	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PDCD1:uc010fzs.3:exon3:c.T441C:p.A147A,PDCD1:uc002wcq.4:exon5:c.T804C:p.A268A	.	AFR:0.6047,AMR:0.5763,EAS:0.5894,FIN:0.7311,NFE:0.7071,OTH:0.5808,ASJ:0.6124	600244	126200;605218;	.	.	.	.	.	.	.	.	.	.	2	1(large_intestine)	0.6462
2	242793433	242793433	G	A	PDCD1	exonic	nonsynonymous SNV	ENSG00000188389	rs2227982	ENSG00000188389:ENST00000334409:exon5:c.C644T:p.A215V	PDCD1:NM_005018:exon5:c.C644T:p.A215V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0827	0.0125	0.136781	1(breast)	1.737	14.62	0.019	2.9	0.002	.	.	.	PDCD1:uc010fzs.3:exon3:c.C281T:p.A94V,PDCD1:uc002wcq.4:exon5:c.C644T:p.A215V	-0.921	AFR:MU19558515,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,EAS:0.0108,FIN:0.2053,NFE:0.0033,OTH:0.4845,ASJ:0.0492	600244	126200;605218;	.	.	.	.	.	.	0.816	-0.1	0.000	1.59	2	1(soft_tissue)	0.0515
2	242800900	242800900	G	A	PDCD1	intronic	.	ENSG00000188389	rs35933396	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1509	0.0237	0.152157	MU19558701	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.0590,EAS:0.2088,FIN:0.0033,NFE:0.5,OTH:0.0514,ASJ:0.0411	600244	126200;605218;	.	.	.	.	.	.	.	.	.	.	2	1(biliary_tract)	0.0164
3	3197918	3197918	A	G	CRBN	exonic	synonymous SNV	ENSG00000113851	rs17027638	ENSG00000113851:ENST00000231948:exon6:c.T735C:p.Y245Y,ENSG00000113851:ENST00000432408:exon6:c.T732C:p.Y244Y	CRBN:NM_001173482:exon6:c.T732C:p.Y244Y,CRBN:NM_016302:exon6:c.T735C:p.Y245Y	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.1349	0.0154	0.248403	0.0734	.	.	.	.	.	.	.	.	CRBN:uc011aso.2:exon5:c.T546C:p.Y182Y,CRBN:uc003bpq.3:exon6:c.T735C:p.Y245Y,CRBN:uc003bpr.3:exon6:c.T732C:p.Y244Y	.	AFR:0.0103,AMR:0.2422,EAS:0.6993,FIN:0.1083,NFE:0.0252,OTH:0.0908,ASJ:0.0099	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	,2055,2057,2056	.	.	.	.	.	.	3	MU18013455	het
3	3215954	3215954	A	G	CRBN	intronic	.	ENSG00000113851	rs1669321	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9673	0.8820	0.883786	0.9009	.	.	.	.	.	0.0001	0.07	.	.	.	AFR:0.6555,AMR:0.9713,EAS:1,FIN:1,NFE:0.9985,OTH:0.9786,ASJ:0.9934	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	3	MU81756919	hom
3	8955389	8955389	C	T	RAD18	exonic	nonsynonymous SNV	ENSG00000070950	rs373572	ENSG00000070950:ENST00000264926:exon8:c.G905A:p.R302Q	RAD18:NM_020165:exon8:c.G905A:p.R302Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6951	0.7043	0.647564	0.6904	3.782	23.4	0.617	4.47	0.998	.	.	SAP domain	RAD18:uc003brd.3:exon8:c.G905A:p.R302Q	-0.988	AFR:0.6630,AMR:0.6631,EAS:0.3531,FIN:0.7584,NFE:0.7244,OTH:0.7270,ASJ:0.7550	605256	.	.	.	.	.	.	.	0.001	1.85	0.000	-1.61	3	MU17638060	hom
3	9005078	9005078	C	T	RAD18	UTR5	.	ENSG00000070950	rs615967	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7529	0.6622	0.597644	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6503,AMR:0.3926,EAS:0.8046,FIN:0.3831,NFE:0.7921,OTH:0.7830,ASJ:0.6914	605256	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.7561
3	9798140	9798140	C	G	OGG1	intronic	.	ENSG00000114026	rs2072668	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2810	0.2437	0.335463	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.2496,AMR:0.2605,EAS:0.2219,FIN:0.6127,NFE:0.1855,OTH:0.2167,ASJ:0.3361	601982	144700;	422526;	422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.2261
3	9798773	9798773	C	G	OGG1	exonic	nonsynonymous SNV	ENSG00000114026	rs1052133	ENSG00000114026:ENST00000302003:exon7:c.C994G:p.P332A,ENSG00000114026:ENST00000344629:exon7:c.C977G:p.S326C	OGG1:NM_001354649:exon5:c.C644G:p.S215C,OGG1:NM_002542:exon7:c.C977G:p.S326C,OGG1:NM_016820:exon7:c.C994G:p.P332A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2721	0.2111	0.302117	2(soft_tissue)	0.045	3.028	0.176	-1.32	0.038	.	.	.	OGG1:uc003bsq.2:exon3:c.C121G:p.P41A,OGG1:uc003bsp.2:exon4:c.C289G:p.P97A,OGG1:uc003bsr.2:exon4:c.C272G:p.S91C,OGG1:uc010hcm.2:exon4:c.C355G:p.P119A,OGG1:uc003bsi.3:exon7:c.C977G:p.S326C,OGG1:uc003bsj.3:exon7:c.C994G:p.P332A	-0.903	AFR:2(lung),AMR:MU138292,EAS:0.2224,FIN:0.1674,NFE:0.3305,OTH:0.2185,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	601982	144700;	422526;	422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.121	0.73	0.000	0.69	3	2(haematopoietic_and_lymphoid_tissue)	0.6068
3	9823302	9823302	T	G	TADA3	intronic	.	ENSG00000114026;ENSG00000171148	rs6443264	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2646	.	0.331869	0.2429	.	.	.	.	.	.	.	.	.	.	AFR:0.2447,AMR:0.3385,EAS:0.6002,FIN:0.1853,NFE:0.2131,OTH:0.2245,ASJ:0.2152	602945	.	.	.	.	.	.	.	.	.	.	.	3	MU792546	het
3	9824651	9824651	C	T	TADA3	intronic	.	ENSG00000114026;ENSG00000171148	rs6443265	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.65016	0.6563	.	.	.	.	.	.	.	.	.	.	AFR:0.5406,AMR:0.6340,EAS:0.7360,FIN:0.6966,NFE:0.7027,OTH:0.6708,ASJ:0.8146	602945	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	10076843	10076844	TT	-	FANCD2	intronic	.	ENSG00000144554	rs55973240	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2080	0.2553	0.211462	0.2354	.	.	.	.	.	.	.	.	.	.	AFR:0.4218,AMR:0.2269,EAS:0.0676,FIN:0.1558,NFE:0.1652,OTH:0.175,ASJ:0.1812	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	.	het
3	10077955	10077955	A	G	FANCD2	intronic	.	ENSG00000144554	rs17032278	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1662	0.2185	0.182109	0.1945	.	.	.	.	.	.	.	.	.	.	AFR:0.3130,AMR:0.1964,EAS:0.0665,FIN:0.1287,NFE:0.1584,OTH:0.1543,ASJ:0.1667	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	MU749573	het
3	10081545	10081545	G	C	FANCD2	intronic	.	ENSG00000144554	rs17032283	ENSG00000144554:ENST00000431693:exon8:c.G711C:p.L237L	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1659	0.2170	0.182109	0.1966	.	.	.	.	.	.	.	.	FANCD2:uc003buv.3:exon9:c.G711C:p.L237L	.	AFR:0.3153,AMR:0.1969,EAS:0.0674,FIN:0.1311,NFE:0.1603,OTH:0.1561,ASJ:0.1656	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	MU764298	het
3	10084224	10084224	C	T	FANCD2	intronic	.	ENSG00000144554	rs9879080	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1743	0.2527	0.210663	0.2261	.	.	.	.	.	.	.	.	.	.	AFR:0.4177,AMR:0.2045,EAS:0.0673,FIN:0.1320,NFE:0.1605,OTH:0.1640,ASJ:0.1656	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	MU117059691	het
3	10085536	10085536	A	G	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs34046352	ENSG00000144554:ENST00000287647:exon14:c.A1122G:p.V374V,ENSG00000144554:ENST00000383806:exon14:c.A1122G:p.V374V,ENSG00000144554:ENST00000383807:exon14:c.A1122G:p.V374V,ENSG00000144554:ENST00000419585:exon14:c.A1122G:p.V374V	FANCD2:NM_001018115:exon14:c.A1122G:p.V374V,FANCD2:NM_001319984:exon14:c.A1122G:p.V374V,FANCD2:NM_033084:exon14:c.A1122G:p.V374V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1239	.	.	ESAD-UK|1|409|0.00244499	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon14:c.A1122G:p.V374V,FANCD2:uc003bux.1:exon14:c.A1122G:p.V374V,FANCD2:uc003buy.1:exon14:c.A1122G:p.V374V	.	AFR:0.1939,AMR:0.3364,EAS:0.15,FIN:0.0598,NFE:0.1226,OTH:0.1466,ASJ:0.1874	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.1493
3	10088266	10088266	G	T	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs72492997	ENSG00000144554:ENST00000287647:exon15:c.G1137T:p.V379V,ENSG00000144554:ENST00000383806:exon15:c.G1137T:p.V379V,ENSG00000144554:ENST00000383807:exon15:c.G1137T:p.V379V,ENSG00000144554:ENST00000419585:exon15:c.G1137T:p.V379V	FANCD2:NM_001018115:exon15:c.G1137T:p.V379V,FANCD2:NM_001319984:exon15:c.G1137T:p.V379V,FANCD2:NM_033084:exon15:c.G1137T:p.V379V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3745	.	.	1(large_intestine)	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon15:c.G1137T:p.V379V,FANCD2:uc003bux.1:exon15:c.G1137T:p.V379V,FANCD2:uc003buy.1:exon15:c.G1137T:p.V379V	.	AFR:1(thyroid),AMR:MU4554264,EAS:0.4393,FIN:0.4755,NFE:0.3902,OTH:0.3111,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	2(skin)	0.4121
3	10088299	10088299	C	T	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs112887807	ENSG00000144554:ENST00000287647:exon15:c.C1170T:p.S390S,ENSG00000144554:ENST00000383806:exon15:c.C1170T:p.S390S,ENSG00000144554:ENST00000383807:exon15:c.C1170T:p.S390S,ENSG00000144554:ENST00000419585:exon15:c.C1170T:p.S390S	FANCD2:NM_001018115:exon15:c.C1170T:p.S390S,FANCD2:NM_001319984:exon15:c.C1170T:p.S390S,FANCD2:NM_033084:exon15:c.C1170T:p.S390S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4304	.	.	MU23560209	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon15:c.C1170T:p.S390S,FANCD2:uc003bux.1:exon15:c.C1170T:p.S390S,FANCD2:uc003buy.1:exon15:c.C1170T:p.S390S	.	AFR:LUSC-KR|6|170|0.0352941,COCA-CN|8|321|0.0249221,RECA-EU|1|422|0.00236967,AMR:0.4501,EAS:0.4059,FIN:0.3421,NFE:0.4245,OTH:0.4638,ASJ:0.4796	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	3(large_intestine)	0.4337
3	10088308	10088308	T	C	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs72492998	ENSG00000144554:ENST00000287647:exon15:c.T1179C:p.T393T,ENSG00000144554:ENST00000383806:exon15:c.T1179C:p.T393T,ENSG00000144554:ENST00000383807:exon15:c.T1179C:p.T393T,ENSG00000144554:ENST00000419585:exon15:c.T1179C:p.T393T	FANCD2:NM_001018115:exon15:c.T1179C:p.T393T,FANCD2:NM_001319984:exon15:c.T1179C:p.T393T,FANCD2:NM_033084:exon15:c.T1179C:p.T393T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4331	.	.	MU4081966	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon15:c.T1179C:p.T393T,FANCD2:uc003bux.1:exon15:c.T1179C:p.T393T,FANCD2:uc003buy.1:exon15:c.T1179C:p.T393T	.	AFR:LUSC-KR|7|170|0.0411765,COCA-CN|9|321|0.0280374,RECA-EU|1|422|0.00236967,AMR:0.4504,EAS:0.4082,FIN:0.3480,NFE:0.4244,OTH:0.4642,ASJ:0.4799	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	4(large_intestine)	0.4338
3	10088343	10088343	A	G	FANCD2	exonic	nonsynonymous SNV	ENSG00000144554	rs73126218	ENSG00000144554:ENST00000287647:exon15:c.A1214G:p.N405S,ENSG00000144554:ENST00000383806:exon15:c.A1214G:p.N405S,ENSG00000144554:ENST00000383807:exon15:c.A1214G:p.N405S,ENSG00000144554:ENST00000419585:exon15:c.A1214G:p.N405S	FANCD2:NM_001018115:exon15:c.A1214G:p.N405S,FANCD2:NM_001319984:exon15:c.A1214G:p.N405S,FANCD2:NM_033084:exon15:c.A1214G:p.N405S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4201	.	.	3(thyroid)	0.077	3.368	0.314	0.307	0.999	.	.	.	FANCD2:uc003buw.3:exon15:c.A1214G:p.N405S,FANCD2:uc003bux.1:exon15:c.A1214G:p.N405S,FANCD2:uc003buy.1:exon15:c.A1214G:p.N405S	-0.975	AFR:1(soft_tissue),AMR:5(large_intestine),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|9|321|0.0280374,THCA-CN|1|50|0.02,FIN:0.4320,NFE:0.4779,OTH:0.4005,ASJ:MU4081957	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.022	0.89	0.000	1.465	3	1(kidney)	0.2822
3	10106532	10106532	C	T	FANCD2	exonic	nonsynonymous SNV	ENSG00000144554	rs3864017	ENSG00000144554:ENST00000287647:exon23:c.C2141T:p.P714L,ENSG00000144554:ENST00000383806:exon23:c.C2141T:p.P714L,ENSG00000144554:ENST00000383807:exon23:c.C2141T:p.P714L,ENSG00000144554:ENST00000419585:exon23:c.C2141T:p.P714L	FANCD2:NM_001018115:exon23:c.C2141T:p.P714L,FANCD2:NM_001319984:exon23:c.C2141T:p.P714L,FANCD2:NM_033084:exon23:c.C2141T:p.P714L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1545	.	.	2(pleura)	-0.097	1.749	0.251	-3.09	0.000	.	.	Armadillo-like helical	FANCD2:uc003buw.3:exon23:c.C2141T:p.P714L,FANCD2:uc003bux.1:exon23:c.C2141T:p.P714L,FANCD2:uc003buy.1:exon23:c.C2141T:p.P714L	-0.974	AFR:.,AMR:.,EAS:0.2802,FIN:0.1883,NFE:0.1552,OTH:0.0638,ASJ:0.1870	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.001	0.88	0.000	0	3	9(upper_aerodigestive_tract)	0.1325
3	10128965	10128965	-	TTT	FANCD2;FANCD2OS	intronic	.	ENSG00000144554;ENSG00000163705	rs371321981	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0164	.	.	0.2057	.	.	.	.	.	.	.	.	.	.	AFR:0.3507,AMR:0.1770,EAS:0.0634,FIN:0.0163,NFE:0.1510,OTH:0.1605,ASJ:0.1364	.	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	10133949	10133949	A	G	FANCD2;FANCD2OS	intronic	.	ENSG00000144554;ENSG00000163705	rs9811771	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1918	0.2754	0.254193	0.2462	.	.	.	.	.	.	.	.	.	.	AFR:0.4832,AMR:0.2249,EAS:0.0897,FIN:0.1311,NFE:0.1603,OTH:0.1711,ASJ:0.1667	.	.	.	.	.	.	.	.	.	.	.	.	3	MU117109838	het
3	10138069	10138069	T	G	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs2272125	ENSG00000144554:ENST00000287647:exon42:c.T4098G:p.L1366L,ENSG00000144554:ENST00000383807:exon42:c.T4098G:p.L1366L,ENSG00000144554:ENST00000419585:exon42:c.T4098G:p.L1366L	FANCD2:NM_001018115:exon42:c.T4098G:p.L1366L,FANCD2:NM_001319984:exon42:c.T4098G:p.L1366L,FANCD2:NM_033084:exon42:c.T4098G:p.L1366L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1868	0.2686	0.242212	MU152343	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon42:c.T4098G:p.L1366L,FANCD2:uc003bux.1:exon42:c.T4098G:p.L1366L,FANCD2:uc003buy.1:exon42:c.T4098G:p.L1366L	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2404,EAS:0.2243,FIN:0.1656,NFE:0.0902,OTH:0.1307,ASJ:0.4626	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.1601
3	12626019	12626019	G	A	RAF1	exonic	synonymous SNV	ENSG00000132155	rs3730297	ENSG00000132155:ENST00000534997:exon13:c.C1296T:p.V432V,ENSG00000132155:ENST00000432427:exon14:c.C1578T:p.V526V,ENSG00000132155:ENST00000542177:exon16:c.C1698T:p.V566V,ENSG00000132155:ENST00000251849:exon17:c.C1941T:p.V647V,ENSG00000132155:ENST00000442415:exon18:c.C2001T:p.V667V	RAF1:NM_001354695:exon15:c.C1599T:p.V533V,RAF1:NM_001354692:exon16:c.C1698T:p.V566V,RAF1:NM_001354693:exon16:c.C1842T:p.V614V,RAF1:NM_001354690:exon17:c.C1941T:p.V647V,RAF1:NM_001354691:exon17:c.C1698T:p.V566V,RAF1:NM_001354694:exon17:c.C1758T:p.V586V,RAF1:NM_002880:exon17:c.C1941T:p.V647V,RAF1:NM_001354689:exon18:c.C2001T:p.V667V	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0071	0.0083	0.00439297	0.0066	.	.	.	.	.	.	.	.	RAF1:uc011aut.2:exon13:c.C1296T:p.V432V,RAF1:uc011auu.2:exon16:c.C1695T:p.V565V,RAF1:uc003bxf.4:exon17:c.C1941T:p.V647V	.	AFR:0.0017,AMR:0.0048,EAS:0,FIN:0.0080,NFE:0.0095,OTH:0.0092,ASJ:0.0166	164760	611553;611554;615916;	154;500;648;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko05034 Alcoholism~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,9371	.	.	.	.	.	.	3	.	het
3	14174427	14174427	A	T	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs4685076	ENSG00000170876:ENST00000306077:exon6:c.A504T:p.K168N	TMEM43:NM_024334:exon6:c.A504T:p.K168N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3209	0.2876	0.352636	0.2969	2.489	19.40	0.219	1.56	1.000	.	.	.	TMEM43:uc003byl.1:exon4:c.A144T:p.K48N,TMEM43:uc003byk.2:exon6:c.A504T:p.K168N	-0.896	AFR:0.2786,AMR:0.4212,EAS:0.4300,FIN:0.2923,NFE:0.2893,OTH:0.2740,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.203	1.3	0.000	2.015	3	MU124093	hom
3	14175262	14175262	T	C	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs2340917	ENSG00000170876:ENST00000306077:exon7:c.T536C:p.M179T	TMEM43:NM_024334:exon7:c.T536C:p.M179T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3724	0.3328	0.463259	0.3565	0.428	6.855	1.0	5.32	0.297	.	.	.	TMEM43:uc003byl.1:exon5:c.T176C:p.M59T,TMEM43:uc003byk.2:exon7:c.T536C:p.M179T	-0.943	AFR:0.4188,AMR:0.5095,EAS:0.6592,FIN:0.3033,NFE:0.2967,OTH:0.3037,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.0	1.6	0.000	-2.25	3	MU124112	hom
3	14180744	14180744	G	C	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876;ENSG00000268279	rs199526104	ENSG00000170876:ENST00000306077:exon11:c.G947C:p.W316S	TMEM43:NM_024334:exon11:c.G947C:p.W316S	clinvar: Uncertain_significance 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	0.0002	0.0002	.	3.231e-05	6.572	31	0.011	5.25	0.996	.	.	.	TMEM43:uc003byk.2:exon11:c.G947C:p.W316S	-0.847	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.671e-05,OTH:0,ASJ:0	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.999	1.2	0.179	2.83	3	.	het
3	14187449	14187449	G	T	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs2228001	ENSG00000154767:ENST00000285021:exon16:c.C2815A:p.Q939K,ENSG00000154767:ENST00000449060:exon16:c.C2704A:p.Q902K	XPC:NM_001354726:exon15:c.C2236A:p.Q746K,XPC:NM_001354727:exon16:c.C2809A:p.Q937K,XPC:NM_001354729:exon16:c.C2797A:p.Q933K,XPC:NM_001354730:exon16:c.C2569A:p.Q857K,XPC:NM_004628:exon16:c.C2815A:p.Q939K	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6325	0.6421	0.684704	0.6556	1.250	12.01	1.0	4.24	0.998	.	.	.	XPC:uc011avf.2:exon15:c.C2236A:p.Q746K,XPC:uc011ave.2:exon16:c.C2815A:p.Q939K,XPC:uc011avg.2:exon16:c.C2704A:p.Q902K	-0.955	AFR:0.7228,AMR:0.7057,EAS:0.6382,FIN:0.6985,NFE:0.6087,OTH:0.6337,ASJ:0.5629	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	1.93	0.000	-2.455	3	MU11483739	het
3	14190237	14190237	T	G	XPC	intronic	.	ENSG00000154767	rs2279017	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6302	0.6353	0.679712	0.6502	.	.	.	.	.	0	0.046	.	.	.	AFR:0.7024,AMR:0.7041,EAS:0.6413,FIN:0.6985,NFE:0.6094,OTH:0.6319,ASJ:0.5667	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU705240	het
3	14193889	14193889	C	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2227998	ENSG00000154767:ENST00000285021:exon11:c.G2061A:p.R687R,ENSG00000154767:ENST00000449060:exon11:c.G1950A:p.R650R	XPC:NM_001354726:exon10:c.G1482A:p.R494R,XPC:NM_001354727:exon11:c.G2055A:p.R685R,XPC:NM_001354729:exon11:c.G2043A:p.R681R,XPC:NM_001354730:exon11:c.G1815A:p.R605R,XPC:NM_004628:exon11:c.G2061A:p.R687R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2734	0.2658	0.235423	1(lung)	.	.	.	.	.	.	.	.	XPC:uc021wtm.1:exon2:c.G364A:p.G122R	.	AFR:MU131806,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2989,FIN:0.3022,NFE:0.2649,OTH:0.0358,ASJ:0.2561	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.2282
3	14195431	14195431	G	C	XPC	exonic	nonsynonymous SNV	ENSG00000154767	.	.	XPC:NM_001354727:exon10:c.C1975G:p.Q659E	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	.	het
3	14197987	14197987	A	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2958057	ENSG00000154767:ENST00000285021:exon10:c.T1881A:p.A627A,ENSG00000154767:ENST00000449060:exon10:c.T1770A:p.A590A	XPC:NM_001354726:exon9:c.T1302A:p.A434A,XPC:NM_001354729:exon10:c.T1863A:p.A621A,XPC:NM_001354730:exon10:c.T1635A:p.A545A,XPC:NM_004628:exon10:c.T1881A:p.A627A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	XPC:uc021wtl.1:exon2:c.T99A:p.A33A,XPC:uc011avf.2:exon9:c.T1302A:p.A434A,XPC:uc011ave.2:exon10:c.T1881A:p.A627A,XPC:uc011avg.2:exon10:c.T1770A:p.A590A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU81758228	hom
3	25639973	25639973	-	T	TOP2B	intronic	.	ENSG00000077097	rs11372851	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4119	0.4146	0.410942	0.4131	.	.	.	.	.	.	.	.	.	.	AFR:0.5379,AMR:0.4036,EAS:0.3201,FIN:0.4214,NFE:0.3537,OTH:0.3549,ASJ:0.38	126431	.	.	.	.	.	.	.	.	.	.	.	3	MU114656088	het
3	25661557	25661557	-	A	TOP2B	intronic	.	ENSG00000077097	rs3832214	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3225	0.3152	0.354233	0.3286	.	.	.	.	.	.	.	.	.	.	AFR:0.4680,AMR:0.3490,EAS:0.3120,FIN:0.2903,NFE:0.2627,OTH:0.2695,ASJ:0.2450	126431	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	25674091	25674091	C	A	TOP2B	intronic	.	ENSG00000077097	rs3736601	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2868	0.2464	0.283746	0.2619	.	.	.	.	.	.	.	.	.	.	AFR:0.2377,AMR:0.3321,EAS:0.3120,FIN:0.2912,NFE:0.2605,OTH:0.2588,ASJ:0.2450	126431	.	.	.	.	.	.	.	.	.	.	.	3	MU24221810	het
3	25679738	25679738	T	C	TOP2B	exonic	synonymous SNV	ENSG00000077097	rs60422476	ENSG00000077097:ENST00000264331:exon5:c.A459G:p.V153V,ENSG00000077097:ENST00000435706:exon5:c.A444G:p.V148V,ENSG00000077097:ENST00000424225:exon6:c.A444G:p.V148V	TOP2B:NM_001068:exon5:c.A444G:p.V148V,TOP2B:NM_001330700:exon5:c.A459G:p.V153V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3412	0.2970	0.335863	MU4617675	.	.	.	.	.	.	.	.	TOP2B:uc003cdj.3:exon5:c.A444G:p.V148V,TOP2B:uc011awn.1:exon5:c.A459G:p.V153V,TOP2B:uc021wug.1:exon6:c.A444G:p.V148V	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053,BLCA-CN|1|103|0.00970874,AMR:0.3104,EAS:0.3319,FIN:0.2399,NFE:0.3102,OTH:0.2835,ASJ:0.4134	126431	.	.	.	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.2584
3	25679806	25679813	AAAAAAAA	-	TOP2B	intronic	.	ENSG00000077097	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	126431	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	30656168	30656168	G	A	TGFBR2	intronic	.	ENSG00000163513	rs6791557	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.502995	0.4614	.	.	.	.	.	.	.	.	.	.	AFR:0.3984,AMR:0.4117,EAS:0.7776,FIN:0.5140,NFE:0.4560,OTH:0.4826,ASJ:0.3154	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU86952688	het
3	30686414	30686414	A	G	TGFBR2	intronic	.	ENSG00000163513	rs1155705	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3725	0.3215	0.412939	0.3733	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3381,AMR:0.3005,EAS:0.6901,FIN:0.3946,NFE:0.3618,OTH:0.3615,ASJ:0.2616	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU15034252	het
3	30713126	30713126	T	A	TGFBR2	intronic	.	ENSG00000163513	rs11466512	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2928	0.2555	0.271965	0.2595	.	.	.	.	.	0.0003	0.022	.	.	.	AFR:0.1511,AMR:0.4243,EAS:0.2998,FIN:0.2978,NFE:0.3006,OTH:0.2658,ASJ:0.2167	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU585873	hom
3	38622467	38622467	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs7430407	ENSG00000183873:ENST00000414099:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000423572:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000449557:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000450102:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000455624:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000333535:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000413689:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000425664:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000443581:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000451551:exon17:c.A3183G:p.E1061E	SCN5A:NM_000335:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099404:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099405:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160160:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160161:exon17:c.A3183G:p.E1061E,SCN5A:NM_001354701:exon17:c.A3183G:p.E1061E,SCN5A:NM_198056:exon17:c.A3183G:p.E1061E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9128	0.8850	0.923123	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SCN5A:uc021wvw.1:exon8:c.A2016G:p.E672E,SCN5A:uc021wvi.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvj.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvk.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvl.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvm.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvn.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvo.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvp.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvq.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvr.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvs.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvt.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvu.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvv.1:exon17:c.A3183G:p.E1061E	.	AFR:0.9032,AMR:0.8836,EAS:0.8742,FIN:0.9994,NFE:0.9242,OTH:0.8978,ASJ:0.9284	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.9155
3	38645420	38645420	T	C	SCN5A	exonic	nonsynonymous SNV	ENSG00000183873	rs1805124	ENSG00000183873:ENST00000414099:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000423572:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000449557:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000450102:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000455624:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000333535:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000413689:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000425664:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000443581:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000451551:exon12:c.A1673G:p.H558R	SCN5A:NM_000335:exon12:c.A1673G:p.H558R,SCN5A:NM_001099404:exon12:c.A1673G:p.H558R,SCN5A:NM_001099405:exon12:c.A1673G:p.H558R,SCN5A:NM_001160160:exon12:c.A1673G:p.H558R,SCN5A:NM_001160161:exon12:c.A1673G:p.H558R,SCN5A:NM_001354701:exon12:c.A1673G:p.H558R,SCN5A:NM_198056:exon12:c.A1673G:p.H558R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2217	0.2463	0.230431	MU23011183	-1.102	0.010	1.0	2.44	0.751	.	.	Voltage-gated Na+ ion channel, cytoplasmic domain	SCN5A:uc021wvw.1:exon3:c.A506G:p.H169R,SCN5A:uc021wvi.1:exon9:c.A1271G:p.H424R,SCN5A:uc021wvj.1:exon9:c.A1271G:p.H424R,SCN5A:uc021wvk.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvl.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvm.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvn.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvo.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvp.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvq.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvr.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvs.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvt.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvu.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvv.1:exon12:c.A1673G:p.H558R	-0.924	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2453,EAS:0.2315,FIN:0.2152,NFE:0.1072,OTH:0.2009,ASJ:0.2934	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	0.0	-3.39	0.000	-2.58	3	1(salivary_gland)	0.2467
3	38647642	38647642	G	T	SCN5A	intronic	.	ENSG00000183873	rs41312433	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1722	0.1664	0.151158	0.1745	.	.	.	.	.	0.9992	0.79	.	.	.	AFR:0.1281,AMR:0.1866,EAS:0.1038,FIN:0.1742,NFE:0.2089,OTH:0.1701,ASJ:0.1722	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU776375	het
3	38674712	38674712	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs6599230	ENSG00000183873:ENST00000414099:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000423572:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000449557:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000450102:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000455624:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000327956:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000333535:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000413689:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000425664:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000443581:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000451551:exon2:c.A87G:p.A29A	SCN5A:NM_000335:exon2:c.A87G:p.A29A,SCN5A:NM_001099404:exon2:c.A87G:p.A29A,SCN5A:NM_001099405:exon2:c.A87G:p.A29A,SCN5A:NM_001160160:exon2:c.A87G:p.A29A,SCN5A:NM_001160161:exon2:c.A87G:p.A29A,SCN5A:NM_001354701:exon2:c.A87G:p.A29A,SCN5A:NM_198056:exon2:c.A87G:p.A29A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7737	0.8360	0.781749	0.7947	.	.	.	.	.	.	.	.	SCN5A:uc021wvx.1:exon2:c.A95G:p.Q32R	.	AFR:0.8943,AMR:0.7255,EAS:0.7012,FIN:0.6997,NFE:0.7774,OTH:0.7398,ASJ:0.7417	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU24669512	hom
3	39108503	39108503	G	A	WDR48	exonic	synonymous SNV	ENSG00000114742	rs7624734	.	WDR48:NM_001346225:exon6:c.G537A:p.L179L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.447085	0.4558	.	.	.	.	.	.	.	.	.	.	AFR:0.7795,AMR:0.3055,EAS:0.3959,FIN:0.2959,NFE:0.3285,OTH:0.3391,ASJ:0.3967	612167	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	39111140	39111140	C	A	WDR48	exonic	synonymous SNV	ENSG00000114742	rs2293312	ENSG00000114742:ENST00000396258:exon6:c.C331A:p.R111R,ENSG00000114742:ENST00000302313:exon7:c.C577A:p.R193R,ENSG00000114742:ENST00000441361:exon7:c.C367A:p.R123R	WDR48:NM_001303402:exon6:c.C331A:p.R111R,WDR48:NM_001346227:exon6:c.C52A:p.R18R,WDR48:NM_001303403:exon7:c.C550A:p.R184R,WDR48:NM_001346226:exon7:c.C406A:p.R136R,WDR48:NM_001346228:exon7:c.C367A:p.R123R,WDR48:NM_020839:exon7:c.C577A:p.R193R,WDR48:NM_001346225:exon8:c.C691A:p.R231R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3509	0.4692	0.447085	MU11645448	.	.	.	.	.	.	.	.	WDR48:uc011ayu.1:exon6:c.C331A:p.R111R,WDR48:uc003cit.3:exon7:c.C577A:p.R193R,WDR48:uc011ayt.1:exon7:c.C550A:p.R184R	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.4561,EAS:0.3055,FIN:0.4033,NFE:0.3949,OTH:0.2959,ASJ:0.7793	612167	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.3289
3	39129742	39129742	A	C	WDR48	intronic	.	ENSG00000114742	rs3736573	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3433	0.4588	0.476038	0.4502	.	.	.	.	.	.	.	.	.	.	AFR:0.8189,AMR:0.3337,EAS:0.5508,FIN:0.2609,NFE:0.2854,OTH:0.3231,ASJ:0.3775	612167	.	.	.	.	.	.	.	.	.	.	.	3	MU18051743	het
3	47125385	47125385	G	A	SETD2	exonic	nonsynonymous SNV	ENSG00000181555	rs4082155	ENSG00000181555:ENST00000409792:exon12:c.C5885T:p.P1962L	SETD2:NM_001349370:exon11:c.C5753T:p.P1918L,SETD2:NM_014159:exon12:c.C5885T:p.P1962L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5342	0.4713	0.469848	0.4931	1.276	12.14	0.311	2.94	0.998	.	.	.	SETD2:uc003cqs.3:exon12:c.C5885T:p.P1962L,SETD2:uc003cqv.3:exon13:c.C6086T:p.P2029L	-0.947	AFR:0.2820,AMR:0.4771,EAS:0.5424,FIN:0.6158,NFE:0.5774,OTH:0.5767,ASJ:0.4933	612778	616831;	.	.	.	,9651,9653,9650	.	.	0.001	1.98	0.000	0.895	3	MU585924	het
3	47162661	47162661	A	G	SETD2	exonic	synonymous SNV	ENSG00000181555	rs6767907	ENSG00000181555:ENST00000409792:exon3:c.T3465C:p.N1155N,ENSG00000181555:ENST00000412450:exon3:c.T3333C:p.N1111N	SETD2:NM_001349370:exon2:c.T3333C:p.N1111N,SETD2:NM_014159:exon3:c.T3465C:p.N1155N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6343	0.6448	0.678315	0.6568	.	.	.	.	.	.	.	.	SETD2:uc003cqs.3:exon3:c.T3465C:p.N1155N,SETD2:uc003cqv.3:exon3:c.T3432C:p.N1144N	.	AFR:0.7570,AMR:0.6945,EAS:0.6937,FIN:0.6316,NFE:0.6017,OTH:0.6337,ASJ:0.5667	612778	616831;	.	.	.	,9651,9653	.	.	.	.	.	.	3	MU18259588	het
3	47164140	47164140	T	C	SETD2	exonic	synonymous SNV	ENSG00000181555	rs146562413	ENSG00000181555:ENST00000409792:exon3:c.A1986G:p.Q662Q,ENSG00000181555:ENST00000412450:exon3:c.A1854G:p.Q618Q	SETD2:NM_001349370:exon2:c.A1854G:p.Q618Q,SETD2:NM_014159:exon3:c.A1986G:p.Q662Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0002	.	0.000399361	0.0002	.	.	.	.	.	.	.	.	SETD2:uc003cqs.3:exon3:c.A1986G:p.Q662Q,SETD2:uc003cqv.3:exon3:c.A1953G:p.Q651Q	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0.0003,OTH:0,ASJ:0	612778	616831;	.	.	.	,9651,9653	.	.	.	.	.	.	3	.	het
3	47449058	47449058	T	C	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900688	ENSG00000076201:ENST00000431726:exon11:c.T609C:p.T203T,ENSG00000076201:ENST00000265562:exon12:c.T987C:p.T329T	PTPN23:NM_001304482:exon11:c.T609C:p.T203T,PTPN23:NM_015466:exon12:c.T987C:p.T329T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9863	0.9493	0.953874	0.9584	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon11:c.T882C:p.T294T,PTPN23:uc011bay.1:exon11:c.T597C:p.T199T,PTPN23:uc003crf.1:exon12:c.T987C:p.T329T	.	AFR:0.8548,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9959,ASJ:0.9901	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU81761996	hom
3	47451411	47451411	C	T	PTPN23	intronic	.	ENSG00000076201	rs3736177	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4389	0.3590	0.400559	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.3680,AMR:0.2721,EAS:0.4967,FIN:0.5317,NFE:0.3682,OTH:0.3949,ASJ:0.5	606584	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.3868
3	47452087	47452087	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900689	ENSG00000076201:ENST00000431726:exon19:c.G2421A:p.P807P,ENSG00000076201:ENST00000265562:exon20:c.G2799A:p.P933P	PTPN23:NM_001304482:exon19:c.G2421A:p.P807P,PTPN23:NM_015466:exon20:c.G2799A:p.P933P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9867	0.9511	0.954872	0.9600	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G2694A:p.P898P,PTPN23:uc011bay.1:exon19:c.G2409A:p.P803P,PTPN23:uc003crf.1:exon20:c.G2799A:p.P933P	.	AFR:0.8595,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9959,ASJ:0.99	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4555978	hom
3	47452118	47452118	G	A	PTPN23	exonic	nonsynonymous SNV	ENSG00000076201	rs6780013	ENSG00000076201:ENST00000431726:exon19:c.G2452A:p.A818T,ENSG00000076201:ENST00000265562:exon20:c.G2830A:p.A944T	PTPN23:NM_001304482:exon19:c.G2452A:p.A818T,PTPN23:NM_015466:exon20:c.G2830A:p.A944T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3708	0.3481	0.345248	1(salivary_gland)	-0.951	0.020	1.0	-5.83	0.018	.	.	.	PTPN23:uc011baw.1:exon19:c.G2725A:p.A909T,PTPN23:uc011bay.1:exon19:c.G2440A:p.A814T,PTPN23:uc003crf.1:exon20:c.G2830A:p.A944T	-0.972	AFR:MU133991,AMR:COCA-CN|2|321|0.00623053,PBCA-DE|1|499|0.00200401,EAS:0.2631,FIN:0.3005,NFE:0.42,OTH:0.3756,ASJ:0.3439	606584	.	.	.	.	.	.	.	0.0	4.31	0.000	-0.77	3	1(thyroid)	0.3590
3	47452786	47452786	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs1531875	ENSG00000076201:ENST00000431726:exon19:c.G3120A:p.E1040E,ENSG00000076201:ENST00000265562:exon20:c.G3498A:p.E1166E	PTPN23:NM_001304482:exon19:c.G3120A:p.E1040E,PTPN23:NM_015466:exon20:c.G3498A:p.E1166E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5413	0.4852	0.458866	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G3393A:p.E1131E,PTPN23:uc011bay.1:exon19:c.G3108A:p.E1036E,PTPN23:uc003crf.1:exon20:c.G3498A:p.E1166E	.	AFR:0.5033,AMR:0.2811,EAS:0.4934,FIN:0.4622,NFE:0.6315,OTH:0.6030,ASJ:0.4819	606584	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.5888
3	47454399	47454399	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs6789730	ENSG00000076201:ENST00000431726:exon24:c.G4257A:p.P1419P,ENSG00000076201:ENST00000265562:exon25:c.G4635A:p.P1545P	PTPN23:NM_001304482:exon24:c.G4257A:p.P1419P,PTPN23:NM_015466:exon25:c.G4635A:p.P1545P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9872	0.9547	0.954673	0.9077	.	.	.	.	.	.	.	.	PTPN23:uc011bay.1:exon24:c.G4245A:p.P1415P,PTPN23:uc003crf.1:exon25:c.G4635A:p.P1545P	.	AFR:0.8071,AMR:0.9365,EAS:0.9812,FIN:0.9173,NFE:0.9510,OTH:0.9412,ASJ:0.9458	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4564936	hom
3	48505964	48505964	C	A	ATRIP-TREX1	ncRNA_intronic	.	ENSG00000164053	rs2242150	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3998	0.4692	0.383586	MU759385	.	.	.	.	.	.	.	.	.	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.4324,EAS:0.2667,FIN:0.4503,NFE:0.2766,OTH:0.4023,ASJ:0.4629	606605	.	.	.	.	.	.	.	.	.	.	.	3	1(skin)	0.4487
3	48508585	48508585	C	T	TREX1	exonic	synonymous SNV	ENSG00000213689	rs11797	ENSG00000213689:ENST00000422277:exon1:c.C696T:p.Y232Y,ENSG00000213689:ENST00000436480:exon2:c.C531T:p.Y177Y,ENSG00000213689:ENST00000444177:exon2:c.C501T:p.Y167Y,ENSG00000213689:ENST00000456089:exon2:c.C114T:p.Y38Y,ENSG00000213689:ENST00000296443:exon3:c.C531T:p.Y177Y,ENSG00000213689:ENST00000433541:exon4:c.C114T:p.Y38Y	TREX1:NM_007248:exon2:c.C501T:p.Y167Y,TREX1:NM_033629:exon2:c.C531T:p.Y177Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3706	0.3931	0.313299	MU759387	.	.	.	.	.	.	.	.	TREX1:uc010hka.4:exon1:c.C696T:p.Y232Y,ATRIP:uc003ctj.3:exon2:c.C696T:p.Y232Y,TREX1:uc010hjz.3:exon2:c.C531T:p.Y177Y,TREX1:uc031rzp.1:exon2:c.C501T:p.Y167Y,TREX1:uc003ctk.3:exon4:c.C114T:p.Y38Y,TREX1:uc010hjy.3:exon10:c.C531T:p.Y177Y	.	AFR:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.3693,EAS:0.2410,FIN:0.4305,NFE:0.2732,OTH:0.3910,ASJ:0.2720	606609	152700;192315;225750;610448;	90280;51;247691;3421;63261;71291;	90280|-|-|-|-|610448 614415 ~51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~247691|RVCL|Unknown|Autosomal dominant|-|192315 ~3421|CRV<br>Grand-Kaine-Fulling syndrome|<1 / 1 000 000|Autosomal dominant|Adult|192315 ~63261|Hereditary endotheliopathy-retinopathy-nephropathy-stroke syndrome|<1 / 1 000 000|Autosomal dominant|No data available|192315 ~71291|HVR<br>Hereditary vascular retinopathy-Raynaud phenomenon-migraine syndrome|<1 / 1 000 000|Autosomal dominant|Adult|192315 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.4361
3	48602523	48602523	-	GGC	COL7A1	intronic	.	ENSG00000114270	rs138595277	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9999	0.9998	0.999401	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	.	.	.	.	3	.	hom
3	48625266	48625266	T	C	COL7A1	exonic	synonymous SNV	ENSG00000114270	rs1264194	ENSG00000114270:ENST00000328333:exon21:c.A2817G:p.P939P,ENSG00000114270:ENST00000454817:exon21:c.A2817G:p.P939P	COL7A1:NM_000094:exon21:c.A2817G:p.P939P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6799	0.7736	0.68111	MU703853	.	.	.	.	.	.	.	.	COL7A1:uc003ctz.2:exon21:c.A2817G:p.P939P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,AMR:0.7408,EAS:0.6086,FIN:0.7947,NFE:0.3558,OTH:0.7227,ASJ:0.9026	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.7018
3	49398514	49398514	C	A	RHOA	intronic	.	ENSG00000067560	rs892974	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8667	.	0.886182	0.8014	.	.	.	.	.	.	.	.	.	.	AFR:0.8630,AMR:0.8333,EAS:0.9944,FIN:0.7823,NFE:0.7436,OTH:0.7887,ASJ:0.7727	165390	.	.	.	~ko04011 MAPK signaling pathway - yeast~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04350 TGF-beta signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04660 T cell receptor signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04972 Pancreatic secretion~ko05100 Bacterial invasion of epithelial cells~ko05130 Pathogenic Escherichia coli infection~ko05133 Pertussis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	.	hom
3	49721532	49721532	G	A	MST1	exonic	nonsynonymous SNV	ENSG00000173531	rs3197999	ENSG00000173531:ENST00000449682:exon18:c.C2107T:p.R703C	MST1:NM_020998:exon18:c.C2107T:p.R703C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2557	0.2738	0.191893	1(upper_aerodigestive_tract)	5.174	25.5	0.02	-2.82	0.942	.	.	Peptidase S1, PA clan|Serine proteases, trypsin domain	MST1:uc003cxg.3:exon18:c.C2107T:p.R703C	-1.025	AFR:MU585952,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2266,FIN:0.1579,NFE:0.3775,OTH:0.0414,ASJ:0.2622	142408	.	.	.	.	.	.	.	0.727	-2.48	0.000	2.26	3	2(soft_tissue)	0.4019
3	49721798	49721798	C	A	MST1	exonic	synonymous SNV	ENSG00000173531	rs13085791	ENSG00000173531:ENST00000449682:exon17:c.G1965T:p.R655R	MST1:NM_020998:exon17:c.G1965T:p.R655R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2663	0.2891	0.208866	0.2799	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon17:c.G1965T:p.R655R	.	AFR:0.2672,AMR:0.1683,EAS:0.0408,FIN:0.4231,NFE:0.2824,OTH:0.3075,ASJ:0.3725	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU29787735	het
3	49723726	49723726	-	CC	MST1	intronic	.	ENSG00000173531	rs71631023	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0625	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.1031_1032insGG:p.G344fs	.	AFR:0.0341,AMR:0.0076,EAS:0.0062,FIN:0.0771,NFE:0.0931,OTH:0.08,ASJ:0.0833	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49723735	49723735	C	G	MST1	intronic	.	ENSG00000173531	rs184629099	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3671	.	.	0.0093	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.G1023C:p.G341G	.	AFR:0.0017,AMR:0.0135,EAS:0,FIN:0.0003,NFE:0.0164,OTH:0.0180,ASJ:0.0327	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49723784	49723784	C	A	MST1	exonic	synonymous SNV	ENSG00000173531	rs9713651	ENSG00000173531:ENST00000383728:exon7:c.G753T:p.P251P,ENSG00000173531:ENST00000449682:exon8:c.G978T:p.P326P	MST1:NM_020998:exon8:c.G978T:p.P326P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4369	0.3782	.	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.G974T:p.R325L	.	AFR:0.4461,AMR:0.3271,EAS:0.3973,FIN:0.9428,NFE:0.4230,OTH:0.4640,ASJ:0.5537	142408	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.4705
3	49724808	49724808	T	C	MST1	exonic	synonymous SNV	ENSG00000173531	rs3020779	ENSG00000173531:ENST00000383728:exon3:c.A234G:p.P78P,ENSG00000173531:ENST00000449682:exon4:c.A459G:p.P153P	MST1:NM_020998:exon4:c.A459G:p.P153P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8574	0.7876	0.860224	0.8201	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon4:c.A459G:p.P153P,MST1:uc010hkx.2:exon4:c.A222G:p.P74P,MST1:uc011bcs.1:exon4:c.A459G:p.P153P,MST1:uc011bct.1:exon4:c.A459G:p.P153P	.	AFR:0.7258,AMR:0.8819,EAS:0.9963,FIN:0.8986,NFE:0.8320,OTH:0.8599,ASJ:0.8079	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU81762505	hom
3	49760039	49760039	T	C	GMPPB	exonic	nonsynonymous SNV	ENSG00000173540	rs1466685	ENSG00000173540:ENST00000308375:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000308388:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000480687:exon6:c.A551G:p.Q184R	GMPPB:NM_013334:exon5:c.A551G:p.Q184R,GMPPB:NM_021971:exon5:c.A551G:p.Q184R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9967	0.9892	0.989018	0.9889	0.422	6.799	0.071	-2.63	0.913	.	.	Nucleotide-diphospho-sugar transferases|Nucleotidyl transferase domain	GMPPB:uc003cxk.1:exon5:c.A551G:p.Q184R,GMPPB:uc003cxl.1:exon5:c.A551G:p.Q184R	-0.902	AFR:0.9620,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	615320	615350;615351;615352;	363623;370959;370968;588;	363623|LGMD2T|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615352 ~370959|CMD with cerebellar involvement<br>CMD-CRB|-|-|-|606612 613151 613155 613156 615351 ~370968|CMD with intellectual disability<br>CMD-MR|-|-|-|606612 608840 613155 613156 615351 ~588|MEB syndrome<br>Muscle-eye-brain syndrome<br>Santavuori congenital muscular dystrophy|Unknown|Autosomal recessive|Infancy<br>Neonatal|236670 253280 253800 613150 613153 613154 615181 615350 ~	.	.	.	.	0.0	-3.29	0.000	-0.49	3	MU81762601	hom
3	49924940	49924940	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs1062633	ENSG00000164078:ENST00000344206:exon19:c.A3856G:p.R1286G,ENSG00000164078:ENST00000296474:exon20:c.A4003G:p.R1335G	MST1R:NM_001318913:exon18:c.A3685G:p.R1229G,MST1R:NM_001244937:exon19:c.A3856G:p.R1286G,MST1R:NM_002447:exon20:c.A4003G:p.R1335G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4180	0.5629	0.419129	3(haematopoietic_and_lymphoid_tissue)	-1.266	0.005	0.51	-4.24	0.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Tyrosine-protein kinase, catalytic domain	MST1R:uc031rzv.1:exon7:c.A337G:p.R113G,MST1R:uc031rzw.1:exon18:c.A3685G:p.R1229G,MST1R:uc011bdc.2:exon19:c.A3856G:p.R1286G,MST1R:uc003cxy.4:exon20:c.A4003G:p.R1335G	-0.969	AFR:MU14496730,AMR:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,EAS:0.6804,FIN:0.3282,NFE:0.4603,OTH:0.1433,ASJ:0.5150	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	0.0	-1.68	0.000	0.895	3	57(lung)	0.3751
3	49927503	49927503	G	T	MST1R	intronic	.	ENSG00000164078	rs12489386	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0648	0.0820	0.0573083	0.0774	.	.	.	.	.	0.0036	0.114	.	.	.	AFR:0.0884,AMR:0.0418,EAS:0.0290,FIN:0.0647,NFE:0.0816,OTH:0.0743,ASJ:0.0667	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	het
3	49928691	49928691	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs7433231	ENSG00000164078:ENST00000344206:exon16:c.A3436G:p.S1146G,ENSG00000164078:ENST00000296474:exon17:c.A3583G:p.S1195G	MST1R:NM_001318913:exon15:c.A3265G:p.S1089G,MST1R:NM_001244937:exon16:c.A3436G:p.S1146G,MST1R:NM_002447:exon17:c.A3583G:p.S1195G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1R:uc031rzv.1:exon6:c.A220G:p.S74G,MST1R:uc031rzw.1:exon15:c.A3265G:p.S1089G,MST1R:uc011bdc.2:exon16:c.A3436G:p.S1146G,MST1R:uc003cxy.4:exon17:c.A3583G:p.S1195G	.	AFR:1.0000,AMR:0.9999,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	23(upper_aerodigestive_tract)	1
3	49929025	49929025	C	A	MST1R	intronic	.	ENSG00000164078	rs55643042	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0624	0.0775	0.0543131	0.0739	.	.	.	.	.	0	0.002	.	.	.	AFR:0.0759,AMR:0.0406,EAS:0.0285,FIN:0.0647,NFE:0.0816,OTH:0.0746,ASJ:0.0728	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	het
3	49936102	49936102	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs2230590	ENSG00000164078:ENST00000296474:exon4:c.A1568G:p.Q523R,ENSG00000164078:ENST00000344206:exon4:c.A1568G:p.Q523R,ENSG00000164078:ENST00000411578:exon4:c.A1568G:p.Q523R	MST1R:NM_001318913:exon2:c.A1250G:p.Q417R,MST1R:NM_001244937:exon4:c.A1568G:p.Q523R,MST1R:NM_002447:exon4:c.A1568G:p.Q523R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4172	0.5606	0.416534	1(haematopoietic_and_lymphoid_tissue)	-3.309	0.001	1.0	-6.78	0.078	.	.	Sema domain|WD40/YVTN repeat-like-containing domain	MST1R:uc011bdf.1:exon2:c.A1250G:p.Q417R,MST1R:uc031rzw.1:exon2:c.A1250G:p.Q417R,MST1R:uc003cxy.4:exon4:c.A1568G:p.Q523R,MST1R:uc011bdc.2:exon4:c.A1568G:p.Q523R,MST1R:uc011bdd.2:exon4:c.A1568G:p.Q523R,MST1R:uc011bde.1:exon4:c.A1568G:p.Q523R	-0.975	AFR:61(lung),AMR:MU14496755,EAS:0.5134,FIN:0.6738,NFE:0.3282,OTH:0.4603,ASJ:PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	0.0	1.05	0.000	0.125	3	1(pancreas)	0.1436
3	49936715	49936715	G	A	MST1R	intronic	.	ENSG00000164078	rs41291716	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0625	0.0735	0.0541134	0.0739	.	.	.	.	.	.	.	.	.	.	AFR:0.0759,AMR:0.0406,EAS:0.0290,FIN:0.0648,NFE:0.0817,OTH:0.0746,ASJ:0.0728	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	het
3	51978220	51978220	A	G	PARP3	exonic	nonsynonymous SNV	ENSG00000041880	rs28547534	ENSG00000041880:ENST00000498510:exon2:c.A299G:p.H100R,ENSG00000041880:ENST00000398755:exon3:c.A320G:p.H107R,ENSG00000041880:ENST00000431474:exon3:c.A299G:p.H100R,ENSG00000041880:ENST00000417220:exon4:c.A299G:p.H100R	PARP3:NM_001003931:exon3:c.A320G:p.H107R,PARP3:NM_001370240:exon3:c.A299G:p.H100R,PARP3:NM_005485:exon3:c.A299G:p.H100R,PARP3:NM_001370239:exon4:c.A299G:p.H100R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9927	0.9920	0.997604	0.9937	.	.	.	.	.	.	.	.	PARP3:uc003dby.3:exon3:c.A299G:p.H100R,PARP3:uc003dbz.3:exon3:c.A320G:p.H107R	.	AFR:0.9977,AMR:0.9928,EAS:1,FIN:0.9946,NFE:0.9907,OTH:0.9908,ASJ:1	607726	.	.	.	.	.	.	.	.	.	.	.	3	MU4565297	hom
3	52436917	52436917	C	G	BAP1	intronic	.	ENSG00000163930	rs146661777	ENSG00000163930:ENST00000478368:exon3:c.G433C:p.D145H	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0063	0.0029	0.00838658	0.0032	-1.105	0.010	0.073	-1.33	0.002	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	BAP1:uc010hmg.4:exon3:c.G88C:p.D30H	-1.024	AFR:0.0008,AMR:0,EAS:0.0099,FIN:0.0014,NFE:0.0042,OTH:0.0071,ASJ:0	603089	614327;	289539;	289539|Tumor susceptibility linked to germline BAP1 mutations|Unknown|Autosomal dominant|Adult|614327 ~	.	.	.	.	.	0.86	0.058	.	3	.	het
3	52439240	52439240	T	C	BAP1	exonic	synonymous SNV	ENSG00000163930	rs28997577	ENSG00000163930:ENST00000296288:exon11:c.A948G:p.L316L,ENSG00000163930:ENST00000460680:exon11:c.A1002G:p.L334L	BAP1:NM_004656:exon11:c.A1002G:p.L334L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0063	0.0030	0.00838658	0.0031	.	.	.	.	.	.	.	.	BAP1:uc003ddx.4:exon11:c.A1002G:p.L334L	.	AFR:0.0008,AMR:0,EAS:0.0099,FIN:0.0014,NFE:0.0041,OTH:0.0071,ASJ:0	603089	614327;	289539;	289539|Tumor susceptibility linked to germline BAP1 mutations|Unknown|Autosomal dominant|Adult|614327 ~	.	,957,958,955,950,953,956,954	.	,951,952	.	.	.	.	3	.	het
3	52584431	52584431	-	CTC	PBRM1	intronic	.	ENSG00000163939;ENSG00000168273	rs34372721	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5037	0.5216	0.496605	0.5078	.	.	.	.	.	.	.	.	.	.	AFR:0.5459,AMR:0.6007,EAS:0.4317,FIN:0.4392,NFE:0.5060,OTH:0.4898,ASJ:0.5099	606083	.	.	.	.	.	.	.	.	.	.	.	3	MU114065483	het
3	52584787	52584787	T	C	PBRM1	exonic	synonymous SNV	ENSG00000163939	rs2251219	ENSG00000163939:ENST00000337303:exon26:c.A4335G:p.P1445P,ENSG00000163939:ENST00000356770:exon26:c.A4395G:p.P1465P,ENSG00000163939:ENST00000409057:exon27:c.A4491G:p.P1497P,ENSG00000163939:ENST00000409767:exon27:c.A4380G:p.P1460P,ENSG00000163939:ENST00000410007:exon27:c.A4416G:p.P1472P,ENSG00000163939:ENST00000296302:exon28:c.A4656G:p.P1552P,ENSG00000163939:ENST00000394830:exon28:c.A4335G:p.P1445P,ENSG00000163939:ENST00000409114:exon28:c.A4545G:p.P1515P	PBRM1:NM_001350075:exon28:c.A4491G:p.P1497P,PBRM1:NM_001366072:exon28:c.A4398G:p.P1466P,PBRM1:NM_001366073:exon28:c.A4389G:p.P1463P,PBRM1:NM_001366076:exon28:c.A4338G:p.P1446P,PBRM1:NM_018313:exon28:c.A4335G:p.P1445P,PBRM1:NM_181042:exon28:c.A4335G:p.P1445P,PBRM1:NM_001350079:exon29:c.A4323G:p.P1441P,PBRM1:NM_001366070:exon29:c.A4443G:p.P1481P,PBRM1:NM_001366071:exon29:c.A4563G:p.P1521P,PBRM1:NM_001366074:exon29:c.A4386G:p.P1462P,PBRM1:NM_001366075:exon29:c.A4368G:p.P1456P,PBRM1:NM_001350074:exon30:c.A4443G:p.P1481P,PBRM1:NM_001350076:exon30:c.A4440G:p.P1480P,PBRM1:NM_001350078:exon30:c.A4443G:p.P1481P,PBRM1:NM_001350077:exon31:c.A4434G:p.P1478P	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3822	0.3293	0.323083	98(meninges)	.	.	.	.	.	.	.	.	PBRM1:uc003deq.2:exon26:c.A4335G:p.P1445P,PBRM1:uc003der.2:exon26:c.A4395G:p.P1465P,PBRM1:uc003det.2:exon27:c.A4380G:p.P1460P,PBRM1:uc003dew.2:exon27:c.A4491G:p.P1497P,PBRM1:uc010hmk.1:exon27:c.A4416G:p.P1472P,PBRM1:uc003des.2:exon28:c.A4656G:p.P1552P,PBRM1:uc003deu.2:exon28:c.A4545G:p.P1515P,PBRM1:uc003dey.2:exon28:c.A4335G:p.P1445P	.	AFR:MU11667185,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.1782,FIN:0.4904,NFE:0.4396,OTH:0.4148,ASJ:0.3415	606083	.	.	.	.	,8456,8453	.	,8455,8454	.	.	.	.	3	1(lung)	0.3605
3	52643685	52643685	T	C	PBRM1	exonic	synonymous SNV	ENSG00000163939	rs3755806	ENSG00000163939:ENST00000356770:exon15:c.A2115G:p.T705T,ENSG00000163939:ENST00000296302:exon16:c.A2211G:p.T737T,ENSG00000163939:ENST00000337303:exon16:c.A2211G:p.T737T,ENSG00000163939:ENST00000409057:exon16:c.A2211G:p.T737T,ENSG00000163939:ENST00000410007:exon16:c.A2211G:p.T737T,ENSG00000163939:ENST00000412587:exon16:c.A2211G:p.T737T,ENSG00000163939:ENST00000423351:exon16:c.A2211G:p.T737T,ENSG00000163939:ENST00000446103:exon16:c.A2088G:p.T696T,ENSG00000163939:ENST00000394830:exon17:c.A2211G:p.T737T,ENSG00000163939:ENST00000409114:exon17:c.A2256G:p.T752T,ENSG00000163939:ENST00000409767:exon17:c.A2256G:p.T752T	PBRM1:NM_001350075:exon17:c.A2211G:p.T737T,PBRM1:NM_018313:exon17:c.A2211G:p.T737T,PBRM1:NM_001366071:exon18:c.A2274G:p.T758T,PBRM1:NM_001366072:exon18:c.A2274G:p.T758T,PBRM1:NM_001366073:exon18:c.A2265G:p.T755T,PBRM1:NM_001366076:exon18:c.A2214G:p.T738T,PBRM1:NM_181042:exon18:c.A2211G:p.T737T,PBRM1:NM_001350079:exon19:c.A2274G:p.T758T,PBRM1:NM_001366070:exon19:c.A2319G:p.T773T,PBRM1:NM_001366074:exon19:c.A2262G:p.T754T,PBRM1:NM_001366075:exon19:c.A2319G:p.T773T,PBRM1:NM_001350074:exon20:c.A2319G:p.T773T,PBRM1:NM_001350076:exon20:c.A2319G:p.T773T,PBRM1:NM_001350078:exon20:c.A2319G:p.T773T,PBRM1:NM_001350077:exon21:c.A2310G:p.T770T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3820	0.3296	0.322484	4(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PBRM1:uc003dfa.1:exon1:c.A249G:p.T83T,PBRM1:uc003dfc.3:exon2:c.A312G:p.T104T,PBRM1:uc003der.2:exon15:c.A2115G:p.T705T,PBRM1:uc003deq.2:exon16:c.A2211G:p.T737T,PBRM1:uc003des.2:exon16:c.A2211G:p.T737T,PBRM1:uc003dew.2:exon16:c.A2211G:p.T737T,PBRM1:uc003dez.1:exon16:c.A2211G:p.T737T,PBRM1:uc003dfb.1:exon16:c.A1950G:p.T650T,PBRM1:uc010hmk.1:exon16:c.A2211G:p.T737T,PBRM1:uc003det.2:exon17:c.A2256G:p.T752T,PBRM1:uc003deu.2:exon17:c.A2256G:p.T752T,PBRM1:uc003dey.2:exon17:c.A2211G:p.T737T	.	AFR:96(meninges),AMR:MU793407,EAS:0.3418,FIN:0.1795,NFE:0.4881,OTH:0.4470,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	606083	.	.	.	.	,8456,8453	.	,8455,8454	.	.	.	.	3	16(soft_tissue)	0.4126
3	52676065	52676065	C	T	PBRM1	intronic	.	ENSG00000163939	rs11719685	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3074	0.3249	0.305911	MU11667377	.	.	.	.	.	0.0005	0.014	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4080,EAS:0.5062,FIN:0.4847,NFE:0.4590,OTH:0.4737,ASJ:0.2370	606083	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.4721
3	52692359	52692359	C	G	PBRM1	intronic	.	ENSG00000163939	rs2590846	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3914	0.3297	0.319089	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3423,AMR:0.1801,EAS:0.4470,FIN:0.4144,NFE:0.3623,OTH:0.4118,ASJ:0.4868	606083	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.3755
3	53213657	53213657	T	C	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs2230493	ENSG00000163932:ENST00000394729:exon3:c.T180C:p.D60D,ENSG00000163932:ENST00000464818:exon3:c.T180C:p.D60D,ENSG00000163932:ENST00000330452:exon4:c.T180C:p.D60D,ENSG00000163932:ENST00000478843:exon4:c.T180C:p.D60D,ENSG00000163932:ENST00000487897:exon4:c.T180C:p.D60D	PRKCD:NM_001354676:exon3:c.T237C:p.D79D,PRKCD:NM_001354678:exon3:c.T228C:p.D76D,PRKCD:NM_212539:exon3:c.T180C:p.D60D,PRKCD:NM_001316327:exon4:c.T180C:p.D60D,PRKCD:NM_001354679:exon4:c.T180C:p.D60D,PRKCD:NM_006254:exon4:c.T180C:p.D60D,PRKCD:NM_001354680:exon5:c.T180C:p.D60D	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1281	0.1296	0.081869	0.1279	.	.	.	.	.	.	.	.	PRKCD:uc003dgn.2:exon2:c.T180C:p.D60D,PRKCD:uc003dgm.3:exon3:c.T180C:p.D60D,PRKCD:uc003dgl.3:exon4:c.T180C:p.D60D	.	AFR:0.0635,AMR:0.0776,EAS:0.0123,FIN:0.1350,NFE:0.1765,OTH:0.1551,ASJ:0.1722	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	.	het
3	53222761	53222761	C	T	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs2306574	ENSG00000163932:ENST00000394729:exon15:c.C1441T:p.L481L,ENSG00000163932:ENST00000330452:exon16:c.C1441T:p.L481L	PRKCD:NM_001354676:exon15:c.C1498T:p.L500L,PRKCD:NM_001354678:exon15:c.C1489T:p.L497L,PRKCD:NM_212539:exon15:c.C1441T:p.L481L,PRKCD:NM_001316327:exon16:c.C1441T:p.L481L,PRKCD:NM_001354679:exon16:c.C1441T:p.L481L,PRKCD:NM_006254:exon16:c.C1441T:p.L481L,PRKCD:NM_001354680:exon17:c.C1441T:p.L481L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.7583	0.713458	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon15:c.C1441T:p.L481L,PRKCD:uc003dgl.3:exon16:c.C1441T:p.L481L	.	AFR:0.7580,AMR:0.7198,EAS:0.7667,FIN:0.7833,NFE:0.7338,OTH:0.7843,ASJ:0.7356	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.7556
3	53223927	53223927	C	G	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs1075865	ENSG00000163932:ENST00000394729:exon17:c.C1782G:p.T594T,ENSG00000163932:ENST00000330452:exon18:c.C1782G:p.T594T	PRKCD:NM_001354676:exon17:c.C1839G:p.T613T,PRKCD:NM_001354678:exon17:c.C1830G:p.T610T,PRKCD:NM_212539:exon17:c.C1782G:p.T594T,PRKCD:NM_001316327:exon18:c.C1782G:p.T594T,PRKCD:NM_001354679:exon18:c.C1782G:p.T594T,PRKCD:NM_006254:exon18:c.C1782G:p.T594T,PRKCD:NM_001354680:exon19:c.C1782G:p.T594T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9655	0.9335	0.901957	0.9428	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.C1782G:p.T594T,PRKCD:uc003dgl.3:exon18:c.C1782G:p.T594T	.	AFR:0.8065,AMR:0.9905,EAS:0.9728,FIN:1,NFE:0.9993,OTH:0.9806,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763707	hom
3	53224002	53224002	T	C	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs900495	ENSG00000163932:ENST00000394729:exon17:c.T1857C:p.P619P,ENSG00000163932:ENST00000330452:exon18:c.T1857C:p.P619P	PRKCD:NM_001354676:exon17:c.T1914C:p.P638P,PRKCD:NM_001354678:exon17:c.T1905C:p.P635P,PRKCD:NM_212539:exon17:c.T1857C:p.P619P,PRKCD:NM_001316327:exon18:c.T1857C:p.P619P,PRKCD:NM_001354679:exon18:c.T1857C:p.P619P,PRKCD:NM_006254:exon18:c.T1857C:p.P619P,PRKCD:NM_001354680:exon19:c.T1857C:p.P619P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9835	0.9393	0.940495	0.9481	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.T1857C:p.P619P,PRKCD:uc003dgl.3:exon18:c.T1857C:p.P619P	.	AFR:0.8192,AMR:0.9905,EAS:1,FIN:1,NFE:0.9993,OTH:0.9888,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763716	hom
3	53700550	53700550	T	C	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs2250736	ENSG00000157388:ENST00000481478:exon1:c.T123C:p.D41D,ENSG00000157388:ENST00000288139:exon7:c.T1104C:p.D368D,ENSG00000157388:ENST00000350061:exon7:c.T1104C:p.D368D,ENSG00000157388:ENST00000422281:exon7:c.T1104C:p.D368D	CACNA1D:NM_000720:exon7:c.T1104C:p.D368D,CACNA1D:NM_001128839:exon7:c.T1104C:p.D368D,CACNA1D:NM_001128840:exon7:c.T1104C:p.D368D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5945	0.6475	0.70647	0.6466	.	.	.	.	.	.	.	.	CACNA1D:uc003dgw.4:exon1:c.T45C:p.D15D,CACNA1D:uc003dgu.5:exon7:c.T1104C:p.D368D,CACNA1D:uc003dgv.5:exon7:c.T1104C:p.D368D,CACNA1D:uc003dgy.5:exon7:c.T1104C:p.D368D	.	AFR:0.8772,AMR:0.6026,EAS:0.6200,FIN:0.5856,NFE:0.5390,OTH:0.5833,ASJ:0.4967	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU19620305	hom
3	53766026	53766026	T	C	CACNA1D	intronic	.	ENSG00000157388	rs2612033	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8887	0.8671	0.910942	0.8868	.	.	.	.	.	.	.	.	.	.	AFR:0.8822,AMR:0.9115,EAS:1,FIN:0.9115,NFE:0.8702,OTH:0.9012,ASJ:0.8344	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU81763800	hom
3	53769479	53769479	C	T	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs1045958	ENSG00000157388:ENST00000481478:exon15:c.C1779T:p.S593S,ENSG00000157388:ENST00000350061:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000422281:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000288139:exon21:c.C2760T:p.S920S	CACNA1D:NM_001128839:exon20:c.C2700T:p.S900S,CACNA1D:NM_001128840:exon20:c.C2700T:p.S900S,CACNA1D:NM_000720:exon21:c.C2760T:p.S920S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2994	0.2545	0.192292	0.2681	.	.	.	.	.	.	.	.	CACNA1D:uc003dgx.1:exon4:c.C144T:p.S48S,CACNA1D:uc003dgw.4:exon15:c.C1701T:p.S567S,CACNA1D:uc003dgv.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgy.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgu.5:exon21:c.C2760T:p.S920S	.	AFR:0.0693,AMR:0.3313,EAS:0.2042,FIN:0.3673,NFE:0.3585,OTH:0.3374,ASJ:0.3377	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU4565454	het
3	53844184	53844184	G	A	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs34388124	ENSG00000157388:ENST00000481478:exon42:c.G5130A:p.P1710P,ENSG00000157388:ENST00000422281:exon45:c.G5979A:p.P1993P,ENSG00000157388:ENST00000350061:exon47:c.G6051A:p.P2017P,ENSG00000157388:ENST00000288139:exon48:c.G6111A:p.P2037P	CACNA1D:NM_001128839:exon45:c.G5979A:p.P1993P,CACNA1D:NM_001128840:exon47:c.G6051A:p.P2017P,CACNA1D:NM_000720:exon48:c.G6111A:p.P2037P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0303	0.0281	0.0155751	0.0244	.	.	.	.	.	.	.	.	CACNA1D:uc003dgw.4:exon42:c.G5052A:p.P1684P,CACNA1D:uc003dgy.5:exon45:c.G5979A:p.P1993P,CACNA1D:uc003dgv.5:exon47:c.G6051A:p.P2017P,CACNA1D:uc003dgu.5:exon48:c.G6111A:p.P2037P	.	AFR:0.0064,AMR:0.0239,EAS:0,FIN:0.0435,NFE:0.0322,OTH:0.0336,ASJ:0.0430	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU114044102	het
3	57132200	57132200	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs2291462	ENSG00000144730:ENST00000296318:exon12:c.T1531C:p.L511L,ENSG00000144730:ENST00000427856:exon12:c.T1459C:p.L487L,ENSG00000144730:ENST00000463523:exon12:c.T1099C:p.L367L,ENSG00000144730:ENST00000320057:exon13:c.T1099C:p.L367L	IL17RD:NM_017563:exon12:c.T1531C:p.L511L,IL17RD:NM_001318864:exon13:c.T1099C:p.L367L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.7910	0.736222	0.7820	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon12:c.T1459C:p.L487L,IL17RD:uc003dil.3:exon12:c.T1531C:p.L511L,IL17RD:uc011bex.1:exon12:c.T1099C:p.L367L,IL17RD:uc010hna.3:exon13:c.T1099C:p.L367L	.	AFR:0.6457,AMR:0.8377,EAS:0.4777,FIN:0.8980,NFE:0.8579,OTH:0.8405,ASJ:0.8841	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327509	hom
3	57136585	57136585	C	T	IL17RD	exonic	nonsynonymous SNV	ENSG00000144730	rs17057718	ENSG00000144730:ENST00000296318:exon10:c.G901A:p.V301M,ENSG00000144730:ENST00000427856:exon10:c.G829A:p.V277M,ENSG00000144730:ENST00000463523:exon10:c.G469A:p.V157M,ENSG00000144730:ENST00000320057:exon11:c.G469A:p.V157M	IL17RD:NM_017563:exon10:c.G901A:p.V301M,IL17RD:NM_001318864:exon11:c.G469A:p.V157M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1967	0.1248	0.205871	MU108396	3.017	22.3	0.352	3.57	0.905	.	.	Interleukin 17 receptor D, N-terminal	IL17RD:uc003dik.3:exon10:c.G829A:p.V277M,IL17RD:uc003dil.3:exon10:c.G901A:p.V301M,IL17RD:uc011bex.1:exon10:c.G469A:p.V157M,IL17RD:uc010hna.3:exon11:c.G469A:p.V157M	-0.929	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.1512,EAS:0.3201,FIN:0.1921,NFE:0.3579,OTH:0.1608,ASJ:0.0639	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	0.669	2.88	0.000	0.345	3	1(large_intestine)	0.1656
3	57138419	57138419	G	A	IL17RD	exonic	nonsynonymous SNV	ENSG00000144730	rs6780995	ENSG00000144730:ENST00000296318:exon8:c.C764T:p.T255M,ENSG00000144730:ENST00000427856:exon8:c.C692T:p.T231M,ENSG00000144730:ENST00000463523:exon8:c.C332T:p.T111M,ENSG00000144730:ENST00000320057:exon9:c.C332T:p.T111M	IL17RD:NM_017563:exon8:c.C764T:p.T255M,IL17RD:NM_001318864:exon9:c.C332T:p.T111M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6490	0.6661	0.530152	ESAD-UK|1|409|0.00244499,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	2.678	20.7	0.094	-0.521	0.999	.	.	Interleukin 17 receptor D, N-terminal	IL17RD:uc003dik.3:exon8:c.C692T:p.T231M,IL17RD:uc003dil.3:exon8:c.C764T:p.T255M,IL17RD:uc011bex.1:exon8:c.C332T:p.T111M,IL17RD:uc010hna.3:exon9:c.C332T:p.T111M	-1.079	AFR:0.6306,AMR:0.5815,EAS:0.6921,FIN:0.1156,NFE:0.7376,OTH:0.6926,ASJ:0.5180	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	0.943	2.89	0.000	1.245	3	1(bone)	0.6633
3	57139972	57139972	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs1545981	ENSG00000144730:ENST00000296318:exon7:c.T660C:p.H220H,ENSG00000144730:ENST00000427856:exon7:c.T588C:p.H196H,ENSG00000144730:ENST00000463523:exon7:c.T228C:p.H76H,ENSG00000144730:ENST00000320057:exon8:c.T228C:p.H76H	IL17RD:NM_017563:exon7:c.T660C:p.H220H,IL17RD:NM_001318864:exon8:c.T228C:p.H76H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8697	0.8589	0.79373	0.8421	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon7:c.T588C:p.H196H,IL17RD:uc003dil.3:exon7:c.T660C:p.H220H,IL17RD:uc011bex.1:exon7:c.T228C:p.H76H,IL17RD:uc010hna.3:exon8:c.T228C:p.H76H	.	AFR:0.7636,AMR:0.8926,EAS:0.4838,FIN:0.9342,NFE:0.8975,OTH:0.8929,ASJ:0.8974	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327553	hom
3	71015021	71015021	G	T	FOXP1	intronic	.	ENSG00000114861	rs7638391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9452	0.9413	0.974641	0.9489	.	.	.	.	.	.	.	.	.	.	AFR:0.9831,AMR:0.9535,EAS:1,FIN:0.9476,NFE:0.9238,OTH:0.9559,ASJ:0.9139	605515	613670;	391372;	391372|-|<1 / 1 000 000|-|Infancy<br>Neonatal|613670 ~	.	.	.	.	.	.	.	.	3	MU81765255	hom
3	78663956	78663956	G	A	ROBO1	intronic	.	ENSG00000169855	rs1027832	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4516	0.3502	0.353435	0.3768	.	.	.	.	.	0	0.012	.	.	.	AFR:0.2184,AMR:0.5679,EAS:0.3237,FIN:0.5078,NFE:0.4363,OTH:0.4279,ASJ:0.4759	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU759938	het
3	78666765	78666765	T	C	ROBO1	intronic	.	ENSG00000169855	rs9839790	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6225	0.6195	0.575479	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.5908,AMR:0.4635,EAS:0.7053,FIN:0.5208,NFE:0.6726,OTH:0.6460,ASJ:0.6483	602430	.	.	.	.	.	.	.	.	.	.	.	3	1(haematopoietic_and_lymphoid_tissue)	0.6148
3	78676467	78676467	A	G	ROBO1	intronic	.	ENSG00000169855	rs7636043	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9648	0.9735	0.969848	0.9692	.	.	.	.	.	0	0	.	.	.	AFR:0.9787,AMR:0.9881,EAS:0.9926,FIN:0.9648,NFE:0.9616,OTH:0.9541,ASJ:0.9901	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU18278522	hom
3	100467018	100467018	T	C	TFG	exonic	synonymous SNV	ENSG00000114354	rs11353	ENSG00000114354:ENST00000240851:exon8:c.T846C:p.P282P,ENSG00000114354:ENST00000418917:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000476228:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000490574:exon8:c.T846C:p.P282P	TFG:NM_001007565:exon8:c.T846C:p.P282P,TFG:NM_001195478:exon8:c.T846C:p.P282P,TFG:NM_001195479:exon8:c.T834C:p.P278P,TFG:NM_006070:exon8:c.T846C:p.P282P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6993	0.6551	0.713059	MU760146	-0.585	0.136	.	4.77	0.997	.	.	.	TFG:uc003due.3:exon8:c.T846C:p.P282P,TFG:uc003duf.3:exon8:c.T846C:p.P282P,TFG:uc003dug.3:exon8:c.T834C:p.P278P,TFG:uc003dui.3:exon8:c.T846C:p.P282P	-1.026	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.6676,EAS:0.7792,FIN:0.6192,NFE:0.5946,OTH:0.6703,ASJ:0.6560	602498	604484;615658;	431329;90117;	431329|SPG57<br>Spastic paraplegia due to partial TFG deficiency|<1 / 1 000 000|Autosomal recessive|Infancy|615658 ~90117|HMSNP<br>Hereditary motor and sensory neuropathy, proximal type|Unknown|Autosomal dominant|-|604484 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	0.000	.	3	2(haematopoietic_and_lymphoid_tissue)	0.6739
3	121154974	121154974	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs1381057	ENSG00000051341:ENST00000264233:exon28:c.A7538G:p.Q2513R	POLQ:NM_199420:exon28:c.A7538G:p.Q2513R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7217	0.6696	0.745208	0.6799	-1.556	0.002	1.0	-0.307	0.086	.	.	DNA-directed DNA polymerase, family A, palm domain	POLQ:uc003eed.3:exon13:c.A5054G:p.Q1685R,POLQ:uc003eee.4:exon28:c.A7538G:p.Q2513R	-0.965	AFR:0.6569,AMR:0.6957,EAS:0.9017,FIN:0.7032,NFE:0.6616,OTH:0.7031,ASJ:0.6767	604419	.	.	.	.	.	.	.	0.0	0.85	0.000	-1.14	3	MU13963964	hom
3	121208176	121208176	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs3218651	ENSG00000051341:ENST00000264233:exon16:c.A3602G:p.H1201R	POLQ:NM_199420:exon16:c.A3602G:p.H1201R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2325	0.1325	0.289736	0.1807	-1.287	0.005	0.275	4.24	0.020	.	.	.	POLQ:uc003eed.3:exon1:c.A1118G:p.H373R,POLQ:uc003eee.4:exon16:c.A3602G:p.H1201R	-0.947	AFR:0.1205,AMR:0.3091,EAS:0.5717,FIN:0.2207,NFE:0.1576,OTH:0.1935,ASJ:0.1159	604419	.	.	.	.	.	.	.	0.048	0.9	0.000	0	3	MU13964063	het
3	121208833	121208833	G	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs3218649	ENSG00000051341:ENST00000264233:exon16:c.C2945G:p.T982R	POLQ:NM_199420:exon16:c.C2945G:p.T982R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6741	0.6028	0.696486	0.6272	-1.568	0.002	0.567	-3.86	0.006	.	.	.	POLQ:uc003eed.3:exon1:c.C461G:p.T154R,POLQ:uc003eee.4:exon16:c.C2945G:p.T982R	-1.009	AFR:0.5635,AMR:0.6376,EAS:0.9020,FIN:0.6802,NFE:0.6208,OTH:0.6663,ASJ:0.5430	604419	.	.	.	.	.	.	.	0.0	0.82	0.000	-0.84	3	MU132061	hom
3	121238749	121238749	G	A	POLQ	exonic	synonymous SNV	ENSG00000051341	rs702018	ENSG00000051341:ENST00000264233:exon9:c.C1437T:p.G479G	POLQ:NM_199420:exon9:c.C1437T:p.G479G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9995	0.9985	0.997404	0.9983	.	.	.	.	.	.	.	.	POLQ:uc003eee.4:exon9:c.C1437T:p.G479G	.	AFR:0.9940,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	604419	.	.	.	.	.	.	.	.	.	.	.	3	MU81768041	hom
3	121263720	121263720	C	A	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs702017	ENSG00000051341:ENST00000264233:exon2:c.G197T:p.R66I	POLQ:NM_199420:exon2:c.G197T:p.R66I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9964	0.9886	0.988618	0.9896	0.494	7.389	0.525	-2.11	0.374	.	.	.	POLQ:uc003eee.4:exon2:c.G197T:p.R66I	-0.988	AFR:0.9637,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604419	.	.	.	.	.	.	.	0.0	0.86	0.000	-1.67	3	MU81768070	hom
3	121976253	121976253	G	A	CASR	intronic	.	ENSG00000036828	rs9869985	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9437	0.9123	0.921925	0.9106	.	.	.	.	.	.	.	.	.	.	AFR:0.8122,AMR:0.9773,EAS:0.9808,FIN:0.9189,NFE:0.9519,OTH:0.9257,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU81768493	hom
3	122001099	122001099	T	C	CASR	intronic	.	ENSG00000036828	rs2270916	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1300	0.1128	0.143171	0.1192	.	.	.	.	.	.	.	.	.	.	AFR:0.0596,AMR:0.0825,EAS:0.4219,FIN:0.1203,NFE:0.1258,OTH:0.0967,ASJ:0.0567	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU11448404	het
3	122003045	122003045	G	C	CASR	exonic	synonymous SNV	ENSG00000036828	rs2036400	ENSG00000036828:ENST00000296154:exon6:c.G2244C:p.P748P,ENSG00000036828:ENST00000490131:exon7:c.G2244C:p.P748P,ENSG00000036828:ENST00000498619:exon7:c.G2274C:p.P758P	CASR:NM_000388:exon7:c.G2244C:p.P748P,CASR:NM_001178065:exon7:c.G2274C:p.P758P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9916	0.9720	0.972843	0.9740	.	.	.	.	.	.	.	.	CASR:uc003eev.4:exon7:c.G2244C:p.P748P,CASR:uc003eew.4:exon7:c.G2274C:p.P758P	.	AFR:0.9092,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU81768516	hom
3	122003832	122003832	G	C	CASR	exonic	nonsynonymous SNV	ENSG00000036828	rs1801726	ENSG00000036828:ENST00000296154:exon6:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000490131:exon7:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000498619:exon7:c.G3061C:p.E1021Q	CASR:NM_000388:exon7:c.G3031C:p.E1011Q,CASR:NM_001178065:exon7:c.G3061C:p.E1021Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9446	0.9178	0.924121	0.9148	-0.624	0.109	1.0	5.79	0.342	.	.	.	CASR:uc003eev.4:exon7:c.G3031C:p.E1011Q,CASR:uc003eew.4:exon7:c.G3061C:p.E1021Q	-0.937	AFR:0.8274,AMR:0.9785,EAS:0.9809,FIN:0.9190,NFE:0.9516,OTH:0.9264,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	0.0	-2.35	0.000	.	3	MU81768527	hom
3	124485065	124485065	T	C	ITGB5	intronic	.	ENSG00000082781	rs2291080	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0398	0.0511	0.0928514	0.0526	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.1367,AMR:0.0740,EAS:0.0833,FIN:0.0223,NFE:0.0089,OTH:0.0245,ASJ:0.0099	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU11452331	het
3	124487849	124487849	A	G	ITGB5	intronic	.	ENSG00000082781	rs2291082	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2695	0.2910	0.36242	0.2918	.	.	.	.	.	.	.	.	.	.	AFR:0.4786,AMR:0.3864,EAS:0.2948,FIN:0.2540,NFE:0.1932,OTH:0.2520,ASJ:0.0960	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU11452336	het
3	124515308	124515308	A	G	ITGB5	exonic	synonymous SNV	ENSG00000082781	rs1803825	ENSG00000082781:ENST00000488466:exon4:c.T804C:p.F268F,ENSG00000082781:ENST00000296181:exon10:c.T1620C:p.F540F	ITGB5:NM_001354766:exon9:c.T1161C:p.F387F,ITGB5:NM_001354764:exon10:c.T1296C:p.F432F,ITGB5:NM_001354765:exon10:c.T1296C:p.F432F,ITGB5:NM_002213:exon10:c.T1620C:p.F540F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2601	0.2742	0.336661	0.2766	.	.	.	.	.	.	.	.	ITGB5:uc003eho.3:exon10:c.T1620C:p.F540F	.	AFR:0.4273,AMR:0.3337,EAS:0.3062,FIN:0.2564,NFE:0.1930,OTH:0.2449,ASJ:0.0960	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU109941	unknown
3	124515314	124515314	G	A	ITGB5	exonic	synonymous SNV	ENSG00000082781	rs2291085	ENSG00000082781:ENST00000488466:exon4:c.C798T:p.S266S,ENSG00000082781:ENST00000296181:exon10:c.C1614T:p.S538S	ITGB5:NM_001354766:exon9:c.C1155T:p.S385S,ITGB5:NM_001354764:exon10:c.C1290T:p.S430S,ITGB5:NM_001354765:exon10:c.C1290T:p.S430S,ITGB5:NM_002213:exon10:c.C1614T:p.S538S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0355	0.0563	0.0964457	0.0550	.	.	.	.	.	.	.	.	ITGB5:uc003eho.3:exon10:c.C1614T:p.S538S	.	AFR:0.1593,AMR:0.0274,EAS:0.0958,FIN:0.0029,NFE:0.0066,OTH:0.0225,ASJ:0.0099	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU11452360	unknown
3	124515395	124515395	G	A	ITGB5	exonic	synonymous SNV	ENSG00000082781	rs2291086	ENSG00000082781:ENST00000488466:exon4:c.C717T:p.N239N,ENSG00000082781:ENST00000296181:exon10:c.C1533T:p.N511N	ITGB5:NM_001354766:exon9:c.C1074T:p.N358N,ITGB5:NM_001354764:exon10:c.C1209T:p.N403N,ITGB5:NM_001354765:exon10:c.C1209T:p.N403N,ITGB5:NM_002213:exon10:c.C1533T:p.N511N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0328	0.0498	0.0880591	0.0476	.	.	.	.	.	.	.	.	ITGB5:uc003eho.3:exon10:c.C1533T:p.N511N	.	AFR:0.1355,AMR:0.0274,EAS:0.0851,FIN:0.0029,NFE:0.0065,OTH:0.0183,ASJ:0.0099	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU11452364	het
3	124515636	124515636	C	T	ITGB5	exonic	nonsynonymous SNV	ENSG00000082781	rs2291089	ENSG00000082781:ENST00000488466:exon4:c.G476A:p.R159Q,ENSG00000082781:ENST00000296181:exon10:c.G1292A:p.R431Q	ITGB5:NM_001354766:exon9:c.G833A:p.R278Q,ITGB5:NM_001354764:exon10:c.G968A:p.R323Q,ITGB5:NM_001354765:exon10:c.G968A:p.R323Q,ITGB5:NM_002213:exon10:c.G1292A:p.R431Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0158	0.0102	0.0443291	0.0149	6.245	28.9	0.143	5.26	0.899	.	.	Integrin beta subunit, VWA domain|Integrin domain	ITGB5:uc003eho.3:exon10:c.G1292A:p.R431Q	-1.087	AFR:0.0339,AMR:0.0048,EAS:0.0852,FIN:0.0023,NFE:0.0006,OTH:0.0071,ASJ:0	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	1.0	-0.13	0.006	1.75	3	MU642535	het
3	128204951	128204951	C	T	GATA2	exonic	nonsynonymous SNV	ENSG00000179348	rs2335052	ENSG00000179348:ENST00000341105:exon3:c.G490A:p.A164T,ENSG00000179348:ENST00000430265:exon3:c.G490A:p.A164T,ENSG00000179348:ENST00000487848:exon4:c.G490A:p.A164T	GATA2:NM_001145662:exon3:c.G490A:p.A164T,GATA2:NM_032638:exon3:c.G490A:p.A164T,GATA2:NM_001145661:exon4:c.G490A:p.A164T	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2056	0.1638	0.232827	1(breast)	1.482	13.22	0.403	1.83	0.999	.	.	.	GATA2:uc003ekn.3:exon3:c.G490A:p.A164T,GATA2:uc003eko.2:exon3:c.G490A:p.A164T,GATA2:uc003ekm.3:exon4:c.G490A:p.A164T	-1.065	AFR:MU83133,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1769,FIN:0.2524,NFE:0.2185,OTH:0.3781,ASJ:0.1800	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	0.013	-4.32	0.000	0	3	1(large_intestine)	0.1862
3	128205860	128205860	G	C	GATA2	exonic	synonymous SNV	ENSG00000179348	rs1573858	ENSG00000179348:ENST00000341105:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000430265:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000492608:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000487848:exon3:c.C15G:p.P5P,ENSG00000179348:ENST00000498200:exon3:c.C15G:p.P5P	GATA2:NM_001145662:exon2:c.C15G:p.P5P,GATA2:NM_032638:exon2:c.C15G:p.P5P,GATA2:NM_001145661:exon3:c.C15G:p.P5P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6943	0.6934	0.709864	1(prostate)	.	.	.	.	.	.	.	.	GATA2:uc003ekn.3:exon2:c.C15G:p.P5P,GATA2:uc003eko.2:exon2:c.C15G:p.P5P,GATA2:uc003ekm.3:exon3:c.C15G:p.P5P	.	AFR:MU77941,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7816,FIN:0.7236,NFE:0.7318,OTH:0.7293,ASJ:0.6532	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	.	.	.	.	3	4(large_intestine)	0.5255
3	129020778	129020778	A	G	HMCES	intronic	.	ENSG00000183624	rs6765930	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7957	0.8211	0.809704	0.8190	.	.	.	.	.	.	.	.	.	.	AFR:0.9009,AMR:0.7524,EAS:0.7009,FIN:0.8328,NFE:0.7859,OTH:0.7984,ASJ:0.8278	.	.	.	.	.	.	.	.	.	.	.	.	3	MU18309036	hom
3	129151927	129151927	G	A	MBD4	intronic	.	ENSG00000129071	rs140697	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1959	0.2280	0.361621	0.2178	.	.	.	.	.	.	.	.	.	.	AFR:0.4689,AMR:0.2026,EAS:0.4870,FIN:0.0459,NFE:0.0915,OTH:0.1191,ASJ:0.1556	603574	.	.	.	.	.	.	.	.	.	.	.	3	MU18309773	het
3	129152089	129152089	G	A	MBD4	exonic	synonymous SNV	ENSG00000129071	rs140696	ENSG00000129071:ENST00000509828:exon2:c.C106T:p.Q36X	MBD4:NM_001276273:exon5:c.C459T:p.G153G,MBD4:NM_001276270:exon6:c.C1395T:p.G465G,MBD4:NM_001276271:exon6:c.C1413T:p.G471G,MBD4:NM_001276272:exon6:c.C1413T:p.G471G,MBD4:NM_003925:exon6:c.C1413T:p.G471G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1224	0.1397	0.167332	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053	.	.	.	.	.	0	0.082	.	MBD4:uc003emk.2:exon5:c.C459T:p.G153G,MBD4:uc003emh.2:exon6:c.C1413T:p.G471G,MBD4:uc003emi.2:exon6:c.C1413T:p.G471G,MBD4:uc003emj.2:exon6:c.C1395T:p.G465G,MBD4:uc011bkw.2:exon6:c.C1413T:p.G471G	.	AFR:0.1152,AMR:0.2107,EAS:0.1490,FIN:0.0699,NFE:0.0395,OTH:0.0863,ASJ:0.0682	603574	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.0786
3	129155463	129155463	A	G	MBD4	exonic	nonsynonymous SNV	ENSG00000129071	rs2307289	ENSG00000129071:ENST00000249910:exon3:c.T1024C:p.S342P,ENSG00000129071:ENST00000429544:exon3:c.T1024C:p.S342P,ENSG00000129071:ENST00000503197:exon3:c.T1024C:p.S342P,ENSG00000129071:ENST00000507208:exon3:c.T1024C:p.S342P	MBD4:NM_001276270:exon3:c.T1024C:p.S342P,MBD4:NM_001276271:exon3:c.T1024C:p.S342P,MBD4:NM_001276272:exon3:c.T1024C:p.S342P,MBD4:NM_003925:exon3:c.T1024C:p.S342P	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0286	0.0431	0.0660942	0.0366	0.659	8.557	0.183	2.69	0.002	.	.	.	MBD4:uc003emh.2:exon3:c.T1024C:p.S342P,MBD4:uc003emi.2:exon3:c.T1024C:p.S342P,MBD4:uc003emj.2:exon3:c.T1024C:p.S342P,MBD4:uc011bkw.2:exon3:c.T1024C:p.S342P	-0.706	AFR:0.1192,AMR:0.0048,EAS:0.0160,FIN:0,NFE:0.0033,OTH:0.0132,ASJ:0	603574	.	.	.	.	.	.	.	0.001	-3.03	0.019	-0.345	3	.	het
3	133329943	133329943	G	A	TOPBP1	exonic	synonymous SNV	ENSG00000163781	rs1444601	ENSG00000163781:ENST00000260810:exon25:c.C4078T:p.L1360L	TOPBP1:NM_001363889:exon25:c.C4063T:p.L1355L,TOPBP1:NM_007027:exon25:c.C4078T:p.L1360L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6905	0.7468	0.682109	0.7131	.	.	.	.	.	.	.	.	TOPBP1:uc003eps.3:exon25:c.C4078T:p.L1360L	.	AFR:0.7736,AMR:0.6842,EAS:0.5854,FIN:0.6523,NFE:0.7102,OTH:0.6811,ASJ:0.6788	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU4134346	het
3	133335787	133335787	C	T	TOPBP1	intronic	.	ENSG00000163781	rs3732574	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6891	0.6987	0.632188	0.6683	.	.	.	.	.	.	.	.	.	.	AFR:0.6156,AMR:0.6706,EAS:0.5899,FIN:0.6531,NFE:0.7103,OTH:0.6725,ASJ:0.6755	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU23050173	het
3	133342206	133342206	C	G	TOPBP1	exonic	synonymous SNV	ENSG00000163781	rs547263106	ENSG00000163781:ENST00000260810:exon18:c.G3024C:p.R1008R	TOPBP1:NM_001363889:exon18:c.G3009C:p.R1003R,TOPBP1:NM_007027:exon18:c.G3024C:p.R1008R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	8.678e-06	.	0.000199681	.	.	.	.	.	.	.	.	.	TOPBP1:uc003ept.1:exon3:c.G36C:p.R12R,TOPBP1:uc003eps.3:exon18:c.G3024C:p.R1008R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607760	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	133368362	133368362	T	G	TOPBP1	exonic	nonsynonymous SNV	ENSG00000163781	rs3192149	ENSG00000163781:ENST00000260810:exon10:c.A1369C:p.K457Q	TOPBP1:NM_001363889:exon10:c.A1354C:p.K452Q,TOPBP1:NM_007027:exon10:c.A1369C:p.K457Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7159	0.7728	0.695887	0.7347	1.150	11.48	1.0	4.84	0.873	.	.	.	TOPBP1:uc003eps.3:exon10:c.A1369C:p.K457Q	-1.029	AFR:0.7850,AMR:0.6957,EAS:0.5878,FIN:0.6737,NFE:0.7405,OTH:0.6976,ASJ:0.7119	607760	.	.	.	.	.	.	.	0.0	2.75	0.000	-1.265	3	MU14391089	hom
3	134670524	134670524	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs7644369	ENSG00000154928:ENST00000398015:exon3:c.C435T:p.S145S,ENSG00000154928:ENST00000474732:exon3:c.C369T:p.S123S,ENSG00000154928:ENST00000482618:exon3:c.C435T:p.S145S	EPHB1:NM_004441:exon3:c.C435T:p.S145S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4628	0.4879	0.48143	2(lung)	.	.	.	.	.	.	.	.	EPHB1:uc003eqt.3:exon3:c.C435T:p.S145S,EPHB1:uc011bly.2:exon3:c.C435T:p.S145S	.	AFR:MU150981,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.6072,FIN:0.5359,NFE:0.5430,OTH:0.1963,ASJ:0.4687	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.3564
3	134898742	134898742	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs1042787	ENSG00000154928:ENST00000493838:exon8:c.C483T:p.Y161Y,ENSG00000154928:ENST00000398015:exon10:c.C1800T:p.Y600Y	EPHB1:NM_004441:exon10:c.C1800T:p.Y600Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4494	0.4166	0.537939	0.4358	.	.	.	.	.	.	.	.	EPHB1:uc003equ.3:exon8:c.C483T:p.Y161Y,EPHB1:uc003eqt.3:exon10:c.C1800T:p.Y600Y	.	AFR:0.5083,AMR:0.4653,EAS:0.7172,FIN:0.3184,NFE:0.3933,OTH:0.4206,ASJ:0.2748	600600	.	.	.	.	.	.	.	.	.	.	.	3	MU4133192	het
3	134967368	134967368	G	A	EPHB1	intronic	.	ENSG00000154928	rs11717042	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3120	0.2276	0.280751	MU28582199	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2490,EAS:0.2386,FIN:0.2914,NFE:0.2867,OTH:0.2944,ASJ:0.2552	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.2304
3	138433568	138433568	C	T	PIK3CB	intronic	.	ENSG00000051382	rs497900	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6224	0.5603	0.701877	0.6127	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.6083,AMR:0.7291,EAS:0.9907,FIN:0.6583,NFE:0.5586,OTH:0.6339,ASJ:0.4735	602925	.	.	.	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	MU4126273	hom
3	142168331	142168331	C	T	ATR	exonic	synonymous SNV	ENSG00000175054	rs1802904	ENSG00000175054:ENST00000383101:exon46:c.G7683A:p.Q2561Q,ENSG00000175054:ENST00000350721:exon47:c.G7875A:p.Q2625Q	ATR:NM_001354579:exon46:c.G7683A:p.Q2561Q,ATR:NM_001184:exon47:c.G7875A:p.Q2625Q	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8646	0.8978	0.916334	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon47:c.G7875A:p.Q2625Q	.	AFR:0.8880,AMR:0.9702,EAS:0.8079,FIN:0.9420,NFE:0.7995,OTH:0.8651,ASJ:0.7775	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,925,926	.	.	.	.	.	.	3	17(meninges)	0.8510
3	142222284	142222284	A	G	ATR	exonic	synonymous SNV	ENSG00000175054	rs2227931	ENSG00000175054:ENST00000383101:exon29:c.T5016C:p.Y1672Y,ENSG00000175054:ENST00000350721:exon30:c.T5208C:p.Y1736Y	ATR:NM_001354579:exon29:c.T5016C:p.Y1672Y,ATR:NM_001184:exon30:c.T5208C:p.Y1736Y	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3640	0.3496	0.3125	11(meninges)	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon30:c.T5208C:p.Y1736Y	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(stomach),EAS:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841,FIN:0.3410,NFE:0.1968,OTH:0.3349,ASJ:MU761169	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,925,926	.	.	.	.	.	.	3	1(breast)	0.4570
3	142277536	142277536	A	G	ATR	exonic	synonymous SNV	ENSG00000175054	rs2227929	ENSG00000175054:ENST00000515149:exon4:c.T666C:p.D222D,ENSG00000175054:ENST00000383101:exon7:c.T1623C:p.D541D,ENSG00000175054:ENST00000350721:exon8:c.T1815C:p.D605D	ATR:NM_001354579:exon7:c.T1623C:p.D541D,ATR:NM_001184:exon8:c.T1815C:p.D605D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3516	0.3458	0.310703	1(kidney)	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon8:c.T1815C:p.D605D	.	AFR:3(large_intestine),AMR:MU653857,EAS:0.3358,FIN:0.1941,NFE:0.3329,OTH:0.4470,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,925,926	.	.	.	.	.	.	3	12(meninges)	0.3747
3	142277575	142277575	A	T	ATR	exonic	synonymous SNV	ENSG00000175054	rs2227930	ENSG00000175054:ENST00000515149:exon4:c.T627A:p.G209G,ENSG00000175054:ENST00000383101:exon7:c.T1584A:p.G528G,ENSG00000175054:ENST00000350721:exon8:c.T1776A:p.G592G	ATR:NM_001354579:exon7:c.T1584A:p.G528G,ATR:NM_001184:exon8:c.T1776A:p.G592G	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5529	0.6630	0.598043	20(soft_tissue)	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon8:c.T1776A:p.G592G	.	AFR:14(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,FIN:0.6300,NFE:0.7950,OTH:0.4976,ASJ:MU586118	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,925,926	.	.	.	.	.	.	3	2(large_intestine)	0.5728
3	142281612	142281612	A	G	ATR	exonic	nonsynonymous SNV	ENSG00000175054	rs2227928	ENSG00000175054:ENST00000350721:exon4:c.T632C:p.M211T,ENSG00000175054:ENST00000383101:exon4:c.T632C:p.M211T	ATR:NM_001184:exon4:c.T632C:p.M211T,ATR:NM_001354579:exon4:c.T632C:p.M211T	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5540	0.6623	0.597444	4(prostate)	-0.115	1.622	1.0	4.6	0.958	.	.	Armadillo-like helical	ATR:uc003eux.4:exon4:c.T632C:p.M211T	-0.930	AFR:14(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:1(biliary_tract),FIN:MU586119,NFE:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,OTH:0.6291,ASJ:3(large_intestine)	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,925,926	.	.	0.0	-0.14	0.000	0.145	3	69(lung)	0.7916
3	148756825	148756825	G	A	HLTF	intronic	.	ENSG00000071794	rs6764352	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9754	0.9796	0.980232	0.9847	.	.	.	.	.	.	.	.	.	.	AFR:0.9954,AMR:0.9857,EAS:1,FIN:0.9903,NFE:0.9752,OTH:0.9878,ASJ:0.9834	603257	.	.	.	.	.	.	.	.	.	.	.	3	MU81772047	hom
3	148759325	148759325	T	C	HLTF	exonic	synonymous SNV	ENSG00000071794	rs2290725	ENSG00000071794:ENST00000467858:exon6:c.A732G:p.A244A,ENSG00000071794:ENST00000310053:exon20:c.A2328G:p.A776A,ENSG00000071794:ENST00000392912:exon20:c.A2328G:p.A776A,ENSG00000071794:ENST00000465259:exon20:c.A2325G:p.A775A,ENSG00000071794:ENST00000494055:exon20:c.A2328G:p.A776A	HLTF:NM_001318934:exon20:c.A2325G:p.A775A,HLTF:NM_001318935:exon20:c.A2328G:p.A776A,HLTF:NM_003071:exon20:c.A2328G:p.A776A,HLTF:NM_139048:exon20:c.A2328G:p.A776A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3187	0.3052	0.315695	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon20:c.A2328G:p.A776A,HLTF:uc003ewr.1:exon20:c.A2328G:p.A776A,HLTF:uc003ews.1:exon20:c.A2325G:p.A775A,HLTF:uc010hve.1:exon20:c.A2325G:p.A775A	.	AFR:1(large_intestine),AMR:1(breast),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.3153,NFE:0.3025,OTH:0.3565,ASJ:MU106674	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(stomach)	0.2980
3	148786108	148786108	C	T	HLTF	exonic	synonymous SNV	ENSG00000071794	rs812249	ENSG00000071794:ENST00000310053:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000392912:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000465259:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000494055:exon8:c.G909A:p.T303T	HLTF:NM_001318934:exon8:c.G909A:p.T303T,HLTF:NM_001318935:exon8:c.G909A:p.T303T,HLTF:NM_003071:exon8:c.G909A:p.T303T,HLTF:NM_139048:exon8:c.G909A:p.T303T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.7527	0.742412	MU16602666	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon8:c.G909A:p.T303T,HLTF:uc003ewr.1:exon8:c.G909A:p.T303T,HLTF:uc003ews.1:exon8:c.G909A:p.T303T,HLTF:uc010hve.1:exon8:c.G909A:p.T303T	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7369,EAS:0.8289,FIN:0.7980,NFE:0.7213,OTH:0.7109,ASJ:0.8307	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(prostate)	0.6853
3	148793779	148793779	T	G	HLTF	exonic	nonsynonymous SNV	ENSG00000071794	.	ENSG00000071794:ENST00000310053:exon3:c.A284C:p.K95T,ENSG00000071794:ENST00000392912:exon3:c.A284C:p.K95T,ENSG00000071794:ENST00000465259:exon3:c.A284C:p.K95T,ENSG00000071794:ENST00000494055:exon3:c.A284C:p.K95T	HLTF:NM_001318934:exon3:c.A284C:p.K95T,HLTF:NM_001318935:exon3:c.A284C:p.K95T,HLTF:NM_003071:exon3:c.A284C:p.K95T,HLTF:NM_139048:exon3:c.A284C:p.K95T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	3.956	23.6	0.216	5.54	0.998	.	.	HIRAN domain	HLTF:uc003ewq.1:exon3:c.A284C:p.K95T,HLTF:uc003ewr.1:exon3:c.A284C:p.K95T,HLTF:uc003ews.1:exon3:c.A284C:p.K95T,HLTF:uc010hve.1:exon3:c.A284C:p.K95T	0.280	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603257	.	.	.	.	.	.	.	0.614	-2.55	0.661	1.7	3	.	het
3	149238595	149238595	-	TTAA	WWTR1	exonic	stopgain	ENSG00000018408	rs112399999	ENSG00000018408:ENST00000360632:exon7:c.1199_1200insTTAA:p.L400_X401delinsLX,ENSG00000018408:ENST00000467467:exon7:c.1199_1200insTTAA:p.L400_X401delinsLX,ENSG00000018408:ENST00000465804:exon8:c.1199_1200insTTAA:p.L400_X401delinsLX	WWTR1:NM_001168280:exon7:c.1199_1200insTTAA:p.L400_X401delinsLX,WWTR1:NM_015472:exon7:c.1199_1200insTTAA:p.L400_X401delinsLX,WWTR1:NM_001168278:exon8:c.1199_1200insTTAA:p.L400_X401delinsLX,WWTR1:NM_001348362:exon10:c.1199_1200insTTAA:p.L400_X401delinsLX	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1008	0.1072	0.114417	0.1038	.	.	.	.	.	.	.	.	WWTR1:uc003exe.3:exon6:c.1199_1200insTTAA:p.L400_X401delinsLX,WWTR1:uc003exf.3:exon7:c.1199_1200insTTAA:p.L400_X401delinsLX,WWTR1:uc021xfm.1:exon7:c.1199_1200insTTAA:p.L400_X401delinsLX,WWTR1:uc003exh.3:exon8:c.1199_1200insTTAA:p.L400_X401delinsLX	.	AFR:0.1316,AMR:0.0670,EAS:0.1990,FIN:0.0879,NFE:0.0836,OTH:0.1041,ASJ:0.0867	607392	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	149374873	149374873	G	T	WWTR1	exonic	nonsynonymous SNV	ENSG00000018408	rs1055153	ENSG00000018408:ENST00000479238:exon1:c.C221A:p.P74Q,ENSG00000018408:ENST00000360632:exon2:c.C221A:p.P74Q,ENSG00000018408:ENST00000467467:exon2:c.C221A:p.P74Q,ENSG00000018408:ENST00000485352:exon2:c.C221A:p.P74Q,ENSG00000018408:ENST00000465804:exon3:c.C221A:p.P74Q,ENSG00000018408:ENST00000475579:exon3:c.C221A:p.P74Q	WWTR1:NM_001168280:exon2:c.C221A:p.P74Q,WWTR1:NM_015472:exon2:c.C221A:p.P74Q,WWTR1:NM_001168278:exon3:c.C221A:p.P74Q,WWTR1:NM_001348362:exon5:c.C221A:p.P74Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1054	0.0609	0.0738818	0.0697	5.001	25.1	0.085	5.09	1.000	.	.	.	WWTR1:uc003exe.3:exon1:c.C221A:p.P74Q,WWTR1:uc003exf.3:exon2:c.C221A:p.P74Q,WWTR1:uc021xfm.1:exon2:c.C221A:p.P74Q,WWTR1:uc003exh.3:exon3:c.C221A:p.P74Q	-1.117	AFR:0.0599,AMR:0.0418,EAS:0.1304,FIN:0.0721,NFE:0.0698,OTH:0.0684,ASJ:0.0762	607392	.	.	.	.	.	.	.	0.999	0.9	0.007	1.78	3	MU71595	het
3	154866453	154866453	T	C	MME	intronic	.	ENSG00000196549	rs1436633	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3223	0.3887	0.333267	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3548,AMR:0.4429,EAS:0.3642,FIN:0.2163,NFE:0.3260,OTH:0.3377,ASJ:0.1904	120520	617017;617018;	443950;	443950|AR-CMT2T<br>Autosomal recessive axonal Charcot-Marie-Tooth disease type 2T<br>CMT2T|<1 / 1 000 000|Autosomal recessive|Adult|616233 617017 ~	.	.	.	.	.	.	.	.	3	1(lung)	0.3010
3	156864399	156864404	AAAAAA	-	CCNL1	intronic	.	ENSG00000163660	rs370594663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3974	.	.	0.2697	.	.	.	.	.	.	.	.	.	.	AFR:0.1564,AMR:0.4884,EAS:0.3810,FIN:0.3577,NFE:0.2936,OTH:0.3046,ASJ:0.2364	613384	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	156867776	156867776	-	AA	CCNL1	intronic	.	ENSG00000163660	rs386398342	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4059	0.375	0.471446	0.3984	.	.	.	.	.	.	.	.	.	.	AFR:0.4588,AMR:0.6320,EAS:0.5539,FIN:0.3358,NFE:0.3495,OTH:0.3766,ASJ:0.37	613384	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	156870816	156870816	A	G	CCNL1	intronic	.	ENSG00000163660	rs41272613	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2546	0.1954	0.23722	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2035,AMR:0.0990,EAS:0.1821,FIN:0.3578,NFE:0.1823,OTH:0.2377,ASJ:0.4580	613384	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.2219
3	156877277	156877278	AA	-	CCNL1	intronic	.	ENSG00000163660	rs59715654	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2563	0.1984	0.241214	0.2060	.	.	.	.	.	.	.	.	.	.	AFR:0.1101,AMR:0.4547,EAS:0.3579,FIN:0.1817,NFE:0.2366,OTH:0.2220,ASJ:0.1846	613384	.	.	.	.	.	.	.	.	.	.	.	3	MU76841695	het
3	158306627	158306627	A	G	MLF1	intronic	.	ENSG00000178053	rs1075551	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5630	.	0.571286	0.5541	.	.	.	.	.	.	.	.	.	.	AFR:0.7255,AMR:0.5407,EAS:0.3040,FIN:0.4707,NFE:0.5063,OTH:0.4856,ASJ:0.5430	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	MU14910846	het
3	158320597	158320597	T	C	MLF1	exonic	synonymous SNV	ENSG00000178053	rs4875	ENSG00000178053:ENST00000491767:exon5:c.T348C:p.S116S,ENSG00000178053:ENST00000498592:exon5:c.T435C:p.S145S,ENSG00000178053:ENST00000355893:exon6:c.T570C:p.S190S,ENSG00000178053:ENST00000359117:exon6:c.T495C:p.S165S,ENSG00000178053:ENST00000469452:exon6:c.T366C:p.S122S,ENSG00000178053:ENST00000482628:exon7:c.T495C:p.S165S,ENSG00000178053:ENST00000484955:exon7:c.T495C:p.S165S,ENSG00000178053:ENST00000392822:exon8:c.T663C:p.S221S,ENSG00000178053:ENST00000471745:exon8:c.T540C:p.S180S,ENSG00000178053:ENST00000478894:exon8:c.T540C:p.S180S	MLF1:NM_001369781:exon5:c.T435C:p.S145S,MLF1:NM_001369782:exon5:c.T348C:p.S116S,MLF1:NM_001130156:exon6:c.T495C:p.S165S,MLF1:NM_001195433:exon6:c.T366C:p.S122S,MLF1:NM_022443:exon6:c.T570C:p.S190S,MLF1:NM_001130157:exon7:c.T495C:p.S165S,MLF1:NM_001369783:exon7:c.T615C:p.S205S,MLF1:NM_001369784:exon7:c.T495C:p.S165S,MLF1:NM_001369785:exon7:c.T540C:p.S180S,MLF1:NM_001195432:exon8:c.T663C:p.S221S,MLF1:NM_001195434:exon8:c.T540C:p.S180S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5453	0.5966	0.576478	LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0043	0.14	.	MLF1:uc003fca.3:exon6:c.T495C:p.S165S,MLF1:uc003fcb.3:exon6:c.T570C:p.S190S,MLF1:uc010hvx.3:exon6:c.T366C:p.S122S,MLF1:uc003fby.3:exon7:c.T348C:p.S116S,MLF1:uc003fbz.3:exon7:c.T495C:p.S165S,MLF1:uc003fbx.3:exon8:c.T540C:p.S180S,MLF1:uc003fcc.3:exon8:c.T663C:p.S221S	.	AFR:0.5732,AMR:0.7265,EAS:0.5464,FIN:0.3068,NFE:0.5278,OTH:0.5294,ASJ:0.5442	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	1(stomach)	0.5133
3	158320703	158320703	C	A	MLF1	exonic	nonsynonymous SNV	ENSG00000178053	rs15967	ENSG00000178053:ENST00000491767:exon5:c.C454A:p.P152T,ENSG00000178053:ENST00000498592:exon5:c.C541A:p.P181T,ENSG00000178053:ENST00000355893:exon6:c.C676A:p.P226T,ENSG00000178053:ENST00000359117:exon6:c.C601A:p.P201T,ENSG00000178053:ENST00000469452:exon6:c.C472A:p.P158T,ENSG00000178053:ENST00000482628:exon7:c.C601A:p.P201T,ENSG00000178053:ENST00000484955:exon7:c.C601A:p.P201T,ENSG00000178053:ENST00000392822:exon8:c.C769A:p.P257T,ENSG00000178053:ENST00000471745:exon8:c.C646A:p.P216T,ENSG00000178053:ENST00000478894:exon8:c.C646A:p.P216T	MLF1:NM_001369781:exon5:c.C541A:p.P181T,MLF1:NM_001369782:exon5:c.C454A:p.P152T,MLF1:NM_001130156:exon6:c.C601A:p.P201T,MLF1:NM_001195433:exon6:c.C472A:p.P158T,MLF1:NM_022443:exon6:c.C676A:p.P226T,MLF1:NM_001130157:exon7:c.C601A:p.P201T,MLF1:NM_001369783:exon7:c.C721A:p.P241T,MLF1:NM_001369784:exon7:c.C601A:p.P201T,MLF1:NM_001369785:exon7:c.C646A:p.P216T,MLF1:NM_001195432:exon8:c.C769A:p.P257T,MLF1:NM_001195434:exon8:c.C646A:p.P216T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3674	0.3470	0.328275	0.3537	-0.045	2.178	0.04	-1.14	0.088	.	.	.	MLF1:uc003fca.3:exon6:c.C601A:p.P201T,MLF1:uc003fcb.3:exon6:c.C676A:p.P226T,MLF1:uc010hvx.3:exon6:c.C472A:p.P158T,MLF1:uc003fby.3:exon7:c.C454A:p.P152T,MLF1:uc003fbz.3:exon7:c.C601A:p.P201T,MLF1:uc003fbx.3:exon8:c.C646A:p.P216T,MLF1:uc003fcc.3:exon8:c.C769A:p.P257T	-0.995	AFR:0.2776,AMR:0.3854,EAS:0.2807,FIN:0.4098,NFE:0.3902,OTH:0.3605,ASJ:0.3642	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.085	0.94	0.000	1.1	3	MU51157802	het
3	169988364	169988364	-	T	PRKCI	intronic	.	ENSG00000163558	rs781691418	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0139	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600539	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	178922274	178922274	C	A	PIK3CA	intronic	.	ENSG00000121879	rs2699896	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.6697	0.584665	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6189,AMR:0.8533,EAS:0.6689,FIN:0.2710,NFE:0.4851,OTH:0.5604,ASJ:0.5203	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	3(soft_tissue)	0.5509
3	178952020	178952020	C	T	PIK3CA	exonic	synonymous SNV	ENSG00000121879	rs17849079	ENSG00000121879:ENST00000263967:exon21:c.C3075T:p.T1025T	PIK3CA:NM_006218:exon21:c.C3075T:p.T1025T	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0233	0.0117	0.0407348	.	.	.	.	.	.	.	.	.	PIK3CA:uc003fjk.3:exon21:c.C3075T:p.T1025T	.	AFR:0.0126,AMR:0.0339,EAS:0,FIN:0.0012,NFE:0.0003,OTH:0.0044,ASJ:0.0060	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,8940,8979,9000,8984,9014,8961,8942,8645,8949,8995,9026,8953,8966,8643,8970,8915,8919,9015,8917,8985,9030,8997,8944,8991,8909,8766,8920,8964,8994,8912,8945,8950,8924,8910,8921,8988,8932,8913,8996,8968,8972,8935,8952,8958,8926,9034,8936,8973,8965,8938,8943,8923,9002,8928,9003,9001,8951,8999,8971,8914,9008,8982,9032,8963,8930,9010,8770,8989,8977,8960,8981,8955,8986,8939,8990,8959,8644,8916,8956,8931,8987,8918,9011,8925,9027,9025,9031,9013,8941,8978,8962,9033,8937,8948,9007,8927,8769,8908,8768,9028,8975,8992,9029,8998,8980,8934,8976,9035,8933,8983,9009,8911,9012,8929,8967,8974,9006,8957,9004,8767,8947,8946,9005,8922,8969,8954	.	8993,	.	.	.	.	3	1(upper_aerodigestive_tract)	0.0194
3	182681740	182681740	C	T	DCUN1D1	exonic	synonymous SNV	ENSG00000043093	rs4859146	ENSG00000043093:ENST00000292782:exon3:c.G318A:p.A106A,ENSG00000043093:ENST00000469954:exon3:c.G273A:p.A91A,ENSG00000043093:ENST00000497606:exon3:c.G273A:p.A91A,ENSG00000043093:ENST00000460412:exon4:c.G273A:p.A91A,ENSG00000043093:ENST00000487822:exon4:c.G273A:p.A91A	DCUN1D1:NM_001308101:exon3:c.G273A:p.A91A,DCUN1D1:NM_020640:exon3:c.G318A:p.A106A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6885	0.7567	0.613019	0.7363	.	.	.	.	.	.	.	.	DCUN1D1:uc003fld.1:exon3:c.G318A:p.A106A	.	AFR:0.7379,AMR:0.6966,EAS:0.2701,FIN:0.7646,NFE:0.7835,OTH:0.7352,ASJ:0.6291	605905	.	.	.	.	.	.	.	.	.	.	.	3	MU11206066	het
3	182681853	182681853	T	C	DCUN1D1	intronic	.	ENSG00000043093	rs4859147	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5527	0.4870	0.377796	0.4947	.	.	.	.	.	.	.	.	.	.	AFR:0.1233,AMR:0.5668,EAS:0.2506,FIN:0.6638,NFE:0.6864,OTH:0.6130,ASJ:0.4768	605905	.	.	.	.	.	.	.	.	.	.	.	3	MU26132409	het
3	185046766	185046766	T	A	MAP3K13	intronic	.	ENSG00000073803	rs9859234	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.730831	0.7726	.	.	.	.	.	.	.	.	.	.	AFR:0.6109,AMR:0.7998,EAS:0.7895,FIN:0.8489,NFE:0.8412,OTH:0.8202,ASJ:0.8167	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	185146702	185146702	C	T	MAP3K13	exonic	synonymous SNV	ENSG00000073803	rs3732577	ENSG00000073803:ENST00000439882:exon1:c.C333T:p.S111S,ENSG00000073803:ENST00000265026:exon2:c.C333T:p.S111S,ENSG00000073803:ENST00000428617:exon2:c.C333T:p.S111S,ENSG00000073803:ENST00000433092:exon2:c.C333T:p.S111S,ENSG00000073803:ENST00000438053:exon2:c.C333T:p.S111S,ENSG00000073803:ENST00000424227:exon3:c.C333T:p.S111S,ENSG00000073803:ENST00000447637:exon3:c.C333T:p.S111S	MAP3K13:NM_004721:exon2:c.C333T:p.S111S,MAP3K13:NM_001242314:exon3:c.C333T:p.S111S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1580	0.1136	0.147165	MU4563475	.	.	.	.	.	.	.	.	MAP3K13:uc003fpi.3:exon2:c.C333T:p.S111S,MAP3K13:uc010hyf.3:exon3:c.C333T:p.S111S	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.1241,EAS:0.1337,FIN:0.1126,NFE:0.2348,OTH:0.1898,ASJ:0.0350	604915	.	.	.	.	.	.	.	.	.	.	.	3	1(thyroid)	0.1460
3	185155430	185155430	-	T	MAP3K13	intronic	.	ENSG00000073803	rs5855064	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5905	.	0.616214	0.7684	.	.	.	.	.	.	.	.	.	.	AFR:0.6852,AMR:0.7870,EAS:0.7418,FIN:0.7263,NFE:0.8259,OTH:0.7861,ASJ:0.8433	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	unknown
3	186507757	186507757	G	A	RFC4	UTR3	.	ENSG00000163918	rs1047148	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1236	0.1006	0.0928514	0.0987	.	.	.	.	.	.	.	.	.	.	AFR:0.0263,AMR:0.0680,EAS:0.1687,FIN:0.1034,NFE:0.1312,OTH:0.1235,ASJ:0.1556	102577	.	.	.	.	.	.	.	.	.	.	.	3	MU67356083	het
3	186507922	186507922	C	T	RFC4	intronic	.	ENSG00000163918	rs2066500	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2827	0.1991	0.279952	0.2482	.	.	.	.	.	.	.	.	.	.	AFR:0.1106,AMR:0.3902,EAS:0.3939,FIN:0.3918,NFE:0.2685,OTH:0.2908,ASJ:0.2417	102577	.	.	.	.	.	.	.	.	.	.	.	3	MU11567550	het
3	186509517	186509517	G	A	RFC4	exonic	synonymous SNV	ENSG00000163918	rs187868	ENSG00000163918:ENST00000417876:exon1:c.C123T:p.A41A,ENSG00000163918:ENST00000433496:exon7:c.C798T:p.A266A,ENSG00000163918:ENST00000296273:exon8:c.C798T:p.A266A,ENSG00000163918:ENST00000392481:exon8:c.C798T:p.A266A	RFC4:NM_002916:exon8:c.C798T:p.A266A,RFC4:NM_181573:exon8:c.C798T:p.A266A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4918	0.4748	0.483826	MU18338543	.	.	.	.	.	.	.	.	RFC4:uc003fqz.3:exon8:c.C798T:p.A266A,RFC4:uc011bsc.2:exon8:c.C798T:p.A266A,RFC4:uc011bsd.2:exon8:c.C798T:p.A266A	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.5062,EAS:0.5215,FIN:0.4172,NFE:0.4684,OTH:0.6110,ASJ:0.4608	102577	.	.	.	.	.	.	.	.	.	.	.	3	1(stomach)	0.5122
3	187443255	187443267	GCCCGCTCCGCTC	-	LOC100131635	ncRNA_intronic	.	ENSG00000113916;ENSG00000228804	rs747298443	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0294	.	.	0.1242	.	.	.	.	.	.	.	.	.	.	AFR:0.1563,AMR:0.0789,EAS:0.0353,FIN:0.1186,NFE:0.1192,OTH:0.1320,ASJ:0.0927	.	.	.	.	.	.	.	.	.	.	.	.	3	.	unknown
3	187447032	187447032	G	A	BCL6	exonic	synonymous SNV	ENSG00000113916	rs1056932	ENSG00000113916:ENST00000450123:exon4:c.C1161T:p.N387N,ENSG00000113916:ENST00000232014:exon5:c.C1161T:p.N387N,ENSG00000113916:ENST00000406870:exon5:c.C1161T:p.N387N	BCL6:NM_001134738:exon4:c.C1161T:p.N387N,BCL6:NM_001130845:exon5:c.C1161T:p.N387N,BCL6:NM_001706:exon5:c.C1161T:p.N387N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6435	0.4974	0.565296	MU794210	.	.	.	.	.	.	.	.	BCL6:uc011bsf.1:exon4:c.C1161T:p.N387N,BCL6:uc003frp.3:exon5:c.C1161T:p.N387N,BCL6:uc003frq.2:exon5:c.C1161T:p.N387N,BCL6:uc010hza.2:exon5:c.C855T:p.N285N	.	AFR:COCA-CN|6|321|0.0186916,AMR:0.5310,EAS:0.7482,FIN:0.7086,NFE:0.7937,OTH:0.6955,ASJ:0.1832	109565	.	.	.	~ko04068 FoxO signaling pathway~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	1(breast)	0.6432
3	191888453	191888453	A	-	FGF12	intronic	.	ENSG00000114279	rs34265167	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4192	.	0.437899	0.4049	.	.	.	.	.	.	.	.	.	.	AFR:0.5939,AMR:0.3778,EAS:0.4905,FIN:0.3292,NFE:0.2925,OTH:0.3448,ASJ:0.3723	601513	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	195594957	195594957	C	T	TNK2	exonic	nonsynonymous SNV	ENSG00000061938	rs565563192	ENSG00000061938:ENST00000416152:exon4:c.G868A:p.G290S,ENSG00000061938:ENST00000333602:exon12:c.G2167A:p.G723S,ENSG00000061938:ENST00000392400:exon12:c.G2167A:p.G723S,ENSG00000061938:ENST00000428187:exon12:c.G2263A:p.G755S,ENSG00000061938:ENST00000381916:exon13:c.G2401A:p.G801S	TNK2:NM_001308046:exon12:c.G2263A:p.G755S,TNK2:NM_005781:exon12:c.G2167A:p.G723S,TNK2:NM_001010938:exon13:c.G2284A:p.G762S	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0002	.	0.000798722	0.0001	-0.585	0.136	0.225	-0.57	0.005	.	.	Mig-6 domain	TNK2:uc003fvq.1:exon1:c.G388A:p.G130S,TNK2:uc003fvr.1:exon4:c.G742A:p.G248S,TNK2:uc003fvs.1:exon12:c.G2263A:p.G755S,TNK2:uc003fvu.1:exon12:c.G2167A:p.G723S,TNK2:uc003fvt.1:exon13:c.G2401A:p.G801S	-1.029	AFR:0,AMR:0.0024,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	606994	.	.	.	.	.	.	.	0.002	0.72	0.054	0.315	3	.	het
3	195778972	195778972	C	T	TFRC	exonic	synonymous SNV	ENSG00000072274	rs1805051	ENSG00000072274:ENST00000535031:exon17:c.G1278A:p.T426T,ENSG00000072274:ENST00000420415:exon18:c.G1881A:p.T627T,ENSG00000072274:ENST00000360110:exon19:c.G2124A:p.T708T,ENSG00000072274:ENST00000392396:exon19:c.G2124A:p.T708T	TFRC:NM_001313966:exon17:c.G1278A:p.T426T,TFRC:NM_001313965:exon18:c.G1881A:p.T627T,TFRC:NM_001128148:exon19:c.G2124A:p.T708T,TFRC:NM_003234:exon19:c.G2124A:p.T708T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0895	0.0780	0.0483227	0.0735	.	.	.	.	.	.	.	.	TFRC:uc011btr.2:exon17:c.G1278A:p.T426T,TFRC:uc010hzy.3:exon18:c.G1881A:p.T627T,TFRC:uc003fvz.4:exon19:c.G2124A:p.T708T,TFRC:uc003fwa.4:exon19:c.G2124A:p.T708T	.	AFR:0.0165,AMR:0.0597,EAS:0.0025,FIN:0.1119,NFE:0.1036,OTH:0.1010,ASJ:0.1126	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU117207737	het
3	195789708	195789708	G	T	TFRC	intronic	.	ENSG00000072274	rs2239640	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5032	0.4971	0.361422	MU11590520	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02,AMR:0.4774,EAS:0.4260,FIN:0.5960,NFE:0.1483,OTH:0.5678,ASJ:0.2867	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.5978
3	195798258	195798258	T	C	TFRC	intronic	.	ENSG00000072274	rs480760	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9497	0.8857	0.894169	0.9015	.	.	.	.	.	.	.	.	.	.	AFR:0.7292,AMR:0.9606,EAS:1,FIN:0.9657,NFE:0.9670,OTH:0.9654,ASJ:0.9768	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776721	hom
3	195800811	195800811	C	T	TFRC	exonic	nonsynonymous SNV	ENSG00000072274	rs3817672	ENSG00000072274:ENST00000420415:exon3:c.G181A:p.G61S,ENSG00000072274:ENST00000360110:exon4:c.G424A:p.G142S,ENSG00000072274:ENST00000392396:exon4:c.G424A:p.G142S	TFRC:NM_001313965:exon3:c.G181A:p.G61S,TFRC:NM_001128148:exon4:c.G424A:p.G142S,TFRC:NM_003234:exon4:c.G424A:p.G142S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4470	0.4380	0.30631	0.4223	0.203	4.709	0.577	1.51	0.008	.	.	.	TFRC:uc010hzy.3:exon3:c.G181A:p.G61S,TFRC:uc003fvz.4:exon4:c.G424A:p.G142S,TFRC:uc003fwa.4:exon4:c.G424A:p.G142S	-0.941	AFR:0.2284,AMR:0.4045,EAS:0.1435,FIN:0.5175,NFE:0.5371,OTH:0.4949,ASJ:0.5199	190010	616740;	.	.	.	.	.	.	0.0	1.15	0.000	-1.61	3	MU64537	het
3	196199204	196199204	G	T	RNF168	exonic	nonsynonymous SNV	ENSG00000163961	rs3796129	ENSG00000163961:ENST00000318037:exon6:c.C1202A:p.P401Q	RNF168:NM_152617:exon6:c.C1202A:p.P401Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5405	0.5172	0.402356	0.5038	2.051	16.54	0.058	4.29	0.713	.	.	.	RNF168:uc010iah.3:exon5:c.C701A:p.P234Q,RNF168:uc003fwq.3:exon6:c.C1202A:p.P401Q	-1.041	AFR:0.2989,AMR:0.4306,EAS:0.1776,FIN:0.6676,NFE:0.6172,OTH:0.5706,ASJ:0.6225	612688	611943;	420741;	420741|RNF168 deficiency<br>Radiosensitivity-immunodeficiency-dysmorphic features-learning difficulties syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Adolescent|611943 ~	.	.	.	.	0.8	3.18	0.000	2.38	3	MU27951640	hom
4	1343405	1343405	T	C	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs2276903	ENSG00000163945:ENST00000389851:exon3:c.T192C:p.I64I,ENSG00000163945:ENST00000507531:exon3:c.T192C:p.I64I,ENSG00000163945:ENST00000511216:exon3:c.T192C:p.I64I	UVSSA:NM_001317934:exon3:c.T192C:p.I64I,UVSSA:NM_001317935:exon3:c.T192C:p.I64I,UVSSA:NM_020894:exon3:c.T192C:p.I64I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5806	0.6383	0.632987	0.6343	.	.	.	.	.	.	.	.	UVSSA:uc003gde.4:exon3:c.T192C:p.I64I	.	AFR:0.8063,AMR:0.7710,EAS:0.4907,FIN:0.5806,NFE:0.5635,OTH:0.5543,ASJ:0.4396	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU641948	het
4	1350322	1350322	C	T	UVSSA	intronic	.	ENSG00000163945	rs2336081	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.779952	0.7631	.	.	.	.	.	.	.	.	.	.	AFR:0.9337,AMR:0.8457,EAS:0.7097,FIN:0.7048,NFE:0.6859,OTH:0.6980,ASJ:0.6060	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	hom
4	1369885	1369885	G	A	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs11724369	ENSG00000163945:ENST00000511563:exon3:c.G150A:p.A50A,ENSG00000163945:ENST00000512728:exon3:c.G150A:p.A50A,ENSG00000163945:ENST00000389851:exon10:c.G1497A:p.A499A,ENSG00000163945:ENST00000507531:exon10:c.G1497A:p.A499A,ENSG00000163945:ENST00000511216:exon10:c.G1497A:p.A499A	UVSSA:NM_001317934:exon10:c.G1497A:p.A499A,UVSSA:NM_001317935:exon10:c.G1497A:p.A499A,UVSSA:NM_020894:exon10:c.G1497A:p.A499A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3676	0.2825	0.182308	0.3021	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon3:c.G150A:p.A50A,UVSSA:uc003gde.4:exon10:c.G1497A:p.A499A	.	AFR:0.0940,AMR:0.3657,EAS:0.0488,FIN:0.4264,NFE:0.4140,OTH:0.3673,ASJ:0.3179	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU41949956	het
4	1374695	1374695	C	A	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs28614045	ENSG00000163945:ENST00000511563:exon5:c.C433A:p.R145R,ENSG00000163945:ENST00000512728:exon5:c.C433A:p.R145R,ENSG00000163945:ENST00000389851:exon12:c.C1780A:p.R594R,ENSG00000163945:ENST00000507531:exon12:c.C1780A:p.R594R,ENSG00000163945:ENST00000511216:exon12:c.C1780A:p.R594R	UVSSA:NM_001317934:exon12:c.C1780A:p.R594R,UVSSA:NM_001317935:exon12:c.C1780A:p.R594R,UVSSA:NM_020894:exon12:c.C1780A:p.R594R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6940	0.6910	0.70028	0.6956	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon5:c.C433A:p.R145R,UVSSA:uc003gde.4:exon12:c.C1780A:p.R594R	.	AFR:0.7032,AMR:0.8313,EAS:0.6937,FIN:0.7049,NFE:0.6846,OTH:0.6837,ASJ:0.5833	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU10012471	hom
4	1374774	1374774	C	T	UVSSA	exonic	nonsynonymous SNV	ENSG00000163945	rs28522910	ENSG00000163945:ENST00000511563:exon5:c.C512T:p.P171L,ENSG00000163945:ENST00000512728:exon5:c.C512T:p.P171L,ENSG00000163945:ENST00000389851:exon12:c.C1859T:p.P620L,ENSG00000163945:ENST00000507531:exon12:c.C1859T:p.P620L,ENSG00000163945:ENST00000511216:exon12:c.C1859T:p.P620L	UVSSA:NM_001317934:exon12:c.C1859T:p.P620L,UVSSA:NM_001317935:exon12:c.C1859T:p.P620L,UVSSA:NM_020894:exon12:c.C1859T:p.P620L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.6946	0.6907	0.696486	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	4.114	23.8	0.017	4.56	0.008	0.8986	0.64	.	UVSSA:uc010ibv.3:exon5:c.C512T:p.P171L,UVSSA:uc003gde.4:exon12:c.C1859T:p.P620L	-1.015	AFR:0.6950,AMR:0.7013,EAS:0.5833,FIN:0.6923,NFE:0.7053,OTH:0.6846,ASJ:0.8317	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	0.67	1.35	0.000	2.125	4	1(haematopoietic_and_lymphoid_tissue)	0.6830
4	1374787	1374787	G	A	UVSSA	intronic	.	ENSG00000163945	rs114546495	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0855	0.0558	0.0489217	0.0709	.	.	.	.	.	.	.	.	.	.	AFR:0.0204,AMR:0.0382,EAS:0.0019,FIN:0.1025,NFE:0.0989,OTH:0.1059,ASJ:0.1192	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU113454610	het
4	1374789	1374789	A	G	UVSSA	intronic	.	ENSG00000163945	rs28733902	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.7530	0.763578	0.7527	.	.	.	.	.	.	.	.	.	.	AFR:0.9011,AMR:0.8425,EAS:0.6951,FIN:0.7057,NFE:0.6853,OTH:0.6939,ASJ:0.59	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU24274429	hom
4	1377615	1377615	A	G	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs9996817	ENSG00000163945:ENST00000511563:exon6:c.A576G:p.S192S,ENSG00000163945:ENST00000512728:exon6:c.A576G:p.S192S,ENSG00000163945:ENST00000389851:exon13:c.A1923G:p.S641S,ENSG00000163945:ENST00000507531:exon13:c.A1923G:p.S641S,ENSG00000163945:ENST00000511216:exon13:c.A1923G:p.S641S	UVSSA:NM_001317934:exon13:c.A1923G:p.S641S,UVSSA:NM_001317935:exon13:c.A1923G:p.S641S,UVSSA:NM_020894:exon13:c.A1923G:p.S641S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7195	0.7205	0.717252	0.7205	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon6:c.A576G:p.S192S,UVSSA:uc003gde.4:exon13:c.A1923G:p.S641S	.	AFR:0.7138,AMR:0.8481,EAS:0.7077,FIN:0.7226,NFE:0.7205,OTH:0.7156,ASJ:0.6225	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU4566462	hom
4	1803704	1803704	T	C	FGFR3	exonic	synonymous SNV	ENSG00000068078	rs2234909	ENSG00000068078:ENST00000260795:exon6:c.T882C:p.N294N,ENSG00000068078:ENST00000352904:exon6:c.T882C:p.N294N,ENSG00000068078:ENST00000340107:exon7:c.T882C:p.N294N,ENSG00000068078:ENST00000412135:exon7:c.T882C:p.N294N,ENSG00000068078:ENST00000440486:exon7:c.T882C:p.N294N,ENSG00000068078:ENST00000481110:exon7:c.T882C:p.N294N	FGFR3:NM_000142:exon7:c.T882C:p.N294N,FGFR3:NM_001163213:exon7:c.T882C:p.N294N,FGFR3:NM_001354809:exon7:c.T882C:p.N294N,FGFR3:NM_001354810:exon7:c.T882C:p.N294N,FGFR3:NM_022965:exon7:c.T882C:p.N294N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1692	0.2139	0.207468	5(meninges)	.	.	.	.	.	.	.	.	FGFR3:uc003gdt.1:exon3:c.T408C:p.N136N,FGFR3:uc003gdq.3:exon7:c.T882C:p.N294N,FGFR3:uc003gdr.3:exon7:c.T882C:p.N294N,FGFR3:uc003gds.3:exon7:c.T882C:p.N294N,FGFR3:uc003gdu.2:exon7:c.T882C:p.N294N	.	AFR:2(skin),AMR:1(large_intestine),EAS:1(breast),FIN:MU153774,NFE:LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,OTH:0.1948,ASJ:1(thyroid)	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer~ko05230 Central carbon metabolism in cancer ~	,5479,5482,5472,5497,5471,5488,5486,5480,5481,5478,5484,5487,5473,5475,5469,5470,5483,5498,5485,5477,5474,5476	.	.	.	.	.	.	4	1(urinary_tract)	0.3538
4	1807894	1807894	G	A	FGFR3	exonic	synonymous SNV	ENSG00000068078	rs7688609	ENSG00000068078:ENST00000352904:exon11:c.G1617A:p.T539T,ENSG00000068078:ENST00000412135:exon12:c.G1617A:p.T539T,ENSG00000068078:ENST00000260795:exon13:c.G1953A:p.T651T,ENSG00000068078:ENST00000340107:exon14:c.G1959A:p.T653T,ENSG00000068078:ENST00000440486:exon14:c.G1953A:p.T651T,ENSG00000068078:ENST00000481110:exon14:c.G1956A:p.T652T	FGFR3:NM_022965:exon12:c.G1617A:p.T539T,FGFR3:NM_000142:exon14:c.G1953A:p.T651T,FGFR3:NM_001163213:exon14:c.G1959A:p.T653T,FGFR3:NM_001354809:exon14:c.G1956A:p.T652T,FGFR3:NM_001354810:exon14:c.G1956A:p.T652T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9873	0.9551	0.95607	MU81778057	.	.	.	.	.	.	.	.	FGFR3:uc003gds.3:exon12:c.G1617A:p.T539T,FGFR3:uc003gdq.3:exon14:c.G1956A:p.T652T,FGFR3:uc003gdr.3:exon14:c.G1953A:p.T651T,FGFR3:uc003gdu.2:exon14:c.G1959A:p.T653T	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.9604,EAS:0.9988,FIN:1,NFE:1,OTH:1,ASJ:0.8608	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer~ko05230 Central carbon metabolism in cancer ~	,5479,5482,5472,5497,5471,5488,5486,5480,5481,5478,5484,5487,5473,5475,5469,5470,5483,5498,5485,5477,5474,5476	.	.	.	.	.	.	4	18(meninges)	0.9997
4	25678199	25678199	A	G	SLC34A2	exonic	nonsynonymous SNV	ENSG00000157765	rs6448389	ENSG00000157765:ENST00000382051:exon13:c.A1901G:p.D634G,ENSG00000157765:ENST00000503434:exon13:c.A1898G:p.D633G,ENSG00000157765:ENST00000504570:exon13:c.A1898G:p.D633G	SLC34A2:NM_001177998:exon13:c.A1898G:p.D633G,SLC34A2:NM_001177999:exon13:c.A1898G:p.D633G,SLC34A2:NM_006424:exon13:c.A1901G:p.D634G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8643	0.8760	0.910743	0.8992	0.576	7.988	1.0	4.99	0.264	.	.	.	SLC34A2:uc003grr.3:exon13:c.A1901G:p.D634G,SLC34A2:uc003grs.3:exon13:c.A1898G:p.D633G,SLC34A2:uc010iev.3:exon13:c.A1898G:p.D633G	-0.970	AFR:0.9638,AMR:0.8612,EAS:0.9994,FIN:0.9121,NFE:0.8528,OTH:0.8824,ASJ:0.8113	604217	265100;	60025;	60025|-|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265100 ~	.	.	.	.	0.0	2.17	0.000	-2.62	4	MU81781878	hom
4	39302029	39302029	T	C	RFC1	exonic	synonymous SNV	ENSG00000035928	rs2066786	ENSG00000035928:ENST00000349703:exon20:c.A2541G:p.P847P,ENSG00000035928:ENST00000381897:exon20:c.A2544G:p.P848P	RFC1:NM_001363495:exon19:c.A2463G:p.P821P,RFC1:NM_001363496:exon19:c.A2466G:p.P822P,RFC1:NM_001204747:exon20:c.A2544G:p.P848P,RFC1:NM_002913:exon20:c.A2541G:p.P847P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5511	0.4247	0.465256	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RFC1:uc003gtx.2:exon20:c.A2541G:p.P847P,RFC1:uc003gty.2:exon20:c.A2544G:p.P848P	.	AFR:0.4539,AMR:0.1328,EAS:0.56,FIN:0.6638,NFE:0.5629,OTH:0.5747,ASJ:0.6139	102579	.	.	.	.	.	.	.	.	.	.	.	4	1(urinary_tract)	0.5541
4	41259633	41259633	C	A	UCHL1	exonic	nonsynonymous SNV	ENSG00000154277	rs5030732	ENSG00000154277:ENST00000512419:exon2:c.C52A:p.P18T,ENSG00000154277:ENST00000284440:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000505232:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000508768:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000512788:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000503431:exon4:c.C53A:p.S18Y,ENSG00000154277:ENST00000514924:exon5:c.C53A:p.S18Y	UCHL1:NM_004181:exon3:c.C53A:p.S18Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3502	0.0986	0.253994	1(liver)	2.700	20.8	0.072	2.84	0.971	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	UCHL1:uc003gvo.3:exon3:c.C53A:p.S18Y	-0.933	AFR:4(thyroid),AMR:1(large_intestine),EAS:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.1632,NFE:0.0390,OTH:0.3242,ASJ:MU4555612	191342	613643;615491;	352654;2828;	352654|-|<1 / 1 000 000|Autosomal recessive|Childhood|615491 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	0.626	0.47	0.000	1.32	4	3(soft_tissue)	0.2433
4	41263718	41263718	-	T	UCHL1	intronic	.	ENSG00000154277	rs3214812	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2981	0.2143	0.307308	0.2392	.	.	.	.	.	.	.	.	.	.	AFR:0.1493,AMR:0.3841,EAS:0.5320,FIN:0.2205,NFE:0.2539,OTH:0.2393,ASJ:0.3592	191342	613643;615491;	352654;2828;	352654|-|<1 / 1 000 000|Autosomal recessive|Childhood|615491 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	4	.	het
4	55130078	55130078	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs2229307	ENSG00000134853:ENST00000257290:exon4:c.T612C:p.N204N,ENSG00000134853:ENST00000508170:exon4:c.T612C:p.N204N,ENSG00000134853:ENST00000509490:exon4:c.T612C:p.N204N	PDGFRA:NM_001347827:exon4:c.T612C:p.N204N,PDGFRA:NM_001347829:exon4:c.T612C:p.N204N,PDGFRA:NM_001347830:exon4:c.T651C:p.N217N,PDGFRA:NM_006206:exon4:c.T612C:p.N204N,PDGFRA:NM_001347828:exon5:c.T687C:p.N229N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1796	0.1650	0.236222	0.1677	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon3:c.T294C:p.N98N,PDGFRA:uc003hal.3:exon4:c.T612C:p.N204N,PDGFRA:uc003han.4:exon4:c.T612C:p.N204N	.	AFR:0.2562,AMR:0.3759,EAS:0.1780,FIN:0.1216,NFE:0.1175,OTH:0.1487,ASJ:0.07	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	.	.	.	.	4	MU12032527	het
4	55133726	55133726	T	G	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs4358459	ENSG00000134853:ENST00000257290:exon7:c.T939G:p.G313G,ENSG00000134853:ENST00000509490:exon7:c.T939G:p.G313G	PDGFRA:NM_001347827:exon7:c.T939G:p.G313G,PDGFRA:NM_001347829:exon7:c.T939G:p.G313G,PDGFRA:NM_001347830:exon7:c.T978G:p.G326G,PDGFRA:NM_006206:exon7:c.T939G:p.G313G,PDGFRA:NM_001347828:exon8:c.T1014G:p.G338G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1775	0.1632	0.234225	0.1669	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon6:c.T621G:p.G207G,PDGFRA:uc003han.4:exon7:c.T939G:p.G313G	.	AFR:0.2557,AMR:0.3747,EAS:0.1782,FIN:0.1219,NFE:0.1162,OTH:0.1472,ASJ:0.0662	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	.	.	.	.	4	MU12032533	het
4	55139771	55139771	T	C	PDGFRA	exonic	nonsynonymous SNV	ENSG00000134853	rs35597368	ENSG00000134853:ENST00000257290:exon10:c.T1432C:p.S478P,ENSG00000134853:ENST00000509490:exon10:c.T1432C:p.S478P	PDGFRA:NM_001347827:exon10:c.T1432C:p.S478P,PDGFRA:NM_001347829:exon10:c.T1432C:p.S478P,PDGFRA:NM_001347830:exon10:c.T1471C:p.S491P,PDGFRA:NM_006206:exon10:c.T1432C:p.S478P,PDGFRA:NM_001347828:exon11:c.T1507C:p.S503P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1516	0.1443	0.199281	0.1473	-0.578	0.142	0.305	0.811	0.000	.	.	Immunoglobulin-like fold	PDGFRA:uc010igq.1:exon9:c.T1114C:p.S372P,PDGFRA:uc003han.4:exon10:c.T1432C:p.S478P	-1.098	AFR:0.2301,AMR:0.2596,EAS:0.1338,FIN:0.1224,NFE:0.1024,OTH:0.1424,ASJ:0.0497	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	0.0	-0.95	0.000	-0.345	4	MU26845387	het
4	55141055	55141055	A	G	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs1873778	ENSG00000134853:ENST00000257290:exon12:c.A1701G:p.P567P,ENSG00000134853:ENST00000509490:exon12:c.A1701G:p.P567P	PDGFRA:NM_001347827:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347829:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347830:exon12:c.A1740G:p.P580P,PDGFRA:NM_006206:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347828:exon13:c.A1776G:p.P592P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9880	0.9589	0.957668	0.9677	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon11:c.A1383G:p.P461P,PDGFRA:uc003han.4:exon12:c.A1701G:p.P567P	.	AFR:0.8906,AMR:0.9881,EAS:0.9994,FIN:1,NFE:0.9986,OTH:0.9908,ASJ:0.9834	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	.	.	.	.	4	MU81783993	hom
4	55143577	55143577	G	A	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs10028020	ENSG00000134853:ENST00000257290:exon13:c.G1809A:p.A603A,ENSG00000134853:ENST00000509490:exon13:c.G1809A:p.A603A,ENSG00000145216:ENST00000507166:exon14:c.G1089A:p.A363A	PDGFRA:NM_001347827:exon13:c.G1809A:p.A603A,PDGFRA:NM_001347829:exon13:c.G1809A:p.A603A,PDGFRA:NM_001347830:exon13:c.G1848A:p.A616A,PDGFRA:NM_006206:exon13:c.G1809A:p.A603A,PDGFRA:NM_001347828:exon14:c.G1884A:p.A628A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1583	0.1662	0.228035	0.1664	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon12:c.G1491A:p.A497A,PDGFRA:uc003han.4:exon13:c.G1809A:p.A603A,PDGFRA:uc003haa.3:exon14:c.G1089A:p.A363A	.	AFR:0.3054,AMR:0.2763,EAS:0.1379,FIN:0.1125,NFE:0.0999,OTH:0.1337,ASJ:0.0497	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	.	.	.	.	4	MU12032552	het
4	55152040	55152040	C	T	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs2228230	ENSG00000134853:ENST00000257290:exon18:c.C2472T:p.V824V,ENSG00000145216:ENST00000507166:exon19:c.C1752T:p.V584V	PDGFRA:NM_001347829:exon18:c.C2472T:p.V824V,PDGFRA:NM_001347830:exon18:c.C2511T:p.V837V,PDGFRA:NM_006206:exon18:c.C2472T:p.V824V,PDGFRA:NM_001347828:exon19:c.C2547T:p.V849V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1820	0.1983	0.240415	0.1941	.	.	.	.	.	.	.	.	PDGFRA:uc003han.4:exon18:c.C2472T:p.V824V,PDGFRA:uc003haa.3:exon19:c.C1752T:p.V584V	.	AFR:0.3254,AMR:0.3026,EAS:0.1316,FIN:0.1271,NFE:0.1392,OTH:0.1582,ASJ:0.0633	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	.	.	.	.	4	MU797701	het
4	55161391	55161391	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs7685117	ENSG00000134853:ENST00000257290:exon23:c.T3222C:p.D1074D,ENSG00000145216:ENST00000507166:exon24:c.T2502C:p.D834D	PDGFRA:NM_001347829:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347830:exon23:c.T3261C:p.D1087D,PDGFRA:NM_006206:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347828:exon24:c.T3297C:p.D1099D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9990	0.9968	0.997204	0.9980	.	.	.	.	.	.	.	.	PDGFRA:uc003han.4:exon23:c.T3222C:p.D1074D,PDGFRA:uc003haa.3:exon24:c.T2502C:p.D834D	.	AFR:0.9929,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	8564,,8557	,8558	.	.	.	.	.	4	MU81784009	hom
4	55948108	55948108	A	G	KDR	intronic	.	ENSG00000250646	rs2412617	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9986	0.9976	0.996805	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9923,AMR:1,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:0.9967	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81784046	hom
4	55968053	55968053	A	C	KDR	intronic	.	ENSG00000128052	rs7655964	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3475	0.2826	0.292931	MU81784053	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3084,EAS:0.5298,FIN:0.2947,NFE:0.3079,OTH:0.3853,ASJ:0.1496	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	1(lung)	0.3656
4	55972974	55972974	T	A	KDR	exonic	nonsynonymous SNV	ENSG00000128052	rs1870377	ENSG00000128052:ENST00000263923:exon11:c.A1416T:p.Q472H	KDR:NM_002253:exon11:c.A1416T:p.Q472H	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.2198	0.1939	0.211861	3(penis)	-0.385	0.421	0.033	-1.82	0.010	.	.	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	KDR:uc003has.3:exon11:c.A1416T:p.Q472H,KDR:uc003hat.1:exon11:c.A1416T:p.Q472H,KDR:uc011bzx.2:exon11:c.A1416T:p.Q472H	-1.046	AFR:6(bone),AMR:1(autonomic_ganglia),EAS:2(ovary),FIN:10(meninges),NFE:5(skin),OTH:3(haematopoietic_and_lymphoid_tissue),ASJ:1(female_genital_tract_(site_indeterminate))	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,6303,6300,6301,6302,6304	.	.	0.955	-1.02	0.000	1.625	4	1(breast)	2(stomach)
4	55976947	55976947	-	A	KDR	intronic	.	ENSG00000128052	rs397762998	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3950	.	.	0.6444	.	.	.	.	.	.	.	.	.	.	AFR:0.6675,AMR:0.6218,EAS:0.7746,FIN:0.5906,NFE:0.6283,OTH:0.6221,ASJ:0.5312	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	.	hom
4	66197804	66197804	C	T	EPHA5	exonic	synonymous SNV	ENSG00000145242	rs7349683	ENSG00000145242:ENST00000432638:exon15:c.G2406A:p.G802G,ENSG00000145242:ENST00000354839:exon16:c.G2829A:p.G943G,ENSG00000145242:ENST00000273854:exon17:c.G2895A:p.G965G,ENSG00000145242:ENST00000511294:exon17:c.G2898A:p.G966G	EPHA5:NM_001281766:exon16:c.G2832A:p.G944G,EPHA5:NM_182472:exon16:c.G2829A:p.G943G,EPHA5:NM_001281765:exon17:c.G2898A:p.G966G,EPHA5:NM_001281767:exon17:c.G2898A:p.G966G,EPHA5:NM_001318761:exon17:c.G2691A:p.G897G,EPHA5:NM_004439:exon17:c.G2895A:p.G965G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3465	0.2829	0.326677	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	EPHA5:uc003hcz.3:exon16:c.G2829A:p.G943G,EPHA5:uc011cai.2:exon16:c.G2832A:p.G944G,EPHA5:uc003hcx.3:exon17:c.G2691A:p.G897G,EPHA5:uc003hcy.3:exon17:c.G2895A:p.G965G,EPHA5:uc003hda.2:exon17:c.G2898A:p.G966G,EPHA5:uc011cah.2:exon17:c.G2898A:p.G966G	.	AFR:0.2977,AMR:0.1274,EAS:0.3411,FIN:0.4289,NFE:0.3329,OTH:0.3694,ASJ:0.2888	600004	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.3796
4	66231686	66231686	C	T	EPHA5	exonic	nonsynonymous SNV	ENSG00000145242	rs36050417	ENSG00000145242:ENST00000432638:exon9:c.G1525A:p.A509T,ENSG00000145242:ENST00000354839:exon10:c.G1948A:p.A650T,ENSG00000145242:ENST00000273854:exon11:c.G2014A:p.A672T,ENSG00000145242:ENST00000511294:exon11:c.G2017A:p.A673T	EPHA5:NM_001281766:exon10:c.G1951A:p.A651T,EPHA5:NM_182472:exon10:c.G1948A:p.A650T,EPHA5:NM_001281765:exon11:c.G2017A:p.A673T,EPHA5:NM_001281767:exon11:c.G2017A:p.A673T,EPHA5:NM_001318761:exon11:c.G1810A:p.A604T,EPHA5:NM_004439:exon11:c.G2014A:p.A672T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0239	0.0217	0.0213658	MU586370	3.420	23.0	0.13	5.54	0.996	.	.	Ephrin receptor, transmembrane domain;Ephrin receptor, transmembrane domain|Protein kinase-like domain	EPHA5:uc003hcz.3:exon10:c.G1948A:p.A650T,EPHA5:uc011cai.2:exon10:c.G1951A:p.A651T,EPHA5:uc003hcx.3:exon11:c.G1810A:p.A604T,EPHA5:uc003hcy.3:exon11:c.G2014A:p.A672T,EPHA5:uc003hda.2:exon11:c.G2017A:p.A673T,EPHA5:uc011cah.2:exon11:c.G2017A:p.A673T	-1.123	AFR:LUSC-KR|1|170|0.00588235,AMR:0.0210,EAS:0.0169,FIN:0.0199,NFE:0.0312,OTH:0.0233,ASJ:0.0060	600004	.	.	.	.	.	.	.	0.156	2.65	0.013	2.64	4	1(lung)	0.0288
4	66280171	66280171	C	T	EPHA5	intronic	.	ENSG00000145242	rs2305351	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1895	0.1131	0.180911	MU586371	.	.	.	.	.	0.0003	0.016	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.1540,EAS:0.3149,FIN:0.1589,NFE:0.2989,OTH:0.2119,ASJ:0.0408	600004	.	.	.	.	.	.	.	.	.	.	.	4	1(stomach)	0.1791
4	75248434	75248434	A	G	EREG	exonic	synonymous SNV	ENSG00000124882	rs2367707	ENSG00000124882:ENST00000244869:exon4:c.A351G:p.E117E	EREG:NM_001432:exon4:c.A351G:p.E117E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7927	0.7781	0.767772	0.7915	.	.	.	.	.	.	.	.	EREG:uc003hie.1:exon4:c.A351G:p.E117E	.	AFR:0.7749,AMR:0.8747,EAS:0.6850,FIN:0.8136,NFE:0.7999,OTH:0.8241,ASJ:0.8377	602061	.	.	.	.	.	.	.	.	.	.	.	4	MU796131	hom
4	83778839	83778839	T	C	SEC31A	intronic	.	ENSG00000138674	rs7658703	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2412	0.2843	0.351637	1(breast)	.	.	.	.	.	0.0303	0.15	.	.	.	AFR:MU586415,AMR:ESAD-UK|2|409|0.00488998,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.4382,FIN:0.1571,NFE:0.2053,OTH:0.5118,ASJ:0.2720	610257	.	.	.	.	.	.	.	.	.	.	.	4	1(stomach)	0.1630
4	83788344	83788344	A	T	SEC31A	exonic	synonymous SNV	ENSG00000138674	rs2045478	ENSG00000138674:ENST00000264405:exon3:c.T324A:p.G108G,ENSG00000138674:ENST00000443462:exon8:c.T993A:p.G331G,ENSG00000138674:ENST00000500777:exon8:c.T1008A:p.G336G,ENSG00000138674:ENST00000505472:exon8:c.T1008A:p.G336G,ENSG00000138674:ENST00000311785:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000326950:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000348405:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000395310:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000432794:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000448323:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000505984:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000508479:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000508502:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000509142:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000513858:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000355196:exon11:c.T1008A:p.G336G	SEC31A:NM_001191049:exon8:c.T993A:p.G331G,SEC31A:NM_001077206:exon9:c.T1008A:p.G336G,SEC31A:NM_001077207:exon9:c.T1008A:p.G336G,SEC31A:NM_001077208:exon9:c.T1008A:p.G336G,SEC31A:NM_001300744:exon9:c.T1008A:p.G336G,SEC31A:NM_001300745:exon9:c.T1008A:p.G336G,SEC31A:NM_001318119:exon9:c.T1008A:p.G336G,SEC31A:NM_016211:exon9:c.T1008A:p.G336G,SEC31A:NM_001318120:exon11:c.T1008A:p.G336G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9967	0.996805	0.9971	.	.	.	.	.	.	.	.	SEC31A:uc003hne.3:exon3:c.T324A:p.G108G,SEC31A:uc011ccm.2:exon8:c.T993A:p.G331G,SEC31A:uc003hnf.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hng.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnh.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hni.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnk.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnl.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnn.2:exon9:c.T1008A:p.G336G,SEC31A:uc003hno.3:exon9:c.T1008A:p.G336G,SEC31A:uc011ccl.2:exon9:c.T1008A:p.G336G,SEC31A:uc011ccn.2:exon9:c.T1008A:p.G336G,SEC31A:uc003hnm.3:exon11:c.T1008A:p.G336G	.	AFR:0.9896,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610257	.	.	.	.	.	.	.	.	.	.	.	4	MU81786544	hom
4	83793243	83793243	A	C	SEC31A	intronic	.	ENSG00000138674	rs4693525	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7608	0.7377	0.712859	0.7453	.	.	.	.	.	0.0004	0.302	.	.	.	AFR:0.6426,AMR:0.8019,EAS:0.7389,FIN:0.8280,NFE:0.7823,OTH:0.7739,ASJ:0.6987	610257	.	.	.	.	.	.	.	.	.	.	.	4	MU16678361	het
4	84374549	84374549	T	C	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	.	ENSG00000163312:ENST00000295488:exon2:c.A847G:p.I283V,ENSG00000163312:ENST00000508591:exon2:c.A847G:p.I283V,ENSG00000163312:ENST00000510985:exon2:c.A847G:p.I283V	HELQ:NM_001297755:exon2:c.A847G:p.I283V,HELQ:NM_001297758:exon2:c.A736G:p.I246V,HELQ:NM_001297759:exon2:c.A847G:p.I283V,HELQ:NM_133636:exon2:c.A847G:p.I283V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	-2.837	0.001	1.0	-8.62	0.904	.	.	P-loop containing nucleoside triphosphate hydrolase	HELQ:uc003hom.3:exon2:c.A847G:p.I283V,HELQ:uc003hon.1:exon2:c.A529G:p.I177V,HELQ:uc003hoo.1:exon2:c.A736G:p.I246V,HELQ:uc003hop.1:exon2:c.A529G:p.I177V,HELQ:uc003hoq.1:exon2:c.A847G:p.I283V,HELQ:uc010ikb.3:exon2:c.A847G:p.I283V	-1.031	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606769	.	.	.	.	.	.	.	0.0	0.38	0.034	-0.235	4	.	het
4	84376743	84376743	A	T	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	rs6831595	ENSG00000163312:ENST00000295488:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000508591:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000510985:exon1:c.T104A:p.V35E	HELQ:NM_001297755:exon1:c.T104A:p.V35E,HELQ:NM_001297758:exon1:c.T104A:p.V35E,HELQ:NM_001297759:exon1:c.T104A:p.V35E,HELQ:NM_133636:exon1:c.T104A:p.V35E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1.0000	0.9999	1	1.0000	-1.530	0.002	1.0	-3.44	0.000	.	.	.	HELQ:uc003hom.3:exon1:c.T104A:p.V35E,HELQ:uc003hoo.1:exon1:c.T104A:p.V35E,HELQ:uc003hoq.1:exon1:c.T104A:p.V35E,HELQ:uc010ikb.3:exon1:c.T104A:p.V35E	-0.964	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	606769	.	.	.	.	.	.	.	0.0	0.53	0.000	-1.24	4	MU81786772	hom
4	88048163	88048163	-	T	AFF1	intronic	.	ENSG00000172493	rs11448202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2324	0.1770	0.213059	0.1729	.	.	.	.	.	.	.	.	.	.	AFR:0.1048,AMR:0.3033,EAS:0.2317,FIN:0.1355,NFE:0.2035,OTH:0.1964,ASJ:0.2986	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	het
4	88052219	88052219	T	C	AFF1	intronic	.	ENSG00000172493	rs342467	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5937	0.5927	0.567292	0.5752	.	.	.	.	.	.	.	.	.	.	AFR:0.5581,AMR:0.7005,EAS:0.5726,FIN:0.5315,NFE:0.5867,OTH:0.5615,ASJ:0.7086	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	MU23102211	het
4	88056720	88056720	T	-	AFF1	intronic	.	ENSG00000172493	rs398083273	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6550	.	0.570288	0.5778	.	.	.	.	.	.	.	.	.	.	AFR:0.5653,AMR:0.7017,EAS:0.5720,FIN:0.5331,NFE:0.5873,OTH:0.5634,ASJ:0.7133	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	het
4	103514658	103514658	T	C	NFKB1	exonic	synonymous SNV	ENSG00000109320	rs1609993	ENSG00000109320:ENST00000600343:exon5:c.T600C:p.A200A,ENSG00000109320:ENST00000508584:exon6:c.T522C:p.A174A,ENSG00000109320:ENST00000226574:exon12:c.T1143C:p.A381A,ENSG00000109320:ENST00000394820:exon12:c.T1140C:p.A380A,ENSG00000109320:ENST00000505458:exon12:c.T1140C:p.A380A	NFKB1:NM_001165412:exon12:c.T1140C:p.A380A,NFKB1:NM_001319226:exon12:c.T1140C:p.A380A,NFKB1:NM_003998:exon12:c.T1143C:p.A381A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9401	0.9420	0.969848	0.9425	.	.	.	.	.	.	.	.	NFKB1:uc011cer.2:exon5:c.T600C:p.A200A,NFKB1:uc011cep.2:exon12:c.T1143C:p.A381A,NFKB1:uc011ceq.2:exon12:c.T1140C:p.A380A	.	AFR:0.9856,AMR:0.9402,EAS:1,FIN:0.9250,NFE:0.9179,OTH:0.9173,ASJ:0.9040	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81788168	hom
4	106196951	106196951	A	G	TET2	exonic	nonsynonymous SNV	ENSG00000168769	rs2454206	ENSG00000168769:ENST00000380013:exon11:c.A5284G:p.I1762V,ENSG00000168769:ENST00000513237:exon11:c.A5347G:p.I1783V,ENSG00000168769:ENST00000540549:exon11:c.A5284G:p.I1762V	TET2:NM_001127208:exon11:c.A5284G:p.I1762V	clinvar: not_provided 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.2951	0.2873	0.230431	3(haematopoietic_and_lymphoid_tissue)	-1.823	0.002	0.047	-10.3	0.007	.	.	2OGFeDO, oxygenase domain|WD40/YVTN repeat-like-containing domain	TET2:uc003hxk.3:exon11:c.A5284G:p.I1762V,TET2:uc011cez.2:exon11:c.A5347G:p.I1783V	-0.904	AFR:5(prostate),AMR:2(lung),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,FIN:0.2616,NFE:0.0885,OTH:0.2416,ASJ:MU96237	612839	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9974,9975	.	,9978,9976,9980,9979,9977,9981	0.001	4.53	0.000	1.445	4	1(thyroid)	0.3013
4	106317429	106317429	C	G	PPA2	exonic	nonsynonymous SNV	ENSG00000138777	rs13787	ENSG00000138777:ENST00000354147:exon3:c.G348C:p.K116N,ENSG00000138777:ENST00000432483:exon5:c.G540C:p.K180N,ENSG00000138777:ENST00000348706:exon8:c.G759C:p.K253N,ENSG00000138777:ENST00000380004:exon8:c.G792C:p.K264N,ENSG00000138777:ENST00000341695:exon9:c.G846C:p.K282N,ENSG00000138777:ENST00000357415:exon11:c.G891C:p.K297N	PPA2:NM_176867:exon3:c.G348C:p.K116N,PPA2:NM_176866:exon5:c.G540C:p.K180N,PPA2:NM_006903:exon8:c.G759C:p.K253N,PPA2:NM_176869:exon9:c.G846C:p.K282N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4544	0.3469	0.432708	0.3671	2.568	19.90	0.069	0.105	0.080	.	.	.	PPA2:uc003hxp.3:exon3:c.G348C:p.K116N,PPA2:uc003hxo.3:exon5:c.G540C:p.K180N,PPA2:uc003hxn.3:exon8:c.G759C:p.K253N,PPA2:uc003hxl.3:exon9:c.G846C:p.K282N,PPA2:uc003hxq.3:exon10:c.G567C:p.K189N	-0.964	AFR:0.1262,AMR:0.4892,EAS:0.6748,FIN:0.4126,NFE:0.4505,OTH:0.4429,ASJ:0.4404	609988	.	.	.	.	.	.	.	0.57	0.81	0.000	2.275	4	MU24790180	het
4	106317499	106317502	CAAA	-	PPA2	intronic	.	ENSG00000138777	rs34331553	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4502	0.3405	0.429113	0.3651	.	.	.	.	.	.	.	.	.	.	AFR:0.1256,AMR:0.4916,EAS:0.6721,FIN:0.4116,NFE:0.4479,OTH:0.4406,ASJ:0.4367	609988	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	106359209	106359209	T	A	PPA2	intronic	.	ENSG00000138777	rs2713862	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4509	0.1964	0.445088	0.3737	.	.	.	.	.	.	.	.	.	.	AFR:0.1701,AMR:0.4926,EAS:0.6596,FIN:0.4041,NFE:0.4427,OTH:0.4392,ASJ:0.4437	609988	.	.	.	.	.	.	.	.	.	.	.	4	MU779627	het
4	106395181	106395181	G	A	PPA2	exonic	synonymous SNV	ENSG00000138777	rs4699179	ENSG00000138777:ENST00000341695:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000348706:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000351450:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000354147:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000357415:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000380004:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000432483:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000504028:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000510015:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000513649:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000514209:exon1:c.C27T:p.R9R	PPA2:NM_006903:exon1:c.C27T:p.R9R,PPA2:NM_176866:exon1:c.C27T:p.R9R,PPA2:NM_176867:exon1:c.C27T:p.R9R,PPA2:NM_176869:exon1:c.C27T:p.R9R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2100	0.1595	0.0810703	0.1587	.	.	.	.	.	.	.	.	PPA2:uc003hxl.3:exon1:c.C27T:p.R9R,PPA2:uc003hxn.3:exon1:c.C27T:p.R9R,PPA2:uc003hxo.3:exon1:c.C27T:p.R9R,PPA2:uc003hxp.3:exon1:c.C27T:p.R9R	.	AFR:0.0438,AMR:0.1367,EAS:0.0006,FIN:0.2048,NFE:0.2304,OTH:0.2177,ASJ:0.1060	609988	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	122742217	122742217	T	C	CCNA2	exonic	nonsynonymous SNV	ENSG00000145386	rs769242	ENSG00000145386:ENST00000274026:exon3:c.A487G:p.I163V	CCNA2:NM_001237:exon3:c.A487G:p.I163V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9629	0.9691	0.96865	0.9672	0.665	8.596	1.0	4.14	0.999	.	.	Cyclin-A, N-terminal	CCNA2:uc003iec.4:exon3:c.A487G:p.I163V	-0.995	AFR:0.9913,AMR:0.9760,EAS:0.9382,FIN:0.9453,NFE:0.9605,OTH:0.9664,ASJ:0.9901	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	2.65	0.000	-2.175	4	MU27950768	het
4	123377482	123377482	C	A	IL2	exonic	synonymous SNV	ENSG00000109471	rs2069763	ENSG00000109471:ENST00000226730:exon1:c.G114T:p.L38L	IL2:NM_000586:exon1:c.G114T:p.L38L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3461	0.2575	0.298722	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	IL2:uc003ier.3:exon1:c.G114T:p.L38L	.	AFR:0.3068,AMR:0.1142,EAS:0.2086,FIN:0.4793,NFE:0.4733,OTH:0.3533,ASJ:0.4159	147680	.	.	.	~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04672 Intestinal immune network for IgA production~ko04940 Type I diabetes mellitus~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05320 Autoimmune thyroid disease~ko05321 Inflammatory bowel disease (IBD)~ko05330 Allograft rejection~ko05332 Graft-versus-host disease ~	.	.	.	.	.	.	.	4	1(lung)	0.3776
4	126238924	126238924	A	T	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs6847454	ENSG00000196159:ENST00000394329:exon1:c.A1358T:p.Q453L	FAT4:NM_001291285:exon1:c.A1358T:p.Q453L,FAT4:NM_001291303:exon1:c.A1358T:p.Q453L,FAT4:NM_024582:exon1:c.A1358T:p.Q453L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4234	0.4656	0.426318	0.4610	-0.880	0.029	0.33	-2.64	0.004	.	.	Cadherin|Cadherin-like	FAT4:uc003ifj.4:exon1:c.A1358T:p.Q453L	-0.928	AFR:0.5632,AMR:0.4141,EAS:0.2528,FIN:0.4023,NFE:0.4462,OTH:0.4094,ASJ:0.3411	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.002	0.61	0.000	0.28	4	MU159971	het
4	126239986	126239986	C	T	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs1039808	ENSG00000196159:ENST00000394329:exon1:c.C2420T:p.A807V	FAT4:NM_001291285:exon1:c.C2420T:p.A807V,FAT4:NM_001291303:exon1:c.C2420T:p.A807V,FAT4:NM_024582:exon1:c.C2420T:p.A807V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4222	0.4641	0.424121	0.4613	4.056	23.7	0.202	5.13	0.975	.	.	Cadherin|Cadherin-like	FAT4:uc003ifj.4:exon1:c.C2420T:p.A807V	-1.062	AFR:0.5648,AMR:0.4151,EAS:0.2441,FIN:0.4030,NFE:0.4467,OTH:0.4092,ASJ:0.3411	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.575	4.63	0.000	0.84	4	MU159977	het
4	126240510	126240510	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs2940779	ENSG00000196159:ENST00000394329:exon1:c.T2944C:p.L982L	FAT4:NM_001291285:exon1:c.T2944C:p.L982L,FAT4:NM_001291303:exon1:c.T2944C:p.L982L,FAT4:NM_024582:exon1:c.T2944C:p.L982L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7012	0.7660	0.721046	0.7296	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.T2944C:p.L982L	.	AFR:0.8901,AMR:0.7243,EAS:0.4728,FIN:0.5910,NFE:0.7007,OTH:0.6646,ASJ:0.7285	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU23614382	hom
4	126241335	126241335	C	G	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs36052762	ENSG00000196159:ENST00000394329:exon1:c.C3769G:p.Q1257E	FAT4:NM_001291285:exon1:c.C3769G:p.Q1257E,FAT4:NM_001291303:exon1:c.C3769G:p.Q1257E,FAT4:NM_024582:exon1:c.C3769G:p.Q1257E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0852	0.0384	0.108626	0.0478	0.853	9.790	0.376	3.89	0.998	.	.	Cadherin|Cadherin-like	FAT4:uc003ifj.4:exon1:c.C3769G:p.Q1257E	-0.679	AFR:0.0306,AMR:0.1663,EAS:0.1989,FIN:0.0407,NFE:0.0357,OTH:0.0601,ASJ:0.0530	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.054	5.33	0.000	0.56	4	MU160106	het
4	126241871	126241871	C	T	FAT4	exonic	synonymous SNV	ENSG00000196159	rs2710555	ENSG00000196159:ENST00000394329:exon1:c.C4305T:p.I1435I	FAT4:NM_001291285:exon1:c.C4305T:p.I1435I,FAT4:NM_001291303:exon1:c.C4305T:p.I1435I,FAT4:NM_024582:exon1:c.C4305T:p.I1435I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6974	0.7544	0.711262	0.7203	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.C4305T:p.I1435I	.	AFR:0.8596,AMR:0.7196,EAS:0.4617,FIN:0.5917,NFE:0.7007,OTH:0.6612,ASJ:0.7285	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU23614425	hom
4	126329789	126329789	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs958415	ENSG00000196159:ENST00000335110:exon4:c.T654C:p.D218D,ENSG00000196159:ENST00000394329:exon4:c.T5760C:p.D1920D	FAT4:NM_001291285:exon4:c.T5760C:p.D1920D,FAT4:NM_001291303:exon4:c.T5760C:p.D1920D,FAT4:NM_024582:exon4:c.T5760C:p.D1920D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9966	0.9905	0.988419	0.9917	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon4:c.T5760C:p.D1920D,FAT4:uc011cgp.2:exon4:c.T654C:p.D218D	.	AFR:0.9728,AMR:0.9952,EAS:1,FIN:1,NFE:0.9991,OTH:0.9959,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789789	hom
4	126369872	126369872	G	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs988863	ENSG00000196159:ENST00000335110:exon9:c.G2595C:p.V865V,ENSG00000196159:ENST00000394329:exon9:c.G7701C:p.V2567V	FAT4:NM_001291285:exon9:c.G7707C:p.V2569V,FAT4:NM_001291303:exon9:c.G7707C:p.V2569V,FAT4:NM_024582:exon9:c.G7701C:p.V2567V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9978	0.9924	0.990815	0.9932	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon1:c.G135C:p.V45V,FAT4:uc003ifj.4:exon9:c.G7701C:p.V2567V,FAT4:uc011cgp.2:exon9:c.G2595C:p.V865V	.	AFR:0.9763,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789833	hom
4	126372742	126372742	G	A	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs1567047	ENSG00000196159:ENST00000335110:exon9:c.G5465A:p.G1822D,ENSG00000196159:ENST00000394329:exon9:c.G10571A:p.G3524D	FAT4:NM_001291285:exon9:c.G10577A:p.G3526D,FAT4:NM_001291303:exon9:c.G10577A:p.G3526D,FAT4:NM_024582:exon9:c.G10571A:p.G3524D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.2673	0.2207	0.230631	1(breast)	5.933	27.6	0.013	5.77	0.424	.	.	Cadherin|Cadherin-like	FAT4:uc003ifi.1:exon1:c.G3005A:p.G1002D,FAT4:uc003ifj.4:exon9:c.G10571A:p.G3524D,FAT4:uc011cgp.2:exon9:c.G5465A:p.G1822D	-1.086	AFR:MU701527,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.0634,FIN:0.2752,NFE:0.2567,OTH:0.4149,ASJ:0.2253	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	1.0	0.59	0.000	2.8	4	2(stomach)	0.2572
4	126373789	126373789	G	A	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs12650153	ENSG00000196159:ENST00000335110:exon9:c.G6512A:p.S2171N,ENSG00000196159:ENST00000394329:exon9:c.G11618A:p.S3873N	FAT4:NM_001291285:exon9:c.G11624A:p.S3875N,FAT4:NM_001291303:exon9:c.G11624A:p.S3875N,FAT4:NM_024582:exon9:c.G11618A:p.S3873N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9978	0.9925	0.991014	0.9931	1.631	14.02	0.671	5.27	0.994	.	.	Cadherin|Cadherin-like;EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FAT4:uc003ifi.1:exon1:c.G4052A:p.S1351N,FAT4:uc003ifj.4:exon9:c.G11618A:p.S3873N,FAT4:uc011cgp.2:exon9:c.G6512A:p.S2171N	-0.924	AFR:0.9760,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.0	-2.26	0.000	-2.215	4	MU81789855	hom
4	126397321	126397321	C	T	FAT4	intronic	.	ENSG00000196159	rs17009761	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3745	0.3960	0.337859	0.3952	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3859,AMR:0.2751,EAS:0.2744,FIN:0.4394,NFE:0.4083,OTH:0.4252,ASJ:0.3907	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU11839003	het
4	126402890	126402890	G	A	FAT4	exonic	synonymous SNV	ENSG00000196159	rs6824160	ENSG00000196159:ENST00000335110:exon13:c.G7536A:p.V2512V,ENSG00000196159:ENST00000394329:exon15:c.G12813A:p.V4271V	FAT4:NM_001291285:exon15:c.G12819A:p.V4273V,FAT4:NM_001291303:exon15:c.G12819A:p.V4273V,FAT4:NM_024582:exon15:c.G12813A:p.V4271V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1354	0.0894	0.134385	0.1052	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon7:c.G5247A:p.V1749V,FAT4:uc011cgp.2:exon13:c.G7536A:p.V2512V,FAT4:uc003ifj.4:exon15:c.G12813A:p.V4271V	.	AFR:0.0263,AMR:0.1158,EAS:0.2618,FIN:0.1274,NFE:0.1276,OTH:0.1303,ASJ:0.0629	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU11839012	het
4	126412575	126412575	A	G	FAT4	exonic	synonymous SNV	ENSG00000196159	rs1014866	ENSG00000196159:ENST00000335110:exon15:c.A9321G:p.R3107R,ENSG00000196159:ENST00000394329:exon17:c.A14598G:p.R4866R	FAT4:NM_001291285:exon17:c.A14601G:p.R4867R,FAT4:NM_001291303:exon17:c.A14604G:p.R4868R,FAT4:NM_024582:exon17:c.A14598G:p.R4866R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7569	0.7442	0.740615	0.7566	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon9:c.A7029G:p.R2343R,FAT4:uc011cgp.2:exon15:c.A9321G:p.R3107R,FAT4:uc003ifj.4:exon17:c.A14598G:p.R4866R	.	AFR:0.7063,AMR:0.7321,EAS:0.8694,FIN:0.7915,NFE:0.7663,OTH:0.7673,ASJ:0.7567	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU21902856	hom
4	143007419	143007419	A	G	INPP4B	intronic	.	ENSG00000109452	rs336324	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7139	0.5949	0.604832	0.6499	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3903,AMR:0.7464,EAS:0.6491,FIN:0.7729,NFE:0.7603,OTH:0.7290,ASJ:0.7086	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU779897	hom
4	143118279	143118279	-	AAAAA	INPP4B	intronic	.	ENSG00000109452	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607494	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	143130034	143130034	A	T	INPP4B	intronic	.	ENSG00000109452	rs1907123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9301	0.9015	0.903355	0.9142	.	.	.	.	.	.	.	.	.	.	AFR:0.8248,AMR:0.9318,EAS:0.9469,FIN:0.9570,NFE:0.9520,OTH:0.9402,ASJ:0.8212	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU27779519	hom
4	143159002	143159002	G	A	INPP4B	intronic	.	ENSG00000109452	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607494	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	143159003	143159003	T	C	INPP4B	intronic	.	ENSG00000109452	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607494	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	143324094	143324094	G	A	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs1982966	ENSG00000109452:ENST00000506297:exon1:c.C69T:p.D23D,ENSG00000109452:ENST00000308502:exon4:c.C369T:p.D123D,ENSG00000109452:ENST00000506217:exon4:c.C369T:p.D123D,ENSG00000109452:ENST00000262992:exon5:c.C369T:p.D123D,ENSG00000109452:ENST00000508116:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000510812:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000512630:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000509777:exon7:c.C369T:p.D123D,ENSG00000109452:ENST00000513000:exon8:c.C369T:p.D123D	INPP4B:NM_001101669:exon7:c.C369T:p.D123D,INPP4B:NM_001331040:exon7:c.C369T:p.D123D,INPP4B:NM_003866:exon8:c.C369T:p.D123D	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3155	0.2579	0.252596	13(soft_tissue)	.	.	.	.	.	.	.	.	INPP4B:uc003iiw.4:exon7:c.C369T:p.D123D,INPP4B:uc003iix.4:exon8:c.C369T:p.D123D	.	AFR:1(large_intestine),AMR:MU586505,EAS:0.2785,FIN:0.0757,NFE:0.2470,OTH:0.3477,ASJ:LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	1(thyroid)	0.2472
4	169799448	169799448	A	G	PALLD	exonic	nonsynonymous SNV	ENSG00000129116	rs62333013	ENSG00000129116:ENST00000507735:exon2:c.A406G:p.S136G,ENSG00000129116:ENST00000335742:exon11:c.A1393G:p.S465G	PALLD:NM_001166110:exon2:c.A406G:p.S136G	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6464	.	0.478634	MU4559796	0.632	8.376	0.751	-5.01	0.971	.	.	.	PALLD:uc003irw.3:exon2:c.A406G:p.S136G	-0.955	AFR:COCA-CN|4|321|0.0124611,AMR:0.5198,EAS:0.6238,FIN:0.6133,NFE:0.5347,OTH:0.7253,ASJ:0.1725	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	0.0	0.32	0.000	1.175	4	1(upper_aerodigestive_tract)	0.6552
4	178243595	178243595	A	G	NEIL3	intronic	.	ENSG00000109674	rs3792606	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0607	0.0286	0.103634	0.0385	.	.	.	.	.	.	.	.	.	.	AFR:0.0236,AMR:0.0923,EAS:0.2667,FIN:0.0143,NFE:0.0266,OTH:0.0286,ASJ:0.0066	608934	.	.	.	.	.	.	.	.	.	.	.	4	MU16711590	het
4	178256978	178256978	-	A	NEIL3	splicing	.	ENSG00000109674	rs35737622	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0641	0.0312	0.10643	0.0421	.	.	.	.	.	.	.	.	.	.	AFR:0.0343,AMR:0.0962,EAS:0.2664,FIN:0.0142,NFE:0.0268,OTH:0.0329,ASJ:0.0166	608934	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	178272700	178272700	A	G	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs17064676	ENSG00000109674:ENST00000264596:exon7:c.A1036G:p.I346V	NEIL3:NM_018248:exon7:c.A1036G:p.I346V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0152	0.0266	0.0483227	0.0262	-2.442	0.001	0.522	-12.0	0.369	.	.	Zinc finger, RanBP2-type	NEIL3:uc003iut.2:exon7:c.A1036G:p.I346V	-0.990	AFR:0.0787,AMR:0.0095,EAS:0.0641,FIN:0,NFE:0.0003,OTH:0.0082,ASJ:0	608934	.	.	.	.	.	.	.	0.0	3.9	0.000	-1.4	4	MU780229	het
4	178274565	178274565	A	G	NEIL3	exonic	synonymous SNV	ENSG00000109674	rs2048074	ENSG00000109674:ENST00000264596:exon8:c.A1143G:p.R381R	NEIL3:NM_018248:exon8:c.A1143G:p.R381R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6907	0.7412	0.609026	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon8:c.A1143G:p.R381R	.	AFR:MU122629,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6957,FIN:0.7026,NFE:0.7682,OTH:0.3804,ASJ:0.7119	608934	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.7453
4	178274694	178274694	T	G	NEIL3	exonic	synonymous SNV	ENSG00000109674	rs10007075	ENSG00000109674:ENST00000264596:exon8:c.T1272G:p.V424V	NEIL3:NM_018248:exon8:c.T1272G:p.V424V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6661	0.6685	0.542532	MU122640	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon8:c.T1272G:p.V424V	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6496,EAS:0.6851,FIN:0.77,NFE:0.3833,OTH:0.7401,ASJ:0.4904	608934	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.7430
4	178274750	178274750	C	T	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112358	ENSG00000109674:ENST00000264596:exon8:c.C1328T:p.P443L	NEIL3:NM_018248:exon8:c.C1328T:p.P443L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6899	0.7407	0.608826	1(haematopoietic_and_lymphoid_tissue)	-0.693	0.075	0.686	-4.99	0.715	.	.	.	NEIL3:uc003iut.2:exon8:c.C1328T:p.P443L	-1.000	AFR:MU122663,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6950,FIN:0.7050,NFE:0.7682,OTH:0.3794,ASJ:0.7119	608934	.	.	.	.	.	.	.	0.0	3.84	0.000	0.485	4	1(lung)	0.7447
4	178274835	178274835	A	C	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112390	ENSG00000109674:ENST00000264596:exon8:c.A1413C:p.Q471H	NEIL3:NM_018248:exon8:c.A1413C:p.Q471H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7337	0.7711	0.66254	1(liver)	-0.597	0.127	0.642	-1.15	0.022	.	.	.	NEIL3:uc003iut.2:exon8:c.A1413C:p.Q471H	-1.063	AFR:1(large_intestine),AMR:MU122675,EAS:0.7413,FIN:0.7233,NFE:0.7691,OTH:0.8013,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	608934	.	.	.	.	.	.	.	0.0	3.81	0.000	-2.515	4	1(prostate)	0.4387
4	178281754	178281754	G	A	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs1876268	ENSG00000109674:ENST00000264596:exon9:c.G1558A:p.G520R	NEIL3:NM_018248:exon9:c.G1558A:p.G520R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9539	0.9492	0.931909	0.9510	0.752	9.165	1.0	4.74	0.398	.	.	Zinc finger, GRF-type	NEIL3:uc003iut.2:exon9:c.G1558A:p.G520R	-0.977	AFR:0.9044,AMR:0.9605,EAS:0.9833,FIN:0.9791,NFE:0.9657,OTH:0.9664,ASJ:0.9901	608934	.	.	.	.	.	.	.	0.0	2.24	0.000	-2.8	4	MU81792852	hom
4	185340725	185340725	-	AA	IRF2	intronic	.	ENSG00000168310	rs72397805	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0668	.	.	0.2124	.	.	.	.	.	.	.	.	.	.	AFR:0.1978,AMR:0.1938,EAS:0.0470,FIN:0.0935,NFE:0.2470,OTH:0.2177,ASJ:0.2079	147576	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	185578485	185578485	C	T	PRIMPOL	intronic	.	ENSG00000164306	rs56194967	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1006	0.0869	0.0541134	0.0837	.	.	.	.	.	.	.	.	.	.	AFR:0.0307,AMR:0.1067,EAS:0.0012,FIN:0.1274,NFE:0.1098,OTH:0.0992,ASJ:0.1433	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	.	het
4	185587165	185587165	A	G	PRIMPOL	exonic	nonsynonymous SNV	ENSG00000164306	rs2463447	ENSG00000164306:ENST00000515774:exon5:c.A116G:p.Q39R,ENSG00000164306:ENST00000314970:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000503752:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000512834:exon6:c.A503G:p.Q168R	PRIMPOL:NM_001300767:exon5:c.A116G:p.Q39R,PRIMPOL:NM_001300768:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345891:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345892:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345893:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345895:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345896:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345899:exon6:c.A503G:p.Q168R,PRIMPOL:NM_152683:exon6:c.A503G:p.Q168R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9873	0.9592	0.966853	0.9642	.	.	.	.	.	.	.	.	CCDC111:uc003iwm.2:exon5:c.A116G:p.Q39R,CCDC111:uc003iwj.2:exon6:c.A503G:p.Q168R,CCDC111:uc003iwk.2:exon6:c.A503G:p.Q168R	.	AFR:0.8792,AMR:0.9893,EAS:1,FIN:0.9977,NFE:0.9981,OTH:0.9919,ASJ:1	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	MU81793151	hom
4	185599489	185599489	G	A	PRIMPOL	exonic	synonymous SNV	ENSG00000164306	rs34985821	ENSG00000164306:ENST00000508001:exon1:c.G59A:p.S20N	PRIMPOL:NM_001345900:exon6:c.G423A:p.Q141Q,PRIMPOL:NM_001345901:exon6:c.G252A:p.Q84Q,PRIMPOL:NM_001300767:exon7:c.G561A:p.Q187Q,PRIMPOL:NM_001345894:exon7:c.G252A:p.Q84Q,PRIMPOL:NM_001345897:exon7:c.G252A:p.Q84Q,PRIMPOL:NM_001345898:exon7:c.G252A:p.Q84Q,PRIMPOL:NM_001300768:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345891:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345892:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345893:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345895:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345896:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_152683:exon8:c.G948A:p.Q316Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1117	0.1048	0.0613019	0.0979	-0.929	0.022	0.311	-1.91	0.003	.	.	.	CCDC111:uc003iwm.2:exon7:c.G561A:p.Q187Q,CCDC111:uc003iwj.2:exon8:c.G948A:p.Q316Q,CCDC111:uc003iwk.2:exon8:c.G948A:p.Q316Q	-1.005	AFR:0.0386,AMR:0.1332,EAS:0.0006,FIN:0.1412,NFE:0.1284,OTH:0.1135,ASJ:0.1767	615421	615420;	.	.	.	.	.	.	.	.	0.001	.	4	.	het
4	185615764	185615764	C	A	PRIMPOL	exonic	nonsynonymous SNV	ENSG00000164306	rs14969	ENSG00000164306:ENST00000515774:exon13:c.C1127A:p.T376K,ENSG00000164306:ENST00000314970:exon14:c.C1514A:p.T505K,ENSG00000164306:ENST00000503752:exon14:c.C1514A:p.T505K,ENSG00000164306:ENST00000512834:exon14:c.C1511A:p.T504K	PRIMPOL:NM_001345899:exon12:c.C1262A:p.T421K,PRIMPOL:NM_001345900:exon12:c.C989A:p.T330K,PRIMPOL:NM_001345901:exon12:c.C818A:p.T273K,PRIMPOL:NM_001300767:exon13:c.C1127A:p.T376K,PRIMPOL:NM_001345897:exon13:c.C818A:p.T273K,PRIMPOL:NM_001345898:exon13:c.C815A:p.T272K,PRIMPOL:NM_001300768:exon14:c.C1511A:p.T504K,PRIMPOL:NM_001345894:exon14:c.C857A:p.T286K,PRIMPOL:NM_001345895:exon14:c.C1514A:p.T505K,PRIMPOL:NM_001345896:exon14:c.C1511A:p.T504K,PRIMPOL:NM_152683:exon14:c.C1514A:p.T505K,PRIMPOL:NM_001345891:exon15:c.C1553A:p.T518K,PRIMPOL:NM_001345892:exon15:c.C1550A:p.T517K,PRIMPOL:NM_001345893:exon15:c.C1550A:p.T517K	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.1473	0.2020	0.146366	0.1759	-0.914	0.024	0.936	-0.002	0.001	.	.	.	CCDC111:uc003iwn.2:exon10:c.C734A:p.T245K,CCDC111:uc003iwm.2:exon13:c.C1127A:p.T376K,CCDC111:uc003iwj.2:exon14:c.C1511A:p.T504K,CCDC111:uc003iwk.2:exon14:c.C1514A:p.T505K	-0.977	AFR:0.2696,AMR:0.1607,EAS:0.0006,FIN:0.1525,NFE:0.1495,OTH:0.1329,ASJ:0.1921	615421	615420;	.	.	.	.	.	.	0.0	1.63	0.000	-1.39	4	.	unknown
4	185615768	185615768	T	G	PRIMPOL	exonic	synonymous SNV	ENSG00000164306	rs3184982	ENSG00000164306:ENST00000515774:exon13:c.T1131G:p.G377G,ENSG00000164306:ENST00000314970:exon14:c.T1518G:p.G506G,ENSG00000164306:ENST00000503752:exon14:c.T1518G:p.G506G,ENSG00000164306:ENST00000512834:exon14:c.T1515G:p.G505G	PRIMPOL:NM_001345899:exon12:c.T1266G:p.G422G,PRIMPOL:NM_001345900:exon12:c.T993G:p.G331G,PRIMPOL:NM_001345901:exon12:c.T822G:p.G274G,PRIMPOL:NM_001300767:exon13:c.T1131G:p.G377G,PRIMPOL:NM_001345897:exon13:c.T822G:p.G274G,PRIMPOL:NM_001345898:exon13:c.T819G:p.G273G,PRIMPOL:NM_001300768:exon14:c.T1515G:p.G505G,PRIMPOL:NM_001345894:exon14:c.T861G:p.G287G,PRIMPOL:NM_001345895:exon14:c.T1518G:p.G506G,PRIMPOL:NM_001345896:exon14:c.T1515G:p.G505G,PRIMPOL:NM_152683:exon14:c.T1518G:p.G506G,PRIMPOL:NM_001345891:exon15:c.T1557G:p.G519G,PRIMPOL:NM_001345892:exon15:c.T1554G:p.G518G,PRIMPOL:NM_001345893:exon15:c.T1554G:p.G518G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1473	0.2019	0.146366	0.1758	.	.	.	.	.	.	.	.	CCDC111:uc003iwn.2:exon10:c.T738G:p.G246G,CCDC111:uc003iwm.2:exon13:c.T1131G:p.G377G,CCDC111:uc003iwj.2:exon14:c.T1515G:p.G505G,CCDC111:uc003iwk.2:exon14:c.T1518G:p.G506G	.	AFR:0.2696,AMR:0.1607,EAS:0.0006,FIN:0.1525,NFE:0.1492,OTH:0.1329,ASJ:0.1921	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	.	unknown
4	187519206	187519206	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280097	ENSG00000083857:ENST00000441802:exon23:c.G12177C:p.K4059N	FAT1:NM_005245:exon23:c.G12177C:p.K4059N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.9953	0.9952	0.997404	0.9958	0.199	4.672	1.0	-0.147	0.797	.	.	EGF-like calcium-binding domain|EGF-like domain	FAT1:uc003izf.3:exon23:c.G12177C:p.K4059N	-0.950	AFR:0.9987,AMR:0.9976,EAS:1,FIN:0.9969,NFE:0.9933,OTH:0.9949,ASJ:1	600976	.	.	.	.	,4923	.	.	0.0	-2.25	0.000	-1.635	4	MU81793643	hom
4	187524744	187524744	G	A	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs375882967	ENSG00000083857:ENST00000441802:exon19:c.C10936T:p.R3646C	FAT1:NM_005245:exon19:c.C10936T:p.R3646C	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	0.0005	7.7e-05	0.00159744	6.461e-05	7.655	35	0.005	5.06	0.917	.	.	.	FAT1:uc003izf.3:exon19:c.C10936T:p.R3646C	-0.293	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	600976	.	.	.	.	,4923	.	.	1.0	0.53	0.361	3.365	4	.	het
4	187534363	187534363	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs2249916	ENSG00000083857:ENST00000441802:exon13:c.C9363T:p.N3121N	FAT1:NM_005245:exon13:c.C9363T:p.N3121N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5913	0.6222	0.611422	0.6188	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon13:c.C9363T:p.N3121N	.	AFR:0.6946,AMR:0.6430,EAS:0.6702,FIN:0.5823,NFE:0.5777,OTH:0.6091,ASJ:0.5861	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	MU14006196	unknown
4	187534375	187534375	A	G	FAT1	exonic	synonymous SNV	ENSG00000083857	rs2249917	ENSG00000083857:ENST00000441802:exon13:c.T9351C:p.D3117D	FAT1:NM_005245:exon13:c.T9351C:p.D3117D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4408	0.4733	0.417931	1(lung)	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon13:c.T9351C:p.D3117D	.	AFR:MU11955310,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,EAS:0.5304,FIN:0.4844,NFE:0.4669,OTH:0.25,ASJ:0.4572	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(urinary_tract)	0.4432
4	187538330	187538330	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs1280099	ENSG00000083857:ENST00000441802:exon11:c.C8904T:p.A2968A	FAT1:NM_005245:exon11:c.C8904T:p.A2968A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4398	0.4755	0.416134	MU18454834	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon11:c.C8904T:p.A2968A	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4575,EAS:0.4820,FIN:0.4636,NFE:0.25,OTH:0.4446,ASJ:0.5317	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(stomach)	0.4388
4	187538942	187538942	T	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280098	ENSG00000083857:ENST00000441802:exon10:c.A8798C:p.Q2933P	FAT1:NM_005245:exon10:c.A8798C:p.Q2933P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5554	0.6234	0.592053	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	-1.112	0.009	1.0	4.04	0.044	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.A8798C:p.Q2933P	-0.940	AFR:0.5898,AMR:0.7045,EAS:0.5298,FIN:0.6355,NFE:0.5183,OTH:0.5375,ASJ:0.5871	600976	.	.	.	.	,4923	.	.	0.0	0.79	0.000	-2.575	4	1(haematopoietic_and_lymphoid_tissue)	0.5682
4	187557893	187557893	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs328418	ENSG00000083857:ENST00000441802:exon5:c.A3818G:p.H1273R	FAT1:NM_005245:exon5:c.A3818G:p.H1273R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5876	0.6338	0.645767	1(kidney)	-1.030	0.014	1.0	4.99	0.003	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon5:c.A3818G:p.H1273R	-0.954	AFR:MU14006434,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,EAS:0.8076,FIN:0.6471,NFE:0.6060,OTH:0.6689,ASJ:0.6358	600976	.	.	.	.	,4923	.	.	0.0	0.84	0.000	-2.11	4	1(urinary_tract)	0.5607
4	187584771	187584771	C	G	FAT1	intronic	.	ENSG00000083857	rs172903	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9673	0.9625	0.983427	0.9714	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.9888,AMR:0.9666,EAS:1,FIN:0.9720,NFE:0.9585,OTH:0.9705,ASJ:0.9702	600976	.	.	.	.	.	.	.	.	.	.	.	4	MU81793736	hom
4	187627792	187627792	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs11939575	ENSG00000083857:ENST00000441802:exon2:c.A3190G:p.R1064G	FAT1:NM_005245:exon2:c.A3190G:p.R1064G	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7609	0.8272	0.745807	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	0.930	10.26	1.0	4.6	0.007	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.A3190G:p.R1064G,FAT1:uc010iso.1:exon2:c.A3190G:p.R1064G	-0.947	AFR:0.7963,AMR:0.8886,EAS:0.7517,FIN:0.5136,NFE:0.7496,OTH:0.7913,ASJ:0.6790	600976	.	.	.	.	,4923	.	.	0.0	0.54	0.000	-3.06	4	1(breast)	0.7959
4	187628054	187628054	C	G	FAT1	exonic	synonymous SNV	ENSG00000083857	rs114279527	ENSG00000083857:ENST00000441802:exon2:c.G2928C:p.V976V	FAT1:NM_005245:exon2:c.G2928C:p.V976V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0338	0.0314	0.0241613	0.0267	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon2:c.G2928C:p.V976V,FAT1:uc010iso.1:exon2:c.G2928C:p.V976V	.	AFR:0.0071,AMR:0.0286,EAS:0,FIN:0.0381,NFE:0.0375,OTH:0.0326,ASJ:0.0430	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	.	het
4	187628398	187628398	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1877731	ENSG00000083857:ENST00000441802:exon2:c.G2584C:p.V862L	FAT1:NM_005245:exon2:c.G2584C:p.V862L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7460	0.7755	0.689097	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	-1.358	0.004	1.0	3.06	0.035	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G2584C:p.V862L,FAT1:uc010iso.1:exon2:c.G2584C:p.V862L	-0.935	AFR:0.7483,AMR:0.7208,EAS:0.7533,FIN:0.5149,NFE:0.7503,OTH:0.7906,ASJ:0.6663	600976	.	.	.	.	,4923	.	.	0.0	0.95	0.000	-0.735	4	5(haematopoietic_and_lymphoid_tissue)	0.7908
4	187629140	187629140	G	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs367863	ENSG00000083857:ENST00000441802:exon2:c.C1842G:p.F614L	FAT1:NM_005245:exon2:c.C1842G:p.F614L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7476	0.7801	0.690495	MU11955600	-0.701	0.071	1.0	3.53	0.206	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.C1842G:p.F614L,FAT1:uc010iso.1:exon2:c.C1842G:p.F614L	-0.980	AFR:LAML-KR|5|205|0.0243902,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.7519,EAS:0.6659,FIN:0.7517,NFE:0.5111,OTH:0.7499,ASJ:0.7350	600976	.	.	.	.	,4923	.	.	0.0	1.35	0.000	-1.85	4	3(lung)	0.7907
4	187629497	187629497	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs458021	ENSG00000083857:ENST00000441802:exon2:c.C1485T:p.N495N	FAT1:NM_005245:exon2:c.C1485T:p.N495N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5644	0.5618	0.421925	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon2:c.C1485T:p.N495N,FAT1:uc010iso.1:exon2:c.C1485T:p.N495N	.	AFR:0.5399,AMR:0.3539,EAS:0.5927,FIN:0.2295,NFE:0.6330,OTH:0.6530,ASJ:0.5465	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(lung)	0.6196
4	187629538	187629538	C	T	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733413	ENSG00000083857:ENST00000441802:exon2:c.G1444A:p.V482I,ENSG00000083857:ENST00000509647:exon2:c.G1444A:p.V482I	FAT1:NM_005245:exon2:c.G1444A:p.V482I	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4865	0.4607	0.338858	MU21520090	0.580	8.014	0.144	2.77	0.069	.	.	Cadherin-like;Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G1444A:p.V482I,FAT1:uc010iso.1:exon2:c.G1444A:p.V482I	-0.917	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.4354,EAS:0.4594,FIN:0.5596,NFE:0.1415,OTH:0.4957,ASJ:0.2282	600976	.	.	.	.	,4923	.	.	0.059	0.44	0.000	1.075	4	1(urinary_tract)	0.5652
4	187629770	187629770	A	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733414	ENSG00000083857:ENST00000441802:exon2:c.T1212G:p.S404R,ENSG00000083857:ENST00000509647:exon2:c.T1212G:p.S404R	FAT1:NM_005245:exon2:c.T1212G:p.S404R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5576	0.5432	0.398962	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	0.506	7.479	0.531	1.45	0.626	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.T1212G:p.S404R,FAT1:uc010iso.1:exon2:c.T1212G:p.S404R	-0.899	AFR:0.5191,AMR:0.2812,EAS:0.6,FIN:0.2302,NFE:0.6335,OTH:0.6523,ASJ:0.5453	600976	.	.	.	.	,4923	.	.	0.134	-1.75	0.000	1.32	4	5(haematopoietic_and_lymphoid_tissue)	0.6186
4	187630597	187630597	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs41278611	ENSG00000083857:ENST00000441802:exon2:c.G385C:p.V129L,ENSG00000083857:ENST00000509647:exon2:c.G385C:p.V129L	FAT1:NM_005245:exon2:c.G385C:p.V129L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.0338	0.0313	0.0241613	.	-3.291	0.001	1.0	2.49	0.185	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G385C:p.V129L,FAT1:uc010iso.1:exon2:c.G385C:p.V129L	-0.999	AFR:0.0267,AMR:0.0071,EAS:0.0430,FIN:0,NFE:0.0381,OTH:0.0375,ASJ:0.0286	600976	.	.	.	.	,4923	.	.	0.0	0.19	0.006	-2.01	4	1(lung)	0.0326
5	230980	230980	A	G	SDHA	intronic	.	ENSG00000073578	rs2288461	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8810	0.9126	0.858427	0.9009	.	.	.	.	.	0	0	.	.	.	AFR:0.9713,AMR:0.8923,EAS:0.6590,FIN:0.9201,NFE:0.8853,OTH:0.8867,ASJ:0.7848	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU16880685	hom
5	231111	231111	T	C	SDHA	exonic	synonymous SNV	ENSG00000073578	rs1126417	ENSG00000073578:ENST00000510361:exon6:c.T747C:p.P249P,ENSG00000073578:ENST00000264932:exon7:c.T891C:p.P297P,ENSG00000073578:ENST00000504309:exon7:c.T891C:p.P297P	SDHA:NM_001294332:exon6:c.T747C:p.P249P,SDHA:NM_001330758:exon7:c.T891C:p.P297P,SDHA:NM_004168:exon7:c.T891C:p.P297P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7078	0.7687	0.653355	MU4562957	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon2:c.T216C:p.P72P,SDHA:uc021xvu.1:exon2:c.T216C:p.P72P,SDHA:uc011clw.2:exon6:c.T747C:p.P249P,SDHA:uc003jao.4:exon7:c.T891C:p.P297P,SDHA:uc011clv.1:exon7:c.T891C:p.P297P	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.7402,EAS:0.6516,FIN:0.7067,NFE:0.3323,OTH:0.7666,ASJ:0.7825	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.7589
5	254861	254861	C	G	SDHA	intronic	.	ENSG00000073578	rs2241600	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.652756	0.7383	.	.	.	.	.	.	.	.	.	.	AFR:0.7851,AMR:0.6516,EAS:0.3348,FIN:0.7478,NFE:0.7577,OTH:0.7418,ASJ:0.6987	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU1256647	het
5	256451	256451	C	T	SDHA	exonic	synonymous SNV	ENSG00000073578	rs11557098	ENSG00000073578:ENST00000509564:exon3:c.C284T:p.S95L	SDHA:NM_001330758:exon13:c.C1668T:p.V556V,SDHA:NM_001294332:exon14:c.C1767T:p.V589V,SDHA:NM_004168:exon15:c.C1911T:p.V637V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0047	0.0004	0.0105831	0.0036	0.278	5.477	0.0	0.626	0.592	.	.	.	SDHA:uc021xvu.1:exon8:c.C993T:p.V331V,SDHA:uc003jaq.4:exon10:c.C1236T:p.V412V,SDHA:uc011clw.2:exon14:c.C1767T:p.V589V,SDHA:uc003jao.4:exon15:c.C1911T:p.V637V	-0.405	AFR:0.0006,AMR:0.0012,EAS:0.0562,FIN:0.0006,NFE:0.0009,OTH:0,ASJ:0	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	-1.88	0.201	.	5	.	het
5	639231	639231	C	A	CEP72	exonic	nonsynonymous SNV	ENSG00000112877	rs12522955	ENSG00000112877:ENST00000264935:exon8:c.C1234A:p.P412T	CEP72:NM_018140:exon8:c.C1234A:p.P412T	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.1489	0.1444	0.0904553	0.1193	2.170	17.31	0.068	3.58	0.002	.	.	.	CEP72:uc003jbf.3:exon8:c.C1234A:p.P412T	-1.041	AFR:0.0319,AMR:0.1432,EAS:0.0025,FIN:0.1272,NFE:0.1762,OTH:0.1660,ASJ:0.1523	616475	.	.	.	.	.	.	.	0.987	1.44	0.000	1.525	5	.	het
5	640728	640728	G	A	CEP72	intronic	.	ENSG00000112877	rs56325086	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1702	0.1434	0.0920527	0.1187	.	.	.	.	.	.	.	.	.	.	AFR:0.0315,AMR:0.1432,EAS:0.0025,FIN:0.1268,NFE:0.1750,OTH:0.1650,ASJ:0.1523	616475	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	644552	644552	G	T	CEP72	intronic	.	ENSG00000112877	rs4957080	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1553	0.1428	0.10024	0.1203	.	.	.	.	.	.	.	.	.	.	AFR:0.0319,AMR:0.1998,EAS:0.0062,FIN:0.1268,NFE:0.1743,OTH:0.1694,ASJ:0.1523	616475	.	.	.	.	.	.	.	.	.	.	.	5	MU87973398	het
5	6600064	6600064	G	T	NSUN2	exonic	nonsynonymous SNV	ENSG00000037474	rs61744358	ENSG00000037474:ENST00000506139:exon18:c.C2174A:p.P725Q,ENSG00000037474:ENST00000539938:exon18:c.C1571A:p.P524Q,ENSG00000037474:ENST00000264670:exon19:c.C2279A:p.P760Q	NSUN2:NM_001193455:exon18:c.C2174A:p.P725Q,NSUN2:NM_017755:exon19:c.C2279A:p.P760Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0588	0.0659	0.0551118	0.0592	0.517	7.556	0.085	1.59	0.000	.	.	.	NSUN2:uc003jdt.3:exon13:c.C1571A:p.P524Q,NSUN2:uc003jdv.3:exon18:c.C1571A:p.P524Q,NSUN2:uc011cmk.2:exon18:c.C2174A:p.P725Q,NSUN2:uc003jdu.3:exon19:c.C2279A:p.P760Q	-1.123	AFR:0.0639,AMR:0.0430,EAS:0.0018,FIN:0.0398,NFE:0.0679,OTH:0.0602,ASJ:0.0629	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	0.003	1.31	0.007	0	5	.	hom
5	6604787	6604787	C	T	NSUN2	exonic	synonymous SNV	ENSG00000037474	rs13181449	ENSG00000037474:ENST00000506139:exon15:c.G1644A:p.T548T,ENSG00000037474:ENST00000539938:exon15:c.G1041A:p.T347T,ENSG00000037474:ENST00000264670:exon16:c.G1749A:p.T583T	NSUN2:NM_001193455:exon15:c.G1644A:p.T548T,NSUN2:NM_017755:exon16:c.G1749A:p.T583T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2153	0.1544	0.222045	MU4560713	.	.	.	.	.	.	.	.	NSUN2:uc003jdt.3:exon10:c.G1041A:p.T347T,NSUN2:uc003jdv.3:exon15:c.G1041A:p.T347T,NSUN2:uc011cmk.2:exon15:c.G1644A:p.T548T,NSUN2:uc003jdu.3:exon16:c.G1749A:p.T583T	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,AMR:0.1752,EAS:0.1990,FIN:0.2384,NFE:0.4325,OTH:0.1997,ASJ:0.0576	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	2(large_intestine)	0.2061
5	6605532	6605532	C	A	NSUN2	intronic	.	ENSG00000037474	rs2303707	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6609	.	0.675319	0.6733	.	.	.	.	.	0	0	.	.	.	AFR:0.7452,AMR:0.6205,EAS:0.6636,FIN:0.5731,NFE:0.6623,OTH:0.6120,ASJ:0.6987	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	MU16722209	hom
5	6622122	6622122	T	A	NSUN2	intronic	.	ENSG00000037474	rs16877704	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0384	0.0430	0.0159744	0.0371	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.0102,AMR:0.0227,EAS:0,FIN:0.0421,NFE:0.0567,OTH:0.0356,ASJ:0.0331	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	.	het
5	10250443	10250443	T	C	CCT5	UTR5	.	ENSG00000150753	rs2578618	ENSG00000150753:ENST00000511700:exon1:c.T89C:p.V30A	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7892	0.7181	0.685304	0.7414	.	.	.	.	.	.	.	.	.	.	AFR:0.4588,AMR:0.7983,EAS:0.8346,FIN:0.8600,NFE:0.8573,OTH:0.8173,ASJ:0.8609	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795367	hom
5	10254817	10254817	A	G	CCT5	exonic	synonymous SNV	ENSG00000150753	rs2578617	ENSG00000150753:ENST00000280326:exon3:c.A198G:p.G66G,ENSG00000150753:ENST00000503026:exon3:c.A135G:p.G45G,ENSG00000150753:ENST00000515676:exon3:c.A84G:p.G28G	CCT5:NM_001306153:exon3:c.A135G:p.G45G,CCT5:NM_001306156:exon3:c.A84G:p.G28G,CCT5:NM_012073:exon3:c.A198G:p.G66G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7895	0.7187	0.685903	0.7418	.	.	.	.	.	.	.	.	CCT5:uc003jeq.3:exon3:c.A198G:p.G66G,CCT5:uc011cms.2:exon3:c.A84G:p.G28G	.	AFR:0.4596,AMR:0.7962,EAS:0.8331,FIN:0.8603,NFE:0.8578,OTH:0.8166,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795384	hom
5	10256161	10256161	T	C	CCT5	exonic	synonymous SNV	ENSG00000150753	rs1042392	ENSG00000150753:ENST00000506600:exon3:c.T147C:p.R49R,ENSG00000150753:ENST00000515390:exon3:c.T261C:p.R87R,ENSG00000150753:ENST00000280326:exon4:c.T426C:p.R142R,ENSG00000150753:ENST00000503026:exon4:c.T363C:p.R121R,ENSG00000150753:ENST00000515676:exon4:c.T312C:p.R104R	CCT5:NM_001306154:exon3:c.T261C:p.R87R,CCT5:NM_001306155:exon3:c.T147C:p.R49R,CCT5:NM_001306153:exon4:c.T363C:p.R121R,CCT5:NM_001306156:exon4:c.T312C:p.R104R,CCT5:NM_012073:exon4:c.T426C:p.R142R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7948	0.7274	0.692492	0.7493	.	.	.	.	.	.	.	.	CCT5:uc011cmr.2:exon3:c.T261C:p.R87R,CCT5:uc011cmt.2:exon3:c.T147C:p.R49R,CCT5:uc003jeq.3:exon4:c.T426C:p.R142R,CCT5:uc011cms.2:exon4:c.T312C:p.R104R	.	AFR:0.4732,AMR:0.7983,EAS:0.8465,FIN:0.8612,NFE:0.8637,OTH:0.8177,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU44187827	hom
5	10262740	10262740	C	A	CCT5	intronic	.	ENSG00000150753	rs2578642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7894	0.7187	0.685903	0.7416	.	.	.	.	.	.	.	.	.	.	AFR:0.4589,AMR:0.7971,EAS:0.8337,FIN:0.8603,NFE:0.8580,OTH:0.8153,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795401	hom
5	14184079	14184079	G	A	TRIO	intronic	.	ENSG00000038382	rs354300	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8173	.	0.8127	0.8239	.	.	.	.	.	.	.	.	.	.	AFR:0.6845,AMR:0.7278,EAS:0.9926,FIN:0.9139,NFE:0.8693,OTH:0.8517,ASJ:0.8179	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU81795659	hom
5	14290805	14290805	G	A	TRIO	intronic	.	ENSG00000038382	rs30629	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5072	0.4419	0.410743	ESAD-UK|2|409|0.00488998,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4647,AMR:0.2003,EAS:0.6126,FIN:0.5478,NFE:0.6005,OTH:0.5712,ASJ:0.4426	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	1(upper_aerodigestive_tract)	0.5409
5	14368975	14368975	C	T	TRIO	exonic	synonymous SNV	ENSG00000038382	rs13189406	ENSG00000038382:ENST00000513206:exon13:c.C2232T:p.N744N,ENSG00000038382:ENST00000344204:exon17:c.C3033T:p.N1011N,ENSG00000038382:ENST00000509967:exon17:c.C2886T:p.N962N,ENSG00000038382:ENST00000512070:exon17:c.C2856T:p.N952N,ENSG00000038382:ENST00000537187:exon17:c.C3033T:p.N1011N	TRIO:NM_007118:exon17:c.C3033T:p.N1011N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2508	0.2317	0.176518	0.2064	.	.	.	.	.	.	.	.	TRIO:uc003jfh.1:exon12:c.C1980T:p.N660N,TRIO:uc003jff.3:exon17:c.C3033T:p.N1011N,TRIO:uc011cna.1:exon17:c.C2886T:p.N962N	.	AFR:0.1072,AMR:0.2900,EAS:0.0432,FIN:0.1974,NFE:0.2714,OTH:0.2714,ASJ:0.3808	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU67363617	het
5	14397238	14397238	T	C	TRIO	exonic	synonymous SNV	ENSG00000038382	rs30774	ENSG00000038382:ENST00000513206:exon25:c.T3597C:p.D1199D,ENSG00000038382:ENST00000344204:exon29:c.T4398C:p.D1466D,ENSG00000038382:ENST00000509967:exon29:c.T4251C:p.D1417D,ENSG00000038382:ENST00000512070:exon29:c.T4221C:p.D1407D,ENSG00000038382:ENST00000537187:exon29:c.T4398C:p.D1466D	TRIO:NM_007118:exon29:c.T4398C:p.D1466D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3826	0.4421	0.393371	1(thyroid)	.	.	.	.	.	.	.	.	TRIO:uc003jfh.1:exon24:c.T3345C:p.D1115D,TRIO:uc003jff.3:exon29:c.T4398C:p.D1466D,TRIO:uc011cna.1:exon29:c.T4251C:p.D1417D	.	AFR:MU4552563,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.6575,FIN:0.4129,NFE:0.4172,OTH:0.0858,ASJ:0.3992	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	1(lung)	0.2722
5	14420027	14420027	A	C	TRIO	exonic	synonymous SNV	ENSG00000038382	rs30612	ENSG00000038382:ENST00000513206:exon30:c.A4299C:p.T1433T,ENSG00000038382:ENST00000344204:exon34:c.A5100C:p.T1700T,ENSG00000038382:ENST00000512070:exon34:c.A4923C:p.T1641T,ENSG00000038382:ENST00000537187:exon34:c.A5100C:p.T1700T	TRIO:NM_007118:exon34:c.A5100C:p.T1700T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8298	0.8960	0.81869	0.8768	.	.	.	.	.	.	.	.	TRIO:uc003jfh.1:exon29:c.A4047C:p.T1349T,TRIO:uc003jff.3:exon34:c.A5100C:p.T1700T	.	AFR:0.9709,AMR:0.8305,EAS:0.7165,FIN:0.8351,NFE:0.8536,OTH:0.8405,ASJ:0.8974	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU4548262	hom
5	35857177	35857177	G	C	IL7R	intronic	.	ENSG00000168685	rs1353252	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6395	0.7428	0.647364	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU586611,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.8686,FIN:0.5442,NFE:0.6567,OTH:0.4019,ASJ:0.7189	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	5	2(lung)	0.7384
5	35861068	35861068	T	C	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs1494558	ENSG00000168685:ENST00000303115:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000343305:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000506850:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000511982:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000514217:exon2:c.T197C:p.I66T	IL7R:NM_002185:exon2:c.T197C:p.I66T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.6279	0.7009	0.59984	3(urinary_tract)	-0.950	0.020	0.881	2.16	0.292	.	.	.	IL7R:uc003jjs.4:exon2:c.T197C:p.I66T,IL7R:uc011coo.3:exon2:c.T197C:p.I66T	-0.953	AFR:2(stomach),AMR:2(large_intestine),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,FIN:0.6843,NFE:0.7474,OTH:0.5358,ASJ:MU586612	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-0.76	0.000	.	5	18(soft_tissue)	0.6556
5	35871190	35871190	G	A	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs1494555	ENSG00000168685:ENST00000303115:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000343305:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000506850:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000514217:exon4:c.G412A:p.V138I	IL7R:NM_002185:exon4:c.G412A:p.V138I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.6519	0.7458	0.666933	18(soft_tissue)	-0.630	0.106	0.664	-1.61	0.008	.	.	Fibronectin type III|Immunoglobulin-like fold	IL7R:uc003jjs.4:exon4:c.G412A:p.V138I,IL7R:uc011coo.3:exon4:c.G412A:p.V138I	-0.974	AFR:2(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:MU586614,FIN:MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,NFE:0.7252,OTH:0.8671,ASJ:1(skin)	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-1.12	0.000	.	5	2(large_intestine)	0.5530
5	35871273	35871273	C	T	IL7R	exonic	synonymous SNV	ENSG00000168685	rs2228141	ENSG00000168685:ENST00000303115:exon4:c.C495T:p.H165H,ENSG00000168685:ENST00000343305:exon4:c.C495T:p.H165H,ENSG00000168685:ENST00000506850:exon4:c.C495T:p.H165H,ENSG00000168685:ENST00000514217:exon4:c.C495T:p.H165H	IL7R:NM_002185:exon4:c.C495T:p.H165H	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1268	0.1351	0.128594	MU108834	.	.	.	.	.	.	.	.	IL7R:uc003jjs.4:exon4:c.C495T:p.H165H,IL7R:uc011coo.3:exon4:c.C495T:p.H165H	.	AFR:ESAD-UK|2|409|0.00488998,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.1268,EAS:0.1531,FIN:0.1490,NFE:0.1518,OTH:0.1143,ASJ:0.1249	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.1270
5	35876274	35876274	A	G	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs3194051	ENSG00000168685:ENST00000505875:exon2:c.A364G:p.I122V,ENSG00000168685:ENST00000303115:exon8:c.A1066G:p.I356V	IL7R:NM_002185:exon8:c.A1066G:p.I356V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2445	0.2932	0.220847	0.2838	-1.571	0.002	0.68	3.23	0.016	.	.	.	IL7R:uc003jjs.4:exon8:c.A1066G:p.I356V	-0.937	AFR:0.3437,AMR:0.1897,EAS:0.0786,FIN:0.2847,NFE:0.2775,OTH:0.2841,ASJ:0.2152	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.044	1.88	0.000	1.625	5	MU113461700	het
5	36985303	36985303	A	G	NIPBL	exonic	nonsynonymous SNV	ENSG00000164190	rs3822471	ENSG00000164190:ENST00000282516:exon10:c.A2021G:p.N674S,ENSG00000164190:ENST00000448238:exon10:c.A2021G:p.N674S	NIPBL:NM_015384:exon10:c.A2021G:p.N674S,NIPBL:NM_133433:exon10:c.A2021G:p.N674S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1322	0.1138	0.1252	3(haematopoietic_and_lymphoid_tissue)	-0.743	0.057	0.181	2.31	1.000	.	.	.	NIPBL:uc003jkm.1:exon6:c.A1658G:p.N553S,NIPBL:uc003jkk.4:exon10:c.A2021G:p.N674S,NIPBL:uc003jkl.4:exon10:c.A2021G:p.N674S	-1.006	AFR:1(lung),AMR:4(soft_tissue),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,FIN:0.1179,NFE:0.0988,OTH:0.2033,ASJ:MU120396	608667	122470;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	0.0	-3.27	0.001	1.75	5	2(large_intestine)	0.2119
5	37001074	37001074	A	G	NIPBL	intronic	.	ENSG00000164190	rs78827246	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1320	0.1132	0.126797	MU767064	.	.	.	.	.	.	.	.	.	.	AFR:MELA-AU|1|183|0.00546448,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.1177,EAS:0.2033,FIN:0.2053,NFE:0.1152,OTH:0.1298,ASJ:0.0984	608667	122470;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	5	1(large_intestine)	0.1191
5	38486065	38486065	C	T	LIFR	exonic	nonsynonymous SNV	ENSG00000113594	rs3110234	ENSG00000113594:ENST00000263409:exon17:c.G2353A:p.V785I,ENSG00000113594:ENST00000453190:exon17:c.G2353A:p.V785I	LIFR:NM_001127671:exon17:c.G2353A:p.V785I,LIFR:NM_001364297:exon17:c.G2353A:p.V785I,LIFR:NM_001364298:exon17:c.G2353A:p.V785I,LIFR:NM_002310:exon17:c.G2353A:p.V785I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.1909	0.1869	0.138379	0.1740	2.442	19.09	0.373	3.61	0.970	.	.	Fibronectin type III|Immunoglobulin-like fold	LIFR:uc003jli.2:exon17:c.G2353A:p.V785I,LIFR:uc010ive.1:exon17:c.G2353A:p.V785I	-1.018	AFR:0.125,AMR:0.2667,EAS:0.0210,FIN:0.1989,NFE:0.2065,OTH:0.2159,ASJ:0.1225	151443	601559;	3206;	3206|Neonatal Schwartz-Jampel syndrome<br>SJS2<br>Schwartz-Jampel syndrome type 2<br>Stve-Wiedemann dysplasia<br>Stve-Wiedemann/Schwartz-Jampel type 2 syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|601559 ~	.	.	.	.	0.451	0.45	0.000	1.4	5	.	het
5	38950776	38950776	G	A	RICTOR	exonic	synonymous SNV	ENSG00000164327	rs2115949	ENSG00000164327:ENST00000296782:exon31:c.C3174T:p.S1058S,ENSG00000164327:ENST00000357387:exon31:c.C3174T:p.S1058S	RICTOR:NM_001285439:exon31:c.C3174T:p.S1058S,RICTOR:NM_001285440:exon31:c.C2319T:p.S773S,RICTOR:NM_152756:exon31:c.C3174T:p.S1058S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9658	0.9521	0.949481	0.9624	.	.	.	.	.	.	.	.	RICTOR:uc003jlo.2:exon31:c.C3174T:p.S1058S,RICTOR:uc003jlp.2:exon31:c.C3174T:p.S1058S,RICTOR:uc010ivf.2:exon31:c.C2319T:p.S773S	.	AFR:0.9120,AMR:0.9665,EAS:0.9926,FIN:0.9914,NFE:0.9802,OTH:0.9755,ASJ:0.9834	609022	.	.	.	.	.	.	.	.	.	.	.	5	MU81796672	hom
5	38953665	38953665	-	A	RICTOR	intronic	.	ENSG00000164327	rs33912683	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9376	0.8929	0.934105	0.9387	.	.	.	.	.	.	.	.	.	.	AFR:0.8858,AMR:0.9494,EAS:0.9913,FIN:0.9582,NFE:0.9581,OTH:0.9537,ASJ:0.9733	609022	.	.	.	.	.	.	.	.	.	.	.	5	.	hom
5	38958750	38958750	A	G	RICTOR	intronic	.	ENSG00000164327	rs6868087	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4063	0.3804	0.382987	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.3617,AMR:0.3386,EAS:0.3133,FIN:0.3488,NFE:0.3637,OTH:0.3701,ASJ:0.4867	609022	.	.	.	.	.	.	.	.	.	.	.	5	14(soft_tissue)	0.3609
5	56111751	56111751	G	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs28710284	ENSG00000095015:ENST00000399503:exon1:c.G351C:p.A117A	MAP3K1:NM_005921:exon1:c.G351C:p.A117A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7955	.	0.685703	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon1:c.G351C:p.A117A	.	AFR:0.7508,AMR:0.6573,EAS:0.8404,FIN:0.5916,NFE:0.8094,OTH:0.8129,ASJ:0.6225	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.7950
5	56152416	56152416	C	A	MAP3K1	intronic	.	ENSG00000237705	rs832567	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6132	0.6989	0.526158	0.6521	.	.	.	.	.	0.0006	0.018	.	.	.	AFR:0.6500,AMR:0.4618,EAS:0.2040,FIN:0.7156,NFE:0.6929,OTH:0.6793,ASJ:0.7748	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU767397	hom
5	56161787	56161787	G	A	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832575	ENSG00000095015:ENST00000399503:exon6:c.G1284A:p.T428T	MAP3K1:NM_005921:exon6:c.G1284A:p.T428T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8479	0.8530	0.804313	0.8481	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon6:c.G1284A:p.T428T	.	AFR:0.7975,AMR:0.7005,EAS:0.7163,FIN:0.9001,NFE:0.8844,OTH:0.8890,ASJ:0.8907	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU18483702	hom
5	56168712	56168712	C	T	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs2229882	ENSG00000095015:ENST00000399503:exon9:c.C1566T:p.T522T	MAP3K1:NM_005921:exon9:c.C1566T:p.T522T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0474	0.0474	0.0445288	MU82305134	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon9:c.C1566T:p.T522T	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.0404,EAS:0.0490,FIN:0.0563,NFE:0.0551,OTH:0.0252,ASJ:0.0329	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(lung)	0.0474
5	56177443	56177443	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs702689	ENSG00000095015:ENST00000399503:exon14:c.G2416A:p.D806N	MAP3K1:NM_005921:exon14:c.G2416A:p.D806N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.5984	0.6501	0.476438	MU12351955	2.329	18.36	0.195	5.56	1.000	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2416A:p.D806N	-0.975	AFR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.6061,EAS:0.4555,FIN:0.7748,NFE:0.2011,OTH:0.7146,ASJ:0.4892	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.999	0.82	0.000	2.085	5	76(lung)	0.6930
5	56177743	56177743	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs832582	ENSG00000095015:ENST00000399503:exon14:c.G2716A:p.V906I	MAP3K1:NM_005921:exon14:c.G2716A:p.V906I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7648	0.7985	0.708267	75(lung)	-2.273	0.001	0.847	3.58	0.036	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2716A:p.V906I	-1.009	AFR:MU12351967,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02,EAS:0.7459,FIN:0.6089,NFE:0.8477,OTH:0.5902,ASJ:0.7760	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.0	1.56	0.000	0.11	5	1(large_intestine)	0.8130
5	56177849	56177851	CAA	-	MAP3K1	exonic	nonframeshift deletion	ENSG00000095015	rs10552703	ENSG00000095015:ENST00000399503:exon14:c.2822_2824del:p.941_942del	MAP3K1:NM_005921:exon14:c.2822_2824del:p.941_942del	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7393	.	.	0.7706	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.2822_2824del:p.941_942del	.	AFR:0.7403,AMR:0.5958,EAS:0.5813,FIN:0.8033,NFE:0.8077,OTH:0.7961,ASJ:0.8425	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	.	hom
5	56178111	56178111	A	G	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs3822625	ENSG00000095015:ENST00000399503:exon14:c.A3084G:p.Q1028Q	MAP3K1:NM_005921:exon14:c.A3084G:p.Q1028Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0721	0.0786	0.0900559	3(soft_tissue)	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.A3084G:p.Q1028Q	.	AFR:25(meninges),AMR:MU19710394,EAS:0.0747,FIN:0.1002,NFE:0.0598,OTH:0.0728,ASJ:PACA-CA|1|268|0.00373134,LICA-CN|2|402|0.00497512,COCA-CN|1|321|0.00311526	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(urinary_tract)	0.1038
5	56178217	56178217	A	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832583	ENSG00000095015:ENST00000399503:exon14:c.A3190C:p.R1064R	MAP3K1:NM_005921:exon14:c.A3190C:p.R1064R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7653	0.7995	0.708267	1(thyroid)	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.A3190C:p.R1064R	.	AFR:2(breast),AMR:MU4558542,EAS:0.7764,FIN:0.7465,NFE:0.6089,OTH:0.8477,ASJ:LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.5897
5	57754004	57754004	C	T	PLK2	intronic	.	ENSG00000145632	rs697135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4229	0.5076	0.422324	0.5019	.	.	.	.	.	0.0001	0.162	.	.	.	AFR:0.6283,AMR:0.4317,EAS:0.2460,FIN:0.4819,NFE:0.4702,OTH:0.4561,ASJ:0.3691	607023	.	.	.	.	.	.	.	.	.	.	.	5	MU27120297	unknown
5	57754005	57754005	G	A	PLK2	intronic	.	ENSG00000145632	rs1848510	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4005	0.3392	0.403155	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0	0.002	.	.	.	AFR:MU10792843,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.2718,FIN:0.4725,NFE:0.4570,OTH:0.4926,ASJ:0.3326	607023	.	.	.	.	.	.	.	.	.	.	.	5	2(lung)	0.3064
5	57754808	57754808	G	A	PLK2	intronic	.	ENSG00000145632	rs697133	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6662	0.6373	0.740216	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0013	0.062	.	.	.	AFR:0.6426,AMR:0.7164,EAS:0.62,FIN:0.8881,NFE:0.6009,OTH:0.5763,ASJ:0.7780	607023	.	.	.	.	.	.	.	.	.	.	.	5	1(liver)	0.6322
5	57754851	57754851	A	G	PLK2	exonic	synonymous SNV	ENSG00000145632	rs702722	ENSG00000145632:ENST00000274289:exon2:c.T339C:p.I113I	PLK2:NM_006622:exon2:c.T339C:p.I113I,PLK2:NM_001252226:exon3:c.T297C:p.I99I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1212	0.1406	0.169728	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PLK2:uc011cql.1:exon1:c.T45C:p.I15I,PLK2:uc003jrn.3:exon2:c.T339C:p.I113I,PLK2:uc021xyx.1:exon3:c.T297C:p.I99I	.	AFR:0.1410,AMR:0.2007,EAS:0.0960,FIN:0.2738,NFE:0.1239,OTH:0.1029,ASJ:0.0610	607023	.	.	.	.	.	.	.	.	.	.	.	5	1(large_intestine)	0.1166
5	57755703	57755703	C	T	PLK2	exonic	synonymous SNV	ENSG00000145632	rs3211270	ENSG00000145632:ENST00000274289:exon1:c.G84A:p.A28A	PLK2:NM_001252226:exon1:c.G84A:p.A28A,PLK2:NM_006622:exon1:c.G84A:p.A28A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3825	0.3143	0.390974	1(lung)	.	.	.	.	.	.	.	.	PLK2:uc003jrn.3:exon1:c.G84A:p.A28A,PLK2:uc021xyx.1:exon1:c.G84A:p.A28A	.	AFR:MU131745,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,EAS:0.2665,FIN:0.4594,NFE:0.4437,OTH:0.4901,ASJ:0.3109	607023	.	.	.	.	.	.	.	.	.	.	.	5	1(thyroid)	0.2623
5	60200665	60200665	A	G	ERCC8	exonic	synonymous SNV	ENSG00000049167	rs4647100	ENSG00000049167:ENST00000265038:exon5:c.T435C:p.Y145Y,ENSG00000049167:ENST00000426742:exon6:c.T261C:p.Y87Y,ENSG00000049167:ENST00000439176:exon6:c.T261C:p.Y87Y	ERCC8:NM_000082:exon5:c.T435C:p.Y145Y,ERCC8:NM_001007234:exon5:c.T435C:p.Y145Y,ERCC8:NM_001007233:exon6:c.T261C:p.Y87Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2058	0.2042	0.135783	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	ERCC8:uc003jsm.3:exon5:c.T435C:p.Y145Y,ERCC8:uc003jsn.3:exon5:c.T435C:p.Y145Y,ERCC8:uc003jsl.3:exon6:c.T261C:p.Y87Y	.	AFR:0.2002,AMR:0.0921,EAS:0.2297,FIN:0.0006,NFE:0.2655,OTH:0.2704,ASJ:0.1579	609412	216400;614621;	178338;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	.	.	.	.	.	.	.	5	1(lung)	0.2478
5	67522722	67522722	C	T	PIK3R1	exonic	synonymous SNV	ENSG00000145675	rs706713	ENSG00000145675:ENST00000274335:exon1:c.C219T:p.Y73Y,ENSG00000145675:ENST00000396611:exon1:c.C219T:p.Y73Y,ENSG00000145675:ENST00000521381:exon2:c.C219T:p.Y73Y,ENSG00000145675:ENST00000521657:exon2:c.C219T:p.Y73Y	PIK3R1:NM_181523:exon2:c.C219T:p.Y73Y	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3129	0.2933	0.419329	1(liver)	.	.	.	.	.	.	.	.	PIK3R1:uc003jva.3:exon2:c.C219T:p.Y73Y	.	AFR:MU10857398,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.4091,FIN:0.3690,NFE:0.2351,OTH:0.6857,ASJ:0.3176	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9068,9067,9069	.	.	.	.	.	.	5	1(breast)	0.2703
5	67522851	67522851	A	C	PIK3R1	intronic	.	ENSG00000145675	rs706714	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3317	0.2939	0.42492	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3193,AMR:0.3820,EAS:0.2450,FIN:0.7184,NFE:0.2758,OTH:0.2513,ASJ:0.3711	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	5	1(liver)	0.2781
5	68531253	68531253	C	T	CDK7	exonic	nonsynonymous SNV	ENSG00000134058	rs2972388	ENSG00000134058:ENST00000256443:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000504147:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000506789:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000508726:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000510106:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000514676:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000515180:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000515391:exon2:c.C99T:p.N33N	CDK7:NM_001324071:exon2:c.C65T:p.T22I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5842	0.5963	0.629792	0.5993	.	.	.	.	.	.	.	.	CDK7:uc003jvs.4:exon2:c.C99T:p.N33N,CDK7:uc010ixd.1:exon2:c.C99T:p.N33N,CDK7:uc021xzo.1:exon2:c.C99T:p.N33N	.	AFR:0.7158,AMR:0.6295,EAS:0.4963,FIN:0.5807,NFE:0.5476,OTH:0.5840,ASJ:0.5298	601955	.	.	.	.	.	.	.	.	.	.	.	5	MU18490713	hom
5	68692375	68692375	-	A	RAD17	splicing	.	ENSG00000152942	rs34097088	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4291	.	.	0.7119	.	.	.	.	.	.	.	.	.	.	AFR:0.8725,AMR:0.6617,EAS:0.5665,FIN:0.5864,NFE:0.6473,OTH:0.6717,ASJ:0.7159	603139	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	68709884	68709884	G	A	RAD17	exonic	nonsynonymous SNV	ENSG00000152942	rs35440980	ENSG00000152942:ENST00000282891:exon16:c.G1520A:p.R507K,ENSG00000152942:ENST00000358030:exon16:c.G1283A:p.R428K,ENSG00000152942:ENST00000380774:exon16:c.G1811A:p.R604K,ENSG00000152942:ENST00000305138:exon17:c.G1778A:p.R593K,ENSG00000152942:ENST00000345306:exon17:c.G1778A:p.R593K,ENSG00000152942:ENST00000521422:exon17:c.G1283A:p.R428K,ENSG00000152942:ENST00000354312:exon18:c.G1778A:p.R593K,ENSG00000152942:ENST00000361732:exon18:c.G1778A:p.R593K,ENSG00000152942:ENST00000509734:exon18:c.G1811A:p.R604K,ENSG00000152942:ENST00000354868:exon19:c.G1778A:p.R593K	RAD17:NM_133339:exon16:c.G1811A:p.R604K,RAD17:NM_133340:exon16:c.G1283A:p.R428K,RAD17:NM_133341:exon16:c.G1520A:p.R507K,RAD17:NM_002873:exon17:c.G1778A:p.R593K,RAD17:NM_133344:exon17:c.G1778A:p.R593K,RAD17:NM_001278622:exon18:c.G1778A:p.R593K,RAD17:NM_133342:exon18:c.G1778A:p.R593K,RAD17:NM_133343:exon18:c.G1778A:p.R593K,RAD17:NM_133338:exon19:c.G1778A:p.R593K	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0118	0.0072	0.00858626	0.0053	0.972	10.50	0.986	2.09	0.803	.	.	.	RAD17:uc003jwm.3:exon16:c.G1283A:p.R428K,RAD17:uc003jwn.3:exon16:c.G1520A:p.R507K,RAD17:uc003jwo.3:exon16:c.G1811A:p.R604K,RAD17:uc003jwj.3:exon17:c.G1778A:p.R593K,RAD17:uc003jwl.3:exon17:c.G1778A:p.R593K,RAD17:uc003jwg.3:exon18:c.G1778A:p.R593K,RAD17:uc003jwh.3:exon18:c.G1778A:p.R593K,RAD17:uc003jwk.3:exon18:c.G1778A:p.R593K,RAD17:uc003jwi.3:exon19:c.G1778A:p.R593K	-0.990	AFR:0.0007,AMR:0.0012,EAS:0,FIN:0.0040,NFE:0.0091,OTH:0.0061,ASJ:0.0066	603139	.	.	.	.	.	.	.	0.0	2.49	0.017	1.535	5	.	het
5	79950724	79950724	-	CCGCAGCGC	MSH3	exonic	nonframeshift insertion	ENSG00000113318	rs758718643	ENSG00000113318:ENST00000265081:exon1:c.178_179insCCGCAGCGC:p.A60delinsAAAP	MSH3:NM_002439:exon1:c.178_179insCCGCAGCGC:p.A60delinsAAAP	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0427	0.0727	.	0.1016	.	.	.	.	.	.	.	.	MSH3:uc003kgz.4:exon1:c.178_179insCCGCAGCGC:p.A60delinsAAAP,DHFR:uc011ctl.2:exon1:c.58_59insGCGCTGCGG:p.A20delinsGAAA	.	AFR:0.0638,AMR:0.1709,EAS:0.2748,FIN:0.1011,NFE:0.0882,OTH:0.1102,ASJ:0.1897	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	.	.	.	.	5	.	het
5	80149981	80149981	A	G	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs184967	ENSG00000113318:ENST00000265081:exon21:c.A2846G:p.Q949R	MSH3:NM_002439:exon21:c.A2846G:p.Q949R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.8731	0.8552	0.902157	MU4549212	0.224	4.933	1.0	0.287	0.991	.	.	DNA mismatch repair protein MutS, C-terminal|P-loop containing nucleoside triphosphate hydrolase	MSH3:uc003kgz.4:exon21:c.A2846G:p.Q949R	-0.948	AFR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,AMR:0.8711,EAS:0.9189,FIN:0.8067,NFE:1,OTH:0.8713,ASJ:0.8881	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.0	-1.93	0.000	-0.32	5	42(large_intestine)	0.8461
5	80168937	80168937	G	A	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs26279	ENSG00000113318:ENST00000265081:exon23:c.G3133A:p.A1045T	MSH3:NM_002439:exon23:c.G3133A:p.A1045T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7305	0.6947	0.720248	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	0.480	7.280	0.551	-2.54	0.009	.	.	DNA mismatch repair protein MutS, C-terminal|P-loop containing nucleoside triphosphate hydrolase	MSH3:uc003kgz.4:exon23:c.G3133A:p.A1045T	-0.949	AFR:0.7083,AMR:0.6658,EAS:0.6987,FIN:0.7423,NFE:0.7239,OTH:0.7223,ASJ:0.7524	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.075	-2.14	0.000	-0.245	5	1(haematopoietic_and_lymphoid_tissue)	0.7249
5	82648943	82648943	G	A	XRCC4	splicing	.	ENSG00000152422	rs1805377	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2302	0.2296	0.3752	0.2567	-0.106	1.684	.	-0.065	0.007	0.9953	0.432	.	.	.	AFR:0.4394,AMR:0.3684,EAS:0.7273,FIN:0.1905,NFE:0.1162,OTH:0.1821,ASJ:0.1358	194363	616541;	436182;	436182|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|616541 ~	.	.	.	.	.	.	.	.	5	MU10944981	het
5	82648977	82648977	T	G	XRCC4	exonic	synonymous SNV	ENSG00000152422	rs1056503	ENSG00000152422:ENST00000282268:exon8:c.T921G:p.S307S,ENSG00000152422:ENST00000338635:exon8:c.T927G:p.S309S,ENSG00000152422:ENST00000396027:exon8:c.T921G:p.S307S,ENSG00000152422:ENST00000511817:exon8:c.T927G:p.S309S	XRCC4:NM_001318012:exon8:c.T927G:p.S309S,XRCC4:NM_003401:exon8:c.T921G:p.S307S,XRCC4:NM_022406:exon8:c.T927G:p.S309S,XRCC4:NM_022550:exon8:c.T921G:p.S307S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2299	0.2305	0.375599	0.2567	.	.	.	.	.	.	.	.	XRCC4:uc003kib.3:exon8:c.T927G:p.S309S,XRCC4:uc003kic.3:exon8:c.T921G:p.S307S,XRCC4:uc003kid.3:exon8:c.T921G:p.S307S,XRCC4:uc003kie.3:exon8:c.T927G:p.S309S	.	AFR:0.4392,AMR:0.3678,EAS:0.7251,FIN:0.1918,NFE:0.1164,OTH:0.1797,ASJ:0.1358	194363	616541;	436182;	436182|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|616541 ~	.	.	.	.	.	.	.	.	5	MU10944986	het
5	98193867	98193867	G	T	CHD1	intronic	.	ENSG00000153922	rs77597932	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0735	0.0606	0.0700879	0.0554	.	.	.	.	.	.	.	.	.	.	AFR:0.0400,AMR:0.0694,EAS:0.0760,FIN:0.0421,NFE:0.0653,OTH:0.0449,ASJ:0.0430	602118	.	.	.	.	.	.	.	.	.	.	.	5	MU11025025	het
5	112162854	112162854	T	C	APC	exonic	synonymous SNV	ENSG00000134982	rs2229992	ENSG00000134982:ENST00000504915:exon3:c.T147C:p.Y49Y,ENSG00000134982:ENST00000507379:exon10:c.T1404C:p.Y468Y,ENSG00000134982:ENST00000257430:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000457016:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000512211:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000508376:exon13:c.T1458C:p.Y486Y	APC:NM_001127511:exon10:c.T1404C:p.Y468Y,APC:NM_001354897:exon11:c.T1488C:p.Y496Y,APC:NM_001354899:exon11:c.T1374C:p.Y458Y,APC:NM_001354901:exon11:c.T1281C:p.Y427Y,APC:NM_001354902:exon11:c.T1185C:p.Y395Y,APC:NM_001354905:exon11:c.T978C:p.Y326Y,APC:NM_000038:exon12:c.T1458C:p.Y486Y,APC:NM_001354895:exon12:c.T1458C:p.Y486Y,APC:NM_001354898:exon12:c.T1383C:p.Y461Y,APC:NM_001354900:exon12:c.T1335C:p.Y445Y,APC:NM_001354903:exon12:c.T1155C:p.Y385Y,APC:NM_001354904:exon12:c.T1080C:p.Y360Y,APC:NM_001127510:exon13:c.T1458C:p.Y486Y,APC:NM_001354896:exon13:c.T1512C:p.Y504Y,APC:NM_001354906:exon13:c.T609C:p.Y203Y	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5780	0.4622	0.509984	0.4692	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon10:c.T1404C:p.Y468Y,APC:uc003kpy.4:exon12:c.T1458C:p.Y486Y,APC:uc003kpz.4:exon13:c.T1458C:p.Y486Y,APC:uc010jbz.3:exon13:c.T609C:p.Y203Y	.	AFR:0.2085,AMR:0.6579,EAS:0.6538,FIN:0.5003,NFE:0.5762,OTH:0.5430,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,738,737	.	,741	.	.	.	.	5	MU151723	hom
5	112164561	112164561	G	A	APC	exonic	synonymous SNV	ENSG00000134982;ENSG00000258864	rs351771	ENSG00000134982:ENST00000504915:exon5:c.G324A:p.A108A,ENSG00000134982:ENST00000507379:exon12:c.G1581A:p.A527A,ENSG00000134982:ENST00000257430:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000457016:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000512211:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000508376:exon15:c.G1635A:p.A545A	APC:NM_001127511:exon12:c.G1581A:p.A527A,APC:NM_001354897:exon13:c.G1665A:p.A555A,APC:NM_001354899:exon13:c.G1551A:p.A517A,APC:NM_001354901:exon13:c.G1458A:p.A486A,APC:NM_001354902:exon13:c.G1362A:p.A454A,APC:NM_001354905:exon13:c.G1155A:p.A385A,APC:NM_000038:exon14:c.G1635A:p.A545A,APC:NM_001354895:exon14:c.G1635A:p.A545A,APC:NM_001354898:exon14:c.G1560A:p.A520A,APC:NM_001354900:exon14:c.G1512A:p.A504A,APC:NM_001354903:exon14:c.G1332A:p.A444A,APC:NM_001354904:exon14:c.G1257A:p.A419A,APC:NM_001127510:exon15:c.G1635A:p.A545A,APC:NM_001354896:exon15:c.G1689A:p.A563A,APC:NM_001354906:exon15:c.G786A:p.A262A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6481	0.5864	0.666134	0.5927	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon12:c.G1581A:p.A527A,APC:uc003kpy.4:exon14:c.G1635A:p.A545A,APC:uc003kpz.4:exon15:c.G1635A:p.A545A,APC:uc010jbz.3:exon15:c.G786A:p.A262A	.	AFR:0.5342,AMR:0.6926,EAS:0.8064,FIN:0.5564,NFE:0.6048,OTH:0.6212,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,738,737	.	,741	.	.	.	.	5	MU151734	hom
5	112175770	112175770	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs41115	ENSG00000134982:ENST00000257430:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000457016:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000508376:exon17:c.G4479A:p.T1493T	APC:NM_001127511:exon14:c.G4425A:p.T1475T,APC:NM_001354897:exon15:c.G4509A:p.T1503T,APC:NM_001354899:exon15:c.G4395A:p.T1465T,APC:NM_001354901:exon15:c.G4302A:p.T1434T,APC:NM_001354902:exon15:c.G4206A:p.T1402T,APC:NM_001354905:exon15:c.G3999A:p.T1333T,APC:NM_000038:exon16:c.G4479A:p.T1493T,APC:NM_001354895:exon16:c.G4479A:p.T1493T,APC:NM_001354898:exon16:c.G4404A:p.T1468T,APC:NM_001354900:exon16:c.G4356A:p.T1452T,APC:NM_001354903:exon16:c.G4176A:p.T1392T,APC:NM_001354904:exon16:c.G4101A:p.T1367T,APC:NM_001127510:exon17:c.G4479A:p.T1493T,APC:NM_001354896:exon17:c.G4533A:p.T1511T,APC:NM_001354906:exon17:c.G3630A:p.T1210T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6486	0.5862	0.665535	0.5933	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2379A:p.T793T,APC:uc011cvt.2:exon14:c.G4425A:p.T1475T,APC:uc003kpy.4:exon16:c.G4479A:p.T1493T,APC:uc003kpz.4:exon17:c.G4479A:p.T1493T,APC:uc010jbz.3:exon17:c.G3630A:p.T1210T	.	AFR:0.5356,AMR:0.6918,EAS:0.8082,FIN:0.5563,NFE:0.6050,OTH:0.6209,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,738,737	.	,741	.	.	.	.	5	MU62815	hom
5	112176325	112176325	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs42427	ENSG00000134982:ENST00000257430:exon16:c.G5034A:p.G1678G,ENSG00000134982:ENST00000457016:exon16:c.G5034A:p.G1678G,ENSG00000134982:ENST00000508376:exon17:c.G5034A:p.G1678G	APC:NM_001127511:exon14:c.G4980A:p.G1660G,APC:NM_001354897:exon15:c.G5064A:p.G1688G,APC:NM_001354899:exon15:c.G4950A:p.G1650G,APC:NM_001354901:exon15:c.G4857A:p.G1619G,APC:NM_001354902:exon15:c.G4761A:p.G1587G,APC:NM_001354905:exon15:c.G4554A:p.G1518G,APC:NM_000038:exon16:c.G5034A:p.G1678G,APC:NM_001354895:exon16:c.G5034A:p.G1678G,APC:NM_001354898:exon16:c.G4959A:p.G1653G,APC:NM_001354900:exon16:c.G4911A:p.G1637G,APC:NM_001354903:exon16:c.G4731A:p.G1577G,APC:NM_001354904:exon16:c.G4656A:p.G1552G,APC:NM_001127510:exon17:c.G5034A:p.G1678G,APC:NM_001354896:exon17:c.G5088A:p.G1696G,APC:NM_001354906:exon17:c.G4185A:p.G1395G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6514	0.5901	0.666733	0.5956	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2934A:p.G978G,APC:uc011cvt.2:exon14:c.G4980A:p.G1660G,APC:uc003kpy.4:exon16:c.G5034A:p.G1678G,APC:uc003kpz.4:exon17:c.G5034A:p.G1678G,APC:uc010jbz.3:exon17:c.G4185A:p.G1395G	.	AFR:0.5373,AMR:0.6950,EAS:0.8068,FIN:0.5573,NFE:0.6082,OTH:0.6255,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,738,737	.	,741	.	.	.	.	5	MU62789	hom
5	112176559	112176559	T	G	APC	exonic	synonymous SNV	ENSG00000134982	rs866006	ENSG00000134982:ENST00000257430:exon16:c.T5268G:p.S1756S,ENSG00000134982:ENST00000457016:exon16:c.T5268G:p.S1756S,ENSG00000134982:ENST00000508376:exon17:c.T5268G:p.S1756S	APC:NM_001127511:exon14:c.T5214G:p.S1738S,APC:NM_001354897:exon15:c.T5298G:p.S1766S,APC:NM_001354899:exon15:c.T5184G:p.S1728S,APC:NM_001354901:exon15:c.T5091G:p.S1697S,APC:NM_001354902:exon15:c.T4995G:p.S1665S,APC:NM_001354905:exon15:c.T4788G:p.S1596S,APC:NM_000038:exon16:c.T5268G:p.S1756S,APC:NM_001354895:exon16:c.T5268G:p.S1756S,APC:NM_001354898:exon16:c.T5193G:p.S1731S,APC:NM_001354900:exon16:c.T5145G:p.S1715S,APC:NM_001354903:exon16:c.T4965G:p.S1655S,APC:NM_001354904:exon16:c.T4890G:p.S1630S,APC:NM_001127510:exon17:c.T5268G:p.S1756S,APC:NM_001354896:exon17:c.T5322G:p.S1774S,APC:NM_001354906:exon17:c.T4419G:p.S1473S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6508	0.5880	0.666933	0.5942	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.T3168G:p.S1056S,APC:uc011cvt.2:exon14:c.T5214G:p.S1738S,APC:uc003kpy.4:exon16:c.T5268G:p.S1756S,APC:uc003kpz.4:exon17:c.T5268G:p.S1756S,APC:uc010jbz.3:exon17:c.T4419G:p.S1473S	.	AFR:0.5361,AMR:0.6933,EAS:0.8055,FIN:0.5574,NFE:0.6065,OTH:0.6214,ASJ:0.5993	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,738,737	.	,741	.	.	.	.	5	MU18515471	hom
5	112176756	112176756	T	A	APC	exonic	nonsynonymous SNV	ENSG00000134982	rs459552	ENSG00000134982:ENST00000257430:exon16:c.T5465A:p.V1822D,ENSG00000134982:ENST00000457016:exon16:c.T5465A:p.V1822D,ENSG00000134982:ENST00000508376:exon17:c.T5465A:p.V1822D	APC:NM_001127511:exon14:c.T5411A:p.V1804D,APC:NM_001354897:exon15:c.T5495A:p.V1832D,APC:NM_001354899:exon15:c.T5381A:p.V1794D,APC:NM_001354901:exon15:c.T5288A:p.V1763D,APC:NM_001354902:exon15:c.T5192A:p.V1731D,APC:NM_001354905:exon15:c.T4985A:p.V1662D,APC:NM_000038:exon16:c.T5465A:p.V1822D,APC:NM_001354895:exon16:c.T5465A:p.V1822D,APC:NM_001354898:exon16:c.T5390A:p.V1797D,APC:NM_001354900:exon16:c.T5342A:p.V1781D,APC:NM_001354903:exon16:c.T5162A:p.V1721D,APC:NM_001354904:exon16:c.T5087A:p.V1696D,APC:NM_001127510:exon17:c.T5465A:p.V1822D,APC:NM_001354896:exon17:c.T5519A:p.V1840D,APC:NM_001354906:exon17:c.T4616A:p.V1539D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.7981	0.8263	0.865415	0.8113	1.486	13.24	0.672	3.59	0.991	.	.	.	APC:uc010jca.3:exon3:c.T3365A:p.V1122D,APC:uc011cvt.2:exon14:c.T5411A:p.V1804D,APC:uc003kpy.4:exon16:c.T5465A:p.V1822D,APC:uc003kpz.4:exon17:c.T5465A:p.V1822D,APC:uc010jbz.3:exon17:c.T4616A:p.V1539D	-0.947	AFR:0.9616,AMR:0.8062,EAS:0.8937,FIN:0.6910,NFE:0.7465,OTH:0.7719,ASJ:0.7767	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,698,738,737	.	,741	0.0	-2.3	0.000	-0.895	5	MU151742	hom
5	112177171	112177171	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs465899	ENSG00000134982:ENST00000257430:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000457016:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000508376:exon17:c.G5880A:p.P1960P	APC:NM_001127511:exon14:c.G5826A:p.P1942P,APC:NM_001354897:exon15:c.G5910A:p.P1970P,APC:NM_001354899:exon15:c.G5796A:p.P1932P,APC:NM_001354901:exon15:c.G5703A:p.P1901P,APC:NM_001354902:exon15:c.G5607A:p.P1869P,APC:NM_001354905:exon15:c.G5400A:p.P1800P,APC:NM_000038:exon16:c.G5880A:p.P1960P,APC:NM_001354895:exon16:c.G5880A:p.P1960P,APC:NM_001354898:exon16:c.G5805A:p.P1935P,APC:NM_001354900:exon16:c.G5757A:p.P1919P,APC:NM_001354903:exon16:c.G5577A:p.P1859P,APC:NM_001354904:exon16:c.G5502A:p.P1834P,APC:NM_001127510:exon17:c.G5880A:p.P1960P,APC:NM_001354896:exon17:c.G5934A:p.P1978P,APC:NM_001354906:exon17:c.G5031A:p.P1677P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6488	0.5869	0.666534	0.5952	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G3780A:p.P1260P,APC:uc011cvt.2:exon14:c.G5826A:p.P1942P,APC:uc003kpy.4:exon16:c.G5880A:p.P1960P,APC:uc003kpz.4:exon17:c.G5880A:p.P1960P,APC:uc010jbz.3:exon17:c.G5031A:p.P1677P	.	AFR:0.5409,AMR:0.6938,EAS:0.8097,FIN:0.5564,NFE:0.6055,OTH:0.6224,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	739,,742,743,740,745,738,737	.	,741	.	.	.	.	5	MU62778	hom
5	127597518	127597518	G	A	FBN2	exonic	synonymous SNV	ENSG00000138829	rs10070365	ENSG00000138829:ENST00000262464:exon64:c.C8274T:p.S2758S,ENSG00000138829:ENST00000508053:exon70:c.C8274T:p.S2758S	FBN2:NM_001999:exon64:c.C8274T:p.S2758S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1043	0.1386	0.112819	0.1328	.	.	.	.	.	.	.	.	FBN2:uc003kuu.3:exon64:c.C8274T:p.S2758S	.	AFR:0.1751,AMR:0.0823,EAS:0.0334,FIN:0.1368,NFE:0.1237,OTH:0.1115,ASJ:0.0629	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU10349839	hom
5	127614472	127614472	A	G	FBN2	exonic	synonymous SNV	ENSG00000138829	rs190450	ENSG00000138829:ENST00000262464:exon57:c.T7200C:p.S2400S,ENSG00000138829:ENST00000508053:exon63:c.T7200C:p.S2400S	FBN2:NM_001999:exon57:c.T7200C:p.S2400S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7281	0.6779	0.726637	0.7155	.	.	.	.	.	.	.	.	FBN2:uc003kuu.3:exon57:c.T7200C:p.S2400S	.	AFR:0.6347,AMR:0.6766,EAS:0.8793,FIN:0.7811,NFE:0.7281,OTH:0.7694,ASJ:0.7119	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU801110	hom
5	127622491	127622491	T	C	FBN2	exonic	nonsynonymous SNV	ENSG00000138829	rs32209	ENSG00000138829:ENST00000262464:exon55:c.A6931G:p.M2311V,ENSG00000138829:ENST00000508053:exon61:c.A6931G:p.M2311V	FBN2:NM_001999:exon55:c.A6931G:p.M2311V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1151	0.0978	0.232827	0.1255	1.914	15.67	0.43	5.34	1.000	.	.	EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FBN2:uc003kuu.3:exon55:c.A6931G:p.M2311V	-0.959	AFR:0.2166,AMR:0.0453,EAS:0.6404,FIN:0.0521,NFE:0.0441,OTH:0.0673,ASJ:0.0662	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	0.0	-2.16	0.000	-0.7	5	MU16768154	het
5	127622983	127622983	C	T	FBN2	intronic	.	ENSG00000138829	rs2042327	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5184	0.4436	0.357628	0.4745	.	.	.	.	.	.	.	.	.	.	AFR:0.1661,AMR:0.5453,EAS:0.1747,FIN:0.6929,NFE:0.6211,OTH:0.6061,ASJ:0.5430	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU798954	het
5	127640783	127640783	G	A	FBN2	intronic	.	ENSG00000138829	rs27713	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7258	.	0.734425	0.6851	.	.	.	.	.	0	0.034	.	.	.	AFR:0.5368,AMR:0.6599,EAS:0.8618,FIN:0.7728,NFE:0.7275,OTH:0.7669,ASJ:0.7	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU681300	hom
5	127648500	127648500	A	G	FBN2	intronic	.	ENSG00000138829	rs10044959	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0858	0.0862	0.0535144	0.0761	.	.	.	.	.	.	.	.	.	.	AFR:0.0208,AMR:0.0716,EAS:0.0012,FIN:0.0899,NFE:0.1127,OTH:0.0866,ASJ:0.0762	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	.	het
5	127685135	127685135	C	T	FBN2	exonic	nonsynonymous SNV	ENSG00000138829	rs154001	ENSG00000138829:ENST00000508989:exon22:c.G2794A:p.V932I,ENSG00000138829:ENST00000262464:exon23:c.G2893A:p.V965I,ENSG00000138829:ENST00000508053:exon29:c.G2893A:p.V965I	FBN2:NM_001999:exon23:c.G2893A:p.V965I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7234	0.6622	0.73103	COCA-CN|5|321|0.0155763	3.009	22.3	0.331	3.32	1.000	.	.	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|TB domain	FBN2:uc003kuv.2:exon22:c.G2794A:p.V932I,FBN2:uc003kuu.3:exon23:c.G2893A:p.V965I	-0.947	AFR:0.6947,AMR:0.6250,EAS:0.7682,FIN:0.9442,NFE:0.7234,OTH:0.6936,ASJ:0.7655	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	0.118	-3.01	0.000	-0.39	5	1(haematopoietic_and_lymphoid_tissue)	0.7357
5	131705949	131705949	T	C	SLC22A5	exonic	synonymous SNV	ENSG00000197375	rs2631365	ENSG00000197375:ENST00000245407:exon1:c.T285C:p.L95L,ENSG00000197375:ENST00000435065:exon1:c.T285C:p.L95L,ENSG00000197375:ENST00000437841:exon1:c.T285C:p.L95L	SLC22A5:NM_001308122:exon1:c.T285C:p.L95L,SLC22A5:NM_003060:exon1:c.T285C:p.L95L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4968	0.3497	0.486222	0.4225	.	.	.	.	.	.	.	.	SLC22A5:uc003kww.4:exon1:c.T285C:p.L95L,SLC22A5:uc003kwx.4:exon1:c.T285C:p.L95L	.	AFR:0.3594,AMR:0.3258,EAS:0.6584,FIN:0.5161,NFE:0.4164,OTH:0.4498,ASJ:0.3733	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU4553927	hom
5	131719999	131719999	A	G	SLC22A5	intronic	.	ENSG00000197375	rs4551059	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU81802464	hom
5	131721174	131721174	A	G	SLC22A5	exonic	synonymous SNV	ENSG00000197375	rs274558	ENSG00000197375:ENST00000245407:exon4:c.A807G:p.L269L,ENSG00000197375:ENST00000415928:exon5:c.A576G:p.L192L,ENSG00000197375:ENST00000435065:exon5:c.A879G:p.L293L	SLC22A5:NM_003060:exon4:c.A807G:p.L269L,SLC22A5:NM_001308122:exon5:c.A879G:p.L293L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4393	0.3783	0.486222	0.4229	.	.	.	.	.	.	.	.	SLC22A5:uc003kww.4:exon4:c.A807G:p.L269L,SLC22A5:uc003kwx.4:exon5:c.A879G:p.L293L	.	AFR:0.3601,AMR:0.3225,EAS:0.6601,FIN:0.5161,NFE:0.4168,OTH:0.4509,ASJ:0.3775	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU159204	hom
5	131721204	131721204	T	C	SLC22A5	intronic	.	ENSG00000197375	rs274557	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4399	0.3739	0.486022	0.4228	.	.	.	.	.	.	.	.	.	.	AFR:0.3599,AMR:0.3233,EAS:0.6611,FIN:0.5157,NFE:0.4168,OTH:0.4477,ASJ:0.3775	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU18216091	hom
5	131822055	131822055	T	C	IRF1	exonic	synonymous SNV	ENSG00000125347	rs9282762	ENSG00000125347:ENST00000245414:exon7:c.A555G:p.P185P,ENSG00000125347:ENST00000405885:exon7:c.A555G:p.P185P,ENSG00000125347:ENST00000458069:exon7:c.A555G:p.P185P	IRF1:NM_001354925:exon7:c.A555G:p.P185P,IRF1:NM_002198:exon7:c.A555G:p.P185P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3541	0.3817	0.40655	MU14589976	.	.	.	.	.	.	.	.	C5orf56:uc010jds.2:exon4:c.T216C:p.H72H,IRF1:uc010jdt.2:exon6:c.A555G:p.P185P,IRF1:uc003kxa.2:exon7:c.A555G:p.P185P,IRF1:uc003kxb.2:exon7:c.A555G:p.P185P	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.3811,EAS:0.3158,FIN:0.2947,NFE:0.3517,OTH:0.3335,ASJ:0.4992	147575	211980;613659;	.	.	.	.	.	.	.	.	.	.	5	1(stomach)	0.3342
5	131822072	131822072	A	G	IRF1	intronic	.	ENSG00000125347	rs2070724	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3542	0.3754	0.40655	0.3815	.	.	.	.	.	0	0	.	C5orf56:uc010jds.2:exon4:c.A233G:p.E78G	.	AFR:0.4999,AMR:0.3158,EAS:0.3540,FIN:0.3336,NFE:0.3344,OTH:0.3490,ASJ:0.2947	147575	211980;613659;	.	.	.	.	.	.	.	.	.	.	5	MU14590015	het
5	131915213	131915213	G	A	RAD50	intronic	.	ENSG00000113522	rs17166050	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1988	0.1759	0.167732	0.1988	.	.	.	.	.	.	.	.	.	.	AFR:0.1184,AMR:0.1408,EAS:0.1656,FIN:0.2596,NFE:0.2351,OTH:0.2280,ASJ:0.2583	604040	613078;	240760;	240760|Microcephaly and chromosomal instability without immunodeficiency<br>NBS-like disorder<br>NBSLD<br>RAD50 deficiency|-|-|-|613078 ~	.	.	.	.	.	.	.	.	5	MU23155169	het
5	135382989	135382989	G	C	TGFBI	exonic	synonymous SNV	ENSG00000120708	rs1442	ENSG00000120708:ENST00000305126:exon6:c.G651C:p.L217L,ENSG00000120708:ENST00000442011:exon6:c.G651C:p.L217L	TGFBI:NM_000358:exon6:c.G651C:p.L217L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4270	0.3435	0.317692	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TGFBI:uc011cyb.2:exon2:c.G129C:p.L43L,TGFBI:uc003lbf.4:exon6:c.G651C:p.L217L,TGFBI:uc003lbh.4:exon6:c.G129C:p.L43L	.	AFR:0.3583,AMR:0.0891,EAS:0.3709,FIN:0.3807,NFE:0.4891,OTH:0.4709,ASJ:0.4582	601692	121820;121900;122200;602082;607541;608470;608471;	98964;98961;98963;98960;98964;98962;98956;	98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98961|Anterior limiting membrane dystrophy type I<br>Atypical granular corneal dystrophy<br>Corneal dystrophy of Bowman layer type I<br>Geographic corneal dystrophy<br>Granular corneal dystrophy type 3<br>Granular corneal dystrophy type III<br>RBCD<br>Superficial granular corneal dystrophy|<1 / 1 000 000|Autosomal dominant|Childhood|608470 ~98963|Avellino corneal dystrophy<br>GCD2<br>GCDII<br>Granular corneal dystrophy type 2<br>Granular-lattice corneal dystrophy|Unknown|Autosomal dominant|Childhood|607541 ~98960|Anterior limiting membrane dystrophy type II<br>Corneal dystrophy of Bowman layer type II<br>Curly fiber corneal dystrophy<br>Honeycomb corneal dystrophy<br>TBCD<br>Waardenburg-Jonker corneal dystrophy|Unknown|Autosomal dominant|Adolescent<br>Childhood<br>Adult|602082 ~98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98962|Classic GCD<br>Classic granular corneal dystrophy<br>Corneal dystrophy Groenouw type I<br>GCD1<br>GCDI<br>Granular corneal dystrophy type 1|Unknown|Autosomal dominant|Childhood|121900 ~98956|-|-|Autosomal dominant|-|121820 ~	.	.	.	.	.	.	.	.	5	3(lung)	0.4418
5	137708434	137708434	C	T	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs4835678	ENSG00000120733:ENST00000510866:exon1:c.C72T:p.I24I,ENSG00000120733:ENST00000314358:exon2:c.C264T:p.I88I	KDM3B:NM_016604:exon2:c.C264T:p.I88I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6376	0.5804	0.67492	0.5873	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon2:c.C264T:p.I88I	.	AFR:0.5556,AMR:0.7237,EAS:0.8572,FIN:0.5458,NFE:0.5802,OTH:0.55,ASJ:0.6225	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU16771788	hom
5	137717213	137717213	G	A	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs10073922	ENSG00000120733:ENST00000510866:exon5:c.G522A:p.E174E,ENSG00000120733:ENST00000314358:exon6:c.G714A:p.E238E	KDM3B:NM_016604:exon6:c.G714A:p.E238E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3497	0.2958	0.290735	0.2882	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon6:c.G714A:p.E238E	.	AFR:0.1523,AMR:0.3962,EAS:0.2704,FIN:0.3093,NFE:0.3568,OTH:0.3088,ASJ:0.2947	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU586785	hom
5	137717265	137717265	G	A	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs6865472	ENSG00000120733:ENST00000510866:exon5:c.G574A:p.A192T,ENSG00000120733:ENST00000314358:exon6:c.G766A:p.A256T	KDM3B:NM_016604:exon6:c.G766A:p.A256T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9951	0.9823	0.978435	0.9828	-0.332	0.561	0.773	-2.75	0.029	.	.	.	KDM3B:uc003lcy.1:exon6:c.G766A:p.A256T	-1.016	AFR:0.9396,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	609373	.	.	.	.	.	.	.	0.0	0.15	0.000	0.69	5	MU81803283	hom
5	137754695	137754695	T	C	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs7726234	ENSG00000120733:ENST00000542866:exon7:c.T585C:p.G195G,ENSG00000120733:ENST00000394866:exon9:c.T2457C:p.G819G,ENSG00000120733:ENST00000314358:exon14:c.T3489C:p.G1163G	KDM3B:NM_016604:exon14:c.T3489C:p.G1163G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6389	0.5840	0.678115	0.5891	.	.	.	.	.	.	.	.	KDM3B:uc011cys.1:exon7:c.T585C:p.G195G,KDM3B:uc003lcy.1:exon14:c.T3489C:p.G1163G,KDM3B:uc010jew.1:exon14:c.T2457C:p.G819G	.	AFR:0.5631,AMR:0.7237,EAS:0.8617,FIN:0.5458,NFE:0.5795,OTH:0.5482,ASJ:0.6225	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU801381	hom
5	138221989	138221989	G	C	CTNNA1	intronic	.	ENSG00000044115	rs288028	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2654	0.2687	0.185703	0.2662	.	.	.	.	.	0.0002	0.01	.	.	.	AFR:0.2088,AMR:0.2518,EAS:0.0006,FIN:0.2963,NFE:0.3196,OTH:0.2914,ASJ:0.3113	116805	608970;	99001;	99001|Butterfly-shaped pattern dystrophy<br>Butterfly-shaped pigmentary macular dystrophy|-|Autosomal dominant|Adult|169150 608970 610125 ~	~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04670 Leukocyte transendothelial migration~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	5	.	het
5	138266546	138266546	G	A	CTNNA1	exonic	synonymous SNV	ENSG00000044115	rs1059110	ENSG00000044115:ENST00000520520:exon2:c.G45A:p.S15S,ENSG00000044115:ENST00000540387:exon10:c.G1110A:p.S370S,ENSG00000044115:ENST00000355078:exon15:c.G1911A:p.S637S,ENSG00000044115:ENST00000518825:exon15:c.G2220A:p.S740S,ENSG00000044115:ENST00000302763:exon16:c.G2220A:p.S740S	CTNNA1:NM_001324010:exon7:c.G771A:p.S257S,CTNNA1:NM_001324012:exon8:c.G867A:p.S289S,CTNNA1:NM_001290312:exon10:c.G1110A:p.S370S,CTNNA1:NM_001323987:exon10:c.G1110A:p.S370S,CTNNA1:NM_001323994:exon10:c.G1110A:p.S370S,CTNNA1:NM_001324001:exon10:c.G1110A:p.S370S,CTNNA1:NM_001324002:exon10:c.G1110A:p.S370S,CTNNA1:NM_001324004:exon10:c.G1110A:p.S370S,CTNNA1:NM_001323989:exon11:c.G1110A:p.S370S,CTNNA1:NM_001323991:exon11:c.G1110A:p.S370S,CTNNA1:NM_001324000:exon11:c.G1110A:p.S370S,CTNNA1:NM_001324008:exon11:c.G771A:p.S257S,CTNNA1:NM_001324009:exon11:c.G771A:p.S257S,CTNNA1:NM_001324013:exon11:c.G867A:p.S289S,CTNNA1:NM_001323990:exon12:c.G1110A:p.S370S,CTNNA1:NM_001324003:exon12:c.G1110A:p.S370S,CTNNA1:NM_001324011:exon12:c.G1017A:p.S339S,CTNNA1:NM_001323988:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323992:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323993:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323995:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323996:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323997:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323998:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323999:exon13:c.G1110A:p.S370S,CTNNA1:NM_001324005:exon13:c.G1110A:p.S370S,CTNNA1:NM_001324007:exon13:c.G771A:p.S257S,CTNNA1:NM_001324006:exon14:c.G771A:p.S257S,CTNNA1:NM_001290309:exon15:c.G1911A:p.S637S,CTNNA1:NM_001323986:exon15:c.G2127A:p.S709S,CTNNA1:NM_001290307:exon16:c.G2220A:p.S740S,CTNNA1:NM_001290310:exon16:c.G1851A:p.S617S,CTNNA1:NM_001323983:exon16:c.G2220A:p.S740S,CTNNA1:NM_001323985:exon16:c.G2220A:p.S740S,CTNNA1:NM_001903:exon16:c.G2220A:p.S740S,CTNNA1:NM_001323982:exon17:c.G2220A:p.S740S,CTNNA1:NM_001323984:exon17:c.G2220A:p.S740S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2796	0.3348	0.249002	0.3223	.	.	.	.	.	.	.	.	CTNNA1:uc003ldl.3:exon10:c.G1110A:p.S370S,CTNNA1:uc003ldi.3:exon13:c.G1314A:p.S438S,CTNNA1:uc003ldj.3:exon15:c.G2220A:p.S740S,CTNNA1:uc011cyx.2:exon15:c.G1911A:p.S637S,CTNNA1:uc003ldh.3:exon16:c.G2220A:p.S740S,CTNNA1:uc011cyy.2:exon16:c.G1851A:p.S617S	.	AFR:0.4084,AMR:0.2704,EAS:0.0006,FIN:0.2952,NFE:0.3176,OTH:0.3,ASJ:0.3179	116805	608970;	99001;	99001|Butterfly-shaped pattern dystrophy<br>Butterfly-shaped pigmentary macular dystrophy|-|Autosomal dominant|Adult|169150 608970 610125 ~	~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04670 Leukocyte transendothelial migration~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	5	.	het
5	141014494	141014494	T	C	HDAC3	exonic	synonymous SNV	ENSG00000171720	rs2530223	ENSG00000171720:ENST00000305264:exon3:c.A165G:p.Q55Q	HDAC3:NM_001355039:exon3:c.A165G:p.Q55Q,HDAC3:NM_003883:exon3:c.A165G:p.Q55Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6253	0.6832	0.639776	0.6716	.	.	.	.	.	.	.	.	HDAC3:uc003llf.2:exon3:c.A165G:p.Q55Q	.	AFR:0.8538,AMR:0.7303,EAS:0.3067,FIN:0.6067,NFE:0.6193,OTH:0.6582,ASJ:0.5927	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU105200	het
5	141016288	141016288	T	G	HDAC3	intronic	.	ENSG00000171720	rs1421896	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6339	0.6985	0.65635	0.6829	.	.	.	.	.	.	.	.	.	.	AFR:0.8823,AMR:0.7506,EAS:0.3059,FIN:0.6066,NFE:0.6247,OTH:0.6609,ASJ:0.6026	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU19773804	unknown
5	141975067	141975067	A	C	FGF1	intronic	.	ENSG00000231185	rs34003	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4951	0.5364	0.56889	LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	.	.	AFR:0.5453,AMR:0.7159,EAS:0.4669,FIN:0.6409,NFE:0.4739,OTH:0.4661,ASJ:0.3950	131220	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04390 Hippo signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	1(lung)	0.4888
5	142254679	142254679	A	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs185200	ENSG00000145819:ENST00000274498:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378004:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378013:exon3:c.A171G:p.R57R	ARHGAP26:NM_001135608:exon3:c.A255G:p.R85R,ARHGAP26:NM_001349547:exon3:c.A147G:p.R49R,ARHGAP26:NM_015071:exon3:c.A255G:p.R85R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4468	0.4620	0.673722	0.4728	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon3:c.A255G:p.R85R,ARHGAP26:uc003lmw.3:exon3:c.A255G:p.R85R,ARHGAP26:uc011dbj.2:exon3:c.A255G:p.R85R	.	AFR:0.8006,AMR:0.5084,EAS:0.8806,FIN:0.2917,NFE:0.2887,OTH:0.3640,ASJ:0.3079	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU24874862	hom
5	142421415	142421415	T	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs2270068	ENSG00000145819:ENST00000274498:exon14:c.T1245G:p.G415G,ENSG00000145819:ENST00000378004:exon14:c.T1245G:p.G415G	ARHGAP26:NM_001135608:exon14:c.T1245G:p.G415G,ARHGAP26:NM_001349547:exon14:c.T1137G:p.G379G,ARHGAP26:NM_015071:exon14:c.T1245G:p.G415G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9619	0.9983	0.888179	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc003lmw.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc011dbj.2:exon14:c.T1245G:p.G415G	.	AFR:0.9698,AMR:0.9969,EAS:1,FIN:0.5162,NFE:0.9885,OTH:0.9983,ASJ:0.9414	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	1(breast)	0.9827
5	142513686	142513686	A	G	ARHGAP26	intronic	.	ENSG00000145819	rs246607	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5453	0.5822	0.502796	MU15247376	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|4|321|0.0124611,AMR:0.5567,EAS:0.3669,FIN:0.6987,NFE:0.3232,OTH:0.5825,ASJ:0.5057	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	15(soft_tissue)	0.6123
5	142593652	142593652	C	T	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs258819	ENSG00000145819:ENST00000425417:exon2:c.C200T:p.T67M	ARHGAP26:NM_001349547:exon21:c.C1971T:p.N657N,ARHGAP26:NM_001135608:exon22:c.C2190T:p.N730N,ARHGAP26:NM_015071:exon22:c.C2355T:p.N785N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9938	0.9962	0.996406	0.9931	.	.	.	.	.	0.0002	0.11	.	ARHGAP26:uc003lmw.3:exon21:c.C2079T:p.N693N,ARHGAP26:uc003lmt.3:exon22:c.C2190T:p.N730N,ARHGAP26:uc011dbj.2:exon22:c.C2355T:p.N785N	.	AFR:0.9993,AMR:0.9964,EAS:1,FIN:0.9675,NFE:0.9949,OTH:0.9876,ASJ:1	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU81804076	hom
5	149447771	149447771	G	A	CSF1R	intronic	.	ENSG00000182578	rs34928010	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1090	0.1139	0.178914	0.1183	.	.	.	.	.	0.0017	0.232	.	.	.	AFR:0.2651,AMR:0.2554,EAS:0.1685,FIN:0.0321,NFE:0.0441,OTH:0.0645,ASJ:0.0927	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	5	MU769524	het
5	149457678	149457678	G	A	CSF1R	exonic	synonymous SNV	ENSG00000182578	rs2228422	ENSG00000182578:ENST00000504875:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000543093:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000286301:exon5:c.C726T:p.T242T	CSF1R:NM_001288705:exon4:c.C726T:p.T242T,CSF1R:NM_005211:exon5:c.C726T:p.T242T,CSF1R:NM_001349736:exon6:c.C726T:p.T242T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5153	0.4807	0.38738	4(lung)	.	.	.	.	.	.	.	.	CSF1R:uc011dcd.2:exon3:c.C282T:p.T94T,CSF1R:uc003lrl.3:exon4:c.C726T:p.T242T,CSF1R:uc011dce.1:exon4:c.C726T:p.T242T,CSF1R:uc011dcf.2:exon4:c.C726T:p.T242T,CSF1R:uc003lrm.3:exon5:c.C726T:p.T242T	.	AFR:1(stomach),AMR:1(breast),EAS:1(thyroid),FIN:MU586881,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,OTH:0.4998,ASJ:1(liver)	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	,2067,2070,2068	.	,2069	.	.	.	.	5	14(meninges)	0.3213
5	149509310	149509310	G	A	PDGFRB	intronic	.	ENSG00000113721	rs571420039	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0007	.	0.000798722	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	173410	131440;228550;601812;615007;616592;	1980;363665;2591;86830;	1980|BSPDC<br>Cerebrovascular ferrocalcinosis<br>Idiopathic basal ganglia calcification<br>PFBC<br>Primary familial brain calcification|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Adult|213600 606656 615007 615483 616413 ~363665|Premature aging syndrome, Penttinen type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|601812 ~2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~86830|CMPD-U<br>Undifferentiated myeloproliferative disease|-|-|-|131440 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	.	het
5	151043103	151043103	G	C	SPARC	exonic	synonymous SNV	ENSG00000113140	rs1053411	.	SPARC:NM_001309444:exon10:c.C939G:p.L313L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1998	0.1439	0.228035	0.1671	.	.	.	.	.	.	.	.	.	.	AFR:0.1507,AMR:0.3813,EAS:0.3401,FIN:0.1397,NFE:0.1527,OTH:0.1673,ASJ:0.1589	182120	616507;	216820;666;	216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~	.	.	.	.	.	.	.	.	5	MU586908	hom
5	161116672	161116672	C	T	GABRA6	exonic	nonsynonymous SNV	ENSG00000145863	rs3811993	ENSG00000145863:ENST00000523691:exon3:c.C320T:p.T107M,ENSG00000145863:ENST00000517823:exon4:c.C401T:p.T134M,ENSG00000145863:ENST00000274545:exon6:c.C560T:p.T187M,ENSG00000145863:ENST00000523217:exon6:c.C530T:p.T177M	GABRA6:NM_000811:exon6:c.C560T:p.T187M	clinvar: Benign 	 CancerVar: -1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0158	0.0093	0.0165735	0.0091	5.258	25.7	0.064	5.41	1.000	.	.	Neurotransmitter-gated ion-channel ligand-binding domain	GABRA6:uc003lyu.2:exon6:c.C560T:p.T187M	-0.226	AFR:0.0021,AMR:0.0107,EAS:0.0080,FIN:0.0149,NFE:0.0113,OTH:0.0143,ASJ:0.0132	137143	.	.	.	.	.	.	.	1.0	-1.27	0.352	1.81	5	.	het
5	161119071	161119071	G	T	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs12522663	ENSG00000145863:ENST00000274545:exon8:c.G951T:p.A317A,ENSG00000145863:ENST00000523217:exon8:c.G921T:p.A307A	GABRA6:NM_000811:exon8:c.G951T:p.A317A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9902	0.9655	0.968251	0.9699	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.G264T:p.A88A,GABRA6:uc003lyu.2:exon8:c.G951T:p.A317A	.	AFR:0.8962,AMR:0.9881,EAS:1,FIN:1,NFE:0.9997,OTH:0.9878,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806764	hom
5	161119125	161119125	C	G	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs13184586	ENSG00000145863:ENST00000274545:exon8:c.C1005G:p.A335A,ENSG00000145863:ENST00000523217:exon8:c.C975G:p.A325A	GABRA6:NM_000811:exon8:c.C1005G:p.A335A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4854	0.4881	0.401158	MU12248552	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.C318G:p.A106A,GABRA6:uc003lyu.2:exon8:c.C1005G:p.A335A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.4862,EAS:0.3801,FIN:0.5695,NFE:0.3021,OTH:0.5499,ASJ:0.3513	137143	.	.	.	.	.	.	.	.	.	.	.	5	2(haematopoietic_and_lymphoid_tissue)	0.5715
5	161128627	161128627	C	T	GABRA6	exonic	nonsynonymous SNV	ENSG00000145863	rs34907804	ENSG00000145863:ENST00000274545:exon9:c.C1210T:p.P404S,ENSG00000145863:ENST00000523217:exon9:c.C1180T:p.P394S	GABRA6:NM_000811:exon9:c.C1210T:p.P404S	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0663	0.0928	0.0728834	0.0777	1.417	12.88	0.174	5.16	0.395	.	.	Neurotransmitter-gated ion-channel transmembrane domain	GABRA6:uc003lyv.2:exon3:c.C523T:p.P175S,GABRA6:uc003lyu.2:exon9:c.C1210T:p.P404S	-0.963	AFR:0.1174,AMR:0.0598,EAS:0,FIN:0.0547,NFE:0.0699,OTH:0.0663,ASJ:0.0861	137143	.	.	.	.	.	.	.	0.005	-1.71	0.006	0.805	5	.	het
5	161128761	161128761	C	G	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs4277944	ENSG00000145863:ENST00000274545:exon9:c.C1344G:p.V448V,ENSG00000145863:ENST00000523217:exon9:c.C1314G:p.V438V	GABRA6:NM_000811:exon9:c.C1344G:p.V448V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9893	0.9620	.	0.9680	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon3:c.C657G:p.V219V,GABRA6:uc003lyu.2:exon9:c.C1344G:p.V448V	.	AFR:0.8895,AMR:0.9869,EAS:1,FIN:1,NFE:0.9996,OTH:0.9888,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806783	hom
5	162890953	162890953	G	A	HMMR	exonic	synonymous SNV	ENSG00000072571	rs380101	ENSG00000072571:ENST00000353866:exon2:c.G138A:p.Q46Q,ENSG00000072571:ENST00000358715:exon2:c.G138A:p.Q46Q,ENSG00000072571:ENST00000393915:exon2:c.G138A:p.Q46Q	HMMR:NM_001142556:exon2:c.G138A:p.Q46Q,HMMR:NM_012484:exon2:c.G138A:p.Q46Q,HMMR:NM_012485:exon2:c.G138A:p.Q46Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1.0000	.	.	.	.	.	.	.	.	HMMR:uc003lzf.3:exon2:c.G138A:p.Q46Q,HMMR:uc003lzg.3:exon2:c.G138A:p.Q46Q,HMMR:uc003lzh.3:exon2:c.G138A:p.Q46Q	.	AFR:0.9999,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	5	MU81806833	hom
5	169127097	169127097	C	A	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2112703	ENSG00000134516:ENST00000256935:exon13:c.C1212A:p.T404T,ENSG00000134516:ENST00000524185:exon13:c.C1212A:p.T404T	DOCK2:NM_004946:exon13:c.C1212A:p.T404T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1695	0.1619	0.121605	0.1472	.	.	.	.	.	.	.	.	DOCK2:uc003maf.3:exon13:c.C1212A:p.T404T	.	AFR:0.0610,AMR:0.0859,EAS:0.1227,FIN:0.1722,NFE:0.1962,OTH:0.1578,ASJ:0.1821	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU29854221	het
5	169129422	169129422	A	G	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2306559	ENSG00000134516:ENST00000256935:exon14:c.A1374G:p.K458K,ENSG00000134516:ENST00000524185:exon14:c.A1374G:p.K458K	DOCK2:NM_004946:exon14:c.A1374G:p.K458K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4067	0.3758	0.385383	0.3894	.	.	.	.	.	.	.	.	DOCK2:uc010jjl.1:exon2:c.A27G:p.K9K,DOCK2:uc003maf.3:exon14:c.A1374G:p.K458K	.	AFR:0.2327,AMR:0.3017,EAS:0.7142,FIN:0.3755,NFE:0.4528,OTH:0.3916,ASJ:0.4367	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU10617326	het
5	169267784	169267784	G	A	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs261623	ENSG00000134516:ENST00000519628:exon4:c.G339A:p.Q113Q,ENSG00000134516:ENST00000520908:exon13:c.G1203A:p.Q401Q,ENSG00000134516:ENST00000256935:exon27:c.G2727A:p.Q909Q,ENSG00000134516:ENST00000524185:exon27:c.G2727A:p.Q909Q	DOCK2:NM_004946:exon27:c.G2727A:p.Q909Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3967	0.4767	0.395367	0.4532	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon13:c.G1203A:p.Q401Q,DOCK2:uc003maf.3:exon27:c.G2727A:p.Q909Q	.	AFR:0.6033,AMR:0.4055,EAS:0.1383,FIN:0.4284,NFE:0.4121,OTH:0.4308,ASJ:0.3510	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU19800195	het
5	169435713	169435713	A	C	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2287727	ENSG00000134516:ENST00000520908:exon18:c.A1671C:p.L557L,ENSG00000134516:ENST00000540750:exon18:c.A378C:p.L126L,ENSG00000134516:ENST00000256935:exon32:c.A3195C:p.L1065L	DOCK2:NM_004946:exon32:c.A3195C:p.L1065L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2919	0.2207	0.243011	0.2467	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon18:c.A1671C:p.L557L,DOCK2:uc003maf.3:exon32:c.A3195C:p.L1065L	.	AFR:0.0696,AMR:0.3517,EAS:0.4252,FIN:0.3768,NFE:0.2895,OTH:0.3129,ASJ:0.2781	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU137499	het
5	169454941	169454941	C	G	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs9791113	ENSG00000134516:ENST00000520908:exon20:c.C1932G:p.L644L,ENSG00000134516:ENST00000540750:exon20:c.C639G:p.L213L,ENSG00000134516:ENST00000256935:exon34:c.C3456G:p.L1152L	DOCK2:NM_004946:exon34:c.C3456G:p.L1152L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3923	0.4059	0.486222	0.4008	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon20:c.C1932G:p.L644L,DOCK2:uc003maf.3:exon34:c.C3456G:p.L1152L	.	AFR:0.5439,AMR:0.3995,EAS:0.5767,FIN:0.3441,NFE:0.3172,OTH:0.3361,ASJ:0.3543	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU21948493	het
5	169461399	169461399	G	A	DOCK2	intronic	.	ENSG00000134516	rs3763047	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3921	0.4232	0.499201	0.4113	.	.	.	.	.	0	0.002	.	.	.	AFR:0.6033,AMR:0.4031,EAS:0.5722,FIN:0.3246,NFE:0.3099,OTH:0.3282,ASJ:0.3510	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU799485	het
5	169461547	169461547	C	T	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs3763048	ENSG00000134516:ENST00000520908:exon21:c.C2088T:p.T696T,ENSG00000134516:ENST00000540750:exon21:c.C795T:p.T265T,ENSG00000134516:ENST00000256935:exon35:c.C3612T:p.T1204T	DOCK2:NM_004946:exon35:c.C3612T:p.T1204T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3995	0.4343	0.506789	0.4184	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon21:c.C2088T:p.T696T,DOCK2:uc003maf.3:exon35:c.C3612T:p.T1204T	.	AFR:0.6093,AMR:0.4069,EAS:0.5732,FIN:0.3263,NFE:0.3194,OTH:0.3306,ASJ:0.37	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU586927	het
5	170837514	170837514	T	-	NPM1	intronic	.	ENSG00000181163	rs34323200	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3378	.	.	0.0407	.	.	.	.	.	.	.	.	.	.	AFR:0.0756,AMR:0.1175,EAS:0.0817,FIN:0.0399,NFE:0.0122,OTH:0.0385,ASJ:0.0297	164040	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	5	.	het
5	176517461	176517461	T	G	FGFR4	exonic	synonymous SNV	ENSG00000160867	rs446382	ENSG00000160867:ENST00000393637:exon2:c.T162G:p.R54R,ENSG00000160867:ENST00000292408:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000292410:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000393648:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000502906:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000503708:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000513166:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000514472:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000510911:exon4:c.T162G:p.R54R	FGFR4:NM_022963:exon2:c.T162G:p.R54R,FGFR4:NM_001291980:exon3:c.T162G:p.R54R,FGFR4:NM_001354984:exon3:c.T162G:p.R54R,FGFR4:NM_002011:exon3:c.T162G:p.R54R,FGFR4:NM_213647:exon3:c.T162G:p.R54R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7647	0.6832	0.775958	MU71026	.	.	.	.	.	.	.	.	FGFR4:uc003mfn.1:exon2:c.T162G:p.R54R,FGFR4:uc003mfo.3:exon2:c.T162G:p.R54R,FGFR4:uc011dfw.1:exon2:c.T162G:p.R54R,FGFR4:uc003mfl.3:exon3:c.T162G:p.R54R,FGFR4:uc003mfm.3:exon3:c.T162G:p.R54R,FGFR4:uc011dfu.2:exon3:c.T162G:p.R54R	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.7118,EAS:0.8103,FIN:0.7119,NFE:0.9729,OTH:0.7490,ASJ:0.5979	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	17(meninges)	0.7323
5	176517797	176517797	C	T	FGFR4	exonic	nonsynonymous SNV	ENSG00000160867	rs376618	ENSG00000160867:ENST00000393637:exon3:c.C407T:p.P136L,ENSG00000160867:ENST00000292408:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000292410:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000393648:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000502906:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000503708:exon4:c.C407T:p.P136L	FGFR4:NM_022963:exon3:c.C407T:p.P136L,FGFR4:NM_001291980:exon4:c.C407T:p.P136L,FGFR4:NM_001354984:exon4:c.C407T:p.P136L,FGFR4:NM_002011:exon4:c.C407T:p.P136L,FGFR4:NM_213647:exon4:c.C407T:p.P136L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7950	0.7211	0.807308	COCA-CN|5|321|0.0155763	0.399	6.606	0.332	2.85	0.010	.	.	.	FGFR4:uc003mfn.1:exon3:c.C407T:p.P136L,FGFR4:uc003mfo.3:exon3:c.C407T:p.P136L,FGFR4:uc011dfw.1:exon3:c.C407T:p.P136L,FGFR4:uc003mfl.3:exon4:c.C407T:p.P136L,FGFR4:uc003mfm.3:exon4:c.C407T:p.P136L,FGFR4:uc011dfu.2:exon4:c.C407T:p.P136L	-0.960	AFR:0.7468,AMR:0.6533,EAS:0.7550,FIN:1,NFE:0.8038,OTH:0.7525,ASJ:0.8337	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	0.0	-1.26	0.000	0	5	17(meninges)	0.7873
5	176518784	176518784	C	T	FGFR4	exonic	synonymous SNV	ENSG00000160867	rs452885	ENSG00000160867:ENST00000393637:exon5:c.C702T:p.R234R,ENSG00000160867:ENST00000292408:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000292410:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000393648:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000502906:exon6:c.C702T:p.R234R	FGFR4:NM_022963:exon5:c.C702T:p.R234R,FGFR4:NM_001291980:exon6:c.C702T:p.R234R,FGFR4:NM_001354984:exon6:c.C702T:p.R234R,FGFR4:NM_002011:exon6:c.C702T:p.R234R,FGFR4:NM_213647:exon6:c.C702T:p.R234R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7949	0.7211	0.807109	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FGFR4:uc003mfo.3:exon5:c.C702T:p.R234R,FGFR4:uc011dfw.1:exon5:c.C702T:p.R234R,FGFR4:uc003mfl.3:exon6:c.C702T:p.R234R,FGFR4:uc003mfm.3:exon6:c.C702T:p.R234R,FGFR4:uc011dfu.2:exon6:c.C702T:p.R234R	.	AFR:0.7460,AMR:0.6523,EAS:0.7550,FIN:1,NFE:0.8033,OTH:0.7520,ASJ:0.8329	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	17(meninges)	0.7883
5	176520243	176520243	G	A	FGFR4	exonic	nonsynonymous SNV	ENSG00000160867	rs351855	ENSG00000160867:ENST00000292408:exon9:c.G1162A:p.G388R,ENSG00000160867:ENST00000502906:exon9:c.G1162A:p.G388R	FGFR4:NM_001354984:exon9:c.G1162A:p.G388R,FGFR4:NM_002011:exon9:c.G1162A:p.G388R,FGFR4:NM_213647:exon9:c.G1162A:p.G388R	clinvar: Pathogenic 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, 1, 1, 0] 	0.3210	0.2423	0.299521	1(breast)	4.800	24.8	0.12	4.29	0.845	.	.	.	FGFR4:uc003mfl.3:exon9:c.G1162A:p.G388R,FGFR4:uc003mfm.3:exon9:c.G1162A:p.G388R	-0.884	AFR:1(liver),AMR:1(large_intestine),EAS:MU153762,FIN:LICA-CN|3|402|0.00746269,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.2730,OTH:0.1278,ASJ:2(thyroid)	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	0.998	-1.67	0.000	1.5	5	16(soft_tissue)	0.3947
5	176522728	176522728	C	T	FGFR4	intronic	.	ENSG00000160867	rs42409	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7280	0.5984	0.701877	0.6355	.	.	.	.	.	0.0001	0.018	.	.	.	AFR:0.4138,AMR:0.7770,EAS:0.9715,FIN:0.7158,NFE:0.6962,OTH:0.7080,ASJ:0.6623	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	MU81808028	hom
5	176523597	176523597	A	G	FGFR4	intronic	.	ENSG00000160867	rs31776	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7643	0.6889	0.785343	0.7157	.	.	.	.	.	0	0.004	.	.	.	AFR:0.6139,AMR:0.8079,EAS:0.9727,FIN:0.7489,NFE:0.7318,OTH:0.7592,ASJ:0.6887	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	MU10675511	hom
5	176636882	176636882	C	T	NSD1	exonic	synonymous SNV	ENSG00000165671	rs1363405	ENSG00000165671:ENST00000361032:exon2:c.C1173T:p.C391C,ENSG00000165671:ENST00000439151:exon5:c.C1482T:p.C494C,ENSG00000165671:ENST00000347982:exon6:c.C675T:p.C225C,ENSG00000165671:ENST00000354179:exon6:c.C675T:p.C225C	NSD1:NM_022455:exon5:c.C1482T:p.C494C,NSD1:NM_001365684:exon6:c.C675T:p.C225C,NSD1:NM_172349:exon6:c.C675T:p.C225C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2999	0.3541	0.468051	1(breast)	.	.	.	.	.	.	.	.	NSD1:uc003mfs.1:exon2:c.C1173T:p.C391C,NSD1:uc003mfr.4:exon5:c.C1482T:p.C494C,NSD1:uc003mft.4:exon6:c.C675T:p.C225C,NSD1:uc011dfx.2:exon6:c.C426T:p.C142C	.	AFR:MU12279827,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.6830,FIN:0.2866,NFE:0.2119,OTH:0.5343,ASJ:0.3742	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	.	.	.	.	5	2(lung)	0.2610
5	176637149	176637149	G	A	NSD1	exonic	synonymous SNV	ENSG00000165671	rs3733874	ENSG00000165671:ENST00000361032:exon2:c.G1440A:p.E480E,ENSG00000165671:ENST00000439151:exon5:c.G1749A:p.E583E,ENSG00000165671:ENST00000347982:exon6:c.G942A:p.E314E,ENSG00000165671:ENST00000354179:exon6:c.G942A:p.E314E	NSD1:NM_022455:exon5:c.G1749A:p.E583E,NSD1:NM_001365684:exon6:c.G942A:p.E314E,NSD1:NM_172349:exon6:c.G942A:p.E314E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1765	0.1004	.	1(oesophagus)	.	.	.	.	.	.	.	.	NSD1:uc003mfs.1:exon2:c.G1440A:p.E480E,NSD1:uc003mfr.4:exon5:c.G1749A:p.E583E,NSD1:uc003mft.4:exon6:c.G942A:p.E314E,NSD1:uc011dfx.2:exon6:c.G693A:p.E231E	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU12279835,EAS:0.1529,FIN:0.0799,NFE:0.2093,OTH:0.1093,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	.	.	.	.	5	4(soft_tissue)	0.5207
5	176637240	176637240	G	T	NSD1	exonic	nonsynonymous SNV	ENSG00000165671	rs3733875	ENSG00000165671:ENST00000361032:exon2:c.G1531T:p.V511L,ENSG00000165671:ENST00000439151:exon5:c.G1840T:p.V614L,ENSG00000165671:ENST00000347982:exon6:c.G1033T:p.V345L,ENSG00000165671:ENST00000354179:exon6:c.G1033T:p.V345L	NSD1:NM_022455:exon5:c.G1840T:p.V614L,NSD1:NM_001365684:exon6:c.G1033T:p.V345L,NSD1:NM_172349:exon6:c.G1033T:p.V345L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1762	0.0993	0.228634	1(oesophagus)	-3.119	0.001	0.316	-1.26	0.000	.	.	PWWP domain	NSD1:uc003mfs.1:exon2:c.G1531T:p.V511L,NSD1:uc003mfr.4:exon5:c.G1840T:p.V614L,NSD1:uc003mft.4:exon6:c.G1033T:p.V345L,NSD1:uc011dfx.2:exon6:c.G784T:p.V262L	-0.976	AFR:1(skin),AMR:MU20707755,EAS:0.1512,FIN:0.0731,NFE:0.2088,OTH:0.1093,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	0.002	-3.03	0.000	0.255	5	7(soft_tissue)	0.5212
5	176637576	176637576	T	C	NSD1	exonic	nonsynonymous SNV	ENSG00000165671	rs28932178	ENSG00000165671:ENST00000361032:exon2:c.T1867C:p.S623P,ENSG00000165671:ENST00000439151:exon5:c.T2176C:p.S726P,ENSG00000165671:ENST00000347982:exon6:c.T1369C:p.S457P,ENSG00000165671:ENST00000354179:exon6:c.T1369C:p.S457P	NSD1:NM_022455:exon5:c.T2176C:p.S726P,NSD1:NM_001365684:exon6:c.T1369C:p.S457P,NSD1:NM_172349:exon6:c.T1369C:p.S457P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.1987	0.1263	0.249601	1(haematopoietic_and_lymphoid_tissue)	-1.117	0.009	0.013	1.28	0.021	.	.	.	NSD1:uc003mfs.1:exon2:c.T1867C:p.S623P,NSD1:uc003mfr.4:exon5:c.T2176C:p.S726P,NSD1:uc003mft.4:exon6:c.T1369C:p.S457P,NSD1:uc011dfx.2:exon6:c.T1120C:p.S374P	-1.012	AFR:MU12279860,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.1047,FIN:0.2206,NFE:0.1192,OTH:0.5224,ASJ:0.1805	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	0.999	-3.14	0.000	2.045	5	1(lung)	0.2297
5	176940384	176940384	G	A	DDX41	exonic	synonymous SNV	ENSG00000183258	rs335438	ENSG00000183258:ENST00000330503:exon10:c.C1254T:p.R418R,ENSG00000183258:ENST00000507955:exon11:c.C1200T:p.R400R	DDX41:NM_001321732:exon10:c.C822T:p.R274R,DDX41:NM_001321830:exon11:c.C822T:p.R274R,DDX41:NM_016222:exon11:c.C1200T:p.R400R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4198	0.4609	0.386382	0.4396	.	.	.	.	.	.	.	.	DDX41:uc003mhq.1:exon9:c.C540T:p.R180R,DDX41:uc003mhn.3:exon10:c.C807T:p.R269R,DDX41:uc003mhp.3:exon10:c.C807T:p.R269R,DDX41:uc003mho.3:exon11:c.C1200T:p.R400R	.	AFR:0.4548,AMR:0.3266,EAS:0.1702,FIN:0.4526,NFE:0.4664,OTH:0.4061,ASJ:0.4040	608170	616871;	.	.	.	.	.	.	.	.	.	.	5	MU157920	het
5	180030313	180030313	C	A	FLT4	exonic	nonsynonymous SNV	ENSG00000037280	rs307821	ENSG00000037280:ENST00000261937:exon30:c.G3971T:p.R1324L	FLT4:NM_182925:exon30:c.G3971T:p.R1324L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0828	0.0895	.	.	0.068	3.268	0.65	-8.82	0.001	.	.	.	FLT4:uc003mlz.4:exon30:c.G3971T:p.R1324L	-1.077	AFR:0.0754,AMR:0.0506,EAS:0.0960,FIN:0.0012,NFE:0.0825,OTH:0.0962,ASJ:0.0776	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-0.86	0.004	0.205	5	4(lung)	0.0682
5	180043388	180043388	G	A	FLT4	exonic	synonymous SNV	ENSG00000037280	rs1130378	ENSG00000037280:ENST00000512795:exon4:c.C312T:p.P104P,ENSG00000037280:ENST00000261937:exon23:c.C3198T:p.P1066P,ENSG00000037280:ENST00000393347:exon23:c.C3198T:p.P1066P,ENSG00000037280:ENST00000502649:exon23:c.C3198T:p.P1066P	FLT4:NM_001354989:exon23:c.C3198T:p.P1066P,FLT4:NM_002020:exon23:c.C3198T:p.P1066P,FLT4:NM_182925:exon23:c.C3198T:p.P1066P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2700	0.2526	0.240415	14(soft_tissue)	.	.	.	.	.	.	.	.	FLT4:uc003mlz.4:exon23:c.C3198T:p.P1066P,FLT4:uc003mma.4:exon23:c.C3198T:p.P1066P	.	AFR:1(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.2371,NFE:0.1658,OTH:0.1727,ASJ:MU160401	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	2(lung)	0.3477
5	180046344	180046344	G	C	FLT4	exonic	nonsynonymous SNV	ENSG00000037280	rs448012	ENSG00000037280:ENST00000261937:exon19:c.C2670G:p.H890Q,ENSG00000037280:ENST00000393347:exon19:c.C2670G:p.H890Q,ENSG00000037280:ENST00000502649:exon19:c.C2670G:p.H890Q	FLT4:NM_001354989:exon19:c.C2670G:p.H890Q,FLT4:NM_002020:exon19:c.C2670G:p.H890Q,FLT4:NM_182925:exon19:c.C2670G:p.H890Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6247	0.5970	0.582668	1(urinary_tract)	5.326	25.8	0.045	1.22	1.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	FLT4:uc003mlz.4:exon19:c.C2670G:p.H890Q,FLT4:uc003mma.4:exon19:c.C2670G:p.H890Q	-0.907	AFR:79(lung),AMR:MU678928,EAS:0.6216,FIN:0.5506,NFE:0.7367,OTH:0.5233,ASJ:SKCA-BR|1|100|0.01,LUSC-KR|3|170|0.0176471,COCA-CN|7|321|0.0218069,BLCA-CN|1|103|0.00970874	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.18	-1.54	0.000	0.04	5	1(thyroid)	0.4763
5	180047863	180047863	C	G	FLT4	intronic	.	ENSG00000037280	rs423086	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9876	0.9531	0.960064	0.9627	.	.	.	.	.	.	.	.	.	.	AFR:0.8699,AMR:0.9940,EAS:1,FIN:1,NFE:0.9993,OTH:0.9929,ASJ:1	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU81809230	hom
5	180051003	180051003	T	C	FLT4	exonic	nonsynonymous SNV	ENSG00000037280	rs307826	ENSG00000037280:ENST00000261937:exon11:c.A1480G:p.T494A,ENSG00000037280:ENST00000393347:exon11:c.A1480G:p.T494A,ENSG00000037280:ENST00000502649:exon11:c.A1480G:p.T494A	FLT4:NM_001354989:exon11:c.A1480G:p.T494A,FLT4:NM_002020:exon11:c.A1480G:p.T494A,FLT4:NM_182925:exon11:c.A1480G:p.T494A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0902	0.0913	0.0529153	MU153538	-0.877	0.029	0.225	2.25	0.281	.	.	Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	FLT4:uc003mmb.1:exon5:c.A79G:p.T27A,FLT4:uc003mlz.4:exon11:c.A1480G:p.T494A,FLT4:uc003mma.4:exon11:c.A1480G:p.T494A,FLT4:uc011dgy.2:exon11:c.A1480G:p.T494A	-0.720	AFR:LUSC-KR|1|170|0.00588235,AMR:0.0743,EAS:0.0849,FIN:0.1026,NFE:0.0037,OTH:0.0814,ASJ:0.0283	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.029	-3.42	0.028	0.975	5	12(lung)	0.1065
5	180053097	180053097	C	T	FLT4	intronic	.	ENSG00000037280	rs56193546	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0532	0.0412	0.0860623	MU10704661	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.0423,EAS:0.0334,FIN:0.1126,NFE:0.1691,OTH:0.0206,ASJ:0.0526	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.0265
5	180055862	180055862	T	G	FLT4	intronic	.	ENSG00000037280	rs383985	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6016	0.4137	0.648363	0.5611	.	.	.	.	.	.	.	.	.	.	AFR:0.5503,AMR:0.7266,EAS:0.8290,FIN:0.5185,NFE:0.5400,OTH:0.5491,ASJ:0.5403	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU681706	unknown
5	180055864	180055864	G	A	FLT4	intronic	.	ENSG00000037280	rs438464	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4711	0.0292	0.458466	0.4631	.	.	.	.	.	.	.	.	.	.	AFR:0.4445,AMR:0.5767,EAS:0.3207,FIN:0.4526,NFE:0.4860,OTH:0.4644,ASJ:0.4459	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU27175866	unknown
6	325126	325126	A	G	DUSP22	intronic	.	ENSG00000112679	rs2757553	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9836	.	.	.	.	.	.	.	.	.	.	AFR:0.9701,AMR:0.9817,EAS:0.9950,FIN:0.9786,NFE:0.9909,OTH:0.9896,ASJ:0.9966	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325357	325357	G	A	DUSP22	intronic	.	ENSG00000112679	rs9503265	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	MU31181673	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|3|402|0.00746269,COCA-CN|1|321|0.00311526,PBCA-DE|1|499|0.00200401,AMR:0.0214,EAS:0.0366,FIN:0.0109,NFE:0.1121,OTH:0.0420,ASJ:0.0262	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.0077
6	325403	325403	G	A	DUSP22	intronic	.	ENSG00000112679	rs28517601	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.448882	SKCA-BR|1|100|0.01	.	.	.	.	.	.	.	.	.	.	AFR:0.4451,AMR:0.4021,EAS:0.4362,FIN:0.4699,NFE:0.4720,OTH:0.4602,ASJ:0.4648	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(skin)	0.448
6	325544	325544	A	G	DUSP22	intronic	.	ENSG00000112679	rs28733103	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	SKCA-BR|1|100|0.01,PRAD-CA|1|306|0.00326797	.	.	.	.	.	.	.	.	.	.	AFR:0.4135,AMR:0.4588,EAS:0.2794,FIN:0.4791,NFE:0.3795,OTH:0.3840,ASJ:0.4074	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.3932
6	325549	325549	G	A	DUSP22	intronic	.	ENSG00000112679	rs2488422	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1463	.	.	.	.	.	.	.	.	.	.	AFR:0.2011,AMR:0.1741,EAS:0.2748,FIN:0.1402,NFE:0.1075,OTH:0.1175,ASJ:0.0481	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698069	het
6	325557	325557	G	T	DUSP22	intronic	.	ENSG00000112679	rs2797328	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1947	.	.	.	.	.	.	.	.	.	.	AFR:0.2682,AMR:0.2135,EAS:0.3047,FIN:0.2377,NFE:0.1407,OTH:0.1202,ASJ:0.0612	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698139	het
6	325711	325711	C	T	DUSP22	intronic	.	ENSG00000112679	rs28546796	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	MU28569467	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|3|402|0.00746269,COCA-CN|1|321|0.00311526,AMR:0.2050,EAS:0.3341,FIN:0.3115,NFE:0.1980,OTH:0.2830,ASJ:0.1067	616778	.	.	.	.	.	.	.	.	.	.	.	6	2(liver)	0.2376
6	325840	325840	G	A	DUSP22	intronic	.	ENSG00000112679	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.0074	.	.	.	.	.	.	.	.	.	.	AFR:0.0012,AMR:0.0028,EAS:0,FIN:0.0137,NFE:0.0108,OTH:0.0073,ASJ:0.0147	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU127195612	het
6	325873	325873	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797329	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.997804	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9902,AMR:0.9986,EAS:0.9992,FIN:0.9932,NFE:0.9986,OTH:0.9974,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325961	325961	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797330	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.971046	0.9765	.	.	.	.	.	.	.	.	.	.	AFR:0.9660,AMR:0.9744,EAS:0.9888,FIN:0.9693,NFE:0.9835,OTH:0.9676,ASJ:0.9795	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU80942806	hom
6	326134	326134	G	A	DUSP22	intronic	.	ENSG00000112679	rs2757557	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9887,AMR:0.9913,EAS:1,FIN:0.9949,NFE:0.9992,OTH:0.9978,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	326491	326553	GGTGCCTGGAGAGTCATCTGCCCTGGGCTTCCGCGTCCTGGTGTGTGCAGTGCTGTATCTGCT	-	DUSP22	intronic	.	ENSG00000112679	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0903	.	.	.	.	.	.	.	.	.	.	AFR:0.0661,AMR:0.0572,EAS:0.1625,FIN:0.1314,NFE:0.0858,OTH:0.1062,ASJ:0.0569	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	335175	335175	A	T	DUSP22	intronic	.	ENSG00000112679	rs2671431	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9993	0.9980	0.997804	0.9980	.	.	.	.	.	.	.	.	.	.	AFR:0.9932,AMR:0.9988,EAS:1,FIN:0.9997,NFE:1,OTH:1,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU81809497	hom
6	348906	348906	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs11242812	ENSG00000112679:ENST00000604971:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000605315:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000603453:exon6:c.G264A:p.P88P,ENSG00000112679:ENST00000419235:exon7:c.G573A:p.P191P	DUSP22:NM_001286555:exon7:c.G573A:p.P191P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4882	.	.	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DUSP22:uc003msy.1:exon6:c.G444A:p.P148P,DUSP22:uc011dhn.1:exon7:c.G573A:p.P191P	.	AFR:MU4553881,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,EAS:0.4929,FIN:0.4795,NFE:0.4567,OTH:0.4781,ASJ:0.4800	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4698
6	350829	350829	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs1129085	ENSG00000112679:ENST00000344450:exon8:c.G516A:p.P172P	DUSP22:NM_020185:exon8:c.G516A:p.P172P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3887	0.3573	.	0.3837	.	.	.	.	.	.	.	.	DUSP22:uc003msx.3:exon8:c.G516A:p.P172P	.	AFR:0.4602,AMR:0.3674,EAS:0.4923,FIN:0.3651,NFE:0.3336,OTH:0.3775,ASJ:0.3423	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU34371818	het
6	1612017	1612017	-	CGG	FOXC1	exonic	nonframeshift insertion	ENSG00000054598	rs398123612	ENSG00000054598:ENST00000380874:exon1:c.1337_1338insCGG:p.H446delinsHG	FOXC1:NM_001453:exon1:c.1337_1338insCGG:p.H446delinsHG	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2174	0.1744	.	0.2663	.	.	.	.	.	.	.	.	FOXC1:uc003mtp.3:exon1:c.1337_1338insCGG:p.H446delinsHG	.	AFR:0.3113,AMR:0.3590,EAS:0.3957,FIN:0.2269,NFE:0.2307,OTH:0.2395,ASJ:0.2164	601090	601631;602482;	782;91483;98978;91483;98978;	782|Axenfeld syndrome<br>Rieger syndrome|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|180500 601499 602482 ~91483|-|-|Autosomal dominant|Neonatal|137600 601631 602482 ~98978|-|-|Autosomal dominant|-|601631 602482 ~91483|-|-|Autosomal dominant|Neonatal|137600 601631 602482 ~98978|-|-|Autosomal dominant|-|601631 602482 ~	.	.	.	.	.	.	.	.	6	MU112447406	het
6	5431340	5431340	A	G	FARS2	exonic	nonsynonymous SNV	ENSG00000145982	rs11243011	ENSG00000145982:ENST00000445533:exon2:c.A227G:p.N76S,ENSG00000145982:ENST00000274680:exon4:c.A839G:p.N280S,ENSG00000145982:ENST00000324331:exon4:c.A839G:p.N280S	FARS2:NM_001318872:exon4:c.A839G:p.N280S,FARS2:NM_006567:exon4:c.A839G:p.N280S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2188	0.1522	0.235224	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	1.402	12.80	0.355	3.13	1.000	.	.	Aminoacyl-tRNA synthetase, class II|Phenylalanyl-tRNA synthetase;Phenylalanyl-tRNA synthetase	FARS2:uc003mwr.2:exon4:c.A839G:p.N280S,FARS2:uc010jnv.1:exon4:c.A839G:p.N280S	-1.069	AFR:0.1663,AMR:0.0759,EAS:0.2616,FIN:0.4969,NFE:0.1535,OTH:0.1795,ASJ:0.2303	611592	614946;617046;	319519;	319519|COXPD14|<1 / 1 000 000|-|Neonatal<br>Infancy|614946 ~	.	.	.	.	0.001	0.01	0.034	-1.405	6	1(prostate)	0.1843
6	5619688	5619688	A	G	FARS2	intronic	.	ENSG00000145982	rs7751107	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.148163	0.1622	.	.	.	.	.	.	.	.	.	.	AFR:0.1359,AMR:0.1563,EAS:0.0315,FIN:0.1849,NFE:0.1846,OTH:0.1782,ASJ:0.2086	611592	614946;617046;	319519;	319519|COXPD14|<1 / 1 000 000|-|Neonatal<br>Infancy|614946 ~	.	.	.	.	.	.	.	.	6	.	het
6	7563983	7563983	T	G	DSP	exonic	synonymous SNV	ENSG00000096696	rs2806234	ENSG00000096696:ENST00000379802:exon6:c.T741G:p.A247A,ENSG00000096696:ENST00000418664:exon6:c.T741G:p.A247A	DSP:NM_001008844:exon6:c.T741G:p.A247A,DSP:NM_001319034:exon6:c.T741G:p.A247A,DSP:NM_004415:exon6:c.T741G:p.A247A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9991	0.9985	1	0.9995	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon6:c.T741G:p.A247A,DSP:uc003mxq.1:exon6:c.T741G:p.A247A,DSP:uc021yle.1:exon6:c.T741G:p.A247A	.	AFR:0.9999,AMR:1,EAS:1,FIN:0.9991,NFE:0.9992,OTH:0.9990,ASJ:1	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU81810273	hom
6	7577260	7577260	C	T	DSP	exonic	synonymous SNV	ENSG00000096696	rs2064217	ENSG00000096696:ENST00000379802:exon20:c.C2862T:p.C954C,ENSG00000096696:ENST00000418664:exon20:c.C2862T:p.C954C	DSP:NM_001008844:exon20:c.C2862T:p.C954C,DSP:NM_001319034:exon20:c.C2862T:p.C954C,DSP:NM_004415:exon20:c.C2862T:p.C954C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2438	0.2688	0.27516	MU586982	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon20:c.C2862T:p.C954C,DSP:uc003mxq.1:exon20:c.C2862T:p.C954C,DSP:uc021yle.1:exon20:c.C2862T:p.C954C	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.2733,EAS:0.2440,FIN:0.2119,NFE:0.2015,OTH:0.2560,ASJ:0.3759	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.2309
6	7581636	7581636	G	A	DSP	exonic	nonsynonymous SNV	ENSG00000096696	rs6929069	ENSG00000096696:ENST00000379802:exon23:c.G5213A:p.R1738Q	DSP:NM_004415:exon23:c.G5213A:p.R1738Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1724	0.1941	0.240415	3(haematopoietic_and_lymphoid_tissue)	0.509	7.501	0.076	3.24	0.272	.	.	.	DSP:uc003mxp.1:exon23:c.G5213A:p.R1738Q	-1.093	AFR:MU586983,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,EAS:0.3352,FIN:0.2053,NFE:0.1391,OTH:0.2005,ASJ:0.1975	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	0.003	-0.62	0.076	0.2	6	1(urinary_tract)	0.1804
6	10398707	10398707	G	A	TFAP2A	exonic	synonymous SNV	ENSG00000137203	rs3734391	ENSG00000137203:ENST00000319516:exon7:c.C1245T:p.N415N,ENSG00000137203:ENST00000379604:exon7:c.C1257T:p.N419N,ENSG00000137203:ENST00000379608:exon7:c.C1239T:p.N413N,ENSG00000137203:ENST00000379613:exon7:c.C1263T:p.N421N,ENSG00000137203:ENST00000482890:exon8:c.C1257T:p.N419N	TFAP2A:NM_001032280:exon7:c.C1239T:p.N413N,TFAP2A:NM_001042425:exon7:c.C1245T:p.N415N,TFAP2A:NM_003220:exon7:c.C1257T:p.N419N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1180	0.1242	0.0888578	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	TFAP2A:uc003myq.3:exon7:c.C1239T:p.N413N,TFAP2A:uc003myr.3:exon7:c.C1257T:p.N419N,TFAP2A:uc003myt.3:exon7:c.C1245T:p.N415N	.	AFR:0.1100,AMR:0.0792,EAS:0.2384,FIN:0.0210,NFE:0.1025,OTH:0.1383,ASJ:0.0815	107580	113620;	1297;	1297|BOFS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;No data available|Neonatal|113620 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.1092
6	10420098	10420098	C	T	TFAP2A	UTR5	.	ENSG00000137203	rs1621700	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.147364	0.1736	.	.	.	.	.	.	.	.	.	.	AFR:0.0385,AMR:0.3580,EAS:0.0470,FIN:0.2999,NFE:0.2238,OTH:0.2168,ASJ:0.1523	107580	113620;	1297;	1297|BOFS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;No data available|Neonatal|113620 ~	.	.	.	.	.	.	.	.	6	MU118048284	het
6	18134021	18134021	C	A	TPMT	intronic	.	ENSG00000137364	rs2842949	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6115	0.4515	0.585064	0.6325	.	.	.	.	.	.	.	.	TPMT:uc010jpm.1:exon7:c.G594T:p.G198G	.	AFR:0.3941,AMR:0.6850,EAS:0.7730,FIN:0.7322,NFE:0.7267,OTH:0.6854,ASJ:0.6803	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	MU799869	het
6	18139214	18139214	G	A	TPMT	exonic	synonymous SNV	ENSG00000137364	rs2842934	ENSG00000137364:ENST00000309983:exon6:c.C474T:p.I158I	TPMT:NM_000367:exon6:c.C474T:p.I158I,TPMT:NM_001346818:exon6:c.C474T:p.I158I,TPMT:NM_001346817:exon7:c.C474T:p.I158I	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7633	0.7943	0.752995	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TPMT:uc003ncm.3:exon6:c.C474T:p.I158I,TPMT:uc010jpm.1:exon6:c.C474T:p.I158I	.	AFR:0.7849,AMR:0.8096,EAS:0.7053,FIN:0.7670,NFE:0.7666,OTH:0.7819,ASJ:0.7596	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	1(stomach)	0.7515
6	18237661	18237661	C	T	DEK	exonic	synonymous SNV	ENSG00000124795	rs1013062	ENSG00000124795:ENST00000507591:exon2:c.G177A:p.K59K,ENSG00000124795:ENST00000244776:exon7:c.G747A:p.K249K,ENSG00000124795:ENST00000397239:exon8:c.G849A:p.K283K,ENSG00000124795:ENST00000505224:exon8:c.G765A:p.K255K	DEK:NM_001134709:exon7:c.G747A:p.K249K,DEK:NM_003472:exon8:c.G849A:p.K283K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1990	0.1593	0.164337	MU14609316	.	.	.	.	.	.	.	.	DEK:uc011djf.1:exon7:c.G747A:p.K249K,DEK:uc003ncr.1:exon8:c.G849A:p.K283K	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.1719,EAS:0.1607,FIN:0.1954,NFE:0.2419,OTH:0.2145,ASJ:0.0606	125264	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.2164
6	18264210	18264210	G	A	DEK	exonic	synonymous SNV	ENSG00000124795	rs11544757	ENSG00000124795:ENST00000515742:exon1:c.C24T:p.A8A,ENSG00000124795:ENST00000244776:exon2:c.C9T:p.A3A,ENSG00000124795:ENST00000397239:exon2:c.C9T:p.A3A,ENSG00000124795:ENST00000505224:exon2:c.C9T:p.A3A	DEK:NM_001134709:exon2:c.C9T:p.A3A,DEK:NM_003472:exon2:c.C9T:p.A3A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2055	0.1604	0.164537	1(thyroid)	.	.	.	.	.	.	.	.	DEK:uc003ncr.1:exon2:c.C9T:p.A3A,DEK:uc011djf.1:exon2:c.C9T:p.A3A	.	AFR:MU4548668,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BRCA-KR|2|50|0.04,EAS:0.0630,FIN:0.1591,NFE:0.1933,OTH:0.2444,ASJ:0.1725	125264	.	.	.	.	.	.	.	.	.	.	.	6	2(breast)	0.2141
6	24653376	24653376	G	A	TDP2	exonic	synonymous SNV	ENSG00000111802	rs1129644	ENSG00000111802:ENST00000341060:exon5:c.C468T:p.N156N,ENSG00000111802:ENST00000378198:exon6:c.C642T:p.N214N,ENSG00000111802:ENST00000545995:exon6:c.C732T:p.N244N	TDP2:NM_016614:exon6:c.C642T:p.N214N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7393	0.7642	0.805112	1(urinary_tract)	.	.	.	.	.	.	.	.	TDP2:uc003nej.3:exon6:c.C642T:p.N214N,TDP2:uc010jpu.1:exon6:c.C642T:p.N214N	.	AFR:1(oesophagus),AMR:MU4132850,EAS:0.7576,FIN:0.9091,NFE:0.8469,OTH:0.6755,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	605764	616949;	404493;	404493|SCAR23<br>Spinocerebellar ataxia autosomal recessive type 23|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|616949 ~	.	.	.	.	.	.	.	.	6	1(kidney)	0.8453
6	26045929	26045929	T	C	HIST1H3C	exonic	synonymous SNV	ENSG00000196532	rs3752416	ENSG00000196532:ENST00000540144:exon1:c.T291C:p.C97C	HIST1H3C:NM_003531:exon1:c.T291C:p.C97C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6713	0.6891	0.705272	0.6989	.	.	.	.	.	.	.	.	HIST1H3C:uc003nfv.3:exon1:c.T291C:p.C97C	.	AFR:0.7176,AMR:0.6591,EAS:0.8665,FIN:0.6825,NFE:0.6759,OTH:0.7071,ASJ:0.6733	602812	.	.	.	~ko05034 Alcoholism~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	.	.	.	.	6	MU4557974	het
6	28872446	28872446	T	C	TRIM27	intronic	.	ENSG00000204713	rs209126	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5675	0.6261	0.680911	0.6037	.	.	.	.	.	0.0011	0.018	.	.	.	AFR:0.8643,AMR:0.5683,EAS:0.6902,FIN:0.4335,NFE:0.4924,OTH:0.4990,ASJ:0.5464	602165	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	30857072	30857072	G	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs2229933	ENSG00000204580:ENST00000376567:exon3:c.G282C:p.L94L,ENSG00000204580:ENST00000513240:exon3:c.G282C:p.L94L,ENSG00000204580:ENST00000376568:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000396342:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000418800:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000421124:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000460944:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000482873:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000503495:exon4:c.G360C:p.L120L,ENSG00000204580:ENST00000504679:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000504927:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000505066:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000508312:exon4:c.G336C:p.L112L,ENSG00000204580:ENST00000511510:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000512694:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000512725:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000515233:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000376569:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000428153:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000437124:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000452441:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000505534:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000508317:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000509639:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000512336:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000324771:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000376570:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000376575:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000446312:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000454612:exon8:c.G282C:p.L94L	DDR1:NM_001202521:exon3:c.G282C:p.L94L,DDR1:NM_001202522:exon3:c.G282C:p.L94L,DDR1:NM_013994:exon3:c.G282C:p.L94L,DDR1:NM_001202523:exon4:c.G336C:p.L112L,DDR1:NM_001297652:exon4:c.G282C:p.L94L,DDR1:NM_001297653:exon4:c.G282C:p.L94L,DDR1:NM_001297654:exon4:c.G282C:p.L94L,DDR1:NM_013993:exon5:c.G282C:p.L94L,DDR1:NM_001954:exon6:c.G282C:p.L94L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3051	0.2076	0.415335	0.2548	.	.	.	.	.	.	.	.	DDR1:uc003nru.3:exon3:c.G282C:p.L94L,DDR1:uc003nrv.3:exon3:c.G282C:p.L94L,DDR1:uc003nrx.2:exon3:c.G282C:p.L94L,DDR1:uc003nry.2:exon3:c.G282C:p.L94L,DDR1:uc011dmu.1:exon3:c.G282C:p.L94L,DDR1:uc003nrs.3:exon4:c.G282C:p.L94L,DDR1:uc003nrt.3:exon4:c.G282C:p.L94L,DDR1:uc010jse.3:exon4:c.G282C:p.L94L,DDR1:uc011dms.2:exon4:c.G336C:p.L112L,DDR1:uc011dmt.2:exon4:c.G360C:p.L120L,DDR1:uc003nrr.3:exon5:c.G282C:p.L94L,DDR1:uc003nrq.3:exon6:c.G282C:p.L94L	.	AFR:0.2781,AMR:0.4594,EAS:0.5861,FIN:0.2629,NFE:0.1910,OTH:0.2776,ASJ:0.2384	600408	.	.	.	.	.	.	.	.	.	.	.	6	MU640884	het
6	30858857	30858857	C	T	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049622	ENSG00000204580:ENST00000515219:exon3:c.C51T:p.S17S,ENSG00000204580:ENST00000376567:exon4:c.C525T:p.S175S,ENSG00000204580:ENST00000513240:exon4:c.C525T:p.S175S,ENSG00000204580:ENST00000376568:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000418800:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000421124:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000460944:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000482873:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000508312:exon5:c.C579T:p.S193S,ENSG00000204580:ENST00000376569:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000428153:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000452441:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000324771:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000376570:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000376575:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000446312:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000454612:exon9:c.C525T:p.S175S	DDR1:NM_001202521:exon4:c.C525T:p.S175S,DDR1:NM_001202522:exon4:c.C525T:p.S175S,DDR1:NM_013994:exon4:c.C525T:p.S175S,DDR1:NM_001202523:exon5:c.C579T:p.S193S,DDR1:NM_001297652:exon5:c.C525T:p.S175S,DDR1:NM_001297653:exon5:c.C525T:p.S175S,DDR1:NM_001297654:exon5:c.C525T:p.S175S,DDR1:NM_013993:exon6:c.C525T:p.S175S,DDR1:NM_001954:exon7:c.C525T:p.S175S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3051	0.2080	0.415535	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	DDR1:uc003nru.3:exon4:c.C525T:p.S175S,DDR1:uc003nrv.3:exon4:c.C525T:p.S175S,DDR1:uc003nrx.2:exon4:c.C525T:p.S175S,DDR1:uc003nry.2:exon4:c.C525T:p.S175S,DDR1:uc011dmu.1:exon4:c.C525T:p.S175S,DDR1:uc003nrs.3:exon5:c.C525T:p.S175S,DDR1:uc003nrt.3:exon5:c.C525T:p.S175S,DDR1:uc010jse.3:exon5:c.C525T:p.S175S,DDR1:uc011dms.2:exon5:c.C579T:p.S193S,DDR1:uc011dmt.2:exon5:c.C603T:p.S201S,DDR1:uc003nrr.3:exon6:c.C525T:p.S175S,DDR1:uc003nrq.3:exon7:c.C525T:p.S175S	.	AFR:0.2552,AMR:0.2786,EAS:0.2384,FIN:0.5855,NFE:0.2630,OTH:0.1914,ASJ:0.4594	600408	.	.	.	.	.	.	.	.	.	.	.	6	52(meninges)	0.2770
6	30864829	30864829	T	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049623	ENSG00000204580:ENST00000361741:exon9:c.T909C:p.V303V,ENSG00000204580:ENST00000417521:exon9:c.T1104C:p.V368V,ENSG00000204580:ENST00000376567:exon12:c.T1797C:p.V599V,ENSG00000204580:ENST00000418800:exon13:c.T1797C:p.V599V,ENSG00000204580:ENST00000508312:exon13:c.T1851C:p.V617V,ENSG00000204580:ENST00000513240:exon13:c.T1908C:p.V636V,ENSG00000204580:ENST00000376568:exon14:c.T1908C:p.V636V,ENSG00000204580:ENST00000376569:exon14:c.T1797C:p.V599V,ENSG00000204580:ENST00000376570:exon15:c.T1797C:p.V599V,ENSG00000204580:ENST00000452441:exon15:c.T1908C:p.V636V,ENSG00000204580:ENST00000324771:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000376575:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000454612:exon17:c.T1797C:p.V599V	DDR1:NM_001202522:exon11:c.T1470C:p.V490V,DDR1:NM_001202523:exon13:c.T1851C:p.V617V,DDR1:NM_001297652:exon13:c.T1797C:p.V599V,DDR1:NM_001297653:exon13:c.T1797C:p.V599V,DDR1:NM_013994:exon13:c.T1908C:p.V636V,DDR1:NM_001297654:exon14:c.T1908C:p.V636V,DDR1:NM_001954:exon15:c.T1797C:p.V599V,DDR1:NM_013993:exon15:c.T1908C:p.V636V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4631	0.4071	0.535743	1(large_intestine)	.	.	.	.	.	.	.	.	DDR1:uc003nrw.1:exon9:c.T1113C:p.V371V,DDR1:uc003nrx.2:exon11:c.T1470C:p.V490V,DDR1:uc003nru.3:exon12:c.T1797C:p.V599V,DDR1:uc003nrt.3:exon13:c.T1797C:p.V599V,DDR1:uc003nrv.3:exon13:c.T1908C:p.V636V,DDR1:uc010jse.3:exon13:c.T1797C:p.V599V,DDR1:uc011dms.2:exon13:c.T1851C:p.V617V,DDR1:uc003nrs.3:exon14:c.T1908C:p.V636V,DDR1:uc003nrq.3:exon15:c.T1797C:p.V599V,DDR1:uc003nrr.3:exon15:c.T1908C:p.V636V	.	AFR:MU157872,AMR:LAML-KR|1|205|0.00487805,EAS:0.4650,FIN:0.5692,NFE:0.3808,OTH:0.6677,ASJ:0.4341	600408	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.4067
6	30877202	30877202	T	C	GTF2H4	intronic	.	ENSG00000213780	rs916920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3007	0.2074	0.407748	0.2543	.	.	.	.	.	0	0	.	.	.	AFR:0.2780,AMR:0.4581,EAS:0.5821,FIN:0.2637,NFE:0.1909,OTH:0.2751,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	.	het
6	30877760	30877760	A	C	GTF2H4	exonic	synonymous SNV	ENSG00000213780	rs1419693	ENSG00000213780:ENST00000539324:exon3:c.A126C:p.T42T,ENSG00000213780:ENST00000259895:exon4:c.A294C:p.T98T,ENSG00000213780:ENST00000376316:exon4:c.A294C:p.T98T,ENSG00000213780:ENST00000453897:exon4:c.A294C:p.T98T	GTF2H4:NM_001517:exon4:c.A294C:p.T98T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3002	0.2076	0.407748	0.2544	.	.	.	.	.	.	.	.	GTF2H4:uc011dmv.1:exon3:c.A126C:p.T42T,GTF2H4:uc003nsa.1:exon4:c.A294C:p.T98T,GTF2H4:uc010jsf.2:exon4:c.A294C:p.T98T	.	AFR:0.2780,AMR:0.4581,EAS:0.5797,FIN:0.2629,NFE:0.1915,OTH:0.2765,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	MU16197142	het
6	30878919	30878919	T	C	GTF2H4	intronic	.	ENSG00000213780	rs2074512	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2979	0.2101	0.407348	0.2541	.	.	.	.	.	.	.	.	.	.	AFR:0.2776,AMR:0.4605,EAS:0.5781,FIN:0.2635,NFE:0.1908,OTH:0.2761,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	.	het
6	31708328	31708328	C	T	MSH5	exonic	nonsynonymous SNV	ENSG00000204410;ENSG00000255152	rs2075789	ENSG00000204410:ENST00000423982:exon1:c.C85T:p.P29S,ENSG00000204410:ENST00000375703:exon2:c.C85T:p.P29S,ENSG00000204410:ENST00000375740:exon2:c.C85T:p.P29S,ENSG00000204410:ENST00000375742:exon2:c.C85T:p.P29S,ENSG00000204410:ENST00000375750:exon2:c.C85T:p.P29S,ENSG00000204410:ENST00000375755:exon2:c.C85T:p.P29S,ENSG00000255152:ENST00000493662:exon2:c.C85T:p.P29S,ENSG00000204410:ENST00000534153:exon2:c.C85T:p.P29S,ENSG00000204410:ENST00000425703:exon3:c.C85T:p.P29S	MSH5:NM_002441:exon2:c.C85T:p.P29S,MSH5:NM_025259:exon2:c.C85T:p.P29S,MSH5:NM_172165:exon2:c.C85T:p.P29S,MSH5:NM_172166:exon2:c.C85T:p.P29S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1463	0.0661	0.101837	0.0905	1.018	10.76	0.022	-2.41	0.006	.	.	.	MSH5-SAPCD1:uc003nwu.2:exon2:c.C85T:p.P29S,MSH5-SAPCD1:uc003nwv.2:exon2:c.C85T:p.P29S,MSH5-SAPCD1:uc003nww.2:exon2:c.C85T:p.P29S,MSH5-SAPCD1:uc003nwx.2:exon2:c.C85T:p.P29S	-1.030	AFR:0.0328,AMR:0.1730,EAS:0.1389,FIN:0.1652,NFE:0.0950,OTH:0.1304,ASJ:0.0497	603382	.	.	.	.	.	.	.	0.0	1.39	0.031	1.825	6	MU27499730	het
6	31729359	31729359	A	G	MSH5	exonic	synonymous SNV	ENSG00000204410;ENSG00000255152	rs707938	ENSG00000204410:ENST00000429846:exon2:c.A162G:p.Q54Q,ENSG00000204410:ENST00000484309:exon4:c.A372G:p.Q124Q,ENSG00000204410:ENST00000395853:exon11:c.A1170G:p.Q390Q,ENSG00000204410:ENST00000431848:exon14:c.A1245G:p.Q415Q,ENSG00000204410:ENST00000375703:exon22:c.A2151G:p.Q717Q,ENSG00000204410:ENST00000375740:exon22:c.A2202G:p.Q734Q,ENSG00000204410:ENST00000375742:exon22:c.A2199G:p.Q733Q,ENSG00000204410:ENST00000375750:exon22:c.A2148G:p.Q716Q,ENSG00000204410:ENST00000375755:exon22:c.A2148G:p.Q716Q,ENSG00000255152:ENST00000493662:exon22:c.A2199G:p.Q733Q,ENSG00000204410:ENST00000534153:exon22:c.A2199G:p.Q733Q	MSH5:NM_002441:exon22:c.A2148G:p.Q716Q,MSH5:NM_025259:exon22:c.A2202G:p.Q734Q,MSH5:NM_172165:exon22:c.A2151G:p.Q717Q,MSH5:NM_172166:exon22:c.A2148G:p.Q716Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3854	0.4283	0.467252	1(kidney)	.	.	.	.	.	.	.	.	MSH5-SAPCD1:uc003nwy.1:exon10:c.A1170G:p.Q390Q,MSH5-SAPCD1:uc011dof.1:exon14:c.A1245G:p.Q415Q,MSH5-SAPCD1:uc003nwu.2:exon22:c.A2151G:p.Q717Q,MSH5-SAPCD1:uc003nwv.2:exon22:c.A2148G:p.Q716Q,MSH5-SAPCD1:uc003nww.2:exon22:c.A2148G:p.Q716Q,MSH5-SAPCD1:uc003nwx.2:exon22:c.A2202G:p.Q734Q	.	AFR:MU616434,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,EAS:0.6417,FIN:0.3866,NFE:0.3113,OTH:0.3181,ASJ:0.4219	603382	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4344
6	32163541	32163541	A	C	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs1044507	ENSG00000204301:ENST00000375023:exon30:c.T5685G:p.S1895S	NOTCH4:NM_004557:exon30:c.T5685G:p.S1895S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0319	0.0224	0.0357428	0.0252	.	.	.	.	.	.	.	.	NOTCH4:uc003oba.3:exon9:c.T1665G:p.S555S,NOTCH4:uc003obb.3:exon30:c.T5685G:p.S1895S	.	AFR:0.0169,AMR:0.0131,EAS:0.0253,FIN:0.0318,NFE:0.0282,OTH:0.0309,ASJ:0.0497	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	het
6	32168771	32168771	G	T	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs3134942	ENSG00000204301:ENST00000375023:exon23:c.C4152A:p.V1384V	NOTCH4:NM_004557:exon23:c.C4152A:p.V1384V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1007	0.1155	0.0776757	2(breast)	.	.	.	.	.	.	.	.	NOTCH4:uc003oba.3:exon2:c.C141A:p.V47V,NOTCH4:uc003obb.3:exon23:c.C4152A:p.V1384V	.	AFR:MU133892,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.0882,FIN:0.0477,NFE:0.1033,OTH:0.0253,ASJ:0.1143	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.1294
6	32172065	32172065	T	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs1044506	ENSG00000204301:ENST00000375023:exon19:c.A2967C:p.G989G	NOTCH4:NM_004557:exon19:c.A2967C:p.G989G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9165	0.9034	0.963259	0.9054	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon19:c.A2967C:p.G989G	.	AFR:0.9704,AMR:0.9427,EAS:0.9957,FIN:0.8716,NFE:0.8629,OTH:0.8988,ASJ:0.9603	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32183175	32183175	G	A	NOTCH4	intronic	.	ENSG00000204301	rs3131290	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4138	0.3276	0.277556	MU113474871	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|2|170|0.0117647,AMR:0.3435,EAS:0.3134,FIN:0.5464,NFE:0.1712,OTH:0.3940,ASJ:0.2134	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	13(soft_tissue)	0.4198
6	32184705	32184705	G	A	NOTCH4	intronic	.	ENSG00000204301	rs3134798	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.7723	0.7697	0.824481	0.7647	.	.	.	.	.	.	.	.	NOTCH4:uc003obc.3:exon11:c.C1878T:p.H626H	.	AFR:0.8603,AMR:0.6782,EAS:0.8995,FIN:0.6301,NFE:0.7298,OTH:0.7311,ASJ:0.9133	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32188383	32188383	T	C	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs422951	ENSG00000204301:ENST00000375023:exon6:c.A958G:p.T320A	NOTCH4:NM_004557:exon6:c.A958G:p.T320A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4035	0.4002	0.343051	MU113489694	-2.277	0.001	0.546	-4.96	0.273	.	.	EGF-like calcium-binding domain|EGF-like domain	NOTCH4:uc003obb.3:exon6:c.A958G:p.T320A,NOTCH4:uc003obc.3:exon6:c.A958G:p.T320A	-0.758	AFR:LUSC-KR|4|170|0.0235294,AMR:0.4018,EAS:0.3174,FIN:0.5767,NFE:0.1597,OTH:0.4453,ASJ:0.3017	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-2.98	0.351	0.57	6	16(soft_tissue)	0.4739
6	32190390	32190390	T	G	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs915894	ENSG00000204301:ENST00000375023:exon3:c.A349C:p.K117Q	NOTCH4:NM_004557:exon3:c.A349C:p.K117Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3584	0.3722	0.398762	1(lung)	-0.306	0.643	0.399	2.36	0.002	.	.	.	NOTCH4:uc003obb.3:exon3:c.A349C:p.K117Q,NOTCH4:uc003obc.3:exon3:c.A349C:p.K117Q	-0.758	AFR:1(urinary_tract),AMR:MU12600545,EAS:0.3603,FIN:0.3721,NFE:0.2542,OTH:0.3609,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-2.92	0.370	0.04	6	1(haematopoietic_and_lymphoid_tissue)	0.4819
6	32190406	32190406	A	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs443198	ENSG00000204301:ENST00000375023:exon3:c.T333C:p.G111G	NOTCH4:NM_004557:exon3:c.T333C:p.G111G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3804	0.4040	0.460663	2(lung)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.T333C:p.G111G,NOTCH4:uc003obc.3:exon3:c.T333C:p.G111G	.	AFR:2(breast),AMR:MU713734,EAS:0.3795,FIN:0.4611,NFE:0.3225,OTH:0.4338,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(urinary_tract)	0.5261
6	32190484	32190484	G	A	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs8192569	ENSG00000204301:ENST00000375023:exon3:c.C255T:p.P85P	NOTCH4:NM_004557:exon3:c.C255T:p.P85P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1414	0.1555	0.215056	1(large_intestine)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.C255T:p.P85P,NOTCH4:uc003obc.3:exon3:c.C255T:p.P85P	.	AFR:1(breast),AMR:MU116684,EAS:0.1588,FIN:0.2985,NFE:0.1196,OTH:0.09,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	5(soft_tissue)	0.2807
6	32190871	32190871	T	A	NOTCH4	intronic	.	ENSG00000204301	rs2854049	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0735	0.0803	0.11262	LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0	.	.	.	AFR:0.0711,AMR:0.1390,EAS:0.0563,FIN:0.1598,NFE:0.0141,OTH:0.0375,ASJ:0.0609	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(lung)	0.0504
6	32191620	32191620	C	T	NOTCH4	intronic	.	ENSG00000204301	rs3134930	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2534	0.2447	0.258187	1(lung)	.	.	.	.	.	.	.	.	.	.	AFR:MU12600591,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.2418,FIN:0.1974,NFE:0.34,OTH:0.3134,ASJ:0.2495	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.1922
6	32191658	32191658	-	AGCAGC	NOTCH4	exonic	nonframeshift insertion	ENSG00000204301	rs546167192	ENSG00000204301:ENST00000375023:exon1:c.47_48insGCTGCT:p.L16delinsLLL	NOTCH4:NM_004557:exon1:c.47_48insGCTGCT:p.L16delinsLLL	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0703	.	0.0672923	0.0909	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon1:c.47_48insGCTGCT:p.L16delinsLLL,NOTCH4:uc003obc.3:exon1:c.47_48insGCTGCT:p.L16delinsLLL	.	AFR:0.0695,AMR:0.0362,EAS:0.0053,FIN:0.0969,NFE:0.1142,OTH:0.1002,ASJ:0.0507	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	het
6	32814975	32814975	T	C	TAP1	exonic	nonsynonymous SNV	ENSG00000168394	rs1135216	ENSG00000168394:ENST00000354258:exon10:c.A2090G:p.D697G,ENSG00000168394:ENST00000425148:exon10:c.A1307G:p.D436G	TAP1:NM_000593:exon10:c.A2090G:p.D697G,TAP1:NM_001292022:exon10:c.A1307G:p.D436G	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1739	0.1700	0.191494	1(thyroid)	1.225	11.88	1.0	5.43	0.206	.	.	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	TAP1:uc003ocg.3:exon10:c.A2090G:p.D697G,TAP1:uc011dqi.2:exon10:c.A1307G:p.D436G	-1.000	AFR:MU652657,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,EAS:0.2366,FIN:0.1599,NFE:0.1854,OTH:0.1669,ASJ:0.1787	170260	604571;	34592;	34592|Bare lymphocyte syndrome type 1|-|Autosomal recessive|Childhood|604571 ~	.	.	.	.	0.0	-2.37	0.107	-1.275	6	3(soft_tissue)	0.1762
6	32818774	32818774	T	C	TAP1	exonic	nonsynonymous SNV	ENSG00000168394	rs1057141	ENSG00000168394:ENST00000354258:exon4:c.A1177G:p.I393V,ENSG00000168394:ENST00000425148:exon4:c.A394G:p.I132V	TAP1:NM_000593:exon4:c.A1177G:p.I393V,TAP1:NM_001292022:exon4:c.A394G:p.I132V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2047	0.1961	0.228235	MU12613212	-0.723	0.064	0.683	-2.4	0.777	.	.	ABC transporter type 1, transmembrane domain	TAP1:uc003ocg.3:exon4:c.A1177G:p.I393V,TAP1:uc011dqi.2:exon4:c.A394G:p.I132V	-0.969	AFR:ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.2059,EAS:0.1671,FIN:0.2185,NFE:0.2379,OTH:0.2017,ASJ:0.2690	170260	604571;	34592;	34592|Bare lymphocyte syndrome type 1|-|Autosomal recessive|Childhood|604571 ~	.	.	.	.	0.0	-2.6	0.162	-0.37	6	3(soft_tissue)	0.1692
6	33288271	33288271	A	G	DAXX	exonic	synonymous SNV	ENSG00000204209	rs1059231	ENSG00000204209:ENST00000414083:exon3:c.T912C:p.Y304Y,ENSG00000204209:ENST00000266000:exon4:c.T1137C:p.Y379Y,ENSG00000204209:ENST00000374542:exon4:c.T1137C:p.Y379Y	DAXX:NM_001254717:exon3:c.T912C:p.Y304Y,DAXX:NM_001141969:exon4:c.T1137C:p.Y379Y,DAXX:NM_001141970:exon4:c.T1173C:p.Y391Y,DAXX:NM_001350:exon4:c.T1137C:p.Y379Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2955	0.2189	0.220847	MU25113587	.	.	.	.	.	.	.	.	DAXX:uc010juw.2:exon3:c.T912C:p.Y304Y,DAXX:uc011drd.2:exon3:c.T912C:p.Y304Y,DAXX:uc021ywn.1:exon3:c.T1137C:p.Y379Y,DAXX:uc021ywo.1:exon3:c.T1137C:p.Y379Y,DAXX:uc003oec.3:exon4:c.T1137C:p.Y379Y,DAXX:uc003oed.3:exon4:c.T1137C:p.Y379Y,DAXX:uc011dre.2:exon4:c.T1173C:p.Y391Y	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2464,EAS:0.3699,FIN:0.2450,NFE:0.2519,OTH:0.3484,ASJ:0.0532	603186	.	.	.	.	.	.	.	.	.	.	.	6	10(meninges)	0.3226
6	35423662	35423662	A	C	FANCE	exonic	synonymous SNV	ENSG00000112039	rs4713867	ENSG00000112039:ENST00000229769:exon2:c.A387C:p.P129P	FANCE:NM_021922:exon2:c.A387C:p.P129P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7211	0.7357	0.777955	0.7433	.	.	.	.	.	.	.	.	FANCE:uc003oko.1:exon2:c.A387C:p.P129P,FANCE:uc010jvw.1:exon2:c.A387C:p.P129P	.	AFR:0.8741,AMR:0.7995,EAS:0.6605,FIN:0.6994,NFE:0.6843,OTH:0.7255,ASJ:0.7417	613976	600901;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	6	MU18657626	hom
6	35426175	35426175	C	T	FANCE	exonic	synonymous SNV	ENSG00000112039	rs3823434	ENSG00000112039:ENST00000229769:exon5:c.C1071T:p.L357L	FANCE:NM_021922:exon5:c.C1071T:p.L357L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0383	0.0178	0.0583067	0.0278	.	.	.	.	.	.	.	.	FANCE:uc003oko.1:exon5:c.C1071T:p.L357L,FANCE:uc010jvw.1:exon5:c.C1050T:p.L350L	.	AFR:0.0069,AMR:0.0322,EAS:0.1241,FIN:0.0384,NFE:0.0254,OTH:0.0409,ASJ:0.0596	613976	600901;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	6	MU12616543	het
6	36645696	36645696	A	G	CDKN1A	exonic	nonsynonymous SNV	ENSG00000124762	rs2395655	ENSG00000124762:ENST00000448526:exon1:c.A83G:p.D28G	CDKN1A:NM_001291549:exon2:c.A83G:p.D28G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4641	.	0.527556	MU46305489	.	.	.	.	.	.	.	.	CDKN1A:uc011dtq.2:exon1:c.A83G:p.D28G	.	AFR:COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4816,EAS:0.3425,FIN:0.5596,NFE:0.4895,OTH:0.3667,ASJ:0.6871	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,1969	.	.	.	.	.	.	6	1(large_intestine)	0.3996
6	36652339	36652339	C	G	CDKN1A	intronic	.	ENSG00000124762	rs3176352	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3667	0.3878	0.503594	MU29871221	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3870,EAS:0.4702,FIN:0.3146,NFE:0.5938,OTH:0.2368,ASJ:0.6302	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	6	1(lung)	0.2599
6	37138220	37138220	C	G	PIM1	exonic	nonsynonymous SNV	ENSG00000137193	rs262936	.	PIM1:NM_001243186:exon1:c.C142G:p.H48D	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3624	.	0.322484	0.3073	.	.	.	.	.	.	.	.	.	.	AFR:0.3932,AMR:0.2806,EAS:0.2233,FIN:0.2622,NFE:0.2828,OTH:0.2771,ASJ:0.1921	164960	.	.	.	~ko04630 JAK-STAT signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05221 Acute myeloid leukemia ~	,9073	.	.	.	.	.	.	6	MU17314189	het
6	37348920	37348920	C	T	RNF8	intronic	.	ENSG00000112130	rs2284923	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5179	0.5006	0.604034	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0	.	.	.	AFR:0.5120,AMR:0.5827,EAS:0.4636,FIN:0.7700,NFE:0.3713,OTH:0.4756,ASJ:0.5835	611685	.	.	.	.	.	.	.	.	.	.	.	6	1(lung)	0.4684
6	37349033	37349033	G	A	RNF8	exonic	synonymous SNV	ENSG00000112130	rs2284922	ENSG00000112130:ENST00000373479:exon7:c.G1344A:p.T448T	RNF8:NM_003958:exon7:c.G1344A:p.T448T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4395	0.4043	0.560304	0.4191	.	.	.	.	.	.	.	.	RNF8:uc003onq.4:exon7:c.G1344A:p.T448T,RNF8:uc011dtx.2:exon7:c.G1140A:p.T380T	.	AFR:0.5315,AMR:0.5322,EAS:0.7497,FIN:0.2789,NFE:0.3482,OTH:0.3615,ASJ:0.4205	611685	.	.	.	.	.	.	.	.	.	.	.	6	MU24947047	hom
6	42931261	42931261	C	G	CNPY3-GNMT;GNMT	intronic	.	ENSG00000124713	rs2296804	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5897	0.6896	0.647364	0.6479	.	.	.	.	.	0.0014	0.014	.	.	.	AFR:0.9126,AMR:0.5574,EAS:0.3269,FIN:0.5114,NFE:0.5733,OTH:0.5758,ASJ:0.48	606628	606664;	289891;	289891|Glycine N-methyltransferase deficiency<br>Hypermethioninemia due to GNMT deficiency|-|-|-|606664 ~	.	.	.	.	.	.	.	.	6	MU20718783	het
6	43581586	43581586	G	A	POLH	exonic	synonymous SNV	ENSG00000170734	rs3734690	ENSG00000170734:ENST00000535400:exon10:c.G1248A:p.T416T,ENSG00000170734:ENST00000372236:exon11:c.G1434A:p.T478T	POLH:NM_001291969:exon9:c.G1062A:p.T354T,POLH:NM_006502:exon11:c.G1434A:p.T478T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0463	0.0557	0.0700879	LAML-KR|2|205|0.0097561	.	.	.	.	.	.	.	.	POLH:uc003ovr.4:exon8:c.G1182A:p.T394T,POLH:uc010jyu.2:exon9:c.G1062A:p.T354T,POLH:uc003ovq.4:exon11:c.G1434A:p.T478T	.	AFR:0.0543,AMR:0.1037,EAS:0.0596,FIN:0.0365,NFE:0.0386,OTH:0.0333,ASJ:0.0251	603968	278750;	90342;	90342|XPV|<1 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|278750 ~	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.0439
6	43582091	43582091	A	T	POLH	exonic	nonsynonymous SNV	ENSG00000170734	rs6941583	ENSG00000170734:ENST00000535400:exon10:c.A1753T:p.M585L,ENSG00000170734:ENST00000372236:exon11:c.A1939T:p.M647L	POLH:NM_001291969:exon9:c.A1567T:p.M523L,POLH:NM_006502:exon11:c.A1939T:p.M647L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0657	0.1236	0.128794	MU113474290	1.884	15.49	0.51	5.73	0.997	.	.	.	POLH:uc003ovr.4:exon8:c.A1687T:p.M563L,POLH:uc010jyu.2:exon9:c.A1567T:p.M523L,POLH:uc003ovq.4:exon11:c.A1939T:p.M647L	-1.063	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.1139,EAS:0.0358,FIN:0.0596,NFE:0.0371,OTH:0.0387,ASJ:0.3120	603968	278750;	90342;	90342|XPV|<1 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|278750 ~	.	.	.	.	0.068	0.42	0.061	2.27	6	1(haematopoietic_and_lymphoid_tissue)	0.0341
6	43738977	43738977	C	T	VEGFA	exonic	synonymous SNV	ENSG00000112715	rs25648	ENSG00000112715:ENST00000324450:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000372055:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000372064:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000372067:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000413642:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000417285:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000425836:exon1:c.C534T:p.S178S,ENSG00000112715:ENST00000482630:exon1:c.C534T:p.S178S	VEGFA:NM_001025366:exon1:c.C534T:p.S178S,VEGFA:NM_001025367:exon1:c.C534T:p.S178S,VEGFA:NM_001025368:exon1:c.C534T:p.S178S,VEGFA:NM_001025369:exon1:c.C534T:p.S178S,VEGFA:NM_001025370:exon1:c.C534T:p.S178S,VEGFA:NM_001033756:exon1:c.C534T:p.S178S,VEGFA:NM_001171622:exon1:c.C534T:p.S178S,VEGFA:NM_001204385:exon1:c.C534T:p.S178S,VEGFA:NM_003376:exon1:c.C534T:p.S178S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1576	0.1186	0.121206	MU17741540	.	.	.	.	.	.	.	.	VEGFA:uc003owd.3:exon1:c.C534T:p.S178S,VEGFA:uc003owe.3:exon1:c.C534T:p.S178S,VEGFA:uc003owf.3:exon1:c.C534T:p.S178S,VEGFA:uc003owg.3:exon1:c.C534T:p.S178S,VEGFA:uc003owh.3:exon1:c.C534T:p.S178S,VEGFA:uc003owi.3:exon1:c.C534T:p.S178S,VEGFA:uc003owj.3:exon1:c.C534T:p.S178S,VEGFA:uc010jyx.3:exon1:c.C534T:p.S178S,VEGFA:uc021yzu.1:exon1:c.C531T:p.S177S	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.1409,EAS:0.1610,FIN:0.1490,NFE:0.0724,OTH:0.1820,ASJ:0.0839	192240	603933;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05219 Bladder cancer~ko05323 Rheumatoid arthritis~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	6	1(breast)	0.1695
6	44268371	44268371	T	C	AARS2	exonic	synonymous SNV	ENSG00000124608	rs325008	ENSG00000124608:ENST00000244571:exon22:c.A2871G:p.S957S	AARS2:NM_020745:exon22:c.A2871G:p.S957S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.8711	0.869409	0.8912	.	.	.	.	.	.	.	.	AARS2:uc010jza.1:exon22:c.A2871G:p.S957S	.	AFR:0.6787,AMR:0.9606,EAS:0.9975,FIN:0.9954,NFE:0.9709,OTH:0.9469,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU4546910	hom
6	44269023	44269023	T	C	AARS2	intronic	.	ENSG00000124608;ENSG00000178233;ENSG00000272442	rs325007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9421	0.8683	0.867812	0.8895	.	.	.	.	.	.	.	.	.	.	AFR:0.6724,AMR:0.9593,EAS:0.9969,FIN:0.9954,NFE:0.9709,OTH:0.9467,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU81815181	hom
6	44269193	44269193	C	T	AARS2	exonic	synonymous SNV	ENSG00000124608	rs498512	ENSG00000124608:ENST00000244571:exon20:c.G2607A:p.K869K	AARS2:NM_020745:exon20:c.G2607A:p.K869K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7015	0.6790	0.582668	0.6673	.	.	.	.	.	.	.	.	AARS2:uc010jza.1:exon20:c.G2607A:p.K869K	.	AFR:0.5090,AMR:0.7823,EAS:0.4097,FIN:0.7069,NFE:0.7661,OTH:0.7284,ASJ:0.7351	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU4552846	het
6	44272284	44272284	G	C	AARS2	intronic	.	ENSG00000124608;ENSG00000178233;ENSG00000272442	rs74950428	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0465	0.0316	0.0557109	0.0422	.	.	.	.	.	.	.	.	.	.	AFR:0.0094,AMR:0.0394,EAS:0.1525,FIN:0.0659,NFE:0.0442,OTH:0.0448,ASJ:0.0232	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU640267	het
6	44274142	44274144	AGA	-	AARS2	intronic	.	ENSG00000124608;ENSG00000178233;ENSG00000272442	rs144914586	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0166	0.0019	0.0421326	0.0093	.	.	.	.	.	.	.	.	.	.	AFR:0.0024,AMR:0.0191,EAS:0.1446,FIN:0.0006,NFE:0.0007,OTH:0.0041,ASJ:0	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	.	het
6	44275011	44275011	T	C	AARS2	exonic	nonsynonymous SNV	ENSG00000124608	rs324136	ENSG00000124608:ENST00000244571:exon6:c.A1015G:p.I339V	AARS2:NM_020745:exon6:c.A1015G:p.I339V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9469	0.8866	0.888978	0.9059	-0.555	0.161	0.378	2.88	0.879	.	.	Alanine-tRNA ligase, class IIc, anti-codon-binding domain|Alanyl-tRNA synthetase, class IIc, N-terminal|Alanyl-tRNA synthetase, class IIc, core domain	AARS2:uc010jza.1:exon6:c.A1015G:p.I339V	-1.086	AFR:0.7292,AMR:0.9618,EAS:0.9975,FIN:0.9954,NFE:0.9716,OTH:0.9497,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	0.0	-0.43	0.033	-1.04	6	MU81815212	hom
6	44279111	44279111	A	G	AARS2	intronic	.	ENSG00000124608;ENSG00000272442	rs9688508	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2400	0.2930	0.258387	0.2896	.	.	.	.	.	.	.	.	.	.	AFR:0.3963,AMR:0.1986,EAS:0.1789,FIN:0.2554,NFE:0.2585,OTH:0.2495,ASJ:0.1291	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU12634469	het
6	44280812	44280812	C	T	AARS2	intronic	.	ENSG00000124608;ENSG00000272442	rs167772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5333	0.4974	0.453275	0.4873	.	.	.	.	.	0.0006	0.04	.	.	.	AFR:0.3649,AMR:0.6158,EAS:0.3812,FIN:0.5097,NFE:0.5520,OTH:0.5297,ASJ:0.6324	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU707496	het
6	91266349	91266349	-	A	MAP3K7	intronic	.	ENSG00000135341	rs3215663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3310	0.0544	0.38139	0.3347	.	.	.	.	.	.	.	.	.	.	AFR:0.4363,AMR:0.2770,EAS:0.3025,FIN:0.2483,NFE:0.3033,OTH:0.2660,ASJ:0.4503	602614	157800;617137;	1826;3238;	1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~3238|Forney syndrome<br>Forney-Robinson-Pascoe syndrome<br>Mitral regurgitation-deafness-skeletal anomalies syndrome|<1 / 1 000 000|Autosomal dominant|All ages|157800 ~	.	.	.	.	.	.	.	.	6	.	het
6	91266350	91266350	A	T	MAP3K7	intronic	.	ENSG00000135341	rs45625637	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1576	.	0.0644968	0.1383	.	.	.	.	.	0.0411	0.086	.	.	.	AFR:0.1667,AMR:0.1598,EAS:0.0340,FIN:0.1059,NFE:0.1445,OTH:0.1204,ASJ:0.2037	602614	157800;617137;	1826;3238;	1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~3238|Forney syndrome<br>Forney-Robinson-Pascoe syndrome<br>Mitral regurgitation-deafness-skeletal anomalies syndrome|<1 / 1 000 000|Autosomal dominant|All ages|157800 ~	.	.	.	.	.	.	.	.	6	MU85144216	het
6	93967851	93967851	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345730	ENSG00000135333:ENST00000369303:exon11:c.G2076A:p.P692P	EPHA7:NM_001288629:exon11:c.G2061A:p.P687P,EPHA7:NM_004440:exon11:c.G2076A:p.P692P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7226	0.6783	0.73123	0.6823	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon11:c.G2076A:p.P692P,EPHA7:uc003pof.3:exon11:c.G2061A:p.P687P,EPHA7:uc011eac.2:exon11:c.G2064A:p.P688P	.	AFR:0.6010,AMR:0.6930,EAS:0.7868,FIN:0.7228,NFE:0.7056,OTH:0.7035,ASJ:0.7550	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU20730318	hom
6	93973569	93973569	A	G	EPHA7	intronic	.	ENSG00000135333	rs345725	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0870	0.0853	0.101438	LICA-CN|2|402|0.00497512,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.0973,AMR:0.1072,EAS:0.0232,FIN:0.1043,NFE:0.1492,OTH:0.0792,ASJ:0.1086	602190	.	.	.	.	.	.	.	.	.	.	.	6	1(soft_tissue)	0.1014
6	93982124	93982124	A	G	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345713	ENSG00000135333:ENST00000369303:exon6:c.T1341C:p.S447S	EPHA7:NM_001288629:exon6:c.T1341C:p.S447S,EPHA7:NM_004440:exon6:c.T1341C:p.S447S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8735	0.9151	0.900359	0.8912	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon6:c.T1341C:p.S447S,EPHA7:uc003pof.3:exon6:c.T1341C:p.S447S,EPHA7:uc011eac.2:exon6:c.T1341C:p.S447S	.	AFR:0.9733,AMR:0.8070,EAS:0.7869,FIN:0.8502,NFE:0.8689,OTH:0.8686,ASJ:0.9437	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU721640	hom
6	94067981	94067981	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs164544	ENSG00000135333:ENST00000369303:exon4:c.G981A:p.A327A	EPHA7:NM_001288629:exon4:c.G981A:p.A327A,EPHA7:NM_004440:exon4:c.G981A:p.A327A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6284	0.6362	0.730431	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon4:c.G981A:p.A327A,EPHA7:uc003pof.3:exon4:c.G981A:p.A327A,EPHA7:uc011eac.2:exon4:c.G981A:p.A327A	.	AFR:0.6591,AMR:0.8392,EAS:0.4899,FIN:0.8439,NFE:0.6164,OTH:0.5493,ASJ:0.6906	602190	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.6063
6	105300262	105300262	-	AG	HACE1	intronic	.	ENSG00000085382	rs10635352	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6682	0.6597	0.620008	0.6452	.	.	.	.	.	.	.	.	.	.	AFR:0.5858,AMR:0.6190,EAS:0.5638,FIN:0.6368,NFE:0.6865,OTH:0.6902,ASJ:0.7633	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	.	hom
6	105307435	105307435	G	A	HACE1	intronic	.	ENSG00000085382	rs2499655	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5276	0.3781	0.438099	0.4390	.	.	.	.	.	0.0013	0.092	.	.	.	AFR:0.2035,AMR:0.4353,EAS:0.5557,FIN:0.5210,NFE:0.5351,OTH:0.5277,ASJ:0.6060	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	MU81819230	hom
6	108882570	108882570	C	T	FOXO3	exonic	synonymous SNV	ENSG00000118689	rs11757217	ENSG00000118689:ENST00000406360:exon1:c.C159T:p.A53A,ENSG00000118689:ENST00000343882:exon2:c.C159T:p.A53A	FOXO3:NM_001455:exon1:c.C159T:p.A53A,FOXO3:NM_201559:exon2:c.C159T:p.A53A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2246	.	0.184305	.	.	.	.	.	.	.	.	.	FOXO3:uc003psm.2:exon1:c.C159T:p.A53A,FOXO3:uc003psk.2:exon2:c.C159T:p.A53A	.	AFR:0.1739,AMR:0.2435,EAS:0.1093,FIN:0.0633,NFE:0.1143,OTH:0.1557,ASJ:0.2917	602681	.	.	.	.	.	.	.	.	.	.	.	6	2(meninges)	0.1495
6	108882830	108882830	C	T	FOXO3	exonic	nonsynonymous SNV	ENSG00000118689	rs111556510	ENSG00000118689:ENST00000406360:exon1:c.C419T:p.A140V,ENSG00000118689:ENST00000343882:exon2:c.C419T:p.A140V	FOXO3:NM_001455:exon1:c.C419T:p.A140V,FOXO3:NM_201559:exon2:c.C419T:p.A140V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1526	0.0334	0.0245607	.	2.523	19.62	0.171	2.98	0.995	.	.	.	FOXO3:uc003psm.2:exon1:c.C419T:p.A140V,FOXO3:uc003psk.2:exon2:c.C419T:p.A140V	-0.467	AFR:0.0347,AMR:0.0094,EAS:0.0411,FIN:0.0012,NFE:0.0336,OTH:0.0531,ASJ:0.0267	602681	.	.	.	.	.	.	.	0.001	-2.8	0.396	0.255	6	1(thyroid)	0.0458
6	111695073	111695073	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455645	ENSG00000009413:ENST00000368802:exon13:c.G4485A:p.S1495S,ENSG00000009413:ENST00000358835:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000368805:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000435970:exon15:c.G4251A:p.S1417S	REV3L:NM_002912:exon14:c.G4485A:p.S1495S,REV3L:NM_001286432:exon15:c.G4251A:p.S1417S,REV3L:NM_001286431:exon16:c.G4251A:p.S1417S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7159	0.6862	0.586462	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4485A:p.S1495S,REV3L:uc003pux.4:exon15:c.G4251A:p.S1417S,REV3L:uc003puz.4:exon15:c.G4251A:p.S1417S	.	AFR:0.6670,AMR:0.4393,EAS:0.7682,FIN:0.4651,NFE:0.6989,OTH:0.8072,ASJ:0.6826	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7169
6	111695268	111695268	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455732	ENSG00000009413:ENST00000368802:exon13:c.G4290A:p.V1430V,ENSG00000009413:ENST00000358835:exon14:c.G4290A:p.V1430V,ENSG00000009413:ENST00000368805:exon14:c.G4290A:p.V1430V,ENSG00000009413:ENST00000435970:exon15:c.G4056A:p.V1352V	REV3L:NM_002912:exon14:c.G4290A:p.V1430V,REV3L:NM_001286432:exon15:c.G4056A:p.V1352V,REV3L:NM_001286431:exon16:c.G4056A:p.V1352V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4703	0.3946	0.354034	1(liver)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4290A:p.V1430V,REV3L:uc003pux.4:exon15:c.G4056A:p.V1352V,REV3L:uc003puz.4:exon15:c.G4056A:p.V1352V	.	AFR:MU721734,AMR:LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,EAS:0.1064,FIN:0.4246,NFE:0.4702,OTH:0.4310,ASJ:0.3983	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4971
6	111695887	111695887	G	A	REV3L	exonic	nonsynonymous SNV	ENSG00000009413	rs462779	ENSG00000009413:ENST00000368802:exon13:c.C3671T:p.T1224I,ENSG00000009413:ENST00000358835:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000368805:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000435970:exon15:c.C3437T:p.T1146I	REV3L:NM_002912:exon14:c.C3671T:p.T1224I,REV3L:NM_001286432:exon15:c.C3437T:p.T1146I,REV3L:NM_001286431:exon16:c.C3437T:p.T1146I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7165	0.6866	0.586462	0.6672	0.396	6.577	1.0	1.45	0.417	.	.	.	REV3L:uc003puy.4:exon13:c.C3671T:p.T1224I,REV3L:uc003pux.4:exon15:c.C3437T:p.T1146I,REV3L:uc003puz.4:exon15:c.C3437T:p.T1146I	-0.991	AFR:0.4399,AMR:0.6818,EAS:0.4652,FIN:0.6987,NFE:0.8075,OTH:0.7172,ASJ:0.7667	602776	.	.	.	.	.	.	.	0.0	5.02	0.001	-1.355	6	MU4714890	hom
6	111696257	111696257	G	A	REV3L	exonic	synonymous SNV	ENSG00000009413	rs461646	ENSG00000009413:ENST00000368802:exon13:c.C3301T:p.L1101L,ENSG00000009413:ENST00000358835:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000368805:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000435970:exon15:c.C3067T:p.L1023L	REV3L:NM_002912:exon14:c.C3301T:p.L1101L,REV3L:NM_001286432:exon15:c.C3067T:p.L1023L,REV3L:NM_001286431:exon16:c.C3067T:p.L1023L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.6859	0.586661	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.C3301T:p.L1101L,REV3L:uc003pux.4:exon15:c.C3067T:p.L1023L,REV3L:uc003puz.4:exon15:c.C3067T:p.L1023L	.	AFR:MU4714901,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4403,FIN:0.6859,NFE:0.7682,OTH:0.4633,ASJ:0.6671	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(liver)	0.6988
6	111696852	111696852	T	C	REV3L	exonic	synonymous SNV	ENSG00000009413	rs458486	ENSG00000009413:ENST00000368802:exon13:c.A2706G:p.G902G,ENSG00000009413:ENST00000358835:exon14:c.A2706G:p.G902G,ENSG00000009413:ENST00000368805:exon14:c.A2706G:p.G902G,ENSG00000009413:ENST00000435970:exon15:c.A2472G:p.G824G	REV3L:NM_002912:exon14:c.A2706G:p.G902G,REV3L:NM_001286432:exon15:c.A2472G:p.G824G,REV3L:NM_001286431:exon16:c.A2472G:p.G824G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4710	0.3945	0.354233	MU12436274	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.A2706G:p.G902G,REV3L:uc003pux.4:exon15:c.A2472G:p.G824G,REV3L:uc003puz.4:exon15:c.A2472G:p.G824G	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,AMR:0.3978,EAS:0.4221,FIN:0.4702,NFE:0.4268,OTH:0.4974,ASJ:0.1059	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(breast)	0.5350
6	117643897	117643897	A	G	ROS1	intronic	.	ENSG00000047936	rs3798375	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.173323	0.2088	.	.	.	.	.	.	.	.	.	.	AFR:0.1854,AMR:0.1372,EAS:0.1096,FIN:0.1954,NFE:0.2399,OTH:0.2230,ASJ:0.1722	165020	.	.	.	.	.	.	.	.	.	.	.	6	MU9240169	hom
6	117651926	117651926	T	C	ROS1	intronic	.	ENSG00000047936	rs521645	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.355631	0.3685	.	.	.	.	.	.	.	.	.	.	AFR:0.4040,AMR:0.2434,EAS:0.3142,FIN:0.3045,NFE:0.3776,OTH:0.3419,ASJ:0.36	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	117654711	117654711	T	C	ROS1	intronic	.	ENSG00000047936	rs2095283	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	0.9990	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:0.9988,FIN:0.9991,NFE:0.9983,OTH:0.9980,ASJ:1	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	117656555	117656555	T	G	ROS1	intronic	.	ENSG00000047936	rs9385006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.757987	0.7751	.	.	.	.	.	.	.	.	.	.	AFR:0.8458,AMR:0.7422,EAS:0.6043,FIN:0.6943,NFE:0.7745,OTH:0.7525,ASJ:0.7767	165020	.	.	.	.	.	.	.	.	.	.	.	6	MU114372260	hom
6	117657686	117657686	A	G	ROS1	intronic	.	ENSG00000047936	rs12199518	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.0908546	0.0856	.	.	.	.	.	.	.	.	.	.	AFR:0.0274,AMR:0.0835,EAS:0.1086,FIN:0.0945,NFE:0.1133,OTH:0.1079,ASJ:0.0960	165020	.	.	.	.	.	.	.	.	.	.	.	6	MU12449148	hom
6	117678083	117678083	A	G	ROS1	intronic	.	ENSG00000047936	rs2243384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4657	0.4254	0.394569	MU687081	.	.	.	.	.	0	0	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4054,EAS:0.4093,FIN:0.5033,NFE:0.4882,OTH:0.4413,ASJ:0.2292	165020	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4875
6	121768710	121768710	G	A	GJA1	exonic	synonymous SNV	ENSG00000152661	rs57946868	ENSG00000152661:ENST00000282561:exon2:c.G717A:p.R239R	GJA1:NM_000165:exon2:c.G717A:p.R239R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0199	0.0349	0.034345	0.0303	.	.	.	.	.	.	.	.	GJA1:uc021zel.1:exon1:c.G717A:p.R239R,GJA1:uc003pyr.3:exon2:c.G717A:p.R239R,GJA1:uc011ebo.1:exon3:c.G420A:p.R140R,GJA1:uc011ebp.1:exon3:c.G81A:p.R27R	.	AFR:0.0776,AMR:0.0048,EAS:0.0018,FIN:0.0026,NFE:0.0153,OTH:0.0122,ASJ:0.0099	121014	104100;133200;164200;186100;218400;241550;257850;600309;	98722;2710;2248;1522;93404;2710;317;495;1010;	98722|AVSD<br>Atrioventricular septal defect|-|-|-|600309 606215 606217 614430 614474 615779 ~2710|Meyer-Schwickerath syndrome<br>ODDD syndrome<br>Oculodentoosseous dysplasia|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|164200 257850 ~2248|HLHS|Unknown|Unknown|Neonatal<br>Antenatal|241550 614435 ~1522|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|123000 218400 ~93404|SD3<br>Syndactyly of fingers 4 and 5|Unknown|Autosomal dominant|Infancy<br>Neonatal|186100 ~2710|Meyer-Schwickerath syndrome<br>ODDD syndrome<br>Oculodentoosseous dysplasia|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|164200 257850 ~317|EKV<br>Erythrokeratodermia variabilis, Mendes da Costa type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|133200 ~495|Greither disease<br>Keratosis extremitatum hereditaria progrediens<br>Keratosis palmoplantaris transgrediens et progrediens<br>Progressive diffuse PPK<br>Progressive diffuse palmoplantar keratoderma<br>Transgrediens et progrediens PPK|-|-|-|133200 ~1010|Autosomal dominant palmoplantar hyperkeratosis and congenital alopecia<br>PPK-CA, Stevanovic type<br>Palmoplantar keratoderma and congenital alopecia, Stevanovic type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|104100 ~	.	.	.	.	.	.	.	.	6	.	het
6	128330424	128330424	A	-	PTPRK	intronic	.	ENSG00000152894	rs576466042	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0786	0.0419	0.0441294	0.0133	.	.	.	.	.	.	.	.	.	.	AFR:0.0306,AMR:0.0503,EAS:0.0190,FIN:0.0070,NFE:0.0010,OTH:0.0061,ASJ:0.0042	602545	.	.	.	.	.	.	.	.	.	.	.	6	MU79724469	het
6	128383562	128383562	-	A	LOC101928140	ncRNA_intronic	.	ENSG00000227945	rs11422080	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.957668	0.9075	.	.	.	.	.	.	.	.	.	.	AFR:0.9730,AMR:0.9342,EAS:1,FIN:0.9064,NFE:0.8568,OTH:0.9090,ASJ:0.9536	.	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	128388799	128388799	G	T	PTPRK	exonic	synonymous SNV	ENSG00000152894	rs35030557	ENSG00000152894:ENST00000368207:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368210:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368213:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368215:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368226:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368227:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000532331:exon12:c.C2022A:p.L674L	PTPRK:NM_001291983:exon11:c.C1635A:p.L545L,PTPRK:NM_001135648:exon12:c.C2022A:p.L674L,PTPRK:NM_001291981:exon12:c.C2022A:p.L674L,PTPRK:NM_001291982:exon12:c.C2022A:p.L674L,PTPRK:NM_001291984:exon12:c.C2022A:p.L674L,PTPRK:NM_002844:exon12:c.C2022A:p.L674L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3739	0.3150	0.245208	1(liver)	.	.	.	.	.	.	.	.	PTPRK:uc003qbl.1:exon10:c.C1632A:p.L544L,PTPRK:uc003qbj.3:exon12:c.C2022A:p.L674L,PTPRK:uc003qbk.3:exon12:c.C2022A:p.L674L,PTPRK:uc010kfc.3:exon12:c.C2022A:p.L674L,PTPRK:uc011ebu.2:exon12:c.C2022A:p.L674L,PTPRK:uc011ebv.1:exon12:c.C2022A:p.L674L	.	AFR:MU134141,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.0922,FIN:0.4234,NFE:0.3543,OTH:0.2363,ASJ:0.3367	602545	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.5055
6	128561307	128561307	G	-	PTPRK	intronic	.	ENSG00000152894	rs72291480	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0680	0.0829	0.153754	0.1054	.	.	.	.	.	.	.	.	.	.	AFR:0.2297,AMR:0.0537,EAS:0.3720,FIN:0.0894,NFE:0.0169,OTH:0.0531,ASJ:0.0033	602545	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	129371106	129371106	C	T	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs1140366	ENSG00000196569:ENST00000421865:exon2:c.C156T:p.I52I	LAMA2:NM_000426:exon2:c.C156T:p.I52I,LAMA2:NM_001079823:exon2:c.C156T:p.I52I	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0996	0.0850	0.0706869	0.0878	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon2:c.C156T:p.I52I,LAMA2:uc003qbo.3:exon2:c.C156T:p.I52I,LAMA2:uc021zfb.1:exon2:c.C156T:p.I52I	.	AFR:0.0174,AMR:0.0658,EAS:0.1566,FIN:0.1046,NFE:0.1159,OTH:0.0980,ASJ:0.1933	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12471561	het
6	129381026	129381026	C	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs4404787	ENSG00000196569:ENST00000421865:exon3:c.C381A:p.T127T	LAMA2:NM_000426:exon3:c.C381A:p.T127T,LAMA2:NM_001079823:exon3:c.C381A:p.T127T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9578	0.9473	0.936701	0.9540	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon3:c.C381A:p.T127T,LAMA2:uc003qbo.3:exon3:c.C381A:p.T127T,LAMA2:uc021zfb.1:exon3:c.C381A:p.T127T	.	AFR:0.9027,AMR:0.9773,EAS:0.9759,FIN:0.9840,NFE:0.9723,OTH:0.9644,ASJ:0.9636	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU81821229	hom
6	129722389	129722389	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749877	ENSG00000196569:ENST00000421865:exon38:c.A5466G:p.E1822E	LAMA2:NM_000426:exon38:c.A5466G:p.E1822E,LAMA2:NM_001079823:exon38:c.A5466G:p.E1822E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4978	0.5161	0.544529	0.5112	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.A5466G:p.E1822E,LAMA2:uc003qbo.3:exon38:c.A5466G:p.E1822E,LAMA2:uc021zfb.1:exon38:c.A5466G:p.E1822E	.	AFR:0.6206,AMR:0.4845,EAS:0.5824,FIN:0.4613,NFE:0.4523,OTH:0.5051,ASJ:0.5705	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12472152	het
6	129722425	129722425	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749878	ENSG00000196569:ENST00000421865:exon38:c.G5502A:p.E1834E	LAMA2:NM_000426:exon38:c.G5502A:p.E1834E,LAMA2:NM_001079823:exon38:c.G5502A:p.E1834E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4963	0.5150	0.543331	0.5089	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.G5502A:p.E1834E,LAMA2:uc003qbo.3:exon38:c.G5502A:p.E1834E,LAMA2:uc021zfb.1:exon38:c.G5502A:p.E1834E	.	AFR:0.6208,AMR:0.4784,EAS:0.5815,FIN:0.4559,NFE:0.4496,OTH:0.5020,ASJ:0.5667	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU4554300	het
6	129762112	129762112	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2297738	ENSG00000196569:ENST00000421865:exon43:c.G6237A:p.T2079T	LAMA2:NM_000426:exon43:c.G6237A:p.T2079T,LAMA2:NM_001079823:exon43:c.G6237A:p.T2079T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1683	0.1390	0.182508	0.1654	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon43:c.G6237A:p.T2079T,LAMA2:uc003qbo.3:exon43:c.G6237A:p.T2079T,LAMA2:uc021zfb.1:exon43:c.G6237A:p.T2079T	.	AFR:0.1297,AMR:0.1993,EAS:0.2135,FIN:0.2033,NFE:0.1698,OTH:0.1864,ASJ:0.1258	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU113879	het
6	129807629	129807629	C	T	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs2229848	ENSG00000196569:ENST00000421865:exon56:c.C7760T:p.A2587V	LAMA2:NM_001079823:exon55:c.C7748T:p.A2583V,LAMA2:NM_000426:exon56:c.C7760T:p.A2587V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.6678	0.6386	0.583866	0.6270	7.378	34	0.056	5.6	0.894	.	.	Concanavalin A-like lectin/glucanase domain|Laminin G domain	LAMA2:uc003qbo.3:exon54:c.C7742T:p.A2581V,LAMA2:uc003qbn.3:exon55:c.C7754T:p.A2585V,LAMA2:uc021zfb.1:exon56:c.C7760T:p.A2587V	0.056	AFR:0.4529,AMR:0.6878,EAS:0.6160,FIN:0.6464,NFE:0.7152,OTH:0.6851,ASJ:0.7384	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.998	-1.2	0.584	2.395	6	MU687237	het
6	129807699	129807699	G	C	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2229849	ENSG00000196569:ENST00000421865:exon56:c.G7830C:p.V2610V	LAMA2:NM_001079823:exon55:c.G7818C:p.V2606V,LAMA2:NM_000426:exon56:c.G7830C:p.V2610V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6682	0.6400	0.584265	0.6279	.	.	.	.	.	.	.	.	LAMA2:uc003qbo.3:exon54:c.G7812C:p.V2604V,LAMA2:uc003qbn.3:exon55:c.G7824C:p.V2608V,LAMA2:uc021zfb.1:exon56:c.G7830C:p.V2610V	.	AFR:0.4568,AMR:0.6894,EAS:0.6113,FIN:0.6461,NFE:0.7153,OTH:0.6857,ASJ:0.7384	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU20737955	het
6	129807714	129807714	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2229850	ENSG00000196569:ENST00000421865:exon56:c.G7845A:p.P2615P	LAMA2:NM_001079823:exon55:c.G7833A:p.P2611P,LAMA2:NM_000426:exon56:c.G7845A:p.P2615P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3080	0.3422	0.403754	0.3535	.	.	.	.	.	.	.	.	LAMA2:uc003qbo.3:exon54:c.G7827A:p.P2609P,LAMA2:uc003qbn.3:exon55:c.G7839A:p.P2613P,LAMA2:uc021zfb.1:exon56:c.G7845A:p.P2615P	.	AFR:0.5389,AMR:0.3007,EAS:0.3878,FIN:0.3129,NFE:0.2609,OTH:0.2953,ASJ:0.2285	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12472301	het
6	129813053	129813053	A	G	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs2244008	ENSG00000196569:ENST00000421865:exon57:c.A7906G:p.T2636A	LAMA2:NM_001079823:exon56:c.A7894G:p.T2632A,LAMA2:NM_000426:exon57:c.A7906G:p.T2636A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0925	0.0808	0.111621	0.0926	2.164	17.27	0.035	5.46	0.968	.	.	Concanavalin A-like lectin/glucanase domain|Laminin G domain	LAMA2:uc003qbo.3:exon55:c.A7888G:p.T2630A,LAMA2:uc003qbn.3:exon56:c.A7900G:p.T2634A,LAMA2:uc021zfb.1:exon57:c.A7906G:p.T2636A	-0.687	AFR:0.1147,AMR:0.0776,EAS:0.1722,FIN:0.1155,NFE:0.0676,OTH:0.0806,ASJ:0.0861	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.015	-1.09	0.247	1.265	6	MU587224	het
6	131948816	131948816	-	AA	MED23	intronic	.	ENSG00000112282	rs369598986	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1687	.	0.0748802	0.2132	.	.	.	.	.	.	.	.	.	.	AFR:0.2566,AMR:0.3085,EAS:0.1738,FIN:0.2370,NFE:0.1858,OTH:0.2237,ASJ:0.1130	605042	614249;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	6	.	hom
6	134494708	134494708	-	A	SGK1	intronic	.	ENSG00000118515	rs199505223	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1221	0.0616	.	0.0177	.	.	.	.	.	.	.	.	.	.	AFR:0.0021,AMR:0.1445,EAS:0.0928,FIN:0.1150,NFE:0.0053,OTH:0.0206,ASJ:0.0048	602958	.	.	.	.	.	.	.	.	.	.	.	6	MU112447824	het
6	137519588	137519588	A	C	IFNGR1	exonic	synonymous SNV	ENSG00000027697	rs11914	ENSG00000027697:ENST00000367739:exon7:c.T1050G:p.S350S,ENSG00000027697:ENST00000543628:exon7:c.T966G:p.S322S	IFNGR1:NM_000416:exon7:c.T1050G:p.S350S,IFNGR1:NM_001363527:exon7:c.T927G:p.S309S,IFNGR1:NM_001363526:exon8:c.T1020G:p.S340S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1317	0.1286	0.0940495	.	.	.	.	.	.	.	.	.	IFNGR1:uc003qho.2:exon7:c.T1050G:p.S350S,IFNGR1:uc011edm.1:exon7:c.T966G:p.S322S	.	AFR:0.1234,AMR:0.0624,EAS:0.2086,FIN:0.1399,NFE:0.0967,OTH:0.1618,ASJ:0.1077	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	6	1(large_intestine)	0.1337
6	137536455	137536455	G	A	IFNGR1	exonic	nonsynonymous SNV	ENSG00000027697	rs1327475	ENSG00000027697:ENST00000367735:exon2:c.C4T:p.L2F,ENSG00000027697:ENST00000414770:exon2:c.C4T:p.L2F	IFNGR1:NM_001363526:exon2:c.C4T:p.L2F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1222	.	0.0924521	0.1205	0.554	7.832	0.0	1.42	0.001	.	.	.	IFNGR1:uc011edn.1:exon2:c.C4T:p.L2F	-0.764	AFR:0.0548,AMR:0.1041,EAS:0.1403,FIN:0.0965,NFE:0.1606,OTH:0.1316,ASJ:0.2086	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	0.137	-2.3	0.317	.	6	.	het
6	137540370	137540370	A	G	IFNGR1	intronic	.	ENSG00000027697	rs7749390	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4834	0.4282	0.502396	0.4295	.	.	.	.	.	.	.	.	.	.	AFR:0.5046,AMR:0.3696,EAS:0.5894,FIN:0.3465,NFE:0.3881,OTH:0.45,ASJ:0.5232	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	6	MU20697206	het
6	146185565	146185565	G	T	LOC100507557	ncRNA_intronic	.	ENSG00000146414	rs117306655	ENSG00000146414:ENST00000417762:exon3:c.C284A:p.S95Y	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0073	.	0.0115815	0.0065	0.755	9.179	0.005	-0.878	0.120	.	.	.	.	-0.967	AFR:0.0002,AMR:0.0012,EAS:0.0803,FIN:0.0136,NFE:0.0010,OTH:0.0062,ASJ:0	608048	.	.	.	.	.	.	.	.	-0.85	0.109	.	6	MU678807	het
6	146207563	146207563	A	G	LOC100507557	ncRNA_exonic	.	ENSG00000235652	rs1062067	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4445	0.3704	0.349641	0.3706	.	.	.	.	.	.	.	.	.	.	AFR:0.2724,AMR:0.2148,EAS:0.3506,FIN:0.4762,NFE:0.4118,OTH:0.3937,ASJ:0.3974	.	.	.	.	.	.	.	.	.	.	.	.	6	MU12506364	hom
6	146234644	146234644	G	A	SHPRH	exonic	synonymous SNV	ENSG00000146414	rs9497426	ENSG00000146414:ENST00000275233:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000367503:exon24:c.C4308T:p.C1436C,ENSG00000146414:ENST00000367505:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000438092:exon24:c.C4308T:p.C1436C	SHPRH:NM_001042683:exon24:c.C4296T:p.C1432C,SHPRH:NM_001370327:exon24:c.C4296T:p.C1432C,SHPRH:NM_173082:exon24:c.C4308T:p.C1436C,SHPRH:NM_001370328:exon26:c.C2853T:p.C951C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7804	0.8120	0.836262	0.8023	.	.	.	.	.	.	.	.	SHPRH:uc003qlg.1:exon23:c.C2964T:p.C988C,SHPRH:uc003qle.3:exon24:c.C4308T:p.C1436C,SHPRH:uc003qlf.3:exon24:c.C4296T:p.C1432C	.	AFR:0.9376,AMR:0.8950,EAS:0.8269,FIN:0.6485,NFE:0.7536,OTH:0.7688,ASJ:0.7980	608048	.	.	.	.	.	.	.	.	.	.	.	6	MU800391	hom
6	146240637	146240637	T	C	SHPRH	intronic	.	ENSG00000146414	rs117008643	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0083	0.0006	0.0115815	0.0067	.	.	.	.	.	0	0	.	.	.	AFR:0.0003,AMR:0.0012,EAS:0.0821,FIN:0.0143,NFE:0.0010,OTH:0.0061,ASJ:0	608048	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	146256316	146256316	A	-	SHPRH	intronic	.	ENSG00000146414	rs200288193	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2198	.	.	0.0140	.	.	.	.	.	.	.	.	.	.	AFR:0.0076,AMR:0.0177,EAS:0.0880,FIN:0.0909,NFE:0.0025,OTH:0.0159,ASJ:0.0050	608048	.	.	.	.	.	.	.	.	.	.	.	6	MU112456779	het
6	146275983	146275983	T	G	SHPRH	exonic	nonsynonymous SNV	ENSG00000146414	rs117586623	ENSG00000146414:ENST00000433355:exon1:c.A410C:p.D137A,ENSG00000146414:ENST00000275233:exon2:c.A476C:p.D159A,ENSG00000146414:ENST00000367503:exon2:c.A476C:p.D159A,ENSG00000146414:ENST00000367505:exon2:c.A476C:p.D159A,ENSG00000146414:ENST00000438092:exon2:c.A476C:p.D159A,ENSG00000146414:ENST00000519632:exon3:c.A143C:p.D48A	SHPRH:NM_001042683:exon2:c.A476C:p.D159A,SHPRH:NM_001370327:exon2:c.A476C:p.D159A,SHPRH:NM_173082:exon2:c.A476C:p.D159A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0082	0.0005	0.0115815	LICA-CN|1|402|0.00248756	2.713	20.9	0.024	5.66	0.998	.	.	.	SHPRH:uc003qle.3:exon2:c.A476C:p.D159A,SHPRH:uc003qlf.3:exon2:c.A476C:p.D159A,SHPRH:uc003qlj.1:exon3:c.A143C:p.D48A	-0.920	AFR:0.0066,AMR:0.0002,EAS:0,FIN:0.0807,NFE:0.0143,OTH:0.0010,ASJ:0.0012	608048	.	.	.	.	.	.	.	0.161	-0.03	0.117	1.935	6	1(pancreas)	0.0061
6	149983216	149983216	G	A	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3924871	ENSG00000131023:ENST00000253339:exon7:c.C3042T:p.D1014D,ENSG00000131023:ENST00000543571:exon8:c.C3042T:p.D1014D	LATS1:NM_001350392:exon7:c.C2202T:p.D734D,LATS1:NM_004690:exon8:c.C3042T:p.D1014D,LATS1:NM_001350340:exon9:c.C2727T:p.D909D,LATS1:NM_001350339:exon10:c.C2826T:p.D942D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4492	0.4227	0.550719	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmu.2:exon8:c.C3042T:p.D1014D,LATS1:uc010kif.2:exon9:c.C2727T:p.D909D	.	AFR:0.4418,AMR:0.5405,EAS:0.3742,FIN:0.8296,NFE:0.3674,OTH:0.3535,ASJ:0.6346	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.3998
6	150004779	150004779	A	G	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3798761	ENSG00000131023:ENST00000253339:exon3:c.T1446C:p.S482S,ENSG00000131023:ENST00000392273:exon4:c.T1446C:p.S482S,ENSG00000131023:ENST00000543571:exon4:c.T1446C:p.S482S	LATS1:NM_001350392:exon3:c.T606C:p.S202S,LATS1:NM_001270519:exon4:c.T1446C:p.S482S,LATS1:NM_004690:exon4:c.T1446C:p.S482S,LATS1:NM_001350339:exon5:c.T1131C:p.S377S,LATS1:NM_001350340:exon5:c.T1131C:p.S377S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4493	0.4243	0.552316	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmv.2:exon3:c.T1446C:p.S482S,LATS1:uc003qmu.2:exon4:c.T1446C:p.S482S,LATS1:uc003qmw.3:exon4:c.T1446C:p.S482S,LATS1:uc010kif.2:exon5:c.T1131C:p.S377S,LATS1:uc010kig.1:exon5:c.T1131C:p.S377S	.	AFR:0.4425,AMR:0.5429,EAS:0.3742,FIN:0.8317,NFE:0.3673,OTH:0.3535,ASJ:0.6376	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(urinary_tract)	0.3949
6	152129077	152129077	T	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs2077647	ENSG00000091831:ENST00000206249:exon1:c.T30C:p.S10S,ENSG00000091831:ENST00000406599:exon1:c.T30C:p.S10S,ENSG00000091831:ENST00000338799:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000443427:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000446550:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000456483:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000404742:exon3:c.T30C:p.S10S,ENSG00000091831:ENST00000440973:exon3:c.T30C:p.S10S	ESR1:NM_000125:exon1:c.T30C:p.S10S,ESR1:NM_001122740:exon2:c.T30C:p.S10S,ESR1:NM_001122741:exon2:c.T30C:p.S10S,ESR1:NM_001291230:exon2:c.T30C:p.S10S,ESR1:NM_001291241:exon2:c.T30C:p.S10S,ESR1:NM_001122742:exon3:c.T30C:p.S10S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4654	0.4789	0.466454	MU159353	.	.	.	.	.	.	.	.	ESR1:uc003qoo.4:exon1:c.T30C:p.S10S,ESR1:uc010kir.3:exon1:c.T30C:p.S10S,ESR1:uc003qon.4:exon2:c.T30C:p.S10S,ESR1:uc010kin.3:exon2:c.T30C:p.S10S,ESR1:uc010kio.3:exon2:c.T30C:p.S10S,ESR1:uc010kip.3:exon2:c.T30C:p.S10S,ESR1:uc031sqc.1:exon2:c.T30C:p.S10S,ESR1:uc003qom.4:exon3:c.T30C:p.S10S,ESR1:uc031sqb.1:exon3:c.T30C:p.S10S,ESR1:uc021zgx.1:exon4:c.T30C:p.S10S,ESR1:uc031spz.1:exon4:c.T30C:p.S10S,ESR1:uc031sqa.1:exon4:c.T30C:p.S10S	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526,AMR:0.4776,EAS:0.4294,FIN:0.5,NFE:0.3759,OTH:0.4365,ASJ:0.4960	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4803,4805,4804	.	.	.	.	.	.	6	3(haematopoietic_and_lymphoid_tissue)	0.4893
6	152129276	152129276	G	A	ESR1	exonic	nonsynonymous SNV	ENSG00000091831	rs9340773	ENSG00000091831:ENST00000206249:exon1:c.G229A:p.G77S,ENSG00000091831:ENST00000406599:exon1:c.G229A:p.G77S,ENSG00000091831:ENST00000338799:exon2:c.G229A:p.G77S,ENSG00000091831:ENST00000443427:exon2:c.G229A:p.G77S,ENSG00000091831:ENST00000446550:exon2:c.G229A:p.G77S,ENSG00000091831:ENST00000456483:exon2:c.G229A:p.G77S,ENSG00000091831:ENST00000404742:exon3:c.G229A:p.G77S,ENSG00000091831:ENST00000440973:exon3:c.G229A:p.G77S	ESR1:NM_000125:exon1:c.G229A:p.G77S,ESR1:NM_001122740:exon2:c.G229A:p.G77S,ESR1:NM_001122741:exon2:c.G229A:p.G77S,ESR1:NM_001291230:exon2:c.G229A:p.G77S,ESR1:NM_001291241:exon2:c.G229A:p.G77S,ESR1:NM_001122742:exon3:c.G229A:p.G77S	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 1] 	0.0080	.	0.0101837	0.0002	-0.232	0.941	0.607	2.39	0.181	.	.	.	ESR1:uc003qoo.4:exon1:c.G229A:p.G77S,ESR1:uc010kir.3:exon1:c.G229A:p.G77S,ESR1:uc003qon.4:exon2:c.G229A:p.G77S,ESR1:uc010kin.3:exon2:c.G229A:p.G77S,ESR1:uc010kio.3:exon2:c.G229A:p.G77S,ESR1:uc010kip.3:exon2:c.G229A:p.G77S,ESR1:uc031sqc.1:exon2:c.G229A:p.G77S,ESR1:uc003qom.4:exon3:c.G229A:p.G77S,ESR1:uc031sqb.1:exon3:c.G229A:p.G77S,ESR1:uc021zgx.1:exon4:c.G229A:p.G77S,ESR1:uc031spz.1:exon4:c.G229A:p.G77S,ESR1:uc031sqa.1:exon4:c.G229A:p.G77S	-1.040	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0.0041,ASJ:0	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4803,4805,4804	.	.	0.982	1.9	0.013	0.575	6	.	het
6	152201875	152201875	T	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs4986934	ENSG00000091831:ENST00000415488:exon1:c.T84C:p.R28R,ENSG00000091831:ENST00000206249:exon3:c.T729C:p.R243R,ENSG00000091831:ENST00000427531:exon3:c.T210C:p.R70R,ENSG00000091831:ENST00000338799:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000443427:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000456483:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000440973:exon5:c.T729C:p.R243R	ESR1:NM_000125:exon3:c.T729C:p.R243R,ESR1:NM_001328100:exon3:c.T210C:p.R70R,ESR1:NM_001122740:exon4:c.T729C:p.R243R,ESR1:NM_001122741:exon4:c.T729C:p.R243R,ESR1:NM_001291230:exon4:c.T735C:p.R245R,ESR1:NM_001291241:exon4:c.T729C:p.R243R,ESR1:NM_001122742:exon5:c.T729C:p.R243R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9707	0.9708	0.985623	0.9679	.	.	.	.	.	.	.	.	ESR1:uc011eex.2:exon1:c.T72C:p.R24R,ESR1:uc010kis.3:exon2:c.T210C:p.R70R,ESR1:uc003qoo.4:exon3:c.T729C:p.R243R,ESR1:uc003qon.4:exon4:c.T729C:p.R243R,ESR1:uc010kin.3:exon4:c.T729C:p.R243R,ESR1:uc010kio.3:exon4:c.T735C:p.R245R,ESR1:uc010kip.3:exon4:c.T729C:p.R243R,ESR1:uc003qom.4:exon5:c.T729C:p.R243R	.	AFR:0.9929,AMR:0.9845,EAS:1,FIN:0.9562,NFE:0.9525,OTH:0.9633,ASJ:0.9437	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4803,4805,4804	.	.	.	.	.	.	6	MU81823068	hom
6	152464839	152464839	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs2256135	ENSG00000131018:ENST00000539504:exon9:c.T1503C:p.R501R,ENSG00000131018:ENST00000354674:exon10:c.T1572C:p.R524R,ENSG00000131018:ENST00000367257:exon18:c.T2976C:p.R992R,ENSG00000131018:ENST00000367251:exon24:c.T3873C:p.R1291R,ENSG00000131018:ENST00000356820:exon53:c.T8610C:p.R2870R,ENSG00000131018:ENST00000265368:exon138:c.T25038C:p.R8346R,ENSG00000131018:ENST00000367255:exon138:c.T25038C:p.R8346R,ENSG00000131018:ENST00000423061:exon138:c.T24894C:p.R8298R,ENSG00000131018:ENST00000341594:exon139:c.T23874C:p.R7958R,ENSG00000131018:ENST00000448038:exon139:c.T24894C:p.R8298R	SYNE1:NM_001347702:exon10:c.T1572C:p.R524R,SYNE1:NM_001347701:exon11:c.T1644C:p.R548R,SYNE1:NM_033071:exon138:c.T24894C:p.R8298R,SYNE1:NM_182961:exon138:c.T25038C:p.R8346R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6109	0.6235	0.689696	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SYNE1:uc003qoq.4:exon11:c.T1644C:p.R548R,SYNE1:uc011eez.2:exon11:c.T1644C:p.R548R,SYNE1:uc003qor.4:exon24:c.T3807C:p.R1269R,SYNE1:uc003qos.4:exon53:c.T8610C:p.R2870R,SYNE1:uc003qot.4:exon138:c.T24894C:p.R8298R,SYNE1:uc003qou.4:exon138:c.T25038C:p.R8346R	.	AFR:0.6144,AMR:0.7548,EAS:0.5927,FIN:0.6994,NFE:0.4963,OTH:0.5468,ASJ:0.7069	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6071
6	152489294	152489294	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs998147	ENSG00000131018:ENST00000354674:exon1:c.A46G:p.S16G,ENSG00000131018:ENST00000539504:exon1:c.A46G:p.S16G	SYNE1:NM_001347702:exon1:c.A46G:p.S16G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8278	0.8572	0.867013	0.8364	2.090	16.79	0.75	2.24	0.979	.	.	.	.	-0.952	AFR:0.9369,AMR:0.8361,EAS:0.8813,FIN:0.7483,NFE:0.7964,OTH:0.8101,ASJ:0.7833	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	4.66	0.001	.	6	MU81823126	hom
6	152540278	152540278	A	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2147377	ENSG00000131018:ENST00000367251:exon5:c.T670G:p.F224V,ENSG00000131018:ENST00000356820:exon35:c.T5476G:p.F1826V,ENSG00000131018:ENST00000423061:exon119:c.T21691G:p.F7231V,ENSG00000131018:ENST00000265368:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000367255:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000448038:exon120:c.T21691G:p.F7231V,ENSG00000131018:ENST00000341594:exon121:c.T20740G:p.F6914V	SYNE1:NM_033071:exon119:c.T21691G:p.F7231V,SYNE1:NM_182961:exon120:c.T21904G:p.F7302V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9923	0.9931	0.995607	0.9922	-0.224	0.977	1.0	3.99	0.127	.	.	.	SYNE1:uc003qor.4:exon5:c.T604G:p.F202V,SYNE1:uc003qos.4:exon35:c.T5476G:p.F1826V,SYNE1:uc003qot.4:exon119:c.T21691G:p.F7231V,SYNE1:uc003qou.4:exon120:c.T21904G:p.F7302V	-0.974	AFR:0.9984,AMR:0.9905,EAS:1,FIN:0.9877,NFE:0.9892,OTH:0.9878,ASJ:0.9868	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	0.82	0.009	-2.32	6	MU81823155	hom
6	152570415	152570415	G	A	SYNE1	intronic	.	ENSG00000131018	rs6557210	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6578	0.6239	0.680711	MU9450659	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.6754,EAS:0.6232,FIN:0.5927,NFE:0.8847,OTH:0.7782,ASJ:0.6512	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.6467
6	152577752	152577752	T	C	SYNE1	intronic	.	ENSG00000131018	rs17082389	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0703	0.0612	0.0764776	MU9450689	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.0539,EAS:0.0465,FIN:0.0960,NFE:0.1108,OTH:0.0232,ASJ:0.0637	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.0500
6	152629617	152629617	C	T	SYNE1	intronic	.	ENSG00000131018	rs9383985	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3236	0.2455	0.304313	0.2809	.	.	.	.	.	0	0	.	.	.	AFR:0.0884,AMR:0.3046,EAS:0.6065,FIN:0.3625,NFE:0.3338,OTH:0.3060,ASJ:0.4027	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU14055157	het
6	152629773	152629773	A	-	SYNE1	intronic	.	ENSG00000131018	rs55633181	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4174	.	0.426518	0.4328	.	.	.	.	.	.	.	.	.	.	AFR:0.3111,AMR:0.5885,EAS:0.7624,FIN:0.4817,NFE:0.4450,OTH:0.4729,ASJ:0.5775	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152647681	152647681	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2306916	ENSG00000131018:ENST00000423061:exon78:c.T14830A:p.L4944M,ENSG00000131018:ENST00000265368:exon79:c.T15043A:p.L5015M,ENSG00000131018:ENST00000367255:exon79:c.T15043A:p.L5015M,ENSG00000131018:ENST00000448038:exon79:c.T14830A:p.L4944M,ENSG00000131018:ENST00000341594:exon82:c.T14284A:p.L4762M	SYNE1:NM_033071:exon78:c.T14830A:p.L4944M,SYNE1:NM_182961:exon79:c.T15043A:p.L5015M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7797	0.8105	0.814696	0.8331	1.978	16.07	0.607	3.2	0.996	.	.	.	SYNE1:uc010kiz.4:exon3:c.T2308A:p.L770M,SYNE1:uc003qot.4:exon78:c.T14830A:p.L4944M,SYNE1:uc003qou.4:exon79:c.T15043A:p.L5015M	-0.977	AFR:0.9341,AMR:0.8592,EAS:0.8358,FIN:0.8481,NFE:0.7754,OTH:0.7802,ASJ:0.6887	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.009	1.24	0.012	-0.165	6	MU641312	het
6	152652034	152652034	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs6911096	ENSG00000131018:ENST00000423061:exon77:c.T13573A:p.S4525T,ENSG00000131018:ENST00000265368:exon78:c.T13786A:p.S4596T,ENSG00000131018:ENST00000367255:exon78:c.T13786A:p.S4596T,ENSG00000131018:ENST00000448038:exon78:c.T13573A:p.S4525T,ENSG00000131018:ENST00000341594:exon81:c.T13027A:p.S4343T	SYNE1:NM_033071:exon77:c.T13573A:p.S4525T,SYNE1:NM_182961:exon78:c.T13786A:p.S4596T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7760	0.7959	0.803315	COCA-CN|4|321|0.0124611	-5.477	0.001	0.568	-11.9	0.002	.	.	.	SYNE1:uc010kiz.4:exon2:c.T1051A:p.S351T,SYNE1:uc003qot.4:exon77:c.T13573A:p.S4525T,SYNE1:uc003qou.4:exon78:c.T13786A:p.S4596T	-1.024	AFR:0.8219,AMR:0.8947,EAS:0.6887,FIN:0.8465,NFE:0.8479,OTH:0.7745,ASJ:0.8568	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	1.35	0.008	0.025	6	1(urinary_tract)	0.7760
6	152653037	152653037	T	C	SYNE1	intronic	.	ENSG00000131018	rs9478314	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4608	0.4863	0.413139	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.4793,AMR:0.5492,EAS:0.5265,FIN:0.1273,NFE:0.4653,OTH:0.4722,ASJ:0.6480	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4398
6	152658142	152658142	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs9479297	ENSG00000131018:ENST00000423061:exon75:c.A12149G:p.K4050R,ENSG00000131018:ENST00000265368:exon76:c.A12362G:p.K4121R,ENSG00000131018:ENST00000367255:exon76:c.A12362G:p.K4121R,ENSG00000131018:ENST00000448038:exon76:c.A12149G:p.K4050R,ENSG00000131018:ENST00000341594:exon78:c.A11957G:p.K3986R	SYNE1:NM_033071:exon75:c.A12149G:p.K4050R,SYNE1:NM_182961:exon76:c.A12362G:p.K4121R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7547	0.7882	0.793131	0.8208	0.371	6.360	1.0	4.48	0.964	.	.	.	SYNE1:uc010kja.2:exon19:c.A2477G:p.K826R,SYNE1:uc003qot.4:exon75:c.A12149G:p.K4050R,SYNE1:uc003qou.4:exon76:c.A12362G:p.K4121R	-0.969	AFR:0.9307,AMR:0.7081,EAS:0.8488,FIN:0.8345,NFE:0.7642,OTH:0.7515,ASJ:0.6788	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	1.37	0.009	-1.81	6	MU21289282	het
6	152665261	152665261	C	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs4645434	ENSG00000131018:ENST00000423061:exon73:c.G11967T:p.E3989D,ENSG00000131018:ENST00000265368:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000367255:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000448038:exon74:c.G11967T:p.E3989D,ENSG00000131018:ENST00000341594:exon76:c.G11775T:p.E3925D	SYNE1:NM_033071:exon73:c.G11967T:p.E3989D,SYNE1:NM_182961:exon74:c.G12180T:p.E4060D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5761	0.5673	0.545527	1(central_nervous_system)	0.235	5.046	0.071	-1.25	0.019	.	.	.	SYNE1:uc010kja.2:exon17:c.G2295T:p.E765D,SYNE1:uc003qot.4:exon73:c.G11967T:p.E3989D,SYNE1:uc003qou.4:exon74:c.G12180T:p.E4060D	-0.976	AFR:2(large_intestine),AMR:MU588841,EAS:0.5601,FIN:0.4517,NFE:0.6160,OTH:0.66,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.203	1.33	0.015	0.345	6	1(skin)	0.6582
6	152671475	152671475	A	C	SYNE1	intronic	.	ENSG00000131018	rs9478320	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5846	0.5962	0.58746	0.5913	.	.	.	.	.	0.7992	0.178	.	.	.	AFR:0.5714,AMR:0.6184,EAS:0.6219,FIN:0.5573,NFE:0.6074,OTH:0.5490,ASJ:0.6589	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU27526564	het
6	152671919	152671919	-	A	SYNE1	intronic	.	ENSG00000131018	rs5880967	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.5746	.	0.56889	0.5828	.	.	.	.	.	.	.	.	.	.	AFR:0.5302,AMR:0.6158,EAS:0.6216,FIN:0.5655,NFE:0.6112,OTH:0.5601,ASJ:0.6567	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152673147	152673147	G	A	SYNE1	intronic	.	ENSG00000131018	rs6908392	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5790	0.5783	0.565895	MU26896544	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.5750,EAS:0.6169,FIN:0.6589,NFE:0.6222,OTH:0.5570,ASJ:0.5128	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6083
6	152675854	152675854	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs9397102	ENSG00000131018:ENST00000265368:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000367255:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000341594:exon70:c.T10779C:p.S3593S	SYNE1:NM_182961:exon67:c.T10866C:p.S3622S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5799	0.5812	0.568291	MU26896631	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon10:c.T981C:p.S327S,SYNE1:uc003qou.4:exon67:c.T10866C:p.S3622S	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.5777,EAS:0.6169,FIN:0.6567,NFE:0.6256,OTH:0.5568,ASJ:0.5229	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6074
6	152683413	152683413	G	T	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs4407724	ENSG00000131018:ENST00000265368:exon64:c.C10191A:p.G3397G,ENSG00000131018:ENST00000367255:exon64:c.C10191A:p.G3397G,ENSG00000131018:ENST00000423061:exon64:c.C10212A:p.G3404G,ENSG00000131018:ENST00000448038:exon65:c.C10212A:p.G3404G	SYNE1:NM_033071:exon64:c.C10212A:p.G3404G,SYNE1:NM_182961:exon64:c.C10191A:p.G3397G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6541	0.6481	0.659145	SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon7:c.C306A:p.G102G,SYNE1:uc003qot.4:exon64:c.C10212A:p.G3404G,SYNE1:uc003qou.4:exon64:c.C10191A:p.G3397G	.	AFR:0.6496,AMR:0.5876,EAS:0.7384,FIN:0.7752,NFE:0.6216,OTH:0.6773,ASJ:0.6746	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.6214
6	152694184	152694184	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs6913579	ENSG00000131018:ENST00000265368:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000367255:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000423061:exon59:c.A9516G:p.E3172E,ENSG00000131018:ENST00000448038:exon60:c.A9516G:p.E3172E,ENSG00000131018:ENST00000341594:exon62:c.A9612G:p.E3204E	SYNE1:NM_033071:exon59:c.A9516G:p.E3172E,SYNE1:NM_182961:exon59:c.A9495G:p.E3165E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4993	0.5288	0.468251	3(lung)	.	.	.	.	.	.	.	.	SYNE1:uc003qov.3:exon4:c.A729G:p.E243E,SYNE1:uc003qot.4:exon59:c.A9516G:p.E3172E,SYNE1:uc003qou.4:exon59:c.A9495G:p.E3165E	.	AFR:MU29885722,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,EAS:0.4821,FIN:0.5276,NFE:0.5298,OTH:0.4532,ASJ:0.5133	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.5040
6	152697706	152697706	C	T	SYNE1	intronic	.	ENSG00000131018	rs214955	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5101	0.4883	0.529153	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4989,AMR:0.5436,EAS:0.4801,FIN:0.5446,NFE:0.4974,OTH:0.4662,ASJ:0.4880	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(liver)	0.5460
6	152708310	152708310	G	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214950	ENSG00000131018:ENST00000265368:exon54:c.C8384T:p.A2795V,ENSG00000131018:ENST00000367255:exon54:c.C8384T:p.A2795V,ENSG00000131018:ENST00000423061:exon54:c.C8405T:p.A2802V,ENSG00000131018:ENST00000448038:exon55:c.C8405T:p.A2802V,ENSG00000131018:ENST00000341594:exon57:c.C8501T:p.A2834V	SYNE1:NM_033071:exon54:c.C8405T:p.A2802V,SYNE1:NM_182961:exon54:c.C8384T:p.A2795V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2373	0.1984	0.249002	1(breast)	0.486	7.324	0.028	1.51	0.000	.	.	.	SYNE1:uc010kjb.1:exon52:c.C8333T:p.A2778V,SYNE1:uc003qot.4:exon54:c.C8405T:p.A2802V,SYNE1:uc003qou.4:exon54:c.C8384T:p.A2795V	-1.029	AFR:MU93209,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.1555,FIN:0.1866,NFE:0.2533,OTH:0.4410,ASJ:0.2061	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.007	1.27	0.017	1.95	6	1(haematopoietic_and_lymphoid_tissue)	0.1855
6	152711395	152711395	T	A	SYNE1	intronic	.	ENSG00000131018	rs214943	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4440	0.4833	0.561901	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4900,AMR:0.6936,EAS:0.4305,FIN:0.7853,NFE:0.3829,OTH:0.3795,ASJ:0.3209	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.4223
6	152712715	152712715	-	AAAAAAA	SYNE1	intronic	.	ENSG00000131018	rs768125041	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0448	.	.	0.1978	.	.	.	.	.	.	.	.	.	.	AFR:0.1473,AMR:0.1475,EAS:0.4007,FIN:0.0942,NFE:0.2054,OTH:0.2165,ASJ:0.2195	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	hom
6	152717896	152717896	T	C	SYNE1	intronic	.	ENSG00000131018	rs78034368	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0277	0.0248	0.014377	0.0226	.	.	.	.	.	.	.	.	.	.	AFR:0.0084,AMR:0.0179,EAS:0,FIN:0.0197,NFE:0.0336,OTH:0.0316,ASJ:0.0232	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152757224	152757224	G	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs34028822	ENSG00000131018:ENST00000367253:exon31:c.C4162T:p.R1388W,ENSG00000131018:ENST00000413186:exon31:c.C4162T:p.R1388W,ENSG00000131018:ENST00000367248:exon32:c.C4132T:p.R1378W,ENSG00000131018:ENST00000265368:exon33:c.C4162T:p.R1388W,ENSG00000131018:ENST00000367255:exon33:c.C4162T:p.R1388W,ENSG00000131018:ENST00000423061:exon33:c.C4183T:p.R1395W,ENSG00000131018:ENST00000448038:exon34:c.C4183T:p.R1395W,ENSG00000131018:ENST00000341594:exon36:c.C4360T:p.R1454W	SYNE1:NM_033071:exon33:c.C4183T:p.R1395W,SYNE1:NM_182961:exon33:c.C4162T:p.R1388W	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0029	0.0043	0.00239617	.	6.572	31	0.002	4.04	0.991	.	.	.	SYNE1:uc003qow.3:exon14:c.C2047T:p.R683W,SYNE1:uc003qox.1:exon20:c.C2710T:p.R904W,SYNE1:uc010kjb.1:exon31:c.C4111T:p.R1371W,SYNE1:uc003qot.4:exon33:c.C4183T:p.R1395W,SYNE1:uc003qou.4:exon33:c.C4162T:p.R1388W	0.464	AFR:0.0024,AMR:0.0008,EAS:0,FIN:0,NFE:0,OTH:0.0041,ASJ:0.0012	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	1.0	0.6	0.685	1.95	6	1(biliary_tract)	0.0041
6	152772264	152772264	A	G	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214976	ENSG00000131018:ENST00000367253:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000413186:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367248:exon25:c.T3074C:p.V1025A,ENSG00000131018:ENST00000265368:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367255:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000423061:exon26:c.T3125C:p.V1042A,ENSG00000131018:ENST00000448038:exon27:c.T3125C:p.V1042A,ENSG00000131018:ENST00000341594:exon29:c.T3302C:p.V1101A	SYNE1:NM_033071:exon26:c.T3125C:p.V1042A,SYNE1:NM_182961:exon26:c.T3104C:p.V1035A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4811	0.5325	0.607228	MU18833080	3.767	23.4	0.006	5.84	0.998	.	.	.	SYNE1:uc003qow.3:exon7:c.T989C:p.V330A,SYNE1:uc003qox.1:exon13:c.T1652C:p.V551A,SYNE1:uc010kjb.1:exon24:c.T3053C:p.V1018A,SYNE1:uc003qot.4:exon26:c.T3125C:p.V1042A,SYNE1:uc003qou.4:exon26:c.T3104C:p.V1035A	0.108	AFR:COCA-CN|5|321|0.0155763,AMR:0.5270,EAS:0.3565,FIN:0.5302,NFE:0.7779,OTH:0.3912,ASJ:0.7437	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.033	0.55	0.536	1.905	6	1(pancreas)	0.4198
6	152779933	152779933	G	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs34610829	ENSG00000131018:ENST00000495090:exon9:c.C1228T:p.R410C,ENSG00000131018:ENST00000367253:exon20:c.C2527T:p.R843C,ENSG00000131018:ENST00000413186:exon20:c.C2527T:p.R843C,ENSG00000131018:ENST00000367248:exon21:c.C2497T:p.R833C,ENSG00000131018:ENST00000265368:exon22:c.C2527T:p.R843C,ENSG00000131018:ENST00000367255:exon22:c.C2527T:p.R843C,ENSG00000131018:ENST00000423061:exon22:c.C2548T:p.R850C,ENSG00000131018:ENST00000341594:exon23:c.C2548T:p.R850C,ENSG00000131018:ENST00000448038:exon23:c.C2548T:p.R850C	SYNE1:NM_033071:exon22:c.C2548T:p.R850C,SYNE1:NM_182961:exon22:c.C2527T:p.R843C	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 1, 0, 0] 	0.0251	0.0228	0.0115815	0.0209	4.640	24.5	0.015	5.34	0.928	.	.	.	SYNE1:uc003qow.3:exon3:c.C412T:p.R138C,SYNE1:uc003qox.1:exon9:c.C1075T:p.R359C,SYNE1:uc003qoy.2:exon9:c.C1228T:p.R410C,SYNE1:uc003qoz.2:exon9:c.C823T:p.R275C,SYNE1:uc010kjb.1:exon20:c.C2476T:p.R826C,SYNE1:uc003qot.4:exon22:c.C2548T:p.R850C,SYNE1:uc003qou.4:exon22:c.C2527T:p.R843C	-0.980	AFR:0.0076,AMR:0.0143,EAS:0,FIN:0.0183,NFE:0.0313,OTH:0.0316,ASJ:0.0199	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.9	1.26	0.103	1.1	6	.	het
6	152809527	152809527	A	T	SYNE1	intronic	.	ENSG00000131018	rs9397106	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4810	0.5072	0.589257	0.5097	.	.	.	.	.	0	0.028	.	.	.	AFR:0.6693,AMR:0.3537,EAS:0.7736,FIN:0.4046,NFE:0.4250,OTH:0.4551,ASJ:0.5232	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU18839010	hom
6	159188128	159188128	A	G	EZR	intronic	.	ENSG00000092820	rs2242318	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6369	0.6978	0.522963	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.6788,AMR:0.6095,EAS:0.5993,FIN:0.1592,NFE:0.8257,OTH:0.7540,ASJ:0.4149	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	2(lung)	0.7296
6	159191788	159191788	C	T	EZR	intronic	.	ENSG00000092820	rs3212308	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4051	0.4257	0.33127	0.4118	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.3299,AMR:0.2811,EAS:0.1406,FIN:0.5043,NFE:0.4736,OTH:0.4458,ASJ:0.34	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU800661	het
6	159205668	159205668	G	A	EZR	intronic	.	ENSG00000092820	rs3103003	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5112	0.5553	0.419129	0.5414	.	.	.	.	.	0	0.002	.	.	.	AFR:0.4613,AMR:0.3365,EAS:0.1527,FIN:0.6371,NFE:0.6173,OTH:0.5799,ASJ:0.5033	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU23689302	het
6	160113872	160113872	A	G	SOD2	exonic	nonsynonymous SNV	ENSG00000112096	rs4880	ENSG00000112096:ENST00000337404:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367054:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367055:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000444946:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000452684:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000535561:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000538183:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000545162:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000546260:exon2:c.T47C:p.V16A	SOD2:NM_000636:exon2:c.T47C:p.V16A,SOD2:NM_001024465:exon2:c.T47C:p.V16A,SOD2:NM_001024466:exon2:c.T47C:p.V16A,SOD2:NM_001322814:exon2:c.T47C:p.V16A,SOD2:NM_001322815:exon2:c.T47C:p.V16A,SOD2:NM_001322816:exon2:c.T47C:p.V16A	clinvar: drug_response 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5024	0.4731	0.410743	MU140155	-0.079	1.894	0.926	3.08	0.004	.	.	.	SOD2:uc003qsg.3:exon2:c.T47C:p.V16A,SOD2:uc003qsh.3:exon2:c.T47C:p.V16A,SOD2:uc003qsi.1:exon2:c.T47C:p.V16A,SOD2:uc003qsj.3:exon2:c.T47C:p.V16A,SOD2:uc011efu.1:exon2:c.T47C:p.V16A,SOD2:uc011efv.1:exon2:c.T47C:p.V16A	-0.931	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.4676,EAS:0.6062,FIN:0.5397,NFE:0.1510,OTH:0.4716,ASJ:0.4235	147460	612634;	.	.	.	.	.	.	0.0	2.8	0.008	.	6	3(lung)	0.5131
6	160453978	160453978	A	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs1570070	ENSG00000197081:ENST00000356956:exon9:c.A1050G:p.S350S	IGF2R:NM_000876:exon9:c.A1050G:p.S350S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3753	0.3021	0.423922	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon9:c.A1050G:p.S350S	.	AFR:0.3321,AMR:0.2580,EAS:0.2682,FIN:0.7640,NFE:0.3156,OTH:0.3272,ASJ:0.4487	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(thyroid)	0.3347
6	160464289	160464289	G	A	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs894817	ENSG00000197081:ENST00000356956:exon12:c.G1590A:p.G530G	IGF2R:NM_000876:exon12:c.G1590A:p.G530G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3553	0.2971	0.423722	0.3197	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon12:c.G1590A:p.G530G	.	AFR:0.2720,AMR:0.4402,EAS:0.7655,FIN:0.2564,NFE:0.3095,OTH:0.3067,ASJ:0.2550	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU9524266	het
6	160468180	160468180	G	A	IGF2R	intronic	.	ENSG00000197081	rs2282137	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0372	0.0334	0.0597045	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0.0017	0.14	.	.	.	AFR:MU12533992,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.0712,FIN:0.0358,NFE:0,OTH:0.0909,ASJ:0.0357	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.0066
6	160468278	160468278	A	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs998075	ENSG00000197081:ENST00000356956:exon16:c.A2139G:p.T713T	IGF2R:NM_000876:exon16:c.A2139G:p.T713T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5299	0.5167	0.577476	0.5485	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon16:c.A2139G:p.T713T	.	AFR:0.6179,AMR:0.5217,EAS:0.6582,FIN:0.5868,NFE:0.4919,OTH:0.5205,ASJ:0.4834	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU23691521	het
6	160468383	160468383	T	C	IGF2R	intronic	.	ENSG00000197081	rs998074	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5357	0.5080	0.573083	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU9524334,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6046,FIN:0.5179,NFE:0.4735,OTH:0.6611,ASJ:0.5441	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.5873
6	160493834	160493834	G	A	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs2230044	ENSG00000197081:ENST00000356956:exon33:c.G4608A:p.A1536A	IGF2R:NM_000876:exon33:c.G4608A:p.A1536A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0376	0.0348	0.0595048	2(soft_tissue)	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon33:c.G4608A:p.A1536A	.	AFR:1(lung),AMR:MU12534024,EAS:0.0368,FIN:0.0748,NFE:0.0359,OTH:0,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	2(haematopoietic_and_lymphoid_tissue)	0.0924
6	160494409	160494409	A	G	IGF2R	exonic	nonsynonymous SNV	ENSG00000197081	rs629849	ENSG00000197081:ENST00000356956:exon34:c.A4855G:p.R1619G	IGF2R:NM_000876:exon34:c.A4855G:p.R1619G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8963	0.9107	0.903155	0.9115	-0.274	0.760	1.0	4.43	0.492	.	.	Mannose-6-phosphate receptor binding domain	IGF2R:uc003qta.3:exon34:c.A4855G:p.R1619G	-0.945	AFR:0.9723,AMR:0.9391,EAS:0.8269,FIN:0.9097,NFE:0.8832,OTH:0.9114,ASJ:0.9570	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	0.0	4.55	0.001	.	6	MU23691754	hom
6	160505199	160505199	C	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs614754	ENSG00000197081:ENST00000356956:exon40:c.C6051G:p.L2017L	IGF2R:NM_000876:exon40:c.C6051G:p.L2017L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9918	0.9897	0.996006	0.9896	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon40:c.C6051G:p.L2017L	.	AFR:0.9954,AMR:0.9916,EAS:0.9994,FIN:0.9906,NFE:0.9845,OTH:0.9919,ASJ:1	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU81824095	hom
6	160517481	160517481	C	T	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs1803989	ENSG00000197081:ENST00000356956:exon45:c.C6666T:p.L2222L	IGF2R:NM_000876:exon45:c.C6666T:p.L2222L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1492	0.1157	0.229433	MU16856501	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon45:c.C6666T:p.L2222L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1453,EAS:0.2828,FIN:0.0066,NFE:0.4101,OTH:0.0844,ASJ:0.2395	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.0735
6	161807855	161807855	C	G	PRKN	exonic	nonsynonymous SNV	ENSG00000185345	rs1801582	ENSG00000185345:ENST00000366896:exon7:c.G691C:p.V231L,ENSG00000185345:ENST00000338468:exon9:c.G565C:p.V189L,ENSG00000185345:ENST00000366894:exon9:c.G565C:p.V189L,ENSG00000185345:ENST00000366897:exon9:c.G1054C:p.V352L,ENSG00000185345:ENST00000366898:exon10:c.G1138C:p.V380L	PRKN:NM_013988:exon7:c.G691C:p.V231L,PRKN:NM_013987:exon9:c.G1054C:p.V352L,PRKN:NM_004562:exon10:c.G1138C:p.V380L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1646	0.1758	0.172125	0.1610	0.084	3.433	0.377	2.74	0.001	.	.	IBR domain	PARK2:uc011egf.2:exon5:c.G160C:p.V54L,PARK2:uc003qtz.4:exon7:c.G691C:p.V231L,PARK2:uc003qtw.4:exon8:c.G565C:p.V189L,PARK2:uc010kkd.3:exon8:c.G565C:p.V189L,PARK2:uc021zhs.1:exon8:c.G904C:p.V302L,PARK2:uc003qty.4:exon9:c.G1054C:p.V352L,PARK2:uc021zhw.1:exon9:c.G565C:p.V189L,PARK2:uc021zhy.1:exon9:c.G988C:p.V330L,PARK2:uc003qtx.4:exon10:c.G1138C:p.V380L,PARK2:uc021zhu.1:exon11:c.G1279C:p.V427L,PARK2:uc021zhv.1:exon11:c.G901C:p.V301L,PARK2:uc031sqz.1:exon12:c.G1333C:p.V445L	-1.065	AFR:0.1788,AMR:0.1304,EAS:0.0877,FIN:0.1554,NFE:0.1615,OTH:0.1439,ASJ:0.2219	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	0.0	-2.73	0.268	-1.1	6	MU26226992	het
6	162622304	162622304	A	G	PRKN	intronic	.	ENSG00000185345	rs4709583	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9329	0.9403	0.950479	0.9475	.	.	.	.	.	.	.	.	.	.	AFR:0.9849,AMR:0.9642,EAS:0.9920,FIN:0.9473,NFE:0.9217,OTH:0.9206,ASJ:0.9536	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	MU81824308	het
6	162683815	162683815	A	-	PRKN	intronic	.	ENSG00000185345	rs756249386	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0782	.	.	0.0489	.	.	.	.	.	.	.	.	.	.	AFR:0.0192,AMR:0.1099,EAS:0.1132,FIN:0.1765,NFE:0.0478,OTH:0.0992,ASJ:0.09	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	.	het
6	163836376	163836376	C	T	QKI	intronic	.	ENSG00000112531	rs2757578	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2768	0.3151	0.222244	0.2778	.	.	.	.	.	.	.	.	.	.	AFR:0.2854,AMR:0.2233,EAS:0.0136,FIN:0.2626,NFE:0.3080,OTH:0.2717,ASJ:0.3489	609590	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	166826255	166826255	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs909631	ENSG00000071242:ENST00000265678:exon21:c.C2197T:p.L733L,ENSG00000071242:ENST00000405189:exon21:c.C1930T:p.L644L,ENSG00000071242:ENST00000481261:exon21:c.C1930T:p.L644L,ENSG00000071242:ENST00000503859:exon22:c.C2221T:p.L741L,ENSG00000071242:ENST00000510118:exon23:c.C2272T:p.L758L	RPS6KA2:NM_001318937:exon19:c.C1903T:p.L635L,RPS6KA2:NM_001318938:exon21:c.C1930T:p.L644L,RPS6KA2:NM_021135:exon21:c.C2197T:p.L733L,RPS6KA2:NM_001006932:exon22:c.C2221T:p.L741L,RPS6KA2:NM_001318936:exon23:c.C2272T:p.L758L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6917	0.5785	0.620208	0.5670	.	.	.	.	.	.	.	.	RPS6KA2:uc010kkk.1:exon6:c.C493T:p.L165L,RPS6KA2:uc003qvb.1:exon21:c.C2197T:p.L733L,RPS6KA2:uc010kkl.1:exon21:c.C1930T:p.L644L,RPS6KA2:uc011ego.1:exon21:c.C1930T:p.L644L,RPS6KA2:uc003qvc.1:exon22:c.C2221T:p.L741L,RPS6KA2:uc003qvd.1:exon23:c.C2272T:p.L758L	.	AFR:0.3648,AMR:0.5837,EAS:0.7602,FIN:0.5688,NFE:0.6530,OTH:0.6577,ASJ:0.7285	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU73172	het
6	166826304	166826304	T	C	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs760670	ENSG00000071242:ENST00000265678:exon21:c.A2148G:p.S716S,ENSG00000071242:ENST00000405189:exon21:c.A1881G:p.S627S,ENSG00000071242:ENST00000481261:exon21:c.A1881G:p.S627S,ENSG00000071242:ENST00000503859:exon22:c.A2172G:p.S724S,ENSG00000071242:ENST00000510118:exon23:c.A2223G:p.S741S	RPS6KA2:NM_001318937:exon19:c.A1854G:p.S618S,RPS6KA2:NM_001318938:exon21:c.A1881G:p.S627S,RPS6KA2:NM_021135:exon21:c.A2148G:p.S716S,RPS6KA2:NM_001006932:exon22:c.A2172G:p.S724S,RPS6KA2:NM_001318936:exon23:c.A2223G:p.S741S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7481	0.7414	0.795527	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RPS6KA2:uc010kkk.1:exon6:c.A444G:p.S148S,RPS6KA2:uc003qvb.1:exon21:c.A2148G:p.S716S,RPS6KA2:uc010kkl.1:exon21:c.A1881G:p.S627S,RPS6KA2:uc011ego.1:exon21:c.A1881G:p.S627S,RPS6KA2:uc003qvc.1:exon22:c.A2172G:p.S724S,RPS6KA2:uc003qvd.1:exon23:c.A2223G:p.S741S	.	AFR:0.7166,AMR:0.8338,EAS:0.7417,FIN:0.8130,NFE:0.5989,OTH:0.6677,ASJ:0.6854	601685	.	.	.	.	.	.	.	.	.	.	.	6	3(large_intestine)	0.7043
6	166827436	166827436	T	C	RPS6KA2	intronic	.	ENSG00000071242	rs2235295	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6984	0.6625	0.726637	0.6510	.	.	.	.	.	.	.	.	.	.	AFR:0.6304,AMR:0.6706,EAS:0.7953,FIN:0.5956,NFE:0.6555,OTH:0.6828,ASJ:0.7351	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU12549640	het
6	166952264	166952264	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs1003857	ENSG00000071242:ENST00000265678:exon2:c.C108T:p.G36G,ENSG00000071242:ENST00000507371:exon2:c.C60T:p.G20G,ENSG00000071242:ENST00000503859:exon3:c.C132T:p.G44G,ENSG00000071242:ENST00000510118:exon4:c.C183T:p.G61G,ENSG00000071242:ENST00000506565:exon5:c.C183T:p.G61G	RPS6KA2:NM_021135:exon2:c.C108T:p.G36G,RPS6KA2:NM_001006932:exon3:c.C132T:p.G44G,RPS6KA2:NM_001318936:exon4:c.C183T:p.G61G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7924	0.7214	0.787939	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon2:c.C108T:p.G36G,RPS6KA2:uc003qvc.1:exon3:c.C132T:p.G44G,RPS6KA2:uc003qvd.1:exon4:c.C183T:p.G61G	.	AFR:0.7292,AMR:0.6418,EAS:0.7649,FIN:0.9518,NFE:0.7648,OTH:0.7372,ASJ:0.8819	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7464
6	167040463	167040463	A	G	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs10946179	ENSG00000071242:ENST00000265678:exon1:c.T45C:p.S15S	RPS6KA2:NM_021135:exon1:c.T45C:p.S15S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2217	0.1620	0.174521	MU4556354	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon1:c.T45C:p.S15S	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.1619,EAS:0.1087,FIN:0.1711,NFE:0.2366,OTH:0.1244,ASJ:0.1518	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(thyroid)	0.1707
6	167271711	167271711	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs943687	ENSG00000071242:ENST00000503859:exon2:c.A100G:p.T34A,ENSG00000071242:ENST00000510118:exon2:c.A100G:p.T34A,ENSG00000071242:ENST00000506565:exon3:c.A100G:p.T34A	RPS6KA2:NM_001006932:exon2:c.A100G:p.T34A,RPS6KA2:NM_001318936:exon2:c.A100G:p.T34A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9643	0.9407	0.922125	0.9515	-3.152	0.001	0.838	-9.48	0.000	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A100G:p.T34A,RPS6KA2:uc003qvd.1:exon2:c.A100G:p.T34A	-1.098	AFR:0.8527,AMR:0.9809,EAS:0.9604,FIN:0.9994,NFE:0.9933,OTH:0.9776,ASJ:0.9570	601685	.	.	.	.	.	.	.	0.0	-0.36	0.034	.	6	MU19401550	unknown
6	167271716	167271716	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs9347162	ENSG00000071242:ENST00000503859:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000510118:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000506565:exon3:c.A95G:p.E32G	RPS6KA2:NM_001006932:exon2:c.A95G:p.E32G,RPS6KA2:NM_001318936:exon2:c.A95G:p.E32G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7054	0.5814	0.607628	0.6165	0.605	8.191	0.335	3.56	0.007	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A95G:p.E32G,RPS6KA2:uc003qvd.1:exon2:c.A95G:p.E32G	-1.027	AFR:0.2480,AMR:0.7912,EAS:0.8784,FIN:0.7153,NFE:0.7601,OTH:0.7357,ASJ:0.6854	601685	.	.	.	.	.	.	.	0.0	-0.5	0.024	.	6	MU19401625	unknown
6	167344583	167344583	A	G	RNASET2	exonic	synonymous SNV	ENSG00000026297	rs13213697	ENSG00000026297:ENST00000508775:exon8:c.T516C:p.L172L,ENSG00000026297:ENST00000366855:exon9:c.T402C:p.L134L,ENSG00000026297:ENST00000476238:exon9:c.T516C:p.L172L,ENSG00000026297:ENST00000478180:exon9:c.T516C:p.L172L	RNASET2:NM_003730:exon8:c.T516C:p.L172L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1731	0.2400	0.184505	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	RNASET2:uc003qve.3:exon8:c.T516C:p.L172L,RNASET2:uc003qvf.3:exon8:c.T240C:p.L80L	.	AFR:0.2106,AMR:0.3386,EAS:0.1589,FIN:0.0012,NFE:0.1829,OTH:0.1727,ASJ:0.1372	612944	612951;	85136;	85136|CLWM|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612951 ~	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.1793
6	167369650	167369650	G	A	RNASET2	exonic	synonymous SNV	ENSG00000026297	rs12193095	ENSG00000026297:ENST00000028008:exon1:c.C21T:p.R7R,ENSG00000026297:ENST00000421787:exon1:c.C21T:p.R7R,ENSG00000026297:ENST00000508775:exon1:c.C21T:p.R7R,ENSG00000026297:ENST00000476238:exon2:c.C21T:p.R7R,ENSG00000026297:ENST00000478180:exon2:c.C21T:p.R7R	RNASET2:NM_003730:exon1:c.C21T:p.R7R	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0401	0.0524	0.0231629	0.0577	.	.	.	.	.	.	.	.	RNASET2:uc003qve.3:exon1:c.C21T:p.R7R	.	AFR:0.0147,AMR:0.0406,EAS:0,FIN:0.0604,NFE:0.0890,OTH:0.0645,ASJ:0.0530	612944	612951;	85136;	85136|CLWM|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612951 ~	.	.	.	.	.	.	.	.	6	MU113466969	het
6	167413539	167413539	T	C	FGFR1OP	intronic	.	ENSG00000272980	rs12212247	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3764	0.3620	0.26278	MU19411290	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3574,EAS:0.3198,FIN:0.4238,NFE:0.2574,OTH:0.4175,ASJ:0.1707	605392	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4625
6	167424293	167424293	T	C	FGFR1OP	intronic	.	ENSG00000272980	rs1322077	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5258	0.3920	0.299321	0.3830	.	.	.	.	.	0.0002	0.058	.	.	.	AFR:0.2612,AMR:0.3246,EAS:0.2574,FIN:0.4182,NFE:0.4624,OTH:0.3817,ASJ:0.3874	605392	.	.	.	.	.	.	.	.	.	.	.	6	MU21296248	het
6	167453519	167453519	-	T	FGFR1OP	UTR3	.	ENSG00000272980	rs368396376	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5074	0.5145	0.520966	0.7698	.	.	.	.	.	.	.	.	.	.	AFR:0.5960,AMR:0.8240,EAS:0.8238,FIN:0.7609,NFE:0.8631,OTH:0.8096,ASJ:0.8346	605392	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
7	1976457	1976457	C	T	MAD1L1	exonic	nonsynonymous SNV	ENSG00000002822	rs1801368	ENSG00000002822:ENST00000437877:exon2:c.G41A:p.R14H,ENSG00000002822:ENST00000450235:exon4:c.G326A:p.R109H,ENSG00000002822:ENST00000402746:exon15:c.G1397A:p.R466H,ENSG00000002822:ENST00000265854:exon16:c.G1673A:p.R558H,ENSG00000002822:ENST00000399654:exon17:c.G1673A:p.R558H,ENSG00000002822:ENST00000406869:exon17:c.G1673A:p.R558H	MAD1L1:NM_001304525:exon2:c.G41A:p.R14H,MAD1L1:NM_001304524:exon15:c.G1397A:p.R466H,MAD1L1:NM_001304523:exon16:c.G1673A:p.R558H,MAD1L1:NM_001013836:exon17:c.G1673A:p.R558H,MAD1L1:NM_001013837:exon17:c.G1673A:p.R558H,MAD1L1:NM_003550:exon17:c.G1673A:p.R558H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4088	0.2749	0.304712	MU109074	2.166	17.29	0.114	-0.002	0.014	.	.	.	MAD1L1:uc003sld.1:exon2:c.G41A:p.R14H,MAD1L1:uc003sle.1:exon9:c.G860A:p.R287H,MAD1L1:uc003sli.1:exon15:c.G1397A:p.R466H,MAD1L1:uc010ksi.1:exon15:c.G1532A:p.R511H,MAD1L1:uc010ksh.1:exon16:c.G1673A:p.R558H,MAD1L1:uc003slf.1:exon17:c.G1673A:p.R558H,MAD1L1:uc003slg.1:exon17:c.G1673A:p.R558H,MAD1L1:uc003slh.1:exon17:c.G1673A:p.R558H,MAD1L1:uc010ksj.3:exon17:c.G1673A:p.R558H	-0.910	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.2800,EAS:0.4248,FIN:0.2715,NFE:0.5105,OTH:0.2857,ASJ:0.0918	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.003	2.01	0.000	1.1	7	1(haematopoietic_and_lymphoid_tissue)	0.3522
7	2108982	2108982	G	C	MAD1L1	intronic	.	ENSG00000002822	rs73048940	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0576	0.0265	0.0411342	0.0266	.	.	.	.	.	0.0041	0.126	.	.	.	AFR:0.0069,AMR:0.1511,EAS:0.0018,FIN:0.0255,NFE:0.0334,OTH:0.0369,ASJ:0.0298	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	7	.	het
7	2257612	2257612	G	A	MAD1L1	exonic	synonymous SNV	ENSG00000002822	rs6951493	ENSG00000002822:ENST00000429625:exon4:c.C450T:p.H150H,ENSG00000002822:ENST00000445959:exon4:c.C294T:p.H98H,ENSG00000002822:ENST00000402746:exon5:c.C387T:p.H129H,ENSG00000002822:ENST00000265854:exon6:c.C663T:p.H221H,ENSG00000002822:ENST00000399654:exon7:c.C663T:p.H221H,ENSG00000002822:ENST00000406869:exon7:c.C663T:p.H221H	MAD1L1:NM_001304524:exon5:c.C387T:p.H129H,MAD1L1:NM_001304523:exon6:c.C663T:p.H221H,MAD1L1:NM_001013836:exon7:c.C663T:p.H221H,MAD1L1:NM_001013837:exon7:c.C663T:p.H221H,MAD1L1:NM_003550:exon7:c.C663T:p.H221H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3496	0.3347	0.365615	0.3322	.	.	.	.	.	.	.	.	MAD1L1:uc003sli.1:exon5:c.C387T:p.H129H,MAD1L1:uc010ksi.1:exon5:c.C522T:p.H174H,MAD1L1:uc010ksh.1:exon6:c.C663T:p.H221H,MAD1L1:uc003slf.1:exon7:c.C663T:p.H221H,MAD1L1:uc003slg.1:exon7:c.C663T:p.H221H,MAD1L1:uc003slh.1:exon7:c.C663T:p.H221H,MAD1L1:uc010ksj.3:exon7:c.C663T:p.H221H	.	AFR:0.2777,AMR:0.4041,EAS:0.5341,FIN:0.2723,NFE:0.3526,OTH:0.3388,ASJ:0.2815	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	7	MU109089	het
7	2290314	2290314	C	T	NUDT1	exonic	synonymous SNV	ENSG00000106268	rs12699806	.	NUDT1:NM_001367555:exon4:c.C336T:p.L112L,NUDT1:NM_001367554:exon5:c.C336T:p.L112L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.610823	0.6427	.	.	.	.	.	.	.	.	.	.	AFR:0.4812,AMR:0.5955,EAS:0.7219,FIN:0.7434,NFE:0.7104,OTH:0.6798,ASJ:0.5714	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290317	2290317	T	G	NUDT1	exonic	nonsynonymous SNV	ENSG00000106268	rs60298419	.	NUDT1:NM_001367555:exon4:c.T339G:p.D113E,NUDT1:NM_001367554:exon5:c.T339G:p.D113E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.611222	0.6413	.	.	.	.	.	.	.	.	.	.	AFR:0.4801,AMR:0.5952,EAS:0.7207,FIN:0.7404,NFE:0.7096,OTH:0.6806,ASJ:0.568	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290320	2290320	C	-	NUDT1	exonic	frameshift deletion	ENSG00000106268	rs373496719	.	NUDT1:NM_001367555:exon4:c.342delC:p.L114fs,NUDT1:NM_001367554:exon5:c.342delC:p.L114fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.611022	0.6409	.	.	.	.	.	.	.	.	.	.	AFR:0.4799,AMR:0.5942,EAS:0.7204,FIN:0.7413,NFE:0.7086,OTH:0.6813,ASJ:0.5650	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290328	2290328	C	T	NUDT1	exonic	nonsynonymous SNV	ENSG00000106268	rs10230814	.	NUDT1:NM_001367555:exon4:c.C350T:p.S117L,NUDT1:NM_001367554:exon5:c.C350T:p.S117L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.611422	0.6436	.	.	.	.	.	.	.	.	.	.	AFR:0.4818,AMR:0.5980,EAS:0.7212,FIN:0.7432,NFE:0.7114,OTH:0.6809,ASJ:0.5853	600312	.	.	.	.	.	.	.	.	.	.	.	7	MU14062065	unknown
7	2290336	2290336	T	G	NUDT1	UTR3	.	ENSG00000106268	rs10249180	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.311901	0.2812	.	.	.	.	.	.	.	.	.	.	AFR:0.1047,AMR:0.3793,EAS:0.5553,FIN:0.2879,NFE:0.3484,OTH:0.3185,ASJ:0.2810	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2946461	2946461	T	C	CARD11	exonic	synonymous SNV	ENSG00000198286	rs1124581	ENSG00000198286:ENST00000396946:exon25:c.A3276G:p.R1092R	CARD11:NM_032415:exon25:c.A3276G:p.R1092R,CARD11:NM_001324281:exon26:c.A3276G:p.R1092R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5163	0.5466	0.596446	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	CARD11:uc003smv.3:exon25:c.A3276G:p.R1092R	.	AFR:MU62210,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,EAS:0.6721,FIN:0.4880,NFE:0.4040,OTH:0.6410,ASJ:0.5349	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	2(large_intestine)	0.4029
7	2962753	2962753	G	A	CARD11	intronic	.	ENSG00000198286	rs2527509	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6795	0.6346	0.505391	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.6370,AMR:0.3526,EAS:0.7550,FIN:0.3714,NFE:0.8256,OTH:0.7775,ASJ:0.6444	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.7383
7	2966445	2966445	T	G	CARD11	intronic	.	ENSG00000198286	rs1182136	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5711	.	0.560503	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5294,AMR:0.3676,EAS:0.4967,FIN:0.2041,NFE:0.7129,OTH:0.6081,ASJ:0.5644	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	12(soft_tissue)	0.6276
7	6026775	6026775	T	C	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs2228006	ENSG00000122512:ENST00000441476:exon8:c.A1303G:p.K435E,ENSG00000122512:ENST00000265849:exon11:c.A1621G:p.K541E,ENSG00000122512:ENST00000406569:exon11:c.A1621G:p.K541E	PMS2:NM_001322008:exon9:c.A1303G:p.K435E,PMS2:NM_001322010:exon9:c.A1060G:p.K354E,PMS2:NM_001322004:exon10:c.A1216G:p.K406E,PMS2:NM_001322006:exon10:c.A1465G:p.K489E,PMS2:NM_001322007:exon10:c.A1303G:p.K435E,PMS2:NM_001322013:exon10:c.A1048G:p.K350E,PMS2:NM_000535:exon11:c.A1621G:p.K541E,PMS2:NM_001322003:exon11:c.A1216G:p.K406E,PMS2:NM_001322005:exon11:c.A1216G:p.K406E,PMS2:NM_001322009:exon11:c.A1216G:p.K406E,PMS2:NM_001322011:exon11:c.A688G:p.K230E,PMS2:NM_001322012:exon11:c.A688G:p.K230E,PMS2:NM_001322014:exon11:c.A1621G:p.K541E,PMS2:NM_001322015:exon11:c.A1312G:p.K438E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8514	0.8704	0.883187	0.8722	-0.586	0.135	1.0	4.66	0.013	.	.	.	PMS2:uc003spj.3:exon8:c.A1303G:p.K435E,PMS2:uc011jwl.2:exon10:c.A1216G:p.K406E,PMS2:uc003spk.3:exon11:c.A1216G:p.K406E,PMS2:uc003spl.3:exon11:c.A1621G:p.K541E,PMS2:uc010ktf.2:exon11:c.A1621G:p.K541E,PMS2:uc010ktg.3:exon11:c.A688G:p.K230E	-0.949	AFR:0.9248,AMR:0.7213,EAS:0.9202,FIN:0.8447,NFE:0.8522,OTH:0.8507,ASJ:0.8974	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.0	1.0	0.000	-1.87	7	MU784023	hom
7	6026988	6026988	G	A	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs1805321	ENSG00000122512:ENST00000441476:exon8:c.C1090T:p.P364S,ENSG00000122512:ENST00000265849:exon11:c.C1408T:p.P470S,ENSG00000122512:ENST00000406569:exon11:c.C1408T:p.P470S	PMS2:NM_001322008:exon9:c.C1090T:p.P364S,PMS2:NM_001322010:exon9:c.C847T:p.P283S,PMS2:NM_001322004:exon10:c.C1003T:p.P335S,PMS2:NM_001322006:exon10:c.C1252T:p.P418S,PMS2:NM_001322007:exon10:c.C1090T:p.P364S,PMS2:NM_001322013:exon10:c.C835T:p.P279S,PMS2:NM_000535:exon11:c.C1408T:p.P470S,PMS2:NM_001322003:exon11:c.C1003T:p.P335S,PMS2:NM_001322005:exon11:c.C1003T:p.P335S,PMS2:NM_001322009:exon11:c.C1003T:p.P335S,PMS2:NM_001322011:exon11:c.C475T:p.P159S,PMS2:NM_001322012:exon11:c.C475T:p.P159S,PMS2:NM_001322014:exon11:c.C1408T:p.P470S,PMS2:NM_001322015:exon11:c.C1099T:p.P367S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3854	0.3738	0.358227	1(large_intestine)	-0.661	0.089	0.844	0.572	0.000	.	.	.	PMS2:uc003spj.3:exon8:c.C1090T:p.P364S,PMS2:uc011jwl.2:exon10:c.C1003T:p.P335S,PMS2:uc003spk.3:exon11:c.C1003T:p.P335S,PMS2:uc003spl.3:exon11:c.C1408T:p.P470S,PMS2:uc010ktf.2:exon11:c.C1408T:p.P470S,PMS2:uc010ktg.3:exon11:c.C475T:p.P159S	-1.002	AFR:1(thyroid),AMR:MU4566009,EAS:0.3706,FIN:0.2827,NFE:0.4045,OTH:0.4040,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.018	1.14	0.000	1.03	7	1(skin)	0.3890
7	6036980	6036980	G	C	PMS2	exonic	synonymous SNV	ENSG00000122512	rs1805319	ENSG00000122512:ENST00000441476:exon4:c.C462G:p.S154S,ENSG00000122512:ENST00000265849:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000382321:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000406569:exon7:c.C780G:p.S260S	PMS2:NM_001322008:exon5:c.C462G:p.S154S,PMS2:NM_001322004:exon6:c.C375G:p.S125S,PMS2:NM_001322007:exon6:c.C462G:p.S154S,PMS2:NM_001322010:exon6:c.C375G:p.S125S,PMS2:NM_001322013:exon6:c.C207G:p.S69S,PMS2:NM_000535:exon7:c.C780G:p.S260S,PMS2:NM_001322003:exon7:c.C375G:p.S125S,PMS2:NM_001322005:exon7:c.C375G:p.S125S,PMS2:NM_001322006:exon7:c.C780G:p.S260S,PMS2:NM_001322009:exon7:c.C375G:p.S125S,PMS2:NM_001322014:exon7:c.C780G:p.S260S,PMS2:NM_001322015:exon7:c.C471G:p.S157S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8109	0.8238	0.83127	0.8205	.	.	.	.	.	.	.	.	PMS2:uc003spj.3:exon4:c.C462G:p.S154S,PMS2:uc011jwl.2:exon6:c.C375G:p.S125S,PMS2:uc003spk.3:exon7:c.C375G:p.S125S,PMS2:uc003spl.3:exon7:c.C780G:p.S260S,PMS2:uc010kte.3:exon7:c.C780G:p.S260S,PMS2:uc010ktf.2:exon7:c.C780G:p.S260S	.	AFR:0.8433,AMR:0.7031,EAS:0.9180,FIN:0.7911,NFE:0.8107,OTH:0.8010,ASJ:0.8444	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	MU4565970	hom
7	6037058	6037058	A	-	PMS2	intronic	.	ENSG00000122512	rs60794673	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0] 	0.4422	.	0.453075	0.4480	.	.	.	.	.	.	.	.	.	.	AFR:0.3371,AMR:0.4701,EAS:0.7010,FIN:0.4676,NFE:0.4763,OTH:0.4749,ASJ:0.4958	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	.	het
7	6038722	6038722	T	C	PMS2	intronic	.	ENSG00000122512	rs62456182	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3678	0.3439	0.325679	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.3392,AMR:0.1978,EAS:0.4007,FIN:0.3626,NFE:0.3525,OTH:0.4139,ASJ:0.3278	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	3(lung)	0.3617
7	6431690	6431690	C	T	RAC1	intronic	.	ENSG00000136238	rs836478	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5603	0.5425	0.691494	0.5664	.	.	.	.	.	.	.	.	.	.	AFR:0.7118,AMR:0.6439,EAS:0.9142,FIN:0.4745,NFE:0.4697,OTH:0.4949,ASJ:0.3874	602048	.	.	.	~ko04010 MAPK signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04310 Wnt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04972 Pancreatic secretion~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05135 Yersinia infection~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05231 Choline metabolism in cancer~ko05416 Viral myocarditis~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	7	MU18753436	het
7	14025727	14025727	C	T	ETV1	intronic	.	ENSG00000006468	rs3823704	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5455	0.5528	0.563698	0.5822	.	.	.	.	.	.	.	.	.	.	AFR:0.6356,AMR:0.6687,EAS:0.5887,FIN:0.6230,NFE:0.5440,OTH:0.5398,ASJ:0.33	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU12866402	het
7	14025766	14025766	T	A	ETV1	exonic	synonymous SNV	ENSG00000006468	rs10215655	ENSG00000006468:ENST00000399357:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000403527:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000420159:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000438956:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000443608:exon1:c.A36T:p.P12P	ETV1:NM_001163150:exon1:c.A36T:p.P12P,ETV1:NM_001163151:exon1:c.A36T:p.P12P,ETV1:NM_001163152:exon1:c.A36T:p.P12P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5744	0.5544	0.564097	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ETV1:uc021zzt.1:exon1:c.A36T:p.P12P,ETV1:uc021zzu.1:exon1:c.A36T:p.P12P,ETV1:uc021zzv.1:exon1:c.A36T:p.P12P,ETV1:uc021zzw.1:exon1:c.A36T:p.P12P,ETV1:uc021zzx.1:exon1:c.A36T:p.P12P,ETV1:uc021zzy.1:exon1:c.A36T:p.P12P	.	AFR:MU159388,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.6351,FIN:0.6675,NFE:0.3278,OTH:0.5915,ASJ:0.5821	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	1(thyroid)	0.6233
7	24756951	24756951	C	T	GSDME	exonic	nonsynonymous SNV	ENSG00000105928	rs12540919	ENSG00000105928:ENST00000411476:exon3:c.G388A:p.V130M,ENSG00000105928:ENST00000409970:exon4:c.G127A:p.V43M,ENSG00000105928:ENST00000419307:exon4:c.G127A:p.V43M,ENSG00000105928:ENST00000342947:exon5:c.G619A:p.V207M,ENSG00000105928:ENST00000409775:exon5:c.G619A:p.V207M,ENSG00000105928:ENST00000545231:exon7:c.G127A:p.V43M	GSDME:NM_001127454:exon4:c.G127A:p.V43M,GSDME:NM_001127453:exon5:c.G619A:p.V207M,GSDME:NM_004403:exon5:c.G619A:p.V207M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0943	0.0783	0.0898562	1(stomach)	6.515	31	0.032	4.82	0.485	.	.	.	DFNA5:uc010kut.1:exon4:c.G127A:p.V43M,DFNA5:uc003sxa.1:exon5:c.G619A:p.V207M,DFNA5:uc010kus.1:exon5:c.G619A:p.V207M	-1.064	AFR:MU3888724,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.0435,FIN:0.0811,NFE:0.0695,OTH:0.1078,ASJ:0.0774	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.994	1.85	0.001	2.93	7	1(breast)	0.0759
7	24758753	24758753	C	T	GSDME	exonic	synonymous SNV	ENSG00000105928	rs754555	ENSG00000105928:ENST00000411476:exon2:c.G258A:p.T86T,ENSG00000105928:ENST00000342947:exon4:c.G489A:p.T163T,ENSG00000105928:ENST00000409775:exon4:c.G489A:p.T163T	GSDME:NM_001127453:exon4:c.G489A:p.T163T,GSDME:NM_004403:exon4:c.G489A:p.T163T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2056	0.1657	0.259185	2(large_intestine)	.	.	.	.	.	.	.	.	DFNA5:uc003sxa.1:exon4:c.G489A:p.T163T,DFNA5:uc010kus.1:exon4:c.G489A:p.T163T	.	AFR:MU61299,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2004,FIN:0.1551,NFE:0.1026,OTH:0.4702,ASJ:0.1827	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.1613
7	24758795	24758795	T	C	GSDME	exonic	synonymous SNV	ENSG00000105928	rs876305	ENSG00000105928:ENST00000411476:exon2:c.A216G:p.E72E,ENSG00000105928:ENST00000342947:exon4:c.A447G:p.E149E,ENSG00000105928:ENST00000409775:exon4:c.A447G:p.E149E	GSDME:NM_001127453:exon4:c.A447G:p.E149E,GSDME:NM_004403:exon4:c.A447G:p.E149E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5712	0.5374	0.73762	0.5719	.	.	.	.	.	.	.	.	DFNA5:uc003sxa.1:exon4:c.A447G:p.E149E,DFNA5:uc010kus.1:exon4:c.A447G:p.E149E	.	AFR:0.7803,AMR:0.6770,EAS:0.9926,FIN:0.4538,NFE:0.4361,OTH:0.4857,ASJ:0.3742	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	MU81828348	het
7	24758818	24758818	G	T	GSDME	exonic	nonsynonymous SNV	ENSG00000105928	rs754554	ENSG00000105928:ENST00000411476:exon2:c.C193A:p.P65T,ENSG00000105928:ENST00000342947:exon4:c.C424A:p.P142T,ENSG00000105928:ENST00000409775:exon4:c.C424A:p.P142T	GSDME:NM_001127453:exon4:c.C424A:p.P142T,GSDME:NM_004403:exon4:c.C424A:p.P142T	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2061	0.1657	0.259185	1(lung)	-1.558	0.002	0.926	0.252	0.000	.	.	.	DFNA5:uc003sxa.1:exon4:c.C424A:p.P142T,DFNA5:uc010kus.1:exon4:c.C424A:p.P142T	-0.927	AFR:MU815198,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2005,FIN:0.1551,NFE:0.1026,OTH:0.4733,ASJ:0.1828	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.267	2.04	0.000	2.32	7	1(large_intestine)	0.1615
7	24758852	24758852	C	T	GSDME	intronic	.	ENSG00000105928	rs754553	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2054	0.1657	0.259784	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1828,AMR:0.2007,EAS:0.1026,FIN:0.4746,NFE:0.1616,OTH:0.1497,ASJ:0.1551	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.1721
7	44112694	44112694	C	T	POLM	exonic	synonymous SNV	ENSG00000122678	rs7779139	ENSG00000122678:ENST00000395831:exon9:c.G1494A:p.V498V	POLM:NM_001284330:exon9:c.G1494A:p.V498V,POLM:NM_001362683:exon11:c.G1734A:p.V578V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2740	.	0.189896	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	POLM:uc003tjx.2:exon9:c.G1494A:p.V498V	.	AFR:0.1883,AMR:0.2876,EAS:0.1192,FIN:0.1117,NFE:0.1831,OTH:0.1404,ASJ:0.2404	606344	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.1595
7	44112873	44112873	G	T	POLM	exonic	nonsynonymous SNV	ENSG00000122678	rs3218660	ENSG00000122678:ENST00000395831:exon9:c.C1315A:p.H439N	POLM:NM_001284330:exon9:c.C1315A:p.H439N,POLM:NM_001362683:exon11:c.C1555A:p.H519N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2448	0.2560	0.231629	0.2665	-0.151	1.381	0.0	-3.99	0.000	.	.	DNA polymerase beta, thumb domain|DNA-directed DNA polymerase X	POLM:uc003tjx.2:exon9:c.C1315A:p.H439N	-0.964	AFR:0.3080,AMR:0.2931,EAS:0.1165,FIN:0.3040,NFE:0.2494,OTH:0.2562,ASJ:0.2450	606344	.	.	.	.	.	.	.	0.0	1.71	0.000	.	7	MU67378315	het
7	44121936	44121936	C	A	POLM	exonic	synonymous SNV	ENSG00000122678	rs3218655	ENSG00000122678:ENST00000242248:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000335195:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000395831:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000414235:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000430942:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000434229:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000435068:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000445616:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000452049:exon1:c.G102T:p.L34L,ENSG00000122678:ENST00000458246:exon1:c.G102T:p.L34L	POLM:NM_001284330:exon1:c.G102T:p.L34L,POLM:NM_001284331:exon1:c.G102T:p.L34L,POLM:NM_001362683:exon1:c.G102T:p.L34L,POLM:NM_013284:exon1:c.G102T:p.L34L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2469	0.1403	0.170327	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	POLM:uc003tjt.3:exon1:c.G102T:p.L34L,POLM:uc003tju.3:exon1:c.G102T:p.L34L,POLM:uc003tjx.2:exon1:c.G102T:p.L34L,POLM:uc003tjz.4:exon1:c.G102T:p.L34L,POLM:uc010kxy.2:exon1:c.G102T:p.L34L,POLM:uc011kbu.1:exon1:c.G102T:p.L34L	.	AFR:0.1724,AMR:0.1994,EAS:0.1457,FIN:0.1259,NFE:0.1944,OTH:0.1541,ASJ:0.2315	606344	.	.	.	.	.	.	.	.	.	.	.	7	2(thyroid)	0.1663
7	45703971	45703971	G	A	ADCY1	exonic	synonymous SNV	ENSG00000164742	rs1042009	ENSG00000164742:ENST00000432715:exon10:c.G1014A:p.T338T	ADCY1:NM_001281768:exon10:c.G1014A:p.T338T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6815	.	0.472644	MU5454033	.	.	.	.	.	.	.	.	ADCY1:uc003tnd.3:exon10:c.G1014A:p.T338T	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.5516,EAS:0.6229,FIN:0.6490,NFE:0.2954,OTH:0.7317,ASJ:0.2343	103072	610154;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko00230 Purine metabolism~ko01100 Metabolic pathways~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05032 Morphine addiction~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	7	2(breast)	0.7067
7	45957055	45957055	G	C	IGFBP3	intronic	.	ENSG00000146674	rs2471551	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1980	0.2001	0.181709	0.1777	.	.	.	.	.	.	.	.	.	.	AFR:0.2016,AMR:0.1623,EAS:0.0327,FIN:0.1329,NFE:0.1898,OTH:0.1823,ASJ:0.2185	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU587416	het
7	45960645	45960645	G	C	IGFBP3	exonic	nonsynonymous SNV	ENSG00000146674	rs2854746	ENSG00000146674:ENST00000275521:exon1:c.C95G:p.A32G,ENSG00000146674:ENST00000381083:exon1:c.C95G:p.A32G	IGFBP3:NM_000598:exon1:c.C95G:p.A32G,IGFBP3:NM_001013398:exon1:c.C95G:p.A32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4761	.	0.42512	0.3803	-0.320	0.598	0.38	0.626	0.150	.	.	.	IGFBP3:uc003tnr.3:exon1:c.C95G:p.A32G,IGFBP3:uc003tns.3:exon1:c.C95G:p.A32G	-0.970	AFR:0.3151,AMR:0.3047,EAS:0.7596,FIN:0.3377,NFE:0.3864,OTH:0.3909,ASJ:0.4933	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.006	2.37	0.000	0.805	7	MU4548620	het
7	48004962	48004962	C	T	HUS1	exonic	synonymous SNV	ENSG00000136273	rs1056663	ENSG00000136273:ENST00000258774:exon8:c.G834A:p.A278A,ENSG00000136273:ENST00000432325:exon8:c.G771A:p.A257A,ENSG00000136273:ENST00000436444:exon8:c.G834A:p.A278A,ENSG00000136273:ENST00000458191:exon8:c.G771A:p.A257A	HUS1:NM_001363683:exon8:c.G771A:p.A257A,HUS1:NM_004507:exon8:c.G834A:p.A278A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4840	0.4439	0.423323	0.4797	.	.	.	.	.	.	.	.	HUS1:uc003tod.2:exon8:c.G834A:p.A278A	.	AFR:0.3069,AMR:0.4785,EAS:0.5627,FIN:0.5856,NFE:0.5456,OTH:0.5163,ASJ:0.4205	603760	.	.	.	.	.	.	.	.	.	.	.	7	MU59165	het
7	48016442	48016442	G	A	HUS1	intronic	.	ENSG00000136273	rs2307252	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1477	0.1630	0.207668	0.1671	.	.	.	.	.	0.0001	0.006	.	.	.	AFR:0.3213,AMR:0.1631,EAS:0.1957,FIN:0.1014,NFE:0.0940,OTH:0.1092,ASJ:0.1490	603760	.	.	.	.	.	.	.	.	.	.	.	7	MU731801	het
7	50435777	50435777	T	G	IKZF1	exonic	synonymous SNV	ENSG00000185811	rs12669559	ENSG00000185811:ENST00000413698:exon4:c.T234G:p.P78P	IKZF1:NM_001291845:exon4:c.T234G:p.P78P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3607	.	0.292133	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	IKZF1:uc003tov.1:exon4:c.T234G:p.P78P	.	AFR:0.2991,AMR:0.2368,EAS:0.4404,FIN:0.1570,NFE:0.2557,OTH:0.3524,ASJ:0.3549	603023	616873;	317473;	317473|CID due to IKAROS deficiency<br>Combined immunodeficiency due to IKAROS deficiency|-|Autosomal dominant|-|616873 ~	.	6183,	.	.	.	.	.	.	7	1(thyroid)	0.3367
7	50436033	50436033	A	G	IKZF1	exonic	nonsynonymous SNV	ENSG00000185811	rs10899750	ENSG00000185811:ENST00000413698:exon4:c.A490G:p.R164G	IKZF1:NM_001291845:exon4:c.A490G:p.R164G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6862	.	0.717652	LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	-0.360	0.481	0.0	-6.26	0.000	.	.	.	IKZF1:uc003tov.1:exon4:c.A490G:p.R164G	-0.968	AFR:0.7485,AMR:0.9139,EAS:0.7351,FIN:0.5297,NFE:0.7467,OTH:0.6808,ASJ:0.7225	603023	616873;	317473;	317473|CID due to IKAROS deficiency<br>Combined immunodeficiency due to IKAROS deficiency|-|Autosomal dominant|-|616873 ~	.	6183,	.	.	0.0	.	0.000	.	7	1(liver)	0.7061
7	55214348	55214348	C	T	EGFR	exonic	synonymous SNV	ENSG00000146648	rs2072454	ENSG00000146648:ENST00000275493:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000342916:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000344576:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000420316:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000442591:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000450046:exon4:c.C315T:p.N105N,ENSG00000146648:ENST00000454757:exon4:c.C315T:p.N105N	EGFR:NM_001346898:exon4:c.C474T:p.N158N,EGFR:NM_001346900:exon4:c.C315T:p.N105N,EGFR:NM_005228:exon4:c.C474T:p.N158N,EGFR:NM_201282:exon4:c.C474T:p.N158N,EGFR:NM_201283:exon4:c.C474T:p.N158N,EGFR:NM_201284:exon4:c.C474T:p.N158N	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5090	0.5151	0.475439	2(central_nervous_system)	.	.	.	.	.	.	.	.	EGFR:uc003tqh.3:exon4:c.C474T:p.N158N,EGFR:uc003tqi.3:exon4:c.C474T:p.N158N,EGFR:uc003tqj.3:exon4:c.C474T:p.N158N,EGFR:uc003tqk.3:exon4:c.C474T:p.N158N,EGFR:uc011kco.2:exon4:c.C315T:p.N105N,EGFR:uc022adm.1:exon4:c.C474T:p.N158N	.	AFR:18(soft_tissue),AMR:1(prostate),EAS:1(large_intestine),FIN:MU4807633,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,OTH:0.5053,ASJ:1(lung)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,3236,2507,3247,2510,3214,3231,3212,3228,3239,2506,3263,3225,3253,3227,3257,3246,3244,3248,3269,2509,3259,3268,3265,3213,3226,3220,3233,3254,3267,3224,3229,3241,3258,3240,3256,3223,3262,3216,3261,3255,3237,3243,3217,3260,3215,3252,2508,3242,3266,3238,3218,3251,3222,3245,3211,3221,3219,3230,3234,3232,3235,3264	.	3250,,3249	.	.	.	.	7	3(haematopoietic_and_lymphoid_tissue)	0.5028
7	55266417	55266417	T	C	EGFR	exonic	synonymous SNV	ENSG00000146648	rs1140475	ENSG00000146648:ENST00000455089:exon22:c.T2574C:p.T858T,ENSG00000146648:ENST00000275493:exon23:c.T2709C:p.T903T,ENSG00000146648:ENST00000454757:exon23:c.T2550C:p.T850T	EGFR:NM_001346941:exon17:c.T1908C:p.T636T,EGFR:NM_001346897:exon22:c.T2574C:p.T858T,EGFR:NM_001346899:exon22:c.T2574C:p.T858T,EGFR:NM_001346898:exon23:c.T2709C:p.T903T,EGFR:NM_001346900:exon23:c.T2550C:p.T850T,EGFR:NM_005228:exon23:c.T2709C:p.T903T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8957	0.8891	0.916733	SKCA-BR|1|100|0.01,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EGFR:uc010kzg.2:exon22:c.T2574C:p.T858T,EGFR:uc022adn.1:exon22:c.T2574C:p.T858T,EGFR:uc003tqk.3:exon23:c.T2709C:p.T903T,EGFR:uc011kco.2:exon23:c.T2550C:p.T850T,EGFR:uc022adm.1:exon23:c.T2709C:p.T903T	.	AFR:0.8922,AMR:0.9260,EAS:0.9139,FIN:0.9228,NFE:0.8832,OTH:0.8703,ASJ:0.9103	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,3236,2507,3247,2510,3214,3231,3212,3228,3239,2506,3263,3225,3253,3227,3257,3246,3244,3248,3269,2509,3259,3268,3265,3213,3226,3220,3233,3254,3267,3224,3229,3241,3258,3240,3256,3223,3262,3216,3261,3255,3237,3243,3217,3260,3215,3252,2508,3242,3266,3238,3218,3251,3222,3245,3211,3221,3219,3230,3234,3232,3235,3264	.	3250,,3249	.	.	.	.	7	3(lung)	0.8878
7	73467650	73467650	-	TG	ELN	intronic	.	ENSG00000049540	rs782441301	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0594	.	.	0.1356	.	.	.	.	.	.	.	.	.	.	AFR:0.1251,AMR:0.1322,EAS:0.1016,FIN:0.1193,NFE:0.1492,OTH:0.1360,ASJ:0.1357	130160	123700;185500;	3193;90348;	3193|SVAS|1-5 / 10 000|Autosomal dominant|All ages|185500 ~90348|ADCL|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123700 614434 616603 ~	.	.	.	.	.	.	.	.	7	.	het
7	75137097	75137097	A	G	PMS2P3	ncRNA_exonic	.	ENSG00000127957	rs62477735	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.44988	0.3287	.	.	.	.	.	.	.	.	.	.	AFR:0.0816,AMR:0.5565,EAS:0.8029,FIN:0.4723,NFE:0.3745,OTH:0.4344,ASJ:0.3586	.	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	75145411	75145411	T	C	PMS2P3	ncRNA_intronic	.	ENSG00000127957	rs794378	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9744	.	0.975839	0.9805	.	.	.	.	.	.	.	.	.	.	AFR:0.9886,AMR:0.9592,EAS:0.9507,FIN:0.9616,NFE:0.9844,OTH:0.9774,ASJ:0.9966	.	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	75145495	75145495	G	A	PMS2P3	ncRNA_exonic	.	ENSG00000127957	rs794377	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4386	0.2710	0.408147	0.3578	.	.	.	.	.	.	.	.	.	.	AFR:0.0864,AMR:0.5921,EAS:0.6756,FIN:0.5270,NFE:0.4207,OTH:0.4785,ASJ:0.4060	.	.	.	.	.	.	.	.	.	.	.	.	7	MU13048068	het
7	75155300	75155300	G	A	PMS2P3	ncRNA_intronic	.	ENSG00000127957	rs1167823	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1857	0.1883	.	0.1766	.	.	.	.	.	.	.	.	.	.	AFR:0.0995,AMR:0.1098,EAS:0.0037,FIN:0.2377,NFE:0.2281,OTH:0.1965,ASJ:0.1987	.	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	75614082	75614082	C	G	POR	intronic	.	ENSG00000127948	rs4732516	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9091	0.8527	0.811901	0.8553	.	.	.	.	.	.	.	.	.	.	AFR:0.6054,AMR:0.8612,EAS:0.8585,FIN:0.9760,NFE:0.9643,OTH:0.9296,ASJ:0.9735	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	MU27551504	hom
7	75614953	75614953	T	C	POR	exonic	synonymous SNV	ENSG00000127948	rs2228104	ENSG00000127948:ENST00000439269:exon7:c.T669C:p.A223A,ENSG00000127948:ENST00000545601:exon8:c.T879C:p.A293A,ENSG00000127948:ENST00000450476:exon9:c.T1152C:p.A384A,ENSG00000127948:ENST00000394893:exon13:c.T1455C:p.A485A,ENSG00000127948:ENST00000419840:exon13:c.T897C:p.A299A,ENSG00000127948:ENST00000461988:exon13:c.T1455C:p.A485A	POR:NM_000941:exon13:c.T1455C:p.A485A,POR:NM_001367562:exon14:c.T1455C:p.A485A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9226	0.8729	0.835264	0.8763	.	.	.	.	.	.	.	.	POR:uc011kge.2:exon7:c.T669C:p.A223A,POR:uc011kgc.2:exon8:c.T879C:p.A293A,POR:uc003udy.3:exon13:c.T1455C:p.A485A	.	AFR:0.6665,AMR:0.8831,EAS:0.8631,FIN:0.9840,NFE:0.9676,OTH:0.9439,ASJ:0.9735	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	MU4554694	hom
7	75615006	75615006	C	T	POR	exonic	nonsynonymous SNV	ENSG00000127948	rs1057868	ENSG00000127948:ENST00000439269:exon7:c.C722T:p.A241V,ENSG00000127948:ENST00000545601:exon8:c.C932T:p.A311V,ENSG00000127948:ENST00000450476:exon9:c.C1205T:p.A402V,ENSG00000127948:ENST00000394893:exon13:c.C1508T:p.A503V,ENSG00000127948:ENST00000419840:exon13:c.C950T:p.A317V,ENSG00000127948:ENST00000461988:exon13:c.C1508T:p.A503V	POR:NM_000941:exon13:c.C1508T:p.A503V,POR:NM_001367562:exon14:c.C1508T:p.A503V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3639	0.2367	0.286142	1(oesophagus)	0.704	8.850	0.218	3.51	0.213	.	.	Ferredoxin reductase-type FAD-binding domain|Riboflavin synthase-like beta-barrel	POR:uc011kge.2:exon7:c.C722T:p.A241V,POR:uc011kgc.2:exon8:c.C932T:p.A311V,POR:uc003udy.3:exon13:c.C1508T:p.A503V	-1.038	AFR:1(large_intestine),AMR:MU132199,EAS:0.2805,FIN:0.1822,NFE:0.2632,OTH:0.2583,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	0.0	-1.64	0.000	1.195	7	1(prostate)	0.3778
7	77648671	77648671	G	C	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs13438302	ENSG00000187391:ENST00000419488:exon21:c.C4287G:p.P1429P,ENSG00000187391:ENST00000354212:exon22:c.C4329G:p.P1443P	MAGI2:NM_001301128:exon21:c.C4287G:p.P1429P,MAGI2:NM_012301:exon22:c.C4329G:p.P1443P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3418	0.1847	0.41234	0.2962	.	.	.	.	.	.	.	.	MAGI2:uc003ugy.3:exon21:c.C4287G:p.P1429P,MAGI2:uc003ugx.3:exon22:c.C4329G:p.P1443P	.	AFR:0.4181,AMR:0.3804,EAS:0.6339,FIN:0.2798,NFE:0.1905,OTH:0.2243,ASJ:0.3160	606382	.	.	.	.	.	.	.	.	.	.	.	7	MU81833259	hom
7	77756580	77756580	T	C	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs2074641	ENSG00000187391:ENST00000419488:exon18:c.A3315G:p.L1105L,ENSG00000187391:ENST00000354212:exon19:c.A3357G:p.L1119L,ENSG00000187391:ENST00000522391:exon19:c.A3357G:p.L1119L	MAGI2:NM_001301128:exon18:c.A3315G:p.L1105L,MAGI2:NM_012301:exon19:c.A3357G:p.L1119L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8248	0.8840	0.786542	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.A2136G:p.L712L,MAGI2:uc003ugy.3:exon18:c.A3315G:p.L1105L,MAGI2:uc003ugx.3:exon19:c.A3357G:p.L1119L	.	AFR:0.8715,AMR:0.9082,EAS:0.8013,FIN:0.6043,NFE:0.8788,OTH:0.8868,ASJ:0.7362	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8615
7	77756724	77756724	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs7812015	ENSG00000187391:ENST00000419488:exon18:c.G3171A:p.S1057S,ENSG00000187391:ENST00000354212:exon19:c.G3213A:p.S1071S,ENSG00000187391:ENST00000522391:exon19:c.G3213A:p.S1071S	MAGI2:NM_001301128:exon18:c.G3171A:p.S1057S,MAGI2:NM_012301:exon19:c.G3213A:p.S1071S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8244	0.8840	0.786342	MU116389	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.G1992A:p.S664S,MAGI2:uc003ugy.3:exon18:c.G3171A:p.S1057S,MAGI2:uc003ugx.3:exon19:c.G3213A:p.S1071S	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.8715,EAS:0.7380,FIN:0.8013,NFE:0.6032,OTH:0.8789,ASJ:0.9082	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8869
7	77789403	77789403	A	G	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs1009524	ENSG00000187391:ENST00000419488:exon15:c.T2742C:p.N914N,ENSG00000187391:ENST00000354212:exon16:c.T2784C:p.N928N,ENSG00000187391:ENST00000522391:exon16:c.T2784C:p.N928N	MAGI2:NM_001301128:exon15:c.T2742C:p.N914N,MAGI2:NM_012301:exon16:c.T2784C:p.N928N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1177	0.1072	0.126797	MU109241	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon11:c.T1563C:p.N521N,MAGI2:uc003ugy.3:exon15:c.T2742C:p.N914N,MAGI2:uc003ugx.3:exon16:c.T2784C:p.N928N	.	AFR:LICA-CN|2|402|0.00497512,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.1150,EAS:0.1627,FIN:0.1490,NFE:0.1681,OTH:0.1405,ASJ:0.1035	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(large_intestine)	0.1061
7	78119109	78119109	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs3735442	ENSG00000187391:ENST00000535697:exon5:c.G525A:p.K175K,ENSG00000187391:ENST00000354212:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000419488:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000522391:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000536571:exon6:c.G510A:p.K170K	MAGI2:NM_001301128:exon6:c.G1014A:p.K338K,MAGI2:NM_012301:exon6:c.G1014A:p.K338K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2942	0.3455	0.323083	1(stomach)	.	.	.	.	.	.	.	.	MAGI2:uc011kgs.1:exon5:c.G525A:p.K175K,MAGI2:uc003ugx.3:exon6:c.G1014A:p.K338K,MAGI2:uc003ugy.3:exon6:c.G1014A:p.K338K,MAGI2:uc011kgr.1:exon6:c.G510A:p.K170K	.	AFR:1(breast),AMR:MU30304050,EAS:0.3279,FIN:0.4237,NFE:0.2208,OTH:0.3543,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.2443
7	80290369	80290369	A	G	CD36	intronic	.	ENSG00000135218	rs3211892	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9649	0.9203	0.918331	0.9293	.	.	.	.	.	0	0	.	.	.	AFR:0.8000,AMR:0.9773,EAS:0.9994,FIN:0.9834,NFE:0.9777,OTH:0.9776,ASJ:0.9603	173510	608404;610938;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	7	MU81833340	hom
7	81346685	81346685	T	C	HGF	intronic	.	ENSG00000019991	rs1800793	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8053	0.7530	0.798323	0.7671	.	.	.	.	.	0.0002	0.044	.	.	.	AFR:0.6746,AMR:0.8675,EAS:0.8335,FIN:0.7857,NFE:0.7983,OTH:0.8136,ASJ:0.8825	142409	608265;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05144 Malaria~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU26259331	hom
7	87032613	87032613	A	G	ABCB4	intronic	.	ENSG00000005471	rs31653	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8775	0.9234	0.879992	0.9026	.	.	.	.	.	.	.	.	.	.	AFR:0.9733,AMR:0.8361,EAS:0.7247,FIN:0.8706,NFE:0.8926,OTH:0.8878,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20973608	hom
7	87053206	87053206	G	A	ABCB4	intronic	.	ENSG00000005471	rs31668	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8990	0.9260	0.873602	0.9132	.	.	.	.	.	.	.	.	.	.	AFR:0.9313,AMR:0.8840,EAS:0.7120,FIN:0.9407,NFE:0.9191,OTH:0.9224,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20974205	hom
7	87082292	87082292	G	A	ABCB4	exonic	synonymous SNV	ENSG00000005471	rs1202283	ENSG00000005471:ENST00000453593:exon5:c.C504T:p.N168N,ENSG00000005471:ENST00000545634:exon5:c.C504T:p.N168N,ENSG00000005471:ENST00000265723:exon6:c.C504T:p.N168N,ENSG00000005471:ENST00000358400:exon6:c.C504T:p.N168N,ENSG00000005471:ENST00000359206:exon6:c.C504T:p.N168N	ABCB4:NM_000443:exon6:c.C504T:p.N168N,ABCB4:NM_018849:exon6:c.C504T:p.N168N,ABCB4:NM_018850:exon6:c.C504T:p.N168N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4765	0.4041	0.347843	MU149931	.	.	.	.	.	.	.	.	ABCB4:uc003uiy.3:exon5:c.C504T:p.N168N,ABCB4:uc003uiv.1:exon6:c.C504T:p.N168N,ABCB4:uc003uiw.1:exon6:c.C504T:p.N168N,ABCB4:uc003uix.1:exon6:c.C504T:p.N168N	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4295,EAS:0.4356,FIN:0.4267,NFE:0.3747,OTH:0.6479,ASJ:0.1106	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.5617
7	87105159	87105159	A	G	ABCB4	upstream	.	ENSG00000005471	rs2071646	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.229832	0.2241	.	.	.	.	.	.	.	.	.	.	AFR:0.1581,AMR:0.3705,EAS:0.2989,FIN:0.1589,NFE:0.2569,OTH:0.2355,ASJ:0.3810	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	.	het
7	91630620	91630620	G	T	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs6964587	ENSG00000127914:ENST00000356239:exon8:c.G1389T:p.M463I,ENSG00000127914:ENST00000358100:exon9:c.G1425T:p.M475I,ENSG00000127914:ENST00000359028:exon9:c.G1425T:p.M475I	AKAP9:NM_005751:exon8:c.G1389T:p.M463I,AKAP9:NM_147185:exon8:c.G1389T:p.M463I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3829	0.4405	0.372204	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	-0.375	0.443	0.064	-3.46	0.045	.	.	ELK domain	AKAP9:uc003uli.3:exon1:c.G264T:p.M88I,AKAP9:uc003ulf.3:exon8:c.G1389T:p.M463I,AKAP9:uc003ulg.3:exon8:c.G1389T:p.M463I,AKAP9:uc003ule.2:exon9:c.G1425T:p.M475I	-0.965	AFR:0.4037,AMR:0.5064,EAS:0.5331,FIN:0.1745,NFE:0.3738,OTH:0.3782,ASJ:0.3213	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.002	3.93	0.000	0.805	7	1(haematopoietic_and_lymphoid_tissue)	0.3937
7	91632306	91632306	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs1989779	ENSG00000127914:ENST00000356239:exon8:c.C3075T:p.T1025T,ENSG00000127914:ENST00000358100:exon9:c.C3111T:p.T1037T,ENSG00000127914:ENST00000359028:exon9:c.C3111T:p.T1037T	AKAP9:NM_005751:exon8:c.C3075T:p.T1025T,AKAP9:NM_147185:exon8:c.C3075T:p.T1025T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8924	0.9064	0.935903	0.8912	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon1:c.C1950T:p.T650T,AKAP9:uc003ulf.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ulg.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ule.2:exon9:c.C3111T:p.T1037T	.	AFR:0.9731,AMR:0.9284,EAS:0.9728,FIN:0.8373,NFE:0.8471,OTH:0.8678,ASJ:0.8676	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	MU81834056	hom
7	91641928	91641928	A	G	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs13245393	ENSG00000127914:ENST00000356239:exon9:c.A3504G:p.E1168E,ENSG00000127914:ENST00000358100:exon10:c.A3540G:p.E1180E,ENSG00000127914:ENST00000359028:exon10:c.A3540G:p.E1180E	AKAP9:NM_005751:exon9:c.A3504G:p.E1168E,AKAP9:NM_147185:exon9:c.A3504G:p.E1168E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3838	0.4418	0.373802	1(large_intestine)	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon2:c.A2379G:p.E793E,AKAP9:uc003ulf.3:exon9:c.A3504G:p.E1168E,AKAP9:uc003ulg.3:exon9:c.A3504G:p.E1168E,AKAP9:uc003ule.2:exon10:c.A3540G:p.E1180E	.	AFR:MU13086418,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.5113,FIN:0.3198,NFE:0.53,OTH:0.1749,ASJ:0.4048	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.3733
7	91652178	91652178	-	AAC	AKAP9	exonic	nonframeshift insertion	ENSG00000127914	rs10644111	ENSG00000127914:ENST00000356239:exon14:c.4003_4004insAAC:p.K1335delinsKQ,ENSG00000127914:ENST00000358100:exon15:c.4039_4040insAAC:p.K1347delinsKQ,ENSG00000127914:ENST00000359028:exon15:c.4039_4040insAAC:p.K1347delinsKQ	AKAP9:NM_005751:exon14:c.4003_4004insAAC:p.K1335delinsKQ,AKAP9:NM_147185:exon14:c.4003_4004insAAC:p.K1335delinsKQ	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3989	0.4791	0.42472	0.4374	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon7:c.2878_2879insAAC:p.K960delinsKQ,AKAP9:uc003ulf.3:exon14:c.4003_4004insAAC:p.K1335delinsKQ,AKAP9:uc003ulg.3:exon14:c.4003_4004insAAC:p.K1335delinsKQ,AKAP9:uc003ule.2:exon15:c.4039_4040insAAC:p.K1347delinsKQ	.	AFR:0.6258,AMR:0.3266,EAS:0.1984,FIN:0.3726,NFE:0.3761,OTH:0.3957,ASJ:0.5298	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	.	het
7	91674302	91674302	G	A	AKAP9	intronic	.	ENSG00000127914	rs9785013	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3993	0.4832	0.428514	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4430,AMR:0.6401,EAS:0.5331,FIN:0.1981,NFE:0.3736,OTH:0.3781,ASJ:0.3301	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.3975
7	91691601	91691601	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs10236397	ENSG00000127914:ENST00000356239:exon24:c.C5778T:p.G1926G,ENSG00000127914:ENST00000358100:exon25:c.C5814T:p.G1938G,ENSG00000127914:ENST00000359028:exon25:c.C5814T:p.G1938G	AKAP9:NM_005751:exon24:c.C5778T:p.G1926G,AKAP9:NM_147185:exon24:c.C5778T:p.G1926G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3795	0.4277	0.359824	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon17:c.C4647T:p.G1549G,AKAP9:uc003ulf.3:exon24:c.C5778T:p.G1926G,AKAP9:uc003ulg.3:exon24:c.C5778T:p.G1926G	.	AFR:0.3895,AMR:0.4581,EAS:0.5331,FIN:0.1741,NFE:0.3737,OTH:0.3776,ASJ:0.3169	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	2(large_intestine)	0.3904
7	91707197	91707197	C	T	AKAP9	intronic	.	ENSG00000127914	rs733957	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4076	0.4270	0.36242	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.006	.	.	.	AFR:0.3916,AMR:0.4648,EAS:0.53,FIN:0.1754,NFE:0.3729,OTH:0.3782,ASJ:0.3177	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3896
7	91712698	91712698	A	G	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs6960867	ENSG00000127914:ENST00000394534:exon7:c.A1913G:p.N638S,ENSG00000127914:ENST00000356239:exon33:c.A8375G:p.N2792S,ENSG00000127914:ENST00000358100:exon34:c.A8411G:p.N2804S,ENSG00000127914:ENST00000359028:exon34:c.A8411G:p.N2804S	AKAP9:NM_005751:exon33:c.A8375G:p.N2792S,AKAP9:NM_147185:exon33:c.A8351G:p.N2784S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3593	0.3561	0.295927	1(kidney)	-0.076	1.912	0.232	-2.13	0.896	.	.	.	AKAP9:uc003ulk.3:exon1:c.A200G:p.N67S,AKAP9:uc003ulj.3:exon7:c.A1685G:p.N562S,AKAP9:uc003uli.3:exon26:c.A7244G:p.N2415S,AKAP9:uc003ulf.3:exon33:c.A8351G:p.N2784S,AKAP9:uc003ulg.3:exon33:c.A8375G:p.N2792S	-0.923	AFR:MU13086466,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,WT-US|1|102|0.00980392,AML-US|3|166|0.0180723,EAS:0.2494,FIN:0.3067,NFE:0.5331,OTH:0.1755,ASJ:0.3294	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.023	0.89	0.000	1.1	7	2(large_intestine)	0.3737
7	91713972	91713972	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs10228334	ENSG00000127914:ENST00000394534:exon8:c.C2203T:p.L735L,ENSG00000127914:ENST00000356239:exon34:c.C8665T:p.L2889L	AKAP9:NM_005751:exon34:c.C8665T:p.L2889L,AKAP9:NM_147185:exon34:c.C8641T:p.L2881L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3832	0.4410	0.373802	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	AKAP9:uc003ulk.3:exon2:c.C490T:p.L164L,AKAP9:uc003ulj.3:exon8:c.C1975T:p.L659L,AKAP9:uc003uli.3:exon27:c.C7534T:p.L2512L,AKAP9:uc003ulf.3:exon34:c.C8641T:p.L2881L,AKAP9:uc003ulg.3:exon34:c.C8665T:p.L2889L	.	AFR:0.4053,AMR:0.5114,EAS:0.5367,FIN:0.1759,NFE:0.3749,OTH:0.3782,ASJ:0.3209	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3947
7	91714911	91714911	C	T	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs1063242	ENSG00000127914:ENST00000394534:exon10:c.C2473T:p.P825S,ENSG00000127914:ENST00000358100:exon35:c.C8785T:p.P2929S,ENSG00000127914:ENST00000356239:exon36:c.C8935T:p.P2979S,ENSG00000127914:ENST00000359028:exon36:c.C8947T:p.P2983S	AKAP9:NM_005751:exon36:c.C8935T:p.P2979S,AKAP9:NM_147185:exon36:c.C8911T:p.P2971S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9962	0.9974	0.998802	0.9959	-0.130	1.518	1.0	2.47	0.977	.	.	.	AKAP9:uc003ulk.3:exon4:c.C760T:p.P254S,AKAP9:uc003ulj.3:exon10:c.C2245T:p.P749S,AKAP9:uc003uli.3:exon29:c.C7804T:p.P2602S,AKAP9:uc003ulf.3:exon36:c.C8911T:p.P2971S,AKAP9:uc003ulg.3:exon36:c.C8935T:p.P2979S	-1.027	AFR:0.9997,AMR:1,EAS:1,FIN:0.9920,NFE:0.9942,OTH:0.9908,ASJ:1	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	4.21	0.000	-2.075	7	MU81834100	hom
7	91715662	91715662	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs28927678	ENSG00000127914:ENST00000394534:exon11:c.C2683T:p.L895L,ENSG00000127914:ENST00000358100:exon36:c.C8995T:p.L2999L,ENSG00000127914:ENST00000356239:exon37:c.C9145T:p.L3049L,ENSG00000127914:ENST00000359028:exon37:c.C9157T:p.L3053L	AKAP9:NM_005751:exon37:c.C9145T:p.L3049L,AKAP9:NM_147185:exon37:c.C9121T:p.L3041L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3589	0.3557	0.295727	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	AKAP9:uc003ulk.3:exon5:c.C970T:p.L324L,AKAP9:uc003ulj.3:exon11:c.C2455T:p.L819L,AKAP9:uc003uli.3:exon30:c.C8014T:p.L2672L,AKAP9:uc003ulf.3:exon37:c.C9121T:p.L3041L,AKAP9:uc003ulg.3:exon37:c.C9145T:p.L3049L	.	AFR:MU13086472,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.2481,FIN:0.3067,NFE:0.5331,OTH:0.1743,ASJ:0.3291	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.3733
7	91726927	91726927	A	C	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs1063243	ENSG00000127914:ENST00000394534:exon16:c.A3964C:p.R1322R,ENSG00000127914:ENST00000358100:exon41:c.A10276C:p.R3426R,ENSG00000127914:ENST00000356239:exon42:c.A10426C:p.R3476R,ENSG00000127914:ENST00000359028:exon42:c.A10438C:p.R3480R	AKAP9:NM_005751:exon42:c.A10426C:p.R3476R,AKAP9:NM_147185:exon42:c.A10402C:p.R3468R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3846	0.4463	0.377396	1(urinary_tract)	.	.	.	.	.	.	.	.	AKAP9:uc003ull.3:exon4:c.A1114C:p.R372R,AKAP9:uc003ulj.3:exon16:c.A3736C:p.R1246R,AKAP9:uc003uli.3:exon35:c.A9295C:p.R3099R,AKAP9:uc003ulf.3:exon42:c.A10402C:p.R3468R,AKAP9:uc003ulg.3:exon42:c.A10426C:p.R3476R	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU183238,EAS:0.4072,FIN:0.5204,NFE:0.3210,OTH:0.5331,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EOPC-DE|1|202|0.0049505,BTCA-JP|1|239|0.0041841	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.1737
7	91842554	91842554	T	C	KRIT1	exonic	synonymous SNV	ENSG00000001631	rs11542682	ENSG00000001631:ENST00000394503:exon15:c.A1836G:p.V612V,ENSG00000001631:ENST00000340022:exon17:c.A1980G:p.V660V,ENSG00000001631:ENST00000394505:exon17:c.A1980G:p.V660V,ENSG00000001631:ENST00000412043:exon17:c.A1980G:p.V660V,ENSG00000001631:ENST00000394507:exon18:c.A1980G:p.V660V	KRIT1:NM_001013406:exon15:c.A1836G:p.V612V,KRIT1:NM_001350669:exon15:c.A1836G:p.V612V,KRIT1:NM_001350672:exon15:c.A1980G:p.V660V,KRIT1:NM_001350691:exon15:c.A1980G:p.V660V,KRIT1:NM_001350695:exon15:c.A1980G:p.V660V,KRIT1:NM_001350670:exon16:c.A1836G:p.V612V,KRIT1:NM_001350671:exon16:c.A1266G:p.V422V,KRIT1:NM_001350673:exon16:c.A1980G:p.V660V,KRIT1:NM_001350677:exon16:c.A1980G:p.V660V,KRIT1:NM_001350678:exon16:c.A1980G:p.V660V,KRIT1:NM_001350679:exon16:c.A1980G:p.V660V,KRIT1:NM_001350680:exon16:c.A1980G:p.V660V,KRIT1:NM_001350683:exon16:c.A1980G:p.V660V,KRIT1:NM_001350686:exon16:c.A1980G:p.V660V,KRIT1:NM_001350687:exon16:c.A1980G:p.V660V,KRIT1:NM_001350688:exon16:c.A1980G:p.V660V,KRIT1:NM_001350690:exon16:c.A1980G:p.V660V,KRIT1:NM_001350692:exon16:c.A1980G:p.V660V,KRIT1:NM_001350694:exon16:c.A1980G:p.V660V,KRIT1:NM_001350696:exon16:c.A1980G:p.V660V,KRIT1:NM_001350675:exon17:c.A1980G:p.V660V,KRIT1:NM_001350676:exon17:c.A1980G:p.V660V,KRIT1:NM_001350684:exon17:c.A1980G:p.V660V,KRIT1:NM_001350685:exon17:c.A1980G:p.V660V,KRIT1:NM_001350689:exon17:c.A1980G:p.V660V,KRIT1:NM_001350693:exon17:c.A1980G:p.V660V,KRIT1:NM_004912:exon17:c.A1980G:p.V660V,KRIT1:NM_194454:exon17:c.A1980G:p.V660V,KRIT1:NM_194455:exon17:c.A1980G:p.V660V,KRIT1:NM_001350674:exon18:c.A1980G:p.V660V,KRIT1:NM_001350681:exon18:c.A1980G:p.V660V,KRIT1:NM_001350682:exon18:c.A1980G:p.V660V,KRIT1:NM_001350697:exon18:c.A1980G:p.V660V,KRIT1:NM_194456:exon18:c.A1980G:p.V660V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1289	0.1023	0.180511	1(lung)	.	.	.	.	.	.	.	.	KRIT1:uc010lev.1:exon11:c.A1251G:p.V417V,KRIT1:uc003ulq.1:exon15:c.A1980G:p.V660V,KRIT1:uc003ult.1:exon15:c.A1836G:p.V612V,KRIT1:uc003ulr.1:exon17:c.A1980G:p.V660V,KRIT1:uc003uls.1:exon17:c.A1980G:p.V660V,KRIT1:uc003ulv.1:exon17:c.A1980G:p.V660V,KRIT1:uc003ulu.1:exon18:c.A1980G:p.V660V	.	AFR:2(breast),AMR:1(thyroid),EAS:MU104095,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,THCA-SA|1|243|0.00411523,NFE:0.1188,OTH:0.1241,ASJ:1(large_intestine)	604214	116860;	221061;	221061|Familial brain cavernous angioma<br>Familial brain cavernous hemangioma<br>Familial cerebral cavernoma<br>Hereditary brain cavernous angioma<br>Hereditary brain cavernous hemangioma<br>Hereditary cerebral cavernoma<br>Hereditary cerebral cavernous malformation|1-5 / 10 000|Autosomal dominant|All ages|116860 603284 603285 ~	.	.	.	.	.	.	.	.	7	1(stomach)	0.1181
7	95800820	95800820	T	C	SLC25A13	exonic	synonymous SNV	ENSG00000004864	rs2301629	ENSG00000004864:ENST00000542654:exon11:c.A870G:p.L290L,ENSG00000004864:ENST00000265631:exon12:c.A1194G:p.L398L,ENSG00000004864:ENST00000416240:exon12:c.A1197G:p.L399L	SLC25A13:NM_001160210:exon12:c.A1197G:p.L399L,SLC25A13:NM_014251:exon12:c.A1194G:p.L398L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3958	0.3202	0.409145	0.3492	.	.	.	.	.	.	.	.	SLC25A13:uc011kik.2:exon11:c.A870G:p.L290L,SLC25A13:uc003uof.4:exon12:c.A1194G:p.L398L,SLC25A13:uc003uog.4:exon12:c.A1197G:p.L399L	.	AFR:0.2530,AMR:0.3612,EAS:0.5739,FIN:0.3732,NFE:0.3748,OTH:0.3806,ASJ:0.2450	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU138872	het
7	95864108	95864108	T	C	SLC25A13	intronic	.	ENSG00000004864	rs6957975	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6179	0.6890	0.609824	0.6656	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7499,AMR:0.6481,EAS:0.4595,FIN:0.6518,NFE:0.6430,OTH:0.6328,ASJ:0.7633	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU13094841	het
7	98556962	98556962	C	T	TRRAP	intronic	.	ENSG00000196367	rs41633	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0932	0.0604	0.0888578	0.0732	.	.	.	.	.	0.0001	0.092	.	.	.	AFR:0.0162,AMR:0.1328,EAS:0.2519,FIN:0.0745,NFE:0.0830,OTH:0.0757,ASJ:0.0861	603015	.	.	.	.	.	.	.	.	.	.	.	7	MU813721	het
7	98558880	98558880	G	C	TRRAP	intronic	.	ENSG00000196367	rs160384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9007	0.9160	0.886981	0.9051	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9094,AMR:0.8616,EAS:0.7432,FIN:0.9255,NFE:0.9166,OTH:0.9175,ASJ:0.9139	603015	.	.	.	.	.	.	.	.	.	.	.	7	MU18827407	het
7	98602990	98602990	G	C	TRRAP	intronic	.	ENSG00000196367	rs219838	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1913	0.3107	0.326478	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.2901,AMR:0.6809,EAS:0.1887,FIN:0.2571,NFE:0.1005,OTH:0.1271,ASJ:0.2029	603015	.	.	.	.	.	.	.	.	.	.	.	7	1(bone)	0.15
7	100775188	100775188	G	A	SERPINE1	exonic	nonsynonymous SNV	ENSG00000106366	rs553824895	ENSG00000106366:ENST00000223095:exon4:c.G538A:p.V180M,ENSG00000106366:ENST00000445463:exon5:c.G493A:p.V165M	SERPINE1:NM_000602:exon4:c.G538A:p.V180M	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 2, 0, 0] 	0.0003	.	0.000399361	3.231e-05	1.117	11.31	0.042	2.26	0.148	.	.	Serpin domain	SERPINE1:uc003uxu.2:exon1:c.G31A:p.V11M,SERPINE1:uc003uxt.4:exon4:c.G538A:p.V180M,SERPINE1:uc011kkj.3:exon5:c.G493A:p.V165M	-0.387	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	173360	613329;	465;	465|Congenital PAI-1 deficiency|Unknown|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|613329 ~	.	.	.	.	0.512	-2.07	0.451	2.785	7	MU81632621	het
7	100781084	100781084	T	C	SERPINE1	UTR3	.	ENSG00000106366	rs11178	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	.	.	0.430911	0.4457	.	.	.	.	.	.	.	.	.	.	AFR:0.4956,AMR:0.3246,EAS:0.4598,FIN:0.4218,NFE:0.4270,OTH:0.4327,ASJ:0.5132	173360	613329;	465;	465|Congenital PAI-1 deficiency|Unknown|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|613329 ~	.	.	.	.	.	.	.	.	7	MU87763021	het
7	103138517	103138517	C	G	LOC101927870	ncRNA_intronic	.	ENSG00000234715	rs2711885	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9870	0.9909	0.995607	0.9867	.	.	.	.	.	0	0	.	.	.	AFR:0.9976,AMR:0.9940,EAS:1,FIN:0.9717,NFE:0.9826,OTH:0.9796,ASJ:0.9834	.	.	.	.	.	.	.	.	.	.	.	.	7	MU81837834	hom
7	103155705	103155705	A	G	RELN	exonic	synonymous SNV	ENSG00000189056	rs2229864	ENSG00000189056:ENST00000343529:exon50:c.T8046C:p.H2682H,ENSG00000189056:ENST00000424685:exon50:c.T8046C:p.H2682H,ENSG00000189056:ENST00000428762:exon50:c.T8046C:p.H2682H	RELN:NM_005045:exon50:c.T8046C:p.H2682H,RELN:NM_173054:exon50:c.T8046C:p.H2682H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4722	0.4955	0.648363	0.5053	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon50:c.T8046C:p.H2682H,RELN:uc022ajq.1:exon50:c.T8046C:p.H2682H,RELN:uc022ajr.1:exon50:c.T8046C:p.H2682H	.	AFR:0.7569,AMR:0.4415,EAS:0.7974,FIN:0.3554,NFE:0.3733,OTH:0.4267,ASJ:0.3841	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	MU81837859	het
7	103202407	103202408	AA	-	RELN	intronic	.	ENSG00000189056	rs796599049	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2175	.	.	0.2698	.	.	.	.	.	.	.	.	.	.	AFR:0.2798,AMR:0.2808,EAS:0.1110,FIN:0.2706,NFE:0.2807,OTH:0.2611,ASJ:0.2683	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	.	hom
7	103206001	103206001	-	A	RELN	intronic	.	ENSG00000189056	rs35268159	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3149	0.2705	0.250799	0.2906	.	.	.	.	.	.	.	.	.	.	AFR:0.2923,AMR:0.2361,EAS:0.0761,FIN:0.3735,NFE:0.3034,OTH:0.3082,ASJ:0.2786	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	.	hom
7	103251161	103251161	G	C	RELN	exonic	nonsynonymous SNV	ENSG00000189056	rs362691	ENSG00000189056:ENST00000343529:exon22:c.C2989G:p.L997V,ENSG00000189056:ENST00000424685:exon22:c.C2989G:p.L997V,ENSG00000189056:ENST00000428762:exon22:c.C2989G:p.L997V	RELN:NM_005045:exon22:c.C2989G:p.L997V,RELN:NM_173054:exon22:c.C2989G:p.L997V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1166	0.0969	0.121006	3(haematopoietic_and_lymphoid_tissue)	1.066	11.03	0.594	4.36	0.977	.	.	Galactose-binding domain-like	RELN:uc010liz.3:exon22:c.C2989G:p.L997V,RELN:uc022ajq.1:exon22:c.C2989G:p.L997V,RELN:uc022ajr.1:exon22:c.C2989G:p.L997V	-1.001	AFR:MU12779493,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.0834,FIN:0.1217,NFE:0.0828,OTH:0.1317,ASJ:0.1016	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	0.185	1.99	0.001	0	7	3(soft_tissue)	0.0988
7	103629803	103629803	-	GCCGCC	RELN	UTR5	.	ENSG00000189056	rs55656324	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.0752	.	0.604233	0.5209	.	.	.	.	.	.	.	.	.	.	AFR:0.5162,AMR:0.5628,EAS:0.7892,FIN:0.4903,NFE:0.4968,OTH:0.5691,ASJ:0.4861	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	MU4408439	unknown
7	106508978	106508978	A	G	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849389	ENSG00000105851:ENST00000359195:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000440650:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000496166:exon2:c.A972G:p.P324P	PIK3CG:NM_001282426:exon2:c.A972G:p.P324P,PIK3CG:NM_001282427:exon2:c.A972G:p.P324P,PIK3CG:NM_002649:exon2:c.A972G:p.P324P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9490	0.9174	0.939497	0.9283	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.A972G:p.P324P,PIK3CG:uc003vdv.4:exon2:c.A972G:p.P324P,PIK3CG:uc003vdw.3:exon2:c.A972G:p.P324P	.	AFR:0.8501,AMR:0.9664,EAS:0.9981,FIN:0.9607,NFE:0.9549,OTH:0.9389,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838218	unknown
7	106508987	106508987	T	C	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849390	ENSG00000105851:ENST00000359195:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000440650:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000496166:exon2:c.T981C:p.D327D	PIK3CG:NM_001282426:exon2:c.T981C:p.D327D,PIK3CG:NM_001282427:exon2:c.T981C:p.D327D,PIK3CG:NM_002649:exon2:c.T981C:p.D327D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9502	0.9187	0.940895	0.9295	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.T981C:p.D327D,PIK3CG:uc003vdv.4:exon2:c.T981C:p.D327D,PIK3CG:uc003vdw.3:exon2:c.T981C:p.D327D	.	AFR:0.8507,AMR:0.9665,EAS:0.9981,FIN:0.9613,NFE:0.9568,OTH:0.9420,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838233	unknown
7	107408041	107408041	G	A	SLC26A3	exonic	nonsynonymous SNV	ENSG00000091138	rs776888978	ENSG00000091138:ENST00000422236:exon19:c.C1915T:p.R639C,ENSG00000091138:ENST00000340010:exon20:c.C2254T:p.R752C	SLC26A3:NM_000111:exon20:c.C2254T:p.R752C	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, 1, 0, 0] 	9.193e-05	.	.	2(urinary_tract)	6.018	27.9	0.001	4.64	1.000	.	.	.	SLC26A3:uc003ves.2:exon19:c.C1915T:p.R639C,SLC26A3:uc003ver.2:exon20:c.C2254T:p.R752C	0.965	AFR:1(large_intestine),AMR:MU1779721,EAS:3.23e-05,FIN:0,NFE:0,OTH:0,ASJ:UCEC-US|1|531|0.00188324,STAD-US|1|439|0.0022779,READ-US|1|143|0.00699301,ESCA-CN|1|332|0.00301205,BLCA-CN|1|103|0.00970874	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	1.0	-3.34	0.874	0.695	7	1(oesophagus)	0.0006
7	107414419	107414419	A	G	SLC26A3	exonic	synonymous SNV	ENSG00000091138	rs41669	ENSG00000091138:ENST00000340010:exon17:c.T1953C:p.L651L	SLC26A3:NM_000111:exon17:c.T1953C:p.L651L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9936	0.9916	0.998003	0.9937	.	.	.	.	.	.	.	.	SLC26A3:uc003ver.2:exon17:c.T1953C:p.L651L	.	AFR:0.9974,AMR:0.9928,EAS:1,FIN:0.9977,NFE:0.9899,OTH:0.9939,ASJ:1	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	.	.	.	.	7	MU81838359	hom
7	107416913	107416913	C	T	SLC26A3	exonic	nonsynonymous SNV	ENSG00000091138	rs2301635	ENSG00000091138:ENST00000340010:exon15:c.G1661A:p.R554Q,ENSG00000091138:ENST00000422236:exon15:c.G1556A:p.R519Q	SLC26A3:NM_000111:exon15:c.G1661A:p.R554Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0023	.	0.00359425	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235	2.467	19.26	0.629	3.31	0.641	.	.	STAS domain	SLC26A3:uc003ver.2:exon15:c.G1661A:p.R554Q,SLC26A3:uc003ves.2:exon15:c.G1556A:p.R519Q	-0.933	AFR:0.0013,AMR:0,EAS:0,FIN:0.0228,NFE:0,OTH:0.0001,ASJ:0	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	0.004	-2.45	0.172	0	7	1(lung)	0.0010
7	107423254	107423254	C	T	SLC26A3	exonic	synonymous SNV	ENSG00000091138	rs3735605	ENSG00000091138:ENST00000340010:exon11:c.G1299A:p.A433A,ENSG00000091138:ENST00000422236:exon11:c.G1194A:p.A398A	SLC26A3:NM_000111:exon11:c.G1299A:p.A433A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1581	0.1423	0.150958	0.1361	.	.	.	.	.	.	.	.	SLC26A3:uc003ver.2:exon11:c.G1299A:p.A433A,SLC26A3:uc003ves.2:exon11:c.G1194A:p.A398A	.	AFR:0.0740,AMR:0.1360,EAS:0.2568,FIN:0.1394,NFE:0.1562,OTH:0.1466,ASJ:0.2219	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	.	.	.	.	7	MU138957	het
7	107545799	107545799	T	C	DLD	intronic	.	ENSG00000091140	rs10263341	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6182	0.6485	0.716054	0.6630	.	.	.	.	.	0.0308	0.07	.	.	.	AFR:0.7964,AMR:0.5635,EAS:0.8418,FIN:0.6017,NFE:0.5913,OTH:0.6053,ASJ:0.5728	238331	246900;	2394;765;	2394|DLD deficiency<br>Dihydrolipoamide dehydrogenase deficiency<br>E3-deficient maple syrup urine disease|<1 / 1 000 000|Autosomal recessive|Childhood|246900 ~765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~	.	.	.	.	.	.	.	.	7	MU713564	hom
7	107559722	107559722	A	T	DLD	UTR3	.	ENSG00000091140	rs8721	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3602	0.2976	0.275759	0.3241	.	.	.	.	.	.	.	.	.	.	AFR:0.1185,AMR:0.3592,EAS:0.3259,FIN:0.3862,NFE:0.4233,OTH:0.3765,ASJ:0.37	238331	246900;	2394;765;	2394|DLD deficiency<br>Dihydrolipoamide dehydrogenase deficiency<br>E3-deficient maple syrup urine disease|<1 / 1 000 000|Autosomal recessive|Childhood|246900 ~765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~	.	.	.	.	.	.	.	.	7	MU12787282	het
7	116397572	116397572	A	G	MET	exonic	synonymous SNV	ENSG00000105976	rs13223756	ENSG00000105976:ENST00000436117:exon6:c.A1944G:p.Q648Q,ENSG00000105976:ENST00000318493:exon7:c.A1944G:p.Q648Q,ENSG00000105976:ENST00000397752:exon7:c.A1944G:p.Q648Q	MET:NM_001324402:exon6:c.A654G:p.Q218Q,MET:NM_000245:exon7:c.A1944G:p.Q648Q,MET:NM_001127500:exon7:c.A1944G:p.Q648Q,MET:NM_001324401:exon7:c.A1944G:p.Q648Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1878	0.1687	0.187899	1(lung)	.	.	.	.	.	.	.	.	MET:uc011knd.2:exon6:c.A1944G:p.Q648Q,MET:uc011kne.2:exon6:c.A1860G:p.Q620Q,MET:uc011knf.2:exon6:c.A1944G:p.Q648Q,MET:uc011kng.1:exon6:c.A1944G:p.Q648Q,MET:uc011knh.1:exon6:c.A1944G:p.Q648Q,MET:uc011kni.2:exon6:c.A1944G:p.Q648Q,MET:uc003vij.3:exon7:c.A1944G:p.Q648Q,MET:uc010lkh.3:exon7:c.A1944G:p.Q648Q,MET:uc011knj.2:exon7:c.A654G:p.Q218Q,MET:uc022akk.1:exon7:c.A1944G:p.Q648Q	.	AFR:61(meninges),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526,FIN:0.1720,NFE:0.1247,OTH:0.0993,ASJ:MU12805326	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7487,7492,7503,7485,7500,7493,7499,7496,7502,7489,7504,7491,7495,7490,7498,7488,7486,7497,7501	.	.	.	.	.	.	7	1(biliary_tract)	0.2318
7	116435768	116435768	C	T	MET	exonic	synonymous SNV	ENSG00000105976	rs41736	ENSG00000105976:ENST00000539704:exon6:c.C468T:p.D156D,ENSG00000105976:ENST00000318493:exon20:c.C3912T:p.D1304D,ENSG00000105976:ENST00000397752:exon20:c.C3858T:p.D1286D	MET:NM_001324402:exon19:c.C2568T:p.D856D,MET:NM_000245:exon20:c.C3858T:p.D1286D,MET:NM_001127500:exon20:c.C3912T:p.D1304D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4228	0.3235	0.352236	5(lung)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon20:c.C3858T:p.D1286D,MET:uc010lkh.3:exon20:c.C3912T:p.D1304D,MET:uc011knj.2:exon20:c.C2568T:p.D856D	.	AFR:2(stomach),AMR:2(urinary_tract),EAS:1(large_intestine),FIN:MU118149,NFE:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,OTH:0.3407,ASJ:1(breast)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7487,7492,7503,7485,7500,7493,7499,7496,7502,7489,7504,7491,7495,7490,7498,7488,7486,7497,7501	.	.	.	.	.	.	7	12(meninges)	0.1006
7	116436022	116436022	G	A	MET	exonic	synonymous SNV	ENSG00000105976	rs2023748	ENSG00000105976:ENST00000539704:exon7:c.G627A:p.A209A,ENSG00000105976:ENST00000318493:exon21:c.G4071A:p.A1357A,ENSG00000105976:ENST00000397752:exon21:c.G4017A:p.A1339A	MET:NM_001324402:exon20:c.G2727A:p.A909A,MET:NM_000245:exon21:c.G4017A:p.A1339A,MET:NM_001127500:exon21:c.G4071A:p.A1357A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4245	0.3225	0.353834	3(lung)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon21:c.G4017A:p.A1339A,MET:uc010lkh.3:exon21:c.G4071A:p.A1357A,MET:uc011knj.2:exon21:c.G2727A:p.A909A	.	AFR:1(prostate),AMR:19(soft_tissue),EAS:1(breast),FIN:2(large_intestine),NFE:MU118166,OTH:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505,BRCA-KR|1|50|0.02,ASJ:2(stomach)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7487,7492,7503,7485,7500,7493,7499,7496,7502,7489,7504,7491,7495,7490,7498,7488,7486,7497,7501	.	.	.	.	.	.	7	12(meninges)	0.3420
7	116436097	116436097	G	A	MET	exonic	synonymous SNV	ENSG00000105976	rs41737	ENSG00000105976:ENST00000539704:exon7:c.G702A:p.P234P,ENSG00000105976:ENST00000318493:exon21:c.G4146A:p.P1382P,ENSG00000105976:ENST00000397752:exon21:c.G4092A:p.P1364P	MET:NM_001324402:exon20:c.G2802A:p.P934P,MET:NM_000245:exon21:c.G4092A:p.P1364P,MET:NM_001127500:exon21:c.G4146A:p.P1382P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4248	0.3210	0.354633	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon21:c.G4092A:p.P1364P,MET:uc010lkh.3:exon21:c.G4146A:p.P1382P,MET:uc011knj.2:exon21:c.G2802A:p.P934P	.	AFR:12(meninges),AMR:2(large_intestine),EAS:MU118189,FIN:COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.3428,OTH:0.1030,ASJ:1(breast)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7487,7492,7503,7485,7500,7493,7499,7496,7502,7489,7504,7491,7495,7490,7498,7488,7486,7497,7501	.	.	.	.	.	.	7	19(soft_tissue)	0.4761
7	117199533	117199533	G	A	CFTR	exonic	nonsynonymous SNV	ENSG00000001626	rs213950	ENSG00000001626:ENST00000426809:exon10:c.G1318A:p.V440M,ENSG00000001626:ENST00000454343:exon10:c.G1225A:p.V409M,ENSG00000001626:ENST00000003084:exon11:c.G1408A:p.V470M	CFTR:NM_000492:exon11:c.G1408A:p.V470M	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4829	0.5976	0.582069	1(large_intestine)	1.458	13.09	1.0	3.05	0.996	.	.	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	CFTR:uc003vjd.3:exon11:c.G1408A:p.V470M	-0.948	AFR:MU155975,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.8655,FIN:0.5431,NFE:0.2848,OTH:0.4282,ASJ:0.5815	602421	167800;211400;219700;277180;	48;586;60033;676;	48|Congenital bilateral agenesis of vas deferens<br>Congenital bilateral aplasia of vas deferens|1-5 / 10 000|X-linked recessive<br>or&nbsp;Autosomal recessive|Adolescent<br>Adult|277180 300985 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~60033|-|-|-|-|211400 613021 613071 ~676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	0.0	-3.39	0.000	0.14	7	4(lung)	0.5529
7	117235055	117235055	T	G	CFTR	exonic	synonymous SNV	ENSG00000001626	rs1042077	ENSG00000001626:ENST00000426809:exon14:c.T2472G:p.T824T,ENSG00000001626:ENST00000454343:exon14:c.T2379G:p.T793T,ENSG00000001626:ENST00000003084:exon15:c.T2562G:p.T854T	CFTR:NM_000492:exon15:c.T2562G:p.T854T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3889	0.4028	0.479233	MU4566070	.	.	.	.	.	.	.	.	CFTR:uc003vjd.3:exon15:c.T2562G:p.T854T,CFTR:uc011knq.2:exon15:c.T780G:p.T260T	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4486,EAS:0.4510,FIN:0.1722,NFE:0.4297,OTH:0.4198,ASJ:0.6375	602421	167800;211400;219700;277180;	48;586;60033;676;	48|Congenital bilateral agenesis of vas deferens<br>Congenital bilateral aplasia of vas deferens|1-5 / 10 000|X-linked recessive<br>or&nbsp;Autosomal recessive|Adolescent<br>Adult|277180 300985 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~60033|-|-|-|-|211400 613021 613071 ~676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	2(haematopoietic_and_lymphoid_tissue)	0.3533
7	124499002	124499002	A	C	POT1	intronic	.	ENSG00000128513	rs6977407	ENSG00000128513:ENST00000487564:exon2:c.T201G:p.Y67X	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5903	0.0976	0.582069	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	0.434	6.906	.	-7.16	0.210	.	.	.	.	.	AFR:0.5920,AMR:0.6336,EAS:0.5772,FIN:0.4887,NFE:0.5055,OTH:0.6043,ASJ:0.5310	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.5710
7	124499003	124499003	T	A	POT1	intronic	.	ENSG00000128513	rs6959712	ENSG00000128513:ENST00000487564:exon2:c.A200T:p.Y67F	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5901	0.1507	0.582468	0.5920	0.678	8.682	.	1.56	0.325	0.0002	0.078	.	.	.	AFR:0.6339,AMR:0.5310,EAS:0.4893,FIN:0.5043,NFE:0.6043,OTH:0.5710,ASJ:0.5772	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	MU787028	unknown
7	127250907	127250907	T	C	PAX4	exonic	stoploss	ENSG00000106331	rs712700	ENSG00000106331:ENST00000378740:exon10:c.A1022G:p.X341W	PAX4:NM_001366111:exon10:c.A1046G:p.X349W	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7632	.	0.669329	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	0.746	9.126	.	1.4	0.731	.	.	.	PAX4:uc003vmg.1:exon10:c.A1022G:p.X341W	.	AFR:0.7255,AMR:0.7065,EAS:0.8676,FIN:0.3628,NFE:0.7340,OTH:0.7704,ASJ:0.7220	167413	125853;612225;612227;	552;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~	.	.	.	.	.	.	.	.	7	1(thyroid)	0.7362
7	127251188	127251188	T	G	PAX4	exonic	nonsynonymous SNV	ENSG00000106331	rs712701	ENSG00000106331:ENST00000463946:exon8:c.A956C:p.H319P,ENSG00000106331:ENST00000341640:exon9:c.A962C:p.H321P	PAX4:NM_001366110:exon12:c.A986C:p.H329P	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7578	0.7689	0.670527	0.7266	-1.141	0.008	0.408	-3.35	0.000	.	.	.	PAX4:uc003vmf.2:exon8:c.A956C:p.H319P,PAX4:uc010lld.1:exon9:c.A962C:p.H321P	-0.966	AFR:0.7089,AMR:0.7220,EAS:0.3638,FIN:0.7345,NFE:0.7708,OTH:0.7347,ASJ:0.8676	167413	125853;612225;612227;	552;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~	.	.	.	.	0.0	-3.33	0.000	.	7	MU25588339	hom
7	128846328	128846328	G	C	SMO	exonic	synonymous SNV	ENSG00000128602	rs2228617	ENSG00000128602:ENST00000462420:exon3:c.G246C:p.G82G,ENSG00000128602:ENST00000249373:exon6:c.G1164C:p.G388G	SMO:NM_005631:exon6:c.G1164C:p.G388G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7975	0.7896	0.75619	0.7929	.	.	.	.	.	.	.	.	SMO:uc003vos.3:exon2:c.G189C:p.G63G,SMO:uc003vor.3:exon6:c.G1164C:p.G388G	.	AFR:0.6895,AMR:0.7721,EAS:0.7674,FIN:0.8099,NFE:0.8520,OTH:0.7837,ASJ:0.8709	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9748,9806,9805,9804	.	.	.	.	.	.	7	MU802754	het
7	137593139	137593139	A	G	CREB3L2	exonic	synonymous SNV	ENSG00000182158	rs60325918	ENSG00000182158:ENST00000330387:exon5:c.T627C:p.S209S,ENSG00000182158:ENST00000456390:exon5:c.T627C:p.S209S	CREB3L2:NM_001318246:exon5:c.T438C:p.S146S,CREB3L2:NM_194071:exon5:c.T627C:p.S209S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0763	0.0767	0.0742812	0.0714	.	.	.	.	.	.	.	.	CREB3L2:uc003vtv.3:exon5:c.T438C:p.S146S,CREB3L2:uc003vtw.3:exon5:c.T627C:p.S209S,CREB3L2:uc003vtx.2:exon5:c.T627C:p.S209S,CREB3L2:uc031szf.1:exon6:c.T438C:p.S146S	.	AFR:0.2126,AMR:0.0334,EAS:0,FIN:0.0146,NFE:0.0167,OTH:0.0205,ASJ:0.0298	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	7	.	het
7	137600690	137600690	C	T	CREB3L2	exonic	nonsynonymous SNV	ENSG00000182158	rs273957	ENSG00000182158:ENST00000330387:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000420629:exon3:c.G367A:p.V123I,ENSG00000182158:ENST00000452463:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000456390:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000458726:exon3:c.G199A:p.V67I	CREB3L2:NM_001253775:exon3:c.G388A:p.V130I,CREB3L2:NM_001318246:exon3:c.G199A:p.V67I,CREB3L2:NM_194071:exon3:c.G388A:p.V130I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6893	0.7151	0.804313	0.7149	-0.089	1.817	1.0	5.01	0.525	.	.	.	CREB3L2:uc003vtv.3:exon3:c.G199A:p.V67I,CREB3L2:uc003vtw.3:exon3:c.G388A:p.V130I,CREB3L2:uc003vtx.2:exon3:c.G388A:p.V130I,CREB3L2:uc003vty.4:exon3:c.G388A:p.V130I,CREB3L2:uc031szf.1:exon4:c.G199A:p.V67I	-0.976	AFR:0.9201,AMR:0.7662,EAS:0.9227,FIN:0.5615,NFE:0.6136,OTH:0.6268,ASJ:0.6093	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	0.0	0.42	0.000	-1.67	7	MU641291	hom
7	137612914	137612916	TGG	-	CREB3L2	exonic	nonframeshift deletion	ENSG00000182158	rs3217268	ENSG00000182158:ENST00000420629:exon1:c.100_102del:p.34_34del,ENSG00000182158:ENST00000330387:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000452463:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000456390:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000458726:exon2:c.110_112del:p.37_38del	CREB3L2:NM_001253775:exon2:c.299_301del:p.100_101del,CREB3L2:NM_001318246:exon2:c.110_112del:p.37_38del,CREB3L2:NM_194071:exon2:c.299_301del:p.100_101del	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6918	0.6397	0.690695	0.6404	.	.	.	.	.	.	.	.	CREB3L2:uc003vtv.3:exon2:c.110_112del:p.37_38del,CREB3L2:uc003vtw.3:exon2:c.299_301del:p.100_101del,CREB3L2:uc003vtx.2:exon2:c.299_301del:p.100_101del,CREB3L2:uc003vty.4:exon2:c.299_301del:p.100_101del,CREB3L2:uc031szf.1:exon3:c.110_112del:p.37_38del	.	AFR:0.6728,AMR:0.7319,EAS:0.8470,FIN:0.6195,NFE:0.6021,OTH:0.6299,ASJ:0.52	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	7	MU28483034	het
7	138145778	138145778	C	T	TRIM24	intronic	.	ENSG00000122779	rs112619223	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4196	.	0.243011	0.3171	.	.	.	.	.	.	.	.	.	.	AFR:0.4192,AMR:0.2027,EAS:0.0012,FIN:0.2593,NFE:0.3127,OTH:0.2676,ASJ:0.4636	603406	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	138200117	138200117	A	T	TRIM24	intronic	.	ENSG00000122779	rs3757381	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7660	0.8246	0.71905	0.7838	.	.	.	.	.	.	.	.	.	.	AFR:0.8205,AMR:0.7333,EAS:0.5149,FIN:0.7665,NFE:0.7985,OTH:0.7551,ASJ:0.8633	603406	.	.	.	.	.	.	.	.	.	.	.	7	MU12863507	het
7	140449071	140449071	C	G	BRAF	intronic	.	ENSG00000157764	rs3789806	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2095	0.3159	0.348043	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.2936,AMR:0.6643,EAS:0.1987,FIN:0.2067,NFE:0.1512,OTH:0.1408,ASJ:0.1124	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04150 mTOR signaling pathway~ko04214 Apoptosis - fly~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	5(large_intestine)	0.1677
7	140449150	140449150	T	C	BRAF	exonic	synonymous SNV	ENSG00000157764	rs9648696	ENSG00000157764:ENST00000479537:exon3:c.A213G:p.G71G,ENSG00000157764:ENST00000288602:exon16:c.A1929G:p.G643G	BRAF:NM_001354609:exon16:c.A1929G:p.G643G,BRAF:NM_004333:exon16:c.A1929G:p.G643G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2124	0.3200	0.351038	5(large_intestine)	.	.	.	.	.	.	.	.	BRAF:uc003vwc.4:exon16:c.A1929G:p.G643G	.	AFR:MU4566697,AMR:ESAD-UK|1|409|0.00244499,COCA-CN|3|321|0.00934579,EAS:0.6694,FIN:0.1172,NFE:0.2086,OTH:0.2079,ASJ:0.2960	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04150 mTOR signaling pathway~ko04214 Apoptosis - fly~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,1174,1217,1223,1181,1212,1180,1175,1189,1176,1222,1213,1218,1219,1168,1203,1214,1165,1166,1184,1207,996,1197,1177,1201,1178,1196,1188,1182,1192,1216,1170,1225,1169,1171,1187,1186,1224,1227,1199,1228,1209,1179,1195,1194,1221,1183,1190,1210,1208,1246,1172,1191,1202,1205,1215,1229,1193,1211,1200,1220,1206,1185,1226,1167,1173,1198,1204	.	1230,1231,1232,	.	.	.	.	7	3(meninges)	0.1509
7	147183143	147183143	A	G	CNTNAP2	intronic	.	ENSG00000174469	rs2286127	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2255	0.1897	0.274561	MU587631	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.2054,EAS:0.3289,FIN:0.1192,NFE:0.3758,OTH:0.1778,ASJ:0.2401	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(stomach)	0.1689
7	147926734	147926734	A	G	CNTNAP2	intronic	.	ENSG00000174469	rs3779031	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2116	0.1615	0.221446	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	0	0.002	.	.	.	AFR:0.1909,AMR:0.1439,EAS:0.1,FIN:0.3366,NFE:0.2577,OTH:0.1802,ASJ:0.3254	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.2067
7	147926888	147926888	A	C	CNTNAP2	intronic	.	ENSG00000174469	rs3779032	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3755	0.4165	0.360224	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3922,AMR:0.4085,EAS:0.3133,FIN:0.3313,NFE:0.3903,OTH:0.3979,ASJ:0.2962	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3724
7	148106475	148106475	-	TT	CNTNAP2	intronic	.	ENSG00000174469	rs397782655	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5027	.	0.547923	0.5785	.	.	.	.	.	.	.	.	.	.	AFR:0.6489,AMR:0.2978,EAS:0.3658,FIN:0.6574,NFE:0.5600,OTH:0.5898,ASJ:0.3924	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU114278353	unknown
7	148106477	148106477	-	TG	CNTNAP2	intronic	.	ENSG00000174469	rs374969707	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5143	.	0.547923	0.5865	.	.	.	.	.	.	.	.	.	.	AFR:0.6502,AMR:0.3034,EAS:0.3666,FIN:0.6578,NFE:0.5737,OTH:0.6,ASJ:0.4053	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU114270516	unknown
7	148106490	148106490	G	A	CNTNAP2	exonic	unknown	ENSG00000174469	rs9648691	ENSG00000174469:ENST00000538075:exon8:c.G900A:p.A300A,ENSG00000174469:ENST00000361727:exon23:c.G3723A:p.A1241A	UNKNOWN	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5407	0.5850	0.549121	0.5892	.	.	.	.	.	.	.	.	CNTNAP2:uc003wev.2:exon3:c.G54A:p.A18A,CNTNAP2:uc003weu.2:exon23:c.G3723A:p.A1241A	.	AFR:0.6502,AMR:0.3081,EAS:0.3694,FIN:0.6578,NFE:0.5783,OTH:0.6066,ASJ:0.4321	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU119103	unknown
7	148514332	148514332	C	T	EZH2	exonic	synonymous SNV	ENSG00000106462	rs202179686	ENSG00000106462:ENST00000350995:exon10:c.G1260A:p.G420G,ENSG00000106462:ENST00000320356:exon11:c.G1392A:p.G464G,ENSG00000106462:ENST00000460911:exon11:c.G1377A:p.G459G,ENSG00000106462:ENST00000476773:exon11:c.G1350A:p.G450G,ENSG00000106462:ENST00000483967:exon11:c.G1350A:p.G450G,ENSG00000106462:ENST00000541220:exon11:c.G1350A:p.G450G,ENSG00000106462:ENST00000478654:exon12:c.G1350A:p.G450G	EZH2:NM_152998:exon10:c.G1260A:p.G420G,EZH2:NM_001203247:exon11:c.G1377A:p.G459G,EZH2:NM_001203248:exon11:c.G1350A:p.G450G,EZH2:NM_001203249:exon11:c.G1350A:p.G450G,EZH2:NM_004456:exon11:c.G1392A:p.G464G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0003	.	0.000199681	.	.	.	.	.	.	.	.	.	EZH2:uc022aov.1:exon9:c.G1260A:p.G420G,EZH2:uc003wfc.2:exon10:c.G1260A:p.G420G,EZH2:uc003wfb.2:exon11:c.G1392A:p.G464G,EZH2:uc003wfd.2:exon11:c.G1377A:p.G459G,EZH2:uc011kug.2:exon11:c.G1350A:p.G450G,EZH2:uc011kuh.2:exon11:c.G1350A:p.G450G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601573	277590;	3447;	3447|Camptodactyly-overgrowth-unusual facies syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|277590 ~	.	4882,,4871,4880,4878,4873	.	,4874,4876,4881,4875,4879,4877	.	.	.	.	7	MU129087532	het
7	148543694	148543694	A	-	EZH2	intronic	.	ENSG00000106462	rs3214332	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7134	.	0.761182	0.7479	.	.	.	.	.	.	.	.	.	.	AFR:0.9272,AMR:0.7404,EAS:0.6804,FIN:0.6355,NFE:0.6781,OTH:0.6721,ASJ:0.6926	601573	277590;	3447;	3447|Camptodactyly-overgrowth-unusual facies syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|277590 ~	.	.	.	.	.	.	.	.	7	.	het
7	150648198	150648198	A	G	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1137617	ENSG00000055118:ENST00000330883:exon4:c.T936C:p.Y312Y,ENSG00000055118:ENST00000392968:exon6:c.T1668C:p.Y556Y,ENSG00000055118:ENST00000262186:exon8:c.T1956C:p.Y652Y,ENSG00000055118:ENST00000430723:exon8:c.T1956C:p.Y652Y	KCNH2:NM_001204798:exon4:c.T936C:p.Y312Y,KCNH2:NM_172057:exon4:c.T936C:p.Y312Y,KCNH2:NM_000238:exon8:c.T1956C:p.Y652Y,KCNH2:NM_172056:exon8:c.T1956C:p.Y652Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6658	0.6905	0.772165	0.7031	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon4:c.T936C:p.Y312Y,KCNH2:uc003wid.3:exon4:c.T936C:p.Y312Y,KCNH2:uc011kux.2:exon6:c.T1668C:p.Y556Y,KCNH2:uc003wic.3:exon8:c.T1956C:p.Y652Y,KCNH2:uc003wie.3:exon8:c.T1956C:p.Y652Y	.	AFR:0.8883,AMR:0.6766,EAS:0.9021,FIN:0.6263,NFE:0.6004,OTH:0.6222,ASJ:0.61	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU4567794	het
7	150648789	150648789	T	C	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1805121	ENSG00000055118:ENST00000330883:exon3:c.A672G:p.L224L,ENSG00000055118:ENST00000392968:exon5:c.A1404G:p.L468L,ENSG00000055118:ENST00000262186:exon7:c.A1692G:p.L564L,ENSG00000055118:ENST00000430723:exon7:c.A1692G:p.L564L	KCNH2:NM_001204798:exon3:c.A672G:p.L224L,KCNH2:NM_172057:exon3:c.A672G:p.L224L,KCNH2:NM_000238:exon7:c.A1692G:p.L564L,KCNH2:NM_172056:exon7:c.A1692G:p.L564L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4786	0.4894	0.608427	0.5247	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon3:c.A672G:p.L224L,KCNH2:uc003wid.3:exon3:c.A672G:p.L224L,KCNH2:uc011kux.2:exon5:c.A1404G:p.L468L,KCNH2:uc003wic.3:exon7:c.A1692G:p.L564L,KCNH2:uc003wie.3:exon7:c.A1692G:p.L564L	.	AFR:0.7417,AMR:0.5263,EAS:0.8605,FIN:0.4644,NFE:0.3836,OTH:0.4491,ASJ:0.3808	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU4567796	het
7	150649531	150649531	G	A	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1805120	ENSG00000055118:ENST00000330883:exon2:c.C519T:p.F173F,ENSG00000055118:ENST00000392968:exon4:c.C1251T:p.F417F,ENSG00000055118:ENST00000262186:exon6:c.C1539T:p.F513F,ENSG00000055118:ENST00000430723:exon6:c.C1539T:p.F513F	KCNH2:NM_001204798:exon2:c.C519T:p.F173F,KCNH2:NM_172057:exon2:c.C519T:p.F173F,KCNH2:NM_000238:exon6:c.C1539T:p.F513F,KCNH2:NM_172056:exon6:c.C1539T:p.F513F	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2935	0.2264	0.341653	0.2667	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon2:c.C519T:p.F173F,KCNH2:uc003wid.3:exon2:c.C519T:p.F173F,KCNH2:uc011kux.2:exon4:c.C1251T:p.F417F,KCNH2:uc003wic.3:exon6:c.C1539T:p.F513F,KCNH2:uc003wie.3:exon6:c.C1539T:p.F513F	.	AFR:0.2454,AMR:0.3756,EAS:0.6539,FIN:0.2964,NFE:0.2223,OTH:0.2838,ASJ:0.3113	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU736249	het
7	150649603	150649603	G	A	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs740952	ENSG00000055118:ENST00000330883:exon2:c.C447T:p.I149I,ENSG00000055118:ENST00000392968:exon4:c.C1179T:p.I393I,ENSG00000055118:ENST00000262186:exon6:c.C1467T:p.I489I,ENSG00000055118:ENST00000430723:exon6:c.C1467T:p.I489I	KCNH2:NM_001204798:exon2:c.C447T:p.I149I,KCNH2:NM_172057:exon2:c.C447T:p.I149I,KCNH2:NM_000238:exon6:c.C1467T:p.I489I,KCNH2:NM_172056:exon6:c.C1467T:p.I489I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2929	0.2302	0.342652	0.2687	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon2:c.C447T:p.I149I,KCNH2:uc003wid.3:exon2:c.C447T:p.I149I,KCNH2:uc011kux.2:exon4:c.C1179T:p.I393I,KCNH2:uc003wic.3:exon6:c.C1467T:p.I489I,KCNH2:uc003wie.3:exon6:c.C1467T:p.I489I	.	AFR:0.2551,AMR:0.3786,EAS:0.6472,FIN:0.2887,NFE:0.2231,OTH:0.2853,ASJ:0.3146	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU18877935	het
7	151842397	151842397	C	T	KMT2C	intronic	.	ENSG00000055609	rs2240819	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0713	0.1166	0.158347	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	.	.	AFR:0.1116,AMR:0.3167,EAS:0.0265,FIN:0.1501,NFE:0.0240,OTH:0.0173,ASJ:0.0766	606833	.	.	.	.	.	.	.	.	.	.	.	7	13(meninges)	0.0397
7	151873853	151873853	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs6464211	ENSG00000055609:ENST00000262189:exon38:c.G8685A:p.Q2895Q,ENSG00000055609:ENST00000355193:exon38:c.G8685A:p.Q2895Q	KMT2C:NM_170606:exon38:c.G8685A:p.Q2895Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2494	0.3412	0.382788	SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	KMT2C:uc003wky.3:exon1:c.G1212A:p.Q404Q,KMT2C:uc003wkz.3:exon24:c.G5868A:p.Q1956Q,KMT2C:uc003wla.3:exon38:c.G8685A:p.Q2895Q	.	AFR:0.3452,AMR:0.6988,EAS:0.2384,FIN:0.2983,NFE:0.2690,OTH:0.1798,ASJ:0.2188	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	6(large_intestine)	0.2281
7	151874498	151874498	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs10252263	ENSG00000055609:ENST00000262189:exon38:c.G8040A:p.Q2680Q,ENSG00000055609:ENST00000355193:exon38:c.G8040A:p.Q2680Q	KMT2C:NM_170606:exon38:c.G8040A:p.Q2680Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0705	0.1165	0.158147	14(meninges)	.	.	.	.	.	.	.	.	KMT2C:uc003wky.3:exon1:c.G567A:p.Q189Q,KMT2C:uc003wkz.3:exon24:c.G5223A:p.Q1741Q,KMT2C:uc003wla.3:exon38:c.G8040A:p.Q2680Q	.	AFR:MU18879409,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.3165,FIN:0.0764,NFE:0.0265,OTH:0.1508,ASJ:0.1117	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(soft_tissue)	0.0241
7	151875101	151875109	AAAAAAAAA	-	KMT2C	intronic	.	ENSG00000055609	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606833	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	151875110	151875110	A	T	KMT2C	intronic	.	ENSG00000055609	rs766061933	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0013	.	.	0.0067	.	.	.	.	.	.	.	.	.	.	AFR:0.0226,AMR:0.0019,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	606833	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	151927021	151927021	C	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs28522267	ENSG00000055609:ENST00000262189:exon18:c.G2963T:p.C988F,ENSG00000055609:ENST00000355193:exon18:c.G2963T:p.C988F	KMT2C:NM_170606:exon18:c.G2963T:p.C988F	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.1065	.	.	20(upper_aerodigestive_tract)	7.018	33	0.0	4.67	1.000	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	KMT2C:uc003wkz.3:exon4:c.G146T:p.C49F,KMT2C:uc003wla.3:exon18:c.G2963T:p.C988F	0.852	AFR:24(central_nervous_system),AMR:3(thyroid),EAS:MU587659,FIN:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,NFE:0.4338,OTH:0.4036,ASJ:2(bone)	606833	.	.	.	.	.	.	,6806	0.999	-8.15	0.996	2.495	7	22(soft_tissue)	0.3934
7	151927026	151927026	T	C	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs28439884	ENSG00000055609:ENST00000262189:exon18:c.A2958G:p.P986P,ENSG00000055609:ENST00000355193:exon18:c.A2958G:p.P986P	KMT2C:NM_170606:exon18:c.A2958G:p.P986P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1156	.	.	1(stomach)	.	.	.	.	.	.	.	.	KMT2C:uc003wkz.3:exon4:c.A141G:p.P47P,KMT2C:uc003wla.3:exon18:c.A2958G:p.P986P	.	AFR:1(upper_aerodigestive_tract),AMR:6(central_nervous_system),EAS:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,FIN:0.4317,NFE:0.4026,OTH:0.3909,ASJ:MU587660	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(thyroid)	0.3976
7	151927127	151927127	A	G	KMT2C	intronic	.	ENSG00000055609	rs62481502	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4893	.	.	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU587661,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.2777,FIN:0.3209,NFE:0.2929,OTH:0.4236,ASJ:0.3394	606833	.	.	.	.	.	.	.	.	.	.	.	7	1(stomach)	0.3022
7	151932908	151932908	T	C	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs112326730	ENSG00000055609:ENST00000262189:exon16:c.A2763G:p.L921L,ENSG00000055609:ENST00000355193:exon16:c.A2763G:p.L921L	KMT2C:NM_170606:exon16:c.A2763G:p.L921L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4790	.	.	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon16:c.A2763G:p.L921L	.	AFR:0.4823,AMR:0.4838,EAS:0.4857,FIN:0.4936,NFE:0.4439,OTH:0.4894,ASJ:0.4512	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	1(liver)	0.4753
7	151935853	151935853	T	C	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs4024420	ENSG00000055609:ENST00000262189:exon15:c.A2591G:p.E864G,ENSG00000055609:ENST00000355193:exon15:c.A2591G:p.E864G	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1442	.	.	MU67451171	4.196	23.9	0.077	5.53	1.000	.	.	.	KMT2C:uc003wla.3:exon15:c.A2591G:p.E864G	-0.013	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,AMR:0.2000,EAS:0.1244,FIN:0.2075,NFE:0.2175,OTH:0.0686,ASJ:0.1680	606833	.	.	.	.	.	.	,6806	0.986	-2.06	0.585	1.95	7	2(haematopoietic_and_lymphoid_tissue)	0.2686
7	151945007	151945007	C	T	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs2479172	ENSG00000055609:ENST00000262189:exon14:c.G2512A:p.G838S,ENSG00000055609:ENST00000355193:exon14:c.G2512A:p.G838S	KMT2C:NM_170606:exon14:c.G2512A:p.G838S	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4944	.	.	1(large_intestine)	6.636	32	0.003	5.67	1.000	.	.	.	KMT2C:uc003wla.3:exon14:c.G2512A:p.G838S	-0.835	AFR:3(bone),AMR:MU31381223,EAS:0.4950,FIN:0.4995,NFE:0.5,OTH:0.4927,ASJ:SKCA-BR|1|100|0.01,COCA-CN|6|321|0.0186916	606833	.	.	.	.	.	.	,6806	1.0	-2.3	0.230	2.075	7	3(prostate)	0.4981
7	151949068	151949068	C	G	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs3735156	ENSG00000055609:ENST00000262189:exon11:c.G1577C:p.R526P,ENSG00000055609:ENST00000355193:exon11:c.G1577C:p.R526P,ENSG00000055609:ENST00000558084:exon11:c.G1577C:p.R526P	KMT2C:NM_170606:exon11:c.G1577C:p.R526P	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.0768	0.1642	0.180911	1(soft_tissue)	1.927	15.75	1.0	5.75	0.972	.	.	.	KMT2C:uc003wla.3:exon11:c.G1577C:p.R526P	-0.998	AFR:MU813118,AMR:COCA-CN|1|321|0.00311526,EAS:0.4621,FIN:0.0835,NFE:0.0199,OTH:0.0783,ASJ:0.1483	606833	.	.	.	.	.	.	,6806	0.0	-1.66	0.000	-1.795	7	14(meninges)	0.0238
7	151970856	151970856	T	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs10454320	ENSG00000055609:ENST00000262189:exon7:c.A946T:p.T316S,ENSG00000055609:ENST00000355193:exon7:c.A946T:p.T316S,ENSG00000055609:ENST00000558084:exon7:c.A946T:p.T316S	KMT2C:NM_170606:exon7:c.A946T:p.T316S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5276	.	.	1(bone)	3.363	22.9	0.415	3.71	0.842	.	.	Extended PHD (ePHD) domain|Zinc finger, PHD-type	KMT2C:uc003wla.3:exon7:c.A946T:p.T316S	-0.940	AFR:MU4218242,AMR:COCA-CN|5|321|0.0155763,EAS:0.4998,FIN:0.4988,NFE:0.4892,OTH:0.5006,ASJ:0.4945	606833	.	.	.	.	.	.	,6806	0.684	-0.5	0.162	1.15	7	2(kidney)	0.5
7	154760369	154760369	A	G	PAXIP1	exonic	synonymous SNV	ENSG00000157212	rs935037	ENSG00000157212:ENST00000397192:exon7:c.T1542C:p.L514L,ENSG00000157212:ENST00000404141:exon7:c.T1542C:p.L514L	PAXIP1:NM_007349:exon7:c.T1542C:p.L514L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5995	0.5959	0.615415	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PAXIP1:uc003wlr.1:exon3:c.T1269C:p.L423L,PAXIP1:uc022aqi.1:exon5:c.T1434C:p.L478L,PAXIP1:uc022aqf.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqg.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqh.1:exon8:c.T1440C:p.L480L	.	AFR:0.5835,AMR:0.5346,EAS:0.6324,FIN:0.5944,NFE:0.6474,OTH:0.5861,ASJ:0.7356	608254	.	.	.	.	.	.	.	.	.	.	.	7	1(thyroid)	0.5869
8	6272399	6272399	G	T	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2305022	ENSG00000147316:ENST00000344683:exon3:c.G228T:p.V76V,ENSG00000147316:ENST00000519480:exon3:c.G228T:p.V76V,ENSG00000147316:ENST00000522905:exon3:c.G228T:p.V76V	MCPH1:NM_001172574:exon3:c.G228T:p.V76V,MCPH1:NM_001172575:exon3:c.G228T:p.V76V,MCPH1:NM_001322042:exon3:c.G228T:p.V76V,MCPH1:NM_001322043:exon3:c.G222T:p.V74V,MCPH1:NM_001322045:exon3:c.G126T:p.V42V,MCPH1:NM_001363979:exon3:c.G228T:p.V76V,MCPH1:NM_001363980:exon3:c.G228T:p.V76V,MCPH1:NM_024596:exon3:c.G228T:p.V76V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.6980	0.678115	0.7172	.	.	.	.	.	.	.	.	MCPH1:uc003wqh.3:exon3:c.G228T:p.V76V,MCPH1:uc003wqi.3:exon3:c.G228T:p.V76V,MCPH1:uc011kwl.2:exon3:c.G228T:p.V76V	.	AFR:0.4414,AMR:0.8189,EAS:0.7833,FIN:0.8881,NFE:0.8188,OTH:0.8033,ASJ:0.6954	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU18893251	hom
8	6296550	6296550	G	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2442513	ENSG00000147316:ENST00000344683:exon6:c.G513T:p.R171S,ENSG00000147316:ENST00000519480:exon6:c.G513T:p.R171S	MCPH1:NM_001172574:exon6:c.G513T:p.R171S,MCPH1:NM_001322042:exon6:c.G513T:p.R171S,MCPH1:NM_001322043:exon6:c.G507T:p.R169S,MCPH1:NM_001322045:exon6:c.G411T:p.R137S,MCPH1:NM_001363979:exon6:c.G513T:p.R171S,MCPH1:NM_001363980:exon6:c.G513T:p.R171S,MCPH1:NM_024596:exon6:c.G513T:p.R171S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9662	0.9251	0.916933	0.9276	-1.150	0.008	0.857	-4.59	0.012	.	.	BRCT domain	MCPH1:uc003wqh.3:exon6:c.G513T:p.R171S,MCPH1:uc003wqi.3:exon6:c.G513T:p.R171S	-1.032	AFR:0.7806,AMR:0.9797,EAS:0.9889,FIN:0.9865,NFE:0.9859,OTH:0.9695,ASJ:0.9768	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	3.78	0.000	-1.355	8	MU81846801	hom
8	6302154	6302154	G	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2083914	ENSG00000147316:ENST00000522905:exon7:c.G767T:p.R256I,ENSG00000147316:ENST00000344683:exon8:c.G911T:p.R304I,ENSG00000147316:ENST00000519480:exon8:c.G911T:p.R304I	MCPH1:NM_001172575:exon7:c.G767T:p.R256I,MCPH1:NM_001172574:exon8:c.G911T:p.R304I,MCPH1:NM_001322042:exon8:c.G911T:p.R304I,MCPH1:NM_001322043:exon8:c.G905T:p.R302I,MCPH1:NM_001322045:exon8:c.G809T:p.R270I,MCPH1:NM_001363979:exon8:c.G911T:p.R304I,MCPH1:NM_001363980:exon8:c.G911T:p.R304I,MCPH1:NM_024596:exon8:c.G911T:p.R304I	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 1, 0, 0] 	0.1153	0.1182	0.0702875	0.0964	2.357	18.54	0.008	-2.24	0.000	.	.	.	MCPH1:uc011kwl.2:exon7:c.G767T:p.R256I,MCPH1:uc003wqh.3:exon8:c.G911T:p.R304I,MCPH1:uc003wqi.3:exon8:c.G911T:p.R304I	-1.055	AFR:0.0426,AMR:0.0895,EAS:0.0105,FIN:0.0674,NFE:0.1398,OTH:0.1125,ASJ:0.2567	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.996	2.62	0.000	2.045	8	.	het
8	6302183	6302183	G	C	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs930557	ENSG00000147316:ENST00000522905:exon7:c.G796C:p.D266H,ENSG00000147316:ENST00000344683:exon8:c.G940C:p.D314H,ENSG00000147316:ENST00000519480:exon8:c.G940C:p.D314H	MCPH1:NM_001172575:exon7:c.G796C:p.D266H,MCPH1:NM_001172574:exon8:c.G940C:p.D314H,MCPH1:NM_001322042:exon8:c.G940C:p.D314H,MCPH1:NM_001322043:exon8:c.G934C:p.D312H,MCPH1:NM_001322045:exon8:c.G838C:p.D280H,MCPH1:NM_001363979:exon8:c.G940C:p.D314H,MCPH1:NM_001363980:exon8:c.G940C:p.D314H,MCPH1:NM_024596:exon8:c.G940C:p.D314H	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.7714	0.6758	0.644768	0.6908	3.901	23.5	0.056	2.68	0.032	.	.	.	MCPH1:uc011kwl.2:exon7:c.G796C:p.D266H,MCPH1:uc003wqh.3:exon8:c.G940C:p.D314H,MCPH1:uc003wqi.3:exon8:c.G940C:p.D314H	-1.055	AFR:0.3336,AMR:0.8222,EAS:0.7984,FIN:0.8821,NFE:0.8270,OTH:0.8092,ASJ:0.6933	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	1.0	2.69	0.000	2.125	8	MU18893493	het
8	6302418	6302418	A	G	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2515569	ENSG00000147316:ENST00000522905:exon7:c.A1031G:p.D344G,ENSG00000147316:ENST00000344683:exon8:c.A1175G:p.D392G,ENSG00000147316:ENST00000519480:exon8:c.A1175G:p.D392G	MCPH1:NM_001172575:exon7:c.A1031G:p.D344G,MCPH1:NM_001172574:exon8:c.A1175G:p.D392G,MCPH1:NM_001322042:exon8:c.A1175G:p.D392G,MCPH1:NM_001322043:exon8:c.A1169G:p.D390G,MCPH1:NM_001322045:exon8:c.A1073G:p.D358G,MCPH1:NM_001363979:exon8:c.A1175G:p.D392G,MCPH1:NM_001363980:exon8:c.A1175G:p.D392G,MCPH1:NM_024596:exon8:c.A1175G:p.D392G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9980	0.9927	0.994409	0.9918	-1.735	0.002	0.573	-11.5	0.000	.	.	.	MCPH1:uc011kwl.2:exon7:c.A1031G:p.D344G,MCPH1:uc003wqh.3:exon8:c.A1175G:p.D392G,MCPH1:uc003wqi.3:exon8:c.A1175G:p.D392G	-0.923	AFR:0.9711,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	2.99	0.000	-1.355	8	MU81846820	hom
8	6402992	6402992	A	G	ANGPT2;MCPH1	intronic	.	ENSG00000091879;ENSG00000147316	rs2442596	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.995807	0.9936	.	.	.	.	.	.	.	.	.	.	AFR:0.9777,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	6403006	6403006	A	C	ANGPT2;MCPH1	intronic	.	ENSG00000091879;ENSG00000147316	rs2515488	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.524161	0.4971	.	.	.	.	.	.	.	.	.	.	AFR:0.5782,AMR:0.4519,EAS:0.5322,FIN:0.4447,NFE:0.4646,OTH:0.4653,ASJ:0.4233	.	.	.	.	.	.	.	.	.	.	.	.	8	MU13321322	het
8	11629119	11629119	T	C	NEIL2	intronic	.	ENSG00000154328	rs804269	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7141	0.6032	0.697883	0.6418	.	.	.	.	.	.	.	.	.	.	AFR:0.4632,AMR:0.8067,EAS:0.9690,FIN:0.7636,NFE:0.6712,OTH:0.6878,ASJ:0.5662	608933	.	.	.	.	.	.	.	.	.	.	.	8	MU81847463	unknown
8	12948951	12948951	A	G	DLC1	intronic	.	ENSG00000164741	rs609020	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5562	0.6111	0.571486	MU587710	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.5898,EAS:0.3735,FIN:0.6623,NFE:0.4107,OTH:0.5433,ASJ:0.7230	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(stomach)	0.5541
8	12950110	12950110	G	A	DLC1	intronic	.	ENSG00000164741	rs7829535	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4475	0.4115	0.336861	0.4052	.	.	.	.	.	.	.	.	.	.	AFR:0.2205,AMR:0.2990,EAS:0.3412,FIN:0.4662,NFE:0.5021,OTH:0.4908,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU32417843	het
8	12957475	12957475	C	T	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs532841	ENSG00000164741:ENST00000358919:exon5:c.G1060A:p.V354M,ENSG00000164741:ENST00000512044:exon5:c.G1162A:p.V388M,ENSG00000164741:ENST00000520226:exon5:c.G838A:p.V280M,ENSG00000164741:ENST00000276297:exon9:c.G2371A:p.V791M	DLC1:NM_001348084:exon4:c.G838A:p.V280M,DLC1:NM_001164271:exon5:c.G838A:p.V280M,DLC1:NM_001316668:exon5:c.G1162A:p.V388M,DLC1:NM_001348083:exon5:c.G838A:p.V280M,DLC1:NM_006094:exon5:c.G1060A:p.V354M,DLC1:NM_001348082:exon8:c.G838A:p.V280M,DLC1:NM_001348081:exon9:c.G2371A:p.V791M,DLC1:NM_182643:exon9:c.G2371A:p.V791M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4935	0.5252	0.496605	28(soft_tissue)	-0.212	1.034	0.322	-6.1	0.746	.	.	.	DLC1:uc003wwk.1:exon5:c.G1060A:p.V354M,DLC1:uc003wwl.1:exon5:c.G1162A:p.V388M,DLC1:uc011kxx.1:exon5:c.G838A:p.V280M,DLC1:uc003wwm.2:exon9:c.G2371A:p.V791M	-0.963	AFR:1(pancreas),AMR:1(thyroid),EAS:MU55000,FIN:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,NFE:0.5114,OTH:0.6111,ASJ:4(large_intestine)	604258	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.11	8	1(stomach)	0.3246
8	12958025	12958025	C	A	DLC1	exonic	synonymous SNV	ENSG00000164741	rs3739298	ENSG00000164741:ENST00000358919:exon5:c.G510T:p.A170A,ENSG00000164741:ENST00000512044:exon5:c.G612T:p.A204A,ENSG00000164741:ENST00000520226:exon5:c.G288T:p.A96A,ENSG00000164741:ENST00000276297:exon9:c.G1821T:p.A607A	DLC1:NM_001348084:exon4:c.G288T:p.A96A,DLC1:NM_001164271:exon5:c.G288T:p.A96A,DLC1:NM_001316668:exon5:c.G612T:p.A204A,DLC1:NM_001348083:exon5:c.G288T:p.A96A,DLC1:NM_006094:exon5:c.G510T:p.A170A,DLC1:NM_001348082:exon8:c.G288T:p.A96A,DLC1:NM_001348081:exon9:c.G1821T:p.A607A,DLC1:NM_182643:exon9:c.G1821T:p.A607A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3605	0.2727	0.35004	2(urinary_tract)	.	.	.	.	.	.	.	.	DLC1:uc003wwk.1:exon5:c.G510T:p.A170A,DLC1:uc003wwl.1:exon5:c.G612T:p.A204A,DLC1:uc011kxx.1:exon5:c.G288T:p.A96A,DLC1:uc003wwm.2:exon9:c.G1821T:p.A607A	.	AFR:13(soft_tissue),AMR:68(meninges),EAS:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,FIN:0.3034,NFE:0.1517,OTH:0.5578,ASJ:MU113075	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(thyroid)	0.2152
8	12960281	12960281	T	C	DLC1	intronic	.	ENSG00000164741	rs2280335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4335	0.3683	0.304712	0.3718	.	.	.	.	.	.	.	.	.	.	AFR:0.1033,AMR:0.2888,EAS:0.3401,FIN:0.4785,NFE:0.4997,OTH:0.4867,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU13156967	het
8	12973078	12973078	T	C	DLC1	intronic	.	ENSG00000164741	rs34462909	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4850	0.4305	0.394569	0.4342	.	.	.	.	.	.	.	.	.	.	AFR:0.2706,AMR:0.4402,EAS:0.3775,FIN:0.5123,NFE:0.5076,OTH:0.5286,ASJ:0.5933	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU803582	het
8	13356802	13356802	G	A	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs3816747	ENSG00000164741:ENST00000276297:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000316609:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000511869:exon2:c.C779T:p.T260I	DLC1:NM_001348081:exon2:c.C779T:p.T260I,DLC1:NM_024767:exon2:c.C779T:p.T260I,DLC1:NM_182643:exon2:c.C779T:p.T260I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8777	0.9101	0.815096	0.8937	-3.066	0.001	0.193	-9.96	0.001	.	.	.	DLC1:uc003wwm.2:exon2:c.C779T:p.T260I,DLC1:uc003wwn.3:exon2:c.C779T:p.T260I,DLC1:uc011kxy.2:exon2:c.C779T:p.T260I	-0.942	AFR:0.8611,AMR:0.7470,EAS:0.6101,FIN:0.9408,NFE:0.9387,OTH:0.9083,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.0	3.65	0.000	-1.245	8	MU18918835	unknown
8	13356818	13356818	T	C	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203494	ENSG00000164741:ENST00000276297:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000316609:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000511869:exon2:c.A763G:p.N255D	DLC1:NM_001348081:exon2:c.A763G:p.N255D,DLC1:NM_024767:exon2:c.A763G:p.N255D,DLC1:NM_182643:exon2:c.A763G:p.N255D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9673	0.9461	0.958067	0.9540	-2.148	0.001	1.0	1.93	0.003	.	.	.	DLC1:uc003wwm.2:exon2:c.A763G:p.N255D,DLC1:uc003wwn.3:exon2:c.A763G:p.N255D,DLC1:uc011kxy.2:exon2:c.A763G:p.N255D	-0.998	AFR:0.9099,AMR:0.9761,EAS:1,FIN:0.9785,NFE:0.9664,OTH:0.9715,ASJ:0.9636	604258	114500;	.	.	.	.	.	.	0.0	3.92	0.000	-0.955	8	MU81847893	unknown
8	13356819	13356819	T	G	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203495	ENSG00000164741:ENST00000276297:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000316609:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000511869:exon2:c.A762C:p.Q254H	DLC1:NM_001348081:exon2:c.A762C:p.Q254H,DLC1:NM_024767:exon2:c.A762C:p.Q254H,DLC1:NM_182643:exon2:c.A762C:p.Q254H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8558	0.8644	0.758387	0.8541	-1.363	0.004	0.208	-5.59	0.000	.	.	.	DLC1:uc003wwm.2:exon2:c.A762C:p.Q254H,DLC1:uc003wwn.3:exon2:c.A762C:p.Q254H,DLC1:uc011kxy.2:exon2:c.A762C:p.Q254H	-1.018	AFR:0.7255,AMR:0.7345,EAS:0.6110,FIN:0.9408,NFE:0.9375,OTH:0.8910,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.005	3.38	0.000	1.055	8	MU18918882	unknown
8	13357587	13357587	G	A	DLC1	UTR5	.	ENSG00000164741	rs1383942	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8562	0.8371	0.741613	0.8287	.	.	.	.	.	.	.	.	.	.	AFR:0.6355,AMR:0.7279,EAS:0.6098,FIN:0.9408,NFE:0.9376,OTH:0.8951,ASJ:0.9267	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU18918940	het
8	15978063	15978063	C	T	MSR1	exonic	synonymous SNV	ENSG00000038945	rs4338104	ENSG00000038945:ENST00000262101:exon9:c.G1086A:p.R362R,ENSG00000038945:ENST00000445506:exon9:c.G1140A:p.R380R	MSR1:NM_001363744:exon9:c.G1140A:p.R380R,MSR1:NM_138715:exon9:c.G1086A:p.R362R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9975	0.997404	0.9982	.	.	.	.	.	.	.	.	MSR1:uc003wwz.3:exon9:c.G1086A:p.R362R,MSR1:uc010lsu.3:exon9:c.G1140A:p.R380R	.	AFR:0.9936,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	MU81848037	hom
8	15978126	15978126	A	-	MSR1	intronic	.	ENSG00000038945	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	.	het
8	17799172	17799172	T	G	PCM1	intronic	.	ENSG00000078674	rs2467076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	21964802	21964802	C	T	NUDT18	UTR3	.	ENSG00000173566	rs1552286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9048	0.8733	0.920527	0.8847	.	.	.	.	.	.	.	.	.	.	AFR:0.8719,AMR:0.9305,EAS:0.9944,FIN:0.9147,NFE:0.8698,OTH:0.8953,ASJ:0.8940	615791	.	.	.	.	.	.	.	.	.	.	.	8	MU81848854	hom
8	21965113	21965113	T	C	NUDT18	exonic	nonsynonymous SNV	ENSG00000173566	rs3739435	ENSG00000173566:ENST00000522405:exon3:c.A439G:p.M147V,ENSG00000173566:ENST00000309188:exon5:c.A670G:p.M224V	NUDT18:NM_024815:exon5:c.A670G:p.M224V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5141	0.4747	0.554113	0.5037	-3.587	0.001	.	-2.23	0.553	.	.	.	NUDT18:uc003xaq.1:exon4:c.A670G:p.M224V	-0.939	AFR:0.5174,AMR:0.6938,EAS:0.6354,FIN:0.5838,NFE:0.4534,OTH:0.5154,ASJ:0.4033	615791	.	.	.	.	.	.	.	.	.	0.000	1.185	8	MU18563877	het
8	23049292	23049292	C	T	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs2230229	ENSG00000104689:ENST00000221132:exon10:c.G1322A:p.R441K	TNFRSF10A:NM_003844:exon10:c.G1322A:p.R441K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8782	0.8493	0.91254	0.8540	-1.070	0.011	1.0	-2.61	0.001	.	.	Death domain|Death-like domain|Tumour necrosis factor receptor 10A/B, death domain	TNFRSF10A:uc003xda.3:exon10:c.G1322A:p.R441K	-0.992	AFR:0.8633,AMR:0.9342,EAS:0.9808,FIN:0.8049,NFE:0.8418,OTH:0.8480,ASJ:0.8742	603611	.	.	.	.	.	.	.	0.0	-2.0	0.000	-1.345	8	MU81849571	hom
8	23058188	23058188	T	C	TNFRSF10A	intronic	.	ENSG00000104689	rs4872077	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2896	0.3095	0.254593	0.3077	.	.	.	.	.	.	.	.	.	.	AFR:0.3094,AMR:0.3840,EAS:0.0371,FIN:0.3513,NFE:0.3202,OTH:0.3522,ASJ:0.23	603611	.	.	.	.	.	.	.	.	.	.	.	8	MU18929365	het
8	23059324	23059324	C	G	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs20575	ENSG00000104689:ENST00000221132:exon4:c.G626C:p.R209T,ENSG00000104689:ENST00000524158:exon4:c.G20C:p.R7T	TNFRSF10A:NM_003844:exon4:c.G626C:p.R209T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5279	0.4103	0.579473	0.4435	-1.605	0.002	1.0	0.222	0.000	.	.	TNFR/NGFR cysteine-rich region;TNFR/NGFR cysteine-rich region|Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon4:c.G626C:p.R209T	-0.966	AFR:0.3146,AMR:0.6432,EAS:0.9735,FIN:0.4050,NFE:0.4544,OTH:0.4867,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.0	-2.7	0.000	-1.105	8	MU64437	het
8	23060256	23060256	T	C	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs17620	ENSG00000104689:ENST00000221132:exon3:c.A422G:p.H141R	TNFRSF10A:NM_003844:exon3:c.A422G:p.H141R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5254	0.4000	0.571685	0.4325	-3.114	0.001	0.419	-6.96	0.000	.	.	Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon3:c.A422G:p.H141R	-0.910	AFR:0.2767,AMR:0.6435,EAS:0.9735,FIN:0.4044,NFE:0.4554,OTH:0.4847,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.824	0.99	0.000	1.15	8	MU144012	het
8	23540417	23540417	C	T	NKX3-1	UTR5	.	ENSG00000167034	rs11781886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7480	0.8300	0.685903	0.7179	.	.	.	.	.	.	.	.	.	.	AFR:0.6950,AMR:0.6803,EAS:0.7186,FIN:0.6328,NFE:0.7556,OTH:0.6921,ASJ:0.6812	602041	.	.	.	~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	8	MU9652193	het
8	29197672	29197672	A	G	DUSP4	exonic	synonymous SNV	ENSG00000120875	rs583034	ENSG00000120875:ENST00000240100:exon2:c.T522C:p.S174S,ENSG00000120875:ENST00000240101:exon3:c.T249C:p.S83S	DUSP4:NM_001394:exon2:c.T522C:p.S174S,DUSP4:NM_057158:exon3:c.T249C:p.S83S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5589	0.5339	0.622404	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	DUSP4:uc003xhm.3:exon2:c.T522C:p.S174S,DUSP4:uc003xhl.3:exon3:c.T249C:p.S83S	.	AFR:0.5519,AMR:0.7727,EAS:0.55,FIN:0.6425,NFE:0.4768,OTH:0.4305,ASJ:0.6523	602747	.	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.4775
8	30469805	30469805	A	C	GTF2E2	intronic	.	ENSG00000197265	rs7815625	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4031	0.3503	0.333666	0.3542	.	.	.	.	.	.	.	.	.	.	AFR:0.1840,AMR:0.2757,EAS:0.2466,FIN:0.4787,NFE:0.4311,OTH:0.4348,ASJ:0.5530	189964	616943;	33364;	33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~	~ko03022 Basal transcription factors~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	MU717268	het
8	30472115	30472115	A	C	GTF2E2	intronic	.	ENSG00000197265	rs370799297	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0059	0.0005	0.0133786	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0.0031,ASJ:0	189964	616943;	33364;	33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~	~ko03022 Basal transcription factors~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	MU113484943	het
8	30924557	30924557	C	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1800389	ENSG00000165392:ENST00000298139:exon6:c.C513T:p.C171C	WRN:NM_000553:exon6:c.C513T:p.C171C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7032	0.6537	0.6873	0.6708	.	.	.	.	.	.	.	.	WRN:uc003xio.4:exon6:c.C513T:p.C171C	.	AFR:0.5312,AMR:0.7715,EAS:0.8622,FIN:0.7583,NFE:0.7012,OTH:0.7147,ASJ:0.7219	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU794190	het
8	30958354	30958354	T	-	WRN	intronic	.	ENSG00000165392	rs397723919	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.9943	0.9784	0.98123	0.9825	.	.	.	.	.	.	.	.	.	.	AFR:0.9388,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	.	hom
8	30973957	30973957	G	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1800392	ENSG00000165392:ENST00000298139:exon20:c.G2361T:p.L787L	WRN:NM_000553:exon20:c.G2361T:p.L787L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4466	0.4482	0.471246	0.4285	.	.	.	.	.	.	.	.	WRN:uc010lvk.3:exon8:c.G762T:p.L254L,WRN:uc003xio.4:exon20:c.G2361T:p.L787L	.	AFR:0.4064,AMR:0.5598,EAS:0.6073,FIN:0.3639,NFE:0.4294,OTH:0.4255,ASJ:0.4570	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU131479	het
8	30999122	30999122	C	T	WRN	intronic	.	ENSG00000165392	rs3024239	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4704	0.3866	0.375	0.4182	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.1976,AMR:0.4031,EAS:0.3604,FIN:0.5664,NFE:0.5129,OTH:0.4908,ASJ:0.49	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU661076	unknown
8	30999123	30999123	G	A	WRN	intronic	.	ENSG00000165392	rs2737335	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4479	0.4660	0.494808	0.4445	.	.	.	.	.	0	0	.	.	.	AFR:0.4792,AMR:0.5514,EAS:0.6203,FIN:0.3598,NFE:0.4203,OTH:0.4235,ASJ:0.4533	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU18938553	unknown
8	30999280	30999280	G	T	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1801195	ENSG00000165392:ENST00000298139:exon26:c.G3222T:p.L1074F	WRN:NM_000553:exon26:c.G3222T:p.L1074F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4492	0.4669	0.496006	0.4457	-0.691	0.076	0.764	1.4	0.007	.	.	Winged helix-turn-helix DNA-binding domain	WRN:uc010lvk.3:exon14:c.G1623T:p.L541F,WRN:uc003xio.4:exon26:c.G3222T:p.L1074F	-0.938	AFR:0.4802,AMR:0.5504,EAS:0.6186,FIN:0.3607,NFE:0.4221,OTH:0.4262,ASJ:0.4536	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.0	1.48	0.000	-1.24	8	MU131494	het
8	31024638	31024638	C	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1801196	ENSG00000165392:ENST00000298139:exon34:c.C4083T:p.S1361S	WRN:NM_000553:exon34:c.C4083T:p.S1361S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2989	0.2821	0.273562	0.2986	.	.	.	.	.	.	.	.	WRN:uc010lvk.3:exon22:c.C2484T:p.S828S,WRN:uc003xio.4:exon34:c.C4083T:p.S1361S	.	AFR:0.2714,AMR:0.2907,EAS:0.2360,FIN:0.3533,NFE:0.3079,OTH:0.3033,ASJ:0.3278	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU147491	het
8	32453358	32453358	G	A	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	rs3924999	ENSG00000157168:ENST00000287842:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000287845:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000338921:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000341377:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000356819:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000405005:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000518104:exon2:c.G50A:p.R17Q,ENSG00000157168:ENST00000519301:exon2:c.G50A:p.R17Q,ENSG00000157168:ENST00000520407:exon2:c.G758A:p.R253Q,ENSG00000157168:ENST00000521670:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000523079:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000523534:exon2:c.G317A:p.R106Q	NRG1:NM_001160002:exon2:c.G113A:p.R38Q,NRG1:NM_001160004:exon2:c.G113A:p.R38Q,NRG1:NM_001160005:exon2:c.G113A:p.R38Q,NRG1:NM_001160007:exon2:c.G113A:p.R38Q,NRG1:NM_001160008:exon2:c.G113A:p.R38Q,NRG1:NM_004495:exon2:c.G113A:p.R38Q,NRG1:NM_013956:exon2:c.G113A:p.R38Q,NRG1:NM_013957:exon2:c.G113A:p.R38Q,NRG1:NM_013958:exon2:c.G113A:p.R38Q,NRG1:NM_013960:exon2:c.G113A:p.R38Q,NRG1:NM_013962:exon2:c.G758A:p.R253Q,NRG1:NM_013964:exon2:c.G113A:p.R38Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3913	0.3068	0.385184	MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611	5.399	26.0	0.044	5.65	0.998	.	.	Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin-like fold;Neuregulin, C-terminal	NRG1:uc010lvp.2:exon1:c.G11A:p.R4Q,NRG1:uc003xip.3:exon2:c.G758A:p.R253Q,NRG1:uc003xir.3:exon2:c.G113A:p.R38Q,NRG1:uc003xis.3:exon2:c.G113A:p.R38Q,NRG1:uc003xit.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiu.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiv.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiw.2:exon2:c.G113A:p.R38Q,NRG1:uc010lvl.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvm.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvn.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvo.2:exon2:c.G113A:p.R38Q,NRG1:uc011lbf.1:exon2:c.G113A:p.R38Q,NRG1:uc022ats.1:exon2:c.G50A:p.R17Q	-1.014	AFR:0.3166,AMR:0.1107,EAS:0.3841,FIN:0.7711,NFE:0.3321,OTH:0.3739,ASJ:0.4234	142445	603013;	.	.	.	.	.	.	0.381	1.02	0.000	0.41	8	1(skin)	0.3554
8	37693302	37693302	T	C	ADGRA2	intronic	.	ENSG00000020181	rs10101560	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9539	0.9521	0.978834	0.9606	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9797,EAS:1,FIN:0.9613,NFE:0.9393,OTH:0.9488,ASJ:0.9768	606823	.	.	.	.	.	.	.	.	.	.	.	8	MU81850840	hom
8	41166638	41166640	GCT	-	SFRP1	exonic	nonframeshift deletion	ENSG00000104332	rs3055861	ENSG00000104332:ENST00000220772:exon1:c.39_41del:p.13_14del	SFRP1:NM_003012:exon1:c.39_41del:p.13_14del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4030	0.0002	0.311102	0.3212	.	.	.	.	.	.	.	.	SFRP1:uc003xnt.3:exon1:c.39_41del:p.13_14del	.	AFR:0.0883,AMR:0.4007,EAS:0.4029,FIN:0.4585,NFE:0.4046,OTH:0.4411,ASJ:0.3013	604156	.	.	.	.	.	.	.	.	.	.	.	8	MU618803	het
8	41519462	41519462	A	G	ANK1	intronic	.	ENSG00000253389	rs515071	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7805	0.7499	0.786342	0.7661	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7498,AMR:0.7799,EAS:0.8492,FIN:0.7946,NFE:0.7620,OTH:0.7643,ASJ:0.6291	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU21380244	het
8	41525914	41525914	C	T	ANK1	exonic	synonymous SNV	ENSG00000029534	rs750625	ENSG00000029534:ENST00000289734:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000347528:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000352337:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000379758:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000396942:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000396945:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000265709:exon40:c.G5388A:p.V1796V	ANK1:NM_000037:exon39:c.G5265A:p.V1755V,ANK1:NM_020475:exon39:c.G5265A:p.V1755V,ANK1:NM_020476:exon39:c.G5265A:p.V1755V,ANK1:NM_020477:exon39:c.G4779A:p.V1593V,ANK1:NM_001142446:exon40:c.G5388A:p.V1796V	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2134	0.2312	0.194688	1(lung)	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon23:c.G2727A:p.V909V,ANK1:uc003xoi.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xoj.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xok.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xol.3:exon39:c.G4779A:p.V1593V,ANK1:uc003xom.3:exon40:c.G5388A:p.V1796V	.	AFR:MU156389,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.1994,FIN:0.2148,NFE:0.3742,OTH:0.1194,ASJ:0.2180	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(large_intestine)	0.2054
8	41529856	41529856	A	G	ANK1	intronic	.	ENSG00000029534	rs508112	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9921	0.9723	0.977636	0.9781	.	.	.	.	.	.	.	.	.	.	AFR:0.9241,AMR:0.9940,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU81851353	hom
8	41553928	41553928	C	G	ANK1	exonic	synonymous SNV	ENSG00000029534	rs504574	ENSG00000029534:ENST00000289734:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000347528:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000352337:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000379758:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000396942:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000396945:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000265709:exon27:c.G3036C:p.L1012L	ANK1:NM_000037:exon26:c.G2913C:p.L971L,ANK1:NM_020475:exon26:c.G2913C:p.L971L,ANK1:NM_020476:exon26:c.G2913C:p.L971L,ANK1:NM_020477:exon26:c.G2913C:p.L971L,ANK1:NM_001142446:exon27:c.G3036C:p.L1012L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4767	0.3628	0.407149	1(large_intestine)	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon10:c.G861C:p.L287L,ANK1:uc003xoi.3:exon26:c.G2913C:p.L971L,ANK1:uc003xoj.3:exon26:c.G2913C:p.L971L,ANK1:uc003xok.3:exon26:c.G2913C:p.L971L,ANK1:uc003xol.3:exon26:c.G2913C:p.L971L,ANK1:uc003xom.3:exon27:c.G3036C:p.L1012L	.	AFR:MU98129,AMR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,EAS:0.1422,FIN:0.5685,NFE:0.4106,OTH:0.5025,ASJ:0.3998	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(stomach)	0.5598
8	41559609	41559609	G	A	ANK1	exonic	synonymous SNV	ENSG00000029534	rs2304880	ENSG00000029534:ENST00000265709:exon21:c.C2448T:p.T816T,ENSG00000029534:ENST00000289734:exon21:c.C2349T:p.T783T,ENSG00000029534:ENST00000347528:exon21:c.C2349T:p.T783T,ENSG00000029534:ENST00000352337:exon21:c.C2349T:p.T783T,ENSG00000029534:ENST00000379758:exon21:c.C2349T:p.T783T,ENSG00000029534:ENST00000396942:exon21:c.C2349T:p.T783T,ENSG00000029534:ENST00000396945:exon21:c.C2349T:p.T783T	ANK1:NM_000037:exon21:c.C2349T:p.T783T,ANK1:NM_001142446:exon21:c.C2448T:p.T816T,ANK1:NM_020475:exon21:c.C2349T:p.T783T,ANK1:NM_020476:exon21:c.C2349T:p.T783T,ANK1:NM_020477:exon21:c.C2349T:p.T783T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2541	0.1962	0.180711	0.2128	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon4:c.C273T:p.T91T,ANK1:uc003xoi.3:exon21:c.C2349T:p.T783T,ANK1:uc003xoj.3:exon21:c.C2349T:p.T783T,ANK1:uc003xok.3:exon21:c.C2349T:p.T783T,ANK1:uc003xol.3:exon21:c.C2349T:p.T783T,ANK1:uc003xom.3:exon21:c.C2448T:p.T816T	.	AFR:0.0515,AMR:0.2816,EAS:0.0561,FIN:0.3436,NFE:0.2833,OTH:0.2885,ASJ:0.2781	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU23794473	het
8	41563685	41563685	G	A	ANK1	exonic	synonymous SNV	ENSG00000029534	rs1137177	ENSG00000029534:ENST00000265709:exon18:c.C2172T:p.G724G,ENSG00000029534:ENST00000289734:exon18:c.C2073T:p.G691G,ENSG00000029534:ENST00000347528:exon18:c.C2073T:p.G691G,ENSG00000029534:ENST00000352337:exon18:c.C2073T:p.G691G,ENSG00000029534:ENST00000379758:exon18:c.C2073T:p.G691G,ENSG00000029534:ENST00000396942:exon18:c.C2073T:p.G691G,ENSG00000029534:ENST00000396945:exon18:c.C2073T:p.G691G	ANK1:NM_000037:exon18:c.C2073T:p.G691G,ANK1:NM_001142446:exon18:c.C2172T:p.G724G,ANK1:NM_020475:exon18:c.C2073T:p.G691G,ANK1:NM_020476:exon18:c.C2073T:p.G691G,ANK1:NM_020477:exon18:c.C2073T:p.G691G	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2538	0.1964	0.180911	MU4554288	.	.	.	.	.	.	.	.	ANK1:uc003xoi.3:exon18:c.C2073T:p.G691G,ANK1:uc003xoj.3:exon18:c.C2073T:p.G691G,ANK1:uc003xok.3:exon18:c.C2073T:p.G691G,ANK1:uc003xol.3:exon18:c.C2073T:p.G691G,ANK1:uc003xom.3:exon18:c.C2172T:p.G724G	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.2123,EAS:0.2804,FIN:0.2781,NFE:0.0561,OTH:0.3439,ASJ:0.0512	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(thyroid)	0.2823
8	41583294	41583294	C	T	ANK1	exonic	synonymous SNV	ENSG00000029534	rs2304873	ENSG00000029534:ENST00000265709:exon6:c.G696A:p.P232P,ENSG00000029534:ENST00000289734:exon6:c.G597A:p.P199P,ENSG00000029534:ENST00000347528:exon6:c.G597A:p.P199P,ENSG00000029534:ENST00000352337:exon6:c.G597A:p.P199P,ENSG00000029534:ENST00000379758:exon6:c.G597A:p.P199P,ENSG00000029534:ENST00000396942:exon6:c.G597A:p.P199P,ENSG00000029534:ENST00000396945:exon6:c.G597A:p.P199P	ANK1:NM_000037:exon6:c.G597A:p.P199P,ANK1:NM_001142446:exon6:c.G696A:p.P232P,ANK1:NM_020475:exon6:c.G597A:p.P199P,ANK1:NM_020476:exon6:c.G597A:p.P199P,ANK1:NM_020477:exon6:c.G597A:p.P199P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1382	0.1021	0.105032	MU107732	.	.	.	.	.	.	.	.	ANK1:uc003xoi.3:exon6:c.G597A:p.P199P,ANK1:uc003xoj.3:exon6:c.G597A:p.P199P,ANK1:uc003xok.3:exon6:c.G597A:p.P199P,ANK1:uc003xol.3:exon6:c.G597A:p.P199P,ANK1:uc003xom.3:exon6:c.G696A:p.P232P	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BLCA-CN|1|103|0.00970874,AMR:0.1105,EAS:0.1325,FIN:0.1921,NFE:0.1465,OTH:0.1418,ASJ:0.0328	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	2(urinary_tract)	0.1401
8	41791283	41791283	G	A	KAT6A	exonic	synonymous SNV	ENSG00000083168	rs3739365	ENSG00000083168:ENST00000265713:exon17:c.C4455T:p.S1485S,ENSG00000083168:ENST00000396930:exon18:c.C4455T:p.S1485S,ENSG00000083168:ENST00000406337:exon18:c.C4455T:p.S1485S	KAT6A:NM_006766:exon17:c.C4455T:p.S1485S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1209	0.0825	0.162141	2(lung)	.	.	.	.	.	.	.	.	KAT6A:uc003xon.4:exon17:c.C4455T:p.S1485S,KAT6A:uc010lxb.3:exon18:c.C4455T:p.S1485S,KAT6A:uc010lxc.3:exon18:c.C4455T:p.S1485S	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU110427,EAS:0.0989,FIN:0.1013,NFE:0.1675,OTH:0.0894,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	601408	616268;	457193;	457193|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|616268 ~	.	.	.	.	.	.	.	.	8	1(salivary_gland)	0.2264
8	41798417	41798417	C	T	KAT6A	exonic	synonymous SNV	ENSG00000083168	rs3824275	ENSG00000083168:ENST00000418721:exon8:c.G1722A:p.P574P,ENSG00000083168:ENST00000265713:exon15:c.G2982A:p.P994P,ENSG00000083168:ENST00000396930:exon16:c.G2982A:p.P994P,ENSG00000083168:ENST00000406337:exon16:c.G2982A:p.P994P	KAT6A:NM_006766:exon15:c.G2982A:p.P994P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1216	.	0.163938	1(lung)	.	.	.	.	.	.	.	.	KAT6A:uc003xon.4:exon15:c.G2982A:p.P994P,KAT6A:uc010lxb.3:exon16:c.G2982A:p.P994P,KAT6A:uc010lxc.3:exon16:c.G2982A:p.P994P	.	AFR:8(soft_tissue),AMR:2(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,FIN:0.0996,NFE:0.1040,OTH:0.1663,ASJ:MU110445	601408	616268;	457193;	457193|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|616268 ~	.	.	.	.	.	.	.	.	8	2(large_intestine)	0.0894
8	41906095	41906095	A	G	KAT6A	exonic	nonsynonymous SNV	ENSG00000083168	rs3824276	ENSG00000083168:ENST00000265713:exon2:c.T401C:p.L134S,ENSG00000083168:ENST00000485568:exon2:c.T401C:p.L134S,ENSG00000083168:ENST00000396930:exon3:c.T401C:p.L134S,ENSG00000083168:ENST00000406337:exon3:c.T401C:p.L134S	KAT6A:NM_001305878:exon2:c.T401C:p.L134S,KAT6A:NM_006766:exon2:c.T401C:p.L134S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1216	0.0833	0.163938	1(skin)	0.716	8.934	0.106	3.39	0.839	.	.	Linker histone H1/H5, domain H15|Winged helix-turn-helix DNA-binding domain	KAT6A:uc003xon.4:exon2:c.T401C:p.L134S,KAT6A:uc010lxd.3:exon2:c.T401C:p.L134S,KAT6A:uc010lxb.3:exon3:c.T401C:p.L134S,KAT6A:uc010lxc.3:exon3:c.T401C:p.L134S	-1.121	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU110464,EAS:0.0995,FIN:0.1032,NFE:0.1671,OTH:0.0927,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	601408	616268;	457193;	457193|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|616268 ~	.	.	.	.	0.014	0.27	0.000	0.55	8	8(soft_tissue)	0.2255
8	48732074	48732074	-	A	PRKDC	intronic	.	ENSG00000253729	rs769584868	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0364	.	.	0.0230	.	.	.	.	.	.	.	.	.	.	AFR:0.0173,AMR:0.0034,EAS:0.0123,FIN:0.0090,NFE:0.0282,OTH:0.0421,ASJ:0.0230	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	MU112564486	het
8	48802834	48802834	G	A	PRKDC	exonic	unknown	ENSG00000253729	rs752878379	ENSG00000253729:ENST00000314191:exon33:c.C4052T:p.S1351F,ENSG00000253729:ENST00000338368:exon33:c.C4052T:p.S1351F	UNKNOWN	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	5.762e-05	.	.	3.232e-05	-0.153	1.367	.	-3.35	0.218	.	.	Armadillo-like helical	PRKDC:uc003xqi.3:exon33:c.C4052T:p.S1351F,PRKDC:uc003xqj.3:exon33:c.C4052T:p.S1351F	-0.916	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.668e-05,OTH:0,ASJ:0	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	0.001	.	0.005	2.35	8	.	het
8	48846519	48846519	T	C	PRKDC	intronic	.	ENSG00000253729	rs1231202	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9598	0.9623	0.983626	0.9656	.	.	.	.	.	.	.	.	.	.	AFR:0.9926,AMR:0.9785,EAS:0.9994,FIN:0.9528,NFE:0.9498,OTH:0.9561,ASJ:0.9338	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	MU81851562	hom
8	48885436	48885436	T	A	MCM4	exonic	nonsynonymous SNV	ENSG00000104738	rs762679	ENSG00000104738:ENST00000262105:exon13:c.T1948A:p.L650M,ENSG00000104738:ENST00000523944:exon14:c.T1948A:p.L650M	MCM4:NM_005914:exon13:c.T1948A:p.L650M,MCM4:NM_182746:exon14:c.T1948A:p.L650M	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8669	0.8730	0.914137	0.8783	1.663	14.20	1.0	5.32	1.000	.	.	MCM domain|P-loop containing nucleoside triphosphate hydrolase	MCM4:uc003xql.2:exon13:c.T1948A:p.L650M,MCM4:uc003xqk.2:exon14:c.T1948A:p.L650M,MCM4:uc011ldi.2:exon15:c.T1909A:p.L637M	-0.942	AFR:0.9223,AMR:0.9308,EAS:0.9994,FIN:0.8306,NFE:0.8494,OTH:0.8635,ASJ:0.8444	602638	609981;	75391;	75391|Primary immunodeficiency due to MCM4 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|609981 ~	.	.	.	.	0.002	2.56	0.000	0.04	8	MU81851575	het
8	56792159	56792159	T	C	LYN	upstream	.	ENSG00000254087	rs1450741	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.715655	0.6942	.	.	.	.	.	.	.	.	.	.	AFR:0.6917,AMR:0.7267,EAS:0.7954,FIN:0.6894,NFE:0.6821,OTH:0.6916,ASJ:0.7980	165120	.	.	.	~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04611 Platelet activation~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04730 Long-term depression~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	.	hom
8	56792586	56792586	G	A	LYN	UTR5	.	ENSG00000254087	rs1050855	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5321	.	0.527157	0.5125	.	.	.	.	.	.	.	.	.	.	AFR:0.4980,AMR:0.6148,EAS:0.6514,FIN:0.5526,NFE:0.4899,OTH:0.5340,ASJ:0.5604	165120	.	.	.	~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04611 Platelet activation~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04730 Long-term depression~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	MU19188446	het
8	57078933	57078933	G	T	PLAG1	exonic	nonsynonymous SNV	ENSG00000181690	rs35883156	ENSG00000181690:ENST00000423799:exon3:c.C1126A:p.P376T,ENSG00000181690:ENST00000429357:exon4:c.C1372A:p.P458T,ENSG00000181690:ENST00000316981:exon5:c.C1372A:p.P458T	PLAG1:NM_001114635:exon3:c.C1126A:p.P376T,PLAG1:NM_001114634:exon4:c.C1372A:p.P458T,PLAG1:NM_002655:exon5:c.C1372A:p.P458T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1503	0.1353	0.109824	0.1273	0.443	6.976	0.284	2.42	0.993	.	.	.	PLAG1:uc022aur.1:exon1:c.C1126A:p.P376T,PLAG1:uc003xsq.4:exon3:c.C1372A:p.P458T,PLAG1:uc010lyj.3:exon3:c.C1126A:p.P376T,PLAG1:uc010lyi.3:exon4:c.C1372A:p.P458T,PLAG1:uc003xsr.4:exon5:c.C1372A:p.P458T	-0.929	AFR:0.0308,AMR:0.1229,EAS:0.0733,FIN:0.1464,NFE:0.1795,OTH:0.1551,ASJ:0.3113	603026	181030;	276148;454821;	276148|-|-|Not applicable|-|181030 ~454821|-|-|Not applicable|All ages|181030 ~	.	.	.	.	0.063	2.78	0.000	1.59	8	MU4564774	het
8	90958422	90958422	T	C	NBN	exonic	synonymous SNV	ENSG00000104320	rs1061302	ENSG00000104320:ENST00000265433:exon13:c.A2016G:p.P672P,ENSG00000104320:ENST00000409330:exon13:c.A1770G:p.P590P	NBN:NM_002485:exon13:c.A2016G:p.P672P,NBN:NM_001024688:exon14:c.A1770G:p.P590P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3451	0.2842	0.352835	9(meninges)	.	.	.	.	.	.	.	.	NBN:uc003yej.1:exon13:c.A2016G:p.P672P,NBN:uc011lgb.1:exon13:c.A2016G:p.P672P,NBN:uc003yei.1:exon14:c.A1770G:p.P590P	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU117817,EAS:0.3122,FIN:0.2281,NFE:0.3394,OTH:0.3311,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(stomach)	0.4275
8	90958530	90958530	T	C	NBN	intronic	.	ENSG00000104320	rs2308962	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3529	0.3131	0.378994	9(meninges)	.	.	.	.	.	0	0.036	.	.	.	AFR:MU13363873,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3078,FIN:0.3484,NFE:0.34,OTH:0.4288,ASJ:0.3357	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.3612
8	90967711	90967711	A	G	NBN	exonic	synonymous SNV	ENSG00000104320	rs709816	ENSG00000104320:ENST00000265433:exon10:c.T1197C:p.D399D,ENSG00000104320:ENST00000409330:exon10:c.T951C:p.D317D	NBN:NM_002485:exon10:c.T1197C:p.D399D,NBN:NM_001024688:exon11:c.T951C:p.D317D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4676	0.4903	0.608626	1(lung)	.	.	.	.	.	.	.	.	NBN:uc003yej.1:exon10:c.T1197C:p.D399D,NBN:uc011lgb.1:exon10:c.T1197C:p.D399D,NBN:uc003yei.1:exon11:c.T951C:p.D317D	.	AFR:1(large_intestine),AMR:MU117828,EAS:0.5139,FIN:0.7626,NFE:0.5477,OTH:0.3675,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.6286
8	90970935	90970935	G	A	NBN	intronic	.	ENSG00000104320	rs2234744	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3446	0.2845	0.353035	MU13363877	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3125,EAS:0.3413,FIN:0.3344,NFE:0.4288,OTH:0.3617,ASJ:0.2273	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(meninges)	0.3334
8	90990479	90990479	C	G	NBN	exonic	nonsynonymous SNV	ENSG00000104320	rs1805794	ENSG00000104320:ENST00000517772:exon3:c.G307C:p.E103Q,ENSG00000104320:ENST00000265433:exon5:c.G553C:p.E185Q,ENSG00000104320:ENST00000409330:exon5:c.G307C:p.E103Q	NBN:NM_002485:exon5:c.G553C:p.E185Q,NBN:NM_001024688:exon6:c.G307C:p.E103Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3453	0.2866	0.357029	1(haematopoietic_and_lymphoid_tissue)	0.367	6.326	1.0	3.08	0.980	.	.	BRCT domain;SMAD/FHA domain	NBN:uc003yej.1:exon5:c.G553C:p.E185Q,NBN:uc011lgb.1:exon5:c.G553C:p.E185Q,NBN:uc003yei.1:exon6:c.G307C:p.E103Q	-0.961	AFR:9(meninges),AMR:2(lung),EAS:MU117841,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,NFE:0.3143,OTH:0.2339,ASJ:1(stomach)	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	0.0	0.43	0.000	-1.225	8	1(thyroid)	0.3434
8	90995019	90995019	C	T	NBN	exonic	synonymous SNV	ENSG00000104320	rs1063045	ENSG00000104320:ENST00000265433:exon2:c.G102A:p.L34L,ENSG00000104320:ENST00000519426:exon2:c.G102A:p.L34L,ENSG00000104320:ENST00000523444:exon2:c.G102A:p.L34L,ENSG00000104320:ENST00000396252:exon4:c.G102A:p.L34L	NBN:NM_002485:exon2:c.G102A:p.L34L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3527	0.3132	0.379193	9(meninges)	.	.	.	.	.	.	.	.	NBN:uc003yej.1:exon2:c.G102A:p.L34L,NBN:uc011lgb.1:exon2:c.G102A:p.L34L	.	AFR:1(large_intestine),AMR:MU117860,EAS:0.3349,FIN:0.3063,NFE:0.3501,OTH:0.3367,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(stomach)	0.4271
8	95419698	95419698	A	G	RAD54B	exonic	synonymous SNV	ENSG00000197275	rs2291439	ENSG00000197275:ENST00000336148:exon5:c.T750C:p.N250N	RAD54B:NM_001205263:exon3:c.T198C:p.N66N,RAD54B:NM_012415:exon5:c.T750C:p.N250N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4125	0.3611	0.418131	1(stomach)	.	.	.	.	.	.	.	.	RAD54B:uc010may.2:exon3:c.T198C:p.N66N,RAD54B:uc003ygk.3:exon5:c.T750C:p.N250N	.	AFR:MU149839,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.3418,FIN:0.5562,NFE:0.3377,OTH:0.4634,ASJ:0.3844	604289	114500;605027;	547;	547|NHL|1-5 / 10 000|-|Adult|605027 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.4116
8	102505658	102505670	CCCTCCCCCGCCT	-	GRHL2	intronic	.	ENSG00000083307	rs145209173	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.8018	.	.	.	.	.	.	.	.	.	.	AFR:0.5719,AMR:0.7888,EAS:0.6440,FIN:0.9188,NFE:0.9198,OTH:0.8755,ASJ:0.8741	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102505705	102505705	A	G	GRHL2	intronic	.	ENSG00000083307	rs581752	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.734824	0.8146	.	.	.	.	.	.	.	.	.	.	AFR:0.5949,AMR:0.7978,EAS:0.6573,FIN:0.9207,NFE:0.9266,OTH:0.8844,ASJ:0.8709	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	unknown
8	102505722	102505722	G	-	GRHL2	intronic	.	ENSG00000083307	rs35836856	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.730831	0.8068	.	.	.	.	.	.	.	.	.	.	AFR:0.5759,AMR:0.7928,EAS:0.6508,FIN:0.9198,NFE:0.9252,OTH:0.8835,ASJ:0.8709	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	unknown
8	102505996	102505996	G	T	GRHL2	intronic	.	ENSG00000083307	rs688757	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.6873	0.7719	.	.	.	.	.	.	.	.	.	.	AFR:0.4513,AMR:0.7824,EAS:0.6555,FIN:0.9197,NFE:0.9262,OTH:0.8830,ASJ:0.8733	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102506074	102506074	T	C	GRHL2	intronic	.	ENSG00000083307	rs688324	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.732228	0.8082	.	.	.	.	.	.	.	.	.	.	AFR:0.5793,AMR:0.7930,EAS:0.6554,FIN:0.9192,NFE:0.9263,OTH:0.8840,ASJ:0.8667	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102506265	102506265	C	T	GRHL2	intronic	.	ENSG00000083307	rs561484	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.729832	0.8074	.	.	.	.	.	.	.	.	.	.	AFR:0.5765,AMR:0.7924,EAS:0.6570,FIN:0.9194,NFE:0.9258,OTH:0.8850,ASJ:0.8676	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102506321	102506321	G	A	GRHL2	intronic	.	ENSG00000083307	rs562319	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.730431	0.8075	.	.	.	.	.	.	.	.	.	.	AFR:0.5774,AMR:0.7924,EAS:0.6573,FIN:0.9193,NFE:0.9258,OTH:0.8855,ASJ:0.8667	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102678798	102678798	C	T	GRHL2	intronic	.	ENSG00000083307	rs10093032	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3972	0.3680	0.434704	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.3675,AMR:0.4313,EAS:0.3742,FIN:0.3645,NFE:0.3236,OTH:0.3355,ASJ:0.4403	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	1(lung)	0.3859
8	102678909	102678909	A	G	GRHL2	exonic	nonsynonymous SNV	ENSG00000083307	rs200589830	ENSG00000083307:ENST00000251808:exon16:c.A1856G:p.K619R,ENSG00000083307:ENST00000395927:exon16:c.A1808G:p.K603R	GRHL2:NM_001330593:exon16:c.A1808G:p.K603R,GRHL2:NM_024915:exon16:c.A1856G:p.K619R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	1.654e-05	.	.	.	2.468	19.26	0.308	5.57	1.000	.	.	.	GRHL2:uc010mbu.3:exon16:c.A1856G:p.K619R	-1.062	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.002	2.68	0.030	0.755	8	.	het
8	103220351	103220351	A	G	RRM2B	UTR3	.	ENSG00000048392	rs1265117	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9999	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:0.9999,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	MU81854103	hom
8	108970367	108970367	A	G	RSPO2	exonic	nonsynonymous SNV	ENSG00000147655	rs601558	ENSG00000147655:ENST00000378439:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517781:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517939:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000521502:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000276659:exon5:c.T557C:p.L186P	RSPO2:NM_001282863:exon4:c.T365C:p.L122P,RSPO2:NM_001317942:exon4:c.T356C:p.L119P,RSPO2:NM_178565:exon5:c.T557C:p.L186P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5784	0.4729	0.490216	COCA-CN|6|321|0.0186916	2.545	19.76	0.655	4.95	0.759	.	.	Growth factor receptor cysteine-rich domain	RSPO2:uc003ymq.3:exon4:c.T356C:p.L119P,RSPO2:uc003ymr.3:exon4:c.T365C:p.L122P,RSPO2:uc003yms.3:exon5:c.T557C:p.L186P	-0.958	AFR:0.4824,AMR:0.1523,EAS:0.5894,FIN:0.7177,NFE:0.5967,OTH:0.6087,ASJ:0.6145	610575	.	.	.	.	.	.	.	0.0	-0.89	0.000	-1.44	8	1(large_intestine)	0.5543
8	118830665	118830665	G	A	EXT1	intronic	.	ENSG00000182197	rs368634215	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	8.237e-06	7.7e-05	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608177	133700;215300;	55880;321;	55880|-|1-9 / 100 000|Unknown<br>or&nbsp;Not applicable|Adult|215300 ~321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	.	.	.	.	8	.	het
8	134292516	134292516	A	G	NDRG1	intronic	.	ENSG00000104419	rs2272653	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5635	0.6678	0.613419	0.6519	.	.	.	.	.	0	0	.	.	.	AFR:0.8639,AMR:0.4952,EAS:0.4506,FIN:0.5755,NFE:0.5806,OTH:0.5906,ASJ:0.66	605262	601455;	99950;	99950|CMT4D<br>HMSN, Lom type<br>HMSN-Lom<br>Hereditary motor and sensory neuropathy, Lom type|Unknown|Autosomal recessive|Childhood<br>Adolescent|601455 ~	.	.	.	.	.	.	.	.	8	MU13169204	hom
8	144992103	144992103	T	C	PLEC	exonic	synonymous SNV	ENSG00000178209	rs6558406	ENSG00000178209:ENST00000322810:exon32:c.A12297G:p.T4099T,ENSG00000178209:ENST00000345136:exon32:c.A11886G:p.T3962T,ENSG00000178209:ENST00000354589:exon32:c.A11886G:p.T3962T,ENSG00000178209:ENST00000354958:exon32:c.A11820G:p.T3940T,ENSG00000178209:ENST00000356346:exon32:c.A11844G:p.T3948T,ENSG00000178209:ENST00000357649:exon32:c.A11898G:p.T3966T,ENSG00000178209:ENST00000398774:exon32:c.A11790G:p.T3930T,ENSG00000178209:ENST00000527096:exon32:c.A11955G:p.T3985T,ENSG00000178209:ENST00000436759:exon33:c.A11967G:p.T3989T	PLEC:NM_201378:exon32:c.A11844G:p.T3948T,PLEC:NM_201379:exon32:c.A11820G:p.T3940T,PLEC:NM_201380:exon32:c.A12297G:p.T4099T,PLEC:NM_201381:exon32:c.A11790G:p.T3930T,PLEC:NM_201382:exon32:c.A11886G:p.T3962T,PLEC:NM_201383:exon32:c.A11898G:p.T3966T,PLEC:NM_201384:exon32:c.A11886G:p.T3962T,PLEC:NM_000445:exon33:c.A11967G:p.T3989T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4343	0.5882	0.490415	LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon32:c.A11886G:p.T3962T,PLEC:uc003zac.1:exon32:c.A11898G:p.T3966T,PLEC:uc003zad.2:exon32:c.A11886G:p.T3962T,PLEC:uc003zae.1:exon32:c.A11790G:p.T3930T,PLEC:uc003zaf.1:exon32:c.A12297G:p.T4099T,PLEC:uc003zag.1:exon32:c.A11820G:p.T3940T,PLEC:uc003zah.2:exon32:c.A11844G:p.T3948T,PLEC:uc003zaj.2:exon33:c.A11967G:p.T3989T	.	AFR:0.5333,AMR:0.8525,EAS:0.4636,FIN:0.1456,NFE:0.4280,OTH:0.4318,ASJ:0.3640	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	3(lung)	0.4287
8	144993686	144993686	C	T	PLEC	exonic	nonsynonymous SNV	ENSG00000178209	rs375044211	ENSG00000178209:ENST00000322810:exon32:c.G10714A:p.G3572S,ENSG00000178209:ENST00000345136:exon32:c.G10303A:p.G3435S,ENSG00000178209:ENST00000354589:exon32:c.G10303A:p.G3435S,ENSG00000178209:ENST00000354958:exon32:c.G10237A:p.G3413S,ENSG00000178209:ENST00000356346:exon32:c.G10261A:p.G3421S,ENSG00000178209:ENST00000357649:exon32:c.G10315A:p.G3439S,ENSG00000178209:ENST00000398774:exon32:c.G10207A:p.G3403S,ENSG00000178209:ENST00000527096:exon32:c.G10372A:p.G3458S,ENSG00000178209:ENST00000436759:exon33:c.G10384A:p.G3462S	PLEC:NM_201378:exon32:c.G10261A:p.G3421S,PLEC:NM_201379:exon32:c.G10237A:p.G3413S,PLEC:NM_201380:exon32:c.G10714A:p.G3572S,PLEC:NM_201381:exon32:c.G10207A:p.G3403S,PLEC:NM_201382:exon32:c.G10303A:p.G3435S,PLEC:NM_201383:exon32:c.G10315A:p.G3439S,PLEC:NM_201384:exon32:c.G10303A:p.G3435S,PLEC:NM_000445:exon33:c.G10384A:p.G3462S	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	5.905e-05	8.2e-05	0.000199681	6.466e-05	5.689	26.8	0.0	5.03	0.449	.	.	.	PLEC:uc003zab.1:exon32:c.G10303A:p.G3435S,PLEC:uc003zac.1:exon32:c.G10315A:p.G3439S,PLEC:uc003zad.2:exon32:c.G10303A:p.G3435S,PLEC:uc003zae.1:exon32:c.G10207A:p.G3403S,PLEC:uc003zaf.1:exon32:c.G10714A:p.G3572S,PLEC:uc003zag.1:exon32:c.G10237A:p.G3413S,PLEC:uc003zah.2:exon32:c.G10261A:p.G3421S,PLEC:uc003zaj.2:exon33:c.G10384A:p.G3462S	0.254	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:6.676e-05,OTH:0,ASJ:0	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	1.0	-0.67	0.574	3.45	8	.	het
8	144996868	144996868	G	A	PLEC	exonic	nonsynonymous SNV	ENSG00000178209	rs543422533	ENSG00000178209:ENST00000322810:exon31:c.C7640T:p.A2547V,ENSG00000178209:ENST00000345136:exon31:c.C7229T:p.A2410V,ENSG00000178209:ENST00000354589:exon31:c.C7229T:p.A2410V,ENSG00000178209:ENST00000354958:exon31:c.C7163T:p.A2388V,ENSG00000178209:ENST00000356346:exon31:c.C7187T:p.A2396V,ENSG00000178209:ENST00000357649:exon31:c.C7241T:p.A2414V,ENSG00000178209:ENST00000398774:exon31:c.C7133T:p.A2378V,ENSG00000178209:ENST00000527096:exon31:c.C7298T:p.A2433V,ENSG00000178209:ENST00000436759:exon32:c.C7310T:p.A2437V	PLEC:NM_201378:exon31:c.C7187T:p.A2396V,PLEC:NM_201379:exon31:c.C7163T:p.A2388V,PLEC:NM_201380:exon31:c.C7640T:p.A2547V,PLEC:NM_201381:exon31:c.C7133T:p.A2378V,PLEC:NM_201382:exon31:c.C7229T:p.A2410V,PLEC:NM_201383:exon31:c.C7241T:p.A2414V,PLEC:NM_201384:exon31:c.C7229T:p.A2410V,PLEC:NM_000445:exon32:c.C7310T:p.A2437V	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0005	.	0.00119808	COAD-US|1|402|0.00248756	6.357	29.4	0.025	4.56	0.919	.	.	.	PLEC:uc003zab.1:exon31:c.C7229T:p.A2410V,PLEC:uc003zac.1:exon31:c.C7241T:p.A2414V,PLEC:uc003zad.2:exon31:c.C7229T:p.A2410V,PLEC:uc003zae.1:exon31:c.C7133T:p.A2378V,PLEC:uc003zaf.1:exon31:c.C7640T:p.A2547V,PLEC:uc003zag.1:exon31:c.C7163T:p.A2388V,PLEC:uc003zah.2:exon31:c.C7187T:p.A2396V,PLEC:uc003zaj.2:exon32:c.C7310T:p.A2437V	-0.153	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	0.999	-1.16	0.534	2.015	8	1(soft_tissue)	.
8	145004546	145004546	G	A	PLEC	intronic	.	ENSG00000178209	rs11780911	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7411	0.6988	0.571885	0.6622	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3862,AMR:0.6411,EAS:0.6188,FIN:0.7603,NFE:0.7994,OTH:0.7162,ASJ:0.78	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	MU81858392	hom
8	145737286	145737286	G	A	RECQL4	intronic	.	ENSG00000160957	rs756627	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4670	0.3500	0.400559	0.3818	-0.092	1.788	.	-1.53	0.005	0	0	.	.	.	AFR:0.1395,AMR:0.5561,EAS:0.4913,FIN:0.4966,NFE:0.4678,OTH:0.4795,ASJ:0.4040	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU684944	hom
8	145737514	145737514	G	A	RECQL4	intronic	.	ENSG00000160957	rs4244610	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5063	0.3932	0.433307	0.4144	.	.	.	.	.	.	.	.	.	.	AFR:0.2530,AMR:0.5692,EAS:0.4672,FIN:0.4969,NFE:0.4705,OTH:0.4846,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU27648814	hom
8	145737636	145737636	A	G	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs4925828	ENSG00000160957:ENST00000428558:exon19:c.T3127C:p.L1043L	RECQL4:NM_004260:exon19:c.T3127C:p.L1043L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9728	0.9984	0.946086	0.9838	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon19:c.T3127C:p.L1043L	.	AFR:0.9944,AMR:0.9224,EAS:0.7879,FIN:0.9960,NFE:0.9989,OTH:0.9878,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561850	hom
8	145737816	145737816	C	T	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs4251691	ENSG00000160957:ENST00000428558:exon18:c.G3014A:p.R1005Q	RECQL4:NM_004260:exon18:c.G3014A:p.R1005Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4612	0.3419	0.384385	0.3717	2.434	19.04	.	0.281	0.015	.	.	.	RECQL4:uc003zdj.3:exon18:c.G3014A:p.R1005Q	.	AFR:0.1265,AMR:0.5502,EAS:0.4412,FIN:0.4940,NFE:0.4624,OTH:0.4703,ASJ:0.3642	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.035	.	.	0.815	8	MU73030	hom
8	145738583	145738584	GG	-	RECQL4	intronic	.	ENSG00000265393	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	unknown
8	145738768	145738768	G	-	RECQL4	splicing	.	ENSG00000160957;ENSG00000160957	rs11342077	ENSG00000160957:ENST00000428558:exon15:c.2296delC:p.R766fs	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon15:c.2296delC:p.R766fs	.	AFR:1,AMR:1,EAS:1,FIN:0.9997,NFE:0.9999,OTH:1,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	hom
8	145739924	145739924	G	A	RECQL4	intronic	.	ENSG00000160957	rs4244611	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4802	0.3505	0.394569	0.3814	.	.	.	.	.	.	.	.	.	.	AFR:0.1378,AMR:0.5549,EAS:0.4703,FIN:0.4991,NFE:0.4696,OTH:0.4784,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU654936	hom
8	145741130	145741130	C	T	RECQL4	intronic	.	ENSG00000160957	rs4251689	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4716	0.3650	0.400958	0.3905	.	.	.	.	.	.	.	.	.	.	AFR:0.1768,AMR:0.5549,EAS:0.4689,FIN:0.4966,NFE:0.4669,OTH:0.4775,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU18988417	hom
8	145741702	145741702	C	G	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs4244612	ENSG00000160957:ENST00000428558:exon5:c.G801C:p.E267D	RECQL4:NM_004260:exon5:c.G801C:p.E267D	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4377	0.3919	0.447684	0.4191	-0.697	0.073	.	-2.99	0.000	.	.	.	RECQL4:uc003zdj.3:exon5:c.G801C:p.E267D	.	AFR:0.4289,AMR:0.5119,EAS:0.4586,FIN:0.4195,NFE:0.4052,OTH:0.4097,ASJ:0.3775	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.002	.	.	.	8	MU69391	hom
8	145741765	145741765	G	A	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs4244613	ENSG00000160957:ENST00000428558:exon5:c.C738T:p.S246S	RECQL4:NM_004260:exon5:c.C738T:p.S246S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4394	0.3392	0.370008	0.3683	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon5:c.C738T:p.S246S	.	AFR:0.1637,AMR:0.5096,EAS:0.4592,FIN:0.4857,NFE:0.4376,OTH:0.4530,ASJ:0.34	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU78580	hom
8	145742011	145742011	C	T	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs368335924	ENSG00000160957:ENST00000428558:exon5:c.G492A:p.E164E	RECQL4:NM_004260:exon5:c.G492A:p.E164E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0103	0.0002	0.0167732	0.0002	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon5:c.G492A:p.E164E	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0061,ASJ:0	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	het
8	145742514	145742514	A	G	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs2721190	ENSG00000160957:ENST00000428558:exon4:c.T274C:p.S92P	RECQL4:NM_004260:exon4:c.T274C:p.S92P	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9733	0.9952	0.943291	0.9815	-1.106	0.010	.	1.99	0.000	.	.	.	RECQL4:uc003zdj.3:exon4:c.T274C:p.S92P	.	AFR:0.9837,AMR:0.9224,EAS:0.8006,FIN:0.9960,NFE:0.999,OTH:0.9857,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561873	hom
8	145742799	145742799	T	C	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs34642881	ENSG00000160957:ENST00000428558:exon3:c.A212G:p.E71G	RECQL4:NM_004260:exon3:c.A212G:p.E71G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0428	0.0034	0.029353	0.0084	2.855	21.6	.	3.82	0.126	0.0222	0.188	.	RECQL4:uc003zdj.3:exon3:c.A212G:p.E71G	.	AFR:0.0054,AMR:0.0514,EAS:0.0068,FIN:0.0057,NFE:0.0080,OTH:0.0123,ASJ:0.0199	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.611	.	.	.	8	MU112778621	het
8	145742879	145742879	T	C	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs2306386	ENSG00000160957:ENST00000428558:exon3:c.A132G:p.E44E	RECQL4:NM_004260:exon3:c.A132G:p.E44E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5552	0.5507	0.57508	0.5372	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon3:c.A132G:p.E44E	.	AFR:0.6164,AMR:0.6533,EAS:0.4931,FIN:0.5158,NFE:0.4973,OTH:0.5164,ASJ:0.4603	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU73049	hom
9	271638	271638	C	T	DOCK8	exonic	nonsynonymous SNV	ENSG00000107099	rs506121	ENSG00000107099:ENST00000453981:exon2:c.C65T:p.A22V,ENSG00000107099:ENST00000469197:exon2:c.C65T:p.A22V	DOCK8:NM_203447:exon2:c.C65T:p.A22V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3245	0.3189	0.307708	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	4.843	24.8	.	4.05	0.971	.	.	.	DOCK8:uc003zgf.2:exon2:c.C65T:p.A22V,DOCK8:uc011lls.1:exon2:c.C65T:p.A22V	-0.952	AFR:0.3393,AMR:0.2787,EAS:0.2384,FIN:0.4333,NFE:0.4020,OTH:0.3550,ASJ:0.2703	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	0.001	.	0.000	2.325	9	2(haematopoietic_and_lymphoid_tissue)	0.35
9	289591	289591	T	-	DOCK8	intronic	.	ENSG00000107099	rs727505303	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0338	0.0322	0.0261581	0.0278	.	.	.	.	.	.	.	.	.	.	AFR:0.0305,AMR:0.0060,EAS:0,FIN:0.0195,NFE:0.0322,OTH:0.0215,ASJ:0.0596	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	.	het
9	312134	312134	G	A	DOCK8	exonic	nonsynonymous SNV	ENSG00000107099	rs11789099	ENSG00000107099:ENST00000469391:exon5:c.G505A:p.E169K,ENSG00000107099:ENST00000483757:exon5:c.G505A:p.E169K,ENSG00000107099:ENST00000432829:exon6:c.G505A:p.E169K,ENSG00000107099:ENST00000453981:exon6:c.G709A:p.E237K	DOCK8:NM_001190458:exon5:c.G505A:p.E169K,DOCK8:NM_001193536:exon5:c.G505A:p.E169K,DOCK8:NM_203447:exon6:c.G709A:p.E237K	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0288	0.0245	0.0175719	0.0197	5.290	25.7	0.538	5.57	0.994	.	.	.	DOCK8:uc003zgg.3:exon5:c.G505A:p.E169K,DOCK8:uc010mgt.3:exon5:c.G505A:p.E169K,DOCK8:uc010mgv.3:exon5:c.G505A:p.E169K,DOCK8:uc022bcu.1:exon5:c.G505A:p.E169K,DOCK8:uc003zgf.2:exon6:c.G709A:p.E237K,DOCK8:uc011lls.1:exon6:c.G709A:p.E237K	-1.134	AFR:0.0085,AMR:0.0072,EAS:0,FIN:0.0143,NFE:0.0298,OTH:0.0193,ASJ:0.0497	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	0.782	2.61	0.029	1.5	9	MU115016664	het
9	328006	328006	T	C	DOCK8	intronic	.	ENSG00000107099	rs2296828	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6886	0.6684	0.695887	LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6703,AMR:0.6491,EAS:0.5331,FIN:0.7367,NFE:0.6710,OTH:0.6803,ASJ:0.6504	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.6531
9	370244	370244	A	G	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs913703	ENSG00000107099:ENST00000382329:exon3:c.A213G:p.K71K,ENSG00000107099:ENST00000469391:exon15:c.A1608G:p.K536K,ENSG00000107099:ENST00000432829:exon16:c.A1608G:p.K536K,ENSG00000107099:ENST00000453981:exon16:c.A1812G:p.K604K	DOCK8:NM_001190458:exon15:c.A1608G:p.K536K,DOCK8:NM_001193536:exon15:c.A1608G:p.K536K,DOCK8:NM_203447:exon16:c.A1812G:p.K604K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2226	0.2518	0.215855	MU137625	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon3:c.A186G:p.K62K,DOCK8:uc010mgv.3:exon15:c.A1608G:p.K536K,DOCK8:uc022bcu.1:exon15:c.A1608G:p.K536K,DOCK8:uc003zgf.2:exon16:c.A1812G:p.K604K	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.2218,EAS:0.1878,FIN:0.2053,NFE:0.0580,OTH:0.1876,ASJ:0.2588	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(urinary_tract)	0.2299
9	377111	377111	G	C	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs10814431	ENSG00000107099:ENST00000382331:exon6:c.G246C:p.L82L,ENSG00000107099:ENST00000382329:exon7:c.G741C:p.L247L,ENSG00000107099:ENST00000469391:exon19:c.G2136C:p.L712L,ENSG00000107099:ENST00000432829:exon20:c.G2136C:p.L712L,ENSG00000107099:ENST00000453981:exon20:c.G2340C:p.L780L	DOCK8:NM_001190458:exon19:c.G2136C:p.L712L,DOCK8:NM_001193536:exon19:c.G2136C:p.L712L,DOCK8:NM_203447:exon20:c.G2340C:p.L780L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2332	0.2666	0.228634	MU137627	.	.	.	.	.	.	.	.	DOCK8:uc010mgw.2:exon6:c.G246C:p.L82L,DOCK8:uc003zgk.2:exon7:c.G714C:p.L238L,DOCK8:uc010mgu.3:exon18:c.G246C:p.L82L,DOCK8:uc010mgv.3:exon19:c.G2136C:p.L712L,DOCK8:uc022bcu.1:exon19:c.G2136C:p.L712L,DOCK8:uc003zgf.2:exon20:c.G2340C:p.L780L	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.2372,EAS:0.1969,FIN:0.2152,NFE:0.0586,OTH:0.1908,ASJ:0.2896	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.2424
9	390512	390512	C	T	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs2297075	ENSG00000107099:ENST00000382331:exon10:c.C822T:p.T274T,ENSG00000107099:ENST00000382329:exon11:c.C1317T:p.T439T,ENSG00000107099:ENST00000469391:exon22:c.C2616T:p.T872T,ENSG00000107099:ENST00000432829:exon24:c.C2712T:p.T904T,ENSG00000107099:ENST00000453981:exon24:c.C2916T:p.T972T	DOCK8:NM_001190458:exon22:c.C2616T:p.T872T,DOCK8:NM_001193536:exon23:c.C2712T:p.T904T,DOCK8:NM_203447:exon24:c.C2916T:p.T972T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2344	0.2850	0.254992	6(lung)	.	.	.	.	.	.	.	.	DOCK8:uc010mgw.2:exon10:c.C822T:p.T274T,DOCK8:uc003zgk.2:exon11:c.C1290T:p.T430T,DOCK8:uc010mgu.3:exon22:c.C822T:p.T274T,DOCK8:uc010mgv.3:exon22:c.C2616T:p.T872T,DOCK8:uc022bcu.1:exon23:c.C2712T:p.T904T,DOCK8:uc003zgf.2:exon24:c.C2916T:p.T972T	.	AFR:MU137638,AMR:PACA-CA|1|268|0.00373134,LUSC-KR|6|170|0.0352941,EAS:0.3682,FIN:0.2017,NFE:0.2086,OTH:0.0641,ASJ:0.2589	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.1989
9	421032	421032	C	G	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs2297079	ENSG00000107099:ENST00000382329:exon19:c.C2508G:p.L836L,ENSG00000107099:ENST00000469391:exon30:c.C3807G:p.L1269L,ENSG00000107099:ENST00000432829:exon32:c.C3903G:p.L1301L,ENSG00000107099:ENST00000453981:exon32:c.C4107G:p.L1369L	DOCK8:NM_001190458:exon30:c.C3807G:p.L1269L,DOCK8:NM_001193536:exon31:c.C3903G:p.L1301L,DOCK8:NM_203447:exon32:c.C4107G:p.L1369L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5094	0.4626	0.391773	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon19:c.C2481G:p.L827L,DOCK8:uc010mgu.3:exon30:c.C2013G:p.L671L,DOCK8:uc010mgv.3:exon30:c.C3807G:p.L1269L,DOCK8:uc022bcu.1:exon31:c.C3903G:p.L1301L,DOCK8:uc003zgf.2:exon32:c.C4107G:p.L1369L	.	AFR:0.4491,AMR:0.1521,EAS:0.4801,FIN:0.5155,NFE:0.4814,OTH:0.6050,ASJ:0.4354	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.4837
9	429719	429719	T	C	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs7854035	ENSG00000107099:ENST00000382329:exon23:c.T2892C:p.F964F,ENSG00000107099:ENST00000469391:exon34:c.T4191C:p.F1397F,ENSG00000107099:ENST00000432829:exon36:c.T4287C:p.F1429F,ENSG00000107099:ENST00000453981:exon36:c.T4491C:p.F1497F	DOCK8:NM_001190458:exon34:c.T4191C:p.F1397F,DOCK8:NM_001193536:exon35:c.T4287C:p.F1429F,DOCK8:NM_203447:exon36:c.T4491C:p.F1497F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9978	0.9968	0.999401	0.9979	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon23:c.T2865C:p.F955F,DOCK8:uc010mgu.3:exon34:c.T2397C:p.F799F,DOCK8:uc010mgv.3:exon34:c.T4191C:p.F1397F,DOCK8:uc022bcu.1:exon35:c.T4287C:p.F1429F,DOCK8:uc003zgf.2:exon36:c.T4491C:p.F1497F	.	AFR:0.9993,AMR:0.9928,EAS:1,FIN:0.9997,NFE:0.9965,OTH:1,ASJ:1	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859376	hom
9	432330	432330	C	G	DOCK8	intronic	.	ENSG00000107099	rs7036567	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7577	0.6692	0.714257	0.7017	.	.	.	.	.	0.0001	0.042	.	.	.	AFR:0.4865,AMR:0.8305,EAS:0.9870,FIN:0.8003,NFE:0.7628,OTH:0.7351,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859387	hom
9	433978	433978	A	G	DOCK8	intronic	.	ENSG00000107099	rs2360712	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7588	0.6749	0.721046	0.7071	.	.	.	.	.	0.0041	0.204	.	.	.	AFR:0.5078,AMR:0.8313,EAS:0.9871,FIN:0.7994,NFE:0.7610,OTH:0.7383,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859414	hom
9	441952	441952	G	A	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs1887957	ENSG00000107099:ENST00000382329:exon29:c.G3834A:p.E1278E,ENSG00000107099:ENST00000469391:exon40:c.G5133A:p.E1711E,ENSG00000107099:ENST00000432829:exon42:c.G5229A:p.E1743E,ENSG00000107099:ENST00000453981:exon42:c.G5433A:p.E1811E	DOCK8:NM_001190458:exon40:c.G5133A:p.E1711E,DOCK8:NM_001193536:exon41:c.G5229A:p.E1743E,DOCK8:NM_203447:exon42:c.G5433A:p.E1811E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8201	0.7429	0.803914	0.7641	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon29:c.G3807A:p.E1269E,DOCK8:uc010mgu.3:exon40:c.G3339A:p.E1113E,DOCK8:uc010mgv.3:exon40:c.G5133A:p.E1711E,DOCK8:uc022bcu.1:exon41:c.G5229A:p.E1743E,DOCK8:uc003zgf.2:exon42:c.G5433A:p.E1811E	.	AFR:0.5880,AMR:0.8795,EAS:0.9981,FIN:0.8293,NFE:0.8162,OTH:0.8020,ASJ:0.8013	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU4566310	hom
9	446352	446352	G	C	DOCK8	intronic	.	ENSG00000107099	rs10814952	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6887	0.5583	0.632987	0.5990	.	.	.	.	.	.	.	.	.	.	AFR:0.2953,AMR:0.7852,EAS:0.9858,FIN:0.7018,NFE:0.6930,OTH:0.6837,ASJ:0.6457	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU32516518	hom
9	712060	712060	G	C	KANK1	exonic	nonsynonymous SNV	ENSG00000107104	rs4465020	ENSG00000107104:ENST00000382293:exon2:c.G820C:p.E274Q,ENSG00000107104:ENST00000382297:exon3:c.G1294C:p.E432Q,ENSG00000107104:ENST00000382303:exon7:c.G1294C:p.E432Q	KANK1:NM_001354335:exon2:c.G820C:p.E274Q,KANK1:NM_001354336:exon2:c.G820C:p.E274Q,KANK1:NM_001354337:exon2:c.G820C:p.E274Q,KANK1:NM_001354338:exon2:c.G820C:p.E274Q,KANK1:NM_001354339:exon2:c.G820C:p.E274Q,KANK1:NM_001354340:exon2:c.G820C:p.E274Q,KANK1:NM_001354341:exon2:c.G820C:p.E274Q,KANK1:NM_001354342:exon2:c.G820C:p.E274Q,KANK1:NM_001354343:exon2:c.G820C:p.E274Q,KANK1:NM_001354344:exon2:c.G820C:p.E274Q,KANK1:NM_153186:exon2:c.G820C:p.E274Q,KANK1:NM_001354331:exon3:c.G1294C:p.E432Q,KANK1:NM_001354332:exon3:c.G1294C:p.E432Q,KANK1:NM_001354333:exon3:c.G820C:p.E274Q,KANK1:NM_015158:exon3:c.G1294C:p.E432Q,KANK1:NM_001256877:exon4:c.G1294C:p.E432Q,KANK1:NM_001354334:exon4:c.G1294C:p.E432Q,KANK1:NM_001256876:exon7:c.G1294C:p.E432Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3392	0.2880	0.235224	0.2889	-0.550	0.166	0.093	4.81	0.013	.	.	.	KANK1:uc003zgq.2:exon2:c.G820C:p.E274Q,KANK1:uc003zgr.1:exon2:c.G820C:p.E274Q,KANK1:uc003zgs.2:exon2:c.G820C:p.E274Q,KANK1:uc003zgm.4:exon3:c.G1294C:p.E432Q,KANK1:uc003zgn.2:exon3:c.G1294C:p.E432Q,KANK1:uc003zgo.1:exon3:c.G1294C:p.E432Q,KANK1:uc003zgp.1:exon4:c.G1294C:p.E432Q,KANK1:uc031tct.1:exon4:c.G1294C:p.E432Q,KANK1:uc003zgl.2:exon7:c.G1294C:p.E432Q	-0.942	AFR:0.0792,AMR:0.2081,EAS:0.1267,FIN:0.3625,NFE:0.4079,OTH:0.3845,ASJ:0.3841	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	0.36	0.85	0.000	2.3	9	MU10850812	het
9	712599	712599	C	T	KANK1	exonic	synonymous SNV	ENSG00000107104	rs11789987	ENSG00000107104:ENST00000382293:exon2:c.C1359T:p.N453N,ENSG00000107104:ENST00000382297:exon3:c.C1833T:p.N611N,ENSG00000107104:ENST00000382303:exon7:c.C1833T:p.N611N	KANK1:NM_001354335:exon2:c.C1359T:p.N453N,KANK1:NM_001354336:exon2:c.C1359T:p.N453N,KANK1:NM_001354337:exon2:c.C1359T:p.N453N,KANK1:NM_001354338:exon2:c.C1359T:p.N453N,KANK1:NM_001354339:exon2:c.C1359T:p.N453N,KANK1:NM_001354340:exon2:c.C1359T:p.N453N,KANK1:NM_001354341:exon2:c.C1359T:p.N453N,KANK1:NM_001354342:exon2:c.C1359T:p.N453N,KANK1:NM_001354343:exon2:c.C1359T:p.N453N,KANK1:NM_001354344:exon2:c.C1359T:p.N453N,KANK1:NM_153186:exon2:c.C1359T:p.N453N,KANK1:NM_001354331:exon3:c.C1833T:p.N611N,KANK1:NM_001354332:exon3:c.C1833T:p.N611N,KANK1:NM_001354333:exon3:c.C1359T:p.N453N,KANK1:NM_015158:exon3:c.C1833T:p.N611N,KANK1:NM_001256877:exon4:c.C1833T:p.N611N,KANK1:NM_001354334:exon4:c.C1833T:p.N611N,KANK1:NM_001256876:exon7:c.C1833T:p.N611N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3486	0.3125	0.252995	0.3095	.	.	.	.	.	.	.	.	KANK1:uc003zgq.2:exon2:c.C1359T:p.N453N,KANK1:uc003zgr.1:exon2:c.C1359T:p.N453N,KANK1:uc003zgs.2:exon2:c.C1359T:p.N453N,KANK1:uc003zgm.4:exon3:c.C1833T:p.N611N,KANK1:uc003zgn.2:exon3:c.C1833T:p.N611N,KANK1:uc003zgo.1:exon3:c.C1833T:p.N611N,KANK1:uc003zgp.1:exon4:c.C1833T:p.N611N,KANK1:uc031tct.1:exon4:c.C1833T:p.N611N,KANK1:uc003zgl.2:exon7:c.C1833T:p.N611N	.	AFR:0.1373,AMR:0.2172,EAS:0.1270,FIN:0.3630,NFE:0.4153,OTH:0.3870,ASJ:0.3974	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU1788343	het
9	740770	740775	TTTTTT	-	KANK1	intronic	.	ENSG00000107104	rs368007873	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3271	.	0.417732	0.3401	.	.	.	.	.	.	.	.	.	.	AFR:0.3280,AMR:0.2619,EAS:0.1738,FIN:0.4033,NFE:0.3595,OTH:0.3548,ASJ:0.2581	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	.	het
9	742342	742342	A	G	KANK1	exonic	synonymous SNV	ENSG00000107104	rs10733535	ENSG00000107104:ENST00000382286:exon5:c.A591G:p.G197G,ENSG00000107104:ENST00000382289:exon6:c.A834G:p.G278G,ENSG00000107104:ENST00000382293:exon9:c.A3360G:p.G1120G,ENSG00000107104:ENST00000382297:exon10:c.A3834G:p.G1278G,ENSG00000107104:ENST00000382303:exon14:c.A3834G:p.G1278G	KANK1:NM_001354336:exon8:c.A3066G:p.G1022G,KANK1:NM_001354339:exon8:c.A3120G:p.G1040G,KANK1:NM_001354342:exon8:c.A3120G:p.G1040G,KANK1:NM_001354343:exon8:c.A3120G:p.G1040G,KANK1:NM_001354331:exon9:c.A3594G:p.G1198G,KANK1:NM_001354335:exon9:c.A3360G:p.G1120G,KANK1:NM_001354337:exon9:c.A3360G:p.G1120G,KANK1:NM_001354338:exon9:c.A3306G:p.G1102G,KANK1:NM_001354340:exon9:c.A3306G:p.G1102G,KANK1:NM_001354341:exon9:c.A3360G:p.G1120G,KANK1:NM_001354344:exon9:c.A3306G:p.G1102G,KANK1:NM_153186:exon9:c.A3360G:p.G1120G,KANK1:NM_001354332:exon10:c.A3780G:p.G1260G,KANK1:NM_001354333:exon10:c.A3360G:p.G1120G,KANK1:NM_015158:exon10:c.A3834G:p.G1278G,KANK1:NM_001256877:exon11:c.A3834G:p.G1278G,KANK1:NM_001354334:exon11:c.A3834G:p.G1278G,KANK1:NM_001256876:exon14:c.A3834G:p.G1278G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9953	0.9934	0.997604	0.9934	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon4:c.A570G:p.G190G,KANK1:uc010mgy.2:exon4:c.A570G:p.G190G,KANK1:uc010mgx.2:exon6:c.A768G:p.G256G,KANK1:uc003zgs.2:exon9:c.A3360G:p.G1120G,KANK1:uc003zgn.2:exon10:c.A3834G:p.G1278G,KANK1:uc031tct.1:exon11:c.A3834G:p.G1278G,KANK1:uc003zgl.2:exon14:c.A3834G:p.G1278G	.	AFR:0.9989,AMR:0.9916,EAS:1,FIN:0.9989,NFE:0.9887,OTH:0.9878,ASJ:1	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU93460	hom
9	2073292	2073292	A	G	SMARCA2	exonic	synonymous SNV	ENSG00000080503	rs13288443	ENSG00000080503:ENST00000382194:exon10:c.A1827G:p.P609P,ENSG00000080503:ENST00000349721:exon11:c.A1827G:p.P609P,ENSG00000080503:ENST00000357248:exon11:c.A1827G:p.P609P,ENSG00000080503:ENST00000382203:exon11:c.A1827G:p.P609P	SMARCA2:NM_001289396:exon11:c.A1827G:p.P609P,SMARCA2:NM_001289397:exon11:c.A1827G:p.P609P,SMARCA2:NM_003070:exon11:c.A1827G:p.P609P,SMARCA2:NM_139045:exon11:c.A1827G:p.P609P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1193	0.1188	0.107428	0.1200	.	.	.	.	.	.	.	.	SMARCA2:uc003zhc.3:exon11:c.A1827G:p.P609P,SMARCA2:uc003zhd.3:exon11:c.A1827G:p.P609P,SMARCA2:uc010mha.3:exon11:c.A1800G:p.P600P	.	AFR:0.1308,AMR:0.1420,EAS:0.0549,FIN:0.1520,NFE:0.1132,OTH:0.1253,ASJ:0.0530	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	.	.	.	.	9	MU20042442	het
9	2191309	2191309	C	G	SMARCA2	exonic	nonsynonymous SNV	ENSG00000080503	rs2296212	ENSG00000080503:ENST00000382183:exon6:c.C576G:p.D192E,ENSG00000080503:ENST00000302401:exon7:c.C702G:p.D234E,ENSG00000080503:ENST00000417599:exon7:c.C696G:p.D232E,ENSG00000080503:ENST00000324954:exon8:c.C576G:p.D192E,ENSG00000080503:ENST00000382185:exon8:c.C576G:p.D192E,ENSG00000080503:ENST00000382186:exon8:c.C630G:p.D210E,ENSG00000080503:ENST00000382194:exon31:c.C4584G:p.D1528E,ENSG00000080503:ENST00000357248:exon32:c.C4584G:p.D1528E,ENSG00000080503:ENST00000349721:exon33:c.C4638G:p.D1546E,ENSG00000080503:ENST00000382203:exon33:c.C4638G:p.D1546E	SMARCA2:NM_001289398:exon6:c.C612G:p.D204E,SMARCA2:NM_001289399:exon7:c.C696G:p.D232E,SMARCA2:NM_001289400:exon7:c.C702G:p.D234E,SMARCA2:NM_001289397:exon32:c.C4410G:p.D1470E,SMARCA2:NM_139045:exon32:c.C4584G:p.D1528E,SMARCA2:NM_001289396:exon33:c.C4638G:p.D1546E,SMARCA2:NM_003070:exon33:c.C4638G:p.D1546E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1684	0.1652	0.223642	1(haematopoietic_and_lymphoid_tissue)	2.083	16.74	1.0	3.76	0.997	.	.	.	SMARCA2:uc010mhb.3:exon6:c.C648G:p.D216E,SMARCA2:uc003zhe.3:exon7:c.C702G:p.D234E,SMARCA2:uc011llw.2:exon7:c.C696G:p.D232E,SMARCA2:uc011llx.2:exon8:c.C576G:p.D192E,SMARCA2:uc003zhd.3:exon32:c.C4584G:p.D1528E,SMARCA2:uc010mha.3:exon32:c.C4383G:p.D1461E,SMARCA2:uc003zhc.3:exon33:c.C4638G:p.D1546E	-1.098	AFR:1(liver),AMR:1(breast),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,FIN:0.1711,NFE:0.2721,OTH:0.2172,ASJ:MU10529735	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	0.0	-2.13	0.000	-1.59	9	3(soft_tissue)	0.1093
9	5050706	5050706	C	T	JAK2	exonic	synonymous SNV	ENSG00000096968	rs2230722	ENSG00000096968:ENST00000544510:exon3:c.C42T:p.H14H,ENSG00000096968:ENST00000539801:exon5:c.C489T:p.H163H,ENSG00000096968:ENST00000381652:exon6:c.C489T:p.H163H	JAK2:NM_001322204:exon3:c.C42T:p.H14H,JAK2:NM_001322195:exon5:c.C489T:p.H163H,JAK2:NM_001322196:exon5:c.C489T:p.H163H,JAK2:NM_001322194:exon6:c.C489T:p.H163H,JAK2:NM_004972:exon6:c.C489T:p.H163H	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3257	0.3565	0.358227	0.3526	.	.	.	.	.	.	.	.	JAK2:uc010mhm.3:exon5:c.C489T:p.H163H,JAK2:uc003ziw.3:exon6:c.C489T:p.H163H	.	AFR:0.4528,AMR:0.3345,EAS:0.2631,FIN:0.3475,NFE:0.3065,OTH:0.3681,ASJ:0.2848	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	.	.	.	.	9	MU80615669	het
9	5069930	5069930	T	C	JAK2	exonic	nonsynonymous SNV	ENSG00000096968	.	ENSG00000096968:ENST00000544510:exon9:c.T1072C:p.S358P,ENSG00000096968:ENST00000539801:exon11:c.T1519C:p.S507P,ENSG00000096968:ENST00000381652:exon12:c.T1519C:p.S507P	JAK2:NM_001322204:exon9:c.T1072C:p.S358P,JAK2:NM_001322195:exon11:c.T1519C:p.S507P,JAK2:NM_001322196:exon11:c.T1519C:p.S507P,JAK2:NM_001322194:exon12:c.T1519C:p.S507P,JAK2:NM_001322198:exon12:c.T304C:p.S102P,JAK2:NM_001322199:exon12:c.T304C:p.S102P,JAK2:NM_004972:exon12:c.T1519C:p.S507P	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	.	.	.	.	6.364	29.4	0.001	4.93	1.000	.	.	SH2 domain	JAK2:uc010mhm.3:exon11:c.T1519C:p.S507P,JAK2:uc003ziw.3:exon12:c.T1519C:p.S507P	0.468	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	0.998	-1.28	0.658	2.915	9	.	het
9	5081780	5081780	G	A	JAK2	exonic	synonymous SNV	ENSG00000096968	rs2230724	ENSG00000096968:ENST00000544510:exon16:c.G2043A:p.L681L,ENSG00000096968:ENST00000539801:exon18:c.G2490A:p.L830L,ENSG00000096968:ENST00000381652:exon19:c.G2490A:p.L830L	JAK2:NM_001322204:exon16:c.G2043A:p.L681L,JAK2:NM_001322195:exon18:c.G2490A:p.L830L,JAK2:NM_001322196:exon18:c.G2490A:p.L830L,JAK2:NM_001322194:exon19:c.G2490A:p.L830L,JAK2:NM_001322198:exon19:c.G1275A:p.L425L,JAK2:NM_001322199:exon19:c.G1275A:p.L425L,JAK2:NM_004972:exon19:c.G2490A:p.L830L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5328	0.6243	0.616813	14(meninges)	.	.	.	.	.	.	.	.	JAK2:uc010mhm.3:exon18:c.G2490A:p.L830L,JAK2:uc003ziw.3:exon19:c.G2490A:p.L830L	.	AFR:3(large_intestine),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6108,NFE:0.8679,OTH:0.5096,ASJ:MU99782	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	.	.	.	.	9	1(lung)	0.6159
9	5557672	5557672	T	C	PDCD1LG2	exonic	nonsynonymous SNV	ENSG00000197646	rs7854303	ENSG00000197646:ENST00000397745:exon4:c.T416C:p.F139S,ENSG00000197646:ENST00000397747:exon5:c.T686C:p.F229S	PDCD1LG2:NM_025239:exon5:c.T686C:p.F229S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9992	0.9988	0.997804	0.9989	-0.047	2.158	0.552	0.724	0.021	.	.	.	PDCD1LG2:uc010mho.1:exon3:c.T416C:p.F139S,PDCD1LG2:uc003zjg.4:exon5:c.T686C:p.F229S,PDCD1LG2:uc011lmc.2:exon5:c.T686C:p.F229S	-1.036	AFR:0.9975,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:1	605723	.	.	.	.	.	.	.	0.0	5.16	0.000	.	9	MU81859703	hom
9	8331574	8331574	-	AACTTACCATTCCTGAACTGT	PTPRD	intronic	.	ENSG00000153707	rs146237556	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1669	.	0.203474	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601598	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	8389364	8389364	C	G	PTPRD	exonic	synonymous SNV	ENSG00000153707	rs2279776	ENSG00000153707:ENST00000397606:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000397617:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000537002:exon20:c.G3024C:p.G1008G,ENSG00000153707:ENST00000397611:exon21:c.G3024C:p.G1008G,ENSG00000153707:ENST00000355233:exon22:c.G3036C:p.G1012G,ENSG00000153707:ENST00000358503:exon22:c.G4188C:p.G1396G,ENSG00000153707:ENST00000486161:exon22:c.G3033C:p.G1011G,ENSG00000153707:ENST00000360074:exon23:c.G4215C:p.G1405G,ENSG00000153707:ENST00000356435:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000540109:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000381196:exon34:c.G4254C:p.G1418G	PTPRD:NM_001171025:exon20:c.G3033C:p.G1011G,PTPRD:NM_130393:exon20:c.G3006C:p.G1002G,PTPRD:NM_001040712:exon21:c.G3024C:p.G1008G,PTPRD:NM_130391:exon22:c.G3033C:p.G1011G,PTPRD:NM_130392:exon22:c.G3036C:p.G1012G,PTPRD:NM_002839:exon37:c.G4254C:p.G1418G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.4992	0.4847	0.55631	0.4920	.	.	.	.	.	.	.	.	PTPRD:uc003zkr.3:exon20:c.G3006C:p.G1002G,PTPRD:uc003zks.3:exon20:c.G3033C:p.G1011G,PTPRD:uc022bdj.1:exon21:c.G3024C:p.G1008G,PTPRD:uc003zkp.3:exon22:c.G3036C:p.G1012G,PTPRD:uc003zkq.3:exon22:c.G3033C:p.G1011G,PTPRD:uc003zkk.3:exon37:c.G4254C:p.G1418G	.	AFR:0.5735,AMR:0.5072,EAS:0.6897,FIN:0.4948,NFE:0.4231,OTH:0.4691,ASJ:0.5066	601598	.	.	.	.	,9360,9359	.	.	.	.	.	.	9	MU733175	het
9	8436703	8436703	C	G	PTPRD	intronic	.	ENSG00000153707	rs1359118	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6025	0.5886	0.622404	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6082,AMR:0.5829,EAS:0.5728,FIN:0.6301,NFE:0.6051,OTH:0.6252,ASJ:0.5504	601598	.	.	.	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.6090
9	8454566	8454566	T	C	PTPRD	intronic	.	ENSG00000153707	rs7031287	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4198	0.4580	0.502995	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.4591,AMR:0.6408,EAS:0.4669,FIN:0.3696,NFE:0.3666,OTH:0.3878,ASJ:0.4459	601598	.	.	.	.	.	.	.	.	.	.	.	9	1(liver)	0.4199
9	20414355	20414355	-	CTGCTGCTGCTGCTGCTGCTA	MLLT3	exonic	nonframeshift insertion	ENSG00000171843	.	ENSG00000171843:ENST00000380338:exon5:c.488_489insTAGCAGCAGCAGCAGCAGCAG:p.S163delinsSSSSSSSS,ENSG00000171843:ENST00000429426:exon5:c.479_480insTAGCAGCAGCAGCAGCAGCAG:p.S160delinsSSSSSSSS	MLLT3:NM_001286691:exon5:c.479_480insTAGCAGCAGCAGCAGCAGCAG:p.S160delinsSSSSSSSS,MLLT3:NM_004529:exon5:c.488_489insTAGCAGCAGCAGCAGCAGCAG:p.S163delinsSSSSSSSS	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	3.251e-05	.	.	.	.	.	.	.	.	MLLT3:uc011lne.1:exon4:c.392_393insTAGCAGCAGCAGCAGCAGCAG:p.S131delinsSSSSSSSS,MLLT3:uc003zoe.2:exon5:c.488_489insTAGCAGCAGCAGCAGCAGCAG:p.S163delinsSSSSSSSS,MLLT3:uc011lnf.1:exon5:c.479_480insTAGCAGCAGCAGCAGCAGCAG:p.S160delinsSSSSSSSS	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.711e-05,OTH:0,ASJ:0	159558	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	9	.	het
9	27183463	27183463	A	C	TEK	exonic	nonsynonymous SNV	ENSG00000120156	rs682632	ENSG00000120156:ENST00000519080:exon5:c.A467C:p.Q156P,ENSG00000120156:ENST00000519097:exon6:c.A596C:p.Q199P,ENSG00000120156:ENST00000406359:exon7:c.A908C:p.Q303P,ENSG00000120156:ENST00000380036:exon8:c.A1037C:p.Q346P	TEK:NM_001290078:exon6:c.A596C:p.Q199P,TEK:NM_001290077:exon7:c.A908C:p.Q303P,TEK:NM_000459:exon8:c.A1037C:p.Q346P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9733	0.9727	0.989816	0.9758	1.658	14.17	0.411	5.52	0.985	.	.	Immunoglobulin-like fold	TEK:uc003zqj.1:exon6:c.A839C:p.Q280P,TEK:uc011lnp.2:exon6:c.A596C:p.Q199P,TEK:uc011lno.2:exon7:c.A908C:p.Q303P,TEK:uc003zqi.4:exon8:c.A1037C:p.Q346P	-0.934	AFR:0.9924,AMR:0.9905,EAS:1,FIN:0.9720,NFE:0.9639,OTH:0.9674,ASJ:0.9834	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	0.0	-0.81	0.000	-0.345	9	MU81860880	hom
9	27220066	27220066	G	A	TEK	exonic	synonymous SNV	ENSG00000120156	rs2273719	ENSG00000120156:ENST00000519097:exon19:c.G2679A:p.G893G,ENSG00000120156:ENST00000406359:exon20:c.G2994A:p.G998G,ENSG00000120156:ENST00000380036:exon21:c.G3123A:p.G1041G	TEK:NM_001290078:exon19:c.G2679A:p.G893G,TEK:NM_001290077:exon20:c.G2994A:p.G998G,TEK:NM_000459:exon21:c.G3123A:p.G1041G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1800	0.2246	0.224241	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TEK:uc011lnp.2:exon19:c.G2679A:p.G893G,TEK:uc011lno.2:exon20:c.G2994A:p.G998G,TEK:uc003zqi.4:exon21:c.G3123A:p.G1041G	.	AFR:0.2107,AMR:0.3527,EAS:0.1192,FIN:0.1890,NFE:0.1657,OTH:0.1513,ASJ:0.1163	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	4(haematopoietic_and_lymphoid_tissue)	0.1640
9	27229141	27229141	T	C	TEK	intronic	.	ENSG00000120156	rs2273715	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1724	0.2111	0.223043	LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.1930,AMR:0.3261,EAS:0.1159,FIN:0.1768,NFE:0.1563,OTH:0.1348,ASJ:0.1146	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	4(haematopoietic_and_lymphoid_tissue)	0.1489
9	32630472	32630472	T	C	TAF1L	exonic	synonymous SNV	ENSG00000122728	rs10758145	ENSG00000122728:ENST00000242310:exon1:c.A5106G:p.K1702K	TAF1L:NM_153809:exon1:c.A5106G:p.K1702K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2810	0.3147	0.346046	0.3276	.	.	.	.	.	.	.	.	TAF1L:uc003zrg.1:exon1:c.A5106G:p.K1702K	.	AFR:0.4882,AMR:0.2267,EAS:0.3814,FIN:0.2693,NFE:0.2532,OTH:0.2749,ASJ:0.2285	607798	.	.	.	.	.	.	.	.	.	.	.	9	MU18619976	hom
9	32631369	32631369	C	T	TAF1L	exonic	synonymous SNV	ENSG00000122728	rs10971047	ENSG00000122728:ENST00000242310:exon1:c.G4209A:p.T1403T	TAF1L:NM_153809:exon1:c.G4209A:p.T1403T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1311	0.0974	0.161542	0.1121	.	.	.	.	.	.	.	.	TAF1L:uc003zrg.1:exon1:c.G4209A:p.T1403T	.	AFR:0.0881,AMR:0.1289,EAS:0.3020,FIN:0.1116,NFE:0.1049,OTH:0.1184,ASJ:0.0861	607798	.	.	.	.	.	.	.	.	.	.	.	9	MU18620054	hom
9	32891930	32891930	T	C	TMEM215;APTX	intergenic	.	ENSG00000236796;ENSG00000223807	rs10115224	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.602436	0.6777	.	.	.	.	.	.	.	.	.	.	AFR:0.6434,AMR:0.5502,EAS:0.2880,FIN:0.6624,NFE:0.7488,OTH:0.7168,ASJ:0.6391	.	.	.	.	.	.	.	.	.	.	.	.	9	MU10673410	hom
9	32924998	32924998	G	T	TMEM215;APTX	intergenic	.	ENSG00000236796;ENSG00000223807	rs12348381	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.159744	0.2303	.	.	.	.	.	.	.	.	.	.	AFR:0.2154,AMR:0.1850,EAS:0.0167,FIN:0.2595,NFE:0.2542,OTH:0.2561,ASJ:0.3245	.	.	.	.	.	.	.	.	.	.	.	.	9	MU32540544	het
9	32926463	32926463	-	AAA	TMEM215;APTX	intergenic	.	ENSG00000223807	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	32966786	32966786	A	-	TMEM215;APTX	intergenic	.	ENSG00000237437;ENSG00000137074	rs201071964	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0288	.	.	.	.	.	.	.	.	.	.	AFR:0.0191,AMR:0.1173,EAS:0.0033,FIN:0.2345,NFE:0.0182,OTH:0.0338,ASJ:0.0462	.	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	32974570	32974570	-	A	APTX	intronic	.	ENSG00000137074	rs34600530	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6513	0.5835	0.688698	0.6408	.	.	.	.	.	.	.	.	.	.	AFR:0.5482,AMR:0.7017,EAS:0.8639,FIN:0.6968,NFE:0.6540,OTH:0.6840,ASJ:0.5567	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	.	hom
9	32986041	32986041	C	A	APTX	intronic	.	ENSG00000137074	rs10123944	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6263	.	.	0.6294	.	.	.	.	.	.	.	.	.	.	AFR:0.6194,AMR:0.6047,EAS:0.8446,FIN:0.4803,NFE:0.6213,OTH:0.6424,ASJ:0.5114	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	MU15306710	hom
9	35074917	35074917	T	C	FANCG	intronic	.	ENSG00000221829	rs587118	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3957	0.3621	0.220248	0.3611	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.0939,AMR:0.4952,EAS:0.0006,FIN:0.5063,NFE:0.5084,OTH:0.4481,ASJ:0.3808	602956	614082;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	9	MU10698616	het
9	36840623	36840623	G	A	PAX5	exonic	nonsynonymous SNV	ENSG00000196092	rs3780135	ENSG00000196092:ENST00000520154:exon7:c.C791T:p.T264I,ENSG00000196092:ENST00000523241:exon8:c.C878T:p.T293I	PAX5:NM_001280550:exon7:c.C791T:p.T264I,PAX5:NM_001280549:exon8:c.C878T:p.T293I	clinvar: not_provided 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8687	0.7631	0.742013	COCA-CN|5|321|0.0155763	-0.039	2.223	0.215	2.41	0.999	.	.	.	PAX5:uc010mls.1:exon7:c.C791T:p.T264I,PAX5:uc010mlr.1:exon8:c.C878T:p.T293I	-0.922	AFR:0.7818,AMR:0.3822,EAS:0.8974,FIN:0.8837,NFE:0.9527,OTH:0.9467,ASJ:0.8816	167414	615545;	99860;	99860|B-ALL<br>Precursor B-cell acute lymphoblastic leukemia/lymphoma<br>Precursor B-cell acute lymphocytic leukemia<br>Precursor B-cell acute lymphocytic leukemia/lymphoma|-|-|-|615545 ~	~ko05202 Transcriptional misregulation in cancer ~	,8446	.	.	0.0	-4.59	0.000	.	9	1(thyroid)	0.8949
9	71831398	71831398	T	C	TJP2	intronic	.	ENSG00000119139	rs2498417	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9209	0.9038	0.894169	0.9094	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.9081,EAS:0.9333,FIN:0.9479,NFE:0.9244,OTH:0.9328,ASJ:0.9205	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	MU81862766	hom
9	71843023	71843023	C	A	TJP2	exonic	nonsynonymous SNV	ENSG00000119139	rs2309428	ENSG00000119139:ENST00000265384:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000348208:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000377245:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000535702:exon9:c.C1458A:p.D486E,ENSG00000119139:ENST00000539225:exon9:c.C1539A:p.D513E,ENSG00000119139:ENST00000453658:exon10:c.C1377A:p.D459E	TJP2:NM_001170415:exon9:c.C1458A:p.D486E,TJP2:NM_001170416:exon9:c.C1539A:p.D513E,TJP2:NM_001369872:exon9:c.C1446A:p.D482E,TJP2:NM_001369873:exon9:c.C1446A:p.D482E,TJP2:NM_001369874:exon9:c.C1458A:p.D486E,TJP2:NM_001369875:exon9:c.C1458A:p.D486E,TJP2:NM_004817:exon9:c.C1446A:p.D482E,TJP2:NM_201629:exon9:c.C1446A:p.D482E,TJP2:NM_001170414:exon10:c.C1377A:p.D459E,TJP2:NM_001369870:exon10:c.C1371A:p.D457E,TJP2:NM_001369871:exon11:c.C1377A:p.D459E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8115	0.7580	0.772165	0.7864	-0.778	0.048	1.0	-1.25	0.390	.	.	PDZ domain	TJP2:uc004ahd.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahe.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahf.3:exon9:c.C1446A:p.D482E,TJP2:uc011lru.2:exon9:c.C1458A:p.D486E,TJP2:uc011lrv.2:exon9:c.C1539A:p.D513E,TJP2:uc011lrs.2:exon10:c.C1377A:p.D459E,TJP2:uc011lrt.1:exon11:c.C1377A:p.D459E	-0.968	AFR:0.6611,AMR:0.8616,EAS:0.8906,FIN:0.8698,NFE:0.8210,OTH:0.8310,ASJ:0.7947	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	0.0	3.13	0.000	-0.485	9	MU10854686	hom
9	71865932	71865932	G	A	TJP2	intronic	.	ENSG00000119139	rs2282335	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3704	0.4050	0.359824	MU44530448	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.4030,EAS:0.2333,FIN:0.4238,NFE:0.1483,OTH:0.4587,ASJ:0.4565	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.3941
9	72897434	72897434	G	A	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs1180116	ENSG00000198887:ENST00000361138:exon7:c.G916A:p.V306I	SMC5:NM_015110:exon7:c.G916A:p.V306I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8824	0.8558	0.855032	0.8686	0.072	3.315	0.655	-1.31	0.909	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon7:c.G916A:p.V306I	-1.035	AFR:0.7743,AMR:0.8849,EAS:0.8476,FIN:0.9321,NFE:0.9100,OTH:0.8845,ASJ:0.8146	609386	.	.	.	.	.	.	.	0.0	2.34	0.000	0	9	MU25197989	hom
9	72901096	72901096	T	C	SMC5	intronic	.	ENSG00000198887	rs1180123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9933	0.9749	0.978235	0.9800	.	.	.	.	.	.	.	.	.	.	AFR:0.9295,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9927,ASJ:1	609386	.	.	.	.	.	.	.	.	.	.	.	9	MU81862879	hom
9	72929765	72929765	A	C	SMC5	intronic	.	ENSG00000198887	rs117931618	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0014	.	0.00439297	0.0009	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0173,FIN:0,NFE:0,OTH:0,ASJ:0	609386	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	80343587	80343587	-	A	GNAQ	intronic	.	ENSG00000156052	rs397773021	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4414	0.4315	0.372005	0.6019	.	.	.	.	.	.	.	.	.	.	AFR:0.4886,AMR:0.5915,EAS:0.4121,FIN:0.5959,NFE:0.6915,OTH:0.6529,ASJ:0.6763	600998	163000;185300;	3205;624;	3205|Encephalofacial angiomatosis<br>Encephalotrigeminal angiomatosis<br>SWS<br>Sturge-Weber-Dimitri syndrome<br>Sturge-Weber-Krabbe angiomatosis<br>Sturge-Weber-Krabbe syndrome|1-9 / 100 000|Not applicable|Infancy<br>Neonatal<br>Childhood<br>Adolescent|185300 ~624|Familial multiple port-wine stains|-|-|Neonatal|163000 ~	~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04071 Sphingolipid signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	9	.	het
9	90219920	90219920	G	A	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs36207428	ENSG00000196730:ENST00000489291:exon2:c.G114A:p.Q38Q,ENSG00000196730:ENST00000491893:exon2:c.G114A:p.Q38Q,ENSG00000196730:ENST00000358077:exon3:c.G114A:p.Q38Q,ENSG00000196730:ENST00000408954:exon3:c.G114A:p.Q38Q,ENSG00000196730:ENST00000469640:exon3:c.G114A:p.Q38Q,ENSG00000196730:ENST00000472284:exon3:c.G114A:p.Q38Q	DAPK1:NM_001288729:exon3:c.G114A:p.Q38Q,DAPK1:NM_001288730:exon3:c.G114A:p.Q38Q,DAPK1:NM_001288731:exon3:c.G114A:p.Q38Q,DAPK1:NM_004938:exon3:c.G114A:p.Q38Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0563	0.0895	0.0864617	0.0927	.	.	.	.	.	.	.	.	DAPK1:uc011ltg.2:exon2:c.G114A:p.Q38Q,DAPK1:uc004apc.3:exon3:c.G114A:p.Q38Q,DAPK1:uc004apd.3:exon3:c.G114A:p.Q38Q,DAPK1:uc004ape.3:exon3:c.G114A:p.Q38Q	.	AFR:0.1919,AMR:0.0480,EAS:0,FIN:0.0937,NFE:0.0509,OTH:0.0458,ASJ:0.0629	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	.	het
9	90255708	90255708	C	G	DAPK1	intronic	.	ENSG00000196730	rs36211678	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0028	0.0059	0.00778754	0.0047	.	.	.	.	.	0.0020	0.066	.	.	.	AFR:0.0161,AMR:0.0036,EAS:0,FIN:0,NFE:6.664e-05,OTH:0.0020,ASJ:0	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	.	het
9	90258281	90258281	T	A	DAPK1	intronic	.	ENSG00000196730	rs200670633	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0041	.	.	1(large_intestine)	.	.	.	.	.	0.8743	0.596	.	.	.	AFR:MU15315638,AMR:MELA-AU|1|183|0.00546448,LICA-CN|3|402|0.00746269,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,EOPC-DE|1|202|0.0049505,BTCA-JP|1|239|0.0041841,EAS:0.0442,FIN:0.0042,NFE:0.0117,OTH:0.0006,ASJ:0.0124	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	2(liver)	0.0004
9	90265015	90265015	C	T	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs3818584	ENSG00000196730:ENST00000491893:exon15:c.C1608T:p.D536D,ENSG00000196730:ENST00000358077:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000408954:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000469640:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000472284:exon16:c.C1608T:p.D536D	DAPK1:NM_001288729:exon16:c.C1608T:p.D536D,DAPK1:NM_001288730:exon16:c.C1608T:p.D536D,DAPK1:NM_001288731:exon16:c.C1608T:p.D536D,DAPK1:NM_004938:exon16:c.C1608T:p.D536D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3895	0.3067	0.354034	LIRI-JP|1|258|0.00387597,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,PBCA-DE|1|499|0.00200401	.	.	.	.	.	.	.	.	DAPK1:uc004apf.1:exon2:c.C270T:p.D90D,DAPK1:uc011lth.2:exon14:c.C819T:p.D273D,DAPK1:uc011ltg.2:exon15:c.C1608T:p.D536D,DAPK1:uc004apc.3:exon16:c.C1608T:p.D536D,DAPK1:uc004apd.3:exon16:c.C1608T:p.D536D,DAPK1:uc004ape.3:exon16:c.C1608T:p.D536D	.	AFR:0.3442,AMR:0.1615,EAS:0.2848,FIN:0.6390,NFE:0.4332,OTH:0.3804,ASJ:0.5873	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(lung)	0.4255
9	90283509	90283509	C	T	DAPK1	intronic	.	ENSG00000196730	rs3750539	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0439	0.0423	0.0499201	0.0423	.	.	.	.	.	0.0029	0.124	.	.	.	AFR:0.0261,AMR:0.0431,EAS:0.1,FIN:0.0547,NFE:0.0421,OTH:0.0357,ASJ:0.0894	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	MU82109656	unknown
9	90283514	90283514	C	T	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs3750538	ENSG00000196730:ENST00000491893:exon18:c.C1926T:p.D642D,ENSG00000196730:ENST00000358077:exon19:c.C1926T:p.D642D,ENSG00000196730:ENST00000408954:exon19:c.C1926T:p.D642D,ENSG00000196730:ENST00000469640:exon19:c.C1926T:p.D642D,ENSG00000196730:ENST00000472284:exon19:c.C1926T:p.D642D	DAPK1:NM_001288729:exon19:c.C1926T:p.D642D,DAPK1:NM_001288730:exon19:c.C1926T:p.D642D,DAPK1:NM_001288731:exon19:c.C1926T:p.D642D,DAPK1:NM_004938:exon19:c.C1926T:p.D642D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0439	0.0424	0.0483227	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	DAPK1:uc004apf.1:exon5:c.C588T:p.D196D,DAPK1:uc011lth.2:exon17:c.C1137T:p.D379D,DAPK1:uc011ltg.2:exon18:c.C1926T:p.D642D,DAPK1:uc004apc.3:exon19:c.C1926T:p.D642D,DAPK1:uc004apd.3:exon19:c.C1926T:p.D642D	.	AFR:0.0423,AMR:0.0260,EAS:0.0894,FIN:0.1,NFE:0.0547,OTH:0.0421,ASJ:0.0431	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(breast)	0.0356
9	90313717	90313717	G	T	DAPK1	intronic	.	ENSG00000196730	rs3128495	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4502	0.3445	0.348842	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3567,AMR:0.1152,EAS:0.48,FIN:0.4037,NFE:0.4845,OTH:0.4428,ASJ:0.6005	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(stomach)	0.4102
9	90321583	90321583	C	T	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs3118863	ENSG00000196730:ENST00000491893:exon24:c.C3399T:p.R1133R,ENSG00000196730:ENST00000358077:exon26:c.C3597T:p.R1199R,ENSG00000196730:ENST00000408954:exon26:c.C3597T:p.R1199R,ENSG00000196730:ENST00000472284:exon26:c.C3597T:p.R1199R,ENSG00000196730:ENST00000469640:exon27:c.C3672T:p.R1224R	DAPK1:NM_001288729:exon26:c.C3597T:p.R1199R,DAPK1:NM_001288730:exon26:c.C3597T:p.R1199R,DAPK1:NM_001288731:exon26:c.C3597T:p.R1199R,DAPK1:NM_004938:exon26:c.C3597T:p.R1199R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4399	0.3619	0.356629	MU112652	.	.	.	.	.	.	.	.	DAPK1:uc004apg.2:exon1:c.C528T:p.R176R,DAPK1:uc011ltg.2:exon24:c.C3399T:p.R1133R,DAPK1:uc011lth.2:exon24:c.C2808T:p.R936R,DAPK1:uc004apc.3:exon26:c.C3597T:p.R1199R,DAPK1:uc004apd.3:exon26:c.C3597T:p.R1199R	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.3708,EAS:0.4892,FIN:0.4868,NFE:0.4056,OTH:0.4837,ASJ:0.1775	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(thyroid)	0.4420
9	90322023	90322023	G	A	DAPK1	exonic	nonsynonymous SNV	ENSG00000196730	rs1056719	ENSG00000196730:ENST00000491893:exon24:c.G3839A:p.S1280N,ENSG00000196730:ENST00000358077:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000408954:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000472284:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000469640:exon27:c.G4112A:p.S1371N	DAPK1:NM_001288729:exon26:c.G4037A:p.S1346N,DAPK1:NM_001288730:exon26:c.G4037A:p.S1346N,DAPK1:NM_001288731:exon26:c.G4037A:p.S1346N,DAPK1:NM_004938:exon26:c.G4037A:p.S1346N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6672	0.5858	0.65595	MU4558958	-2.158	0.001	0.528	-2.04	0.011	.	.	Death domain|Death-like domain	DAPK1:uc004apg.2:exon1:c.G968A:p.S323N,DAPK1:uc011ltg.2:exon24:c.G3839A:p.S1280N,DAPK1:uc011lth.2:exon24:c.G3248A:p.S1083N,DAPK1:uc004apc.3:exon26:c.G4037A:p.S1346N,DAPK1:uc004apd.3:exon26:c.G4037A:p.S1346N	-0.943	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AML-US|1|166|0.0060241,AMR:0.5999,EAS:0.7290,FIN:0.6424,NFE:0.8327,OTH:0.6407,ASJ:0.4523	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	0.0	-1.98	0.000	-0.14	9	71(lung)	0.6415
9	93606309	93606309	G	A	SYK	exonic	synonymous SNV	ENSG00000165025	rs35758162	ENSG00000165025:ENST00000375746:exon2:c.G129A:p.Q43Q,ENSG00000165025:ENST00000375747:exon2:c.G129A:p.Q43Q,ENSG00000165025:ENST00000375751:exon2:c.G129A:p.Q43Q,ENSG00000165025:ENST00000375754:exon2:c.G129A:p.Q43Q	SYK:NM_001135052:exon2:c.G129A:p.Q43Q,SYK:NM_001174167:exon2:c.G129A:p.Q43Q,SYK:NM_001174168:exon2:c.G129A:p.Q43Q,SYK:NM_003177:exon2:c.G129A:p.Q43Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1781	0.1787	0.111022	0.1537	.	.	.	.	.	.	.	.	SYK:uc004aqz.3:exon2:c.G129A:p.Q43Q,SYK:uc004ara.3:exon2:c.G129A:p.Q43Q,SYK:uc004arb.3:exon2:c.G129A:p.Q43Q,SYK:uc004arc.3:exon2:c.G129A:p.Q43Q	.	AFR:0.1133,AMR:0.0885,EAS:0.0105,FIN:0.1162,NFE:0.2026,OTH:0.1690,ASJ:0.2285	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	MU113484569	het
9	93639846	93639846	C	G	SYK	intronic	.	ENSG00000165025	rs290223	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2504	0.2069	0.301518	0.2204	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.2107,AMR:0.1993,EAS:0.5286,FIN:0.2602,NFE:0.1853,OTH:0.2179,ASJ:0.2067	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	MU684467	het
9	93641193	93641193	C	T	SYK	exonic	synonymous SNV	ENSG00000165025	rs34231418	ENSG00000165025:ENST00000375747:exon10:c.C1470T:p.F490F,ENSG00000165025:ENST00000375751:exon10:c.C1470T:p.F490F,ENSG00000165025:ENST00000375746:exon11:c.C1539T:p.F513F,ENSG00000165025:ENST00000375754:exon11:c.C1539T:p.F513F	SYK:NM_001135052:exon10:c.C1470T:p.F490F,SYK:NM_001174168:exon10:c.C1470T:p.F490F,SYK:NM_001174167:exon11:c.C1539T:p.F513F,SYK:NM_003177:exon11:c.C1539T:p.F513F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0390	0.0443	0.0341454	.	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon10:c.C1470T:p.F490F,SYK:uc004arb.3:exon10:c.C1470T:p.F490F,SYK:uc004aqz.3:exon11:c.C1539T:p.F513F,SYK:uc004arc.3:exon11:c.C1539T:p.F513F	.	AFR:0.0400,AMR:0.0448,EAS:0.02,FIN:0,NFE:0.0555,OTH:0.0395,ASJ:0.0179	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	1(large_intestine)	0.0407
9	95993326	95993326	T	C	WNK2	exonic	synonymous SNV	ENSG00000165238	rs11787888	ENSG00000165238:ENST00000297954:exon3:c.T1011C:p.S337S,ENSG00000165238:ENST00000395475:exon3:c.T969C:p.S323S,ENSG00000165238:ENST00000395477:exon3:c.T1011C:p.S337S,ENSG00000165238:ENST00000448039:exon3:c.T1011C:p.S337S	WNK2:NM_001282394:exon3:c.T1011C:p.S337S,WNK2:NM_006648:exon3:c.T1011C:p.S337S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1490	0.1267	0.148562	0.1281	.	.	.	.	.	.	.	.	WNK2:uc004ati.1:exon3:c.T1011C:p.S337S,WNK2:uc004atj.3:exon3:c.T1011C:p.S337S,WNK2:uc010mrc.1:exon3:c.T1011C:p.S337S,WNK2:uc011lud.1:exon3:c.T1011C:p.S337S	.	AFR:0.0991,AMR:0.0861,EAS:0.0742,FIN:0.1721,NFE:0.1403,OTH:0.1527,ASJ:0.1722	606249	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	96000622	96000622	C	T	WNK2	intronic	.	ENSG00000165238	rs1539670	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9482	0.9682	0.94349	0.9599	.	.	.	.	.	.	.	.	.	.	AFR:0.9757,AMR:0.9773,EAS:0.8938,FIN:0.9550,NFE:0.9595,OTH:0.95,ASJ:0.9205	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU82109719	hom
9	96015256	96015256	C	T	WNK2	exonic	synonymous SNV	ENSG00000165238	rs4744201	ENSG00000165238:ENST00000297954:exon8:c.C1926T:p.D642D,ENSG00000165238:ENST00000349097:exon8:c.C762T:p.D254D,ENSG00000165238:ENST00000395475:exon8:c.C1884T:p.D628D,ENSG00000165238:ENST00000395477:exon8:c.C1926T:p.D642D,ENSG00000165238:ENST00000427277:exon8:c.C762T:p.D254D,ENSG00000165238:ENST00000448039:exon8:c.C1926T:p.D642D	WNK2:NM_001282394:exon8:c.C1926T:p.D642D,WNK2:NM_006648:exon8:c.C1926T:p.D642D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4840	0.3729	0.316094	0.3945	.	.	.	.	.	.	.	.	WNK2:uc004atk.3:exon5:c.C837T:p.D279D,WNK2:uc004ati.1:exon8:c.C1926T:p.D642D,WNK2:uc004atj.3:exon8:c.C1926T:p.D642D,WNK2:uc010mrc.1:exon8:c.C1926T:p.D642D,WNK2:uc011lud.1:exon8:c.C1926T:p.D642D	.	AFR:0.1299,AMR:0.6067,EAS:0.4387,FIN:0.4745,NFE:0.5109,OTH:0.4356,ASJ:0.3940	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU684061	het
9	96015377	96015377	A	G	WNK2	intronic	.	ENSG00000165238	rs4744202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9528	0.9707	0.948283	0.9646	.	.	.	.	.	.	.	.	.	.	AFR:0.9917,AMR:0.9785,EAS:0.8936,FIN:0.9548,NFE:0.9597,OTH:0.9499,ASJ:0.9238	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU81864351	hom
9	96021312	96021312	G	A	WNK2	exonic	nonsynonymous SNV	ENSG00000165238	rs10761203	ENSG00000165238:ENST00000395475:exon10:c.G2284A:p.V762M,ENSG00000165238:ENST00000448039:exon10:c.G2326A:p.V776M,ENSG00000165238:ENST00000297954:exon11:c.G2482A:p.V828M,ENSG00000165238:ENST00000349097:exon11:c.G1318A:p.V440M,ENSG00000165238:ENST00000395477:exon11:c.G2482A:p.V828M,ENSG00000165238:ENST00000427277:exon11:c.G1318A:p.V440M	WNK2:NM_001282394:exon11:c.G2482A:p.V828M,WNK2:NM_006648:exon11:c.G2482A:p.V828M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.4327	0.3680	0.313498	2(thyroid)	2.757	21.1	0.013	2.9	0.024	.	.	.	WNK2:uc004atk.3:exon8:c.G1393A:p.V465M,WNK2:uc010mrc.1:exon10:c.G2326A:p.V776M,WNK2:uc004ati.1:exon11:c.G2482A:p.V828M,WNK2:uc004atj.3:exon11:c.G2482A:p.V828M,WNK2:uc011lud.1:exon11:c.G2482A:p.V828M	-0.915	AFR:MU4551848,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,GACA-JP|1|585|0.0017094,EAS:0.1329,FIN:0.6014,NFE:0.3933,OTH:0.4368,ASJ:0.3837	606249	.	.	.	.	.	.	.	0.675	-0.72	0.000	2.35	9	52(lung)	0.4357
9	96024182	96024182	G	C	WNK2	exonic	synonymous SNV	ENSG00000165238	rs12000967	ENSG00000165238:ENST00000297954:exon12:c.G3153C:p.S1051S,ENSG00000165238:ENST00000349097:exon12:c.G1989C:p.S663S,ENSG00000165238:ENST00000395477:exon12:c.G3153C:p.S1051S,ENSG00000165238:ENST00000427277:exon12:c.G1989C:p.S663S	WNK2:NM_001282394:exon12:c.G3153C:p.S1051S,WNK2:NM_006648:exon12:c.G3153C:p.S1051S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1114	0.1644	0.132788	0.1526	.	.	.	.	.	.	.	.	WNK2:uc004atk.3:exon9:c.G2064C:p.S688S,WNK2:uc004ati.1:exon12:c.G3153C:p.S1051S,WNK2:uc004atj.3:exon12:c.G3153C:p.S1051S,WNK2:uc011lud.1:exon12:c.G3153C:p.S1051S	.	AFR:0.2587,AMR:0.0823,EAS:0,FIN:0.1563,NFE:0.1126,OTH:0.1237,ASJ:0.1457	606249	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	96026243	96026243	G	A	WNK2	exonic	synonymous SNV	ENSG00000165238	rs55981123	ENSG00000165238:ENST00000297954:exon15:c.G3624A:p.T1208T,ENSG00000165238:ENST00000349097:exon15:c.G2460A:p.T820T,ENSG00000165238:ENST00000395477:exon15:c.G3624A:p.T1208T,ENSG00000165238:ENST00000427277:exon15:c.G2460A:p.T820T	WNK2:NM_001282394:exon15:c.G3624A:p.T1208T,WNK2:NM_006648:exon15:c.G3624A:p.T1208T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1101	0.1346	0.102636	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	WNK2:uc004atk.3:exon12:c.G2535A:p.T845T,WNK2:uc004ati.1:exon15:c.G3624A:p.T1208T,WNK2:uc004atj.3:exon15:c.G3624A:p.T1208T,WNK2:uc011lud.1:exon15:c.G3624A:p.T1208T	.	AFR:0.1290,AMR:0.1574,EAS:0.1523,FIN:0,NFE:0.1628,OTH:0.1214,ASJ:0.0800	606249	.	.	.	.	.	.	.	.	.	.	.	9	1(lung)	0.1211
9	96051521	96051521	A	G	WNK2	exonic	synonymous SNV	ENSG00000165238	rs2169756	ENSG00000165238:ENST00000395477:exon19:c.A4485G:p.Q1495Q,ENSG00000165238:ENST00000427277:exon19:c.A3321G:p.Q1107Q,ENSG00000165238:ENST00000297954:exon20:c.A4596G:p.Q1532Q,ENSG00000165238:ENST00000349097:exon20:c.A3432G:p.Q1144Q	WNK2:NM_006648:exon19:c.A4485G:p.Q1495Q,WNK2:NM_001282394:exon20:c.A4596G:p.Q1532Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9500	0.9056	0.920527	0.9124	.	.	.	.	.	.	.	.	WNK2:uc004atl.1:exon1:c.A270G:p.Q90Q,WNK2:uc004atk.3:exon16:c.A3396G:p.Q1132Q,WNK2:uc004atj.3:exon19:c.A4485G:p.Q1495Q,WNK2:uc011lud.1:exon19:c.A4485G:p.Q1495Q,WNK2:uc004ati.1:exon20:c.A4596G:p.Q1532Q	.	AFR:0.7950,AMR:0.9749,EAS:1,FIN:0.9708,NFE:0.9491,OTH:0.9641,ASJ:0.9934	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU67319	hom
9	98209594	98209594	G	A	PTCH1	exonic	nonsynonymous SNV	ENSG00000185920	rs357564	ENSG00000185920:ENST00000331920:exon23:c.C3944T:p.P1315L,ENSG00000185920:ENST00000375274:exon23:c.C3941T:p.P1314L,ENSG00000185920:ENST00000418258:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000421141:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000429896:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000430669:exon23:c.C3746T:p.P1249L,ENSG00000185920:ENST00000437951:exon23:c.C3746T:p.P1249L	PTCH1:NM_001354918:exon22:c.C3788T:p.P1263L,PTCH1:NM_000264:exon23:c.C3944T:p.P1315L,PTCH1:NM_001083602:exon23:c.C3746T:p.P1249L,PTCH1:NM_001083603:exon23:c.C3941T:p.P1314L,PTCH1:NM_001083604:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083605:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083606:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083607:exon23:c.C3491T:p.P1164L	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.3855	0.2993	0.396765	1(biliary_tract)	6.218	28.8	0.025	4.83	0.995	.	.	.	PTCH1:uc010mrn.3:exon2:c.C320T:p.P107L,PTCH1:uc004avk.4:exon23:c.C3944T:p.P1315L,PTCH1:uc004avl.4:exon23:c.C3491T:p.P1164L,PTCH1:uc004avm.4:exon23:c.C3941T:p.P1314L,PTCH1:uc010mro.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrp.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrq.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrr.3:exon23:c.C3746T:p.P1249L	-1.000	AFR:1(bone),AMR:2(pancreas),EAS:2(lung),FIN:11(soft_tissue),NFE:1(large_intestine),OTH:MU148935,ASJ:3(penis)	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9114,9112,9111,9110,9113	.	.	0.944	-2.76	0.000	2.295	9	3(haematopoietic_and_lymphoid_tissue)	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BOCA-UK|1|130|0.00769231,BRCA-KR|1|50|0.02
9	98270647	98270658	GCCGCCGCCGCC	-	PTCH1	UTR5	.	ENSG00000185920	rs555069082	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0	.	0.00159744	0.0001	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:7.315e-05,OTH:0.0025,ASJ:0	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	9	.	het
9	100459578	100459578	T	C	XPA	UTR5	.	ENSG00000136936	rs1800975	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6335	0.7470	0.646366	ESAD-UK|1|409|0.00244499,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	.	.	AFR:0.6936,AMR:0.8036,EAS:0.6093,FIN:0.5068,NFE:0.6476,OTH:0.6669,ASJ:0.6286	611153	278700;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.6765
9	101569983	101569983	G	A	GALNT12	exonic	nonsynonymous SNV	ENSG00000119514	rs267606839	ENSG00000119514:ENST00000375011:exon1:c.G3A:p.M1I	GALNT12:NM_024642:exon1:c.G3A:p.M1I	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0004	3.408	23.0	0.0	3.32	0.938	.	.	.	GALNT12:uc004ayz.3:exon1:c.G3A:p.M1I	-0.965	AFR:0.0013,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	610290	608812;	.	.	.	.	.	.	0.118	0.67	0.129	.	9	.	hom
9	102591042	102591042	A	G	NR4A3	exonic	nonsynonymous SNV	ENSG00000119508	rs12344570	ENSG00000119508:ENST00000330847:exon2:c.A751G:p.S251G,ENSG00000119508:ENST00000338488:exon3:c.A718G:p.S240G,ENSG00000119508:ENST00000395097:exon3:c.A718G:p.S240G	NR4A3:NM_006981:exon3:c.A718G:p.S240G,NR4A3:NM_173199:exon3:c.A718G:p.S240G,NR4A3:NM_173200:exon4:c.A751G:p.S251G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4025	.	0.373203	.	-0.433	0.322	0.968	3.65	0.884	.	.	.	NR4A3:uc004bae.3:exon3:c.A718G:p.S240G,NR4A3:uc004baf.1:exon3:c.A718G:p.S240G,NR4A3:uc022bky.1:exon4:c.A751G:p.S251G	-1.001	AFR:0.4588,AMR:0.4667,EAS:0.5331,FIN:0.2364,NFE:0.4483,OTH:0.4872,ASJ:0.3198	600542	612237;	209916;	209916|-|1-9 / 1 000 000|Not applicable|Adult|612237 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	-2.29	0.000	-1.445	9	1(salivary_gland)	0.4512
9	102595069	102595069	G	A	NR4A3	exonic	synonymous SNV	ENSG00000119508	rs41274654	ENSG00000119508:ENST00000330847:exon3:c.G1083A:p.Q361Q,ENSG00000119508:ENST00000338488:exon4:c.G1050A:p.Q350Q,ENSG00000119508:ENST00000395097:exon4:c.G1050A:p.Q350Q	NR4A3:NM_006981:exon4:c.G1050A:p.Q350Q,NR4A3:NM_173199:exon4:c.G1050A:p.Q350Q,NR4A3:NM_173200:exon5:c.G1083A:p.Q361Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1140	0.1076	0.0796725	MU134219	.	.	.	.	.	.	.	.	NR4A3:uc004bae.3:exon4:c.G1050A:p.Q350Q,NR4A3:uc004baf.1:exon4:c.G1050A:p.Q350Q,NR4A3:uc022bky.1:exon5:c.G1083A:p.Q361Q	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526,AMR:0.1064,EAS:0.1026,FIN:0.1424,NFE:0.0822,OTH:0.1436,ASJ:0.0370	600542	612237;	209916;	209916|-|1-9 / 1 000 000|Not applicable|Adult|612237 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	9	1(salivary_gland)	0.1375
9	110045992	110045992	-	GGGGCA	RAD23B	intronic	.	ENSG00000119318	rs11573612	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1107	0.0536	0.0427316	0.0542	.	.	.	.	.	.	.	.	.	.	AFR:0.0160,AMR:0.0410,EAS:0.0006,FIN:0.0507,NFE:0.0817,OTH:0.0638,ASJ:0.1267	600062	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	110081018	110081018	A	G	RAD23B	intronic	.	ENSG00000119318	rs1805335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5495	0.5537	0.579073	0.5503	.	.	.	.	.	.	.	.	.	.	AFR:0.5487,AMR:0.5383,EAS:0.7920,FIN:0.5692,NFE:0.5193,OTH:0.5463,ASJ:0.6567	600062	.	.	.	.	.	.	.	.	.	.	.	9	MU81865700	het
9	110084261	110084261	C	T	RAD23B	intronic	.	ENSG00000119318	rs1805330	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1007	0.1272	0.100839	0.1083	.	.	.	.	.	0.0003	0.064	.	.	.	AFR:0.2003,AMR:0.0561,EAS:0.0006,FIN:0.0513,NFE:0.0843,OTH:0.0724,ASJ:0.1424	600062	.	.	.	.	.	.	.	.	.	.	.	9	MU118211845	het
9	111653574	111653574	C	G	ELP1	exonic	synonymous SNV	ENSG00000070061	rs1063110	ENSG00000070061:ENST00000537196:exon21:c.G2022C:p.L674L,ENSG00000070061:ENST00000374647:exon28:c.G3069C:p.L1023L	ELP1:NM_001330749:exon26:c.G2022C:p.L674L,ELP1:NM_001318360:exon28:c.G2727C:p.L909L,ELP1:NM_003640:exon28:c.G3069C:p.L1023L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3913	0.3389	0.315495	1(breast)	.	.	.	.	.	.	.	.	IKBKAP:uc004bdk.3:exon1:c.G81C:p.L27L,IKBKAP:uc004bdl.3:exon20:c.G2022C:p.L674L,IKBKAP:uc010mtq.3:exon21:c.G2022C:p.L674L,IKBKAP:uc004bdm.4:exon28:c.G3069C:p.L1023L,IKBKAP:uc011lwc.2:exon28:c.G2727C:p.L909L	.	AFR:1(liver),AMR:1(large_intestine),EAS:MU91232,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,NFE:0.3421,OTH:0.1048,ASJ:2(thyroid)	603722	223900;	1764;	1764|HSAN3<br>Hereditary sensory and autonomic neuropathy type 3<br>Riley-Day syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|223900 ~	.	.	.	.	.	.	.	.	9	2(lung)	0.4209
9	120475302	120475302	A	G	TLR4	exonic	nonsynonymous SNV	ENSG00000136869	rs4986790	ENSG00000136869:ENST00000355622:exon3:c.A896G:p.D299G,ENSG00000136869:ENST00000394487:exon4:c.A776G:p.D259G	TLR4:NM_138557:exon2:c.A296G:p.D99G,TLR4:NM_138554:exon3:c.A896G:p.D299G,TLR4:NM_003266:exon4:c.A776G:p.D259G	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0599	0.0639	0.0599042	0.0661	0.388	6.513	0.093	4.64	0.002	.	.	Leucine-rich repeat domain, L domain-like	TLR4:uc004bkb.4:exon2:c.A296G:p.D99G,TLR4:uc004bjz.4:exon3:c.A896G:p.D299G,TLR4:uc004bka.4:exon4:c.A776G:p.D259G	-1.094	AFR:0.0753,AMR:0.0394,EAS:0.0006,FIN:0.0933,NFE:0.0624,OTH:0.0733,ASJ:0.0629	603030	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05170 Human immunodeficiency virus 1 infection~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis ~	.	.	.	0.026	2.03	0.004	2.415	9	.	het
9	131085373	131085373	G	C	COQ4	exonic	nonsynonymous SNV	ENSG00000167113	rs3003601	ENSG00000167113:ENST00000300452:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000372875:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000608951:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000609948:exon2:c.G149C:p.G50A	COQ4:NM_001305942:exon2:c.G149C:p.G50A,COQ4:NM_016035:exon2:c.G149C:p.G50A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9988	0.9970	0.998003	0.9967	-0.680	0.080	1.0	-2.65	0.956	.	.	.	COQ4:uc010mxy.3:exon1:c.G77C:p.G26A,COQ4:uc004bur.4:exon2:c.G149C:p.G50A,COQ4:uc011max.1:exon2:c.G149C:p.G50A	-1.009	AFR:0.9890,AMR:0.9988,EAS:1,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	0.001	1.13	0.000	-1.765	9	MU81869115	hom
9	131088076	131088076	G	A	COQ4	exonic	nonsynonymous SNV	ENSG00000167113	rs2270203	ENSG00000167113:ENST00000300452:exon4:c.G318A:p.S106S,ENSG00000167113:ENST00000372875:exon4:c.G318A:p.S106S	COQ4:NM_001305942:exon3:c.G221A:p.R74Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0789	0.0925	0.133387	0.0968	.	.	.	.	.	.	.	.	COQ4:uc010mxy.3:exon3:c.G246A:p.S82S,COQ4:uc004bur.4:exon4:c.G318A:p.S106S,COQ4:uc011max.1:exon4:c.G318A:p.S106S	.	AFR:0.1890,AMR:0.1002,EAS:0.1899,FIN:0.0742,NFE:0.0419,OTH:0.0622,ASJ:0.0232	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	.	.	.	.	9	MU82313405	het
9	131095112	131095112	A	C	COQ4	intronic	.	ENSG00000167113	rs7850697	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2450	0.3542	0.377796	0.3328	.	.	.	.	.	.	.	.	.	.	AFR:0.7013,AMR:0.2267,EAS:0.2689,FIN:0.1980,NFE:0.1726,OTH:0.1994,ASJ:0.2748	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	.	.	.	.	9	MU81869124	het
9	131346218	131346218	A	C	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs10760566	ENSG00000197694:ENST00000358161:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372731:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372739:exon16:c.A2163C:p.A721A	SPTAN1:NM_001130438:exon16:c.A2163C:p.A721A,SPTAN1:NM_001195532:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363759:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363765:exon16:c.A2163C:p.A721A,SPTAN1:NM_003127:exon16:c.A2163C:p.A721A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9914	0.9701	0.969848	0.9713	.	.	.	.	.	.	.	.	SPTAN1:uc004bvl.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvm.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvn.4:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbg.2:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbh.2:exon17:c.A2199C:p.A733A	.	AFR:0.8996,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869219	hom
9	131360750	131360750	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227864	ENSG00000197694:ENST00000358161:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372731:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372739:exon25:c.C3486T:p.L1162L	SPTAN1:NM_001195532:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001363765:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001130438:exon25:c.C3486T:p.L1162L,SPTAN1:NM_001363759:exon25:c.C3486T:p.L1162L,SPTAN1:NM_003127:exon25:c.C3486T:p.L1162L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8064	0.7604	0.642772	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon24:c.C3426T:p.L1142L,SPTAN1:uc011mbg.2:exon24:c.C3426T:p.L1142L,SPTAN1:uc004bvl.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc004bvm.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc011mbh.2:exon26:c.C3522T:p.L1174L	.	AFR:0.7491,AMR:0.4777,EAS:0.9172,FIN:0.5161,NFE:0.8242,OTH:0.9048,ASJ:0.7828	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(salivary_gland)	0.8160
9	131375701	131375701	A	G	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs1415568	ENSG00000197694:ENST00000372731:exon39:c.A5070G:p.L1690L,ENSG00000197694:ENST00000358161:exon40:c.A5085G:p.L1695L,ENSG00000197694:ENST00000372739:exon40:c.A5085G:p.L1695L	SPTAN1:NM_001195532:exon38:c.A5010G:p.L1670L,SPTAN1:NM_001363765:exon39:c.A5025G:p.L1675L,SPTAN1:NM_003127:exon39:c.A5070G:p.L1690L,SPTAN1:NM_001130438:exon40:c.A5085G:p.L1695L,SPTAN1:NM_001363759:exon40:c.A5085G:p.L1695L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9959	0.9854	0.984824	0.9846	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon38:c.A5010G:p.L1670L,SPTAN1:uc004bvl.4:exon39:c.A5070G:p.L1690L,SPTAN1:uc004bvm.4:exon40:c.A5085G:p.L1695L	.	AFR:0.9466,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869234	hom
9	131379967	131379967	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227862	ENSG00000197694:ENST00000372731:exon41:c.C5391T:p.T1797T,ENSG00000197694:ENST00000358161:exon42:c.C5406T:p.T1802T,ENSG00000197694:ENST00000372739:exon42:c.C5406T:p.T1802T	SPTAN1:NM_001195532:exon40:c.C5331T:p.T1777T,SPTAN1:NM_001363765:exon41:c.C5346T:p.T1782T,SPTAN1:NM_003127:exon41:c.C5391T:p.T1797T,SPTAN1:NM_001130438:exon42:c.C5406T:p.T1802T,SPTAN1:NM_001363759:exon42:c.C5406T:p.T1802T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7913	0.7328	0.617013	MU4566604	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon40:c.C5331T:p.T1777T,SPTAN1:uc004bvl.4:exon41:c.C5391T:p.T1797T,SPTAN1:uc004bvm.4:exon42:c.C5406T:p.T1802T	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.7233,EAS:0.7709,FIN:0.9133,NFE:0.5099,OTH:0.8235,ASJ:0.3892	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(thyroid)	0.9049
9	131454120	131454120	C	T	SET	intronic	.	ENSG00000119335	rs3750330	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9470	0.8618	0.846645	0.8696	.	.	.	.	.	.	.	.	.	.	AFR:0.5820,AMR:0.9570,EAS:0.9061,FIN:0.9716,NFE:0.9960,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478205	hom
9	131455903	131455903	C	T	SET	intronic	.	ENSG00000119335	rs4836618	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9465	0.8600	0.845248	0.8698	.	.	.	.	.	.	.	.	.	.	AFR:0.5824,AMR:0.9570,EAS:0.9068,FIN:0.9719,NFE:0.9959,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478277	hom
9	131456382	131456382	-	GT	SET	intronic	.	ENSG00000119335	rs35148693	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.0199681	0.0348	.	.	.	.	.	.	.	.	.	.	AFR:0.0105,AMR:0,EAS:0.2735,FIN:0.1422,NFE:0.0166,OTH:0.0706,ASJ:0.0132	600960	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	133710819	133710819	-	C	ABL1	UTR5	.	ENSG00000097007	rs11433463	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	189980	.	.	.	~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04110 Cell cycle~ko04360 Axon guidance~ko04722 Neurotrophin signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	9	.	unknown
9	133761001	133761001	A	G	ABL1	exonic	synonymous SNV	ENSG00000097007	rs1056171	ENSG00000097007:ENST00000318560:exon11:c.A3324G:p.P1108P,ENSG00000097007:ENST00000372348:exon11:c.A3381G:p.P1127P	ABL1:NM_005157:exon11:c.A3324G:p.P1108P,ABL1:NM_007313:exon11:c.A3381G:p.P1127P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5490	0.5849	0.654153	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ABL1:uc004bzv.3:exon11:c.A3381G:p.P1127P,ABL1:uc004bzw.3:exon11:c.A3324G:p.P1108P	.	AFR:16(soft_tissue),AMR:MU27188632,EAS:0.5911,FIN:0.8308,NFE:0.6969,OTH:0.5099,ASJ:LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	189980	.	.	.	~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04110 Cell cycle~ko04360 Axon guidance~ko04722 Neurotrophin signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia~ko05416 Viral myocarditis ~	,155	.	.	.	.	.	.	9	1(large_intestine)	0.6222
9	134021630	134021630	A	G	NUP214	exonic	synonymous SNV	ENSG00000126883	rs2296710	ENSG00000126883:ENST00000359428:exon13:c.A1884G:p.T628T,ENSG00000126883:ENST00000411637:exon13:c.A1851G:p.T617T,ENSG00000126883:ENST00000451030:exon13:c.A1884G:p.T628T	NUP214:NM_001318324:exon13:c.A1851G:p.T617T,NUP214:NM_005085:exon13:c.A1884G:p.T628T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3309	0.3022	0.346446	0.3227	.	.	.	.	.	.	.	.	NUP214:uc004cai.3:exon2:c.A171G:p.T57T,NUP214:uc004caf.1:exon13:c.A1851G:p.T617T,NUP214:uc004cag.3:exon13:c.A1884G:p.T628T,NUP214:uc004cah.3:exon13:c.A1851G:p.T617T	.	AFR:0.2908,AMR:0.2416,EAS:0.4250,FIN:0.3437,NFE:0.3280,OTH:0.3299,ASJ:0.3833	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	MU588209	hom
9	134027138	134027138	A	G	NUP214	exonic	nonsynonymous SNV	ENSG00000126883	rs61756081	ENSG00000126883:ENST00000359428:exon17:c.A2293G:p.I765V,ENSG00000126883:ENST00000411637:exon17:c.A2263G:p.I755V,ENSG00000126883:ENST00000451030:exon17:c.A2296G:p.I766V	NUP214:NM_001318324:exon17:c.A2263G:p.I755V,NUP214:NM_005085:exon17:c.A2293G:p.I765V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0097	0.0061	0.0091853	0.0045	3.955	23.6	0.247	5.93	0.999	.	.	.	NUP214:uc010mzf.3:exon5:c.A187G:p.I63V,NUP214:uc004cai.3:exon6:c.A583G:p.I195V,NUP214:uc004caf.1:exon17:c.A2260G:p.I754V,NUP214:uc004cag.3:exon17:c.A2293G:p.I765V,NUP214:uc004cah.3:exon17:c.A2263G:p.I755V	-0.879	AFR:0.0013,AMR:0.0048,EAS:0,FIN:0.0020,NFE:0.0071,OTH:0.0061,ASJ:0.0099	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	0.662	1.15	0.098	2.36	9	.	het
9	134062770	134062770	-	TT	NUP214	intronic	.	ENSG00000126883	rs762584920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0172	.	.	0.0323	.	.	.	.	.	.	.	.	.	.	AFR:0.0493,AMR:0.0212,EAS:0,FIN:0.0114,NFE:0.0278,OTH:0.0254,ASJ:0.0253	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	.	unknown
9	135773000	135773000	-	AA	TSC1	intronic	.	ENSG00000165699	rs397722330	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1533	.	.	0.5231	.	.	.	.	.	.	.	.	.	.	AFR:0.3307,AMR:0.4931,EAS:0.6234,FIN:0.3103,NFE:0.6008,OTH:0.6232,ASJ:0.6596	605284	191100;606690;	538;805;	538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~	~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	9	.	het
9	136643994	136643994	T	C	VAV2	exonic	nonsynonymous SNV	ENSG00000160293	rs602990	ENSG00000160293:ENST00000371851:exon20:c.A1750G:p.M584V,ENSG00000160293:ENST00000406606:exon20:c.A1750G:p.M584V,ENSG00000160293:ENST00000371850:exon22:c.A1780G:p.M594V	VAV2:NM_003371:exon20:c.A1750G:p.M584V,VAV2:NM_001134398:exon22:c.A1780G:p.M594V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5016	0.6222	0.495208	2(liver)	-0.716	0.066	0.805	1.91	0.853	.	.	SH3 domain;SH3 domain|Variant SH3 domain	VAV2:uc004cet.1:exon8:c.A397G:p.M133V,VAV2:uc004cer.3:exon20:c.A1750G:p.M584V,VAV2:uc004ces.3:exon22:c.A1780G:p.M594V	-1.032	AFR:MU588223,AMR:COCA-CN|2|321|0.00623053,EAS:0.7957,FIN:0.4653,NFE:0.56,OTH:0.0531,ASJ:0.5778	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	0.0	3.35	0.000	-0.655	9	1(stomach)	0.5003
9	136645079	136645079	G	C	VAV2	intronic	.	ENSG00000160293	rs540626	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2969	0.3162	0.241613	0.3013	.	.	.	.	.	.	.	.	.	.	AFR:0.2653,AMR:0.2249,EAS:0.0086,FIN:0.3247,NFE:0.3507,OTH:0.3143,ASJ:0.3675	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	het
9	136648606	136648606	G	A	VAV2	intronic	.	ENSG00000160293	rs1468128	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7246	0.6048	0.690096	0.6390	.	.	.	.	.	.	.	.	.	.	AFR:0.4276,AMR:0.7222,EAS:0.9639,FIN:0.6866,NFE:0.7070,OTH:0.6936,ASJ:0.7207	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU81871689	hom
9	136648611	136648611	-	G	VAV2	intronic	.	ENSG00000160293	rs56145872	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8287	0.7097	0.131789	0.7542	.	.	.	.	.	.	.	.	.	.	AFR:0.4406,AMR:0.8017,EAS:0.9682,FIN:0.8421,NFE:0.8711,OTH:0.8333,ASJ:0.8699	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	hom
9	136804211	136804211	G	A	VAV2	intronic	.	ENSG00000160293	rs2073886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7450	0.7196	0.702676	0.7217	.	.	.	.	.	.	.	.	.	.	AFR:0.6228,AMR:0.7041,EAS:0.7892,FIN:0.7327,NFE:0.7658,OTH:0.7658,ASJ:0.8046	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU19104859	het
9	139391636	139391636	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229974	ENSG00000148400:ENST00000277541:exon34:c.C6555T:p.D2185D	NOTCH1:NM_017617:exon34:c.C6555T:p.D2185D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6187	0.5813	0.695088	1(breast)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon34:c.C6555T:p.D2185D	.	AFR:1(large_intestine),AMR:MU123836,EAS:0.5914,FIN:0.6176,NFE:0.6734,OTH:0.5232,ASJ:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7811,7816,7818,,7810,7822,7823,7815,7817,7820,7821,7812	.	7819,7814,7813,	.	.	.	.	9	2(skin)	0.9635
9	139397707	139397707	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs10521	ENSG00000148400:ENST00000277541:exon27:c.C5094T:p.D1698D	NOTCH1:NM_017617:exon27:c.C5094T:p.D1698D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4443	0.4080	0.553514	13(soft_tissue)	.	.	.	.	.	.	.	.	NOTCH1:uc004cia.1:exon14:c.C2784T:p.D928D,NOTCH1:uc004chz.3:exon27:c.C5094T:p.D1698D	.	AFR:1(lung),AMR:12(haematopoietic_and_lymphoid_tissue),EAS:MU58034,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,NFE:0.4460,OTH:0.5089,ASJ:12(meninges)	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7811,7816,7818,,7810,7822,7823,7815,7817,7820,7821,7812	.	7819,7814,7813,	.	.	.	.	9	1(liver)	0.5240
9	139405261	139405261	C	T	NOTCH1	intronic	.	ENSG00000148400	rs3125001	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4725	0.4549	0.585463	0.5007	.	.	.	.	.	0	0	.	.	.	AFR:0.6460,AMR:0.5372,EAS:0.8807,FIN:0.4638,NFE:0.3871,OTH:0.4418,ASJ:0.4040	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU677644	het
9	139407932	139407932	A	G	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229971	ENSG00000148400:ENST00000277541:exon14:c.T2265C:p.N755N	NOTCH1:NM_017617:exon14:c.T2265C:p.N755N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3977	0.3975	0.527756	MU123856	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon14:c.T2265C:p.N755N	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.4428,EAS:0.5024,FIN:0.2152,NFE:0.8152,OTH:0.4293,ASJ:0.6200	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7811,7816,7818,,7810,7822,7823,7815,7817,7820,7821,7812	.	7819,7814,7813,	.	.	.	.	9	1(skin)	0.3095
9	139410177	139410177	T	C	NOTCH1	intronic	.	ENSG00000148400	rs3124603	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4361	0.3961	0.58726	0.4866	.	.	.	.	.	0	0.006	.	.	.	AFR:0.6389,AMR:0.5383,EAS:0.8663,FIN:0.4845,NFE:0.3626,OTH:0.4294,ASJ:0.2781	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU32592860	het
9	139410424	139410424	A	G	NOTCH1	intronic	.	ENSG00000148400	rs3125006	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8704	0.8733	0.883986	0.8911	.	.	.	.	.	.	.	.	.	.	AFR:0.8972,AMR:0.9153,EAS:0.9463,FIN:0.9257,NFE:0.8743,OTH:0.8867,ASJ:0.7980	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU81872781	hom
9	139411714	139411714	T	C	NOTCH1	intronic	.	ENSG00000148400	rs11145767	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5481	0.4280	0.605431	0.4993	.	.	.	.	.	.	.	.	.	.	AFR:0.7107,AMR:0.5180,EAS:0.8767,FIN:0.4902,NFE:0.3459,OTH:0.4308,ASJ:0.2450	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU26998549	het
9	139412197	139412197	G	A	NOTCH1	intronic	.	ENSG00000148400	rs9411208	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5768	0.5544	0.696286	COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0010	0.052	.	.	.	AFR:0.5928,AMR:0.7293,EAS:0.4603,FIN:0.9273,NFE:0.5904,OTH:0.4803,ASJ:0.6280	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	13(meninges)	0.5612
9	139418260	139418260	A	G	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs4489420	ENSG00000148400:ENST00000277541:exon3:c.T312C:p.N104N	NOTCH1:NM_017617:exon3:c.T312C:p.N104N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5970	0.6087	0.740016	1(salivary_gland)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon3:c.T312C:p.N104N	.	AFR:MU4624948,AMR:COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874,EAS:0.8853,FIN:0.6388,NFE:0.46,OTH:0.8547,ASJ:0.6424	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7811,7816,7818,,7810,7822,7823,7815,7817,7820,7821,7812	.	7819,7814,7813,	.	.	.	.	9	13(meninges)	0.6006
10	14976414	14976414	G	A	DCLRE1C	exonic	synonymous SNV	ENSG00000152457	rs7076862	ENSG00000152457:ENST00000357717:exon6:c.C298T:p.L100L,ENSG00000152457:ENST00000378249:exon6:c.C298T:p.L100L,ENSG00000152457:ENST00000378246:exon7:c.C298T:p.L100L,ENSG00000152457:ENST00000378278:exon8:c.C643T:p.L215L,ENSG00000152457:ENST00000378289:exon8:c.C643T:p.L215L,ENSG00000152457:ENST00000453695:exon8:c.C283T:p.L95L,ENSG00000152457:ENST00000378254:exon9:c.C283T:p.L95L,ENSG00000152457:ENST00000378258:exon9:c.C283T:p.L95L,ENSG00000152457:ENST00000418843:exon9:c.C205T:p.L69L,ENSG00000152457:ENST00000378255:exon10:c.C283T:p.L95L,ENSG00000152457:ENST00000396817:exon10:c.C283T:p.L95L	DCLRE1C:NM_001289076:exon6:c.C298T:p.L100L,DCLRE1C:NM_001289078:exon6:c.C298T:p.L100L,DCLRE1C:NM_001350966:exon6:c.C298T:p.L100L,DCLRE1C:NM_022487:exon7:c.C298T:p.L100L,DCLRE1C:NM_001033855:exon8:c.C643T:p.L215L,DCLRE1C:NM_001350965:exon8:c.C643T:p.L215L,DCLRE1C:NM_001033857:exon9:c.C283T:p.L95L,DCLRE1C:NM_001289077:exon9:c.C283T:p.L95L,DCLRE1C:NM_001350967:exon9:c.C283T:p.L95L,DCLRE1C:NM_001033858:exon10:c.C283T:p.L95L,DCLRE1C:NM_001289079:exon10:c.C283T:p.L95L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4187	0.4497	0.5	0.4302	.	.	.	.	.	.	.	.	DCLRE1C:uc021pni.1:exon4:c.C298T:p.L100L,DCLRE1C:uc001inr.3:exon6:c.C298T:p.L100L,DCLRE1C:uc009xji.3:exon6:c.C298T:p.L100L,DCLRE1C:uc001ino.3:exon7:c.C298T:p.L100L,DCLRE1C:uc001inn.3:exon8:c.C643T:p.L215L,DCLRE1C:uc010qbx.2:exon8:c.C643T:p.L215L,DCLRE1C:uc001inl.3:exon9:c.C283T:p.L95L,DCLRE1C:uc001inp.3:exon9:c.C283T:p.L95L,DCLRE1C:uc001inm.3:exon10:c.C283T:p.L95L,DCLRE1C:uc001inq.3:exon10:c.C283T:p.L95L	.	AFR:0.6495,AMR:0.4796,EAS:0.4133,FIN:0.2474,NFE:0.3506,OTH:0.3276,ASJ:0.4503	605988	602450;603554;	39041;275;	39041|Combined immunodeficiency with hypereosinophilia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|603554 ~275|SCID due to ARTEMIS deficiency<br>SCID due to DCLRE1C deficiency<br>SCID, Athabascan type<br>SCID, Athabaskan type<br>Severe combined immunodeficiency due to ARTEMIS deficiency<br>Severe combined immunodeficiency, Athabascan type<br>Severe combined immunodeficiency, Athabaskan type|Unknown|Autosomal recessive|Infancy<br>Neonatal|602450 ~	.	.	.	.	.	.	.	.	10	MU19126674	het
10	21827796	21827796	G	A	MLLT10	exonic	synonymous SNV	ENSG00000078403	rs1802669	ENSG00000078403:ENST00000377059:exon2:c.G195A:p.P65P,ENSG00000078403:ENST00000307729:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000377072:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000377091:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000377100:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000446906:exon3:c.G195A:p.P65P	MLLT10:NM_001195626:exon3:c.G195A:p.P65P,MLLT10:NM_001195627:exon3:c.G195A:p.P65P,MLLT10:NM_001195628:exon3:c.G195A:p.P65P,MLLT10:NM_001195630:exon3:c.G195A:p.P65P,MLLT10:NM_001324296:exon3:c.G195A:p.P65P,MLLT10:NM_004641:exon3:c.G195A:p.P65P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3118	0.3664	0.277356	0.3427	.	.	.	.	.	.	.	.	MLLT10:uc001iqw.1:exon2:c.G195A:p.P65P,MLLT10:uc021pny.1:exon2:c.G195A:p.P65P,MLLT10:uc001iqq.2:exon3:c.G195A:p.P65P,MLLT10:uc001iqr.2:exon3:c.G195A:p.P65P,MLLT10:uc001iqs.3:exon3:c.G195A:p.P65P,MLLT10:uc001iqt.3:exon3:c.G195A:p.P65P,MLLT10:uc001iqu.2:exon3:c.G195A:p.P65P	.	AFR:0.4100,AMR:0.2883,EAS:0.0402,FIN:0.3237,NFE:0.3428,OTH:0.3357,ASJ:0.4073	602409	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	10	MU119020	het
10	27269516	27269516	C	G	FAM238C;ANKRD26	intergenic	.	ENSG00000236983;ENSG00000107890	rs3740229	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0694888	0.0194	.	.	.	.	.	.	.	.	.	.	AFR:0.0009,AMR:0.0251,EAS:0.1502,FIN:0.0561,NFE:0.0061,OTH:0.0418,ASJ:0.0033	.	.	.	.	.	.	.	.	.	.	.	.	10	.	het
10	27271749	27271749	A	-	FAM238C;ANKRD26	intergenic	.	ENSG00000236983;ENSG00000107890	rs144481731	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0770767	0.0252	.	.	.	.	.	.	.	.	.	.	AFR:0.0194,AMR:0.0252,EAS:0.1582,FIN:0.0572,NFE:0.0061,OTH:0.0420,ASJ:0.0066	.	.	.	.	.	.	.	.	.	.	.	.	10	.	het
10	27303605	27303605	A	T	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs2274741	ENSG00000107890:ENST00000376070:exon16:c.T3213A:p.F1071L,ENSG00000107890:ENST00000376087:exon31:c.T4542A:p.F1514L,ENSG00000107890:ENST00000436985:exon31:c.T4590A:p.F1530L	ANKRD26:NM_001256053:exon31:c.T4539A:p.F1513L,ANKRD26:NM_014915:exon31:c.T4542A:p.F1514L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2258	0.1717	0.317292	0.2050	0.365	6.303	1.0	1.33	0.834	.	.	.	ANKRD26:uc001itg.2:exon25:c.T3600A:p.F1200L,ANKRD26:uc001ith.2:exon31:c.T4539A:p.F1513L,ANKRD26:uc009xku.1:exon31:c.T4542A:p.F1514L	-0.964	AFR:0.2263,AMR:0.1675,EAS:0.5643,FIN:0.2329,NFE:0.1498,OTH:0.2147,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.91	0.000	-3.085	10	MU794304	het
10	27317840	27317840	C	T	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs10829163	ENSG00000107890:ENST00000376070:exon12:c.G2584A:p.V862I,ENSG00000107890:ENST00000376087:exon27:c.G3913A:p.V1305I,ENSG00000107890:ENST00000436985:exon27:c.G3961A:p.V1321I	ANKRD26:NM_001256053:exon27:c.G3910A:p.V1304I,ANKRD26:NM_014915:exon27:c.G3913A:p.V1305I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2217	0.1723	0.317292	0.2051	-0.852	0.033	1.0	-4.39	0.007	.	.	.	ANKRD26:uc001itg.2:exon21:c.G2971A:p.V991I,ANKRD26:uc001ith.2:exon27:c.G3910A:p.V1304I,ANKRD26:uc009xku.1:exon27:c.G3913A:p.V1305I	-1.016	AFR:0.2260,AMR:0.1683,EAS:0.5649,FIN:0.2339,NFE:0.1498,OTH:0.2137,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	-0.9	0.000	-0.63	10	MU794298	het
10	27319465	27319465	T	C	ANKRD26	intronic	.	ENSG00000107890	rs10829165	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.857628	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.8599,AMR:0.7133,EAS:0.9932,FIN:0.8683,NFE:0.7763,OTH:0.8378,ASJ:0.7833	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27319546	27319546	T	C	ANKRD26	intronic	.	ENSG00000107890	rs34844053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.317292	0.2052	.	.	.	.	.	.	.	.	.	.	AFR:0.2264,AMR:0.1671,EAS:0.5665,FIN:0.2332,NFE:0.1499,OTH:0.2143,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27322303	27322303	C	G	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs12572862	ENSG00000107890:ENST00000376070:exon10:c.G2329C:p.V777L,ENSG00000107890:ENST00000376087:exon25:c.G3658C:p.V1220L,ENSG00000107890:ENST00000436985:exon25:c.G3706C:p.V1236L	ANKRD26:NM_001256053:exon25:c.G3655C:p.V1219L,ANKRD26:NM_014915:exon25:c.G3658C:p.V1220L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0358	0.0016	0.0672923	0.0191	1.348	12.52	0.07	-3.7	0.752	.	.	.	ANKRD26:uc001itg.2:exon19:c.G2716C:p.V906L,ANKRD26:uc001ith.2:exon25:c.G3655C:p.V1219L,ANKRD26:uc009xku.1:exon25:c.G3658C:p.V1220L	-0.985	AFR:0.0009,AMR:0.0252,EAS:0.1459,FIN:0.0562,NFE:0.0061,OTH:0.0400,ASJ:0.0033	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.005	1.49	0.000	2.34	10	MU80621918	het
10	27326999	27326999	T	C	ANKRD26	intronic	.	ENSG00000107890	rs7096505	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8408	0.8289	0.865216	0.8452	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.7321,EAS:0.9932,FIN:0.9057,NFE:0.8121,OTH:0.8612,ASJ:0.8067	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU19136977	hom
10	27342286	27342288	TCT	-	ANKRD26	exonic	nonframeshift deletion	ENSG00000107890	rs138423863	ENSG00000107890:ENST00000376087:exon16:c.1596_1598del:p.532_533del,ENSG00000107890:ENST00000436985:exon16:c.1644_1646del:p.548_549del	ANKRD26:NM_001256053:exon16:c.1596_1598del:p.532_533del,ANKRD26:NM_014915:exon16:c.1596_1598del:p.532_533del	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0366	0.0032	0.0676917	0.0207	.	.	.	.	.	.	.	.	ANKRD26:uc001itg.2:exon10:c.654_656del:p.218_219del,ANKRD26:uc001ith.2:exon16:c.1596_1598del:p.532_533del,ANKRD26:uc009xku.1:exon16:c.1596_1598del:p.532_533del	.	AFR:0.0077,AMR:0.0239,EAS:0.1418,FIN:0.0564,NFE:0.0061,OTH:0.0400,ASJ:0.0033	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27355404	27355405	CA	-	ANKRD26	intronic	.	ENSG00000107890	rs375101238	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0095	.	.	0.0214	.	.	.	.	.	.	.	.	.	.	AFR:0.0113,AMR:0.0240,EAS:0.1381,FIN:0.0569,NFE:0.0058,OTH:0.0389,ASJ:0	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27355407	27355409	AGA	-	ANKRD26	intronic	.	ENSG00000107890	rs200015812	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0110	0.0028	.	0.0215	.	.	.	.	.	.	.	.	.	.	AFR:0.0113,AMR:0.0239,EAS:0.1382,FIN:0.0567,NFE:0.0058,OTH:0.0390,ASJ:0.0033	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27381349	27381349	T	C	ANKRD26	exonic	synonymous SNV	ENSG00000107890	rs2297145	ENSG00000107890:ENST00000376087:exon4:c.A624G:p.V208V,ENSG00000107890:ENST00000436985:exon4:c.A624G:p.V208V	ANKRD26:NM_001256053:exon4:c.A624G:p.V208V,ANKRD26:NM_014915:exon4:c.A624G:p.V208V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2571	0.2101	0.346645	0.2429	.	.	.	.	.	.	.	.	ANKRD26:uc001ith.2:exon4:c.A624G:p.V208V,ANKRD26:uc009xku.1:exon4:c.A624G:p.V208V	.	AFR:0.3237,AMR:0.1830,EAS:0.5597,FIN:0.2497,NFE:0.1657,OTH:0.2352,ASJ:0.1722	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU16245236	het
10	27389197	27389197	T	C	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs7897309	ENSG00000107890:ENST00000376087:exon1:c.A59G:p.Q20R,ENSG00000107890:ENST00000436985:exon1:c.A59G:p.Q20R	ANKRD26:NM_001256053:exon1:c.A59G:p.Q20R,ANKRD26:NM_014915:exon1:c.A59G:p.Q20R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8977	0.8935	0.944688	0.9039	-1.524	0.002	1.0	-1.08	0.003	.	.	.	ANKRD26:uc001ith.2:exon1:c.A59G:p.Q20R,ANKRD26:uc009xku.1:exon1:c.A59G:p.Q20R	-0.984	AFR:0.9727,AMR:0.9010,EAS:1,FIN:0.9275,NFE:0.8493,OTH:0.9043,ASJ:0.8477	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.63	0.000	-1.355	10	MU71687	hom
10	31803516	31803516	G	A	ZEB1	intronic	.	ENSG00000148516	rs220060	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9425	0.9154	0.921326	0.9197	.	.	.	.	.	.	.	.	.	.	AFR:0.8338,AMR:0.9725,EAS:1,FIN:0.9372,NFE:0.9520,OTH:0.9407,ASJ:0.9503	189909	609141;613270;	98974;98973;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~98973|PPCD<br>Posterior polymorphous dystrophy<br>Schlichting dystrophy|Unknown|Autosomal dominant|Childhood|122000 609140 609141 ~	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	10	MU81878063	hom
10	32311969	32311969	A	G	KIF5B	intronic	.	ENSG00000170759	rs176924	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9914	0.9677	0.967053	0.9753	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.9135,AMR:0.9940,EAS:1,FIN:1,NFE:1,OTH:0.9939,ASJ:1	602809	.	.	.	.	.	.	.	.	.	.	.	10	MU81878086	hom
10	43595968	43595968	A	G	RET	exonic	synonymous SNV	ENSG00000165731	rs1800858	ENSG00000165731:ENST00000340058:exon2:c.A135G:p.A45A,ENSG00000165731:ENST00000355710:exon2:c.A135G:p.A45A	RET:NM_020630:exon2:c.A135G:p.A45A,RET:NM_020975:exon2:c.A135G:p.A45A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7365	0.8092	0.753594	1(breast)	.	.	.	.	.	.	.	.	RET:uc001jak.1:exon2:c.A135G:p.A45A,RET:uc001jal.3:exon2:c.A135G:p.A45A	.	AFR:17(meninges),AMR:MU4562096,EAS:0.7726,FIN:0.9506,NFE:0.7787,OTH:0.6656,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9512,9510,9509,9511,9514,9508,9506,9513,9507	.	.	.	.	.	.	10	1(large_intestine)	0.5790
10	43604950	43604950	A	G	RET	intronic	.	ENSG00000165731	rs1864403	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.754193	0.7729	.	.	.	.	.	.	.	.	.	.	AFR:0.9488,AMR:0.7792,EAS:0.5774,FIN:0.6494,NFE:0.7265,OTH:0.7041,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605247	43605249	AAA	-	RET	intronic	.	ENSG00000165731	rs57979030	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.309904	0.3186	.	.	.	.	.	.	.	.	.	.	AFR:0.2101,AMR:0.4689,EAS:0.3306,FIN:0.3449,NFE:0.3626,OTH:0.3663,ASJ:0.3377	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43605392	43605392	G	A	RET	intronic	.	ENSG00000165731	rs2251674	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.72484	0.7456	.	.	.	.	.	.	.	.	.	.	AFR:0.8580,AMR:0.7745,EAS:0.5737,FIN:0.6429,NFE:0.7254,OTH:0.6973,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605617	43605617	-	G	RET	intronic	.	ENSG00000165731	rs397725440	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.105431	0.0767	.	.	.	.	.	.	.	.	.	.	AFR:0.0841,AMR:0.0430,EAS:0.1150,FIN:0.0736,NFE:0.0705,OTH:0.0777,ASJ:0.0927	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43605860	43605860	T	G	RET	intronic	.	ENSG00000165731	rs1864402	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.742412	0.7599	.	.	.	.	.	.	.	.	.	.	AFR:0.9029,AMR:0.7769,EAS:0.5978,FIN:0.6426,NFE:0.7258,OTH:0.7029,ASJ:0.6767	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605902	43605902	A	G	RET	intronic	.	ENSG00000165731	rs1864401	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.743011	0.7603	.	.	.	.	.	.	.	.	.	.	AFR:0.9015,AMR:0.7799,EAS:0.5972,FIN:0.6460,NFE:0.7263,OTH:0.7100,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43606687	43606687	A	G	RET	exonic	synonymous SNV	ENSG00000165731	rs1800860	ENSG00000165731:ENST00000340058:exon7:c.A1296G:p.A432A,ENSG00000165731:ENST00000355710:exon7:c.A1296G:p.A432A	RET:NM_001355216:exon4:c.A534G:p.A178A,RET:NM_020630:exon7:c.A1296G:p.A432A,RET:NM_020975:exon7:c.A1296G:p.A432A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7061	0.7486	0.77516	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RET:uc010qez.1:exon4:c.A534G:p.A178A,RET:uc001jak.1:exon7:c.A1296G:p.A432A,RET:uc001jal.3:exon7:c.A1296G:p.A432A	.	AFR:0.7388,AMR:0.8614,EAS:0.7351,FIN:0.7862,NFE:0.6981,OTH:0.6843,ASJ:0.5586	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9512,9510,9509,9511,9514,9508,9506,9513,9507	.	.	.	.	.	.	10	17(meninges)	0.7031
10	43607756	43607756	G	A	RET	intronic	.	ENSG00000165731	rs3026750	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.701677	0.7643	.	.	.	.	.	.	.	.	.	.	AFR:0.8353,AMR:0.7823,EAS:0.5280,FIN:0.7655,NFE:0.7497,OTH:0.7335,ASJ:0.7433	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	unknown
10	43607760	43607760	C	-	RET	intronic	.	ENSG00000165731	rs34827976	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.70008	0.7642	.	.	.	.	.	.	.	.	.	.	AFR:0.8353,AMR:0.7823,EAS:0.5287,FIN:0.7655,NFE:0.7493,OTH:0.7335,ASJ:0.7433	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	unknown
10	43607789	43607789	C	T	RET	intronic	.	ENSG00000165731	rs3026752	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.00299521	0.0005	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0086,FIN:0,NFE:0,OTH:0,ASJ:0	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	MU113379977	het
10	43608653	43608653	G	A	RET	intronic	.	ENSG00000165731	rs78601594	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.0509185	0.0468	.	.	.	.	.	.	.	.	.	.	AFR:0.0689,AMR:0.0274,EAS:0.0006,FIN:0.0335,NFE:0.0438,OTH:0.0388,ASJ:0.0367	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43608807	43608807	G	T	RET	intronic	.	ENSG00000165731	rs112675631	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.0636981	0.0563	.	.	.	.	.	.	.	.	.	.	AFR:0.1013,AMR:0.0311,EAS:0.0006,FIN:0.0335,NFE:0.0438,OTH:0.0452,ASJ:0.0397	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43610366	43610366	G	A	RET	intronic	.	ENSG00000165731	rs1864400	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.7498	0.8143	.	.	.	.	.	.	.	.	.	.	AFR:0.9094,AMR:0.8115,EAS:0.5405,FIN:0.7994,NFE:0.7951,OTH:0.7735,ASJ:0.7914	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	MU17394467	hom
10	43610455	43610455	T	C	RET	intronic	.	ENSG00000165731	rs1864399	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.717851	0.7822	.	.	.	.	.	.	.	.	.	.	AFR:0.8892,AMR:0.7888,EAS:0.5442,FIN:0.7656,NFE:0.7523,OTH:0.7392,ASJ:0.7483	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43610558	43610558	C	T	RET	intronic	.	ENSG00000165731	rs2742233	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.71246	0.7797	.	.	.	.	.	.	.	.	.	.	AFR:0.8828,AMR:0.7876,EAS:0.5391,FIN:0.7659,NFE:0.7520,OTH:0.7347,ASJ:0.7483	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43611708	43611708	A	G	RET	intronic	.	ENSG00000165731	rs741968	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.752995	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.9157,AMR:0.8138,EAS:0.5377,FIN:0.8102,NFE:0.8049,OTH:0.7796,ASJ:0.7914	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43611865	43611865	T	C	RET	intronic	.	ENSG00000165731	rs2256550	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.469449	MU17394675	.	.	.	.	.	.	.	.	.	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.5585,EAS:0.4354,FIN:0.5199,NFE:0.3123,OTH:0.5117,ASJ:0.6646	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	1(skin)	0.5449
10	43612609	43612609	C	T	RET	intronic	.	ENSG00000165731	rs2742234	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.690895	0.7585	.	.	.	.	.	.	.	.	.	.	AFR:0.8088,AMR:0.7864,EAS:0.5366,FIN:0.7662,NFE:0.7517,OTH:0.7372,ASJ:0.7351	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43613843	43613843	G	T	RET	exonic	synonymous SNV	ENSG00000165731	rs1800861	ENSG00000165731:ENST00000340058:exon13:c.G2307T:p.L769L,ENSG00000165731:ENST00000355710:exon13:c.G2307T:p.L769L	RET:NM_001355216:exon10:c.G1545T:p.L515L,RET:NM_020630:exon13:c.G2307T:p.L769L,RET:NM_020975:exon13:c.G2307T:p.L769L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7419	0.8026	0.71246	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	RET:uc010qez.1:exon10:c.G1545T:p.L515L,RET:uc001jak.1:exon13:c.G2307T:p.L769L,RET:uc001jal.3:exon13:c.G2307T:p.L769L	.	AFR:17(meninges),AMR:1(breast),EAS:MU11676670,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,NFE:0.7799,OTH:0.8831,ASJ:3(biliary_tract)	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9512,9510,9509,9511,9514,9508,9506,9513,9507	.	.	.	.	.	.	10	1(soft_tissue)	0.7888
10	43615094	43615094	C	T	RET	exonic	synonymous SNV	ENSG00000165731	rs1800862	ENSG00000165731:ENST00000340058:exon14:c.C2508T:p.S836S,ENSG00000165731:ENST00000355710:exon14:c.C2508T:p.S836S	RET:NM_001355216:exon11:c.C1746T:p.S582S,RET:NM_020630:exon14:c.C2508T:p.S836S,RET:NM_020975:exon14:c.C2508T:p.S836S	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0467	0.0424	0.0359425	.	.	.	.	.	.	.	.	.	RET:uc010qez.1:exon11:c.C1746T:p.S582S,RET:uc001jak.1:exon14:c.C2508T:p.S836S,RET:uc001jal.3:exon14:c.C2508T:p.S836S	.	AFR:0.0340,AMR:0.0248,EAS:0.0430,FIN:0.0006,NFE:0.0335,OTH:0.0435,ASJ:0.0227	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9512,9510,9509,9511,9514,9508,9506,9513,9507	.	.	.	.	.	.	10	1(prostate)	0.0367
10	43622217	43622217	T	C	RET	UTR3	.	ENSG00000165731	rs2075912	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8031	0.8533	0.754992	MU17395356	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.8233,EAS:0.8138,FIN:0.7781,NFE:0.5378,OTH:0.8112,ASJ:0.9165	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	1(breast)	0.8068
10	50681033	50681033	G	A	ERCC6	exonic	synonymous SNV	ENSG00000225830	rs2229760	ENSG00000225830:ENST00000542458:exon9:c.C861T:p.G287G,ENSG00000225830:ENST00000355832:exon15:c.C2751T:p.G917G	ERCC6:NM_000124:exon15:c.C2751T:p.G917G,ERCC6:NM_001346440:exon15:c.C2751T:p.G917G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.3370	0.3238	0.254193	1(stomach)	.	.	.	.	.	.	.	.	ERCC6:uc009xod.4:exon5:c.C231T:p.G77G,ERCC6:uc001jhr.5:exon9:c.C855T:p.G285G,ERCC6:uc010qgr.3:exon9:c.C861T:p.G287G,ERCC6:uc001jhs.5:exon15:c.C2751T:p.G917G	.	AFR:12(soft_tissue),AMR:1(lung),EAS:MU159322,FIN:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,PACA-AU|1|391|0.00255754,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,NFE:0.3151,OTH:0.1333,ASJ:1(haematopoietic_and_lymphoid_tissue)	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	1(pancreas)	0.3031
10	50701156	50701156	G	A	ERCC6	intronic	.	ENSG00000225830	rs4253132	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8887	0.8322	0.876997	0.8456	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.7220,AMR:0.9269,EAS:0.9994,FIN:0.9026,NFE:0.8787,OTH:0.9057,ASJ:0.8642	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	.	.	.	.	.	.	.	10	MU81879491	hom
10	50723684	50723684	G	A	ERCC6;PGBD3	exonic	synonymous SNV	ENSG00000243251;ENSG00000258838	rs4253073	ENSG00000243251:ENST00000508005:exon1:c.C1477T:p.L493L,ENSG00000243251:ENST00000374127:exon2:c.C1477T:p.L493L,ENSG00000258838:ENST00000447839:exon6:c.C2881T:p.L961L,ENSG00000258838:ENST00000515869:exon6:c.C2881T:p.L961L,ENSG00000243251:ENST00000603152:exon6:c.C2881T:p.L961L	PGBD3:NM_170753:exon2:c.C1477T:p.L493L,ERCC6:NM_001277058:exon6:c.C2881T:p.L961L,ERCC6:NM_001277059:exon6:c.C2881T:p.L961L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.9070	0.8491	0.893371	0.8616	.	.	.	.	.	.	.	.	PGBD3:uc021pqe.1:exon1:c.C1477T:p.L493L,ERCC6-PGBD3:uc001jhu.3:exon6:c.C2881T:p.L961L,ERCC6-PGBD3:uc009xoe.4:exon6:c.C2881T:p.L961L	.	AFR:0.7277,AMR:0.9368,EAS:0.9994,FIN:0.9319,NFE:0.8994,OTH:0.9196,ASJ:0.8974	.	.	.	.	.	,4781	.	.	.	.	.	.	10	MU81879509	hom
10	50724016	50724016	C	T	ERCC6;PGBD3	exonic	nonsynonymous SNV	ENSG00000243251;ENSG00000258838	rs4253072	ENSG00000243251:ENST00000508005:exon1:c.G1145A:p.R382K,ENSG00000243251:ENST00000374127:exon2:c.G1145A:p.R382K,ENSG00000258838:ENST00000447839:exon6:c.G2549A:p.R850K,ENSG00000258838:ENST00000515869:exon6:c.G2549A:p.R850K,ENSG00000243251:ENST00000603152:exon6:c.G2549A:p.R850K	PGBD3:NM_170753:exon2:c.G1145A:p.R382K,ERCC6:NM_001277058:exon6:c.G2549A:p.R850K,ERCC6:NM_001277059:exon6:c.G2549A:p.R850K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.9983	0.9939	0.996206	0.9951	0.120	3.819	1.0	0.699	0.923	.	.	PiggyBac transposable element-derived protein	PGBD3:uc021pqe.1:exon1:c.G1145A:p.R382K,ERCC6-PGBD3:uc001jhu.3:exon6:c.G2549A:p.R850K,ERCC6-PGBD3:uc009xoe.4:exon6:c.G2549A:p.R850K	-1.056	AFR:0.9835,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9959,ASJ:1	.	.	.	.	.	,4781	.	.	0.0	2.35	0.000	-0.75	10	MU81879516	hom
10	50732280	50732280	C	T	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830;ENSG00000243251;ENSG00000258838	rs2228528	ENSG00000225830:ENST00000355832:exon5:c.G1196A:p.G399D,ENSG00000258838:ENST00000447839:exon5:c.G1196A:p.G399D,ENSG00000258838:ENST00000515869:exon5:c.G1196A:p.G399D,ENSG00000243251:ENST00000603152:exon5:c.G1196A:p.G399D	ERCC6:NM_000124:exon5:c.G1196A:p.G399D,ERCC6:NM_001277058:exon5:c.G1196A:p.G399D,ERCC6:NM_001277059:exon5:c.G1196A:p.G399D,ERCC6:NM_001346440:exon5:c.G1196A:p.G399D	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.1958	0.1623	0.237819	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	-1.092	0.010	1.0	-3.85	0.000	.	.	.	ERCC6:uc001jhs.5:exon5:c.G1196A:p.G399D,ERCC6-PGBD3:uc001jhu.3:exon5:c.G1196A:p.G399D,ERCC6-PGBD3:uc009xoe.4:exon5:c.G1196A:p.G399D	-1.032	AFR:0.1840,AMR:0.1696,EAS:0.1755,FIN:0.4769,NFE:0.1742,OTH:0.1597,ASJ:0.2590	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.001	-1.51	0.000	0.37	10	7(soft_tissue)	0.1786
10	50740600	50740600	C	T	ERCC6	exonic	synonymous SNV	ENSG00000225830;ENSG00000243251;ENSG00000258838	rs4253013	ENSG00000225830:ENST00000355832:exon2:c.G411A:p.L137L,ENSG00000258838:ENST00000447839:exon2:c.G411A:p.L137L,ENSG00000225830:ENST00000462247:exon2:c.G411A:p.L137L,ENSG00000258838:ENST00000515869:exon2:c.G411A:p.L137L,ENSG00000243251:ENST00000603152:exon2:c.G411A:p.L137L	ERCC6:NM_000124:exon2:c.G411A:p.L137L,ERCC6:NM_001277058:exon2:c.G411A:p.L137L,ERCC6:NM_001277059:exon2:c.G411A:p.L137L,ERCC6:NM_001346440:exon2:c.G411A:p.L137L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.1190	0.0788	0.175719	1(lung)	.	.	.	.	.	.	.	.	ERCC6:uc001jhs.5:exon2:c.G411A:p.L137L,ERCC6-PGBD3:uc001jhu.3:exon2:c.G411A:p.L137L,ERCC6-PGBD3:uc009xoe.4:exon2:c.G411A:p.L137L	.	AFR:MU23472391,AMR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.1091,FIN:0.2255,NFE:0.0828,OTH:0.4057,ASJ:0.1080	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	3(haematopoietic_and_lymphoid_tissue)	0.1216
10	50740876	50740876	G	C	ERCC6	exonic	synonymous SNV	ENSG00000225830;ENSG00000243251;ENSG00000258838	rs2228524	ENSG00000225830:ENST00000355832:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000447839:exon2:c.C135G:p.L45L,ENSG00000225830:ENST00000462247:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000515869:exon2:c.C135G:p.L45L,ENSG00000243251:ENST00000603152:exon2:c.C135G:p.L45L	ERCC6:NM_000124:exon2:c.C135G:p.L45L,ERCC6:NM_001277058:exon2:c.C135G:p.L45L,ERCC6:NM_001277059:exon2:c.C135G:p.L45L,ERCC6:NM_001346440:exon2:c.C135G:p.L45L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6946	0.6276	0.590855	0.6264	.	.	.	.	.	.	.	.	ERCC6:uc001jhs.5:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc001jhu.3:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc009xoe.4:exon2:c.C135G:p.L45L	.	AFR:0.3820,AMR:0.6595,EAS:0.5217,FIN:0.7570,NFE:0.7389,OTH:0.7286,ASJ:0.7219	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	MU786536	het
10	51568378	51568378	T	G	NCOA4	exonic	nonsynonymous SNV	ENSG00000138293	rs10761581	ENSG00000138293:ENST00000438493:exon2:c.T22G:p.F8V,ENSG00000138293:ENST00000452682:exon2:c.T22G:p.F8V	NCOA4:NM_001145260:exon2:c.T22G:p.F8V,NCOA4:NM_001145261:exon2:c.T22G:p.F8V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5164	0.4135	0.459665	MU122440	.	.	.	0.858	0.001	.	.	.	NCOA4:uc009xon.3:exon2:c.T22G:p.F8V,NCOA4:uc010qhd.2:exon2:c.T22G:p.F8V	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,AMR:0.4109,EAS:0.2644,FIN:0.4272,NFE:0.5466,OTH:0.4610,ASJ:0.3500	601984	.	.	.	~ko04216 Ferroptosis~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.4255
10	61552774	61552774	C	T	CCDC6	exonic	synonymous SNV	ENSG00000108091	rs1053265	ENSG00000108091:ENST00000263102:exon9:c.G1326A:p.P442P	CCDC6:NM_005436:exon9:c.G1326A:p.P442P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7276	0.6525	0.611621	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CCDC6:uc001jks.4:exon9:c.G1326A:p.P442P	.	AFR:0.6649,AMR:0.4247,EAS:0.7318,FIN:0.6781,NFE:0.7385,OTH:0.7733,ASJ:0.8094	601985	.	.	.	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	1(thyroid)	0.7163
10	61612467	61612467	A	-	CCDC6	intronic	.	ENSG00000108091	rs3215226	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3561	0.2819	0.313299	0.2585	.	.	.	.	.	.	.	.	.	.	AFR:0.4213,AMR:0.2048,EAS:0.2212,FIN:0.3118,NFE:0.1607,OTH:0.2128,ASJ:0.2481	601985	.	.	.	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	.	het
10	61831408	61831408	G	A	ANK3	exonic	synonymous SNV	ENSG00000151150	rs757578753	ENSG00000151150:ENST00000280772:exon37:c.C9231T:p.L3077L	ANK3:NM_020987:exon37:c.C9231T:p.L3077L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 1, 0] 	5.07e-05	.	.	3.231e-05	.	.	.	.	.	.	.	.	ANK3:uc001jky.3:exon37:c.C9231T:p.L3077L	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.667e-05,OTH:0,ASJ:0	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	MU129222299	het
10	64573771	64573771	C	T	EGR2	exonic	synonymous SNV	ENSG00000122877	rs224083	ENSG00000122877:ENST00000242480:exon2:c.G627A:p.P209P,ENSG00000122877:ENST00000411732:exon3:c.G477A:p.P159P,ENSG00000122877:ENST00000439032:exon4:c.G627A:p.P209P	EGR2:NM_000399:exon2:c.G627A:p.P209P,EGR2:NM_001136177:exon3:c.G627A:p.P209P,EGR2:NM_001136179:exon3:c.G477A:p.P159P,EGR2:NM_001321037:exon3:c.G477A:p.P159P,EGR2:NM_001136178:exon4:c.G627A:p.P209P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9953	0.9822	0.986022	0.9847	.	.	.	.	.	.	.	.	EGR2:uc001jmi.3:exon2:c.G627A:p.P209P,EGR2:uc010qim.2:exon3:c.G627A:p.P209P,EGR2:uc010qin.2:exon3:c.G477A:p.P159P,EGR2:uc010qio.2:exon3:c.G666A:p.P222P,EGR2:uc009xph.3:exon4:c.G627A:p.P209P	.	AFR:0.9457,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	129010	145900;605253;607678;	101084;99951;64748;	101084|CMT1D|-|Autosomal dominant|Adolescent<br>Infancy<br>Childhood<br>Adult|607678 ~99951|Autosomal recessive congenital hypomyelinating neuropathy<br>CMT4E|-|Autosomal recessive|Infancy<br>Neonatal|605253 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	~ko04625 C-type lectin receptor signaling pathway~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	10	MU81880257	hom
10	70225504	70225504	G	T	DNA2	exonic	synonymous SNV	ENSG00000138346	rs3758626	ENSG00000138346:ENST00000358410:exon4:c.C507A:p.A169A,ENSG00000138346:ENST00000399179:exon4:c.C507A:p.A169A,ENSG00000138346:ENST00000399180:exon4:c.C765A:p.A255A,ENSG00000138346:ENST00000551118:exon4:c.C507A:p.A169A	DNA2:NM_001080449:exon4:c.C507A:p.A169A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2867	0.2758	0.366414	MU136554	.	.	.	.	.	.	.	.	DNA2:uc001jog.3:exon4:c.C507A:p.A169A,DNA2:uc031pvh.1:exon4:c.C507A:p.A169A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.2914,EAS:0.3433,FIN:0.1954,NFE:0.4090,OTH:0.2734,ASJ:0.4193	601810	615156;615807;	808;352470;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~352470|Mitochondrial DNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with progressive myopathy|<1 / 1 000 000|Autosomal dominant|All ages|615156 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.2092
10	70227964	70227964	C	T	DNA2	exonic	synonymous SNV	ENSG00000138346	rs10998205	ENSG00000138346:ENST00000358410:exon3:c.G357A:p.L119L,ENSG00000138346:ENST00000399179:exon3:c.G357A:p.L119L,ENSG00000138346:ENST00000399180:exon3:c.G615A:p.L205L,ENSG00000138346:ENST00000551118:exon3:c.G357A:p.L119L	DNA2:NM_001080449:exon3:c.G357A:p.L119L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1311	0.0701	0.139177	MU32636269	.	.	.	.	.	.	.	.	DNA2:uc001jog.3:exon3:c.G357A:p.L119L,DNA2:uc031pvh.1:exon3:c.G357A:p.L119L	.	AFR:LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,AMR:0.0898,EAS:0.2230,FIN:0.0894,NFE:0.1530,OTH:0.1438,ASJ:0.0312	601810	615156;615807;	808;352470;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~352470|Mitochondrial DNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with progressive myopathy|<1 / 1 000 000|Autosomal dominant|All ages|615156 ~	.	.	.	.	.	.	.	.	10	1(bone)	0.0949
10	70332672	70332672	T	A	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs12773594	ENSG00000138336:ENST00000373644:exon2:c.T577A:p.S193T	TET1:NM_030625:exon2:c.T577A:p.S193T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1788	0.1372	0.171725	0.1695	2.453	19.16	0.055	2.55	0.838	.	.	.	TET1:uc001jok.4:exon2:c.T577A:p.S193T	-0.922	AFR:0.0991,AMR:0.1851,EAS:0.1607,FIN:0.2527,NFE:0.1904,OTH:0.1984,ASJ:0.1126	607790	.	.	.	.	.	.	.	0.808	3.17	0.000	1.735	10	MU11738600	het
10	70332862	70332862	C	T	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs12221107	ENSG00000138336:ENST00000373644:exon2:c.C767T:p.A256V	TET1:NM_030625:exon2:c.C767T:p.A256V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1122	0.0567	0.109425	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	1.916	15.68	0.094	4.63	0.883	.	.	.	TET1:uc001jok.4:exon2:c.C767T:p.A256V	-1.002	AFR:0.0892,AMR:0.0133,EAS:0.0762,FIN:0.1398,NFE:0.1623,OTH:0.1075,ASJ:0.1268	607790	.	.	.	.	.	.	.	0.022	3.08	0.000	1.43	10	2(large_intestine)	0.1133
10	70405237	70405237	G	A	TET1	exonic	synonymous SNV	ENSG00000138336	rs12241767	ENSG00000138336:ENST00000373644:exon4:c.G2751A:p.E917E	TET1:NM_030625:exon4:c.G2751A:p.E917E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1601	0.1894	0.212859	MU793310	.	.	.	.	.	.	.	.	TET1:uc001jok.4:exon4:c.G2751A:p.E917E	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.2136,EAS:0.1782,FIN:0.0695,NFE:0.1307,OTH:0.1950,ASJ:0.3645	607790	.	.	.	.	.	.	.	.	.	.	.	10	1(stomach)	0.1481
10	70405539	70405539	A	G	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs16925541	ENSG00000138336:ENST00000373644:exon4:c.A3053G:p.N1018S	TET1:NM_030625:exon4:c.A3053G:p.N1018S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1032	0.0541	0.0832668	1(stomach)	-0.621	0.111	0.09	0.475	0.059	.	.	.	TET1:uc001jok.4:exon4:c.A3053G:p.N1018S	-0.964	AFR:MU793307,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,EAS:0.0124,FIN:0.1325,NFE:0.0629,OTH:0.1153,ASJ:0.0868	607790	.	.	.	.	.	.	.	0.024	3.08	0.000	0.92	10	1(pancreas)	0.1638
10	70405855	70405855	A	G	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs3998860	ENSG00000138336:ENST00000373644:exon4:c.A3369G:p.I1123M	TET1:NM_030625:exon4:c.A3369G:p.I1123M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7737	0.7212	0.693291	1(haematopoietic_and_lymphoid_tissue)	-1.096	0.010	0.157	-3.65	0.415	.	.	.	TET1:uc001jok.4:exon4:c.A3369G:p.I1123M	-0.998	AFR:MU4560467,AMR:LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916,EAS:0.4861,FIN:0.7351,NFE:0.8874,OTH:0.8407,ASJ:0.7067	607790	.	.	.	.	.	.	.	0.07	3.12	0.000	0.69	10	1(liver)	0.7855
10	72358577	72358577	G	A	PRF1	exonic	synonymous SNV	ENSG00000180644	rs885822	ENSG00000180644:ENST00000373209:exon3:c.C900T:p.H300H,ENSG00000180644:ENST00000441259:exon3:c.C900T:p.H300H	PRF1:NM_001083116:exon3:c.C900T:p.H300H,PRF1:NM_005041:exon3:c.C900T:p.H300H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6357	0.6624	0.695887	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PRF1:uc001jrf.4:exon3:c.C900T:p.H300H,PRF1:uc009xqg.3:exon3:c.C900T:p.H300H	.	AFR:0.6730,AMR:0.8060,EAS:0.5705,FIN:0.7645,NFE:0.6571,OTH:0.5915,ASJ:0.6878	170280	603553;605027;609135;	88;547;540;	88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~547|NHL|1-5 / 10 000|-|Adult|605027 ~540|Familial HLH|Unknown|Autosomal recessive|Infancy<br>Adolescent|267700 603552 603553 608898 613101 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.6619
10	72358845	72358845	G	A	PRF1	exonic	nonsynonymous SNV	ENSG00000180644	rs368524364	ENSG00000180644:ENST00000373209:exon3:c.C632T:p.A211V,ENSG00000180644:ENST00000441259:exon3:c.C632T:p.A211V	PRF1:NM_001083116:exon3:c.C632T:p.A211V,PRF1:NM_005041:exon3:c.C632T:p.A211V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, -1, 1, -1, 1, 0] 	0.0024	.	0.00299521	3.23e-05	-0.603	0.122	0.27	0.208	0.004	.	.	Membrane attack complex component/perforin (MACPF) domain	PRF1:uc001jrf.4:exon3:c.C632T:p.A211V,PRF1:uc009xqg.3:exon3:c.C632T:p.A211V	-0.719	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.665e-05,OTH:0,ASJ:0	170280	603553;605027;609135;	88;547;540;	88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~547|NHL|1-5 / 10 000|-|Adult|605027 ~540|Familial HLH|Unknown|Autosomal recessive|Infancy<br>Adolescent|267700 603552 603553 608898 613101 ~	.	.	.	.	0.251	-1.89	0.469	1.975	10	.	het
10	73082563	73082563	A	G	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2277257	ENSG00000198246:ENST00000373189:exon2:c.A52G:p.R18G	SLC29A3:NM_001174098:exon2:c.A52G:p.R18G,SLC29A3:NM_018344:exon2:c.A52G:p.R18G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4247	0.4874	0.469249	0.4753	0.245	5.151	0.114	1.21	0.017	.	.	.	SLC29A3:uc001jrr.4:exon2:c.A52G:p.R18G,SLC29A3:uc001jrs.4:exon2:c.A52G:p.R18G	-0.950	AFR:0.6475,AMR:0.3513,EAS:0.3461,FIN:0.4266,NFE:0.4106,OTH:0.4296,ASJ:0.4603	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.001	-0.32	0.000	1.43	10	MU4138358	hom
10	73104056	73104056	A	G	SLC29A3	intronic	.	ENSG00000198246	rs2243540	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8674	0.8794	0.814297	0.8696	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.8539,AMR:0.8640,EAS:0.7043,FIN:0.8585,NFE:0.8980,OTH:0.8806,ASJ:0.91	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14180483	hom
10	73111408	73111408	C	T	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs780668	ENSG00000198246:ENST00000373189:exon4:c.C473T:p.S158F	SLC29A3:NM_001174098:exon4:c.C473T:p.S158F,SLC29A3:NM_001363518:exon4:c.C239T:p.S80F,SLC29A3:NM_018344:exon4:c.C473T:p.S158F	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.6384	0.6183	0.479832	MU139025	6.297	29.1	0.062	4.62	0.992	.	.	.	SLC29A3:uc010qjq.2:exon3:c.C35T:p.S12F,SLC29A3:uc001jrr.4:exon4:c.C473T:p.S158F,SLC29A3:uc001jrs.4:exon4:c.C473T:p.S158F	-0.969	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6241,EAS:0.5227,FIN:0.7417,NFE:0.4472,OTH:0.7288,ASJ:0.3520	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.656	0.33	0.000	3.085	10	1(liver)	0.7743
10	73115941	73115941	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs2252997	ENSG00000198246:ENST00000373189:exon5:c.T714C:p.T238T	SLC29A3:NM_001174098:exon5:c.T714C:p.T238T,SLC29A3:NM_001363518:exon5:c.T480C:p.T160T,SLC29A3:NM_018344:exon5:c.T714C:p.T238T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8294	0.8891	0.780751	0.8679	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon3:c.T96C:p.T32T,SLC29A3:uc010qjq.2:exon4:c.T276C:p.T92T,SLC29A3:uc001jrr.4:exon5:c.T714C:p.T238T,SLC29A3:uc001jrs.4:exon5:c.T714C:p.T238T	.	AFR:0.8897,AMR:0.6885,EAS:0.6926,FIN:0.8490,NFE:0.8879,OTH:0.8551,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239655	unknown
10	73115942	73115942	G	A	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2252996	ENSG00000198246:ENST00000373189:exon5:c.G715A:p.V239I	SLC29A3:NM_001174098:exon5:c.G715A:p.V239I,SLC29A3:NM_001363518:exon5:c.G481A:p.V161I,SLC29A3:NM_018344:exon5:c.G715A:p.V239I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8217	0.8616	0.760184	0.8453	-0.811	0.040	0.508	-2.2	0.000	.	.	.	SLC29A3:uc001jrt.4:exon3:c.G97A:p.V33I,SLC29A3:uc010qjq.2:exon4:c.G277A:p.V93I,SLC29A3:uc001jrr.4:exon5:c.G715A:p.V239I,SLC29A3:uc001jrs.4:exon5:c.G715A:p.V239I	-0.980	AFR:0.8111,AMR:0.6850,EAS:0.6926,FIN:0.8490,NFE:0.8875,OTH:0.8520,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	-0.28	0.000	1.37	10	MU14239707	unknown
10	73121913	73121913	A	G	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2487068	ENSG00000198246:ENST00000373189:exon6:c.A976G:p.I326V	SLC29A3:NM_001363518:exon6:c.A742G:p.I248V,SLC29A3:NM_018344:exon6:c.A976G:p.I326V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8246	0.8923	0.792732	0.8745	-2.319	0.001	1.0	-9.0	0.003	.	.	.	SLC29A3:uc001jrt.4:exon4:c.A358G:p.I120V,SLC29A3:uc010qjq.2:exon5:c.A538G:p.I180V,SLC29A3:uc001jrr.4:exon6:c.A976G:p.I326V	-0.954	AFR:0.9235,AMR:0.6771,EAS:0.7228,FIN:0.8389,NFE:0.8824,OTH:0.8599,ASJ:0.8874	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	0.05	0.000	-0.515	10	MU14239795	hom
10	73121945	73121945	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs1084004	ENSG00000198246:ENST00000373189:exon6:c.T1008C:p.G336G	SLC29A3:NM_001363518:exon6:c.T774C:p.G258G,SLC29A3:NM_018344:exon6:c.T1008C:p.G336G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8302	0.8666	0.753794	0.8444	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon4:c.T390C:p.G130G,SLC29A3:uc010qjq.2:exon5:c.T570C:p.G190G,SLC29A3:uc001jrr.4:exon6:c.T1008C:p.G336G	.	AFR:0.7526,AMR:0.6758,EAS:0.7271,FIN:0.8288,NFE:0.9204,OTH:0.8643,ASJ:0.9338	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239860	hom
10	75865065	75865065	G	A	VCL	exonic	synonymous SNV	ENSG00000035403	rs767809	ENSG00000035403:ENST00000436396:exon9:c.G1404A:p.P468P,ENSG00000035403:ENST00000211998:exon16:c.G2388A:p.P796P,ENSG00000035403:ENST00000372755:exon16:c.G2388A:p.P796P	VCL:NM_003373:exon16:c.G2388A:p.P796P,VCL:NM_014000:exon16:c.G2388A:p.P796P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4761	0.4387	0.324681	3(lung)	.	.	.	.	.	.	.	.	VCL:uc010qky.1:exon15:c.G2109A:p.P703P,VCL:uc001jwd.3:exon16:c.G2388A:p.P796P,VCL:uc001jwe.3:exon16:c.G2388A:p.P796P,VCL:uc009xrr.3:exon18:c.G1635A:p.P545P	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU63916,EAS:0.4299,FIN:0.1369,NFE:0.4511,OTH:0.6967,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	193065	611407;613255;	154;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~	.	.	.	.	.	.	.	.	10	1(large_intestine)	0.2801
10	75871735	75871735	C	G	VCL	exonic	synonymous SNV	ENSG00000035403	rs2131956	ENSG00000035403:ENST00000436396:exon12:c.C1830G:p.G610G,ENSG00000035403:ENST00000211998:exon19:c.C2814G:p.G938G	VCL:NM_014000:exon19:c.C2814G:p.G938G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6734	0.7624	0.623003	1(thyroid)	.	.	.	.	.	.	.	.	VCL:uc010qky.1:exon18:c.C2535G:p.G845G,VCL:uc001jwd.3:exon19:c.C2814G:p.G938G	.	AFR:MU4547934,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.7918,FIN:0.6447,NFE:0.8676,OTH:0.3861,ASJ:0.7277	193065	611407;613255;	154;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.6712
10	88930249	88930249	A	T	SHLD2	exonic	nonsynonymous SNV	ENSG00000122376	rs11202365	ENSG00000122376:ENST00000298784:exon5:c.A1648T:p.S550C,ENSG00000122376:ENST00000298786:exon5:c.A1648T:p.S550C	SHLD2:NM_001330112:exon5:c.A1648T:p.S550C,SHLD2:NM_019054:exon5:c.A1648T:p.S550C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.3463	0.3246	0.275359	1(lung)	4.059	23.7	0.017	2.92	0.150	.	.	.	FAM35A:uc001kei.4:exon5:c.A1648T:p.S550C	-0.930	AFR:MU4559196,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1987,FIN:0.2668,NFE:0.3543,OTH:0.1609,ASJ:0.3152	.	.	.	.	.	.	.	.	0.995	-0.13	0.000	2.3	10	2(thyroid)	0.3434
10	88939898	88939898	C	T	SHLD2	exonic	nonsynonymous SNV	ENSG00000122376	rs77534648	ENSG00000122376:ENST00000298784:exon7:c.C2030T:p.A677V,ENSG00000122376:ENST00000298786:exon8:c.C2237T:p.A746V	SHLD2:NM_019054:exon7:c.C2030T:p.A677V,SHLD2:NM_001330112:exon8:c.C2237T:p.A746V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0168	0.0003	0.0385383	MU80623628	1.019	10.77	0.784	-3.05	0.853	.	.	Protein FAM35A, C-terminal domain	FAM35A:uc001kej.4:exon5:c.C368T:p.A123V,FAM35A:uc001kei.4:exon7:c.C2030T:p.A677V	-1.069	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,GACA-JP|1|585|0.0017094,BRCA-KR|1|50|0.02,AMR:0.0028,EAS:0.0012,FIN:0,NFE:0.0451,OTH:0.0003,ASJ:0.0005	.	.	.	.	.	.	.	.	0.001	0.02	0.011	0.29	10	1(lung)	0.0003
10	88939962	88939962	T	C	SHLD2	exonic	synonymous SNV	ENSG00000122376	rs7081609	ENSG00000122376:ENST00000298784:exon7:c.T2094C:p.G698G,ENSG00000122376:ENST00000298786:exon8:c.T2301C:p.G767G	SHLD2:NM_019054:exon7:c.T2094C:p.G698G,SHLD2:NM_001330112:exon8:c.T2301C:p.G767G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8356	0.8848	0.793331	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	FAM35A:uc001kej.4:exon5:c.T432C:p.G144G,FAM35A:uc001kei.4:exon7:c.T2094C:p.G698G	.	AFR:0.8588,AMR:0.9648,EAS:0.8758,FIN:0.3841,NFE:0.8222,OTH:0.8577,ASJ:0.8317	.	.	.	.	.	.	.	.	.	.	.	.	10	2(lung)	0.8632
10	89623861	89623861	T	-	PTEN	splicing	.	ENSG00000171862	rs71022512	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	1	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9993,AMR:0.9963,EAS:0.9969,FIN:0.9897,NFE:0.9986,OTH:0.9947,ASJ:0.9933	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	89623901	89623901	G	C	PTEN	exonic	nonsynonymous SNV	ENSG00000171862	rs2943772	.	PTEN:NM_001304717:exon2:c.G194C:p.C65S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 0, -1, 1, 0, 1, 1] 	.	.	1	0.9996	.	.	.	.	.	.	.	.	.	.	AFR:0.9998,AMR:0.9976,EAS:1,FIN:0.9983,NFE:0.9999,OTH:1,ASJ:1	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,9317,9294,9324,9325,9290,9313,9305,9301,9323,9267,9304,9292,9314,9296,9268,9299,9322,9273,9303,9269,9297,9330,9307,9326,9295,9320,9276,9321,9293,9270,9300,9309,9302,9271,9310,9327,9298,9308,9316,9315,9319,9291,9306,9275,9272,9274,9329,9311,9328	,9312	.	.	.	.	.	10	.	het
10	90749256	90749256	G	A	ACTA2	intronic	.	ENSG00000107796	rs2234767	.	.	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1475	0.0978	0.184105	1(biliary_tract)	.	.	.	.	.	.	.	.	.	.	AFR:MU11775963,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,EAS:0.0530,FIN:0.1587,NFE:0.1159,OTH:0.4108,ASJ:0.1142	102620	611788;613834;614042;	2573;404463;91387;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~404463|-|<1 / 1 000 000|Unknown|Infancy|613834 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	10	2(lung)	0.1234
10	90750982	90750982	T	G	ACTA2	UTR5	.	ENSG00000107796	rs7079111	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.937899	0.9023	.	.	.	.	.	.	.	.	.	.	AFR:0.9738,AMR:0.8780,EAS:0.9957,FIN:0.8421,NFE:0.8684,OTH:0.8709,ASJ:0.8808	102620	611788;613834;614042;	2573;404463;91387;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~404463|-|<1 / 1 000 000|Unknown|Infancy|613834 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	10	.	hom
10	90771829	90771829	T	C	FAS	exonic	synonymous SNV	ENSG00000026103	rs2234978	ENSG00000026103:ENST00000357339:exon6:c.T579C:p.T193T,ENSG00000026103:ENST00000352159:exon7:c.T642C:p.T214T,ENSG00000026103:ENST00000355279:exon7:c.T642C:p.T214T,ENSG00000026103:ENST00000355740:exon7:c.T642C:p.T214T	FAS:NM_152871:exon6:c.T579C:p.T193T,FAS:NM_000043:exon7:c.T642C:p.T214T,FAS:NM_152872:exon7:c.T642C:p.T214T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7561	0.6952	0.775359	0.7328	-0.976	0.018	.	-0.619	0.000	.	.	.	FAS:uc001kft.3:exon6:c.T579C:p.T193T,FAS:uc001kfr.3:exon7:c.T642C:p.T214T,FAS:uc001kfs.3:exon7:c.T642C:p.T214T	.	AFR:0.6849,AMR:0.8146,EAS:0.9840,FIN:0.7967,NFE:0.7117,OTH:0.7576,ASJ:0.7649	134637	601859;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04217 Necroptosis~ko04650 Natural killer cell mediated cytotoxicity~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04940 Type I diabetes mellitus~ko05010 Alzheimer disease~ko05130 Pathogenic Escherichia coli infection~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05320 Autoimmune thyroid disease~ko05330 Allograft rejection~ko05332 Graft-versus-host disease ~	.	.	.	.	.	.	.	10	MU67395980	het
10	95549836	95549836	-	TT	LGI1	intronic	.	ENSG00000108231	rs371933363	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4481	.	0.453075	0.8264	.	.	.	.	.	.	.	.	.	.	AFR:0.6826,AMR:0.9059,EAS:0.8932,FIN:0.7581,NFE:0.9027,OTH:0.8843,ASJ:0.8578	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	.	hom
10	95552653	95552653	T	C	LGI1	exonic	synonymous SNV	ENSG00000108231	rs1111820	ENSG00000108231:ENST00000542308:exon4:c.T513C:p.F171F,ENSG00000108231:ENST00000371413:exon6:c.T657C:p.F219F,ENSG00000108231:ENST00000371418:exon6:c.T657C:p.F219F	LGI1:NM_001308276:exon4:c.T513C:p.F171F,LGI1:NM_001308275:exon6:c.T657C:p.F219F,LGI1:NM_005097:exon6:c.T657C:p.F219F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9928	0.9769	0.977436	0.9798	.	.	.	.	.	.	.	.	LGI1:uc010qnv.2:exon4:c.T513C:p.F171F,LGI1:uc001kjc.4:exon6:c.T657C:p.F219F,LGI1:uc021pwk.1:exon6:c.T657C:p.F219F	.	AFR:0.9302,AMR:0.9964,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9959,ASJ:1	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	MU81883389	hom
10	95791613	95791613	T	C	PLCE1	exonic	synonymous SNV	ENSG00000138193	rs17109671	ENSG00000138193:ENST00000371380:exon1:c.T810C:p.C270C,ENSG00000138193:ENST00000260766:exon2:c.T810C:p.C270C	PLCE1:NM_001288989:exon2:c.T810C:p.C270C,PLCE1:NM_016341:exon2:c.T810C:p.C270C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3197	0.3965	0.460463	0.4010	.	.	.	.	.	.	.	.	PLCE1:uc010qnx.2:exon1:c.T810C:p.C270C,PLCE1:uc001kjk.3:exon2:c.T810C:p.C270C	.	AFR:0.7076,AMR:0.2093,EAS:0.4593,FIN:0.2942,NFE:0.2599,OTH:0.3258,ASJ:0.2715	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	MU19200714	het
10	95791763	95791763	G	A	PLCE1	exonic	synonymous SNV	ENSG00000138193	rs17109674	ENSG00000138193:ENST00000371380:exon1:c.G960A:p.E320E,ENSG00000138193:ENST00000260766:exon2:c.G960A:p.E320E	PLCE1:NM_001288989:exon2:c.G960A:p.E320E,PLCE1:NM_016341:exon2:c.G960A:p.E320E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2860	0.3182	0.378195	0.3281	.	.	.	.	.	.	.	.	PLCE1:uc010qnx.2:exon1:c.G960A:p.E320E,PLCE1:uc001kjk.3:exon2:c.G960A:p.E320E	.	AFR:0.4769,AMR:0.1647,EAS:0.4226,FIN:0.2937,NFE:0.2519,OTH:0.3122,ASJ:0.2148	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	MU19200752	het
10	96039597	96039597	G	C	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs2274224	ENSG00000138193:ENST00000371375:exon19:c.G3800C:p.R1267P,ENSG00000138193:ENST00000371380:exon19:c.G4724C:p.R1575P,ENSG00000138193:ENST00000371385:exon19:c.G3800C:p.R1267P,ENSG00000138193:ENST00000260766:exon20:c.G4724C:p.R1575P	PLCE1:NM_001165979:exon19:c.G3800C:p.R1267P,PLCE1:NM_001288989:exon20:c.G4676C:p.R1559P,PLCE1:NM_016341:exon20:c.G4724C:p.R1575P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4378	0.4759	0.486222	MU11784347	1.510	13.37	1.0	4.64	0.741	.	.	PLC-like phosphodiesterase, TIM beta/alpha-barrel domain	PLCE1:uc001kjm.3:exon19:c.G3800C:p.R1267P,PLCE1:uc010qnx.2:exon19:c.G4676C:p.R1559P,PLCE1:uc001kjk.3:exon20:c.G4724C:p.R1575P	-0.950	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4707,EAS:0.3732,FIN:0.5033,NFE:0.5462,OTH:0.3449,ASJ:0.5530	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	1.92	0.000	-0.55	10	1(stomach)	0.4521
10	96044734	96044734	C	A	PLCE1-AS1	ncRNA_intronic	.	ENSG00000268894	rs3736901	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3431	0.2717	0.230232	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.2925,AMR:0.0706,EAS:0.3146,FIN:0.1764,NFE:0.4759,OTH:0.3743,ASJ:0.4821	.	.	.	.	.	.	.	.	.	.	.	.	10	1(large_intestine)	0.3855
10	96058298	96058298	C	T	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs3765524	ENSG00000138193:ENST00000371375:exon23:c.C4406T:p.T1469I,ENSG00000138193:ENST00000371380:exon23:c.C5330T:p.T1777I,ENSG00000138193:ENST00000371385:exon23:c.C4406T:p.T1469I,ENSG00000138193:ENST00000260766:exon24:c.C5330T:p.T1777I	PLCE1:NM_001165979:exon23:c.C4406T:p.T1469I,PLCE1:NM_001288989:exon24:c.C5282T:p.T1761I,PLCE1:NM_016341:exon24:c.C5330T:p.T1777I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2711	0.3210	0.307907	1(stomach)	1.616	13.94	1.0	5.6	1.000	.	.	PLC-like phosphodiesterase, TIM beta/alpha-barrel domain|Phosphatidylinositol-specific phospholipase C, X domain;PLC-like phosphodiesterase, TIM beta/alpha-barrel domain|Phospholipase C, phosphatidylinositol-specific, Y domain	PLCE1:uc001kjp.3:exon3:c.C404T:p.T135I,PLCE1:uc001kjm.3:exon23:c.C4406T:p.T1469I,PLCE1:uc010qnx.2:exon23:c.C5282T:p.T1761I,PLCE1:uc001kjk.3:exon24:c.C5330T:p.T1777I	-0.957	AFR:3(large_intestine),AMR:MU82115281,EAS:0.3104,FIN:0.4131,NFE:0.1874,OTH:0.4233,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	0.76	0.000	-1.49	10	9(soft_tissue)	0.2135
10	96058433	96058433	G	A	PLCE1	intronic	.	ENSG00000138193	rs17516758	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1372	0.1354	0.106829	0.1412	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.0907,AMR:0.0847,EAS:0.0012,FIN:0.1581,NFE:0.1820,OTH:0.1619,ASJ:0.2152	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	.	het
10	96066341	96066341	A	G	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs2274223	ENSG00000138193:ENST00000371375:exon25:c.A4856G:p.H1619R,ENSG00000138193:ENST00000371380:exon25:c.A5780G:p.H1927R,ENSG00000138193:ENST00000371385:exon25:c.A4856G:p.H1619R,ENSG00000138193:ENST00000260766:exon26:c.A5780G:p.H1927R	PLCE1:NM_001165979:exon25:c.A4856G:p.H1619R,PLCE1:NM_001288989:exon26:c.A5732G:p.H1911R,PLCE1:NM_016341:exon26:c.A5780G:p.H1927R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2846	0.3186	0.298522	4(large_intestine)	0.210	4.782	1.0	5.43	0.992	.	.	C2 domain;PLC-like phosphodiesterase, TIM beta/alpha-barrel domain	PLCE1:uc001kjp.3:exon5:c.A854G:p.H285R,PLCE1:uc001kjm.3:exon25:c.A4856G:p.H1619R,PLCE1:uc010qnx.2:exon25:c.A5732G:p.H1911R,PLCE1:uc001kjk.3:exon26:c.A5780G:p.H1927R	-1.071	AFR:MU82115293,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.3440,FIN:0.1926,NFE:0.4272,OTH:0.2126,ASJ:0.3086	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	-0.31	0.000	-0.955	10	10(soft_tissue)	0.2199
10	96076495	96076495	C	G	PLCE1	exonic	synonymous SNV	ENSG00000138193	rs942676	ENSG00000138193:ENST00000371375:exon28:c.C5400G:p.V1800V,ENSG00000138193:ENST00000371380:exon28:c.C6324G:p.V2108V,ENSG00000138193:ENST00000371385:exon28:c.C5400G:p.V1800V,ENSG00000138193:ENST00000260766:exon29:c.C6324G:p.V2108V	PLCE1:NM_001165979:exon28:c.C5400G:p.V1800V,PLCE1:NM_001288989:exon29:c.C6276G:p.V2092V,PLCE1:NM_016341:exon29:c.C6324G:p.V2108V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1456	0.1188	0.0870607	0.1299	.	.	.	.	.	.	.	.	PLCE1:uc001kjp.3:exon8:c.C1398G:p.V466V,PLCE1:uc001kjm.3:exon28:c.C5400G:p.V1800V,PLCE1:uc010qnx.2:exon28:c.C6276G:p.V2092V,PLCE1:uc001kjk.3:exon29:c.C6324G:p.V2108V	.	AFR:0.0324,AMR:0.1611,EAS:0.0006,FIN:0.2172,NFE:0.1765,OTH:0.1711,ASJ:0.0960	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	.	het
10	96802737	96802737	G	A	CYP2C8	exonic	synonymous SNV	ENSG00000138115	rs11188150	ENSG00000138115:ENST00000535898:exon6:c.C753T:p.H251H,ENSG00000138115:ENST00000539050:exon6:c.C801T:p.H267H,ENSG00000138115:ENST00000371270:exon7:c.C1059T:p.H353H,ENSG00000138115:ENST00000527420:exon7:c.C1059T:p.H353H	CYP2C8:NM_001198854:exon6:c.C753T:p.H251H,CYP2C8:NM_000770:exon7:c.C1059T:p.H353H,CYP2C8:NM_001198853:exon7:c.C849T:p.H283H,CYP2C8:NM_001198855:exon8:c.C849T:p.H283H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0096	0.0032	0.00978435	0.0015	.	.	.	.	.	.	.	.	CYP2C8:uc010qob.2:exon6:c.C801T:p.H267H,CYP2C8:uc010qoc.2:exon6:c.C753T:p.H251H,CYP2C8:uc010qod.1:exon6:c.C801T:p.H267H,CYP2C8:uc001kkb.3:exon7:c.C1059T:p.H353H,CYP2C8:uc010qoa.2:exon7:c.C849T:p.H283H,CYP2C8:uc021pwl.1:exon8:c.C849T:p.H283H	.	AFR:0.0002,AMR:0.0024,EAS:0,FIN:0,NFE:0.0021,OTH:0.0102,ASJ:0.0099	601129	.	.	.	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00830 Retinol metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	.	het
10	99220707	99220707	C	T	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs3740526	ENSG00000155229:ENST00000327238:exon22:c.G2075A:p.G692D,ENSG00000155229:ENST00000355839:exon23:c.G2240A:p.G747D,ENSG00000155229:ENST00000438925:exon24:c.G2369A:p.G790D,ENSG00000155229:ENST00000370782:exon25:c.G2369A:p.G790D	MMS19:NM_001330128:exon22:c.G2075A:p.G692D,MMS19:NM_001289403:exon23:c.G2240A:p.G747D,MMS19:NM_001289404:exon23:c.G1892A:p.G631D,MMS19:NM_001351357:exon23:c.G1895A:p.G632D,MMS19:NM_001351358:exon23:c.G1277A:p.G426D,MMS19:NM_001351359:exon24:c.G1277A:p.G426D,MMS19:NM_022362:exon24:c.G2369A:p.G790D,MMS19:NM_001289405:exon25:c.G2369A:p.G790D,MMS19:NM_001351356:exon25:c.G2486A:p.G829D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4288	0.3420	0.330072	1(pancreas)	1.394	12.76	0.406	3.64	0.256	.	.	Armadillo-like helical|Armadillo-type fold|MMS19, C-terminal;Armadillo-like helical|MMS19, C-terminal	MMS19:uc001knq.3:exon2:c.G158A:p.G53D,MMS19:uc009xvs.3:exon11:c.G1124A:p.G375D,MMS19:uc009xvt.3:exon21:c.G1601A:p.G534D,MMS19:uc001knr.3:exon23:c.G1892A:p.G631D,MMS19:uc010qox.3:exon23:c.G2240A:p.G747D,MMS19:uc001kns.4:exon24:c.G2369A:p.G790D,MMS19:uc001knt.3:exon25:c.G2369A:p.G790D	-0.937	AFR:MU581955,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.2058,FIN:0.4701,NFE:0.3609,OTH:0.3984,ASJ:0.3559	614777	.	.	.	.	.	.	.	0.103	1.62	0.000	-0.805	10	1(prostate)	0.4042
10	99240758	99240758	G	C	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs2275586	ENSG00000155229:ENST00000327238:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000355839:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000422685:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000437002:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000438925:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000439048:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000448660:exon3:c.C197G:p.A66G,ENSG00000155229:ENST00000370782:exon4:c.C203G:p.A68G	MMS19:NM_001289403:exon3:c.C203G:p.A68G,MMS19:NM_001330128:exon3:c.C203G:p.A68G,MMS19:NM_001351356:exon3:c.C203G:p.A68G,MMS19:NM_022362:exon3:c.C203G:p.A68G,MMS19:NM_001289405:exon4:c.C203G:p.A68G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9649	0.9468	0.9375	0.9507	1.135	11.40	1.0	6.08	0.993	.	.	Armadillo-like helical;Armadillo-like helical|Armadillo-type fold	MMS19:uc001kns.4:exon3:c.C203G:p.A68G,MMS19:uc010qox.3:exon3:c.C203G:p.A68G,MMS19:uc001knt.3:exon4:c.C203G:p.A68G	-0.955	AFR:0.8826,AMR:0.9821,EAS:0.9796,FIN:0.9614,NFE:0.9804,OTH:0.9827,ASJ:0.9669	614777	.	.	.	.	.	.	.	0.0	-0.57	0.000	-0.515	10	MU81883983	het
10	99531571	99531571	C	G	SFRP5	exonic	nonsynonymous SNV	ENSG00000120057	rs11815012	ENSG00000120057:ENST00000266066:exon1:c.G20C:p.G7A	SFRP5:NM_003015:exon1:c.G20C:p.G7A	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.8387	.	0.78155	0.8447	-1.393	0.003	1.0	.	0.001	.	.	.	SFRP5:uc001kor.4:exon1:c.G20C:p.G7A	-0.961	AFR:0.9526,AMR:0.6704,EAS:0.4913,FIN:0.8104,NFE:0.8344,OTH:0.8225,ASJ:0.7953	604158	.	.	.	.	.	.	.	.	-0.17	0.000	0	10	.	hom
10	101544447	101544447	A	T	ABCC2	exonic	nonsynonymous SNV	ENSG00000023839	rs927344	ENSG00000023839:ENST00000370434:exon2:c.A116T:p.Y39F,ENSG00000023839:ENST00000370449:exon2:c.A116T:p.Y39F	ABCC2:NM_000392:exon2:c.A116T:p.Y39F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9980	0.9935	0.994609	0.9944	1.609	13.90	1.0	5.58	0.991	.	.	.	ABCC2:uc001kqf.2:exon2:c.A116T:p.Y39F	-0.937	AFR:0.9802,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	0.0	0.5	0.000	-1.375	10	MU81884479	hom
10	101604207	101604207	C	T	ABCC2	exonic	synonymous SNV	ENSG00000023839	rs3740066	ENSG00000023839:ENST00000370449:exon28:c.C3972T:p.I1324I	ABCC2:NM_000392:exon28:c.C3972T:p.I1324I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3420	0.3335	0.288139	0.3248	.	.	.	.	.	.	.	.	ABCC2:uc001kqf.2:exon28:c.C3972T:p.I1324I	.	AFR:0.2637,AMR:0.3520,EAS:0.2136,FIN:0.3455,NFE:0.3656,OTH:0.3282,ASJ:0.3377	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	.	.	.	.	10	MU157609	het
10	102506070	102506070	G	C	PAX2	intronic	.	ENSG00000075891	rs4472867	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8365	0.7750	0.846645	0.8077	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8086,EAS:1,FIN:0.8548,NFE:0.8090,OTH:0.8160,ASJ:0.8311	167409	120330;616002;	656;1475;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~1475|Coloboma of optic nerve with renal disease<br>Papillo-renal syndrome|Unknown|Autosomal dominant|Childhood|120330 ~	.	.	.	.	.	.	.	.	10	MU81884534	hom
10	104157727	104157727	C	T	NFKB2	intronic	.	ENSG00000077150	rs4919632	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9646	0.9222	0.922125	0.9335	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.8030,AMR:0.9678,EAS:1,FIN:0.9963,NFE:0.9820,OTH:0.9785,ASJ:0.9636	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU81884905	hom
10	104159196	104159196	A	G	NFKB2	exonic	synonymous SNV	ENSG00000077150	rs4919633	ENSG00000077150:ENST00000189444:exon13:c.A1269G:p.P423P,ENSG00000077150:ENST00000369966:exon13:c.A1269G:p.P423P,ENSG00000077150:ENST00000428099:exon13:c.A1269G:p.P423P	NFKB2:NM_001261403:exon12:c.A1269G:p.P423P,NFKB2:NM_001322935:exon12:c.A1143G:p.P381P,NFKB2:NM_001077494:exon13:c.A1269G:p.P423P,NFKB2:NM_001288724:exon13:c.A1269G:p.P423P,NFKB2:NM_001322934:exon13:c.A1269G:p.P423P,NFKB2:NM_002502:exon13:c.A1269G:p.P423P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9971	0.9919	0.986821	0.9893	.	.	.	.	.	.	.	.	NFKB2:uc009xxc.4:exon12:c.A1269G:p.P423P,NFKB2:uc001kva.4:exon13:c.A1269G:p.P423P,NFKB2:uc001kvb.4:exon13:c.A1269G:p.P423P,NFKB2:uc001kvd.4:exon13:c.A1269G:p.P423P	.	AFR:0.9632,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU68086	hom
10	104160434	104160434	A	G	NFKB2	exonic	synonymous SNV	ENSG00000077150	rs4919634	ENSG00000077150:ENST00000189444:exon17:c.A1821G:p.A607A,ENSG00000077150:ENST00000369966:exon17:c.A1821G:p.A607A,ENSG00000077150:ENST00000428099:exon17:c.A1821G:p.A607A	NFKB2:NM_001261403:exon16:c.A1821G:p.A607A,NFKB2:NM_001322935:exon16:c.A1695G:p.A565A,NFKB2:NM_001077494:exon17:c.A1821G:p.A607A,NFKB2:NM_001288724:exon17:c.A1821G:p.A607A,NFKB2:NM_001322934:exon17:c.A1821G:p.A607A,NFKB2:NM_002502:exon17:c.A1821G:p.A607A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9968	0.9895	0.986821	0.9894	.	.	.	.	.	.	.	.	NFKB2:uc009xxc.4:exon16:c.A1821G:p.A607A,NFKB2:uc001kva.4:exon17:c.A1821G:p.A607A,NFKB2:uc001kvb.4:exon17:c.A1821G:p.A607A,NFKB2:uc001kvd.4:exon17:c.A1821G:p.A607A	.	AFR:0.9636,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU4556917	hom
10	104264107	104264107	C	T	SUFU	intronic	.	ENSG00000107882	rs2274351	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4857	0.4795	0.396166	0.4626	.	.	.	.	.	.	.	.	.	.	AFR:0.3195,AMR:0.3652,EAS:0.3451,FIN:0.5258,NFE:0.5417,OTH:0.5103,ASJ:0.6854	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU26588926	hom
10	104387019	104387019	T	C	SUFU	intronic	.	ENSG00000107882	rs12414407	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6628	0.6811	0.719649	0.6861	.	.	.	.	.	.	.	.	.	.	AFR:0.7605,AMR:0.5979,EAS:0.7627,FIN:0.6097,NFE:0.6594,OTH:0.6510,ASJ:0.6967	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU23889391	hom
10	104389932	104389932	T	G	SUFU	UTR3	.	ENSG00000107882	rs4917980	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9994	0.9978	0.997404	0.9983	.	.	.	.	.	.	.	.	.	.	AFR:0.9940,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU81885050	hom
10	104592249	104592249	A	C	CYP17A1	intronic	.	ENSG00000148795	rs4919686	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2238	0.2204	0.138778	0.2242	.	.	.	.	.	.	.	.	.	.	AFR:0.0703,AMR:0.2093,EAS:0.1642,FIN:0.2716,NFE:0.3051,OTH:0.2673,ASJ:0.34	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU82115785	het
10	104596924	104596924	C	A	CYP17A1	exonic	synonymous SNV	ENSG00000148795	rs6163	ENSG00000148795:ENST00000369887:exon1:c.G195T:p.S65S	CYP17A1:NM_000102:exon1:c.G195T:p.S65S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3974	0.3833	0.410343	0.4008	.	.	.	.	.	.	.	.	CYP17A1:uc001kwg.3:exon1:c.G195T:p.S65S	.	AFR:0.3645,AMR:0.3962,EAS:0.5989,FIN:0.3584,NFE:0.4089,OTH:0.4180,ASJ:0.4470	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU61497	het
10	104596981	104596981	G	A	CYP17A1	exonic	synonymous SNV	ENSG00000148795	rs6162	ENSG00000148795:ENST00000369887:exon1:c.C138T:p.H46H	CYP17A1:NM_000102:exon1:c.C138T:p.H46H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4248	0.3949	0.442492	0.4116	.	.	.	.	.	.	.	.	CYP17A1:uc001kwg.3:exon1:c.C138T:p.H46H	.	AFR:0.3683,AMR:0.4117,EAS:0.5963,FIN:0.3645,NFE:0.4254,OTH:0.4305,ASJ:0.4735	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU135047	het
10	104849468	104849468	G	A	NT5C2	exonic	synonymous SNV	ENSG00000076685	rs3740387	ENSG00000076685:ENST00000404739:exon17:c.C1647T:p.D549D,ENSG00000076685:ENST00000423468:exon17:c.C1560T:p.D520D,ENSG00000076685:ENST00000343289:exon18:c.C1647T:p.D549D	NT5C2:NM_001351181:exon16:c.C1074T:p.D358D,NT5C2:NM_001351174:exon17:c.C1560T:p.D520D,NT5C2:NM_001351183:exon17:c.C1074T:p.D358D,NT5C2:NM_001351191:exon17:c.C1074T:p.D358D,NT5C2:NM_001134373:exon18:c.C1647T:p.D549D,NT5C2:NM_001351176:exon18:c.C1074T:p.D358D,NT5C2:NM_001351180:exon18:c.C1074T:p.D358D,NT5C2:NM_001351192:exon18:c.C1074T:p.D358D,NT5C2:NM_001351194:exon18:c.C933T:p.D311D,NT5C2:NM_001351169:exon19:c.C1647T:p.D549D,NT5C2:NM_001351170:exon19:c.C1671T:p.D557D,NT5C2:NM_001351173:exon19:c.C1671T:p.D557D,NT5C2:NM_001351177:exon19:c.C1074T:p.D358D,NT5C2:NM_001351184:exon19:c.C1074T:p.D358D,NT5C2:NM_001351185:exon19:c.C1074T:p.D358D,NT5C2:NM_001351188:exon19:c.C1074T:p.D358D,NT5C2:NM_001351189:exon19:c.C1074T:p.D358D,NT5C2:NM_001351190:exon19:c.C1074T:p.D358D,NT5C2:NM_001351193:exon19:c.C1074T:p.D358D,NT5C2:NM_012229:exon19:c.C1647T:p.D549D,NT5C2:NM_001351171:exon20:c.C1671T:p.D557D,NT5C2:NM_001351172:exon20:c.C1671T:p.D557D,NT5C2:NM_001351175:exon20:c.C1554T:p.D518D,NT5C2:NM_001351179:exon20:c.C1074T:p.D358D,NT5C2:NM_001351182:exon20:c.C1074T:p.D358D,NT5C2:NM_001351195:exon20:c.C933T:p.D311D,NT5C2:NM_001351197:exon20:c.C1074T:p.D358D,NT5C2:NM_001351178:exon21:c.C1074T:p.D358D,NT5C2:NM_001351186:exon21:c.C1074T:p.D358D,NT5C2:NM_001351196:exon21:c.C933T:p.D311D,NT5C2:NM_001351187:exon22:c.C1074T:p.D358D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4171	0.3968	0.422125	1(stomach)	.	.	.	.	.	.	.	.	NT5C2:uc010qqp.2:exon17:c.C1560T:p.D520D,NT5C2:uc001kwq.3:exon18:c.C1647T:p.D549D,NT5C2:uc001kwo.3:exon19:c.C1647T:p.D549D,NT5C2:uc001kwp.3:exon19:c.C1188T:p.D396D	.	AFR:1(urinary_tract),AMR:MU23889750,EAS:0.4122,FIN:0.3846,NFE:0.4067,OTH:0.4735,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	.	,8380	.	.	.	.	.	.	10	2(haematopoietic_and_lymphoid_tissue)	0.5211
10	104896078	104896078	T	A	NT5C2	exonic	stopgain	ENSG00000076685	rs34104646	.	NT5C2:NM_001351175:exon5:c.A10T:p.R4X	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	.	.	0.286741	0.3245	.	.	.	.	.	.	.	.	.	.	AFR:0.3276,AMR:0.2344,EAS:0.3171,FIN:0.2951,NFE:0.3353,OTH:0.2990,ASJ:0.4073	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	.	,8380	.	.	.	.	.	.	10	MU115986040	het
10	112343591	112343591	G	A	SMC3	intronic	.	ENSG00000108055	rs11195199	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1490	0.0973	0.148163	0.1170	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.0806,AMR:0.2153,EAS:0.2330,FIN:0.1345,NFE:0.1169,OTH:0.1112,ASJ:0.0993	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	10	MU20249066	het
10	112343923	112343923	T	C	SMC3	intronic	.	ENSG00000108055	rs11195200	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1489	0.0981	0.148163	0.1168	.	.	.	.	.	.	.	.	.	.	AFR:0.0804,AMR:0.2172,EAS:0.2337,FIN:0.1343,NFE:0.1163,OTH:0.1110,ASJ:0.0993	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	10	MU11573771	het
10	112360316	112360316	T	-	SMC3	intronic	.	ENSG00000108055	rs397847637	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3748	.	0.388179	0.1393	.	.	.	.	.	.	.	.	.	.	AFR:0.0928,AMR:0.3123,EAS:0.278,FIN:0.2411,NFE:0.1327,OTH:0.1515,ASJ:0.1423	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	10	.	het
10	112361870	112361870	A	G	SMC3	exonic	synonymous SNV	ENSG00000108055	rs2419565	ENSG00000108055:ENST00000361804:exon25:c.A3039G:p.S1013S	SMC3:NM_005445:exon25:c.A3039G:p.S1013S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.9963	0.9899	0.986821	0.9897	.	.	.	.	.	.	.	.	SMC3:uc001kze.3:exon25:c.A3039G:p.S1013S	.	AFR:0.9651,AMR:0.9976,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:0.9834	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	,9741	.	.	.	.	.	.	10	MU81885879	hom
10	112745535	112745535	G	A	SHOC2	intronic	.	ENSG00000108061	rs201258692	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0125	.	0.0223642	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0012,FIN:0,NFE:0.0001,OTH:0.0061,ASJ:0	602775	607721;	2701;	2701|NS/LAH<br>Tosti syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|607721 ~	.	.	.	.	.	.	.	.	10	MU29620551	het
10	112764352	112764352	T	-	SHOC2	intronic	.	ENSG00000108061	rs730881016	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0128	0.0009	0.0223642	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0012,FIN:0,NFE:0.0001,OTH:0.0061,ASJ:0	602775	607721;	2701;	2701|NS/LAH<br>Tosti syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|607721 ~	.	.	.	.	.	.	.	.	10	MU63466305	het
10	114925369	114925369	C	A	TCF7L2	exonic	nonsynonymous SNV	ENSG00000148737	rs77961654	ENSG00000148737:ENST00000277945:exon7:c.C598A:p.P200T,ENSG00000148737:ENST00000369389:exon7:c.C507A:p.H169Q,ENSG00000148737:ENST00000355717:exon13:c.C1446A:p.H482Q,ENSG00000148737:ENST00000369397:exon14:c.C1429A:p.P477T,ENSG00000148737:ENST00000536810:exon14:c.C1447A:p.P483T,ENSG00000148737:ENST00000538897:exon14:c.C1425A:p.H475Q,ENSG00000148737:ENST00000543371:exon14:c.C1447A:p.P483T,ENSG00000148737:ENST00000355995:exon15:c.C1498A:p.P500T,ENSG00000148737:ENST00000542695:exon15:c.C646A:p.P216T,ENSG00000148737:ENST00000545257:exon15:c.C1498A:p.P500T	TCF7L2:NM_001198530:exon11:c.C1203A:p.H401Q,TCF7L2:NM_001146286:exon12:c.C1305A:p.H435Q,TCF7L2:NM_001146283:exon13:c.C1446A:p.H482Q,TCF7L2:NM_001146284:exon13:c.C1344A:p.H448Q,TCF7L2:NM_001146285:exon13:c.C1378A:p.P460T,TCF7L2:NM_001198526:exon13:c.C1378A:p.P460T,TCF7L2:NM_001198529:exon13:c.C1356A:p.H452Q,TCF7L2:NM_001198531:exon13:c.C1374A:p.H458Q,TCF7L2:NM_001146274:exon14:c.C1447A:p.P483T,TCF7L2:NM_001363501:exon14:c.C1425A:p.H475Q,TCF7L2:NM_030756:exon14:c.C1429A:p.P477T,TCF7L2:NM_001367943:exon15:c.C1498A:p.P500T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.0503	0.0220	0.0696885	1(breast)	4.863	24.9	0.252	4.44	1.000	.	.	.	TCF7L2:uc010qrn.2:exon11:c.C1203A:p.H401Q,TCF7L2:uc010qru.2:exon11:c.C1122A:p.H374Q,TCF7L2:uc010qro.2:exon12:c.C1305A:p.H435Q,TCF7L2:uc021pyl.1:exon12:c.C1320A:p.H440Q,TCF7L2:uc021pym.1:exon12:c.C1293A:p.H431Q,TCF7L2:uc001lad.4:exon13:c.C1344A:p.H448Q,TCF7L2:uc001laf.4:exon13:c.C1378A:p.P460T,TCF7L2:uc001lag.4:exon13:c.C1446A:p.H482Q,TCF7L2:uc010qrk.2:exon13:c.C1356A:p.H452Q,TCF7L2:uc010qrl.2:exon13:c.C1378A:p.P460T,TCF7L2:uc010qrm.2:exon13:c.C1374A:p.H458Q,TCF7L2:uc010qrs.2:exon13:c.C1111A:p.P371T,TCF7L2:uc010qrt.2:exon13:c.C1111A:p.P371T,TCF7L2:uc021pyh.1:exon13:c.C1371A:p.H457Q,TCF7L2:uc021pyk.1:exon13:c.C1393A:p.P465T,TCF7L2:uc021pyo.1:exon13:c.C1389A:p.H463Q,TCF7L2:uc021pyp.1:exon13:c.C1362A:p.H454Q,TCF7L2:uc001lac.4:exon14:c.C1429A:p.P477T,TCF7L2:uc001lae.4:exon14:c.C1447A:p.P483T,TCF7L2:uc010qrr.2:exon14:c.C1243A:p.P415T,TCF7L2:uc021pyj.1:exon14:c.C1425A:p.H475Q,TCF7L2:uc021pyn.1:exon14:c.C1462A:p.P488T,TCF7L2:uc021pyg.1:exon15:c.C646A:p.P216T,TCF7L2:uc021pyi.1:exon15:c.C1498A:p.P500T	-1.495	AFR:MU14847817,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.0072,FIN:0.0489,NFE:0.0199,OTH:0.2537,ASJ:0.0365	602228	125853;	.	.	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04916 Melanogenesis~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	1.0	-4.87	0.008	0.975	10	2(lung)	0.0373
10	115605542	115605542	C	G	DCLRE1A	exonic	nonsynonymous SNV	ENSG00000198924	rs554244920	ENSG00000198924:ENST00000361384:exon4:c.G2280C:p.K760N,ENSG00000198924:ENST00000369305:exon5:c.G2280C:p.K760N	DCLRE1A:NM_014881:exon4:c.G2280C:p.K760N,DCLRE1A:NM_001271816:exon5:c.G2280C:p.K760N	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0010	.	0.00159744	.	5.306	25.8	0.053	0.236	0.897	.	.	Metallo-beta-lactamase	DCLRE1A:uc001law.3:exon4:c.G2280C:p.K760N,DCLRE1A:uc031pxf.1:exon5:c.G2280C:p.K760N	-0.753	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609682	.	.	.	.	.	.	.	0.013	-1.04	0.301	1.68	10	.	het
10	115609814	115609814	G	C	DCLRE1A	exonic	synonymous SNV	ENSG00000198924	rs564784331	ENSG00000198924:ENST00000361384:exon2:c.C1050G:p.P350P,ENSG00000198924:ENST00000369305:exon3:c.C1050G:p.P350P	DCLRE1A:NM_014881:exon2:c.C1050G:p.P350P,DCLRE1A:NM_001271816:exon3:c.C1050G:p.P350P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0009	.	0.00139776	.	.	.	.	.	.	.	.	.	DCLRE1A:uc001law.3:exon2:c.C1050G:p.P350P,DCLRE1A:uc031pxf.1:exon3:c.C1050G:p.P350P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609682	.	.	.	.	.	.	.	.	.	.	.	10	.	het
10	123239112	123239112	G	A	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs1047057	ENSG00000066468:ENST00000357555:exon17:c.C2107T:p.L703L	FGFR2:NM_001144915:exon17:c.C2107T:p.L703L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5311	0.4345	0.414337	14(meninges)	.	.	.	.	.	.	.	.	FGFR2:uc021pzx.1:exon17:c.C2107T:p.L703L	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU582048,EAS:0.4191,FIN:0.1433,NFE:0.7254,OTH:0.5567,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,5291,5284,5283,5282,5219,5281,5323,5280,5285,5295,5286,5288,5289,5293,5287,5292,5290,5294	.	.	.	.	.	.	10	1(stomach)	0.3736
10	123243197	123243197	G	A	FGFR2	intronic	.	ENSG00000066468	rs2278202	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.4544	0.423123	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	.	.	AFR:MU582049,AMR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,EAS:0.1718,FIN:0.7375,NFE:0.5795,OTH:0.3275,ASJ:0.4422	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	1(stomach)	0.5
10	123298158	123298158	T	C	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs1047100	ENSG00000066468:ENST00000356226:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000369059:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000604236:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000336553:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000346997:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000357555:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000360144:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000369056:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000369061:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000351936:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000358487:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000359354:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369058:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369060:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000457416:exon6:c.A696G:p.V232V	FGFR2:NM_001144916:exon3:c.A351G:p.V117V,FGFR2:NM_001144918:exon4:c.A351G:p.V117V,FGFR2:NM_023029:exon4:c.A429G:p.V143V,FGFR2:NM_001144913:exon5:c.A696G:p.V232V,FGFR2:NM_001144914:exon5:c.A696G:p.V232V,FGFR2:NM_001144915:exon5:c.A429G:p.V143V,FGFR2:NM_001144919:exon5:c.A429G:p.V143V,FGFR2:NM_000141:exon6:c.A696G:p.V232V,FGFR2:NM_001144917:exon6:c.A696G:p.V232V,FGFR2:NM_001320658:exon6:c.A696G:p.V232V,FGFR2:NM_022970:exon6:c.A696G:p.V232V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7797	0.7667	0.795327	0.7635	.	.	.	.	.	.	.	.	FGFR2:uc010qto.2:exon3:c.A408G:p.V136V,FGFR2:uc021pzw.1:exon3:c.A351G:p.V117V,FGFR2:uc010qtm.2:exon4:c.A351G:p.V117V,FGFR2:uc031pxk.1:exon4:c.A429G:p.V143V,FGFR2:uc010qtn.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtp.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtq.2:exon5:c.A753G:p.V251V,FGFR2:uc021pzv.1:exon5:c.A696G:p.V232V,FGFR2:uc021pzx.1:exon5:c.A429G:p.V143V,FGFR2:uc021qaa.1:exon5:c.A696G:p.V232V,FGFR2:uc021qab.1:exon5:c.A429G:p.V143V,FGFR2:uc021qac.1:exon5:c.A486G:p.V162V,FGFR2:uc001lfo.1:exon6:c.A753G:p.V251V,FGFR2:uc010qtl.2:exon6:c.A696G:p.V232V,FGFR2:uc021pzy.1:exon6:c.A696G:p.V232V,FGFR2:uc021pzz.1:exon6:c.A696G:p.V232V	.	AFR:0.7530,AMR:0.8126,EAS:0.9030,FIN:0.7590,NFE:0.7519,OTH:0.7459,ASJ:0.8676	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,5291,5284,5283,5282,5219,5281,5323,5280,5285,5295,5286,5288,5289,5293,5287,5292,5290,5294	.	.	.	.	.	.	10	MU81887223	hom
10	124221270	124221270	C	T	HTRA1	exonic	synonymous SNV	ENSG00000166033	rs1049331	ENSG00000166033:ENST00000368984:exon1:c.C102T:p.A34A	HTRA1:NM_002775:exon1:c.C102T:p.A34A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4159	.	0.293131	0.2510	.	.	.	.	.	.	.	.	HTRA1:uc001lgj.2:exon1:c.C102T:p.A34A	.	AFR:0.2426,AMR:0.2943,EAS:0.4204,FIN:0.2546,NFE:0.2346,OTH:0.2579,ASJ:0.2366	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU68023589	unknown
10	124221276	124221276	G	T	HTRA1	exonic	synonymous SNV	ENSG00000166033	rs2293870	ENSG00000166033:ENST00000368984:exon1:c.G108T:p.G36G	HTRA1:NM_002775:exon1:c.G108T:p.G36G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4104	.	0.291334	0.2502	.	.	.	.	.	.	.	.	HTRA1:uc001lgj.2:exon1:c.G108T:p.G36G	.	AFR:0.2404,AMR:0.2949,EAS:0.4202,FIN:0.2552,NFE:0.2342,OTH:0.2594,ASJ:0.2366	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU30116630	unknown
10	124271589	124271589	G	A	HTRA1	intronic	.	ENSG00000166033	rs2672586	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9998	0.9994	0.999401	0.9996	.	.	.	.	.	0.0001	0.076	.	.	.	AFR:0.9986,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU81887516	unknown
10	124271595	124271595	G	A	HTRA1	intronic	.	ENSG00000166033	rs2272599	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6113	0.6506	0.627995	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	.	.	AFR:0.6342,AMR:0.7012,EAS:0.6391,FIN:0.6190,NFE:0.6070,OTH:0.6126,ASJ:0.4892	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	2(lung)	0.6133
10	131565064	131565064	A	G	MGMT	exonic	nonsynonymous SNV	ENSG00000170430	rs2308321	ENSG00000170430:ENST00000306010:exon5:c.A520G:p.I174V	MGMT:NM_002412:exon5:c.A427G:p.I143V	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0988	0.0925	0.0513179	0.0833	-0.330	0.567	0.505	-0.425	0.971	.	.	Methylated-DNA-[protein]-cysteine S-methyltransferase, DNA binding|Winged helix-turn-helix DNA-binding domain	MGMT:uc001lkh.2:exon5:c.A520G:p.I174V	-0.906	AFR:0.0216,AMR:0.0610,EAS:0.0117,FIN:0.1291,NFE:0.1173,OTH:0.0845,ASJ:0.0927	156569	.	.	.	.	.	.	.	0.035	2.57	0.000	-0.455	10	.	het
10	131565170	131565170	A	G	MGMT	exonic	nonsynonymous SNV	ENSG00000170430	rs2308327	ENSG00000170430:ENST00000306010:exon5:c.A626G:p.K209R	MGMT:NM_002412:exon5:c.A533G:p.K178R	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0947	0.0925	0.0513179	0.0833	0.757	9.194	0.046	-3.61	0.026	.	.	Winged helix-turn-helix DNA-binding domain	MGMT:uc001lkh.2:exon5:c.A626G:p.K209R	-0.952	AFR:0.0216,AMR:0.0609,EAS:0.0117,FIN:0.1291,NFE:0.1173,OTH:0.0845,ASJ:0.0927	156569	.	.	.	.	.	.	.	0.001	3.39	0.000	0.695	10	.	het
11	2016619	2016619	A	G	HOTS	exonic	nonsynonymous SNV	ENSG00000130600	rs3741219	.	HOTS:NM_001293171:exon1:c.A193G:p.T65A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4208	0.3961	0.298323	0.3805	.	.	.	.	.	.	.	.	.	.	AFR:0.1407,AMR:0.3628,EAS:0.3176,FIN:0.5362,NFE:0.4846,OTH:0.4448,ASJ:0.53	615509	.	.	.	.	.	.	.	.	.	.	.	11	MU641843	het
11	2016659	2016659	T	C	HOTS	exonic	nonsynonymous SNV	ENSG00000130600	rs2839704	.	HOTS:NM_001293171:exon1:c.T233C:p.V78A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3381	0.3088	0.26877	0.2926	.	.	.	.	.	.	.	.	.	.	AFR:0.1188,AMR:0.3294,EAS:0.3106,FIN:0.3657,NFE:0.3664,OTH:0.3488,ASJ:0.4470	615509	.	.	.	.	.	.	.	.	.	.	.	11	MU641826	unknown
11	2016662	2016662	T	C	HOTS	exonic	nonsynonymous SNV	ENSG00000130600	rs2839703	.	HOTS:NM_001293171:exon1:c.T236C:p.L79P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3378	0.3088	0.26897	0.2925	.	.	.	.	.	.	.	.	.	.	AFR:0.1188,AMR:0.3294,EAS:0.3110,FIN:0.3657,NFE:0.3662,OTH:0.3488,ASJ:0.4470	615509	.	.	.	.	.	.	.	.	.	.	.	11	MU641807	unknown
11	2016924	2016924	A	G	H19	ncRNA_exonic	.	ENSG00000130600	rs10840159	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4183	0.3921	0.291334	0.3742	.	.	.	.	.	.	.	.	.	.	AFR:0.1167,AMR:0.3612,EAS:0.3168,FIN:0.5408,NFE:0.4849,OTH:0.4426,ASJ:0.5232	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU20292210	het
11	2017017	2017017	A	C	H19	ncRNA_exonic	.	ENSG00000130600	rs2839702	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4211	0.3907	0.290136	0.3742	.	.	.	.	.	.	.	.	.	.	AFR:0.1161,AMR:0.3624,EAS:0.3148,FIN:0.5420,NFE:0.4858,OTH:0.4434,ASJ:0.5232	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU751270	het
11	2017110	2017110	C	G	H19	ncRNA_exonic	.	ENSG00000130600	rs2839701	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4142	0.3888	0.290136	0.3693	.	.	.	.	.	.	.	.	.	.	AFR:0.1154,AMR:0.3585,EAS:0.3155,FIN:0.5247,NFE:0.4799,OTH:0.4356,ASJ:0.53	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU18733638	het
11	2017439	2017439	C	G	H19	ncRNA_intronic	.	ENSG00000130600	rs3024270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5041	0.4241	0.365415	0.4171	.	.	.	.	.	.	.	.	.	.	AFR:0.1915,AMR:0.3831,EAS:0.4876,FIN:0.5588,NFE:0.5037,OTH:0.4639,ASJ:0.5667	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU698421	het
11	2018168	2018168	C	T	H19	ncRNA_exonic	.	ENSG00000130600	rs2067051	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3852	.	0.286342	0.3717	.	.	.	.	.	.	.	.	.	.	AFR:0.1176,AMR:0.3636,EAS:0.2918,FIN:0.5485,NFE:0.4806,OTH:0.4414,ASJ:0.5066	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU727189	het
11	2018336	2018336	A	T	H19	ncRNA_exonic	.	ENSG00000130600	rs2075745	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3831	.	0.292931	0.3762	.	.	.	.	.	.	.	.	.	.	AFR:0.1186,AMR:0.3678,EAS:0.3104,FIN:0.5527,NFE:0.4856,OTH:0.4452,ASJ:0.5133	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU18733733	het
11	2018449	2018449	A	G	H19	ncRNA_exonic	.	ENSG00000130600	rs2075744	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3626	.	0.29353	0.3779	.	.	.	.	.	.	.	.	.	.	AFR:0.1188,AMR:0.3696,EAS:0.3109,FIN:0.5534,NFE:0.4882,OTH:0.4462,ASJ:0.5233	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU18733797	het
11	2018853	2018853	G	A	H19	ncRNA_exonic	.	ENSG00000130600	rs2839698	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3592	.	0.292931	0.3757	.	.	.	.	.	.	.	.	.	.	AFR:0.1185,AMR:0.3675,EAS:0.3098,FIN:0.5523,NFE:0.4850,OTH:0.4433,ASJ:0.5132	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU29996451	het
11	6629665	6629665	C	T	ILK	exonic	synonymous SNV	ENSG00000166333	rs1043388	ENSG00000166333:ENST00000396751:exon3:c.C297T:p.H99H,ENSG00000166333:ENST00000299421:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000420936:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000527327:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000527394:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000528995:exon4:c.C297T:p.H99H	ILK:NM_001014795:exon3:c.C297T:p.H99H,ILK:NM_001014794:exon4:c.C297T:p.H99H,ILK:NM_001278441:exon4:c.C297T:p.H99H,ILK:NM_004517:exon4:c.C297T:p.H99H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2677	0.2950	0.314696	0.2953	.	.	.	.	.	.	.	.	ILK:uc001meh.3:exon3:c.C297T:p.H99H,ILK:uc001mee.3:exon4:c.C297T:p.H99H,ILK:uc001mef.3:exon4:c.C297T:p.H99H,ILK:uc010raq.2:exon4:c.C297T:p.H99H	.	AFR:0.3774,AMR:0.2053,EAS:0.3455,FIN:0.2407,NFE:0.2609,OTH:0.2755,ASJ:0.3079	602366	.	.	.	.	.	.	.	.	.	.	.	11	MU108851	het
11	6630029	6630029	C	-	TAF10	UTR3	.	ENSG00000166333	rs11314683	ENSG00000166333:ENST00000527327:exon5:c.457delC:p.P153fs,ENSG00000166333:ENST00000527394:exon5:c.457delC:p.P153fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600475	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	6630833	6630833	G	A	ILK	exonic	synonymous SNV	ENSG00000166333	rs1043390	ENSG00000166333:ENST00000528995:exon7:c.G636A:p.P212P,ENSG00000166333:ENST00000396751:exon8:c.G819A:p.P273P,ENSG00000166333:ENST00000537806:exon8:c.G417A:p.P139P,ENSG00000166333:ENST00000299421:exon9:c.G819A:p.P273P,ENSG00000166333:ENST00000420936:exon9:c.G819A:p.P273P	ILK:NM_001278441:exon7:c.G636A:p.P212P,ILK:NM_001014795:exon8:c.G819A:p.P273P,ILK:NM_001278442:exon8:c.G417A:p.P139P,ILK:NM_001014794:exon9:c.G819A:p.P273P,ILK:NM_004517:exon9:c.G819A:p.P273P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2782	0.3269	0.347444	0.3227	.	.	.	.	.	.	.	.	ILK:uc010raq.2:exon7:c.G636A:p.P212P,ILK:uc001meh.3:exon8:c.G819A:p.P273P,ILK:uc010rap.2:exon8:c.G417A:p.P139P,ILK:uc001mee.3:exon9:c.G819A:p.P273P,ILK:uc001mef.3:exon9:c.G819A:p.P273P	.	AFR:0.4732,AMR:0.2076,EAS:0.3462,FIN:0.2414,NFE:0.2613,OTH:0.2787,ASJ:0.3079	602366	.	.	.	.	.	.	.	.	.	.	.	11	MU108871	het
11	8251921	8251921	G	C	LMO1	exonic	synonymous SNV	ENSG00000166407	rs3750952	ENSG00000166407:ENST00000335790:exon2:c.C156G:p.A52A,ENSG00000166407:ENST00000428101:exon2:c.C153G:p.A51A,ENSG00000166407:ENST00000534484:exon2:c.C123G:p.A41A	LMO1:NM_001270428:exon2:c.C153G:p.A51A,LMO1:NM_002315:exon2:c.C156G:p.A52A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4466	0.3592	0.333866	1(stomach)	.	.	.	.	.	.	.	.	LMO1:uc001mgg.2:exon2:c.C156G:p.A52A,LMO1:uc001mgh.2:exon2:c.C153G:p.A51A	.	AFR:1(lung),AMR:MU728619,EAS:0.3704,FIN:0.1079,NFE:0.5096,OTH:0.4768,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	186921	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.3315
11	8256125	8256125	C	G	LMO1	intronic	.	ENSG00000166407	rs204925	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.595847	0.6416	.	.	.	.	.	.	.	.	.	.	AFR:0.4044,AMR:0.6340,EAS:0.6163,FIN:0.7532,NFE:0.7485,OTH:0.7276,ASJ:0.7815	186921	.	.	.	.	.	.	.	.	.	.	.	11	MU87154591	hom
11	8256255	8256255	A	C	LMO1	intronic	.	ENSG00000166407	rs204924	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.995807	0.9964	.	.	.	.	.	.	.	.	.	.	AFR:0.9877,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	186921	.	.	.	.	.	.	.	.	.	.	.	11	.	unknown
11	8717003	8717003	C	T	ST5	intronic	.	ENSG00000254665	rs2270956	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4271	0.3648	0.336462	ESAD-UK|2|409|0.00488998,LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	0.0002	0.026	.	.	.	AFR:0.3852,AMR:0.1700,EAS:0.4073,FIN:0.4328,NFE:0.5123,OTH:0.4711,ASJ:0.4163	140750	.	.	.	.	.	.	.	.	.	.	.	11	4(haematopoietic_and_lymphoid_tissue)	0.4192
11	8751577	8751577	A	G	ST5	exonic	synonymous SNV	ENSG00000166444	rs200801002	ENSG00000166444:ENST00000313726:exon3:c.T1260C:p.P420P,ENSG00000166444:ENST00000357665:exon4:c.T1260C:p.P420P,ENSG00000166444:ENST00000534127:exon6:c.T1260C:p.P420P	ST5:NM_213618:exon3:c.T1260C:p.P420P,ST5:NM_005418:exon6:c.T1260C:p.P420P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0039	.	0.00479233	0.0011	.	.	.	.	.	.	.	.	ST5:uc001mgt.3:exon3:c.T1260C:p.P420P,ST5:uc001mgv.3:exon6:c.T1260C:p.P420P,ST5:uc001mgw.1:exon7:c.T1260C:p.P420P	.	AFR:0,AMR:0.0012,EAS:0,FIN:0.0006,NFE:0.0019,OTH:0.0020,ASJ:0	140750	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	8751640	8751640	G	C	ST5	exonic	nonsynonymous SNV	ENSG00000166444	rs3812762	ENSG00000166444:ENST00000313726:exon3:c.C1197G:p.D399E,ENSG00000166444:ENST00000357665:exon4:c.C1197G:p.D399E,ENSG00000166444:ENST00000534127:exon6:c.C1197G:p.D399E	ST5:NM_213618:exon3:c.C1197G:p.D399E,ST5:NM_005418:exon6:c.C1197G:p.D399E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3119	0.2586	0.265375	1(skin)	0.700	8.829	0.747	5.25	1.000	.	.	.	ST5:uc001mgt.3:exon3:c.C1197G:p.D399E,ST5:uc001mgv.3:exon6:c.C1197G:p.D399E,ST5:uc001mgw.1:exon7:c.C1197G:p.D399E	-0.921	AFR:MU4552266,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.1477,FIN:0.3484,NFE:0.4040,OTH:0.2009,ASJ:0.2639	140750	.	.	.	.	.	.	.	0.02	3.61	0.000	1.59	11	1(thyroid)	0.3100
11	8788225	8788225	A	C	ST5	intronic	.	ENSG00000166444	rs10734637	ENSG00000166444:ENST00000527930:exon1:c.T24G:p.G8G,ENSG00000166444:ENST00000532734:exon1:c.T24G:p.G8G	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6366	.	0.616813	0.6461	.	.	.	.	.	.	.	.	.	.	AFR:0.5597,AMR:0.6280,EAS:0.6776,FIN:0.6955,NFE:0.6832,OTH:0.6459,ASJ:0.61	140750	.	.	.	.	.	.	.	.	.	.	.	11	MU4552287	het
11	10786142	10786142	C	T	CTR9	exonic	synonymous SNV	ENSG00000198730	rs3736326	ENSG00000198730:ENST00000361367:exon12:c.C1461T:p.H487H	CTR9:NM_001346279:exon12:c.C1461T:p.H487H,CTR9:NM_014633:exon12:c.C1461T:p.H487H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6377	0.5111	0.611621	0.5535	.	.	.	.	.	.	.	.	CTR9:uc001mja.3:exon12:c.C1461T:p.H487H	.	AFR:0.3711,AMR:0.7184,EAS:0.8395,FIN:0.6282,NFE:0.5961,OTH:0.6255,ASJ:0.6192	609366	.	.	.	.	.	.	.	.	.	.	.	11	MU4555501	hom
11	11986061	11986061	T	C	DKK3	exonic	nonsynonymous SNV	ENSG00000050165	rs3206824	ENSG00000050165:ENST00000450094:exon6:c.A919G:p.R307G,ENSG00000050165:ENST00000326932:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000396505:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000525493:exon8:c.A1045G:p.R349G	DKK3:NM_001018057:exon7:c.A1003G:p.R335G,DKK3:NM_001330220:exon8:c.A1045G:p.R349G,DKK3:NM_013253:exon8:c.A1003G:p.R335G,DKK3:NM_015881:exon8:c.A1003G:p.R335G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7781	0.7718	0.812101	1(liver)	-0.421	0.344	0.693	-2.65	0.008	.	.	.	DKK3:uc010rcf.2:exon6:c.A919G:p.R307G,DKK3:uc001mju.3:exon7:c.A1003G:p.R335G,DKK3:uc001mjv.3:exon8:c.A1003G:p.R335G,DKK3:uc001mjw.3:exon8:c.A1003G:p.R335G,DKK3:uc010rcg.1:exon8:c.A1045G:p.R349G	-1.001	AFR:1(thyroid),AMR:MU751806,EAS:0.7566,FIN:0.8232,NFE:0.8711,OTH:0.8676,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	605416	.	.	.	.	.	.	.	0.0	2.29	0.000	-2.08	11	1(urinary_tract)	0.8019
11	14303282	14303282	T	A	RRAS2	intronic	.	ENSG00000133818	rs2303972	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4165	0.3645	0.338458	SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3537,AMR:0.1989,EAS:0.3907,FIN:0.3213,NFE:0.3285,OTH:0.4365,ASJ:0.5933	600098	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.3912
11	14385941	14385941	G	A	RRAS2	UTR5	.	ENSG00000133818	rs75033079	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0948	.	0.0571086	0.0836	.	.	.	.	.	.	.	.	.	.	AFR:0.0249,AMR:0.1079,EAS:0.0012,FIN:0.1009,NFE:0.1199,OTH:0.0969,ASJ:0.11	600098	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	.	het
11	20623007	20623007	C	T	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs7109418	ENSG00000165970:ENST00000298923:exon2:c.C336T:p.S112S,ENSG00000165970:ENST00000525748:exon2:c.C336T:p.S112S	SLC6A5:NM_004211:exon2:c.C336T:p.S112S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2624	0.2661	0.190296	0.2524	.	.	.	.	.	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C336T:p.S112S	.	AFR:0.2385,AMR:0.1420,EAS:0.0049,FIN:0.2951,NFE:0.2817,OTH:0.2848,ASJ:0.2384	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	.	unknown
11	20623023	20623023	C	T	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs2241941	ENSG00000165970:ENST00000298923:exon2:c.C352T:p.L118L,ENSG00000165970:ENST00000525748:exon2:c.C352T:p.L118L	SLC6A5:NM_004211:exon2:c.C352T:p.L118L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3503	0.3245	0.326877	0.3308	.	.	.	.	.	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C352T:p.L118L	.	AFR:0.3058,AMR:0.3640,EAS:0.3300,FIN:0.3718,NFE:0.3325,OTH:0.3493,ASJ:0.3411	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU4554537	unknown
11	20623042	20623042	T	C	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs1443548	ENSG00000165970:ENST00000298923:exon2:c.T371C:p.F124S,ENSG00000165970:ENST00000525748:exon2:c.T371C:p.F124S	SLC6A5:NM_004211:exon2:c.T371C:p.F124S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7789	0.7950	0.793131	0.791	0.592	8.102	0.44	2.8	0.440	.	.	.	SLC6A5:uc001mqd.3:exon2:c.T371C:p.F124S	-0.983	AFR:0.8759,AMR:0.7398,EAS:0.7438,FIN:0.7420,NFE:0.7632,OTH:0.7541,ASJ:0.8013	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.0	-0.48	0.000	0	11	MU81309978	unknown
11	20623156	20623156	C	G	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs1443549	ENSG00000165970:ENST00000298923:exon2:c.C485G:p.A162G,ENSG00000165970:ENST00000525748:exon2:c.C485G:p.A162G	SLC6A5:NM_004211:exon2:c.C485G:p.A162G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9983	0.9932	0.99361	0.9951	1.483	13.22	1.0	5.59	0.995	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C485G:p.A162G	-0.929	AFR:0.9829,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.0	-0.5	0.000	-1.845	11	MU81897454	hom
11	20639400	20639400	A	G	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs7925597	ENSG00000165970:ENST00000525748:exon7:c.A1230G:p.S410S	SLC6A5:NM_001318369:exon6:c.A528G:p.S176S,SLC6A5:NM_004211:exon7:c.A1230G:p.S410S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9989	0.9950	0.997404	0.9969	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon6:c.A525G:p.S175S,SLC6A5:uc001mqd.3:exon7:c.A1230G:p.S410S	.	AFR:0.9891,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU81897460	hom
11	20673867	20673867	G	A	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs2276433	ENSG00000165970:ENST00000525748:exon15:c.G2103A:p.E701E	SLC6A5:NM_001318369:exon14:c.G1401A:p.E467E,SLC6A5:NM_004211:exon15:c.G2103A:p.E701E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4506	0.3238	0.478235	0.3685	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon14:c.G1398A:p.E466E,SLC6A5:uc001mqd.3:exon15:c.G2103A:p.E701E	.	AFR:0.1879,AMR:0.6103,EAS:0.8486,FIN:0.4015,NFE:0.3941,OTH:0.4296,ASJ:0.4934	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU159624	het
11	31811461	31811461	T	-	PAX6	exonic	frameshift deletion	ENSG00000007372	rs780753075	.	PAX6:NM_001368929:exon9:c.731delA:p.K244fs,PAX6:NM_001368911:exon10:c.1184delA:p.K395fs,PAX6:NM_001368916:exon11:c.1139delA:p.K380fs,PAX6:NM_001368913:exon12:c.1181delA:p.K394fs,PAX6:NM_001368915:exon12:c.1139delA:p.K380fs,PAX6:NM_001368917:exon12:c.1139delA:p.K380fs,PAX6:NM_001368912:exon13:c.1181delA:p.K394fs,PAX6:NM_001368914:exon13:c.1181delA:p.K394fs,PAX6:NM_001368921:exon13:c.980delA:p.K327fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0009	.	.	0.1682	.	.	.	.	.	.	.	.	.	.	AFR:0.1336,AMR:0.1561,EAS:0.0359,FIN:0.0268,NFE:0.2075,OTH:0.1606,ASJ:0.2121	607108	106210;120200;120430;136520;148190;165550;604229;	708;137902;2334;2253;35737;194;98942;98944;250923;	708|Peters congenital glaucoma|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|604229 ~137902|-|-|Autosomal dominant|-|165550 ~2334|Hereditary keratitis|Unknown|Autosomal dominant|Childhood|148190 ~2253|O'Donnell-Pappas syndrome|<1 / 1 000 000|Autosomal dominant|Adult|136520 ~35737|Ectasic coloboma<br>Volubilis syndrome|Unknown|Autosomal dominant|Childhood|120430 ~194|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|120200 216820 ~98942|-|-|-|-|120200 ~98944|-|-|-|-|120200 ~250923|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|106210 617141 617142 ~	.	.	.	.	.	.	.	.	11	.	het
11	32417945	32417945	T	C	WT1	exonic	synonymous SNV	ENSG00000184937	rs16754	ENSG00000184937:ENST00000452863:exon6:c.A1056G:p.R352R,ENSG00000184937:ENST00000530998:exon6:c.A420G:p.R140R,ENSG00000184937:ENST00000332351:exon7:c.A1107G:p.R369R,ENSG00000184937:ENST00000379079:exon7:c.A471G:p.R157R,ENSG00000184937:ENST00000448076:exon7:c.A1107G:p.R369R,ENSG00000184937:ENST00000527775:exon7:c.A360G:p.R120R	WT1:NM_000378:exon6:c.A1071G:p.R357R,WT1:NM_001198552:exon6:c.A420G:p.R140R,WT1:NM_001198551:exon7:c.A471G:p.R157R,WT1:NM_024424:exon7:c.A1122G:p.R374R,WT1:NM_024426:exon7:c.A1122G:p.R374R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2335	0.1303	0.33147	2(large_intestine)	.	.	.	.	.	.	.	.	WT1:uc001mtm.2:exon6:c.A420G:p.R140R,WT1:uc001mtq.2:exon6:c.A1056G:p.R352R,WT1:uc001mtl.2:exon7:c.A471G:p.R157R,WT1:uc001mtn.2:exon7:c.A1107G:p.R369R,WT1:uc001mto.2:exon7:c.A1107G:p.R369R	.	AFR:1(bone),AMR:MU117615,EAS:0.1757,FIN:0.1051,NFE:0.3270,OTH:0.1921,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|7|321|0.0218069	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	,10422	.	.	.	.	.	.	11	94(prostate)	0.7135
11	32456562	32456562	G	A	WT1	exonic	synonymous SNV	ENSG00000184937	rs1799925	ENSG00000184937:ENST00000332351:exon1:c.C330T:p.P110P,ENSG00000184937:ENST00000379077:exon1:c.C330T:p.P110P,ENSG00000184937:ENST00000448076:exon1:c.C330T:p.P110P,ENSG00000184937:ENST00000452863:exon1:c.C330T:p.P110P	WT1:NM_000378:exon1:c.C345T:p.P115P,WT1:NM_024424:exon1:c.C345T:p.P115P,WT1:NM_024426:exon1:c.C345T:p.P115P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3243	.	0.303914	0.1647	.	.	.	.	.	.	.	.	WT1:uc001mtn.2:exon1:c.C330T:p.P110P,WT1:uc001mto.2:exon1:c.C330T:p.P110P,WT1:uc001mtq.2:exon1:c.C330T:p.P110P	.	AFR:0.0700,AMR:0.3251,EAS:0.6864,FIN:0.1693,NFE:0.1518,OTH:0.1811,ASJ:0.1722	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	,10422	.	.	.	.	.	.	11	MU81898088	hom
11	33881016	33881016	T	C	LMO2	exonic	synonymous SNV	ENSG00000135363	rs3740617	ENSG00000135363:ENST00000395833:exon3:c.A363G:p.K121K,ENSG00000135363:ENST00000257818:exon6:c.A570G:p.K190K	LMO2:NM_001142316:exon3:c.A363G:p.K121K,LMO2:NM_001142315:exon4:c.A363G:p.K121K,LMO2:NM_005574:exon6:c.A570G:p.K190K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6001	0.5722	0.5625	1(stomach)	.	.	.	.	.	.	.	.	LMO2:uc001mvc.3:exon2:c.A342G:p.K114K,LMO2:uc001mvd.3:exon3:c.A342G:p.K114K,LMO2:uc001mve.3:exon3:c.A363G:p.K121K,LMO2:uc010rel.2:exon4:c.A363G:p.K121K,LMO2:uc010rem.2:exon6:c.A570G:p.K190K	.	AFR:MU582199,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.5070,FIN:0.7410,NFE:0.6987,OTH:0.5317,ASJ:0.5711	180385	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	18(soft_tissue)	0.4894
11	43911365	43911365	T	C	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs2434478	ENSG00000166199:ENST00000529366:exon5:c.T354C:p.T118T,ENSG00000166199:ENST00000302708:exon6:c.T357C:p.T119T,ENSG00000166199:ENST00000378840:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000530803:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000532962:exon6:c.T357C:p.T119T	ALKBH3:NM_139178:exon6:c.T357C:p.T119T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9968	0.997604	0.9968	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon6:c.T357C:p.T119T	.	AFR:0.9888,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU81898914	hom
11	43940644	43940644	G	T	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs1048928	ENSG00000166199:ENST00000302708:exon9:c.G726T:p.G242G	ALKBH3:NM_139178:exon9:c.G726T:p.G242G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6514	0.5354	0.616214	0.5714	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon9:c.G726T:p.G242G	.	AFR:0.3515,AMR:0.7387,EAS:0.8282,FIN:0.6657,NFE:0.6325,OTH:0.6782,ASJ:0.6060	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU728136	hom
11	44129290	44129290	C	A	EXT2	exonic	synonymous SNV	ENSG00000151348	rs4755228	ENSG00000151348:ENST00000343631:exon2:c.C28A:p.R10R,ENSG00000151348:ENST00000358681:exon2:c.C28A:p.R10R,ENSG00000151348:ENST00000395673:exon2:c.C127A:p.R43R,ENSG00000151348:ENST00000533608:exon2:c.C28A:p.R10R,ENSG00000151348:ENST00000527014:exon3:c.C28A:p.R10R,ENSG00000151348:ENST00000532479:exon4:c.C28A:p.R10R	EXT2:NM_000401:exon2:c.C127A:p.R43R,EXT2:NM_001178083:exon2:c.C28A:p.R10R,EXT2:NM_207122:exon2:c.C28A:p.R10R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0334	0.0058	0.0780751	0.0236	.	.	.	.	.	.	.	.	EXT2:uc001mxz.3:exon2:c.C28A:p.R10R,EXT2:uc001mya.3:exon2:c.C127A:p.R43R,EXT2:uc009ykt.3:exon2:c.C28A:p.R10R,EXT2:uc010rfo.2:exon2:c.C112A:p.R38R	.	AFR:0.0050,AMR:0.0299,EAS:0.3092,FIN:0.0157,NFE:0.0062,OTH:0.0143,ASJ:0.0033	608210	133701;616682;	321;	321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	.	.	.	.	11	MU82206464	hom
11	47238522	47238522	T	C	DDB2	exonic	synonymous SNV	ENSG00000134574	rs326212	ENSG00000134574:ENST00000256996:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378600:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378601:exon3:c.T378C:p.T126T	DDB2:NM_000107:exon3:c.T378C:p.T126T,DDB2:NM_001300734:exon3:c.T378C:p.T126T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9987	0.9953	0.994209	0.9963	.	.	.	.	.	.	.	.	DDB2:uc001nef.2:exon2:c.T336C:p.T112T,DDB2:uc001neb.2:exon3:c.T378C:p.T126T,DDB2:uc001nee.2:exon3:c.T378C:p.T126T	.	AFR:0.9869,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600811	278740;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	~ko03420 Nucleotide excision repair~ko04115 p53 signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko05161 Hepatitis B~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU81899467	hom
11	47354787	47354787	C	T	MYBPC3	exonic	synonymous SNV	ENSG00000134571	rs1052373	ENSG00000134571:ENST00000256993:exon28:c.G3285A:p.E1095E,ENSG00000134571:ENST00000399249:exon29:c.G3288A:p.E1096E,ENSG00000134571:ENST00000545968:exon30:c.G3288A:p.E1096E	MYBPC3:NM_000256:exon29:c.G3288A:p.E1096E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4707	0.3550	0.476238	0.3986	.	.	.	.	.	.	.	.	MYBPC3:uc021qir.1:exon28:c.G2244A:p.E748E,MYBPC3:uc021qis.1:exon30:c.G3288A:p.E1096E	.	AFR:0.4834,AMR:0.4010,EAS:0.6979,FIN:0.4185,NFE:0.3157,OTH:0.3914,ASJ:0.2517	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	MU120858	het
11	47357416	47357416	G	A	MYBPC3	intronic	.	ENSG00000134571	rs3729936	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1009	0.0338	0.0547125	0.0350	.	.	.	.	.	.	.	.	.	.	AFR:0.0554,AMR:0.0143,EAS:0.0347,FIN:0.0221,NFE:0.0275,OTH:0.0337,ASJ:0.0331	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	.	het
11	47358997	47358997	G	A	MYBPC3	exonic	synonymous SNV	ENSG00000134571	rs3729953	ENSG00000134571:ENST00000256993:exon23:c.C2544T:p.V848V,ENSG00000134571:ENST00000399249:exon24:c.C2547T:p.V849V,ENSG00000134571:ENST00000545968:exon25:c.C2547T:p.V849V	MYBPC3:NM_000256:exon24:c.C2547T:p.V849V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0464	0.0300	0.048123	0.0358	.	.	.	.	.	.	.	.	MYBPC3:uc021qir.1:exon23:c.C1503T:p.V501V,MYBPC3:uc021qis.1:exon25:c.C2547T:p.V849V	.	AFR:0.0209,AMR:0.0131,EAS:0.0364,FIN:0.0518,NFE:0.0411,OTH:0.0491,ASJ:0.0331	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	MU115897229	het
11	47360053	47360053	G	C	MYBPC3	intronic	.	ENSG00000134571	rs3729948	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0522	0.0506	0.0694888	0.0540	.	.	.	.	.	.	.	.	.	.	AFR:0.0828,AMR:0.0179,EAS:0.0364,FIN:0.0521,NFE:0.0421,OTH:0.0550,ASJ:0.0331	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	MU113406639	het
11	47371485	47371485	G	-	MYBPC3	intronic	.	ENSG00000134571	rs11570050	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6879	0.6200	0.610823	0.6108	.	.	.	.	.	.	.	.	.	.	AFR:0.3940,AMR:0.6396,EAS:0.6646,FIN:0.6201,NFE:0.7226,OTH:0.6398,ASJ:0.7450	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	.	hom
11	48145166	48145166	G	A	PTPRJ	exonic	synonymous SNV	ENSG00000149177	rs2270993	ENSG00000149177:ENST00000527952:exon4:c.G354A:p.E118E,ENSG00000149177:ENST00000418331:exon5:c.G618A:p.E206E,ENSG00000149177:ENST00000440289:exon5:c.G618A:p.E206E	PTPRJ:NM_001098503:exon5:c.G618A:p.E206E,PTPRJ:NM_002843:exon5:c.G618A:p.E206E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1403	0.1633	0.155551	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,GACA-JP|1|585|0.0017094	.	.	.	.	.	0.0001	0.02	.	PTPRJ:uc001ngo.4:exon5:c.G618A:p.E206E,PTPRJ:uc001ngp.4:exon5:c.G618A:p.E206E	.	AFR:0.1657,AMR:0.2409,EAS:0.1026,FIN:0.1660,NFE:0.1616,OTH:0.1282,ASJ:0.1158	600925	114500;	.	.	.	.	.	.	.	.	.	.	11	2(stomach)	0.1493
11	48145375	48145375	A	C	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs1566734	ENSG00000149177:ENST00000418331:exon5:c.A827C:p.Q276P,ENSG00000149177:ENST00000440289:exon5:c.A827C:p.Q276P	PTPRJ:NM_001098503:exon5:c.A827C:p.Q276P,PTPRJ:NM_002843:exon5:c.A827C:p.Q276P	clinvar: Pathogenic 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, -1, 0, 0] 	0.1694	0.1475	0.189896	1(prostate)	-0.709	0.069	0.237	1.54	0.002	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngo.4:exon5:c.A827C:p.Q276P,PTPRJ:uc001ngp.4:exon5:c.A827C:p.Q276P	-0.983	AFR:1(lung),AMR:1(pancreas),EAS:MU14713834,FIN:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,NFE:0.1398,OTH:0.1199,ASJ:1(large_intestine)	600925	114500;	.	.	.	.	.	.	0.001	2.56	0.000	0.895	11	2(haematopoietic_and_lymphoid_tissue)	0.1205
11	48146622	48146622	G	A	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs1503185	ENSG00000149177:ENST00000418331:exon6:c.G977A:p.R326Q,ENSG00000149177:ENST00000440289:exon6:c.G977A:p.R326Q	PTPRJ:NM_001098503:exon6:c.G977A:p.R326Q,PTPRJ:NM_002843:exon6:c.G977A:p.R326Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1807	0.1922	0.242812	1(urinary_tract)	-2.199	0.001	0.491	-10.3	0.000	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngo.4:exon6:c.G977A:p.R326Q,PTPRJ:uc001ngp.4:exon6:c.G977A:p.R326Q	-0.987	AFR:1(stomach),AMR:MU149213,EAS:0.1762,FIN:0.2477,NFE:0.1256,OTH:0.2384,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	600925	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.315	11	1(large_intestine)	0.2921
11	57428462	57428462	C	T	CLP1	exonic	synonymous SNV	ENSG00000172409	rs200917931	ENSG00000172409:ENST00000302731:exon3:c.C640T:p.L214L,ENSG00000172409:ENST00000525602:exon3:c.C832T:p.L278L,ENSG00000172409:ENST00000529430:exon3:c.C865T:p.L289L,ENSG00000172409:ENST00000533682:exon3:c.C832T:p.L278L	CLP1:NM_001142597:exon3:c.C640T:p.L214L,CLP1:NM_006831:exon3:c.C832T:p.L278L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0007	7.7e-05	0.00239617	0.0004	.	.	.	.	.	.	.	.	CLP1:uc001nkw.3:exon3:c.C832T:p.L278L,CLP1:uc009yml.3:exon3:c.C832T:p.L278L,CLP1:uc010rjw.2:exon3:c.C640T:p.L214L	.	AFR:0.0002,AMR:0,EAS:0.0068,FIN:0,NFE:0,OTH:0,ASJ:0	608757	615803;	411493;	411493|CLP1-related pontocerebellar hypoplasia<br>PCH10|<1 / 1 000 000|Autosomal recessive|Neonatal|615803 ~	.	.	.	.	.	.	.	.	11	.	het
11	57571232	57571232	C	T	CTNND1	exonic	synonymous SNV	ENSG00000198561	rs11229137	ENSG00000198561:ENST00000525902:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000526772:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000527467:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000531014:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000533667:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000532245:exon5:c.C1257T:p.H419H,ENSG00000198561:ENST00000415361:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000426142:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000528232:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000529986:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000530094:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532463:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532787:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000428599:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000526357:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000526938:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000528621:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000529873:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000530748:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000532844:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000358694:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000360682:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361332:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361391:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361796:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399039:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399050:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000524630:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000529526:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000529919:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000532649:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000534579:exon8:c.C1398T:p.H466H	CTNND1:NM_001085469:exon5:c.C1257T:p.H419H,CTNND1:NM_001085463:exon6:c.C1257T:p.H419H,CTNND1:NM_001085464:exon6:c.C1257T:p.H419H,CTNND1:NM_001085465:exon6:c.C1257T:p.H419H,CTNND1:NM_001085466:exon6:c.C1257T:p.H419H,CTNND1:NM_001085467:exon6:c.C1257T:p.H419H,CTNND1:NM_001085468:exon6:c.C1257T:p.H419H,CTNND1:NM_001206890:exon6:c.C1257T:p.H419H,CTNND1:NM_001085462:exon7:c.C1560T:p.H520H,CTNND1:NM_001206883:exon7:c.C1398T:p.H466H,CTNND1:NM_001206884:exon7:c.C1398T:p.H466H,CTNND1:NM_001206886:exon7:c.C1398T:p.H466H,CTNND1:NM_001206887:exon7:c.C1398T:p.H466H,CTNND1:NM_001206888:exon7:c.C1398T:p.H466H,CTNND1:NM_001085458:exon8:c.C1560T:p.H520H,CTNND1:NM_001085459:exon8:c.C1560T:p.H520H,CTNND1:NM_001085460:exon8:c.C1560T:p.H520H,CTNND1:NM_001085461:exon8:c.C1560T:p.H520H,CTNND1:NM_001206885:exon8:c.C1560T:p.H520H,CTNND1:NM_001206889:exon8:c.C1398T:p.H466H,CTNND1:NM_001206891:exon8:c.C1398T:p.H466H,CTNND1:NM_001331:exon8:c.C1560T:p.H520H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9979	0.996206	0.9972	.	.	.	.	.	.	.	.	CTNND1:uc001nlx.4:exon3:c.C591T:p.H197H,CTNND1:uc001nly.4:exon3:c.C591T:p.H197H,CTNND1:uc001nlz.4:exon3:c.C591T:p.H197H,CTNND1:uc001nma.4:exon3:c.C591T:p.H197H,CTNND1:uc001nmb.4:exon3:c.C591T:p.H197H,CTNND1:uc009ymn.3:exon3:c.C591T:p.H197H,CTNND1:uc001nlw.4:exon5:c.C1257T:p.H419H,CTNND1:uc001nlo.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlq.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nls.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlt.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlu.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlv.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nmi.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlj.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlk.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nln.4:exon7:c.C1560T:p.H520H,CTNND1:uc001nlp.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlr.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nmd.4:exon7:c.C1398T:p.H466H,TMX2-CTNND1:uc001nlh.1:exon8:c.C1560T:p.H520H,CTNND1:uc001nli.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nll.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nlm.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmc.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nme.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmf.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmg.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nmh.4:exon8:c.C1560T:p.H520H,CTNND1:uc021qjk.1:exon8:c.C1560T:p.H520H,TMX2-CTNND1:uc001nlf.2:exon9:c.C1560T:p.H520H	.	AFR:0.9899,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601045	.	.	.	.	.	.	.	.	.	.	.	11	MU81901822	hom
11	57578974	57578974	G	A	TMX2-CTNND1	ncRNA_intronic	.	ENSG00000198561	rs182884019	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0005	8.3e-05	0.00139776	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0,EAS:0.0018,FIN:0,NFE:0,OTH:0,ASJ:0	601045	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	57581818	57581818	A	G	CTNND1	exonic	nonsynonymous SNV	ENSG00000198561	rs181230846	ENSG00000198561:ENST00000526772:exon12:c.A1687G:p.N563D,ENSG00000198561:ENST00000531014:exon12:c.A1687G:p.N563D,ENSG00000198561:ENST00000525902:exon13:c.A1705G:p.N569D,ENSG00000198561:ENST00000527467:exon13:c.A1705G:p.N569D,ENSG00000198561:ENST00000532245:exon14:c.A2353G:p.N785D,ENSG00000198561:ENST00000426142:exon15:c.A2353G:p.N785D,ENSG00000198561:ENST00000529986:exon15:c.A2353G:p.N785D,ENSG00000198561:ENST00000530094:exon15:c.A2353G:p.N785D,ENSG00000198561:ENST00000532463:exon15:c.A2353G:p.N785D,ENSG00000198561:ENST00000415361:exon16:c.A2371G:p.N791D,ENSG00000198561:ENST00000428599:exon16:c.A2656G:p.N886D,ENSG00000198561:ENST00000526357:exon16:c.A2494G:p.N832D,ENSG00000198561:ENST00000528232:exon16:c.A2371G:p.N791D,ENSG00000198561:ENST00000528621:exon16:c.A2494G:p.N832D,ENSG00000198561:ENST00000358694:exon17:c.A2656G:p.N886D,ENSG00000198561:ENST00000361332:exon17:c.A2656G:p.N886D,ENSG00000198561:ENST00000361796:exon17:c.A2656G:p.N886D,ENSG00000198561:ENST00000524630:exon17:c.A2656G:p.N886D,ENSG00000198561:ENST00000529526:exon17:c.A2494G:p.N832D,ENSG00000198561:ENST00000530748:exon17:c.A2512G:p.N838D,ENSG00000198561:ENST00000532649:exon17:c.A2494G:p.N832D,ENSG00000198561:ENST00000532844:exon17:c.A2512G:p.N838D,ENSG00000198561:ENST00000534579:exon17:c.A2494G:p.N832D,ENSG00000198561:ENST00000399039:exon18:c.A2674G:p.N892D,ENSG00000198561:ENST00000399050:exon18:c.A2674G:p.N892D,ENSG00000198561:ENST00000529919:exon18:c.A2674G:p.N892D	CTNND1:NM_001085469:exon14:c.A2353G:p.N785D,CTNND1:NM_001085464:exon15:c.A2353G:p.N785D,CTNND1:NM_001085467:exon15:c.A2353G:p.N785D,CTNND1:NM_001085468:exon15:c.A2353G:p.N785D,CTNND1:NM_001206890:exon15:c.A2353G:p.N785D,CTNND1:NM_001085462:exon16:c.A2656G:p.N886D,CTNND1:NM_001085463:exon16:c.A2371G:p.N791D,CTNND1:NM_001085466:exon16:c.A2371G:p.N791D,CTNND1:NM_001206886:exon16:c.A2494G:p.N832D,CTNND1:NM_001206888:exon16:c.A2494G:p.N832D,CTNND1:NM_001085459:exon17:c.A2656G:p.N886D,CTNND1:NM_001085460:exon17:c.A2656G:p.N886D,CTNND1:NM_001085461:exon17:c.A2656G:p.N886D,CTNND1:NM_001206883:exon17:c.A2512G:p.N838D,CTNND1:NM_001206884:exon17:c.A2512G:p.N838D,CTNND1:NM_001206889:exon17:c.A2494G:p.N832D,CTNND1:NM_001206891:exon17:c.A2494G:p.N832D,CTNND1:NM_001085458:exon18:c.A2674G:p.N892D,CTNND1:NM_001206885:exon18:c.A2674G:p.N892D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	0.0006	8.5e-05	0.00139776	0.0002	1.807	15.02	0.674	5.36	0.995	.	.	Armadillo-like helical|Armadillo-type fold	CTNND1:uc001nly.4:exon12:c.A1687G:p.N563D,CTNND1:uc001nmb.4:exon12:c.A1687G:p.N563D,CTNND1:uc009ymn.3:exon12:c.A1687G:p.N563D,CTNND1:uc001nlx.4:exon13:c.A1705G:p.N569D,CTNND1:uc001nlz.4:exon13:c.A1705G:p.N569D,CTNND1:uc001nlw.4:exon14:c.A2353G:p.N785D,CTNND1:uc001nlo.4:exon15:c.A2353G:p.N785D,CTNND1:uc001nlt.4:exon15:c.A2353G:p.N785D,CTNND1:uc001nlu.4:exon15:c.A2353G:p.N785D,CTNND1:uc001nlv.4:exon15:c.A2353G:p.N785D,CTNND1:uc001nlj.4:exon16:c.A2494G:p.N832D,CTNND1:uc001nln.4:exon16:c.A2656G:p.N886D,CTNND1:uc001nlq.4:exon16:c.A2371G:p.N791D,CTNND1:uc001nlr.4:exon16:c.A2494G:p.N832D,CTNND1:uc001nmi.4:exon16:c.A2371G:p.N791D,CTNND1:uc001nlk.4:exon17:c.A2512G:p.N838D,CTNND1:uc001nll.4:exon17:c.A2494G:p.N832D,CTNND1:uc001nlm.4:exon17:c.A2656G:p.N886D,CTNND1:uc001nmd.4:exon17:c.A2512G:p.N838D,CTNND1:uc001nme.4:exon17:c.A2656G:p.N886D,CTNND1:uc001nmg.4:exon17:c.A2494G:p.N832D,CTNND1:uc001nmh.4:exon17:c.A2656G:p.N886D,CTNND1:uc021qjk.1:exon17:c.A2656G:p.N886D,TMX2-CTNND1:uc001nlh.1:exon18:c.A2674G:p.N892D,CTNND1:uc001nmc.4:exon18:c.A2674G:p.N892D,CTNND1:uc001nmf.4:exon18:c.A2674G:p.N892D,TMX2-CTNND1:uc001nlf.2:exon19:c.A2674G:p.N892D	-0.979	AFR:0.0002,AMR:0,EAS:0.0019,FIN:0,NFE:0,OTH:0,ASJ:0	601045	.	.	.	.	.	.	.	0.001	-0.13	0.099	-0.505	11	.	het
11	60666116	60666116	G	T	PRPF19	intronic	.	ENSG00000110107	rs3763841	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3711	0.3298	0.309904	0.3285	.	.	.	.	.	.	.	.	.	.	AFR:0.1902,AMR:0.4427,EAS:0.2856,FIN:0.3985,NFE:0.3850,OTH:0.3778,ASJ:0.4570	608330	.	.	.	.	.	.	.	.	.	.	.	11	MU30007000	hom
11	60666341	60666341	G	A	PRPF19	exonic	synonymous SNV	ENSG00000110107	rs3763840	ENSG00000110107:ENST00000535326:exon1:c.C63T:p.S21S,ENSG00000110107:ENST00000227524:exon12:c.C1047T:p.S349S	PRPF19:NM_014502:exon12:c.C1047T:p.S349S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4315	0.3265	0.308506	LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	PRPF19:uc001nqf.3:exon12:c.C1047T:p.S349S	.	AFR:0.3279,AMR:0.1864,EAS:0.4570,FIN:0.2853,NFE:0.4,OTH:0.3860,ASJ:0.4400	608330	.	.	.	.	.	.	.	.	.	.	.	11	1(stomach)	0.3765
11	60673868	60673868	T	C	PRPF19	UTR5	.	ENSG00000110107	rs17155470	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4474	0.3585	0.357428	COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	.	.	AFR:0.3669,AMR:0.3223,EAS:0.4636,FIN:0.2886,NFE:0.3991,OTH:0.3859,ASJ:0.4487	608330	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.3875
11	62292882	62292882	G	T	AHNAK	exonic	nonsynonymous SNV	ENSG00000124942	rs566144	ENSG00000124942:ENST00000378024:exon5:c.C9007A:p.Q3003K	AHNAK:NM_001346445:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001346446:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001620:exon5:c.C9007A:p.Q3003K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1	.	1	0.9999	-0.671	0.084	1.0	3.97	0.067	.	.	.	AHNAK:uc001ntl.3:exon5:c.C9007A:p.Q3003K	-1.013	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	103390	.	.	.	.	.	.	.	0.0	2.88	0.000	-2.045	11	MU81903251	hom
11	62293948	62293948	G	A	AHNAK	exonic	synonymous SNV	ENSG00000124942	rs486903	ENSG00000124942:ENST00000378024:exon5:c.C7941T:p.S2647S	AHNAK:NM_001346445:exon5:c.C7941T:p.S2647S,AHNAK:NM_001346446:exon5:c.C7941T:p.S2647S,AHNAK:NM_001620:exon5:c.C7941T:p.S2647S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6638	0.5583	0.473043	1(large_intestine)	.	.	.	.	.	.	.	.	AHNAK:uc001ntl.3:exon5:c.C7941T:p.S2647S	.	AFR:MU150832,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.1716,FIN:0.6845,NFE:0.6093,OTH:0.2963,ASJ:0.5748	103390	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.8322
11	64572018	64572018	T	C	MEN1	exonic	nonsynonymous SNV	ENSG00000133895	rs2959656	ENSG00000133895:ENST00000377316:exon8:c.A1456G:p.T486A,ENSG00000133895:ENST00000377313:exon9:c.A1636G:p.T546A,ENSG00000133895:ENST00000377326:exon9:c.A1621G:p.T541A,ENSG00000133895:ENST00000312049:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000315422:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000337652:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000377321:exon10:c.A1516G:p.T506A,ENSG00000133895:ENST00000394374:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000443283:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000394376:exon11:c.A1636G:p.T546A	MEN1:NM_000244:exon10:c.A1636G:p.T546A,MEN1:NM_001370259:exon10:c.A1621G:p.T541A,MEN1:NM_001370260:exon10:c.A1621G:p.T541A,MEN1:NM_001370261:exon10:c.A1621G:p.T541A,MEN1:NM_001370262:exon10:c.A1516G:p.T506A,MEN1:NM_001370263:exon10:c.A1516G:p.T506A,MEN1:NM_130799:exon10:c.A1621G:p.T541A,MEN1:NM_130800:exon10:c.A1636G:p.T546A,MEN1:NM_130801:exon10:c.A1636G:p.T546A,MEN1:NM_130802:exon10:c.A1636G:p.T546A,MEN1:NM_130803:exon10:c.A1636G:p.T546A,MEN1:NM_001370251:exon11:c.A1747G:p.T583A,MEN1:NM_130804:exon11:c.A1636G:p.T546A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9378	0.9084	0.834465	MU17436755	-0.869	0.030	0.866	3.35	0.004	.	.	.	MEN1:uc001obj.3:exon10:c.A1636G:p.T546A,MEN1:uc001obk.3:exon10:c.A1636G:p.T546A,MEN1:uc001obl.3:exon10:c.A1516G:p.T506A,MEN1:uc001obm.3:exon10:c.A1621G:p.T541A,MEN1:uc001obn.3:exon10:c.A1636G:p.T546A,MEN1:uc001obo.3:exon10:c.A1636G:p.T546A,MEN1:uc001obr.3:exon10:c.A1636G:p.T546A,MEN1:uc001obq.3:exon11:c.A1636G:p.T546A	-0.936	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.8934,EAS:0.8986,FIN:0.9967,NFE:0.6936,OTH:0.9814,ASJ:0.7058	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	-5.71	0.000	-0.69	11	22(soft_tissue)	0.9959
11	64572557	64572557	A	G	MEN1	exonic	synonymous SNV	ENSG00000133895	rs540012	ENSG00000133895:ENST00000377313:exon8:c.T1314C:p.H438H,ENSG00000133895:ENST00000377326:exon8:c.T1299C:p.H433H,ENSG00000133895:ENST00000312049:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000315422:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000337652:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000377321:exon9:c.T1194C:p.H398H,ENSG00000133895:ENST00000394374:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000443283:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000394376:exon10:c.T1314C:p.H438H	MEN1:NM_000244:exon9:c.T1314C:p.H438H,MEN1:NM_001370259:exon9:c.T1299C:p.H433H,MEN1:NM_001370260:exon9:c.T1299C:p.H433H,MEN1:NM_001370261:exon9:c.T1299C:p.H433H,MEN1:NM_001370262:exon9:c.T1194C:p.H398H,MEN1:NM_001370263:exon9:c.T1194C:p.H398H,MEN1:NM_130799:exon9:c.T1299C:p.H433H,MEN1:NM_130800:exon9:c.T1314C:p.H438H,MEN1:NM_130801:exon9:c.T1314C:p.H438H,MEN1:NM_130802:exon9:c.T1314C:p.H438H,MEN1:NM_130803:exon9:c.T1314C:p.H438H,MEN1:NM_001370251:exon10:c.T1425C:p.H475H,MEN1:NM_130804:exon10:c.T1314C:p.H438H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9927	0.9761	0.976038	0.9768	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.T1314C:p.H438H,MEN1:uc001obk.3:exon9:c.T1314C:p.H438H,MEN1:uc001obl.3:exon9:c.T1194C:p.H398H,MEN1:uc001obm.3:exon9:c.T1299C:p.H433H,MEN1:uc001obn.3:exon9:c.T1314C:p.H438H,MEN1:uc001obo.3:exon9:c.T1314C:p.H438H,MEN1:uc001obr.3:exon9:c.T1314C:p.H438H,MEN1:uc001obq.3:exon10:c.T1314C:p.H438H	.	AFR:0.9185,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	MU81904595	hom
11	65628334	65628334	G	A	MUS81	exonic	nonsynonymous SNV	ENSG00000172732	rs13817	ENSG00000172732:ENST00000308110:exon1:c.G110A:p.R37H,ENSG00000172732:ENST00000529857:exon3:c.G305A:p.R102H	MUS81:NM_001350283:exon1:c.G110A:p.R37H,MUS81:NM_025128:exon1:c.G110A:p.R37H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.6667	0.5526	0.427915	COCA-CN|3|321|0.00934579	3.885	23.5	0.17	3.44	0.998	.	.	DNA polymerase beta-like, N-terminal domain	MUS81:uc001ofv.4:exon1:c.G110A:p.R37H	-0.948	AFR:0.5323,AMR:0.2558,EAS:0.6722,FIN:0.3086,NFE:0.7028,OTH:0.6765,ASJ:0.4014	606591	.	.	.	.	.	.	.	0.999	0.84	0.000	2.42	11	3(large_intestine)	0.6148
11	65629932	65629932	T	C	MUS81	exonic	synonymous SNV	ENSG00000172732	rs659857	ENSG00000172732:ENST00000525768:exon5:c.T312C:p.A104A,ENSG00000172732:ENST00000308110:exon6:c.T537C:p.A179A,ENSG00000172732:ENST00000533035:exon6:c.T312C:p.A104A	MUS81:NM_001350283:exon6:c.T537C:p.A179A,MUS81:NM_025128:exon6:c.T537C:p.A179A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5752	0.5247	0.428115	COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon6:c.T537C:p.A179A	.	AFR:0.5305,AMR:0.2557,EAS:0.6722,FIN:0.3077,NFE:0.7027,OTH:0.6739,ASJ:0.4017	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(thyroid)	0.6167
11	65629934	65629934	G	C	MUS81	exonic	nonsynonymous SNV	ENSG00000172732	rs545500	ENSG00000172732:ENST00000525768:exon5:c.G314C:p.R105P,ENSG00000172732:ENST00000308110:exon6:c.G539C:p.R180P,ENSG00000172732:ENST00000533035:exon6:c.G314C:p.R105P	MUS81:NM_001350283:exon6:c.G539C:p.R180P,MUS81:NM_025128:exon6:c.G539C:p.R180P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5752	0.5262	0.428115	MU115031	1.935	15.80	0.087	-1.98	0.337	.	.	Winged helix-turn-helix DNA-binding domain	MUS81:uc001ofv.4:exon6:c.G539C:p.R180P	-0.973	AFR:COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.5303,EAS:0.4017,FIN:0.6722,NFE:0.3077,OTH:0.7027,ASJ:0.2555	606591	.	.	.	.	.	.	.	0.678	2.47	0.000	1.79	11	1(large_intestine)	0.6738
11	65631167	65631167	C	T	MUS81	exonic	synonymous SNV	ENSG00000172732	rs648732	ENSG00000172732:ENST00000308110:exon9:c.C936T:p.A312A,ENSG00000172732:ENST00000533035:exon9:c.C711T:p.A237A	MUS81:NM_001350283:exon9:c.C936T:p.A312A,MUS81:NM_025128:exon9:c.C936T:p.A312A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5789	0.5302	0.428115	MU89872	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon9:c.C936T:p.A312A	.	AFR:LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.5327,EAS:0.3998,FIN:0.6722,NFE:0.3105,OTH:0.7029,ASJ:0.2562	606591	.	.	.	.	.	.	.	.	.	.	.	11	4(lung)	0.6772
11	65631203	65631203	G	A	MUS81	intronic	.	ENSG00000172732	rs149199066	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0234	0.0123	0.0139776	0.0199	.	.	.	.	.	.	.	.	.	.	AFR:0.0038,AMR:0.0740,EAS:0,FIN:0.0435,NFE:0.0221,OTH:0.0378,ASJ:0	606591	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	65631973	65631973	G	A	MUS81	exonic	synonymous SNV	ENSG00000172732	rs630303	ENSG00000172732:ENST00000308110:exon11:c.G1065A:p.R355R,ENSG00000172732:ENST00000533035:exon11:c.G840A:p.R280R	MUS81:NM_001350283:exon11:c.G1068A:p.R356R,MUS81:NM_025128:exon11:c.G1065A:p.R355R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5793	0.5308	0.429912	1(breast)	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon11:c.G1065A:p.R355R	.	AFR:2(large_intestine),AMR:MU115052,EAS:0.5330,FIN:0.2591,NFE:0.4007,OTH:0.6722,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.3088
11	65632262	65632262	G	T	MUS81	exonic	synonymous SNV	ENSG00000172732	rs558114	ENSG00000172732:ENST00000308110:exon12:c.G1248T:p.T416T,ENSG00000172732:ENST00000533035:exon12:c.G1023T:p.T341T	MUS81:NM_001350283:exon12:c.G1251T:p.T417T,MUS81:NM_025128:exon12:c.G1248T:p.T416T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5789	0.5299	0.428315	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon12:c.G1248T:p.T416T	.	AFR:0.5323,AMR:0.2571,EAS:0.6722,FIN:0.3093,NFE:0.7030,OTH:0.6762,ASJ:0.4017	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.6111
11	66618403	66618403	A	C	PC	intronic	.	ENSG00000173599	rs45560936	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0413	.	0.0259585	0.0327	.	.	.	.	.	0.0001	0.032	.	.	.	AFR:0.0114,AMR:0.0275,EAS:0,FIN:0.0384,NFE:0.0455,OTH:0.0542,ASJ:0.0629	608786	266150;	3008;	3008|Ataxia with lactic acidosis type 2<br>Ataxia with lactic acidosis type II<br>Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency<br>Leigh syndrome due to PC deficiency<br>Leigh syndrome due to pyruvate carboxylase deficiency|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|266150 ~	.	.	.	.	.	.	.	.	11	.	het
11	67257823	67257823	C	A	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs641081	ENSG00000110711:ENST00000525341:exon3:c.C334A:p.Q112K,ENSG00000110711:ENST00000528641:exon4:c.C493A:p.Q165K,ENSG00000110711:ENST00000279146:exon5:c.C682A:p.Q228K	AIP:NM_001302959:exon5:c.C505A:p.Q169K,AIP:NM_001302960:exon5:c.C682A:p.Q228K,AIP:NM_003977:exon5:c.C682A:p.Q228K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9550	0.8343	0.845447	0.8508	-1.180	0.007	1.0	1.08	0.068	.	.	Tetratricopeptide-like helical domain	AIP:uc001olv.3:exon5:c.C682A:p.Q228K	-0.952	AFR:0.4803,AMR:0.9582,EAS:0.9994,FIN:1,NFE:0.9977,OTH:0.9755,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	0.0	-0.72	0.000	0.42	11	MU4550249	hom
11	67258391	67258391	A	G	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs4930199	ENSG00000110711:ENST00000279146:exon6:c.A920G:p.Q307R	AIP:NM_001302959:exon6:c.A743G:p.Q248R,AIP:NM_003977:exon6:c.A920G:p.Q307R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9998	0.999401	0.9998	.	.	.	.	.	.	.	.	AIP:uc001olv.3:exon6:c.A920G:p.Q307R	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	.	.	.	.	11	MU4550266	hom
11	67351585	67351585	C	G	GSTP1	intronic	.	ENSG00000084207	rs4147581	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4913	0.3879	0.424321	0.4018	.	.	.	.	.	.	.	.	.	.	AFR:0.1433,AMR:0.3816,EAS:0.7071,FIN:0.5032,NFE:0.4885,OTH:0.4815,ASJ:0.5933	134660	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	11	MU796812	hom
11	68171013	68171013	T	C	LRP5	exonic	synonymous SNV	ENSG00000162337	rs545382	ENSG00000162337:ENST00000294304:exon8:c.T1647C:p.F549F	LRP5:NM_002335:exon8:c.T1647C:p.F549F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9001	0.8154	0.841454	0.8459	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon8:c.T1647C:p.F549F	.	AFR:0.6314,AMR:0.9320,EAS:0.9883,FIN:0.9645,NFE:0.9169,OTH:0.9153,ASJ:0.9073	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU4557319	hom
11	68192690	68192690	G	A	LRP5	exonic	synonymous SNV	ENSG00000162337	rs556442	ENSG00000162337:ENST00000294304:exon15:c.G3357A:p.V1119V	LRP5:NM_001291902:exon15:c.G1614A:p.V538V,LRP5:NM_002335:exon15:c.G3357A:p.V1119V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6755	0.5265	0.579273	2(large_intestine)	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon15:c.G3357A:p.V1119V	.	AFR:MU64296,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.2359,FIN:0.6675,NFE:0.6258,OTH:0.7689,ASJ:0.5925	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	1(skin)	0.8595
11	68822739	68822739	T	C	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs1470892	ENSG00000162341:ENST00000294309:exon4:c.T348C:p.A116A,ENSG00000162341:ENST00000542467:exon4:c.T348C:p.A116A	TPCN2:NM_139075:exon4:c.T348C:p.A116A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9975	0.998802	0.9977	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon4:c.T348C:p.A116A,TPCN2:uc010rqg.1:exon4:c.T348C:p.A116A	.	AFR:0.9921,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU81906316	hom
11	68825037	68825037	A	C	TPCN2	intronic	.	ENSG00000162341	rs3750973	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8786	0.9005	0.747804	0.8742	.	.	.	.	.	0.0001	0.028	.	.	.	AFR:0.7215,AMR:0.6026,EAS:0.5278,FIN:0.9797,NFE:0.9844,OTH:0.9399,ASJ:0.9768	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU726998	hom
11	68834968	68834968	T	C	TPCN2	intronic	.	ENSG00000162341	rs6591368	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9577	0.9435	0.898363	0.9415	.	.	.	.	.	0.0001	0.02	.	.	.	AFR:0.8347,AMR:0.9296,EAS:0.8609,FIN:0.9926,NFE:0.9974,OTH:0.9827,ASJ:0.9901	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU23558361	hom
11	68840160	68840160	A	G	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs3750965	ENSG00000162341:ENST00000294309:exon12:c.A1127G:p.K376R,ENSG00000162341:ENST00000542467:exon12:c.A1127G:p.K376R	TPCN2:NM_139075:exon12:c.A1127G:p.K376R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2934	0.2917	0.290735	MU23558422	-0.014	2.458	0.5	2.61	0.618	.	.	.	TPCN2:uc001oor.2:exon10:c.A872G:p.K291R,TPCN2:uc001oos.2:exon12:c.A1127G:p.K376R,TPCN2:uc010rqg.1:exon12:c.A1127G:p.K376R	-1.154	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.2626,EAS:0.1719,FIN:0.2833,NFE:0.2160,OTH:0.2224,ASJ:0.2376	612163	612267;	.	.	.	.	.	.	0.287	-4.16	0.000	1.95	11	1(upper_aerodigestive_tract)	0.2962
11	68840397	68840397	T	C	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs1466221	ENSG00000162341:ENST00000294309:exon13:c.T1158C:p.Y386Y,ENSG00000162341:ENST00000542467:exon13:c.T1158C:p.Y386Y	TPCN2:NM_139075:exon13:c.T1158C:p.Y386Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4153	0.4650	0.338059	1(bone)	.	.	.	.	.	.	.	.	TPCN2:uc001oor.2:exon11:c.T903C:p.Y301Y,TPCN2:uc001oos.2:exon13:c.T1158C:p.Y386Y,TPCN2:uc010rqg.1:exon13:c.T1158C:p.Y386Y	.	AFR:1(large_intestine),AMR:1(liver),EAS:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,FIN:0.4356,NFE:0.3949,OTH:0.3477,ASJ:MU125443	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.4932
11	68840412	68840412	C	G	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs1466220	ENSG00000162341:ENST00000294309:exon13:c.C1173G:p.L391L,ENSG00000162341:ENST00000542467:exon13:c.C1173G:p.L391L	TPCN2:NM_139075:exon13:c.C1173G:p.L391L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4140	0.4620	0.334465	1(large_intestine)	.	.	.	.	.	.	.	.	TPCN2:uc001oor.2:exon11:c.C918G:p.L306L,TPCN2:uc001oos.2:exon13:c.C1173G:p.L391L,TPCN2:uc010rqg.1:exon13:c.C1173G:p.L391L	.	AFR:1(biliary_tract),AMR:MU125473,EAS:0.4326,FIN:0.3829,NFE:0.3429,OTH:0.4932,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.2938
11	68851414	68851414	T	C	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs2376558	ENSG00000162341:ENST00000294309:exon19:c.T1691C:p.L564P	TPCN2:NM_139075:exon19:c.T1691C:p.L564P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8797	0.9113	0.752995	LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	1.001	10.67	0.245	2.65	0.031	0.0001	0.01	Ion transport domain	TPCN2:uc001oos.2:exon19:c.T1691C:p.L564P	-0.952	AFR:0.8821,AMR:0.7519,EAS:0.9768,FIN:0.5155,NFE:0.9797,OTH:0.9843,ASJ:0.6014	612163	612267;	.	.	.	.	.	.	0.001	-4.93	0.000	.	11	1(haematopoietic_and_lymphoid_tissue)	0.9409
11	68851466	68851466	G	T	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs896973	ENSG00000162341:ENST00000294309:exon19:c.G1743T:p.A581A	TPCN2:NM_139075:exon19:c.G1743T:p.A581A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4139	0.4596	0.333466	ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon19:c.G1743T:p.A581A	.	AFR:0.4331,AMR:0.3801,EAS:0.5066,FIN:0.2942,NFE:0.4424,OTH:0.4784,ASJ:0.3481	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	2(lung)	0.4572
11	68855363	68855363	G	A	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs3829241	ENSG00000162341:ENST00000542467:exon18:c.G1655A:p.G552E,ENSG00000162341:ENST00000294309:exon25:c.G2201A:p.G734E	TPCN2:NM_139075:exon25:c.G2201A:p.G734E	clinvar: association 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3025	0.2893	0.176318	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	-1.841	0.002	1.0	-3.6	0.099	.	.	.	TPCN2:uc010rqg.1:exon18:c.G1655A:p.G552E,TPCN2:uc001oos.2:exon25:c.G2201A:p.G734E	-0.966	AFR:0.2817,AMR:0.0960,EAS:0.2649,FIN:0.2165,NFE:0.3582,OTH:0.3799,ASJ:0.2208	612163	612267;	.	.	.	.	.	.	0.0	-4.07	0.000	0	11	1(breast)	0.3303
11	69462910	69462910	G	A	CCND1	exonic	synonymous SNV	ENSG00000110092	rs9344	ENSG00000110092:ENST00000227507:exon4:c.G723A:p.P241P	CCND1:NM_053056:exon4:c.G723A:p.P241P	clinvar: risk_factor 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4551	0.3867	0.413538	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0.4188	0.388	.	CCND1:uc001opa.3:exon4:c.G723A:p.P241P	.	AFR:12(meninges),AMR:1(thyroid),EAS:MU4550663,FIN:LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,NFE:0.3966,OTH:0.2158,ASJ:1(salivary_gland)	168461	114500;193300;254500;	29073;314701;85443;892;	29073|Kahler's disease<br>Medullary plasmacytoma<br>Myelomatosis<br>Plasma cell myeloma|1-5 / 10 000|-|Adult|254500 ~314701|Systemic AL amyloidosis|-|Not applicable|-|254500 ~85443|Light-chain amyloidosis<br>Primary amyloidosis|1-5 / 10 000|Not applicable|Adult|254500 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~	~ko01522 Endocrine resistance~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04340 Hedgehog signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04530 Tight junction~ko04630 JAK-STAT signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	11	1(prostate)	0.4125
11	74329615	74329615	T	C	POLD3	exonic	synonymous SNV	ENSG00000077514	rs4944052	ENSG00000077514:ENST00000531615:exon4:c.T309C:p.P103P,ENSG00000077514:ENST00000532497:exon5:c.T108C:p.P36P,ENSG00000077514:ENST00000263681:exon6:c.T426C:p.P142P,ENSG00000077514:ENST00000527458:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000528481:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000530511:exon6:c.T309C:p.P103P	POLD3:NM_001363597:exon6:c.T309C:p.P103P,POLD3:NM_006591:exon6:c.T426C:p.P142P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3710	0.4061	0.449081	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	POLD3:uc009yua.2:exon5:c.T108C:p.P36P,POLD3:uc001ovf.2:exon6:c.T426C:p.P142P,POLD3:uc031qcr.1:exon6:c.T309C:p.P103P	.	AFR:MU132016,AMR:SKCA-BR|1|100|0.01,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.5660,FIN:0.4200,NFE:0.2616,OTH:0.3259,ASJ:0.3766	611415	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.2702
11	76253374	76253374	C	T	EMSY	exonic	nonsynonymous SNV	ENSG00000158636	rs553195345	ENSG00000158636:ENST00000532719:exon1:c.C92T:p.A31V,ENSG00000158636:ENST00000524451:exon3:c.C488T:p.A163V,ENSG00000158636:ENST00000533248:exon15:c.C2399T:p.A800V,ENSG00000158636:ENST00000524490:exon16:c.C2378T:p.A793V,ENSG00000158636:ENST00000525038:exon17:c.C2675T:p.A892V,ENSG00000158636:ENST00000525919:exon17:c.C2675T:p.A892V,ENSG00000158636:ENST00000529032:exon17:c.C2672T:p.A891V,ENSG00000158636:ENST00000334736:exon18:c.C2672T:p.A891V,ENSG00000158636:ENST00000343878:exon18:c.C2672T:p.A891V,ENSG00000158636:ENST00000524767:exon18:c.C2717T:p.A906V	EMSY:NM_001300943:exon18:c.C2675T:p.A892V,EMSY:NM_001300944:exon18:c.C2675T:p.A892V,EMSY:NM_020193:exon18:c.C2672T:p.A891V,EMSY:NM_001300942:exon19:c.C2717T:p.A906V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	6.589e-05	.	0.000199681	.	4.680	24.6	0.248	5.53	0.996	.	.	WD40/YVTN repeat-like-containing domain	C11orf30:uc010rse.2:exon3:c.C413T:p.A138V,C11orf30:uc001oxo.1:exon5:c.C734T:p.A245V,C11orf30:uc010rsd.2:exon15:c.C2399T:p.A800V,C11orf30:uc001oxm.3:exon16:c.C2378T:p.A793V,C11orf30:uc001oxn.3:exon17:c.C2675T:p.A892V,C11orf30:uc010rsc.2:exon17:c.C2675T:p.A892V,C11orf30:uc001oxl.3:exon18:c.C2672T:p.A891V,C11orf30:uc010rsb.2:exon18:c.C2717T:p.A906V	-0.790	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608574	.	.	.	.	.	.	.	0.993	.	0.207	0.205	11	.	het
11	85968623	85968623	C	T	EED	exonic	synonymous SNV	ENSG00000074266	rs974144	ENSG00000074266:ENST00000263360:exon6:c.C619T:p.L207L,ENSG00000074266:ENST00000327320:exon6:c.C619T:p.L207L,ENSG00000074266:ENST00000351625:exon6:c.C619T:p.L207L,ENSG00000074266:ENST00000528180:exon6:c.C619T:p.L207L	EED:NM_001308007:exon6:c.C619T:p.L207L,EED:NM_001330334:exon6:c.C619T:p.L207L,EED:NM_003797:exon6:c.C619T:p.L207L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3724	0.3244	0.294728	MU17479045	.	.	.	.	.	.	.	.	EED:uc001pbp.3:exon6:c.C619T:p.L207L,EED:uc001pbq.3:exon6:c.C619T:p.L207L,EED:uc001pbr.3:exon6:c.C619T:p.L207L,EED:uc010rtm.2:exon6:c.C619T:p.L207L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,AMR:0.3452,EAS:0.2590,FIN:0.3046,NFE:0.3387,OTH:0.4218,ASJ:0.1770	605984	.	.	.	.	,2256	.	.	.	.	.	.	11	16(soft_tissue)	0.4264
11	85977117	85977117	G	A	EED	intronic	.	ENSG00000074266	rs10898460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7872	0.8184	0.764976	0.8069	.	.	.	.	.	0	0.032	.	.	.	AFR:0.8129,AMR:0.6504,EAS:0.7118,FIN:0.7643,NFE:0.8347,OTH:0.8200,ASJ:0.65	605984	.	.	.	.	.	.	.	.	.	.	.	11	MU17479112	het
11	92227198	92227200	TTT	-	FAT3	intronic	.	ENSG00000165323	rs201710620	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.4738	.	.	.	.	.	.	.	.	.	.	AFR:0.4523,AMR:0.5763,EAS:0.5728,FIN:0.4808,NFE:0.4673,OTH:0.4742,ASJ:0.5752	612483	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	92531356	92531356	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs7949157	ENSG00000165323:ENST00000298047:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000409404:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000525166:exon9:c.A4727G:p.Q1576R	FAT3:NM_001008781:exon9:c.A5177G:p.Q1726R,FAT3:NM_001367949:exon10:c.A5177G:p.Q1726R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8230	0.7982	0.769768	0.8011	-0.294	0.685	0.348	0.257	0.132	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A5177G:p.Q1726R	-1.004	AFR:0.6949,AMR:0.8589,EAS:0.7438,FIN:0.8701,NFE:0.8467,OTH:0.8371,ASJ:0.8212	612483	.	.	.	.	.	.	.	0.0	0.75	0.000	0.215	11	MU17485846	hom
11	92532677	92532677	T	C	FAT3	exonic	synonymous SNV	ENSG00000165323	rs12362722	ENSG00000165323:ENST00000298047:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000409404:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000525166:exon9:c.T6048C:p.P2016P	FAT3:NM_001008781:exon9:c.T6498C:p.P2166P,FAT3:NM_001367949:exon10:c.T6498C:p.P2166P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8272	0.8269	0.799321	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon9:c.T6498C:p.P2166P	.	AFR:0.8210,AMR:0.7962,EAS:0.8179,FIN:0.7469,NFE:0.8353,OTH:0.8374,ASJ:0.8652	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.8238
11	92534060	92534060	C	T	FAT3	exonic	synonymous SNV	ENSG00000165323	rs372331075	ENSG00000165323:ENST00000298047:exon9:c.C7881T:p.P2627P,ENSG00000165323:ENST00000409404:exon9:c.C7881T:p.P2627P,ENSG00000165323:ENST00000525166:exon9:c.C7431T:p.P2477P	FAT3:NM_001008781:exon9:c.C7881T:p.P2627P,FAT3:NM_001367949:exon10:c.C7881T:p.P2627P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	7.762e-05	0.0002	0.000199681	1(stomach)	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon9:c.C7881T:p.P2627P	.	AFR:MU1971401,AMR:UCEC-US|2|531|0.00376648,GACA-JP|1|585|0.0017094,HNSC-US|1|508|0.0019685,EAS:0.0001,FIN:0,NFE:0,OTH:0,ASJ:0.0001	612483	.	.	.	.	.	.	.	.	.	.	.	11	2(upper_aerodigestive_tract)	0
11	92534442	92534442	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs3847531	ENSG00000165323:ENST00000298047:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000409404:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000525166:exon9:c.A7813G:p.I2605V	FAT3:NM_001008781:exon9:c.A8263G:p.I2755V,FAT3:NM_001367949:exon10:c.A8263G:p.I2755V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8637	0.8229	0.85643	0.8408	-0.756	0.054	1.0	4.8	0.559	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A8263G:p.I2755V	-0.957	AFR:0.7577,AMR:0.8699,EAS:0.9543,FIN:0.9124,NFE:0.8554,OTH:0.8735,ASJ:0.8907	612483	.	.	.	.	.	.	.	0.0	0.18	0.000	-0.49	11	MU23948427	hom
11	92573911	92573911	G	T	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs10765565	ENSG00000165323:ENST00000298047:exon17:c.G10552T:p.V3518L,ENSG00000165323:ENST00000409404:exon17:c.G10552T:p.V3518L,ENSG00000165323:ENST00000525166:exon17:c.G10102T:p.V3368L	FAT3:NM_001008781:exon17:c.G10552T:p.V3518L,FAT3:NM_001367949:exon18:c.G10552T:p.V3518L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3740	0.3404	0.323482	MU160112	0.718	8.947	1.0	0.41	0.873	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon17:c.G10552T:p.V3518L	-0.955	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.3264,EAS:0.3657,FIN:0.3675,NFE:0.2007,OTH:0.3317,ASJ:0.2266	612483	.	.	.	.	.	.	.	0.001	0.62	0.000	-0.09	11	1(thyroid)	0.3924
11	92590448	92590448	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs4753069	ENSG00000165323:ENST00000533797:exon2:c.A439G:p.S147G,ENSG00000165323:ENST00000298047:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000409404:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000525166:exon19:c.A10984G:p.S3662G	FAT3:NM_001008781:exon19:c.A11434G:p.S3812G,FAT3:NM_001367949:exon20:c.A11434G:p.S3812G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8175	0.8418	0.828474	0.8266	1.015	10.75	0.872	4.1	0.893	.	.	EGF-like domain	FAT3:uc001pdi.4:exon3:c.A754G:p.S252G,FAT3:uc001pdj.4:exon19:c.A11434G:p.S3812G	-1.008	AFR:0.9099,AMR:0.8278,EAS:0.6755,FIN:0.7872,NFE:0.8031,OTH:0.8200,ASJ:0.8676	612483	.	.	.	.	.	.	.	0.0	1.64	0.000	-1.04	11	MU737516	hom
11	92623877	92623877	G	A	FAT3	exonic	synonymous SNV	ENSG00000165323	rs12277422	ENSG00000165323:ENST00000533797:exon8:c.G2277A:p.P759P,ENSG00000165323:ENST00000409404:exon25:c.G13272A:p.P4424P,ENSG00000165323:ENST00000298047:exon27:c.G13368A:p.P4456P,ENSG00000165323:ENST00000525166:exon27:c.G12918A:p.P4306P	FAT3:NM_001008781:exon25:c.G13272A:p.P4424P,FAT3:NM_001367949:exon28:c.G13368A:p.P4456P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2439	0.2399	0.226238	1(large_intestine)	.	.	.	.	.	.	.	.	FAT3:uc001pdi.4:exon11:c.G2688A:p.P896P,FAT3:uc001pdj.4:exon25:c.G13272A:p.P4424P	.	AFR:MU12019243,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.2369,FIN:0.2864,NFE:0.2649,OTH:0.2491,ASJ:0.2541	612483	.	.	.	.	.	.	.	.	.	.	.	11	2(lung)	0.2595
11	93517874	93517874	C	G	MED17	exonic	synonymous SNV	ENSG00000042429	rs7116967	ENSG00000042429:ENST00000251871:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000530819:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000533133:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000533359:exon1:c.C195G:p.G65G	MED17:NM_004268:exon1:c.C195G:p.G65G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6174	0.5453	0.565695	0.5575	.	.	.	.	.	.	.	.	MED17:uc001pel.2:exon1:c.C195G:p.G65G,MED17:uc001pem.4:exon1:c.C195G:p.G65G	.	AFR:0.3368,AMR:0.7902,EAS:0.7509,FIN:0.6596,NFE:0.6234,OTH:0.6386,ASJ:0.54	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU90907	unknown
11	93517886	93517886	G	C	MED17	exonic	nonsynonymous SNV	ENSG00000042429	rs2848477	ENSG00000042429:ENST00000251871:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000530819:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000533133:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000533359:exon1:c.G207C:p.E69D	MED17:NM_004268:exon1:c.G207C:p.E69D	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6183	0.5506	0.565695	0.5573	0.495	7.396	0.867	1.67	0.309	.	.	.	MED17:uc001pel.2:exon1:c.G207C:p.E69D,MED17:uc001pem.4:exon1:c.G207C:p.E69D	-0.952	AFR:0.3363,AMR:0.7902,EAS:0.7491,FIN:0.6591,NFE:0.6237,OTH:0.6380,ASJ:0.54	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	0.0	0.51	0.000	1.445	11	MU90893	unknown
11	93527219	93527219	T	C	MED17	intronic	.	ENSG00000042429	rs657177	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9826	0.9399	0.933107	0.9455	.	.	.	.	.	.	.	.	.	.	AFR:0.8101,AMR:0.9856,EAS:1,FIN:0.9994,NFE:0.9992,OTH:0.9949,ASJ:1	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU81909259	hom
11	93534990	93534990	G	A	MED17	intronic	.	ENSG00000042429	rs655699	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6075	0.4893	0.527556	0.5235	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.2167,AMR:0.7709,EAS:0.7481,FIN:0.6594,NFE:0.6247,OTH:0.6260,ASJ:0.5397	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU19347293	hom
11	94180388	94180388	T	C	MRE11	exonic	nonsynonymous SNV	ENSG00000020922	rs576878377	ENSG00000020922:ENST00000323929:exon15:c.A1780G:p.R594G,ENSG00000020922:ENST00000323977:exon15:c.A1780G:p.R594G,ENSG00000020922:ENST00000393241:exon15:c.A1780G:p.R594G,ENSG00000020922:ENST00000407439:exon15:c.A1789G:p.R597G	MRE11:NM_001330347:exon15:c.A1780G:p.R594G,MRE11:NM_005590:exon15:c.A1780G:p.R594G,MRE11:NM_005591:exon15:c.A1780G:p.R594G	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, -1, 0, 0] 	0.0013	.	0.00299521	3.228e-05	2.159	17.24	0.162	0.737	0.980	.	.	.	MRE11A:uc001peu.2:exon15:c.A1780G:p.R594G,MRE11A:uc001pev.2:exon15:c.A1780G:p.R594G,MRE11A:uc009ywj.2:exon15:c.A1789G:p.R597G	-0.559	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	0.981	-0.92	0.356	2.47	11	.	het
11	94197260	94197260	A	G	MRE11	intronic	.	ENSG00000020922	rs641936	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3783	0.3521	0.388778	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(large_intestine),AMR:MU14901128,EAS:0.3562,FIN:0.3732,NFE:0.4366,OTH:0.3874,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.3964
11	94212048	94212048	C	T	MRE11	intronic	.	ENSG00000020922	rs535801	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3252	0.2696	0.313099	1(oesophagus)	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:MU16125001,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.2035,FIN:0.4209,NFE:0.3543,OTH:0.3858,ASJ:0.2863	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	1(breast)	0.3499
11	95528714	95528714	C	T	CEP57	exonic	synonymous SNV	ENSG00000166037	rs522536	ENSG00000166037:ENST00000541150:exon1:c.C9T:p.T3T,ENSG00000166037:ENST00000544522:exon2:c.C9T:p.T3T	CEP57:NM_001243776:exon2:c.C9T:p.T3T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2993	.	0.271366	MU12024637	.	.	.	.	.	.	.	.	CEP57:uc010ruh.2:exon2:c.C9T:p.T3T	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.3406,EAS:0.2751,FIN:0.6225,NFE:0.3061,OTH:0.3289,ASJ:0.2308	607951	614114;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	.	.	.	.	11	1(stomach)	0.4080
11	108114661	108114661	-	T	ATM	intronic	.	ENSG00000149311	rs786201087	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1158	0.0938	.	0.0053	.	.	.	.	.	.	.	.	.	.	AFR:0.0071,AMR:0.0103,EAS:0,FIN:0.0199,NFE:0.0032,OTH:0.0040,ASJ:0	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	het
11	108121410	108121410	-	T	ATM	intronic	.	ENSG00000149311	rs34325032	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3717	0.3252	0.40595	0.5019	.	.	.	.	.	.	.	.	.	.	AFR:0.4265,AMR:0.5668,EAS:0.4125,FIN:0.4710,NFE:0.5539,OTH:0.5839,ASJ:0.5875	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	hom
11	108151707	108151707	-	A	ATM	intronic	.	ENSG00000149311	rs3218681	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.5675	0.5562	0.542133	0.5369	.	.	.	.	.	.	.	.	.	.	AFR:0.4641,AMR:0.6383,EAS:0.3782,FIN:0.6205,NFE:0.5659,OTH:0.6052,ASJ:0.6324	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	hom
11	108183167	108183167	A	G	ATM	exonic	nonsynonymous SNV	ENSG00000149311	rs659243	ENSG00000149311:ENST00000278616:exon40:c.A5948G:p.N1983S,ENSG00000149311:ENST00000452508:exon41:c.A5948G:p.N1983S	ATM:NM_000051:exon40:c.A5948G:p.N1983S,ATM:NM_001351834:exon41:c.A5948G:p.N1983S	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	1	.	1	MU81910525	.	.	.	.	.	.	.	.	ATM:uc009yxt.1:exon3:c.A290G:p.N97S,ATM:uc001pkg.1:exon8:c.A1019G:p.N340S,ATM:uc001pke.2:exon14:c.A1904G:p.N635S,ATM:uc001pkb.1:exon40:c.A5948G:p.N1983S,ATM:uc009yxr.1:exon41:c.A5948G:p.N1983S	.	AFR:COCA-CN|5|321|0.0155763,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	,907,893,910,900,895,911,903,898,902,909,894,877,904,912,899,906,908,901	.	896,,897	.	.	.	.	11	85(lung)	1
11	108205767	108205767	A	C	ATM	exonic	synonymous SNV	ENSG00000149311	rs540266635	ENSG00000149311:ENST00000278616:exon55:c.A8082C:p.G2694G,ENSG00000149311:ENST00000452508:exon56:c.A8082C:p.G2694G	ATM:NM_000051:exon55:c.A8082C:p.G2694G,ATM:NM_001351834:exon56:c.A8082C:p.G2694G	clinvar: Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0001	.	0.000199681	.	.	.	.	.	.	.	.	.	ATM:uc001pke.2:exon29:c.A4038C:p.G1346G,ATM:uc001pkb.1:exon55:c.A8082C:p.G2694G,ATM:uc009yxr.1:exon56:c.A8082C:p.G2694G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	,907,893,910,900,895,911,903,898,902,909,894,877,904,912,899,906,908,901	.	896,,897	.	.	.	.	11	.	het
11	111227170	111227170	T	C	POU2AF1	intronic	.	ENSG00000110777	rs4387383	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.429912	0.5191	.	.	.	.	.	.	.	.	.	.	AFR:0.3196,AMR:0.6802,EAS:0.3004,FIN:0.5802,NFE:0.6319,OTH:0.5755,ASJ:0.5	601206	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	111248514	111248514	C	G	POU2AF1	intronic	.	ENSG00000110777	rs4622303	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.561102	0.6695	.	.	.	.	.	.	.	.	.	.	AFR:0.5779,AMR:0.8177,EAS:0.3790,FIN:0.6764,NFE:0.7414,OTH:0.6893,ASJ:0.7433	601206	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	111963860	111963860	A	G	SDHD	exonic	nonsynonymous SNV	ENSG00000204370	rs592626	ENSG00000204370:ENST00000526592:exon4:c.A371G:p.Q124R	SDHD:NM_001276506:exon4:c.A371G:p.Q124R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	.	0.945487	0.9510	-0.354	0.498	0.269	-0.298	0.000	.	.	.	SDHD:uc031qee.1:exon4:c.A371G:p.Q124R	-0.867	AFR:0.8286,AMR:0.9866,EAS:0.9988,FIN:1,NFE:0.9995,OTH:0.9907,ASJ:1	602690	114900;168000;171300;252011;606864;615106;	201;97286;3208;29072;29072;100093;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~100093|-|-|-|-|114900 ~	.	.	.	.	.	-2.93	0.000	.	11	MU81910959	hom
11	118625609	118625609	C	T	DDX6	intronic	.	ENSG00000110367	rs580079	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8909	.	0.88758	0.8687	.	.	.	.	.	.	.	.	.	.	AFR:0.7968,AMR:0.9141,EAS:0.9994,FIN:0.9066,NFE:0.8832,OTH:0.8941,ASJ:0.8742	600326	.	.	.	.	.	.	.	.	.	.	.	11	MU81912502	hom
11	118629613	118629613	-	G	DDX6	splicing	.	ENSG00000110367	rs200755405	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0048	0.0073	.	0.0022	.	.	.	.	.	.	.	.	.	.	AFR:0.0017,AMR:0,EAS:0,FIN:0.0014,NFE:0.0031,OTH:0.0020,ASJ:0	600326	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	118636073	118636073	T	A	DDX6	intronic	.	ENSG00000110367	rs540602564	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0004	.	0.000199681	.	.	.	.	.	.	0	0.004	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600326	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	119148573	119148573	G	T	CBL	intronic	.	ENSG00000110395	rs2510152	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6011	0.6246	0.728634	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(bone),AMR:MU21722970,EAS:0.6228,FIN:0.8009,NFE:0.4055,OTH:0.6523,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	165360	607785;613563;	363972;86834;	363972|CBL syndrome<br>Noonan syndrome-like disorder with JMML|-|Autosomal dominant|-|613563 ~86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	~ko04012 ErbB signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko04910 Insulin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	11	1(lung)	0.8846
11	120292570	120292570	T	A	ARHGEF12	intronic	.	ENSG00000196914	rs532006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9964	0.9865	0.985024	0.9891	.	.	.	.	.	.	.	.	.	.	AFR:0.9618,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	MU81913066	hom
11	120319064	120319064	A	C	ARHGEF12	intronic	.	ENSG00000196914	rs2305008	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4203	0.4354	0.427716	MU11826432	.	.	.	.	.	0.0001	0	.	ARHGEF12:uc021qrm.1:exon19:c.A1687C:p.M563L	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.4342,EAS:0.3457,FIN:0.4467,NFE:0.2976,OTH:0.4504,ASJ:0.5346	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	3(haematopoietic_and_lymphoid_tissue)	0.3905
11	120340060	120340060	A	T	ARHGEF12	exonic	nonsynonymous SNV	ENSG00000196914	rs2305013	ENSG00000196914:ENST00000356641:exon29:c.A2861T:p.Y954F,ENSG00000196914:ENST00000397843:exon30:c.A2918T:p.Y973F,ENSG00000196914:ENST00000532993:exon30:c.A2609T:p.Y870F	ARHGEF12:NM_001198665:exon29:c.A2861T:p.Y954F,ARHGEF12:NM_001301084:exon30:c.A2609T:p.Y870F,ARHGEF12:NM_015313:exon30:c.A2918T:p.Y973F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0643	0.0385	0.0632987	MU80633662	2.447	19.12	0.275	4.89	0.998	.	.	Dbl homology (DH) domain	ARHGEF12:uc009zat.3:exon29:c.A2861T:p.Y954F,ARHGEF12:uc001pxl.2:exon30:c.A2918T:p.Y973F,ARHGEF12:uc009zau.1:exon30:c.A2609T:p.Y870F,ARHGEF12:uc010rzn.1:exon30:c.A2609T:p.Y870F	-1.072	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.0521,EAS:0.0179,FIN:0.0563,NFE:0.1295,OTH:0.0933,ASJ:0.0107	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	0.001	-0.03	0.002	-0.09	11	1(lung)	0.0589
11	120355230	120355230	A	G	ARHGEF12	intronic	.	ENSG00000196914	rs503473	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4158	0.3649	0.344848	0.3830	.	.	.	.	.	.	.	.	.	.	AFR:0.1563,AMR:0.2661,EAS:0.6576,FIN:0.4627,NFE:0.4709,OTH:0.4143,ASJ:0.4073	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	MU11826461	het
11	125525195	125525195	A	G	CHEK1	exonic	nonsynonymous SNV	ENSG00000149554	rs506504	ENSG00000149554:ENST00000278916:exon11:c.A1279G:p.I427V,ENSG00000149554:ENST00000427383:exon12:c.A1459G:p.I487V,ENSG00000149554:ENST00000524737:exon12:c.A1411G:p.I471V,ENSG00000149554:ENST00000544373:exon12:c.A1309G:p.I437V,ENSG00000149554:ENST00000428830:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000438015:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000534070:exon13:c.A1411G:p.I471V	CHEK1:NM_001244846:exon12:c.A1309G:p.I437V,CHEK1:NM_001330427:exon12:c.A1459G:p.I487V,CHEK1:NM_001330428:exon12:c.A1129G:p.I377V,CHEK1:NM_001114121:exon13:c.A1411G:p.I471V,CHEK1:NM_001114122:exon13:c.A1411G:p.I471V,CHEK1:NM_001274:exon13:c.A1411G:p.I471V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9726	0.9738	0.985823	0.9774	-0.257	0.830	1.0	1.8	0.993	.	.	.	CHEK1:uc010sbh.2:exon12:c.A1459G:p.I487V,CHEK1:uc010sbi.2:exon12:c.A1309G:p.I437V,CHEK1:uc001qcf.4:exon13:c.A1411G:p.I471V,CHEK1:uc001qcg.4:exon13:c.A1411G:p.I471V,CHEK1:uc009zbo.3:exon13:c.A1411G:p.I471V,CHEK1:uc009zbp.3:exon13:c.A1411G:p.I471V	-0.951	AFR:0.9928,AMR:0.9761,EAS:1,FIN:0.9694,NFE:0.9683,OTH:0.9776,ASJ:0.9603	603078	.	.	.	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	-0.5	0.000	-1.155	11	MU81914120	hom
11	125830970	125830970	A	T	CDON	exonic	nonsynonymous SNV	ENSG00000064309	rs684535	ENSG00000064309:ENST00000531738:exon11:c.T1793A:p.I598N,ENSG00000064309:ENST00000263577:exon20:c.T3662A:p.I1221N,ENSG00000064309:ENST00000392693:exon20:c.T3731A:p.I1244N	CDON:NM_001243597:exon20:c.T3731A:p.I1244N,CDON:NM_016952:exon20:c.T3662A:p.I1221N	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7310	0.73	.	COCA-CN|5|321|0.0155763	-0.119	1.592	1.0	4.34	0.018	.	.	.	CDON:uc001qdb.4:exon11:c.T1793A:p.I598N,CDON:uc001qdc.4:exon20:c.T3662A:p.I1221N,CDON:uc009zbw.3:exon20:c.T3731A:p.I1244N	-0.950	AFR:0.7411,AMR:0.8439,EAS:0.7318,FIN:0.9321,NFE:0.6754,OTH:0.6769,ASJ:0.7792	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.0	-0.03	0.000	-2.05	11	1(salivary_gland)	0.6939
11	125831701	125831701	G	A	CDON	exonic	synonymous SNV	ENSG00000064309	rs2276061	ENSG00000064309:ENST00000531738:exon10:c.C1680T:p.V560V,ENSG00000064309:ENST00000263577:exon19:c.C3549T:p.V1183V,ENSG00000064309:ENST00000392693:exon19:c.C3549T:p.V1183V	CDON:NM_001243597:exon19:c.C3549T:p.V1183V,CDON:NM_016952:exon19:c.C3549T:p.V1183V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2906	0.2531	0.242212	LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon10:c.C1680T:p.V560V,CDON:uc001qdc.4:exon19:c.C3549T:p.V1183V,CDON:uc009zbw.3:exon19:c.C3549T:p.V1183V	.	AFR:0.2547,AMR:0.1235,EAS:0.2980,FIN:0.2954,NFE:0.3078,OTH:0.3128,ASJ:0.2554	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.2627
11	125848261	125848261	C	T	CDON	exonic	synonymous SNV	ENSG00000064309	rs3740904	ENSG00000064309:ENST00000531738:exon9:c.G1425A:p.T475T,ENSG00000064309:ENST00000263577:exon18:c.G3294A:p.T1098T,ENSG00000064309:ENST00000392693:exon18:c.G3294A:p.T1098T	CDON:NM_001243597:exon18:c.G3294A:p.T1098T,CDON:NM_016952:exon18:c.G3294A:p.T1098T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4143	0.3565	0.399561	1(large_intestine)	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon9:c.G1425A:p.T475T,CDON:uc001qdc.4:exon18:c.G3294A:p.T1098T,CDON:uc009zbw.3:exon18:c.G3294A:p.T1098T	.	AFR:MU77425,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.3498,FIN:0.4415,NFE:0.3467,OTH:0.3958,ASJ:0.3650	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.4055
11	125871735	125871735	C	T	CDON	exonic	synonymous SNV	ENSG00000064309	rs516664	ENSG00000064309:ENST00000531738:exon2:c.G168A:p.A56A,ENSG00000064309:ENST00000263577:exon11:c.G2037A:p.A679A,ENSG00000064309:ENST00000392693:exon11:c.G2037A:p.A679A	CDON:NM_001243597:exon11:c.G2037A:p.A679A,CDON:NM_016952:exon11:c.G2037A:p.A679A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3127	0.3454	0.302516	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon2:c.G168A:p.A56A,CDON:uc001qdc.4:exon11:c.G2037A:p.A679A,CDON:uc009zbw.3:exon11:c.G2037A:p.A679A	.	AFR:0.3286,AMR:0.3686,EAS:0.3675,FIN:0.1795,NFE:0.3486,OTH:0.3148,ASJ:0.3469	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(stomach)	0.3292
11	125891269	125891269	C	T	CDON	exonic	nonsynonymous SNV	ENSG00000064309	rs3740912	ENSG00000064309:ENST00000263577:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000392693:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000527967:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000531586:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000534818:exon3:c.G223A:p.V75I	CDON:NM_001243597:exon3:c.G223A:p.V75I,CDON:NM_016952:exon3:c.G223A:p.V75I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5573	0.6452	0.572284	0.6357	-0.550	0.165	0.792	1.84	0.002	.	.	Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	CDON:uc001qdc.4:exon3:c.G223A:p.V75I,CDON:uc009zbw.3:exon3:c.G223A:p.V75I,CDON:uc009zbx.3:exon3:c.G223A:p.V75I	-0.960	AFR:0.8210,AMR:0.5538,EAS:0.3190,FIN:0.6323,NFE:0.5715,OTH:0.5784,ASJ:0.6093	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.0	1.08	0.000	0.645	11	MU582469	het
11	128333503	128333503	T	C	ETS1	exonic	synonymous SNV	ENSG00000134954	rs2230004	ENSG00000134954:ENST00000535549:exon3:c.A363G:p.L121L,ENSG00000134954:ENST00000345075:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000526145:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000319397:exon7:c.A1011G:p.L337L,ENSG00000134954:ENST00000392668:exon9:c.A1143G:p.L381L	ETS1:NM_001162422:exon3:c.A363G:p.L121L,ETS1:NM_001330451:exon6:c.A750G:p.L250L,ETS1:NM_005238:exon7:c.A1011G:p.L337L,ETS1:NM_001143820:exon9:c.A1143G:p.L381L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4668	0.4712	0.479633	0.4959	.	.	.	.	.	.	.	.	ETS1:uc009zch.2:exon3:c.A363G:p.L121L,ETS1:uc010sbs.1:exon7:c.A1011G:p.L337L,ETS1:uc001qej.2:exon9:c.A1143G:p.L381L	.	AFR:0.4745,AMR:0.3385,EAS:0.5700,FIN:0.5507,NFE:0.4991,OTH:0.4898,ASJ:0.38	164720	.	.	.	~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	11	MU20946672	hom
11	128350071	128350071	C	T	ETS1	intronic	.	ENSG00000134954	rs61909072	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1162	0.1149	0.0591054	0.1007	.	.	.	.	.	.	.	.	.	.	AFR:0.0249,AMR:0.0597,EAS:0.0012,FIN:0.1142,NFE:0.1518,OTH:0.1306,ASJ:0.1523	164720	.	.	.	~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	11	.	het
11	128675292	128675292	T	A	FLI1	exonic	synonymous SNV	ENSG00000151702	rs7113191	ENSG00000151702:ENST00000525560:exon4:c.T108A:p.A36A,ENSG00000151702:ENST00000281428:exon5:c.T489A:p.A163A,ENSG00000151702:ENST00000344954:exon6:c.T588A:p.A196A,ENSG00000151702:ENST00000527786:exon6:c.T687A:p.A229A,ENSG00000151702:ENST00000534087:exon7:c.T588A:p.A196A	FLI1:NM_001271012:exon4:c.T108A:p.A36A,FLI1:NM_002017:exon6:c.T687A:p.A229A,FLI1:NM_001167681:exon7:c.T588A:p.A196A,FLI1:NM_001271010:exon7:c.T489A:p.A163A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2190	0.1521	0.17512	1(breast)	.	.	.	.	.	.	.	.	FLI1:uc010sbt.2:exon4:c.T108A:p.A36A,FLI1:uc010sbu.2:exon6:c.T687A:p.A229A,FLI1:uc009zci.3:exon7:c.T489A:p.A163A,FLI1:uc010sbv.2:exon7:c.T588A:p.A196A	.	AFR:MU160365,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.2473,FIN:0.1181,NFE:0.1623,OTH:0.1944,ASJ:0.1532	193067	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.1043
11	128781339	128781339	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs6590357	ENSG00000120457:ENST00000533599:exon1:c.T171C:p.S57S,ENSG00000120457:ENST00000529694:exon2:c.T171C:p.S57S,ENSG00000120457:ENST00000338350:exon3:c.T171C:p.S57S	KCNJ5:NM_000890:exon2:c.T171C:p.S57S,KCNJ5:NM_001354169:exon3:c.T171C:p.S57S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8436	0.8483	0.869808	0.8476	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T171C:p.S57S,KCNJ5:uc001qet.3:exon2:c.T171C:p.S57S,KCNJ5:uc009zck.3:exon3:c.T171C:p.S57S	.	AFR:0.9048,AMR:0.8162,EAS:0.8915,FIN:0.7991,NFE:0.8249,OTH:0.8218,ASJ:0.8179	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381753	hom
11	128781978	128781978	T	G	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118824	ENSG00000120457:ENST00000533599:exon1:c.T810G:p.L270L,ENSG00000120457:ENST00000529694:exon2:c.T810G:p.L270L,ENSG00000120457:ENST00000338350:exon3:c.T810G:p.L270L	KCNJ5:NM_000890:exon2:c.T810G:p.L270L,KCNJ5:NM_001354169:exon3:c.T810G:p.L270L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8414	0.8427	0.866214	0.8424	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T810G:p.L270L,KCNJ5:uc001qet.3:exon2:c.T810G:p.L270L,KCNJ5:uc009zck.3:exon3:c.T810G:p.L270L	.	AFR:0.8930,AMR:0.8150,EAS:0.8912,FIN:0.7990,NFE:0.8212,OTH:0.8203,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381815	unknown
11	128782002	128782002	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118833	ENSG00000120457:ENST00000533599:exon1:c.T834C:p.H278H,ENSG00000120457:ENST00000529694:exon2:c.T834C:p.H278H,ENSG00000120457:ENST00000338350:exon3:c.T834C:p.H278H	KCNJ5:NM_000890:exon2:c.T834C:p.H278H,KCNJ5:NM_001354169:exon3:c.T834C:p.H278H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8416	0.8440	0.867013	0.8435	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T834C:p.H278H,KCNJ5:uc001qet.3:exon2:c.T834C:p.H278H,KCNJ5:uc009zck.3:exon3:c.T834C:p.H278H	.	AFR:0.8970,AMR:0.8182,EAS:0.8912,FIN:0.7991,NFE:0.8211,OTH:0.8193,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU16066762	unknown
11	128782012	128782012	C	G	KCNJ5	exonic	nonsynonymous SNV	ENSG00000120457	rs7102584	ENSG00000120457:ENST00000533599:exon1:c.C844G:p.Q282E,ENSG00000120457:ENST00000529694:exon2:c.C844G:p.Q282E,ENSG00000120457:ENST00000338350:exon3:c.C844G:p.Q282E	KCNJ5:NM_000890:exon2:c.C844G:p.Q282E,KCNJ5:NM_001354169:exon3:c.C844G:p.Q282E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9865	0.9871	0.995008	0.9849	0.157	4.219	1.0	5.46	0.990	.	.	Immunoglobulin E-set|Potassium channel, inwardly rectifying, Kir, cytoplasmic	KCNJ5:uc001qew.3:exon1:c.C844G:p.Q282E,KCNJ5:uc001qet.3:exon2:c.C844G:p.Q282E,KCNJ5:uc009zck.3:exon3:c.C844G:p.Q282E	-0.907	AFR:0.9984,AMR:0.9940,EAS:1,FIN:0.9728,NFE:0.9776,OTH:0.9805,ASJ:1	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	-2.58	0.000	-1.455	11	MU194151	unknown
11	128786294	128786294	G	A	KCNJ5	intronic	.	ENSG00000120457	rs4937391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7346	0.7478	0.735823	0.7394	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7966,AMR:0.7022,EAS:0.6720,FIN:0.6878,NFE:0.7287,OTH:0.7274,ASJ:0.7219	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU17126561	hom
12	406292	406292	G	A	KDM5A	exonic	synonymous SNV	ENSG00000073614	rs2229351	ENSG00000073614:ENST00000382815:exon25:c.C4149T:p.S1383S,ENSG00000073614:ENST00000399788:exon25:c.C4149T:p.S1383S	KDM5A:NM_001042603:exon25:c.C4149T:p.S1383S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3104	0.2732	0.352636	0.3029	.	.	.	.	.	.	.	.	KDM5A:uc001qif.1:exon25:c.C4149T:p.S1383S	.	AFR:0.3108,AMR:0.3413,EAS:0.5175,FIN:0.3369,NFE:0.2666,OTH:0.2918,ASJ:0.2715	180202	.	.	.	.	.	.	.	.	.	.	.	12	MU19386993	het
12	427575	427575	A	G	KDM5A	exonic	nonsynonymous SNV	ENSG00000073614	rs11062385	ENSG00000073614:ENST00000544760:exon10:c.T1451C:p.M484T,ENSG00000073614:ENST00000382815:exon19:c.T2594C:p.M865T,ENSG00000073614:ENST00000399788:exon19:c.T2594C:p.M865T	KDM5A:NM_001042603:exon19:c.T2594C:p.M865T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3102	0.2734	0.353035	0.3030	1.007	10.70	0.496	3.99	1.000	.	.	Lysine-specific demethylase-like domain	KDM5A:uc010sdn.1:exon18:c.T2471C:p.M824T,KDM5A:uc001qif.1:exon19:c.T2594C:p.M865T	-0.915	AFR:0.3112,AMR:0.3413,EAS:0.5167,FIN:0.3379,NFE:0.2661,OTH:0.2930,ASJ:0.2748	180202	.	.	.	.	.	.	.	0.0	1.05	0.000	0.695	12	MU19387110	het
12	432377	432379	AAA	-	KDM5A	intronic	.	ENSG00000073614	rs756310068	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0871	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180202	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	498268	498270	GGG	-	KDM5A	UTR5	.	ENSG00000073614	rs574143336	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1516	.	.	0.1330	.	.	.	.	.	.	.	.	.	.	AFR:0.2482,AMR:0.1049,EAS:0.1191,FIN:0.0843,NFE:0.0495,OTH:0.1008,ASJ:0.1284	180202	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	862989	862989	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs3168640	ENSG00000060237:ENST00000315939:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000447667:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000530271:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000535572:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000537687:exon1:c.T258C:p.C86C	WNK1:NM_001184985:exon1:c.T258C:p.C86C,WNK1:NM_014823:exon1:c.T258C:p.C86C,WNK1:NM_018979:exon1:c.T258C:p.C86C,WNK1:NM_213655:exon1:c.T258C:p.C86C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9924	0.9724	0.975639	0.9784	.	.	.	.	.	.	.	.	WNK1:uc001qin.3:exon1:c.T258C:p.C86C,WNK1:uc001qio.4:exon1:c.T258C:p.C86C,WNK1:uc001qip.4:exon1:c.T258C:p.C86C,WNK1:uc021qss.1:exon1:c.T258C:p.C86C,WNK1:uc021qst.1:exon1:c.T258C:p.C86C,WNK1:uc031qfk.1:exon1:c.T258C:p.C86C	.	AFR:0.9240,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU81915326	hom
12	939302	939302	A	G	WNK1	exonic	synonymous SNV	ENSG00000060237	rs10774466	ENSG00000060237:ENST00000315939:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000530271:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000535572:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000537687:exon4:c.A1287G:p.A429A	WNK1:NM_001184985:exon4:c.A1287G:p.A429A,WNK1:NM_014823:exon4:c.A1287G:p.A429A,WNK1:NM_018979:exon4:c.A1287G:p.A429A,WNK1:NM_213655:exon4:c.A1287G:p.A429A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7451	0.6855	0.69349	0.7201	.	.	.	.	.	.	.	.	WNK1:uc001qio.4:exon4:c.A1287G:p.A429A,WNK1:uc001qip.4:exon4:c.A1287G:p.A429A,WNK1:uc021qss.1:exon4:c.A1287G:p.A429A,WNK1:uc021qst.1:exon4:c.A1287G:p.A429A,WNK1:uc031qfk.1:exon4:c.A1287G:p.A429A	.	AFR:0.5713,AMR:0.7757,EAS:0.8843,FIN:0.8041,NFE:0.7632,OTH:0.7796,ASJ:0.6689	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU147437	het
12	971291	971291	C	T	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs2286007	ENSG00000060237:ENST00000340908:exon5:c.C773T:p.T258I,ENSG00000060237:ENST00000315939:exon8:c.C1994T:p.T665I,ENSG00000060237:ENST00000530271:exon8:c.C1994T:p.T665I,ENSG00000060237:ENST00000535572:exon8:c.C1994T:p.T665I,ENSG00000060237:ENST00000537687:exon8:c.C1994T:p.T665I	WNK1:NM_001184985:exon8:c.C1994T:p.T665I,WNK1:NM_014823:exon8:c.C1994T:p.T665I,WNK1:NM_018979:exon8:c.C1994T:p.T665I,WNK1:NM_213655:exon8:c.C1994T:p.T665I	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0639	0.0554	0.0569089	MU721522	4.825	24.8	0.001	5.91	1.000	.	.	.	WNK1:uc001qir.4:exon2:c.C335T:p.T112I,WNK1:uc001qio.4:exon8:c.C1994T:p.T665I,WNK1:uc001qip.4:exon8:c.C1994T:p.T665I,WNK1:uc021qss.1:exon8:c.C1994T:p.T665I,WNK1:uc021qst.1:exon8:c.C1994T:p.T665I,WNK1:uc031qfk.1:exon8:c.C1994T:p.T665I	-1.100	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,AMR:0.0553,EAS:0.0682,FIN:0.0762,NFE:0.0809,OTH:0.0858,ASJ:0.0144	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.335	2.29	0.002	2.095	12	1(haematopoietic_and_lymphoid_tissue)	0.0675
12	974355	974355	-	C	WNK1	exonic	frameshift insertion	ENSG00000060237	rs11441897	ENSG00000060237:ENST00000530271:exon9:c.2220dupC:p.L740fs	WNK1:NM_213655:exon9:c.2220dupC:p.L740fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5445	.	0.518371	0.5581	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.2220dupC:p.L740fs	.	AFR:0.4628,AMR:0.4189,EAS:0.5392,FIN:0.6465,NFE:0.6012,OTH:0.5969,ASJ:0.5133	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	hom
12	974404	974404	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs7300829	ENSG00000060237:ENST00000530271:exon9:c.T2268C:p.P756P	WNK1:NM_213655:exon9:c.T2268C:p.P756P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6031	.	0.653954	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.T2268C:p.P756P	.	AFR:0.6457,AMR:0.7034,EAS:0.5596,FIN:0.5876,NFE:0.6814,OTH:0.6158,ASJ:0.5871	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	3(haematopoietic_and_lymphoid_tissue)	0.6350
12	987482	987482	G	A	WNK1	exonic	synonymous SNV	ENSG00000060237	rs1012729	ENSG00000060237:ENST00000535698:exon2:c.G138A:p.Q46Q,ENSG00000060237:ENST00000340908:exon7:c.G1107A:p.Q369Q,ENSG00000060237:ENST00000315939:exon10:c.G2328A:p.Q776Q,ENSG00000060237:ENST00000535572:exon10:c.G2325A:p.Q775Q,ENSG00000060237:ENST00000537687:exon11:c.G3567A:p.Q1189Q,ENSG00000060237:ENST00000530271:exon12:c.G3822A:p.Q1274Q	WNK1:NM_014823:exon10:c.G2325A:p.Q775Q,WNK1:NM_018979:exon10:c.G2328A:p.Q776Q,WNK1:NM_001184985:exon11:c.G3567A:p.Q1189Q,WNK1:NM_213655:exon12:c.G3822A:p.Q1274Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7340	0.6795	0.679513	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon3:c.G585A:p.Q195Q,WNK1:uc001qio.4:exon10:c.G2328A:p.Q776Q,WNK1:uc001qip.4:exon10:c.G2325A:p.Q775Q,WNK1:uc021qss.1:exon11:c.G3567A:p.Q1189Q,WNK1:uc031qfk.1:exon11:c.G3567A:p.Q1189Q,WNK1:uc021qst.1:exon12:c.G3822A:p.Q1274Q	.	AFR:0.7141,AMR:0.5771,EAS:0.6433,FIN:0.8181,NFE:0.8038,OTH:0.7559,ASJ:0.7715	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7740
12	987533	987533	-	T	WNK1	intronic	.	ENSG00000060237	rs398116010	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4607	.	0.442093	0.6757	.	.	.	.	.	.	.	.	.	.	AFR:0.5438,AMR:0.6859,EAS:0.8054,FIN:0.6491,NFE:0.7405,OTH:0.7359,ASJ:0.6194	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	het
12	990912	990912	A	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs956868	ENSG00000060237:ENST00000340908:exon10:c.A1945C:p.T649P,ENSG00000060237:ENST00000535572:exon11:c.A2425C:p.T809P,ENSG00000060237:ENST00000315939:exon13:c.A3166C:p.T1056P,ENSG00000060237:ENST00000537687:exon13:c.A3946C:p.T1316P,ENSG00000060237:ENST00000530271:exon15:c.A4660C:p.T1554P	WNK1:NM_014823:exon11:c.A2425C:p.T809P,WNK1:NM_001184985:exon13:c.A3946C:p.T1316P,WNK1:NM_018979:exon13:c.A3166C:p.T1056P,WNK1:NM_213655:exon13:c.A3922C:p.T1308P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8314	0.8526	0.852835	0.8317	-0.728	0.062	1.0	0.635	0.064	.	.	.	WNK1:uc001qir.4:exon4:c.A685C:p.T229P,WNK1:uc001qip.4:exon11:c.A2425C:p.T809P,WNK1:uc001qio.4:exon13:c.A3166C:p.T1056P,WNK1:uc021qss.1:exon13:c.A3946C:p.T1316P,WNK1:uc021qst.1:exon13:c.A3922C:p.T1308P,WNK1:uc031qfk.1:exon14:c.A4405C:p.T1469P	-1.004	AFR:0.8503,AMR:0.8783,EAS:0.8021,FIN:0.7460,NFE:0.8424,OTH:0.8194,ASJ:0.8212	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	2.86	0.000	-1.445	12	MU777778	hom
12	993930	993930	C	T	WNK1	exonic	synonymous SNV	ENSG00000060237	rs7300444	ENSG00000060237:ENST00000340908:exon16:c.C2739T:p.N913N,ENSG00000060237:ENST00000535572:exon17:c.C3219T:p.N1073N,ENSG00000060237:ENST00000315939:exon19:c.C3960T:p.N1320N,ENSG00000060237:ENST00000537687:exon19:c.C4740T:p.N1580N,ENSG00000060237:ENST00000530271:exon21:c.C5454T:p.N1818N	WNK1:NM_014823:exon17:c.C3219T:p.N1073N,WNK1:NM_001184985:exon19:c.C4740T:p.N1580N,WNK1:NM_018979:exon19:c.C3960T:p.N1320N,WNK1:NM_213655:exon19:c.C4716T:p.N1572N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4192	0.3917	0.398962	MU147462	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon10:c.C1479T:p.N493N,WNK1:uc001qip.4:exon17:c.C3219T:p.N1073N,WNK1:uc001qio.4:exon19:c.C3960T:p.N1320N,WNK1:uc021qss.1:exon19:c.C4740T:p.N1580N,WNK1:uc021qst.1:exon19:c.C4716T:p.N1572N,WNK1:uc031qfk.1:exon20:c.C5199T:p.N1733N	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4107,EAS:0.4402,FIN:0.3642,NFE:0.5438,OTH:0.4436,ASJ:0.3114	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.4451
12	994487	994487	G	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs7955371	ENSG00000060237:ENST00000340908:exon16:c.G3296C:p.C1099S,ENSG00000060237:ENST00000535572:exon17:c.G3776C:p.C1259S,ENSG00000060237:ENST00000315939:exon19:c.G4517C:p.C1506S,ENSG00000060237:ENST00000537687:exon19:c.G5297C:p.C1766S,ENSG00000060237:ENST00000530271:exon21:c.G6011C:p.C2004S	WNK1:NM_014823:exon17:c.G3776C:p.C1259S,WNK1:NM_001184985:exon19:c.G5297C:p.C1766S,WNK1:NM_018979:exon19:c.G4517C:p.C1506S,WNK1:NM_213655:exon19:c.G5273C:p.C1758S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9963	0.9861	0.986821	0.9877	-1.695	0.002	1.0	5.3	0.235	.	.	.	WNK1:uc001qir.4:exon10:c.G2036C:p.C679S,WNK1:uc001qip.4:exon17:c.G3776C:p.C1259S,WNK1:uc001qio.4:exon19:c.G4517C:p.C1506S,WNK1:uc021qss.1:exon19:c.G5297C:p.C1766S,WNK1:uc021qst.1:exon19:c.G5273C:p.C1758S,WNK1:uc031qfk.1:exon20:c.G5756C:p.C1919S	-0.954	AFR:0.9570,AMR:0.9964,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	-0.2	0.000	-1.79	12	MU81915388	hom
12	998365	998365	G	T	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs12828016	ENSG00000060237:ENST00000340908:exon18:c.G4203T:p.M1401I,ENSG00000060237:ENST00000535572:exon19:c.G4683T:p.M1561I,ENSG00000060237:ENST00000315939:exon21:c.G5424T:p.M1808I,ENSG00000060237:ENST00000537687:exon21:c.G6204T:p.M2068I,ENSG00000060237:ENST00000530271:exon23:c.G6918T:p.M2306I	WNK1:NM_014823:exon19:c.G4683T:p.M1561I,WNK1:NM_001184985:exon21:c.G6204T:p.M2068I,WNK1:NM_018979:exon21:c.G5424T:p.M1808I,WNK1:NM_213655:exon21:c.G6180T:p.M2060I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3766	0.4314	0.417532	1(large_intestine)	1.329	12.42	0.207	2.16	0.311	.	.	.	WNK1:uc001qir.4:exon12:c.G2943T:p.M981I,WNK1:uc001qip.4:exon19:c.G4683T:p.M1561I,WNK1:uc001qio.4:exon21:c.G5424T:p.M1808I,WNK1:uc021qss.1:exon21:c.G6204T:p.M2068I,WNK1:uc021qst.1:exon21:c.G6180T:p.M2060I,WNK1:uc031qfk.1:exon22:c.G6663T:p.M2221I	-0.925	AFR:MU131371,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.4944,FIN:0.2978,NFE:0.3967,OTH:0.2581,ASJ:0.3909	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	1.71	0.000	-0.69	12	59(lung)	0.2836
12	1017197	1017197	C	T	WNK1	exonic	synonymous SNV	ENSG00000060237	rs4766334	ENSG00000060237:ENST00000340908:exon24:c.C5607T:p.Y1869Y,ENSG00000060237:ENST00000535572:exon25:c.C6084T:p.Y2028Y,ENSG00000060237:ENST00000315939:exon27:c.C6828T:p.Y2276Y,ENSG00000060237:ENST00000537687:exon27:c.C7608T:p.Y2536Y,ENSG00000060237:ENST00000530271:exon29:c.C8322T:p.Y2774Y	WNK1:NM_014823:exon25:c.C6084T:p.Y2028Y,WNK1:NM_001184985:exon27:c.C7608T:p.Y2536Y,WNK1:NM_018979:exon27:c.C6828T:p.Y2276Y,WNK1:NM_213655:exon27:c.C7584T:p.Y2528Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9964	0.9862	0.987021	0.9884	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon18:c.C4347T:p.Y1449Y,WNK1:uc001qip.4:exon25:c.C6084T:p.Y2028Y,WNK1:uc001qio.4:exon27:c.C6828T:p.Y2276Y,WNK1:uc021qss.1:exon27:c.C7608T:p.Y2536Y,WNK1:uc021qst.1:exon27:c.C7584T:p.Y2528Y,WNK1:uc031qfk.1:exon30:c.C8181T:p.Y2727Y	.	AFR:0.9597,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU4552882	hom
12	1035947	1035947	C	A	RAD52	intronic	.	ENSG00000002016	rs6489763	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9969	0.9937	0.992812	0.9935	.	.	.	.	.	.	.	.	.	.	AFR:0.9773,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	600392	.	.	.	.	.	.	.	.	.	.	.	12	MU81915469	hom
12	1040373	1040373	T	C	RAD52	intronic	.	ENSG00000002016	rs7303748	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5490	0.5512	0.544928	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.5323,AMR:0.5221,EAS:0.6126,FIN:0.4588,NFE:0.5437,OTH:0.5467,ASJ:0.4185	600392	.	.	.	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.5575
12	4388084	4388084	C	G	CCND2	exonic	synonymous SNV	ENSG00000118971	rs3217805	ENSG00000118971:ENST00000261254:exon3:c.C570G:p.T190T	CCND2:NM_001759:exon3:c.C570G:p.T190T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3226	0.3263	0.219848	MU113292219	.	.	.	.	.	0.0001	0	.	CCND2:uc001qmo.3:exon3:c.C570G:p.T190T	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.3148,EAS:0.3019,FIN:0.4669,NFE:0.0619,OTH:0.3546,ASJ:0.1994	123833	615938;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04630 JAK-STAT signaling pathway~ko04917 Prolactin signaling pathway~ko05162 Measles~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	14(soft_tissue)	0.3950
12	4553332	4553332	A	G	FGF6	exonic	synonymous SNV	ENSG00000111241	rs2241280	ENSG00000111241:ENST00000543077:exon1:c.T54C:p.V18V,ENSG00000111241:ENST00000228837:exon2:c.T417C:p.V139V	FGF6:NM_020996:exon2:c.T417C:p.V139V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4245	0.4533	0.472244	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon2:c.T417C:p.V139V	.	AFR:0.4362,AMR:0.5645,EAS:0.2967,FIN:0.4356,NFE:0.4028,OTH:0.3793,ASJ:0.3489	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.4012
12	4553383	4553383	A	G	FGF6	exonic	synonymous SNV	ENSG00000111241	rs2241279	ENSG00000111241:ENST00000543077:exon1:c.T3C:p.T1T,ENSG00000111241:ENST00000228837:exon2:c.T366C:p.T122T	FGF6:NM_020996:exon2:c.T366C:p.T122T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4265	0.4612	0.479633	1(lung)	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon2:c.T366C:p.T122T	.	AFR:MU153822,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.5890,FIN:0.3505,NFE:0.3013,OTH:0.4338,ASJ:0.4430	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	1(large_intestine)	0.4028
12	4554548	4554548	G	C	FGF6	exonic	synonymous SNV	ENSG00000111241	rs7358740	ENSG00000111241:ENST00000228837:exon1:c.C189G:p.A63A	FGF6:NM_020996:exon1:c.C189G:p.A63A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9721	0.9056	0.903155	0.9177	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon1:c.C189G:p.A63A	.	AFR:0.7134,AMR:0.9821,EAS:1,FIN:1,NFE:0.9993,OTH:0.9764,ASJ:0.9967	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	MU4555769	hom
12	6711147	6711147	C	A	CHD4	exonic	nonsynonymous SNV	ENSG00000111642	rs1639122	ENSG00000111642:ENST00000309577:exon4:c.G417T:p.E139D,ENSG00000111642:ENST00000357008:exon4:c.G417T:p.E139D,ENSG00000111642:ENST00000544040:exon4:c.G396T:p.E132D,ENSG00000111642:ENST00000544484:exon4:c.G408T:p.E136D,ENSG00000111642:ENST00000545942:exon4:c.G417T:p.E139D	CHD4:NM_001297553:exon3:c.G396T:p.E132D,CHD4:NM_001273:exon4:c.G417T:p.E139D,CHD4:NM_001363606:exon4:c.G417T:p.E139D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4118	0.5487	0.553115	4(haematopoietic_and_lymphoid_tissue)	-2.517	0.001	1.0	-8.15	0.143	.	.	.	CHD4:uc001qpn.3:exon3:c.G396T:p.E132D,CHD4:uc001qpo.3:exon4:c.G417T:p.E139D,CHD4:uc001qpp.3:exon4:c.G408T:p.E136D	-0.910	AFR:1(skin),AMR:3(large_intestine),EAS:MU79283,FIN:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,GACA-JP|1|585|0.0017094,NFE:0.5568,OTH:0.8376,ASJ:1(pancreas)	603277	.	.	.	~ko05165 Human papillomavirus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	-2.64	0.000	-0.37	12	2(prostate)	0.4015
12	7065576	7065576	G	A	PTPN6	intronic	.	ENSG00000111679	rs2110071	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9141	0.7978	0.816094	0.8137	.	.	.	.	.	0	0.042	.	.	.	AFR:0.4921,AMR:0.9296,EAS:0.9994,FIN:0.9304,NFE:0.9366,OTH:0.9184,ASJ:0.9735	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917016	hom
12	7065635	7065635	T	C	PTPN6	exonic	synonymous SNV	ENSG00000111679	rs2110072	ENSG00000111679:ENST00000447931:exon8:c.T861C:p.G287G,ENSG00000111679:ENST00000318974:exon9:c.T978C:p.G326G,ENSG00000111679:ENST00000399448:exon9:c.T984C:p.G328G,ENSG00000111679:ENST00000456013:exon9:c.T978C:p.G326G	PTPN6:NM_002831:exon9:c.T978C:p.G326G,PTPN6:NM_080548:exon9:c.T984C:p.G328G,PTPN6:NM_080549:exon9:c.T978C:p.G326G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9499	0.9216	0.948682	0.9221	.	.	.	.	.	.	.	.	PTPN6:uc010sfr.1:exon8:c.T861C:p.G287G,PTPN6:uc010sfs.1:exon8:c.T942C:p.G314G,PTPN6:uc001qsa.1:exon9:c.T984C:p.G328G,PTPN6:uc001qsb.2:exon9:c.T978C:p.G326G,PTPN6:uc009zfl.1:exon9:c.T978C:p.G326G	.	AFR:0.8686,AMR:0.9606,EAS:1,FIN:0.9306,NFE:0.9383,OTH:0.9409,ASJ:0.9768	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917038	hom
12	12301898	12301898	C	T	LRP6	exonic	nonsynonymous SNV	ENSG00000070018	rs2302685	ENSG00000070018:ENST00000261349:exon14:c.G3184A:p.V1062I,ENSG00000070018:ENST00000543091:exon14:c.G3184A:p.V1062I	LRP6:NM_002336:exon14:c.G3184A:p.V1062I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8474	0.8400	0.885583	0.8348	2.258	17.89	1.0	5.45	1.000	.	.	Six-bladed beta-propeller, TolB-like	LRP6:uc001rah.4:exon14:c.G3184A:p.V1062I,LRP6:uc010shl.1:exon14:c.G3184A:p.V1062I	-0.936	AFR:0.8707,AMR:0.9113,EAS:0.9376,FIN:0.8148,NFE:0.8037,OTH:0.8227,ASJ:0.85	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.0	-2.67	0.000	-2.195	12	MU25428801	hom
12	12334006	12334006	G	C	LRP6	exonic	synonymous SNV	ENSG00000070018	rs10082834	ENSG00000070018:ENST00000261349:exon6:c.C1344G:p.P448P,ENSG00000070018:ENST00000543091:exon6:c.C1344G:p.P448P	LRP6:NM_002336:exon6:c.C1344G:p.P448P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0762	0.0727	0.048722	.	.	.	.	.	.	.	.	.	LRP6:uc001rah.4:exon6:c.C1344G:p.P448P,LRP6:uc010shl.1:exon6:c.C1344G:p.P448P	.	AFR:.,AMR:0.0682,EAS:0.1468,FIN:0.0762,NFE:0,OTH:0.0633,ASJ:0.0344	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	1(large_intestine)	0.0912
12	12336966	12336966	A	G	LRP6	exonic	synonymous SNV	ENSG00000070018	rs7978064	ENSG00000070018:ENST00000261349:exon5:c.T924C:p.C308C,ENSG00000070018:ENST00000543091:exon5:c.T924C:p.C308C	LRP6:NM_002336:exon5:c.T924C:p.C308C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1013	0.1578	0.138179	.	.	.	.	.	.	.	.	.	LRP6:uc001rah.4:exon5:c.T924C:p.C308C,LRP6:uc010shl.1:exon5:c.T924C:p.C308C	.	AFR:0.1422,AMR:0.2884,EAS:0.0762,FIN:0.0019,NFE:0.0633,OTH:0.0938,ASJ:0.1718	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	4(soft_tissue)	0.0881
12	12337061	12337061	C	T	LRP6	intronic	.	ENSG00000070018;ENSG00000121380	rs11829211	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0759	0.0730	0.0479233	0.0684	.	.	.	.	.	.	.	.	.	.	AFR:0.0343,AMR:0.1468,EAS:0,FIN:0.0630,NFE:0.0916,OTH:0.0786,ASJ:0.0762	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	.	het
12	15656832	15656832	T	A	PTPRO	intronic	.	ENSG00000151490	rs4764199	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8496	0.8513	0.786342	0.8396	.	.	.	.	.	0.1606	0.498	.	.	.	AFR:0.7807,AMR:0.8198,EAS:0.6214,FIN:0.8987,NFE:0.8816,OTH:0.8668,ASJ:0.9007	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	MU12093012	hom
12	15679120	15679120	C	A	PTPRO	exonic	synonymous SNV	ENSG00000151490	rs6488782	ENSG00000151490:ENST00000281171:exon12:c.C2088A:p.G696G,ENSG00000151490:ENST00000348962:exon12:c.C2088A:p.G696G	PTPRO:NM_002848:exon12:c.C2088A:p.G696G,PTPRO:NM_030667:exon12:c.C2088A:p.G696G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3996	0.4457	0.403155	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PTPRO:uc001rcv.2:exon12:c.C2088A:p.G696G,PTPRO:uc001rcw.2:exon12:c.C2088A:p.G696G	.	AFR:0.4283,AMR:0.5493,EAS:0.4430,FIN:0.1017,NFE:0.4100,OTH:0.3924,ASJ:0.5275	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.4146
12	15679208	15679208	G	A	PTPRO	intronic	.	ENSG00000151490	rs7134888	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3992	0.4455	0.401158	0.4279	.	.	.	.	.	.	.	.	.	.	AFR:0.5483,AMR:0.5288,EAS:0.0999,FIN:0.4101,NFE:0.3924,OTH:0.4141,ASJ:0.4404	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	MU30027836	het
12	18435399	18435401	CCC	-	PIK3C2G	exonic	nonframeshift deletion	ENSG00000139144	rs35277916	ENSG00000139144:ENST00000266497:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000538779:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000546003:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000433979:exon2:c.384_386del:p.128_129del,ENSG00000139144:ENST00000535651:exon2:c.384_386del:p.128_129del	PIK3C2G:NM_001288772:exon2:c.384_386del:p.128_129del,PIK3C2G:NM_004570:exon2:c.384_386del:p.128_129del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3732	0.3424	0.308307	0.3505	.	.	.	.	.	.	.	.	PIK3C2G:uc010sib.2:exon1:c.384_386del:p.128_129del,PIK3C2G:uc001rdt.3:exon2:c.384_386del:p.128_129del	.	AFR:0.2142,AMR:0.3759,EAS:0.2612,FIN:0.4338,NFE:0.4158,OTH:0.3887,ASJ:0.3758	609001	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	18435452	18435452	C	T	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs11044004	ENSG00000139144:ENST00000266497:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000538779:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000546003:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000433979:exon2:c.C437T:p.P146L,ENSG00000139144:ENST00000535651:exon2:c.C437T:p.P146L	PIK3C2G:NM_001288772:exon2:c.C437T:p.P146L,PIK3C2G:NM_004570:exon2:c.C437T:p.P146L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3865	0.3859	0.353235	2(haematopoietic_and_lymphoid_tissue)	0.582	8.028	0.047	3.9	0.050	.	.	.	PIK3C2G:uc010sib.2:exon1:c.C437T:p.P146L,PIK3C2G:uc001rdt.3:exon2:c.C437T:p.P146L	-1.054	AFR:18(lung),AMR:MU718438,EAS:0.3920,FIN:0.3533,NFE:0.3858,OTH:0.3841,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	609001	.	.	.	.	.	.	.	0.003	1.22	0.000	1.5	12	1(large_intestine)	0.2627
12	18499777	18499777	C	G	PIK3C2G	intronic	.	ENSG00000139144	rs10770357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0002	0.032	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	609001	.	.	.	.	.	.	.	.	.	.	.	12	MU81920074	hom
12	18649057	18649057	C	T	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs12312266	ENSG00000139144:ENST00000266497:exon19:c.C2732T:p.P911L,ENSG00000139144:ENST00000433979:exon20:c.C2732T:p.P911L,ENSG00000139144:ENST00000538779:exon20:c.C2855T:p.P952L	PIK3C2G:NM_004570:exon20:c.C2732T:p.P911L,PIK3C2G:NM_001288772:exon21:c.C2855T:p.P952L,PIK3C2G:NM_001288774:exon21:c.C2189T:p.P730L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0] 	0.3560	0.2933	0.374401	1(haematopoietic_and_lymphoid_tissue)	7.430	34	0.017	4.37	1.000	.	.	Protein kinase-like domain	PIK3C2G:uc001rdt.3:exon20:c.C2732T:p.P911L,PIK3C2G:uc010sib.2:exon20:c.C2855T:p.P952L,PIK3C2G:uc010sic.2:exon20:c.C2189T:p.P730L	-1.157	AFR:6(meninges),AMR:9(lung),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523,FIN:0.2980,NFE:0.4763,OTH:0.3210,ASJ:MU130618	609001	.	.	.	.	.	.	.	1.0	-1.55	0.000	3.08	12	1(large_intestine)	0.2384
12	21011480	21011480	T	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs4149117	ENSG00000257046:ENST00000381541:exon3:c.T334G:p.S112A,ENSG00000257046:ENST00000540229:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000553473:exon3:c.T334G:p.S112A,ENSG00000205754:ENST00000554957:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000261196:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000540853:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000381545:exon5:c.T334G:p.S112A	SLCO1B3:NM_001349920:exon3:c.T250G:p.S84A,SLCO1B3-SLCO1B7:NM_001371097:exon3:c.T334G:p.S112A,SLCO1B3:NM_019844:exon5:c.T334G:p.S112A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8045	0.7229	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.800	9.463	1.0	3.99	0.885	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon3:c.T334G:p.S112A,SLCO1B7:uc010sim.2:exon3:c.T334G:p.S112A,SLCO1B3:uc031qgp.1:exon4:c.T334G:p.S112A,SLCO1B3:uc001rel.4:exon5:c.T334G:p.S112A	-0.938	AFR:0.7021,AMR:0.4330,EAS:0.8841,FIN:0.7351,NFE:0.7477,OTH:0.8294,ASJ:0.8007	.	.	.	.	.	.	.	.	0.0	0.68	0.000	-1.73	12	1(haematopoietic_and_lymphoid_tissue)	0.7924
12	21013948	21013948	C	T	SLCO1B3;SLCO1B3-SLCO1B7	intronic	.	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs3764009	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8066	0.7222	0.702276	0.7025	.	.	.	.	.	0.0003	0.02	.	.	.	AFR:0.4334,AMR:0.7998,EAS:0.7364,FIN:0.7469,NFE:0.8296,OTH:0.7929,ASJ:0.8841	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12102388	hom
12	21015760	21015760	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000257046	rs7311358	ENSG00000111700:ENST00000544370:exon2:c.G171A:p.M57I,ENSG00000257046:ENST00000540229:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000553473:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000261196:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000540853:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000381545:exon8:c.G699A:p.M233I	SLCO1B3:NM_001349920:exon6:c.G615A:p.M205I,SLCO1B3-SLCO1B7:NM_001371097:exon6:c.G699A:p.M233I,SLCO1B3:NM_019844:exon8:c.G699A:p.M233I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8044	0.7228	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.775	9.308	0.447	-2.0	0.910	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon6:c.G699A:p.M233I,SLCO1B3:uc031qgp.1:exon7:c.G699A:p.M233I,SLCO1B3:uc001rel.4:exon8:c.G699A:p.M233I	-1.046	AFR:0.7024,AMR:0.4328,EAS:0.8833,FIN:0.7379,NFE:0.7470,OTH:0.8296,ASJ:0.8002	.	.	.	.	.	.	.	.	0.092	1.31	0.000	0.33	12	1(haematopoietic_and_lymphoid_tissue)	0.7933
12	21036411	21036411	A	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs2053098	ENSG00000111700:ENST00000544370:exon7:c.A1029G:p.A343A,ENSG00000257046:ENST00000540229:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000553473:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000261196:exon12:c.A1557G:p.A519A,ENSG00000111700:ENST00000381545:exon13:c.A1557G:p.A519A	SLCO1B3:NM_001349920:exon11:c.A1473G:p.A491A,SLCO1B3-SLCO1B7:NM_001371097:exon11:c.A1557G:p.A519A,SLCO1B3:NM_019844:exon13:c.A1557G:p.A519A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8047	0.7231	0.702875	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon11:c.A1557G:p.A519A,SLCO1B3:uc001rel.4:exon13:c.A1557G:p.A519A	.	AFR:0.7023,AMR:0.4326,EAS:0.8841,FIN:0.7348,NFE:0.7468,OTH:0.8298,ASJ:0.8002	.	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.7904
12	21054369	21054369	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs3764006	ENSG00000111700:ENST00000544370:exon9:c.G1305A:p.G435G,ENSG00000257046:ENST00000540229:exon13:c.G1833A:p.G611G,ENSG00000111700:ENST00000553473:exon13:c.G1833A:p.G611G,ENSG00000111700:ENST00000261196:exon14:c.G1833A:p.G611G,ENSG00000111700:ENST00000381545:exon15:c.G1833A:p.G611G	SLCO1B3:NM_001349920:exon13:c.G1749A:p.G583G,SLCO1B3-SLCO1B7:NM_001371097:exon13:c.G1833A:p.G611G,SLCO1B3:NM_019844:exon15:c.G1833A:p.G611G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8182	0.7124	0.678714	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon13:c.G1833A:p.G611G,SLCO1B3:uc001rel.4:exon15:c.G1833A:p.G611G	.	AFR:0.7044,AMR:0.3483,EAS:0.9172,FIN:0.7531,NFE:0.7802,OTH:0.8721,ASJ:0.7769	.	.	.	.	.	.	.	.	.	.	.	.	12	1(stomach)	0.8173
12	21327652	21327652	-	A	SLCO1B1	intronic	.	ENSG00000134538;ENSG00000257062	rs34728625	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	0.4002	0.3504	0.370607	0.4005	.	.	.	.	.	.	.	.	.	.	AFR:0.2754,AMR:0.4601,EAS:0.4438,FIN:0.4279,NFE:0.4551,OTH:0.5057,ASJ:0.5296	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	.	hom
12	21329738	21329738	A	G	SLCO1B1	exonic	nonsynonymous SNV	ENSG00000134538	rs2306283	ENSG00000134538:ENST00000256958:exon5:c.A388G:p.N130D	SLCO1B1:NM_006446:exon5:c.A388G:p.N130D	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 1] 	0.4795	0.5263	0.622404	0.5307	-1.733	0.002	0.45	-2.63	0.000	.	.	Major facilitator superfamily domain	SLCO1B1:uc001req.4:exon5:c.A388G:p.N130D	-0.983	AFR:0.7688,AMR:0.4412,EAS:0.7571,FIN:0.4593,NFE:0.3971,OTH:0.4414,ASJ:0.4262	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	9700,	.	.	0.0	1.12	0.000	0.6	12	MU4554337	hom
12	21623122	21623122	T	G	PYROXD1;RECQL	UTR3	.	ENSG00000004700;ENSG00000121350	rs13035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4280	0.3396	0.369409	0.3718	.	.	.	.	.	.	.	.	.	.	AFR:0.1470,AMR:0.4029,EAS:0.4245,FIN:0.5281,NFE:0.4527,OTH:0.4534,ASJ:0.5	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12104130	het
12	21623284	21623284	-	AAA	PYROXD1	UTR3	.	ENSG00000121350	rs71053317	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0771	.	0.000599042	0.3913	.	.	.	.	.	.	.	.	.	.	AFR:0.1729,AMR:0.4113,EAS:0.4743,FIN:0.2636,NFE:0.5007,OTH:0.4706,ASJ:0.5230	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21623886	21623889	AATT	-	PYROXD1	UTR3	.	ENSG00000004700	rs200957510	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1110	0.0359	0.0239617	0.0260	.	.	.	.	.	.	.	.	.	.	AFR:0.0072,AMR:0.0228,EAS:0.0006,FIN:0.0106,NFE:0.0425,OTH:0.0347,ASJ:0.0464	600537	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21639529	21639529	A	-	RECQL	intronic	.	ENSG00000004700	rs10712738	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4521	.	0.378395	0.4745	.	.	.	.	.	.	.	.	.	.	AFR:0.3694,AMR:0.4942,EAS:0.6075,FIN:0.5817,NFE:0.4950,OTH:0.5243,ASJ:0.4133	600537	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	21644666	21644666	C	G	RECQL	intronic	.	ENSG00000004700	rs71581964	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0416	0.0479	0.0393371	0.0378	.	.	.	.	.	.	.	.	.	.	AFR:0.0520,AMR:0.0251,EAS:0.0006,FIN:0.0140,NFE:0.0399,OTH:0.0346,ASJ:0.0467	600537	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	25368462	25368462	C	T	KRAS	exonic	synonymous SNV	ENSG00000133703	rs4362222	ENSG00000133703:ENST00000256078:exon5:c.G483A:p.R161R	KRAS:NM_001369786:exon5:c.G483A:p.R161R,KRAS:NM_033360:exon5:c.G483A:p.R161R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9995	0.9985	0.997604	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KRAS:uc001rgp.1:exon5:c.G483A:p.R161R	.	AFR:0.9985,AMR:0.9948,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04137 Mitophagy - animal~ko04138 Autophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7061,7006,7034,7054,7023,6837,6843,7031,7025,7059,7043,7038,7009,7048,7064,7046,7063,7055,7051,7000,7024,7058,7021,6839,7015,7033,6998,7062,7042,7029,7018,7041,7016,6845,7047,7039,7003,7032,7008,7001,7045,6840,7053,6844,7049,7005,7052,7044,7022,7010,7014,7040,6835,7037,7028,7060,6842,6999,7056,7035,6838,6836,7036,7057,7019,7013,7017,6997,7004,7002,7030,7027,7050,7007,7012,6841	.	7011,,7026,7020	.	.	.	.	12	4(meninges)	1
12	32949029	32949029	-	G	PKP2	intronic	.	ENSG00000057294	rs149968852	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2108	0.1903	0.318291	0.2044	.	.	.	.	.	.	.	.	.	.	AFR:0.2708,AMR:0.1706,EAS:0.5513,FIN:0.1713,NFE:0.1401,OTH:0.1892,ASJ:0.1733	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	12	.	het
12	32955330	32955330	G	A	PKP2	intronic	.	ENSG00000057294	rs74072938	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0324	0.0723	0.0716853	0.0590	.	.	.	.	.	0	0.006	.	.	.	AFR:0.1851,AMR:0.0251,EAS:0.0025,FIN:0.0063,NFE:0.0099,OTH:0.0163,ASJ:0.0132	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	12	.	het
12	33021934	33021934	A	G	PKP2	exonic	nonsynonymous SNV	ENSG00000057294	rs1046116	ENSG00000057294:ENST00000070846:exon4:c.T1097C:p.L366P,ENSG00000057294:ENST00000340811:exon4:c.T1097C:p.L366P	PKP2:NM_001005242:exon4:c.T1097C:p.L366P,PKP2:NM_004572:exon4:c.T1097C:p.L366P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1800	0.2201	0.151358	0.1976	0.112	3.732	0.413	4.19	0.000	.	.	Armadillo-like helical|Armadillo-type fold	PKP2:uc001rlj.4:exon4:c.T1097C:p.L366P,PKP2:uc001rlk.4:exon4:c.T1097C:p.L366P,PKP2:uc010skj.2:exon4:c.T1097C:p.L366P	-1.029	AFR:0.1977,AMR:0.1599,EAS:0.0308,FIN:0.1875,NFE:0.2192,OTH:0.2088,ASJ:0.2086	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.0	0.83	0.000	-1.79	12	MU67317419	het
12	33049457	33049457	C	A	PKP2	exonic	nonsynonymous SNV	ENSG00000057294	rs75909145	ENSG00000057294:ENST00000070846:exon1:c.G209T:p.S70I,ENSG00000057294:ENST00000340811:exon1:c.G209T:p.S70I	PKP2:NM_001005242:exon1:c.G209T:p.S70I,PKP2:NM_004572:exon1:c.G209T:p.S70I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0242	0.0186	0.0131789	0.0184	3.446	23.0	0.008	3.17	0.949	.	.	.	PKP2:uc001rlj.4:exon1:c.G209T:p.S70I,PKP2:uc001rlk.4:exon1:c.G209T:p.S70I,PKP2:uc010skj.2:exon1:c.G209T:p.S70I	-0.737	AFR:0.0037,AMR:0.0203,EAS:0,FIN:0.0129,NFE:0.0297,OTH:0.0204,ASJ:0.0364	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.279	-1.47	0.187	1.845	12	.	het
12	40619082	40619082	G	A	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs2256408	ENSG00000188906:ENST00000298910:exon1:c.G149A:p.R50H,ENSG00000188906:ENST00000343742:exon1:c.G149A:p.R50H	LRRK2:NM_198578:exon1:c.G149A:p.R50H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9911	0.9655	0.969249	0.9708	1.601	13.86	1.0	-1.31	0.559	0	0	Armadillo-like helical|Armadillo-type fold;Armadillo-type fold	LRRK2:uc001rmg.4:exon1:c.G149A:p.R50H	-0.974	AFR:0.8981,AMR:0.9916,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	0.7	0.000	-0.255	12	MU81922046	hom
12	40631791	40631791	T	C	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878245	ENSG00000188906:ENST00000298910:exon5:c.T457C:p.L153L,ENSG00000188906:ENST00000343742:exon5:c.T457C:p.L153L,ENSG00000188906:ENST00000416796:exon5:c.T244C:p.L82L	LRRK2:NM_198578:exon5:c.T457C:p.L153L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5263	0.5291	0.452875	LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	LRRK2:uc001rmg.4:exon5:c.T457C:p.L153L	.	AFR:0.5142,AMR:0.3922,EAS:0.5166,FIN:0.3601,NFE:0.5112,OTH:0.6100,ASJ:0.3612	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	1(prostate)	0.5297
12	40645257	40645257	C	A	LRRK2	intronic	.	ENSG00000188906	rs7955902	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3622	0.3182	0.319489	0.3368	.	.	.	.	.	0.0076	0.038	.	.	.	AFR:0.2174,AMR:0.2375,EAS:0.3544,FIN:0.3829,NFE:0.3978,OTH:0.3577,ASJ:0.3467	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU14313152	het
12	40681142	40681142	-	T	LRRK2	intronic	.	ENSG00000188906	rs397692808	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4361	0.4043	0.386382	0.4133	.	.	.	.	.	.	.	.	.	.	AFR:0.3012,AMR:0.2763,EAS:0.355,FIN:0.4558,NFE:0.4821,OTH:0.4381,ASJ:0.3642	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	.	het
12	40713834	40713834	C	A	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs1427263	ENSG00000188906:ENST00000298910:exon34:c.C4872A:p.G1624G	LRRK2:NM_198578:exon34:c.C4872A:p.G1624G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6781	0.6859	0.682907	0.7114	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon9:c.C1371A:p.G457G,LRRK2:uc009zjw.3:exon13:c.C1386A:p.G462G,LRRK2:uc001rmg.4:exon34:c.C4872A:p.G1624G	.	AFR:0.7787,AMR:0.7344,EAS:0.5075,FIN:0.7790,NFE:0.6787,OTH:0.7243,ASJ:0.5894	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU108484	het
12	40713873	40713873	A	G	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs11176013	ENSG00000188906:ENST00000298910:exon34:c.A4911G:p.K1637K	LRRK2:NM_198578:exon34:c.A4911G:p.K1637K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5734	0.5517	0.585663	0.5647	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon9:c.A1410G:p.K470K,LRRK2:uc009zjw.3:exon13:c.A1425G:p.K475K,LRRK2:uc001rmg.4:exon34:c.A4911G:p.K1637K	.	AFR:0.5966,AMR:0.6514,EAS:0.4805,FIN:0.5359,NFE:0.5579,OTH:0.5584,ASJ:0.5367	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU108500	het
12	40713901	40713901	T	A	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs11564148	ENSG00000188906:ENST00000298910:exon34:c.T4939A:p.S1647T	LRRK2:NM_198578:exon34:c.T4939A:p.S1647T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2983	0.2577	0.285942	0.2888	0.057	3.160	0.953	0.447	0.986	.	.	C-terminal of Roc (COR) domain	LRRK2:uc001rmi.3:exon9:c.T1438A:p.S480T,LRRK2:uc009zjw.3:exon13:c.T1453A:p.S485T,LRRK2:uc001rmg.4:exon34:c.T4939A:p.S1647T	-1.033	AFR:0.1896,AMR:0.2129,EAS:0.3543,FIN:0.3685,NFE:0.3254,OTH:0.3070,ASJ:0.2285	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	-0.61	0.000	0.39	12	MU4129146	het
12	40716260	40716260	T	C	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878371	ENSG00000188906:ENST00000298910:exon37:c.T5457C:p.G1819G	LRRK2:NM_198578:exon37:c.T5457C:p.G1819G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5733	0.5534	0.585264	0.5631	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon12:c.T1956C:p.G652G,LRRK2:uc009zjw.3:exon16:c.T1971C:p.G657G,LRRK2:uc001rmg.4:exon37:c.T5457C:p.G1819G	.	AFR:0.5938,AMR:0.6506,EAS:0.4783,FIN:0.5362,NFE:0.5567,OTH:0.5603,ASJ:0.5331	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU12139841	het
12	40742254	40742254	G	A	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878405	ENSG00000188906:ENST00000298910:exon43:c.G6324A:p.E2108E	LRRK2:NM_198578:exon43:c.G6324A:p.E2108E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3001	0.2561	0.273762	0.2919	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon18:c.G2823A:p.E941E,LRRK2:uc009zjw.3:exon22:c.G2838A:p.E946E,LRRK2:uc001rmg.4:exon43:c.G6324A:p.E2108E	.	AFR:0.1564,AMR:0.2253,EAS:0.3550,FIN:0.3786,NFE:0.3455,OTH:0.3395,ASJ:0.2384	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU4129165	het
12	40753044	40753044	-	T	LRRK2	intronic	.	ENSG00000188906	rs111612315	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6216	0.6696	0.592252	0.7410	.	.	.	.	.	.	.	.	.	.	AFR:0.5599,AMR:0.6227,EAS:0.6724,FIN:0.7778,NFE:0.8499,OTH:0.8063,ASJ:0.8111	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU41962212	het
12	40757187	40757187	T	-	LRRK2	intronic	.	ENSG00000188906	rs11317573	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6319	.	0.551318	0.6344	.	.	.	.	.	.	.	.	.	.	AFR:0.5420,AMR:0.5242,EAS:0.4879,FIN:0.7517,NFE:0.6796,OTH:0.6883,ASJ:0.5993	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	.	het
12	40758652	40758652	T	C	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs3761863	ENSG00000188906:ENST00000298910:exon49:c.T7190C:p.M2397T	LRRK2:NM_198578:exon49:c.T7190C:p.M2397T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6240	0.6123	0.551717	0.6344	-1.254	0.005	0.466	3.03	0.137	.	.	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	LRRK2:uc001rmi.3:exon24:c.T3689C:p.M1230T,LRRK2:uc009zjw.3:exon28:c.T3704C:p.M1235T,LRRK2:uc001rmg.4:exon49:c.T7190C:p.M2397T	-0.923	AFR:0.5410,AMR:0.5193,EAS:0.4828,FIN:0.7524,NFE:0.6807,OTH:0.6914,ASJ:0.5993	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	-0.53	0.000	1.735	12	MU108529	het
12	42854205	42854205	A	G	PRICKLE1	exonic	synonymous SNV	ENSG00000139174	rs3747562	ENSG00000139174:ENST00000345127:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000445766:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000455697:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000548696:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000552240:exon8:c.T1902C:p.S634S	PRICKLE1:NM_001144881:exon8:c.T1902C:p.S634S,PRICKLE1:NM_001144882:exon8:c.T1902C:p.S634S,PRICKLE1:NM_001144883:exon8:c.T1902C:p.S634S,PRICKLE1:NM_153026:exon8:c.T1902C:p.S634S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4385	0.4353	0.429313	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRICKLE1:uc001rnl.3:exon8:c.T1902C:p.S634S,PRICKLE1:uc001rnm.3:exon8:c.T1902C:p.S634S,PRICKLE1:uc010skv.2:exon8:c.T1902C:p.S634S,PRICKLE1:uc010skw.2:exon8:c.T1902C:p.S634S	.	AFR:0.4552,AMR:0.4609,EAS:0.4073,FIN:0.4338,NFE:0.4291,OTH:0.4633,ASJ:0.4689	608500	612437;	308;	308|PME type 1<br>Progressive myoclonic epilepsy type 1<br>Progressive myoclonus epilepsy type 1<br>ULD|1-9 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|254800 310370 612437 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.4110
12	42854208	42854208	A	G	PRICKLE1	exonic	synonymous SNV	ENSG00000139174	rs3747563	ENSG00000139174:ENST00000345127:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000445766:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000455697:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000548696:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000552240:exon8:c.T1899C:p.F633F	PRICKLE1:NM_001144881:exon8:c.T1899C:p.F633F,PRICKLE1:NM_001144882:exon8:c.T1899C:p.F633F,PRICKLE1:NM_001144883:exon8:c.T1899C:p.F633F,PRICKLE1:NM_153026:exon8:c.T1899C:p.F633F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3459	0.2999	0.270567	5(lung)	.	.	.	.	.	.	.	.	PRICKLE1:uc001rnl.3:exon8:c.T1899C:p.F633F,PRICKLE1:uc001rnm.3:exon8:c.T1899C:p.F633F,PRICKLE1:uc010skv.2:exon8:c.T1899C:p.F633F,PRICKLE1:uc010skw.2:exon8:c.T1899C:p.F633F	.	AFR:MU12145019,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|6|170|0.0352941,COCA-CN|3|321|0.00934579,EAS:0.2048,FIN:0.3720,NFE:0.3113,OTH:0.2640,ASJ:0.3308	608500	612437;	308;	308|PME type 1<br>Progressive myoclonic epilepsy type 1<br>Progressive myoclonus epilepsy type 1<br>ULD|1-9 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|254800 310370 612437 ~	.	.	.	.	.	.	.	.	12	1(breast)	0.3948
12	48368464	48368464	G	A	COL2A1	exonic	synonymous SNV	ENSG00000139219	rs17122498	ENSG00000139219:ENST00000337299:exon51:c.C3861T:p.G1287G,ENSG00000139219:ENST00000380518:exon52:c.C4068T:p.G1356G	COL2A1:NM_033150:exon51:c.C3861T:p.G1287G,COL2A1:NM_001844:exon52:c.C4068T:p.G1356G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0237	0.0480	0.066893	0.0396	.	.	.	.	.	.	.	.	COL2A1:uc001rqt.3:exon2:c.C411T:p.G137G,COL2A1:uc001rqv.3:exon51:c.C3861T:p.G1287G,COL2A1:uc001rqu.3:exon52:c.C4068T:p.G1356G	.	AFR:0.1352,AMR:0.0203,EAS:0.0055,FIN:0,NFE:0.0007,OTH:0.0122,ASJ:0	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	.	het
12	48389023	48389023	C	T	COL2A1	intronic	.	ENSG00000139219	rs10875716	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2935	0.2676	0.160743	0.2519	.	.	.	.	.	.	.	.	.	.	AFR:0.0677,AMR:0.2596,EAS:0.0074,FIN:0.3253,NFE:0.3610,OTH:0.3286,ASJ:0.3609	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU113684275	het
12	48389643	48389643	A	C	COL2A1	intronic	.	ENSG00000139219	rs1034762	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7489	0.8209	0.682708	0.7858	.	.	.	.	.	.	.	.	.	.	AFR:0.7785,AMR:0.6062,EAS:0.5261,FIN:0.7533,NFE:0.8354,OTH:0.7782,ASJ:0.8146	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU12153333	het
12	48398002	48398002	G	C	COL2A1	intronic	.	ENSG00000139219	rs3803184	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7712	0.7842	0.685903	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,LINC-JP|3|394|0.00761421	.	.	.	.	.	.	.	.	.	.	AFR:0.7536,AMR:0.6662,EAS:0.7947,FIN:0.6135,NFE:0.7450,OTH:0.8263,ASJ:0.6199	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.7848
12	48398080	48398080	T	A	COL2A1	exonic	nonsynonymous SNV	ENSG00000139219	rs3803183	ENSG00000139219:ENST00000337299:exon1:c.A25T:p.T9S,ENSG00000139219:ENST00000380518:exon1:c.A25T:p.T9S	COL2A1:NM_001844:exon1:c.A25T:p.T9S,COL2A1:NM_033150:exon1:c.A25T:p.T9S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7726	0.7891	0.685304	COCA-CN|5|321|0.0155763	2.078	16.71	0.645	2.88	0.995	.	.	.	COL2A1:uc001rqu.3:exon1:c.A25T:p.T9S,COL2A1:uc001rqv.3:exon1:c.A25T:p.T9S	-0.948	AFR:0.7543,AMR:0.6675,EAS:0.7947,FIN:0.6134,NFE:0.7461,OTH:0.8267,ASJ:0.6193	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	0.0	-2.49	0.000	-0.345	12	1(thyroid)	0.7869
12	48399403	48399403	T	C	COL2A1;SENP1	intergenic	.	ENSG00000258203	rs1859444	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.702077	0.7673	.	.	.	.	.	.	.	.	.	.	AFR:0.7114,AMR:0.6196,EAS:0.6157,FIN:0.7464,NFE:0.8272,OTH:0.7883,ASJ:0.8	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	49416047	49416047	C	-	KMT2D	intronic	.	ENSG00000167548	rs34546217	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3221	0.2555	0.274561	0.2772	.	.	.	.	.	.	.	.	.	.	AFR:0.0802,AMR:0.2434,EAS:0.4504,FIN:0.3604,NFE:0.3514,OTH:0.3541,ASJ:0.2483	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU114556438	het
12	49425978	49425978	T	C	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs3741622	ENSG00000167548:ENST00000301067:exon39:c.A12510G:p.P4170P	KMT2D:NM_003482:exon39:c.A12510G:p.P4170P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3192	0.2507	0.275359	0.2777	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon39:c.A12510G:p.P4170P	.	AFR:0.0801,AMR:0.2464,EAS:0.4498,FIN:0.3607,NFE:0.3524,OTH:0.3525,ASJ:0.2483	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU582657	het
12	49427652	49427652	C	T	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs3782357	ENSG00000167548:ENST00000301067:exon39:c.G10836A:p.Q3612Q	KMT2D:NM_003482:exon39:c.G10836A:p.Q3612Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4616	0.4217	0.44349	0.4374	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon39:c.G10836A:p.Q3612Q	.	AFR:0.5324,AMR:0.3067,EAS:0.4504,FIN:0.4064,NFE:0.3999,OTH:0.4199,ASJ:0.2682	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118941	het
12	49434074	49434074	C	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs10747559	ENSG00000167548:ENST00000301067:exon31:c.G7479T:p.G2493G	KMT2D:NM_003482:exon31:c.G7479T:p.G2493G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4197	0.4165	0.435503	0.4423	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon31:c.G7479T:p.G2493G	.	AFR:0.4714,AMR:0.3377,EAS:0.4647,FIN:0.4266,NFE:0.4355,OTH:0.4448,ASJ:0.2914	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118954	het
12	49434409	49434409	G	A	KMT2D	exonic	nonsynonymous SNV	ENSG00000167548	rs3741626	ENSG00000167548:ENST00000301067:exon31:c.C7144T:p.P2382S	KMT2D:NM_003482:exon31:c.C7144T:p.P2382S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.0121	0.0037	0.0259585	0.0100	2.778	21.3	0.003	5.21	0.998	.	.	.	KMT2D:uc001rta.4:exon31:c.C7144T:p.P2382S	-0.454	AFR:0.0015,AMR:0,EAS:0.0907,FIN:0.0120,NFE:0.0061,OTH:0.0163,ASJ:0.0033	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	0.835	-2.21	0.080	0.55	12	MU674495	het
12	49444545	49444545	G	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs2241726	ENSG00000167548:ENST00000301067:exon11:c.C2826T:p.I942I	KMT2D:NM_003482:exon11:c.C2826T:p.I942I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3796	0.3854	0.403554	0.4069	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon11:c.C2826T:p.I942I	.	AFR:0.4267,AMR:0.3010,EAS:0.4382,FIN:0.4082,NFE:0.3998,OTH:0.4177,ASJ:0.2682	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118972	het
12	49579696	49579696	C	G	TUBA1A	exonic	synonymous SNV	ENSG00000167552	rs697624	ENSG00000167552:ENST00000546918:exon3:c.G605C:p.R202P	TUBA1A:NM_001270399:exon4:c.G453C:p.S151S,TUBA1A:NM_001270400:exon4:c.G348C:p.S116S,TUBA1A:NM_006009:exon4:c.G453C:p.S151S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4203	0.4351	0.547724	0.4685	0.695	8.793	0.004	0.167	0.997	.	.	.	TUBA1A:uc001rtp.4:exon4:c.G453C:p.S151S,TUBA1A:uc009zlf.4:exon4:c.G453C:p.S151S,TUBA1A:uc031qhc.1:exon4:c.G348C:p.S116S	-0.950	AFR:0.6547,AMR:0.3840,EAS:0.7585,FIN:0.4167,NFE:0.3527,OTH:0.4273,ASJ:0.2867	602529	611603;	171680;	171680|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|-|611603 ~	.	.	.	.	.	0.02	0.000	.	12	MU16146878	het
12	49580180	49580180	T	C	TUBA1A	exonic	synonymous SNV	ENSG00000167552	rs1056875	ENSG00000167552:ENST00000546918:exon2:c.A440G:p.K147R	TUBA1A:NM_001270399:exon3:c.A288G:p.K96K,TUBA1A:NM_001270400:exon3:c.A183G:p.K61K,TUBA1A:NM_006009:exon3:c.A288G:p.K96K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4258	0.4420	0.55631	0.4736	-1.209	0.006	0.0	3.41	0.999	.	.	Tubulin/FtsZ, GTPase domain	TUBA1A:uc001rtp.4:exon3:c.A288G:p.K96K,TUBA1A:uc009zlf.4:exon3:c.A288G:p.K96K,TUBA1A:uc031qhc.1:exon3:c.A183G:p.K61K	-0.921	AFR:0.6684,AMR:0.3855,EAS:0.7587,FIN:0.4208,NFE:0.3531,OTH:0.4268,ASJ:0.29	602529	611603;	171680;	171680|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|-|611603 ~	.	.	.	.	.	0.02	0.000	.	12	MU17233097	het
12	56079084	56079084	C	G	ITGA7	intronic	.	ENSG00000135424	rs3852533	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5841	0.4394	0.594649	0.5018	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.2954,AMR:0.6400,EAS:0.9442,FIN:0.6297,NFE:0.5333,OTH:0.5684,ASJ:0.4536	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926243	het
12	56088773	56088773	C	T	ITGA7	intronic	.	ENSG00000135424	rs2293410	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5900	0.4380	0.589257	0.5015	.	.	.	.	.	.	.	.	.	.	AFR:0.2915,AMR:0.6379,EAS:0.9442,FIN:0.6311,NFE:0.5346,OTH:0.5647,ASJ:0.4463	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926272	het
12	56089357	56089357	C	T	ITGA7	exonic	nonsynonymous SNV	ENSG00000135424	rs1800974	ENSG00000135424:ENST00000257879:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000347027:exon14:c.G1934A:p.R645H,ENSG00000135424:ENST00000394229:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000394230:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000452168:exon14:c.G1673A:p.R558H,ENSG00000135424:ENST00000553804:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000257880:exon15:c.G2084A:p.R695H,ENSG00000135424:ENST00000555728:exon15:c.G2084A:p.R695H	ITGA7:NM_001367994:exon13:c.G608A:p.R203H,ITGA7:NM_001144996:exon14:c.G1964A:p.R655H,ITGA7:NM_001144997:exon14:c.G1673A:p.R558H,ITGA7:NM_002206:exon14:c.G1952A:p.R651H,ITGA7:NM_001367993:exon15:c.G1625A:p.R542H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5854	0.4513	0.599441	0.5134	2.355	18.52	0.281	-0.706	0.124	.	.	Integrin alpha-2|Integrin domain	ITGA7:uc009znx.3:exon12:c.G1595A:p.R532H,ITGA7:uc001shg.3:exon14:c.G1952A:p.R651H,ITGA7:uc001shh.3:exon14:c.G1964A:p.R655H,ITGA7:uc010sps.2:exon14:c.G1673A:p.R558H	-1.002	AFR:0.3328,AMR:0.6423,EAS:0.9455,FIN:0.6320,NFE:0.5344,OTH:0.5661,ASJ:0.45	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	0.0	0.84	0.000	0.345	12	MU4556768	het
12	56091617	56091617	A	G	ITGA7	intronic	.	ENSG00000135424	rs2293412	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6206	0.5648	0.702676	0.6065	.	.	.	.	.	0.0041	0	.	.	.	AFR:0.6506,AMR:0.6790,EAS:0.9524,FIN:0.6341,NFE:0.5370,OTH:0.5792,ASJ:0.4765	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU4326330	het
12	56092682	56092682	C	T	ITGA7	exonic	synonymous SNV	ENSG00000135424	rs3847675	ENSG00000135424:ENST00000556273:exon3:c.G84A:p.G28G,ENSG00000135424:ENST00000557257:exon4:c.G336A:p.G112G,ENSG00000135424:ENST00000257879:exon6:c.G810A:p.G270G,ENSG00000135424:ENST00000347027:exon6:c.G810A:p.G270G,ENSG00000135424:ENST00000394229:exon6:c.G810A:p.G270G,ENSG00000135424:ENST00000394230:exon6:c.G822A:p.G274G,ENSG00000135424:ENST00000452168:exon6:c.G531A:p.G177G,ENSG00000135424:ENST00000553804:exon6:c.G822A:p.G274G,ENSG00000135424:ENST00000257880:exon7:c.G942A:p.G314G,ENSG00000135424:ENST00000555728:exon7:c.G942A:p.G314G	ITGA7:NM_001144996:exon6:c.G822A:p.G274G,ITGA7:NM_001144997:exon6:c.G531A:p.G177G,ITGA7:NM_002206:exon6:c.G810A:p.G270G,ITGA7:NM_001367993:exon7:c.G483A:p.G161G	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0718	0.0594	0.0349441	0.0580	.	.	.	.	.	.	.	.	ITGA7:uc009znx.3:exon4:c.G471A:p.G157G,ITGA7:uc001shg.3:exon6:c.G810A:p.G270G,ITGA7:uc001shh.3:exon6:c.G822A:p.G274G,ITGA7:uc010sps.2:exon6:c.G531A:p.G177G	.	AFR:0.0137,AMR:0.0609,EAS:0.0012,FIN:0.0622,NFE:0.0861,OTH:0.0837,ASJ:0.1126	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	.	het
12	56096816	56096816	T	C	ITGA7	intronic	.	ENSG00000135424	rs2293413	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5902	0.4637	0.612021	0.5229	.	.	.	.	.	.	.	.	.	.	AFR:0.3660,AMR:0.6456,EAS:0.9431,FIN:0.6318,NFE:0.5344,OTH:0.5676,ASJ:0.48	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926323	het
12	56477694	56477694	A	T	ERBB3	intronic	.	ENSG00000065361	rs2271194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6173	0.4955	0.592252	0.5370	.	.	.	.	.	0	0	.	.	.	AFR:0.3344,AMR:0.7279,EAS:0.7841,FIN:0.5922,NFE:0.6002,OTH:0.6074,ASJ:0.5199	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	MU28644046	hom
12	57499139	57499139	C	T	STAT6	intronic	.	ENSG00000166888	rs373089810	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0017	.	0.00459265	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601512	.	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	12	.	het
12	57911160	57911160	G	A	DDIT3	exonic	synonymous SNV	ENSG00000175197	rs697221	ENSG00000175197:ENST00000552740:exon2:c.C99T:p.F33F,ENSG00000175197:ENST00000346473:exon3:c.C30T:p.F10F,ENSG00000175197:ENST00000547303:exon3:c.C30T:p.F10F,ENSG00000175197:ENST00000547526:exon3:c.C99T:p.F33F,ENSG00000175197:ENST00000551116:exon3:c.C99T:p.F33F	DDIT3:NM_001195056:exon2:c.C99T:p.F33F,DDIT3:NM_001195053:exon3:c.C99T:p.F33F,DDIT3:NM_001195054:exon3:c.C99T:p.F33F,DDIT3:NM_001195055:exon3:c.C99T:p.F33F,DDIT3:NM_001195057:exon3:c.C30T:p.F10F,DDIT3:NM_004083:exon3:c.C30T:p.F10F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1669	0.1698	0.201478	11(soft_tissue)	1.445	13.03	.	-7.58	0.981	.	.	.	DDIT3:uc009zps.3:exon2:c.C99T:p.F33F,DDIT3:uc001soi.3:exon3:c.C30T:p.F10F,DDIT3:uc009zpt.3:exon3:c.C99T:p.F33F,DDIT3:uc021qzj.1:exon3:c.C30T:p.F10F,DDIT3:uc021qzk.1:exon3:c.C99T:p.F33F,DDIT3:uc021qzl.1:exon3:c.C99T:p.F33F	.	AFR:MU12167322,AMR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.2187,FIN:0.1184,NFE:0.1623,OTH:0.3096,ASJ:0.1920	126337	613488;	69078;99967;	69078|-|Unknown|Unknown|All ages|613488 ~99967|MRCLS|Unknown|Not applicable|Adult|613488 ~	~ko04010 MAPK signaling pathway~ko04141 Protein processing in endoplasmic reticulum~ko04210 Apoptosis~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.2355
12	59274493	59274493	G	A	LRIG3	exonic	synonymous SNV	ENSG00000139263	rs566187872	ENSG00000139263:ENST00000320743:exon13:c.C1671T:p.G557G,ENSG00000139263:ENST00000379141:exon13:c.C1491T:p.G497G,ENSG00000139263:ENST00000433272:exon13:c.C1671T:p.G557G	LRIG3:NM_001136051:exon13:c.C1491T:p.G497G,LRIG3:NM_153377:exon13:c.C1671T:p.G557G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0004	.	0.000199681	3.229e-05	.	.	.	.	.	.	.	.	LRIG3:uc001sqr.4:exon13:c.C1671T:p.G557G,LRIG3:uc009zqh.3:exon13:c.C1491T:p.G497G	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.663e-05,OTH:0,ASJ:0	608870	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	59284551	59284551	G	T	LRIG3	exonic	synonymous SNV	ENSG00000139263	rs11172799	ENSG00000139263:ENST00000552267:exon3:c.C132A:p.L44L,ENSG00000139263:ENST00000320743:exon4:c.C411A:p.L137L,ENSG00000139263:ENST00000379141:exon4:c.C231A:p.L77L,ENSG00000139263:ENST00000433272:exon4:c.C411A:p.L137L	LRIG3:NM_001136051:exon4:c.C231A:p.L77L,LRIG3:NM_153377:exon4:c.C411A:p.L137L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0290	0.0778	0.0888578	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	LRIG3:uc001sqr.4:exon4:c.C411A:p.L137L,LRIG3:uc009zqh.3:exon4:c.C231A:p.L77L	.	AFR:0.0722,AMR:0.2467,EAS:0.0033,FIN:0.0359,NFE:0,OTH:0.0007,ASJ:0.0119	608870	.	.	.	.	.	.	.	.	.	.	.	12	1(biliary_tract)	0.0061
12	59307849	59307849	A	-	LRIG3	intronic	.	ENSG00000139263	rs72005968	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2450	0.1568	.	0.1348	.	.	.	.	.	.	.	.	.	.	AFR:0.2746,AMR:0.1710,EAS:0.2115,FIN:0.1295,NFE:0.0339,OTH:0.0623,ASJ:0.0641	608870	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	59313248	59313248	G	A	LRIG3	exonic	synonymous SNV	ENSG00000139263	rs12426969	ENSG00000139263:ENST00000379141:exon1:c.C16T:p.L6L	LRIG3:NM_001136051:exon1:c.C16T:p.L6L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1020	.	0.0806709	1(lung)	.	.	.	.	.	.	.	.	LRIG3:uc009zqh.3:exon1:c.C16T:p.L6L	.	AFR:MU107605,AMR:LIRI-JP|1|258|0.00387597,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.0415,FIN:0.2029,NFE:0.0728,OTH:0.0469,ASJ:0.1204	608870	.	.	.	.	.	.	.	.	.	.	.	12	1(breast)	0.1491
12	59313936	59313936	T	G	LRIG3	exonic	synonymous SNV	ENSG00000139263	rs61754220	ENSG00000139263:ENST00000320743:exon1:c.A81C:p.S27S,ENSG00000139263:ENST00000433272:exon1:c.A81C:p.S27S	LRIG3:NM_153377:exon1:c.A81C:p.S27S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0997	.	0.0800719	0.1202	.	.	.	.	.	.	.	.	LRIG3:uc001sqr.4:exon1:c.A81C:p.S27S	.	AFR:0.0414,AMR:0.1988,EAS:0.0463,FIN:0.1467,NFE:0.1630,OTH:0.1439,ASJ:0.0733	608870	.	.	.	.	.	.	.	.	.	.	.	12	MU1781920	het
12	65461457	65461457	A	G	WIF1	intronic	.	ENSG00000156076	rs12298938	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0330	0.0747	0.0838658	0.0607	.	.	.	.	.	.	.	.	.	.	AFR:0.1949,AMR:0.0215,EAS:0.0006,FIN:0.0023,NFE:0.0093,OTH:0.0102,ASJ:0	605186	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	65514266	65514266	T	C	WIF1	exonic	synonymous SNV	ENSG00000156076	rs7301320	ENSG00000156076:ENST00000546001:exon1:c.A33G:p.A11A,ENSG00000156076:ENST00000286574:exon2:c.A219G:p.A73A	WIF1:NM_007191:exon2:c.A219G:p.A73A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7765	0.7476	0.824081	0.7638	.	.	.	.	.	.	.	.	WIF1:uc001ssk.3:exon2:c.A219G:p.A73A	.	AFR:0.7632,AMR:0.7005,EAS:0.9981,FIN:0.7507,NFE:0.7451,OTH:0.7612,ASJ:0.7881	605186	.	.	.	.	.	.	.	.	.	.	.	12	MU81927819	hom
12	66346121	66346121	A	G	HMGA2	intronic	.	ENSG00000149948	rs1480469	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2840	.	0.31889	0.1919	.	.	.	.	.	.	.	.	.	.	AFR:0.0861,AMR:0.3918,EAS:0.7758,FIN:0.1460,NFE:0.1892,OTH:0.1861,ASJ:0.2583	600698	150699;	.	.	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	MU81927840	het
12	69968737	69968737	C	T	FRS2	UTR3	.	ENSG00000166225	rs61754563	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0096	0.0034	0.00998403	0.0024	.	.	.	.	.	.	.	.	.	.	AFR:0.0009,AMR:0.0036,EAS:0.0006,FIN:0.0014,NFE:0.0033,OTH:0.0031,ASJ:0.0132	607743	.	.	.	~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	12	.	het
12	88454594	88454594	-	A	CEP290	intronic	.	ENSG00000198707	rs11405846	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.8612	0.7616	0.761581	0.7892	.	.	.	.	.	.	.	.	.	.	AFR:0.4244,AMR:0.9159,EAS:0.9685,FIN:0.9578,NFE:0.9262,OTH:0.9165,ASJ:0.8885	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	88483273	88483273	A	-	CEP290	intronic	.	ENSG00000198707	rs10717563	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9161	0.8720	0.873602	0.8910	.	.	.	.	.	.	.	.	.	.	AFR:0.7273,AMR:0.9426,EAS:0.9852,FIN:0.9845,NFE:0.9472,OTH:0.9499,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	88505078	88505078	T	C	CEP290	exonic	synonymous SNV	ENSG00000198707	rs2468255	ENSG00000198707:ENST00000604024:exon14:c.A1527G:p.S509S,ENSG00000198707:ENST00000309041:exon22:c.A2274G:p.S758S,ENSG00000198707:ENST00000552810:exon22:c.A2268G:p.S756S	CEP290:NM_025114:exon22:c.A2268G:p.S756S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8888	0.7713	0.764577	0.7923	.	.	.	.	.	.	.	.	CEP290:uc001tat.3:exon14:c.A1647G:p.S549S,CEP290:uc001tar.3:exon22:c.A2268G:p.S756S	.	AFR:0.4264,AMR:0.9199,EAS:0.9746,FIN:0.9595,NFE:0.9282,OTH:0.9194,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	MU81929253	hom
12	88510165	88510165	C	T	CEP290	intronic	.	ENSG00000198707	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	het
12	88522823	88522823	-	C	CEP290	intronic	.	ENSG00000198707	rs71082425	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9284	0.8705	0.873602	0.8899	.	.	.	.	.	.	.	.	.	.	AFR:0.7247,AMR:0.9415,EAS:0.9856,FIN:0.9846,NFE:0.9472,OTH:0.9489,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	89743223	89743223	G	A	DUSP6	exonic	synonymous SNV	ENSG00000139318	rs704075	ENSG00000139318:ENST00000308385:exon2:c.C516T:p.D172D,ENSG00000139318:ENST00000547291:exon2:c.C579T:p.D193D,ENSG00000139318:ENST00000279488:exon3:c.C954T:p.D318D	DUSP6:NM_022652:exon2:c.C516T:p.D172D,DUSP6:NM_001946:exon3:c.C954T:p.D318D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9965	0.9882	0.985024	0.9884	.	.	.	.	.	.	.	.	DUSP6:uc001taz.3:exon2:c.C516T:p.D172D,DUSP6:uc001tay.3:exon3:c.C954T:p.D318D	.	AFR:0.9594,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	602748	615269;	432;478;	432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	~ko04010 MAPK signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	12	MU81929270	hom
12	89745477	89745477	C	A	DUSP6	exonic	nonsynonymous SNV	ENSG00000139318	rs2279574	ENSG00000139318:ENST00000279488:exon1:c.G340T:p.V114L,ENSG00000139318:ENST00000308385:exon1:c.G340T:p.V114L,ENSG00000139318:ENST00000548755:exon2:c.G340T:p.V114L	DUSP6:NM_001946:exon1:c.G340T:p.V114L,DUSP6:NM_022652:exon1:c.G340T:p.V114L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5378	0.4316	0.466254	COCA-CN|5|321|0.0155763	3.920	23.5	0.014	5.09	0.966	.	.	Rhodanese-like domain	DUSP6:uc001tay.3:exon1:c.G340T:p.V114L,DUSP6:uc001taz.3:exon1:c.G340T:p.V114L	-0.909	AFR:0.4826,AMR:0.2928,EAS:0.5433,FIN:0.6555,NFE:0.6344,OTH:0.5332,ASJ:0.4988	602748	615269;	432;478;	432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	~ko04010 MAPK signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.086	2.06	0.000	1.525	12	1(thyroid)	0.5348
12	102576308	102576308	T	-	PARPBP	intronic	.	ENSG00000185480	rs778046139	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1986	0.1400	.	0.0077	.	.	.	.	.	.	.	.	.	.	AFR:0.0013,AMR:0.0255,EAS:0,FIN:0.0579,NFE:0.0043,OTH:0.0193,ASJ:0.0189	613687	.	.	.	.	.	.	.	.	.	.	.	12	MU9283021	het
12	102875569	102875569	A	G	IGF1;LINC00485	intergenic	.	ENSG00000017427;ENSG00000257254	rs35767	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.696286	0.7437	.	.	.	.	.	.	.	.	.	.	AFR:0.5698,AMR:0.7513,EAS:0.6484,FIN:0.8014,NFE:0.8411,OTH:0.7927,ASJ:0.7886	.	.	.	.	.	.	.	.	.	.	.	.	12	MU19938323	hom
12	104373600	104373600	G	A	TDG	intronic	.	ENSG00000139372	rs3751209	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2883	0.2516	0.337061	0.2805	.	.	.	.	.	0.0002	0.012	.	.	.	AFR:0.3070,AMR:0.2264,EAS:0.5355,FIN:0.2728,NFE:0.2427,OTH:0.2796,ASJ:0.2781	601423	.	.	.	.	.	.	.	.	.	.	.	12	MU582822	hom
12	109551233	109551233	G	C	UNG;ACACB	intergenic	.	ENSG00000256139	rs34259	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.243211	0.2680	.	.	.	.	.	.	.	.	.	.	AFR:0.4281,AMR:0.1435,EAS:0.0841,FIN:0.2111,NFE:0.2219,OTH:0.1980,ASJ:0.1556	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	109577735	109577735	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs2878960	ENSG00000076555:ENST00000377848:exon1:c.C525T:p.S175S,ENSG00000076555:ENST00000377854:exon1:c.C525T:p.S175S,ENSG00000076555:ENST00000338432:exon2:c.C525T:p.S175S	ACACB:NM_001093:exon2:c.C525T:p.S175S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5578	0.5455	0.397764	1(lung)	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon1:c.C525T:p.S175S,ACACB:uc001tob.3:exon2:c.C525T:p.S175S	.	AFR:1(thyroid),AMR:2(large_intestine),EAS:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,FIN:0.5347,NFE:0.2944,OTH:0.4222,ASJ:MU4553372	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(breast)	0.6126
12	109605730	109605730	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs4766516	ENSG00000076555:ENST00000377848:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000377854:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000544726:exon3:c.C210T:p.A70A,ENSG00000076555:ENST00000338432:exon4:c.C816T:p.A272A	ACACB:NM_001093:exon4:c.C816T:p.A272A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2280	0.1571	0.231629	MU668362	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon3:c.C816T:p.A272A,ACACB:uc001tob.3:exon4:c.C816T:p.A272A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.1855,EAS:0.2506,FIN:0.2550,NFE:0.5685,OTH:0.2227,ASJ:0.0723	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1947
12	109617865	109617865	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs11065772	ENSG00000076555:ENST00000377848:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000377854:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000338432:exon11:c.T1791C:p.D597D	ACACB:NM_001093:exon11:c.T1791C:p.D597D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7715	0.7400	0.677316	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon10:c.T1791C:p.D597D,ACACB:uc001tob.3:exon11:c.T1791C:p.D597D	.	AFR:0.7444,AMR:0.5579,EAS:0.9067,FIN:0.7333,NFE:0.8340,OTH:0.8309,ASJ:0.6587	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.7996
12	109623516	109623516	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2300455	ENSG00000076555:ENST00000377848:exon11:c.G1951A:p.A651T,ENSG00000076555:ENST00000377854:exon11:c.G1951A:p.A651T,ENSG00000076555:ENST00000338432:exon12:c.G1951A:p.A651T	ACACB:NM_001093:exon12:c.G1951A:p.A651T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1889	0.1462	0.159545	MU724553	4.805	24.8	0.052	4.44	0.968	.	.	Biotin carboxylase, C-terminal|Biotin carboxylation domain|Rudiment single hybrid motif	ACACB:uc001toc.3:exon11:c.G1951A:p.A651T,ACACB:uc001tob.3:exon12:c.G1951A:p.A651T	-1.256	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,AMR:0.1528,EAS:0.1706,FIN:0.2384,NFE:0.2976,OTH:0.1759,ASJ:0.0404	601557	.	.	.	.	.	.	.	1.0	-1.67	0.000	2.06	12	3(large_intestine)	0.1927
12	109625981	109625984	TCCT	-	ACACB	intronic	.	ENSG00000076555	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601557	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	109629457	109629457	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs7135947	ENSG00000076555:ENST00000377848:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000377854:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000338432:exon14:c.C2184T:p.G728G	ACACB:NM_001093:exon14:c.C2184T:p.G728G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4891	0.4450	0.38139	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon13:c.C2184T:p.G728G,ACACB:uc001tob.3:exon14:c.C2184T:p.G728G	.	AFR:MU4553399,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.2543,FIN:0.5361,NFE:0.5397,OTH:0.2611,ASJ:0.4447	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.5198
12	109637188	109637188	G	C	ACACB	intronic	.	ENSG00000076555	rs7299171	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5686	0.6176	0.571086	0.5994	.	.	.	.	.	.	.	.	.	.	AFR:0.7023,AMR:0.5863,EAS:0.2957,FIN:0.5544,NFE:0.5851,OTH:0.5767,ASJ:0.5927	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU12049097	het
12	109670468	109670468	T	C	ACACB	intronic	.	ENSG00000076555	rs3742027	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8819	0.9263	0.866414	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.022	.	.	.	AFR:0.9149,AMR:0.9797,EAS:0.9040,FIN:0.7463,NFE:0.8896,OTH:0.9024,ASJ:0.9308	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.8857
12	109674992	109674992	G	T	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs200016239	ENSG00000076555:ENST00000543201:exon6:c.G467T:p.R156L,ENSG00000076555:ENST00000377854:exon32:c.G4259T:p.R1420L,ENSG00000076555:ENST00000377848:exon33:c.G4469T:p.R1490L,ENSG00000076555:ENST00000338432:exon34:c.G4469T:p.R1490L	ACACB:NM_001093:exon34:c.G4469T:p.R1490L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 0, 0] 	4.119e-05	.	.	.	7.575	34	0.0	4.75	0.988	.	.	Acetyl-CoA carboxylase, central domain	ACACB:uc010sxm.2:exon7:c.G467T:p.R156L,ACACB:uc001toc.3:exon33:c.G4469T:p.R1490L,ACACB:uc001tob.3:exon34:c.G4469T:p.R1490L	0.828	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601557	.	.	.	.	.	.	.	1.0	-1.9	0.807	3.405	12	.	het
12	109675029	109675029	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs2241220	ENSG00000076555:ENST00000543201:exon6:c.T504C:p.L168L,ENSG00000076555:ENST00000377854:exon32:c.T4296C:p.L1432L,ENSG00000076555:ENST00000377848:exon33:c.T4506C:p.L1502L,ENSG00000076555:ENST00000338432:exon34:c.T4506C:p.L1502L	ACACB:NM_001093:exon34:c.T4506C:p.L1502L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.8030	0.779153	0.8114	.	.	.	.	.	.	.	.	ACACB:uc010sxm.2:exon7:c.T504C:p.L168L,ACACB:uc001toc.3:exon33:c.T4506C:p.L1502L,ACACB:uc001tob.3:exon34:c.T4506C:p.L1502L	.	AFR:0.7388,AMR:0.8914,EAS:0.7469,FIN:0.8231,NFE:0.8507,OTH:0.8340,ASJ:0.8642	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU16253196	het
12	109683468	109683468	C	G	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs545762685	ENSG00000076555:ENST00000543201:exon10:c.C1214G:p.P405R,ENSG00000076555:ENST00000377854:exon36:c.C5006G:p.P1669R,ENSG00000076555:ENST00000377848:exon37:c.C5216G:p.P1739R,ENSG00000076555:ENST00000338432:exon38:c.C5216G:p.P1739R	ACACB:NM_001093:exon38:c.C5216G:p.P1739R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 0, 0] 	0.0014	.	0.00159744	6.458e-05	4.309	24.0	0.001	5.48	0.998	.	.	Acetyl-coenzyme A carboxyltransferase, N-terminal|ClpP/crotonase-like domain	ACACB:uc010sxm.2:exon11:c.C1214G:p.P405R,ACACB:uc001toc.3:exon37:c.C5216G:p.P1739R,ACACB:uc001tob.3:exon38:c.C5216G:p.P1739R	1.070	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	601557	.	.	.	.	.	.	.	0.994	-3.92	0.939	3.095	12	.	het
12	109693982	109693982	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs3742023	ENSG00000076555:ENST00000543201:exon17:c.C2202T:p.H734H,ENSG00000076555:ENST00000377854:exon43:c.C5994T:p.H1998H,ENSG00000076555:ENST00000377848:exon44:c.C6204T:p.H2068H,ENSG00000076555:ENST00000338432:exon45:c.C6204T:p.H2068H	ACACB:NM_001093:exon45:c.C6204T:p.H2068H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3267	0.2893	0.255192	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	ACACB:uc010sxm.2:exon18:c.C2202T:p.H734H,ACACB:uc001toc.3:exon44:c.C6204T:p.H2068H,ACACB:uc001tob.3:exon45:c.C6204T:p.H2068H	.	AFR:0.3050,AMR:0.1502,EAS:0.3775,FIN:0.2780,NFE:0.4404,OTH:0.3594,ASJ:0.3505	601557	.	.	.	.	.	.	.	.	.	.	.	12	5(large_intestine)	0.3501
12	109696838	109696838	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2075260	ENSG00000076555:ENST00000543201:exon19:c.G2419A:p.V807I,ENSG00000076555:ENST00000377854:exon45:c.G6211A:p.V2071I,ENSG00000076555:ENST00000377848:exon46:c.G6421A:p.V2141I,ENSG00000076555:ENST00000338432:exon47:c.G6421A:p.V2141I	ACACB:NM_001093:exon47:c.G6421A:p.V2141I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7891	0.7810	0.738818	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	2.067	16.64	1.0	5.07	0.992	.	.	Acetyl-CoA carboxylase|Acetyl-coenzyme A carboxyltransferase, C-terminal|ClpP/crotonase-like domain	ACACB:uc010sxm.2:exon20:c.G2419A:p.V807I,ACACB:uc001toc.3:exon46:c.G6421A:p.V2141I,ACACB:uc001tob.3:exon47:c.G6421A:p.V2141I	-0.903	AFR:0.7894,AMR:0.7096,EAS:0.8642,FIN:0.7373,NFE:0.8456,OTH:0.8210,ASJ:0.8711	601557	.	.	.	.	.	.	.	0.002	-4.36	0.000	-3.51	12	1(lung)	0.8084
12	109704177	109704177	G	A	ACACB	UTR3	.	ENSG00000076555	rs2075262	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4828	0.5209	0.359824	0.5063	.	.	.	.	.	.	.	.	.	.	AFR:0.4857,AMR:0.4833,EAS:0.3697,FIN:0.5662,NFE:0.5204,OTH:0.4877,ASJ:0.56	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU668314	het
12	111351030	111351030	C	-	MYL2	intronic	.	ENSG00000111245	rs3833910	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2888	0.2806	0.252596	0.2850	.	.	.	.	.	.	.	.	.	.	AFR:0.2264,AMR:0.3401,EAS:0.2466,FIN:0.3338,NFE:0.3084,OTH:0.3258,ASJ:0.1767	160781	608758;	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	112036754	112036756	GCT	-	ATXN2	exonic	nonframeshift deletion	ENSG00000204842	rs10560189	ENSG00000204842:ENST00000377617:exon1:c.563_565del:p.188_189del,ENSG00000204842:ENST00000550104:exon1:c.563_565del:p.188_189del,ENSG00000204842:ENST00000608853:exon1:c.83_85del:p.28_29del	ATXN2:NM_002973:exon1:c.83_85del:p.28_29del	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.5912	0.9081	0.951078	0.8379	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.563_565del:p.188_189del	.	AFR:0.6558,AMR:0.8634,EAS:0.9291,FIN:0.9112,NFE:0.9045,OTH:0.8974,ASJ:0.9148	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	.	unknown
12	112036797	112036797	C	T	ATXN2	exonic	synonymous SNV	ENSG00000204842	rs4098854	ENSG00000204842:ENST00000377617:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000550104:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000608853:exon1:c.G42A:p.Q14Q	ATXN2:NM_002973:exon1:c.G42A:p.Q14Q	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6209	.	0.656749	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.G522A:p.Q174Q	.	AFR:0.7523,AMR:0.7127,EAS:0.8596,FIN:0.6469,NFE:0.7924,OTH:0.7792,ASJ:0.7054	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7306
12	118463653	118463653	-	T	RFC5	intronic	.	ENSG00000111445	rs762856035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0978	.	.	0.0957	.	.	.	.	.	.	.	.	.	.	AFR:0.0300,AMR:0.1538,EAS:0.1095,FIN:0.0733,NFE:0.1316,OTH:0.1261,ASJ:0.1767	600407	.	.	.	.	.	.	.	.	.	.	.	12	MU111829293	het
12	118464688	118464688	A	G	RFC5	intronic	.	ENSG00000111445	rs5745870	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3610	0.3278	0.409545	0.3382	.	.	.	.	.	0.0006	0.008	.	.	.	AFR:0.3623,AMR:0.3717,EAS:0.5155,FIN:0.3209,NFE:0.3070,OTH:0.3452,ASJ:0.3311	600407	.	.	.	.	.	.	.	.	.	.	.	12	MU12062845	het
12	121416622	121416622	C	G	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs1169289	ENSG00000135100:ENST00000257555:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000400024:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000402929:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000538626:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000538646:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000540108:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000541395:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000541924:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000544413:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000544574:exon1:c.C51G:p.L17L	HNF1A:NM_000545:exon1:c.C51G:p.L17L,HNF1A:NM_001306179:exon1:c.C51G:p.L17L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4722	0.4175	0.428514	MU94809	.	.	.	.	.	.	.	.	HNF1A:uc001tze.2:exon1:c.C51G:p.L17L,HNF1A:uc001tzf.3:exon1:c.C51G:p.L17L,HNF1A:uc001tzg.3:exon1:c.C51G:p.L17L,HNF1A:uc010szn.2:exon1:c.C51G:p.L17L,HNF1A:uc021rez.1:exon1:c.C51G:p.L17L,HNF1A:uc021rfa.1:exon1:c.C51G:p.L17L	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,AMR:0.4253,EAS:0.4713,FIN:0.5533,NFE:0.3823,OTH:0.4897,ASJ:0.3333	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	15(liver)	0.4598
12	121416650	121416650	A	C	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1169288	ENSG00000135100:ENST00000257555:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000400024:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000402929:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000538646:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000540108:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000541395:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000541924:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000544413:exon1:c.A79C:p.I27L	HNF1A:NM_000545:exon1:c.A79C:p.I27L,HNF1A:NM_001306179:exon1:c.A79C:p.I27L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3533	0.2625	0.298522	4(prostate)	5.234	25.6	0.082	4.45	0.999	.	.	Hepatocyte nuclear factor 1, N-terminal|Hepatocyte nuclear factor 1, dimerisation domain	HNF1A:uc001tze.2:exon1:c.A79C:p.I27L,HNF1A:uc001tzf.3:exon1:c.A79C:p.I27L,HNF1A:uc001tzg.3:exon1:c.A79C:p.I27L,HNF1A:uc010szn.2:exon1:c.A79C:p.I27L,HNF1A:uc021rfa.1:exon1:c.A79C:p.I27L	-1.199	AFR:10(soft_tissue),AMR:1(urinary_tract),EAS:COCA-CN|4|321|0.0124611,FIN:0.2924,NFE:0.1228,OTH:0.3648,ASJ:MU94794	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.02	-4.99	0.000	2.125	12	1(large_intestine)	0.43
12	121416864	121416864	C	T	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1800574	ENSG00000135100:ENST00000257555:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000400024:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000402929:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000538646:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000540108:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000541395:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000541924:exon1:c.C293T:p.A98V,ENSG00000135100:ENST00000544413:exon1:c.C293T:p.A98V	HNF1A:NM_000545:exon1:c.C293T:p.A98V,HNF1A:NM_001306179:exon1:c.C293T:p.A98V	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0367	0.0186	0.0199681	.	3.834	23.4	0.063	4.52	0.977	.	.	Hepatocyte nuclear factor 1, N-terminal|Lambda repressor-like, DNA-binding domain	HNF1A:uc001tze.2:exon1:c.C293T:p.A98V,HNF1A:uc001tzf.3:exon1:c.C293T:p.A98V,HNF1A:uc001tzg.3:exon1:c.C293T:p.A98V,HNF1A:uc010szn.2:exon1:c.C293T:p.A98V,HNF1A:uc021rfa.1:exon1:c.C293T:p.A98V,HNF1A:uc021rfb.1:exon1:c.C109T:p.P37S	0.400	AFR:0.0217,AMR:0.0047,EAS:0.0298,FIN:0.0006,NFE:0.0461,OTH:0.0272,ASJ:0.0203	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.209	-5.21	0.682	1.935	12	20(prostate)	0.0347
12	121435342	121435342	C	T	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs2259820	ENSG00000135100:ENST00000535955:exon2:c.C91T:p.L31L,ENSG00000135100:ENST00000538626:exon2:c.C121T:p.L41L,ENSG00000135100:ENST00000257555:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000400024:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000541395:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000544413:exon7:c.C1375T:p.L459L	HNF1A:NM_000545:exon7:c.C1375T:p.L459L,HNF1A:NM_001306179:exon7:c.C1375T:p.L459L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3368	0.2464	0.316693	1(large_intestine)	.	.	.	.	.	.	.	.	HNF1A:uc021rey.1:exon2:c.C22T:p.L8L,HNF1A:uc021rez.1:exon2:c.C121T:p.L41L,HNF1A:uc021rex.1:exon3:c.C163T:p.L55L,HNF1A:uc021rfb.1:exon6:c.C991T:p.L331L,HNF1A:uc001tzf.3:exon7:c.C1375T:p.L459L,HNF1A:uc001tzg.3:exon7:c.C1375T:p.L459L,HNF1A:uc010szn.2:exon7:c.C1375T:p.L459L,HNF1A:uc021rfa.1:exon7:c.C1375T:p.L459L	.	AFR:MU4605555,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,EAS:0.1214,FIN:0.3624,NFE:0.4533,OTH:0.4839,ASJ:0.2679	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	1(urinary_tract)	0.3200
12	121435427	121435427	G	A	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs2464196	ENSG00000135100:ENST00000535955:exon2:c.G176A:p.S59N,ENSG00000135100:ENST00000538626:exon2:c.G206A:p.S69N,ENSG00000135100:ENST00000257555:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000400024:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000541395:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000544413:exon7:c.G1460A:p.S487N	HNF1A:NM_000545:exon7:c.G1460A:p.S487N,HNF1A:NM_001306179:exon7:c.G1460A:p.S487N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3465	0.2473	0.317692	1(thymus)	1.856	15.32	0.111	3.53	0.998	.	.	Hepatocyte nuclear factor 1, beta isoform, C-terminal	HNF1A:uc021rey.1:exon2:c.G107A:p.S36N,HNF1A:uc021rez.1:exon2:c.G206A:p.S69N,HNF1A:uc021rex.1:exon3:c.G248A:p.S83N,HNF1A:uc021rfb.1:exon6:c.G1076A:p.S359N,HNF1A:uc001tzf.3:exon7:c.G1460A:p.S487N,HNF1A:uc001tzg.3:exon7:c.G1460A:p.S487N,HNF1A:uc010szn.2:exon7:c.G1460A:p.S487N,HNF1A:uc021rfa.1:exon7:c.G1460A:p.S487N	-1.097	AFR:1(large_intestine),AMR:MU30045786,EAS:0.2682,FIN:0.1233,NFE:0.3628,OTH:0.4536,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	-4.39	0.000	1.1	12	11(soft_tissue)	0.4839
12	121435475	121435475	G	A	HNF1A	intronic	.	ENSG00000135100	rs2464195	ENSG00000135100:ENST00000535955:exon2:c.G224A:p.R75H,ENSG00000135100:ENST00000538626:exon2:c.G254A:p.R85H,ENSG00000135100:ENST00000400024:exon7:c.G1508A:p.R503H	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4347	0.2901	0.359625	0.3080	-0.684	0.078	.	-8.98	0.005	0	0.002	.	HNF1A:uc021rey.1:exon2:c.G155A:p.R52H,HNF1A:uc021rez.1:exon2:c.G254A:p.R85H,HNF1A:uc021rex.1:exon3:c.G296A:p.R99H,HNF1A:uc001tzf.3:exon7:c.G1508A:p.R503H	-1.027	AFR:0.1407,AMR:0.4069,EAS:0.4851,FIN:0.3794,NFE:0.3552,OTH:0.3867,ASJ:0.5	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	.	0.000	.	12	MU30045803	hom
12	121437221	121437221	T	C	HNF1A	intronic	.	ENSG00000135100	rs1169304	ENSG00000135100:ENST00000541395:exon8:c.T1652C:p.L551S	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8145	0.7439	0.776957	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.395	0.398	0.046	-10.8	0.000	.	.	.	HNF1A:uc021rfa.1:exon8:c.T1652C:p.L551S	-0.976	AFR:0.7423,AMR:0.5893,EAS:0.8808,FIN:0.8666,NFE:0.8200,OTH:0.7835,ASJ:0.8986	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	-5.3	0.000	.	12	18(meninges)	0.8170
12	121437382	121437382	A	G	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1169305	ENSG00000135100:ENST00000541395:exon8:c.A1813G:p.S605G,ENSG00000135100:ENST00000257555:exon9:c.A1720G:p.S574G,ENSG00000135100:ENST00000544413:exon9:c.A1741G:p.S581G	HNF1A:NM_000545:exon9:c.A1720G:p.S574G,HNF1A:NM_001306179:exon9:c.A1741G:p.S581G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9958	0.9869	0.985224	0.9870	0.272	5.414	0.779	2.58	0.047	.	.	Hepatocyte nuclear factor 1, alpha isoform C-terminal	HNF1A:uc021rfa.1:exon8:c.A1813G:p.S605G,HNF1A:uc021rfb.1:exon8:c.A1336G:p.S446G,HNF1A:uc001tzg.3:exon9:c.A1720G:p.S574G,HNF1A:uc010szn.2:exon9:c.A1741G:p.S581G	-0.950	AFR:0.9548,AMR:0.9940,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	-2.86	0.000	.	12	MU81933200	hom
12	121840360	121840360	-	A	RNF34	intronic	.	ENSG00000170633	rs201268373	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.262181	0.2284	.	.	.	.	.	.	.	.	.	.	AFR:0.5201,AMR:0.1097,EAS:0.1062,FIN:0.1158,NFE:0.1008,OTH:0.1361,ASJ:0.0821	608299	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	122762763	122762763	-	A	CLIP1	intronic	.	ENSG00000130779	rs3066171	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1726	.	.	0.1761	.	.	.	.	.	.	.	.	.	.	AFR:0.4775,AMR:0.0721,EAS:0.0033,FIN:0.0469,NFE:0.0215,OTH:0.0451,ASJ:0.0614	179838	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	122807369	122807369	A	C	CLIP1	intronic	.	ENSG00000256304	rs868181	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.436901	0.5076	.	.	.	.	.	.	.	.	.	.	AFR:0.1974,AMR:0.5286,EAS:0.3930,FIN:0.7046,NFE:0.6419,OTH:0.6367,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	122807572	122807572	C	T	CLIP1	intronic	.	ENSG00000256304	rs11057522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.436502	0.5075	.	.	.	.	.	.	.	.	.	.	AFR:0.1971,AMR:0.5288,EAS:0.3904,FIN:0.7040,NFE:0.6422,OTH:0.6378,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	MU27354982	hom
12	122812503	122812503	G	C	CLIP1	exonic	nonsynonymous SNV	ENSG00000130779	rs1129167	ENSG00000130779:ENST00000545889:exon12:c.C1965G:p.D655E,ENSG00000130779:ENST00000302528:exon15:c.C3207G:p.D1069E,ENSG00000130779:ENST00000361654:exon15:c.C2874G:p.D958E,ENSG00000130779:ENST00000537178:exon15:c.C3102G:p.D1034E,ENSG00000130779:ENST00000358808:exon16:c.C3207G:p.D1069E,ENSG00000130779:ENST00000540338:exon16:c.C3240G:p.D1080E	CLIP1:NM_198240:exon15:c.C3102G:p.D1034E,CLIP1:NM_002956:exon16:c.C3207G:p.D1069E,CLIP1:NM_001247997:exon17:c.C3240G:p.D1080E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5625	0.4683	0.40655	MU12068476	-0.563	0.154	0.428	0.728	0.376	.	.	.	CLIP1:uc001ucj.1:exon12:c.C1965G:p.D655E,CLIP1:uc001uci.1:exon15:c.C3102G:p.D1034E,CLIP1:uc001uch.1:exon16:c.C3207G:p.D1069E,CLIP1:uc001ucg.2:exon17:c.C3240G:p.D1080E	-0.930	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.4857,EAS:0.5191,FIN:0.6324,NFE:0.3775,OTH:0.7017,ASJ:0.1444	179838	.	.	.	.	.	.	.	0.0	1.26	0.000	0.145	12	4(lung)	0.6316
12	124144395	124144395	A	G	GTF2H3	exonic	synonymous SNV	ENSG00000111358	rs1051793	ENSG00000111358:ENST00000543415:exon10:c.A592G:p.S198G	GTF2H3:NM_001271866:exon9:c.A609G:p.P203P,GTF2H3:NM_001271867:exon10:c.A615G:p.P205P,GTF2H3:NM_001271868:exon10:c.A300G:p.P100P,GTF2H3:NM_001516:exon11:c.A738G:p.P246P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3648	0.4673	0.351038	0.4285	.	.	.	.	.	.	.	.	GTF2H3:uc031qkd.1:exon9:c.A609G:p.P203P,GTF2H3:uc010tau.2:exon10:c.A615G:p.P205P,GTF2H3:uc031qkc.1:exon10:c.A300G:p.P100P,GTF2H3:uc001ufo.2:exon11:c.A738G:p.P246P	.	AFR:0.6014,AMR:0.2993,EAS:0.0692,FIN:0.3079,NFE:0.409,OTH:0.3520,ASJ:0.3377	601750	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	12	MU666011	het
12	133201947	133201947	T	C	POLE	intronic	.	ENSG00000177084	rs4883544	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6446	0.6455	0.716254	0.6670	.	.	.	.	.	.	.	.	.	.	AFR:0.8092,AMR:0.7721,EAS:0.8098,FIN:0.5787,NFE:0.5909,OTH:0.6014,ASJ:0.5099	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU10345598	hom
12	133202004	133202004	C	T	POLE	intronic	.	ENSG00000177084	rs4883543	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4917	0.4674	0.566494	0.4949	.	.	.	.	.	.	.	.	.	.	AFR:0.5844,AMR:0.5825,EAS:0.7052,FIN:0.4396,NFE:0.4328,OTH:0.4601,ASJ:0.3775	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU19385780	hom
12	133202215	133202215	G	A	POLE	intronic	.	ENSG00000177084	rs5745075	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3703	0.3203	0.423323	0.3590	.	.	.	.	.	.	.	.	.	.	AFR:0.3566,AMR:0.4726,EAS:0.6983,FIN:0.4014,NFE:0.3111,OTH:0.3561,ASJ:0.19	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU12087933	hom
12	133208886	133208886	C	T	POLE	intronic	.	ENSG00000177084	rs5745023	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4941	0.4803	0.565096	0.4931	.	.	.	.	.	.	.	.	.	.	AFR:0.5854,AMR:0.5813,EAS:0.7048,FIN:0.4327,NFE:0.4301,OTH:0.4611,ASJ:0.3775	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU731565	hom
12	133208979	133208979	T	C	POLE	exonic	synonymous SNV	ENSG00000177084	rs5745022	ENSG00000177084:ENST00000535270:exon44:c.A6171G:p.S2057S,ENSG00000177084:ENST00000320574:exon45:c.A6252G:p.S2084S	POLE:NM_006231:exon45:c.A6252G:p.S2084S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6381	0.6427	0.699081	0.6546	.	.	.	.	.	.	.	.	POLE:uc001ukq.1:exon7:c.A882G:p.S294S,POLE:uc001ukr.1:exon19:c.A2664G:p.S888S,POLE:uc001uks.1:exon45:c.A6252G:p.S2084S	.	AFR:0.7676,AMR:0.7685,EAS:0.8075,FIN:0.5790,NFE:0.5901,OTH:0.5992,ASJ:0.5099	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	9091,,9089,9090	.	.	.	.	.	.	12	MU20983838	hom
12	133219831	133219831	T	C	POLE	exonic	synonymous SNV	ENSG00000177084	rs5744944	ENSG00000177084:ENST00000535270:exon34:c.A4449G:p.A1483A,ENSG00000177084:ENST00000320574:exon35:c.A4530G:p.A1510A	POLE:NM_006231:exon35:c.A4530G:p.A1510A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5032	0.5224	0.605232	0.5291	.	.	.	.	.	.	.	.	POLE:uc001ukr.1:exon9:c.A942G:p.A314A,POLE:uc009zyu.1:exon34:c.A4449G:p.A1483A,POLE:uc001uks.1:exon35:c.A4530G:p.A1510A	.	AFR:0.7113,AMR:0.5897,EAS:0.7043,FIN:0.4335,NFE:0.4301,OTH:0.4684,ASJ:0.3733	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	9091,,9089,9090	.	.	.	.	.	.	12	MU4555145	hom
12	133233705	133233705	T	C	POLE	intronic	.	ENSG00000177084	rs5744889	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9712	0.9729	0.983826	0.9764	.	.	.	.	.	.	.	.	.	.	AFR:0.9929,AMR:0.9749,EAS:1,FIN:0.9625,NFE:0.9678,OTH:0.9694,ASJ:0.9868	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU81935649	hom
12	133236000	133236000	C	T	POLE	exonic	synonymous SNV	ENSG00000177084	rs5744857	ENSG00000177084:ENST00000536445:exon1:c.G87A:p.T29T,ENSG00000177084:ENST00000539006:exon20:c.G2496A:p.T832T,ENSG00000177084:ENST00000535270:exon25:c.G3075A:p.T1025T,ENSG00000177084:ENST00000320574:exon26:c.G3156A:p.T1052T	POLE:NM_006231:exon26:c.G3156A:p.T1052T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5029	0.5225	0.605431	0.5300	.	.	.	.	.	.	.	.	POLE:uc009zyu.1:exon25:c.G3075A:p.T1025T,POLE:uc001uks.1:exon26:c.G3156A:p.T1052T	.	AFR:0.7123,AMR:0.5935,EAS:0.7048,FIN:0.4338,NFE:0.4309,OTH:0.4682,ASJ:0.3885	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	9091,,9089,9090	.	.	.	.	.	.	12	MU19389260	hom
13	21562482	21562482	-	GGGGCG	LATS2	exonic	nonframeshift insertion	ENSG00000150457	rs550642106	ENSG00000150457:ENST00000382592:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP,ENSG00000150457:ENST00000542899:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	LATS2:NM_014572:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0072	0.1606	0.254393	0.4392	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP,LATS2:uc009zzs.3:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	.	AFR:0.2789,AMR:0.4558,EAS:0.3763,FIN:0.4664,NFE:0.5314,OTH:0.4918,ASJ:0.5584	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU3892220	het
13	21562832	21562832	C	T	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	rs2770928	ENSG00000150457:ENST00000382592:exon4:c.G1087A:p.G363S,ENSG00000150457:ENST00000542899:exon4:c.G1087A:p.G363S	LATS2:NM_014572:exon4:c.G1087A:p.G363S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8729	0.8326	0.85024	MU64421	-0.186	1.173	0.472	-1.07	0.002	.	.	.	LATS2:uc001unr.4:exon4:c.G1087A:p.G363S,LATS2:uc009zzs.3:exon4:c.G1087A:p.G363S	-0.913	AFR:COCA-CN|5|321|0.0155763,AMR:0.8239,EAS:0.9270,FIN:0.9503,NFE:0.9981,OTH:0.8210,ASJ:0.7116	604861	.	.	.	.	.	.	.	0.002	0.4	0.000	0.38	13	1(thyroid)	0.8614
13	21562948	21562948	G	A	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	rs558614	ENSG00000150457:ENST00000382592:exon4:c.C971T:p.A324V,ENSG00000150457:ENST00000542899:exon4:c.C971T:p.A324V	LATS2:NM_014572:exon4:c.C971T:p.A324V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7345	0.7346	0.629593	1(peritoneum)	1.454	13.07	0.194	2.72	0.215	.	.	.	LATS2:uc001unr.4:exon4:c.C971T:p.A324V,LATS2:uc009zzs.3:exon4:c.C971T:p.A324V	-0.968	AFR:MU60225,AMR:COCA-CN|3|321|0.00934579,EAS:0.5518,FIN:0.6842,NFE:0.8733,OTH:0.5211,ASJ:0.6984	604861	.	.	.	.	.	.	.	0.216	0.29	0.000	0.345	13	1(thyroid)	0.7110
13	21620085	21620085	T	C	LATS2	exonic	synonymous SNV	ENSG00000150457	rs7317471	ENSG00000150457:ENST00000382592:exon2:c.A81G:p.K27K,ENSG00000150457:ENST00000542899:exon2:c.A81G:p.K27K	LATS2:NM_014572:exon2:c.A81G:p.K27K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8496	0.7806	0.807508	0.8142	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon2:c.A81G:p.K27K,LATS2:uc009zzs.3:exon2:c.A81G:p.K27K	.	AFR:0.6717,AMR:0.8969,EAS:0.9047,FIN:0.8845,NFE:0.8646,OTH:0.8661,ASJ:0.7185	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU114292	hom
13	22249144	22249144	C	G	FGF9	intronic	.	ENSG00000102678	rs12430456	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.834864	0.8289	.	.	.	.	.	.	.	.	.	.	AFR:0.7127,AMR:0.8990,EAS:1,FIN:0.8364,NFE:0.8634,OTH:0.8610,ASJ:0.8214	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	hom
13	22275394	22275394	A	G	FGF9	exonic	synonymous SNV	ENSG00000102678	rs9509841	ENSG00000102678:ENST00000382353:exon3:c.A447G:p.S149S	FGF9:NM_002010:exon3:c.A447G:p.S149S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8398	0.7740	0.832468	0.7863	.	.	.	.	.	.	.	.	FGF9:uc001uog.2:exon3:c.A447G:p.S149S	.	AFR:0.6565,AMR:0.9067,EAS:0.9561,FIN:0.7947,NFE:0.8312,OTH:0.8259,ASJ:0.8278	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU28813827	hom
13	22275583	22275583	G	A	FGF9	UTR3	.	ENSG00000102678	rs9509842	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9948	0.9805	0.981829	0.9831	.	.	.	.	.	.	.	.	.	.	AFR:0.9409,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:0.9967	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU81936344	hom
13	26273385	26273385	G	C	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs6491088	ENSG00000132932:ENST00000255283:exon24:c.G2166C:p.L722L,ENSG00000132932:ENST00000281620:exon24:c.G1806C:p.L602L,ENSG00000132932:ENST00000381655:exon25:c.G2286C:p.L762L	ATP8A2:NM_001313741:exon25:c.G2166C:p.L722L,ATP8A2:NM_016529:exon25:c.G2286C:p.L762L	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9898	0.98742	0.9919	.	.	.	.	.	.	.	.	ATP8A2:uc010aaj.1:exon11:c.G936C:p.L312L,ATP8A2:uc001uqk.3:exon25:c.G2286C:p.L762L,ATP8A2:uc010tdi.2:exon25:c.G2166C:p.L722L	.	AFR:0.9715,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU81937382	hom
13	26436425	26436425	A	G	ATP8A2	intronic	.	ENSG00000132932	rs34674796	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2283	0.2050	0.194089	0.1991	.	.	.	.	.	.	.	.	.	.	AFR:0.0995,AMR:0.2124,EAS:0.1875,FIN:0.1748,NFE:0.2601,OTH:0.2057,ASJ:0.3245	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU26642252	het
13	26436641	26436641	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2249800	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.503195	0.5360	.	.	.	.	.	.	.	.	.	.	AFR:0.4786,AMR:0.3864,EAS:0.6225,FIN:0.6073,NFE:0.5490,OTH:0.5898,ASJ:0.5	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU12280346	het
13	26586775	26586775	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2274135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4948	0.4447	0.534545	0.5218	.	.	.	.	.	.	.	.	.	.	AFR:0.4039,AMR:0.6131,EAS:0.7478,FIN:0.6004,NFE:0.5386,OTH:0.5867,ASJ:0.4422	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU18447171	het
13	28609825	28609825	A	G	FLT3	intronic	.	ENSG00000122025	rs2491227	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7014	0.6164	0.563099	MU14977712	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,AMR:0.6230,EAS:0.7110,FIN:0.7450,NFE:0.7574,OTH:0.8025,ASJ:0.2617	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	13	10(meninges)	0.7641
13	28610183	28610183	A	G	FLT3	intronic	.	ENSG00000122025	rs2491231	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6993	0.6164	0.563299	1(bone)	.	.	.	.	.	0	0.01	.	.	.	AFR:1(soft_tissue),AMR:MU12284971,EAS:0.6236,FIN:0.261,NFE:0.7117,OTH:0.7450,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	13	1(breast)	0.7584
13	28624294	28624294	G	A	FLT3	exonic	nonsynonymous SNV	ENSG00000122025	rs1933437	ENSG00000122025:ENST00000241453:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380982:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380987:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000537084:exon6:c.C680T:p.T227M	FLT3:NM_004119:exon6:c.C680T:p.T227M	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.5988	0.5229	0.558706	11(meninges)	4.144	23.8	0.042	3.85	0.613	.	.	.	FLT3:uc001urw.3:exon6:c.C680T:p.T227M,FLT3:uc010tdn.2:exon6:c.C680T:p.T227M	-0.903	AFR:MU24013025,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916,EAS:0.3404,FIN:0.6154,NFE:0.5861,OTH:0.7751,ASJ:0.5435	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	5782,,5779,5791,5800,5783,5780,5795,5789,5786,5784,5785,5790,5788,5787,5781	.	.	0.999	-1.23	0.000	0.895	13	18(soft_tissue)	0.6133
13	28636084	28636084	G	A	FLT3	exonic	synonymous SNV	ENSG00000122025	rs7338903	ENSG00000122025:ENST00000241453:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380982:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380987:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000537084:exon3:c.C288T:p.D96D	FLT3:NM_004119:exon3:c.C288T:p.D96D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9827	0.9599	0.958067	0.9662	.	.	.	.	.	.	.	.	FLT3:uc001urw.3:exon3:c.C288T:p.D96D,FLT3:uc010tdn.2:exon3:c.C288T:p.D96D	.	AFR:0.9027,AMR:0.9869,EAS:0.9994,FIN:0.9957,NFE:0.9893,OTH:0.9898,ASJ:0.9967	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	5782,,5779,5791,5783,5780,5795,5789,5786,5784,5785,5790,5788,5787,5781	.	.	.	.	.	.	13	MU81937601	hom
13	28883061	28883061	G	A	FLT1	exonic	synonymous SNV	ENSG00000102755	rs7993418	ENSG00000102755:ENST00000543394:exon8:c.C708T:p.Y236Y,ENSG00000102755:ENST00000540678:exon15:c.C1293T:p.Y431Y,ENSG00000102755:ENST00000282397:exon28:c.C3639T:p.Y1213Y	FLT1:NM_002019:exon28:c.C3639T:p.Y1213Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7921	0.6465	0.730831	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FLT1:uc010aap.2:exon7:c.C654T:p.Y218Y,FLT1:uc010aaq.2:exon10:c.C1014T:p.Y338Y,FLT1:uc001usa.3:exon15:c.C1293T:p.Y431Y,FLT1:uc001usb.3:exon28:c.C3639T:p.Y1213Y	.	AFR:0.6798,AMR:0.3548,EAS:0.8477,FIN:0.9969,NFE:0.7871,OTH:0.7888,ASJ:0.8433	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	1(lung)	0.7990
13	28886113	28886113	A	G	FLT1	intronic	.	ENSG00000102755	rs7328692	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9929	0.9751	0.974042	0.9748	.	.	.	.	.	.	.	.	.	.	AFR:0.9122,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:0.9967	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	MU81937639	hom
13	28893642	28893642	A	G	FLT1	exonic	synonymous SNV	ENSG00000102755	rs2296189	ENSG00000102755:ENST00000543394:exon4:c.T273C:p.P91P,ENSG00000102755:ENST00000540678:exon11:c.T858C:p.P286P,ENSG00000102755:ENST00000282397:exon24:c.T3204C:p.P1068P	FLT1:NM_002019:exon24:c.T3204C:p.P1068P	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2188	0.2141	0.243011	MU10475303	.	.	.	.	.	.	.	.	FLT1:uc010aap.2:exon3:c.T219C:p.P73P,FLT1:uc010aaq.2:exon6:c.T579C:p.P193P,FLT1:uc001usa.3:exon11:c.T858C:p.P286P,FLT1:uc001usb.3:exon24:c.T3204C:p.P1068P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.1991,EAS:0.1086,FIN:0.2433,NFE:0.1788,OTH:0.1274,ASJ:0.2770	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	2(lung)	0.1782
13	32893344	32893344	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs28897700	ENSG00000139618:ENST00000380152:exon3:c.A198G:p.Q66Q,ENSG00000139618:ENST00000544455:exon3:c.A198G:p.Q66Q	BRCA2:NM_000059:exon3:c.A198G:p.Q66Q	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0011	0.0002	0.00199681	0.0001	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon3:c.A198G:p.Q66Q	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0003,OTH:0,ASJ:0	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1837,1827,1845,1825,1834,1840,1836,1828,1843,1820,1823,1841,1830,1826,1839,1842,1819,1829,1832,1824,1835,1844,1838,1831,1833	.	,1821,1822	.	.	.	.	13	MU4373567	het
13	32911888	32911888	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs1801406	ENSG00000139618:ENST00000380152:exon11:c.A3396G:p.K1132K,ENSG00000139618:ENST00000544455:exon11:c.A3396G:p.K1132K	BRCA2:NM_000059:exon11:c.A3396G:p.K1132K	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2945	0.2798	0.266773	0.2984	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A3396G:p.K1132K	.	AFR:0.2348,AMR:0.2100,EAS:0.3863,FIN:0.3113,NFE:0.3267,OTH:0.3108,ASJ:0.3212	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1837,1827,1845,1825,1834,1840,1836,1828,1843,1820,1823,1841,1830,1826,1839,1842,1819,1829,1832,1824,1835,1844,1838,1831,1833	.	,1821,1822	.	.	.	.	13	MU12290327	het
13	32912299	32912299	T	C	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs543304	ENSG00000139618:ENST00000380152:exon11:c.T3807C:p.V1269V,ENSG00000139618:ENST00000544455:exon11:c.T3807C:p.V1269V	BRCA2:NM_000059:exon11:c.T3807C:p.V1269V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1898	0.1911	0.168131	0.1816	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.T3807C:p.V1269V	.	AFR:0.1911,AMR:0.1998,EAS:0.1648,FIN:0.1869,NFE:0.1770,OTH:0.1684,ASJ:0.1523	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1837,1827,1845,1825,1834,1840,1836,1828,1843,1820,1823,1841,1830,1826,1839,1842,1819,1829,1832,1824,1835,1844,1838,1831,1833	.	,1821,1822	.	.	.	.	13	MU12290336	het
13	32913055	32913055	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206075	ENSG00000139618:ENST00000380152:exon11:c.A4563G:p.L1521L,ENSG00000139618:ENST00000544455:exon11:c.A4563G:p.L1521L	BRCA2:NM_000059:exon11:c.A4563G:p.L1521L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9931	0.9758	0.974042	0.9799	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A4563G:p.L1521L	.	AFR:0.9301,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1837,1827,1845,1825,1834,1840,1836,1828,1843,1820,1823,1841,1830,1826,1839,1842,1819,1829,1832,1824,1835,1844,1838,1831,1833	.	,1821,1822	.	.	.	.	13	MU81938056	hom
13	32915005	32915005	G	C	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206076	ENSG00000139618:ENST00000380152:exon11:c.G6513C:p.V2171V,ENSG00000139618:ENST00000544455:exon11:c.G6513C:p.V2171V	BRCA2:NM_000059:exon11:c.G6513C:p.V2171V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9930	0.9755	0.973642	0.9798	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.G6513C:p.V2171V	.	AFR:0.9299,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1837,1827,1845,1825,1834,1840,1836,1828,1843,1820,1823,1841,1830,1826,1839,1842,1819,1829,1832,1824,1835,1844,1838,1831,1833	.	,1821,1822	.	.	.	.	13	MU4551142	hom
13	32929387	32929387	T	C	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs169547	ENSG00000139618:ENST00000380152:exon14:c.T7397C:p.V2466A,ENSG00000139618:ENST00000544455:exon14:c.T7397C:p.V2466A	BRCA2:NM_000059:exon14:c.T7397C:p.V2466A	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9937	0.9777	0.975839	0.9819	-0.407	0.372	1.0	5.07	0.005	.	.	.	BRCA2:uc031qky.1:exon1:c.T221C:p.V74A,BRCA2:uc001uub.1:exon14:c.T7397C:p.V2466A	-0.930	AFR:0.9369,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1837,1827,1845,1825,1834,1840,1836,1828,1843,1820,1823,1841,1830,1826,1839,1842,1819,1829,1832,1824,1835,1844,1838,1831,1833	.	,1821,1822	.	5.95	0.000	.	13	MU81938081	hom
13	33232435	33232435	A	G	PDS5B	exonic	synonymous SNV	ENSG00000083642	rs2301393	ENSG00000083642:ENST00000315596:exon4:c.A372G:p.Q124Q,ENSG00000083642:ENST00000450460:exon4:c.A372G:p.Q124Q	PDS5B:NM_015032:exon4:c.A372G:p.Q124Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3724	0.3797	0.271366	0.3782	.	.	.	.	.	.	.	.	PDS5B:uc001uuo.3:exon4:c.A372G:p.Q124Q,PDS5B:uc010abf.3:exon4:c.A372G:p.Q124Q	.	AFR:0.2715,AMR:0.3789,EAS:0.1648,FIN:0.4355,NFE:0.4491,OTH:0.3961,ASJ:0.37	605333	.	.	.	.	,8616	.	.	.	.	.	.	13	MU129748	het
13	33315206	33315206	G	A	PDS5B	intronic	.	ENSG00000083642	rs733487	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3649	0.3840	0.274561	0.3918	.	.	.	.	.	0	0	.	.	.	AFR:0.2883,AMR:0.3865,EAS:0.1770,FIN:0.4473,NFE:0.4653,OTH:0.4099,ASJ:0.4051	605333	.	.	.	.	.	.	.	.	.	.	.	13	MU28569403	het
13	33344242	33344242	T	-	PDS5B	intronic	.	ENSG00000083642	rs112309957	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4256	0.4040	0.288938	0.3943	.	.	.	.	.	.	.	.	.	.	AFR:0.3134,AMR:0.3886,EAS:0.1642,FIN:0.4492,NFE:0.4540,OTH:0.4056,ASJ:0.3878	605333	.	.	.	.	.	.	.	.	.	.	.	13	MU41099207	het
13	33590851	33590851	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs2772364	ENSG00000133116:ENST00000380099:exon1:c.T273C:p.D91D	KL:NM_004795:exon1:c.T273C:p.D91D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9865	0.9475	0.944089	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon1:c.T273C:p.D91D	.	AFR:0.9500,AMR:0.8254,EAS:1,FIN:1,NFE:1,OTH:0.9993,ASJ:0.9892	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	2(thyroid)	0.9927
13	33634983	33634983	C	T	KL	exonic	synonymous SNV	ENSG00000133116	rs564481	ENSG00000133116:ENST00000380099:exon4:c.C1767T:p.H589H	KL:NM_004795:exon4:c.C1767T:p.H589H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3623	0.3040	0.249201	0.2960	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.C1767T:p.H589H	.	AFR:0.0839,AMR:0.5024,EAS:0.1636,FIN:0.3746,NFE:0.3980,OTH:0.3694,ASJ:0.3709	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU19701059	het
13	33635463	33635463	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs648202	ENSG00000133116:ENST00000380099:exon4:c.T2247C:p.A749A	KL:NM_004795:exon4:c.T2247C:p.A749A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8036	0.7690	0.710863	0.7635	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2247C:p.A749A	.	AFR:0.5728,AMR:0.7955,EAS:0.6103,FIN:0.8794,NFE:0.8528,OTH:0.8514,ASJ:0.9205	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU13667379	hom
13	33635835	33635835	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs649964	ENSG00000133116:ENST00000380099:exon4:c.T2619C:p.N873N	KL:NM_004795:exon4:c.T2619C:p.N873N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9919	0.9683	0.976238	0.9760	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2619C:p.N873N	.	AFR:0.9164,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9997,OTH:1,ASJ:1	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU81938143	hom
13	36225929	36225929	T	C	NBEA	intronic	.	ENSG00000172915	rs7991019	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3558	0.3216	0.234425	0.3342	.	.	.	.	.	.	.	.	.	.	AFR:0.1770,AMR:0.3429,EAS:0.0623,FIN:0.3945,NFE:0.4361,OTH:0.3737,ASJ:0.4371	604889	.	.	.	.	.	.	.	.	.	.	.	13	MU582958	hom
13	41188292	41188292	A	G	FOXO1	intronic	.	ENSG00000150907	rs3900833	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.492013	0.3903	.	.	.	.	.	.	.	.	.	.	AFR:0.4657,AMR:0.4605,EAS:0.7395,FIN:0.3845,NFE:0.3100,OTH:0.3676,ASJ:0.2815	136533	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	~ko04068 FoxO signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	13	.	hom
13	48914792	48914792	A	G	RB1	intronic	.	ENSG00000139687	rs198636	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.914137	0.9411	.	.	.	.	.	.	.	.	.	.	AFR:0.8226,AMR:0.9461,EAS:0.9957,FIN:0.9991,NFE:0.9882,OTH:0.9845,ASJ:0.9404	614041	109800;180200;182280;259500;	668;70573;790;	668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~70573|SCLC|1-5 / 10 000|Not applicable|Adult|182280 ~790|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Childhood<br>Antenatal|180200 ~	~ko01522 Endocrine resistance~ko04110 Cell cycle~ko04218 Cellular senescence~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	hom
13	49051481	49051481	T	A	RB1	intronic	.	ENSG00000139687	rs3092904	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2603	0.1955	0.188698	0.2142	.	.	.	.	.	0.0005	0.062	.	.	.	AFR:0.0939,AMR:0.2129,EAS:0.2354,FIN:0.2806,NFE:0.2628,OTH:0.2791,ASJ:0.1933	614041	109800;180200;182280;259500;	668;70573;790;	668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~70573|SCLC|1-5 / 10 000|Not applicable|Adult|182280 ~790|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Childhood<br>Antenatal|180200 ~	~ko01522 Endocrine resistance~ko04110 Cell cycle~ko04218 Cellular senescence~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU583001	het
13	52511606	52511606	G	A	ATP7B	intronic	.	ENSG00000123191	rs2282057	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5374	0.5491	0.501797	LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	0	0	.	.	.	AFR:0.5452,AMR:0.4886,EAS:0.5762,FIN:0.3923,NFE:0.6126,OTH:0.5789,ASJ:0.4976	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	.	.	.	.	13	3(lung)	0.5757
13	52515354	52515354	A	G	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1801249	ENSG00000123191:ENST00000400370:exon8:c.T2129C:p.V710A,ENSG00000123191:ENST00000417240:exon9:c.T1052C:p.V351A,ENSG00000123191:ENST00000344297:exon12:c.T2798C:p.V933A,ENSG00000123191:ENST00000418097:exon15:c.T3224C:p.V1075A,ENSG00000123191:ENST00000448424:exon15:c.T3185C:p.V1062A,ENSG00000123191:ENST00000242839:exon16:c.T3419C:p.V1140A,ENSG00000123191:ENST00000400366:exon17:c.T3086C:p.V1029A	ATP7B:NM_001005918:exon12:c.T2798C:p.V933A,ATP7B:NM_001330579:exon14:c.T3167C:p.V1056A,ATP7B:NM_001330578:exon15:c.T3185C:p.V1062A,ATP7B:NM_000053:exon16:c.T3419C:p.V1140A,ATP7B:NM_001243182:exon17:c.T3086C:p.V1029A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5653	0.5776	0.540535	MU10592943	-0.774	0.049	0.914	0.087	0.314	.	.	HAD-like domain;P-type ATPase,  transmembrane domain;P-type ATPase, cytoplasmic domain N	ATP7B:uc010adv.2:exon8:c.T2129C:p.V710A,ATP7B:uc001vfv.2:exon9:c.T1235C:p.V412A,ATP7B:uc010tgs.1:exon9:c.T1052C:p.V351A,ATP7B:uc001vfx.2:exon12:c.T2798C:p.V933A,ATP7B:uc010tgt.1:exon15:c.T3224C:p.V1075A,ATP7B:uc010tgv.1:exon15:c.T3185C:p.V1062A,ATP7B:uc001vfw.2:exon16:c.T3419C:p.V1140A,ATP7B:uc010tgu.1:exon16:c.T3275C:p.V1092A,ATP7B:uc001vfy.2:exon17:c.T3086C:p.V1029A	-0.954	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,AMR:0.5733,EAS:0.6340,FIN:0.5795,NFE:0.3925,OTH:0.6140,ASJ:0.5601	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.0	-3.86	0.000	0.155	13	2(pancreas)	0.5859
13	52520471	52520471	C	T	ATP7B	exonic	synonymous SNV	ENSG00000123191	rs1801247	ENSG00000123191:ENST00000400370:exon5:c.G1719A:p.A573A,ENSG00000123191:ENST00000417240:exon7:c.G825A:p.A275A,ENSG00000123191:ENST00000344297:exon9:c.G2388A:p.A796A,ENSG00000123191:ENST00000448424:exon12:c.G2775A:p.A925A,ENSG00000123191:ENST00000242839:exon13:c.G3009A:p.A1003A,ENSG00000123191:ENST00000400366:exon14:c.G2676A:p.A892A	ATP7B:NM_001005918:exon9:c.G2388A:p.A796A,ATP7B:NM_001330579:exon11:c.G2757A:p.A919A,ATP7B:NM_001330578:exon12:c.G2775A:p.A925A,ATP7B:NM_000053:exon13:c.G3009A:p.A1003A,ATP7B:NM_001243182:exon14:c.G2676A:p.A892A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0868	0.0399	0.0369409	MU10592973	.	.	.	.	.	.	.	.	ATP7B:uc010adv.2:exon5:c.G1719A:p.A573A,ATP7B:uc001vfv.2:exon6:c.G825A:p.A275A,ATP7B:uc010tgs.1:exon7:c.G825A:p.A275A,ATP7B:uc001vfx.2:exon9:c.G2388A:p.A796A,ATP7B:uc010tgv.1:exon12:c.G2775A:p.A925A,ATP7B:uc001vfw.2:exon13:c.G3009A:p.A1003A,ATP7B:uc010tgu.1:exon13:c.G2865A:p.A955A,ATP7B:uc001vfy.2:exon14:c.G2676A:p.A892A	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.0439,EAS:0.0251,FIN:0.0662,NFE:0.0111,OTH:0.0805,ASJ:0.0101	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	.	.	.	.	13	1(lung)	0.0574
13	52523808	52523808	C	T	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs732774	ENSG00000123191:ENST00000400370:exon4:c.G1565A:p.R522K,ENSG00000123191:ENST00000417240:exon6:c.G671A:p.R224K,ENSG00000123191:ENST00000448424:exon11:c.G2621A:p.R874K,ENSG00000123191:ENST00000242839:exon12:c.G2855A:p.R952K,ENSG00000123191:ENST00000418097:exon12:c.G2855A:p.R952K,ENSG00000123191:ENST00000400366:exon13:c.G2522A:p.R841K	ATP7B:NM_001330579:exon10:c.G2603A:p.R868K,ATP7B:NM_001330578:exon11:c.G2621A:p.R874K,ATP7B:NM_000053:exon12:c.G2855A:p.R952K,ATP7B:NM_001243182:exon13:c.G2522A:p.R841K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5627	0.5717	0.53095	1(stomach)	2.122	17.00	1.0	6.06	0.970	.	.	P-type ATPase,  transmembrane domain;P-type ATPase, A  domain	ATP7B:uc010adv.2:exon4:c.G1565A:p.R522K,ATP7B:uc001vfv.2:exon5:c.G671A:p.R224K,ATP7B:uc010tgs.1:exon6:c.G671A:p.R224K,ATP7B:uc010tgv.1:exon11:c.G2621A:p.R874K,ATP7B:uc001vfw.2:exon12:c.G2855A:p.R952K,ATP7B:uc010tgt.1:exon12:c.G2855A:p.R952K,ATP7B:uc010tgu.1:exon12:c.G2711A:p.R904K,ATP7B:uc001vfy.2:exon13:c.G2522A:p.R841K	-0.965	AFR:MU155025,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5304,FIN:0.6313,NFE:0.5828,OTH:0.3902,ASJ:0.5645	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.0	-3.79	0.000	-0.405	13	1(liver)	0.6128
13	52524488	52524488	T	C	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1061472	ENSG00000123191:ENST00000417240:exon4:c.A311G:p.K104R,ENSG00000123191:ENST00000344297:exon7:c.A2009G:p.K670R,ENSG00000123191:ENST00000448424:exon9:c.A2261G:p.K754R,ENSG00000123191:ENST00000242839:exon10:c.A2495G:p.K832R,ENSG00000123191:ENST00000418097:exon10:c.A2495G:p.K832R,ENSG00000123191:ENST00000400366:exon11:c.A2162G:p.K721R	ATP7B:NM_001005918:exon7:c.A2009G:p.K670R,ATP7B:NM_001330579:exon8:c.A2243G:p.K748R,ATP7B:NM_001330578:exon9:c.A2261G:p.K754R,ATP7B:NM_000053:exon10:c.A2495G:p.K832R,ATP7B:NM_001243182:exon11:c.A2162G:p.K721R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5384	0.5522	0.502396	MU155019	2.981	22.2	0.087	5.54	1.000	.	.	P-type ATPase, A  domain	ATP7B:uc001vfv.2:exon3:c.A311G:p.K104R,ATP7B:uc010tgs.1:exon4:c.A311G:p.K104R,ATP7B:uc001vfx.2:exon7:c.A2009G:p.K670R,ATP7B:uc010tgv.1:exon9:c.A2261G:p.K754R,ATP7B:uc001vfw.2:exon10:c.A2495G:p.K832R,ATP7B:uc010tgt.1:exon10:c.A2495G:p.K832R,ATP7B:uc010tgu.1:exon10:c.A2351G:p.K784R,ATP7B:uc001vfy.2:exon11:c.A2162G:p.K721R	-0.931	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.5472,EAS:0.4988,FIN:0.5795,NFE:0.3883,OTH:0.6105,ASJ:0.4975	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.111	-2.64	0.000	0.41	13	3(large_intestine)	0.5787
13	52544805	52544805	C	G	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1801244	ENSG00000123191:ENST00000542656:exon2:c.G1270C:p.V424L,ENSG00000123191:ENST00000242839:exon3:c.G1366C:p.V456L,ENSG00000123191:ENST00000344297:exon3:c.G1366C:p.V456L,ENSG00000123191:ENST00000418097:exon3:c.G1366C:p.V456L,ENSG00000123191:ENST00000448424:exon3:c.G1366C:p.V456L,ENSG00000123191:ENST00000400366:exon4:c.G1033C:p.V345L	ATP7B:NM_000053:exon3:c.G1366C:p.V456L,ATP7B:NM_001005918:exon3:c.G1366C:p.V456L,ATP7B:NM_001330578:exon3:c.G1366C:p.V456L,ATP7B:NM_001330579:exon3:c.G1366C:p.V456L,ATP7B:NM_001243182:exon4:c.G1033C:p.V345L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4346	0.4052	0.376997	MU155015	0.761	9.223	0.599	-0.181	0.954	.	.	.	ATP7B:uc001vfw.2:exon3:c.G1366C:p.V456L,ATP7B:uc001vfx.2:exon3:c.G1366C:p.V456L,ATP7B:uc010tgt.1:exon3:c.G1366C:p.V456L,ATP7B:uc010tgu.1:exon3:c.G1366C:p.V456L,ATP7B:uc010tgv.1:exon3:c.G1366C:p.V456L,ATP7B:uc010tgw.1:exon3:c.G1270C:p.V424L,ATP7B:uc001vfy.2:exon4:c.G1033C:p.V345L	-1.006	AFR:COCA-CN|3|321|0.00934579,AMR:0.4190,EAS:0.3986,FIN:0.4470,NFE:0.4716,OTH:0.5332,ASJ:0.2383	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.009	-3.8	0.000	0.695	13	1(liver)	0.4891
13	52548140	52548140	A	C	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1801243	ENSG00000123191:ENST00000542656:exon1:c.T1120G:p.S374A,ENSG00000123191:ENST00000242839:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000344297:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000400370:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000418097:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000448424:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000400366:exon3:c.T883G:p.S295A	ATP7B:NM_000053:exon2:c.T1216G:p.S406A,ATP7B:NM_001005918:exon2:c.T1216G:p.S406A,ATP7B:NM_001330578:exon2:c.T1216G:p.S406A,ATP7B:NM_001330579:exon2:c.T1216G:p.S406A,ATP7B:NM_001243182:exon3:c.T883G:p.S295A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4388	0.4012	0.376198	0.4155	-0.551	0.164	0.753	-0.027	0.946	.	.	Heavy metal-associated domain, HMA|Heavy metal-associated domain, copper ion-binding	ATP7B:uc001vfw.2:exon2:c.T1216G:p.S406A,ATP7B:uc001vfx.2:exon2:c.T1216G:p.S406A,ATP7B:uc010adv.2:exon2:c.T1216G:p.S406A,ATP7B:uc010tgt.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgu.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgv.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgw.1:exon2:c.T1120G:p.S374A,ATP7B:uc001vfy.2:exon3:c.T883G:p.S295A	-0.999	AFR:0.1954,AMR:0.4069,EAS:0.5285,FIN:0.5421,NFE:0.4971,OTH:0.4744,ASJ:0.4901	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.003	-2.09	0.000	0.695	13	MU155008	het
13	52569451	52569451	T	C	ATP7B	intronic	.	ENSG00000123191	rs113115720	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0353435	0.0383	.	.	.	.	.	.	.	.	.	.	AFR:0.0370,AMR:0.0143,EAS:0.0080,FIN:0.0289,NFE:0.0452,OTH:0.0519,ASJ:0.0331	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	.	.	.	.	13	.	het
13	73343039	73343039	C	T	DIS3	exonic	synonymous SNV	ENSG00000083520	rs2196979	ENSG00000083520:ENST00000377767:exon14:c.G1767A:p.T589T,ENSG00000083520:ENST00000377780:exon14:c.G1677A:p.T559T,ENSG00000083520:ENST00000545453:exon15:c.G1281A:p.T427T	DIS3:NM_001322348:exon13:c.G1398A:p.T466T,DIS3:NM_001128226:exon14:c.G1677A:p.T559T,DIS3:NM_014953:exon14:c.G1767A:p.T589T,DIS3:NM_001322349:exon15:c.G1281A:p.T427T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7373	0.7476	0.770168	0.7393	.	.	.	.	.	.	.	.	DIS3:uc001vix.4:exon14:c.G1767A:p.T589T,DIS3:uc001viy.4:exon14:c.G1677A:p.T559T	.	AFR:0.8187,AMR:0.8098,EAS:0.7503,FIN:0.6790,NFE:0.7044,OTH:0.7026,ASJ:0.7384	607533	.	.	.	.	.	.	.	.	.	.	.	13	MU20994899	hom
13	73350079	73350079	T	C	DIS3	exonic	nonsynonymous SNV	ENSG00000083520	rs4883918	ENSG00000083520:ENST00000377767:exon5:c.A806G:p.N269S,ENSG00000083520:ENST00000377780:exon5:c.A716G:p.N239S,ENSG00000083520:ENST00000490646:exon5:c.A806G:p.N269S,ENSG00000083520:ENST00000545453:exon6:c.A320G:p.N107S	DIS3:NM_001322348:exon4:c.A437G:p.N146S,DIS3:NM_001128226:exon5:c.A716G:p.N239S,DIS3:NM_014953:exon5:c.A806G:p.N269S,DIS3:NM_001322349:exon6:c.A320G:p.N107S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3363	0.2346	0.327077	0.2589	-1.853	0.002	0.464	-8.07	0.645	.	.	Nucleic acid-binding, OB-fold|Rrp44-like cold shock domain	DIS3:uc001vix.4:exon5:c.A806G:p.N269S,DIS3:uc001viy.4:exon5:c.A716G:p.N239S	-0.938	AFR:0.1060,AMR:0.5084,EAS:0.4807,FIN:0.3083,NFE:0.2964,OTH:0.3108,ASJ:0.2152	607533	.	.	.	.	.	.	.	0.0	2.09	0.000	-0.59	13	MU742526	hom
13	101720300	101720300	T	G	NALCN	exonic	synonymous SNV	ENSG00000102452	rs1289556	ENSG00000102452:ENST00000251127:exon39:c.A4416C:p.I1472I	NALCN:NM_001350750:exon38:c.A4329C:p.I1443I,NALCN:NM_001350751:exon38:c.A4329C:p.I1443I,NALCN:NM_001350749:exon39:c.A4416C:p.I1472I,NALCN:NM_052867:exon39:c.A4416C:p.I1472I,NALCN:NM_001350748:exon40:c.A4503C:p.I1501I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3529	0.4826	0.402955	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon39:c.A4416C:p.I1472I	.	AFR:MU4557800,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,EAS:0.7140,FIN:0.2446,NFE:0.4272,OTH:0.1326,ASJ:0.4464	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	1(biliary_tract)	0.3573
13	101736075	101736075	A	G	NALCN	exonic	synonymous SNV	ENSG00000102452	rs686141	ENSG00000102452:ENST00000251127:exon31:c.T3570C:p.L1190L	NALCN:NM_001350750:exon30:c.T3483C:p.L1161L,NALCN:NM_001350751:exon30:c.T3483C:p.L1161L,NALCN:NM_001350749:exon31:c.T3570C:p.L1190L,NALCN:NM_052867:exon31:c.T3570C:p.L1190L,NALCN:NM_001350748:exon32:c.T3657C:p.L1219L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6992	0.7610	0.724641	1(thyroid)	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon31:c.T3570C:p.L1190L	.	AFR:MU117493,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,THCA-SA|1|243|0.00411523,EAS:0.8418,FIN:0.5,NFE:0.7682,OTH:0.6006,ASJ:0.7478	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	2(haematopoietic_and_lymphoid_tissue)	0.7252
13	101757011	101757011	A	C	NALCN	intronic	.	ENSG00000102452	rs16958350	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0280	0.0273	0.0373403	0.0259	.	.	.	.	.	0.8343	0.678	.	.	.	AFR:0.0366,AMR:0.0179,EAS:0.0725,FIN:0.0037,NFE:0.0203,OTH:0.0235,ASJ:0.0298	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	MU12240138	unknown
13	101763582	101763582	-	A	NALCN	intronic	.	ENSG00000102452	rs66537139	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1088	0.0516	0.135184	0.0913	.	.	.	.	.	.	.	.	.	.	AFR:0.0489,AMR:0.2319,EAS:0.4262,FIN:0.1351,NFE:0.0608,OTH:0.1198,ASJ:0.0069	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	.	het
13	101795422	101795422	A	G	NALCN	intronic	.	ENSG00000102452	rs661585	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4910	0.5050	0.521765	0.5118	.	.	.	.	.	.	.	.	NALCN:uc001voy.3:exon17:c.T1272C:p.S424S	.	AFR:0.6003,AMR:0.3998,EAS:0.5087,FIN:0.5146,NFE:0.4689,OTH:0.4836,ASJ:0.4768	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	MU13671660	het
13	101999939	101999939	A	G	NALCN	intronic	.	ENSG00000102452	rs9582475	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.388778	0.3415	.	.	.	.	.	.	.	.	.	.	AFR:0.3471,AMR:0.4820,EAS:0.3717,FIN:0.2897,NFE:0.3368,OTH:0.3569,ASJ:0.4172	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	.	het
13	102480271	102480271	T	A	FGF14	exonic	nonsynonymous SNV	ENSG00000102466	rs9518577	.	FGF14:NM_001321937:exon4:c.A425T:p.K142I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.405152	0.3289	.	.	.	.	.	.	.	.	.	.	AFR:0.2408,AMR:0.3343,EAS:0.5505,FIN:0.2417,NFE:0.3681,OTH:0.3659,ASJ:0.2959	601515	609307;	98764;	98764|SCA27|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|609307 ~	.	.	.	.	.	.	.	.	13	.	het
13	103527849	103527849	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs9514066	ENSG00000134899:ENST00000375954:exon6:c.G856C:p.G286R,ENSG00000134899:ENST00000355739:exon15:c.G3157C:p.G1053R	ERCC5:NM_000123:exon15:c.G3157C:p.G1053R,BIVM-ERCC5:NM_001204425:exon23:c.G4519C:p.G1507R	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.9994	0.9975	0.998203	0.9981	3.453	23.0	0.039	4.28	0.996	.	.	.	ERCC5:uc001vpw.3:exon15:c.G3157C:p.G1053R,BIVM-ERCC5:uc001vpu.2:exon23:c.G4519C:p.G1507R	-0.856	AFR:0.9934,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.926	3.59	0.000	2.14	13	MU81941476	hom
13	103527930	103527930	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs9514067	ENSG00000134899:ENST00000375954:exon6:c.G937C:p.G313R,ENSG00000134899:ENST00000355739:exon15:c.G3238C:p.G1080R	ERCC5:NM_000123:exon15:c.G3238C:p.G1080R,BIVM-ERCC5:NM_001204425:exon23:c.G4600C:p.G1534R	clinvar: not_provided 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9993	0.9975	0.997204	0.9981	-0.838	0.035	0.588	0.141	0.016	.	.	.	ERCC5:uc001vpw.3:exon15:c.G3238C:p.G1080R,BIVM-ERCC5:uc001vpu.2:exon23:c.G4600C:p.G1534R	-1.004	AFR:0.9934,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	3.65	0.000	-0.205	13	MU81941490	hom
13	103528002	103528002	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs17655	ENSG00000134899:ENST00000375954:exon6:c.G1009C:p.D337H,ENSG00000134899:ENST00000355739:exon15:c.G3310C:p.D1104H	ERCC5:NM_000123:exon15:c.G3310C:p.D1104H,BIVM-ERCC5:NM_001204425:exon23:c.G4672C:p.D1558H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2777	0.3058	0.361422	1(liver)	4.613	24.4	0.004	4.11	0.001	.	.	PIN domain-like	ERCC5:uc001vpw.3:exon15:c.G3310C:p.D1104H,BIVM-ERCC5:uc001vpu.2:exon23:c.G4672C:p.D1558H	-0.903	AFR:2(large_intestine),AMR:MU62519,EAS:0.3035,FIN:0.4516,NFE:0.3031,OTH:0.3013,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.995	3.27	0.000	1.975	13	5(soft_tissue)	0.4969
13	110435914	110435914	G	A	IRS2	exonic	synonymous SNV	ENSG00000185950	rs12853546	ENSG00000185950:ENST00000375856:exon1:c.C2487T:p.P829P	IRS2:NM_003749:exon1:c.C2487T:p.P829P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3112	0.2078	0.22504	0.2169	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.C2487T:p.P829P	.	AFR:0.1950,AMR:0.1667,EAS:0.2370,FIN:0.2443,NFE:0.2218,OTH:0.2423,ASJ:0.2417	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU93852	het
13	113888201	113888201	T	C	CUL4A	intronic	.	ENSG00000139842	rs2146408	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9753	0.9108	0.911941	0.9240	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7357,AMR:0.9809,EAS:1,FIN:1,NFE:0.9987,OTH:0.9878,ASJ:0.9901	603137	.	.	.	.	.	.	.	.	.	.	.	13	MU81942591	hom
13	113889474	113889474	C	T	CUL4A	intronic	.	ENSG00000139842	rs2287250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6738	0.7040	0.573283	MU732829	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6723,EAS:0.5767,FIN:0.8344,NFE:0.4093,OTH:0.7117,ASJ:0.5802	603137	.	.	.	.	.	.	.	.	.	.	.	13	1(haematopoietic_and_lymphoid_tissue)	0.7467
13	113907391	113907391	A	G	CUL4A	intronic	.	ENSG00000139842	rs9549365	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2943	0.1802	0.3125	0.2293	.	.	.	.	.	0	0	.	.	.	AFR:0.0775,AMR:0.4038,EAS:0.5898,FIN:0.2894,NFE:0.2519,OTH:0.3020,ASJ:0.1556	603137	.	.	.	.	.	.	.	.	.	.	.	13	MU17327153	het
13	113965003	113965004	TT	-	LAMP1	intronic	.	ENSG00000185896	rs201559462	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0272	.	.	0.0114	.	.	.	.	.	.	.	.	.	.	AFR:0.0022,AMR:0.0437,EAS:0.1400,FIN:0.0218,NFE:0.0005,OTH:0.0116,ASJ:0	153330	.	.	.	.	.	.	.	.	.	.	.	13	MU2275405	het
13	113965176	113965176	C	A	LAMP1	exonic	synonymous SNV	ENSG00000185896	rs9577503	ENSG00000185896:ENST00000332556:exon4:c.C556A:p.R186R	LAMP1:NM_005561:exon4:c.C556A:p.R186R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9916	0.9809	0.979233	0.9753	.	.	.	.	.	.	.	.	LAMP1:uc001vtm.1:exon4:c.C556A:p.R186R	.	AFR:0.9157,AMR:0.9905,EAS:1,FIN:1,NFE:0.9989,OTH:0.9928,ASJ:1	153330	.	.	.	.	.	.	.	.	.	.	.	13	MU81942635	hom
13	113973832	113973832	C	T	LAMP1	exonic	nonsynonymous SNV	ENSG00000185896	rs9577229	ENSG00000185896:ENST00000397181:exon4:c.C452T:p.A151V,ENSG00000185896:ENST00000332556:exon5:c.C611T:p.A204V	LAMP1:NM_005561:exon5:c.C611T:p.A204V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0309	0.0506	0.0796725	0.0573	0.733	9.040	0.296	0.159	0.000	.	.	.	LAMP1:uc010tka.1:exon4:c.C452T:p.A151V,LAMP1:uc001vtm.1:exon5:c.C611T:p.A204V	-1.016	AFR:0.1656,AMR:0.0406,EAS:0.1463,FIN:0.0086,NFE:0.0009,OTH:0.0173,ASJ:0	153330	.	.	.	.	.	.	.	0.007	1.33	0.000	-0.59	13	MU583086	het
13	113975768	113975768	T	C	LAMP1	exonic	nonsynonymous SNV	ENSG00000185896	rs9577230	ENSG00000185896:ENST00000397181:exon6:c.T767C:p.I256T,ENSG00000185896:ENST00000332556:exon7:c.T926C:p.I309T	LAMP1:NM_005561:exon7:c.T926C:p.I309T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0256	0.0295	0.0644968	0.0385	-1.705	0.002	1.0	0.566	0.084	.	.	.	LAMP1:uc010tka.1:exon6:c.T767C:p.I256T,LAMP1:uc001vtm.1:exon7:c.T926C:p.I309T	-0.963	AFR:0.1006,AMR:0.0382,EAS:0.1404,FIN:0.0086,NFE:0.0007,OTH:0.0173,ASJ:0	153330	.	.	.	.	.	.	.	0.0	1.55	0.000	-1.395	13	MU583087	het
13	113975894	113975894	C	T	LAMP1	exonic	synonymous SNV	ENSG00000185896	rs2270393	ENSG00000185896:ENST00000397181:exon7:c.C807T:p.N269N,ENSG00000185896:ENST00000332556:exon8:c.C966T:p.N322N	LAMP1:NM_005561:exon8:c.C966T:p.N322N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0179	0.0019	0.0353435	0.0117	.	.	.	.	.	.	.	.	LAMP1:uc010tka.1:exon7:c.C807T:p.N269N,LAMP1:uc001vtm.1:exon8:c.C966T:p.N322N	.	AFR:0.0061,AMR:0.0322,EAS:0.1439,FIN:0.0086,NFE:0.0005,OTH:0.0122,ASJ:0	153330	.	.	.	.	.	.	.	.	.	.	.	13	MU720300	het
14	20813289	20813289	G	A	PARP2	intronic	.	ENSG00000254846	rs2297616	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2459	0.1972	0.205471	0.2123	.	.	.	.	.	0.0002	0.08	.	.	.	AFR:0.0834,AMR:0.2494,EAS:0.1900,FIN:0.2943,NFE:0.2654,OTH:0.2597,ASJ:0.2152	607725	.	.	.	.	.	.	.	.	.	.	.	14	MU638667	hom
14	20815013	20815013	C	T	PARP2	intronic	.	ENSG00000254846	rs1713430	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4150	0.4595	0.516573	MU12429369	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.4596,EAS:0.4387,FIN:0.3389,NFE:0.3596,OTH:0.3623,ASJ:0.7040	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.3599
14	20825321	20825321	-	TTCAC	PARP2	intronic	.	ENSG00000129484	rs10625811	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2710	0.2235	.	.	.	.	.	.	.	.	.	.	PARP2:uc010tle.2:exon7:c.730_731insTTCAC:p.Y244fs	.	AFR:0.2449,AMR:0.1465,EAS:0.2252,FIN:0.2691,NFE:0.2970,OTH:0.2848,ASJ:0.2644	607725	.	.	.	.	.	.	.	.	.	.	.	14	11(upper_aerodigestive_tract)	0.2746
14	20825323	20825323	T	G	PARP2	intronic	.	ENSG00000129484	rs200223594	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2712	.	0.249201	1(liver)	.	.	.	.	.	.	.	.	PARP2:uc010tle.2:exon7:c.T732G:p.Y244X	.	AFR:MU12429430,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1462,FIN:0.2644,NFE:0.2252,OTH:0.2687,ASJ:0.2446	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.2970
14	20825965	20825965	A	C	PARP2	UTR3	.	ENSG00000129484	rs2700	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2799	0.2325	0.23722	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	.	.	AFR:0.2396,AMR:0.0988,EAS:0.2517,FIN:0.2741,NFE:0.3115,OTH:0.2969,ASJ:0.2697	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.2770
14	20925154	20925154	T	G	APEX1	exonic	nonsynonymous SNV	ENSG00000100823	rs1130409	ENSG00000100823:ENST00000216714:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000398030:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000553681:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000555414:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000556054:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000557150:exon5:c.T393G:p.D131E,ENSG00000100823:ENST00000557592:exon5:c.T393G:p.D131E	APEX1:NM_001244249:exon5:c.T444G:p.D148E,APEX1:NM_001641:exon5:c.T444G:p.D148E,APEX1:NM_080648:exon5:c.T444G:p.D148E,APEX1:NM_080649:exon5:c.T444G:p.D148E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4280	0.4356	0.375599	COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	-1.666	0.002	1.0	-2.6	0.267	.	.	Endonuclease/exonuclease/phosphatase	APEX1:uc001vxg.3:exon5:c.T444G:p.D148E,APEX1:uc001vxh.3:exon5:c.T444G:p.D148E,APEX1:uc001vxi.3:exon5:c.T444G:p.D148E,APEX1:uc021rnr.1:exon5:c.T444G:p.D148E	-1.027	AFR:0.4400,AMR:0.3563,EAS:0.3675,FIN:0.3941,NFE:0.5232,OTH:0.4764,ASJ:0.4141	107748	.	.	.	.	.	.	.	0.0	-1.31	0.000	0.625	14	1(large_intestine)	0.4508
14	21871653	21871653	C	T	CHD8	exonic	synonymous SNV	ENSG00000100888	rs8022395	ENSG00000100888:ENST00000399982:exon16:c.G3477A:p.V1159V,ENSG00000100888:ENST00000430710:exon17:c.G2640A:p.V880V,ENSG00000100888:ENST00000557364:exon17:c.G3477A:p.V1159V	CHD8:NM_001170629:exon17:c.G3477A:p.V1159V,CHD8:NM_020920:exon17:c.G2640A:p.V880V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9093	0.9410	0.907348	0.9174	.	.	.	.	.	.	.	.	CHD8:uc001wav.1:exon7:c.G966A:p.V322V,CHD8:uc001war.2:exon16:c.G3477A:p.V1159V,CHD8:uc001was.2:exon17:c.G2640A:p.V880V	.	AFR:0.9449,AMR:0.7943,EAS:0.8552,FIN:0.8938,NFE:0.9202,OTH:0.9121,ASJ:0.9536	610528	615032;	.	.	.	.	.	.	.	.	.	.	14	MU14351469	hom
14	21899631	21899631	C	T	CHD8	exonic	nonsynonymous SNV	ENSG00000100888	rs10467770	ENSG00000100888:ENST00000399982:exon1:c.G172A:p.V58M,ENSG00000100888:ENST00000557364:exon2:c.G172A:p.V58M,ENSG00000100888:ENST00000553622:exon4:c.G97A:p.V33M	CHD8:NM_001170629:exon2:c.G172A:p.V58M	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2516	0.2462	0.252796	MU4553303	0.062	3.209	0.002	0.251	0.973	.	.	.	CHD8:uc001war.2:exon1:c.G172A:p.V58M	-1.066	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,AMR:0.2585,EAS:0.1770,FIN:0.1821,NFE:0.3288,OTH:0.2514,ASJ:0.2396	610528	615032;	.	.	.	.	.	.	.	-2.77	0.000	0	14	1(large_intestine)	0.2691
14	23777374	23777374	A	G	BCL2L2;BCL2L2-PABPN1	exonic	nonsynonymous SNV	ENSG00000129473;ENSG00000258643	rs910332	ENSG00000258643:ENST00000557008:exon2:c.A398G:p.Q133R,ENSG00000129473:ENST00000250405:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000553781:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000556100:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557236:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557579:exon3:c.A398G:p.Q133R	BCL2L2:NM_001199839:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:NM_001199864:exon3:c.A398G:p.Q133R,BCL2L2:NM_004050:exon3:c.A398G:p.Q133R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9979	0.9977	0.999401	0.9983	-0.797	0.043	0.187	1.43	0.992	.	.	.	BCL2L2:uc001wji.4:exon2:c.A398G:p.Q133R,BCL2L2:uc001wjg.4:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:uc001wjh.4:exon3:c.A398G:p.Q133R,BCL2L2:uc021rqx.1:exon3:c.A398G:p.Q133R	-1.011	AFR:0.9993,AMR:0.9988,EAS:1,FIN:1,NFE:0.9970,OTH:0.9990,ASJ:1	.	.	.	.	.	.	.	.	0.0	1.1	0.000	0.11	14	MU4559093	hom
14	23901012	23901012	T	C	MYH7	exonic	synonymous SNV	ENSG00000092054	rs2069541	ENSG00000092054:ENST00000355349:exon7:c.A597G:p.A199A	MYH7:NM_000257:exon7:c.A597G:p.A199A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0109	0.0108	0.00579073	0.0078	.	.	.	.	.	.	.	.	MYH7:uc001wjx.3:exon7:c.A597G:p.A199A	.	AFR:0.0026,AMR:0.0060,EAS:0,FIN:0.0034,NFE:0.0127,OTH:0.0112,ASJ:0.0033	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	.	het
14	23902753	23902753	G	A	MYH7	exonic	synonymous SNV	ENSG00000092054	rs2069540	ENSG00000092054:ENST00000355349:exon3:c.C189T:p.T63T	MYH7:NM_000257:exon3:c.C189T:p.T63T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4888	0.5275	0.520367	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MYH7:uc001wjx.3:exon3:c.C189T:p.T63T	.	AFR:0.5085,AMR:0.6281,EAS:0.4603,FIN:0.3933,NFE:0.4186,OTH:0.4778,ASJ:0.4510	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	1(large_intestine)	0.4898
14	30047580	30047580	C	T	PRKD1	intronic	.	ENSG00000184304	rs2273815	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6894	0.7311	0.626398	LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.7117,AMR:0.7253,EAS:0.6623,FIN:0.5692,NFE:0.6564,OTH:0.7390,ASJ:0.6366	605435	.	.	.	.	.	.	.	.	.	.	.	14	2(lung)	0.6743
14	30066929	30066929	A	G	PRKD1	exonic	synonymous SNV	ENSG00000184304	rs2230505	ENSG00000184304:ENST00000331968:exon16:c.T2202C:p.I734I,ENSG00000184304:ENST00000415220:exon17:c.T2226C:p.I742I	PRKD1:NM_002742:exon16:c.T2202C:p.I734I,PRKD1:NM_001330069:exon17:c.T2226C:p.I742I,PRKD1:NM_001348390:exon17:c.T1938C:p.I646I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4350	0.5095	0.511781	MU133037	.	.	.	.	.	.	.	.	PRKD1:uc001wqh.3:exon16:c.T2202C:p.I734I	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,AMR:0.4944,EAS:0.4590,FIN:0.3311,NFE:0.2010,OTH:0.4068,ASJ:0.7796	605435	.	.	.	.	.	.	.	.	.	.	.	14	3(haematopoietic_and_lymphoid_tissue)	0.3912
14	30066976	30066976	A	T	PRKD1	intronic	.	ENSG00000184304	rs3783299	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4170	0.4305	0.430711	0.4260	.	.	.	.	.	0.2090	0.472	.	.	.	AFR:0.5418,AMR:0.4356,EAS:0.2017,FIN:0.4064,NFE:0.3902,OTH:0.4031,ASJ:0.3333	605435	.	.	.	.	.	.	.	.	.	.	.	14	MU12450159	hom
14	30194899	30194899	T	C	PRKD1	intronic	.	ENSG00000184304	rs11626603	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1972	0.1821	0.164537	0.1821	.	.	.	.	.	.	.	.	.	.	AFR:0.1315,AMR:0.2584,EAS:0.0438,FIN:0.1874,NFE:0.2180,OTH:0.2138,ASJ:0.2285	605435	.	.	.	.	.	.	.	.	.	.	.	14	MU82277372	hom
14	30396622	30396622	-	CCCGGA	PRKD1	exonic	nonframeshift insertion	ENSG00000184304	rs45471692	ENSG00000184304:ENST00000331968:exon1:c.96_97insTCCGGG:p.P33delinsSGP,ENSG00000184304:ENST00000415220:exon1:c.96_97insTCCGGG:p.P33delinsSGP	PRKD1:NM_001330069:exon1:c.96_97insTCCGGG:p.P33delinsSGP,PRKD1:NM_002742:exon1:c.96_97insTCCGGG:p.P33delinsSGP	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0651	0.0346	0.0684904	0.0442	.	.	.	.	.	.	.	.	PRKD1:uc001wqh.3:exon1:c.96_97insTCCGGG:p.P33delinsSGP	.	AFR:0.0132,AMR:0.0457,EAS:0.1667,FIN:0.0219,NFE:0.0536,OTH:0.0424,ASJ:0.0278	605435	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	35242828	35242828	G	A	BAZ1A	exonic	synonymous SNV	ENSG00000198604	rs2275145	ENSG00000198604:ENST00000358716:exon19:c.C3006T:p.D1002D,ENSG00000198604:ENST00000382422:exon19:c.C3102T:p.D1034D,ENSG00000198604:ENST00000360310:exon20:c.C3102T:p.D1034D	BAZ1A:NM_182648:exon19:c.C3006T:p.D1002D,BAZ1A:NM_013448:exon20:c.C3102T:p.D1034D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5180	0.4943	0.515375	0.5217	.	.	.	.	.	.	.	.	BAZ1A:uc001wsl.3:exon19:c.C3006T:p.D1002D,BAZ1A:uc001wsk.3:exon20:c.C3102T:p.D1034D	.	AFR:0.4800,AMR:0.5744,EAS:0.4715,FIN:0.5963,NFE:0.5292,OTH:0.5609,ASJ:0.5	605680	.	.	.	.	.	.	.	.	.	.	.	14	MU643123	hom
14	35263983	35263983	T	C	BAZ1A	exonic	synonymous SNV	ENSG00000198604	rs17102745	ENSG00000198604:ENST00000382422:exon10:c.A1335G:p.Q445Q,ENSG00000198604:ENST00000358716:exon11:c.A1335G:p.Q445Q,ENSG00000198604:ENST00000360310:exon11:c.A1335G:p.Q445Q	BAZ1A:NM_013448:exon11:c.A1335G:p.Q445Q,BAZ1A:NM_182648:exon11:c.A1335G:p.Q445Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1032	0.1008	0.115815	.	.	.	.	.	.	.	.	.	BAZ1A:uc001wsk.3:exon11:c.A1335G:p.Q445Q,BAZ1A:uc001wsl.3:exon11:c.A1335G:p.Q445Q	.	AFR:0.1011,AMR:0.1161,EAS:0.1457,FIN:0.0290,NFE:0.0865,OTH:0.1032,ASJ:0.0847	605680	.	.	.	.	.	.	.	.	.	.	.	14	1(breast)	0.1061
14	35264033	35264033	G	A	BAZ1A	exonic	synonymous SNV	ENSG00000198604	rs145022216	ENSG00000198604:ENST00000382422:exon10:c.C1285T:p.L429L,ENSG00000198604:ENST00000358716:exon11:c.C1285T:p.L429L,ENSG00000198604:ENST00000360310:exon11:c.C1285T:p.L429L	BAZ1A:NM_013448:exon11:c.C1285T:p.L429L,BAZ1A:NM_182648:exon11:c.C1285T:p.L429L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0008	0.0005	0.000599042	0.0005	.	.	.	.	.	.	.	.	BAZ1A:uc001wsk.3:exon11:c.C1285T:p.L429L,BAZ1A:uc001wsl.3:exon11:c.C1285T:p.L429L	.	AFR:0.0006,AMR:0,EAS:0,FIN:0.0014,NFE:0.0005,OTH:0,ASJ:0	605680	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	36988505	36988505	G	A	NKX2-1	exonic	synonymous SNV	ENSG00000136352	.	ENSG00000136352:ENST00000498187:exon1:c.C58T:p.L20L,ENSG00000136352:ENST00000354822:exon2:c.C148T:p.L50L,ENSG00000136352:ENST00000518149:exon2:c.C58T:p.L20L,ENSG00000136352:ENST00000522719:exon3:c.C58T:p.L20L	NKX2-1:NM_003317:exon1:c.C58T:p.L20L,NKX2-1:NM_001079668:exon2:c.C148T:p.L50L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	NKX2-1:uc001wtt.3:exon1:c.C58T:p.L20L,NKX2-1:uc001wtu.3:exon2:c.C148T:p.L50L,NKX2-1:uc001wtv.3:exon3:c.C58T:p.L20L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600635	118700;188550;610978;	209905;146;319487;1429;	209905|Choreoathetosis-hypothyroidism-neonatal respiratory distress syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610978 ~146|Papillary or follicular thyroid carcinoma<br>Well-differentiated thyroid carcinoma|Unknown|Not applicable|Adult|188550 607464 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~1429|Hereditary benign chorea|-|Autosomal dominant|Infancy<br>Childhood|118700 215450 ~	.	.	.	.	.	.	.	.	14	.	het
14	39648629	39648629	C	T	PNN	exonic	synonymous SNV	ENSG00000100941	rs11558739	ENSG00000100941:ENST00000216832:exon8:c.C756T:p.T252T	PNN:NM_002687:exon8:c.C756T:p.T252T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1361	0.1292	0.124601	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	PNN:uc001wuw.4:exon8:c.C756T:p.T252T	.	AFR:0.1248,AMR:0.1432,EAS:0.11,FIN:0.0959,NFE:0.1494,OTH:0.1089,ASJ:0.1799	603154	.	.	.	.	.	.	.	.	.	.	.	14	1(lung)	0.1209
14	39650234	39650234	A	T	PNN	exonic	nonsynonymous SNV	ENSG00000100941	rs2180792	ENSG00000100941:ENST00000216832:exon9:c.A1321T:p.T441S	PNN:NM_002687:exon9:c.A1321T:p.T441S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9155	0.9383	0.902955	0.9305	-1.118	0.009	0.642	3.5	0.998	.	.	.	PNN:uc001wuw.4:exon9:c.A1321T:p.T441S	-0.938	AFR:0.9297,AMR:0.8473,EAS:0.95,FIN:0.9210,NFE:0.9360,OTH:0.9277,ASJ:0.9238	603154	.	.	.	.	.	.	.	.	0.95	0.000	.	14	MU81947250	hom
14	50585248	50585248	C	T	SOS2	exonic	synonymous SNV	ENSG00000100485	rs2227276	ENSG00000100485:ENST00000543680:exon22:c.G3714A:p.P1238P,ENSG00000100485:ENST00000216373:exon23:c.G3813A:p.P1271P	SOS2:NM_006939:exon23:c.G3813A:p.P1271P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1980	0.1721	0.243211	ESAD-UK|1|409|0.00244499,LAML-KR|5|205|0.0243902,LUSC-KR|1|170|0.00588235,COCA-CN|7|321|0.0218069	.	.	.	.	.	.	.	.	SOS2:uc010ans.3:exon4:c.G318A:p.P106P,SOS2:uc010tql.2:exon22:c.G3714A:p.P1238P,SOS2:uc001wxs.4:exon23:c.G3813A:p.P1271P	.	AFR:0.2030,AMR:0.2141,EAS:0.1225,FIN:0.4511,NFE:0.1942,OTH:0.1721,ASJ:0.2434	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	3(haematopoietic_and_lymphoid_tissue)	0.1878
14	50605507	50605507	-	A	SOS2	intronic	.	ENSG00000100485	rs201957103	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1942	0.1582	0.241613	0.2343	.	.	.	.	.	.	.	.	.	.	AFR:0.2389,AMR:0.2434,EAS:0.4571,FIN:0.2691,NFE:0.2029,OTH:0.2188,ASJ:0.1371	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	.	hom
14	51192659	51192659	G	A	NIN	exonic	synonymous SNV	ENSG00000100503	rs1983764	ENSG00000100503:ENST00000382043:exon28:c.C4065T:p.P1355P,ENSG00000100503:ENST00000382041:exon30:c.C6204T:p.P2068P	NIN:NM_016350:exon29:c.C4065T:p.P1355P,NIN:NM_182946:exon30:c.C6204T:p.P2068P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3321	0.2643	0.244609	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	NIN:uc001wyk.3:exon29:c.C4065T:p.P1355P,NIN:uc001wym.2:exon30:c.C6204T:p.P2068P	.	AFR:0.2928,AMR:0.0781,EAS:0.3067,FIN:0.3238,NFE:0.4203,OTH:0.3811,ASJ:0.2835	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(large_intestine)	0.3538
14	51202311	51202311	G	C	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs2295847	ENSG00000100503:ENST00000485005:exon3:c.C253G:p.Q85E,ENSG00000100503:ENST00000382043:exon26:c.C3661G:p.Q1221E,ENSG00000100503:ENST00000530997:exon26:c.C5800G:p.Q1934E,ENSG00000100503:ENST00000389868:exon27:c.C3661G:p.Q1221E,ENSG00000100503:ENST00000245441:exon28:c.C5800G:p.Q1934E,ENSG00000100503:ENST00000324330:exon28:c.C5800G:p.Q1934E,ENSG00000100503:ENST00000382041:exon28:c.C5800G:p.Q1934E,ENSG00000100503:ENST00000453196:exon28:c.C5800G:p.Q1934E,ENSG00000100503:ENST00000476352:exon28:c.C5800G:p.Q1934E	NIN:NM_016350:exon27:c.C3661G:p.Q1221E,NIN:NM_020921:exon28:c.C5800G:p.Q1934E,NIN:NM_182944:exon28:c.C5800G:p.Q1934E,NIN:NM_182946:exon28:c.C5800G:p.Q1934E	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1494	0.0794	0.193291	MU123094	3.314	22.9	0.157	3.55	0.992	.	.	.	NIN:uc001wyk.3:exon27:c.C3661G:p.Q1221E,NIN:uc001wyi.3:exon28:c.C5800G:p.Q1934E,NIN:uc001wym.2:exon28:c.C5800G:p.Q1934E,NIN:uc001wyo.3:exon28:c.C5800G:p.Q1934E	-0.901	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.1212,EAS:0.2416,FIN:0.0464,NFE:0.5155,OTH:0.1486,ASJ:0.0239	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.094	3.65	0.000	1.04	14	1(large_intestine)	0.1216
14	51204996	51204996	C	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs11376	ENSG00000100503:ENST00000485005:exon2:c.G90A:p.Q30Q,ENSG00000100503:ENST00000382043:exon25:c.G3498A:p.Q1166Q,ENSG00000100503:ENST00000530997:exon25:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000389868:exon26:c.G3498A:p.Q1166Q,ENSG00000100503:ENST00000245441:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000324330:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000382041:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000453196:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000476352:exon27:c.G5637A:p.Q1879Q	NIN:NM_016350:exon26:c.G3498A:p.Q1166Q,NIN:NM_020921:exon27:c.G5637A:p.Q1879Q,NIN:NM_182944:exon27:c.G5637A:p.Q1879Q,NIN:NM_182946:exon27:c.G5637A:p.Q1879Q	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5044	0.5779	0.508786	0.5656	.	.	.	.	.	.	.	.	NIN:uc001wyk.3:exon26:c.G3498A:p.Q1166Q,NIN:uc001wyi.3:exon27:c.G5637A:p.Q1879Q,NIN:uc001wym.2:exon27:c.G5637A:p.Q1879Q,NIN:uc001wyo.3:exon27:c.G5637A:p.Q1879Q	.	AFR:0.6990,AMR:0.4125,EAS:0.3525,FIN:0.5467,NFE:0.5282,OTH:0.5092,ASJ:0.5533	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU23624074	het
14	51206021	51206021	A	G	NIN	intronic	.	ENSG00000100503	rs3015485	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9976	0.9913	0.992612	0.9927	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9748,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947943	hom
14	51223789	51223789	C	T	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs2073347	ENSG00000100503:ENST00000530997:exon16:c.G3959A:p.G1320E,ENSG00000100503:ENST00000245441:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000324330:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000382041:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000453196:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000476352:exon18:c.G3959A:p.G1320E	NIN:NM_020921:exon18:c.G3959A:p.G1320E,NIN:NM_182944:exon18:c.G3959A:p.G1320E,NIN:NM_182946:exon18:c.G3959A:p.G1320E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7454	0.7922	0.764377	MU28671496	1.353	12.54	1.0	6.06	0.945	.	.	.	NIN:uc001wyi.3:exon18:c.G3959A:p.G1320E,NIN:uc001wym.2:exon18:c.G3959A:p.G1320E,NIN:uc001wyo.3:exon18:c.G3959A:p.G1320E	-0.997	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7599,EAS:0.8353,FIN:0.8245,NFE:0.6617,OTH:0.6770,ASJ:0.8613	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.8	0.000	-2.085	14	2(lung)	0.7277
14	51224374	51224374	T	G	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs12882191	ENSG00000100503:ENST00000530997:exon16:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000245441:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000324330:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000382041:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000453196:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000476352:exon18:c.A3374C:p.Q1125P	NIN:NM_020921:exon18:c.A3374C:p.Q1125P,NIN:NM_182944:exon18:c.A3374C:p.Q1125P,NIN:NM_182946:exon18:c.A3374C:p.Q1125P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7533	0.8076	0.784944	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	-2.411	0.001	1.0	4.07	0.000	.	.	.	NIN:uc001wyi.3:exon18:c.A3374C:p.Q1125P,NIN:uc001wym.2:exon18:c.A3374C:p.Q1125P,NIN:uc001wyo.3:exon18:c.A3374C:p.Q1125P	-1.024	AFR:0.7732,AMR:0.9003,EAS:0.8245,FIN:0.6792,NFE:0.6768,OTH:0.7299,ASJ:0.8421	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.58	0.000	-2.125	14	1(liver)	0.7281
14	51224658	51224658	T	A	NIN	exonic	synonymous SNV	ENSG00000100503	rs2073348	ENSG00000100503:ENST00000530997:exon16:c.A3090T:p.S1030S,ENSG00000100503:ENST00000245441:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000324330:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000382041:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000453196:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000476352:exon18:c.A3090T:p.S1030S	NIN:NM_020921:exon18:c.A3090T:p.S1030S,NIN:NM_182944:exon18:c.A3090T:p.S1030S,NIN:NM_182946:exon18:c.A3090T:p.S1030S	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3248	0.2751	0.320887	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.A3090T:p.S1030S,NIN:uc001wym.2:exon18:c.A3090T:p.S1030S,NIN:uc001wyo.3:exon18:c.A3090T:p.S1030S	.	AFR:MU12492660,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.1963,FIN:0.4511,NFE:0.3245,OTH:0.5180,ASJ:0.2960	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(liver)	0.3312
14	51225132	51225132	G	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs2073349	ENSG00000100503:ENST00000530997:exon16:c.C2616A:p.A872A,ENSG00000100503:ENST00000245441:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000324330:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000382041:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000453196:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000476352:exon18:c.C2616A:p.A872A	NIN:NM_020921:exon18:c.C2616A:p.A872A,NIN:NM_182944:exon18:c.C2616A:p.A872A,NIN:NM_182946:exon18:c.C2616A:p.A872A	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3775	0.3411	0.38758	MU718965	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.C2616A:p.A872A,NIN:uc001wym.2:exon18:c.C2616A:p.A872A,NIN:uc001wyo.3:exon18:c.C2616A:p.A872A	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3583,EAS:0.4964,FIN:0.3974,NFE:0.5248,OTH:0.3697,ASJ:0.2917	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(lung)	0.3667
14	51237701	51237701	A	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs17793018	ENSG00000100503:ENST00000530997:exon9:c.T1128C:p.V376V,ENSG00000100503:ENST00000382043:exon10:c.T1128C:p.V376V,ENSG00000100503:ENST00000245441:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000324330:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000382041:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000389868:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453196:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453401:exon11:c.T1014C:p.V338V,ENSG00000100503:ENST00000476352:exon11:c.T1128C:p.V376V	NIN:NM_016350:exon11:c.T1128C:p.V376V,NIN:NM_020921:exon11:c.T1128C:p.V376V,NIN:NM_182944:exon11:c.T1128C:p.V376V,NIN:NM_182946:exon11:c.T1128C:p.V376V	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6207	0.5033	0.577276	0.5651	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon11:c.T1128C:p.V376V,NIN:uc001wyk.3:exon11:c.T1128C:p.V376V,NIN:uc001wym.2:exon11:c.T1128C:p.V376V,NIN:uc001wyo.3:exon11:c.T1128C:p.V376V,NIN:uc001wyp.1:exon11:c.T1014C:p.V338V	.	AFR:0.2872,AMR:0.6611,EAS:0.8744,FIN:0.6938,NFE:0.6522,OTH:0.6663,ASJ:0.5232	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU123123	hom
14	51239067	51239067	C	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs8020503	ENSG00000100503:ENST00000530997:exon7:c.G933C:p.L311L,ENSG00000100503:ENST00000382043:exon8:c.G933C:p.L311L,ENSG00000100503:ENST00000245441:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000324330:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000382041:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000389868:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453196:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453401:exon9:c.G819C:p.L273L,ENSG00000100503:ENST00000476352:exon9:c.G933C:p.L311L	NIN:NM_016350:exon9:c.G933C:p.L311L,NIN:NM_020921:exon9:c.G933C:p.L311L,NIN:NM_182944:exon9:c.G933C:p.L311L,NIN:NM_182946:exon9:c.G933C:p.L311L	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9973	0.9907	0.992412	0.9924	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon9:c.G933C:p.L311L,NIN:uc001wyk.3:exon9:c.G933C:p.L311L,NIN:uc001wym.2:exon9:c.G933C:p.L311L,NIN:uc001wyo.3:exon9:c.G933C:p.L311L,NIN:uc001wyp.1:exon9:c.G819C:p.L273L	.	AFR:0.9735,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947976	hom
14	58831142	58831142	A	G	ARID4A	exonic	nonsynonymous SNV	ENSG00000032219	rs1051858	ENSG00000032219:ENST00000417477:exon10:c.A1369G:p.T457A,ENSG00000032219:ENST00000431317:exon19:c.A2335G:p.T779A,ENSG00000032219:ENST00000348476:exon20:c.A2335G:p.T779A,ENSG00000032219:ENST00000355431:exon20:c.A2335G:p.T779A,ENSG00000032219:ENST00000395168:exon20:c.A2335G:p.T779A	ARID4A:NM_002892:exon20:c.A2335G:p.T779A,ARID4A:NM_023000:exon20:c.A2335G:p.T779A,ARID4A:NM_023001:exon20:c.A2335G:p.T779A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3469	0.3343	0.349441	ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916	-0.834	0.036	1.0	1.52	0.981	.	.	.	ARID4A:uc010apg.1:exon10:c.A1369G:p.T457A,ARID4A:uc001xdo.3:exon20:c.A2335G:p.T779A,ARID4A:uc001xdp.3:exon20:c.A2335G:p.T779A,ARID4A:uc001xdq.3:exon20:c.A2335G:p.T779A	-0.927	AFR:0.3607,AMR:0.3597,EAS:0.2252,FIN:0.4833,NFE:0.4114,OTH:0.3438,ASJ:0.2957	180201	.	.	.	.	.	.	.	0.0	2.59	0.000	-0.345	14	1(pancreas)	0.3447
14	58838668	58838668	A	G	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs1051860	ENSG00000032219:ENST00000431317:exon22:c.A3528G:p.S1176S,ENSG00000032219:ENST00000348476:exon23:c.A3528G:p.S1176S,ENSG00000032219:ENST00000355431:exon24:c.A3735G:p.S1245S,ENSG00000032219:ENST00000395168:exon24:c.A3573G:p.S1191S	ARID4A:NM_023001:exon23:c.A3528G:p.S1176S,ARID4A:NM_002892:exon24:c.A3735G:p.S1245S,ARID4A:NM_023000:exon24:c.A3573G:p.S1191S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.5303	0.539137	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ARID4A:uc001xdq.3:exon23:c.A3528G:p.S1176S,ARID4A:uc001xdo.3:exon24:c.A3573G:p.S1191S,ARID4A:uc001xdp.3:exon24:c.A3735G:p.S1245S	.	AFR:1(oesophagus),AMR:MU791666,EAS:0.5370,FIN:0.4099,NFE:0.6571,OTH:0.5767,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	180201	.	.	.	.	.	.	.	.	.	.	.	14	1(lung)	0.5118
14	58838701	58838701	C	T	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs1051861	ENSG00000032219:ENST00000431317:exon22:c.C3561T:p.C1187C,ENSG00000032219:ENST00000348476:exon23:c.C3561T:p.C1187C,ENSG00000032219:ENST00000355431:exon24:c.C3768T:p.C1256C,ENSG00000032219:ENST00000395168:exon24:c.C3606T:p.C1202C	ARID4A:NM_023001:exon23:c.C3561T:p.C1187C,ARID4A:NM_002892:exon24:c.C3768T:p.C1256C,ARID4A:NM_023000:exon24:c.C3606T:p.C1202C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5737	0.5220	0.531949	1(breast)	.	.	.	.	.	.	.	.	ARID4A:uc001xdq.3:exon23:c.C3561T:p.C1187C,ARID4A:uc001xdo.3:exon24:c.C3606T:p.C1202C,ARID4A:uc001xdp.3:exon24:c.C3768T:p.C1256C	.	AFR:1(oesophagus),AMR:MU791663,EAS:0.5304,FIN:0.3867,NFE:0.6567,OTH:0.5767,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	180201	.	.	.	.	.	.	.	.	.	.	.	14	1(stomach)	0.5137
14	61445967	61445967	A	G	TRMT5	exonic	nonsynonymous SNV	ENSG00000126814	rs7142228	ENSG00000126814:ENST00000261249:exon2:c.T649C:p.S217P	TRMT5:NM_001350253:exon2:c.T733C:p.S245P,TRMT5:NM_001350254:exon2:c.T730C:p.S244P,TRMT5:NM_020810:exon2:c.T649C:p.S217P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	TRMT5:uc001xff.4:exon2:c.T649C:p.S217P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	611023	616539;	.	.	.	.	.	.	.	.	.	.	14	MU81949241	hom
14	64699940	64699940	C	T	ESR2	exonic	nonsynonymous SNV	ENSG00000140009	rs188329310	ENSG00000140009:ENST00000267525:exon7:c.G1235A:p.C412Y,ENSG00000140009:ENST00000341099:exon9:c.G1508A:p.C503Y	ESR2:NM_001271877:exon6:c.G1235A:p.C412Y,ESR2:NM_001437:exon9:c.G1508A:p.C503Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	0.0001	.	0.000399361	9.688e-05	-1.550	0.002	0.975	-2.51	0.282	.	.	Nuclear hormone receptor, ligand-binding domain	ESR2:uc010aqc.1:exon6:c.G1235A:p.C412Y,ESR2:uc001xha.1:exon9:c.G1508A:p.C503Y	-0.765	AFR:0,AMR:0,EAS:0.0012,FIN:0,NFE:6.664e-05,OTH:0,ASJ:0	601663	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04929 GnRH secretion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-2.1	0.324	-1.61	14	.	het
14	67147816	67147816	T	C	GPHN	intronic	.	ENSG00000171723	rs3759753	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2661	0.3141	0.45028	MU583252	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3165,EAS:0.4017,FIN:0.2483,NFE:0.4813,OTH:0.1581,ASJ:0.6641	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	2(haematopoietic_and_lymphoid_tissue)	0.1373
14	67291186	67291186	T	C	GPHN	intronic	.	ENSG00000171723	rs3784075	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1856	0.2184	0.38119	MU645105	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.2249,EAS:0.3301,FIN:0.0695,NFE:0.4763,OTH:0.0866,ASJ:0.5662	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.0364
14	75483812	75483812	T	C	MLH3	exonic	synonymous SNV	ENSG00000119684	rs13712	ENSG00000119684:ENST00000554697:exon4:c.A348G:p.Q116Q,ENSG00000119684:ENST00000556257:exon7:c.A3801G:p.Q1267Q,ENSG00000119684:ENST00000238662:exon12:c.A4263G:p.Q1421Q,ENSG00000119684:ENST00000380968:exon12:c.A1149G:p.Q383Q,ENSG00000119684:ENST00000556740:exon12:c.A4335G:p.Q1445Q,ENSG00000119684:ENST00000355774:exon13:c.A4335G:p.Q1445Q	MLH3:NM_014381:exon12:c.A4263G:p.Q1421Q,MLH3:NM_001040108:exon13:c.A4335G:p.Q1445Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5634	0.5019	0.580072	0.5295	.	.	.	.	.	.	.	.	MLH3:uc001xre.1:exon12:c.A4263G:p.Q1421Q,MLH3:uc001xrd.1:exon13:c.A4335G:p.Q1445Q	.	AFR:0.4433,AMR:0.7076,EAS:0.8401,FIN:0.5384,NFE:0.5341,OTH:0.5491,ASJ:0.4570	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	.	.	.	.	14	MU16492371	het
14	75513721	75513721	G	C	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs201453923	ENSG00000119684:ENST00000556740:exon1:c.C2638G:p.L880V,ENSG00000119684:ENST00000238662:exon2:c.C2638G:p.L880V,ENSG00000119684:ENST00000355774:exon2:c.C2638G:p.L880V,ENSG00000119684:ENST00000556257:exon2:c.C2638G:p.L880V	MLH3:NM_001040108:exon2:c.C2638G:p.L880V,MLH3:NM_014381:exon2:c.C2638G:p.L880V	clinvar: Uncertain_significance 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	0.0002	7.7e-05	.	9.682e-05	2.181	17.39	0.02	3.76	0.651	.	.	.	MLH3:uc001xrd.1:exon2:c.C2638G:p.L880V,MLH3:uc001xre.1:exon2:c.C2638G:p.L880V	-0.270	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.577	-1.95	0.463	1.32	14	.	het
14	75513828	75513828	G	A	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175080	ENSG00000119684:ENST00000556740:exon1:c.C2531T:p.P844L,ENSG00000119684:ENST00000238662:exon2:c.C2531T:p.P844L,ENSG00000119684:ENST00000355774:exon2:c.C2531T:p.P844L,ENSG00000119684:ENST00000556257:exon2:c.C2531T:p.P844L	MLH3:NM_001040108:exon2:c.C2531T:p.P844L,MLH3:NM_014381:exon2:c.C2531T:p.P844L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4126	0.4426	0.363818	MU112082	0.239	5.081	0.286	4.12	0.920	.	.	.	MLH3:uc001xrd.1:exon2:c.C2531T:p.P844L,MLH3:uc001xre.1:exon2:c.C2531T:p.P844L	-0.979	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.4205,EAS:0.2788,FIN:0.5397,NFE:0.1481,OTH:0.4607,ASJ:0.3988	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.01	-1.43	0.000	1.15	14	2(lung)	0.4575
14	75513883	75513883	T	C	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175081	ENSG00000119684:ENST00000556740:exon1:c.A2476G:p.N826D,ENSG00000119684:ENST00000238662:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000355774:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000556257:exon2:c.A2476G:p.N826D	MLH3:NM_001040108:exon2:c.A2476G:p.N826D,MLH3:NM_014381:exon2:c.A2476G:p.N826D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9968	0.9888	0.990415	0.9902	-0.981	0.017	0.848	1.33	0.019	.	.	.	MLH3:uc001xrd.1:exon2:c.A2476G:p.N826D,MLH3:uc001xre.1:exon2:c.A2476G:p.N826D	-0.969	AFR:0.9660,AMR:0.9988,EAS:0.9994,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.001	-1.3	0.000	0	14	MU81951479	hom
14	81574959	81574959	A	G	TSHR	exonic	synonymous SNV	ENSG00000165409	rs3783942	ENSG00000165409:ENST00000342443:exon9:c.A696G:p.L232L,ENSG00000165409:ENST00000554435:exon9:c.A759G:p.L253L	TSHR:NM_001018036:exon9:c.A696G:p.L232L,TSHR:NM_001142626:exon9:c.A759G:p.L253L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6468	0.6438	0.611222	0.6259	.	.	.	.	.	.	.	.	TSHR:uc001xvc.3:exon9:c.A696G:p.L232L,TSHR:uc010tvs.2:exon9:c.A759G:p.L253L	.	AFR:0.6285,AMR:0.6635,EAS:0.3247,FIN:0.6673,NFE:0.6404,OTH:0.6612,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU16499962	hom
14	81575005	81575005	C	A	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs3783941	ENSG00000165409:ENST00000342443:exon9:c.C742A:p.R248S,ENSG00000165409:ENST00000554435:exon9:c.C805A:p.R269S	TSHR:NM_001018036:exon9:c.C742A:p.R248S,TSHR:NM_001142626:exon9:c.C805A:p.R269S	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6465	0.6425	0.610224	0.6233	0.085	3.453	1.0	-8.59	0.000	.	.	Leucine-rich repeat domain, L domain-like	TSHR:uc001xvc.3:exon9:c.C742A:p.R248S,TSHR:uc010tvs.2:exon9:c.C805A:p.R269S	-1.021	AFR:0.6213,AMR:0.6623,EAS:0.3224,FIN:0.6665,NFE:0.6397,OTH:0.6608,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-1.17	0.000	.	14	MU16500020	hom
14	81610583	81610583	G	C	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs1991517	ENSG00000165409:ENST00000298171:exon10:c.G2181C:p.E727D,ENSG00000165409:ENST00000541158:exon11:c.G2181C:p.E727D	TSHR:NM_000369:exon10:c.G2181C:p.E727D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9004	0.9233	0.896765	0.8977	-1.490	0.003	1.0	2.08	0.751	.	.	.	TSHR:uc001xvd.1:exon10:c.G2181C:p.E727D	-0.975	AFR:0.9392,AMR:0.8675,EAS:0.8100,FIN:0.8495,NFE:0.8968,OTH:0.8798,ASJ:0.9106	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-0.92	0.000	.	14	MU19600230	hom
14	92441066	92441066	C	T	TRIP11	exonic	nonsynonymous SNV	ENSG00000100815	rs1051340	ENSG00000100815:ENST00000267622:exon19:c.G5479A:p.G1827S	TRIP11:NM_001321851:exon19:c.G5476A:p.G1826S,TRIP11:NM_004239:exon19:c.G5479A:p.G1827S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3155	0.2933	0.271366	0.2923	3.315	22.9	0.045	3.9	0.123	.	.	.	TRIP11:uc010auf.2:exon13:c.G4687A:p.G1563S,TRIP11:uc001xzy.3:exon19:c.G5479A:p.G1827S	-0.973	AFR:0.2330,AMR:0.2012,EAS:0.3263,FIN:0.3179,NFE:0.3196,OTH:0.3033,ASJ:0.3940	604505	200600;	932;93299;	932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93299|Achondrogenesis, Houston-Harris type|Unknown|Autosomal recessive|Antenatal<br>Neonatal|200600 ~	.	.	.	.	0.973	3.52	0.000	1.805	14	MU126413	het
14	93263982	93263982	C	G	GOLGA5	exonic	nonsynonymous SNV	ENSG00000066455	rs17128572	ENSG00000066455:ENST00000163416:exon2:c.C200G:p.A67G,ENSG00000066455:ENST00000355976:exon2:c.C200G:p.A67G	GOLGA5:NM_005113:exon2:c.C200G:p.A67G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 1, 0] 	0.1030	0.0566	0.119409	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	4.676	24.5	0.233	5.65	0.989	.	.	.	GOLGA5:uc001yaz.1:exon2:c.C200G:p.A67G	-1.230	AFR:0.0811,AMR:0.0424,EAS:0.0364,FIN:0.1543,NFE:0.1271,OTH:0.0806,ASJ:0.1328	606918	.	.	.	.	.	.	.	0.983	0.98	0.001	2.33	14	2(haematopoietic_and_lymphoid_tissue)	0.1163
14	93275841	93275841	A	G	GOLGA5	exonic	synonymous SNV	ENSG00000066455	rs17128583	ENSG00000066455:ENST00000163416:exon4:c.A969G:p.E323E,ENSG00000066455:ENST00000355976:exon4:c.A969G:p.E323E	GOLGA5:NM_005113:exon4:c.A969G:p.E323E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1158	0.0558	0.136781	0.0839	.	.	.	.	.	.	.	.	GOLGA5:uc001yaz.1:exon4:c.A969G:p.E323E	.	AFR:0.0415,AMR:0.1325,EAS:0.1811,FIN:0.1309,NFE:0.0822,OTH:0.1327,ASJ:0.0364	606918	.	.	.	.	.	.	.	.	.	.	.	14	MU103173	het
14	93276654	93276654	T	C	GOLGA5	exonic	nonsynonymous SNV	ENSG00000066455	rs1040835	ENSG00000066455:ENST00000163416:exon5:c.T1048C:p.F350L,ENSG00000066455:ENST00000355976:exon5:c.T1048C:p.F350L	GOLGA5:NM_005113:exon5:c.T1048C:p.F350L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7999	0.7962	0.859625	MU103194	1.303	12.28	1.0	4.75	0.990	.	.	.	GOLGA5:uc001yaz.1:exon5:c.T1048C:p.F350L	-0.989	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.8175,EAS:0.8484,FIN:0.7252,NFE:0.8802,OTH:0.8143,ASJ:0.9357	606918	.	.	.	.	.	.	.	0.0	2.73	0.000	-1.975	14	1(thyroid)	0.7439
14	93286047	93286047	C	G	GOLGA5	intronic	.	ENSG00000066455	rs17128593	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1004	0.0465	0.111422	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	0.0005	0.048	.	.	.	AFR:0.0737,AMR:0.0165,EAS:0.0364,FIN:0.1549,NFE:0.1274,OTH:0.0808,ASJ:0.1280	606918	.	.	.	.	.	.	.	.	.	.	.	14	1(lung)	0.1163
14	94844843	94844843	T	G	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs1303	ENSG00000197249:ENST00000355814:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000393087:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000440909:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000404814:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000437397:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000449399:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000393088:exon7:c.A1200C:p.E400D,ENSG00000197249:ENST00000448921:exon7:c.A1200C:p.E400D	SERPINA1:NM_000295:exon5:c.A1200C:p.E400D,SERPINA1:NM_001002235:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127700:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127702:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127706:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127707:exon6:c.A1200C:p.E400D,SERPINA1:NM_001002236:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127701:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127703:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127704:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127705:exon7:c.A1200C:p.E400D	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2747	0.2071	0.280351	3(stomach)	-2.890	0.001	1.0	-9.02	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon5:c.A1200C:p.E400D,SERPINA1:uc001ycz.4:exon5:c.A1200C:p.E400D,SERPINA1:uc010aux.3:exon5:c.A1200C:p.E400D,SERPINA1:uc001ydc.4:exon6:c.A1200C:p.E400D,SERPINA1:uc010auz.3:exon6:c.A1200C:p.E400D,SERPINA1:uc010avb.3:exon6:c.A1200C:p.E400D,SERPINA1:uc001ycy.4:exon7:c.A1200C:p.E400D,SERPINA1:uc001ydb.4:exon7:c.A1200C:p.E400D,SERPINA1:uc010auw.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010auy.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010ava.3:exon7:c.A1200C:p.E400D	-0.918	AFR:4(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU158468,FIN:LAML-KR|2|205|0.0097561,GACA-CN|1|123|0.00813008,COCA-CN|3|321|0.00934579,NFE:0.2132,OTH:0.1141,ASJ:1(biliary_tract)	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-2.13	0.000	-0.585	14	1(prostate)	0.3441
14	94847285	94847285	A	G	SERPINA1	exonic	synonymous SNV	ENSG00000197249	rs1049800	ENSG00000197249:ENST00000489769:exon2:c.T840C:p.D280D,ENSG00000197249:ENST00000355814:exon3:c.T840C:p.D280D,ENSG00000197249:ENST00000393087:exon3:c.T840C:p.D280D,ENSG00000197249:ENST00000402629:exon3:c.T840C:p.D280D,ENSG00000197249:ENST00000440909:exon3:c.T840C:p.D280D,ENSG00000197249:ENST00000404814:exon4:c.T840C:p.D280D,ENSG00000197249:ENST00000437397:exon4:c.T840C:p.D280D,ENSG00000197249:ENST00000449399:exon4:c.T840C:p.D280D,ENSG00000197249:ENST00000393088:exon5:c.T840C:p.D280D,ENSG00000197249:ENST00000448921:exon5:c.T840C:p.D280D	SERPINA1:NM_000295:exon3:c.T840C:p.D280D,SERPINA1:NM_001002235:exon3:c.T840C:p.D280D,SERPINA1:NM_001127700:exon3:c.T840C:p.D280D,SERPINA1:NM_001127702:exon4:c.T840C:p.D280D,SERPINA1:NM_001127706:exon4:c.T840C:p.D280D,SERPINA1:NM_001127707:exon4:c.T840C:p.D280D,SERPINA1:NM_001002236:exon5:c.T840C:p.D280D,SERPINA1:NM_001127701:exon5:c.T840C:p.D280D,SERPINA1:NM_001127703:exon5:c.T840C:p.D280D,SERPINA1:NM_001127704:exon5:c.T840C:p.D280D,SERPINA1:NM_001127705:exon5:c.T840C:p.D280D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0216	0.0408	0.0569089	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	SERPINA1:uc001ycx.4:exon3:c.T840C:p.D280D,SERPINA1:uc001ycz.4:exon3:c.T840C:p.D280D,SERPINA1:uc001yda.1:exon3:c.T840C:p.D280D,SERPINA1:uc010aux.3:exon3:c.T840C:p.D280D,SERPINA1:uc001ydc.4:exon4:c.T840C:p.D280D,SERPINA1:uc010auz.3:exon4:c.T840C:p.D280D,SERPINA1:uc010avb.3:exon4:c.T840C:p.D280D,SERPINA1:uc001ycy.4:exon5:c.T840C:p.D280D,SERPINA1:uc001ydb.4:exon5:c.T840C:p.D280D,SERPINA1:uc010auw.3:exon5:c.T840C:p.D280D,SERPINA1:uc010auy.3:exon5:c.T840C:p.D280D,SERPINA1:uc010ava.3:exon5:c.T840C:p.D280D	.	AFR:0.0377,AMR:0.1224,EAS:0,FIN:0.0421,NFE:0,OTH:0.0005,ASJ:0.0107	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	.	.	.	.	14	1(stomach)	0.0153
14	94849201	94849201	C	T	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs709932	ENSG00000197249:ENST00000489769:exon1:c.G374A:p.R125H,ENSG00000197249:ENST00000355814:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000393087:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000402629:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000440909:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000554720:exon2:c.G116A:p.R39H,ENSG00000197249:ENST00000556091:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000404814:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000437397:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000449399:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000393088:exon4:c.G374A:p.R125H,ENSG00000197249:ENST00000448921:exon4:c.G374A:p.R125H,ENSG00000197249:ENST00000557492:exon4:c.G374A:p.R125H	SERPINA1:NM_000295:exon2:c.G374A:p.R125H,SERPINA1:NM_001002235:exon2:c.G374A:p.R125H,SERPINA1:NM_001127700:exon2:c.G374A:p.R125H,SERPINA1:NM_001127702:exon3:c.G374A:p.R125H,SERPINA1:NM_001127706:exon3:c.G374A:p.R125H,SERPINA1:NM_001127707:exon3:c.G374A:p.R125H,SERPINA1:NM_001002236:exon4:c.G374A:p.R125H,SERPINA1:NM_001127701:exon4:c.G374A:p.R125H,SERPINA1:NM_001127703:exon4:c.G374A:p.R125H,SERPINA1:NM_001127704:exon4:c.G374A:p.R125H,SERPINA1:NM_001127705:exon4:c.G374A:p.R125H	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1631	0.1216	0.160543	6(haematopoietic_and_lymphoid_tissue)	-0.526	0.190	1.0	-2.82	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon2:c.G374A:p.R125H,SERPINA1:uc001ycz.4:exon2:c.G374A:p.R125H,SERPINA1:uc001yda.1:exon2:c.G374A:p.R125H,SERPINA1:uc010aux.3:exon2:c.G374A:p.R125H,SERPINA1:uc001ydc.4:exon3:c.G374A:p.R125H,SERPINA1:uc010auz.3:exon3:c.G374A:p.R125H,SERPINA1:uc010avb.3:exon3:c.G374A:p.R125H,SERPINA1:uc001ycy.4:exon4:c.G374A:p.R125H,SERPINA1:uc001ydb.4:exon4:c.G374A:p.R125H,SERPINA1:uc010auw.3:exon4:c.G374A:p.R125H,SERPINA1:uc010auy.3:exon4:c.G374A:p.R125H,SERPINA1:uc010ava.3:exon4:c.G374A:p.R125H	-1.077	AFR:2(large_intestine),AMR:MU12568955,EAS:0.1219,FIN:0.0372,NFE:0.1388,OTH:0.1589,ASJ:LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-1.77	0.000	-1.17	14	3(soft_tissue)	0.2074
14	95566104	95566104	C	-	DICER1	intronic	.	ENSG00000100697	rs35300142	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2971	.	.	0.4139	.	.	.	.	.	.	.	.	.	.	AFR:0.2451,AMR:0.4189,EAS:0.4108,FIN:0.4285,NFE:0.5062,OTH:0.4602,ASJ:0.4394	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	MU114385099	het
14	95566106	95566108	CAC	-	DICER1	intronic	.	ENSG00000100697	rs367764979	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3077	.	.	0.4123	.	.	.	.	.	.	.	.	.	.	AFR:0.2442,AMR:0.4092,EAS:0.4085,FIN:0.4213,NFE:0.5058,OTH:0.4658,ASJ:0.4351	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	.	unknown
14	95566108	95566108	C	-	DICER1	intronic	.	ENSG00000100697	rs368080354	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1122	.	.	0.1932	.	.	.	.	.	.	.	.	.	.	AFR:0.3258,AMR:0.2214,EAS:0.1437,FIN:0.1523,NFE:0.1326,OTH:0.1456,ASJ:0.1142	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	.	het
14	96157187	96157187	G	A	TCL1B	exonic	nonsynonymous SNV	ENSG00000213231	rs1064017	ENSG00000213231:ENST00000340722:exon2:c.G277A:p.G93R	TCL1B:NM_004918:exon2:c.G277A:p.G93R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3571	0.3941	0.262181	3(haematopoietic_and_lymphoid_tissue)	4.004	23.6	0.886	0.758	0.000	.	.	.	TCL1B:uc001yez.3:exon2:c.G277A:p.G93R,TCL1B:uc001yfa.3:exon2:c.G277A:p.G93R	-0.965	AFR:1(pancreas),AMR:1(large_intestine),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,FIN:0.3541,NFE:0.2762,OTH:0.3282,ASJ:MU639316	603769	.	.	.	.	.	.	.	0.946	1.67	0.000	1.645	14	1(urinary_tract)	0.4603
14	97321689	97321689	C	T	VRK1	exonic	synonymous SNV	ENSG00000100749	rs2230532	ENSG00000100749:ENST00000216639:exon8:c.C705T:p.G235G	VRK1:NM_003384:exon8:c.C705T:p.G235G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3892	0.2903	0.416733	0.3425	.	.	.	.	.	.	.	.	VRK1:uc001yft.3:exon8:c.C705T:p.G235G	.	AFR:0.1756,AMR:0.4701,EAS:0.8554,FIN:0.3877,NFE:0.3620,OTH:0.3827,ASJ:0.4371	602168	607596;	2254;	2254|Norman disease<br>PCH1|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607596 614678 616081 ~	.	.	.	.	.	.	.	.	14	MU19610309	het
14	101295830	101295830	G	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs941575	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.955671	0.9330	.	.	.	.	.	.	.	.	.	.	AFR:0.9362,AMR:0.9594,EAS:0.9790,FIN:0.9390,NFE:0.9228,OTH:0.9338,ASJ:0.9570	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101301012	101301012	T	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs10132552	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.23742	0.2605	.	.	.	.	.	.	.	.	.	.	AFR:0.2148,AMR:0.3305,EAS:0.2633,FIN:0.3544,NFE:0.2604,OTH:0.2802,ASJ:0.2185	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU85249504	het
14	101302086	101302086	C	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs4906022	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.21266	0.2411	.	.	.	.	.	.	.	.	.	.	AFR:0.1487,AMR:0.3261,EAS:0.2643,FIN:0.3542,NFE:0.2594,OTH:0.2777,ASJ:0.2167	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101302211	101302211	G	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs11859	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.351038	0.2551	.	.	.	.	.	.	.	.	.	.	AFR:0.3916,AMR:0.1770,EAS:0.4522,FIN:0.1464,NFE:0.1890,OTH:0.1861,ASJ:0.2367	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101312243	101312243	-	G	MEG3	ncRNA_exonic	.	ENSG00000214548	rs200608518	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.00738818	0.0105	.	.	.	.	.	.	.	.	.	.	AFR:0.0031,AMR:0.0095,EAS:0,FIN:0.0135,NFE:0.0150,OTH:0.0132,ASJ:0.0166	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101313093	101313093	A	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs11160608	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.443291	0.5173	.	.	.	.	.	.	.	.	.	.	AFR:0.3314,AMR:0.6794,EAS:0.4652,FIN:0.6104,NFE:0.5972,OTH:0.5512,ASJ:0.5629	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101313986	101313986	C	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs3742395	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.427716	0.5025	.	.	.	.	.	.	.	.	.	.	AFR:0.293,AMR:0.6715,EAS:0.4665,FIN:0.6022,NFE:0.5913,OTH:0.5519,ASJ:0.5533	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101314846	101314846	G	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs78153996	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.00758786	0.0103	.	.	.	.	.	.	.	.	.	.	AFR:0.0031,AMR:0.0095,EAS:0,FIN:0.0135,NFE:0.0147,OTH:0.0132,ASJ:0.0166	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101314945	101314945	-	G	MEG3	ncRNA_exonic	.	ENSG00000214548	rs11439366	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.444888	0.5170	.	.	.	.	.	.	.	.	.	.	AFR:0.3311,AMR:0.6782,EAS:0.4670,FIN:0.6086,NFE:0.5968,OTH:0.5554,ASJ:0.5629	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101315668	101315668	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548	rs4906023	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.448083	0.5217	.	.	.	.	.	.	.	.	.	.	AFR:0.3446,AMR:0.6802,EAS:0.4658,FIN:0.6097,NFE:0.5981,OTH:0.5551,ASJ:0.5629	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU113707892	het
14	101319424	101319424	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs7158663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.515375	0.4184	.	.	.	.	.	.	.	.	.	.	AFR:0.2245,AMR:0.5668,EAS:0.7553,FIN:0.4255,NFE:0.4807,OTH:0.4796,ASJ:0.4338	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101319655	101319655	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs3742396	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.227436	0.1256	.	.	.	.	.	.	.	.	.	.	AFR:0.0666,AMR:0.1053,EAS:0.4415,FIN:0.1057,NFE:0.1302,OTH:0.1507,ASJ:0.1258	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101319914	101319914	C	T	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs1998052	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.154952	0.2319	.	.	.	.	.	.	.	.	.	.	AFR:0.2507,AMR:0.2183,EAS:0.1180,FIN:0.2644,NFE:0.2308,OTH:0.1998,ASJ:0.2450	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101319964	101319964	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs117372974	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.00758786	0.0101	.	.	.	.	.	.	.	.	.	.	AFR:0.0031,AMR:0.0096,EAS:0,FIN:0.0123,NFE:0.0145,OTH:0.0123,ASJ:0.0166	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101320034	101320034	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs1998053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.936901	0.9265	.	.	.	.	.	.	.	.	.	.	AFR:0.9848,AMR:0.9582,EAS:0.8832,FIN:0.8650,NFE:0.9116,OTH:0.8921,ASJ:0.9536	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101320319	101320319	G	A	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs2400942	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.39996	0.3599	.	.	.	.	.	.	.	.	.	.	AFR:0.3129,AMR:0.3225,EAS:0.5589,FIN:0.3736,NFE:0.3645,OTH:0.3589,ASJ:0.3709	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	104165927	104165927	T	C	KLC1;XRCC3	intronic	.	ENSG00000126214;ENSG00000126215	rs1799796	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3048	0.2643	0.246805	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.3060,AMR:0.1587,EAS:0.2351,FIN:0.3460,NFE:0.4421,OTH:0.3514,ASJ:0.3329	.	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.3661
14	105238711	105238711	G	A	AKT1	exonic	synonymous SNV	ENSG00000142208	rs139297659	ENSG00000142208:ENST00000555458:exon3:c.C336T:p.Y112Y,ENSG00000142208:ENST00000554192:exon4:c.C312T:p.Y104Y,ENSG00000142208:ENST00000544168:exon10:c.C1065T:p.Y355Y,ENSG00000142208:ENST00000554581:exon11:c.C1251T:p.Y417Y,ENSG00000142208:ENST00000402615:exon12:c.C1251T:p.Y417Y,ENSG00000142208:ENST00000407796:exon12:c.C1251T:p.Y417Y,ENSG00000142208:ENST00000554848:exon12:c.C1251T:p.Y417Y,ENSG00000142208:ENST00000555528:exon12:c.C1251T:p.Y417Y,ENSG00000142208:ENST00000349310:exon13:c.C1251T:p.Y417Y	AKT1:NM_001014431:exon12:c.C1251T:p.Y417Y,AKT1:NM_005163:exon12:c.C1251T:p.Y417Y,AKT1:NM_001014432:exon13:c.C1251T:p.Y417Y	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0131	0.0095	0.00898562	.	.	.	.	.	.	.	.	.	AKT1:uc010tyk.2:exon10:c.C1065T:p.Y355Y,AKT1:uc001ypl.3:exon11:c.C1251T:p.Y417Y,AKT1:uc001ypk.3:exon12:c.C1251T:p.Y417Y,AKT1:uc001ypn.3:exon12:c.C1251T:p.Y417Y,AKT1:uc010axa.3:exon12:c.C1251T:p.Y417Y,AKT1:uc001ypm.3:exon13:c.C1251T:p.Y417Y	.	AFR:0.0108,AMR:0.0019,EAS:0.0166,FIN:0.0006,NFE:0.0112,OTH:0.0169,ASJ:0.0012	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,393,396,390,391,395,394,392	.	.	.	.	.	.	14	4(meninges)	0.0173
14	105239894	105239894	C	T	AKT1	exonic	synonymous SNV	ENSG00000142208	rs1130233	ENSG00000142208:ENST00000544168:exon7:c.G540A:p.E180E,ENSG00000142208:ENST00000554581:exon8:c.G726A:p.E242E,ENSG00000142208:ENST00000402615:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000407796:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000554848:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000555528:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000349310:exon10:c.G726A:p.E242E	AKT1:NM_001014431:exon9:c.G726A:p.E242E,AKT1:NM_005163:exon9:c.G726A:p.E242E,AKT1:NM_001014432:exon10:c.G726A:p.E242E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3141	0.2016	0.322484	54(meninges)	.	.	.	.	.	.	.	.	AKT1:uc010tyk.2:exon7:c.G540A:p.E180E,AKT1:uc001ypl.3:exon8:c.G726A:p.E242E,AKT1:uc001ypk.3:exon9:c.G726A:p.E242E,AKT1:uc001ypn.3:exon9:c.G726A:p.E242E,AKT1:uc010axa.3:exon9:c.G726A:p.E242E,AKT1:uc001ypm.3:exon10:c.G726A:p.E242E	.	AFR:1(oesophagus),AMR:1(urinary_tract),EAS:3(lung),FIN:MU4606458,NFE:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205,BLCA-CN|1|103|0.00970874,OTH:0.2264,ASJ:1(stomach)	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,393,396,390,391,395,394,392	.	.	.	.	.	.	14	1(breast)	0.1037
15	28359744	28359744	G	A	HERC2	intronic	.	ENSG00000128731	rs7495441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9275	0.8259	0.790935	0.8527	.	.	.	.	.	.	.	.	.	.	AFR:0.4982,AMR:0.9618,EAS:0.9759,FIN:0.9997,NFE:0.9947,OTH:0.9633,ASJ:0.9633	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU81958444	hom
15	28414665	28414665	T	C	HERC2	exonic	synonymous SNV	ENSG00000128731	rs7494786	ENSG00000128731:ENST00000261609:exon66:c.A10194G:p.S3398S	HERC2:NM_004667:exon66:c.A10194G:p.S3398S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9524	0.9188	0.88119	0.9316	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon66:c.A10194G:p.S3398S	.	AFR:0.7761,AMR:0.9725,EAS:0.9895,FIN:0.9994,NFE:0.9941,OTH:0.9755,ASJ:0.9636	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU81958486	hom
15	28467246	28467246	T	C	HERC2	exonic	synonymous SNV	ENSG00000128731	rs7163444	ENSG00000128731:ENST00000261609:exon36:c.A5580G:p.G1860G	HERC2:NM_004667:exon36:c.A5580G:p.G1860G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3729	.	0.326078	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon36:c.A5580G:p.G1860G	.	AFR:0.6631,AMR:0.2819,EAS:0.7520,FIN:0.2591,NFE:0.9618,OTH:0.8727,ASJ:0.5874	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	2(thyroid)	0.8
15	28502279	28502279	A	G	HERC2	exonic	synonymous SNV	ENSG00000128731	rs11631797	ENSG00000128731:ENST00000261609:exon17:c.T2445C:p.G815G	HERC2:NM_004667:exon17:c.T2445C:p.G815G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6876	0.6671	0.442492	0.6865	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon17:c.T2445C:p.G815G,HERC2:uc001zbl.2:exon18:c.T1530C:p.G510G	.	AFR:0.2970,AMR:0.6127,EAS:0.2889,FIN:0.9628,NFE:0.8841,OTH:0.8218,ASJ:0.7781	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU15035966	hom
15	38614525	38614525	G	A	SPRED1	exonic	synonymous SNV	ENSG00000166068	rs7182445	ENSG00000166068:ENST00000299084:exon3:c.G291A:p.K97K,ENSG00000166068:ENST00000561317:exon4:c.G228A:p.K76K	SPRED1:NM_152594:exon3:c.G291A:p.K97K	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8258	0.80012	LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPRED1:uc001zka.4:exon3:c.G291A:p.K97K	.	AFR:0.8318,AMR:0.6692,EAS:0.8709,FIN:0.7922,NFE:0.9345,OTH:0.9005,ASJ:0.8517	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	1(thyroid)	0.8939
15	38631930	38631930	C	A	SPRED1	intronic	.	ENSG00000166068	rs7180446	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8255	0.799321	0.8318	.	.	.	.	.	0.0051	0.082	.	.	.	AFR:0.6692,AMR:0.8520,EAS:0.7932,FIN:0.9352,NFE:0.9005,OTH:0.8939,ASJ:0.8709	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	MU666813	het
15	38643574	38643574	T	C	SPRED1	exonic	synonymous SNV	ENSG00000166068	rs3751526	ENSG00000166068:ENST00000299084:exon7:c.T1044C:p.V348V	SPRED1:NM_152594:exon7:c.T1044C:p.V348V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8254	0.799521	LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPRED1:uc001zka.4:exon7:c.T1044C:p.V348V	.	AFR:0.8315,AMR:0.6681,EAS:0.8709,FIN:0.7924,NFE:0.9345,OTH:0.9005,ASJ:0.8508	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	4(haematopoietic_and_lymphoid_tissue)	0.8941
15	40477831	40477831	G	A	BUB1B	exonic	nonsynonymous SNV	ENSG00000156970	rs1801376	ENSG00000156970:ENST00000287598:exon8:c.G1046A:p.R349Q,ENSG00000156970:ENST00000412359:exon8:c.G1088A:p.R363Q	BUB1B:NM_001211:exon8:c.G1046A:p.R349Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6566	0.7360	0.628195	72(lung)	2.297	18.15	1.0	4.72	0.977	.	.	.	BUB1B:uc010ucl.1:exon4:c.G635A:p.R212Q,BUB1B:uc001zkx.4:exon8:c.G1046A:p.R349Q	-0.980	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU20627954,EAS:0.7235,FIN:0.8293,NFE:0.6325,OTH:0.6159,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	0.0	2.74	0.000	-2.255	15	1(large_intestine)	0.3188
15	40488851	40488851	G	A	BUB1B	exonic	synonymous SNV	ENSG00000156970	rs1047130	ENSG00000156970:ENST00000287598:exon9:c.G1164A:p.A388A,ENSG00000156970:ENST00000412359:exon9:c.G1206A:p.A402A	BUB1B:NM_001211:exon9:c.G1164A:p.A388A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2668	0.2264	0.190695	1(lung)	.	.	.	.	.	.	.	.	BUB1B:uc010ucl.1:exon5:c.G753A:p.A251A,BUB1B:uc001zkx.4:exon9:c.G1164A:p.A388A	.	AFR:MU80646858,AMR:ESAD-UK|2|409|0.00488998,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0665,FIN:0.3325,NFE:0.1954,OTH:0.1302,ASJ:0.2283	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	.	.	.	.	15	1(large_intestine)	0.2920
15	40500986	40500986	C	T	BUB1B	intronic	.	ENSG00000156970	rs11630664	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4916	0.4667	0.396965	0.4666	.	.	.	.	.	.	.	.	.	.	AFR:0.3045,AMR:0.5072,EAS:0.2349,FIN:0.5516,NFE:0.5612,OTH:0.5327,ASJ:0.3874	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	.	.	.	.	15	MU20628209	het
15	40898643	40898643	G	C	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs7177192	ENSG00000137812:ENST00000346991:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000399668:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000527044:exon4:c.G128C:p.R43T	KNL1:NM_144508:exon4:c.G128C:p.R43T,KNL1:NM_170589:exon4:c.G128C:p.R43T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7456	0.8222	0.653754	1(haematopoietic_and_lymphoid_tissue)	-1.469	0.003	0.53	-4.84	0.891	.	.	.	CASC5:uc001zme.3:exon4:c.G128C:p.R43T,CASC5:uc010bbs.1:exon4:c.G128C:p.R43T,CASC5:uc010bbt.1:exon4:c.G128C:p.R43T	-0.968	AFR:1(large_intestine),AMR:MU583520,EAS:0.7939,FIN:0.7709,NFE:0.5634,OTH:0.8046,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	1.93	0.000	-1.61	15	2(prostate)	0.2983
15	40913840	40913840	G	T	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs2412541	ENSG00000137812:ENST00000399668:exon10:c.G1378T:p.A460S,ENSG00000137812:ENST00000346991:exon11:c.G1456T:p.A486S	KNL1:NM_144508:exon10:c.G1378T:p.A460S,KNL1:NM_170589:exon11:c.G1456T:p.A486S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7455	0.8217	0.653954	0.7942	-1.118	0.009	1.0	1.67	0.975	.	.	.	CASC5:uc010ucq.1:exon9:c.G928T:p.A310S,CASC5:uc001zme.3:exon10:c.G1378T:p.A460S,CASC5:uc010bbt.1:exon10:c.G1378T:p.A460S,CASC5:uc010bbs.1:exon11:c.G1456T:p.A486S	-1.032	AFR:0.7706,AMR:0.5621,EAS:0.3,FIN:0.8417,NFE:0.8617,OTH:0.8008,ASJ:0.8046	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	3.69	0.000	-0.46	15	MU25432617	het
15	40915190	40915190	A	G	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs8040502	ENSG00000137812:ENST00000399668:exon10:c.A2728G:p.R910G,ENSG00000137812:ENST00000346991:exon11:c.A2806G:p.R936G	KNL1:NM_144508:exon10:c.A2728G:p.R910G,KNL1:NM_170589:exon11:c.A2806G:p.R936G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7589	0.8695	0.705671	1(prostate)	0.453	7.062	1.0	3.03	0.884	.	.	.	CASC5:uc010ucq.1:exon9:c.A2278G:p.R760G,CASC5:uc001zme.3:exon10:c.A2728G:p.R910G,CASC5:uc010bbt.1:exon10:c.A2728G:p.R910G,CASC5:uc010bbs.1:exon11:c.A2806G:p.R936G	-1.015	AFR:1(stomach),AMR:2(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.8352,NFE:0.9146,OTH:0.5680,ASJ:MU583521	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	2.57	0.000	-1.59	15	1(lung)	0.8046
15	40916237	40916237	A	G	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs17747633	ENSG00000137812:ENST00000399668:exon10:c.A3775G:p.K1259E,ENSG00000137812:ENST00000346991:exon11:c.A3853G:p.K1285E	KNL1:NM_144508:exon10:c.A3775G:p.K1259E,KNL1:NM_170589:exon11:c.A3853G:p.K1285E	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3270	0.3282	0.203474	0.2991	0.752	9.163	0.035	3.44	0.008	.	.	.	CASC5:uc010ucq.1:exon9:c.A3325G:p.K1109E,CASC5:uc001zme.3:exon10:c.A3775G:p.K1259E,CASC5:uc010bbt.1:exon10:c.A3775G:p.K1259E,CASC5:uc010bbs.1:exon11:c.A3853G:p.K1285E	-0.911	AFR:0.0902,AMR:0.2602,EAS:0.0797,FIN:0.3794,NFE:0.4228,OTH:0.3436,ASJ:0.4205	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.987	2.09	0.000	0.805	15	MU72975	het
15	41803914	41803914	A	G	LTK	intronic	.	ENSG00000062524	rs2254078	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.379992	0.4025	.	.	.	.	.	.	.	.	.	.	AFR:0.2809,AMR:0.4771,EAS:0.3181,FIN:0.4378,NFE:0.4672,OTH:0.4380,ASJ:0.4333	151520	.	.	.	.	.	.	.	.	.	.	.	15	.	het
15	41857216	41857216	G	A	TYRO3	intronic	.	ENSG00000092445	rs11639399	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2691	0.2436	0.159744	0.2240	.	.	.	.	.	0.0003	0.012	.	.	.	AFR:0.1222,AMR:0.1866,EAS:0.0173,FIN:0.3016,NFE:0.2832,OTH:0.2832,ASJ:0.3477	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU12623019	het
15	41857303	41857303	T	C	TYRO3	exonic	synonymous SNV	ENSG00000092445	rs2277536	ENSG00000092445:ENST00000263798:exon6:c.T747C:p.A249A,ENSG00000092445:ENST00000559066:exon6:c.T612C:p.A204A	TYRO3:NM_001330264:exon6:c.T612C:p.A204A,TYRO3:NM_006293:exon6:c.T747C:p.A249A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2746	0.2572	0.267173	MU30087667	.	.	.	.	.	.	.	.	TYRO3:uc001zof.2:exon6:c.T747C:p.A249A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.2660,EAS:0.3592,FIN:0.3013,NFE:0.1681,OTH:0.3025,ASJ:0.2084	600341	.	.	.	.	.	.	.	.	.	.	.	15	1(stomach)	0.2957
15	41860411	41860411	G	A	TYRO3	intronic	.	ENSG00000092445	rs7171675	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3679	0.4417	0.332668	0.4087	.	.	.	.	.	0	0	.	.	.	AFR:0.4962,AMR:0.3113,EAS:0.0193,FIN:0.4139,NFE:0.4032,OTH:0.4227,ASJ:0.4167	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU25623926	het
15	41860490	41860490	T	A	TYRO3	exonic	nonsynonymous SNV	ENSG00000092445	rs12148316	ENSG00000092445:ENST00000263798:exon8:c.T1037A:p.I346N,ENSG00000092445:ENST00000559066:exon8:c.T902A:p.I301N	TYRO3:NM_001330264:exon8:c.T902A:p.I301N,TYRO3:NM_006293:exon8:c.T1037A:p.I346N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2264	0.2348	0.154752	.	2.834	21.5	0.474	3.95	0.988	.	.	Fibronectin type III|Immunoglobulin-like fold	TYRO3:uc001zof.2:exon8:c.T1037A:p.I346N	-1.052	AFR:.,AMR:0.2159,EAS:0.1862,FIN:0.3411,NFE:0.0173,OTH:0.2907,ASJ:0.1191	600341	.	.	.	.	.	.	.	0.408	-0.67	0.000	1.79	15	34(lung)	0.2726
15	43701947	43701947	A	-	TUBGCP4	UTR3	.	ENSG00000067369	rs397711844	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3694	.	0.2502	0.2293	.	.	.	.	.	.	.	.	.	.	AFR:0.1166,AMR:0.3038,EAS:0.3439,FIN:0.3038,NFE:0.2604,OTH:0.2850,ASJ:0.3051	609610	616335;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	15	MU41120617	het
15	43707808	43707808	A	T	TP53BP1	exonic	synonymous SNV	ENSG00000067369	rs2230451	ENSG00000067369:ENST00000434561:exon3:c.T462A:p.S154S,ENSG00000067369:ENST00000382039:exon22:c.T4923A:p.S1641S,ENSG00000067369:ENST00000263801:exon23:c.T5058A:p.S1686S,ENSG00000067369:ENST00000382044:exon23:c.T5073A:p.S1691S,ENSG00000067369:ENST00000450115:exon23:c.T5073A:p.S1691S	TP53BP1:NM_001141979:exon23:c.T5073A:p.S1691S,TP53BP1:NM_001141980:exon23:c.T5073A:p.S1691S,TP53BP1:NM_005657:exon23:c.T5058A:p.S1686S,TP53BP1:NM_001355001:exon24:c.T2193A:p.S731S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1634	0.1829	0.128594	COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TP53BP1:uc001zrp.3:exon2:c.T309A:p.S103S,TP53BP1:uc010udp.2:exon22:c.T5058A:p.S1686S,TP53BP1:uc001zrq.4:exon23:c.T5073A:p.S1691S,TP53BP1:uc001zrr.4:exon23:c.T5073A:p.S1691S,TP53BP1:uc001zrs.3:exon23:c.T5058A:p.S1686S,TP53BP1:uc010udq.1:exon23:c.T5073A:p.S1691S	.	AFR:0.1590,AMR:0.1726,EAS:0.1854,FIN:0.0006,NFE:0.1320,OTH:0.1751,ASJ:0.1205	605230	.	.	.	.	.	.	.	.	.	.	.	15	1(thyroid)	0.1762
15	43720197	43720197	C	T	TP53BP1	intronic	.	ENSG00000067369	rs550239	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2075	0.2879	0.380391	0.2747	.	.	.	.	.	.	.	.	.	.	AFR:0.6461,AMR:0.2160,EAS:0.4006,FIN:0.0795,NFE:0.1041,OTH:0.1232,ASJ:0.2053	605230	.	.	.	.	.	.	.	.	.	.	.	15	MU703379	het
15	43724646	43724646	T	G	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs2602141	ENSG00000067369:ENST00000263801:exon17:c.A3406C:p.K1136Q,ENSG00000067369:ENST00000382039:exon17:c.A3421C:p.K1141Q,ENSG00000067369:ENST00000382044:exon17:c.A3421C:p.K1141Q,ENSG00000067369:ENST00000450115:exon17:c.A3421C:p.K1141Q	TP53BP1:NM_001141979:exon17:c.A3421C:p.K1141Q,TP53BP1:NM_001141980:exon17:c.A3421C:p.K1141Q,TP53BP1:NM_005657:exon17:c.A3406C:p.K1136Q,TP53BP1:NM_001355001:exon18:c.A541C:p.K181Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3750	0.4836	0.526358	4(haematopoietic_and_lymphoid_tissue)	1.331	12.43	1.0	4.45	0.961	.	.	.	TP53BP1:uc010udp.2:exon16:c.A3406C:p.K1136Q,TP53BP1:uc001zrq.4:exon17:c.A3421C:p.K1141Q,TP53BP1:uc001zrr.4:exon17:c.A3421C:p.K1141Q,TP53BP1:uc001zrs.3:exon17:c.A3406C:p.K1136Q,TP53BP1:uc010udq.1:exon17:c.A3421C:p.K1141Q	-1.000	AFR:MU125397,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.8481,FIN:0.3353,NFE:0.3907,OTH:0.3995,ASJ:0.4422	605230	.	.	.	.	.	.	.	0.0	3.86	0.000	-2.28	15	1(pancreas)	0.2126
15	43748304	43748304	A	G	TP53BP1	exonic	synonymous SNV	ENSG00000067369	rs690367	ENSG00000067369:ENST00000263801:exon12:c.T2487C:p.D829D,ENSG00000067369:ENST00000382039:exon12:c.T2502C:p.D834D,ENSG00000067369:ENST00000382044:exon12:c.T2502C:p.D834D,ENSG00000067369:ENST00000413546:exon12:c.T2502C:p.D834D,ENSG00000067369:ENST00000450115:exon12:c.T2502C:p.D834D	TP53BP1:NM_001141979:exon12:c.T2502C:p.D834D,TP53BP1:NM_001141980:exon12:c.T2502C:p.D834D,TP53BP1:NM_005657:exon12:c.T2487C:p.D829D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3739	0.4882	0.526158	4(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TP53BP1:uc010udp.2:exon11:c.T2487C:p.D829D,TP53BP1:uc001zrq.4:exon12:c.T2502C:p.D834D,TP53BP1:uc001zrr.4:exon12:c.T2502C:p.D834D,TP53BP1:uc001zrs.3:exon12:c.T2487C:p.D829D,TP53BP1:uc010udq.1:exon12:c.T2502C:p.D834D	.	AFR:MU125412,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.8642,FIN:0.3349,NFE:0.3907,OTH:0.4004,ASJ:0.4464	605230	.	.	.	.	.	.	.	.	.	.	.	15	2(lung)	0.2127
15	43762196	43762196	C	T	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs689647	ENSG00000067369:ENST00000263801:exon11:c.G1234A:p.G412S,ENSG00000067369:ENST00000382039:exon11:c.G1249A:p.G417S,ENSG00000067369:ENST00000382044:exon11:c.G1249A:p.G417S,ENSG00000067369:ENST00000413546:exon11:c.G1249A:p.G417S,ENSG00000067369:ENST00000450115:exon11:c.G1249A:p.G417S	TP53BP1:NM_001141979:exon11:c.G1249A:p.G417S,TP53BP1:NM_001141980:exon11:c.G1249A:p.G417S,TP53BP1:NM_005657:exon11:c.G1234A:p.G412S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2064	0.2881	0.382388	1(lung)	1.910	15.65	0.049	5.31	0.837	.	.	.	TP53BP1:uc010udp.2:exon10:c.G1234A:p.G412S,TP53BP1:uc001zrq.4:exon11:c.G1249A:p.G417S,TP53BP1:uc001zrr.4:exon11:c.G1249A:p.G417S,TP53BP1:uc001zrs.3:exon11:c.G1234A:p.G412S,TP53BP1:uc010udq.1:exon11:c.G1249A:p.G417S	-1.046	AFR:2(large_intestine),AMR:MU64385,EAS:0.2743,FIN:0.6468,NFE:0.2105,OTH:0.2067,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	605230	.	.	.	.	.	.	.	0.0	3.83	0.000	-0.69	15	1(urinary_tract)	0.3989
15	43767774	43767774	G	C	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs560191	ENSG00000067369:ENST00000263801:exon9:c.C1059G:p.D353E,ENSG00000067369:ENST00000382039:exon9:c.C1074G:p.D358E,ENSG00000067369:ENST00000382044:exon9:c.C1074G:p.D358E,ENSG00000067369:ENST00000413546:exon9:c.C1074G:p.D358E,ENSG00000067369:ENST00000450115:exon9:c.C1074G:p.D358E	TP53BP1:NM_001141979:exon9:c.C1074G:p.D358E,TP53BP1:NM_001141980:exon9:c.C1074G:p.D358E,TP53BP1:NM_005657:exon9:c.C1059G:p.D353E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3737	0.4881	0.525759	2(large_intestine)	1.026	10.81	1.0	1.95	0.996	.	.	.	TP53BP1:uc010udp.2:exon8:c.C1059G:p.D353E,TP53BP1:uc001zrq.4:exon9:c.C1074G:p.D358E,TP53BP1:uc001zrr.4:exon9:c.C1074G:p.D358E,TP53BP1:uc001zrs.3:exon9:c.C1059G:p.D353E,TP53BP1:uc010udq.1:exon9:c.C1074G:p.D358E	-1.012	AFR:MU125433,AMR:SKCA-BR|1|100|0.01,LIRI-JP|1|258|0.00387597,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.8644,FIN:0.3353,NFE:0.39,OTH:0.3983,ASJ:0.4462	605230	.	.	.	.	.	.	.	0.0	4.33	0.000	-1.4	15	1(lung)	0.2127
15	43784475	43784475	C	T	TP53BP1	intronic	.	ENSG00000067369	rs2439831	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2003	0.2706	0.369409	MU12625859	.	.	.	.	.	0	0	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,AMR:0.2608,EAS:0.2081,FIN:0.1987,NFE:0.3989,OTH:0.0767,ASJ:0.6070	605230	.	.	.	.	.	.	.	.	.	.	.	15	4(haematopoietic_and_lymphoid_tissue)	0.1011
15	48720526	48720526	G	C	FBN1	intronic	.	ENSG00000166147	rs363832	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7404	0.6784	0.65595	0.6718	.	.	.	.	.	.	.	.	.	.	AFR:0.4800,AMR:0.7847,EAS:0.6314,FIN:0.7437,NFE:0.7594,OTH:0.7219,ASJ:0.7616	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU12633444	hom
15	48807637	48807637	C	T	FBN1	exonic	nonsynonymous SNV	ENSG00000166147	rs4775765	ENSG00000166147:ENST00000316623:exon12:c.G1415A:p.C472Y	FBN1:NM_000138:exon12:c.G1415A:p.C472Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon12:c.G1415A:p.C472Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU81961571	hom
15	51502986	51502986	G	A	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs10046	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4492	0.4329	0.362819	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4477,AMR:0.2428,EAS:0.5331,FIN:0.5267,NFE:0.5272,OTH:0.5416,ASJ:0.3305	.	.	.	.	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4949
15	51510868	51510868	A	C	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs4324076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4867	0.3976	0.367212	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU23684803,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.2364,FIN:0.3301,NFE:0.5298,OTH:0.5249,ASJ:0.4418	.	.	.	.	.	.	.	.	.	.	.	.	15	1(lung)	0.5011
15	51529112	51529112	T	C	CYP19A1	exonic	synonymous SNV	ENSG00000137869	rs700518	ENSG00000137869:ENST00000405913:exon2:c.A240G:p.V80V,ENSG00000137869:ENST00000559878:exon2:c.A240G:p.V80V,ENSG00000137869:ENST00000260433:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000396402:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000557858:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000557934:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000558328:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000559646:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000561075:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000396404:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000405011:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000439712:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000453807:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000559980:exon5:c.A240G:p.V80V	CYP19A1:NM_001347256:exon2:c.A240G:p.V80V,CYP19A1:NM_000103:exon3:c.A240G:p.V80V,CYP19A1:NM_001347248:exon3:c.A240G:p.V80V,CYP19A1:NM_001347249:exon3:c.A240G:p.V80V,CYP19A1:NM_001347250:exon3:c.A240G:p.V80V,CYP19A1:NM_001347251:exon3:c.A240G:p.V80V,CYP19A1:NM_001347252:exon3:c.A240G:p.V80V,CYP19A1:NM_001347253:exon3:c.A240G:p.V80V,CYP19A1:NM_001347254:exon3:c.A240G:p.V80V,CYP19A1:NM_001347255:exon3:c.A240G:p.V80V,CYP19A1:NM_031226:exon4:c.A240G:p.V80V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4253	0.4046	0.325879	1(stomach)	.	.	.	.	.	.	.	.	CYP19A1:uc001zzd.3:exon2:c.A240G:p.V80V,CYP19A1:uc001zza.4:exon3:c.A240G:p.V80V,CYP19A1:uc001zyz.4:exon4:c.A240G:p.V80V,CYP19A1:uc001zzb.2:exon4:c.A240G:p.V80V,CYP19A1:uc010bey.1:exon5:c.A240G:p.V80V	.	AFR:MU583554,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.1972,FIN:0.3098,NFE:0.5099,OTH:0.4479,ASJ:0.4174	107910	139300;613546;	91;178345;	91|Congenital estrogen deficiency|<1 / 1 000 000|Autosomal recessive|All ages|613546 ~178345|AEXS<br>Familial hyperestrogenism<br>Hereditary prepubertal gynecomastia|-|Autosomal dominant|-|139300 ~	.	.	.	.	.	.	.	.	15	1(prostate)	0.4997
15	58284966	58284966	C	T	ALDH1A2	exonic	synonymous SNV	ENSG00000128918	rs144628261	ENSG00000128918:ENST00000559517:exon5:c.G447A:p.T149T,ENSG00000128918:ENST00000249750:exon7:c.G735A:p.T245T,ENSG00000128918:ENST00000558231:exon7:c.G648A:p.T216T,ENSG00000128918:ENST00000537372:exon8:c.G672A:p.T224T	ALDH1A2:NM_170697:exon5:c.G447A:p.T149T,ALDH1A2:NM_003888:exon7:c.G735A:p.T245T,ALDH1A2:NM_001206897:exon8:c.G672A:p.T224T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0019	.	0.00319489	3.23e-05	.	.	.	.	.	.	.	.	ALDH1A2:uc002aew.3:exon5:c.G447A:p.T149T,ALDH1A2:uc002aex.3:exon7:c.G735A:p.T245T,ALDH1A2:uc010ugw.2:exon7:c.G648A:p.T216T,ALDH1A2:uc010ugv.2:exon8:c.G672A:p.T224T	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	603687	.	.	.	.	.	.	.	.	.	.	.	15	.	het
15	63351840	63351840	C	A	TPM1	exonic	synonymous SNV	ENSG00000140416	rs1071646	ENSG00000140416:ENST00000558264:exon2:c.C75A:p.A25A,ENSG00000140416:ENST00000317516:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000334895:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000404484:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000559281:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000559831:exon3:c.C225A:p.A75A,ENSG00000140416:ENST00000560615:exon3:c.C75A:p.A25A,ENSG00000140416:ENST00000560959:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000267996:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000288398:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000358278:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000403994:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000559397:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000559556:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000357980:exon5:c.C579A:p.A193A	TPM1:NM_001018008:exon3:c.C345A:p.A115A,TPM1:NM_001301289:exon3:c.C345A:p.A115A,TPM1:NM_001330344:exon3:c.C345A:p.A115A,TPM1:NM_001330346:exon3:c.C345A:p.A115A,TPM1:NM_001330351:exon3:c.C345A:p.A115A,TPM1:NM_001365780:exon3:c.C345A:p.A115A,TPM1:NM_001365781:exon3:c.C345A:p.A115A,TPM1:NM_001365782:exon3:c.C345A:p.A115A,TPM1:NM_000366:exon4:c.C453A:p.A151A,TPM1:NM_001018004:exon4:c.C453A:p.A151A,TPM1:NM_001018005:exon4:c.C453A:p.A151A,TPM1:NM_001018006:exon4:c.C453A:p.A151A,TPM1:NM_001018007:exon4:c.C453A:p.A151A,TPM1:NM_001018020:exon4:c.C453A:p.A151A,TPM1:NM_001301244:exon4:c.C453A:p.A151A,TPM1:NM_001365776:exon4:c.C453A:p.A151A,TPM1:NM_001365777:exon4:c.C453A:p.A151A,TPM1:NM_001365779:exon4:c.C453A:p.A151A,TPM1:NM_001365778:exon5:c.C579A:p.A193A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6737	0.6357	0.705671	0.6615	.	.	.	.	.	.	.	.	TPM1:uc002alr.3:exon3:c.C345A:p.A115A,TPM1:uc002als.3:exon3:c.C345A:p.A115A,TPM1:uc002alt.3:exon3:c.C345A:p.A115A,TPM1:uc010uif.2:exon3:c.C345A:p.A115A,TPM1:uc010uig.2:exon3:c.C345A:p.A115A,TPM1:uc002alg.3:exon4:c.C453A:p.A151A,TPM1:uc002alh.3:exon4:c.C453A:p.A151A,TPM1:uc002ali.3:exon4:c.C453A:p.A151A,TPM1:uc002alj.3:exon4:c.C453A:p.A151A,TPM1:uc002alk.3:exon4:c.C453A:p.A151A,TPM1:uc002all.3:exon4:c.C453A:p.A151A,TPM1:uc002alp.3:exon4:c.C453A:p.A151A,TPM1:uc010uie.2:exon4:c.C453A:p.A151A,TPM1:uc002alm.3:exon5:c.C579A:p.A193A	.	AFR:0.6124,AMR:0.5610,EAS:0.9604,FIN:0.6959,NFE:0.6548,OTH:0.6741,ASJ:0.6490	191010	115196;611878;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	15	MU125580	hom
15	66745890	66745890	G	A	MAP2K1	intronic	.	ENSG00000169032	rs7169326	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9989	.	0.983227	0.9869	.	.	.	.	.	.	.	.	.	.	AFR:0.9543,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04626 Plant-pathogen interaction~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05034 Alcoholism~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	15	.	hom
15	66782048	66782048	C	T	MAP2K1	intronic	.	ENSG00000169032	rs41306345	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0843	0.0918	0.0892572	ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526	.	.	.	.	.	0.0003	0.008	.	.	.	AFR:0.0938,AMR:0.1058,EAS:0.0828,FIN:0.0451,NFE:0.1154,OTH:0.0887,ASJ:0.0561	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04626 Plant-pathogen interaction~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05034 Alcoholism~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.1041
15	67457335	67457335	A	G	SMAD3	exonic	synonymous SNV	ENSG00000166949	rs1065080	ENSG00000166949:ENST00000559092:exon2:c.A254G:p.Y85C	SMAD3:NM_001145103:exon2:c.A177G:p.L59L,SMAD3:NM_005902:exon2:c.A309G:p.L103L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8635	0.88	0.834065	0.8640	0.949	10.37	.	2.36	0.993	.	.	.	SMAD3:uc002aqj.3:exon2:c.A309G:p.L103L,SMAD3:uc010ujs.2:exon2:c.A177G:p.L59L	.	AFR:0.8614,AMR:0.9177,EAS:0.7472,FIN:0.8660,NFE:0.8754,OTH:0.8582,ASJ:0.8477	603109	613795;	284984;	284984|-|<1 / 1 000 000|Autosomal dominant|All ages|613795 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04659 Th17 cell differentiation~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	15	MU675295	hom
15	74287172	74287172	C	A	PML	exonic	synonymous SNV	ENSG00000140464	rs574579963	ENSG00000140464:ENST00000268058:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000268059:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000354026:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000359928:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000395132:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000395135:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000435786:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000436891:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000563500:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000564428:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000565898:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000567543:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000569477:exon1:c.C19A:p.R7R,ENSG00000140464:ENST00000569965:exon1:c.C19A:p.R7R	PML:NM_002675:exon1:c.C19A:p.R7R,PML:NM_033238:exon1:c.C19A:p.R7R,PML:NM_033239:exon1:c.C19A:p.R7R,PML:NM_033240:exon1:c.C19A:p.R7R,PML:NM_033244:exon1:c.C19A:p.R7R,PML:NM_033246:exon1:c.C19A:p.R7R,PML:NM_033247:exon1:c.C19A:p.R7R,PML:NM_033249:exon1:c.C19A:p.R7R,PML:NM_033250:exon1:c.C19A:p.R7R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0007	.	0.00119808	.	.	.	.	.	.	.	.	.	PML:uc002awj.1:exon1:c.C19A:p.R7R,PML:uc002awk.3:exon1:c.C19A:p.R7R,PML:uc002awl.3:exon1:c.C19A:p.R7R,PML:uc002awm.3:exon1:c.C19A:p.R7R,PML:uc002awn.3:exon1:c.C19A:p.R7R,PML:uc002awo.3:exon1:c.C19A:p.R7R,PML:uc002awp.3:exon1:c.C19A:p.R7R,PML:uc002awq.3:exon1:c.C19A:p.R7R,PML:uc002awr.3:exon1:c.C19A:p.R7R,PML:uc002aws.3:exon1:c.C19A:p.R7R,PML:uc002awt.3:exon1:c.C19A:p.R7R,PML:uc002awu.3:exon1:c.C19A:p.R7R,PML:uc002awv.3:exon1:c.C19A:p.R7R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	15	.	het
15	74328116	74328116	A	G	PML	exonic	nonsynonymous SNV	ENSG00000140464	rs743580	ENSG00000140464:ENST00000354026:exon7:c.A2170G:p.S724G,ENSG00000140464:ENST00000268059:exon8:c.A2314G:p.S772G	PML:NM_033250:exon7:c.A2170G:p.S724G,PML:NM_033239:exon8:c.A2314G:p.S772G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5226	0.4991	0.551917	MU131868	0.090	3.499	1.0	0.623	0.000	.	.	.	PML:uc002awy.3:exon3:c.A601G:p.S201G,PML:uc002awo.3:exon7:c.A2170G:p.S724G,PML:uc002awk.3:exon8:c.A2314G:p.S772G	-0.930	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763,PBCA-DE|1|499|0.00200401,AMR:0.5295,EAS:0.5203,FIN:0.4702,NFE:0.6387,OTH:0.5699,ASJ:0.5075	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.0	.	0.000	.	15	1(large_intestine)	0.5204
15	74328141	74328141	G	T	PML	exonic	nonsynonymous SNV	ENSG00000140464	rs743581	ENSG00000140464:ENST00000354026:exon7:c.G2195T:p.G732V,ENSG00000140464:ENST00000268059:exon8:c.G2339T:p.G780V	PML:NM_033250:exon7:c.G2195T:p.G732V,PML:NM_033239:exon8:c.G2339T:p.G780V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3599	0.3464	0.351238	1(liver)	-0.295	0.683	0.22	-2.39	0.002	.	.	.	PML:uc002awy.3:exon3:c.G626T:p.G209V,PML:uc002awo.3:exon7:c.G2195T:p.G732V,PML:uc002awk.3:exon8:c.G2339T:p.G780V	-0.910	AFR:1(large_intestine),AMR:MU627388,EAS:0.3743,FIN:0.3175,NFE:0.4294,OTH:0.22,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,BLCA-CN|1|103|0.00970874	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.077	.	0.000	.	15	1(urinary_tract)	0.4156
15	74836316	74836316	A	G	ARID3B	exonic	synonymous SNV	ENSG00000179361	rs8043032	ENSG00000179361:ENST00000346246:exon2:c.A39G:p.Q13Q	ARID3B:NM_001307939:exon2:c.A39G:p.Q13Q,ARID3B:NM_006465:exon2:c.A39G:p.Q13Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1884	0.1398	0.360823	0.2159	.	.	.	.	.	.	.	.	ARID3B:uc002ayc.3:exon2:c.A39G:p.Q13Q,ARID3B:uc002ayd.3:exon2:c.A39G:p.Q13Q,ARID3B:uc002aye.3:exon2:c.A39G:p.Q13Q	.	AFR:0.3483,AMR:0.4146,EAS:0.5316,FIN:0.1312,NFE:0.1177,OTH:0.1887,ASJ:0.1567	612457	.	.	.	.	.	.	.	.	.	.	.	15	MU698715	het
15	75685175	75685175	A	C	SIN3A	intronic	.	ENSG00000169375	rs71401694	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0721	0.0463	0.0688898	0.0543	.	.	.	.	.	.	.	.	.	.	AFR:0.0125,AMR:0.0670,EAS:0.1406,FIN:0.0530,NFE:0.0666,OTH:0.0743,ASJ:0.1060	607776	613406;	94065;	94065|Del(15)(q24)<br>Monosomy 15q24|<1 / 1 000 000|Not applicable<br>or&nbsp;Unknown|Childhood|613406 ~	~ko04139 Mitophagy - yeast~ko04919 Thyroid hormone signaling pathway~ko05016 Huntington disease~ko05169 Epstein-Barr virus infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	15	MU12688803	het
15	80450389	80450389	G	A	FAH	intronic	.	ENSG00000103876	rs1370275	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5141	0.4463	0.506789	0.4629	.	.	.	.	.	.	.	.	.	.	AFR:0.3137,AMR:0.4233,EAS:0.7553,FIN:0.4593,NFE:0.5188,OTH:0.4794,ASJ:0.5265	613871	276700;	882;	882|FAH deficiency<br>Fumarylacetoacetase deficiency<br>Fumarylacetoacetate hydrolase deficiency<br>Hepatorenal tyrosinemia<br>Tyrosinemia type I|Unknown|Autosomal recessive|All ages|276700 ~	.	.	.	.	.	.	.	.	15	MU20682033	hom
15	85188994	85188994	T	C	WDR73	exonic	synonymous SNV	ENSG00000177082	rs2271432	ENSG00000177082:ENST00000434634:exon7:c.A591G:p.S197S	WDR73:NM_032856:exon7:c.A591G:p.S197S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8550	0.8788	0.895367	0.8747	.	.	.	.	.	.	.	.	AL357213:uc002bky.1:exon1:c.T486C:p.P162P,WDR73:uc002bkw.2:exon7:c.A591G:p.S197S	.	AFR:0.9672,AMR:0.9117,EAS:0.9407,FIN:0.7903,NFE:0.8342,OTH:0.8259,ASJ:0.8874	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	MU4561231	hom
15	85189464	85189464	T	G	WDR73	exonic	synonymous SNV	ENSG00000177082	rs2271431	ENSG00000177082:ENST00000434634:exon6:c.A468C:p.R156R	WDR73:NM_032856:exon6:c.A468C:p.R156R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2294	0.2045	0.147165	MU131122	.	.	.	.	.	.	.	.	WDR73:uc002bkw.2:exon6:c.A468C:p.R156R,WDR73:uc010upa.1:exon6:c.A468C:p.R156R	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1911,EAS:0.2242,FIN:0.2219,NFE:0.1255,OTH:0.2244,ASJ:0.0585	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	1(lung)	0.2608
15	88451765	88451765	A	G	NTRK3	intronic	.	ENSG00000140538	rs3784441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.713259	0.7411	.	.	.	.	.	.	.	.	.	.	AFR:0.7618,AMR:0.6794,EAS:0.6981,FIN:0.7182,NFE:0.7455,OTH:0.7020,ASJ:0.7185	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	.	hom
15	88576185	88576185	G	T	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs2229910	ENSG00000140538:ENST00000557856:exon11:c.C1464A:p.A488A,ENSG00000140538:ENST00000558676:exon11:c.C1464A:p.A488A,ENSG00000140538:ENST00000357724:exon12:c.C1464A:p.A488A,ENSG00000140538:ENST00000540489:exon12:c.C1488A:p.A496A,ENSG00000140538:ENST00000542733:exon12:c.C1194A:p.A398A,ENSG00000140538:ENST00000317501:exon13:c.C1488A:p.A496A,ENSG00000140538:ENST00000355254:exon13:c.C1488A:p.A496A,ENSG00000140538:ENST00000360948:exon13:c.C1488A:p.A496A,ENSG00000140538:ENST00000394480:exon14:c.C1488A:p.A496A	NTRK3:NM_001320134:exon12:c.C1488A:p.A496A,NTRK3:NM_001320135:exon12:c.C1194A:p.A398A,NTRK3:NM_001243101:exon13:c.C1464A:p.A488A,NTRK3:NM_001007156:exon14:c.C1488A:p.A496A,NTRK3:NM_001012338:exon14:c.C1488A:p.A496A,NTRK3:NM_002530:exon14:c.C1488A:p.A496A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0008	.	0.00159744	0.0009	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon11:c.C1464A:p.A488A,NTRK3:uc010bnh.1:exon11:c.C1464A:p.A488A,NTRK3:uc010upl.1:exon12:c.C1194A:p.A398A,NTRK3:uc021sua.1:exon13:c.C1464A:p.A488A,NTRK3:uc002bme.2:exon14:c.C1488A:p.A496A,NTRK3:uc002bmf.2:exon14:c.C1488A:p.A496A,NTRK3:uc002bmg.3:exon14:c.C1488A:p.A496A	.	AFR:0.0012,AMR:0,EAS:0.0101,FIN:0,NFE:0,OTH:0,ASJ:0	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	.	het
15	88679785	88679785	G	A	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs1863480	ENSG00000140538:ENST00000540489:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000542733:exon6:c.C384T:p.N128N,ENSG00000140538:ENST00000557856:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000558676:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000317501:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000355254:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000357724:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000360948:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000394480:exon8:c.C678T:p.N226N	NTRK3:NM_001320134:exon6:c.C678T:p.N226N,NTRK3:NM_001320135:exon6:c.C384T:p.N128N,NTRK3:NM_001007156:exon8:c.C678T:p.N226N,NTRK3:NM_001012338:exon8:c.C678T:p.N226N,NTRK3:NM_001243101:exon8:c.C678T:p.N226N,NTRK3:NM_002530:exon8:c.C678T:p.N226N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	0.9958	0.998203	0.9971	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon6:c.C678T:p.N226N,NTRK3:uc010bnh.1:exon6:c.C678T:p.N226N,NTRK3:uc010upl.1:exon6:c.C384T:p.N128N,NTRK3:uc002bme.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmf.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmg.3:exon8:c.C678T:p.N226N,NTRK3:uc021sua.1:exon8:c.C678T:p.N226N	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:0.9977,NFE:0.9951,OTH:0.9969,ASJ:0.9967	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	MU4561260	hom
15	89804043	89804043	C	T	FANCI	exonic	nonsynonymous SNV	ENSG00000140525	rs17803620	ENSG00000140525:ENST00000300027:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000310775:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000447611:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000563250:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000565255:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000567891:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000564920:exon5:c.C257T:p.A86V,ENSG00000140525:ENST00000567996:exon6:c.C257T:p.A86V	FANCI:NM_001113378:exon4:c.C257T:p.A86V,FANCI:NM_018193:exon4:c.C257T:p.A86V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3569	0.2863	0.259784	1(large_intestine)	3.818	23.4	0.339	4.45	0.984	.	.	FANCI solenoid 1 domain	FANCI:uc002bnm.1:exon4:c.C257T:p.A86V,FANCI:uc010bnp.1:exon4:c.C257T:p.A86V,FANCI:uc002bno.3:exon6:c.C257T:p.A86V	-0.962	AFR:1(thyroid),AMR:MU152349,EAS:0.3184,FIN:0.0916,NFE:0.3365,OTH:0.3907,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.191	0.95	0.000	2.215	15	1(lung)	0.3213
15	89806710	89806710	C	T	FANCI	intronic	.	ENSG00000140525	rs1981623	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3820	0.3481	0.338858	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU731492,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.3333,FIN:0.3556,NFE:0.3940,OTH:0.3221,ASJ:0.3888	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	14(soft_tissue)	0.4573
15	89826496	89826496	C	T	FANCI	intronic	.	ENSG00000140525	rs9806604	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4173	0.4680	0.439297	MU731523	.	.	.	.	.	.	.	.	.	.	AFR:SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.4804,EAS:0.3854,FIN:0.3742,NFE:0.3445,OTH:0.4857,ASJ:0.6261	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4195
15	89836228	89836228	G	C	FANCI	exonic	nonsynonymous SNV	ENSG00000140525	rs2283432	ENSG00000140525:ENST00000300027:exon22:c.G2225C:p.C742S,ENSG00000140525:ENST00000310775:exon22:c.G2225C:p.C742S,ENSG00000140525:ENST00000447611:exon22:c.G2225C:p.C742S	FANCI:NM_001113378:exon22:c.G2225C:p.C742S,FANCI:NM_018193:exon22:c.G2225C:p.C742S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3623	0.2899	0.264976	14(soft_tissue)	1.945	15.87	0.498	4.89	0.995	.	.	FANCI helical domain 2	FANCI:uc002bnq.1:exon8:c.G464C:p.C155S,FANCI:uc002bnp.1:exon16:c.G1688C:p.C563S,FANCI:uc002bnm.1:exon22:c.G2225C:p.C742S,FANCI:uc010bnp.1:exon22:c.G2225C:p.C742S	-0.901	AFR:1(liver),AMR:1(breast),EAS:1(large_intestine),FIN:MU152359,NFE:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,OTH:0.3209,ASJ:1(thyroid)	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.007	1.63	0.000	1.95	15	1(lung)	0.0924
15	89838236	89838236	G	A	FANCI	exonic	synonymous SNV	ENSG00000140525	rs7183618	ENSG00000140525:ENST00000310775:exon24:c.G2547A:p.K849K	FANCI:NM_001113378:exon24:c.G2547A:p.K849K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9593	0.9601	0.980831	0.9538	.	.	.	.	.	.	.	.	FANCI:uc002bnq.1:exon10:c.G786A:p.K262K,FANCI:uc010bnp.1:exon24:c.G2547A:p.K849K	.	AFR:0.9905,AMR:0.9821,EAS:1,FIN:0.8758,NFE:0.9457,OTH:0.9274,ASJ:0.9636	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	MU81967158	hom
15	89844688	89844688	A	C	FANCI	intronic	.	ENSG00000140525	rs2159081	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3944	0.3672	0.36262	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:1(breast),AMR:MU12715937,EAS:0.3999,FIN:0.3389,NFE:0.3612,OTH:0.3940,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	1(lung)	0.3837
15	89858602	89858602	T	C	FANCI	exonic	synonymous SNV	ENSG00000140525	rs1138465	ENSG00000140525:ENST00000300027:exon36:c.T3726C:p.G1242G,ENSG00000140525:ENST00000310775:exon37:c.T3906C:p.G1302G	FANCI:NM_018193:exon36:c.T3726C:p.G1242G,FANCI:NM_001113378:exon37:c.T3906C:p.G1302G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4123	0.4096	0.41234	MU152374	.	.	.	.	.	.	.	.	FANCI:uc002bnq.1:exon23:c.T2145C:p.G715G,FANCI:uc002bnp.1:exon30:c.T3186C:p.G1062G,FANCI:uc002bnm.1:exon36:c.T3726C:p.G1242G,FANCI:uc010bnp.1:exon37:c.T3906C:p.G1302G	.	AFR:COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.4372,EAS:0.3768,FIN:0.3933,NFE:0.4398,OTH:0.5040,ASJ:0.4436	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	1(large_intestine)	0.4220
15	89860786	89860786	A	C	POLG	intronic	.	ENSG00000140521	rs2307438	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4209	0.4355	0.419928	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.4530,AMR:0.5164,EAS:0.3974,FIN:0.3539,NFE:0.4756,OTH:0.4227,ASJ:0.4772	174763	157640;203700;258450;607459;613662;	298;254881;70595;254886;726;254892;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~254881|MSCAE<br>Mitochondrial spinocerebellar ataxia with epilepsy<br>SCAE|-|Autosomal recessive|Adolescent<br>Childhood|607459 ~70595|SANDO|Unknown|Autosomal recessive|Adult|607459 ~254886|arPEO|-|Autosomal recessive|All ages|258450 617069 ~726|Alpers progressive sclerosing poliodystrophy<br>Alpers syndrome<br>Progressive neuronal degeneration of childhood with liver disease|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|203700 ~254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4322
15	89862341	89862341	A	G	POLG	intronic	.	ENSG00000140521	rs2302084	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3747	.	0.298123	COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0001	0.136	.	.	.	AFR:0.3518,AMR:0.1837,EAS:0.3907,FIN:0.3249,NFE:0.4745,OTH:0.4197,ASJ:0.3477	174763	157640;203700;258450;607459;613662;	298;254881;70595;254886;726;254892;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~254881|MSCAE<br>Mitochondrial spinocerebellar ataxia with epilepsy<br>SCAE|-|Autosomal recessive|Adolescent<br>Childhood|607459 ~70595|SANDO|Unknown|Autosomal recessive|Adult|607459 ~254886|arPEO|-|Autosomal recessive|All ages|258450 617069 ~726|Alpers progressive sclerosing poliodystrophy<br>Alpers syndrome<br>Progressive neuronal degeneration of childhood with liver disease|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|203700 ~254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4092
15	91312823	91312823	T	C	BLM	intronic	.	ENSG00000197299	rs3815003	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2956	0.3819	0.366613	0.3771	.	.	.	.	.	0.0013	0.002	.	.	.	AFR:0.5764,AMR:0.2590,EAS:0.3152,FIN:0.2817,NFE:0.3059,OTH:0.2853,ASJ:0.2318	604610	210900;	125;	125|BSyn|Unknown|Autosomal recessive|Neonatal<br>Antenatal|210900 ~	.	.	.	.	.	.	.	.	15	MU16713855	het
15	91337564	91337564	-	ACAAAAATCAG	BLM	exonic	frameshift insertion	ENSG00000197299	.	ENSG00000197299:ENST00000355112:exon16:c.3187_3188insACAAAAATCAG:p.C1063fs,ENSG00000197299:ENST00000560509:exon16:c.3187_3188insACAAAAATCAG:p.C1063fs	BLM:NM_000057:exon16:c.3187_3188insACAAAAATCAG:p.C1063fs,BLM:NM_001287247:exon16:c.3187_3188insACAAAAATCAG:p.C1063fs,BLM:NM_001287248:exon16:c.2062_2063insACAAAAATCAG:p.C688fs,BLM:NM_001287246:exon17:c.3187_3188insACAAAAATCAG:p.C1063fs	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	BLM:uc002bpr.3:exon16:c.3187_3188insACAAAAATCAG:p.C1063fs,BLM:uc010bnx.3:exon16:c.3187_3188insACAAAAATCAG:p.C1063fs,BLM:uc010uqi.2:exon16:c.2062_2063insACAAAAATCAG:p.C688fs,BLM:uc010uqh.2:exon17:c.3187_3188insACAAAAATCAG:p.C1063fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604610	210900;	125;	125|BSyn|Unknown|Autosomal recessive|Neonatal<br>Antenatal|210900 ~	.	.	.	.	.	.	.	.	15	.	het
15	91428290	91428290	C	T	FES	exonic	synonymous SNV	ENSG00000182511	rs11539637	ENSG00000182511:ENST00000394300:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000444422:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000450438:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000328850:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000394302:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000414248:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000416779:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000443697:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000452243:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000464684:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000470152:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000559355:exon2:c.C15T:p.S5S	FES:NM_001143783:exon1:c.C15T:p.S5S,FES:NM_001143784:exon1:c.C15T:p.S5S,FES:NM_001143785:exon2:c.C15T:p.S5S,FES:NM_002005:exon2:c.C15T:p.S5S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5849	0.4937	0.58746	1(cervix)	.	.	.	.	.	.	.	.	FES:uc002bpx.3:exon1:c.C15T:p.S5S,FES:uc002bpy.3:exon1:c.C15T:p.S5S,FES:uc010bny.3:exon1:c.C15T:p.S5S,FES:uc002bpv.3:exon2:c.C15T:p.S5S,FES:uc010uqj.2:exon2:c.C15T:p.S5S,FES:uc010uqk.2:exon2:c.C15T:p.S5S	.	AFR:MU4326664,AMR:COCA-CN|5|321|0.0155763,EAS:0.4141,FIN:0.7416,NFE:0.5033,OTH:0.8063,ASJ:0.5301	190030	.	.	.	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.6337
15	91428636	91428636	G	A	FES	intronic	.	ENSG00000182511	rs7177338	ENSG00000182511:ENST00000470152:exon2:c.G361A:p.V121I	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5809	0.5079	0.587859	17(soft_tissue)	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:MU10889595,AMR:COCA-CN|5|321|0.0155763,EAS:0.4676,FIN:0.6687,NFE:0.5,OTH:0.8016,ASJ:0.5425	190030	.	.	.	.	.	.	.	.	.	.	.	15	20(lung)	0.6343
15	91430436	91430436	T	C	FES	exonic	synonymous SNV	ENSG00000182511	rs2071383	ENSG00000182511:ENST00000394300:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000450438:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000394302:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000414248:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000444422:exon4:c.T504C:p.A168A,ENSG00000182511:ENST00000328850:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000464684:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000559355:exon5:c.T504C:p.A168A	FES:NM_001143783:exon3:c.T330C:p.A110A,FES:NM_001143784:exon4:c.T504C:p.A168A,FES:NM_001143785:exon4:c.T330C:p.A110A,FES:NM_002005:exon5:c.T504C:p.A168A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9608	0.9552	0.9377	0.9534	.	.	.	.	.	.	.	.	FES:uc002bpy.3:exon3:c.T330C:p.A110A,FES:uc010bny.3:exon3:c.T330C:p.A110A,FES:uc002bpx.3:exon4:c.T504C:p.A168A,FES:uc010uqj.2:exon4:c.T330C:p.A110A,FES:uc002bpv.3:exon5:c.T504C:p.A168A,FES:uc010uqk.2:exon5:c.T450C:p.A150A	.	AFR:0.9307,AMR:0.9821,EAS:0.8909,FIN:0.9533,NFE:0.9708,OTH:0.9664,ASJ:0.9603	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU82136926	hom
15	91430617	91430617	G	A	FES	intronic	.	ENSG00000182511	rs2071384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4634	0.2910	0.453674	0.3484	.	.	.	.	.	.	.	.	.	.	AFR:0.1717,AMR:0.6193,EAS:0.7797,FIN:0.4327,NFE:0.3646,OTH:0.4287,ASJ:0.3467	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU29420728	hom
15	93510603	93510603	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs4777755	ENSG00000173575:ENST00000394196:exon17:c.A2049G:p.E683E,ENSG00000173575:ENST00000557381:exon17:c.A2049G:p.E683E	CHD2:NM_001271:exon17:c.A2049G:p.E683E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8419	0.7656	0.826478	0.7708	.	.	.	.	.	.	.	.	CHD2:uc002bso.1:exon17:c.A2049G:p.E683E,CHD2:uc002bsp.3:exon17:c.A2049G:p.E683E	.	AFR:0.6178,AMR:0.9105,EAS:0.9981,FIN:0.7596,NFE:0.8233,OTH:0.8219,ASJ:0.9305	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967798	het
15	93521604	93521604	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs11074121	ENSG00000173575:ENST00000557116:exon3:c.A258G:p.Q86Q,ENSG00000173575:ENST00000394196:exon21:c.A2718G:p.Q906Q,ENSG00000173575:ENST00000557381:exon21:c.A2718G:p.Q906Q	CHD2:NM_001271:exon21:c.A2718G:p.Q906Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8353	0.7477	0.809105	0.7534	.	.	.	.	.	.	.	.	CHD2:uc010bog.1:exon4:c.A539G:p.K180R	.	AFR:0.5632,AMR:0.9069,EAS:0.9981,FIN:0.7585,NFE:0.8202,OTH:0.8112,ASJ:0.9272	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967815	het
15	99251356	99251356	C	T	IGF1R	intronic	.	ENSG00000140443	rs7174918	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2907	0.2642	0.233427	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2568,AMR:0.1319,EAS:0.3974,FIN:0.2311,NFE:0.2657,OTH:0.3260,ASJ:0.2356	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	9(soft_tissue)	0.2957
15	99456253	99456253	T	C	IGF1R	intronic	.	ENSG00000140443	rs2272037	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5775	0.4694	0.511182	MU20714555	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5149,EAS:0.6160,FIN:0.5099,NFE:0.7108,OTH:0.6427,ASJ:0.2497	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	17(soft_tissue)	0.6059
15	99486159	99486159	T	C	IGF1R	exonic	synonymous SNV	ENSG00000140443	rs747960306	ENSG00000140443:ENST00000268035:exon19:c.T3465C:p.G1155G,ENSG00000140443:ENST00000558762:exon19:c.T3462C:p.G1154G	IGF1R:NM_000875:exon19:c.T3465C:p.G1155G,IGF1R:NM_001291858:exon19:c.T3462C:p.G1154G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	1.647e-05	.	.	.	.	.	.	.	.	.	.	.	IGF1R:uc002bul.3:exon19:c.T3465C:p.G1155G,IGF1R:uc010bon.3:exon19:c.T3462C:p.G1154G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	.	het
15	100218867	100218867	A	G	MEF2A	exonic	nonsynonymous SNV	ENSG00000068305	rs2581470	.	MEF2A:NM_001365210:exon8:c.A691G:p.K231E,MEF2A:NM_001365211:exon8:c.A685G:p.K229E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.630791	0.6681	.	.	.	.	.	.	.	.	.	.	AFR:0.3552,AMR:0.7045,EAS:0.7109,FIN:0.8311,NFE:0.7923,OTH:0.8143,ASJ:0.8510	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU12577973	hom
15	100246936	100246936	T	C	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325408	ENSG00000068305:ENST00000449277:exon7:c.T657C:p.N219N,ENSG00000068305:ENST00000453228:exon8:c.T861C:p.N287N,ENSG00000068305:ENST00000558812:exon8:c.T681C:p.N227N,ENSG00000068305:ENST00000354410:exon9:c.T867C:p.N289N,ENSG00000068305:ENST00000557785:exon9:c.T861C:p.N287N,ENSG00000068305:ENST00000338042:exon10:c.T888C:p.N296N,ENSG00000068305:ENST00000557942:exon10:c.T885C:p.N295N	MEF2A:NM_001130928:exon6:c.T657C:p.N219N,MEF2A:NM_001130926:exon8:c.T861C:p.N287N,MEF2A:NM_001130927:exon8:c.T681C:p.N227N,MEF2A:NM_001365206:exon8:c.T879C:p.N293N,MEF2A:NM_001365207:exon8:c.T867C:p.N289N,MEF2A:NM_001352616:exon9:c.T885C:p.N295N,MEF2A:NM_001352617:exon9:c.T867C:p.N289N,MEF2A:NM_001352618:exon9:c.T879C:p.N293N,MEF2A:NM_001365202:exon9:c.T903C:p.N301N,MEF2A:NM_001365204:exon9:c.T891C:p.N297N,MEF2A:NM_001365205:exon9:c.T885C:p.N295N,MEF2A:NM_001365208:exon9:c.T861C:p.N287N,MEF2A:NM_001365209:exon9:c.T681C:p.N227N,MEF2A:NM_005587:exon9:c.T867C:p.N289N,MEF2A:NM_001171894:exon10:c.T861C:p.N287N,MEF2A:NM_001319206:exon10:c.T885C:p.N295N,MEF2A:NM_001352614:exon10:c.T861C:p.N287N,MEF2A:NM_001365201:exon10:c.T903C:p.N301N,MEF2A:NM_001365203:exon10:c.T891C:p.N297N,MEF2A:NM_001352615:exon11:c.T861C:p.N287N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7471	0.6406	0.61242	0.6476	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.T657C:p.N219N,MEF2A:uc002bvi.3:exon8:c.T861C:p.N287N,MEF2A:uc010bos.3:exon8:c.T861C:p.N287N,MEF2A:uc010urv.2:exon8:c.T681C:p.N227N,MEF2A:uc002bvf.3:exon9:c.T867C:p.N289N,MEF2A:uc010urw.2:exon9:c.T891C:p.N297N,MEF2A:uc002bve.3:exon10:c.T885C:p.N295N,MEF2A:uc002bvg.3:exon10:c.T861C:p.N287N	.	AFR:0.2872,AMR:0.6974,EAS:0.7153,FIN:0.8232,NFE:0.7910,OTH:0.8086,ASJ:0.8477	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU700988	unknown
15	100246942	100246942	G	A	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325407	ENSG00000068305:ENST00000449277:exon7:c.G663A:p.Q221Q,ENSG00000068305:ENST00000453228:exon8:c.G867A:p.Q289Q,ENSG00000068305:ENST00000558812:exon8:c.G687A:p.Q229Q,ENSG00000068305:ENST00000354410:exon9:c.G873A:p.Q291Q,ENSG00000068305:ENST00000557785:exon9:c.G867A:p.Q289Q,ENSG00000068305:ENST00000338042:exon10:c.G894A:p.Q298Q,ENSG00000068305:ENST00000557942:exon10:c.G891A:p.Q297Q	MEF2A:NM_001130928:exon6:c.G663A:p.Q221Q,MEF2A:NM_001130926:exon8:c.G867A:p.Q289Q,MEF2A:NM_001130927:exon8:c.G687A:p.Q229Q,MEF2A:NM_001365206:exon8:c.G885A:p.Q295Q,MEF2A:NM_001365207:exon8:c.G873A:p.Q291Q,MEF2A:NM_001352616:exon9:c.G891A:p.Q297Q,MEF2A:NM_001352617:exon9:c.G873A:p.Q291Q,MEF2A:NM_001352618:exon9:c.G885A:p.Q295Q,MEF2A:NM_001365202:exon9:c.G909A:p.Q303Q,MEF2A:NM_001365204:exon9:c.G897A:p.Q299Q,MEF2A:NM_001365205:exon9:c.G891A:p.Q297Q,MEF2A:NM_001365208:exon9:c.G867A:p.Q289Q,MEF2A:NM_001365209:exon9:c.G687A:p.Q229Q,MEF2A:NM_005587:exon9:c.G873A:p.Q291Q,MEF2A:NM_001171894:exon10:c.G867A:p.Q289Q,MEF2A:NM_001319206:exon10:c.G891A:p.Q297Q,MEF2A:NM_001352614:exon10:c.G867A:p.Q289Q,MEF2A:NM_001365201:exon10:c.G909A:p.Q303Q,MEF2A:NM_001365203:exon10:c.G897A:p.Q299Q,MEF2A:NM_001352615:exon11:c.G867A:p.Q289Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9669	0.8850	0.886781	0.8929	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.G663A:p.Q221Q,MEF2A:uc002bvi.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010bos.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010urv.2:exon8:c.G687A:p.Q229Q,MEF2A:uc002bvf.3:exon9:c.G873A:p.Q291Q,MEF2A:uc010urw.2:exon9:c.G897A:p.Q299Q,MEF2A:uc002bve.3:exon10:c.G891A:p.Q297Q,MEF2A:uc002bvg.3:exon10:c.G867A:p.Q289Q	.	AFR:0.6237,AMR:0.9821,EAS:1,FIN:1,NFE:0.9985,OTH:0.9868,ASJ:1	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU81968211	unknown
15	100252710	100252715	CAGCAG	-	MEF2A	exonic	nonframeshift deletion	ENSG00000068305	rs3138597	ENSG00000068305:ENST00000449277:exon9:c.1024_1029del:p.342_343del,ENSG00000068305:ENST00000453228:exon10:c.1228_1233del:p.410_411del,ENSG00000068305:ENST00000558812:exon10:c.1048_1053del:p.350_351del,ENSG00000068305:ENST00000354410:exon11:c.1234_1239del:p.412_413del,ENSG00000068305:ENST00000557785:exon11:c.1228_1233del:p.410_411del,ENSG00000068305:ENST00000338042:exon12:c.1255_1260del:p.419_420del,ENSG00000068305:ENST00000557942:exon12:c.1252_1257del:p.418_419del	MEF2A:NM_001130928:exon8:c.1024_1029del:p.342_343del,MEF2A:NM_001130926:exon10:c.1228_1233del:p.410_411del,MEF2A:NM_001130927:exon10:c.1048_1053del:p.350_351del,MEF2A:NM_001365206:exon10:c.1246_1251del:p.416_417del,MEF2A:NM_001365207:exon10:c.1234_1239del:p.412_413del,MEF2A:NM_001352616:exon11:c.1252_1257del:p.418_419del,MEF2A:NM_001352617:exon11:c.1234_1239del:p.412_413del,MEF2A:NM_001352618:exon11:c.1246_1251del:p.416_417del,MEF2A:NM_001365202:exon11:c.1270_1275del:p.424_425del,MEF2A:NM_001365204:exon11:c.1258_1263del:p.420_421del,MEF2A:NM_001365205:exon11:c.1252_1257del:p.418_419del,MEF2A:NM_001365208:exon11:c.1228_1233del:p.410_411del,MEF2A:NM_001365209:exon11:c.1048_1053del:p.350_351del,MEF2A:NM_005587:exon11:c.1234_1239del:p.412_413del,MEF2A:NM_001171894:exon12:c.1228_1233del:p.410_411del,MEF2A:NM_001319206:exon12:c.1252_1257del:p.418_419del,MEF2A:NM_001352614:exon12:c.1228_1233del:p.410_411del,MEF2A:NM_001365201:exon12:c.1270_1275del:p.424_425del,MEF2A:NM_001365203:exon12:c.1258_1263del:p.420_421del,MEF2A:NM_001352615:exon13:c.1228_1233del:p.410_411del	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2791	0.1623	.	0.2751	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.1024_1029del:p.342_343del,MEF2A:uc002bvi.3:exon10:c.1228_1233del:p.410_411del,MEF2A:uc010bos.3:exon10:c.1228_1233del:p.410_411del,MEF2A:uc010urv.2:exon10:c.1048_1053del:p.350_351del,MEF2A:uc002bvf.3:exon11:c.1234_1239del:p.412_413del,MEF2A:uc010urw.2:exon11:c.1258_1263del:p.420_421del,MEF2A:uc002bve.3:exon12:c.1252_1257del:p.418_419del,MEF2A:uc002bvg.3:exon12:c.1228_1233del:p.410_411del	.	AFR:0.0642,AMR:0.2845,EAS:0.3553,FIN:0.3896,NFE:0.3560,OTH:0.3650,ASJ:0.3221	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	.	het
15	100252736	100252744	GCAGCAGCC	-	MEF2A	exonic	nonframeshift deletion	ENSG00000068305	rs560400205	ENSG00000068305:ENST00000449277:exon9:c.1050_1058del:p.350_353del,ENSG00000068305:ENST00000453228:exon10:c.1254_1262del:p.418_421del,ENSG00000068305:ENST00000558812:exon10:c.1074_1082del:p.358_361del,ENSG00000068305:ENST00000354410:exon11:c.1260_1268del:p.420_423del,ENSG00000068305:ENST00000557785:exon11:c.1254_1262del:p.418_421del,ENSG00000068305:ENST00000338042:exon12:c.1281_1289del:p.427_430del,ENSG00000068305:ENST00000557942:exon12:c.1278_1286del:p.426_429del	MEF2A:NM_001130928:exon8:c.1050_1058del:p.350_353del,MEF2A:NM_001130926:exon10:c.1254_1262del:p.418_421del,MEF2A:NM_001130927:exon10:c.1074_1082del:p.358_361del,MEF2A:NM_001365206:exon10:c.1272_1280del:p.424_427del,MEF2A:NM_001365207:exon10:c.1260_1268del:p.420_423del,MEF2A:NM_001352616:exon11:c.1278_1286del:p.426_429del,MEF2A:NM_001352617:exon11:c.1260_1268del:p.420_423del,MEF2A:NM_001352618:exon11:c.1272_1280del:p.424_427del,MEF2A:NM_001365202:exon11:c.1296_1304del:p.432_435del,MEF2A:NM_001365204:exon11:c.1284_1292del:p.428_431del,MEF2A:NM_001365205:exon11:c.1278_1286del:p.426_429del,MEF2A:NM_001365208:exon11:c.1254_1262del:p.418_421del,MEF2A:NM_001365209:exon11:c.1074_1082del:p.358_361del,MEF2A:NM_005587:exon11:c.1260_1268del:p.420_423del,MEF2A:NM_001171894:exon12:c.1254_1262del:p.418_421del,MEF2A:NM_001319206:exon12:c.1278_1286del:p.426_429del,MEF2A:NM_001352614:exon12:c.1254_1262del:p.418_421del,MEF2A:NM_001365201:exon12:c.1296_1304del:p.432_435del,MEF2A:NM_001365203:exon12:c.1284_1292del:p.428_431del,MEF2A:NM_001352615:exon13:c.1254_1262del:p.418_421del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0053	0.1690	0.00559105	0.0069	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.1050_1058del:p.350_353del,MEF2A:uc002bvi.3:exon10:c.1254_1262del:p.418_421del,MEF2A:uc010bos.3:exon10:c.1254_1262del:p.418_421del,MEF2A:uc010urv.2:exon10:c.1074_1082del:p.358_361del,MEF2A:uc002bvf.3:exon11:c.1260_1268del:p.420_423del,MEF2A:uc010urw.2:exon11:c.1284_1292del:p.428_431del,MEF2A:uc002bve.3:exon12:c.1278_1286del:p.426_429del,MEF2A:uc002bvg.3:exon12:c.1254_1262del:p.418_421del	.	AFR:0.0095,AMR:0.0133,EAS:0.0402,FIN:0.0052,NFE:0.0021,OTH:0.0082,ASJ:0	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	.	het
15	100252805	100252805	G	T	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325400	ENSG00000068305:ENST00000449277:exon9:c.G1119T:p.G373G,ENSG00000068305:ENST00000453228:exon10:c.G1323T:p.G441G,ENSG00000068305:ENST00000558812:exon10:c.G1143T:p.G381G,ENSG00000068305:ENST00000354410:exon11:c.G1329T:p.G443G,ENSG00000068305:ENST00000557785:exon11:c.G1323T:p.G441G,ENSG00000068305:ENST00000338042:exon12:c.G1350T:p.G450G,ENSG00000068305:ENST00000557942:exon12:c.G1347T:p.G449G	MEF2A:NM_001130928:exon8:c.G1119T:p.G373G,MEF2A:NM_001130926:exon10:c.G1323T:p.G441G,MEF2A:NM_001130927:exon10:c.G1143T:p.G381G,MEF2A:NM_001365206:exon10:c.G1341T:p.G447G,MEF2A:NM_001365207:exon10:c.G1329T:p.G443G,MEF2A:NM_001352616:exon11:c.G1347T:p.G449G,MEF2A:NM_001352617:exon11:c.G1329T:p.G443G,MEF2A:NM_001352618:exon11:c.G1341T:p.G447G,MEF2A:NM_001365202:exon11:c.G1365T:p.G455G,MEF2A:NM_001365204:exon11:c.G1353T:p.G451G,MEF2A:NM_001365205:exon11:c.G1347T:p.G449G,MEF2A:NM_001365208:exon11:c.G1323T:p.G441G,MEF2A:NM_001365209:exon11:c.G1143T:p.G381G,MEF2A:NM_005587:exon11:c.G1329T:p.G443G,MEF2A:NM_001171894:exon12:c.G1323T:p.G441G,MEF2A:NM_001319206:exon12:c.G1347T:p.G449G,MEF2A:NM_001352614:exon12:c.G1323T:p.G441G,MEF2A:NM_001365201:exon12:c.G1365T:p.G455G,MEF2A:NM_001365203:exon12:c.G1353T:p.G451G,MEF2A:NM_001352615:exon13:c.G1323T:p.G441G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4953	0.3889	0.349241	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.G1119T:p.G373G,MEF2A:uc002bvi.3:exon10:c.G1323T:p.G441G,MEF2A:uc010bos.3:exon10:c.G1323T:p.G441G,MEF2A:uc010urv.2:exon10:c.G1143T:p.G381G,MEF2A:uc002bvf.3:exon11:c.G1329T:p.G443G,MEF2A:uc010urw.2:exon11:c.G1353T:p.G451G,MEF2A:uc002bve.3:exon12:c.G1347T:p.G449G,MEF2A:uc002bvg.3:exon12:c.G1323T:p.G441G	.	AFR:0.4154,AMR:0.1778,EAS:0.5403,FIN:0.3194,NFE:0.5307,OTH:0.5236,ASJ:0.4916	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	1(lung)	0.5144
16	129277	129277	A	G	MPG	UTR5	.	ENSG00000103152	rs710080	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1977	0.2142	0.291134	0.2077	.	.	.	.	.	.	.	.	.	.	AFR:0.6642,AMR:0.1400,EAS:0.0927,FIN:0.0398,NFE:0.0107,OTH:0.0733,ASJ:0.0099	156565	.	.	.	.	.	.	.	.	.	.	.	16	MU80650107	het
16	129654	129654	C	T	MPG	exonic	synonymous SNV	ENSG00000103152	rs710081	ENSG00000103152:ENST00000356432:exon2:c.C255T:p.F85F,ENSG00000103152:ENST00000397817:exon2:c.C219T:p.F73F,ENSG00000103152:ENST00000436333:exon2:c.C219T:p.F73F,ENSG00000103152:ENST00000219431:exon3:c.C270T:p.F90F	MPG:NM_001015052:exon2:c.C255T:p.F85F,MPG:NM_001015054:exon2:c.C219T:p.F73F,MPG:NM_002434:exon3:c.C270T:p.F90F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1658	0.1696	0.249401	MU583735	.	.	.	.	.	.	.	.	MPG:uc002cfm.4:exon2:c.C219T:p.F73F,MPG:uc002cfo.4:exon2:c.C255T:p.F85F,MPG:uc010bqp.3:exon2:c.C219T:p.F73F,MPG:uc002cfn.4:exon3:c.C270T:p.F90F	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1708,EAS:0.1301,FIN:0.0033,NFE:0.0878,OTH:0.0323,ASJ:0.5416	156565	.	.	.	.	.	.	.	.	.	.	.	16	1(lung)	0.0095
16	339544	339544	C	T	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs199901645	ENSG00000103126:ENST00000354866:exon9:c.G2250A:p.A750A,ENSG00000103126:ENST00000262320:exon10:c.G2358A:p.A786A	AXIN1:NM_181050:exon9:c.G2250A:p.A750A,AXIN1:NM_003502:exon10:c.G2358A:p.A786A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 1, 0] 	0.0006	7.7e-05	0.00299521	.	.	.	.	.	.	.	.	.	AXIN1:uc002cgq.2:exon9:c.G2250A:p.A750A,AXIN1:uc002cgp.2:exon10:c.G2358A:p.A786A	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU128973599	het
16	348204	348204	C	A	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs562247902	ENSG00000103126:ENST00000262320:exon6:c.G1302T:p.P434P,ENSG00000103126:ENST00000354866:exon6:c.G1302T:p.P434P	AXIN1:NM_003502:exon6:c.G1302T:p.P434P,AXIN1:NM_181050:exon6:c.G1302T:p.P434P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0003	.	0.000599042	.	.	.	.	.	.	.	.	.	AXIN1:uc002cgp.2:exon6:c.G1302T:p.P434P,AXIN1:uc002cgq.2:exon6:c.G1302T:p.P434P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	.	het
16	349221	349221	T	C	AXIN1	intronic	.	ENSG00000103126	rs214247	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.388179	0.4249	.	.	.	.	.	.	.	.	.	.	AFR:0.6136,AMR:0.2488,EAS:0.2110,FIN:0.3297,NFE:0.3773,OTH:0.3452,ASJ:0.3278	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU10930938	het
16	354287	354287	C	T	AXIN1	intronic	.	ENSG00000103126	rs62032881	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1426	0.1268	0.125799	0.1233	.	.	.	.	.	.	.	.	.	.	AFR:0.0643,AMR:0.0835,EAS:0.1545,FIN:0.1258,NFE:0.1563,OTH:0.1155,ASJ:0.1325	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU10931196	het
16	359953	359953	A	G	AXIN1	intronic	.	ENSG00000103126	rs2301522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6387	0.7276	0.649161	0.6909	.	.	.	.	.	.	.	.	.	.	AFR:0.8845,AMR:0.5647,EAS:0.3653,FIN:0.6372,NFE:0.6400,OTH:0.6235,ASJ:0.5430	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU27447663	hom
16	396264	396264	A	G	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs1805105	ENSG00000103126:ENST00000262320:exon2:c.T762C:p.D254D,ENSG00000103126:ENST00000354866:exon2:c.T762C:p.D254D	AXIN1:NM_003502:exon2:c.T762C:p.D254D,AXIN1:NM_181050:exon2:c.T762C:p.D254D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6218	0.7141	0.638978	0.6766	.	.	.	.	.	.	.	.	AXIN1:uc002cgp.2:exon2:c.T762C:p.D254D,AXIN1:uc002cgq.2:exon2:c.T762C:p.D254D	.	AFR:0.8682,AMR:0.4940,EAS:0.3050,FIN:0.6045,NFE:0.6388,OTH:0.6109,ASJ:0.5497	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU152642	hom
16	397044	397044	G	T	AXIN1	UTR5	.	ENSG00000103126	rs758033	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2252	0.2248	0.201478	0.2089	.	.	.	.	.	.	.	.	.	.	AFR:0.1701,AMR:0.1535,EAS:0.1259,FIN:0.2017,NFE:0.2444,OTH:0.2102,ASJ:0.2384	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU583737	het
16	1823444	1823444	C	G	EME2	exonic	synonymous SNV	ENSG00000197774	rs761065	ENSG00000197774:ENST00000307394:exon1:c.C216G:p.V72V,ENSG00000197774:ENST00000568449:exon1:c.C216G:p.V72V	EME2:NM_001257370:exon1:c.C216G:p.V72V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5569	0.4177	0.336062	MU78075	.	.	.	.	.	.	.	.	EME2:uc002cmq.1:exon1:c.C216G:p.V72V,EME2:uc010brw.1:exon1:c.C216G:p.V72V	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611,LINC-JP|1|394|0.00253807,AMR:0.4234,EAS:0.5467,FIN:0.5795,NFE:0.3053,OTH:0.4753,ASJ:0.1388	610886	.	.	.	.	.	.	.	.	.	.	.	16	2(large_intestine)	0.5734
16	2097722	2097722	C	G	NTHL1	exonic	nonsynonymous SNV	ENSG00000065057	rs747272786	ENSG00000065057:ENST00000219066:exon1:c.G127C:p.E43Q	NTHL1:NM_001318193:exon1:c.G103C:p.E35Q,NTHL1:NM_002528:exon1:c.G103C:p.E35Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	5.955e-05	.	.	3.235e-05	0.530	7.657	0.136	1.63	0.089	.	.	.	NTHL1:uc002col.1:exon1:c.G127C:p.E43Q	-1.035	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	602656	616415;	220460;454840;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~454840|NTHL1-related AFAP|-|Autosomal recessive|-|616415 ~	.	.	.	.	0.675	2.45	0.032	2.35	16	.	het
16	2138198	2138201	AGTG	-	TSC2	intronic	.	ENSG00000103197	rs1799758	.	.	clinvar: not_provided 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0085	0.0077	0.00519169	0.0086	.	.	.	.	.	.	.	.	.	.	AFR:0.0008,AMR:0.0012,EAS:0,FIN:0.0037,NFE:0.0155,OTH:0.0102,ASJ:0.0099	191092	606690;613254;	805;538;	805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~	~ko04072 Phospholipase D signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	16	.	het
16	2160494	2160494	C	T	PKD1	exonic	synonymous SNV	ENSG00000008710	rs79884128	ENSG00000008710:ENST00000262304:exon15:c.G4674A:p.T1558T,ENSG00000008710:ENST00000423118:exon15:c.G4674A:p.T1558T	PKD1:NM_000296:exon15:c.G4674A:p.T1558T,PKD1:NM_001009944:exon15:c.G4674A:p.T1558T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0757	0.0541	0.0710863	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	PKD1:uc002cos.1:exon15:c.G4674A:p.T1558T,PKD1:uc002cot.1:exon15:c.G4674A:p.T1558T	.	AFR:0.0705,AMR:0.0123,EAS:0.0795,FIN:0.1665,NFE:0.0837,OTH:0.0909,ASJ:0.0585	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	1(large_intestine)	0.0786
16	2164808	2164808	C	T	PKD1	exonic	nonsynonymous SNV	ENSG00000008710	rs40433	ENSG00000008710:ENST00000262304:exon11:c.G2216A:p.R739Q,ENSG00000008710:ENST00000423118:exon11:c.G2216A:p.R739Q	PKD1:NM_000296:exon11:c.G2216A:p.R739Q,PKD1:NM_001009944:exon11:c.G2216A:p.R739Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9586	.	0.979233	.	-0.560	0.156	0.719	-2.55	0.000	.	.	Polycystin cation channel	PKD1:uc002cos.1:exon11:c.G2216A:p.R739Q,PKD1:uc002cot.1:exon11:c.G2216A:p.R739Q	-0.965	AFR:0.9693,AMR:0.9926,EAS:0.9133,FIN:0.9994,NFE:0.9653,OTH:0.9545,ASJ:0.9758	601313	173900;	.	.	.	.	.	.	0.005	1.27	0.000	-0.625	16	22(upper_aerodigestive_tract)	0.9629
16	2167874	2167874	G	A	PKD1	exonic	synonymous SNV	ENSG00000008710	rs35842	ENSG00000008710:ENST00000568591:exon1:c.C87T:p.L29L,ENSG00000008710:ENST00000262304:exon5:c.C1119T:p.L373L,ENSG00000008710:ENST00000423118:exon5:c.C1119T:p.L373L	PKD1:NM_000296:exon5:c.C1119T:p.L373L,PKD1:NM_001009944:exon5:c.C1119T:p.L373L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9051	.	0.944289	.	.	.	.	.	.	.	.	.	PKD1:uc002cos.1:exon5:c.C1119T:p.L373L,PKD1:uc002cot.1:exon5:c.C1119T:p.L373L	.	AFR:0.8356,AMR:0.9129,EAS:0.7743,FIN:0.9515,NFE:0.8171,OTH:0.7820,ASJ:0.8883	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	1(upper_aerodigestive_tract)	0.8191
16	3639139	3639139	A	G	SLX4	exonic	synonymous SNV	ENSG00000188827	rs3810812	ENSG00000188827:ENST00000294008:exon12:c.T4500C:p.N1500N	SLX4:NM_032444:exon12:c.T4500C:p.N1500N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6116	0.6266	0.739617	0.6327	.	.	.	.	.	.	.	.	SLX4:uc002cvp.2:exon12:c.T4500C:p.N1500N	.	AFR:0.8818,AMR:0.6244,EAS:0.7336,FIN:0.5011,NFE:0.5156,OTH:0.5608,ASJ:0.47	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU25678123	het
16	3656482	3656482	C	T	SLX4	exonic	synonymous SNV	ENSG00000188827	rs8061528	ENSG00000188827:ENST00000294008:exon3:c.G753A:p.A251A	SLX4:NM_032444:exon3:c.G753A:p.A251A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2138	0.2189	0.230831	0.2190	.	.	.	.	.	.	.	.	SLX4:uc002cvp.2:exon3:c.G753A:p.A251A,SLX4:uc002cvq.1:exon3:c.G753A:p.A251A	.	AFR:0.2580,AMR:0.2112,EAS:0.3092,FIN:0.1578,NFE:0.2025,OTH:0.2016,ASJ:0.2119	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU23721097	het
16	5122072	5122072	-	GTCT	ALG1	intronic	.	ENSG00000033011	rs112683515	ENSG00000033011:ENST00000591822:exon1:c.222_223insGTCT:p.R74fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6041	0.5126	0.583466	0.5624	.	.	.	.	.	.	.	.	.	.	AFR:0.5416,AMR:0.4556,EAS:0.6941,FIN:0.5931,NFE:0.5623,OTH:0.5484,ASJ:0.4536	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	.	het
16	5128001	5128001	C	T	ALG1	exonic	synonymous SNV	ENSG00000033011	rs7195893	ENSG00000033011:ENST00000262374:exon6:c.C723T:p.H241H,ENSG00000033011:ENST00000544428:exon6:c.C390T:p.H130H,ENSG00000033011:ENST00000591783:exon6:c.C390T:p.H130H,ENSG00000033011:ENST00000588623:exon7:c.C390T:p.H130H	ALG1:NM_001330504:exon6:c.C390T:p.H130H,ALG1:NM_019109:exon6:c.C723T:p.H241H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0695	0.0647	0.0924521	.	.	.	.	.	.	.	.	.	ALG1:uc002cym.3:exon6:c.C723T:p.H241H,ALG1:uc010bue.3:exon6:c.C390T:p.H130H,ALG1:uc002cyj.3:exon7:c.C390T:p.H130H	.	AFR:0.0657,AMR:0.0969,EAS:0.0728,FIN:0.0358,NFE:0.0478,OTH:0.0506,ASJ:0.1408	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	1(large_intestine)	0.0665
16	5132636	5132636	C	T	ALG1	exonic	synonymous SNV	ENSG00000033011	rs1047732	ENSG00000033011:ENST00000262374:exon11:c.C1149T:p.F383F,ENSG00000033011:ENST00000544428:exon11:c.C816T:p.F272F,ENSG00000033011:ENST00000588623:exon12:c.C816T:p.F272F	ALG1:NM_001330504:exon11:c.C816T:p.F272F,ALG1:NM_019109:exon11:c.C1149T:p.F383F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.4694	0.519768	0.5046	.	.	.	.	.	.	.	.	ALG1:uc002cym.3:exon11:c.C1149T:p.F383F,ALG1:uc010bue.3:exon11:c.C816T:p.F272F,ALG1:uc002cyj.3:exon12:c.C816T:p.F272F	.	AFR:0.4030,AMR:0.4400,EAS:0.6658,FIN:0.5702,NFE:0.5350,OTH:0.5204,ASJ:0.4404	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	MU62996	het
16	5134774	5134774	T	A	ALG1	exonic	nonsynonymous SNV	ENSG00000033011	rs9745522	ENSG00000033011:ENST00000262374:exon13:c.T1287A:p.D429E,ENSG00000033011:ENST00000544428:exon13:c.T954A:p.D318E,ENSG00000033011:ENST00000588623:exon14:c.T954A:p.D318E	ALG1:NM_001330504:exon13:c.T954A:p.D318E,ALG1:NM_019109:exon13:c.T1287A:p.D429E	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.1174	0.1136	0.126997	0.1174	0.413	6.728	0.313	0.753	0.794	.	.	Glycosyl transferase, family 1	ALG1:uc002cym.3:exon13:c.T1287A:p.D429E,ALG1:uc010bue.3:exon13:c.T954A:p.D318E,ALG1:uc002cyj.3:exon14:c.T954A:p.D318E	-1.072	AFR:0.1452,AMR:0.1706,EAS:0.0364,FIN:0.1266,NFE:0.1044,OTH:0.1245,ASJ:0.1126	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	0.048	-0.95	0.001	1.85	16	.	het
16	9916204	9916204	C	G	GRIN2A	exonic	synonymous SNV	ENSG00000183454	rs9806806	ENSG00000183454:ENST00000396575:exon9:c.G2085C:p.R695R,ENSG00000183454:ENST00000535259:exon9:c.G1614C:p.R538R,ENSG00000183454:ENST00000562109:exon9:c.G2085C:p.R695R,ENSG00000183454:ENST00000330684:exon10:c.G2085C:p.R695R,ENSG00000183454:ENST00000404927:exon10:c.G2085C:p.R695R,ENSG00000183454:ENST00000396573:exon11:c.G2085C:p.R695R	GRIN2A:NM_001134407:exon10:c.G2085C:p.R695R,GRIN2A:NM_001134408:exon10:c.G2085C:p.R695R,GRIN2A:NM_000833:exon11:c.G2085C:p.R695R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2648	0.3511	0.28115	1(large_intestine)	.	.	.	.	.	.	.	.	GRIN2A:uc010uyn.2:exon9:c.G1614C:p.R538R,GRIN2A:uc002czo.4:exon10:c.G2085C:p.R695R,GRIN2A:uc002czr.4:exon10:c.G2085C:p.R695R,GRIN2A:uc010uym.2:exon11:c.G2085C:p.R695R	.	AFR:MU86207,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,EAS:0.5147,FIN:0.2506,NFE:0.3033,OTH:0.0708,ASJ:0.3315	138253	245570;	163721;1945;725;98818;	163721|-|-|Autosomal dominant<br>or&nbsp;X-linked dominant|-|245570 300643 ~1945|BECRS<br>BECTS<br>BRE<br>Benign epilepsy of childhood with centrotemporal spikes<br>Benign familial epilepsy of childhood with rolandic spikes<br>Benign rolandic epilepsy<br>Centrotemporal epilepsy|Unknown|Autosomal dominant|Childhood|117100 245570 ~725|CSWS<br>CSWSS syndrome<br>Continuous spikes and waves during slow-wave sleep<br>Epileptic encephalopathy with continuous spike-and-wave during slow sleep|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|245570 ~98818|Acquired epileptic aphasia<br>LKS|-|Autosomal dominant|Childhood|245570 ~	.	.	.	.	.	.	.	.	16	3(lung)	0.2842
16	9943666	9943666	C	T	GRIN2A	exonic	synonymous SNV	ENSG00000183454	rs2229193	ENSG00000183454:ENST00000396575:exon4:c.G1275A:p.L425L,ENSG00000183454:ENST00000535259:exon4:c.G804A:p.L268L,ENSG00000183454:ENST00000562109:exon4:c.G1275A:p.L425L,ENSG00000183454:ENST00000330684:exon5:c.G1275A:p.L425L,ENSG00000183454:ENST00000404927:exon5:c.G1275A:p.L425L,ENSG00000183454:ENST00000396573:exon6:c.G1275A:p.L425L	GRIN2A:NM_001134407:exon5:c.G1275A:p.L425L,GRIN2A:NM_001134408:exon5:c.G1275A:p.L425L,GRIN2A:NM_000833:exon6:c.G1275A:p.L425L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2542	0.2965	0.225839	MU12882240	.	.	.	.	.	.	.	.	GRIN2A:uc010uyn.2:exon4:c.G804A:p.L268L,GRIN2A:uc002czo.4:exon5:c.G1275A:p.L425L,GRIN2A:uc002czr.4:exon5:c.G1275A:p.L425L,GRIN2A:uc010uym.2:exon6:c.G1275A:p.L425L	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,AMR:0.2786,EAS:0.2363,FIN:0.3,NFE:0.0693,OTH:0.2864,ASJ:0.3105	138253	245570;	163721;1945;725;98818;	163721|-|-|Autosomal dominant<br>or&nbsp;X-linked dominant|-|245570 300643 ~1945|BECRS<br>BECTS<br>BRE<br>Benign epilepsy of childhood with centrotemporal spikes<br>Benign familial epilepsy of childhood with rolandic spikes<br>Benign rolandic epilepsy<br>Centrotemporal epilepsy|Unknown|Autosomal dominant|Childhood|117100 245570 ~725|CSWS<br>CSWSS syndrome<br>Continuous spikes and waves during slow-wave sleep<br>Epileptic encephalopathy with continuous spike-and-wave during slow sleep|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|245570 ~98818|Acquired epileptic aphasia<br>LKS|-|Autosomal dominant|Childhood|245570 ~	.	.	.	.	.	.	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.2833
16	10989374	10989374	C	T	CIITA	intronic	.	ENSG00000179583	rs11074937	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.949681	0.9548	.	.	.	.	.	.	.	.	.	.	AFR:0.8423,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9994,OTH:0.9980,ASJ:0.9901	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	10995933	10995933	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs8046121	ENSG00000179583:ENST00000324288:exon7:c.A520G:p.R174G,ENSG00000179583:ENST00000576601:exon7:c.A448G:p.R150G	CIITA:NM_000246:exon7:c.A520G:p.R174G,CIITA:NM_001286402:exon7:c.A523G:p.R175G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9959	0.9831	0.98722	0.9861	.	.	.	.	.	.	.	.	CIITA:uc002dag.2:exon7:c.A520G:p.R174G,CIITA:uc002dai.4:exon7:c.A520G:p.R174G,CIITA:uc002daj.4:exon7:c.A523G:p.R175G,CIITA:uc010bup.1:exon7:c.A520G:p.R174G	.	AFR:0.9511,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU4561336	hom
16	11001743	11001743	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2229320	ENSG00000179583:ENST00000324288:exon11:c.G2394A:p.P798P	CIITA:NM_000246:exon11:c.G2394A:p.P798P,CIITA:NM_001286402:exon11:c.G2397A:p.P799P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2122	0.1512	0.189297	MU90735	.	.	.	.	.	.	.	.	CIITA:uc002dah.2:exon10:c.G2250A:p.P750P,CIITA:uc002dag.2:exon11:c.G2394A:p.P798P,CIITA:uc002dai.4:exon11:c.G2394A:p.P798P,CIITA:uc002daj.4:exon11:c.G2397A:p.P799P	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.1683,EAS:0.1396,FIN:0.1954,NFE:0.3030,OTH:0.2417,ASJ:0.0527	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	6(soft_tissue)	0.2022
16	11002904	11002904	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2228238	ENSG00000179583:ENST00000381835:exon10:c.G924A:p.T308T,ENSG00000179583:ENST00000324288:exon12:c.G2676A:p.T892T	CIITA:NM_001286403:exon10:c.G924A:p.T308T,CIITA:NM_000246:exon12:c.G2676A:p.T892T,CIITA:NM_001286402:exon12:c.G2679A:p.T893T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6840	0.6347	0.663139	0.6606	.	.	.	.	.	.	.	.	CIITA:uc002dak.4:exon10:c.G924A:p.T308T,CIITA:uc002dai.4:exon12:c.G2676A:p.T892T,CIITA:uc002daj.4:exon12:c.G2679A:p.T893T	.	AFR:0.5082,AMR:0.5490,EAS:0.8681,FIN:0.7666,NFE:0.7023,OTH:0.7336,ASJ:0.7267	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU27455469	unknown
16	11002927	11002927	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs7197779	ENSG00000179583:ENST00000381835:exon10:c.A947G:p.Q316R,ENSG00000179583:ENST00000324288:exon12:c.A2699G:p.Q900R	CIITA:NM_001286403:exon10:c.A947G:p.Q316R,CIITA:NM_000246:exon12:c.A2699G:p.Q900R,CIITA:NM_001286402:exon12:c.A2702G:p.Q901R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9787	0.9199	0.928714	0.9325	-0.355	0.495	0.518	-0.248	0.010	.	.	.	CIITA:uc002dak.4:exon10:c.A947G:p.Q316R,CIITA:uc002dai.4:exon12:c.A2699G:p.Q900R,CIITA:uc002daj.4:exon12:c.A2702G:p.Q901R	-0.980	AFR:0.7626,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9949,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	0.001	-0.68	0.000	1.3	16	MU81973165	unknown
16	11012695	11012695	C	T	CIITA	intronic	.	ENSG00000179583	rs8057835	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.375799	0.4303	.	.	.	.	.	.	.	.	.	.	AFR:0.5121,AMR:0.3103,EAS:0.2153,FIN:0.4694,NFE:0.4084,OTH:0.4112,ASJ:0.2483	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU26440559	het
16	11012734	11012734	T	C	CIITA	intronic	.	ENSG00000179583	rs8062961	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.978435	0.9790	.	.	.	.	.	.	.	.	.	.	AFR:0.9259,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	12060163	12060163	A	G	TNFRSF17	exonic	nonsynonymous SNV	ENSG00000048462	rs373496	ENSG00000048462:ENST00000053243:exon2:c.A242G:p.N81S	TNFRSF17:NM_001192:exon2:c.A242G:p.N81S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9792	0.9581	0.961262	0.9635	-2.420	0.001	1.0	-3.14	0.038	.	.	.	TNFRSF17:uc002dbv.3:exon2:c.A242G:p.N81S,TNFRSF17:uc010buy.3:exon2:c.A242G:p.N81S	-0.975	AFR:0.9007,AMR:0.9881,EAS:1,FIN:0.9917,NFE:0.9861,OTH:0.9868,ASJ:0.9901	109545	.	.	.	.	.	.	.	0.0	2.97	0.000	-0.345	16	MU81973453	hom
16	14026007	14026007	G	A	ERCC4	intronic	.	ENSG00000262732	rs254942	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9661	0.9846	0.946486	0.9716	.	.	.	.	.	0.0002	0.002	.	.	.	AFR:0.9954,AMR:0.9857,EAS:0.7519,FIN:0.9754,NFE:0.9797,OTH:0.9745,ASJ:0.9669	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	16	MU25355495	hom
16	15820863	15820863	C	T	MYH11	exonic	nonsynonymous SNV	ENSG00000133392	rs16967494	ENSG00000133392:ENST00000300036:exon28:c.G3700A:p.A1234T,ENSG00000133392:ENST00000576790:exon28:c.G3700A:p.A1234T,ENSG00000133392:ENST00000396324:exon29:c.G3721A:p.A1241T,ENSG00000133392:ENST00000452625:exon29:c.G3721A:p.A1241T	MYH11:NM_002474:exon28:c.G3700A:p.A1234T,MYH11:NM_022844:exon28:c.G3700A:p.A1234T,MYH11:NM_001040113:exon29:c.G3721A:p.A1241T,MYH11:NM_001040114:exon29:c.G3721A:p.A1241T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2457	0.2068	0.203874	13(soft_tissue)	2.980	22.2	0.256	4.68	0.993	.	.	Myosin tail	MYH11:uc002ddw.3:exon28:c.G3700A:p.A1234T,MYH11:uc002ddy.3:exon28:c.G3700A:p.A1234T,MYH11:uc002ddv.3:exon29:c.G3721A:p.A1241T,MYH11:uc002ddx.3:exon29:c.G3721A:p.A1241T,MYH11:uc010bvg.3:exon29:c.G3196A:p.A1066T	-1.088	AFR:1(lung),AMR:MU4561658,EAS:0.2187,FIN:0.0831,NFE:0.2314,OTH:0.1490,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	0.053	-1.15	0.000	1.005	16	3(haematopoietic_and_lymphoid_tissue)	0.2964
16	15839034	15839034	G	A	MYH11	exonic	synonymous SNV	ENSG00000133392	rs1050113	ENSG00000133392:ENST00000300036:exon20:c.C2472T:p.A824A,ENSG00000133392:ENST00000576790:exon20:c.C2472T:p.A824A,ENSG00000133392:ENST00000396324:exon21:c.C2493T:p.A831A,ENSG00000133392:ENST00000452625:exon21:c.C2493T:p.A831A	MYH11:NM_002474:exon20:c.C2472T:p.A824A,MYH11:NM_022844:exon20:c.C2472T:p.A824A,MYH11:NM_001040113:exon21:c.C2493T:p.A831A,MYH11:NM_001040114:exon21:c.C2493T:p.A831A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2975	0.2632	0.253594	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MYH11:uc002ddw.3:exon20:c.C2472T:p.A824A,MYH11:uc002ddy.3:exon20:c.C2472T:p.A824A,MYH11:uc002ddv.3:exon21:c.C2493T:p.A831A,MYH11:uc002ddx.3:exon21:c.C2493T:p.A831A,MYH11:uc010bvg.3:exon21:c.C1968T:p.A656A	.	AFR:MU12753083,AMR:LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.1352,FIN:0.2536,NFE:0.2616,OTH:0.4082,ASJ:0.2782	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(stomach)	0.3073
16	15850204	15850204	A	G	MYH11	exonic	synonymous SNV	ENSG00000133392	rs2272554	ENSG00000133392:ENST00000300036:exon14:c.T1743C:p.A581A,ENSG00000133392:ENST00000576790:exon14:c.T1743C:p.A581A,ENSG00000133392:ENST00000396324:exon15:c.T1764C:p.A588A,ENSG00000133392:ENST00000452625:exon15:c.T1764C:p.A588A	MYH11:NM_002474:exon14:c.T1743C:p.A581A,MYH11:NM_022844:exon14:c.T1743C:p.A581A,MYH11:NM_001040113:exon15:c.T1764C:p.A588A,MYH11:NM_001040114:exon15:c.T1764C:p.A588A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4437	0.4990	0.548123	MU4561662	.	.	.	.	.	.	.	.	MYH11:uc002dea.1:exon9:c.T861C:p.A287A,MYH11:uc002ddw.3:exon14:c.T1743C:p.A581A,MYH11:uc002ddy.3:exon14:c.T1743C:p.A581A,MYH11:uc002ddv.3:exon15:c.T1764C:p.A588A,MYH11:uc002ddx.3:exon15:c.T1764C:p.A588A,MYH11:uc010bvg.3:exon15:c.T1239C:p.A413A	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,AMR:0.5053,EAS:0.3453,FIN:0.4205,NFE:0.7153,OTH:0.3848,ASJ:0.6841	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(thyroid)	0.4232
16	15853596	15853596	C	G	MYH11	intronic	.	ENSG00000133392	rs2280764	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4164	0.4732	0.534345	MU14395645	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,AMR:0.4711,EAS:0.3294,FIN:0.4139,NFE:0.7022,OTH:0.3394,ASJ:0.6661	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(large_intestine)	0.3780
16	23646191	23646191	T	C	PALB2	exonic	nonsynonymous SNV	ENSG00000083093	rs152451	ENSG00000083093:ENST00000261584:exon4:c.A1676G:p.Q559R	PALB2:NM_024675:exon4:c.A1676G:p.Q559R	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1176	0.1348	0.150759	0.1302	-2.181	0.001	1.0	-2.73	0.000	.	.	.	PALB2:uc002dlx.1:exon4:c.A1676G:p.Q559R	-0.980	AFR:0.2125,AMR:0.0885,EAS:0.1605,FIN:0.0960,NFE:0.0929,OTH:0.0978,ASJ:0.0662	610355	114480;610832;613348;	1333;84;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,8442,8445,8444,8443	.	.	0.0	2.49	0.000	-0.41	16	MU24101773	het
16	27506743	27506743	C	T	GTF3C1	exonic	synonymous SNV	ENSG00000077235	rs527810527	ENSG00000077235:ENST00000356183:exon15:c.G2421A:p.L807L,ENSG00000077235:ENST00000561623:exon15:c.G2421A:p.L807L	GTF3C1:NM_001286242:exon15:c.G2421A:p.L807L,GTF3C1:NM_001520:exon15:c.G2421A:p.L807L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0010	.	0.00239617	3.229e-05	.	.	.	.	.	.	.	.	GTF3C1:uc002dou.3:exon15:c.G2421A:p.L807L,GTF3C1:uc002dov.2:exon15:c.G2421A:p.L807L	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	603246	.	.	.	.	.	.	.	.	.	.	.	16	.	het
16	28617485	28617485	C	T	SULT1A1	exonic	nonsynonymous SNV	ENSG00000196502	rs1801030	ENSG00000196502:ENST00000350842:exon5:c.G433A:p.V145M,ENSG00000196502:ENST00000569554:exon6:c.G667A:p.V223M,ENSG00000196502:ENST00000314752:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000395607:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000566189:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000395609:exon9:c.G667A:p.V223M	SULT1A1:NM_177536:exon5:c.G433A:p.V145M,SULT1A1:NM_177534:exon6:c.G667A:p.V223M,SULT1A1:NM_001055:exon7:c.G667A:p.V223M,SULT1A1:NM_177529:exon7:c.G667A:p.V223M,SULT1A1:NM_177530:exon7:c.G667A:p.V223M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9714	0.8729	.	0.9256	2.497	19.45	0.093	2.18	0.007	.	.	P-loop containing nucleoside triphosphate hydrolase|Sulfotransferase domain	SULT1A1:uc002dqm.3:exon5:c.G433A:p.V145M,SULT1A1:uc002dqi.3:exon6:c.G667A:p.V223M,SULT1A1:uc002dqj.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dqk.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dql.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dqp.3:exon9:c.G667A:p.V223M,SULT1A1:uc002dqn.3:exon10:c.G940A:p.V314M	-1.034	AFR:0.7421,AMR:0.9808,EAS:1,FIN:1,NFE:0.9987,OTH:0.9907,ASJ:0.9901	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	0.036	4.53	0.000	2.515	16	MU81975347	hom
16	28621311	28621311	T	C	SULT1A1	UTR5	.	ENSG00000196502;ENSG00000196502	rs2077412	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6819	.	0.676518	MU25371586	.	.	.	.	.	.	.	.	SULT1A1:uc002dqn.3:exon3:c.A137G:p.N46S	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.7180,EAS:0.7653,FIN:0.7682,NFE:0.5227,OTH:0.7194,ASJ:0.7639	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	22(upper_aerodigestive_tract)	0.7106
16	31143993	31143993	C	T	PRSS8	intronic	.	ENSG00000052344	rs45619735	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2347	0.2461	0.122404	LUSC-KR|2|170|0.0117647	.	.	.	.	.	.	.	.	.	.	AFR:0.2350,AMR:0.0802,EAS:0.2318,FIN:0.0012,NFE:0.2944,OTH:0.3378,ASJ:0.1742	600823	.	.	.	.	.	.	.	.	.	.	.	16	2(lung)	0.2724
16	31193942	31193942	C	A	FUS	exonic	synonymous SNV	ENSG00000089280	rs741810	ENSG00000089280:ENST00000254108:exon3:c.C147A:p.G49G,ENSG00000089280:ENST00000380244:exon3:c.C147A:p.G49G,ENSG00000089280:ENST00000566605:exon3:c.C147A:p.G49G,ENSG00000089280:ENST00000568685:exon3:c.C147A:p.G49G	FUS:NM_001170634:exon3:c.C147A:p.G49G,FUS:NM_001170937:exon3:c.C147A:p.G49G,FUS:NM_004960:exon3:c.C147A:p.G49G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3221	0.2167	0.278954	MU71012	.	.	.	.	.	.	.	.	FUS:uc002ebe.2:exon3:c.C147A:p.G49G,FUS:uc002ebf.3:exon3:c.C147A:p.G49G,FUS:uc002ebh.3:exon3:c.C147A:p.G49G,FUS:uc010vfi.2:exon3:c.C147A:p.G49G	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.2545,EAS:0.3389,FIN:0.2053,NFE:0.2522,OTH:0.3872,ASJ:0.0677	137070	608030;614782;	275872;803;	275872|FTD-ALS<br>FTD-MND<br>Frontotemporal dementia with amyotrophic lateral sclerosis|Unknown|Autosomal dominant|Adult|105550 608030 612069 613954 615911 616437 616439 ~803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	16	2(lung)	0.3223
16	55519701	55519701	C	T	MMP2	intronic	.	ENSG00000087245	rs17859889	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0401	0.0231	0.0553115	0.0305	.	.	.	.	.	.	.	.	.	.	AFR:0.0249,AMR:0.0406,EAS:0.1041,FIN:0.0467,NFE:0.0208,OTH:0.0356,ASJ:0.0497	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	MU82281797	het
16	55523705	55523705	T	C	MMP2	exonic	synonymous SNV	ENSG00000087245	rs243849	ENSG00000087245:ENST00000219070:exon7:c.T1149C:p.D383D,ENSG00000087245:ENST00000437642:exon7:c.T999C:p.D333D,ENSG00000087245:ENST00000543485:exon7:c.T921C:p.D307D,ENSG00000087245:ENST00000570308:exon8:c.T921C:p.D307D	MMP2:NM_001127891:exon7:c.T999C:p.D333D,MMP2:NM_001302508:exon7:c.T921C:p.D307D,MMP2:NM_001302509:exon7:c.T921C:p.D307D,MMP2:NM_001302510:exon7:c.T921C:p.D307D,MMP2:NM_004530:exon7:c.T1149C:p.D383D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8378	0.7993	0.79992	0.8073	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon7:c.T1149C:p.D383D,MMP2:uc010ccc.3:exon7:c.T999C:p.D333D,MMP2:uc010vhd.2:exon7:c.T921C:p.D307D	.	AFR:0.7081,AMR:0.7955,EAS:0.7652,FIN:0.8688,NFE:0.8527,OTH:0.8476,ASJ:0.8278	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	MU4562717	hom
16	55536687	55536687	A	G	MMP2	intronic	.	ENSG00000087245	rs243834	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4841	0.4432	0.48762	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.4569,AMR:0.3905,EAS:0.44,FIN:0.6386,NFE:0.5221,OTH:0.4596,ASJ:0.4519	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	1(lung)	0.4836
16	56855496	56855496	C	G	NUP93	exonic	synonymous SNV	ENSG00000102900	rs2118017	ENSG00000102900:ENST00000563858:exon3:c.C24G:p.L8L,ENSG00000102900:ENST00000542526:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000564887:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000567641:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000569863:exon6:c.C276G:p.L92L,ENSG00000102900:ENST00000308159:exon7:c.C645G:p.L215L,ENSG00000102900:ENST00000569842:exon7:c.C645G:p.L215L	NUP93:NM_001242795:exon5:c.C276G:p.L92L,NUP93:NM_001242796:exon5:c.C276G:p.L92L,NUP93:NM_014669:exon7:c.C645G:p.L215L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8299	0.8329	0.875799	0.8261	.	.	.	.	.	.	.	.	NUP93:uc002ekb.3:exon5:c.C276G:p.L92L,NUP93:uc010vhi.2:exon5:c.C276G:p.L92L,NUP93:uc002eka.3:exon7:c.C645G:p.L215L	.	AFR:0.8848,AMR:0.8568,EAS:0.9137,FIN:0.7923,NFE:0.7896,OTH:0.8035,ASJ:0.8467	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	MU116544	hom
16	56868700	56868700	A	G	NUP93	intronic	.	ENSG00000102900	rs1347591	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4775	0.4722	0.541733	ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4610,AMR:0.5376,EAS:0.3974,FIN:0.7051,NFE:0.3354,OTH:0.4230,ASJ:0.4472	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.4375
16	56873495	56873495	C	T	NUP93	exonic	synonymous SNV	ENSG00000102900	rs1138295	ENSG00000102900:ENST00000569322:exon2:c.C123T:p.A41A,ENSG00000102900:ENST00000542526:exon18:c.C1830T:p.A610A,ENSG00000102900:ENST00000564887:exon18:c.C1830T:p.A610A,ENSG00000102900:ENST00000308159:exon20:c.C2199T:p.A733A,ENSG00000102900:ENST00000569842:exon20:c.C2199T:p.A733A	NUP93:NM_001242795:exon18:c.C1830T:p.A610A,NUP93:NM_001242796:exon18:c.C1830T:p.A610A,NUP93:NM_014669:exon20:c.C2199T:p.A733A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1797	0.1668	0.210663	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NUP93:uc002ekb.3:exon18:c.C1830T:p.A610A,NUP93:uc010vhi.2:exon18:c.C1830T:p.A610A,NUP93:uc002eka.3:exon20:c.C2199T:p.A733A	.	AFR:MU12798719,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,THCA-SA|1|243|0.00411523,EAS:0.1995,FIN:0.2041,NFE:0.1424,OTH:0.3412,ASJ:0.1735	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	1(breast)	0.1264
16	65005462	65005462	G	A	CDH11	intronic	.	ENSG00000140937	rs12597529	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5274	0.4151	0.547324	0.4590	.	.	.	.	.	.	.	.	.	.	AFR:0.3247,AMR:0.6110,EAS:0.7916,FIN:0.5542,NFE:0.4681,OTH:0.5061,ASJ:0.4305	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU21091308	hom
16	65016087	65016087	A	C	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs35213	ENSG00000140937:ENST00000566827:exon7:c.T739G:p.S247A,ENSG00000140937:ENST00000268603:exon8:c.T1117G:p.S373A,ENSG00000140937:ENST00000394156:exon8:c.T1117G:p.S373A	CDH11:NM_001330576:exon7:c.T739G:p.S247A,CDH11:NM_001308392:exon8:c.T1117G:p.S373A,CDH11:NM_001797:exon8:c.T1117G:p.S373A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8043	0.6928	0.745407	0.7215	-0.605	0.122	0.716	1.34	0.089	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon7:c.T739G:p.S247A,CDH11:uc002eoi.3:exon8:c.T1117G:p.S373A,CDH11:uc002eoj.3:exon8:c.T1117G:p.S373A	-0.969	AFR:0.4484,AMR:0.8213,EAS:0.9981,FIN:0.7975,NFE:0.8188,OTH:0.8184,ASJ:0.8046	600023	.	.	.	.	.	.	.	0.001	4.7	0.000	1.52	16	MU81978235	hom
16	65022234	65022234	C	T	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs1130821	ENSG00000140937:ENST00000566827:exon6:c.G447A:p.M149I,ENSG00000140937:ENST00000268603:exon7:c.G825A:p.M275I,ENSG00000140937:ENST00000394156:exon7:c.G825A:p.M275I	CDH11:NM_001330576:exon6:c.G447A:p.M149I,CDH11:NM_001308392:exon7:c.G825A:p.M275I,CDH11:NM_001797:exon7:c.G825A:p.M275I	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.1824	0.1153	0.217252	4(stomach)	6.014	27.9	0.039	5.75	1.000	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon6:c.G447A:p.M149I,CDH11:uc002eoi.3:exon7:c.G825A:p.M275I,CDH11:uc002eoj.3:exon7:c.G825A:p.M275I	-0.566	AFR:1(lung),AMR:MU155566,EAS:0.1546,FIN:0.0987,NFE:0.3565,OTH:0.0894,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|7|321|0.0218069	600023	.	.	.	.	.	.	.	0.94	4.71	0.000	0.21	16	1(oesophagus)	0.4493
16	65025658	65025658	T	C	CDH11	intronic	.	ENSG00000140937	rs35196	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9150	0.9021	0.926917	0.9068	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.8998,EAS:1,FIN:0.8955,NFE:0.9033,OTH:0.9124,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978243	hom
16	65025849	65025849	A	G	CDH11	intronic	.	ENSG00000140937	rs35194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9144	0.8999	0.925919	0.9052	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.8951,AMR:0.8995,EAS:1,FIN:0.8955,NFE:0.9029,OTH:0.9121,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978256	hom
16	68771372	68771372	C	T	CDH1	intronic	.	ENSG00000039068	rs3743674	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8111	0.8603	0.763379	16(meninges)	.	.	.	.	.	0	0.032	.	.	.	AFR:1(lung),AMR:MU51154082,EAS:0.7976,FIN:0.6539,NFE:0.7548,OTH:0.9367,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	1(breast)	0.7605
16	68857441	68857441	T	C	CDH1	exonic	synonymous SNV	ENSG00000039068	rs1801552	ENSG00000039068:ENST00000422392:exon12:c.T1893C:p.A631A,ENSG00000039068:ENST00000261769:exon13:c.T2076C:p.A692A	CDH1:NM_001317184:exon12:c.T1893C:p.A631A,CDH1:NM_001317186:exon12:c.T111C:p.A37A,CDH1:NM_001317185:exon13:c.T528C:p.A176A,CDH1:NM_004360:exon13:c.T2076C:p.A692A	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 1, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6548	0.7161	0.71865	MU166733	.	.	.	.	.	.	.	.	CDH1:uc010cfg.1:exon12:c.T1893C:p.A631A,CDH1:uc002ewg.1:exon13:c.T2076C:p.A692A	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,AMR:0.6961,EAS:0.6615,FIN:0.5927,NFE:0.6658,OTH:0.5878,ASJ:0.8838	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	,1948,1945,1944	,1946	,1947	.	.	.	.	16	13(meninges)	0.6235
16	68862204	68862204	C	T	CDH1	exonic	synonymous SNV	ENSG00000039068	rs61747636	ENSG00000039068:ENST00000422392:exon13:c.C2109T:p.D703D,ENSG00000039068:ENST00000261769:exon14:c.C2292T:p.D764D	CDH1:NM_001317184:exon13:c.C2109T:p.D703D,CDH1:NM_001317186:exon13:c.C327T:p.D109D,CDH1:NM_001317185:exon14:c.C744T:p.D248D,CDH1:NM_004360:exon14:c.C2292T:p.D764D	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 1, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0015	0.0020	0.00179712	0.0014	.	.	.	.	.	.	.	.	CDH1:uc010cfg.1:exon13:c.C2109T:p.D703D,CDH1:uc002ewg.1:exon14:c.C2292T:p.D764D	.	AFR:0.0009,AMR:0.0012,EAS:0,FIN:0,NFE:0.0019,OTH:0.0031,ASJ:0.0033	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	,1948,1945,1944	,1946	,1947	.	.	.	.	16	.	het
16	69365123	69365123	G	T	COG8	intronic	.	ENSG00000213380;ENSG00000272617	rs9928658	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.185703	0.2326	.	.	.	.	.	.	.	.	.	.	AFR:0.2312,AMR:0.1602,EAS:0.0811,FIN:0.2228,NFE:0.2558,OTH:0.2312,ASJ:0.2651	606979	611182;	95428;	95428|CDG syndrome type IIh<br>CDG-IIh<br>CDG2H<br>Carbohydrate deficient glycoprotein syndrome type IIh<br>Congenital disorder of glycosylation type 2h<br>Congenital disorder of glycosylation type IIh|<1 / 1 000 000|Autosomal recessive|Childhood|611182 ~	.	.	.	.	.	.	.	.	16	.	het
16	69365153	69365153	C	T	COG8	intronic	.	ENSG00000213380;ENSG00000272617	rs139824417	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0321486	0.0028	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0,EAS:0.0453,FIN:0,NFE:6.739e-05,OTH:0.0115,ASJ:0	606979	611182;	95428;	95428|CDG syndrome type IIh<br>CDG-IIh<br>CDG2H<br>Carbohydrate deficient glycoprotein syndrome type IIh<br>Congenital disorder of glycosylation type 2h<br>Congenital disorder of glycosylation type IIh|<1 / 1 000 000|Autosomal recessive|Childhood|611182 ~	.	.	.	.	.	.	.	.	16	.	het
16	69373414	69373414	T	C	COG8	exonic	synonymous SNV	ENSG00000213380	rs11542583	ENSG00000213380:ENST00000306875:exon1:c.A42G:p.T14T,ENSG00000213380:ENST00000562081:exon1:c.A42G:p.T14T	COG8:NM_032382:exon1:c.A42G:p.T14T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2968	0.3244	0.257588	LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	COG8:uc002ewy.2:exon1:c.A42G:p.T14T	.	AFR:0.3016,AMR:0.3365,EAS:0.33,FIN:0.0907,NFE:0.2605,OTH:0.3176,ASJ:0.2231	606979	611182;	95428;	95428|CDG syndrome type IIh<br>CDG-IIh<br>CDG2H<br>Carbohydrate deficient glycoprotein syndrome type IIh<br>Congenital disorder of glycosylation type 2h<br>Congenital disorder of glycosylation type IIh|<1 / 1 000 000|Autosomal recessive|Childhood|611182 ~	.	.	.	.	.	.	.	.	16	2(lung)	0.3014
16	70287177	70287177	A	G	AARS	exonic	synonymous SNV	ENSG00000090861	rs4081753	ENSG00000090861:ENST00000261772:exon20:c.T2715C:p.V905V	AARS:NM_001605:exon20:c.T2715C:p.V905V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8241	0.8492	0.88119	0.8640	.	.	.	.	.	.	.	.	AARS:uc010vlu.1:exon16:c.T2253C:p.V751V,AARS:uc002eyn.1:exon20:c.T2715C:p.V905V	.	AFR:0.9664,AMR:0.8549,EAS:0.9697,FIN:0.8542,NFE:0.8008,OTH:0.8153,ASJ:0.7616	601065	613287;616339;	442835;228174;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~228174|CMT2N|<1 / 1 000 000|Autosomal dominant|All ages|613287 ~	.	.	.	.	.	.	.	.	16	MU4563135	hom
16	70303580	70303580	G	A	AARS	exonic	synonymous SNV	ENSG00000090861	rs2070203	ENSG00000090861:ENST00000261772:exon7:c.C903T:p.H301H	AARS:NM_001605:exon7:c.C903T:p.H301H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4659	0.4908	0.425319	MU29609616	.	.	.	.	.	.	.	.	AARS:uc010vlu.1:exon3:c.C393T:p.H131H,AARS:uc002eyn.1:exon7:c.C903T:p.H301H	.	AFR:LICA-CN|3|402|0.00746269,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.5054,EAS:0.4308,FIN:0.5563,NFE:0.4080,OTH:0.6069,ASJ:0.4641	601065	613287;616339;	442835;228174;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~228174|CMT2N|<1 / 1 000 000|Autosomal dominant|All ages|613287 ~	.	.	.	.	.	.	.	.	16	1(urinary_tract)	0.5190
16	72827758	72827758	T	C	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs699444	ENSG00000140836:ENST00000397992:exon8:c.A6081G:p.G2027G,ENSG00000140836:ENST00000268489:exon9:c.A8823G:p.G2941G	ZFHX3:NM_001164766:exon8:c.A6081G:p.G2027G,ZFHX3:NM_006885:exon9:c.A8823G:p.G2941G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8771	0.8816	0.920727	0.8969	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A6081G:p.G2027G,ZFHX3:uc002fck.3:exon9:c.A8823G:p.G2941G	.	AFR:0.9704,AMR:0.8950,EAS:0.9981,FIN:0.9041,NFE:0.8456,OTH:0.8676,ASJ:0.7914	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979263	het
16	72829426	72829426	C	T	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs62639997	ENSG00000140836:ENST00000397992:exon8:c.G4413A:p.P1471P,ENSG00000140836:ENST00000268489:exon9:c.G7155A:p.P2385P	ZFHX3:NM_001164766:exon8:c.G4413A:p.P1471P,ZFHX3:NM_006885:exon9:c.G7155A:p.P2385P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0260	0.0099	0.0419329	0.0125	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.G4413A:p.P1471P,ZFHX3:uc002fck.3:exon9:c.G7155A:p.P2385P	.	AFR:0.0017,AMR:0.0060,EAS:0.1022,FIN:0.0060,NFE:0.0109,OTH:0.0174,ASJ:0	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU12830279	het
16	72832135	72832135	T	A	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs740178	ENSG00000140836:ENST00000397992:exon8:c.A1704T:p.A568A,ENSG00000140836:ENST00000268489:exon9:c.A4446T:p.A1482A	ZFHX3:NM_001164766:exon8:c.A1704T:p.A568A,ZFHX3:NM_006885:exon9:c.A4446T:p.A1482A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8362	0.8548	0.886182	0.8673	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A1704T:p.A568A,ZFHX3:uc002fck.3:exon9:c.A4446T:p.A1482A	.	AFR:0.9647,AMR:0.8373,EAS:0.9710,FIN:0.8709,NFE:0.8043,OTH:0.8350,ASJ:0.7649	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979273	het
16	72991660	72991660	C	G	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs10852515	ENSG00000140836:ENST00000268489:exon2:c.G2385C:p.P795P	ZFHX3:NM_006885:exon2:c.G2385C:p.P795P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8359	0.8359	0.770966	MU4555792	.	.	.	.	.	.	.	.	ZFHX3:uc002fck.3:exon2:c.G2385C:p.P795P	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.8398,EAS:0.9153,FIN:0.8278,NFE:0.6621,OTH:0.9107,ASJ:0.7901	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.8661
16	72991715	72991715	A	G	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs4788682	ENSG00000140836:ENST00000268489:exon2:c.T2330C:p.V777A	ZFHX3:NM_006885:exon2:c.T2330C:p.V777A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7713	0.8221	0.765575	MU15108548	-0.599	0.126	0.771	4.54	0.002	.	.	.	ZFHX3:uc002fck.3:exon2:c.T2330C:p.V777A	-0.974	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.8262,EAS:0.8898,FIN:0.8167,NFE:0.6629,OTH:0.8708,ASJ:0.7827	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.002	-0.67	0.000	-0.69	16	1(prostate)	0.8546
16	72992667	72992667	C	G	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs2073852	ENSG00000140836:ENST00000268489:exon2:c.G1378C:p.E460Q	ZFHX3:NM_006885:exon2:c.G1378C:p.E460Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.0282	0.0080	0.0467252	MU4563321	2.615	20.3	0.006	3.94	0.998	.	.	.	ZFHX3:uc002fck.3:exon2:c.G1378C:p.E460Q	-0.973	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.0155,EAS:0.0095,FIN:0.0099,NFE:0.1272,OTH:0.0100,ASJ:0.0048	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.99	-0.79	0.001	-0.345	16	1(breast)	0.0111
16	72993831	72993831	A	C	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs7193297	ENSG00000140836:ENST00000268489:exon2:c.T214G:p.S72A	ZFHX3:NM_006885:exon2:c.T214G:p.S72A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4014	0.4739	0.470447	1(lung)	0.001	2.598	1.0	5.11	0.788	.	.	.	ZFHX3:uc002fck.3:exon2:c.T214G:p.S72A	-0.963	AFR:MU71249,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.7036,FIN:0.2542,NFE:0.4503,OTH:0.2667,ASJ:0.4903	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.006	-0.66	0.000	0.345	16	1(thyroid)	0.4885
16	78198192	78198192	T	C	WWOX	intronic	.	ENSG00000186153	rs2303191	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7482	0.7435	0.789137	0.7460	.	.	.	.	.	0.0002	0.046	.	.	.	AFR:0.8026,AMR:0.8158,EAS:0.8854,FIN:0.6865,NFE:0.7112,OTH:0.7261,ASJ:0.6556	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU772162	hom
16	78312489	78312489	G	T	WWOX	intronic	.	ENSG00000186153	rs8048830	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1035	0.0975	0.131789	0.1066	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.1647,AMR:0.0680,EAS:0.1344,FIN:0.0841,NFE:0.0786,OTH:0.0890,ASJ:0.0960	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU12844875	unknown
16	78312497	78312497	C	A	WWOX	intronic	.	ENSG00000186153	rs8050128	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4595	0.4620	0.472244	0.4589	.	.	.	.	.	0	0	.	.	.	AFR:0.5141,AMR:0.4284,EAS:0.5,FIN:0.4225,NFE:0.4315,OTH:0.4541,ASJ:0.5364	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU25384686	unknown
16	78312527	78312527	A	G	WWOX	exonic	nonsynonymous SNV	ENSG00000186153	rs77067228	ENSG00000186153:ENST00000355860:exon6:c.A544G:p.K182E	WWOX:NM_130791:exon6:c.A544G:p.K182E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0804	0.0519	0.0646965	0.0597	0.118	3.806	0.0	1.18	0.015	.	.	NAD(P)-binding domain	WWOX:uc002ffj.2:exon6:c.A544G:p.K182E	-0.917	AFR:0.0178,AMR:0.0537,EAS:0.0600,FIN:0.0839,NFE:0.0773,OTH:0.0724,ASJ:0.0960	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.0	-1.46	0.025	.	16	MU12844881	het
16	79633806	79633808	GCC	-	MAF	UTR5	.	ENSG00000178573	rs5818251	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7107	.	0.808706	0.7762	.	.	.	.	.	.	.	.	.	.	AFR:0.7969,AMR:0.7631,EAS:0.9253,FIN:0.8126,NFE:0.7421,OTH:0.7653,ASJ:0.7138	177075	601088;610202;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	~ko04658 Th1 and Th2 cell differentiation~ko05202 Transcriptional misregulation in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	16	.	hom
16	81819768	81819768	T	C	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143685	ENSG00000197943:ENST00000359376:exon2:c.T174C:p.A58A,ENSG00000197943:ENST00000565054:exon3:c.T174C:p.A58A	PLCG2:NM_002661:exon2:c.T174C:p.A58A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7248	0.6680	0.733227	0.6846	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon1:c.T174C:p.A58A,PLCG2:uc002fgt.3:exon2:c.T174C:p.A58A	.	AFR:0.6496,AMR:0.7566,EAS:0.8813,FIN:0.7388,NFE:0.6671,OTH:0.6898,ASJ:0.6589	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU21476980	hom
16	81888152	81888152	A	G	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143686	ENSG00000197943:ENST00000359376:exon3:c.A297G:p.L99L,ENSG00000197943:ENST00000565054:exon4:c.A297G:p.L99L	PLCG2:NM_002661:exon3:c.A297G:p.L99L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2752	0.2557	0.212061	0.2652	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon2:c.A297G:p.L99L,PLCG2:uc002fgt.3:exon3:c.A297G:p.L99L	.	AFR:0.1688,AMR:0.2859,EAS:0.0760,FIN:0.3166,NFE:0.3263,OTH:0.2847,ASJ:0.3179	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU12857569	het
16	81892708	81892708	T	A	PLCG2	intronic	.	ENSG00000197943	rs4888183	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5509	0.5570	0.541134	0.5554	.	.	.	.	.	.	.	.	.	.	AFR:0.5220,AMR:0.5490,EAS:0.6235,FIN:0.6192,NFE:0.5506,OTH:0.5703,ASJ:0.6258	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU19853130	het
16	81929488	81929488	C	T	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143688	ENSG00000197943:ENST00000359376:exon13:c.C1149T:p.D383D	PLCG2:NM_002661:exon13:c.C1149T:p.D383D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4158	0.2885	0.40655	0.3500	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon12:c.C1149T:p.D383D,PLCG2:uc002fgt.3:exon13:c.C1149T:p.D383D	.	AFR:0.1426,AMR:0.6005,EAS:0.7348,FIN:0.4361,NFE:0.3913,OTH:0.4090,ASJ:0.3543	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU19853194	het
16	81939028	81939028	A	G	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs369098550	ENSG00000197943:ENST00000359376:exon15:c.A1383G:p.R461R	PLCG2:NM_002661:exon15:c.A1383G:p.R461R	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0003	0.0002	0.000399361	0.0002	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon14:c.A1383G:p.R461R,PLCG2:uc002fgt.3:exon15:c.A1383G:p.R461R	.	AFR:0,AMR:0.0024,EAS:0,FIN:0,NFE:0.0003,OTH:0,ASJ:0	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	.	het
16	81941319	81941319	C	T	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143689	ENSG00000197943:ENST00000359376:exon16:c.C1497T:p.A499A	PLCG2:NM_002661:exon16:c.C1497T:p.A499A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7837	0.7225	0.77496	0.7313	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon15:c.C1497T:p.A499A,PLCG2:uc002fgt.3:exon16:c.C1497T:p.A499A	.	AFR:0.6046,AMR:0.8708,EAS:0.9765,FIN:0.7461,NFE:0.7639,OTH:0.7699,ASJ:0.7748	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU22636505	het
16	81953081	81953081	T	C	PLCG2	intronic	.	ENSG00000197943	rs12448130	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9969	0.9884	0.988618	0.9912	.	.	.	.	.	0	0	.	.	.	AFR:0.9698,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:1,ASJ:1	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU17469065	hom
16	81954789	81954789	C	G	PLCG2	intronic	.	ENSG00000197943	rs12446127	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5893	0.4681	0.519768	0.4890	.	.	.	.	.	.	.	.	.	.	AFR:0.2226,AMR:0.6763,EAS:0.7893,FIN:0.5656,NFE:0.5750,OTH:0.5713,ASJ:0.6133	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU81980644	het
16	85953846	85953847	TT	-	IRF8	intronic	.	ENSG00000140968	rs779733168	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0010	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601565	614893;614894;	319600;	319600|MSMD due to partial IRF8 deficiency<br>MSMD due to partial interferon regulatory factor 8 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial interferon regulatory factor 8 deficiency|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614893 ~	.	.	.	.	.	.	.	.	16	.	het
16	88872145	88872145	T	C	CDT1	exonic	nonsynonymous SNV	ENSG00000167513	rs507329	ENSG00000167513:ENST00000301019:exon5:c.T700C:p.C234R	CDT1:NM_030928:exon5:c.T700C:p.C234R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9993	0.9995	0.9998	0.9996	-0.295	0.681	1.0	3.83	0.188	.	.	CDT1 Geminin-binding domain-like|Winged helix-turn-helix DNA-binding domain	CDT1:uc002flu.3:exon5:c.T700C:p.C234R	-0.972	AFR:0.9998,AMR:1,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9990,ASJ:1	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	0.001	1.7	0.000	-2.455	16	MU81982302	hom
16	88872229	88872229	A	G	CDT1	exonic	nonsynonymous SNV	ENSG00000167513	rs480727	ENSG00000167513:ENST00000301019:exon5:c.A784G:p.T262A	CDT1:NM_030928:exon5:c.A784G:p.T262A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4442	0.4955	0.571286	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-1.173	0.007	0.723	-1.33	0.000	.	.	CDT1 Geminin-binding domain-like|Winged helix-turn-helix DNA-binding domain	CDT1:uc002flu.3:exon5:c.A784G:p.T262A	-1.004	AFR:0.4841,AMR:0.7062,EAS:0.5298,FIN:0.7302,NFE:0.3454,OTH:0.3683,ASJ:0.4474	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	0.003	1.84	0.000	0.08	16	1(pancreas)	0.3827
16	88872511	88872511	T	C	CDT1	exonic	synonymous SNV	ENSG00000167513	rs510862	ENSG00000167513:ENST00000301019:exon6:c.T915C:p.H305H	CDT1:NM_030928:exon6:c.T915C:p.H305H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8183	0.8476	0.870208	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	CDT1:uc002flu.3:exon6:c.T915C:p.H305H	.	AFR:0.8308,AMR:0.9556,EAS:0.8510,FIN:0.9142,NFE:0.7572,OTH:0.7749,ASJ:0.7146	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	.	.	.	.	16	1(thyroid)	0.7912
16	88874632	88874632	C	G	CDT1	exonic	synonymous SNV	ENSG00000167513	rs572275	ENSG00000167513:ENST00000301019:exon10:c.C1587G:p.L529L	CDT1:NM_030928:exon10:c.C1587G:p.L529L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4737	0.4832	0.552716	MU111131	.	.	.	.	.	.	.	.	CDT1:uc002flu.3:exon10:c.C1587G:p.L529L	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4733,EAS:0.4390,FIN:0.5232,NFE:0.7093,OTH:0.3407,ASJ:0.7017	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	.	.	.	.	16	1(large_intestine)	0.3528
16	89345822	89345822	G	C	ANKRD11	exonic	nonsynonymous SNV	ENSG00000167522	rs4785560	ENSG00000167522:ENST00000301030:exon9:c.C7128G:p.D2376E,ENSG00000167522:ENST00000378330:exon10:c.C7128G:p.D2376E	ANKRD11:NM_001256183:exon9:c.C7128G:p.D2376E,ANKRD11:NM_013275:exon9:c.C7128G:p.D2376E,ANKRD11:NM_001256182:exon10:c.C7128G:p.D2376E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1635	.	0.185903	0.1089	-1.009	0.015	1.0	-2.53	0.016	.	.	.	AX748291:uc002fna.1:exon1:c.C123G:p.D41E,ANKRD11:uc002fnb.1:exon6:c.C6999G:p.D2333E,ANKRD11:uc002fmx.2:exon9:c.C7128G:p.D2376E,ANKRD11:uc002fnc.2:exon9:c.C7128G:p.D2376E,ANKRD11:uc002fmy.2:exon10:c.C7128G:p.D2376E	-1.021	AFR:0.1374,AMR:0.0627,EAS:0.4074,FIN:0.0781,NFE:0.0716,OTH:0.0979,ASJ:0.0548	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	0.001	1.63	0.000	-0.62	16	MU4554632	het
16	89350038	89350038	G	A	ANKRD11	exonic	nonsynonymous SNV	ENSG00000167522	rs2279348	ENSG00000167522:ENST00000301030:exon9:c.C2912T:p.A971V,ENSG00000167522:ENST00000378330:exon10:c.C2912T:p.A971V	ANKRD11:NM_001256183:exon9:c.C2912T:p.A971V,ANKRD11:NM_013275:exon9:c.C2912T:p.A971V,ANKRD11:NM_001256182:exon10:c.C2912T:p.A971V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6379	0.6970	0.533546	0.6443	0.084	3.439	0.459	-3.5	0.000	.	.	.	ANKRD11:uc002fnb.1:exon6:c.C2783T:p.A928V,ANKRD11:uc002fmx.2:exon9:c.C2912T:p.A971V,ANKRD11:uc002fnc.2:exon9:c.C2912T:p.A971V,ANKRD11:uc002fmy.2:exon10:c.C2912T:p.A971V	-0.978	AFR:0.6321,AMR:0.6205,EAS:0.1873,FIN:0.5913,NFE:0.7104,OTH:0.6364,ASJ:0.8775	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	0.014	1.2	0.000	1.185	16	MU12878222	het
16	89350178	89350178	G	A	ANKRD11	exonic	synonymous SNV	ENSG00000167522	rs2279349	ENSG00000167522:ENST00000301030:exon9:c.C2772T:p.T924T,ENSG00000167522:ENST00000378330:exon10:c.C2772T:p.T924T	ANKRD11:NM_001256183:exon9:c.C2772T:p.T924T,ANKRD11:NM_013275:exon9:c.C2772T:p.T924T,ANKRD11:NM_001256182:exon10:c.C2772T:p.T924T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7981	0.8522	0.763578	0.8195	.	.	.	.	.	.	.	.	ANKRD11:uc002fnb.1:exon6:c.C2643T:p.T881T,ANKRD11:uc002fmx.2:exon9:c.C2772T:p.T924T,ANKRD11:uc002fnc.2:exon9:c.C2772T:p.T924T,ANKRD11:uc002fmy.2:exon10:c.C2772T:p.T924T	.	AFR:0.8567,AMR:0.7208,EAS:0.6056,FIN:0.7905,NFE:0.8313,OTH:0.8102,ASJ:0.9470	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	.	.	.	.	16	MU21099320	hom
16	89805977	89805977	G	A	ZNF276	UTR3	.	ENSG00000158805	rs1061646	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4098	0.3475	0.538139	0.4091	.	.	.	.	.	.	.	.	.	.	AFR:0.5340,AMR:0.5680,EAS:0.7338,FIN:0.3808,NFE:0.3033,OTH:0.4002,ASJ:0.2367	608460	.	.	.	.	.	.	.	.	.	.	.	16	MU67342665	hom
16	89836323	89836323	C	T	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs7195066	ENSG00000187741:ENST00000567205:exon1:c.G110A:p.G37D,ENSG00000187741:ENST00000389301:exon26:c.G2426A:p.G809D,ENSG00000187741:ENST00000568369:exon26:c.G2426A:p.G809D	FANCA:NM_000135:exon26:c.G2426A:p.G809D,FANCA:NM_001286167:exon26:c.G2426A:p.G809D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4690	0.4307	0.666733	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	0.068	3.273	0.528	-0.167	0.000	.	.	.	FANCA:uc002fou.1:exon26:c.G2426A:p.G809D,FANCA:uc010vpn.1:exon26:c.G2426A:p.G809D	-1.008	AFR:0.4758,AMR:0.6626,EAS:0.2583,FIN:0.9796,NFE:0.3961,OTH:0.3317,ASJ:0.5800	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	-1.85	0.000	-0.345	16	10(soft_tissue)	0.4488
16	89838078	89838078	A	G	FANCA	intronic	.	ENSG00000187741	rs1800340	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4315	0.3743	0.559904	0.4106	.	.	.	.	.	0	0	.	.	.	AFR:0.5094,AMR:0.5692,EAS:0.7345,FIN:0.3960,NFE:0.3151,OTH:0.4264,ASJ:0.2567	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU80655261	hom
16	89845194	89845194	A	G	FANCA	intronic	.	ENSG00000187741	rs1800337	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5115	0.4882	0.682508	0.5225	.	.	.	.	.	.	.	.	.	.	AFR:0.6752,AMR:0.6005,EAS:0.9790,FIN:0.4579,NFE:0.4010,OTH:0.4959,ASJ:0.3079	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983268	hom
16	89849480	89849480	C	T	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs2239359	ENSG00000187741:ENST00000389301:exon16:c.G1501A:p.G501S,ENSG00000187741:ENST00000568369:exon16:c.G1501A:p.G501S	FANCA:NM_000135:exon16:c.G1501A:p.G501S,FANCA:NM_001286167:exon16:c.G1501A:p.G501S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4995	0.4823	0.624002	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-0.709	0.069	1.0	-4.64	0.012	.	.	Fanconi anaemia group A protein, N-terminal domain	FANCA:uc002fou.1:exon16:c.G1501A:p.G501S,FANCA:uc010vpn.1:exon16:c.G1501A:p.G501S	-0.957	AFR:0.5222,AMR:0.6818,EAS:0.35,FIN:0.8375,NFE:0.5413,OTH:0.3945,ASJ:0.5742	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	-1.65	0.000	-1.245	16	1(kidney)	0.4764
16	89857964	89857964	T	C	FANCA	intronic	.	ENSG00000187741	rs1800330	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4370	0.3907	0.571885	0.4208	.	.	.	.	.	.	.	.	.	.	AFR:0.5416,AMR:0.5728,EAS:0.7447,FIN:0.3912,NFE:0.3170,OTH:0.4236,ASJ:0.2467	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983299	hom
16	89866043	89866043	T	C	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs7190823	ENSG00000187741:ENST00000565582:exon7:c.A626G:p.H209R,ENSG00000187741:ENST00000543736:exon8:c.A700G:p.T234A,ENSG00000187741:ENST00000389301:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000389302:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000534992:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000563673:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000568369:exon9:c.A796G:p.T266A	FANCA:NM_001351830:exon8:c.A700G:p.T234A,FANCA:NM_000135:exon9:c.A796G:p.T266A,FANCA:NM_001018112:exon9:c.A796G:p.T266A,FANCA:NM_001286167:exon9:c.A796G:p.T266A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5166	0.5060	0.690495	0.5344	-1.498	0.003	1.0	1.85	0.024	.	.	Fanconi anaemia group A protein, N-terminal domain	FANCA:uc010ciu.1:exon8:c.A700G:p.T234A,FANCA:uc002fou.1:exon9:c.A796G:p.T266A,FANCA:uc002fow.1:exon9:c.A796G:p.T266A,FANCA:uc002fox.1:exon9:c.A796G:p.T266A,FANCA:uc010vpn.1:exon9:c.A796G:p.T266A	-1.001	AFR:0.7087,AMR:0.6062,EAS:0.9802,FIN:0.4539,NFE:0.4064,OTH:0.5020,ASJ:0.3079	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	1.19	0.000	-2.125	16	MU81983326	hom
16	89869761	89869761	T	C	FANCA	intronic	.	ENSG00000187741	rs1800286	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7013	0.6958	0.842851	0.7226	.	.	.	.	.	0.0002	0.04	.	.	.	AFR:0.9146,AMR:0.7404,EAS:0.9852,FIN:0.6640,NFE:0.6020,OTH:0.6759,ASJ:0.5132	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983327	hom
16	89986154	89986154	G	A	MC1R	exonic	nonsynonymous SNV	ENSG00000198211;ENSG00000258839	rs885479	ENSG00000258839:ENST00000555147:exon1:c.G488A:p.R163Q,ENSG00000198211:ENST00000556922:exon1:c.G488A:p.R163Q,ENSG00000258839:ENST00000555427:exon3:c.G488A:p.R163Q	MC1R:NM_002386:exon1:c.G488A:p.R163Q	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1358	0.0371	0.191294	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.791	9.407	0.035	4.81	0.001	.	.	GPCR, rhodopsin-like, 7TM	MC1R:uc002fpe.4:exon1:c.G488A:p.R163Q,TUBB3:uc002fpf.2:exon1:c.G488A:p.R163Q	-0.918	AFR:0.1022,AMR:0.0185,EAS:0.0367,FIN:0.6183,NFE:0.2086,OTH:0.0562,ASJ:0.3365	155555	203200;266300;613098;613099;	618;79432;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~79432|OCA2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|203200 ~	.	.	.	.	0.004	-0.61	0.000	1.855	16	1(breast)	0.1415
17	423051	423051	T	C	VPS53	intronic	.	ENSG00000141252	rs2034088	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6120	0.6207	0.726637	0.6106	.	.	.	.	.	.	.	.	.	.	AFR:0.8862,AMR:0.7022,EAS:0.8327,FIN:0.4173,NFE:0.4712,OTH:0.5418,ASJ:0.5927	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	MU22359267	het
17	465775	465775	G	A	VPS53	exonic	synonymous SNV	ENSG00000141252	rs2075443	ENSG00000141252:ENST00000401468:exon7:c.C693T:p.Y231Y,ENSG00000141252:ENST00000291074:exon13:c.C1437T:p.Y479Y,ENSG00000141252:ENST00000389040:exon13:c.C1380T:p.Y460Y,ENSG00000141252:ENST00000437048:exon14:c.C1524T:p.Y508Y,ENSG00000141252:ENST00000571805:exon14:c.C1524T:p.Y508Y,ENSG00000141252:ENST00000446250:exon15:c.C930T:p.Y310Y	VPS53:NM_018289:exon13:c.C1437T:p.Y479Y,VPS53:NM_001128159:exon14:c.C1524T:p.Y508Y,VPS53:NM_001366253:exon14:c.C1524T:p.Y508Y,VPS53:NM_001366254:exon15:c.C930T:p.Y310Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2784	0.3342	0.348642	LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	VPS53:uc010cjp.1:exon7:c.C693T:p.Y231Y,VPS53:uc002frk.3:exon9:c.C81T:p.Y27Y,VPS53:uc002frm.2:exon13:c.C1437T:p.Y479Y,VPS53:uc002frn.2:exon14:c.C1524T:p.Y508Y,VPS53:uc010cjo.2:exon14:c.C1524T:p.Y508Y,VPS53:uc002fro.2:exon15:c.C930T:p.Y310Y	.	AFR:0.3181,AMR:0.5503,EAS:0.1854,FIN:0.1925,NFE:0.1881,OTH:0.2281,ASJ:0.3947	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.2741
17	600735	600735	A	G	VPS53	intronic	.	ENSG00000141252	rs4968100	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1863	0.1881	0.221046	0.1878	.	.	.	.	.	0.0540	0.334	.	.	.	AFR:0.2585,AMR:0.2410,EAS:0.1897,FIN:0.1490,NFE:0.1537,OTH:0.1914,ASJ:0.1159	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	MU22359478	het
17	1733399	1733399	A	G	RPA1	exonic	synonymous SNV	ENSG00000132383	rs5030749	ENSG00000132383:ENST00000254719:exon1:c.A12G:p.Q4Q	RPA1:NM_001355121:exon1:c.A12G:p.Q4Q,RPA1:NM_002945:exon1:c.A12G:p.Q4Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7023	0.7446	0.544129	0.6919	.	.	.	.	.	.	.	.	RPA1:uc002fto.2:exon1:c.A12G:p.Q4Q	.	AFR:0.6418,AMR:0.4388,EAS:0.3939,FIN:0.6881,NFE:0.7698,OTH:0.6660,ASJ:0.6887	179835	.	.	.	.	.	.	.	.	.	.	.	17	MU153162	hom
17	4448967	4448967	G	A	MYBBP1A	exonic	nonsynonymous SNV	ENSG00000132382	rs139356015	ENSG00000132382:ENST00000254718:exon15:c.C2011T:p.R671W,ENSG00000132382:ENST00000381556:exon15:c.C2011T:p.R671W	MYBBP1A:NM_001105538:exon15:c.C2011T:p.R671W,MYBBP1A:NM_014520:exon15:c.C2011T:p.R671W	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0044	0.0030	0.00539137	0.0020	7.688	35	0.002	5.22	0.665	.	.	Armadillo-like helical|Armadillo-type fold	MYBBP1A:uc002fxz.4:exon15:c.C2011T:p.R671W,MYBBP1A:uc002fyb.4:exon15:c.C2011T:p.R671W	-0.118	AFR:0.0014,AMR:0,EAS:0,FIN:0,NFE:0.0032,OTH:0.0020,ASJ:0	604885	.	.	.	.	.	.	.	1.0	-0.34	0.421	2.79	17	.	het
17	4455166	4455166	A	G	MYBBP1A	intronic	.	ENSG00000132382	rs3816686	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2465	0.1781	0.291933	MU661817	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,AMR:0.1965,EAS:0.3377,FIN:0.1291,NFE:0.5507,OTH:0.1987,ASJ:0.1315	604885	.	.	.	.	.	.	.	.	.	.	.	17	1(oesophagus)	0.1881
17	4455500	4455500	T	C	MYBBP1A	exonic	synonymous SNV	ENSG00000132382	rs7206974	ENSG00000132382:ENST00000254718:exon7:c.A825G:p.A275A,ENSG00000132382:ENST00000381556:exon7:c.A825G:p.A275A	MYBBP1A:NM_001105538:exon7:c.A825G:p.A275A,MYBBP1A:NM_014520:exon7:c.A825G:p.A275A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9977	0.9906	0.992812	0.9914	.	.	.	.	.	.	.	.	MYBBP1A:uc002fxz.4:exon7:c.A825G:p.A275A,MYBBP1A:uc002fyb.4:exon7:c.A825G:p.A275A	.	AFR:0.9704,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	604885	.	.	.	.	.	.	.	.	.	.	.	17	MU4564618	hom
17	5042894	5042894	T	C	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs8073787	ENSG00000129204:ENST00000250066:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000572949:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000304328:exon15:c.T472C:p.W158R,ENSG00000129204:ENST00000332776:exon22:c.T1423C:p.W475R,ENSG00000129204:ENST00000574788:exon22:c.T1423C:p.W475R	USP6:NM_004505:exon14:c.T1423C:p.W475R,USP6:NM_001304284:exon22:c.T1423C:p.W475R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6492	0.6377	0.77496	MU9249277	-0.312	0.625	0.067	-0.532	0.000	.	.	.	USP6:uc002gav.1:exon14:c.T1423C:p.W475R,USP6:uc010ckz.1:exon15:c.T472C:p.W158R,USP6:uc002gau.1:exon22:c.T1423C:p.W475R	-1.065	AFR:COCA-CN|5|321|0.0155763,AMR:0.6723,EAS:0.5791,FIN:0.5662,NFE:0.8974,OTH:0.6812,ASJ:0.8215	604334	.	.	.	.	.	.	.	0.003	3.11	0.000	0.69	17	1(salivary_gland)	0.5679
17	5418107	5418107	G	A	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs74929853	ENSG00000091592:ENST00000577119:exon15:c.C4167T:p.G1389G,ENSG00000091592:ENST00000345221:exon16:c.C4257T:p.G1419G,ENSG00000091592:ENST00000354411:exon16:c.C4299T:p.G1433G,ENSG00000091592:ENST00000269280:exon17:c.C4257T:p.G1419G,ENSG00000091592:ENST00000572272:exon17:c.C4389T:p.G1463G	NLRP1:NM_033007:exon15:c.C4167T:p.G1389G,NLRP1:NM_014922:exon16:c.C4257T:p.G1419G,NLRP1:NM_033006:exon16:c.C4299T:p.G1433G,NLRP1:NM_033004:exon17:c.C4389T:p.G1463G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0328	0.0015	0.0696885	0.0088	.	.	.	.	.	.	.	.	NLRP1:uc002gcl.3:exon15:c.C4167T:p.G1389G,NLRP1:uc002gcj.3:exon16:c.C4299T:p.G1433G,NLRP1:uc002gck.3:exon16:c.C4257T:p.G1419G,NLRP1:uc002gch.4:exon17:c.C4257T:p.G1419G,NLRP1:uc002gci.3:exon17:c.C4389T:p.G1463G	.	AFR:0.0031,AMR:0.0012,EAS:0.1372,FIN:0,NFE:0.0005,OTH:0.0154,ASJ:0	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	MU81986150	het
17	5418799	5418799	G	A	NLRP1	exonic	nonsynonymous SNV	ENSG00000091592	rs2137722	ENSG00000091592:ENST00000577119:exon14:c.C3874T:p.R1292C,ENSG00000091592:ENST00000345221:exon15:c.C3964T:p.R1322C,ENSG00000091592:ENST00000354411:exon15:c.C4006T:p.R1336C,ENSG00000091592:ENST00000269280:exon16:c.C3964T:p.R1322C,ENSG00000091592:ENST00000572272:exon16:c.C4096T:p.R1366C	NLRP1:NM_033007:exon14:c.C3874T:p.R1292C,NLRP1:NM_014922:exon15:c.C3964T:p.R1322C,NLRP1:NM_033006:exon15:c.C4006T:p.R1336C,NLRP1:NM_033004:exon16:c.C4096T:p.R1366C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0777	0.0515	0.101238	0.0568	1.063	11.01	0.114	-4.28	0.001	.	.	FIIND domain	NLRP1:uc002gcl.3:exon14:c.C3874T:p.R1292C,NLRP1:uc002gcj.3:exon15:c.C4006T:p.R1336C,NLRP1:uc002gck.3:exon15:c.C3964T:p.R1322C,NLRP1:uc002gch.4:exon16:c.C3964T:p.R1322C,NLRP1:uc002gci.3:exon16:c.C4096T:p.R1366C	-1.106	AFR:0.0520,AMR:0.0394,EAS:0.1383,FIN:0.0547,NFE:0.0517,OTH:0.0622,ASJ:0.0695	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	0.002	-0.48	0.002	0.345	17	MU18333347	het
17	5424886	5424886	G	A	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs2301583	ENSG00000091592:ENST00000354411:exon12:c.C3651T:p.T1217T,ENSG00000091592:ENST00000577119:exon12:c.C3651T:p.T1217T,ENSG00000091592:ENST00000262467:exon13:c.C3753T:p.T1251T,ENSG00000091592:ENST00000345221:exon13:c.C3741T:p.T1247T,ENSG00000091592:ENST00000544378:exon13:c.C3753T:p.T1251T,ENSG00000091592:ENST00000572272:exon13:c.C3741T:p.T1247T,ENSG00000091592:ENST00000269280:exon14:c.C3741T:p.T1247T	NLRP1:NM_033006:exon12:c.C3651T:p.T1217T,NLRP1:NM_033007:exon12:c.C3651T:p.T1217T,NLRP1:NM_001033053:exon13:c.C3753T:p.T1251T,NLRP1:NM_014922:exon13:c.C3741T:p.T1247T,NLRP1:NM_033004:exon13:c.C3741T:p.T1247T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0322	.	0.0688898	0.0084	.	.	.	.	.	.	.	.	NLRP1:uc002gcj.3:exon12:c.C3651T:p.T1217T,NLRP1:uc002gcl.3:exon12:c.C3651T:p.T1217T,NLRP1:uc002gcg.1:exon13:c.C3753T:p.T1251T,NLRP1:uc002gci.3:exon13:c.C3741T:p.T1247T,NLRP1:uc002gck.3:exon13:c.C3741T:p.T1247T,NLRP1:uc002gch.4:exon14:c.C3741T:p.T1247T	.	AFR:0.0017,AMR:0.0012,EAS:0.1401,FIN:0,NFE:0.0002,OTH:0.0153,ASJ:0	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	MU18333608	het
17	5425077	5425077	T	C	NLRP1	exonic	nonsynonymous SNV	ENSG00000091592	rs11651270	ENSG00000091592:ENST00000354411:exon12:c.A3460G:p.M1154V,ENSG00000091592:ENST00000577119:exon12:c.A3460G:p.M1154V,ENSG00000091592:ENST00000262467:exon13:c.A3562G:p.M1188V,ENSG00000091592:ENST00000345221:exon13:c.A3550G:p.M1184V,ENSG00000091592:ENST00000544378:exon13:c.A3562G:p.M1188V,ENSG00000091592:ENST00000572272:exon13:c.A3550G:p.M1184V,ENSG00000091592:ENST00000269280:exon14:c.A3550G:p.M1184V	NLRP1:NM_033006:exon12:c.A3460G:p.M1154V,NLRP1:NM_033007:exon12:c.A3460G:p.M1154V,NLRP1:NM_001033053:exon13:c.A3562G:p.M1188V,NLRP1:NM_014922:exon13:c.A3550G:p.M1184V,NLRP1:NM_033004:exon13:c.A3550G:p.M1184V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4549	0.4826	0.417931	MU12944592	-0.778	0.048	1.0	2.26	0.973	.	.	FIIND domain	NLRP1:uc002gcj.3:exon12:c.A3460G:p.M1154V,NLRP1:uc002gcl.3:exon12:c.A3460G:p.M1154V,NLRP1:uc002gcg.1:exon13:c.A3562G:p.M1188V,NLRP1:uc002gci.3:exon13:c.A3550G:p.M1184V,NLRP1:uc002gck.3:exon13:c.A3550G:p.M1184V,NLRP1:uc002gch.4:exon14:c.A3550G:p.M1184V	-0.940	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.4631,EAS:0.4474,FIN:0.4967,NFE:0.2407,OTH:0.4631,ASJ:0.5107	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	0.0	2.82	0.000	-2.87	17	2(lung)	0.4601
17	5440197	5440197	T	C	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs7215856	ENSG00000091592:ENST00000262467:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000345221:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000544378:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000571451:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000572272:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000269280:exon9:c.A2934G:p.K978K	NLRP1:NM_001033053:exon8:c.A2934G:p.K978K,NLRP1:NM_014922:exon8:c.A2934G:p.K978K,NLRP1:NM_033004:exon8:c.A2934G:p.K978K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0795	0.0659	0.119209	0.0663	.	.	.	.	.	.	.	.	NLRP1:uc002gcg.1:exon8:c.A2934G:p.K978K,NLRP1:uc002gci.3:exon8:c.A2934G:p.K978K,NLRP1:uc002gck.3:exon8:c.A2934G:p.K978K,NLRP1:uc002gch.4:exon9:c.A2934G:p.K978K,NLRP1:uc010clh.3:exon9:c.A2934G:p.K978K	.	AFR:0.0877,AMR:0.0394,EAS:0.1460,FIN:0.0545,NFE:0.0497,OTH:0.0633,ASJ:0.0629	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	MU22370800	het
17	5456727	5456727	C	T	NLRP1	exonic	nonsynonymous SNV	ENSG00000091592	rs201879763	ENSG00000091592:ENST00000262467:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000345221:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000354411:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000544378:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000571451:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000572272:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000577119:exon5:c.G2507A:p.R836H,ENSG00000091592:ENST00000269280:exon6:c.G2507A:p.R836H	NLRP1:NM_001033053:exon5:c.G2507A:p.R836H,NLRP1:NM_014922:exon5:c.G2507A:p.R836H,NLRP1:NM_033004:exon5:c.G2507A:p.R836H,NLRP1:NM_033006:exon5:c.G2507A:p.R836H,NLRP1:NM_033007:exon5:c.G2507A:p.R836H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	0.0009	7.7e-05	0.00119808	.	1.456	13.08	0.127	-5.93	0.240	.	.	.	NLRP1:uc002gcg.1:exon5:c.G2507A:p.R836H,NLRP1:uc002gci.3:exon5:c.G2507A:p.R836H,NLRP1:uc002gcj.3:exon5:c.G2507A:p.R836H,NLRP1:uc002gck.3:exon5:c.G2507A:p.R836H,NLRP1:uc002gcl.3:exon5:c.G2507A:p.R836H,NLRP1:uc002gch.4:exon6:c.G2507A:p.R836H,NLRP1:uc010clh.3:exon6:c.G2507A:p.R836H	-1.069	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	0.108	0.67	0.037	-0.395	17	.	het
17	5487164	5487164	C	G	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs884367	ENSG00000091592:ENST00000262467:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000345221:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000354411:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000544378:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000571451:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000572272:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000577119:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000269280:exon2:c.G114C:p.S38S	NLRP1:NM_001033053:exon1:c.G114C:p.S38S,NLRP1:NM_014922:exon1:c.G114C:p.S38S,NLRP1:NM_033004:exon1:c.G114C:p.S38S,NLRP1:NM_033006:exon1:c.G114C:p.S38S,NLRP1:NM_033007:exon1:c.G114C:p.S38S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3234	0.1299	0.283147	MU123380	.	.	.	.	.	.	.	.	NLRP1:uc002gcg.1:exon1:c.G114C:p.S38S,NLRP1:uc002gci.3:exon1:c.G114C:p.S38S,NLRP1:uc002gcj.3:exon1:c.G114C:p.S38S,NLRP1:uc002gck.3:exon1:c.G114C:p.S38S,NLRP1:uc002gcl.3:exon1:c.G114C:p.S38S,NLRP1:uc002gch.4:exon2:c.G114C:p.S38S,NLRP1:uc010clh.3:exon2:c.G114C:p.S38S	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.1752,EAS:0.2146,FIN:0.2583,NFE:0.6922,OTH:0.2467,ASJ:0.0423	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.1725
17	7154534	7154534	G	A	CTDNEP1	exonic	synonymous SNV	ENSG00000175826	rs414206	ENSG00000175826:ENST00000570380:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574205:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574322:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000318988:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000571409:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000573600:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000575783:exon2:c.C82T:p.L28L	CTDNEP1:NM_001143775:exon1:c.C82T:p.L28L,CTDNEP1:NM_015343:exon2:c.C82T:p.L28L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6607	0.6938	0.701078	0.6985	.	.	.	.	.	.	.	.	CTDNEP1:uc002gfd.2:exon1:c.C82T:p.L28L,CTDNEP1:uc002gfe.2:exon2:c.C82T:p.L28L	.	AFR:0.8422,AMR:0.6017,EAS:0.6611,FIN:0.6675,NFE:0.6355,OTH:0.6478,ASJ:0.6589	610684	.	.	.	.	.	.	.	.	.	.	.	17	MU18201074	het
17	7154582	7154582	T	C	CTDNEP1	exonic	nonsynonymous SNV	ENSG00000175826	rs3744399	ENSG00000175826:ENST00000570380:exon1:c.A34G:p.T12A,ENSG00000175826:ENST00000574205:exon1:c.A34G:p.T12A,ENSG00000175826:ENST00000574322:exon1:c.A34G:p.T12A,ENSG00000175826:ENST00000318988:exon2:c.A34G:p.T12A,ENSG00000175826:ENST00000571409:exon2:c.A34G:p.T12A,ENSG00000175826:ENST00000573600:exon2:c.A34G:p.T12A,ENSG00000175826:ENST00000575783:exon2:c.A34G:p.T12A	CTDNEP1:NM_001143775:exon1:c.A34G:p.T12A,CTDNEP1:NM_015343:exon2:c.A34G:p.T12A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1558	0.1084	0.109425	0.1040	0.345	6.120	1.0	4.88	1.000	.	.	.	CTDNEP1:uc002gfd.2:exon1:c.A34G:p.T12A,CTDNEP1:uc002gfe.2:exon2:c.A34G:p.T12A	-0.985	AFR:0.0293,AMR:0.2458,EAS:0.0833,FIN:0.0900,NFE:0.1422,OTH:0.1439,ASJ:0.1093	610684	.	.	.	.	.	.	.	0.0	2.63	0.000	0.35	17	MU36793	het
17	7579472	7579472	G	C	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs1042522	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	clinvar: drug_response 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.6600	0.6300	0.542931	2(thyroid)	-0.415	0.355	0.262	1.87	0.001	.	.	.	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	-0.929	AFR:38(large_intestine),AMR:5(penis),EAS:15(bone),FIN:1(small_intestine),NFE:18(meninges),OTH:10(skin),ASJ:3(pancreas)	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04071 Sphingolipid signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04137 Mitophagy - animal~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04216 Ferroptosis~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04722 Neurotrophin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,10097,10110,10138,10093,10183,10144,10040,10193,10145,10169,10148,10127,10191,10100,10122,10035,10037,10130,10107,10150,10099,10137,10176,10182,10151,10103,10096,10178,10123,10141,10117,10112,10189,10134,10194,10162,10173,10116,10115,10119,10152,10089,10092,10109,10125,10190,10175,10174,10043,10114,10140,10036,10094,10177,10132,10124,10128,10179,10098,10102,10143,10091,10032,10041,10087,10142,10101,10104,10166,10139,10181,10164,10042,10121,10095,10108,10118,10149,10113,10088,10133,10172,10044,10192,10039,10188,10154,10131,10153,10120,10126,10106,10105,10136,10180,10135,10038	.	,10155,10033,10146,10129,10160,10147,10163,10170,10159,10158,10165,10111,10157,10167,10171,10168,10090,10156,10161	0.0	-5.23	0.000	1.355	17	1(pleura)	1(endometrium)
17	7788409	7788409	C	G	CHD3;NAA38	intronic	.	ENSG00000170004;ENSG00000183011	rs201772788	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	1	.	.	0.9997	.	.	.	.	.	0.0002	0.004	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9996,OTH:0.9984,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	17	.	unknown
17	7802454	7802454	A	C	CHD3	exonic	synonymous SNV	ENSG00000170004	rs11651304	ENSG00000170004:ENST00000330494:exon14:c.A2277C:p.L759L,ENSG00000170004:ENST00000358181:exon14:c.A2277C:p.L759L,ENSG00000170004:ENST00000380358:exon14:c.A2454C:p.L818L	CHD3:NM_001005271:exon14:c.A2454C:p.L818L,CHD3:NM_001005273:exon14:c.A2277C:p.L759L,CHD3:NM_005852:exon14:c.A2277C:p.L759L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0472	0.0314	0.0499201	0.0377	.	.	.	.	.	.	.	.	CHD3:uc002gjd.2:exon14:c.A2454C:p.L818L,CHD3:uc002gje.2:exon14:c.A2277C:p.L759L,CHD3:uc002gjf.2:exon14:c.A2277C:p.L759L	.	AFR:0.0089,AMR:0.1065,EAS:0.0457,FIN:0.0674,NFE:0.0415,OTH:0.0593,ASJ:0.0364	602120	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	7811998	7811998	T	C	CHD3	intronic	.	ENSG00000170004	rs4239111	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8852	0.8802	0.944888	0.9012	.	.	.	.	.	.	.	.	.	.	AFR:0.9727,AMR:0.9105,EAS:0.9988,FIN:0.8931,NFE:0.8527,OTH:0.8918,ASJ:0.8212	602120	.	.	.	.	.	.	.	.	.	.	.	17	MU81987243	hom
17	8046772	8046772	C	G	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs2585405	ENSG00000179094:ENST00000581082:exon18:c.G2815C:p.A939P,ENSG00000179094:ENST00000317276:exon19:c.G2884C:p.A962P	PER1:NM_002616:exon19:c.G2884C:p.A962P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8544	0.8592	0.771765	MU650358	0.259	5.289	0.581	3.22	0.001	.	.	.	PER1:uc002gkd.3:exon19:c.G2884C:p.A962P	-1.042	AFR:COCA-CN|4|321|0.0124611,AMR:0.8581,EAS:0.8091,FIN:0.7848,NFE:0.5131,OTH:0.9364,ASJ:0.8049	602260	.	.	.	.	.	.	.	0.0	2.59	0.000	-1.665	17	1(bone)	0.9092
17	8048169	8048169	T	C	PER1	exonic	synonymous SNV	ENSG00000179094	rs2253820	ENSG00000179094:ENST00000583559:exon2:c.A210G:p.T70T,ENSG00000179094:ENST00000581082:exon17:c.A2301G:p.T767T,ENSG00000179094:ENST00000317276:exon18:c.A2361G:p.T787T,ENSG00000179094:ENST00000354903:exon18:c.A2313G:p.T771T,ENSG00000179094:ENST00000582719:exon18:c.A2361G:p.T787T	PER1:NM_002616:exon18:c.A2361G:p.T787T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7486	0.7404	0.570288	MU4550577	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.A2361G:p.T787T,PER1:uc010vur.1:exon18:c.A2313G:p.T771T	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.7271,EAS:0.4582,FIN:0.6433,NFE:0.2971,OTH:0.8701,ASJ:0.5607	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.8475
17	8048283	8048283	G	A	PER1	exonic	synonymous SNV	ENSG00000179094	rs2735611	ENSG00000179094:ENST00000583559:exon2:c.C96T:p.G32G,ENSG00000179094:ENST00000581082:exon17:c.C2187T:p.G729G,ENSG00000179094:ENST00000317276:exon18:c.C2247T:p.G749G,ENSG00000179094:ENST00000354903:exon18:c.C2199T:p.G733G,ENSG00000179094:ENST00000582719:exon18:c.C2247T:p.G749G	PER1:NM_002616:exon18:c.C2247T:p.G749G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7253	0.7423	0.570487	MU657495	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.C2247T:p.G749G,PER1:uc010vur.1:exon18:c.C2199T:p.G733G	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7275,EAS:0.4582,FIN:0.6467,NFE:0.2966,OTH:0.8698,ASJ:0.5619	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(thyroid)	0.8477
17	8053916	8053916	G	A	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs72845601	ENSG00000179094:ENST00000581082:exon1:c.C109T:p.P37S,ENSG00000179094:ENST00000317276:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000354903:exon2:c.C61T:p.P21S,ENSG00000179094:ENST00000577253:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000581395:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000581703:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000582719:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000584202:exon3:c.C109T:p.P37S	PER1:NM_002616:exon2:c.C109T:p.P37S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0110	0.0135	0.00539137	0.0092	1.954	15.92	0.005	4.33	0.986	.	.	.	PER1:uc010vus.1:exon1:c.C109T:p.P37S,PER1:uc002gkd.3:exon2:c.C109T:p.P37S,PER1:uc010vur.1:exon2:c.C61T:p.P21S	-0.934	AFR:0.0037,AMR:0.0072,EAS:0,FIN:0.0037,NFE:0.0147,OTH:0.0102,ASJ:0.0066	602260	.	.	.	.	.	.	.	0.999	2.61	0.053	0.55	17	.	het
17	8108331	8108331	A	G	AURKB	exonic	nonsynonymous SNV	ENSG00000178999	rs1059476	ENSG00000178999:ENST00000534871:exon8:c.T770C:p.M257T,ENSG00000178999:ENST00000578549:exon8:c.T797C:p.M266T,ENSG00000178999:ENST00000316199:exon9:c.T896C:p.M299T,ENSG00000178999:ENST00000585124:exon9:c.T893C:p.M298T	AURKB:NM_001313955:exon7:c.T389C:p.M130T,AURKB:NM_001256834:exon8:c.T770C:p.M257T,AURKB:NM_001313952:exon8:c.T773C:p.M258T,AURKB:NM_001284526:exon9:c.T896C:p.M299T,AURKB:NM_001313950:exon9:c.T893C:p.M298T,AURKB:NM_001313951:exon9:c.T770C:p.M257T,AURKB:NM_001313953:exon9:c.T797C:p.M266T,AURKB:NM_001313954:exon9:c.T437C:p.M146T,AURKB:NM_004217:exon9:c.T893C:p.M298T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8306	0.8219	0.736022	MU656579	-1.014	0.015	0.39	-1.93	0.312	.	.	Protein kinase domain|Protein kinase-like domain	AURKB:uc010cnu.3:exon7:c.T353C:p.M118T,AURKB:uc010vuu.3:exon8:c.T770C:p.M257T,AURKB:uc021tpy.1:exon8:c.T797C:p.M266T,AURKB:uc002gkm.4:exon9:c.T893C:p.M298T,AURKB:uc002gkn.4:exon9:c.T896C:p.M299T	-0.992	AFR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,AMR:0.8160,EAS:0.7728,FIN:0.76,NFE:0.5252,OTH:0.9068,ASJ:0.6942	604970	.	.	.	.	.	.	.	0.0	-0.07	0.000	-0.44	17	33(lung)	0.8955
17	8108339	8108339	G	A	AURKB	exonic	synonymous SNV	ENSG00000178999	rs2241909	ENSG00000178999:ENST00000534871:exon8:c.C762T:p.S254S,ENSG00000178999:ENST00000578549:exon8:c.C789T:p.S263S,ENSG00000178999:ENST00000316199:exon9:c.C888T:p.S296S,ENSG00000178999:ENST00000585124:exon9:c.C885T:p.S295S	AURKB:NM_001313955:exon7:c.C381T:p.S127S,AURKB:NM_001256834:exon8:c.C762T:p.S254S,AURKB:NM_001313952:exon8:c.C765T:p.S255S,AURKB:NM_001284526:exon9:c.C888T:p.S296S,AURKB:NM_001313950:exon9:c.C885T:p.S295S,AURKB:NM_001313951:exon9:c.C762T:p.S254S,AURKB:NM_001313953:exon9:c.C789T:p.S263S,AURKB:NM_001313954:exon9:c.C429T:p.S143S,AURKB:NM_004217:exon9:c.C885T:p.S295S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6547	0.6183	0.620807	2(thyroid)	.	.	.	.	.	.	.	.	AURKB:uc010cnu.3:exon7:c.C345T:p.S115S,AURKB:uc010vuu.3:exon8:c.C762T:p.S254S,AURKB:uc021tpy.1:exon8:c.C789T:p.S263S,AURKB:uc002gkm.4:exon9:c.C885T:p.S295S,AURKB:uc002gkn.4:exon9:c.C888T:p.S296S	.	AFR:MU773382,AMR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5578,FIN:0.6719,NFE:0.5403,OTH:0.4729,ASJ:0.6398	604970	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.7446
17	8387438	8387438	-	ATGA	MYH10	intronic	.	ENSG00000133026;ENSG00000166579	rs113838551	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9900	0.9616	0.971246	0.9685	.	.	.	.	.	.	.	.	.	.	AFR:0.8902,AMR:0.9940,EAS:1,FIN:1,NFE:0.9996,OTH:0.9918,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	8390733	8390733	A	G	MYH10	intronic	.	ENSG00000133026;ENSG00000166579	rs3826463	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5619	0.5012	0.496605	MU81987538	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5070,EAS:0.6017,FIN:0.6887,NFE:0.5841,OTH:0.5613,ASJ:0.3239	160776	.	.	.	.	.	.	.	.	.	.	.	17	1(bone)	0.5782
17	8416901	8416901	C	T	MYH10	exonic	synonymous SNV	ENSG00000133026	rs11374	ENSG00000133026:ENST00000269243:exon21:c.G2607A:p.T869T,ENSG00000133026:ENST00000379980:exon22:c.G2655A:p.T885T,ENSG00000133026:ENST00000396239:exon22:c.G2670A:p.T890T,ENSG00000133026:ENST00000360416:exon23:c.G2700A:p.T900T	MYH10:NM_005964:exon21:c.G2607A:p.T869T,MYH10:NM_001256095:exon22:c.G2634A:p.T878T,MYH10:NM_001256012:exon23:c.G2700A:p.T900T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4031	0.3832	0.423323	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon21:c.G2607A:p.T869T,MYH10:uc010cnx.4:exon22:c.G2634A:p.T878T,MYH10:uc002glm.4:exon23:c.G2700A:p.T900T	.	AFR:MU12983113,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3787,FIN:0.3612,NFE:0.2933,OTH:0.4969,ASJ:0.4027	160776	.	.	.	.	.	.	.	.	.	.	.	17	1(prostate)	0.4441
17	8417007	8417007	T	-	MYH10	intronic	.	ENSG00000133026	rs66631876	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3986	.	.	0.4548	.	.	.	.	.	.	.	.	.	.	AFR:0.5514,AMR:0.4113,EAS:0.4899,FIN:0.4603,NFE:0.3992,OTH:0.4135,ASJ:0.3346	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	8424270	8424270	G	A	MYH10	exonic	synonymous SNV	ENSG00000133026	rs8067456	ENSG00000133026:ENST00000269243:exon17:c.C2106T:p.N702N,ENSG00000133026:ENST00000379980:exon18:c.C2154T:p.N718N,ENSG00000133026:ENST00000396239:exon18:c.C2169T:p.N723N,ENSG00000133026:ENST00000360416:exon19:c.C2199T:p.N733N	MYH10:NM_005964:exon17:c.C2106T:p.N702N,MYH10:NM_001256095:exon18:c.C2133T:p.N711N,MYH10:NM_001256012:exon19:c.C2199T:p.N733N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9923	0.9700	0.979433	0.9765	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon17:c.C2106T:p.N702N,MYH10:uc010cnx.4:exon18:c.C2133T:p.N711N,MYH10:uc002glm.4:exon19:c.C2199T:p.N733N	.	AFR:0.9179,AMR:0.9964,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	MU81987554	hom
17	8451745	8451745	A	-	MYH10	intronic	.	ENSG00000133026	rs398030289	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9907	.	0.97484	0.9711	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.9952,EAS:1,FIN:0.9997,NFE:0.9994,OTH:0.9949,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	10411822	10411822	A	G	MYH1	exonic	synonymous SNV	ENSG00000109061	rs528137077	ENSG00000109061:ENST00000226207:exon16:c.T1755C:p.Y585Y	MYH1:NM_005963:exon16:c.T1755C:p.Y585Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	2.471e-05	.	0.000199681	3.229e-05	.	.	.	.	.	.	.	.	MYH1:uc002gmo.3:exon16:c.T1755C:p.Y585Y	.	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	160730	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	10415840	10415840	A	G	MYH1	exonic	synonymous SNV	ENSG00000109061	rs2007027	ENSG00000109061:ENST00000226207:exon12:c.T1032C:p.F344F	MYH1:NM_005963:exon12:c.T1032C:p.F344F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9288	0.8759	0.88139	0.8945	.	.	.	.	.	.	.	.	MYH1:uc002gmo.3:exon12:c.T1032C:p.F344F	.	AFR:0.7410,AMR:0.9436,EAS:0.9988,FIN:0.9805,NFE:0.9471,OTH:0.9318,ASJ:0.9040	160730	.	.	.	.	.	.	.	.	.	.	.	17	MU81988040	hom
17	12899963	12899963	T	C	ELAC2	exonic	synonymous SNV	ENSG00000006744	rs11545302	ENSG00000006744:ENST00000426905:exon16:c.A1440G:p.T480T,ENSG00000006744:ENST00000338034:exon17:c.A1560G:p.T520T,ENSG00000006744:ENST00000395962:exon17:c.A1503G:p.T501T	ELAC2:NM_001165962:exon16:c.A1440G:p.T480T,ELAC2:NM_018127:exon17:c.A1560G:p.T520T,ELAC2:NM_173717:exon17:c.A1557G:p.T519T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2716	0.2699	0.207268	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ELAC2:uc002gnv.4:exon6:c.A444G:p.T148T,ELAC2:uc002gnx.4:exon9:c.A840G:p.T280T,ELAC2:uc010vvo.2:exon12:c.A954G:p.T318T,ELAC2:uc010vvr.2:exon16:c.A1440G:p.T480T,ELAC2:uc002gnz.4:exon17:c.A1560G:p.T520T,ELAC2:uc010vvp.3:exon17:c.A1458G:p.T486T,ELAC2:uc010vvq.2:exon17:c.A1557G:p.T519T	.	AFR:0.2689,AMR:0.2269,EAS:0.3576,FIN:0.0241,NFE:0.3175,OTH:0.3055,ASJ:0.2626	605367	614731;615440;	369913;1331;	369913|COXPD17|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615440 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	17	1(breast)	0.2936
17	12903599	12903599	A	G	ELAC2	intronic	.	ENSG00000006744	rs3760316	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3035	0.3282	0.286342	1(liver)	.	.	.	.	.	0	0.052	.	.	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU11021393,EAS:0.3170,FIN:0.3876,NFE:0.2709,OTH:0.3907,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841	605367	614731;615440;	369913;1331;	369913|COXPD17|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615440 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	17	3(lung)	0.0266
17	12905574	12905574	T	A	ELAC2	intronic	.	ENSG00000006744	rs55674356	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2706	0.2696	0.20627	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2685,AMR:0.2249,EAS:0.3576,FIN:0.0241,NFE:0.3176,OTH:0.3055,ASJ:0.2620	605367	614731;615440;	369913;1331;	369913|COXPD17|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615440 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	17	1(liver)	0.2984
17	12905743	12905743	G	A	ELAC2	intronic	.	ENSG00000006744	rs55825263	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2808	0.2697	0.20627	MU11021562	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.2685,EAS:0.2608,FIN:0.3576,NFE:0.0241,OTH:0.3174,ASJ:0.2249	605367	614731;615440;	369913;1331;	369913|COXPD17|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615440 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	17	1(liver)	0.3056
17	12915009	12915009	G	A	ELAC2	exonic	nonsynonymous SNV	ENSG00000006744	rs4792311	ENSG00000006744:ENST00000338034:exon7:c.C650T:p.S217L,ENSG00000006744:ENST00000395962:exon7:c.C593T:p.S198L,ENSG00000006744:ENST00000581499:exon7:c.C368T:p.S123L,ENSG00000006744:ENST00000609101:exon7:c.C368T:p.S123L,ENSG00000006744:ENST00000609757:exon7:c.C368T:p.S123L	ELAC2:NM_018127:exon7:c.C650T:p.S217L,ELAC2:NM_173717:exon7:c.C650T:p.S217L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2711	0.2757	0.214457	MU11022100	0.989	10.60	0.321	3.23	0.004	.	.	Metallo-beta-lactamase	ELAC2:uc010vvo.2:exon2:c.C119T:p.S40L,ELAC2:uc002gnz.4:exon7:c.C650T:p.S217L,ELAC2:uc010vvp.3:exon7:c.C548T:p.S183L,ELAC2:uc010vvq.2:exon7:c.C650T:p.S217L	-1.000	AFR:LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,AMR:0.2744,EAS:0.2638,FIN:0.3576,NFE:0.0242,OTH:0.3173,ASJ:0.2458	605367	614731;615440;	369913;1331;	369913|COXPD17|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615440 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.05	-0.16	0.000	2.43	17	1(liver)	0.3052
17	12920260	12920260	A	G	ELAC2	intronic	.	ENSG00000006744	rs58809197	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2716	0.2723	0.208466	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	0	0.034	.	.	.	AFR:0.2713,AMR:0.2326,EAS:0.3567,FIN:0.0254,NFE:0.3164,OTH:0.3068,ASJ:0.2650	605367	614731;615440;	369913;1331;	369913|COXPD17|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615440 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	17	1(bone)	0.2996
17	17122327	17122327	G	A	FLCN	intronic	.	ENSG00000154803;ENSG00000264187	rs8065832	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5023	0.4491	0.502995	0.4924	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3692,AMR:0.5525,EAS:0.6512,FIN:0.6579,NFE:0.5025,OTH:0.5305,ASJ:0.4834	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	.	.	.	.	.	.	.	17	MU19893918	het
17	17124815	17124815	C	T	FLCN	exonic	nonsynonymous SNV	ENSG00000154803	rs3744124	ENSG00000154803:ENST00000389169:exon8:c.G907A:p.G303R	FLCN:NM_144606:exon8:c.G907A:p.G303R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0725	0.0775	0.0996406	1(breast)	-0.012	2.469	0.377	-4.69	0.000	.	.	.	FLCN:uc002grb.4:exon8:c.G907A:p.G303R	-1.005	AFR:MU4553464,AMR:LICA-CN|2|402|0.00497512,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.1312,FIN:0.0322,NFE:0.0265,OTH:0.2020,ASJ:0.0743	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	,5615,5614	.	.	0.002	-3.3	0.003	.	17	3(soft_tissue)	0.0258
17	17127471	17127471	G	A	FLCN	intronic	.	ENSG00000154803;ENSG00000264187	rs1736219	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4841	0.3738	0.405152	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4296,AMR:0.1533,EAS:0.4834,FIN:0.6512,NFE:0.6583,OTH:0.5001,ASJ:0.5419	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	.	.	.	.	.	.	.	17	1(prostate)	0.5194
17	20107773	20107773	T	C	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703805	ENSG00000128487:ENST00000395522:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395525:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395530:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000261503:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395527:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395529:exon4:c.T411C:p.S137S	SPECC1:NM_001033554:exon2:c.T168C:p.S56S,SPECC1:NM_001033555:exon2:c.T168C:p.S56S,SPECC1:NM_001243438:exon2:c.T168C:p.S56S,SPECC1:NM_001033553:exon4:c.T411C:p.S137S,SPECC1:NM_001243439:exon4:c.T411C:p.S137S,SPECC1:NM_152904:exon4:c.T411C:p.S137S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4782	0.3982	0.539936	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwu.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwv.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwq.3:exon4:c.T411C:p.S137S,SPECC1:uc002gwr.3:exon4:c.T411C:p.S137S,SPECC1:uc002gws.3:exon4:c.T411C:p.S137S,SPECC1:uc010cqx.3:exon4:c.T411C:p.S137S	.	AFR:0.4545,AMR:0.4073,EAS:0.4305,FIN:0.8220,NFE:0.5049,OTH:0.4264,ASJ:0.4964	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(urinary_tract)	0.4867
17	20108239	20108239	A	T	SPECC1	exonic	nonsynonymous SNV	ENSG00000128487	rs2703806	ENSG00000128487:ENST00000395522:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000395525:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000395530:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000261503:exon4:c.A877T:p.M293L,ENSG00000128487:ENST00000395527:exon4:c.A877T:p.M293L,ENSG00000128487:ENST00000395529:exon4:c.A877T:p.M293L	SPECC1:NM_001033554:exon2:c.A634T:p.M212L,SPECC1:NM_001033555:exon2:c.A634T:p.M212L,SPECC1:NM_001243438:exon2:c.A634T:p.M212L,SPECC1:NM_001033553:exon4:c.A877T:p.M293L,SPECC1:NM_001243439:exon4:c.A877T:p.M293L,SPECC1:NM_152904:exon4:c.A877T:p.M293L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6741	0.6898	0.819289	0.7198	-3.117	0.001	1.0	-10.8	0.053	.	.	.	SPECC1:uc002gwt.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwu.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwv.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwq.3:exon4:c.A877T:p.M293L,SPECC1:uc002gwr.3:exon4:c.A877T:p.M293L,SPECC1:uc002gws.3:exon4:c.A877T:p.M293L,SPECC1:uc010cqx.3:exon4:c.A877T:p.M293L	-0.902	AFR:0.9190,AMR:0.6722,EAS:0.9914,FIN:0.6289,NFE:0.6068,OTH:0.6516,ASJ:0.5166	608793	.	.	.	.	.	.	.	0.0	0.16	0.000	-2.28	17	MU81989794	het
17	20109189	20109189	C	T	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703807	ENSG00000128487:ENST00000584527:exon1:c.C81T:p.N27N,ENSG00000128487:ENST00000395522:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395525:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395530:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000261503:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395527:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395529:exon4:c.C1827T:p.N609N	SPECC1:NM_001033554:exon2:c.C1584T:p.N528N,SPECC1:NM_001033555:exon2:c.C1584T:p.N528N,SPECC1:NM_001243438:exon2:c.C1584T:p.N528N,SPECC1:NM_001033553:exon4:c.C1827T:p.N609N,SPECC1:NM_001243439:exon4:c.C1827T:p.N609N,SPECC1:NM_152904:exon4:c.C1827T:p.N609N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4747	0.3805	0.522764	PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwu.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwv.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwq.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gwr.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gws.3:exon4:c.C1827T:p.N609N,SPECC1:uc010cqx.3:exon4:c.C1827T:p.N609N	.	AFR:0.4403,AMR:0.3638,EAS:0.4305,FIN:0.8201,NFE:0.5006,OTH:0.4247,ASJ:0.4905	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.4786
17	20163529	20163529	A	G	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703791	ENSG00000128487:ENST00000536879:exon9:c.A882G:p.A294A,ENSG00000128487:ENST00000395530:exon10:c.A2619G:p.A873A,ENSG00000128487:ENST00000261503:exon12:c.A2862G:p.A954A,ENSG00000128487:ENST00000395527:exon12:c.A2862G:p.A954A	SPECC1:NM_001033555:exon10:c.A2619G:p.A873A,SPECC1:NM_001033553:exon12:c.A2862G:p.A954A,SPECC1:NM_001243439:exon12:c.A2862G:p.A954A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6741	0.6896	0.819289	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPECC1:uc010vzf.2:exon9:c.A882G:p.A294A,SPECC1:uc002gwv.3:exon10:c.A2619G:p.A873A,SPECC1:uc002gwq.3:exon12:c.A2862G:p.A954A,SPECC1:uc002gws.3:exon12:c.A2862G:p.A954A	.	AFR:0.7198,AMR:0.9185,EAS:0.5166,FIN:0.9914,NFE:0.6289,OTH:0.6070,ASJ:0.6718	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.6517
17	20216095	20216095	T	C	SPECC1	intronic	.	ENSG00000263494	rs11870147	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.819289	0.7198	.	.	.	.	.	.	.	.	.	.	AFR:0.9192,AMR:0.6706,EAS:0.9914,FIN:0.6285,NFE:0.6069,OTH:0.6496,ASJ:0.5166	608793	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	29508775	29508775	G	A	NF1	exonic	synonymous SNV	ENSG00000196712	rs1801052	ENSG00000196712:ENST00000356175:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000358273:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000431387:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000579081:exon7:c.G804A:p.L268L	NF1:NM_000267:exon7:c.G702A:p.L234L,NF1:NM_001042492:exon7:c.G702A:p.L234L,NF1:NM_001128147:exon7:c.G702A:p.L234L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6228	0.5744	0.511781	3(large_intestine)	.	.	.	.	.	.	.	.	NF1:uc010csn.2:exon5:c.G282A:p.L94L,NF1:uc002hge.2:exon7:c.G702A:p.L234L,NF1:uc002hgf.2:exon7:c.G702A:p.L234L,NF1:uc002hgg.3:exon7:c.G702A:p.L234L,NF1:uc002hgh.3:exon7:c.G702A:p.L234L	.	AFR:MU120056,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.3000,FIN:0.5365,NFE:0.7285,OTH:0.5877,ASJ:0.5603	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	,7730,7733,7720,7723,7707,7715,7714,7711,7709,7724,7729,7735,7704,7736,7719,7710,7727,7728,7731,7722,7737,7726,7705,7721,7712,7717,7716,7713,7732,7718,7708,7725,7734,7706	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.6524
17	29508819	29508819	-	T	NF1	intronic	.	ENSG00000196712	rs373999174	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3108	.	.	0.4967	.	.	.	.	.	.	.	.	.	.	AFR:0.1881,AMR:0.5038,EAS:0.5859,FIN:0.5072,NFE:0.6616,OTH:0.6062,ASJ:0.7246	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	.	.	.	.	.	.	.	17	.	het
17	29509641	29509641	G	A	NF1	exonic	synonymous SNV	ENSG00000196712	rs138840528	ENSG00000196712:ENST00000356175:exon8:c.G846A:p.Q282Q,ENSG00000196712:ENST00000358273:exon8:c.G846A:p.Q282Q,ENSG00000196712:ENST00000431387:exon8:c.G846A:p.Q282Q,ENSG00000196712:ENST00000579081:exon8:c.G948A:p.Q316Q	NF1:NM_000267:exon8:c.G846A:p.Q282Q,NF1:NM_001042492:exon8:c.G846A:p.Q282Q,NF1:NM_001128147:exon8:c.G846A:p.Q282Q	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0061	0.0017	0.0061901	.	.	.	.	.	.	.	.	.	NF1:uc010csn.2:exon6:c.G426A:p.Q142Q,NF1:uc002hge.2:exon8:c.G846A:p.Q282Q,NF1:uc002hgf.2:exon8:c.G846A:p.Q282Q,NF1:uc002hgg.3:exon8:c.G846A:p.Q282Q,NF1:uc002hgh.3:exon8:c.G846A:p.Q282Q	.	AFR:0.0008,AMR:0.0001,EAS:0.0066,FIN:0,NFE:0,OTH:0.0015,ASJ:0	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	,7730,7733,7720,7723,7707,7715,7714,7711,7709,7724,7729,7735,7704,7736,7719,7710,7727,7728,7731,7722,7737,7726,7705,7721,7712,7717,7716,7713,7732,7718,7708,7725,7734,7706	.	.	.	.	.	.	17	1(pancreas)	0.0010
17	29553485	29553485	G	A	NF1	exonic	synonymous SNV	ENSG00000196712	rs2285892	ENSG00000196712:ENST00000456735:exon10:c.G1032A:p.P344P,ENSG00000196712:ENST00000356175:exon18:c.G2034A:p.P678P,ENSG00000196712:ENST00000358273:exon18:c.G2034A:p.P678P,ENSG00000196712:ENST00000579081:exon18:c.G2136A:p.P712P	NF1:NM_000267:exon18:c.G2034A:p.P678P,NF1:NM_001042492:exon18:c.G2034A:p.P678P	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3827	0.4163	0.496805	1(lung)	.	.	.	.	.	.	.	.	NF1:uc010csn.2:exon16:c.G1614A:p.P538P,NF1:uc002hgg.3:exon18:c.G2034A:p.P678P,NF1:uc002hgh.3:exon18:c.G2034A:p.P678P	.	AFR:7(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.4369,NFE:0.6742,OTH:0.4642,ASJ:MU14445632	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	,7730,7733,7720,7723,7707,7715,7714,7711,7709,7724,7729,7735,7704,7736,7719,7710,7727,7728,7731,7722,7737,7726,7705,7721,7712,7717,7716,7713,7732,7718,7708,7725,7734,7706	.	.	.	.	.	.	17	1(breast)	0.2770
17	29654876	29654876	T	A	NF1	intronic	.	ENSG00000196712	rs2285894	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5364	0.5162	0.431909	8(meninges)	.	.	.	.	.	.	.	.	.	.	AFR:1(lung),AMR:MU695061,EAS:0.4925,FIN:0.2920,NFE:0.4221,OTH:0.6788,ASJ:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	.	.	.	.	.	.	.	17	1(pancreas)	0.3480
17	34171590	34171590	A	G	TAF15	exonic	synonymous SNV	ENSG00000172660	rs4251785	ENSG00000172660:ENST00000311979:exon15:c.A1278G:p.G426G,ENSG00000172660:ENST00000588240:exon15:c.A1287G:p.G429G	TAF15:NM_003487:exon15:c.A1278G:p.G426G,TAF15:NM_139215:exon15:c.A1287G:p.G429G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1423	0.1369	0.204073	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TAF15:uc002hkc.4:exon15:c.A1278G:p.G426G,TAF15:uc002hkd.4:exon15:c.A1287G:p.G429G	.	AFR:MU774328,AMR:COCA-CN|3|321|0.00934579,EAS:0.2059,FIN:0.1955,NFE:0.0633,OTH:0.1403,ASJ:0.1414	601574	612237;	209916;	209916|-|1-9 / 1 000 000|Not applicable|Adult|612237 ~	~ko03022 Basal transcription factors~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	17	1(large_intestine)	0.1310
17	34252537	34252537	A	C	RDM1	exonic	nonsynonymous SNV	ENSG00000187456	rs2251660	ENSG00000187456:ENST00000394527:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000394529:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000419453:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000430160:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000585884:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000585939:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000591402:exon2:c.T312G:p.C104W,ENSG00000187456:ENST00000592489:exon2:c.T201G:p.C67W,ENSG00000187456:ENST00000293273:exon3:c.T381G:p.C127W,ENSG00000187456:ENST00000394528:exon3:c.T381G:p.C127W,ENSG00000187456:ENST00000425909:exon3:c.T381G:p.C127W,ENSG00000187456:ENST00000431884:exon3:c.T381G:p.C127W,ENSG00000187456:ENST00000436836:exon3:c.T381G:p.C127W,ENSG00000187456:ENST00000591420:exon3:c.T381G:p.C127W	RDM1:NM_001163122:exon2:c.T312G:p.C104W,RDM1:NM_001163124:exon2:c.T312G:p.C104W,RDM1:NM_001163125:exon2:c.T312G:p.C104W,RDM1:NM_001163130:exon2:c.T312G:p.C104W,RDM1:NM_001034836:exon3:c.T381G:p.C127W,RDM1:NM_001163120:exon3:c.T381G:p.C127W,RDM1:NM_001163121:exon3:c.T381G:p.C127W,RDM1:NM_001330194:exon3:c.T381G:p.C127W,RDM1:NM_145654:exon3:c.T381G:p.C127W	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2029	0.2414	0.273962	1(large_intestine)	1.837	15.21	.	3.86	0.992	.	.	.	RDM1:uc002hkg.4:exon2:c.T312G:p.C104W,RDM1:uc010ctz.3:exon2:c.T312G:p.C104W,RDM1:uc010cua.3:exon2:c.T312G:p.C104W,RDM1:uc010cub.4:exon2:c.T43G:p.F15V,RDM1:uc010wco.2:exon2:c.T312G:p.C104W,RDM1:uc010wcp.2:exon2:c.T312G:p.C104W,RDM1:uc002hkh.3:exon3:c.T381G:p.C127W,RDM1:uc002hki.3:exon3:c.T381G:p.C127W,RDM1:uc010cuc.3:exon3:c.T381G:p.C127W,RDM1:uc010cud.3:exon3:c.T381G:p.C127W	-0.965	AFR:MU150179,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4298,FIN:0.2780,NFE:0.2020,OTH:0.2349,ASJ:0.2305	612896	.	.	.	.	.	.	.	0.0	.	0.000	-2.89	17	1(skin)	0.1416
17	34257069	34257069	T	A	RDM1	intronic	.	ENSG00000187456	rs9913559	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1773	0.1413	0.1875	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.1482,AMR:0.1419,EAS:0.2020,FIN:0.2355,NFE:0.1418,OTH:0.1383,ASJ:0.2566	612896	.	.	.	.	.	.	.	.	.	.	.	17	1(lung)	0.1263
17	36861983	36861983	T	C	MLLT6	exonic	nonsynonymous SNV	ENSG00000108292	rs17855918	ENSG00000108292:ENST00000325718:exon1:c.T98C:p.V33A,ENSG00000108292:ENST00000378137:exon1:c.T98C:p.V33A	MLLT6:NM_005937:exon1:c.T98C:p.V33A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MLLT6:uc002hqi.4:exon1:c.T98C:p.V33A,MLLT6:uc010cvm.1:exon1:c.T98C:p.V33A,MLLT6:uc010wdr.2:exon1:c.T98C:p.V33A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600328	.	.	.	.	.	.	.	.	.	.	.	17	1(thyroid)	1
17	37868715	37868715	C	T	ERBB2	intronic	.	ENSG00000141736	rs4252627	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6058	0.5123	0.444489	3(lung)	.	.	.	.	.	.	.	.	.	.	AFR:20(soft_tissue),AMR:MU584146,EAS:0.5113,FIN:0.2147,NFE:0.5573,OTH:0.6358,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|4|170|0.0235294,COCA-CN|5|321|0.0155763	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	17	1(liver)	0.3486
17	37879588	37879588	A	G	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs1136201	ENSG00000141736:ENST00000445658:exon11:c.A1135G:p.I379V,ENSG00000141736:ENST00000269571:exon17:c.A1963G:p.I655V,ENSG00000141736:ENST00000540147:exon17:c.A1873G:p.I625V,ENSG00000141736:ENST00000541774:exon17:c.A1918G:p.I640V,ENSG00000141736:ENST00000584450:exon17:c.A1963G:p.I655V,ENSG00000141736:ENST00000406381:exon19:c.A1873G:p.I625V,ENSG00000141736:ENST00000584601:exon21:c.A1873G:p.I625V	ERBB2:NM_001289937:exon17:c.A1963G:p.I655V,ERBB2:NM_004448:exon17:c.A1963G:p.I655V,ERBB2:NM_001005862:exon20:c.A1873G:p.I625V,ERBB2:NM_001289936:exon21:c.A1918G:p.I640V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1964	0.1685	0.121406	24(lung)	1.572	13.70	1.0	4.97	0.823	.	.	Growth factor receptor cysteine-rich domain|Growth factor receptor domain 4	ERBB2:uc010wek.2:exon11:c.A1135G:p.I379V,ERBB2:uc002hso.3:exon17:c.A1963G:p.I655V,ERBB2:uc002hsp.3:exon17:c.A1372G:p.I458V,ERBB2:uc010cwb.3:exon17:c.A1963G:p.I655V,ERBB2:uc002hsm.3:exon20:c.A1873G:p.I625V,ERBB2:uc010cwa.3:exon21:c.A1918G:p.I640V	-1.086	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:1(oesophagus),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,ESCA-CN|1|332|0.00301205,AML-US|1|166|0.0060241,FIN:0.1876,NFE:0.0444,OTH:0.1659,ASJ:MU813324	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,4457,4441,4415,4382,4495,4398,4484,4490,4434,4403,4481,4456,4466,4405,4500,4429,4387,4399,4439,4377,4511,4459,4492,4423,4409,4384,4473,4458,4421,4476,4451,4414,4510,4445,4446,4485,4386,4465,4479,4383,4447,4427,4488,4404,4462,4478,4480,4512,4467,4483,4431,4392,4450,4440,4416,4406,4397,4475,4420,4443,4438,4400,4464,4452,4389,4430,4498,4448,4454,4513,4424,4411,4418,4460,4413,4388,4432,4436,4469,4502,4437,4410,4385,4449,4379,4381,4470,4461,4407,4419,4402,4408,4494,4426,4468,4422,4378,4435,4393,4401,4433,4453,4504,4501,4509,4472,4477,4463,4497,4428,4474,4390,4391,4493,4455,4417,4482,4486,4491,4396,4412,4395,4444,4182,4394,4442,4380,4496,4471,4487,4489,4503,4499,4425	.	.	0.406	-1.01	0.000	1.15	17	1(urinary_tract)	0.1467
17	37884037	37884037	C	G	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs1058808	ENSG00000141736:ENST00000445658:exon21:c.C2680G:p.P894A,ENSG00000141736:ENST00000269571:exon27:c.C3508G:p.P1170A,ENSG00000141736:ENST00000540147:exon27:c.C3418G:p.P1140A,ENSG00000141736:ENST00000541774:exon27:c.C3463G:p.P1155A,ENSG00000141736:ENST00000406381:exon29:c.C3418G:p.P1140A,ENSG00000141736:ENST00000584601:exon31:c.C3418G:p.P1140A	ERBB2:NM_004448:exon27:c.C3508G:p.P1170A,ERBB2:NM_001005862:exon30:c.C3418G:p.P1140A,ERBB2:NM_001289936:exon31:c.C3463G:p.P1155A	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.6070	0.5135	0.452077	2(oesophagus)	4.041	23.7	0.03	5.04	0.999	.	.	.	ERBB2:uc010wek.2:exon21:c.C2680G:p.P894A,ERBB2:uc002hso.3:exon27:c.C3508G:p.P1170A,ERBB2:uc002hsp.3:exon27:c.C2917G:p.P973A,ERBB2:uc002hsm.3:exon30:c.C3418G:p.P1140A,ERBB2:uc010cwa.3:exon31:c.C3463G:p.P1155A	-0.881	AFR:MU774596,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|2|332|0.0060241,EAS:0.2211,FIN:0.5589,NFE:0.6358,OTH:0.3504,ASJ:0.5139	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,4457,4441,4415,4382,4495,4398,4484,4490,4434,4403,4481,4456,4466,4405,4500,4429,4387,4399,4439,4377,4511,4459,4492,4423,4409,4384,4473,4458,4421,4476,4451,4414,4510,4445,4446,4485,4386,4465,4479,4383,4447,4427,4488,4404,4462,4478,4480,4512,4467,4483,4431,4392,4450,4440,4416,4406,4397,4475,4420,4443,4438,4400,4464,4452,4389,4430,4498,4448,4454,4513,4424,4411,4418,4460,4413,4388,4432,4436,4469,4502,4437,4410,4385,4449,4379,4381,4470,4461,4407,4419,4402,4408,4494,4426,4468,4422,4378,4435,4393,4401,4433,4453,4504,4501,4509,4472,4477,4463,4497,4428,4474,4390,4391,4493,4455,4417,4482,4486,4491,4396,4412,4395,4444,4394,4442,4380,4496,4471,4487,4489,4503,4499,4425	.	.	0.941	-0.81	0.000	0.695	17	1(biliary_tract)	0.6785
17	38496320	38496320	G	A	RARA	intronic	.	ENSG00000131759	rs2715553	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.595048	0.6302	.	.	.	.	.	.	.	.	.	.	AFR:0.8626,AMR:0.3705,EAS:0.5093,FIN:0.5618,NFE:0.5452,OTH:0.5450,ASJ:0.5563	180240	612376;	520;	520|AML M3<br>AML with t(15;17)(q22;q12);(PML/RARalpha) and variants<br>APML<br>Acute myeloblastic leukemia 3<br>Acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants|Unknown|-|Adult|612376 ~	~ko04659 Th17 cell differentiation~ko04915 Estrogen signaling pathway~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	17	.	het
17	38556770	38556770	T	C	TOP2A	intronic	.	ENSG00000131747	rs471692	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7958	0.8615	0.812899	0.8623	.	.	.	.	.	.	.	.	.	.	AFR:0.9581,AMR:0.6770,EAS:0.7426,FIN:0.8749,NFE:0.8294,OTH:0.8330,ASJ:0.8344	126430	.	.	.	.	.	.	.	.	.	.	.	17	MU19923769	het
17	39912145	39912145	T	A	JUP	exonic	nonsynonymous SNV	ENSG00000173801	rs1126821	ENSG00000173801:ENST00000310706:exon14:c.A2089T:p.M697L,ENSG00000173801:ENST00000393930:exon14:c.A2089T:p.M697L,ENSG00000173801:ENST00000393931:exon14:c.A2089T:p.M697L	JUP:NM_001352773:exon14:c.A2089T:p.M697L,JUP:NM_001352774:exon14:c.A2089T:p.M697L,JUP:NM_001352775:exon14:c.A2089T:p.M697L,JUP:NM_001352777:exon14:c.A2089T:p.M697L,JUP:NM_002230:exon14:c.A2089T:p.M697L,JUP:NM_021991:exon14:c.A2089T:p.M697L,JUP:NM_001352776:exon15:c.A2089T:p.M697L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6592	0.6970	0.58726	LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	1.242	11.97	0.706	1.12	0.998	.	.	.	JUP:uc002hxq.2:exon14:c.A2089T:p.M697L,JUP:uc002hxr.2:exon14:c.A2089T:p.M697L,JUP:uc002hxs.2:exon14:c.A2089T:p.M697L	-0.959	AFR:0.6634,AMR:0.6017,EAS:0.6821,FIN:0.3202,NFE:0.6645,OTH:0.7421,ASJ:0.4880	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	0.0	0.31	0.000	-0.625	17	4(lung)	0.7119
17	39923614	39923614	A	G	JUP	intronic	.	ENSG00000173801	rs12942034	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7638	0.8343	0.744209	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.8105,AMR:0.8903,EAS:0.8033,FIN:0.4975,NFE:0.7995,OTH:0.8146,ASJ:0.5704	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	1(lung)	0.7980
17	39925925	39925925	A	G	JUP	exonic	synonymous SNV	ENSG00000173801	rs7405731	ENSG00000173801:ENST00000540235:exon2:c.T213C:p.D71D,ENSG00000173801:ENST00000310706:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393930:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393931:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000420370:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000437187:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000449889:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000591690:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000424457:exon4:c.T213C:p.D71D,ENSG00000173801:ENST00000437369:exon4:c.T213C:p.D71D	JUP:NM_001352773:exon3:c.T213C:p.D71D,JUP:NM_001352774:exon3:c.T213C:p.D71D,JUP:NM_001352775:exon3:c.T213C:p.D71D,JUP:NM_001352777:exon3:c.T213C:p.D71D,JUP:NM_002230:exon3:c.T213C:p.D71D,JUP:NM_021991:exon3:c.T213C:p.D71D,JUP:NM_001352776:exon4:c.T213C:p.D71D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7364	0.7956	0.715655	1(breast)	.	.	.	.	.	.	.	.	JUP:uc010wfs.2:exon2:c.T213C:p.D71D,JUP:uc002hxq.2:exon3:c.T213C:p.D71D,JUP:uc002hxr.2:exon3:c.T213C:p.D71D,JUP:uc002hxs.2:exon3:c.T213C:p.D71D	.	AFR:MU23590898,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.8828,FIN:0.5632,NFE:0.8278,OTH:0.5056,ASJ:0.7654	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	2(lung)	0.6822
17	40459737	40459737	C	T	STAT5A	exonic	synonymous SNV	ENSG00000126561	rs1135669	ENSG00000126561:ENST00000587646:exon3:c.C366T:p.D122D,ENSG00000126561:ENST00000546010:exon14:c.C1812T:p.D604D,ENSG00000126561:ENST00000588868:exon14:c.C1809T:p.D603D,ENSG00000126561:ENST00000590949:exon15:c.C1902T:p.D634D,ENSG00000126561:ENST00000345506:exon16:c.C1902T:p.D634D,ENSG00000126561:ENST00000452307:exon16:c.C1893T:p.D631D	STAT5A:NM_001288719:exon14:c.C1812T:p.D604D,STAT5A:NM_001288720:exon14:c.C1809T:p.D603D,STAT5A:NM_001288718:exon15:c.C1902T:p.D634D,STAT5A:NM_003152:exon16:c.C1902T:p.D634D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1979	0.1791	0.241014	0.1895	.	.	.	.	.	.	.	.	STAT5A:uc010cyd.1:exon3:c.C366T:p.D122D,STAT5A:uc010cye.1:exon3:c.C366T:p.D122D,STAT5A:uc010cyb.2:exon14:c.C1809T:p.D603D,STAT5A:uc010cyc.2:exon14:c.C1812T:p.D604D,STAT5A:uc010cya.2:exon15:c.C1902T:p.D634D,STAT5A:uc002hzj.2:exon16:c.C1902T:p.D634D	.	AFR:0.2020,AMR:0.1077,EAS:0.3394,FIN:0.1816,NFE:0.1706,OTH:0.2076,ASJ:0.2285	601511	.	.	.	~ko04012 ErbB signaling pathway~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer ~	.	.	.	.	.	.	.	17	MU709305	het
17	40475650	40475650	-	A	STAT3	intronic	.	ENSG00000168610	rs3830585	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2617	0.3545	0.401957	0.3398	.	.	.	.	.	.	.	.	.	.	AFR:0.6827,AMR:0.1504,EAS:0.3482,FIN:0.1925,NFE:0.1918,OTH:0.2439,ASJ:0.2649	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	17	.	het
17	40481529	40481529	G	C	STAT3	intronic	.	ENSG00000168610	rs2293152	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6025	0.6879	0.653754	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6533,AMR:0.8458,EAS:0.5596,FIN:0.5218,NFE:0.5835,OTH:0.5875,ASJ:0.4462	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	17	1(breast)	0.6166
17	40835819	40835819	-	T	CNTNAP1	intronic	.	ENSG00000267765	rs36108420	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5941	0.5652	0.547324	0.5643	.	.	.	.	.	.	.	.	.	.	AFR:0.5075,AMR:0.5144,EAS:0.4491,FIN:0.6350,NFE:0.5958,OTH:0.6160,ASJ:0.4172	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	MU113836025	hom
17	40835922	40835922	A	C	CNTNAP1	exonic	synonymous SNV	ENSG00000108797	rs2271029	ENSG00000108797:ENST00000264638:exon2:c.A151C:p.R51R,ENSG00000108797:ENST00000591662:exon2:c.A151C:p.R51R	CNTNAP1:NM_003632:exon2:c.A151C:p.R51R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5981	0.5985	0.578275	1(large_intestine)	.	.	.	.	.	.	.	.	CNTNAP1:uc002iay.3:exon2:c.A151C:p.R51R	.	AFR:MU78204,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5912,FIN:0.5180,NFE:0.4305,OTH:0.4522,ASJ:0.5899	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	1(liver)	0.6354
17	40842762	40842762	C	A	CNTNAP1	exonic	synonymous SNV	ENSG00000108797	rs1553469	ENSG00000108797:ENST00000264638:exon13:c.C1861A:p.R621R,ENSG00000108797:ENST00000591662:exon13:c.C1861A:p.R621R	CNTNAP1:NM_003632:exon13:c.C1861A:p.R621R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0659	0.0560	0.0395367	0.0562	.	.	.	.	.	.	.	.	CNTNAP1:uc002iay.3:exon13:c.C1861A:p.R621R	.	AFR:0.0280,AMR:0.1313,EAS:0.0006,FIN:0.0726,NFE:0.0694,OTH:0.0662,ASJ:0.0762	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	.	het
17	40843392	40843392	G	T	CNTNAP1	intronic	.	ENSG00000267765	rs874640	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0647	0.0522	0.0363419	0.0527	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.0169,AMR:0.1301,EAS:0.0006,FIN:0.0727,NFE:0.0690,OTH:0.0644,ASJ:0.0762	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	.	het
17	41245333	41245333	-	A	BRCA1	exonic	stopgain	ENSG00000012048	rs397507197	ENSG00000012048:ENST00000309486:exon9:c.1326dupT:p.K443_V444delinsX,ENSG00000012048:ENST00000493795:exon9:c.2073dupT:p.K692_V693delinsX,ENSG00000012048:ENST00000346315:exon10:c.2214dupT:p.K739_V740delinsX,ENSG00000012048:ENST00000354071:exon10:c.2214dupT:p.K739_V740delinsX,ENSG00000012048:ENST00000357654:exon10:c.2214dupT:p.K739_V740delinsX,ENSG00000012048:ENST00000471181:exon10:c.2214dupT:p.K739_V740delinsX	BRCA1:NM_007297:exon9:c.2073dupT:p.K692_V693delinsX,BRCA1:NM_007294:exon10:c.2214dupT:p.K739_V740delinsX,BRCA1:NM_007300:exon10:c.2214dupT:p.K739_V740delinsX	clinvar: Pathogenic 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 1, 1, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.1326dupT:p.K443_V444delinsX,BRCA1:uc002ide.1:exon4:c.1707dupT:p.K570_V571delinsX,BRCA1:uc002idd.3:exon9:c.2214dupT:p.K739_V740delinsX,BRCA1:uc010cyx.3:exon9:c.2073dupT:p.K692_V693delinsX,BRCA1:uc010cza.2:exon9:c.2136dupT:p.K713_V714delinsX,BRCA1:uc002icp.4:exon10:c.2001dupT:p.K668_V669delinsX,BRCA1:uc002icq.3:exon10:c.2214dupT:p.K739_V740delinsX,BRCA1:uc002ict.3:exon10:c.2214dupT:p.K739_V740delinsX,BRCA1:uc010cyy.1:exon10:c.2214dupT:p.K739_V740delinsX,BRCA1:uc010whs.1:exon10:c.2214dupT:p.K739_V740delinsX,BRCA1:uc010cyz.2:exon11:c.2073dupT:p.K692_V693delinsX	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1782,1794,1785,1793,1781,1772,1789,1783,1784,1788,1778,1777,1786,1780,1798,1792,1799,1790,1787,1776,1773,1796,1779,1795,1791,1797	.	,1774,1775	.	.	.	.	17	.	het
17	43342141	43342141	G	C	MAP3K14	exonic	unknown	ENSG00000006062	rs1047833	.	UNKNOWN	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7173	0.7471	0.718251	0.7495	.	.	.	.	.	.	.	.	MAP3K14:uc002iiu.1:exon8:c.C1296G:p.V432V,MAP3K14:uc002iiv.1:exon15:c.C1458G:p.V486V,MAP3K14:uc002iiw.1:exon17:c.C2703G:p.V901V	.	AFR:0.7872,AMR:0.7560,EAS:0.7321,FIN:0.7081,NFE:0.7416,OTH:0.7224,ASJ:0.6987	604655	.	.	.	.	.	.	.	.	.	.	.	17	MU14991608	hom
17	45368337	45368337	A	C	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs15908	ENSG00000259207:ENST00000435993:exon9:c.A1002C:p.V334V,ENSG00000259207:ENST00000559488:exon9:c.A1143C:p.V381V,ENSG00000259207:ENST00000571680:exon9:c.A1143C:p.V381V	ITGB3:NM_000212:exon9:c.A1143C:p.V381V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3902	0.3851	0.43111	0.3933	.	.	.	.	.	.	.	.	ITGB3:uc002ili.1:exon9:c.A1143C:p.V381V,ITGB3:uc002ilj.3:exon9:c.A1143C:p.V381V	.	AFR:0.4354,AMR:0.3222,EAS:0.6072,FIN:0.3199,NFE:0.3673,OTH:0.3834,ASJ:0.4033	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU13755074	het
17	45369777	45369777	A	G	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs4642	ENSG00000259207:ENST00000435993:exon10:c.A1392G:p.E464E,ENSG00000259207:ENST00000559488:exon10:c.A1533G:p.E511E	ITGB3:NM_000212:exon10:c.A1533G:p.E511E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2871	0.2839	0.28734	0.2891	.	.	.	.	.	.	.	.	ITGB3:uc002ilj.3:exon10:c.A1533G:p.E511E	.	AFR:0.2635,AMR:0.2566,EAS:0.3493,FIN:0.2818,NFE:0.3007,OTH:0.3027,ASJ:0.2649	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU775201	het
17	45369789	45369789	G	A	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs4634	ENSG00000259207:ENST00000435993:exon10:c.G1404A:p.R468R,ENSG00000259207:ENST00000559488:exon10:c.G1545A:p.R515R	ITGB3:NM_000212:exon10:c.G1545A:p.R515R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2873	0.2839	0.28734	0.2890	.	.	.	.	.	.	.	.	ITGB3:uc002ilj.3:exon10:c.G1545A:p.R515R	.	AFR:0.2638,AMR:0.2560,EAS:0.3502,FIN:0.2815,NFE:0.3001,OTH:0.3041,ASJ:0.2649	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU775204	het
17	45385012	45385012	C	T	THCAT158	ncRNA_intronic	.	ENSG00000263293	rs3809863	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4383	0.4790	0.398962	0.4653	.	.	.	.	.	.	.	.	.	.	AFR:0.4784,AMR:0.3508,EAS:0.2419,FIN:0.4986,NFE:0.4800,OTH:0.4817,ASJ:0.4305	.	.	.	.	.	.	.	.	.	.	.	.	17	MU27804922	het
17	48263021	48263021	C	T	COL1A1	intronic	.	ENSG00000108821	rs2249492	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5828	0.5103	0.485024	0.5145	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.2833,AMR:0.6835,EAS:0.5075,FIN:0.6341,NFE:0.6035,OTH:0.5969,ASJ:0.6722	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU797249	het
17	48265495	48265495	T	C	COL1A1	exonic	nonsynonymous SNV	ENSG00000108821	rs1800215	ENSG00000108821:ENST00000225964:exon44:c.A3223G:p.T1075A	COL1A1:NM_000088:exon44:c.A3223G:p.T1075A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9848	0.9710	0.978834	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon44:c.A3223G:p.T1075A	.	AFR:0.9727,AMR:0.9433,EAS:0.9967,FIN:1,NFE:0.9794,OTH:0.9834,ASJ:0.9869	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.9836
17	48267291	48267291	G	C	COL1A1	intronic	.	ENSG00000108821	rs2075559	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5261	0.5249	0.541334	0.5101	.	.	.	.	.	.	.	.	.	.	AFR:0.5630,AMR:0.6492,EAS:0.5143,FIN:0.4616,NFE:0.4831,OTH:0.4969,ASJ:0.51	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU699787	het
17	48268223	48268223	A	G	COL1A1	exonic	synonymous SNV	ENSG00000108821	rs2734272	ENSG00000108821:ENST00000225964:exon33:c.T2298C:p.T766T	COL1A1:NM_000088:exon33:c.T2298C:p.T766T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9998	0.9998	0.9998	0.9996	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon33:c.T2298C:p.T766T	.	AFR:0.9991,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU4564816	hom
17	48276971	48276971	G	C	COL1A1	intronic	.	ENSG00000108821	rs2256835	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6187	0.5531	0.518171	0.5630	.	.	.	.	.	.	.	.	.	.	AFR:0.2800,AMR:0.6160,EAS:0.6118,FIN:0.7435,NFE:0.6685,OTH:0.6794,ASJ:0.6225	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU762212	het
17	57065401	57065401	G	A	TRIM37	intronic	.	ENSG00000108395	rs7214892	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.60024	0.6428	.	.	.	.	.	.	.	.	.	.	AFR:0.7150,AMR:0.4330,EAS:0.4981,FIN:0.6466,NFE:0.6300,OTH:0.6202,ASJ:0.5695	605073	253250;	2576;	2576|MULIBREY dwarfism<br>Muscle-liver-brain-eye nanism<br>Perheentupa syndrome<br>Pericardial constriction-growth failure syndrome|Unknown|Autosomal recessive|Infancy<br>Neonata253250 ~	.	.	.	.	.	.	.	.	17	MU14145121	het
17	59760996	59760996	A	G	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986763	ENSG00000136492:ENST00000259008:exon20:c.T3411C:p.Y1137Y	BRIP1:NM_032043:exon20:c.T3411C:p.Y1137Y	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5941	0.6060	0.620807	0.5824	.	.	.	.	.	.	.	.	BRIP1:uc002izk.2:exon20:c.T3411C:p.Y1137Y	.	AFR:0.6486,AMR:0.7584,EAS:0.7076,FIN:0.4205,NFE:0.5619,OTH:0.5133,ASJ:0.6291	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU67347164	het
17	59763347	59763347	A	G	BRIP1	exonic	nonsynonymous SNV	ENSG00000136492	rs4986764	ENSG00000136492:ENST00000577598:exon18:c.T2755C:p.S919P,ENSG00000136492:ENST00000259008:exon19:c.T2755C:p.S919P	BRIP1:NM_032043:exon19:c.T2755C:p.S919P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5972	0.6134	0.627796	LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916	-0.521	0.195	0.154	0.71	0.000	.	.	.	BRIP1:uc002izl.1:exon8:c.T898C:p.S300P,BRIP1:uc002izk.2:exon19:c.T2755C:p.S919P	-0.937	AFR:0.5893,AMR:0.6691,EAS:0.6490,FIN:0.7063,NFE:0.4212,OTH:0.5632,ASJ:0.7655	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.0	-0.86	0.000	.	17	1(stomach)	0.5173
17	59763465	59763465	T	C	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986765	ENSG00000136492:ENST00000577598:exon18:c.A2637G:p.E879E,ENSG00000136492:ENST00000259008:exon19:c.A2637G:p.E879E	BRIP1:NM_032043:exon19:c.A2637G:p.E879E	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7188	0.7343	0.815096	0.7178	.	.	.	.	.	.	.	.	BRIP1:uc002izl.1:exon8:c.A780G:p.E260E,BRIP1:uc002izk.2:exon19:c.A2637G:p.E879E	.	AFR:0.9073,AMR:0.8473,EAS:0.8812,FIN:0.5120,NFE:0.6355,OTH:0.6307,ASJ:0.7483	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU13758307	hom
17	59856129	59856129	G	A	BRIP1	intronic	.	ENSG00000136492	rs4968449	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.989816	0.9893	.	.	.	.	.	.	.	.	.	.	AFR:0.9623,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	.	hom
17	60043884	60043884	G	A	MED13	exonic	synonymous SNV	ENSG00000108510	rs671347	ENSG00000108510:ENST00000397786:exon19:c.C4320T:p.D1440D	MED13:NM_005121:exon19:c.C4320T:p.D1440D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9983	0.9931	0.996206	0.9943	.	.	.	.	.	.	.	.	MED13:uc002izo.3:exon19:c.C4320T:p.D1440D	.	AFR:0.9796,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603808	.	.	.	.	.	.	.	.	.	.	.	17	MU81997073	hom
17	62007498	62007498	A	G	CD79B	exonic	synonymous SNV	ENSG00000007312	rs2070776	ENSG00000007312:ENST00000006750:exon3:c.T366C:p.C122C,ENSG00000007312:ENST00000392795:exon3:c.T369C:p.C123C	CD79B:NM_000626:exon3:c.T366C:p.C122C,CD79B:NM_001039933:exon3:c.T369C:p.C123C	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5952	0.6596	0.561701	1(lung)	.	.	.	.	.	.	.	.	CD79B:uc002jdp.1:exon3:c.T369C:p.C123C,CD79B:uc002jdq.1:exon3:c.T366C:p.C122C	.	AFR:20(soft_tissue),AMR:MU584252,EAS:0.6411,FIN:0.6678,NFE:0.5203,OTH:0.6656,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	147245	612692;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	.	,1939	.	.	.	.	.	.	17	1(breast)	0.4424
17	63052715	63052717	GCC	-	GNA13	UTR5	.	ENSG00000120063	rs200801511	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0670	0.0734	0.0537141	0.0607	.	.	.	.	.	.	.	.	.	.	AFR:0.0291,AMR:0.0399,EAS:0.0292,FIN:0.0874,NFE:0.0747,OTH:0.0970,ASJ:0.1115	604406	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04270 Vascular smooth muscle contraction~ko04371 Apelin signaling pathway~ko04611 Platelet activation~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04928 Parathyroid hormone synthesis, secretion and action~ko05130 Pathogenic Escherichia coli infection~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	17	.	het
17	63532517	63532517	G	A	AXIN2	exonic	synonymous SNV	ENSG00000168646	rs35415678	ENSG00000168646:ENST00000375702:exon6:c.C1867T:p.L623L,ENSG00000168646:ENST00000307078:exon8:c.C2062T:p.L688L	AXIN2:NM_001363813:exon7:c.C1867T:p.L623L,AXIN2:NM_004655:exon8:c.C2062T:p.L688L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0905	0.0967	0.164337	0.1088	.	.	.	.	.	.	.	.	AXIN2:uc002jfh.3:exon6:c.C1867T:p.L623L,AXIN2:uc002jfi.3:exon8:c.C2062T:p.L688L	.	AFR:0.2120,AMR:0.1527,EAS:0.2580,FIN:0.0722,NFE:0.0445,OTH:0.0509,ASJ:0.0232	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU4565081	het
17	63533423	63533423	C	A	AXIN2	intronic	.	ENSG00000168646	rs7219582	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1219	0.1575	0.174121	0.1442	.	.	.	.	.	.	.	.	.	.	AFR:0.2440,AMR:0.0895,EAS:0.1131,FIN:0.0705,NFE:0.1124,OTH:0.1049,ASJ:0.1457	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU81997778	het
17	63533789	63533789	T	C	AXIN2	exonic	synonymous SNV	ENSG00000168646	rs9915936	ENSG00000168646:ENST00000375702:exon5:c.A1365G:p.P455P,ENSG00000168646:ENST00000307078:exon6:c.A1365G:p.P455P	AXIN2:NM_001363813:exon6:c.A1365G:p.P455P,AXIN2:NM_004655:exon6:c.A1365G:p.P455P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9144	0.9109	0.909744	0.8961	.	.	.	.	.	.	.	.	AXIN2:uc002jfh.3:exon5:c.A1365G:p.P455P,AXIN2:uc002jfi.3:exon6:c.A1365G:p.P455P	.	AFR:0.9306,AMR:0.8971,EAS:0.8079,FIN:0.9022,NFE:0.8823,OTH:0.9061,ASJ:0.9536	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU94566	hom
17	63534478	63534478	G	A	AXIN2	intronic	.	ENSG00000168646;ENSG00000266076	rs35399989	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1188	0.1476	0.164137	0.1381	.	.	.	.	.	.	.	.	.	.	AFR:0.2218,AMR:0.0861,EAS:0.1141,FIN:0.0699,NFE:0.1130,OTH:0.1033,ASJ:0.1457	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU81997791	het
17	63545622	63545622	T	C	AXIN2	intronic	.	ENSG00000168646;ENSG00000266076	rs35285779	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0851	0.0695	0.146965	0.0835	.	.	.	.	.	.	.	.	.	.	AFR:0.1218,AMR:0.1480,EAS:0.2602,FIN:0.0731,NFE:0.0443,OTH:0.0521,ASJ:0.0199	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU14234234	het
17	63554307	63554307	A	G	AXIN2	exonic	synonymous SNV	ENSG00000168646	rs2240307	ENSG00000168646:ENST00000375702:exon1:c.T432C:p.I144I,ENSG00000168646:ENST00000307078:exon2:c.T432C:p.I144I,ENSG00000168646:ENST00000544103:exon2:c.T432C:p.I144I,ENSG00000168646:ENST00000577278:exon2:c.T432C:p.I144I,ENSG00000168646:ENST00000580513:exon2:c.T432C:p.I144I,ENSG00000168646:ENST00000585045:exon2:c.T432C:p.I144I	AXIN2:NM_001363813:exon2:c.T432C:p.I144I,AXIN2:NM_004655:exon2:c.T432C:p.I144I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0400	0.0284	0.0786741	0.0398	.	.	.	.	.	.	.	.	AXIN2:uc002jfh.3:exon1:c.T432C:p.I144I,AXIN2:uc002jfi.3:exon2:c.T432C:p.I144I,AXIN2:uc002jfj.1:exon2:c.T432C:p.I144I,AXIN2:uc010den.1:exon4:c.T432C:p.I144I	.	AFR:0.0727,AMR:0.1086,EAS:0.1617,FIN:0.0324,NFE:0.0075,OTH:0.0183,ASJ:0.0099	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU80659206	het
17	66519857	66519857	-	T	PRKAR1A	intronic	.	ENSG00000108946	rs3841514	ENSG00000108946:ENST00000585608:exon4:c.352dupT:p.F117fs	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2224	0.2268	0.22524	0.2330	.	.	.	.	.	.	.	.	.	.	AFR:0.2381,AMR:0.1850,EAS:0.1321,FIN:0.2615,NFE:0.2362,OTH:0.2561,ASJ:0.2020	188830	101800;160980;255960;610489;	189439;615;1359;280651;950;	189439|PPNAD|<1 / 1 000 000|Autosomal dominant|All ages|610475 610489 614190 615830 ~615|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|255960 ~1359|Carney syndrome<br>Myxoma-spotty pigmentation-endocrine overactivity syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|160980 605244 ~280651|-|<1 / 1 000 000|Autosomal dominant|Childhood|101800 614613 ~950|Acrodysplasia<br>Arkless-Graham syndrome<br>Maroteaux-Malamut syndrome|Unknown|Autosomal dominant|Neonatal<br>Antenatal|101800 614613 ~	.	.	.	.	.	.	.	.	17	.	het
17	66547249	66547249	G	A	PRKAR1A	exonic	nonsynonymous SNV	ENSG00000108946	rs9789047	ENSG00000108946:ENST00000588188:exon10:c.G998A:p.S333N	PRKAR1A:NM_001276290:exon10:c.G998A:p.S333N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1521	.	0.147963	0.1683	-0.988	0.017	.	-1.66	0.011	.	.	Cyclic nucleotide-binding domain|Cyclic nucleotide-binding, conserved site|Cyclic nucleotide-binding-like|RmlC-like jelly roll fold	PRKAR1A:uc031ref.1:exon10:c.G998A:p.S333N	.	AFR:0.1375,AMR:0.1205,EAS:0.0900,FIN:0.2421,NFE:0.1787,OTH:0.1902,ASJ:0.17	188830	101800;160980;255960;610489;	189439;615;1359;280651;950;	189439|PPNAD|<1 / 1 000 000|Autosomal dominant|All ages|610475 610489 614190 615830 ~615|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|255960 ~1359|Carney syndrome<br>Myxoma-spotty pigmentation-endocrine overactivity syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|160980 605244 ~280651|-|<1 / 1 000 000|Autosomal dominant|Childhood|101800 614613 ~950|Acrodysplasia<br>Arkless-Graham syndrome<br>Maroteaux-Malamut syndrome|Unknown|Autosomal dominant|Neonatal<br>Antenatal|101800 614613 ~	.	.	.	.	.	-2.62	.	.	17	MU4556449	het
17	72859078	72859078	A	G	FDXR	intronic	.	ENSG00000161513	rs690371	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2694	0.2636	0.297724	MU648000	.	.	.	.	.	0.0011	0.01	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.2584,EAS:0.1766,FIN:0.3775,NFE:0.5185,OTH:0.2410,ASJ:0.2630	103270	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.2351
17	72860253	72860253	A	G	FDXR	intronic	.	ENSG00000161513	rs552432	ENSG00000161513:ENST00000455107:exon10:c.T887C:p.L296P	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2657	0.2620	0.286941	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:1(large_intestine),AMR:MU796872,EAS:0.2554,FIN:0.2564,NFE:0.1758,OTH:0.3733,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	103270	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.5161
17	72860653	72860653	G	A	FDXR	exonic	nonsynonymous SNV	ENSG00000161513	rs34038065	ENSG00000161513:ENST00000420580:exon7:c.C631T:p.R211W,ENSG00000161513:ENST00000544854:exon7:c.C595T:p.R199W,ENSG00000161513:ENST00000293195:exon8:c.C751T:p.R251W,ENSG00000161513:ENST00000442102:exon8:c.C880T:p.R294W,ENSG00000161513:ENST00000581530:exon8:c.C769T:p.R257W,ENSG00000161513:ENST00000582944:exon8:c.C727T:p.R243W,ENSG00000161513:ENST00000413947:exon9:c.C844T:p.R282W,ENSG00000161513:ENST00000455107:exon9:c.C619T:p.R207W	FDXR:NM_001258015:exon7:c.C631T:p.R211W,FDXR:NM_001258016:exon7:c.C595T:p.R199W,FDXR:NM_001258012:exon8:c.C880T:p.R294W,FDXR:NM_001258014:exon8:c.C727T:p.R243W,FDXR:NM_004110:exon8:c.C769T:p.R257W,FDXR:NM_024417:exon8:c.C751T:p.R251W,FDXR:NM_001258013:exon9:c.C844T:p.R282W	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0170	0.0164	0.0425319	0.0180	4.922	25.0	0.02	3.68	0.997	.	.	FAD/NAD(P)-binding domain	FDXR:uc010wri.2:exon7:c.C595T:p.R199W,FDXR:uc010wrm.2:exon7:c.C631T:p.R211W,FDXR:uc002jlx.3:exon8:c.C769T:p.R257W,FDXR:uc002jly.3:exon8:c.C751T:p.R251W,FDXR:uc002jlz.3:exon8:c.C727T:p.R243W,FDXR:uc010wrj.3:exon8:c.C745T:p.R249W,FDXR:uc010wrl.2:exon8:c.C880T:p.R294W,FDXR:uc010wrk.2:exon9:c.C844T:p.R282W	-1.139	AFR:0.0409,AMR:0.0048,EAS:0.1028,FIN:0,NFE:0.0011,OTH:0.0102,ASJ:0.0132	103270	.	.	.	.	.	.	.	0.076	2.3	0.002	2.82	17	MU82327434	unknown
17	72860654	72860654	G	A	FDXR	exonic	synonymous SNV	ENSG00000161513	rs2070921	ENSG00000161513:ENST00000420580:exon7:c.C630T:p.A210A,ENSG00000161513:ENST00000544854:exon7:c.C594T:p.A198A,ENSG00000161513:ENST00000293195:exon8:c.C750T:p.A250A,ENSG00000161513:ENST00000442102:exon8:c.C879T:p.A293A,ENSG00000161513:ENST00000581530:exon8:c.C768T:p.A256A,ENSG00000161513:ENST00000582944:exon8:c.C726T:p.A242A,ENSG00000161513:ENST00000413947:exon9:c.C843T:p.A281A,ENSG00000161513:ENST00000455107:exon9:c.C618T:p.A206A	FDXR:NM_001258015:exon7:c.C630T:p.A210A,FDXR:NM_001258016:exon7:c.C594T:p.A198A,FDXR:NM_001258012:exon8:c.C879T:p.A293A,FDXR:NM_001258014:exon8:c.C726T:p.A242A,FDXR:NM_004110:exon8:c.C768T:p.A256A,FDXR:NM_024417:exon8:c.C750T:p.A250A,FDXR:NM_001258013:exon9:c.C843T:p.A281A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0336	0.0072	0.0553115	0.0160	.	.	.	.	.	.	.	.	FDXR:uc010wri.2:exon7:c.C594T:p.A198A,FDXR:uc010wrm.2:exon7:c.C630T:p.A210A,FDXR:uc002jlx.3:exon8:c.C768T:p.A256A,FDXR:uc002jly.3:exon8:c.C750T:p.A250A,FDXR:uc002jlz.3:exon8:c.C726T:p.A242A,FDXR:uc010wrj.3:exon8:c.C744T:p.A248A,FDXR:uc010wrl.2:exon8:c.C879T:p.A293A,FDXR:uc010wrk.2:exon9:c.C843T:p.A281A	.	AFR:0.0020,AMR:0.0825,EAS:0.1300,FIN:0.0011,NFE:0.0118,OTH:0.0134,ASJ:0.0132	103270	.	.	.	.	.	.	.	.	.	.	.	17	MU21491471	unknown
17	72861829	72861829	C	A	FDXR	intronic	.	ENSG00000161513	rs35893883	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0319	0.0389	0.0547125	0.0361	.	.	.	.	.	.	.	.	.	.	AFR:0.1119,AMR:0.0072,EAS:0.0660,FIN:0,NFE:0.0009,OTH:0.0112,ASJ:0.0132	103270	.	.	.	.	.	.	.	.	.	.	.	17	MU82327435	het
17	73625430	73625430	G	A	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs4788902	ENSG00000108469:ENST00000582548:exon1:c.C93T:p.H31H,ENSG00000108469:ENST00000580707:exon9:c.C540T:p.H180H,ENSG00000108469:ENST00000317905:exon16:c.C2073T:p.H691H,ENSG00000108469:ENST00000423245:exon16:c.C1992T:p.H664H	RECQL5:NM_004259:exon16:c.C2073T:p.H691H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6127	0.4752	0.525958	0.5025	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.C1992T:p.H664H,RECQL5:uc010dgl.3:exon16:c.C2073T:p.H691H	.	AFR:0.2075,AMR:0.6507,EAS:0.8189,FIN:0.6151,NFE:0.6010,OTH:0.5789,ASJ:0.4834	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU75672	hom
17	73625478	73625478	T	C	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820191	ENSG00000108469:ENST00000582548:exon1:c.A45G:p.T15T,ENSG00000108469:ENST00000580707:exon9:c.A492G:p.T164T,ENSG00000108469:ENST00000317905:exon16:c.A2025G:p.T675T,ENSG00000108469:ENST00000423245:exon16:c.A1944G:p.T648T	RECQL5:NM_004259:exon16:c.A2025G:p.T675T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.989217	0.9894	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.A1944G:p.T648T,RECQL5:uc010dgl.3:exon16:c.A2025G:p.T675T	.	AFR:0.9629,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565309	hom
17	73626922	73626922	-	T	RECQL5	intronic	.	ENSG00000108469	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4182	.	0.539936	0.5894	.	.	.	.	.	.	.	.	.	.	AFR:0.5300,AMR:0.5507,EAS:0.5989,FIN:0.6203,NFE:0.6076,OTH:0.5986,ASJ:0.5488	603781	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	73626923	73626923	-	T	RECQL5	intronic	.	ENSG00000108469	rs55982817	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1247	.	0.539936	0.4526	.	.	.	.	.	.	.	.	.	.	AFR:0.2492,AMR:0.4331,EAS:0.5013,FIN:0.5298,NFE:0.5315,OTH:0.4974,ASJ:0.3761	603781	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	73627539	73627539	T	C	RECQL5	exonic	nonsynonymous SNV	ENSG00000108469	rs820196	ENSG00000108469:ENST00000578201:exon8:c.A1439G:p.D480G,ENSG00000108469:ENST00000317905:exon9:c.A1439G:p.D480G,ENSG00000108469:ENST00000423245:exon9:c.A1358G:p.D453G	RECQL5:NM_004259:exon9:c.A1439G:p.D480G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2536	0.2013	0.265775	0.2116	1.615	13.94	1.0	5.97	0.933	.	.	Winged helix-turn-helix DNA-binding domain	RECQL5:uc010dgk.3:exon8:c.A1358G:p.D453G,RECQL5:uc010dgl.3:exon9:c.A1439G:p.D480G	-1.019	AFR:0.1812,AMR:0.3317,EAS:0.2642,FIN:0.2039,NFE:0.2175,OTH:0.2219,ASJ:0.2384	603781	.	.	.	.	.	.	.	0.0	0.24	0.000	-0.975	17	MU25518356	het
17	73627565	73627565	A	G	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820197	ENSG00000108469:ENST00000578201:exon8:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000317905:exon9:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000423245:exon9:c.T1332C:p.Y444Y	RECQL5:NM_004259:exon9:c.T1413C:p.Y471Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.988618	0.9890	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon8:c.T1332C:p.Y444Y,RECQL5:uc010dgl.3:exon9:c.T1413C:p.Y471Y	.	AFR:0.9615,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565311	hom
17	74475024	74475024	G	A	RHBDF2	exonic	nonsynonymous SNV	ENSG00000129667	rs3744045	ENSG00000129667:ENST00000313080:exon6:c.C623T:p.P208L,ENSG00000129667:ENST00000389760:exon6:c.C536T:p.P179L,ENSG00000129667:ENST00000591885:exon6:c.C536T:p.P179L	RHBDF2:NM_001005498:exon5:c.C536T:p.P179L,RHBDF2:NM_024599:exon6:c.C623T:p.P208L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8787	0.7952	0.765176	0.8090	2.245	17.80	0.078	4.57	0.047	.	.	.	RHBDF2:uc002jrr.1:exon3:c.C179T:p.P60L,RHBDF2:uc002jrs.1:exon3:c.C608T:p.P203L,RHBDF2:uc010wtf.1:exon5:c.C536T:p.P179L,RHBDF2:uc021udh.1:exon5:c.C536T:p.P179L,RHBDF2:uc002jrq.2:exon6:c.C623T:p.P208L	-1.042	AFR:0.5027,AMR:0.8804,EAS:0.9523,FIN:0.9178,NFE:0.9344,OTH:0.8891,ASJ:0.9272	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	0.247	-0.18	0.000	1.81	17	MU4552271	hom
17	74732507	74732507	A	G	SRSF2	exonic	synonymous SNV	ENSG00000161547	rs237058	ENSG00000161547:ENST00000358156:exon2:c.T381C:p.S127S,ENSG00000161547:ENST00000359995:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000392485:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000452355:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000508921:exon2:c.T366C:p.S122S,ENSG00000161547:ENST00000583836:exon2:c.T345C:p.S115S,ENSG00000161547:ENST00000585202:exon2:c.T402C:p.S134S	SRSF2:NM_001195427:exon2:c.T402C:p.S134S,SRSF2:NM_003016:exon2:c.T402C:p.S134S	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9973	0.9911	0.990615	0.9916	.	.	.	.	.	.	.	.	SRSF2:uc002jsv.3:exon2:c.T402C:p.S134S,SRSF2:uc002jsy.4:exon2:c.T402C:p.S134S,SRSF2:uc010wtg.2:exon2:c.T366C:p.S122S	.	AFR:0.9703,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600813	.	.	.	.	,9882,9888,9889,9887,9886	.	9883,,9885,9884	.	.	.	.	17	MU4554584	hom
17	74733099	74733099	G	A	SRSF2	exonic	synonymous SNV	ENSG00000161547	rs237057	ENSG00000161547:ENST00000358156:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000359995:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000392485:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000452355:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000508921:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000583836:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000585202:exon1:c.C144T:p.D48D	SRSF2:NM_001195427:exon1:c.C144T:p.D48D,SRSF2:NM_003016:exon1:c.C144T:p.D48D	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8886	0.7970	0.785543	0.8039	.	.	.	.	.	.	.	.	SRSF2:uc002jsv.3:exon1:c.C144T:p.D48D,SRSF2:uc002jsy.4:exon1:c.C144T:p.D48D,SRSF2:uc010wtg.2:exon1:c.C144T:p.D48D	.	AFR:0.4961,AMR:0.9033,EAS:0.9210,FIN:0.8920,NFE:0.9347,OTH:0.8901,ASJ:0.9669	600813	.	.	.	.	,9882,9888,9889,9887,9886	.	9883,,9885,9884	.	.	.	.	17	MU82000212	hom
17	75303298	75303298	T	C	SEPTIN9	intronic	.	ENSG00000184640	rs4789439	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8853	0.8623	0.91873	0.8897	.	.	.	.	.	.	.	.	.	.	AFR:0.9079,AMR:0.9129,EAS:0.9889,FIN:0.9123,NFE:0.8646,OTH:0.8837,ASJ:0.7682	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU82000309	hom
17	75483528	75483528	C	T	SEPTIN9	exonic	synonymous SNV	ENSG00000184640	rs3765043	ENSG00000184640:ENST00000589920:exon2:c.C183T:p.S61S,ENSG00000184640:ENST00000427180:exon3:c.C600T:p.S200S,ENSG00000184640:ENST00000541152:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000585638:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000585929:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000585930:exon3:c.C264T:p.S88S,ENSG00000184640:ENST00000586433:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000586521:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000588958:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000590938:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000591020:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000591088:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000591472:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000591704:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000592951:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000593189:exon3:c.C183T:p.S61S,ENSG00000184640:ENST00000329047:exon4:c.C882T:p.S294S,ENSG00000184640:ENST00000423034:exon4:c.C915T:p.S305S,ENSG00000184640:ENST00000427674:exon4:c.C444T:p.S148S,ENSG00000184640:ENST00000586128:exon4:c.C183T:p.S61S,ENSG00000184640:ENST00000588690:exon4:c.C444T:p.S148S,ENSG00000184640:ENST00000590059:exon4:c.C387T:p.S129S,ENSG00000184640:ENST00000590294:exon4:c.C882T:p.S294S,ENSG00000184640:ENST00000591198:exon4:c.C879T:p.S293S,ENSG00000184640:ENST00000427177:exon5:c.C936T:p.S312S,ENSG00000184640:ENST00000431235:exon5:c.C444T:p.S148S,ENSG00000184640:ENST00000449803:exon5:c.C444T:p.S148S	SEPTIN9:NM_001113495:exon3:c.C600T:p.S200S,SEPTIN9:NM_001113496:exon3:c.C183T:p.S61S,SEPTIN9:NM_001293696:exon3:c.C264T:p.S88S,SEPTIN9:NM_001293697:exon3:c.C183T:p.S61S,SEPTIN9:NM_001293698:exon3:c.C183T:p.S61S,SEPTIN9:NM_001113493:exon4:c.C915T:p.S305S,SEPTIN9:NM_001113494:exon4:c.C444T:p.S148S,SEPTIN9:NM_001293695:exon4:c.C879T:p.S293S,SEPTIN9:NM_006640:exon4:c.C882T:p.S294S,SEPTIN9:NM_001113491:exon5:c.C936T:p.S312S,SEPTIN9:NM_001113492:exon5:c.C444T:p.S148S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0160	0.0064	0.0211661	0.0141	.	.	.	.	.	.	.	.	SEPT9:uc002jty.4:exon3:c.C183T:p.S61S,SEPT9:uc010dhd.3:exon3:c.C600T:p.S200S,SEPT9:uc010wtl.2:exon3:c.C264T:p.S88S,SEPT9:uc010wtm.2:exon3:c.C183T:p.S61S,SEPT9:uc010wtn.2:exon3:c.C183T:p.S61S,SEPT9:uc002jtu.4:exon4:c.C882T:p.S294S,SEPT9:uc002jtv.3:exon4:c.C915T:p.S305S,SEPT9:uc002jtw.3:exon4:c.C444T:p.S148S,SEPT9:uc010wtk.2:exon4:c.C879T:p.S293S,SEPT9:uc002jts.4:exon5:c.C936T:p.S312S,SEPT9:uc002jtt.4:exon5:c.C444T:p.S148S	.	AFR:0.0249,AMR:0.0012,EAS:0.0760,FIN:0.0132,NFE:0.0023,OTH:0.0143,ASJ:0	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU24193929	het
17	75494705	75494705	A	G	SEPTIN9	exonic	nonsynonymous SNV	ENSG00000184640	rs2627223	ENSG00000184640:ENST00000427180:exon10:c.A1390G:p.M464V,ENSG00000184640:ENST00000541152:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000585930:exon10:c.A1054G:p.M352V,ENSG00000184640:ENST00000591088:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000592951:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000329047:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000423034:exon11:c.A1705G:p.M569V,ENSG00000184640:ENST00000427674:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000588690:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000590294:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000591198:exon11:c.A1669G:p.M557V,ENSG00000184640:ENST00000427177:exon12:c.A1726G:p.M576V,ENSG00000184640:ENST00000431235:exon12:c.A1234G:p.M412V,ENSG00000184640:ENST00000449803:exon12:c.A1234G:p.M412V	SEPTIN9:NM_001113495:exon10:c.A1390G:p.M464V,SEPTIN9:NM_001113496:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293696:exon10:c.A1054G:p.M352V,SEPTIN9:NM_001293697:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293698:exon10:c.A973G:p.M325V,SEPTIN9:NM_001113493:exon11:c.A1705G:p.M569V,SEPTIN9:NM_001113494:exon11:c.A1234G:p.M412V,SEPTIN9:NM_001293695:exon11:c.A1669G:p.M557V,SEPTIN9:NM_006640:exon11:c.A1672G:p.M558V,SEPTIN9:NM_001113491:exon12:c.A1726G:p.M576V,SEPTIN9:NM_001113492:exon12:c.A1234G:p.M412V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9371	0.8923	0.90655	0.8893	-0.847	0.034	1.0	2.77	0.063	.	.	P-loop containing nucleoside triphosphate hydrolase|Septin-type guanine nucleotide-binding (G) domain;Septin-type guanine nucleotide-binding (G) domain	SEPT9:uc002jty.4:exon10:c.A973G:p.M325V,SEPT9:uc010dhd.3:exon10:c.A1390G:p.M464V,SEPT9:uc010wtl.2:exon10:c.A1054G:p.M352V,SEPT9:uc010wtm.2:exon10:c.A973G:p.M325V,SEPT9:uc010wtn.2:exon10:c.A973G:p.M325V,SEPT9:uc002jtu.4:exon11:c.A1672G:p.M558V,SEPT9:uc002jtv.3:exon11:c.A1705G:p.M569V,SEPT9:uc002jtw.3:exon11:c.A1234G:p.M412V,SEPT9:uc010wtk.2:exon11:c.A1669G:p.M557V,SEPT9:uc002jts.4:exon12:c.A1726G:p.M576V,SEPT9:uc002jtt.4:exon12:c.A1234G:p.M412V	-0.966	AFR:0.7668,AMR:0.9614,EAS:1,FIN:0.9147,NFE:0.9343,OTH:0.9255,ASJ:0.9503	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	0.0	1.55	0.000	-2.36	17	MU4565432	hom
17	75494746	75494746	A	G	SEPTIN9	UTR3	.	ENSG00000184640	rs1059485	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5267	0.3937	0.561701	0.4535	.	.	.	.	.	.	.	.	.	.	AFR:0.337,AMR:0.6783,EAS:0.9082,FIN:0.5047,NFE:0.4478,OTH:0.4405,ASJ:0.4333	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU17423690	hom
17	78261730	78261730	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs17853714	ENSG00000173821:ENST00000319921:exon4:c.G378A:p.P126P,ENSG00000173821:ENST00000456466:exon4:c.G378A:p.P126P,ENSG00000173821:ENST00000582970:exon4:c.G378A:p.P126P,ENSG00000173821:ENST00000508628:exon5:c.G525A:p.P175P	RNF213:NM_001256071:exon4:c.G378A:p.P126P,RNF213:NM_020954:exon4:c.G378A:p.P126P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2171	0.1545	0.116613	0.1515	.	.	.	.	.	.	.	.	RNF213:uc002jyf.4:exon4:c.G378A:p.P126P,RNF213:uc021uen.2:exon4:c.G378A:p.P126P,RNF213:uc031ret.1:exon5:c.G525A:p.P175P	.	AFR:0.1041,AMR:0.0823,EAS:0.0625,FIN:0.1411,NFE:0.1951,OTH:0.1571,ASJ:0.1325	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU15032039	het
17	78261805	78261805	A	G	RNF213	exonic	synonymous SNV	ENSG00000173821	rs7215243	ENSG00000173821:ENST00000319921:exon4:c.A453G:p.P151P,ENSG00000173821:ENST00000456466:exon4:c.A453G:p.P151P,ENSG00000173821:ENST00000582970:exon4:c.A453G:p.P151P,ENSG00000173821:ENST00000508628:exon5:c.A600G:p.P200P	RNF213:NM_001256071:exon4:c.A453G:p.P151P,RNF213:NM_020954:exon4:c.A453G:p.P151P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3249	0.3034	0.295727	MU9293062	.	.	.	.	.	.	.	.	RNF213:uc002jyf.4:exon4:c.A453G:p.P151P,RNF213:uc021uen.2:exon4:c.A453G:p.P151P,RNF213:uc031ret.1:exon5:c.A600G:p.P200P	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.2962,EAS:0.1599,FIN:0.1854,NFE:0.1264,OTH:0.1929,ASJ:0.5214	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(stomach)	0.2230
17	78262161	78262161	T	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs17857135	ENSG00000173821:ENST00000319921:exon4:c.T809C:p.M270T,ENSG00000173821:ENST00000456466:exon4:c.T809C:p.M270T,ENSG00000173821:ENST00000582970:exon4:c.T809C:p.M270T,ENSG00000173821:ENST00000508628:exon5:c.T956C:p.M319T	RNF213:NM_001256071:exon4:c.T809C:p.M270T,RNF213:NM_020954:exon4:c.T809C:p.M270T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1592	0.2248	0.211462	1(urinary_tract)	-1.984	0.001	0.598	-1.33	0.006	0	0	.	RNF213:uc002jyg.1:exon1:c.T2C:p.M1T,RNF213:uc002jyf.4:exon4:c.T809C:p.M270T,RNF213:uc021uen.2:exon4:c.T809C:p.M270T,RNF213:uc031ret.1:exon5:c.T956C:p.M319T	-0.953	AFR:MU113420915,AMR:LUSC-KR|1|170|0.00588235,EAS:0.4021,FIN:0.0943,NFE:0.1242,OTH:0.0637,ASJ:0.2181	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.0	1.04	0.000	0	17	2(soft_tissue)	0.1220
17	78263486	78263486	T	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs17853989	ENSG00000173821:ENST00000319921:exon6:c.T962C:p.M321T,ENSG00000173821:ENST00000456466:exon6:c.T962C:p.M321T,ENSG00000173821:ENST00000582970:exon6:c.T962C:p.M321T,ENSG00000173821:ENST00000508628:exon7:c.T1109C:p.M370T	RNF213:NM_001256071:exon6:c.T962C:p.M321T,RNF213:NM_020954:exon6:c.T962C:p.M321T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1797	0.2591	0.219848	4(soft_tissue)	-3.809	0.001	0.73	-8.69	0.000	.	.	.	RNF213:uc002jyg.1:exon3:c.T155C:p.M52T,RNF213:uc002jyf.4:exon6:c.T962C:p.M321T,RNF213:uc021uen.2:exon6:c.T962C:p.M321T	-1.048	AFR:1(lung),AMR:.,EAS:0.2390,FIN:0.4072,NFE:0.1041,OTH:0.1391,ASJ:.	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.0	1.09	0.000	-1.43	17	1(stomach)	0.0637
17	78263514	78263514	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs17853713	ENSG00000173821:ENST00000319921:exon6:c.G990A:p.K330K,ENSG00000173821:ENST00000456466:exon6:c.G990A:p.K330K,ENSG00000173821:ENST00000582970:exon6:c.G990A:p.K330K,ENSG00000173821:ENST00000508628:exon7:c.G1137A:p.K379K	RNF213:NM_001256071:exon6:c.G990A:p.K330K,RNF213:NM_020954:exon6:c.G990A:p.K330K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1800	0.2585	0.220248	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon3:c.G183A:p.K61K,RNF213:uc002jyf.4:exon6:c.G990A:p.K330K,RNF213:uc021uen.2:exon6:c.G990A:p.K330K	.	AFR:0.2384,AMR:0.4061,EAS:0.1391,FIN:0.0642,NFE:0.1422,OTH:0.1963,ASJ:0.1050	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(stomach)	0.1670
17	78293189	78293189	A	T	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs55996424	ENSG00000173821:ENST00000319921:exon17:c.A3101T:p.K1034M	RNF213:NM_020954:exon17:c.A3101T:p.K1034M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2373	0.1895	0.329673	1(haematopoietic_and_lymphoid_tissue)	0.184	4.506	0.063	1.35	0.000	.	.	.	RNF213:uc002jyf.4:exon17:c.A3101T:p.K1034M	-0.963	AFR:MU135850,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,EAS:0.2428,FIN:0.3086,NFE:0.2550,OTH:0.6045,ASJ:0.2204	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.957	.	0.000	.	17	1(liver)	0.2143
17	78298938	78298938	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs6565674	ENSG00000173821:ENST00000456466:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000582970:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000508628:exon19:c.A3280G:p.N1094D	RNF213:NM_001256071:exon18:c.A3133G:p.N1045D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9999	.	0.999401	0.9999	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon15:c.A2326G:p.N776D,RNF213:uc021uen.2:exon18:c.A3133G:p.N1045D	.	AFR:1,AMR:1,EAS:0.9981,FIN:1,NFE:1,OTH:1,ASJ:1	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU82001690	hom
17	78302157	78302157	C	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs8082521	ENSG00000173821:ENST00000456466:exon20:c.C3397A:p.Q1133K,ENSG00000173821:ENST00000582970:exon20:c.C3397A:p.Q1133K,ENSG00000173821:ENST00000508628:exon21:c.C3544A:p.Q1182K	RNF213:NM_001256071:exon20:c.C3397A:p.Q1133K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6362	0.7008	0.558307	1(lung)	-2.287	0.001	0.998	-10.6	0.000	.	.	.	RNF213:uc002jyg.1:exon17:c.C2590A:p.Q864K,RNF213:uc021uen.2:exon20:c.C3397A:p.Q1133K	-1.007	AFR:1(stomach),AMR:2(large_intestine),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,FIN:0.6569,NFE:0.7177,OTH:0.4475,ASJ:MU584308	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	2.1	0.000	-0.63	17	17(soft_tissue)	0.6788
17	78305871	78305871	G	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs10782008	ENSG00000173821:ENST00000456466:exon21:c.G3583A:p.V1195M,ENSG00000173821:ENST00000582970:exon21:c.G3583A:p.V1195M,ENSG00000173821:ENST00000508628:exon22:c.G3730A:p.V1244M	RNF213:NM_001256071:exon21:c.G3583A:p.V1195M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5764	0.5907	0.488818	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	0.340	6.078	0.203	1.26	0.018	.	.	.	RNF213:uc002jyg.1:exon18:c.G2776A:p.V926M,RNF213:uc021uen.2:exon21:c.G3583A:p.V1195M	-0.996	AFR:0.5731,AMR:0.4597,EAS:0.6233,FIN:0.4054,NFE:0.6884,OTH:0.6364,ASJ:0.3947	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.88	0.000	0.99	17	2(lung)	0.6150
17	78306102	78306102	G	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs9913636	ENSG00000173821:ENST00000456466:exon21:c.G3814C:p.E1272Q,ENSG00000173821:ENST00000582970:exon21:c.G3814C:p.E1272Q,ENSG00000173821:ENST00000508628:exon22:c.G3961C:p.E1321Q	RNF213:NM_001256071:exon21:c.G3814C:p.E1272Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4389	0.3866	0.343251	1(lung)	-0.469	0.263	0.481	-2.58	0.000	.	.	.	RNF213:uc002jyg.1:exon18:c.G3007C:p.E1003Q,RNF213:uc021uen.2:exon21:c.G3814C:p.E1272Q	-0.918	AFR:MU12980178,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.2291,FIN:0.2745,NFE:0.4735,OTH:0.3888,ASJ:0.4053	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.86	0.000	2.045	17	1(haematopoietic_and_lymphoid_tissue)	0.5682
17	78306280	78306280	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs8074015	ENSG00000173821:ENST00000456466:exon21:c.A3992G:p.D1331G,ENSG00000173821:ENST00000582970:exon21:c.A3992G:p.D1331G,ENSG00000173821:ENST00000508628:exon22:c.A4139G:p.D1380G	RNF213:NM_001256071:exon21:c.A3992G:p.D1331G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6440	0.7032	0.596645	MU12980184	-0.774	0.049	0.198	-2.19	0.000	.	.	.	RNF213:uc002jyg.1:exon18:c.A3185G:p.D1062G,RNF213:uc021uen.2:exon21:c.A3992G:p.D1331G	-1.081	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,AMR:0.6691,EAS:0.4522,FIN:0.6788,NFE:0.4024,OTH:0.7059,ASJ:0.7250	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	3.93	0.000	2.14	17	1(haematopoietic_and_lymphoid_tissue)	0.6691
17	78306308	78306308	C	G	RNF213	exonic	synonymous SNV	ENSG00000173821	rs9908287	ENSG00000173821:ENST00000456466:exon21:c.C4020G:p.V1340V,ENSG00000173821:ENST00000582970:exon21:c.C4020G:p.V1340V,ENSG00000173821:ENST00000508628:exon22:c.C4167G:p.V1389V	RNF213:NM_001256071:exon21:c.C4020G:p.V1340V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5725	0.5907	0.48742	MU14558322	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon18:c.C3213G:p.V1071V,RNF213:uc021uen.2:exon21:c.C4020G:p.V1340V	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.5724,EAS:0.3938,FIN:0.6258,NFE:0.3937,OTH:0.6883,ASJ:0.4601	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	2(large_intestine)	0.6360
17	78311508	78311508	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4890009	ENSG00000173821:ENST00000582970:exon24:c.G4650A:p.A1550A,ENSG00000173821:ENST00000508628:exon25:c.G4797A:p.A1599A	RNF213:NM_001256071:exon24:c.G4650A:p.A1550A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6463	0.7081	0.598043	0.6720	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon24:c.G4650A:p.A1550A	.	AFR:0.7383,AMR:0.4532,EAS:0.3756,FIN:0.7053,NFE:0.6702,OTH:0.6602,ASJ:0.6867	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU4565558	het
17	78313281	78313281	C	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs147868237	ENSG00000173821:ENST00000582970:exon26:c.C5114A:p.T1705K,ENSG00000173821:ENST00000508628:exon27:c.C5261A:p.T1754K	RNF213:NM_001256071:exon26:c.C5114A:p.T1705K	clinvar: Uncertain_significance 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0044	0.0070	0.00179712	0.0038	6.826	32	0.003	4.76	0.533	.	.	.	RNF213:uc021uen.2:exon26:c.C5114A:p.T1705K	-0.472	AFR:0.0017,AMR:0.0048,EAS:0,FIN:0.0003,NFE:0.0061,OTH:0.0061,ASJ:0	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.22	0.258	2.51	17	.	het
17	78319136	78319136	G	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs9674961	ENSG00000173821:ENST00000336301:exon4:c.G1220A:p.S407N,ENSG00000173821:ENST00000582970:exon29:c.G7001A:p.S2334N,ENSG00000173821:ENST00000508628:exon30:c.G7148A:p.S2383N	RNF213:NM_001256071:exon29:c.G7001A:p.S2334N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6081	0.6605	0.558506	2(prostate)	-1.677	0.002	1.0	0.943	0.001	.	.	.	RNF213:uc021uen.2:exon29:c.G7001A:p.S2334N	-0.981	AFR:1(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,FIN:0.6355,NFE:0.6383,OTH:0.4318,ASJ:MU584311	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.0	1.99	0.000	-0.74	17	2(lung)	0.6490
17	78319380	78319380	G	C	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4890012	ENSG00000173821:ENST00000336301:exon4:c.G1464C:p.P488P,ENSG00000173821:ENST00000582970:exon29:c.G7245C:p.P2415P,ENSG00000173821:ENST00000508628:exon30:c.G7392C:p.P2464P	RNF213:NM_001256071:exon29:c.G7245C:p.P2415P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5673	0.5725	0.473243	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon29:c.G7245C:p.P2415P	.	AFR:0.5618,AMR:0.4197,EAS:0.6324,FIN:0.3897,NFE:0.6884,OTH:0.6375,ASJ:0.3969	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	3(large_intestine)	0.6181
17	78327358	78327358	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs7216493	ENSG00000173821:ENST00000336301:exon9:c.G4689A:p.E1563E,ENSG00000173821:ENST00000582970:exon34:c.G10470A:p.E3490E,ENSG00000173821:ENST00000508628:exon35:c.G10617A:p.E3539E	RNF213:NM_001256071:exon34:c.G10470A:p.E3490E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6657	0.7094	0.628994	1(stomach)	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon34:c.G10470A:p.E3490E	.	AFR:MU584313,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.6880,FIN:0.4797,NFE:0.7152,OTH:0.5329,ASJ:0.6846	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.7239
17	78334206	78334206	G	A	RNF213-AS1	ncRNA_intronic	.	ENSG00000263069	rs8078251	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.45008	0.5860	.	.	.	.	.	.	.	.	.	.	AFR:0.3870,AMR:0.4189,EAS:0.3572,FIN:0.7182,NFE:0.6973,OTH:0.6609,ASJ:0.7053	.	.	.	.	.	.	.	.	.	.	.	.	17	MU14558984	het
17	78341776	78341776	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs77506504	ENSG00000173821:ENST00000336301:exon19:c.G6207A:p.P2069P,ENSG00000173821:ENST00000582970:exon44:c.G11988A:p.P3996P,ENSG00000173821:ENST00000508628:exon45:c.G12135A:p.P4045P	RNF213:NM_001256071:exon44:c.G11988A:p.P3996P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0184	0.0015	0.0301518	MU30156608	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon44:c.G11988A:p.P3996P	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.0104,EAS:0.0513,FIN:0.0033,NFE:0.1238,OTH:0.0072,ASJ:0.0015	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(breast)	0.0019
17	78354661	78354661	C	T	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4889848	ENSG00000173821:ENST00000336301:exon31:c.C7890T:p.H2630H,ENSG00000173821:ENST00000582970:exon56:c.C13671T:p.H4557H,ENSG00000173821:ENST00000508628:exon57:c.C13818T:p.H4606H	RNF213:NM_001256071:exon56:c.C13671T:p.H4557H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7762	0.8817	0.759385	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon56:c.C13671T:p.H4557H	.	AFR:0.8452,AMR:0.9568,EAS:0.8808,FIN:0.5702,NFE:0.8092,OTH:0.8334,ASJ:0.5979	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.8106
17	78401588	78401588	G	T	ENDOV	intronic	.	ENSG00000173818	rs8065290	ENSG00000173818:ENST00000519331:exon2:c.G238T:p.G80C	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7144	.	0.763379	0.8478	-0.437	0.314	0.288	-2.2	0.002	.	.	.	.	-1.014	AFR:0.9585,AMR:0.6184,EAS:0.6346,FIN:0.8140,NFE:0.8284,OTH:0.8160,ASJ:0.8775	.	.	.	.	.	.	.	.	.	0.53	0.000	.	17	MU82228311	hom
17	78820329	78820329	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs3751945	ENSG00000141564:ENST00000537330:exon10:c.C714T:p.G238G,ENSG00000141564:ENST00000306801:exon11:c.C1269T:p.G423G,ENSG00000141564:ENST00000544334:exon11:c.C1269T:p.G423G	RPTOR:NM_001163034:exon11:c.C1269T:p.G423G,RPTOR:NM_020761:exon11:c.C1269T:p.G423G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.4962	0.436701	1(thyroid)	.	.	.	.	.	.	.	.	RPTOR:uc010wuf.1:exon10:c.C714T:p.G238G,RPTOR:uc002jyt.1:exon11:c.C1269T:p.G423G,RPTOR:uc010wug.1:exon11:c.C1269T:p.G423G	.	AFR:1(large_intestine),AMR:MU153336,EAS:0.5072,FIN:0.2247,NFE:0.6065,OTH:0.4901,ASJ:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.4466
17	78854223	78854223	A	G	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs2289759	ENSG00000141564:ENST00000306801:exon14:c.A1518G:p.Q506Q	RPTOR:NM_020761:exon14:c.A1518G:p.Q506Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2540	0.2231	0.248003	1(stomach)	.	.	.	.	.	.	.	.	RPTOR:uc002jyt.1:exon14:c.A1518G:p.Q506Q	.	AFR:1(breast),AMR:1(liver),EAS:MU98324,FIN:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.2190,OTH:0.1425,ASJ:1(large_intestine)	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(lung)	0.2613
17	78896529	78896529	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs2271603	ENSG00000141564:ENST00000576366:exon1:c.C6T:p.T2T,ENSG00000141564:ENST00000544334:exon18:c.C2052T:p.T684T,ENSG00000141564:ENST00000306801:exon22:c.C2526T:p.T842T	RPTOR:NM_001163034:exon18:c.C2052T:p.T684T,RPTOR:NM_020761:exon22:c.C2526T:p.T842T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3670	0.2726	0.245407	3(lung)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon18:c.C2052T:p.T684T,RPTOR:uc002jyt.1:exon22:c.C2526T:p.T842T	.	AFR:11(soft_tissue),AMR:MU98342,EAS:0.2760,FIN:0.1690,NFE:0.2679,OTH:0.4139,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(haematopoietic_and_lymphoid_tissue)	0.1922
17	78919558	78919558	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs1567962	ENSG00000141564:ENST00000544334:exon22:c.C2643T:p.A881A,ENSG00000141564:ENST00000306801:exon26:c.C3117T:p.A1039A	RPTOR:NM_001163034:exon22:c.C2643T:p.A881A,RPTOR:NM_020761:exon26:c.C3117T:p.A1039A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3595	0.3622	0.374601	1(stomach)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon22:c.C2643T:p.A881A,RPTOR:uc002jyt.1:exon26:c.C3117T:p.A1039A	.	AFR:MU730207,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.3922,FIN:0.3321,NFE:0.3767,OTH:0.4504,ASJ:0.3587	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.2964
17	78921117	78921117	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs4969231	ENSG00000141564:ENST00000544334:exon23:c.C2757T:p.N919N,ENSG00000141564:ENST00000306801:exon27:c.C3231T:p.N1077N	RPTOR:NM_001163034:exon23:c.C2757T:p.N919N,RPTOR:NM_020761:exon27:c.C3231T:p.N1077N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2749	0.2367	0.197684	1(lung)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon23:c.C2757T:p.N919N,RPTOR:uc002jyt.1:exon27:c.C3231T:p.N1077N	.	AFR:MU93712,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.0681,FIN:0.2721,NFE:0.3642,OTH:0.2006,ASJ:0.2375	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(stomach)	0.2734
17	78935197	78935197	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs9899178	ENSG00000141564:ENST00000544334:exon27:c.C3135T:p.R1045R,ENSG00000141564:ENST00000306801:exon31:c.C3609T:p.R1203R	RPTOR:NM_001163034:exon27:c.C3135T:p.R1045R,RPTOR:NM_020761:exon31:c.C3609T:p.R1203R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3298	0.2502	0.309505	0.2998	.	.	.	.	.	.	.	.	RPTOR:uc002jyu.1:exon4:c.C288T:p.R96R,RPTOR:uc010wug.1:exon27:c.C3135T:p.R1045R,RPTOR:uc002jyt.1:exon31:c.C3609T:p.R1203R	.	AFR:0.1310,AMR:0.3678,EAS:0.5547,FIN:0.3723,NFE:0.3449,OTH:0.3535,ASJ:0.3874	607130	.	.	.	.	.	.	.	.	.	.	.	17	MU4552093	het
17	79508400	79508400	T	C	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs14422	ENSG00000185504:ENST00000425898:exon4:c.A1396G:p.T466A,ENSG00000185504:ENST00000327787:exon8:c.A2449G:p.T817A,ENSG00000185504:ENST00000537152:exon8:c.A1996G:p.T666A	FAAP100:NM_025161:exon8:c.A2449G:p.T817A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9258	0.9239	0.946486	0.9253	-0.334	0.554	1.0	2.88	0.014	.	.	.	C17orf70:uc002kao.1:exon4:c.A1396G:p.T466A,C17orf70:uc002kap.3:exon8:c.A1996G:p.T666A,C17orf70:uc002kaq.3:exon8:c.A2449G:p.T817A	-1.002	AFR:0.9493,AMR:0.9451,EAS:1,FIN:0.8901,NFE:0.9112,OTH:0.9276,ASJ:0.8709	611301	.	.	.	.	.	.	.	0.0	1.82	0.000	-2.595	17	MU4565620	hom
17	79511135	79511135	A	G	FAAP100	exonic	synonymous SNV	ENSG00000185504	rs8077430	ENSG00000185504:ENST00000425898:exon3:c.T1269C:p.T423T,ENSG00000185504:ENST00000327787:exon7:c.T2322C:p.T774T,ENSG00000185504:ENST00000537152:exon7:c.T1869C:p.T623T	FAAP100:NM_025161:exon7:c.T2322C:p.T774T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7571	0.6971	0.704473	MU9296095	.	.	.	.	.	.	.	.	C17orf70:uc002kao.1:exon3:c.T1269C:p.T423T,C17orf70:uc002kap.3:exon7:c.T1869C:p.T623T,C17orf70:uc002kaq.3:exon7:c.T2322C:p.T774T	.	AFR:COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,AMR:0.7152,EAS:0.8261,FIN:0.69,NFE:0.7673,OTH:0.7745,ASJ:0.5533	611301	.	.	.	.	.	.	.	.	.	.	.	17	1(biliary_tract)	0.7801
17	79514129	79514129	G	A	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs11552304	ENSG00000185504:ENST00000425898:exon1:c.C926T:p.P309L,ENSG00000185504:ENST00000545865:exon1:c.C101T:p.P34L,ENSG00000185504:ENST00000327787:exon5:c.C1979T:p.P660L,ENSG00000185504:ENST00000537152:exon5:c.C1526T:p.P509L	FAAP100:NM_025161:exon5:c.C1979T:p.P660L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6217	0.5780	0.55631	1(thyroid)	0.156	4.215	0.358	0.069	0.001	.	.	.	C17orf70:uc002kao.1:exon1:c.C926T:p.P309L,C17orf70:uc002kap.3:exon5:c.C1526T:p.P509L,C17orf70:uc002kaq.3:exon5:c.C1979T:p.P660L	-0.955	AFR:1(urinary_tract),AMR:MU109692,EAS:0.5992,FIN:0.4122,NFE:0.4880,OTH:0.5728,ASJ:COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	611301	.	.	.	.	.	.	.	0.394	1.53	0.000	1.5	17	1(breast)	0.6735
17	79974731	79974731	T	C	ASPSCR1	exonic	synonymous SNV	ENSG00000169696	rs13087	ENSG00000169696:ENST00000584454:exon15:c.T1351C:p.C451R	ASPSCR1:NM_001330528:exon13:c.T1305C:p.D435D,ASPSCR1:NM_024083:exon14:c.T1461C:p.D487D,ASPSCR1:NM_001251888:exon15:c.T1743C:p.D581D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5906	0.6464	0.580272	1(urinary_tract)	.	.	.	.	.	.	.	.	ASPSCR1:uc002kda.3:exon13:c.T1305C:p.D435D,ASPSCR1:uc021ufj.1:exon13:c.T1230C:p.D410D,ASPSCR1:uc002kcx.3:exon14:c.T1461C:p.D487D,ASPSCR1:uc002kcy.3:exon15:c.T1743C:p.D581D	.	AFR:1(stomach),AMR:2(lung),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6414,NFE:0.7619,OTH:0.5167,ASJ:MU796615	606236	606243;	163699;	163699|ASPS<br>Alveolar soft-part sarcoma|-|-|All ages|606243 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.6093
17	80039028	80039028	A	G	FASN	intronic	.	ENSG00000169710	rs4246445	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6901	0.7545	0.664337	0.7443	.	.	.	.	.	.	.	.	.	.	AFR:0.8027,AMR:0.7464,EAS:0.4422,FIN:0.7504,NFE:0.7442,OTH:0.7362,ASJ:0.6258	600212	.	.	.	.	.	.	.	.	.	.	.	17	MU16099716	het
17	80040186	80040186	G	A	FASN	intronic	.	ENSG00000169710	rs139527766	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0046	0.0022	0.00658946	0.0018	.	.	.	.	.	.	.	.	.	.	AFR:0.0005,AMR:0,EAS:0,FIN:0.0023,NFE:0.0029,OTH:0,ASJ:0	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	80042792	80042792	C	T	FASN	exonic	nonsynonymous SNV	ENSG00000169710	rs2228305	ENSG00000169710:ENST00000306749:exon26:c.G4447A:p.V1483I	FASN:NM_004104:exon26:c.G4447A:p.V1483I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0628	0.0387	0.0507188	COCA-CN|1|321|0.00311526	0.263	5.326	0.512	-1.68	0.000	.	.	.	FASN:uc002kdu.3:exon26:c.G4447A:p.V1483I	-1.015	AFR:0.0407,AMR:0.0764,EAS:0.0364,FIN:0.0018,NFE:0.0215,OTH:0.0282,ASJ:0.0574	600212	.	.	.	.	.	.	.	0.012	1.77	0.004	0.255	17	1(large_intestine)	0.0347
17	80050555	80050556	GG	-	FASN	intronic	.	ENSG00000169710	rs10591316	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.8259	.	.	0.9578	.	.	.	.	.	.	.	.	.	.	AFR:0.9723,AMR:0.9644,EAS:0.9889,FIN:0.9440,NFE:0.9507,OTH:0.9350,ASJ:0.9195	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	80051183	80051183	A	G	FASN	exonic	synonymous SNV	ENSG00000169710	rs2228309	ENSG00000169710:ENST00000306749:exon5:c.T567C:p.N189N	FASN:NM_004104:exon5:c.T567C:p.N189N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5373	0.5416	0.391773	1(thyroid)	.	.	.	.	.	.	.	.	FASN:uc002kdu.3:exon5:c.T567C:p.N189N	.	AFR:3(lung),AMR:MU69626,EAS:0.5230,FIN:0.5036,NFE:0.3469,OTH:0.4228,ASJ:LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	600212	.	.	.	.	.	.	.	.	.	.	.	17	2(breast)	0.1609
18	724612	724612	A	G	YES1	exonic	synonymous SNV	ENSG00000176105	rs537141	ENSG00000176105:ENST00000314574:exon12:c.T1444C:p.L482L,ENSG00000176105:ENST00000577961:exon12:c.T1459C:p.L487L,ENSG00000176105:ENST00000584307:exon12:c.T1444C:p.L482L	YES1:NM_005433:exon12:c.T1444C:p.L482L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9973	0.9913	0.989816	0.9924	.	.	.	.	.	.	.	.	YES1:uc002kky.3:exon12:c.T1444C:p.L482L,YES1:uc002kkz.3:exon12:c.T1444C:p.L482L	.	AFR:0.9731,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	164880	.	.	.	.	.	.	.	.	.	.	.	18	MU82003345	hom
18	22642717	22642728	AAAAAAAAAAAA	-	ZNF521	intronic	.	ENSG00000198795	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610974	.	.	.	.	.	.	.	.	.	.	.	18	.	unknown
18	22775185	22775185	C	T	ZNF521	exonic	synonymous SNV	ENSG00000198795	rs1140026	ENSG00000198795:ENST00000399425:exon6:c.G3677A:p.S1226N	ZNF521:NM_001308225:exon4:c.G2937A:p.K979K,ZNF521:NM_015461:exon5:c.G3597A:p.K1199K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2427	0.2088	0.226637	0.2121	.	.	.	.	.	.	.	.	ZNF521:uc002kvl.2:exon4:c.G2937A:p.K979K,ZNF521:uc002kvk.2:exon5:c.G3597A:p.K1199K,ZNF521:uc010dly.2:exon5:c.G3597A:p.K1199K	.	AFR:0.1366,AMR:0.2017,EAS:0.2774,FIN:0.2345,NFE:0.2409,OTH:0.2520,ASJ:0.2682	610974	.	.	.	.	.	.	.	.	.	.	.	18	MU21621172	het
18	22901967	22901967	T	C	ZNF521	intronic	.	ENSG00000198795	rs45590038	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0401	0.0369	0.0181709	0.0345	.	.	.	.	.	0.0855	0.116	.	.	.	AFR:0.0080,AMR:0.0215,EAS:0.0006,FIN:0.0633,NFE:0.0466,OTH:0.0489,ASJ:0.0331	610974	.	.	.	.	.	.	.	.	.	.	.	18	MU116850363	het
18	23619435	23619435	A	C	SS18	intronic	.	ENSG00000141380	rs9953448	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0216	0.0656	0.0632987	0.0582	.	.	.	.	.	.	.	.	.	.	AFR:0.1956,AMR:0.0155,EAS:0,FIN:0,NFE:0.0037,OTH:0.0143,ASJ:0.0530	600192	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	18	.	het
18	28648975	28648975	C	T	DSC2	exonic	nonsynonymous SNV	ENSG00000134755	rs61731921	ENSG00000134755:ENST00000251081:exon15:c.G2393A:p.R798Q,ENSG00000134755:ENST00000280904:exon15:c.G2393A:p.R798Q	DSC2:NM_004949:exon15:c.G2393A:p.R798Q,DSC2:NM_024422:exon15:c.G2393A:p.R798Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0495	0.0342	0.0275559	0.0442	0.324	5.922	0.159	-5.21	0.000	.	.	.	DSC2:uc002kwk.4:exon15:c.G2393A:p.R798Q,DSC2:uc002kwl.4:exon15:c.G2393A:p.R798Q	-0.977	AFR:0.0077,AMR:0.0144,EAS:0,FIN:0.1216,NFE:0.0521,OTH:0.0789,ASJ:0.0232	125645	610476;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.006	-1.79	0.051	0.79	18	.	het
18	42456653	42456653	G	A	SETBP1	exonic	nonsynonymous SNV	ENSG00000152217	rs663651	ENSG00000152217:ENST00000426838:exon4:c.G664A:p.A222T	SETBP1:NM_001130110:exon4:c.G664A:p.A222T	clinvar: Likely_benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5073	.	0.493011	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	0.009	2.674	0.0	-0.915	0.008	.	.	.	SETBP1:uc002lay.3:exon4:c.G664A:p.A222T	-0.932	AFR:0.5436,AMR:0.5363,EAS:0.5430,FIN:0.4806,NFE:0.5923,OTH:0.5489,ASJ:0.4330	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9646,9647	0.0	.	0.000	.	18	1(haematopoietic_and_lymphoid_tissue)	0.5521
18	42456670	42456670	-	TCTT	SETBP1	exonic	frameshift insertion	ENSG00000152217	rs3085861	ENSG00000152217:ENST00000426838:exon4:c.681_682insTCTT:p.L227fs	SETBP1:NM_001130110:exon4:c.681_682insTCTT:p.L227fs	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5146	0.5344	0.49381	.	.	.	.	.	.	.	.	.	SETBP1:uc002lay.3:exon4:c.681_682insTCTT:p.L227fs	.	AFR:.,AMR:0.5398,EAS:0.4305,FIN:0.54,NFE:0.4763,OTH:0.5917,ASJ:0.5336	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9646,9647	.	.	.	.	18	16(upper_aerodigestive_tract)	0.5438
18	42532606	42532606	G	A	SETBP1	exonic	nonsynonymous SNV	ENSG00000152217	rs3744825	ENSG00000152217:ENST00000282030:exon4:c.G3301A:p.V1101I	SETBP1:NM_015559:exon4:c.G3301A:p.V1101I	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1212	0.1018	0.1248	0.1094	-0.498	0.222	0.135	-0.533	0.834	.	.	.	SETBP1:uc010dni.3:exon4:c.G3301A:p.V1101I	-1.031	AFR:0.0489,AMR:0.0813,EAS:0.2636,FIN:0.1322,NFE:0.1226,OTH:0.1314,ASJ:0.1192	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9646,9647	0.052	-0.33	0.000	0.345	18	MU584406	het
18	42533130	42533130	A	G	SETBP1	exonic	synonymous SNV	ENSG00000152217	rs8096662	ENSG00000152217:ENST00000282030:exon4:c.A3825G:p.S1275S	SETBP1:NM_015559:exon4:c.A3825G:p.S1275S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8775	0.8996	0.906949	0.9062	.	.	.	.	.	.	.	.	SETBP1:uc010dni.3:exon4:c.A3825G:p.S1275S	.	AFR:0.9722,AMR:0.9427,EAS:0.9560,FIN:0.8886,NFE:0.8676,OTH:0.8663,ASJ:0.8775	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9646,9647	.	.	.	.	18	MU21144927	hom
18	49867224	49867224	T	C	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs9951523	ENSG00000187323:ENST00000442544:exon1:c.T67C:p.F23L	DCC:NM_005215:exon1:c.T67C:p.F23L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9862	0.9892	0.995807	0.9833	1.932	15.79	1.0	4.83	0.995	.	.	Immunoglobulin-like domain	DCC:uc002lfe.2:exon1:c.T67C:p.F23L	-0.966	AFR:0.9979,AMR:0.9904,EAS:1,FIN:0.9399,NFE:0.9834,OTH:0.9735,ASJ:0.9801	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.0	0.84	0.000	0	18	MU82007106	hom
18	50278686	50278686	G	A	DCC	exonic	synonymous SNV	ENSG00000187323	rs13381333	ENSG00000187323:ENST00000581559:exon1:c.G150A:p.E50E,ENSG00000187323:ENST00000582875:exon1:c.G156A:p.E52E,ENSG00000187323:ENST00000442544:exon2:c.G354A:p.E118E	DCC:NM_005215:exon2:c.G354A:p.E118E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1071	0.1089	0.0676917	0.0908	.	.	.	.	.	.	.	.	DCC:uc002lfe.2:exon2:c.G354A:p.E118E	.	AFR:0.0379,AMR:0.0955,EAS:0.0012,FIN:0.0782,NFE:0.1308,OTH:0.0959,ASJ:0.2318	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	MU116568169	het
18	50432602	50432602	C	G	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs2229080	ENSG00000187323:ENST00000412726:exon3:c.C145G:p.R49G,ENSG00000187323:ENST00000442544:exon3:c.C601G:p.R201G	DCC:NM_005215:exon3:c.C601G:p.R201G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4447	0.3594	0.477436	MU788932	2.708	20.9	0.114	-0.494	0.993	.	.	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	DCC:uc002lfe.2:exon3:c.C601G:p.R201G,DCC:uc010xdr.1:exon3:c.C145G:p.R49G	-0.913	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3620,EAS:0.5769,FIN:0.4867,NFE:0.5330,OTH:0.3907,ASJ:0.3290	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.083	1.11	0.000	0.405	18	1(haematopoietic_and_lymphoid_tissue)	0.3401
18	50831969	50831969	C	T	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs527722963	ENSG00000187323:ENST00000581580:exon10:c.C898T:p.P300S,ENSG00000187323:ENST00000412726:exon13:c.C1477T:p.P493S,ENSG00000187323:ENST00000442544:exon13:c.C1933T:p.P645S	DCC:NM_005215:exon13:c.C1933T:p.P645S	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0002	.	0.000199681	.	6.496	31	0.003	5.45	0.995	.	.	Fibronectin type III|Immunoglobulin-like fold	DCC:uc010dpf.2:exon10:c.C898T:p.P300S,DCC:uc002lfe.2:exon13:c.C1933T:p.P645S,DCC:uc010xdr.1:exon13:c.C1477T:p.P493S	-0.127	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.975	0.12	0.425	2.415	18	.	het
18	50832102	50832102	A	G	DCC	intronic	.	ENSG00000187323	rs1431196	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3183	0.3201	0.161741	0.3176	.	.	.	.	.	.	.	.	.	.	AFR:0.1015,AMR:0.2064,EAS:0.0364,FIN:0.3975,NFE:0.4558,OTH:0.3931,ASJ:0.3543	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	MU124308961	het
18	50929276	50929276	A	G	DCC	intronic	.	ENSG00000187323	rs72933411	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1166	0.0978	0.125399	0.1224	.	.	.	.	.	.	.	.	.	.	AFR:0.0996,AMR:0.0585,EAS:0.2017,FIN:0.1963,NFE:0.1122,OTH:0.1462,ASJ:0.1093	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	MU13066529	het
18	50936994	50936994	T	C	DCC	exonic	synonymous SNV	ENSG00000187323	rs2229082	ENSG00000187323:ENST00000581580:exon17:c.T2013C:p.P671P,ENSG00000187323:ENST00000412726:exon20:c.T2592C:p.P864P,ENSG00000187323:ENST00000442544:exon20:c.T3108C:p.P1036P	DCC:NM_005215:exon20:c.T3108C:p.P1036P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4517	0.4359	0.310304	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DCC:uc010dpf.2:exon17:c.T2013C:p.P671P,DCC:uc002lfe.2:exon20:c.T3108C:p.P1036P,DCC:uc010xdr.1:exon20:c.T2592C:p.P864P	.	AFR:3(lung),AMR:MU13066566,EAS:0.4582,FIN:0.2317,NFE:0.2924,OTH:0.4570,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	3(large_intestine)	0.2382
18	50937026	50937026	A	G	DCC	intronic	.	ENSG00000187323	rs11873515	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4537	0.4358	0.309904	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4583,AMR:0.2323,EAS:0.46,FIN:0.2392,NFE:0.6188,OTH:0.5789,ASJ:0.2924	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	1(haematopoietic_and_lymphoid_tissue)	0.5594
18	51056915	51056915	G	T	DCC	intronic	.	ENSG00000264263	rs2270953	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1585	0.1243	0.182109	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU584431,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1456,FIN:0.3282,NFE:0.0927,OTH:0.2166,ASJ:0.1343	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	1(stomach)	0.1246
18	51795958	51795960	CGA	-	POLI	exonic	nonframeshift deletion	ENSG00000101751	rs10584411	ENSG00000101751:ENST00000406285:exon1:c.42_44del:p.14_15del,ENSG00000101751:ENST00000579534:exon1:c.42_44del:p.14_15del	POLI:NM_001351610:exon1:c.42_44del:p.14_15del,POLI:NM_001351613:exon1:c.42_44del:p.14_15del,POLI:NM_001351616:exon1:c.42_44del:p.14_15del,POLI:NM_001351621:exon1:c.42_44del:p.14_15del,POLI:NM_007195:exon1:c.42_44del:p.14_15del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7635	0.7612	0.783946	0.7640	.	.	.	.	.	.	.	.	POLI:uc002lfj.4:exon1:c.42_44del:p.14_15del,POLI:uc010xds.2:exon1:c.42_44del:p.14_15del	.	AFR:0.9280,AMR:0.6019,EAS:0.7032,FIN:0.7334,NFE:0.6922,OTH:0.7330,ASJ:0.8079	605252	.	.	.	.	.	.	.	.	.	.	.	18	MU99873	hom
18	51796003	51796003	G	A	POLI	exonic	synonymous SNV	ENSG00000101751	rs3730669	ENSG00000101751:ENST00000406285:exon1:c.G87A:p.A29A,ENSG00000101751:ENST00000579534:exon1:c.G87A:p.A29A	POLI:NM_001351610:exon1:c.G87A:p.A29A,POLI:NM_001351613:exon1:c.G87A:p.A29A,POLI:NM_001351616:exon1:c.G87A:p.A29A,POLI:NM_001351621:exon1:c.G87A:p.A29A,POLI:NM_001351632:exon1:c.G12A:p.A4A,POLI:NM_007195:exon1:c.G87A:p.A29A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0399	0.0179	0.0391374	MU109243	.	.	.	.	.	.	.	.	POLI:uc002lfj.4:exon1:c.G87A:p.A29A,POLI:uc010xds.2:exon1:c.G87A:p.A29A	.	AFR:MELA-AU|1|183|0.00546448,AMR:0.0182,EAS:0.0084,FIN:0.0033,NFE:0.0006,OTH:0,ASJ:0.0605	605252	.	.	.	.	.	.	.	.	.	.	.	18	1(thyroid)	0.0010
18	51818418	51818419	CT	-	POLI	intronic	.	ENSG00000101751	rs3730809	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0569	0.0752	0.0497204	0.0708	.	.	.	.	.	.	.	.	.	.	AFR:0.0897,AMR:0.0349,EAS:0.0037,FIN:0.0689,NFE:0.0693,OTH:0.0745,ASJ:0.07	605252	.	.	.	.	.	.	.	.	.	.	.	18	.	het
18	51820805	51820805	G	A	POLI	exonic	nonsynonymous SNV	ENSG00000101751	rs8305	ENSG00000101751:ENST00000217800:exon9:c.G1813A:p.A605T,ENSG00000101751:ENST00000406285:exon9:c.G1954A:p.A652T,ENSG00000101751:ENST00000579434:exon9:c.G1882A:p.A628T,ENSG00000101751:ENST00000579534:exon10:c.G2191A:p.A731T	POLI:NM_001351616:exon8:c.G1828A:p.A610T,POLI:NM_001351610:exon9:c.G2065A:p.A689T,POLI:NM_001351613:exon9:c.G1954A:p.A652T,POLI:NM_001351614:exon9:c.G1882A:p.A628T,POLI:NM_001351615:exon9:c.G1882A:p.A628T,POLI:NM_001351617:exon9:c.G1648A:p.A550T,POLI:NM_001351620:exon9:c.G1411A:p.A471T,POLI:NM_001351611:exon10:c.G1987A:p.A663T,POLI:NM_001351612:exon10:c.G1987A:p.A663T,POLI:NM_001351618:exon10:c.G1648A:p.A550T,POLI:NM_001351619:exon10:c.G1648A:p.A550T,POLI:NM_001351632:exon10:c.G2116A:p.A706T,POLI:NM_007195:exon10:c.G2191A:p.A731T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7282	0.7780	0.789137	LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,WT-US|1|102|0.00980392	-0.572	0.146	0.892	-5.15	0.278	.	.	.	POLI:uc010dpg.3:exon6:c.G979A:p.A327T,POLI:uc002lfk.4:exon9:c.G1882A:p.A628T,POLI:uc010xds.2:exon9:c.G1954A:p.A652T,POLI:uc002lfj.4:exon10:c.G2191A:p.A731T	-0.992	AFR:0.7686,AMR:0.9401,EAS:0.8079,FIN:0.7055,NFE:0.7325,OTH:0.6945,ASJ:0.6041	605252	.	.	.	.	.	.	.	0.001	1.12	0.000	-0.345	18	2(lung)	0.7311
18	53303101	53303101	C	G	TCF4	exonic	nonsynonymous SNV	ENSG00000196628	rs611326	ENSG00000196628:ENST00000398339:exon1:c.G28C:p.A10P,ENSG00000196628:ENST00000565124:exon1:c.G28C:p.A10P	TCF4:NM_001243226:exon1:c.G28C:p.A10P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9988	0.996805	0.9987	.	.	.	.	.	.	.	.	TCF4:uc002lga.3:exon1:c.G28C:p.A10P,TCF4:uc021ukp.1:exon1:c.G28C:p.A10P	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602272	610954;613267;	98974;2896;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~2896|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610954 ~	.	.	.	.	.	.	.	.	18	MU82007295	hom
18	60562298	60562298	A	T	PHLPP1	exonic	synonymous SNV	ENSG00000081913	rs624821	ENSG00000081913:ENST00000262719:exon5:c.A2121T:p.P707P,ENSG00000081913:ENST00000400316:exon5:c.A585T:p.P195P	PHLPP1:NM_194449:exon5:c.A2121T:p.P707P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5547	0.5873	0.486222	MU13087612	.	.	.	.	.	.	.	.	PHLPP1:uc021ule.1:exon5:c.A2121T:p.P707P	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.5775,EAS:0.5346,FIN:0.7285,NFE:0.3595,OTH:0.5576,ASJ:0.5394	609396	.	.	.	.	.	.	.	.	.	.	.	18	1(breast)	0.6255
18	60572438	60572438	T	-	PHLPP1	intronic	.	ENSG00000081913	rs3217528	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5439	.	0.41893	0.4674	.	.	.	.	.	.	.	.	.	.	AFR:0.3979,AMR:0.5208,EAS:0.3503,FIN:0.4792,NFE:0.5103,OTH:0.5220,ASJ:0.6585	609396	.	.	.	.	.	.	.	.	.	.	.	18	.	het
18	60970036	60970036	C	A	BCL2	intronic	.	ENSG00000171791	rs4941195	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.583067	0.5089	.	.	.	.	.	.	.	.	.	.	AFR:0.6602,AMR:0.4544,EAS:0.7348,FIN:0.4121,NFE:0.4239,OTH:0.4561,ASJ:0.6026	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	18	MU13088314	het
18	60985879	60985879	T	C	BCL2	exonic	synonymous SNV	ENSG00000171791	rs1801018	ENSG00000171791:ENST00000398117:exon1:c.A21G:p.T7T,ENSG00000171791:ENST00000589955:exon1:c.A21G:p.T7T,ENSG00000171791:ENST00000333681:exon2:c.A21G:p.T7T,ENSG00000171791:ENST00000444484:exon2:c.A21G:p.T7T	BCL2:NM_000633:exon2:c.A21G:p.T7T,BCL2:NM_000657:exon2:c.A21G:p.T7T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3688	0.3104	0.243211	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	BCL2:uc002liu.1:exon1:c.A21G:p.T7T,BCL2:uc021ulf.1:exon1:c.A21G:p.T7T,BCL2:uc002lit.1:exon2:c.A21G:p.T7T,BCL2:uc002liv.1:exon2:c.A21G:p.T7T	.	AFR:MU13088333,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,EAS:0.0841,FIN:0.4055,NFE:0.3113,OTH:0.0953,ASJ:0.3240	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	,966	.	.	.	.	18	2(lung)	0.4679
18	67687860	67687860	T	C	RTTN	exonic	synonymous SNV	ENSG00000176225	rs2304378	ENSG00000176225:ENST00000255674:exon45:c.A6144G:p.V2048V	RTTN:NM_001318520:exon44:c.A3408G:p.V1136V,RTTN:NM_173630:exon45:c.A6144G:p.V2048V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1919	0.1695	0.152356	1(breast)	.	.	.	.	.	.	.	.	RTTN:uc002lkn.2:exon1:c.A114G:p.V38V,RTTN:uc010dqp.2:exon11:c.A900G:p.V300V,RTTN:uc010xfb.1:exon44:c.A3408G:p.V1136V,RTTN:uc002lkp.2:exon45:c.A6144G:p.V2048V	.	AFR:MU13106685,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,BRCA-KR|1|50|0.02,EAS:0.0914,FIN:0.1277,NFE:0.2583,OTH:0.1918,ASJ:0.1680	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	3(lung)	0.2034
18	67718688	67718688	A	G	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs4891392	ENSG00000176225:ENST00000255674:exon39:c.T5282C:p.F1761S	RTTN:NM_001318520:exon38:c.T2546C:p.F849S,RTTN:NM_173630:exon39:c.T5282C:p.F1761S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9184	0.8027	0.790735	0.8082	-0.332	0.561	0.978	-1.23	0.000	.	.	Armadillo-like helical	RTTN:uc010dqp.2:exon5:c.T38C:p.F13S,RTTN:uc010xfb.1:exon38:c.T2546C:p.F849S,RTTN:uc002lkp.2:exon39:c.T5282C:p.F1761S	-1.032	AFR:0.4213,AMR:0.9391,EAS:1,FIN:0.9619,NFE:0.9574,OTH:0.9439,ASJ:0.9404	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.93	0.000	-0.65	18	MU82008699	hom
18	67753931	67753945	AAAAAAAAAAAAAAA	-	RTTN	intronic	.	ENSG00000176225	rs768452992	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0147	.	.	0.3739	.	.	.	.	.	.	.	.	.	.	AFR:0.3004,AMR:0.3427,EAS:0.6305,FIN:0.05,NFE:0.3849,OTH:0.3669,ASJ:0.2662	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67802449	67802449	T	C	RTTN	exonic	synonymous SNV	ENSG00000176225	rs35139926	ENSG00000176225:ENST00000255674:exon22:c.A2856G:p.L952L,ENSG00000176225:ENST00000437017:exon22:c.A2856G:p.L952L	RTTN:NM_001318520:exon21:c.A120G:p.L40L,RTTN:NM_173630:exon22:c.A2856G:p.L952L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0193	0.0181	0.00539137	0.0237	.	.	.	.	.	.	.	.	RTTN:uc010xfb.1:exon21:c.A120G:p.L40L,RTTN:uc002lkp.2:exon22:c.A2856G:p.L952L	.	AFR:0.0036,AMR:0.0024,EAS:0,FIN:0.0522,NFE:0.0323,OTH:0.0316,ASJ:0.0132	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	het
18	67863850	67863850	-	CTC	RTTN	exonic	nonframeshift insertion	ENSG00000176225	rs58913700	ENSG00000176225:ENST00000583043:exon2:c.97_98insGAG:p.D33delinsGD,ENSG00000176225:ENST00000255674:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000437017:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000454359:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000581161:exon7:c.727_728insGAG:p.D243delinsGD	RTTN:NM_173630:exon7:c.727_728insGAG:p.D243delinsGD	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9870	0.9540	0.952676	0.9584	.	.	.	.	.	.	.	.	RTTN:uc002lkp.2:exon7:c.727_728insGAG:p.D243delinsGD,RTTN:uc002lkq.1:exon7:c.727_728insGAG:p.D243delinsGD	.	AFR:0.8541,AMR:0.9892,EAS:1,FIN:1,NFE:0.9994,OTH:0.9969,ASJ:1	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67871343	67871343	A	C	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs3911730	ENSG00000176225:ENST00000255674:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000437017:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000454359:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000581161:exon3:c.T376G:p.S126A	RTTN:NM_173630:exon3:c.T376G:p.S126A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8654	0.7273	0.71226	0.7339	-0.692	0.075	0.698	-1.54	0.175	.	.	Armadillo-like helical	RTTN:uc002lkp.2:exon3:c.T376G:p.S126A,RTTN:uc002lkq.1:exon3:c.T376G:p.S126A	-0.920	AFR:0.2612,AMR:0.8747,EAS:0.9994,FIN:0.9160,NFE:0.9166,OTH:0.8798,ASJ:0.8940	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.58	0.000	1.43	18	MU82008748	hom
18	72343008	72343008	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs7243081	ENSG00000215421:ENST00000299687:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000309902:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000577538:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000582337:exon2:c.T33C:p.D11D	ZNF407:NM_001146189:exon1:c.T33C:p.D11D,ZNF407:NM_001146190:exon1:c.T33C:p.D11D,ZNF407:NM_017757:exon1:c.T33C:p.D11D	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9898	0.9987	0.99361	0.9969	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T33C:p.D11D,ZNF407:uc010dqu.2:exon1:c.T33C:p.D11D,ZNF407:uc010xfc.2:exon1:c.T33C:p.D11D,ZNF407:uc002llu.2:exon2:c.T30C:p.D10D	.	AFR:0.9984,AMR:0.9093,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU82009013	hom
18	72776121	72776121	G	A	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs3744913	ENSG00000215421:ENST00000299687:exon8:c.G6444A:p.T2148T	ZNF407:NM_017757:exon8:c.G6444A:p.T2148T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8322	0.7615	0.760383	0.7835	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon8:c.G6444A:p.T2148T	.	AFR:0.5472,AMR:0.8022,EAS:0.9116,FIN:0.9124,NFE:0.8690,OTH:0.8637,ASJ:0.8477	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU4566146	het
18	74962645	74962645	T	C	GALR1	exonic	synonymous SNV	ENSG00000166573	rs5374	ENSG00000166573:ENST00000299727:exon1:c.T141C:p.G47G	GALR1:NM_001480:exon1:c.T141C:p.G47G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5824	0.5881	0.489816	2(lung)	.	.	.	.	.	.	.	.	GALR1:uc002lms.4:exon1:c.T141C:p.G47G	.	AFR:MU96341,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.4728,FIN:0.3926,NFE:0.7583,OTH:0.3617,ASJ:0.5746	600377	.	.	.	.	.	.	.	.	.	.	.	18	2(large_intestine)	0.6352
18	74980809	74980809	G	A	GALR1	exonic	nonsynonymous SNV	ENSG00000166573	rs5376	ENSG00000166573:ENST00000299727:exon3:c.G1001A:p.S334N	GALR1:NM_001480:exon3:c.G1001A:p.S334N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9731	0.8956	0.90615	0.9156	-0.581	0.139	0.882	1.01	0.007	.	.	.	GALR1:uc002lms.4:exon3:c.G1001A:p.S334N	-0.988	AFR:0.7061,AMR:0.9749,EAS:1,FIN:1,NFE:0.9992,OTH:0.9807,ASJ:1	600377	.	.	.	.	.	.	.	0.0	-0.49	0.000	-0.845	18	MU82009144	hom
19	680378	680378	C	T	FSTL3	exonic	synonymous SNV	ENSG00000070404	rs7246311	ENSG00000070404:ENST00000588773:exon2:c.C128T:p.A43V	FSTL3:NM_005860:exon3:c.C394T:p.L132L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5719	.	0.348842	0.3951	.	.	.	.	.	.	.	.	FSTL3:uc002lpk.1:exon3:c.C394T:p.L132L	.	AFR:0.2872,AMR:0.3487,EAS:0.2271,FIN:0.4825,NFE:0.4570,OTH:0.4435,ASJ:0.3412	605343	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	855587	855587	C	T	ELANE	exonic	synonymous SNV	ENSG00000197561	rs17223045	ENSG00000197561:ENST00000263621:exon4:c.C390T:p.N130N,ENSG00000197561:ENST00000590230:exon5:c.C390T:p.N130N	ELANE:NM_001972:exon4:c.C390T:p.N130N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0163	0.0316	0.0249601	0.0263	.	.	.	.	.	.	.	.	ELANE:uc002lqb.3:exon4:c.C390T:p.N130N	.	AFR:0.0723,AMR:0.0095,EAS:0,FIN:0.0043,NFE:0.0096,OTH:0.0164,ASJ:0.0033	130130	162800;202700;	486;2686;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2686|-|1-9 / 1 000 000|Autosomal dominant|All ages|162800 ~	~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	.	.	.	.	19	.	het
19	929678	929678	G	A	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs3826948	ENSG00000116017:ENST00000263620:exon2:c.G150A:p.E50E	ARID3A:NM_005224:exon2:c.G150A:p.E50E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6249	0.4235	0.460863	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon2:c.G150A:p.E50E	.	AFR:0.5016,AMR:0.1950,EAS:0.5671,FIN:0.6404,NFE:0.625,OTH:0.6324,ASJ:0.4450	603265	.	.	.	.	.	.	.	.	.	.	.	19	2(large_intestine)	0.5983
19	929753	929753	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1799595	ENSG00000116017:ENST00000263620:exon2:c.A225G:p.P75P	ARID3A:NM_005224:exon2:c.A225G:p.P75P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8572	0.8751	0.884185	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon2:c.A225G:p.P75P	.	AFR:0.8675,AMR:0.9034,EAS:0.8344,FIN:0.9994,NFE:0.8457,OTH:0.8432,ASJ:0.8077	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.8415
19	965043	965043	T	C	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs12608658	ENSG00000116017:ENST00000587532:exon4:c.T702C:p.N234N,ENSG00000116017:ENST00000263620:exon6:c.T1161C:p.N387N	ARID3A:NM_005224:exon6:c.T1161C:p.N387N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9575	0.9483	0.938898	0.9532	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon6:c.T1161C:p.N387N	.	AFR:0.8858,AMR:0.8699,EAS:1,FIN:0.9951,NFE:0.9802,OTH:0.9735,ASJ:0.9868	603265	.	.	.	.	.	.	.	.	.	.	.	19	MU82010062	het
19	966693	966693	C	T	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs6510986	ENSG00000116017:ENST00000263620:exon7:c.C1320T:p.A440A	ARID3A:NM_005224:exon7:c.C1320T:p.A440A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7977	0.8170	0.714856	MU70212	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon7:c.C1320T:p.A440A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,AMR:0.7864,EAS:0.6304,FIN:0.9007,NFE:0.5902,OTH:0.7896,ASJ:0.7121	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(liver)	0.8559
19	971933	971933	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1051504	ENSG00000116017:ENST00000263620:exon9:c.A1650G:p.G550G	ARID3A:NM_005224:exon9:c.A1650G:p.G550G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6590	0.7290	0.594848	2(lung)	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon9:c.A1650G:p.G550G	.	AFR:MU1781969,AMR:LICA-CN|3|402|0.00746269,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6337,FIN:0.5725,NFE:0.8033,OTH:0.4660,ASJ:0.6893	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.6883
19	971949	971949	G	A	ARID3A	exonic	nonsynonymous SNV	ENSG00000116017	rs1051505	ENSG00000116017:ENST00000263620:exon9:c.G1666A:p.G556S	ARID3A:NM_005224:exon9:c.G1666A:p.G556S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7812	0.8295	0.71865	1(lung)	-0.025	2.348	0.369	-7.15	0.000	.	.	.	ARID3A:uc002lql.3:exon9:c.G1666A:p.G556S	-0.998	AFR:MU98751,AMR:LIRI-JP|1|258|0.00387597,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7094,FIN:0.6337,NFE:0.8974,OTH:0.5896,ASJ:0.7803	603265	.	.	.	.	.	.	.	0.0	1.17	0.000	-0.405	19	1(thyroid)	0.7743
19	1615796	1615796	G	A	TCF3	exonic	nonsynonymous SNV	ENSG00000071564	rs2074888	ENSG00000071564:ENST00000586164:exon1:c.C2T:p.A1V,ENSG00000071564:ENST00000587425:exon1:c.C2T:p.A1V,ENSG00000071564:ENST00000590684:exon1:c.C2T:p.A1V,ENSG00000071564:ENST00000592395:exon1:c.C2T:p.A1V,ENSG00000071564:ENST00000585855:exon2:c.C65T:p.A22V,ENSG00000071564:ENST00000592628:exon2:c.C50T:p.A17V,ENSG00000071564:ENST00000453954:exon13:c.C1223T:p.A408V,ENSG00000071564:ENST00000395423:exon14:c.C1322T:p.A441V,ENSG00000071564:ENST00000588136:exon16:c.C1475T:p.A492V,ENSG00000071564:ENST00000262965:exon17:c.C1475T:p.A492V,ENSG00000071564:ENST00000344749:exon17:c.C1475T:p.A492V	TCF3:NM_001136139:exon17:c.C1475T:p.A492V,TCF3:NM_001351778:exon17:c.C1472T:p.A491V,TCF3:NM_001351779:exon17:c.C1475T:p.A492V,TCF3:NM_003200:exon17:c.C1475T:p.A492V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0527	0.0135	0.113618	LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	0.954	10.40	0.44	1.92	0.001	.	.	.	TCF3:uc002lto.3:exon8:c.C758T:p.A253V,TCF3:uc002lts.1:exon13:c.C1223T:p.A408V,TCF3:uc002ltq.3:exon14:c.C1322T:p.A441V,TCF3:uc002ltt.4:exon16:c.C1475T:p.A492V,TCF3:uc002ltr.3:exon17:c.C1475T:p.A492V	-0.910	AFR:0.0352,AMR:0.0250,EAS:0.0695,FIN:0.4222,NFE:0.0034,OTH:0.0049,ASJ:0.0707	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.001	2.56	0.000	-2.085	19	1(liver)	0.0255
19	1619339	1619339	T	C	TCF3	exonic	synonymous SNV	ENSG00000071564	rs8140	ENSG00000071564:ENST00000453954:exon11:c.A1050G:p.S350S,ENSG00000071564:ENST00000395423:exon12:c.A1149G:p.S383S,ENSG00000071564:ENST00000588136:exon14:c.A1302G:p.S434S,ENSG00000071564:ENST00000262965:exon15:c.A1302G:p.S434S,ENSG00000071564:ENST00000344749:exon15:c.A1302G:p.S434S	TCF3:NM_001136139:exon15:c.A1302G:p.S434S,TCF3:NM_001351778:exon15:c.A1299G:p.S433S,TCF3:NM_001351779:exon15:c.A1302G:p.S434S,TCF3:NM_003200:exon15:c.A1302G:p.S434S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4963	0.4902	0.623802	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TCF3:uc002lto.3:exon6:c.A585G:p.S195S,TCF3:uc002lts.1:exon11:c.A1050G:p.S350S,TCF3:uc002ltq.3:exon12:c.A1149G:p.S383S,TCF3:uc002ltt.4:exon14:c.A1302G:p.S434S,TCF3:uc002ltr.3:exon15:c.A1302G:p.S434S	.	AFR:0.5347,AMR:0.7222,EAS:0.4533,FIN:0.8829,NFE:0.4464,OTH:0.4131,ASJ:0.5300	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	1(lung)	0.4897
19	1622116	1622116	G	A	TCF3	exonic	synonymous SNV	ENSG00000071564	rs2240590	ENSG00000071564:ENST00000453954:exon6:c.C507T:p.S169S,ENSG00000071564:ENST00000395423:exon7:c.C606T:p.S202S,ENSG00000071564:ENST00000588136:exon9:c.C759T:p.S253S,ENSG00000071564:ENST00000262965:exon10:c.C759T:p.S253S,ENSG00000071564:ENST00000344749:exon10:c.C759T:p.S253S	TCF3:NM_001136139:exon10:c.C759T:p.S253S,TCF3:NM_001351778:exon10:c.C759T:p.S253S,TCF3:NM_001351779:exon10:c.C759T:p.S253S,TCF3:NM_003200:exon10:c.C759T:p.S253S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2973	0.2314	0.339058	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TCF3:uc002lto.3:exon1:c.C45T:p.S15S,TCF3:uc002lts.1:exon6:c.C507T:p.S169S,TCF3:uc002ltq.3:exon7:c.C606T:p.S202S,TCF3:uc002ltt.4:exon9:c.C759T:p.S253S,TCF3:uc002ltr.3:exon10:c.C759T:p.S253S	.	AFR:0.2416,AMR:0.5231,EAS:0.0767,FIN:0.2142,NFE:0.0981,OTH:0.1189,ASJ:0.3305	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.1540
19	1624007	1624007	A	G	TCF3	intronic	.	ENSG00000071564	rs55677929	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2663	0.2472	0.366813	0.2731	.	.	.	.	.	0	0	.	.	.	AFR:0.2959,AMR:0.2518,EAS:0.6677,FIN:0.2319,NFE:0.2289,OTH:0.2602,ASJ:0.2815	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	MU27524588	het
19	1627422	1627422	T	C	TCF3	exonic	nonsynonymous SNV	ENSG00000071564;ENSG00000071564	rs41275842	ENSG00000071564:ENST00000395423:exon3:c.A149G:p.K50R,ENSG00000071564:ENST00000588136:exon5:c.A302G:p.K101R,ENSG00000071564:ENST00000262965:exon6:c.A302G:p.K101R,ENSG00000071564:ENST00000344749:exon6:c.A302G:p.K101R,ENSG00000071564:ENST00000587235:exon6:c.A389G:p.K130R	TCF3:NM_001136139:exon6:c.A302G:p.K101R,TCF3:NM_001351778:exon6:c.A302G:p.K101R,TCF3:NM_001351779:exon6:c.A302G:p.K101R,TCF3:NM_003200:exon6:c.A302G:p.K101R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0119	0.0107	0.00299521	0.0110	2.336	18.40	0.012	3.48	0.109	.	.	.	TCF3:uc002ltq.3:exon3:c.A149G:p.K50R,TCF3:uc002ltt.4:exon5:c.A302G:p.K101R,TCF3:uc002ltr.3:exon6:c.A302G:p.K101R	-0.376	AFR:0.0017,AMR:0.0024,EAS:0,FIN:0.0126,NFE:0.0180,OTH:0.0081,ASJ:0	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.975	-0.13	0.286	2.65	19	.	het
19	3110349	3110349	T	G	GNA11	intronic	.	ENSG00000088256	rs11085000	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4198	0.3661	0.344249	MU727156	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.3824,EAS:0.4341,FIN:0.34,NFE:0.4108,OTH:0.3693,ASJ:0.2228	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	19	9(meninges)	0.4702
19	3119184	3119184	T	G	GNA11	intronic	.	ENSG00000267139	rs308046	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8340	0.8159	0.773562	0.8281	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8914,EAS:0.7451,FIN:0.8723,NFE:0.8656,OTH:0.8801,ASJ:0.8411	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	19	MU21352930	hom
19	3119239	3119239	C	T	GNA11	exonic	synonymous SNV	ENSG00000088256	rs4900	ENSG00000088256:ENST00000078429:exon6:c.C771T:p.T257T	GNA11:NM_002067:exon6:c.C771T:p.T257T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4263	0.3822	0.348842	10(meninges)	.	.	.	.	.	.	.	.	GNA11:uc002lxd.3:exon6:c.C771T:p.T257T	.	AFR:1(lung),AMR:MU58843,EAS:0.3830,FIN:0.2226,NFE:0.4448,OTH:0.3775,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	5854,5853,5857,,5856,5855,5852,5859,5858,5851,5850,5849	.	.	.	.	.	.	19	1(large_intestine)	0.4158
19	3533274	3533274	G	A	FZR1	intronic	.	ENSG00000105325	rs740681	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3405	0.2002	0.353435	0.2694	.	.	.	.	.	.	.	.	.	.	AFR:0.0594,AMR:0.5227,EAS:0.8459,FIN:0.3465,NFE:0.2934,OTH:0.3190,ASJ:0.2867	603619	.	.	.	.	.	.	.	.	.	.	.	19	MU82012116	het
19	3534842	3534842	G	A	FZR1	UTR3	.	ENSG00000105325	rs10155	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3344	0.2001	0.348043	0.2691	.	.	.	.	.	.	.	.	.	.	AFR:0.0592,AMR:0.5203,EAS:0.8396,FIN:0.3474,NFE:0.2943,OTH:0.3143,ASJ:0.2881	603619	.	.	.	.	.	.	.	.	.	.	.	19	MU736221	het
19	4099187	4099187	T	C	MAP2K2	intronic	.	ENSG00000126934	rs350911	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7718	0.7441	0.773562	0.7575	.	.	.	.	.	.	.	.	.	.	AFR:0.7408,AMR:0.8493,EAS:0.9270,FIN:0.7614,NFE:0.7420,OTH:0.7788,ASJ:0.7252	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	19	MU50776075	hom
19	4362691	4362691	G	C	SH3GL1	exonic	synonymous SNV	ENSG00000141985	rs243261	ENSG00000141985:ENST00000417295:exon7:c.C627G:p.P209P,ENSG00000141985:ENST00000269886:exon8:c.C771G:p.P257P,ENSG00000141985:ENST00000598564:exon8:c.C579G:p.P193P	SH3GL1:NM_001199943:exon7:c.C627G:p.P209P,SH3GL1:NM_001199944:exon8:c.C579G:p.P193P,SH3GL1:NM_003025:exon8:c.C771G:p.P257P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3346	0.3021	0.391573	0.3198	.	.	.	.	.	.	.	.	SH3GL1:uc010xig.2:exon7:c.C627G:p.P209P,SH3GL1:uc002maj.3:exon8:c.C771G:p.P257P,SH3GL1:uc002mak.3:exon8:c.C579G:p.P193P	.	AFR:0.3323,AMR:0.4484,EAS:0.5743,FIN:0.3356,NFE:0.2734,OTH:0.3340,ASJ:0.3133	601768	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	19	MU4612009	het
19	4365468	4365468	G	A	SH3GL1	intronic	.	ENSG00000141985	rs775540178	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	1.655e-05	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601768	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	19	.	het
19	5595354	5595354	T	C	SAFB2	intronic	.	ENSG00000130254	rs10413286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7299	0.7219	0.809305	0.7275	.	.	.	.	.	.	.	.	.	.	AFR:0.8615,AMR:0.7780,EAS:0.8908,FIN:0.6507,NFE:0.6490,OTH:0.6837,ASJ:0.77	608066	.	.	.	.	.	.	.	.	.	.	.	19	MU19175690	hom
19	6213734	6213734	C	G	MLLT1	intronic	.	ENSG00000130382	rs2233196	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0545	0.0451	0.0363419	0.0366	.	.	.	.	.	0.3931	0.54	.	.	.	AFR:0.0087,AMR:0.0550,EAS:0.0043,FIN:0.0302,NFE:0.0549,OTH:0.0525,ASJ:0.0833	159556	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	.	het
19	6586268	6586268	G	A	CD70	exonic	synonymous SNV	ENSG00000125726	rs1862511	ENSG00000125726:ENST00000245903:exon3:c.C345T:p.C115C,ENSG00000125726:ENST00000423145:exon3:c.C345T:p.C115C	CD70:NM_001252:exon3:c.C345T:p.C115C,CD70:NM_001330332:exon3:c.C345T:p.C115C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3201	0.2632	0.350639	0.2883	.	.	.	.	.	.	.	.	CD70:uc002mfi.3:exon3:c.C345T:p.C115C,CD70:uc010xjf.1:exon3:c.C345T:p.C115C	.	AFR:0.1934,AMR:0.2279,EAS:0.6958,FIN:0.3762,NFE:0.2822,OTH:0.2971,ASJ:0.2616	602840	.	.	.	.	.	.	.	.	.	.	.	19	MU4574437	het
19	6821625	6821625	C	T	VAV1	intronic	.	ENSG00000141968	rs28617395	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1270	0.1456	0.0928514	0.1227	.	.	.	.	.	0	0	.	.	.	AFR:0.1067,AMR:0.0887,EAS:0.0401,FIN:0.1262,NFE:0.1426,OTH:0.1137,ASJ:0.13	164875	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU13780375	het
19	6822219	6822219	T	C	VAV1	intronic	.	ENSG00000141968	rs347033	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2609	0.2214	0.211262	0.2123	.	.	.	.	.	.	.	.	.	.	AFR:0.2801,AMR:0.1480,EAS:0.2419,FIN:0.1973,NFE:0.1791,OTH:0.1840,ASJ:0.1954	164875	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU82014037	het
19	7166376	7166376	C	T	INSR	exonic	synonymous SNV	ENSG00000171105	rs2059806	ENSG00000171105:ENST00000600492:exon2:c.G51A:p.A17A,ENSG00000171105:ENST00000302850:exon8:c.G1650A:p.A550A,ENSG00000171105:ENST00000341500:exon8:c.G1650A:p.A550A	INSR:NM_000208:exon8:c.G1650A:p.A550A,INSR:NM_001079817:exon8:c.G1650A:p.A550A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2549	0.2255	0.244808	1(salivary_gland)	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon8:c.G1650A:p.A550A,INSR:uc002mge.1:exon8:c.G1650A:p.A550A,INSR:uc002mgf.3:exon8:c.G1650A:p.A550A	.	AFR:1(thyroid),AMR:MU584487,EAS:0.2328,FIN:0.1834,NFE:0.2584,OTH:0.3179,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,GACA-JP|1|585|0.0017094	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.2432
19	7184652	7184653	GA	-	INSR	intronic	.	ENSG00000171105	rs770709059	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2823	.	.	0.1372	.	.	.	.	.	.	.	.	.	.	AFR:0.0593,AMR:0.2173,EAS:0.1152,FIN:0.2199,NFE:0.1541,OTH:0.2085,ASJ:0.2022	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	MU9370433	unknown
19	7684547	7684547	G	A	XAB2	intronic	.	ENSG00000076924	rs190323188	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0005	.	0.000998403	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0.0006,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	610850	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	7688039	7688039	C	T	XAB2	intronic	.	ENSG00000076924	rs4134846	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1059	0.1241	0.0758786	0.1154	.	.	.	.	.	.	.	.	.	.	AFR:0.0857,AMR:0.1077,EAS:0.0012,FIN:0.1425,NFE:0.1393,OTH:0.1227,ASJ:0.0867	610850	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	7688614	7688614	T	C	XAB2	intronic	.	ENSG00000076924	rs2335521	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1437	0.1473	0.123602	0.1501	.	.	.	.	.	0.1988	0.222	.	.	.	AFR:0.1544,AMR:0.2578,EAS:0.0451,FIN:0.1847,NFE:0.1457,OTH:0.1520,ASJ:0.1060	610850	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	7694393	7694393	G	A	XAB2	exonic	synonymous SNV	ENSG00000076924	rs4134809	ENSG00000076924:ENST00000358368:exon1:c.C21T:p.L7L,ENSG00000076924:ENST00000534844:exon1:c.C12T:p.L4L	XAB2:NM_020196:exon1:c.C21T:p.L7L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3691	0.3139	0.263578	3(lung)	.	.	.	.	.	.	.	.	XAB2:uc002mgx.3:exon1:c.C21T:p.L7L	.	AFR:MU147529,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,EAS:0.2061,FIN:0.2416,NFE:0.2848,OTH:0.1990,ASJ:0.3124	610850	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.4126
19	10265248	10265248	T	C	DNMT1	intronic	.	ENSG00000130816	rs2114724	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5180	0.4882	0.533347	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5121,AMR:0.4941,EAS:0.5267,FIN:0.7122,NFE:0.5213,OTH:0.4972,ASJ:0.5168	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5276
19	10265312	10265312	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs721186	ENSG00000130816:ENST00000340748:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000540357:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000359526:exon21:c.A1782G:p.T594T	DNMT1:NM_001318730:exon20:c.A1734G:p.T578T,DNMT1:NM_001379:exon20:c.A1734G:p.T578T,DNMT1:NM_001130823:exon21:c.A1782G:p.T594T,DNMT1:NM_001318731:exon21:c.A1419G:p.T473T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9910	0.9897	0.995807	0.9905	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon20:c.A1734G:p.T578T,DNMT1:uc010xld.2:exon20:c.A1734G:p.T578T,DNMT1:uc002mnh.3:exon21:c.A1419G:p.T473T,DNMT1:uc010xlc.2:exon21:c.A1782G:p.T594T	.	AFR:0.9961,AMR:0.9916,EAS:1,FIN:0.9888,NFE:0.9862,OTH:0.9969,ASJ:0.9901	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	MU82016881	hom
19	10267077	10267077	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs2228611	ENSG00000130816:ENST00000340748:exon17:c.A1341G:p.P447P,ENSG00000130816:ENST00000540357:exon17:c.A1341G:p.P447P,ENSG00000130816:ENST00000359526:exon18:c.A1389G:p.P463P	DNMT1:NM_001318730:exon17:c.A1341G:p.P447P,DNMT1:NM_001379:exon17:c.A1341G:p.P447P,DNMT1:NM_001130823:exon18:c.A1389G:p.P463P,DNMT1:NM_001318731:exon18:c.A1026G:p.P342P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5188	0.4912	0.533946	MU13784738	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon17:c.A1341G:p.P447P,DNMT1:uc010xld.2:exon17:c.A1341G:p.P447P,DNMT1:uc002mnh.3:exon18:c.A1026G:p.P342P,DNMT1:uc010xlc.2:exon18:c.A1389G:p.P463P	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.5138,EAS:0.5169,FIN:0.5298,NFE:0.7114,OTH:0.5205,ASJ:0.5008	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	2(urinary_tract)	0.4972
19	10270748	10270748	A	-	DNMT1	intronic	.	ENSG00000130816	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	unknown
19	10273372	10273372	T	C	DNMT1	exonic	nonsynonymous SNV	ENSG00000130816	rs2228612	ENSG00000130816:ENST00000340748:exon12:c.A931G:p.I311V,ENSG00000130816:ENST00000540357:exon12:c.A931G:p.I311V,ENSG00000130816:ENST00000359526:exon13:c.A979G:p.I327V	DNMT1:NM_001318730:exon12:c.A931G:p.I311V,DNMT1:NM_001379:exon12:c.A931G:p.I311V,DNMT1:NM_001130823:exon13:c.A979G:p.I327V,DNMT1:NM_001318731:exon13:c.A616G:p.I206V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1320	0.0863	0.198283	MU13145431	-1.756	0.002	1.0	-4.65	0.001	.	.	.	DNMT1:uc002mng.3:exon12:c.A931G:p.I311V,DNMT1:uc010xld.2:exon12:c.A931G:p.I311V,DNMT1:uc002mnh.3:exon13:c.A616G:p.I206V,DNMT1:uc010xlc.2:exon13:c.A979G:p.I327V	-1.092	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,AMR:0.1059,EAS:0.2222,FIN:0.0946,NFE:0.4440,OTH:0.0918,ASJ:0.1236	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	0.0	-1.29	0.000	-0.345	19	1(oesophagus)	0.0562
19	10472933	10472933	A	G	TYK2	intronic	.	ENSG00000105397	rs280519	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5082	0.5264	0.533147	0.5251	.	.	.	.	.	0	0	.	.	.	AFR:0.5636,AMR:0.3401,EAS:0.6213,FIN:0.5195,NFE:0.5036,OTH:0.5287,ASJ:0.5331	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	.	.	.	.	19	MU23957937	het
19	10473138	10473138	A	G	TYK2	intronic	.	ENSG00000105397	rs280520	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3217	0.2730	0.329872	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	0	0	.	.	.	AFR:0.2844,AMR:0.3772,EAS:0.1954,FIN:0.4287,NFE:0.2797,OTH:0.2232,ASJ:0.2019	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	.	.	.	.	19	1(breast)	0.2710
19	10600442	10600442	G	C	KEAP1	exonic	synonymous SNV	ENSG00000079999	rs1048290	ENSG00000079999:ENST00000171111:exon4:c.C1413G:p.L471L,ENSG00000079999:ENST00000393623:exon4:c.C1413G:p.L471L	KEAP1:NM_012289:exon4:c.C1413G:p.L471L,KEAP1:NM_203500:exon4:c.C1413G:p.L471L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4203	0.4780	0.508187	1(urinary_tract)	.	.	.	.	.	.	.	.	KEAP1:uc002mop.1:exon2:c.C567G:p.L189L,KEAP1:uc002moq.1:exon4:c.C1413G:p.L471L,KEAP1:uc002mor.1:exon4:c.C1413G:p.L471L	.	AFR:3(lung),AMR:17(soft_tissue),EAS:MU111229,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.4760,OTH:0.6959,ASJ:1(haematopoietic_and_lymphoid_tissue)	606016	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	2(breast)	0.3230
19	11105608	11105608	T	C	SMARCA4	exonic	synonymous SNV	ENSG00000127616	rs7935	ENSG00000127616:ENST00000413806:exon8:c.T1524C:p.H508H,ENSG00000127616:ENST00000450717:exon8:c.T1524C:p.H508H,ENSG00000127616:ENST00000344626:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000358026:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000590574:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000429416:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000444061:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000541122:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000589677:exon10:c.T1524C:p.H508H	SMARCA4:NM_001128845:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128846:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128848:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128847:exon9:c.T1524C:p.H508H,SMARCA4:NM_001128849:exon9:c.T1524C:p.H508H,SMARCA4:NM_003072:exon9:c.T1524C:p.H508H,SMARCA4:NM_001128844:exon10:c.T1524C:p.H508H	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3353	0.3283	0.311502	11(soft_tissue)	.	.	.	.	.	.	.	.	SMARCA4:uc002mqg.1:exon8:c.T1524C:p.H508H,SMARCA4:uc002mqj.4:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxq.3:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxr.3:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxs.3:exon8:c.T1524C:p.H508H,SMARCA4:uc002mqe.2:exon9:c.T1524C:p.H508H,SMARCA4:uc002mqf.4:exon9:c.T1524C:p.H508H,SMARCA4:uc010dxo.3:exon9:c.T1524C:p.H508H,SMARCA4:uc010dxp.3:exon10:c.T1524C:p.H508H	.	AFR:96(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.3248,NFE:0.3065,OTH:0.2127,ASJ:MU763313	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	,9728	,9727	.	.	.	.	.	19	1(liver)	0.3808
19	11113997	11113997	G	T	SMARCA4	intronic	.	ENSG00000127616	rs74942410	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0675	0.0604	0.0609026	ESAD-UK|1|409|0.00244499	.	.	.	.	.	.	.	.	.	.	AFR:0.0618,AMR:0.0530,EAS:0.0695,FIN:0.0333,NFE:0.0905,OTH:0.0635,ASJ:0.0430	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	.	.	.	.	.	.	.	19	26(meninges)	0.0745
19	11145691	11145691	C	T	SMARCA4	exonic	synonymous SNV	ENSG00000127616	rs28997582	ENSG00000127616:ENST00000413806:exon27:c.C3954T:p.D1318D,ENSG00000127616:ENST00000450717:exon27:c.C3954T:p.D1318D,ENSG00000127616:ENST00000590574:exon28:c.C3954T:p.D1318D,ENSG00000127616:ENST00000344626:exon29:c.C4053T:p.D1351D,ENSG00000127616:ENST00000358026:exon29:c.C4053T:p.D1351D,ENSG00000127616:ENST00000444061:exon29:c.C3954T:p.D1318D,ENSG00000127616:ENST00000541122:exon29:c.C3954T:p.D1318D,ENSG00000127616:ENST00000589677:exon29:c.C3954T:p.D1318D,ENSG00000127616:ENST00000429416:exon30:c.C4053T:p.D1351D	SMARCA4:NM_001128845:exon27:c.C3954T:p.D1318D,SMARCA4:NM_001128846:exon27:c.C3954T:p.D1318D,SMARCA4:NM_001128848:exon27:c.C3954T:p.D1318D,SMARCA4:NM_001128847:exon28:c.C3954T:p.D1318D,SMARCA4:NM_001128849:exon29:c.C4053T:p.D1351D,SMARCA4:NM_003072:exon29:c.C4053T:p.D1351D,SMARCA4:NM_001128844:exon30:c.C4053T:p.D1351D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0727	0.0461	0.0471246	ESAD-UK|1|409|0.00244499	.	.	.	.	.	.	.	.	SMARCA4:uc002mqi.1:exon10:c.C1563T:p.D521D,SMARCA4:uc002mqh.4:exon11:c.C1323T:p.D441D,SMARCA4:uc010dxt.1:exon13:c.C1614T:p.D538D,SMARCA4:uc002mqj.4:exon27:c.C3954T:p.D1318D,SMARCA4:uc010dxq.3:exon27:c.C3954T:p.D1318D,SMARCA4:uc010dxr.3:exon27:c.C3954T:p.D1318D,SMARCA4:uc010dxs.3:exon27:c.C3954T:p.D1318D,SMARCA4:uc002mqf.4:exon29:c.C4053T:p.D1351D,SMARCA4:uc010dxo.3:exon29:c.C4053T:p.D1351D,SMARCA4:uc010dxp.3:exon30:c.C4053T:p.D1351D	.	AFR:0.0496,AMR:0.0123,EAS:0.0662,FIN:0.0327,NFE:0.0901,OTH:0.0622,ASJ:0.0432	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	,9728	,9727	.	.	.	.	.	19	22(meninges)	0.0743
19	11221454	11221454	T	C	LDLR	intronic	.	ENSG00000130164	rs2738442	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	0	0.006	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017144	hom
19	11224265	11224265	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5930	ENSG00000130164:ENST00000455727:exon8:c.A909G:p.R303R,ENSG00000130164:ENST00000535915:exon9:c.A1290G:p.R430R,ENSG00000130164:ENST00000545707:exon9:c.A1032G:p.R344R,ENSG00000130164:ENST00000557933:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558013:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558518:exon10:c.A1413G:p.R471R	LDLR:NM_001195800:exon8:c.A909G:p.R303R,LDLR:NM_001195799:exon9:c.A1290G:p.R430R,LDLR:NM_001195803:exon9:c.A1032G:p.R344R,LDLR:NM_000527:exon10:c.A1413G:p.R471R,LDLR:NM_001195798:exon10:c.A1413G:p.R471R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6266	0.6566	0.654952	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon8:c.A909G:p.R303R,LDLR:uc010xll.2:exon9:c.A1290G:p.R430R,LDLR:uc010xlm.2:exon9:c.A972G:p.R324R,LDLR:uc010xln.2:exon9:c.A1032G:p.R344R,LDLR:uc021upc.1:exon9:c.A1050G:p.R350R,LDLR:uc002mqk.4:exon10:c.A1413G:p.R471R,LDLR:uc010xlk.2:exon10:c.A1413G:p.R471R,LDLR:uc021upd.1:exon10:c.A624G:p.R208R	.	AFR:0.6454,AMR:0.7415,EAS:0.5762,FIN:0.6163,NFE:0.6376,OTH:0.5965,ASJ:0.6933	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5900
19	11233941	11233941	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5927	ENSG00000130164:ENST00000455727:exon13:c.A1728G:p.R576R,ENSG00000130164:ENST00000545707:exon13:c.A1698G:p.R566R,ENSG00000130164:ENST00000535915:exon14:c.A2109G:p.R703R,ENSG00000130164:ENST00000557933:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558013:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558518:exon15:c.A2232G:p.R744R	LDLR:NM_001195800:exon13:c.A1728G:p.R576R,LDLR:NM_001195803:exon13:c.A1698G:p.R566R,LDLR:NM_001195799:exon14:c.A2109G:p.R703R,LDLR:NM_000527:exon15:c.A2232G:p.R744R,LDLR:NM_001195798:exon15:c.A2232G:p.R744R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7762	0.7387	0.780152	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LDLR:uc010xln.2:exon13:c.A1698G:p.R566R,LDLR:uc010xlo.2:exon13:c.A1728G:p.R576R,LDLR:uc010xll.2:exon14:c.A2109G:p.R703R,LDLR:uc010xlm.2:exon14:c.A1791G:p.R597R,LDLR:uc021upc.1:exon14:c.A1869G:p.R623R,LDLR:uc002mqk.4:exon15:c.A2232G:p.R744R,LDLR:uc010xlk.2:exon15:c.A2232G:p.R744R,LDLR:uc021upd.1:exon15:c.A1443G:p.R481R	.	AFR:0.7480,AMR:0.6849,EAS:0.7053,FIN:0.9491,NFE:0.7702,OTH:0.7530,ASJ:0.8484	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.75
19	13318673	13318678	CTGCTG	-	CACNA1A	exonic	nonframeshift deletion	ENSG00000141837	rs16054	ENSG00000141837:ENST00000587525:exon19:c.2395_2400del:p.799_800del,ENSG00000141837:ENST00000585802:exon23:c.2992_2997del:p.998_999del,ENSG00000141837:ENST00000360228:exon47:c.6970_6975del:p.2324_2325del	CACNA1A:NM_001127222:exon47:c.6970_6975del:p.2324_2325del	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2904	0.2257	.	0.3644	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon19:c.2485_2490del:p.829_830del,CACNA1A:uc002mwx.3:exon23:c.3052_3057del:p.1018_1019del,CACNA1A:uc010dzc.2:exon38:c.5548_5553del:p.1850_1851del,CACNA1A:uc002mwy.3:exon47:c.6970_6975del:p.2324_2325del,CACNA1A:uc010xne.2:exon47:c.6979_6984del:p.2327_2328del	.	AFR:0.5415,AMR:0.4185,EAS:0.2021,FIN:0.2323,NFE:0.3016,OTH:0.3398,ASJ:0.3910	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	.	het
19	13319693	13319693	A	G	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs16051	ENSG00000141837:ENST00000587525:exon18:c.T2082C:p.H694H,ENSG00000141837:ENST00000585802:exon22:c.T2679C:p.H893H,ENSG00000141837:ENST00000360228:exon46:c.T6657C:p.H2219H,ENSG00000141837:ENST00000573710:exon46:c.T6660C:p.H2220H	CACNA1A:NM_001127221:exon46:c.T6660C:p.H2220H,CACNA1A:NM_001127222:exon46:c.T6657C:p.H2219H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6160	0.6088	0.686901	COCA-CN|8|321|0.0249221	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon18:c.T2172C:p.H724H,CACNA1A:uc002mwx.3:exon22:c.T2739C:p.H913H,CACNA1A:uc010dzc.2:exon37:c.T5235C:p.H1745H,CACNA1A:uc002mwy.3:exon46:c.T6657C:p.H2219H,CACNA1A:uc010dze.2:exon46:c.T6657C:p.H2219H,CACNA1A:uc010xnd.2:exon46:c.T6666C:p.H2222H,CACNA1A:uc010xne.2:exon46:c.T6666C:p.H2222H,CACNA1A:uc021ups.1:exon46:c.T6657C:p.H2219H,CACNA1A:uc021upt.1:exon46:c.T6660C:p.H2220H	.	AFR:0.6902,AMR:0.7687,EAS:0.5352,FIN:0.7786,NFE:0.7115,OTH:0.6401,ASJ:0.6079	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	4(large_intestine)	0.6366
19	13341037	13341037	G	A	CACNA1A	intronic	.	ENSG00000141837	rs16042	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1942	0.1448	0.289537	0.1684	.	.	.	.	.	.	.	.	.	.	AFR:0.1766,AMR:0.2895,EAS:0.6669,FIN:0.0939,NFE:0.1229,OTH:0.1472,ASJ:0.1291	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU17224664	het
19	13397560	13397560	C	T	CACNA1A	exonic	nonsynonymous SNV	ENSG00000141837	rs16027	ENSG00000141837:ENST00000360228:exon20:c.G3310A:p.G1104S,ENSG00000141837:ENST00000573710:exon20:c.G3313A:p.G1105S	CACNA1A:NM_001127221:exon20:c.G3313A:p.G1105S,CACNA1A:NM_001127222:exon20:c.G3310A:p.G1104S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1127	0.0739	0.100439	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	2.876	21.7	0.193	-0.306	0.175	.	.	.	CACNA1A:uc010dzc.2:exon11:c.G1888A:p.G630S,CACNA1A:uc002mwy.3:exon20:c.G3310A:p.G1104S,CACNA1A:uc010dze.2:exon20:c.G3310A:p.G1104S,CACNA1A:uc010xnd.2:exon20:c.G3319A:p.G1107S,CACNA1A:uc010xne.2:exon20:c.G3319A:p.G1107S,CACNA1A:uc021ups.1:exon20:c.G3310A:p.G1104S,CACNA1A:uc021upt.1:exon20:c.G3313A:p.G1105S	-0.501	AFR:0.0736,AMR:0.0332,EAS:0.0894,FIN:0.0885,NFE:0.0815,OTH:0.0901,ASJ:0.0969	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	0.001	-3.75	0.078	1.1	19	1(lung)	0.1053
19	13411482	13411482	G	A	CACNA1A	intronic	.	ENSG00000141837	rs16018	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7491	0.6452	0.739217	0.6801	.	.	.	.	.	0	0.006	.	.	.	AFR:0.5061,AMR:0.7955,EAS:0.9981,FIN:0.7861,NFE:0.7122,OTH:0.7209,ASJ:0.7219	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU82017954	hom
19	13414594	13414594	C	T	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs16016	ENSG00000141837:ENST00000360228:exon16:c.G2091A:p.T697T,ENSG00000141837:ENST00000573710:exon16:c.G2094A:p.T698T	CACNA1A:NM_001127221:exon16:c.G2094A:p.T698T,CACNA1A:NM_001127222:exon16:c.G2091A:p.T697T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1607	0.1141	0.185104	1(thyroid)	.	.	.	.	.	.	.	.	CACNA1A:uc010dzc.2:exon7:c.G669A:p.T223T,CACNA1A:uc002mwy.3:exon16:c.G2091A:p.T697T,CACNA1A:uc010dze.2:exon16:c.G2091A:p.T697T,CACNA1A:uc010xnd.2:exon16:c.G2091A:p.T697T,CACNA1A:uc010xne.2:exon16:c.G2091A:p.T697T,CACNA1A:uc021ups.1:exon16:c.G2091A:p.T697T,CACNA1A:uc021upt.1:exon16:c.G2094A:p.T698T	.	AFR:MU4566431,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.0831,FIN:0.2255,NFE:0.1523,OTH:0.2919,ASJ:0.1230	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.1160
19	13445208	13445208	C	T	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs2248069	ENSG00000141837:ENST00000360228:exon8:c.G1182A:p.E394E,ENSG00000141837:ENST00000573710:exon8:c.G1182A:p.E394E	CACNA1A:NM_001127221:exon8:c.G1182A:p.E394E,CACNA1A:NM_001127222:exon8:c.G1182A:p.E394E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6857	0.6437	0.641174	0.6399	.	.	.	.	.	.	.	.	CACNA1A:uc002mwy.3:exon8:c.G1182A:p.E394E,CACNA1A:uc010dze.2:exon8:c.G1182A:p.E394E,CACNA1A:uc010xnd.2:exon8:c.G1182A:p.E394E,CACNA1A:uc010xne.2:exon8:c.G1182A:p.E394E,CACNA1A:uc021ups.1:exon8:c.G1182A:p.E394E,CACNA1A:uc021upt.1:exon8:c.G1182A:p.E394E	.	AFR:0.5194,AMR:0.7596,EAS:0.6225,FIN:0.6723,NFE:0.6930,OTH:0.7108,ASJ:0.6391	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU20064845	hom
19	15271771	15271771	G	A	NOTCH3	exonic	nonsynonymous SNV	ENSG00000074181	rs1044009	ENSG00000074181:ENST00000263388:exon33:c.C6668T:p.A2223V	NOTCH3:NM_000435:exon33:c.C6668T:p.A2223V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7591	0.7349	0.629393	0.7049	0.823	9.604	0.175	0.427	0.005	.	.	Domain of unknown function DUF3454, notch	NOTCH3:uc002nan.3:exon33:c.C6668T:p.A2223V	-0.953	AFR:0.5350,AMR:0.5943,EAS:0.5856,FIN:0.8099,NFE:0.7920,OTH:0.7813,ASJ:0.7682	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.001	-1.47	0.000	0.895	19	MU75620	hom
19	15273381	15273381	A	G	NOTCH3	intronic	.	ENSG00000074181	rs4809030	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8745	0.9233	0.86901	0.9108	.	.	.	.	.	0	0	.	.	.	AFR:0.9753,AMR:0.7578,EAS:0.8047,FIN:0.8885,NFE:0.9008,OTH:0.8801,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU23789083	hom
19	15276919	15276919	G	A	NOTCH3	intronic	.	ENSG00000074181	rs2074619	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8717	0.9222	0.866613	0.9094	.	.	.	.	.	.	.	.	.	.	AFR:0.9718,AMR:0.7578,EAS:0.8025,FIN:0.8884,NFE:0.9003,OTH:0.8788,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU649788	unknown
19	15278057	15278057	A	G	NOTCH3	intronic	.	ENSG00000074181	rs1548555	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8741	0.9237	0.870008	0.9112	.	.	.	.	.	0.0001	0.034	.	.	.	AFR:0.9764,AMR:0.7566,EAS:0.8049,FIN:0.8884,NFE:0.9009,OTH:0.8786,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU19223798	hom
19	15285052	15285052	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1044006	ENSG00000074181:ENST00000263388:exon25:c.A4563G:p.P1521P	NOTCH3:NM_000435:exon25:c.A4563G:p.P1521P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8812	0.9261	0.871805	0.9112	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon25:c.A4563G:p.P1521P	.	AFR:0.9774,AMR:0.7560,EAS:0.8045,FIN:0.8885,NFE:0.9005,OTH:0.8798,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU72607	hom
19	15292437	15292437	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043997	ENSG00000074181:ENST00000601011:exon16:c.A2583G:p.P861P,ENSG00000074181:ENST00000263388:exon17:c.A2742G:p.P914P	NOTCH3:NM_000435:exon17:c.A2742G:p.P914P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8019	0.7905	0.739018	0.7822	.	.	.	.	.	.	.	.	NOTCH3:uc002nao.1:exon16:c.A2586G:p.P862P,NOTCH3:uc002nan.3:exon17:c.A2742G:p.P914P	.	AFR:0.6053,AMR:0.7076,EAS:0.8340,FIN:0.8445,NFE:0.8651,OTH:0.8187,ASJ:0.8709	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU4550901	hom
19	15295134	15295134	G	A	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043996	ENSG00000074181:ENST00000263388:exon16:c.C2538T:p.C846C	NOTCH3:NM_000435:exon16:c.C2538T:p.C846C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6427	0.5664	0.519968	0.5867	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon16:c.C2538T:p.C846C	.	AFR:0.2616,AMR:0.5395,EAS:0.6050,FIN:0.7516,NFE:0.7284,OTH:0.6988,ASJ:0.6887	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU786918	hom
19	15300069	15300069	T	C	NOTCH3	intronic	.	ENSG00000074181	rs10423702	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8572	0.8891	0.854233	0.8807	.	.	.	.	.	.	.	.	.	.	AFR:0.9086,AMR:0.7434,EAS:0.8798,FIN:0.8635,NFE:0.8780,OTH:0.8449,ASJ:0.9040	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU19224492	hom
19	15302844	15302844	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043994	ENSG00000074181:ENST00000263388:exon4:c.A606G:p.A202A,ENSG00000074181:ENST00000601011:exon4:c.A603G:p.A201A	NOTCH3:NM_000435:exon4:c.A606G:p.A202A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8581	0.8893	0.855831	0.8808	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon4:c.A606G:p.A202A,NOTCH3:uc002nao.1:exon4:c.A606G:p.A202A	.	AFR:0.9088,AMR:0.7452,EAS:0.8795,FIN:0.8643,NFE:0.8779,OTH:0.8469,ASJ:0.9073	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU763505	hom
19	15350594	15350594	G	A	BRD4	exonic	synonymous SNV	ENSG00000141867	rs11669901	ENSG00000141867:ENST00000263377:exon16:c.C3321T:p.L1107L	BRD4:NM_058243:exon16:c.C3321T:p.L1107L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1629	0.1613	0.131989	0.1617	.	.	.	.	.	.	.	.	BRD4:uc002nar.3:exon16:c.C3321T:p.L1107L	.	AFR:0.1351,AMR:0.1134,EAS:0.0587,FIN:0.1999,NFE:0.1823,OTH:0.1616,ASJ:0.1589	608749	.	.	.	.	.	.	.	.	.	.	.	19	MU68367	hom
19	17392894	17392894	G	A	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs8100241	ENSG00000160117:ENST00000394458:exon2:c.G91A:p.A31T,ENSG00000160117:ENST00000404085:exon2:c.G157A:p.A53T,ENSG00000160117:ENST00000404261:exon2:c.G91A:p.A31T,ENSG00000160117:ENST00000433424:exon2:c.G253A:p.A85T,ENSG00000160117:ENST00000594072:exon2:c.G58A:p.A20T,ENSG00000160117:ENST00000598347:exon2:c.G91A:p.A31T	ANKLE1:NM_001278443:exon2:c.G58A:p.A20T,ANKLE1:NM_001278444:exon2:c.G91A:p.A31T,ANKLE1:NM_001278445:exon2:c.G49A:p.A17T,ANKLE1:NM_152363:exon2:c.G91A:p.A31T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4908	0.4351	0.427316	LICA-CN|2|402|0.00497512,COCA-CN|3|321|0.00934579	4.739	24.7	.	1.65	0.145	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon2:c.G58A:p.A20T,ANKLE1:uc002nga.2:exon2:c.G91A:p.A31T,ANKLE1:uc010eao.1:exon2:c.G157A:p.A53T,ANKLE1:uc010xpn.1:exon2:c.G253A:p.A85T	-0.912	AFR:0.4815,AMR:0.4017,EAS:0.4934,FIN:0.3410,NFE:0.5655,OTH:0.5252,ASJ:0.4159	.	.	.	.	.	.	.	.	0.634	-0.13	0.000	2.555	19	9(large_intestine)	0.5082
19	17393015	17393015	C	T	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs1864116	ENSG00000160117:ENST00000394458:exon2:c.C212T:p.A71V,ENSG00000160117:ENST00000404085:exon2:c.C278T:p.A93V,ENSG00000160117:ENST00000404261:exon2:c.C212T:p.A71V,ENSG00000160117:ENST00000433424:exon2:c.C374T:p.A125V,ENSG00000160117:ENST00000594072:exon2:c.C179T:p.A60V,ENSG00000160117:ENST00000598347:exon2:c.C212T:p.A71V	ANKLE1:NM_001278443:exon2:c.C179T:p.A60V,ANKLE1:NM_001278444:exon2:c.C212T:p.A71V,ANKLE1:NM_001278445:exon2:c.C170T:p.A57V,ANKLE1:NM_152363:exon2:c.C212T:p.A71V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7176	0.8695	0.635383	COCA-CN|3|321|0.00934579	2.020	16.34	.	0.796	0.923	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon2:c.C179T:p.A60V,ANKLE1:uc002nga.2:exon2:c.C212T:p.A71V,ANKLE1:uc010eao.1:exon2:c.C278T:p.A93V,ANKLE1:uc010xpn.1:exon2:c.C374T:p.A125V	-1.007	AFR:0.7910,AMR:0.7959,EAS:0.8245,FIN:0.3402,NFE:0.8764,OTH:0.8288,ASJ:0.5694	.	.	.	.	.	.	.	.	0.005	1.6	0.000	1.29	19	5(large_intestine)	0.7853
19	17393504	17393504	G	C	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs1864113	ENSG00000160117:ENST00000394458:exon3:c.G255C:p.A85A,ENSG00000160117:ENST00000404085:exon3:c.G321C:p.A107A,ENSG00000160117:ENST00000404261:exon3:c.G255C:p.A85A,ENSG00000160117:ENST00000433424:exon3:c.G417C:p.A139A,ENSG00000160117:ENST00000594072:exon3:c.G222C:p.A74A,ENSG00000160117:ENST00000598347:exon3:c.G255C:p.A85A	ANKLE1:NM_001278443:exon3:c.G222C:p.A74A,ANKLE1:NM_001278444:exon3:c.G255C:p.A85A,ANKLE1:NM_001278445:exon3:c.G213C:p.A71A,ANKLE1:NM_152363:exon3:c.G255C:p.A85A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7006	0.8398	0.635383	3(lung)	.	.	.	.	.	.	.	.	ANKLE1:uc002nfy.2:exon3:c.G222C:p.A74A,ANKLE1:uc002nga.2:exon3:c.G255C:p.A85A,ANKLE1:uc010eao.1:exon3:c.G321C:p.A107A,ANKLE1:uc010xpn.1:exon3:c.G417C:p.A139A	.	AFR:MU112067,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.7954,FIN:0.5680,NFE:0.8245,OTH:0.3397,ASJ:0.7911	.	.	.	.	.	.	.	.	.	.	.	.	19	5(large_intestine)	0.8759
19	17393530	17393530	T	A	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs8108174	ENSG00000160117:ENST00000394458:exon3:c.T281A:p.L94Q,ENSG00000160117:ENST00000404085:exon3:c.T347A:p.L116Q,ENSG00000160117:ENST00000404261:exon3:c.T281A:p.L94Q,ENSG00000160117:ENST00000433424:exon3:c.T443A:p.L148Q,ENSG00000160117:ENST00000594072:exon3:c.T248A:p.L83Q,ENSG00000160117:ENST00000598347:exon3:c.T281A:p.L94Q	ANKLE1:NM_001278443:exon3:c.T248A:p.L83Q,ANKLE1:NM_001278444:exon3:c.T281A:p.L94Q,ANKLE1:NM_001278445:exon3:c.T239A:p.L80Q,ANKLE1:NM_152363:exon3:c.T281A:p.L94Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.5191	0.5679	0.460663	1(lung)	5.385	26.0	.	4.27	0.033	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon3:c.T248A:p.L83Q,ANKLE1:uc002nga.2:exon3:c.T281A:p.L94Q,ANKLE1:uc010eao.1:exon3:c.T347A:p.L116Q,ANKLE1:uc010xpn.1:exon3:c.T443A:p.L148Q	-0.867	AFR:MU67496,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4994,FIN:0.4248,NFE:0.4967,OTH:0.3399,ASJ:0.5102	.	.	.	.	.	.	.	.	0.793	.	0.000	2.605	19	12(large_intestine)	0.5665
19	17394124	17394124	T	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs2363956	ENSG00000160117:ENST00000394458:exon5:c.T551G:p.L184W,ENSG00000160117:ENST00000404085:exon5:c.T617G:p.L206W,ENSG00000160117:ENST00000404261:exon5:c.T551G:p.L184W,ENSG00000160117:ENST00000433424:exon5:c.T713G:p.L238W,ENSG00000160117:ENST00000594072:exon5:c.T518G:p.L173W,ENSG00000160117:ENST00000598347:exon5:c.T551G:p.L184W	ANKLE1:NM_001278443:exon5:c.T518G:p.L173W,ANKLE1:NM_001278444:exon5:c.T551G:p.L184W,ANKLE1:NM_001278445:exon5:c.T509G:p.L170W,ANKLE1:NM_152363:exon5:c.T551G:p.L184W	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4869	0.5125	0.460663	3(lung)	3.307	22.9	.	2.26	0.002	.	.	.	ANKLE1:uc002nfy.2:exon5:c.T518G:p.L173W,ANKLE1:uc002nga.2:exon5:c.T551G:p.L184W,ANKLE1:uc010eao.1:exon5:c.T617G:p.L206W,ANKLE1:uc010xpn.1:exon5:c.T713G:p.L238W	-0.933	AFR:MU151415,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,PEME-CA|1|112|0.00892857,EAS:0.5,FIN:0.4269,NFE:0.4934,OTH:0.3395,ASJ:0.5096	.	.	.	.	.	.	.	.	0.246	.	0.000	1.65	19	1(thyroid)	0.5662
19	17394504	17394504	A	C	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs891017	ENSG00000160117:ENST00000394458:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000404085:exon5:c.A997C:p.T333P,ENSG00000160117:ENST00000404261:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000433424:exon5:c.A1093C:p.T365P,ENSG00000160117:ENST00000594072:exon5:c.A898C:p.T300P,ENSG00000160117:ENST00000598347:exon5:c.A931C:p.T311P	ANKLE1:NM_001278443:exon5:c.A898C:p.T300P,ANKLE1:NM_001278444:exon5:c.A931C:p.T311P,ANKLE1:NM_001278445:exon5:c.A889C:p.T297P,ANKLE1:NM_152363:exon5:c.A931C:p.T311P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7211	0.8005	0.635383	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	-0.449	0.293	.	0.314	0.003	.	.	LEM domain|LEM/LEM-like domain	ANKLE1:uc002nfz.2:exon4:c.A49C:p.T17P,ANKLE1:uc002nfy.2:exon5:c.A898C:p.T300P,ANKLE1:uc002nga.2:exon5:c.A931C:p.T311P,ANKLE1:uc010eao.1:exon5:c.A997C:p.T333P,ANKLE1:uc010xpn.1:exon5:c.A1093C:p.T365P	-0.972	AFR:0.7912,AMR:0.7954,EAS:0.8245,FIN:0.3402,NFE:0.8756,OTH:0.8296,ASJ:0.5680	.	.	.	.	.	.	.	.	0.0	.	0.000	-1.15	19	1(haematopoietic_and_lymphoid_tissue)	0.7848
19	17395003	17395003	A	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs11086065	ENSG00000160117:ENST00000394458:exon6:c.A1304G:p.Q435R,ENSG00000160117:ENST00000404085:exon6:c.A1292G:p.Q431R,ENSG00000160117:ENST00000594072:exon6:c.A1193G:p.Q398R,ENSG00000160117:ENST00000598347:exon6:c.A1226G:p.Q409R	ANKLE1:NM_001278443:exon6:c.A1193G:p.Q398R,ANKLE1:NM_001278444:exon6:c.A1226G:p.Q409R,ANKLE1:NM_001278445:exon6:c.A1184G:p.Q395R,ANKLE1:NM_152363:exon6:c.A1304G:p.Q435R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7206	0.8009	0.635184	1(haematopoietic_and_lymphoid_tissue)	-2.006	0.001	.	-7.51	0.017	.	.	GIY-YIG nuclease superfamily	ANKLE1:uc002nfz.2:exon5:c.A422G:p.Q141R,ANKLE1:uc002nfy.2:exon6:c.A1193G:p.Q398R,ANKLE1:uc002nga.2:exon6:c.A1304G:p.Q435R,ANKLE1:uc010eao.1:exon6:c.A1292G:p.Q431R,ANKLE1:uc010xpn.1:exon6:c.A1388G:p.Q463R	-0.963	AFR:MU4566639,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.7954,FIN:0.5680,NFE:0.8233,OTH:0.3398,ASJ:0.7908	.	.	.	.	.	.	.	.	0.0	.	0.000	0.475	19	1(breast)	0.8756
19	17395055	17395055	C	G	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs11882562	ENSG00000160117:ENST00000394458:exon6:c.C1356G:p.T452T,ENSG00000160117:ENST00000404085:exon6:c.C1344G:p.T448T,ENSG00000160117:ENST00000594072:exon6:c.C1245G:p.T415T,ENSG00000160117:ENST00000598347:exon6:c.C1278G:p.T426T	ANKLE1:NM_001278443:exon6:c.C1245G:p.T415T,ANKLE1:NM_001278444:exon6:c.C1278G:p.T426T,ANKLE1:NM_001278445:exon6:c.C1236G:p.T412T,ANKLE1:NM_152363:exon6:c.C1356G:p.T452T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7208	0.8008	0.635383	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ANKLE1:uc002nfz.2:exon5:c.C474G:p.T158T,ANKLE1:uc002nfy.2:exon6:c.C1245G:p.T415T,ANKLE1:uc002nga.2:exon6:c.C1356G:p.T452T,ANKLE1:uc010eao.1:exon6:c.C1344G:p.T448T,ANKLE1:uc010xpn.1:exon6:c.C1440G:p.T480T	.	AFR:0.7910,AMR:0.7954,EAS:0.8221,FIN:0.3418,NFE:0.8756,OTH:0.8289,ASJ:0.5680	.	.	.	.	.	.	.	.	.	.	.	.	19	3(lung)	0.7867
19	17396549	17396549	T	C	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs751599	ENSG00000160117:ENST00000394458:exon8:c.T1596C:p.G532G,ENSG00000160117:ENST00000404085:exon8:c.T1584C:p.G528G,ENSG00000160117:ENST00000594072:exon8:c.T1485C:p.G495G	ANKLE1:NM_001278443:exon8:c.T1485C:p.G495G,ANKLE1:NM_001278445:exon8:c.T1476C:p.G492G,ANKLE1:NM_152363:exon8:c.T1596C:p.G532G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7214	0.8006	0.635383	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ANKLE1:uc002nfz.2:exon7:c.T714C:p.G238G,ANKLE1:uc002nfy.2:exon8:c.T1485C:p.G495G,ANKLE1:uc002nga.2:exon8:c.T1596C:p.G532G,ANKLE1:uc010eao.1:exon8:c.T1584C:p.G528G	.	AFR:0.7914,AMR:0.7960,EAS:0.8245,FIN:0.3420,NFE:0.8757,OTH:0.8300,ASJ:0.5680	.	.	.	.	.	.	.	.	.	.	.	.	19	1(lung)	0.7857
19	17397481	17397481	G	T	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs1465581	ENSG00000160117:ENST00000598347:exon8:c.G1751T:p.C584F	ANKLE1:NM_001278444:exon8:c.G1751T:p.C584F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1944	.	.	15(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	ANKLE1:uc010xpn.1:exon8:c.G1913T:p.C638F	.	AFR:1(skin),AMR:MU4566645,EAS:0.3276,FIN:0.2027,NFE:0.3154,OTH:0.4053,ASJ:BTCA-JP|1|239|0.0041841,THCA-SA|1|243|0.00411523	.	.	.	.	.	.	.	.	.	.	.	.	19	1(biliary_tract)	0.1114
19	17941294	17941294	T	C	JAK3	intronic	.	ENSG00000105639	rs2302603	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4096	0.3479	0.434305	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.3627,AMR:0.4001,EAS:0.2533,FIN:0.4688,NFE:0.3369,OTH:0.3299,ASJ:0.4759	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	12(soft_tissue)	0.3835
19	18266672	18266672	C	T	PIK3R2	UTR5	.	ENSG00000105647;ENSG00000268173	rs148245146	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0008	.	0.00279553	0.0005	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0087,FIN:0,NFE:6.67e-05,OTH:0,ASJ:0	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	.	het
19	18272190	18272190	A	C	PIK3R2	exonic	nonsynonymous SNV	ENSG00000105647;ENSG00000268173	rs2241088	ENSG00000105647:ENST00000426902:exon5:c.A700C:p.S234R,ENSG00000105647:ENST00000222254:exon6:c.A700C:p.S234R,ENSG00000268173:ENST00000593731:exon6:c.A700C:p.S234R	PIK3R2:NM_005027:exon6:c.A700C:p.S234R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.8961	.	0.923922	0.9373	1.371	12.64	0.315	2.02	0.732	.	.	Rho GTPase activation protein|Rho GTPase-activating protein domain	PIK3R2:uc002nia.2:exon6:c.A700C:p.S234R	-1.064	AFR:0.9734,AMR:0.9224,EAS:0.8998,FIN:0.8977,NFE:0.9293,OTH:0.9072,ASJ:0.9375	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	2.17	0.000	0.295	19	.	hom
19	18273047	18273047	T	C	PIK3R2	exonic	nonsynonymous SNV	ENSG00000105647;ENSG00000268173	rs1011320	ENSG00000105647:ENST00000426902:exon7:c.T937C:p.S313P,ENSG00000105647:ENST00000222254:exon8:c.T937C:p.S313P,ENSG00000268173:ENST00000593731:exon8:c.T937C:p.S313P	PIK3R2:NM_005027:exon8:c.T937C:p.S313P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9501	0.9552	0.953474	0.9570	-1.239	0.006	0.722	-1.99	0.006	.	.	.	PIK3R2:uc002nia.2:exon8:c.T937C:p.S313P	-1.020	AFR:0.9703,AMR:0.9737,EAS:0.9635,FIN:0.9587,NFE:0.9480,OTH:0.9418,ASJ:0.9667	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	0.88	0.000	-1.04	19	MU82021073	hom
19	18279638	18279638	T	C	PIK3R2	exonic	synonymous SNV	ENSG00000105647;ENSG00000268173	rs273269	ENSG00000105647:ENST00000222254:exon15:c.T1911C:p.S637S,ENSG00000268173:ENST00000593731:exon15:c.T1911C:p.S637S	PIK3R2:NM_005027:exon15:c.T1911C:p.S637S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8800	0.8511	0.86242	0.8614	.	.	.	.	.	.	.	.	PIK3R2:uc002nia.2:exon15:c.T1911C:p.S637S	.	AFR:0.7798,AMR:0.9021,EAS:0.9227,FIN:0.9186,NFE:0.8861,OTH:0.8666,ASJ:0.8709	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	MU4566745	hom
19	18562438	18562438	C	T	ELL	exonic	nonsynonymous SNV	ENSG00000105656	rs2303694	ENSG00000105656:ENST00000262809:exon7:c.G890A:p.S297N,ENSG00000105656:ENST00000596124:exon7:c.G491A:p.S164N	ELL:NM_006532:exon7:c.G890A:p.S297N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1843	0.125	0.151957	1(lung)	-0.962	0.019	1.0	-0.837	0.106	.	.	.	ELL:uc002njg.3:exon7:c.G491A:p.S164N,ELL:uc002njh.3:exon7:c.G890A:p.S297N,ELL:uc010ebq.3:exon8:c.G719A:p.S240N	-0.987	AFR:MU114062,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.1900,FIN:0.0752,NFE:0.0993,OTH:0.1069,ASJ:0.1480	600284	.	.	.	.	.	.	.	0.0	1.89	0.000	0.46	19	1(thyroid)	0.1628
19	18567189	18567189	A	G	ELL	intronic	.	ENSG00000105656	rs76184771	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.158946	0.1553	.	.	.	.	.	.	.	.	.	.	AFR:0.2078,AMR:0.0776,EAS:0.1093,FIN:0.1650,NFE:0.1333,OTH:0.1495,ASJ:0.0993	600284	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	18857939	18857939	-	C	CRTC1	intronic	.	ENSG00000105662	rs56040769	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0949	0.1257	.	0.2415	.	.	.	.	.	.	.	.	.	.	AFR:0.1758,AMR:0.2623,EAS:0.2141,FIN:0.3460,NFE:0.2525,OTH:0.2926,ASJ:0.2826	607536	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	18876309	18876309	A	G	CRTC1	exonic	nonsynonymous SNV	ENSG00000105662	rs3746266	ENSG00000105662:ENST00000601916:exon8:c.A757G:p.T253A,ENSG00000105662:ENST00000321949:exon9:c.A982G:p.T328A,ENSG00000105662:ENST00000594658:exon9:c.A859G:p.T287A,ENSG00000105662:ENST00000338797:exon10:c.A1030G:p.T344A	CRTC1:NM_015321:exon9:c.A982G:p.T328A,CRTC1:NM_001098482:exon10:c.A1030G:p.T344A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.1452	0.1307	0.126797	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	2.664	20.6	0.052	3.31	0.998	.	.	.	CRTC1:uc010ebw.3:exon6:c.A577G:p.T193A,CRTC1:uc002nkb.4:exon9:c.A982G:p.T328A,CRTC1:uc010ebv.3:exon10:c.A1030G:p.T344A	-1.061	AFR:0.1253,AMR:0.0700,EAS:0.2450,FIN:0.2043,NFE:0.1201,OTH:0.1484,ASJ:0.1086	607536	.	.	.	.	.	.	.	0.979	2.64	0.000	2.24	19	5(soft_tissue)	0.1296
19	18886431	18886431	T	C	CRTC1	intronic	.	ENSG00000105662	rs12609934	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2262	0.2186	0.221645	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU28604669,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,EAS:0.3493,FIN:0.1265,NFE:0.2567,OTH:0.2038,ASJ:0.2009	607536	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.1069
19	31769763	31769763	G	A	TSHZ3	exonic	synonymous SNV	ENSG00000121297	rs12461253	ENSG00000121297:ENST00000240587:exon2:c.C936T:p.V312V	TSHZ3:NM_020856:exon2:c.C936T:p.V312V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3156	0.2691	0.35004	MU145347	.	.	.	.	.	.	.	.	TSHZ3:uc002nsy.4:exon2:c.C936T:p.V312V	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2985,EAS:0.2828,FIN:0.3079,NFE:0.5668,OTH:0.3321,ASJ:0.2317	614119	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.2999
19	31770009	31770009	C	T	TSHZ3	exonic	synonymous SNV	ENSG00000121297	rs28609894	ENSG00000121297:ENST00000240587:exon2:c.G690A:p.T230T	TSHZ3:NM_020856:exon2:c.G690A:p.T230T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2503	0.2834	0.314696	1(lung)	.	.	.	.	.	.	.	.	TSHZ3:uc002nsy.4:exon2:c.G690A:p.T230T	.	AFR:1(urinary_tract),AMR:MU126805,EAS:0.2566,FIN:0.4071,NFE:0.2053,OTH:0.4040,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	614119	.	.	.	.	.	.	.	.	.	.	.	19	1(thyroid)	0.2351
19	33467357	33467357	G	A	FAAP24	exonic	synonymous SNV	ENSG00000131944	rs2304102	ENSG00000131944:ENST00000590179:exon3:c.G132A:p.E44E,ENSG00000131944:ENST00000589646:exon4:c.G132A:p.E44E,ENSG00000131944:ENST00000588258:exon5:c.G417A:p.E139E,ENSG00000131944:ENST00000590281:exon5:c.G417A:p.E139E	FAAP24:NM_001300978:exon3:c.G132A:p.E44E,FAAP24:NM_152266:exon5:c.G417A:p.E139E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4029	0.3782	0.423922	1(breast)	.	.	.	.	.	.	.	.	C19orf40:uc002nud.4:exon5:c.G417A:p.E139E	.	AFR:MU153963,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.4024,FIN:0.5525,NFE:0.3874,OTH:0.4739,ASJ:0.4004	610884	.	.	.	.	.	.	.	.	.	.	.	19	3(haematopoietic_and_lymphoid_tissue)	0.3965
19	33467413	33467413	C	T	FAAP24	exonic	nonsynonymous SNV	ENSG00000131944	rs2304103	ENSG00000131944:ENST00000590179:exon3:c.C188T:p.S63L,ENSG00000131944:ENST00000589646:exon4:c.C188T:p.S63L,ENSG00000131944:ENST00000588258:exon5:c.C473T:p.S158L,ENSG00000131944:ENST00000590281:exon5:c.C473T:p.S158L	FAAP24:NM_001300978:exon3:c.C188T:p.S63L,FAAP24:NM_152266:exon5:c.C473T:p.S158L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0589	0.0502	0.0702875	0.0440	-0.030	2.310	.	0.673	0.056	.	.	RuvA domain 2-like	C19orf40:uc002nud.4:exon5:c.C473T:p.S158L	-1.073	AFR:0.0625,AMR:0.0598,EAS:0.0611,FIN:0.0117,NFE:0.0375,OTH:0.0347,ASJ:0.0993	610884	.	.	.	.	.	.	.	0.382	3.43	0.003	0.805	19	MU13185881	het
19	33467515	33467515	T	C	FAAP24	exonic	nonsynonymous SNV	ENSG00000131944	rs3816032	ENSG00000131944:ENST00000590179:exon3:c.T290C:p.I97T,ENSG00000131944:ENST00000589646:exon4:c.T290C:p.I97T,ENSG00000131944:ENST00000588258:exon5:c.T575C:p.I192T,ENSG00000131944:ENST00000590281:exon5:c.T575C:p.I192T	FAAP24:NM_001300978:exon3:c.T290C:p.I97T,FAAP24:NM_152266:exon5:c.T575C:p.I192T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1583	0.1070	0.189696	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	-0.030	2.308	.	3.21	0.047	.	.	RuvA domain 2-like	C19orf40:uc002nud.4:exon5:c.T575C:p.I192T	-1.003	AFR:0.1155,AMR:0.0885,EAS:0.1821,FIN:0.3079,NFE:0.0868,OTH:0.1118,ASJ:0.1722	610884	.	.	.	.	.	.	.	0.002	2.02	0.000	1.585	19	1(lung)	0.1296
19	33792631	33792631	C	A	CEBPA	exonic	synonymous SNV	ENSG00000245848	rs34529039	ENSG00000245848:ENST00000498907:exon1:c.G690T:p.T230T	CEBPA:NM_001285829:exon1:c.G333T:p.T111T,CEBPA:NM_001287424:exon1:c.G795T:p.T265T,CEBPA:NM_001287435:exon1:c.G648T:p.T216T,CEBPA:NM_004364:exon1:c.G690T:p.T230T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.2143	.	0.132788	0.1567	.	.	.	.	.	.	.	.	CEBPA:uc002nun.3:exon1:c.G690T:p.T230T	.	AFR:0.2520,AMR:0.1017,EAS:0.0025,FIN:0.1166,NFE:0.1266,OTH:0.1114,ASJ:0.1475	116897	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	2033,,2035,2039,2038,2034	.	,2044,2037,2040,2041,2036,2042,2043	.	.	.	.	19	.	het
19	35832823	35832823	A	G	CD22	exonic	nonsynonymous SNV	ENSG00000012124	rs17719289	ENSG00000012124:ENST00000594250:exon6:c.A1459G:p.S487G,ENSG00000012124:ENST00000341773:exon7:c.A1459G:p.S487G,ENSG00000012124:ENST00000419549:exon8:c.A1474G:p.S492G,ENSG00000012124:ENST00000536635:exon8:c.A1726G:p.S576G,ENSG00000012124:ENST00000085219:exon9:c.A1990G:p.S664G,ENSG00000012124:ENST00000270311:exon9:c.A1630G:p.S544G,ENSG00000012124:ENST00000544992:exon9:c.A1990G:p.S664G	CD22:NM_001185101:exon7:c.A1459G:p.S487G,CD22:NM_001185099:exon8:c.A1726G:p.S576G,CD22:NM_001278417:exon8:c.A1474G:p.S492G,CD22:NM_001185100:exon9:c.A1990G:p.S664G,CD22:NM_001771:exon9:c.A1990G:p.S664G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0038	.	0.00898562	0.0023	-1.938	0.001	0.356	-10.6	0.014	.	.	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	CD22:uc002nzb.4:exon7:c.A1459G:p.S487G,CD22:uc010edu.3:exon8:c.A1726G:p.S576G,CD22:uc010edt.3:exon9:c.A1990G:p.S664G,CD22:uc010edv.3:exon9:c.A1990G:p.S664G,CD22:uc010xst.2:exon9:c.A1474G:p.S492G	-0.950	AFR:0,AMR:0,EAS:0.0432,FIN:0,NFE:0,OTH:0.0010,ASJ:0	107266	.	.	.	.	.	.	.	0.002	2.7	0.003	0.29	19	MU82233474	het
19	35835940	35835940	C	T	CD22	intronic	.	ENSG00000012124	rs45453699	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2795	0.3193	0.332668	0.2999	.	.	.	.	.	.	.	.	.	.	AFR:0.4144,AMR:0.3687,EAS:0.2491,FIN:0.2111,NFE:0.258,OTH:0.2623,ASJ:0.3013	107266	.	.	.	.	.	.	.	.	.	.	.	19	MU26144015	het
19	35836600	35836600	C	A	CD22	exonic	synonymous SNV	ENSG00000012124	rs34826052	ENSG00000012124:ENST00000594250:exon9:c.C1773A:p.P591P,ENSG00000012124:ENST00000341773:exon10:c.C1773A:p.P591P,ENSG00000012124:ENST00000419549:exon11:c.C1788A:p.P596P,ENSG00000012124:ENST00000536635:exon11:c.C2040A:p.P680P,ENSG00000012124:ENST00000085219:exon12:c.C2304A:p.P768P	CD22:NM_001185101:exon10:c.C1773A:p.P591P,CD22:NM_001185099:exon11:c.C2040A:p.P680P,CD22:NM_001278417:exon11:c.C1788A:p.P596P,CD22:NM_001771:exon12:c.C2304A:p.P768P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0401	0.0229	0.0607029	0.0310	.	.	.	.	.	.	.	.	CD22:uc002nzb.4:exon10:c.C1773A:p.P591P,CD22:uc010edu.3:exon11:c.C2040A:p.P680P,CD22:uc010edt.3:exon12:c.C2304A:p.P768P,CD22:uc010xst.2:exon12:c.C1788A:p.P596P	.	AFR:0.0193,AMR:0.0119,EAS:0.1525,FIN:0.0269,NFE:0.0271,OTH:0.0336,ASJ:0.0099	107266	.	.	.	.	.	.	.	.	.	.	.	19	MU584603	het
19	36224705	36224705	A	G	KMT2B	exonic	nonsynonymous SNV	ENSG00000272333	rs231591	ENSG00000272333:ENST00000222270:exon30:c.A7091G:p.D2364G,ENSG00000272333:ENST00000420124:exon30:c.A7091G:p.D2364G	KMT2B:NM_014727:exon30:c.A7091G:p.D2364G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5331	0.5792	0.620407	1(pleura)	-0.588	0.134	1.0	1.66	0.103	.	.	.	KMT2B:uc021usv.1:exon30:c.A7091G:p.D2364G	-0.961	AFR:1(lung),AMR:1(stomach),EAS:MU112187,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.5734,OTH:0.7952,ASJ:1(haematopoietic_and_lymphoid_tissue)	606834	.	.	.	.	.	.	.	0.0	-1.64	0.000	-0.69	19	1(large_intestine)	0.4209
19	36228954	36228954	G	T	KMT2B	intronic	.	ENSG00000105663	rs2242522	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4597	0.4054	0.377995	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.01	.	.	.	AFR:0.4194,AMR:0.2030,EAS:0.4669,FIN:0.5105,NFE:0.5020,OTH:0.5032,ASJ:0.5909	606834	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.4537
19	38939408	38939408	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs10406027	ENSG00000196218:ENST00000355481:exon11:c.T1077C:p.A359A,ENSG00000196218:ENST00000359596:exon11:c.T1077C:p.A359A,ENSG00000196218:ENST00000360985:exon11:c.T1077C:p.A359A	RYR1:NM_000540:exon11:c.T1077C:p.A359A,RYR1:NM_001042723:exon11:c.T1077C:p.A359A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8844	0.8952	0.903954	0.9058	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon11:c.T1077C:p.A359A,RYR1:uc002oiu.3:exon11:c.T1077C:p.A359A	.	AFR:0.9348,AMR:0.9165,EAS:0.9938,FIN:0.9272,NFE:0.8741,OTH:0.8937,ASJ:0.9272	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	MU4567228	het
19	38946182	38946182	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2288888	ENSG00000196218:ENST00000355481:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000359596:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000360985:exon15:c.G1668A:p.S556S	RYR1:NM_000540:exon15:c.G1668A:p.S556S,RYR1:NM_001042723:exon15:c.G1668A:p.S556S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6366	0.6321	0.571286	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon15:c.G1668A:p.S556S,RYR1:uc002oiu.3:exon15:c.G1668A:p.S556S	.	AFR:0.6389,AMR:0.5420,EAS:0.6954,FIN:0.6088,NFE:0.7077,OTH:0.6745,ASJ:0.7100	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6838
19	38949904	38949904	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs3745847	ENSG00000196218:ENST00000355481:exon19:c.C2286T:p.P762P,ENSG00000196218:ENST00000359596:exon19:c.C2286T:p.P762P,ENSG00000196218:ENST00000360985:exon19:c.C2286T:p.P762P	RYR1:NM_000540:exon19:c.C2286T:p.P762P,RYR1:NM_001042723:exon19:c.C2286T:p.P762P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6211	0.6170	0.554113	MU4567230	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon19:c.C2286T:p.P762P,RYR1:uc002oiu.3:exon19:c.C2286T:p.P762P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6271,EAS:0.7005,FIN:0.6623,NFE:0.5893,OTH:0.6999,ASJ:0.5264	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6645
19	38956803	38956803	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2228069	ENSG00000196218:ENST00000355481:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000359596:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000360985:exon24:c.G2943A:p.T981T	RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5962	0.5971	0.545527	1(liver)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon24:c.G2943A:p.T981T,RYR1:uc002oiu.3:exon24:c.G2943A:p.T981T	.	AFR:MU153475,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.5620,FIN:0.6993,NFE:0.6556,OTH:0.5235,ASJ:0.5968	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5798
19	39408360	39408360	A	G	SARS2	intronic	.	ENSG00000104835;ENSG00000269547	rs7508411	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7066	0.7052	0.834665	0.7254	.	.	.	.	.	0	0.074	.	.	.	AFR:0.8753,AMR:0.7803,EAS:0.9659,FIN:0.6919,NFE:0.6179,OTH:0.6801,ASJ:0.7416	612804	613845;	363694;	363694|HUPRA syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613845 ~	.	.	.	.	.	.	.	.	19	MU9418845	het
19	39421388	39421388	A	G	MRPS12;SARS2	UTR5	.	ENSG00000104835;ENSG00000128626	rs730078	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7121	0.7138	0.842053	0.7293	.	.	.	.	.	.	.	.	.	.	AFR:0.8959,AMR:0.7769,EAS:0.9605,FIN:0.6932,NFE:0.6155,OTH:0.6820,ASJ:0.76	.	.	.	.	.	.	.	.	.	.	.	.	19	MU82024794	het
19	39914308	39914308	C	T	PLEKHG2	intronic	.	ENSG00000090924	rs31725	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5017	0.5200	0.579073	0.5340	.	.	.	.	.	.	.	.	.	.	AFR:0.6675,AMR:0.5012,EAS:0.5318,FIN:0.5330,NFE:0.4606,OTH:0.5092,ASJ:0.5232	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	MU635556	het
19	39914748	39914748	G	A	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31726	ENSG00000090924:ENST00000425673:exon17:c.G2888A:p.R963K,ENSG00000090924:ENST00000409794:exon19:c.G2975A:p.R992K,ENSG00000090924:ENST00000458508:exon19:c.G2798A:p.R933K	PLEKHG2:NM_001351693:exon19:c.G2798A:p.R933K,PLEKHG2:NM_022835:exon19:c.G2975A:p.R992K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5083	0.5226	0.575879	2(large_intestine)	0.257	5.263	0.101	0.404	0.001	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G2309A:p.R770K,PLEKHG2:uc010xuy.2:exon19:c.G2798A:p.R933K,PLEKHG2:uc010xuz.2:exon19:c.G2975A:p.R992K	-0.924	AFR:MU146422,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.6473,FIN:0.5119,NFE:0.5232,OTH:0.5702,ASJ:0.5393	611893	616763;	.	.	.	.	.	.	0.004	-0.57	0.000	1.835	19	1(biliary_tract)	0.5350
19	39915637	39915637	G	A	PLEKHG2	exonic	synonymous SNV	ENSG00000090924	rs31727	ENSG00000090924:ENST00000425673:exon17:c.G3777A:p.Q1259Q,ENSG00000090924:ENST00000409794:exon19:c.G3864A:p.Q1288Q	PLEKHG2:NM_022835:exon19:c.G3864A:p.Q1288Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5511	0.5581	0.596845	MU146433	.	.	.	.	.	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G3198A:p.Q1066Q,PLEKHG2:uc010xuz.2:exon19:c.G3864A:p.Q1288Q	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.5804,EAS:0.5346,FIN:0.55,NFE:0.5713,OTH:0.6101,ASJ:0.6601	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5333
19	39915758	39915758	C	G	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31728	ENSG00000090924:ENST00000425673:exon17:c.C3898G:p.P1300A,ENSG00000090924:ENST00000409794:exon19:c.C3985G:p.P1329A	PLEKHG2:NM_022835:exon19:c.C3985G:p.P1329A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5527	0.5783	0.592252	MU74687	4.517	24.3	.	3.03	0.954	.	.	.	PLEKHG2:uc010xva.2:exon15:c.C3319G:p.P1107A,PLEKHG2:uc010xuz.2:exon19:c.C3985G:p.P1329A	-0.846	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.5787,EAS:0.5288,FIN:0.5364,NFE:0.5760,OTH:0.6131,ASJ:0.6577	611893	616763;	.	.	.	.	.	.	0.582	.	0.000	1.04	19	3(large_intestine)	0.5309
19	40900865	40900865	C	T	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268674	ENSG00000105227:ENST00000324001:exon7:c.G3394A:p.G1132R	PRX:NM_181882:exon7:c.G3394A:p.G1132R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9469	0.9538	0.965455	0.9599	0.019	2.769	0.129	3.64	0.017	.	.	.	PRX:uc002onq.3:exon3:c.G2977A:p.G993R,PRX:uc002onr.3:exon7:c.G3394A:p.G1132R	-1.009	AFR:0.9899,AMR:0.9678,EAS:0.9691,FIN:0.9472,NFE:0.9444,OTH:0.9561,ASJ:0.9437	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.2	0.000	-0.625	19	MU69136	het
19	40901496	40901496	T	C	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268673	ENSG00000105227:ENST00000324001:exon7:c.A2763G:p.I921M	PRX:NM_181882:exon7:c.A2763G:p.I921M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3504	0.3663	0.296725	0.3517	-1.801	0.002	0.315	-5.36	0.878	.	.	.	PRX:uc002onq.3:exon3:c.A2346G:p.I782M,PRX:uc002onr.3:exon7:c.A2763G:p.I921M	-0.919	AFR:0.3290,AMR:0.4391,EAS:0.1300,FIN:0.3443,NFE:0.3845,OTH:0.3652,ASJ:0.3576	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.05	0.000	-1.79	19	MU133393	het
19	40901604	40901604	A	G	PRX	exonic	synonymous SNV	ENSG00000105227	rs268672	ENSG00000105227:ENST00000324001:exon7:c.T2655C:p.P885P	PRX:NM_181882:exon7:c.T2655C:p.P885P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5070	0.6091	0.531949	0.5686	.	.	.	.	.	.	.	.	PRX:uc002onq.3:exon3:c.T2238C:p.P746P,PRX:uc002onr.3:exon7:c.T2655C:p.P885P	.	AFR:0.8020,AMR:0.5337,EAS:0.1805,FIN:0.4487,NFE:0.5106,OTH:0.4949,ASJ:0.4901	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	.	.	.	.	19	MU4560643	unknown
19	40901614	40901614	A	G	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268671	ENSG00000105227:ENST00000324001:exon7:c.T2645C:p.V882A	PRX:NM_181882:exon7:c.T2645C:p.V882A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5069	0.6097	0.531949	0.5680	-2.006	0.001	0.381	2.7	0.001	.	.	.	PRX:uc002onq.3:exon3:c.T2228C:p.V743A,PRX:uc002onr.3:exon7:c.T2645C:p.V882A	-1.137	AFR:0.8017,AMR:0.5337,EAS:0.1818,FIN:0.4487,NFE:0.5097,OTH:0.4980,ASJ:0.4867	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	5.32	0.000	-1.95	19	MU707749	unknown
19	41512792	41512792	C	T	CYP2B6	intronic	.	ENSG00000197408	rs4803419	.	.	clinvar: drug_response 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3353	0.2394	0.289137	0.2824	.	.	.	.	.	.	.	.	.	.	AFR:0.1143,AMR:0.4617,EAS:0.4512,FIN:0.3721,NFE:0.3277,OTH:0.3224,ASJ:0.3013	123930	614546;	240869;	240869|-|-|-|-|614546 ~	.	.	.	.	.	.	.	.	19	MU30125766	het
19	41522715	41522715	C	T	CYP2B6	exonic	nonsynonymous SNV	ENSG00000197408	rs3211371	ENSG00000197408:ENST00000330446:exon5:c.C859T:p.R287C,ENSG00000197408:ENST00000593831:exon5:c.C751T:p.R251C,ENSG00000197408:ENST00000324071:exon9:c.C1459T:p.R487C	CYP2B6:NM_000767:exon9:c.C1459T:p.R487C	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0909	0.0909	0.0535144	0.0851	-0.440	0.310	1.0	-6.04	0.240	.	.	.	CYP2B6:uc010xvu.1:exon5:c.C859T:p.R287C,CYP2B6:uc002opr.1:exon9:c.C1459T:p.R487C	-1.086	AFR:0.0271,AMR:0.0443,EAS:0.0031,FIN:0.1193,NFE:0.1206,OTH:0.0934,ASJ:0.1333	123930	614546;	240869;	240869|-|-|-|-|614546 ~	.	.	.	.	0.008	-0.25	0.001	-0.905	19	.	het
19	41743861	41743861	A	G	AXL	exonic	nonsynonymous SNV	ENSG00000167601	rs7249222	ENSG00000167601:ENST00000301178:exon7:c.A796G:p.N266D,ENSG00000167601:ENST00000359092:exon7:c.A796G:p.N266D	AXL:NM_001699:exon7:c.A796G:p.N266D,AXL:NM_021913:exon7:c.A796G:p.N266D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	AXL:uc010ehi.1:exon7:c.A796G:p.N266D,AXL:uc010ehj.3:exon7:c.A796G:p.N266D,AXL:uc010ehk.3:exon7:c.A796G:p.N266D	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	109135	.	.	.	.	.	.	.	.	.	.	.	19	23(upper_aerodigestive_tract)	1
19	41759632	41759632	C	-	AXL	intronic	.	ENSG00000167601	rs770636352	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0824	.	.	0.1114	.	.	.	.	.	.	.	.	.	.	AFR:0.1108,AMR:0.1937,EAS:0.0958,FIN:0.1784,NFE:0.0942,OTH:0.1019,ASJ:0.0894	109135	.	.	.	.	.	.	.	.	.	.	.	19	MU75290710	het
19	44047550	44047550	T	C	XRCC1	exonic	synonymous SNV	ENSG00000073050	rs3547	ENSG00000073050:ENST00000543982:exon16:c.A1803G:p.Q601Q,ENSG00000073050:ENST00000262887:exon17:c.A1896G:p.Q632Q	XRCC1:NM_006297:exon17:c.A1896G:p.Q632Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6365	0.6075	0.710663	0.6135	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon16:c.A1803G:p.Q601Q,XRCC1:uc002owt.2:exon17:c.A1896G:p.Q632Q	.	AFR:0.6640,AMR:0.7849,EAS:0.8777,FIN:0.5536,NFE:0.5609,OTH:0.5935,ASJ:0.6556	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU168901	het
19	44047826	44047826	T	A	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs2682557	ENSG00000073050:ENST00000543982:exon15:c.A1633T:p.N545Y,ENSG00000073050:ENST00000262887:exon16:c.A1726T:p.N576Y	XRCC1:NM_006297:exon16:c.A1726T:p.N576Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon15:c.A1633T:p.N545Y,XRCC1:uc002owt.2:exon16:c.A1726T:p.N576Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU82026153	hom
19	44050195	44050195	C	T	XRCC1	intronic	.	ENSG00000073050	rs25479	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3636	0.3922	0.289337	0.3802	.	.	.	.	.	.	.	.	.	.	AFR:0.3275,AMR:0.2110,EAS:0.1183,FIN:0.4449,NFE:0.4335,OTH:0.4002,ASJ:0.3389	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU708115	het
19	44055726	44055726	T	C	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs25487	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.6834	0.7092	0.739617	0.7200	0.745	9.117	1.0	4.13	0.976	.	.	BRCT domain	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	-0.976	AFR:0.8520,AMR:0.7231,EAS:0.7370,FIN:0.7022,NFE:0.6510,OTH:0.6691,ASJ:0.5960	194360	.	.	.	.	,10431	.	,10432	0.0	2.81	0.000	.	19	MU71535	hom
19	44057227	44057227	T	C	XRCC1	exonic	synonymous SNV	ENSG00000073050	rs915927	ENSG00000073050:ENST00000543982:exon6:c.A525G:p.P175P,ENSG00000073050:ENST00000594107:exon6:c.A507G:p.P169P,ENSG00000073050:ENST00000262887:exon7:c.A618G:p.P206P,ENSG00000073050:ENST00000598165:exon7:c.A639G:p.P213P	XRCC1:NM_006297:exon7:c.A618G:p.P206P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4409	0.4203	0.321286	0.4070	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon6:c.A525G:p.P175P,XRCC1:uc002owt.2:exon7:c.A618G:p.P206P	.	AFR:0.3929,AMR:0.2243,EAS:0.1230,FIN:0.4470,NFE:0.4475,OTH:0.4122,ASJ:0.3567	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU147598	het
19	44057574	44057574	G	A	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs1799782	ENSG00000073050:ENST00000543982:exon5:c.C487T:p.R163W,ENSG00000073050:ENST00000594107:exon5:c.C469T:p.R157W,ENSG00000073050:ENST00000262887:exon6:c.C580T:p.R194W,ENSG00000073050:ENST00000598165:exon6:c.C601T:p.R201W	XRCC1:NM_006297:exon6:c.C580T:p.R194W	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 1] 	0.0928	0.0617	0.123802	0.0722	6.753	32	0.001	1.03	0.997	.	.	.	XRCC1:uc010xwp.1:exon5:c.C487T:p.R163W,XRCC1:uc002owt.2:exon6:c.C580T:p.R194W	-0.959	AFR:0.0619,AMR:0.1599,EAS:0.2877,FIN:0.0418,NFE:0.0574,OTH:0.0735,ASJ:0.0662	194360	.	.	.	.	,10433	.	.	0.912	3.83	0.000	2.39	19	MU147607	het
19	45251156	45251156	A	C	BCL3	upstream	.	ENSG00000069399	rs2965169	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.534545	0.4760	.	.	.	.	.	.	.	.	.	.	AFR:0.6915,AMR:0.5683,EAS:0.4152,FIN:0.3566,NFE:0.3829,OTH:0.4138,ASJ:0.5167	109560	.	.	.	.	.	.	.	.	.	.	.	19	MU9424118	het
19	45868309	45868309	T	G	ERCC2	exonic	synonymous SNV	ENSG00000104884	rs238406	ENSG00000104884:ENST00000586856:exon4:c.A318C:p.R106R,ENSG00000104884:ENST00000391941:exon5:c.A396C:p.R132R,ENSG00000104884:ENST00000485403:exon5:c.A396C:p.R132R,ENSG00000104884:ENST00000391940:exon6:c.A396C:p.R132R,ENSG00000104884:ENST00000391945:exon6:c.A468C:p.R156R,ENSG00000104884:ENST00000586131:exon6:c.A396C:p.R132R	ERCC2:NM_001130867:exon5:c.A396C:p.R132R,ERCC2:NM_000400:exon6:c.A468C:p.R156R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5898	0.6625	0.636182	0.6449	.	.	.	.	.	.	.	.	ERCC2:uc002pbk.2:exon5:c.A396C:p.R132R,ERCC2:uc002pbl.4:exon5:c.A396C:p.R132R,ERCC2:uc002pbj.2:exon6:c.A468C:p.R156R	.	AFR:0.8673,AMR:0.5143,EAS:0.5068,FIN:0.5899,NFE:0.5556,OTH:0.5717,ASJ:0.6060	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	4779,4778,	.	.	.	.	.	.	19	MU21174602	het
19	45923653	45923653	A	G	ERCC1	exonic	synonymous SNV	ENSG00000012061	rs11615	ENSG00000012061:ENST00000589381:exon2:c.T138C:p.N46N,ENSG00000012061:ENST00000013807:exon3:c.T354C:p.N118N,ENSG00000012061:ENST00000423698:exon3:c.T138C:p.N46N,ENSG00000012061:ENST00000591636:exon3:c.T354C:p.N118N,ENSG00000012061:ENST00000300853:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000340192:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000589165:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000589214:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000592023:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000592083:exon5:c.T354C:p.N118N	ERCC1:NM_001369411:exon3:c.T354C:p.N118N,ERCC1:NM_001369416:exon3:c.T354C:p.N118N,ERCC1:NM_001369419:exon3:c.T354C:p.N118N,ERCC1:NM_202001:exon3:c.T354C:p.N118N,ERCC1:NM_001166049:exon4:c.T354C:p.N118N,ERCC1:NM_001369408:exon4:c.T354C:p.N118N,ERCC1:NM_001369409:exon4:c.T354C:p.N118N,ERCC1:NM_001369410:exon4:c.T354C:p.N118N,ERCC1:NM_001369412:exon4:c.T354C:p.N118N,ERCC1:NM_001369415:exon4:c.T354C:p.N118N,ERCC1:NM_001369418:exon4:c.T354C:p.N118N,ERCC1:NM_001983:exon4:c.T354C:p.N118N,ERCC1:NM_001369413:exon5:c.T354C:p.N118N,ERCC1:NM_001369414:exon5:c.T354C:p.N118N,ERCC1:NM_001369417:exon5:c.T354C:p.N118N	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.5085	0.5401	0.66893	0.5425	.	.	.	.	.	.	.	.	ERCC1:uc002pbu.2:exon3:c.T138C:p.N46N,ERCC1:uc002pbv.3:exon3:c.T354C:p.N118N,ERCC1:uc002pbs.2:exon4:c.T354C:p.N118N,ERCC1:uc002pbt.2:exon4:c.T354C:p.N118N	.	AFR:0.875,AMR:0.6691,EAS:0.7413,FIN:0.3622,NFE:0.3723,OTH:0.4187,ASJ:0.4338	126380	610758;	1466;191;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~	.	,4775,4774	.	.	.	.	.	.	19	MU19278464	het
19	48621036	48621036	C	G	LIG1	exonic	synonymous SNV	ENSG00000105486	rs13436	ENSG00000105486:ENST00000536218:exon24:c.G2238C:p.A746A,ENSG00000105486:ENST00000427526:exon25:c.G2349C:p.A783A,ENSG00000105486:ENST00000263274:exon26:c.G2442C:p.A814A	LIG1:NM_001289064:exon24:c.G2238C:p.A746A,LIG1:NM_001289063:exon25:c.G2349C:p.A783A,LIG1:NM_001320971:exon25:c.G2352C:p.A784A,LIG1:NM_000234:exon26:c.G2442C:p.A814A,LIG1:NM_001320970:exon26:c.G2439C:p.A813A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4747	0.4595	0.544529	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LIG1:uc010xze.1:exon21:c.G1521C:p.A507A,LIG1:uc010xzf.1:exon24:c.G2238C:p.A746A,LIG1:uc010xzg.1:exon25:c.G2349C:p.A783A,LIG1:uc002pia.1:exon26:c.G2442C:p.A814A	.	AFR:0.4895,AMR:0.5486,EAS:0.3974,FIN:0.7577,NFE:0.4928,OTH:0.4324,ASJ:0.3974	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.4888
19	48622427	48622427	A	G	LIG1	exonic	synonymous SNV	ENSG00000105486	rs20581	ENSG00000105486:ENST00000536218:exon23:c.T2202C:p.D734D,ENSG00000105486:ENST00000427526:exon24:c.T2313C:p.D771D,ENSG00000105486:ENST00000263274:exon25:c.T2406C:p.D802D	LIG1:NM_001289064:exon23:c.T2202C:p.D734D,LIG1:NM_001289063:exon24:c.T2313C:p.D771D,LIG1:NM_001320971:exon24:c.T2316C:p.D772D,LIG1:NM_000234:exon25:c.T2406C:p.D802D,LIG1:NM_001320970:exon25:c.T2403C:p.D801D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6228	0.6380	0.718051	1(pancreas)	.	.	.	.	.	.	.	.	LIG1:uc010xze.1:exon20:c.T1485C:p.D495D,LIG1:uc010xzf.1:exon23:c.T2202C:p.D734D,LIG1:uc010xzg.1:exon24:c.T2313C:p.D771D,LIG1:uc002pia.1:exon25:c.T2406C:p.D802D	.	AFR:1(thyroid),AMR:MU27558186,EAS:0.6542,FIN:0.8492,NFE:0.5251,OTH:0.4868,ASJ:COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(prostate)	0.8826
19	48634319	48634319	T	A	LIG1	intronic	.	ENSG00000105486	rs392891	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4684	0.4646	0.549121	0.4918	.	.	.	.	.	.	.	.	.	.	AFR:0.5584,AMR:0.3962,EAS:0.7550,FIN:0.4926,NFE:0.4322,OTH:0.4857,ASJ:0.3974	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU23821406	het
19	48654553	48654553	G	T	LIG1	exonic	synonymous SNV	ENSG00000105486	rs20580	ENSG00000105486:ENST00000427526:exon6:c.C417A:p.A139A,ENSG00000105486:ENST00000542460:exon6:c.C414A:p.A138A,ENSG00000105486:ENST00000263274:exon7:c.C510A:p.A170A,ENSG00000105486:ENST00000594759:exon7:c.C507A:p.A169A,ENSG00000105486:ENST00000601091:exon7:c.C510A:p.A170A	LIG1:NM_001289063:exon6:c.C417A:p.A139A,LIG1:NM_001320971:exon6:c.C420A:p.A140A,LIG1:NM_000234:exon7:c.C510A:p.A170A,LIG1:NM_001320970:exon7:c.C507A:p.A169A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4875	0.5066	0.532947	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LIG1:uc010xzg.1:exon6:c.C417A:p.A139A,LIG1:uc002pia.1:exon7:c.C510A:p.A170A	.	AFR:0.5190,AMR:0.5483,EAS:0.4067,FIN:0.6944,NFE:0.5161,OTH:0.4918,ASJ:0.4329	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.5031
19	48660244	48660251	AAGGGGCA	-	LIG1	intronic	.	ENSG00000105486	rs3730867	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4760	0.4378	0.510383	0.4796	.	.	.	.	.	.	.	.	.	.	AFR:0.4413,AMR:0.4279,EAS:0.6863,FIN:0.5038,NFE:0.4788,OTH:0.4764,ASJ:0.3897	126391	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	48668795	48668795	G	A	LIG1	intronic	.	ENSG00000105486	rs3730849	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3548	0.2846	0.317292	0.3193	.	.	.	.	.	.	.	.	.	.	AFR:0.1153,AMR:0.2931,EAS:0.5666,FIN:0.4274,NFE:0.3833,OTH:0.4029,ASJ:0.3079	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU23821673	het
19	49459104	49459104	A	G	BAX	intronic	.	ENSG00000087088	rs1805419	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6744	0.6774	0.621805	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	.	.	AFR:0.6610,AMR:0.5862,EAS:0.8079,FIN:0.5753,NFE:0.6486,OTH:0.7149,ASJ:0.6118	600040	114500;613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04141 Protein processing in endoplasmic reticulum~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04722 Neurotrophin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05020 Prion diseases~ko05130 Pathogenic Escherichia coli infection~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	19	2(lung)	0.6828
19	50139119	50139119	G	C	RRAS	intronic	.	ENSG00000126458	rs731861	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3564	0.2423	0.250599	0.2295	.	.	.	.	.	0	0.006	.	.	.	AFR:0.3419,AMR:0.1142,EAS:0.0367,FIN:0.1945,NFE:0.2021,OTH:0.2259,ASJ:0.1678	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU113433341	het
19	50140068	50140068	C	T	RRAS	intronic	.	ENSG00000126458	rs1368464	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	0.7241	.	.	.	.	.	.	.	.	.	.	AFR:0.7666,AMR:0.8341,EAS:0.8300,FIN:0.6882,NFE:0.6942,OTH:0.6814,ASJ:0.6577	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU21511377	het
19	50140092	50140092	G	A	RRAS	exonic	synonymous SNV	ENSG00000126458	rs1865077	ENSG00000126458:ENST00000246792:exon3:c.C333T:p.N111N	RRAS:NM_006270:exon3:c.C333T:p.N111N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RRAS:uc002pop.1:exon3:c.C333T:p.N111N	.	AFR:0.7243,AMR:0.7670,EAS:0.6577,FIN:0.8284,NFE:0.6881,OTH:0.6947,ASJ:0.8329	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	1(large_intestine)	0.6814
19	50713713	50713713	C	A	MYH14	exonic	nonsynonymous SNV	ENSG00000105357	rs590722	ENSG00000105357:ENST00000262269:exon1:c.C91A:p.P31T,ENSG00000105357:ENST00000596571:exon1:c.C91A:p.P31T,ENSG00000105357:ENST00000376970:exon2:c.C91A:p.P31T,ENSG00000105357:ENST00000425460:exon2:c.C91A:p.P31T,ENSG00000105357:ENST00000440075:exon2:c.C91A:p.P31T,ENSG00000105357:ENST00000598205:exon2:c.C91A:p.P31T,ENSG00000105357:ENST00000599920:exon2:c.C91A:p.P31T,ENSG00000105357:ENST00000601313:exon2:c.C91A:p.P31T	MYH14:NM_001077186:exon2:c.C91A:p.P31T,MYH14:NM_001145809:exon2:c.C91A:p.P31T,MYH14:NM_024729:exon2:c.C91A:p.P31T	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2324	0.1140	0.187899	MU72820	0.778	9.327	0.022	2.2	0.007	.	.	.	MYH14:uc002prq.1:exon2:c.C91A:p.P31T,MYH14:uc002prr.1:exon2:c.C91A:p.P31T,MYH14:uc010enu.1:exon2:c.C91A:p.P31T	-1.067	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.1466,EAS:0.1505,FIN:0.1060,NFE:0.2651,OTH:0.1161,ASJ:0.1559	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.162	-2.02	0.000	1.04	19	1(thyroid)	0.1367
19	50726570	50726570	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs4801822	ENSG00000105357:ENST00000262269:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000596571:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000376970:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000425460:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000440075:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000598205:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000599920:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000601313:exon5:c.G657A:p.A219A	MYH14:NM_001077186:exon5:c.G657A:p.A219A,MYH14:NM_001145809:exon5:c.G657A:p.A219A,MYH14:NM_024729:exon5:c.G657A:p.A219A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6057	0.4933	0.472843	1(large_intestine)	.	.	.	.	.	.	.	.	MYH14:uc002prq.1:exon5:c.G657A:p.A219A,MYH14:uc002prr.1:exon5:c.G657A:p.A219A,MYH14:uc010enu.1:exon5:c.G657A:p.A219A	.	AFR:MU115546,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763,EAS:0.2085,FIN:0.4233,NFE:0.5099,OTH:0.5513,ASJ:0.4990	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(prostate)	0.6498
19	50735340	50735340	C	T	MYH14	intronic	.	ENSG00000105357	rs11666328	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3588	0.3246	0.321486	0.3170	.	.	.	.	.	.	.	.	.	.	AFR:0.2318,AMR:0.3505,EAS:0.3714,FIN:0.3305,NFE:0.3531,OTH:0.3371,ASJ:0.3859	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU30144974	het
19	50760716	50760716	C	G	MYH14	exonic	synonymous SNV	ENSG00000105357	rs378811	ENSG00000105357:ENST00000596571:exon15:c.C2082G:p.R694R,ENSG00000105357:ENST00000262269:exon17:c.C2205G:p.R735R,ENSG00000105357:ENST00000376970:exon17:c.C2181G:p.R727R,ENSG00000105357:ENST00000425460:exon17:c.C2106G:p.R702R,ENSG00000105357:ENST00000598205:exon17:c.C2106G:p.R702R,ENSG00000105357:ENST00000599920:exon17:c.C2106G:p.R702R,ENSG00000105357:ENST00000440075:exon18:c.C2205G:p.R735R,ENSG00000105357:ENST00000601313:exon18:c.C2205G:p.R735R	MYH14:NM_024729:exon16:c.C2082G:p.R694R,MYH14:NM_001077186:exon17:c.C2106G:p.R702R,MYH14:NM_001145809:exon18:c.C2205G:p.R735R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4141	0.3862	0.357827	MU120935	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon16:c.C2082G:p.R694R,MYH14:uc002prq.1:exon17:c.C2106G:p.R702R,MYH14:uc010enu.1:exon18:c.C2205G:p.R735R	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.3751,EAS:0.2601,FIN:0.5298,NFE:0.3846,OTH:0.3720,ASJ:0.3040	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.4192
19	50762418	50762418	A	G	MYH14	exonic	synonymous SNV	ENSG00000105357	rs1651553	ENSG00000105357:ENST00000596571:exon16:c.A2127G:p.P709P,ENSG00000105357:ENST00000262269:exon18:c.A2250G:p.P750P,ENSG00000105357:ENST00000376970:exon18:c.A2226G:p.P742P,ENSG00000105357:ENST00000425460:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000598205:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000599920:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000440075:exon19:c.A2250G:p.P750P,ENSG00000105357:ENST00000601313:exon19:c.A2250G:p.P750P	MYH14:NM_024729:exon17:c.A2127G:p.P709P,MYH14:NM_001077186:exon18:c.A2151G:p.P717P,MYH14:NM_001145809:exon19:c.A2250G:p.P750P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.7375	0.761182	0.7616	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon17:c.A2127G:p.P709P,MYH14:uc002prq.1:exon18:c.A2151G:p.P717P,MYH14:uc010enu.1:exon19:c.A2250G:p.P750P	.	AFR:0.7206,AMR:0.8365,EAS:0.8255,FIN:0.8212,NFE:0.7614,OTH:0.7939,ASJ:0.6126	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17693652	het
19	50763886	50763886	C	T	MYH14	intronic	.	ENSG00000105357	rs28482851	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3167	0.2314	0.284545	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2529,AMR:0.1230,EAS:0.35,FIN:0.5155,NFE:0.2731,OTH:0.2954,ASJ:0.1675	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.2963
19	50771635	50771635	T	C	MYH14	intronic	.	ENSG00000105357	rs930086	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8757	0.8753	0.864617	0.8758	.	.	.	.	.	.	.	.	.	.	AFR:0.8629,AMR:0.9177,EAS:0.8422,FIN:0.8987,NFE:0.8784,OTH:0.8988,ASJ:0.8411	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17694162	het
19	50796905	50796905	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs3745509	ENSG00000105357:ENST00000596571:exon36:c.G5307A:p.S1769S,ENSG00000105357:ENST00000262269:exon38:c.G5430A:p.S1810S,ENSG00000105357:ENST00000376970:exon38:c.G5406A:p.S1802S,ENSG00000105357:ENST00000425460:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000598205:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000440075:exon39:c.G5430A:p.S1810S,ENSG00000105357:ENST00000601313:exon39:c.G5430A:p.S1810S	MYH14:NM_024729:exon37:c.G5307A:p.S1769S,MYH14:NM_001077186:exon38:c.G5331A:p.S1777S,MYH14:NM_001145809:exon39:c.G5430A:p.S1810S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.6146	0.682109	0.6579	.	.	.	.	.	.	.	.	MYH14:uc002prs.1:exon6:c.G360A:p.S120S,MYH14:uc010ycb.2:exon8:c.G360A:p.S120S,MYH14:uc002prr.1:exon37:c.G5307A:p.S1769S,MYH14:uc002prq.1:exon38:c.G5331A:p.S1777S,MYH14:uc010enu.1:exon39:c.G5430A:p.S1810S	.	AFR:0.3589,AMR:0.8313,EAS:0.9247,FIN:0.7665,NFE:0.7606,OTH:0.7546,ASJ:0.6921	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029104	hom
19	50796960	50796960	C	T	MYH14	intronic	.	ENSG00000105357	rs3745510	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7496	0.6257	0.694489	0.6671	.	.	.	.	.	.	.	.	.	.	AFR:0.3895,AMR:0.8349,EAS:0.9258,FIN:0.7672,NFE:0.7611,OTH:0.7622,ASJ:0.6954	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU26334128	hom
19	50805138	50805138	C	T	MYH14	intronic	.	ENSG00000105357	rs3826772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8300	0.7947	0.750799	0.7877	.	.	.	.	.	.	.	.	.	.	AFR:0.6329,AMR:0.8577,EAS:0.8077,FIN:0.8333,NFE:0.8556,OTH:0.8429,ASJ:0.87	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029120	hom
19	50918729	50918729	G	A	POLD1	exonic	nonsynonymous SNV	ENSG00000062822	rs367680864	ENSG00000062822:ENST00000595904:exon20:c.G2677A:p.V893I,ENSG00000062822:ENST00000440232:exon21:c.G2599A:p.V867I,ENSG00000062822:ENST00000599857:exon21:c.G2599A:p.V867I,ENSG00000062822:ENST00000600859:exon21:c.G2599A:p.V867I	POLD1:NM_001308632:exon20:c.G2677A:p.V893I,POLD1:NM_001256849:exon21:c.G2599A:p.V867I,POLD1:NM_002691:exon21:c.G2599A:p.V867I	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 1, 1, -1, 1, 0] 	0.0005	7.7e-05	0.000399361	.	1.433	12.96	0.332	3.21	0.934	.	.	DNA-directed DNA polymerase, family B, multifunctional domain	POLD1:uc010eny.4:exon20:c.G2677A:p.V893I,POLD1:uc002psb.5:exon21:c.G2599A:p.V867I,POLD1:uc002psc.5:exon21:c.G2599A:p.V867I	-1.079	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	0.003	2.16	0.034	0.725	19	.	het
19	50919797	50919797	C	T	POLD1	intronic	.	ENSG00000062822;ENSG00000142539	rs3218776	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5793	0.5810	0.408347	0.5601	.	.	.	.	.	.	.	.	.	.	AFR:0.3293,AMR:0.6938,EAS:0.1361,FIN:0.6914,NFE:0.6986,OTH:0.6286,ASJ:0.5298	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	MU27559754	het
19	52725338	52725338	T	C	MIR6801	ncRNA_exonic	.	ENSG00000105568	rs10412196	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1952	0.1746	0.152556	0.1606	.	.	.	.	.	.	.	.	.	.	AFR:0.2707,AMR:0.0574,EAS:0.0998,FIN:0.1337,NFE:0.1193,OTH:0.1189,ASJ:0.0894	605983	616362;	457284;	457284|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|616362 ~	.	.	.	.	.	.	.	.	19	.	het
19	52729030	52729030	C	T	PPP2R1A	exonic	synonymous SNV	ENSG00000105568	rs10413435	ENSG00000105568:ENST00000444322:exon13:c.C1557T:p.D519D,ENSG00000105568:ENST00000322088:exon14:c.C1722T:p.D574D,ENSG00000105568:ENST00000462990:exon14:c.C1185T:p.D395D	PPP2R1A:NM_001363656:exon14:c.C1185T:p.D395D,PPP2R1A:NM_014225:exon14:c.C1722T:p.D574D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0745	0.0972	0.0830671	0.0958	.	.	.	.	.	.	.	.	PPP2R1A:uc010ydk.2:exon13:c.C1557T:p.D519D,PPP2R1A:uc002pyp.3:exon14:c.C1722T:p.D574D,PPP2R1A:uc002pyq.3:exon14:c.C1185T:p.D395D	.	AFR:0.1308,AMR:0.0370,EAS:0.0641,FIN:0.1074,NFE:0.0806,OTH:0.0845,ASJ:0.0733	605983	616362;	457284;	457284|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|616362 ~	.	.	.	.	.	.	.	.	19	MU85655130	het
19	55665584	55665584	A	C	TNNI3	intronic	.	ENSG00000129991	rs7252610	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0052	0.15	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	191044	115210;611880;613286;613690;	154;154;75249;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~	.	.	.	.	.	.	.	.	19	MU82031742	hom
19	55668509	55668509	A	T	TNNI3	intronic	.	ENSG00000129991;ENSG00000267110	rs3729836	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3537	0.3162	0.458067	0.3397	.	.	.	.	.	0.0021	0.14	.	.	.	AFR:0.6132,AMR:0.4294,EAS:0.4355,FIN:0.2298,NFE:0.1976,OTH:0.2867,ASJ:0.2086	191044	115210;611880;613286;613690;	154;154;75249;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~	.	.	.	.	.	.	.	.	19	MU18536585	het
20	2633326	2633331	GGGCGC	-	NOP56	intronic	.	ENSG00000101361	rs150527448	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3010	0.2422	0.336861	0.3169	.	.	.	.	.	.	.	.	.	.	AFR:0.2855,AMR:0.3354,EAS:0.3335,FIN:0.3198,NFE:0.3305,OTH:0.3365,ASJ:0.3146	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU43736563	het
20	2633936	2633936	T	C	NOP56	exonic	synonymous SNV	ENSG00000101361	rs2073194	ENSG00000101361:ENST00000329276:exon3:c.T105C:p.S35S,ENSG00000101361:ENST00000445139:exon3:c.T105C:p.S35S	NOP56:NM_006392:exon3:c.T105C:p.S35S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8285	0.8343	0.861222	0.8402	.	.	.	.	.	.	.	.	NOP56:uc002wgh.3:exon3:c.T105C:p.S35S	.	AFR:0.8992,AMR:0.9234,EAS:0.8636,FIN:0.8038,NFE:0.8076,OTH:0.8350,ASJ:0.8344	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU745225	hom
20	2637071	2637071	T	C	NOP56	exonic	synonymous SNV	ENSG00000101361	rs8958	ENSG00000101361:ENST00000329276:exon9:c.T1035C:p.T345T	NOP56:NM_006392:exon9:c.T1035C:p.T345T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6336	0.6509	0.673722	0.6509	.	.	.	.	.	.	.	.	NOP56:uc002wgi.3:exon8:c.T537C:p.T179T,NOP56:uc002wgh.3:exon9:c.T1035C:p.T345T	.	AFR:0.7235,AMR:0.7351,EAS:0.6194,FIN:0.5441,NFE:0.6347,OTH:0.6426,ASJ:0.5563	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU4554470	hom
20	2638579	2638579	T	C	NOP56	exonic	nonsynonymous SNV	ENSG00000101361	rs6753	ENSG00000101361:ENST00000329276:exon12:c.T1424C:p.M475T	NOP56:NM_006392:exon12:c.T1424C:p.M475T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3098	0.3584	0.376997	0.3530	-1.917	0.001	1.0	-3.07	0.004	.	.	.	NOP56:uc002wgi.3:exon11:c.T926C:p.M309T,NOP56:uc002wgh.3:exon12:c.T1424C:p.M475T	-0.964	AFR:0.5534,AMR:0.3981,EAS:0.2677,FIN:0.2348,NFE:0.2762,OTH:0.2965,ASJ:0.2483	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	0.0	1.05	0.000	-1.6	20	MU20182269	het
20	2638882	2638882	T	C	NOP56	exonic	nonsynonymous SNV	ENSG00000101361	rs5856	ENSG00000101361:ENST00000329276:exon12:c.T1727C:p.V576A	NOP56:NM_006392:exon12:c.T1727C:p.V576A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2931	0.3389	0.377396	0.3550	-1.703	0.002	1.0	1.17	0.001	.	.	.	NOP56:uc002wgi.3:exon11:c.T1229C:p.V410A,NOP56:uc002wgh.3:exon12:c.T1727C:p.V576A	-0.923	AFR:0.5534,AMR:0.3971,EAS:0.2671,FIN:0.2448,NFE:0.2782,OTH:0.2992,ASJ:0.25	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	0.0	0.46	0.000	-0.695	20	MU745243	het
20	3193978	3193978	G	A	ITPA	exonic	synonymous SNV	ENSG00000125877	rs8362	ENSG00000125877:ENST00000380113:exon3:c.G138A:p.Q46Q,ENSG00000125877:ENST00000455664:exon3:c.G87A:p.Q29Q	ITPA:NM_001324240:exon3:c.G138A:p.Q46Q,ITPA:NM_033453:exon3:c.G138A:p.Q46Q,ITPA:NM_181493:exon3:c.G87A:p.Q29Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3520	0.3399	0.470447	MU99581	.	.	.	.	.	.	.	.	ITPA:uc002wid.4:exon3:c.G138A:p.Q46Q,ITPA:uc002wie.4:exon3:c.G87A:p.Q29Q	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3449,EAS:0.2950,FIN:0.3411,NFE:0.5827,OTH:0.1970,ASJ:0.4528	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	1(urinary_tract)	0.2981
20	3202069	3202069	C	T	ITPA	intronic	.	ENSG00000125877	rs6139034	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.309704	0.2150	.	.	.	.	.	.	.	.	.	.	AFR:0.0912,AMR:0.2578,EAS:0.4727,FIN:0.1921,NFE:0.2589,OTH:0.2428,ASJ:0.2947	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU88198053	het
20	3202129	3202129	T	C	ITPA	intronic	.	ENSG00000125877	rs6139035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.332668	0.2501	.	.	.	.	.	.	.	.	.	.	AFR:0.1039,AMR:0.2794,EAS:0.4702,FIN:0.2160,NFE:0.3144,OTH:0.2721,ASJ:0.3543	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU114150678	het
20	3204084	3204084	G	A	ITPA	exonic	nonsynonymous SNV	ENSG00000125877	rs9101	ENSG00000125877:ENST00000399838:exon6:c.G438A:p.E146E,ENSG00000125877:ENST00000380113:exon8:c.G561A:p.E187E,ENSG00000125877:ENST00000455664:exon8:c.G510A:p.E170E	ITPA:NM_001324236:exon7:c.G224A:p.S75N,ITPA:NM_001324238:exon7:c.G224A:p.S75N,ITPA:NM_001351739:exon7:c.G224A:p.S75N,ITPA:NM_001324237:exon8:c.G224A:p.S75N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3257	0.2270	0.340455	0.2473	.	.	.	.	.	.	.	.	ITPA:uc031rsg.1:exon6:c.G438A:p.E146E,ITPA:uc002wid.4:exon8:c.G561A:p.E187E,ITPA:uc002wie.4:exon8:c.G510A:p.E170E	.	AFR:0.1036,AMR:0.2691,EAS:0.4938,FIN:0.2136,NFE:0.3077,OTH:0.2695,ASJ:0.3533	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU21200389	het
20	3784110	3784110	C	T	CDC25B	exonic	synonymous SNV	ENSG00000101224	rs1056720	ENSG00000101224:ENST00000340833:exon13:c.C1293T:p.I431I,ENSG00000101224:ENST00000379598:exon13:c.C1143T:p.I381I,ENSG00000101224:ENST00000245960:exon14:c.C1416T:p.I472I,ENSG00000101224:ENST00000344256:exon14:c.C1224T:p.I408I,ENSG00000101224:ENST00000439880:exon14:c.C1374T:p.I458I	CDC25B:NM_001287524:exon10:c.C840T:p.I280I,CDC25B:NM_001287518:exon13:c.C1143T:p.I381I,CDC25B:NM_001287522:exon13:c.C957T:p.I319I,CDC25B:NM_021872:exon13:c.C1293T:p.I431I,CDC25B:NM_001287516:exon14:c.C1224T:p.I408I,CDC25B:NM_001287517:exon14:c.C1182T:p.I394I,CDC25B:NM_001287519:exon14:c.C1080T:p.I360I,CDC25B:NM_001287520:exon14:c.C1080T:p.I360I,CDC25B:NM_004358:exon14:c.C1374T:p.I458I,CDC25B:NM_021873:exon14:c.C1416T:p.I472I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2474	0.2050	0.230032	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	CDC25B:uc002wjq.3:exon10:c.C816T:p.I272I,CDC25B:uc002wjp.3:exon13:c.C1293T:p.I431I,CDC25B:uc010zqm.2:exon13:c.C1143T:p.I381I,CDC25B:uc021waa.1:exon13:c.C957T:p.I319I,CDC25B:uc002wjl.3:exon14:c.C1080T:p.I360I,CDC25B:uc002wjm.3:exon14:c.C1080T:p.I360I,CDC25B:uc002wjn.3:exon14:c.C1416T:p.I472I,CDC25B:uc002wjo.3:exon14:c.C1374T:p.I458I,CDC25B:uc010zqk.2:exon14:c.C1224T:p.I408I,CDC25B:uc010zql.2:exon14:c.C1182T:p.I394I	.	AFR:0.2082,AMR:0.1278,EAS:0.3233,FIN:0.3579,NFE:0.1915,OTH:0.2332,ASJ:0.3153	116949	.	.	.	.	.	.	.	.	.	.	.	20	1(large_intestine)	0.2295
20	5798114	5798114	G	A	SHLD1	intronic	.	ENSG00000171984	rs2876001	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.273962	0.0711	.	.	.	.	.	.	.	.	.	.	AFR:0.0259,AMR:0.0439,EAS:0.0547,FIN:0.0898,NFE:0.1011,OTH:0.0915,ASJ:0.0870	.	.	.	.	.	.	.	.	.	.	.	.	20	.	hom
20	5935329	5935329	A	T	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs200203649	ENSG00000125885:ENST00000265187:exon4:c.A329T:p.Y110F,ENSG00000125885:ENST00000378883:exon4:c.A329T:p.Y110F,ENSG00000125885:ENST00000378886:exon4:c.A329T:p.Y110F,ENSG00000125885:ENST00000378896:exon4:c.A329T:p.Y110F	MCM8:NM_001281520:exon4:c.A329T:p.Y110F,MCM8:NM_001281521:exon4:c.A329T:p.Y110F,MCM8:NM_001281522:exon4:c.A329T:p.Y110F,MCM8:NM_032485:exon4:c.A329T:p.Y110F,MCM8:NM_182802:exon4:c.A329T:p.Y110F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0032	.	0.00858626	0.0002	3.954	23.6	0.32	5.37	0.984	.	.	Nucleic acid-binding, OB-fold	MCM8:uc002wmi.3:exon4:c.A329T:p.Y110F,MCM8:uc002wmj.3:exon4:c.A329T:p.Y110F,MCM8:uc002wmk.3:exon4:c.A329T:p.Y110F,MCM8:uc002wml.3:exon4:c.A329T:p.Y110F,MCM8:uc010gbp.3:exon4:c.A329T:p.Y110F	-1.080	AFR:0.0001,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0.0031,ASJ:0	608187	612885;	.	.	.	.	.	.	0.011	2.82	0.039	1.76	20	.	het
20	6064710	6064710	A	G	FERMT1	exonic	synonymous SNV	ENSG00000101311	rs753927	ENSG00000101311:ENST00000536936:exon12:c.T924C:p.F308F,ENSG00000101311:ENST00000217289:exon13:c.T1695C:p.F565F	FERMT1:NM_017671:exon13:c.T1695C:p.F565F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3683	0.3597	0.395767	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FERMT1:uc002wmq.3:exon5:c.T354C:p.F118F,FERMT1:uc010gbt.3:exon12:c.T924C:p.F308F,FERMT1:uc002wmr.3:exon13:c.T1695C:p.F565F	.	AFR:0.3680,AMR:0.3557,EAS:0.3808,FIN:0.6337,NFE:0.2629,OTH:0.3661,ASJ:0.4725	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	1(breast)	0.3513
20	6065729	6065729	C	T	FERMT1	exonic	nonsynonymous SNV	ENSG00000101311	rs2232074	ENSG00000101311:ENST00000536936:exon11:c.G806A:p.R269K,ENSG00000101311:ENST00000217289:exon12:c.G1577A:p.R526K	FERMT1:NM_017671:exon12:c.G1577A:p.R526K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3977	0.0627	0.457069	COCA-CN|5|321|0.0155763	1.768	14.80	1.0	5.17	0.978	.	.	Band 4.1 domain|FERM central domain|FERM/acyl-CoA-binding protein, 3-helical bundle;FERM central domain|FERM/acyl-CoA-binding protein, 3-helical bundle	FERMT1:uc002wmq.3:exon4:c.G236A:p.R79K,FERMT1:uc010gbt.3:exon11:c.G806A:p.R269K,FERMT1:uc002wmr.3:exon12:c.G1577A:p.R526K	-0.915	AFR:0.4055,AMR:0.4635,EAS:0.43,FIN:0.6593,NFE:0.2662,OTH:0.3751,ASJ:0.4832	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	0.0	-0.81	0.000	-2.445	20	1(haematopoietic_and_lymphoid_tissue)	0.3678
20	6065731	6065731	T	C	FERMT1	exonic	synonymous SNV	ENSG00000101311	rs2232073	ENSG00000101311:ENST00000536936:exon11:c.A804G:p.K268K,ENSG00000101311:ENST00000217289:exon12:c.A1575G:p.K525K	FERMT1:NM_017671:exon12:c.A1575G:p.K525K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3978	0.0659	0.457069	MU11289991	.	.	.	.	.	.	.	.	FERMT1:uc002wmq.3:exon4:c.A234G:p.K78K,FERMT1:uc010gbt.3:exon11:c.A804G:p.K268K,FERMT1:uc002wmr.3:exon12:c.A1575G:p.K525K	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.4055,EAS:0.4832,FIN:0.43,NFE:0.6593,OTH:0.2659,ASJ:0.4634	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.3751
20	6096695	6096695	C	T	FERMT1	intronic	.	ENSG00000101311	rs2295435	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4489	0.4070	0.419329	0.3801	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.3611,AMR:0.4291,EAS:0.2906,FIN:0.3177,NFE:0.4083,OTH:0.3953,ASJ:0.5464	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	MU655370	het
20	6100088	6100088	A	G	FERMT1	exonic	synonymous SNV	ENSG00000101311	rs10373	ENSG00000101311:ENST00000217289:exon2:c.T114C:p.H38H,ENSG00000101311:ENST00000378844:exon2:c.T114C:p.H38H	FERMT1:NM_017671:exon2:c.T114C:p.H38H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.5324	0.524561	ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	FERMT1:uc002wmr.3:exon2:c.T114C:p.H38H,FERMT1:uc002wms.3:exon2:c.T114C:p.H38H	.	AFR:0.5005,AMR:0.5294,EAS:0.6225,FIN:0.3752,NFE:0.4129,OTH:0.5169,ASJ:0.4845	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.4878
20	8755243	8755243	T	C	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2235613	ENSG00000182621:ENST00000338037:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378637:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378641:exon27:c.T2988C:p.A996A	PLCB1:NM_015192:exon27:c.T2988C:p.A996A,PLCB1:NM_182734:exon27:c.T2988C:p.A996A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6155	0.6402	0.613219	MU146166	.	.	.	.	.	.	.	.	PLCB1:uc002wnd.1:exon15:c.T1719C:p.A573A,PLCB1:uc002wnc.1:exon25:c.T2685C:p.A895A,PLCB1:uc002wna.4:exon27:c.T2988C:p.A996A,PLCB1:uc002wnb.4:exon27:c.T2988C:p.A996A,PLCB1:uc010zrb.1:exon27:c.T2685C:p.A895A	.	AFR:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.6163,EAS:0.5096,FIN:0.7119,NFE:0.5167,OTH:0.5516,ASJ:0.6384	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	1(prostate)	0.6330
20	8769180	8769180	C	T	PLCB1	intronic	.	ENSG00000182621	rs2327089	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9408	0.8914	0.896965	0.9039	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7424,AMR:0.9630,EAS:0.9988,FIN:0.9820,NFE:0.9625,OTH:0.9481,ASJ:0.9371	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	MU82035692	hom
20	8770822	8770822	C	T	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2294597	ENSG00000182621:ENST00000338037:exon31:c.C3337T:p.L1113L,ENSG00000182621:ENST00000378637:exon31:c.C3337T:p.L1113L,ENSG00000182621:ENST00000378641:exon31:c.C3337T:p.L1113L	PLCB1:NM_015192:exon31:c.C3337T:p.L1113L,PLCB1:NM_182734:exon31:c.C3337T:p.L1113L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2970	0.2533	0.228634	LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0.0008	0.19	.	PLCB1:uc002wna.4:exon31:c.C3337T:p.L1113L,PLCB1:uc002wnb.4:exon31:c.C3337T:p.L1113L	.	AFR:0.2549,AMR:0.1392,EAS:0.3377,FIN:0.1706,NFE:0.2873,OTH:0.3211,ASJ:0.2291	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	2(haematopoietic_and_lymphoid_tissue)	0.2929
20	10620386	10620386	A	G	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1051419	ENSG00000101384:ENST00000423891:exon24:c.T2940C:p.Y980Y,ENSG00000101384:ENST00000254958:exon26:c.T3417C:p.Y1139Y	JAG1:NM_000214:exon26:c.T3417C:p.Y1139Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6592	0.7272	0.71266	3(lung)	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon26:c.T3417C:p.Y1139Y	.	AFR:1(large_intestine),AMR:MU110199,EAS:0.6923,FIN:0.9037,NFE:0.6146,OTH:0.5828,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(urinary_tract)	0.4141
20	10625804	10625804	T	G	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1801140	ENSG00000101384:ENST00000423891:exon15:c.A1737C:p.T579T,ENSG00000101384:ENST00000254958:exon17:c.A2214C:p.T738T	JAG1:NM_000214:exon17:c.A2214C:p.T738T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1095	0.0755	0.100839	0.0813	.	.	.	.	.	.	.	.	JAG1:uc010gcd.1:exon9:c.A888C:p.T296T,JAG1:uc002wnw.2:exon17:c.A2214C:p.T738T	.	AFR:0.0357,AMR:0.1483,EAS:0.0370,FIN:0.1228,NFE:0.0979,OTH:0.1063,ASJ:0.0695	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU82290190	het
20	10633237	10633237	G	A	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1131695	ENSG00000101384:ENST00000423891:exon4:c.C288T:p.Y96Y,ENSG00000101384:ENST00000254958:exon6:c.C765T:p.Y255Y	JAG1:NM_000214:exon6:c.C765T:p.Y255Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4541	0.4247	0.423323	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon6:c.C765T:p.Y255Y	.	AFR:0.4224,AMR:0.3535,EAS:0.4934,FIN:0.3276,NFE:0.4487,OTH:0.4636,ASJ:0.4177	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	3(large_intestine)	0.4507
20	10639222	10639222	G	A	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1801138	ENSG00000101384:ENST00000423891:exon2:c.C111T:p.C37C,ENSG00000101384:ENST00000254958:exon4:c.C588T:p.C196C	JAG1:NM_000214:exon4:c.C588T:p.C196C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1088	0.1040	0.181909	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon4:c.C588T:p.C196C	.	AFR:0.1006,AMR:0.2229,EAS:0.0695,FIN:0.2126,NFE:0.0200,OTH:0.0364,ASJ:0.1432	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(oesophagus)	0.0724
20	10639385	10639385	A	G	JAG1	intronic	.	ENSG00000101384	rs2273060	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4375	0.4240	0.457668	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4235,AMR:0.4592,EAS:0.4404,FIN:0.4095,NFE:0.4096,OTH:0.4062,ASJ:0.4678	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.4012
20	23028724	23028724	G	A	THBD	exonic	nonsynonymous SNV	ENSG00000178726	rs1042579	ENSG00000178726:ENST00000377103:exon1:c.C1418T:p.A473V	THBD:NM_000361:exon1:c.C1418T:p.A473V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1997	0.1379	0.164537	0.1692	-0.032	2.285	0.401	-1.34	0.000	.	.	EGF-like calcium-binding domain|EGF-like domain	THBD:uc002wss.3:exon1:c.C1418T:p.A473V,THBD:uc002wsu.1:exon2:c.C1241T:p.A414V	-1.142	AFR:0.0502,AMR:0.1830,EAS:0.2901,FIN:0.3021,NFE:0.1953,OTH:0.1711,ASJ:0.0795	188040	612926;614486;	436169;2134;217023;	436169|THBD-related bleeding disorder<br>THBD-related coagulopathy<br>Thrombomodulin-related coagulopathy|<1 / 1 000 000|Autosomal dominant|All ages|614486 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~217023|Atypical HUS with thrombomodulin anomaly<br>D-HUS with thrombomodulin anomaly<br>Hemolytic-uremic syndrome without diarrhea with thrombomodulin anomaly<br>aHUS with thrombomodulin anomaly|<1 / 1 000 000|Autosomal recessive|Childhood|612926 ~	.	.	.	.	0.0	-1.31	0.000	1.14	20	MU20605418	hom
20	23860178	23860178	A	G	CST5	exonic	nonsynonymous SNV	ENSG00000170367	rs1799841	ENSG00000170367:ENST00000304710:exon1:c.T136C:p.C46R	CST5:NM_001900:exon1:c.T136C:p.C46R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4830	0.5414	0.565096	0.5442	-2.295	0.001	1.0	-0.399	0.001	.	.	Cystatin domain	CST5:uc002wtr.1:exon1:c.T136C:p.C46R	-0.970	AFR:0.7542,AMR:0.5347,EAS:0.4795,FIN:0.5451,NFE:0.4390,OTH:0.4579,ASJ:0.3467	123858	.	.	.	.	.	.	.	0.0	1.84	0.000	-1.845	20	MU585490	het
20	31022959	31022959	T	C	ASXL1	exonic	nonsynonymous SNV	ENSG00000171456	rs6058694	ENSG00000171456:ENST00000306058:exon12:c.T2429C:p.L810P,ENSG00000171456:ENST00000375687:exon13:c.T2444C:p.L815P	ASXL1:NM_001363734:exon11:c.T2261C:p.L754P,ASXL1:NM_015338:exon12:c.T2444C:p.L815P	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[1, 1, 1, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	ASXL1:uc010geb.3:exon9:c.T2117C:p.L706P,ASXL1:uc002wxs.3:exon12:c.T2441C:p.L814P,ASXL1:uc021wbw.1:exon13:c.T2444C:p.L815P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	612990	605039;614286;	52688;97297;	52688|-|1-9 / 100 000|-|All ages|614286 ~97297|BOS syndrome<br>Bohring syndrome<br>C-like syndrome<br>Oberklaid-Danks syndrome<br>Opitz trigonocephaly-like syndrome|<1 / 1 000 000|-|-|605039 ~	.	,844,842,839	,853	843,,850,846,851,847,852,854,845,849,848	.	.	.	.	20	MU82037741	hom
20	31383353	31383353	T	G	DNMT3B	intronic	.	ENSG00000088305	rs910085	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4836	0.4029	0.584864	0.4343	.	.	.	.	.	.	.	.	.	.	AFR:0.4486,AMR:0.6499,EAS:0.9406,FIN:0.3651,NFE:0.3789,OTH:0.3990,ASJ:0.3818	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU25969455	het
20	31386347	31386347	T	C	DNMT3B	exonic	synonymous SNV	ENSG00000088305	rs6058891	ENSG00000088305:ENST00000456297:exon12:c.T1284C:p.C428C,ENSG00000088305:ENST00000443239:exon13:c.T1386C:p.C462C,ENSG00000088305:ENST00000201963:exon14:c.T1548C:p.C516C,ENSG00000088305:ENST00000344505:exon14:c.T1512C:p.C504C,ENSG00000088305:ENST00000348286:exon14:c.T1512C:p.C504C,ENSG00000088305:ENST00000353855:exon14:c.T1512C:p.C504C,ENSG00000088305:ENST00000328111:exon15:c.T1572C:p.C524C	DNMT3B:NM_001207056:exon12:c.T1284C:p.C428C,DNMT3B:NM_001207055:exon13:c.T1386C:p.C462C,DNMT3B:NM_175848:exon14:c.T1512C:p.C504C,DNMT3B:NM_175849:exon14:c.T1512C:p.C504C,DNMT3B:NM_175850:exon14:c.T1548C:p.C516C,DNMT3B:NM_006892:exon15:c.T1572C:p.C524C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5806	0.5791	0.755791	0.5962	.	.	.	.	.	.	.	.	DNMT3B:uc002wyg.3:exon8:c.T669C:p.C223C,DNMT3B:uc010zua.2:exon12:c.T1284C:p.C428C,DNMT3B:uc010ztz.2:exon13:c.T1386C:p.C462C,DNMT3B:uc002wyd.3:exon14:c.T1512C:p.C504C,DNMT3B:uc002wye.3:exon14:c.T1512C:p.C504C,DNMT3B:uc002wyf.3:exon14:c.T1548C:p.C516C,DNMT3B:uc002wyc.3:exon15:c.T1572C:p.C524C	.	AFR:0.8523,AMR:0.7050,EAS:0.9957,FIN:0.4335,NFE:0.4437,OTH:0.5102,ASJ:0.47	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU4554871	het
20	31386449	31386449	T	C	DNMT3B	exonic	synonymous SNV	ENSG00000088305	rs2424922	ENSG00000088305:ENST00000456297:exon12:c.T1386C:p.Y462Y,ENSG00000088305:ENST00000443239:exon13:c.T1488C:p.Y496Y,ENSG00000088305:ENST00000201963:exon14:c.T1650C:p.Y550Y,ENSG00000088305:ENST00000344505:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000348286:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000353855:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000328111:exon15:c.T1674C:p.Y558Y	DNMT3B:NM_001207056:exon12:c.T1386C:p.Y462Y,DNMT3B:NM_001207055:exon13:c.T1488C:p.Y496Y,DNMT3B:NM_175848:exon14:c.T1614C:p.Y538Y,DNMT3B:NM_175849:exon14:c.T1614C:p.Y538Y,DNMT3B:NM_175850:exon14:c.T1650C:p.Y550Y,DNMT3B:NM_006892:exon15:c.T1674C:p.Y558Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5792	0.5777	0.755791	0.5958	.	.	.	.	.	0.0001	0.2	.	DNMT3B:uc002wyg.3:exon8:c.T771C:p.Y257Y,DNMT3B:uc010zua.2:exon12:c.T1386C:p.Y462Y,DNMT3B:uc010ztz.2:exon13:c.T1488C:p.Y496Y,DNMT3B:uc002wyd.3:exon14:c.T1614C:p.Y538Y,DNMT3B:uc002wye.3:exon14:c.T1614C:p.Y538Y,DNMT3B:uc002wyf.3:exon14:c.T1650C:p.Y550Y,DNMT3B:uc002wyc.3:exon15:c.T1674C:p.Y558Y	.	AFR:0.8515,AMR:0.7064,EAS:0.9957,FIN:0.4333,NFE:0.4433,OTH:0.5102,ASJ:0.4702	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU4554877	het
20	31387954	31387954	C	G	DNMT3B	intronic	.	ENSG00000088305	rs1997797	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5663	0.5340	0.714058	0.5577	.	.	.	.	.	0.0005	0.056	.	.	.	AFR:0.7205,AMR:0.6986,EAS:0.9957,FIN:0.4313,NFE:0.4426,OTH:0.5031,ASJ:0.4636	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU30256080	het
20	31388636	31388636	T	C	DNMT3B	intronic	.	ENSG00000088305	rs2424928	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5737	0.5621	0.742612	0.5818	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.8052,AMR:0.7014,EAS:0.9951,FIN:0.4303,NFE:0.4430,OTH:0.5071,ASJ:0.4636	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU30256113	het
20	36030939	36030939	G	C	SRC	exonic	synonymous SNV	ENSG00000197122	rs1885257	ENSG00000197122:ENST00000358208:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000373558:exon10:c.G1236C:p.A412A,ENSG00000197122:ENST00000373567:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000360723:exon11:c.G1236C:p.A412A,ENSG00000197122:ENST00000445403:exon11:c.G1218C:p.A406A,ENSG00000197122:ENST00000373578:exon12:c.G1218C:p.A406A	SRC:NM_005417:exon12:c.G1218C:p.A406A,SRC:NM_198291:exon12:c.G1218C:p.A406A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	1	.	1	1	.	.	.	.	.	.	.	.	SRC:uc002xgx.3:exon12:c.G1218C:p.A406A,SRC:uc002xgy.3:exon12:c.G1218C:p.A406A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190090	114500;616937;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04137 Mitophagy - animal~ko04144 Endocytosis~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04540 Gap junction~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05131 Shigellosis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9871,9870,9874,9880,9879,9869,9877,9872,9875,9876,9878,9873	.	.	.	.	.	.	20	MU82038480	hom
20	39797465	39797465	T	C	PLCG1	exonic	nonsynonymous SNV	ENSG00000124181	rs753381	ENSG00000124181:ENST00000373271:exon21:c.T2438C:p.I813T,ENSG00000124181:ENST00000373272:exon21:c.T2438C:p.I813T,ENSG00000124181:ENST00000244007:exon22:c.T2438C:p.I813T	PLCG1:NM_002660:exon21:c.T2438C:p.I813T,PLCG1:NM_182811:exon21:c.T2438C:p.I813T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6155	0.6693	0.732827	0.6790	1.643	14.09	0.547	5.82	0.998	.	.	Pleckstrin homology domain|SH3 domain	PLCG1:uc010ggf.3:exon4:c.T410C:p.I137T,PLCG1:uc010zwe.1:exon10:c.T1316C:p.I439T,PLCG1:uc002xjo.1:exon21:c.T2438C:p.I813T,PLCG1:uc002xjp.1:exon21:c.T2438C:p.I813T	-0.938	AFR:0.9256,AMR:0.6031,EAS:0.8300,FIN:0.5917,NFE:0.5500,OTH:0.6043,ASJ:0.58	172420	.	.	.	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05135 Yersinia infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	0.91	0.000	-1.165	20	MU17685332	het
20	40713314	40713314	G	A	PTPRT	intronic	.	ENSG00000196090	rs6130030	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0416	0.0267	0.0469249	0.0291	.	.	.	.	.	0.0004	0.018	.	.	.	AFR:0.0065,AMR:0.0465,EAS:0.1043,FIN:0.0206,NFE:0.0343,OTH:0.0397,ASJ:0.0331	608712	.	.	.	.	.	.	.	.	.	.	.	20	MU726522	het
20	40743829	40743829	A	G	PTPRT	intronic	.	ENSG00000196090	rs2076248	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5308	0.5650	0.55651	0.5599	.	.	.	.	.	.	.	.	.	.	AFR:0.6257,AMR:0.5144,EAS:0.5632,FIN:0.5309,NFE:0.5305,OTH:0.5431,ASJ:0.6225	608712	.	.	.	.	.	.	.	.	.	.	.	20	MU23851333	het
20	41306488	41306488	-	AA	PTPRT	intronic	.	ENSG00000196090	rs111229158	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4277	.	0.477236	0.5209	.	.	.	.	.	.	.	.	.	.	AFR:0.5062,AMR:0.5315,EAS:0.5224,FIN:0.4946,NFE:0.5329,OTH:0.5231,ASJ:0.5906	608712	.	.	.	.	.	.	.	.	.	.	.	20	.	hom
20	42310509	42310509	T	C	MYBL2	intronic	.	ENSG00000101057	rs442143	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8496	0.8537	0.825679	0.8648	.	.	.	.	.	.	.	.	.	.	AFR:0.8206,AMR:0.7225,EAS:0.8247,FIN:0.9226,NFE:0.8886,OTH:0.8829,ASJ:0.8411	601415	.	.	.	.	.	.	.	.	.	.	.	20	MU82039042	het
20	42320881	42320881	C	T	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs2229036	ENSG00000101057:ENST00000396863:exon5:c.C513T:p.D171D,ENSG00000101057:ENST00000217026:exon6:c.C585T:p.D195D	MYBL2:NM_001278610:exon5:c.C513T:p.D171D,MYBL2:NM_002466:exon6:c.C585T:p.D195D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0472	0.0405	0.0505192	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon5:c.C513T:p.D171D,MYBL2:uc002xlb.1:exon6:c.C585T:p.D195D	.	AFR:0.0385,AMR:0.0259,EAS:0.0596,FIN:0.0760,NFE:0.0309,OTH:0.0434,ASJ:0.0346	601415	.	.	.	.	.	.	.	.	.	.	.	20	2(haematopoietic_and_lymphoid_tissue)	0.0388
20	42328639	42328639	T	C	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs285162	ENSG00000101057:ENST00000396863:exon6:c.T834C:p.P278P,ENSG00000101057:ENST00000217026:exon7:c.T906C:p.P302P	MYBL2:NM_001278610:exon6:c.T834C:p.P278P,MYBL2:NM_002466:exon7:c.T906C:p.P302P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9141	0.9372	0.932109	0.9385	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon6:c.T834C:p.P278P,MYBL2:uc002xlb.1:exon7:c.T906C:p.P302P	.	AFR:0.9724,AMR:0.7602,EAS:0.9082,FIN:0.9505,NFE:0.9297,OTH:0.9235,ASJ:0.9570	601415	.	.	.	.	.	.	.	.	.	.	.	20	MU25976801	hom
20	42331457	42331457	A	G	MYBL2	exonic	nonsynonymous SNV	ENSG00000101057	rs2070235	ENSG00000101057:ENST00000396863:exon7:c.A1207G:p.S403G,ENSG00000101057:ENST00000217026:exon8:c.A1279G:p.S427G	MYBL2:NM_001278610:exon7:c.A1207G:p.S403G,MYBL2:NM_002466:exon8:c.A1279G:p.S427G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1080	0.1525	0.15655	1(breast)	1.102	11.22	0.55	2.73	0.923	.	.	.	MYBL2:uc010zwj.1:exon7:c.A1207G:p.S403G,MYBL2:uc002xlb.1:exon8:c.A1279G:p.S427G	-0.903	AFR:MU4557321,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.2664,FIN:0.0694,NFE:0.1159,OTH:0.0883,ASJ:0.1377	601415	.	.	.	.	.	.	.	0.002	2.52	0.000	0.805	20	1(haematopoietic_and_lymphoid_tissue)	0.0922
20	43595856	43595856	G	T	STK4	intronic	.	ENSG00000101109	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604965	614868;	314689;	314689|CID due to STK4 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|614868 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04068 FoxO signaling pathway~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer ~	.	.	.	.	.	.	.	20	.	het
20	43964407	43964407	G	C	SDC4	intronic	.	ENSG00000124145	rs2072791	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7710	0.7280	0.769369	0.7446	.	.	.	.	.	.	.	.	.	.	AFR:0.6624,AMR:0.7912,EAS:0.9618,FIN:0.7983,NFE:0.7548,OTH:0.7377,ASJ:0.7067	600017	.	.	.	~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	20	MU71379439	hom
20	46267950	46267950	C	T	NCOA3	intronic	.	ENSG00000124151	rs4810648	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9411	0.9406	0.978435	0.9373	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:0.9842,AMR:0.9533,EAS:1,FIN:0.9273,NFE:0.9051,OTH:0.9257,ASJ:0.9570	601937	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU82039696	hom
20	47604825	47604825	G	A	ARFGEF2	intronic	.	ENSG00000124198	rs4810905	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3062	0.2178	0.290735	0.2368	.	.	.	.	.	.	.	.	.	.	AFR:0.1178,AMR:0.4045,EAS:0.4770,FIN:0.2652,NFE:0.2597,OTH:0.3057,ASJ:0.2233	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	.	.	.	.	20	MU585566	het
20	47611017	47611017	C	T	ARFGEF2	exonic	synonymous SNV	ENSG00000124198	rs752737205	ENSG00000124198:ENST00000371917:exon22:c.C3003T:p.L1001L	ARFGEF2:NM_006420:exon22:c.C3003T:p.L1001L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	1.649e-05	.	.	9.688e-05	.	.	.	.	.	.	.	.	ARFGEF2:uc010zyf.2:exon8:c.C882T:p.L294L,ARFGEF2:uc002xtx.4:exon22:c.C3003T:p.L1001L	.	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:6.666e-05,OTH:0,ASJ:0	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	.	.	.	.	20	.	het
20	50408482	50408482	A	G	SALL4	exonic	synonymous SNV	ENSG00000101115	rs6013281	ENSG00000101115:ENST00000217086:exon2:c.T540C:p.N180N,ENSG00000101115:ENST00000395997:exon2:c.T540C:p.N180N	SALL4:NM_001318031:exon2:c.T540C:p.N180N,SALL4:NM_020436:exon2:c.T540C:p.N180N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9965	0.9956	0.997404	0.9967	.	.	.	.	.	.	.	.	SALL4:uc002xwh.4:exon2:c.T540C:p.N180N,SALL4:uc010gii.3:exon2:c.T540C:p.N180N	.	AFR:0.9976,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9953,OTH:0.9980,ASJ:0.9901	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	MU82040420	hom
20	52185814	52185814	C	A	LOC101927770	ncRNA_intronic	.	ENSG00000197670	rs4602270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7256	.	0.779153	0.7405	.	.	.	.	.	0	0	.	.	.	AFR:0.8270,AMR:0.7626,EAS:0.8209,FIN:0.7318,NFE:0.6834,OTH:0.7301,ASJ:0.7152	.	.	.	.	.	.	.	.	.	.	.	.	20	MU14541605	het
20	52192957	52192957	C	G	ZNF217	exonic	synonymous SNV	ENSG00000171940	rs41274708	ENSG00000171940:ENST00000302342:exon3:c.G2346C:p.A782A,ENSG00000171940:ENST00000371471:exon4:c.G2346C:p.A782A	ZNF217:NM_006526:exon3:c.G2346C:p.A782A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0066	0.0046	0.00379393	0.0040	.	.	.	.	.	.	.	.	ZNF217:uc002xwq.4:exon3:c.G2346C:p.A782A,ZNF217:uc010gij.1:exon4:c.G2322C:p.A774A	.	AFR:0.0009,AMR:0.0012,EAS:0,FIN:0.0029,NFE:0.0068,OTH:0.0020,ASJ:0	602967	.	.	.	.	.	.	.	.	.	.	.	20	.	het
20	54961463	54961463	T	C	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs1047972	ENSG00000087586:ENST00000347343:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395907:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395913:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395915:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000312783:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000371356:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395911:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395914:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000422322:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000441357:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395909:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000420474:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000451915:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000456249:exon5:c.A169G:p.I57V	AURKA:NM_003600:exon3:c.A169G:p.I57V,AURKA:NM_198435:exon3:c.A169G:p.I57V,AURKA:NM_198437:exon3:c.A169G:p.I57V,AURKA:NM_001323303:exon4:c.A169G:p.I57V,AURKA:NM_001323304:exon4:c.A169G:p.I57V,AURKA:NM_198434:exon4:c.A169G:p.I57V,AURKA:NM_198436:exon4:c.A169G:p.I57V,AURKA:NM_001323305:exon5:c.A169G:p.I57V,AURKA:NM_198433:exon5:c.A169G:p.I57V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8482	0.8378	0.84984	COCA-CN|5|321|0.0155763	-2.027	0.001	1.0	1.97	0.069	.	.	.	AURKA:uc002xxg.1:exon3:c.A169G:p.I57V,AURKA:uc002xxh.1:exon3:c.A169G:p.I57V,AURKA:uc002xxi.1:exon3:c.A169G:p.I57V,AURKA:uc002xxe.1:exon4:c.A169G:p.I57V,AURKA:uc002xxf.1:exon4:c.A169G:p.I57V,AURKA:uc002xxj.1:exon4:c.A169G:p.I57V,AURKA:uc002xxd.1:exon5:c.A169G:p.I57V	-0.937	AFR:0.8413,AMR:0.8405,EAS:0.8676,FIN:0.8881,NFE:0.8129,OTH:0.8406,ASJ:0.8986	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	.	20	1(stomach)	0.8262
20	54961541	54961541	A	T	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs2273535	ENSG00000087586:ENST00000347343:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395907:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395913:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395915:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000312783:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000371356:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395911:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395914:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000422322:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000441357:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395909:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000420474:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000451915:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000456249:exon5:c.T91A:p.F31I	AURKA:NM_003600:exon3:c.T91A:p.F31I,AURKA:NM_198435:exon3:c.T91A:p.F31I,AURKA:NM_198437:exon3:c.T91A:p.F31I,AURKA:NM_001323303:exon4:c.T91A:p.F31I,AURKA:NM_001323304:exon4:c.T91A:p.F31I,AURKA:NM_198434:exon4:c.T91A:p.F31I,AURKA:NM_198436:exon4:c.T91A:p.F31I,AURKA:NM_001323305:exon5:c.T91A:p.F31I,AURKA:NM_198433:exon5:c.T91A:p.F31I	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2735	0.1882	0.309704	1(skin)	-1.212	0.006	0.497	-7.55	0.093	.	.	.	AURKA:uc002xxg.1:exon3:c.T91A:p.F31I,AURKA:uc002xxh.1:exon3:c.T91A:p.F31I,AURKA:uc002xxi.1:exon3:c.T91A:p.F31I,AURKA:uc002xxe.1:exon4:c.T91A:p.F31I,AURKA:uc002xxf.1:exon4:c.T91A:p.F31I,AURKA:uc002xxj.1:exon4:c.T91A:p.F31I,AURKA:uc002xxd.1:exon5:c.T91A:p.F31I	-0.990	AFR:MU714003,AMR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.1428,FIN:0.3341,NFE:0.1689,OTH:0.6750,ASJ:0.2338	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	0.69	20	8(soft_tissue)	0.2761
20	57478807	57478807	C	T	GNAS	exonic	synonymous SNV	ENSG00000087460	rs7121	ENSG00000087460:ENST00000265620:exon4:c.C348T:p.I116I,ENSG00000087460:ENST00000371095:exon4:c.C351T:p.I117I,ENSG00000087460:ENST00000371102:exon4:c.C2280T:p.I760I,ENSG00000087460:ENST00000306090:exon5:c.C351T:p.I117I,ENSG00000087460:ENST00000349036:exon5:c.C444T:p.I148I,ENSG00000087460:ENST00000354359:exon5:c.C396T:p.I132I,ENSG00000087460:ENST00000371085:exon5:c.C393T:p.I131I,ENSG00000087460:ENST00000371100:exon5:c.C2322T:p.I774I,ENSG00000087460:ENST00000603546:exon5:c.C216T:p.I72I,ENSG00000087460:ENST00000604005:exon5:c.C216T:p.I72I	GNAS:NM_001077489:exon4:c.C348T:p.I116I,GNAS:NM_080426:exon4:c.C351T:p.I117I,GNAS:NM_000516:exon5:c.C393T:p.I131I,GNAS:NM_001077488:exon5:c.C396T:p.I132I,GNAS:NM_001309840:exon5:c.C216T:p.I72I,GNAS:NM_001309861:exon5:c.C216T:p.I72I,GNAS:NM_080425:exon5:c.C2322T:p.I774I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5473	0.5794	0.644369	15(meninges)	.	.	.	.	.	.	.	.	GNAS:uc002yae.3:exon2:c.C168T:p.I56I,GNAS:uc002yad.3:exon3:c.C66T:p.I22I,GNAS:uc002yaa.3:exon4:c.C348T:p.I116I,GNAS:uc021wfp.1:exon4:c.C351T:p.I117I,GNAS:uc002xzt.3:exon5:c.C297T:p.I99I,GNAS:uc002xzw.3:exon5:c.C2322T:p.I774I,GNAS:uc002xzx.3:exon5:c.C216T:p.I72I,GNAS:uc010gjq.3:exon5:c.C216T:p.I72I,GNAS:uc021wfn.1:exon5:c.C393T:p.I131I,GNAS:uc021wfo.1:exon5:c.C396T:p.I132I	.	AFR:1(eye),AMR:MU84578,EAS:0.5563,FIN:0.7561,NFE:0.6235,OTH:0.64,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	139320	102200;103580;166350;174800;219080;603233;612462;612463;	79445;79444;94089;189427;562;2762;79443;314777;96256;963;99725;	79445|AHO-PPHP syndrome<br>Albright hereditary osteodystrophy-PPHP syndrome|Unknown|Autosomal dominant|All ages|612463 ~79444|-|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|612462 ~94089|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Infancy<br>Childhood<br>Adolescent|603233 ~189427|Primary bilateral macronodular adrenal hyperplasia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|219080 615954 ~562|Gonadotropin-independent female-limited sexual precocity|1-9 / 1 000 000|Not applicable|Childhood|174800 ~2762|Familial ectopic ossification<br>POH|-|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|166350 ~79443|AHO-PHP syndrome Ia<br>Albright hereditary osteodystrophy-PHP syndrome Ia|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|103580 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04724 Glutamatergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04962 Vasopressin-regulated water reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05032 Morphine addiction~ko05034 Alcoholism~ko05110 Vibrio cholerae infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	,5904,5905	.	.	.	.	.	.	20	1(urinary_tract)	0.6584
21	34399401	34399401	A	G	OLIG2	exonic	synonymous SNV	ENSG00000205927	rs762178	ENSG00000205927:ENST00000333337:exon1:c.A231G:p.S77S,ENSG00000205927:ENST00000382357:exon2:c.A231G:p.S77S	OLIG2:NM_005806:exon2:c.A231G:p.S77S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5212	0.5559	0.439696	2(lung)	.	.	.	.	.	.	.	.	OLIG2:uc021wil.1:exon1:c.A231G:p.S77S,OLIG2:uc002yqx.2:exon2:c.A231G:p.S77S	.	AFR:MU9764520,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.5249,FIN:0.4928,NFE:0.6324,OTH:0.1719,ASJ:0.5263	606386	.	.	.	.	.	.	.	.	.	.	.	21	1(breast)	0.5195
21	36164597	36164597	-	GGGGGGGGGGGGGGGG	RUNX1	exonic	frameshift insertion	ENSG00000159216	.	ENSG00000159216:ENST00000399240:exon5:c.1004_1005insCCCCCCCCCCCCCCCC:p.P335fs,ENSG00000159216:ENST00000344691:exon6:c.1196_1197insCCCCCCCCCCCCCCCC:p.P399fs,ENSG00000159216:ENST00000325074:exon7:c.1241_1242insCCCCCCCCCCCCCCCC:p.P414fs,ENSG00000159216:ENST00000300305:exon8:c.1277_1278insCCCCCCCCCCCCCCCC:p.P426fs,ENSG00000159216:ENST00000437180:exon9:c.1277_1278insCCCCCCCCCCCCCCCC:p.P426fs	RUNX1:NM_001001890:exon6:c.1196_1197insCCCCCCCCCCCCCCCC:p.P399fs,RUNX1:NM_001754:exon9:c.1277_1278insCCCCCCCCCCCCCCCC:p.P426fs	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	RUNX1:uc002yuh.3:exon6:c.1196_1197insCCCCCCCCCCCCCCCC:p.P399fs,RUNX1:uc002yuj.4:exon7:c.881_882insCCCCCCCCCCCCCCCC:p.P294fs,RUNX1:uc002yuk.4:exon8:c.1277_1278insCCCCCCCCCCCCCCCC:p.P426fs,RUNX1:uc010gmu.3:exon9:c.1277_1278insCCCCCCCCCCCCCCCC:p.P426fs,RUNX1:uc010gmv.3:exon9:c.1277_1278insCCCCCCCCCCCCCCCC:p.P426fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	151385	601399;601626;	519;71290;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~71290|FPD/AML syndrome<br>FPS/AML syndrome<br>Familial platelet disorder with associated myeloid malignancy<br>Familial platelet syndrome|<1 / 1 000 000|Autosomal dominant|No data available|601399 ~	~ko04530 Tight junction~ko04659 Th17 cell differentiation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia ~	9624,,9630	.	,9633,9626,9631,9629,9625,9632,9627,9628	.	.	.	.	21	.	het
21	39870310	39870310	G	A	ERG	UTR5	.	ENSG00000157554	rs2836441	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8707	0.8875	0.890775	0.8875	.	.	.	.	.	.	.	.	.	.	AFR:0.9436,AMR:0.8103,EAS:0.8129,FIN:0.9064,NFE:0.8628,OTH:0.8727,ASJ:0.9404	165080	.	.	.	~ko05202 Transcriptional misregulation in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	21	MU13675292	het
21	40191431	40191431	T	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs457705	ENSG00000157557:ENST00000360938:exon8:c.T816G:p.T272T,ENSG00000157557:ENST00000360214:exon9:c.T816G:p.T272T	ETS2:NM_005239:exon8:c.T816G:p.T272T,ETS2:NM_001256295:exon9:c.T1236G:p.T412T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7220	0.7713	0.58107	MU748847	.	.	.	.	.	.	.	.	ETS2:uc002yxg.4:exon8:c.T816G:p.T272T,ETS2:uc002yxf.3:exon9:c.T1236G:p.T412T	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.7428,EAS:0.5943,FIN:0.8543,NFE:0.4708,OTH:0.7596,ASJ:0.6169	164740	.	.	.	.	.	.	.	.	.	.	.	21	1(liver)	0.8457
21	40191638	40191638	A	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs461155	ENSG00000157557:ENST00000360938:exon8:c.A1023G:p.P341P,ENSG00000157557:ENST00000360214:exon9:c.A1023G:p.P341P	ETS2:NM_005239:exon8:c.A1023G:p.P341P,ETS2:NM_001256295:exon9:c.A1443G:p.P481P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7228	0.7706	0.580671	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ETS2:uc002yxg.4:exon8:c.A1023G:p.P341P,ETS2:uc002yxf.3:exon9:c.A1443G:p.P481P	.	AFR:0.7422,AMR:0.6138,EAS:0.8543,FIN:0.4721,NFE:0.7594,OTH:0.8462,ASJ:0.5943	164740	.	.	.	.	.	.	.	.	.	.	.	21	2(lung)	0.7658
21	44837551	44837551	G	A	SIK1;SIK1B	exonic	synonymous SNV	ENSG00000142178	rs430552	ENSG00000142178:ENST00000270162:exon13:c.C1848T:p.P616P	SIK1B:NM_001320643:exon13:c.C1848T:p.P616P,SIK1:NM_173354:exon13:c.C1848T:p.P616P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8000	0.7241	0.725439	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SIK1:uc002zdf.2:exon13:c.C1848T:p.P616P	.	AFR:0.7315,AMR:0.5034,EAS:0.7162,FIN:0.8904,NFE:0.8819,OTH:0.7974,ASJ:0.8702	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	2(large_intestine)	0.8364
21	44837555	44837555	G	A	SIK1;SIK1B	exonic	nonsynonymous SNV	ENSG00000142178	rs430554	ENSG00000142178:ENST00000270162:exon13:c.C1844T:p.A615V	SIK1B:NM_001320643:exon13:c.C1844T:p.A615V,SIK1:NM_173354:exon13:c.C1844T:p.A615V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8900	0.8455	0.830671	3(lung)	1.313	12.34	0.005	2.25	0.200	.	.	.	SIK1:uc002zdf.2:exon13:c.C1844T:p.A615V	-1.004	AFR:MU9773887,AMR:COCA-CN|5|321|0.0155763,EAS:0.7171,FIN:0.9173,NFE:0.8221,OTH:0.9047,ASJ:0.8533	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	0.281	-0.59	0.000	1.04	21	1(liver)	0.9561
21	44838330	44838330	C	A	SIK1;SIK1B	exonic	synonymous SNV	ENSG00000142178	rs34487963	ENSG00000142178:ENST00000270162:exon12:c.G1554T:p.A518A	SIK1B:NM_001320643:exon12:c.G1554T:p.A518A,SIK1:NM_173354:exon12:c.G1554T:p.A518A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0349	0.0161	0.0535144	0.0159	.	.	.	.	.	.	.	.	SIK1:uc002zdf.2:exon12:c.G1554T:p.A518A	.	AFR:0.0137,AMR:0.0084,EAS:0.0580,FIN:0.0049,NFE:0.0150,OTH:0.0246,ASJ:0.0199	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	MU749038	het
21	44845888	44845888	A	G	SIK1;SIK1B	intronic	.	ENSG00000142178	rs56796001	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1835	0.1802	0.163339	0.1776	.	.	.	.	.	.	.	.	.	.	AFR:0.4231,AMR:0.0549,EAS:0.0043,FIN:0.0702,NFE:0.0933,OTH:0.0849,ASJ:0.1026	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	MU113338961	het
21	46875564	46875564	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs914230	ENSG00000182871:ENST00000355480:exon1:c.T120C:p.H40H,ENSG00000182871:ENST00000359759:exon1:c.T120C:p.H40H	COL18A1:NM_030582:exon1:c.T120C:p.H40H,COL18A1:NM_130444:exon1:c.T120C:p.H40H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9705	0.9693	0.988419	0.9678	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon1:c.T120C:p.H40H	.	AFR:0.9925,AMR:0.9785,EAS:1,FIN:0.9631,NFE:0.9510,OTH:0.9551,ASJ:0.9801	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU82046823	hom
21	46896294	46896294	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2230686	ENSG00000182871:ENST00000355480:exon5:c.G1368A:p.A456A,ENSG00000182871:ENST00000359759:exon5:c.G2073A:p.A691A,ENSG00000182871:ENST00000400337:exon6:c.G828A:p.A276A	COL18A1:NM_030582:exon5:c.G1368A:p.A456A,COL18A1:NM_130444:exon5:c.G2073A:p.A691A,COL18A1:NM_130445:exon6:c.G828A:p.A276A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0341	0.0683	0.0958466	0.0651	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon5:c.G1368A:p.A456A,COL18A1:uc002zhg.3:exon6:c.G828A:p.A276A	.	AFR:0.2052,AMR:0.0179,EAS:0.0703,FIN:0.0009,NFE:0.0047,OTH:0.0234,ASJ:0.0099	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU749669	unknown
21	46896303	46896303	C	G	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2230687	ENSG00000182871:ENST00000355480:exon5:c.C1377G:p.P459P,ENSG00000182871:ENST00000359759:exon5:c.C2082G:p.P694P,ENSG00000182871:ENST00000400337:exon6:c.C837G:p.P279P	COL18A1:NM_030582:exon5:c.C1377G:p.P459P,COL18A1:NM_130444:exon5:c.C2082G:p.P694P,COL18A1:NM_130445:exon6:c.C837G:p.P279P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1526	0.1804	0.245407	MU749673	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon5:c.C1377G:p.P459P,COL18A1:uc002zhg.3:exon6:c.C837G:p.P279P	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.1958,EAS:0.1432,FIN:0.1623,NFE:0.3089,OTH:0.1252,ASJ:0.3884	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(lung)	0.0957
21	46896312	46896312	G	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2230688	ENSG00000182871:ENST00000355480:exon5:c.G1386T:p.T462T,ENSG00000182871:ENST00000359759:exon5:c.G2091T:p.T697T,ENSG00000182871:ENST00000400337:exon6:c.G846T:p.T282T	COL18A1:NM_030582:exon5:c.G1386T:p.T462T,COL18A1:NM_130444:exon5:c.G2091T:p.T697T,COL18A1:NM_130445:exon6:c.G846T:p.T282T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1474	0.1655	0.227835	1(stomach)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon5:c.G1386T:p.T462T,COL18A1:uc002zhg.3:exon6:c.G846T:p.T282T	.	AFR:MU121117,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.3296,FIN:0.1396,NFE:0.1711,OTH:0.3101,ASJ:0.1793	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(breast)	0.1251
21	46899842	46899842	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1131100	ENSG00000182871:ENST00000355480:exon9:c.C1815T:p.P605P,ENSG00000182871:ENST00000359759:exon9:c.C2520T:p.P840P,ENSG00000182871:ENST00000400337:exon10:c.C1275T:p.P425P	COL18A1:NM_030582:exon9:c.C1815T:p.P605P,COL18A1:NM_130444:exon9:c.C2520T:p.P840P,COL18A1:NM_130445:exon10:c.C1275T:p.P425P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0933	0.1310	0.163139	MU749678	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon9:c.C1815T:p.P605P,COL18A1:uc002zhg.3:exon10:c.C1275T:p.P425P	.	AFR:ESAD-UK|1|409|0.00244499,LINC-JP|1|394|0.00253807,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,AMR:0.1225,EAS:0.1208,FIN:0.0695,NFE:0.0898,OTH:0.0209,ASJ:0.2759	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(liver)	0.0646
21	46899857	46899857	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1131101	ENSG00000182871:ENST00000355480:exon9:c.C1830T:p.D610D,ENSG00000182871:ENST00000359759:exon9:c.C2535T:p.D845D,ENSG00000182871:ENST00000400337:exon10:c.C1290T:p.D430D	COL18A1:NM_030582:exon9:c.C1830T:p.D610D,COL18A1:NM_130444:exon9:c.C2535T:p.D845D,COL18A1:NM_130445:exon10:c.C1290T:p.D430D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0881	0.1306	0.157348	ESAD-UK|1|409|0.00244499,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon9:c.C1830T:p.D610D,COL18A1:uc002zhg.3:exon10:c.C1290T:p.D430D	.	AFR:0.1195,AMR:0.2704,EAS:0.0695,FIN:0.0861,NFE:0.0206,OTH:0.0640,ASJ:0.0873	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.0792
21	46899872	46899872	C	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1131102	ENSG00000182871:ENST00000355480:exon9:c.C1845A:p.G615G,ENSG00000182871:ENST00000359759:exon9:c.C2550A:p.G850G,ENSG00000182871:ENST00000400337:exon10:c.C1305A:p.G435G	COL18A1:NM_030582:exon9:c.C1845A:p.G615G,COL18A1:NM_130444:exon9:c.C2550A:p.G850G,COL18A1:NM_130445:exon10:c.C1305A:p.G435G	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0832	0.1142	0.140375	MU673649	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon9:c.C1845A:p.G615G,COL18A1:uc002zhg.3:exon10:c.C1305A:p.G435G	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,AMR:0.1033,EAS:0.0863,FIN:0.0695,NFE:0.0853,OTH:0.0206,ASJ:0.2139	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.0639
21	46900410	46900410	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2236467	ENSG00000182871:ENST00000355480:exon11:c.C1968T:p.F656F,ENSG00000182871:ENST00000359759:exon11:c.C2673T:p.F891F,ENSG00000182871:ENST00000400337:exon12:c.C1428T:p.F476F	COL18A1:NM_030582:exon11:c.C1968T:p.F656F,COL18A1:NM_130444:exon11:c.C2673T:p.F891F,COL18A1:NM_130445:exon12:c.C1428T:p.F476F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0876	0.1296	0.15595	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon11:c.C1968T:p.F656F,COL18A1:uc002zhg.3:exon12:c.C1428T:p.F476F	.	AFR:MU11355673,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.2682,FIN:0.0871,NFE:0.0695,OTH:0.0853,ASJ:0.1189	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(breast)	0.0206
21	46908355	46908355	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs11702425	ENSG00000182871:ENST00000355480:exon17:c.T2460C:p.L820L,ENSG00000182871:ENST00000359759:exon17:c.T3165C:p.L1055L,ENSG00000182871:ENST00000400337:exon18:c.T1920C:p.L640L	COL18A1:NM_030582:exon17:c.T2460C:p.L820L,COL18A1:NM_130444:exon17:c.T3165C:p.L1055L,COL18A1:NM_130445:exon18:c.T1920C:p.L640L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3052	0.3129	0.319888	2(breast)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon17:c.T2460C:p.L820L,COL18A1:uc002zhg.3:exon18:c.T1920C:p.L640L	.	AFR:MU156625,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.3687,FIN:0.2613,NFE:0.3233,OTH:0.2420,ASJ:0.3220	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.3456
21	46909426	46909426	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs61731167	ENSG00000182871:ENST00000355480:exon18:c.G2490A:p.P830P,ENSG00000182871:ENST00000359759:exon18:c.G3195A:p.P1065P,ENSG00000182871:ENST00000400337:exon19:c.G1950A:p.P650P	COL18A1:NM_030582:exon18:c.G2490A:p.P830P,COL18A1:NM_130444:exon18:c.G3195A:p.P1065P,COL18A1:NM_130445:exon19:c.G1950A:p.P650P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0942	0.0453	0.0459265	0.0651	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon18:c.G2490A:p.P830P,COL18A1:uc002zhg.3:exon19:c.G1950A:p.P650P	.	AFR:0.0287,AMR:0.0323,EAS:0.0099,FIN:0.1469,NFE:0.0738,OTH:0.0777,ASJ:0.0762	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU117063561	het
21	46910210	46910210	G	A	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs62000962	ENSG00000182871:ENST00000342220:exon1:c.G22A:p.V8I,ENSG00000182871:ENST00000355480:exon19:c.G2521A:p.V841I,ENSG00000182871:ENST00000359759:exon19:c.G3226A:p.V1076I,ENSG00000182871:ENST00000400337:exon20:c.G1981A:p.V661I	COL18A1:NM_030582:exon19:c.G2521A:p.V841I,COL18A1:NM_130444:exon19:c.G3226A:p.V1076I,COL18A1:NM_130445:exon20:c.G1981A:p.V661I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2169	0.1234	0.115615	SKCA-BR|1|100|0.01	-0.436	0.315	0.424	-2.52	0.008	.	.	.	COL18A1:uc002zhi.3:exon19:c.G2521A:p.V841I,COL18A1:uc002zhg.3:exon20:c.G1981A:p.V661I	-0.859	AFR:0.1330,AMR:0.1533,EAS:0.1358,FIN:0.0144,NFE:0.1644,OTH:0.1285,ASJ:0.0974	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	0.048	-3.2	0.004	0.05	21	1(liver)	0.1360
21	46911188	46911188	C	G	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs79980197	ENSG00000182871:ENST00000342220:exon3:c.C158G:p.P53R,ENSG00000182871:ENST00000355480:exon21:c.C2657G:p.P886R,ENSG00000182871:ENST00000359759:exon21:c.C3362G:p.P1121R,ENSG00000182871:ENST00000400337:exon22:c.C2117G:p.P706R	COL18A1:NM_030582:exon21:c.C2657G:p.P886R,COL18A1:NM_130444:exon21:c.C3362G:p.P1121R,COL18A1:NM_130445:exon22:c.C2117G:p.P706R	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0877	0.0598	0.0688898	0.0785	5.006	25.1	0.094	3.85	0.004	.	.	.	COL18A1:uc002zhi.3:exon21:c.C2657G:p.P886R,COL18A1:uc002zhg.3:exon22:c.C2117G:p.P706R	-0.339	AFR:0.0342,AMR:0.0370,EAS:0.0729,FIN:0.1571,NFE:0.0883,OTH:0.0835,ASJ:0.0894	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	1.0	-3.09	0.242	2.3	21	MU4555974	het
21	46913477	46913477	G	C	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs2230693	ENSG00000182871:ENST00000342220:exon7:c.G381C:p.Q127H,ENSG00000182871:ENST00000355480:exon25:c.G2880C:p.Q960H,ENSG00000182871:ENST00000359759:exon25:c.G3585C:p.Q1195H,ENSG00000182871:ENST00000400337:exon26:c.G2340C:p.Q780H	COL18A1:NM_030582:exon25:c.G2880C:p.Q960H,COL18A1:NM_130444:exon25:c.G3585C:p.Q1195H,COL18A1:NM_130445:exon26:c.G2340C:p.Q780H	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0367	0.0280	0.063099	MU26831746	0.508	7.491	0.25	0.37	0.959	.	.	.	COL18A1:uc002zhi.3:exon25:c.G2880C:p.Q960H,COL18A1:uc002zhg.3:exon26:c.G2340C:p.Q780H	-0.854	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,AMR:0.0315,EAS:0.0143,FIN:0.0099,NFE:0.0840,OTH:0.0009,ASJ:0.0843	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	0.011	-3.22	0.011	1.88	21	1(biliary_tract)	0.0046
21	46924426	46924434	GGCCCCCCA	-	COL18A1	exonic	frameshift deletion	ENSG00000182871	rs149296338	ENSG00000182871:ENST00000342220:exon15:c.865_873del:p.289_291del,ENSG00000182871:ENST00000355480:exon33:c.3364_3372del:p.1122_1124del,ENSG00000182871:ENST00000359759:exon33:c.4069_4077del:p.1357_1359del,ENSG00000182871:ENST00000400337:exon34:c.2824_2832del:p.942_944del	COL18A1:NM_030582:exon33:c.3364delG:p.G1122fs,COL18A1:NM_130444:exon33:c.4069delG:p.G1357fs,COL18A1:NM_130445:exon34:c.2824delG:p.G942fs	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9693	0.8055	.	0.9637	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon33:c.3364_3372del:p.1122_1124del,COL18A1:uc002zhg.3:exon34:c.2824_2832del:p.942_944del	.	AFR:0.9550,AMR:0.9737,EAS:0.9994,FIN:0.9728,NFE:0.9608,OTH:0.9762,ASJ:0.9868	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU56575	hom
21	46925140	46925140	-	GGCCCCCCA	COL18A1	exonic	nonframeshift insertion	ENSG00000182871	rs759403198	ENSG00000182871:ENST00000342220:exon16:c.1002_1003insGGCCCCCCA:p.P334delinsPGPP,ENSG00000182871:ENST00000355480:exon34:c.3501_3502insGGCCCCCCA:p.P1167delinsPGPP,ENSG00000182871:ENST00000359759:exon34:c.4206_4207insGGCCCCCCA:p.P1402delinsPGPP,ENSG00000182871:ENST00000400337:exon35:c.2961_2962insGGCCCCCCA:p.P987delinsPGPP	COL18A1:NM_030582:exon35:c.3492_3493insGGCCCCCCA:p.P1164delinsPGPP,COL18A1:NM_130444:exon35:c.4197_4198insGGCCCCCCA:p.P1399delinsPGPP,COL18A1:NM_130445:exon36:c.2952_2953insGGCCCCCCA:p.P984delinsPGPP	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0010	.	.	0.0004	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon34:c.3501_3502insGGCCCCCCA:p.P1167delinsPGPP,COL18A1:uc002zhg.3:exon35:c.2961_2962insGGCCCCCCA:p.P987delinsPGPP	.	AFR:0.0015,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	.	het
21	46925353	46925354	TC	-	COL18A1	intronic	.	ENSG00000173638;ENSG00000182871	rs373823632	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0290	0.0153	0.0183706	0.0193	.	.	.	.	.	.	.	.	.	.	AFR:0.0193,AMR:0.0096,EAS:0.0049,FIN:0.0458,NFE:0.0152,OTH:0.0225,ASJ:0.0099	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	.	het
21	46929467	46929467	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1050351	ENSG00000182871:ENST00000342220:exon20:c.G1491A:p.A497A,ENSG00000182871:ENST00000355480:exon38:c.G3987A:p.A1329A,ENSG00000182871:ENST00000359759:exon38:c.G4692A:p.A1564A,ENSG00000182871:ENST00000400337:exon39:c.G3447A:p.A1149A	COL18A1:NM_030582:exon39:c.G3978A:p.A1326A,COL18A1:NM_130444:exon39:c.G4683A:p.A1561A,COL18A1:NM_130445:exon40:c.G3438A:p.A1146A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5110	0.3778	0.503594	MU77662	.	.	.	.	.	.	.	.	COL18A1:uc002zhj.3:exon6:c.G381A:p.A127A,COL18A1:uc002zhi.3:exon38:c.G3987A:p.A1329A,COL18A1:uc002zhg.3:exon39:c.G3447A:p.A1149A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,AMR:0.4346,EAS:0.5613,FIN:0.3675,NFE:0.5509,OTH:0.4365,ASJ:0.4536	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.4068
21	46929523	46929523	C	-	COL18A1	intronic	.	ENSG00000173638;ENSG00000182871	rs3835286	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4859	0.4999	0.554912	0.4949	.	.	.	.	.	.	.	.	.	.	AFR:0.6141,AMR:0.4606,EAS:0.5893,FIN:0.4610,NFE:0.4306,OTH:0.4486,ASJ:0.3841	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU117081558	het
21	46932328	46932328	G	A	COL18A1	UTR3	.	ENSG00000182871	rs7499	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4461	0.4030	0.467252	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.4212,AMR:0.4371,EAS:0.3576,FIN:0.5584,NFE:0.4191,OTH:0.4000,ASJ:0.4330	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.3959
22	18900669	18900669	A	G	LOC102724788;PRODH	UTR3	.	ENSG00000100033;ENSG00000183628	rs383964	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9212	0.9154	0.907548	0.9076	.	.	.	.	.	.	.	.	.	.	AFR:0.8428,AMR:0.9582,EAS:0.9540,FIN:0.9162,NFE:0.9332,OTH:0.9284,ASJ:0.9470	.	.	.	.	.	.	.	.	.	.	.	.	22	MU82047850	hom
22	18900750	18900750	G	A	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs372055	ENSG00000100033:ENST00000334029:exon14:c.C1417T:p.L473L,ENSG00000100033:ENST00000357068:exon14:c.C1741T:p.L581L,ENSG00000100033:ENST00000420436:exon14:c.C1417T:p.L473L	PRODH:NM_001195226:exon14:c.C1417T:p.L473L,LOC102724788:NM_001368250:exon14:c.C1417T:p.L473L,LOC102724788:NM_001368249:exon15:c.C1741T:p.L581L,PRODH:NM_016335:exon15:c.C1741T:p.L581L	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7890	0.7588	0.763379	0.7524	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon14:c.C1417T:p.L473L,PRODH:uc002zol.4:exon14:c.C1417T:p.L473L,PRODH:uc002zok.4:exon15:c.C1741T:p.L581L	.	AFR:0.6254,AMR:0.7757,EAS:0.8455,FIN:0.7544,NFE:0.8110,OTH:0.7900,ASJ:0.7914	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU4559149	hom
22	18901004	18901004	C	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs450046	ENSG00000100033:ENST00000334029:exon13:c.G1238A:p.R413Q,ENSG00000100033:ENST00000357068:exon13:c.G1562A:p.R521Q,ENSG00000100033:ENST00000420436:exon13:c.G1238A:p.R413Q	PRODH:NM_001195226:exon13:c.G1238A:p.R413Q,LOC102724788:NM_001368250:exon13:c.G1238A:p.R413Q,LOC102724788:NM_001368249:exon14:c.G1562A:p.R521Q,PRODH:NM_016335:exon14:c.G1562A:p.R521Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9171	0.9042	0.905551	0.9057	3.411	23.0	0.455	4.67	0.202	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain	PRODH:uc002zoj.5:exon13:c.G1238A:p.R413Q,PRODH:uc002zol.4:exon13:c.G1238A:p.R413Q,PRODH:uc002zok.4:exon14:c.G1562A:p.R521Q	-0.985	AFR:0.8372,AMR:0.9570,EAS:0.9530,FIN:0.9155,NFE:0.9328,OTH:0.9283,ASJ:0.9470	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	1.63	0.000	.	22	MU4615939	hom
22	18904414	18904414	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs455072	ENSG00000100033:ENST00000334029:exon12:c.T1191C:p.F397F,ENSG00000100033:ENST00000357068:exon12:c.T1515C:p.F505F,ENSG00000100033:ENST00000420436:exon12:c.T1191C:p.F397F	PRODH:NM_001195226:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368250:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368249:exon13:c.T1515C:p.F505F,PRODH:NM_016335:exon13:c.T1515C:p.F505F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9034	.	0.83746	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon12:c.T1191C:p.F397F,PRODH:uc002zol.4:exon12:c.T1191C:p.F397F,PRODH:uc002zok.4:exon13:c.T1515C:p.F505F	.	AFR:0.8495,AMR:0.6583,EAS:0.9404,FIN:0.9016,NFE:0.9156,OTH:0.9287,ASJ:0.9474	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	1(thyroid)	0.9084
22	18905977	18905977	C	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs2238731	ENSG00000100033:ENST00000334029:exon11:c.G955A:p.V319M,ENSG00000100033:ENST00000357068:exon11:c.G1279A:p.V427M,ENSG00000100033:ENST00000420436:exon11:c.G955A:p.V319M	PRODH:NM_001195226:exon11:c.G955A:p.V319M,LOC102724788:NM_001368250:exon11:c.G955A:p.V319M,LOC102724788:NM_001368249:exon12:c.G1279A:p.V427M,PRODH:NM_016335:exon12:c.G1279A:p.V427M	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0411	0.0365	0.0654952	0.0386	1.944	15.86	0.499	-1.05	0.721	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain	PRODH:uc002zoj.5:exon11:c.G955A:p.V319M,PRODH:uc002zol.4:exon11:c.G955A:p.V319M,PRODH:uc002zok.4:exon12:c.G1279A:p.V427M	-1.018	AFR:0.0750,AMR:0.0933,EAS:0.1320,FIN:0.0029,NFE:0.0142,OTH:0.0205,ASJ:0.0166	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.303	1.31	0.001	0.765	22	MU750193	het
22	18907124	18907124	G	A	LOC102724788;PRODH	intronic	.	ENSG00000100033	rs1076466	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4689	0.4110	0.525958	0.4203	.	.	.	.	.	.	.	.	.	.	AFR:0.4126,AMR:0.4053,EAS:0.7574,FIN:0.3869,NFE:0.3974,OTH:0.4018,ASJ:0.4533	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU26626450	het
22	18908875	18908875	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs1808320	ENSG00000100033:ENST00000334029:exon8:c.T667C:p.L223L,ENSG00000100033:ENST00000357068:exon8:c.T991C:p.L331L,ENSG00000100033:ENST00000420436:exon8:c.T667C:p.L223L	PRODH:NM_001195226:exon8:c.T667C:p.L223L,LOC102724788:NM_001368250:exon8:c.T667C:p.L223L,LOC102724788:NM_001368249:exon9:c.T991C:p.L331L,PRODH:NM_016335:exon9:c.T991C:p.L331L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6781	0.6645	0.73143	0.6492	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon8:c.T667C:p.L223L,PRODH:uc002zol.4:exon8:c.T667C:p.L223L,PRODH:uc002zok.4:exon9:c.T991C:p.L331L	.	AFR:0.8364,AMR:0.5692,EAS:0.8062,FIN:0.5492,NFE:0.5560,OTH:0.5749,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU82163080	het
22	18910355	18910355	G	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs5747933	ENSG00000100033:ENST00000334029:exon6:c.C500A:p.T167N,ENSG00000100033:ENST00000357068:exon6:c.C824A:p.T275N,ENSG00000100033:ENST00000420436:exon6:c.C500A:p.T167N,ENSG00000100033:ENST00000450579:exon6:c.C347A:p.T116N	PRODH:NM_001195226:exon6:c.C500A:p.T167N,LOC102724788:NM_001368250:exon6:c.C500A:p.T167N,LOC102724788:NM_001368249:exon7:c.C824A:p.T275N,PRODH:NM_016335:exon7:c.C824A:p.T275N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0579	0.0333	0.0720847	MU750197	0.353	6.194	0.604	0.756	0.085	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain;Proline dehydrogenase domain	PRODH:uc002zoj.5:exon6:c.C500A:p.T167N,PRODH:uc002zol.4:exon6:c.C500A:p.T167N,PRODH:uc002zok.4:exon7:c.C824A:p.T275N	-1.014	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.0376,EAS:0.1468,FIN:0.0894,NFE:0.1807,OTH:0.0077,ASJ:0.0126	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.355	1.43	0.000	1.67	22	1(lung)	0.0362
22	18910451	18910451	A	-	LOC102724788;PRODH	intronic	.	ENSG00000100033	rs3216765	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2381	0.3126	0.28734	0.2780	.	.	.	.	.	.	.	.	.	.	AFR:0.4684,AMR:0.3089,EAS:0.2092,FIN:0.1748,NFE:0.2007,OTH:0.2209,ASJ:0.3046	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU114637233	het
22	18912678	18912678	A	G	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs386819653	ENSG00000100033:ENST00000334029:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000357068:exon4:c.T553C:p.W185R,ENSG00000100033:ENST00000420436:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000450579:exon4:c.T76C:p.W26R	PRODH:NM_001195226:exon4:c.T229C:p.W77R,LOC102724788:NM_001368250:exon4:c.T229C:p.W77R,LOC102724788:NM_001368249:exon5:c.T553C:p.W185R,PRODH:NM_016335:exon5:c.T553C:p.W185R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6417	0.6739	0.78095	0.6509	-0.442	0.306	0.503	2.88	0.105	.	.	FAD-linked oxidoreductase-like	PRODH:uc002zoj.5:exon4:c.T229C:p.W77R,PRODH:uc002zol.4:exon4:c.T229C:p.W77R,PRODH:uc002zok.4:exon5:c.T553C:p.W185R	-0.991	AFR:0.8626,AMR:0.6583,EAS:0.9617,FIN:0.4811,NFE:0.5384,OTH:0.5685,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	-0.92	0.000	.	22	MU82047927	hom
22	18923745	18923745	G	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs2008720	ENSG00000100033:ENST00000357068:exon1:c.C56A:p.P19Q	LOC102724788:NM_001368249:exon2:c.C56A:p.P19Q,PRODH:NM_016335:exon2:c.C56A:p.P19Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6653	.	0.553315	0.4404	0.360	6.258	0.369	-0.024	0.000	.	.	.	PRODH:uc002zok.4:exon2:c.C56A:p.P19Q	-1.088	AFR:0.3919,AMR:0.5025,EAS:0.8088,FIN:0.3811,NFE:0.4376,OTH:0.4397,ASJ:0.4767	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	2.31	0.000	.	22	MU4585894	het
22	19363318	19363318	G	A	HIRA	intronic	.	ENSG00000100084;ENSG00000242259	rs202083166	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0021	0.0017	0.00159744	0.0013	.	.	.	.	.	0.0008	0.058	.	.	.	AFR:0.0007,AMR:0,EAS:0.0006,FIN:0.0006,NFE:0.0021,OTH:0,ASJ:0	600237	.	.	.	.	.	.	.	.	.	.	.	22	.	het
22	19789541	19789541	A	C	GNB1L	exonic	nonsynonymous SNV	ENSG00000185838	rs2073770	ENSG00000185838:ENST00000403325:exon6:c.T715G:p.W239G,ENSG00000185838:ENST00000329517:exon7:c.T715G:p.W239G	GNB1L:NM_053004:exon7:c.T715G:p.W239G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2697	0.0877	0.20607	0.1128	1.065	11.03	0.544	4.78	0.598	.	.	WD40-repeat-containing domain	GNB1L:uc002zqf.1:exon7:c.T715G:p.W239G	-0.944	AFR:0.0381,AMR:0.2990,EAS:0.4759,FIN:0.0647,NFE:0.1176,OTH:0.0980,ASJ:0.1788	610778	.	.	.	.	.	.	.	0.0	2.33	0.000	-1.36	22	MU131611	het
22	19808874	19808874	G	A	GNB1L	exonic	nonsynonymous SNV	ENSG00000185838	rs36070348	ENSG00000185838:ENST00000403325:exon2:c.C5T:p.T2M,ENSG00000185838:ENST00000453108:exon2:c.C5T:p.T2M,ENSG00000185838:ENST00000329517:exon3:c.C5T:p.T2M,ENSG00000185838:ENST00000405009:exon3:c.C5T:p.T2M	GNB1L:NM_053004:exon3:c.C5T:p.T2M	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0312	0.0213	0.0323482	0.0183	4.572	24.4	0.043	3.7	0.007	.	.	.	GNB1L:uc002zqf.1:exon3:c.C5T:p.T2M	-0.983	AFR:0.0047,AMR:0.0167,EAS:0.0037,FIN:0.0223,NFE:0.0263,OTH:0.0286,ASJ:0.0132	610778	.	.	.	.	.	.	.	0.013	1.12	0.059	-0.345	22	.	het
22	21337325	21337325	G	A	LZTR1	exonic	synonymous SNV	ENSG00000099949	rs13054014	ENSG00000099949:ENST00000443265:exon2:c.G215A:p.S72N	LZTR1:NM_006767:exon2:c.G210A:p.K70K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2850	0.2623	0.285144	MU116325	.	.	.	.	.	.	.	.	LZTR1:uc002zto.3:exon2:c.G210A:p.K70K,LZTR1:uc011ahy.2:exon2:c.G210A:p.K70K,LZTR1:uc002ztn.3:exon3:c.G87A:p.K29K	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.2716,EAS:0.4153,FIN:0.2219,NFE:0.2177,OTH:0.2582,ASJ:0.2520	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	37(meninges)	0.2845
22	21343983	21344019	GGGGAGCCAGGGCGCAGGTAGAGGAGGTGAGGGGCAC	-	LZTR1	intronic	.	ENSG00000099949	rs138025454	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5810	0.8134	.	0.6272	.	.	.	.	.	.	.	.	.	.	AFR:0.6289,AMR:0.5974,EAS:0.7554,FIN:0.6237,NFE:0.6136,OTH:0.6087,ASJ:0.5329	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	.	unknown
22	21346485	21346485	T	C	LZTR1	intronic	.	ENSG00000099949	rs112544	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7070	0.7312	0.64397	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.7055,AMR:0.6778,EAS:0.7219,FIN:0.5644,NFE:0.6603,OTH:0.7457,ASJ:0.7375	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	1(lung)	0.6998
22	23627369	23627369	A	G	BCR	exonic	nonsynonymous SNV	ENSG00000186716	rs140504	ENSG00000186716:ENST00000305877:exon10:c.A2387G:p.N796S,ENSG00000186716:ENST00000359540:exon10:c.A2387G:p.N796S	BCR:NM_004327:exon10:c.A2387G:p.N796S,BCR:NM_021574:exon10:c.A2387G:p.N796S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8186	0.8774	0.79373	1(large_intestine)	0.337	6.042	1.0	1.63	0.908	.	.	PH domain-like|Pleckstrin homology domain	BCR:uc002zwy.2:exon2:c.A245G:p.N82S,BCR:uc010gtx.1:exon8:c.A788G:p.N263S,BCR:uc002zww.3:exon10:c.A2387G:p.N796S,BCR:uc002zwx.3:exon10:c.A2387G:p.N796S,BCR:uc011aiy.2:exon10:c.A1154G:p.N385S	-0.964	AFR:MU152970,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,THCA-CN|1|50|0.02,EAS:0.9315,FIN:0.8496,NFE:0.8974,OTH:0.5118,ASJ:0.8471	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	0.002	1.85	0.000	-0.975	22	1(lung)	0.8400
22	23631801	23631801	T	C	BCR	exonic	synonymous SNV	ENSG00000186716	rs2227939	ENSG00000186716:ENST00000305877:exon13:c.T2700C:p.N900N,ENSG00000186716:ENST00000359540:exon13:c.T2700C:p.N900N	BCR:NM_004327:exon13:c.T2700C:p.N900N,BCR:NM_021574:exon13:c.T2700C:p.N900N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2964	0.3688	0.322684	MU152980	-0.021	2.391	.	2.7	0.992	.	.	.	BCR:uc002zwy.2:exon5:c.T558C:p.N186N,BCR:uc002zww.3:exon13:c.T2700C:p.N900N,BCR:uc002zwx.3:exon13:c.T2700C:p.N900N,BCR:uc011aiy.2:exon13:c.T1467C:p.N489N	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.3254,EAS:0.2990,FIN:0.3642,NFE:0.0580,OTH:0.1924,ASJ:0.5199	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	1(large_intestine)	0.2766
22	23631813	23631813	-	C	BCR	intronic	.	ENSG00000186716	rs113087899	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2965	0.3638	0.31849	0.3199	.	.	.	.	.	.	.	.	BCR:uc002zwy.2:exon5:c.571dupC:p.G190fs	.	AFR:0.5050,AMR:0.2990,EAS:0.0580,FIN:0.1924,NFE:0.2745,OTH:0.2684,ASJ:0.3609	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	.	unknown
22	23631823	23631823	T	C	BCR	intronic	.	ENSG00000186716	rs62219796	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3055	0.3661	0.322684	MU9796380	.	.	.	.	.	.	.	.	BCR:uc002zwy.2:exon5:c.T580C:p.F194L	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.3231,EAS:0.2990,FIN:0.3609,NFE:0.0580,OTH:0.1923,ASJ:0.5165	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	4(large_intestine)	0.2745
22	23632513	23632513	A	G	BCR	intronic	.	ENSG00000186716	rs16802	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2901	0.3696	0.311302	MU11366556	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.3275,EAS:0.3031,FIN:0.3642,NFE:0.0575,OTH:0.1949,ASJ:0.5207	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	1(lung)	0.2798
22	23637200	23637200	T	C	BCR	intronic	.	ENSG00000186716	rs2239666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3210	0.3528	0.341454	0.3275	.	.	.	.	.	0	0.018	.	.	.	AFR:0.4510,AMR:0.3473,EAS:0.1829,FIN:0.2331,NFE:0.2946,OTH:0.2929,ASJ:0.3146	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU718621	het
22	23653880	23653880	G	A	BCR	intronic	.	ENSG00000186716	rs180801	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4195	.	0.459465	0.3749	.	.	.	.	.	0	0.002	.	.	.	AFR:0.4072,AMR:0.3448,EAS:0.4577,FIN:0.3726,NFE:0.3519,OTH:0.3549,ASJ:0.3390	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU11366598	het
22	23655084	23655084	C	T	BCR	exonic	synonymous SNV	ENSG00000186716	rs11558697	ENSG00000186716:ENST00000359540:exon19:c.C3201T:p.D1067D,ENSG00000186716:ENST00000305877:exon20:c.C3333T:p.D1111D	BCR:NM_021574:exon19:c.C3201T:p.D1067D,BCR:NM_004327:exon20:c.C3333T:p.D1111D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1839	0.1938	0.11881	0.1954	.	.	.	.	.	.	.	.	BCR:uc002zwx.3:exon19:c.C3201T:p.D1067D,BCR:uc002zww.3:exon20:c.C3333T:p.D1111D,BCR:uc011aiy.2:exon20:c.C2100T:p.D700D	.	AFR:0.1158,AMR:0.1492,EAS:0.0006,FIN:0.2996,NFE:0.2402,OTH:0.2004,ASJ:0.2318	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU30441031	het
22	23655219	23655219	G	A	BCR	intronic	.	ENSG00000186716	rs180806	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4106	.	0.45627	0.4053	.	.	.	.	.	.	.	.	.	.	AFR:0.4138,AMR:0.3822,EAS:0.5778,FIN:0.4026,NFE:0.3853,OTH:0.3881,ASJ:0.3874	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU21269186	het
22	23656148	23656148	T	G	BCR	intronic	.	ENSG00000186716	rs66569843	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1805	0.1920	0.108427	0.1894	.	.	.	.	.	0.0193	0.184	.	.	.	AFR:0.0946,AMR:0.1468,EAS:0,FIN:0.2925,NFE:0.2420,OTH:0.2014,ASJ:0.2318	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU113428149	het
22	26166900	26166900	G	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs3859866	ENSG00000133454:ENST00000539302:exon5:c.G1641C:p.W547C,ENSG00000133454:ENST00000335473:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000407587:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000536101:exon6:c.G1641C:p.W547C	MYO18B:NM_001318245:exon6:c.G1641C:p.W547C,MYO18B:NM_032608:exon6:c.G1641C:p.W547C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9579	0.9776	0.938498	0.9730	1.276	12.14	0.049	3.72	0.972	.	.	P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon2:c.G180C:p.W60C,MYO18B:uc003aca.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guy.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guz.1:exon4:c.G1284C:p.W428C,MYO18B:uc003abz.1:exon6:c.G1641C:p.W547C	-0.952	AFR:0.9534,AMR:0.9857,EAS:0.8844,FIN:0.9914,NFE:0.9891,OTH:0.9715,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-0.56	0.000	-1.245	22	MU28574395	hom
22	26173661	26173661	T	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761170	ENSG00000133454:ENST00000539302:exon7:c.T1981C:p.W661R,ENSG00000133454:ENST00000335473:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000407587:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000536101:exon8:c.T1981C:p.W661R	MYO18B:NM_001318245:exon8:c.T1981C:p.W661R,MYO18B:NM_032608:exon8:c.T1981C:p.W661R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9647	0.9714	0.932508	0.9680	-1.452	0.003	1.0	-0.033	0.975	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon4:c.T520C:p.W174R,MYO18B:uc003aca.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guy.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guz.1:exon6:c.T1624C:p.W542R,MYO18B:uc003abz.1:exon8:c.T1981C:p.W661R	-0.944	AFR:0.9366,AMR:0.9857,EAS:0.8820,FIN:0.9914,NFE:0.9888,OTH:0.9684,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.18	0.000	.	22	MU635506	hom
22	26193982	26193982	C	G	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738642	ENSG00000133454:ENST00000335473:exon12:c.C2439G:p.L813L,ENSG00000133454:ENST00000407587:exon12:c.C2439G:p.L813L,ENSG00000133454:ENST00000536101:exon12:c.C2439G:p.L813L	MYO18B:NM_001318245:exon12:c.C2439G:p.L813L,MYO18B:NM_032608:exon12:c.C2439G:p.L813L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7296	0.6482	0.684305	0.6554	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.C978G:p.L326L,MYO18B:uc003aca.1:exon10:c.C2082G:p.L694L,MYO18B:uc010guy.1:exon10:c.C2082G:p.L694L,MYO18B:uc010guz.1:exon10:c.C2082G:p.L694L,MYO18B:uc003abz.1:exon12:c.C2439G:p.L813L	.	AFR:0.4509,AMR:0.7931,EAS:0.8969,FIN:0.6795,NFE:0.7307,OTH:0.7383,ASJ:0.5833	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU20292388	hom
22	26194045	26194045	T	C	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738643	ENSG00000133454:ENST00000335473:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000407587:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000536101:exon12:c.T2502C:p.G834G	MYO18B:NM_001318245:exon12:c.T2502C:p.G834G,MYO18B:NM_032608:exon12:c.T2502C:p.G834G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6636	0.5936	0.56889	0.5952	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.T1041C:p.G347G,MYO18B:uc003aca.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guy.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guz.1:exon10:c.T2145C:p.G715G,MYO18B:uc003abz.1:exon12:c.T2502C:p.G834G	.	AFR:0.3391,AMR:0.6806,EAS:0.6966,FIN:0.6597,NFE:0.7093,OTH:0.6834,ASJ:0.5232	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU13839222	hom
22	26219605	26219605	G	A	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs4820658	ENSG00000133454:ENST00000335473:exon13:c.G2655A:p.G885G,ENSG00000133454:ENST00000407587:exon13:c.G2655A:p.G885G,ENSG00000133454:ENST00000536101:exon13:c.G2655A:p.G885G	MYO18B:NM_001318245:exon13:c.G2655A:p.G885G,MYO18B:NM_032608:exon13:c.G2655A:p.G885G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2913	0.2649	0.159145	MU121292	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon9:c.G1194A:p.G398G,MYO18B:uc011aka.1:exon10:c.G117A:p.G39G,MYO18B:uc003aca.1:exon11:c.G2298A:p.G766G,MYO18B:uc010guy.1:exon11:c.G2298A:p.G766G,MYO18B:uc010guz.1:exon11:c.G2298A:p.G766G,MYO18B:uc003abz.1:exon13:c.G2655A:p.G885G	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.2639,EAS:0.3962,FIN:0.4205,NFE:0.0314,OTH:0.3575,ASJ:0.0662	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	1(haematopoietic_and_lymphoid_tissue)	0.3660
22	26239850	26239850	C	A	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761268	ENSG00000133454:ENST00000335473:exon18:c.C3357A:p.H1119Q,ENSG00000133454:ENST00000407587:exon18:c.C3360A:p.H1120Q,ENSG00000133454:ENST00000536101:exon18:c.C3357A:p.H1119Q	MYO18B:NM_001318245:exon18:c.C3360A:p.H1120Q,MYO18B:NM_032608:exon18:c.C3357A:p.H1119Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7340	0.6421	0.723442	0.6653	-0.536	0.179	1.0	-3.23	0.984	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon14:c.C1896A:p.H632Q,MYO18B:uc011aka.1:exon15:c.C819A:p.H273Q,MYO18B:uc003aca.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc010guy.1:exon16:c.C3003A:p.H1001Q,MYO18B:uc010guz.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc003abz.1:exon18:c.C3357A:p.H1119Q	-0.932	AFR:0.4657,AMR:0.7721,EAS:0.9975,FIN:0.7676,NFE:0.7124,OTH:0.7352,ASJ:0.5927	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.06	0.000	-2.535	22	MU4555172	hom
22	26247456	26247456	G	A	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs5996988	ENSG00000133454:ENST00000335473:exon21:c.G3795A:p.G1265G,ENSG00000133454:ENST00000407587:exon21:c.G3798A:p.G1266G,ENSG00000133454:ENST00000536101:exon21:c.G3795A:p.G1265G	MYO18B:NM_001318245:exon21:c.G3798A:p.G1266G,MYO18B:NM_032608:exon21:c.G3795A:p.G1265G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3586	0.3179	0.242013	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon17:c.G2334A:p.G778G,MYO18B:uc011aka.1:exon18:c.G1257A:p.G419G,MYO18B:uc003aca.1:exon19:c.G3438A:p.G1146G,MYO18B:uc010guy.1:exon19:c.G3441A:p.G1147G,MYO18B:uc010guz.1:exon19:c.G3438A:p.G1146G,MYO18B:uc003abz.1:exon21:c.G3795A:p.G1265G	.	AFR:0.3211,AMR:0.2050,EAS:0.3543,FIN:0.0898,NFE:0.3576,OTH:0.3950,ASJ:0.4103	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	1(large_intestine)	0.3931
22	26342232	26342232	T	C	MYO18B	intronic	.	ENSG00000133454	rs9613047	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1923	0.1593	0.17512	LICA-CN|3|402|0.00746269,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.1749,AMR:0.1925,EAS:0.1867,FIN:0.2544,NFE:0.1885,OTH:0.1564,ASJ:0.1301	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	1(liver)	0.1569
22	26343805	26343805	A	G	MYO18B	intronic	.	ENSG00000133454	rs2072007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8055	0.8749	0.711861	MU585744	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.8292,EAS:0.6124,FIN:0.9603,NFE:0.4714,OTH:0.7786,ASJ:0.8210	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	3(haematopoietic_and_lymphoid_tissue)	0.8942
22	26422454	26422454	T	C	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs117270969	ENSG00000133454:ENST00000335473:exon43:c.T6514C:p.L2172L,ENSG00000133454:ENST00000407587:exon43:c.T6517C:p.L2173L,ENSG00000133454:ENST00000536101:exon43:c.T6514C:p.L2172L	MYO18B:NM_001318245:exon43:c.T6517C:p.L2173L,MYO18B:NM_032608:exon43:c.T6514C:p.L2172L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0118	0.0005	0.0301518	COCA-CN|1|321|0.00311526,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	MYO18B:uc010gva.1:exon4:c.T463C:p.L155L,MYO18B:uc011akb.1:exon39:c.T5053C:p.L1685L,MYO18B:uc011aka.1:exon40:c.T3976C:p.L1326L,MYO18B:uc003aca.1:exon41:c.T6157C:p.L2053L,MYO18B:uc010guy.1:exon41:c.T6160C:p.L2054L,MYO18B:uc010guz.1:exon41:c.T6154C:p.L2052L,MYO18B:uc003abz.1:exon43:c.T6514C:p.L2172L	.	AFR:0.0039,AMR:0.0010,EAS:0,FIN:0.0619,NFE:0,OTH:0.0003,ASJ:0.0012	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	1(urinary_tract)	0.0072
22	26422980	26422980	A	G	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs2236005	ENSG00000133454:ENST00000335473:exon43:c.A7040G:p.Q2347R,ENSG00000133454:ENST00000407587:exon43:c.A7043G:p.Q2348R,ENSG00000133454:ENST00000536101:exon43:c.A7040G:p.Q2347R	MYO18B:NM_001318245:exon43:c.A7043G:p.Q2348R,MYO18B:NM_032608:exon43:c.A7040G:p.Q2347R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2570	0.3497	0.426318	1(breast)	-1.521	0.002	1.0	3.78	0.464	.	.	.	MYO18B:uc010gva.1:exon4:c.A989G:p.Q330R,MYO18B:uc011akb.1:exon39:c.A5579G:p.Q1860R,MYO18B:uc011aka.1:exon40:c.A4502G:p.Q1501R,MYO18B:uc003aca.1:exon41:c.A6683G:p.Q2228R,MYO18B:uc010guy.1:exon41:c.A6686G:p.Q2229R,MYO18B:uc010guz.1:exon41:c.A6680G:p.Q2227R,MYO18B:uc003abz.1:exon43:c.A7040G:p.Q2347R	-0.944	AFR:1(thyroid),AMR:MU4555165,EAS:0.3534,FIN:0.8016,NFE:0.2780,OTH:0.1523,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-1.86	0.000	-1.935	22	1(lung)	0.1771
22	28194895	28194900	TGCTGT	-	MN1	exonic	nonframeshift deletion	ENSG00000169184	rs202212250	ENSG00000169184:ENST00000302326:exon1:c.1632_1637del:p.544_546del	MN1:NM_002430:exon1:c.1632_1637del:p.544_546del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0425	0.0394	.	0.0376	.	.	.	.	.	.	.	.	MN1:uc003adj.3:exon1:c.1632_1637del:p.544_546del	.	AFR:0.0469,AMR:0.0371,EAS:0.0124,FIN:0.0335,NFE:0.0355,OTH:0.0357,ASJ:0.0596	156100	607174;	263662;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~	.	.	.	.	.	.	.	.	22	.	het
22	29108229	29108229	A	G	CHEK2	intronic	.	ENSG00000183765	rs5752776	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.682308	0.6598	.	.	.	.	.	.	.	.	.	.	AFR:0.4911,AMR:0.6575,EAS:0.8455,FIN:0.7517,NFE:0.7095,OTH:0.7255,ASJ:0.8013	604373	114480;176807;259500;609265;	524;668;1331;227535;	524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	22	MU117008065	hom
22	33253280	33253280	T	C	TIMP3	exonic	synonymous SNV	ENSG00000100234	rs9862	ENSG00000100234:ENST00000266085:exon3:c.T249C:p.H83H	TIMP3:NM_000362:exon3:c.T249C:p.H83H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5518	0.6127	0.650958	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TIMP3:uc003anb.3:exon3:c.T249C:p.H83H	.	AFR:0.5980,AMR:0.8374,EAS:0.5629,FIN:0.5945,NFE:0.4422,OTH:0.4965,ASJ:0.6993	188826	136900;	59181;	59181|-|Unknown|Autosomal dominant|Adult|136900 264420 ~	~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	22	1(haematopoietic_and_lymphoid_tissue)	0.5051
22	36684331	36684331	C	T	MYH9	exonic	synonymous SNV	ENSG00000100345	rs5756130	ENSG00000100345:ENST00000216181:exon34:c.G4899A:p.R1633R	MYH9:NM_002473:exon34:c.G4899A:p.R1633R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0702	0.0607	0.096246	0.0770	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon34:c.G4899A:p.R1633R	.	AFR:0.1228,AMR:0.0933,EAS:0.0878,FIN:0.0647,NFE:0.0527,OTH:0.0621,ASJ:0.0430	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82292477	unknown
22	36684354	36684354	T	C	MYH9	exonic	nonsynonymous SNV	ENSG00000100345	rs2269529	ENSG00000100345:ENST00000216181:exon34:c.A4876G:p.I1626V	MYH9:NM_002473:exon34:c.A4876G:p.I1626V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2584	0.1555	0.294129	0.1759	0.134	3.970	0.332	4.47	0.359	.	.	Myosin tail	MYH9:uc003apg.3:exon34:c.A4876G:p.I1626V	-0.911	AFR:0.0724,AMR:0.2440,EAS:0.6067,FIN:0.1758,NFE:0.1814,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	0.042	-1.05	0.000	0.805	22	MU14584538	unknown
22	36684358	36684358	C	A	MYH9	exonic	synonymous SNV	ENSG00000100345	rs2269530	ENSG00000100345:ENST00000216181:exon34:c.G4872T:p.A1624A	MYH9:NM_002473:exon34:c.G4872T:p.A1624A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2582	0.1552	0.29373	0.1754	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon34:c.G4872T:p.A1624A	.	AFR:0.0712,AMR:0.2440,EAS:0.6068,FIN:0.1755,NFE:0.1813,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584585	unknown
22	36691607	36691607	A	C	MYH9	exonic	synonymous SNV	ENSG00000100345	rs710181	ENSG00000100345:ENST00000216181:exon26:c.T3429G:p.A1143A	MYH9:NM_002473:exon26:c.T3429G:p.A1143A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9766	0.9712	0.982628	0.9725	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon26:c.T3429G:p.A1143A	.	AFR:0.9718,AMR:0.9773,EAS:0.9994,FIN:0.9673,NFE:0.9719,OTH:0.9693,ASJ:0.9404	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82051855	hom
22	36708084	36708084	C	T	MYH9	intronic	.	ENSG00000100345	rs2413396	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8714	0.7555	0.760783	0.7779	.	.	.	.	.	.	.	.	.	.	AFR:0.4512,AMR:0.9021,EAS:0.9030,FIN:0.8967,NFE:0.9108,OTH:0.8755,ASJ:0.8874	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584855	hom
22	36710183	36710183	T	C	MYH9	intronic	.	ENSG00000100345	rs3752462	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.5347	0.39357	0.5361	.	.	.	.	.	0	0	.	.	.	AFR:0.2688,AMR:0.6367,EAS:0.2249,FIN:0.6641,NFE:0.6840,OTH:0.6176,ASJ:0.5533	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82240671	het
22	36717852	36717852	G	A	MYH9	exonic	synonymous SNV	ENSG00000100345	rs556214390	ENSG00000100345:ENST00000216181:exon7:c.C720T:p.R240R	MYH9:NM_002473:exon7:c.C720T:p.R240R	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0002	.	0.000399361	.	.	.	.	.	.	.	.	.	MYH9:uc003aph.1:exon5:c.C312T:p.R104R,MYH9:uc003apg.3:exon7:c.C720T:p.R240R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	.	het
22	38369976	38369976	A	G	SOX10	exonic	synonymous SNV	ENSG00000100146	rs139884	ENSG00000100146:ENST00000396884:exon4:c.T927C:p.H309H,ENSG00000100146:ENST00000360880:exon5:c.T927C:p.H309H	SOX10:NM_006941:exon4:c.T927C:p.H309H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6537	0.6958	0.713259	0.6920	.	.	.	.	.	.	.	.	SOX10:uc003aun.1:exon4:c.T927C:p.H309H,SOX10:uc003auo.1:exon5:c.T927C:p.H309H	.	AFR:0.8266,AMR:0.6244,EAS:0.7833,FIN:0.6317,NFE:0.6281,OTH:0.6207,ASJ:0.6033	602229	609136;611584;613266;	897;3440;895;163746;	897|Shah-Waardenburg syndrome<br>WS4<br>Waardenburg syndrome type 4<br>Waardenburg-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|277580 613265 613266 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~895|WS2<br>Waardenburg syndrome type II|Unknown|Autosomal dominant|Neonatal|193510 600193 606662 608890 611584 ~163746|PCWH<br>Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Hirschsprung disease-Waardenburg syndrome<br>WS4 plus|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609136 ~	.	.	.	.	.	.	.	.	22	MU4560542	hom
22	38905446	38905446	G	A	DDX17;DMC1	intergenic	.	ENSG00000100201;ENSG00000100206	rs138462	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.934904	0.9569	.	.	.	.	.	.	.	.	.	.	AFR:0.9021,AMR:0.9821,EAS:0.8983,FIN:0.9954,NFE:0.9827,OTH:0.9806,ASJ:0.9801	.	.	.	.	.	.	.	.	.	.	.	.	22	.	hom
22	39381826	39381826	A	G	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs2076109	ENSG00000179750:ENST00000333467:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000335760:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000402182:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000407298:exon3:c.A184G:p.K62E	APOBEC3B:NM_001270411:exon3:c.A184G:p.K62E,APOBEC3B:NM_004900:exon3:c.A184G:p.K62E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6016	0.6057	0.641174	0.6012	-1.879	0.002	0.72	-1.15	0.000	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.A184G:p.K62E,APOBEC3B:uc003awp.2:exon3:c.A184G:p.K62E	-0.903	AFR:0.6745,AMR:0.5195,EAS:0.6416,FIN:0.6176,NFE:0.5592,OTH:0.5826,ASJ:0.4796	607110	.	.	.	.	.	.	.	0.032	-0.14	0.000	0.185	22	MU151842	het
22	39381999	39381999	T	C	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs2076111	ENSG00000179750:ENST00000333467:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000335760:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000402182:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000407298:exon3:c.T357C:p.S119S	APOBEC3B:NM_001270411:exon3:c.T357C:p.S119S,APOBEC3B:NM_004900:exon3:c.T357C:p.S119S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5857	.	.	0.5927	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon3:c.T357C:p.S119S,APOBEC3B:uc003awp.2:exon3:c.T357C:p.S119S	.	AFR:0.6495,AMR:0.5225,EAS:0.6783,FIN:0.6151,NFE:0.5550,OTH:0.5689,ASJ:0.4755	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU4559442	het
22	39382079	39382079	C	A	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs5995649	ENSG00000179750:ENST00000333467:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000335760:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000402182:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000407298:exon3:c.C437A:p.T146K	APOBEC3B:NM_001270411:exon3:c.C437A:p.T146K,APOBEC3B:NM_004900:exon3:c.C437A:p.T146K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9492	0.9511	0.949681	0.9538	-0.635	0.103	1.0	-4.25	0.000	.	.	APOBEC-like, N-terminal|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.C437A:p.T146K,APOBEC3B:uc003awp.2:exon3:c.C437A:p.T146K	-0.995	AFR:0.9398,AMR:0.9526,EAS:0.9757,FIN:0.9672,NFE:0.9586,OTH:0.9557,ASJ:0.87	607110	.	.	.	.	.	.	.	0.0	-0.02	0.000	-1.695	22	MU82052701	het
22	39387558	39387558	C	T	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs1065184	ENSG00000179750:ENST00000333467:exon6:c.C945T:p.Y315Y,ENSG00000179750:ENST00000402182:exon6:c.C945T:p.Y315Y,ENSG00000179750:ENST00000407298:exon6:c.C870T:p.Y290Y	APOBEC3B:NM_001270411:exon6:c.C870T:p.Y290Y,APOBEC3B:NM_004900:exon6:c.C945T:p.Y315Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4729	0.4836	.	0.4854	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon6:c.C945T:p.Y315Y,APOBEC3B:uc003awp.2:exon6:c.C870T:p.Y290Y	.	AFR:0.5375,AMR:0.4413,EAS:0.5290,FIN:0.4868,NFE:0.4591,OTH:0.4378,ASJ:0.4034	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU151851	het
22	39414166	39414166	A	G	APOBEC3C	intronic	.	ENSG00000243811;ENSG00000244509	rs4820361	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.647564	0.6780	.	.	.	.	.	.	.	.	.	.	AFR:0.6676,AMR:0.7201,EAS:0.6938,FIN:0.7478,NFE:0.6645,OTH:0.6855,ASJ:0.6192	607750	.	.	.	.	.	.	.	.	.	.	.	22	MU26443964	het
22	39414224	39414224	A	G	APOBEC3C	intronic	.	ENSG00000243811;ENSG00000244509	rs4821854	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6487	0.6434	0.647764	0.6781	.	.	.	.	.	.	.	.	.	.	AFR:0.6680,AMR:0.7201,EAS:0.6948,FIN:0.7477,NFE:0.6645,OTH:0.6824,ASJ:0.6192	607750	.	.	.	.	.	.	.	.	.	.	.	22	MU26546283	het
22	39497509	39497509	A	G	APOBEC3H	splicing	.	ENSG00000100298	rs139300	ENSG00000100298:ENST00000348946:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000401756:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000421988:exon3:c.A418G:p.N140D,ENSG00000100298:ENST00000442487:exon3:c.A418G:p.K140E	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.006	.	APOBEC3H:uc021wps.1:exon3:c.A418G:p.N140D,APOBEC3H:uc021wpt.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpu.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpv.1:exon3:c.A418G:p.K140E	.	AFR:0.9998,AMR:0.9998,EAS:1,FIN:1,NFE:1,OTH:0.9998,ASJ:1	610976	.	.	.	.	.	.	.	.	.	.	.	22	1(thyroid)	1
22	41537234	41537234	G	T	EP300	intronic	.	ENSG00000100393	rs6002267	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9892	.	0.961661	0.9661	.	.	.	.	.	0	0	.	.	.	AFR:0.8811,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9919,ASJ:1	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU82053044	hom
22	41551039	41551039	T	A	EP300	exonic	synonymous SNV	ENSG00000100393	rs20552	ENSG00000100393:ENST00000263253:exon17:c.T3183A:p.T1061T	EP300:NM_001362843:exon16:c.T3105A:p.T1035T,EP300:NM_001429:exon17:c.T3183A:p.T1061T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6572	0.5831	0.673922	0.5925	.	.	.	.	.	.	.	.	EP300:uc003azl.4:exon17:c.T3183A:p.T1061T	.	AFR:0.5116,AMR:0.8122,EAS:0.8058,FIN:0.6084,NFE:0.5985,OTH:0.6133,ASJ:0.6225	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	,3901	.	.	.	.	.	.	22	MU13931129	het
22	41569609	41569609	C	T	EP300	intronic	.	ENSG00000232754	rs2076578	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3085	0.2582	0.264177	0.2586	.	.	.	.	.	.	.	.	.	.	AFR:0.0917,AMR:0.2320,EAS:0.4607,FIN:0.2785,NFE:0.3278,OTH:0.3131,ASJ:0.2351	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU13931522	het
22	41911525	41911525	C	T	ACO2	exonic	synonymous SNV	ENSG00000100412	rs1799932	ENSG00000100412:ENST00000216254:exon5:c.C670T:p.L224L,ENSG00000100412:ENST00000396512:exon5:c.C670T:p.L224L	ACO2:NM_001098:exon5:c.C670T:p.L224L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3993	0.3837	0.270367	1(thyroid)	.	.	.	.	.	.	.	.	ACO2:uc003bac.3:exon5:c.C670T:p.L224L	.	AFR:MU4554543,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.1564,FIN:0.2506,NFE:0.4233,OTH:0.1634,ASJ:0.3708	100850	614559;616289;	313850;	313850|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614559 ~	.	.	.	.	.	.	.	.	22	1(salivary_gland)	0.4417
22	42059768	42059768	G	T	XRCC6	exonic	synonymous SNV	ENSG00000196419	rs132788	ENSG00000196419:ENST00000405506:exon11:c.G1629T:p.G543G,ENSG00000196419:ENST00000359308:exon12:c.G1779T:p.G593G,ENSG00000196419:ENST00000428575:exon12:c.G1380T:p.G460G,ENSG00000196419:ENST00000360079:exon13:c.G1779T:p.G593G,ENSG00000196419:ENST00000402580:exon13:c.G1656T:p.G552G,ENSG00000196419:ENST00000405878:exon13:c.G1779T:p.G593G	XRCC6:NM_001288978:exon12:c.G1629T:p.G543G,XRCC6:NM_001288976:exon13:c.G1779T:p.G593G,XRCC6:NM_001288977:exon13:c.G1656T:p.G552G,XRCC6:NM_001469:exon13:c.G1779T:p.G593G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2935	0.2681	0.209065	MU147619	.	.	.	.	.	.	.	.	XRCC6:uc003bar.2:exon12:c.G1779T:p.G593G,XRCC6:uc011apc.1:exon12:c.G1629T:p.G543G,XRCC6:uc003bao.1:exon13:c.G1779T:p.G593G,XRCC6:uc003bap.1:exon13:c.G1656T:p.G552G	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.2661,EAS:0.2064,FIN:0.2848,NFE:0.2587,OTH:0.3456,ASJ:0.0825	152690	.	.	.	.	.	.	.	.	.	.	.	22	2(lung)	0.3558
22	42522613	42522613	G	C	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs1135840	ENSG00000100197:ENST00000359033:exon8:c.C1304G:p.T435S,ENSG00000100197:ENST00000360608:exon9:c.C1457G:p.T486S,ENSG00000100197:ENST00000389970:exon10:c.C1457G:p.T486S	CYP2D6:NM_001025161:exon8:c.C1304G:p.T435S,CYP2D6:NM_000106:exon9:c.C1457G:p.T486S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4556	0.4083	0.401158	1(pancreas)	.	.	.	.	.	.	.	.	CYP2D6:uc010gyu.3:exon7:c.C539G:p.T180S,CYP2D6:uc003bcf.3:exon8:c.C1304G:p.T435S,CYP2D6:uc003bce.3:exon9:c.C1457G:p.T486S	.	AFR:1(breast),AMR:MU157529,EAS:0.4196,FIN:0.3487,NFE:0.5652,OTH:0.3742,ASJ:LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	1(central_nervous_system)	0.2780
22	42523003	42523003	A	G	LOC101929829	ncRNA_intronic	.	ENSG00000237037	rs4987144	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0598	.	.	0.6294	.	.	.	.	.	0.0004	0.044	.	.	.	AFR:0.5494,AMR:0.6962,EAS:0.8447,FIN:0.6498,NFE:0.6407,OTH:0.6293,ASJ:0.6493	.	.	.	.	.	.	.	.	.	.	.	.	22	MU14341492	hom
22	42523943	42523943	A	G	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs16947	ENSG00000100197:ENST00000359033:exon5:c.T733C:p.C245R,ENSG00000100197:ENST00000360608:exon6:c.T886C:p.C296R,ENSG00000100197:ENST00000389970:exon7:c.T886C:p.C296R	CYP2D6:NM_001025161:exon5:c.T733C:p.C245R,CYP2D6:NM_000106:exon6:c.T886C:p.C296R	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6567	0.5996	0.640775	MU157540	.	.	.	.	.	.	.	.	CYP2D6:uc003bcf.3:exon5:c.T733C:p.C245R,CYP2D6:uc003bce.3:exon6:c.T886C:p.C296R	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.6150,EAS:0.7,FIN:0.65,NFE:0.8514,OTH:0.6486,ASJ:0.4759	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	19(soft_tissue)	0.6542
22	42524795	42524795	A	G	CYP2D6	exonic	synonymous SNV	ENSG00000100197	rs28371713	ENSG00000100197:ENST00000360124:exon2:c.T324C:p.F108F,ENSG00000100197:ENST00000359033:exon3:c.T504C:p.F168F,ENSG00000100197:ENST00000360608:exon4:c.T657C:p.F219F,ENSG00000100197:ENST00000389970:exon5:c.T657C:p.F219F	CYP2D6:NM_001025161:exon3:c.T504C:p.F168F,CYP2D6:NM_000106:exon4:c.T657C:p.F219F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3434	.	.	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	CYP2D6:uc003bcf.3:exon3:c.T504C:p.F168F,CYP2D6:uc003bce.3:exon4:c.T657C:p.F219F	.	AFR:6(central_nervous_system),AMR:1(kidney),EAS:2(liver),FIN:3(thyroid),NFE:1(large_intestine),OTH:MU157546,ASJ:1(breast)	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	2(lung)	SKCA-BR|1|100|0.01,LIRI-JP|1|258|0.00387597,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,PBCA-DE|1|499|0.00200401,BRCA-KR|1|50|0.02
22	42525132	42525132	G	C	CYP2D6	exonic	synonymous SNV	ENSG00000100197	rs1058164	ENSG00000100197:ENST00000360608:exon3:c.C408G:p.V136V,ENSG00000100197:ENST00000389970:exon4:c.C408G:p.V136V	CYP2D6:NM_000106:exon3:c.C408G:p.V136V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4515	0.3929	0.400958	2(large_intestine)	.	.	.	.	.	.	.	.	CYP2D6:uc003bce.3:exon3:c.C408G:p.V136V	.	AFR:MU69977,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.3528,FIN:0.5692,NFE:0.3841,OTH:0.2731,ASJ:0.4233	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	3(lung)	0.5297
22	50657010	50657010	C	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838864	ENSG00000128159:ENST00000425018:exon7:c.G919C:p.V307L,ENSG00000128159:ENST00000248846:exon22:c.G4861C:p.V1621L	TUBGCP6:NM_020461:exon22:c.G4861C:p.V1621L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9956	0.9947	0.998802	0.9955	1.233	11.92	1.0	1.61	0.999	.	.	.	TUBGCP6:uc003bka.1:exon7:c.G2122C:p.V708L,TUBGCP6:uc003bkb.1:exon22:c.G4861C:p.V1621L,TUBGCP6:uc010har.1:exon22:c.G4837C:p.V1613L	-1.016	AFR:0.9985,AMR:0.9976,EAS:1,FIN:0.9994,NFE:0.9922,OTH:0.9949,ASJ:1	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.003	3.43	0.000	-2.67	22	MU82055240	hom
22	50657112	50657112	C	T	TUBGCP6	intronic	.	ENSG00000128159	rs11912397	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1380	0.1210	0.108027	0.1186	.	.	.	.	.	.	.	.	.	.	AFR:0.0756,AMR:0.0955,EAS:0.0216,FIN:0.1377,NFE:0.1498,OTH:0.1443,ASJ:0.0960	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU82241411	het
22	50658053	50658053	A	G	TUBGCP6	intronic	.	ENSG00000128159	rs6537642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9660	0.9595	0.982428	0.9677	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9665,EAS:1,FIN:0.9891,NFE:0.9481,OTH:0.9663,ASJ:0.9272	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU82055281	hom
22	50658161	50658161	C	T	TUBGCP6	exonic	synonymous SNV	ENSG00000128159	rs200451987	ENSG00000128159:ENST00000439308:exon18:c.G4286A:p.R1429Q	TUBGCP6:NM_020461:exon18:c.G4227A:p.A1409A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0002	.	0.000399361	9.699e-05	1.666	14.22	0.0	-10.6	0.002	.	.	.	TUBGCP6:uc003bka.1:exon3:c.G1488A:p.A496A,TUBGCP6:uc003bkb.1:exon18:c.G4227A:p.A1409A,TUBGCP6:uc010har.1:exon18:c.G4203A:p.A1401A	-0.972	AFR:0,AMR:0,EAS:0,FIN:0.0006,NFE:6.674e-05,OTH:0,ASJ:0	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	2.55	0.022	.	22	.	het
22	50664612	50664612	A	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838865	ENSG00000128159:ENST00000248846:exon9:c.T1700C:p.L567S,ENSG00000128159:ENST00000439308:exon9:c.T1700C:p.L567S	TUBGCP6:NM_020461:exon9:c.T1700C:p.L567S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7912	0.8244	0.858826	0.8162	-1.386	0.003	0.692	-5.69	0.055	.	.	.	TUBGCP6:uc003bkb.1:exon9:c.T1700C:p.L567S,TUBGCP6:uc010har.1:exon9:c.T1700C:p.L567S	-1.069	AFR:0.9504,AMR:0.6563,EAS:0.8241,FIN:0.7956,NFE:0.7544,OTH:0.7888,ASJ:0.7318	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.005	3.31	0.000	-0.51	22	MU67370157	hom
22	50678620	50678620	G	C	TUBGCP6	intronic	.	ENSG00000128159	rs17248329	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0205	0.0053	0.0313498	0.0139	.	.	.	.	.	.	.	.	TUBGCP6:uc010hau.1:exon2:c.C918G:p.F306L	.	AFR:0.0015,AMR:0.0251,EAS:0.1196,FIN:0.0054,NFE:0.0115,OTH:0.0102,ASJ:0.0033	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU30224689	het
22	50964236	50964236	G	A	TYMP	exonic	nonsynonymous SNV	ENSG00000025708	rs11479	ENSG00000025708:ENST00000425169:exon9:c.C1313T:p.S438L,ENSG00000025708:ENST00000252029:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395678:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395680:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395681:exon10:c.C1427T:p.S476L	TYMP:NM_001113756:exon9:c.C1412T:p.S471L,TYMP:NM_001113755:exon10:c.C1412T:p.S471L,TYMP:NM_001257988:exon10:c.C1412T:p.S471L,TYMP:NM_001257989:exon10:c.C1427T:p.S476L,TYMP:NM_001953:exon10:c.C1412T:p.S471L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1393	0.0684	0.142772	MU26811700	4.372	24.1	0.398	2.19	0.047	.	.	Pyrimidine nucleoside phosphorylase, C-terminal	TYMP:uc003bmb.5:exon9:c.C1412T:p.S471L,TYMP:uc003bmc.5:exon10:c.C1412T:p.S471L,TYMP:uc003bmd.5:exon10:c.C1412T:p.S471L,TYMP:uc003bme.5:exon10:c.C1427T:p.S476L,TYMP:uc010hbd.4:exon10:c.C1412T:p.S471L	-0.663	AFR:LAML-KR|1|205|0.00487805,THCA-CN|1|50|0.02,AMR:0.0932,EAS:0.1918,FIN:0.0927,NFE:0.2414,OTH:0.0967,ASJ:0.0498	131222	603041;	298;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	0.986	-1.57	0.000	1.725	22	2(thyroid)	0.0946
22	50964862	50964862	G	A	TYMP	exonic	synonymous SNV	ENSG00000025708	rs131804	ENSG00000025708:ENST00000425169:exon7:c.C873T:p.A291A,ENSG00000025708:ENST00000252029:exon8:c.C972T:p.A324A,ENSG00000025708:ENST00000395678:exon8:c.C972T:p.A324A,ENSG00000025708:ENST00000395680:exon8:c.C972T:p.A324A,ENSG00000025708:ENST00000395681:exon8:c.C972T:p.A324A	TYMP:NM_001113756:exon7:c.C972T:p.A324A,TYMP:NM_001113755:exon8:c.C972T:p.A324A,TYMP:NM_001257988:exon8:c.C972T:p.A324A,TYMP:NM_001257989:exon8:c.C972T:p.A324A,TYMP:NM_001953:exon8:c.C972T:p.A324A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6721	0.6305	0.532947	0.5203	.	.	.	.	.	.	.	.	TYMP:uc003bmb.5:exon7:c.C972T:p.A324A,TYMP:uc003bmc.5:exon8:c.C972T:p.A324A,TYMP:uc003bmd.5:exon8:c.C972T:p.A324A,TYMP:uc003bme.5:exon8:c.C972T:p.A324A,TYMP:uc010hbd.4:exon8:c.C972T:p.A324A	.	AFR:0.3494,AMR:0.5988,EAS:0.7124,FIN:0.6102,NFE:0.5717,OTH:0.5565,ASJ:0.5166	131222	603041;	298;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	22	MU67370257	het
X	14868806	14868806	A	G	FANCB	intronic	.	ENSG00000181544	rs2905223	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5638	0.5539	0.433642	0.5374	.	.	.	.	.	0	0	.	.	.	AFR:0.4759,AMR:0.4234,EAS:0.1773,FIN:0.5810,NFE:0.6027,OTH:0.5487,ASJ:0.5889	300515	300514;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	X	MU22087306	hom
X	19364644	19364644	C	T	PDHA1	exonic	nonsynonymous SNV	ENSG00000131828	rs7883320	ENSG00000131828:ENST00000379806:exon2:c.C74T:p.T25M,ENSG00000131828:ENST00000423505:exon2:c.C74T:p.T25M	PDHA1:NM_001173454:exon2:c.C74T:p.T25M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.1375	.	0.247947	0.2065	-0.327	0.577	0.336	-0.854	0.001	.	.	.	PDHA1:uc004czh.4:exon2:c.C74T:p.T25M	-0.933	AFR:0.6692,AMR:0.0891,EAS:0.0068,FIN:0.0292,NFE:0.0324,OTH:0.0834,ASJ:0.1444	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	0.0	-4.72	0.000	.	X	.	het
X	19373452	19373452	C	T	PDHA1	intronic	.	ENSG00000131828	rs13440874	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0416	0.0416	.	0.0333	.	.	.	.	.	.	.	.	.	.	AFR:0.0623,AMR:0.0275,EAS:0.0066,FIN:0.0219,NFE:0.0201,OTH:0.0510,ASJ:0.1164	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19373789	19373789	C	A	PDHA1	intronic	.	ENSG00000131828	rs7058209	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1155	0.2614	0.247947	0.2065	.	.	.	.	.	.	.	.	.	.	AFR:0.6648,AMR:0.0884,EAS:0.0068,FIN:0.0293,NFE:0.0323,OTH:0.0764,ASJ:0.1568	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19373839	19373839	A	G	PDHA1	exonic	synonymous SNV	ENSG00000131828	rs1126565	ENSG00000131828:ENST00000540249:exon7:c.A702G:p.A234A,ENSG00000131828:ENST00000422285:exon8:c.A795G:p.A265A,ENSG00000131828:ENST00000545074:exon8:c.A816G:p.A272A,ENSG00000131828:ENST00000379806:exon9:c.A909G:p.A303A	PDHA1:NM_001173456:exon7:c.A702G:p.A234A,PDHA1:NM_000284:exon8:c.A795G:p.A265A,PDHA1:NM_001173455:exon8:c.A816G:p.A272A,PDHA1:NM_001173454:exon9:c.A909G:p.A303A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1339	0.3246	0.304636	0.2591	.	.	.	.	.	.	.	.	PDHA1:uc010nfl.3:exon2:c.A168G:p.A56A,PDHA1:uc011mjd.2:exon7:c.A702G:p.A234A,PDHA1:uc004czg.4:exon8:c.A795G:p.A265A,PDHA1:uc011mjc.2:exon8:c.A816G:p.A272A,PDHA1:uc004czh.4:exon9:c.A909G:p.A303A	.	AFR:0.8521,AMR:0.1077,EAS:0.0067,FIN:0.0292,NFE:0.0330,OTH:0.0882,ASJ:0.1444	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19377712	19377712	G	A	PDHA1	exonic	nonsynonymous SNV	ENSG00000131828	rs199879809	ENSG00000131828:ENST00000379804:exon4:c.G271A:p.D91N,ENSG00000131828:ENST00000540249:exon10:c.G1021A:p.D341N,ENSG00000131828:ENST00000422285:exon11:c.G1114A:p.D372N,ENSG00000131828:ENST00000545074:exon11:c.G1135A:p.D379N,ENSG00000131828:ENST00000379806:exon12:c.G1228A:p.D410N	PDHA1:NM_001173456:exon10:c.G1021A:p.D341N,PDHA1:NM_000284:exon11:c.G1114A:p.D372N,PDHA1:NM_001173455:exon11:c.G1135A:p.D379N,PDHA1:NM_001173454:exon12:c.G1228A:p.D410N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	0.0001	9.5e-05	.	0.0002	1.681	14.30	0.974	4.73	0.475	.	.	Dehydrogenase, E1 component|Thiamin diphosphate-binding fold;Thiamin diphosphate-binding fold	PDHA1:uc010nfl.3:exon5:c.G487A:p.D163N,PDHA1:uc011mjd.2:exon10:c.G1021A:p.D341N,PDHA1:uc004czg.4:exon11:c.G1114A:p.D372N,PDHA1:uc011mjc.2:exon11:c.G1135A:p.D379N,PDHA1:uc004czh.4:exon12:c.G1228A:p.D410N	0.025	AFR:0.0005,AMR:0,EAS:0,FIN:0.0004,NFE:0,OTH:0.0014,ASJ:0	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	0.001	-4.25	0.662	-0.825	X	.	het
X	30326983	30326983	C	T	NR0B1	exonic	synonymous SNV	ENSG00000169297	rs2269345	ENSG00000169297:ENST00000378970:exon1:c.G498A:p.R166R,ENSG00000169297:ENST00000453287:exon1:c.G498A:p.R166R	NR0B1:NM_000475:exon1:c.G498A:p.R166R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3984	0.2828	0.476556	1(stomach)	.	.	.	.	.	.	.	.	NR0B1:uc004dcf.4:exon1:c.G498A:p.R166R	.	AFR:MU124109,AMR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.4177,FIN:0.4086,NFE:0.2222,OTH:0.7192,ASJ:0.2768	300473	300018;300200;	95702;242;	95702|X-linked congenital adrenal hypoplasia|-|X-linked recessive|-|202155 300200 ~242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	X	1(thyroid)	0.1727
X	31213723	31213723	C	T	DMD	intronic	.	ENSG00000198947	rs5972332	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.94649	0.9636	.	.	.	.	.	.	.	.	.	.	AFR:0.9022,AMR:0.9900,EAS:0.9700,FIN:0.9954,NFE:0.9868,OTH:0.9747,ASJ:0.9622	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	hom
X	31224684	31224684	A	G	DMD	intronic	.	ENSG00000198947	rs2293668	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8836	0.8265	0.803974	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.8406,AMR:0.7370,EAS:0.8723,FIN:0.7939,NFE:0.8858,OTH:0.8864,ASJ:0.9152	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.8396
X	31496350	31496350	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1800280	ENSG00000198947:ENST00000358062:exon12:c.G1898A:p.R633Q,ENSG00000198947:ENST00000343523:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000359836:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000378707:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000474231:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000541735:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000357033:exon59:c.G8810A:p.R2937Q,ENSG00000198947:ENST00000378677:exon59:c.G8798A:p.R2933Q	DMD:NM_004014:exon5:c.G623A:p.R208Q,DMD:NM_004013:exon16:c.G1430A:p.R477Q,DMD:NM_004020:exon16:c.G1430A:p.R477Q,DMD:NM_004021:exon16:c.G1430A:p.R477Q,DMD:NM_004022:exon16:c.G1430A:p.R477Q,DMD:NM_004023:exon16:c.G1430A:p.R477Q,DMD:NM_004011:exon31:c.G4787A:p.R1596Q,DMD:NM_004012:exon31:c.G4778A:p.R1593Q,DMD:NM_000109:exon59:c.G8786A:p.R2929Q,DMD:NM_004006:exon59:c.G8810A:p.R2937Q,DMD:NM_004009:exon59:c.G8798A:p.R2933Q,DMD:NM_004010:exon59:c.G8441A:p.R2814Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9045	0.9568	0.881854	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	2.138	17.10	0.624	4.23	0.995	.	.	.	DMD:uc004dcq.1:exon5:c.G623A:p.R208Q,DMD:uc004dcr.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcs.1:exon16:c.G1430A:p.R477Q,DMD:uc004dct.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcu.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcv.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcw.2:exon31:c.G4778A:p.R1593Q,DMD:uc004dcx.2:exon31:c.G4787A:p.R1596Q,DMD:uc004dcy.1:exon59:c.G8798A:p.R2933Q,DMD:uc004dcz.2:exon59:c.G8441A:p.R2814Q,DMD:uc004dda.1:exon59:c.G8810A:p.R2937Q,DMD:uc004ddb.1:exon59:c.G8786A:p.R2929Q	-0.945	AFR:0.9524,AMR:0.9879,EAS:0.9565,FIN:0.9268,NFE:0.9410,OTH:0.9457,ASJ:0.8336	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	1.01	0.000	.	X	1(lung)	0.9392
X	31676096	31676096	G	A	DMD	intronic	.	ENSG00000198947	rs2270672	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3398	0.3389	0.328477	0.3560	.	.	.	.	.	.	.	.	.	.	AFR:0.3183,AMR:0.2039,EAS:0.3036,FIN:0.4195,NFE:0.3714,OTH:0.4003,ASJ:0.3770	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	MU14600441	hom
X	32380996	32380996	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1801187	ENSG00000198947:ENST00000357033:exon37:c.G5234A:p.R1745H,ENSG00000198947:ENST00000378677:exon37:c.G5222A:p.R1741H	DMD:NM_004011:exon9:c.G1211A:p.R404H,DMD:NM_004012:exon9:c.G1202A:p.R401H,DMD:NM_000109:exon37:c.G5210A:p.R1737H,DMD:NM_004006:exon37:c.G5234A:p.R1745H,DMD:NM_004009:exon37:c.G5222A:p.R1741H,DMD:NM_004010:exon37:c.G4865A:p.R1622H	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5142	0.3331	0.465166	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	6.788	32	0.006	5.24	0.940	.	.	.	DMD:uc004dcw.2:exon9:c.G1202A:p.R401H,DMD:uc004dcx.2:exon9:c.G1211A:p.R404H,DMD:uc004dcy.1:exon37:c.G5222A:p.R1741H,DMD:uc004dcz.2:exon37:c.G4865A:p.R1622H,DMD:uc004dda.1:exon37:c.G5234A:p.R1745H,DMD:uc004ddb.1:exon37:c.G5210A:p.R1737H	-0.904	AFR:0.3913,AMR:0.0789,EAS:0.4293,FIN:0.7234,NFE:0.5224,OTH:0.4730,ASJ:0.6987	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.999	0.74	0.000	2.64	X	1(lung)	0.5245
X	32472763	32472763	-	T	DMD	intronic	.	ENSG00000198947	rs5902031	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4978	0.3803	0.464106	0.5453	.	.	.	.	.	.	.	.	.	.	AFR:0.2239,AMR:0.7074,EAS:0.7851,FIN:0.6083,NFE:0.6948,OTH:0.7,ASJ:0.6408	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	het
X	32503194	32503194	T	C	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs228406	ENSG00000198947:ENST00000357033:exon21:c.A2645G:p.D882G,ENSG00000198947:ENST00000378677:exon21:c.A2633G:p.D878G	DMD:NM_000109:exon21:c.A2621G:p.D874G,DMD:NM_004006:exon21:c.A2645G:p.D882G,DMD:NM_004009:exon21:c.A2633G:p.D878G,DMD:NM_004010:exon21:c.A2276G:p.D759G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7211	0.6502	0.748344	0.6958	0.631	8.366	0.523	3.07	0.978	.	.	.	DMD:uc004dcy.1:exon21:c.A2633G:p.D878G,DMD:uc004dcz.2:exon21:c.A2276G:p.D759G,DMD:uc004dda.1:exon21:c.A2645G:p.D882G,DMD:uc004ddb.1:exon21:c.A2621G:p.D874G	-0.978	AFR:0.6291,AMR:0.8068,EAS:0.8869,FIN:0.8215,NFE:0.6750,OTH:0.7336,ASJ:0.6243	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	0.73	0.000	0	X	MU4584954	hom
X	32536144	32536144	T	G	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs750526692	ENSG00000198947:ENST00000288447:exon18:c.A2249C:p.D750A,ENSG00000198947:ENST00000357033:exon18:c.A2273C:p.D758A,ENSG00000198947:ENST00000378677:exon18:c.A2261C:p.D754A	DMD:NM_000109:exon18:c.A2249C:p.D750A,DMD:NM_004006:exon18:c.A2273C:p.D758A,DMD:NM_004009:exon18:c.A2261C:p.D754A,DMD:NM_004010:exon18:c.A1904C:p.D635A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0003	.	0.000529801	.	4.774	24.7	0.056	5.07	0.991	.	.	.	DMD:uc004dcy.1:exon18:c.A2261C:p.D754A,DMD:uc004dcz.2:exon18:c.A1904C:p.D635A,DMD:uc004dda.1:exon18:c.A2273C:p.D758A,DMD:uc004ddb.1:exon18:c.A2249C:p.D750A,DMD:uc004ddf.3:exon18:c.A2249C:p.D750A	0.056	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.191	0.88	0.511	1.78	X	.	het
X	32563263	32563263	A	G	DMD	intronic	.	ENSG00000198947	rs228373	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3203	0.3247	0.412185	LUSC-KR|6|170|0.0352941,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.3193,AMR:0.4698,EAS:0.2742,FIN:0.5252,NFE:0.2816,OTH:0.2242,ASJ:0.4092	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(breast)	0.2640
X	39921666	39921666	C	T	BCOR	intronic	.	ENSG00000183337	rs374547123	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0045	9.5e-05	0.00741722	4.731e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0014,ASJ:0	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	.	.	.	.	.	.	.	X	.	het
X	39932907	39932907	T	C	BCOR	exonic	synonymous SNV	ENSG00000183337	rs6520618	ENSG00000183337:ENST00000342274:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000378444:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000378455:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000397354:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000406200:exon4:c.A1692G:p.A564A	BCOR:NM_001123383:exon4:c.A1692G:p.A564A,BCOR:NM_001123384:exon4:c.A1692G:p.A564A,BCOR:NM_001123385:exon4:c.A1692G:p.A564A,BCOR:NM_017745:exon4:c.A1692G:p.A564A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2671	0.3615	0.523974	MU14602427	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.A1692G:p.A564A,BCOR:uc004den.4:exon4:c.A1692G:p.A564A,BCOR:uc004deo.4:exon4:c.A1692G:p.A564A,BCOR:uc004dep.4:exon4:c.A1692G:p.A564A,BCOR:uc004deq.4:exon4:c.A1692G:p.A564A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3308,EAS:0.1980,FIN:0.1323,NFE:0.7143,OTH:0.1283,ASJ:0.8037	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,972,969	.	,971,970	.	.	.	.	X	8(soft_tissue)	0.0976
X	39933339	39933339	A	G	BCOR	exonic	synonymous SNV	ENSG00000183337	rs5917933	ENSG00000183337:ENST00000342274:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000378444:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000378455:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000397354:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000406200:exon4:c.T1260C:p.D420D	BCOR:NM_001123383:exon4:c.T1260C:p.D420D,BCOR:NM_001123384:exon4:c.T1260C:p.D420D,BCOR:NM_001123385:exon4:c.T1260C:p.D420D,BCOR:NM_017745:exon4:c.T1260C:p.D420D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8952	0.8957	0.903046	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.T1260C:p.D420D,BCOR:uc004den.4:exon4:c.T1260C:p.D420D,BCOR:uc004deo.4:exon4:c.T1260C:p.D420D,BCOR:uc004dep.4:exon4:c.T1260C:p.D420D,BCOR:uc004deq.4:exon4:c.T1260C:p.D420D	.	AFR:0.9153,AMR:0.9232,EAS:0.8771,FIN:0.9756,NFE:0.9487,OTH:0.8959,ASJ:0.9469	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,972,969	.	,971,970	.	.	.	.	X	1(thyroid)	0.9042
X	41206134	41206134	C	T	DDX3X	exonic	synonymous SNV	ENSG00000215301	rs929461072	ENSG00000215301:ENST00000457138:exon14:c.C1590T:p.N530N,ENSG00000215301:ENST00000399959:exon15:c.C1638T:p.N546N	DDX3X:NM_001193417:exon14:c.C1590T:p.N530N,DDX3X:NM_001193416:exon15:c.C1638T:p.N546N,DDX3X:NM_001356:exon15:c.C1638T:p.N546N,DDX3X:NM_001363819:exon15:c.C1080T:p.N360N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	UCEC-US|1|531|0.00188324,STAD-US|1|439|0.0022779	.	.	.	.	.	.	.	.	DDX3X:uc011mkr.2:exon13:c.C1248T:p.N416N,DDX3X:uc011mkq.2:exon14:c.C1590T:p.N530N,DDX3X:uc004dfe.3:exon15:c.C1638T:p.N546N,DDX3X:uc004dff.3:exon15:c.C1638T:p.N546N	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300160	300958;	457260;	457260|-|<1 / 1 000 000|X-linked dominant|Childhood<br>Adolescent|300958 ~	~ko04622 RIG-I-like receptor signaling pathway~ko05161 Hepatitis B~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	X	1(endometrium)	.
X	44935925	44935925	T	-	KDM6A	intronic	.	ENSG00000147050	rs10605935	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6166	.	0.605828	0.7357	.	.	.	.	.	.	.	.	.	.	AFR:0.5684,AMR:0.8716,EAS:0.6364,FIN:0.6648,NFE:0.8421,OTH:0.7743,ASJ:0.7984	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	MU112687125	hom
X	44938563	44938563	G	A	KDM6A	exonic	synonymous SNV	ENSG00000147050	rs20539	ENSG00000147050:ENST00000543216:exon18:c.G2874A:p.Q958Q,ENSG00000147050:ENST00000536777:exon19:c.G2976A:p.Q992Q,ENSG00000147050:ENST00000377967:exon20:c.G3111A:p.Q1037Q,ENSG00000147050:ENST00000382899:exon20:c.G3132A:p.Q1044Q	KDM6A:NM_001291418:exon18:c.G2874A:p.Q958Q,KDM6A:NM_001291421:exon18:c.G2223A:p.Q741Q,KDM6A:NM_001291417:exon19:c.G2976A:p.Q992Q,KDM6A:NM_001291416:exon20:c.G3132A:p.Q1044Q,KDM6A:NM_021140:exon20:c.G3111A:p.Q1037Q,KDM6A:NM_001291415:exon21:c.G3267A:p.Q1089Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2384	0.1320	0.221722	47(meninges)	.	.	.	.	.	.	.	.	KDM6A:uc011mld.2:exon9:c.G2028A:p.Q676Q,KDM6A:uc011mlc.2:exon18:c.G2223A:p.Q741Q,KDM6A:uc022bvj.1:exon18:c.G2874A:p.Q958Q,KDM6A:uc010nhk.2:exon19:c.G3009A:p.Q1003Q,KDM6A:uc011mla.2:exon19:c.G2976A:p.Q992Q,KDM6A:uc004dge.4:exon20:c.G3111A:p.Q1037Q,KDM6A:uc011mlb.2:exon20:c.G3132A:p.Q1044Q,KDM6A:uc011mkz.2:exon21:c.G3267A:p.Q1089Q	.	AFR:MU768289,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579,EAS:0.0313,FIN:0.4365,NFE:0.2350,OTH:0.3330,ASJ:0.1641	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	,6286	.	.	.	.	.	.	X	1(prostate)	0.2260
X	48125798	48125798	T	C	SSX1	exonic	synonymous SNV	ENSG00000126752	rs5952493	ENSG00000126752:ENST00000376919:exon7:c.T543C:p.S181S	SSX1:NM_005635:exon7:c.T543C:p.S181S,SSX1:NM_001278691:exon8:c.T543C:p.S181S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5025	0.4724	0.486093	0.4912	.	.	.	.	.	.	.	.	SSX1:uc004djb.1:exon7:c.T543C:p.S181S	.	AFR:0.4634,AMR:0.5637,EAS:0.6101,FIN:0.5306,NFE:0.4816,OTH:0.4979,ASJ:0.4420	312820	300813;	3273;	3273|Synovialosarcoma|Unknown|Not applicable|All ages|300813 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	MU729878	het
X	48888074	48888074	T	C	TFE3	exonic	synonymous SNV	ENSG00000068323	rs3027472	ENSG00000068323:ENST00000315869:exon10:c.A1323G:p.V441V	TFE3:NM_001282142:exon10:c.A1008G:p.V336V,TFE3:NM_006521:exon10:c.A1323G:p.V441V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3921	0.3650	0.231258	LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TFE3:uc004dmb.3:exon10:c.A1323G:p.V441V,TFE3:uc004dmc.3:exon10:c.A1008G:p.V336V	.	AFR:0.3553,AMR:0.0703,EAS:0.5824,FIN:0.0832,NFE:0.4753,OTH:0.5083,ASJ:0.3203	314310	300854;	319308;	319308|Carcinoma associated with MITF/TFE translocation<br>Translocation carcinoma|-|-|-|300854 ~	~ko04137 Mitophagy - animal~ko05202 Transcriptional misregulation in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	X	1(breast)	0.4226
X	53228148	53228148	C	A	KDM5C	intronic	.	ENSG00000126012	rs1977364	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8920	0.7829	0.730331	0.8161	.	.	.	.	.	.	.	.	.	.	AFR:0.4295,AMR:0.8821,EAS:0.7619,FIN:0.9883,NFE:0.9786,OTH:0.9393,ASJ:0.9227	314690	300534;	85279;	85279|-|<1 / 1 000 000|X-linked recessive|Childhood|300534 ~	.	.	.	.	.	.	.	.	X	MU14608707	hom
X	53246959	53246959	C	T	KDM5C	intronic	.	ENSG00000126012	rs41308052	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0302	0.0382	0.0103311	MU113371243	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.0292,EAS:0.0197,FIN:0.0435,NFE:0,OTH:0.0215,ASJ:0.0053	314690	300534;	85279;	85279|-|<1 / 1 000 000|X-linked recessive|Childhood|300534 ~	.	.	.	.	.	.	.	.	X	1(soft_tissue)	0.0475
X	53563589	53563589	A	G	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs426298	ENSG00000086758:ENST00000342160:exon78:c.T12177C:p.G4059G,ENSG00000086758:ENST00000262854:exon79:c.T12177C:p.G4059G	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9920	0.994967	0.9942	.	.	.	.	.	.	.	.	HUWE1:uc004dsn.4:exon48:c.T8601C:p.G2867G,HUWE1:uc004dsp.4:exon79:c.T12177C:p.G4059G	.	AFR:0.9787,AMR:0.9984,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	MU82057962	hom
X	66765159	66765173	GCAGCAGCAGCAGCA	-	AR	exonic	nonframeshift deletion	ENSG00000169083	rs745982326	ENSG00000169083:ENST00000374690:exon1:c.171_185del:p.57_62del,ENSG00000169083:ENST00000396044:exon1:c.171_185del:p.57_62del,ENSG00000169083:ENST00000504326:exon1:c.171_185del:p.57_62del,ENSG00000169083:ENST00000514029:exon1:c.171_185del:p.57_62del	AR:NM_000044:exon1:c.171_185del:p.57_62del,AR:NM_001348061:exon1:c.171_185del:p.57_62del,AR:NM_001348063:exon1:c.171_185del:p.57_62del,AR:NM_001348064:exon1:c.171_185del:p.57_62del	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0065	.	.	.	.	.	.	.	.	.	.	.	AR:uc004dwu.2:exon1:c.171_185del:p.57_62del,AR:uc011mpd.2:exon1:c.171_185del:p.57_62del,AR:uc011mpf.1:exon1:c.171_185del:p.57_62del,AR:uc022byk.1:exon1:c.171_185del:p.57_62del	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04114 Oocyte meiosis~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	,823,830	.	.	.	.	.	.	X	MU32438491	unknown
X	66766356	66766356	-	GGC	AR	exonic	nonframeshift insertion	ENSG00000169083	rs760580125	ENSG00000169083:ENST00000374690:exon1:c.1368_1369insGGC:p.G456delinsGG,ENSG00000169083:ENST00000396044:exon1:c.1368_1369insGGC:p.G456delinsGG,ENSG00000169083:ENST00000504326:exon1:c.1368_1369insGGC:p.G456delinsGG,ENSG00000169083:ENST00000514029:exon1:c.1368_1369insGGC:p.G456delinsGG	AR:NM_000044:exon1:c.1368_1369insGGC:p.G456delinsGG,AR:NM_001348061:exon1:c.1368_1369insGGC:p.G456delinsGG,AR:NM_001348063:exon1:c.1368_1369insGGC:p.G456delinsGG,AR:NM_001348064:exon1:c.1368_1369insGGC:p.G456delinsGG	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	.	.	0.197616	0.2183	.	.	.	.	.	.	.	.	AR:uc004dwu.2:exon1:c.1368_1369insGGC:p.G456delinsGG,AR:uc011mpd.2:exon1:c.1368_1369insGGC:p.G456delinsGG,AR:uc011mpf.1:exon1:c.1368_1369insGGC:p.G456delinsGG,AR:uc022byk.1:exon1:c.1368_1369insGGC:p.G456delinsGG	.	AFR:0.2612,AMR:0.1721,EAS:0.0549,FIN:0.0348,NFE:0.2421,OTH:0.2124,ASJ:0.2069	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04114 Oocyte meiosis~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	,823,830	.	.	.	.	.	.	X	.	het
X	70341169	70341169	A	C	MED12	intronic	.	ENSG00000184634	rs62609586	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2230	0.2368	0.114172	0.2145	.	.	.	.	.	0	0	.	.	.	AFR:0.0664,AMR:0.1626,EAS:0.0020,FIN:0.2779,NFE:0.3014,OTH:0.2434,ASJ:0.3730	300188	300895;305450;309520;	776;293707;	776|Lujan syndrome<br>Lujan-Fryns syndrome<br>X-linked mental retardation with marfanoid habitus<br>XLMR with marfanoid habitus|Unknown|X-linked recessive|Infancy<br>Neonatal|300676 309520 ~293707|BMRS, MKB type<br>BMRS, Maat-Kievit-Brunner type<br>Blepharophimosis-intellectual disability syndrome, Maat-Kievit-Brunner type<br>X-linked Ohdo syndrome|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|300895 ~	.	.	.	.	.	.	.	.	X	MU113491442	het
X	70349947	70349947	A	C	MED12	exonic	synonymous SNV	ENSG00000184634	rs5030619	ENSG00000184634:ENST00000333646:exon28:c.A3930C:p.P1310P,ENSG00000184634:ENST00000374080:exon28:c.A3930C:p.P1310P,ENSG00000184634:ENST00000374102:exon28:c.A3930C:p.P1310P	MED12:NM_005120:exon28:c.A3930C:p.P1310P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2461	0.2259	0.110993	MU117862	.	.	.	.	.	.	.	.	MED12:uc004dza.3:exon25:c.A3471C:p.P1157P,MED12:uc004dyy.3:exon28:c.A3930C:p.P1310P,MED12:uc004dyz.3:exon28:c.A3930C:p.P1310P,MED12:uc011mpq.1:exon28:c.A3930C:p.P1310P	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.2093,EAS:0.1607,FIN:0.3804,NFE:0.0010,OTH:0.2770,ASJ:0.0513	300188	300895;305450;309520;	776;293707;	776|Lujan syndrome<br>Lujan-Fryns syndrome<br>X-linked mental retardation with marfanoid habitus<br>XLMR with marfanoid habitus|Unknown|X-linked recessive|Infancy<br>Neonatal|300676 309520 ~293707|BMRS, MKB type<br>BMRS, Maat-Kievit-Brunner type<br>Blepharophimosis-intellectual disability syndrome, Maat-Kievit-Brunner type<br>X-linked Ohdo syndrome|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|300895 ~	.	.	.	.	.	.	.	.	X	1(large_intestine)	0.3003
X	70356863	70356863	C	T	MED12	exonic	synonymous SNV	ENSG00000184634	rs34784349	ENSG00000184634:ENST00000333646:exon38:c.C5535T:p.N1845N,ENSG00000184634:ENST00000374080:exon38:c.C5535T:p.N1845N,ENSG00000184634:ENST00000374102:exon38:c.C5535T:p.N1845N	MED12:NM_005120:exon38:c.C5535T:p.N1845N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0249	0.0008	0.0222517	0.0062	.	.	.	.	.	.	.	.	MED12:uc010nla.3:exon12:c.C1413T:p.N471N,MED12:uc004dza.3:exon35:c.C5076T:p.N1692N,MED12:uc004dyy.3:exon38:c.C5535T:p.N1845N,MED12:uc004dyz.3:exon38:c.C5535T:p.N1845N,MED12:uc011mpq.1:exon38:c.C5535T:p.N1845N	.	AFR:0.0028,AMR:0.1373,EAS:0.0181,FIN:0,NFE:0.0003,OTH:0.0126,ASJ:0	300188	300895;305450;309520;	776;293707;	776|Lujan syndrome<br>Lujan-Fryns syndrome<br>X-linked mental retardation with marfanoid habitus<br>XLMR with marfanoid habitus|Unknown|X-linked recessive|Infancy<br>Neonatal|300676 309520 ~293707|BMRS, MKB type<br>BMRS, Maat-Kievit-Brunner type<br>Blepharophimosis-intellectual disability syndrome, Maat-Kievit-Brunner type<br>X-linked Ohdo syndrome|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|300895 ~	.	.	.	.	.	.	.	.	X	MU36737024	het
X	70627813	70627813	C	T	TAF1	intronic	.	ENSG00000147133	rs772897916	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	2.399e-05	.	.	.	.	.	.	.	.	0.0001	0	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	313650	300966;314250;	53351;	53351|DYT3<br>Lubag<br>Lubag syndrome<br>XDP|<1 / 1 000 000|X-linked recessive<br>or&nbsp;Not applicable|Adult|314250 ~	.	.	.	.	.	.	.	.	X	.	het
X	100608191	100608191	G	A	BTK	exonic	synonymous SNV	ENSG00000010671	rs1135363	ENSG00000010671:ENST00000372880:exon16:c.C1371T:p.C457C,ENSG00000010671:ENST00000308731:exon18:c.C1899T:p.C633C	BTK:NM_001287345:exon16:c.C1371T:p.C457C,BTK:NM_000061:exon18:c.C1899T:p.C633C,BTK:NM_001287344:exon18:c.C2001T:p.C667C	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3208	0.3904	0.508079	MU20355874	.	.	.	.	.	.	.	.	BTK:uc010nnl.2:exon5:c.C327T:p.C109C,BTK:uc004ehf.2:exon6:c.C399T:p.C133C,BTK:uc010nnn.2:exon16:c.C1371T:p.C457C,BTK:uc004ehg.2:exon18:c.C1899T:p.C633C,BTK:uc010nno.2:exon18:c.C2001T:p.C667C	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.3666,EAS:0.5041,FIN:0.1492,NFE:0.4289,OTH:0.1658,ASJ:0.8149	300300	300755;307200;	231692;631;632;229717;47;	231692|Congenital IGHD type III<br>Congenital isolated GH deficiency type III<br>Congenital isolated growth hormone deficiency type III<br>X-linked IGHD<br>X-linked isolated growth hormone deficiency|-|X-linked recessive|Infancy<br>Neonatal|300123 307200 ~631|Congenital IGHD<br>Congenital isolated GH deficiency<br>Congenital isolated growth hormone deficiency|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal|173100 262400 262650 300123 307200 612781 ~632|-|-|X-linked recessive|Infancy<br>Neonatal|307200 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~47|BTK-deficiency<br>Bruton type agammaglobulinemia|1-9 / 1 000 000|X-linked recessive<br>or&nbsp;Not applicable|Childhood|300310 300755 ~	.	.	.	,1857	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.1657
X	100645467	100645467	T	C	BTK	exonic	nonsynonymous SNV	ENSG00000241343;ENSG00000257529	rs5951308	.	BTK:NM_001287344:exon1:c.A71G:p.E24G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3387	.	0.399205	0.3149	-0.099	1.736	.	-0.875	0.000	0.0001	0	PH domain-like|Pleckstrin homology domain	BTK:uc010nno.2:exon1:c.A71G:p.E24G	.	AFR:0.7493,AMR:0.3268,EAS:0.1166,FIN:0.1100,NFE:0.1542,OTH:0.1903,ASJ:0.1330	300300	300755;307200;	231692;631;632;229717;47;	231692|Congenital IGHD type III<br>Congenital isolated GH deficiency type III<br>Congenital isolated growth hormone deficiency type III<br>X-linked IGHD<br>X-linked isolated growth hormone deficiency|-|X-linked recessive|Infancy<br>Neonatal|300123 307200 ~631|Congenital IGHD<br>Congenital isolated GH deficiency<br>Congenital isolated growth hormone deficiency|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal|173100 262400 262650 300123 307200 612781 ~632|-|-|X-linked recessive|Infancy<br>Neonatal|307200 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~47|BTK-deficiency<br>Bruton type agammaglobulinemia|1-9 / 1 000 000|X-linked recessive<br>or&nbsp;Not applicable|Childhood|300310 300755 ~	.	.	.	,1857	.	.	.	.	X	MU13522464	hom
X	100653950	100653950	T	C	GLA;RPL36A-HNRNPH2	intronic	.	ENSG00000102393;ENSG00000257529	rs2071397	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1447	0.1307	0.16106	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.1234,AMR:0.1412,EAS:0.1223,FIN:0.0890,NFE:0.0995,OTH:0.1226,ASJ:0.1361	.	.	.	.	.	.	.	.	.	.	.	.	X	2(haematopoietic_and_lymphoid_tissue)	0.1151
X	100662901	100662901	G	A	GLA	UTR5	.	ENSG00000102393	rs2071225	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0955	0.0628	0.124503	0.0654	.	.	.	.	.	.	.	.	.	.	AFR:0.0627,AMR:0.1,EAS:0.0750,FIN:0.0712,NFE:0.0609,OTH:0.0956,ASJ:0.0376	300644	301500;	324;	324|Alpha-galactosidase A deficiency<br>Anderson-Fabry disease<br>Angiokeratoma corporis diffusum<br>Diffuse angiokeratoma<br>FD|1-5 / 10 000|X-linked recessive|Childhood|301500 ~	.	.	.	.	.	.	.	.	X	MU13522484	unknown
X	100662903	100662903	C	T	GLA	UTR5	.	ENSG00000102393	rs3027585	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0611	0.0717	0.0988079	0.0606	.	.	.	.	.	.	.	.	.	.	AFR:0.1507,AMR:0.1465,EAS:0.0284,FIN:0.0098,NFE:0.0239,OTH:0.0399,ASJ:0.0054	300644	301500;	324;	324|Alpha-galactosidase A deficiency<br>Anderson-Fabry disease<br>Angiokeratoma corporis diffusum<br>Diffuse angiokeratoma<br>FD|1-5 / 10 000|X-linked recessive|Childhood|301500 ~	.	.	.	.	.	.	.	.	X	MU13522488	unknown
X	118985712	118985712	T	-	UPF3B	intronic	.	ENSG00000125351	rs373850121	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4812	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300298	300676;	776;	776|Lujan syndrome<br>Lujan-Fryns syndrome<br>X-linked mental retardation with marfanoid habitus<br>XLMR with marfanoid habitus|Unknown|X-linked recessive|Infancy<br>Neonatal|300676 309520 ~	.	.	.	.	.	.	.	.	X	.	unknown
X	129147079	129147079	T	C	BCORL1	exonic	nonsynonymous SNV	ENSG00000085185	rs4830173	ENSG00000085185:ENST00000540052:exon3:c.T331C:p.F111L,ENSG00000085185:ENST00000218147:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000303743:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000359304:exon4:c.T331C:p.F111L	BCORL1:NM_001184772:exon3:c.T331C:p.F111L,BCORL1:NM_021946:exon3:c.T331C:p.F111L	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	BCORL1:uc010nrd.1:exon1:c.T37C:p.F13L,BCORL1:uc022cdu.1:exon3:c.T331C:p.F111L	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300688	.	.	.	.	,968	.	.	.	.	.	.	X	MU82059516	hom
X	129150111	129150111	C	T	BCORL1	exonic	synonymous SNV	ENSG00000085185	rs148695728	ENSG00000085185:ENST00000456822:exon1:c.C2163T:p.C721C,ENSG00000085185:ENST00000540052:exon3:c.C3363T:p.C1121C,ENSG00000085185:ENST00000218147:exon4:c.C3363T:p.C1121C,ENSG00000085185:ENST00000303743:exon4:c.C3363T:p.C1121C,ENSG00000085185:ENST00000359304:exon4:c.C3363T:p.C1121C	BCORL1:NM_001184772:exon3:c.C3363T:p.C1121C,BCORL1:NM_021946:exon3:c.C3363T:p.C1121C	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0018	0.0002	0.00317881	0.0003	.	.	.	.	.	.	.	.	BCORL1:uc010nrd.1:exon1:c.C3069T:p.C1023C,BCORL1:uc022cdu.1:exon3:c.C3363T:p.C1121C	.	AFR:0.0010,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0014,ASJ:0	300688	.	.	.	.	,968	.	.	.	.	.	.	X	.	het
X	140966946	140966946	T	C	MAGEC3	intronic	.	ENSG00000165509	rs73577990	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1425	0.0520	0.210066	0.0863	.	.	.	.	.	.	.	.	.	.	AFR:0.0747,AMR:0.2150,EAS:0.38,FIN:0.0970,NFE:0.0534,OTH:0.1041,ASJ:0.0430	300469	.	.	.	.	.	.	.	.	.	.	.	X	MU82059791	het
X	140967121	140967121	A	T	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs12852593	ENSG00000165509:ENST00000298296:exon3:c.A419T:p.D140V	MAGEC3:NM_138702:exon3:c.A419T:p.D140V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0902	0.0429	0.0831788	0.0452	2.715	20.9	0.001	-0.286	0.001	.	.	.	MAGEC3:uc011mwp.2:exon3:c.A419T:p.D140V	-0.994	AFR:0.0817,AMR:0.2144,EAS:0.0297,FIN:0.0336,NFE:0.0206,OTH:0.0350,ASJ:0.0053	300469	.	.	.	.	.	.	.	0.969	3.0	0.001	0	X	MU85288574	het
X	140967165	140967165	T	C	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs11095909	ENSG00000165509:ENST00000298296:exon3:c.T463C:p.S155P	MAGEC3:NM_138702:exon3:c.T463C:p.S155P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3294	0.2664	0.439205	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	-2.705	0.001	1.0	-1.44	0.000	.	.	.	MAGEC3:uc011mwp.2:exon3:c.T463C:p.S155P	-0.984	AFR:0.2448,AMR:0.5102,EAS:0.0437,FIN:0.4561,NFE:0.1739,OTH:0.0899,ASJ:0.4851	300469	.	.	.	.	.	.	.	0.0	3.29	0.000	0	X	3(lung)	0.1784
X	140967195	140967195	T	A	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs11095910	ENSG00000165509:ENST00000298296:exon3:c.T493A:p.L165M	MAGEC3:NM_138702:exon3:c.T493A:p.L165M	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3177	0.2054	0.369536	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	-3.271	0.001	1.0	-0.451	0.000	.	.	.	MAGEC3:uc011mwp.2:exon3:c.T493A:p.L165M	-0.904	AFR:0.2242,AMR:0.4256,EAS:0.0398,FIN:0.4646,NFE:0.1739,OTH:0.0923,ASJ:0.4708	300469	.	.	.	.	.	.	.	0.0	3.15	0.000	0	X	4(lung)	0.1858
X	140983064	140983064	G	A	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs176024	ENSG00000165509:ENST00000448920:exon4:c.G175A:p.A59T,ENSG00000165509:ENST00000298296:exon5:c.G919A:p.A307T	MAGEC3:NM_138702:exon5:c.G919A:p.A307T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8454	0.8996	0.713907	1(stomach)	0.945	10.34	0.21	0.007	0.000	.	.	MAGE homology domain	MAGEC3:uc011mwp.2:exon5:c.G919A:p.A307T	-1.058	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU4555845,EAS:0.8706,FIN:0.8067,NFE:0.7443,OTH:0.9399,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	300469	.	.	.	.	.	.	.	0.001	4.02	0.000	-0.505	X	1(large_intestine)	0.4662
X	140983127	140983127	G	A	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs176026	ENSG00000165509:ENST00000448920:exon4:c.G238A:p.A80T,ENSG00000165509:ENST00000298296:exon5:c.G982A:p.A328T	MAGEC3:NM_138702:exon5:c.G982A:p.A328T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7950	0.7776	0.616689	1(lung)	2.885	21.8	0.019	0.684	0.001	.	.	MAGE homology domain	MAGEC3:uc011mwp.2:exon5:c.G982A:p.A328T	-0.972	AFR:MU128713,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.5052,FIN:0.7178,NFE:0.8913,OTH:0.4501,ASJ:0.7762	300469	.	.	.	.	.	.	.	0.98	3.78	0.000	1.885	X	1(stomach)	0.9066
X	140993716	140993716	G	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs78700965	ENSG00000155495:ENST00000285879:exon4:c.G526T:p.V176L	MAGEC1:NM_005462:exon4:c.G526T:p.V176L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, -1, 0, 0] 	8.656e-05	.	0.00582781	8.613e-05	-1.953	0.001	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G526T:p.V176L	-0.931	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0002,OTH:0,ASJ:0	300223	.	.	.	.	.	.	.	0.002	4.18	0.004	-0.205	X	MU80975438	het
X	140993781	140993781	A	T	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs151047723	ENSG00000155495:ENST00000285879:exon4:c.A591T:p.P197P	MAGEC1:NM_005462:exon4:c.A591T:p.P197P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0008	.	0.0161589	MU63791795	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.A591T:p.P197P	.	AFR:COCA-CN|1|321|0.00311526,ESCA-CN|1|332|0.00301205,AMR:0.0007,EAS:0,FIN:0,NFE:0.0025,OTH:0.0008,ASJ:0	300223	.	.	.	.	.	.	.	.	.	.	.	X	1(large_intestine)	0.0010
X	140993852	140993852	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176038	ENSG00000155495:ENST00000285879:exon4:c.C662G:p.T221S	MAGEC1:NM_005462:exon4:c.C662G:p.T221S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3109	.	.	5(biliary_tract)	-1.617	0.002	0.612	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C662G:p.T221S	-0.928	AFR:18(upper_aerodigestive_tract),AMR:1(skin),EAS:MU24313706,FIN:SKCA-BR|1|100|0.01,LICA-CN|5|402|0.0124378,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,THCA-CN|2|50|0.04,NFE:0.4042,OTH:0.4465,ASJ:1(haematopoietic_and_lymphoid_tissue)	300223	.	.	.	.	.	.	.	0.002	3.86	0.005	1.1	X	4(thyroid)	0.4260
X	140993859	140993859	T	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs6634333	ENSG00000155495:ENST00000285879:exon4:c.T669A:p.S223R	MAGEC1:NM_005462:exon4:c.T669A:p.S223R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3075	.	0.410861	1(skin)	1.014	10.74	0.352	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T669A:p.S223R	-0.927	AFR:MU29513613,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,THCA-CN|1|50|0.02,EAS:0.4339,FIN:0.3969,NFE:0.3649,OTH:0.3150,ASJ:0.4004	300223	.	.	.	.	.	.	.	0.162	4.26	0.004	1.65	X	1(bone)	0.3734
X	140993906	140993906	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs146816736	ENSG00000155495:ENST00000285879:exon4:c.C716G:p.P239R	MAGEC1:NM_005462:exon4:c.C716G:p.P239R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0110	.	0.0333775	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	-0.082	1.869	0.004	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C716G:p.P239R	-0.978	AFR:0.0017,AMR:0.0013,EAS:0.0075,FIN:0,NFE:0,OTH:0.0025,ASJ:0.0038	300223	.	.	.	.	.	.	.	0.012	4.29	0.015	1.04	X	1(liver)	0.0017
X	140993912	140993912	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs12558365	ENSG00000155495:ENST00000285879:exon4:c.C722T:p.S241F	MAGEC1:NM_005462:exon4:c.C722T:p.S241F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2012	.	.	1(lung)	0.015	2.732	0.935	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C722T:p.S241F	-0.929	AFR:7(upper_aerodigestive_tract),AMR:MU776507,EAS:0.1641,FIN:0.1707,NFE:0.1561,OTH:0.2051,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	300223	.	.	.	.	.	.	.	0.001	4.3	0.000	0.345	X	1(skin)	0.1169
X	140993932	140993932	C	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs141965436	ENSG00000155495:ENST00000285879:exon4:c.C742A:p.L248I	MAGEC1:NM_005462:exon4:c.C742A:p.L248I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0233	.	.	1(urinary_tract)	0.706	8.865	0.427	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C742A:p.L248I	-0.919	AFR:6(upper_aerodigestive_tract),AMR:MU4625886,EAS:0.0164,FIN:0.0161,NFE:0.0056,OTH:0.0222,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,ESCA-CN|1|332|0.00301205,BLCA-CN|1|103|0.00970874	300223	.	.	.	.	.	.	.	0.784	4.33	0.004	1.3	X	3(pancreas)	0.0027
X	140993945	140993945	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs145765891	ENSG00000155495:ENST00000285879:exon4:c.T755C:p.F252S	MAGEC1:NM_005462:exon4:c.T755C:p.F252S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1945	0.3136	0.488212	LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	-1.133	0.009	0.623	.	0.002	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T755C:p.F252S	-0.914	AFR:0.3061,AMR:0.3252,EAS:0.2281,FIN:0.1908,NFE:0.3180,OTH:0.3054,ASJ:0.3102	300223	.	.	.	.	.	.	.	0.034	4.38	0.000	-0.83	X	1(lung)	0.3284
X	140993947	140993947	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs148942485	ENSG00000155495:ENST00000285879:exon4:c.T757C:p.S253P	MAGEC1:NM_005462:exon4:c.T757C:p.S253P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1733	0.3126	0.489272	MU4551709	-1.923	0.001	1.0	.	0.004	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T757C:p.S253P	-1.014	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.2855,EAS:0.2780,FIN:0.2241,NFE:0.1754,OTH:0.2958,ASJ:0.3084	300223	.	.	.	.	.	.	.	0.898	4.22	0.000	-0.975	X	1(thyroid)	0.2822
X	140993989	140993989	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs77648555	ENSG00000155495:ENST00000285879:exon4:c.T799C:p.S267P	MAGEC1:NM_005462:exon4:c.T799C:p.S267P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1739	0.4526	0.536159	LAML-KR|1|205|0.00487805,THCA-CN|1|50|0.02	-2.009	0.001	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T799C:p.S267P	-0.951	AFR:0.1795,AMR:0.1165,EAS:0.2683,FIN:0.1216,NFE:0.1693,OTH:0.2173,ASJ:0.2087	300223	.	.	.	.	.	.	.	0.0	4.22	0.000	-0.77	X	2(thyroid)	0.2324
X	140994011	140994011	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176043	ENSG00000155495:ENST00000285879:exon4:c.C821G:p.P274R	MAGEC1:NM_005462:exon4:c.C821G:p.P274R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0032	.	0.0768212	LUSC-KR|2|170|0.0117647	-0.305	0.647	0.585	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C821G:p.P274R	-0.960	AFR:0.0029,AMR:0.0029,EAS:0,FIN:0.0014,NFE:0.0041,OTH:0.0030,ASJ:0	300223	.	.	.	.	.	.	.	0.969	4.29	0.001	1.24	X	4(haematopoietic_and_lymphoid_tissue)	0.0024
X	140994031	140994031	G	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176044	ENSG00000155495:ENST00000285879:exon4:c.G841T:p.V281L	MAGEC1:NM_005462:exon4:c.G841T:p.V281L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0061	.	0.0458278	LUSC-KR|1|170|0.00588235	-1.503	0.003	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G841T:p.V281L	-0.906	AFR:0.0067,AMR:0.0106,EAS:0,FIN:0.0145,NFE:0.0024,OTH:0.0059,ASJ:0	300223	.	.	.	.	.	.	.	0.002	4.21	0.009	-1.3	X	1(large_intestine)	0
X	140994037	140994037	C	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176045	ENSG00000155495:ENST00000285879:exon4:c.C847A:p.L283I	MAGEC1:NM_005462:exon4:c.C847A:p.L283I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3838	.	0.448477	2(skin)	-0.998	0.016	0.425	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C847A:p.L283I	-0.908	AFR:MU11069098,AMR:SKCA-BR|1|100|0.01,LUSC-KR|3|170|0.0176471,PBCA-DE|1|499|0.00200401,EAS:0.6332,FIN:0.196,NFE:0.4167,OTH:0.0529,ASJ:0.4311	300223	.	.	.	.	.	.	.	0.114	4.33	0.000	0.255	X	1(lung)	0.3701
X	140994066	140994066	G	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs140075882	ENSG00000155495:ENST00000285879:exon4:c.G876C:p.Q292H	MAGEC1:NM_005462:exon4:c.G876C:p.Q292H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0202	0.0547	.	LICA-CN|3|402|0.00746269,GACA-CN|1|123|0.00813008	-0.714	0.067	0.001	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G876C:p.Q292H	-1.000	AFR:0.0220,AMR:0.0557,EAS:0,FIN:0,NFE:0.0139,OTH:0.0096,ASJ:0.0162	300223	.	.	.	.	.	.	.	0.932	4.36	0.001	1.7	X	3(liver)	0.0110
X	140994085	140994085	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176046	ENSG00000155495:ENST00000285879:exon4:c.C895G:p.P299A	MAGEC1:NM_005462:exon4:c.C895G:p.P299A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0197	.	.	MU35594087	0.585	8.053	0.977	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C895G:p.P299A	-0.995	AFR:SKCA-BR|1|100|0.01,COCA-CN|1|321|0.00311526,AMR:0.0872,EAS:0.0876,FIN:0.0440,NFE:0.0172,OTH:0.0656,ASJ:0.1258	300223	.	.	.	.	.	.	.	0.414	4.47	0.000	0.64	X	1(biliary_tract)	0.0787
X	140994095	140994095	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs112191471	ENSG00000155495:ENST00000285879:exon4:c.C905T:p.P302L	MAGEC1:NM_005462:exon4:c.C905T:p.P302L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0143	0.0116	.	0.0091	3.785	23.4	0.0	.	0.003	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C905T:p.P302L	-1.060	AFR:0.0013,AMR:0.0019,EAS:0,FIN:0.0158,NFE:0.0130,OTH:0.0143,ASJ:0.0189	300223	.	.	.	.	.	.	.	0.003	4.39	0.016	1.65	X	MU83735153	het
X	140994109	140994109	G	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs879185216	ENSG00000155495:ENST00000285879:exon4:c.G919A:p.V307M	MAGEC1:NM_005462:exon4:c.G919A:p.V307M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0003	.	.	MU24104180	0.236	5.058	0.0	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G919A:p.V307M	-1.002	AFR:BRCA-US|1|1020|0.000980392,AMR:0.0001,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	300223	.	.	.	.	.	.	.	0.932	4.23	0.014	1.445	X	1(lung)	0.0002
X	140994113	140994113	G	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs879070866	ENSG00000155495:ENST00000285879:exon4:c.G923C:p.S308T	MAGEC1:NM_005462:exon4:c.G923C:p.S308T	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0002	.	.	0.0001	-1.642	0.002	0.0	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G923C:p.S308T	-0.993	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0002,OTH:0,ASJ:0	300223	.	.	.	.	.	.	.	0.003	3.79	0.018	1.7	X	.	het
X	140994115	140994115	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs138660605	ENSG00000155495:ENST00000285879:exon4:c.T925C:p.S309P	MAGEC1:NM_005462:exon4:c.T925C:p.S309P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0315	.	0.0193377	2(upper_aerodigestive_tract)	-0.598	0.126	1.0	.	0.002	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T925C:p.S309P	-0.962	AFR:MU4585436,AMR:COCA-CN|2|321|0.00623053,THCA-CN|1|50|0.02,EAS:0.0091,FIN:0.0087,NFE:0.0163,OTH:0.0015,ASJ:0.0298	300223	.	.	.	.	.	.	.	0.984	4.21	0.027	-0.64	X	3(thyroid)	0.0505
X	140994116	140994116	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs141900922	ENSG00000155495:ENST00000285879:exon4:c.C926G:p.S309C	MAGEC1:NM_005462:exon4:c.C926G:p.S309C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0104	.	.	.	1.398	12.78	0.001	.	0.004	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C926G:p.S309C	-1.045	AFR:0.0082,AMR:0.0023,EAS:0,FIN:0,NFE:0.0133,OTH:0.0121,ASJ:0	300223	.	.	.	.	.	.	.	0.996	4.2	0.038	0.805	X	1(thyroid)	0.0071
X	140994122	140994122	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs1055491	ENSG00000155495:ENST00000285879:exon4:c.C932T:p.S311F	MAGEC1:NM_005462:exon4:c.C932T:p.S311F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0263	0.0098	0.0180132	0.0378	-1.495	0.003	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C932T:p.S311F	-0.987	AFR:0.0127,AMR:0.0096,EAS:0.0019,FIN:0.0568,NFE:0.0540,OTH:0.0363,ASJ:0.0182	300223	.	.	.	.	.	.	.	0.001	4.3	0.010	-0.895	X	MU4550438	hom
X	140994142	140994142	C	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs111809877	ENSG00000155495:ENST00000285879:exon4:c.C952A:p.L318I	MAGEC1:NM_005462:exon4:c.C952A:p.L318I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0020	.	.	.	-1.416	0.003	0.727	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C952A:p.L318I	-0.794	AFR:0.0017,AMR:0.0043,EAS:0,FIN:0.0021,NFE:0.0009,OTH:0.0006,ASJ:0	300223	.	.	.	.	.	.	.	0.386	4.33	0.004	0.695	X	1(upper_aerodigestive_tract)	0
X	140994171	140994171	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176047	ENSG00000155495:ENST00000285879:exon4:c.C981G:p.H327Q	MAGEC1:NM_005462:exon4:c.C981G:p.H327Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7166	0.6707	0.702517	2(pancreas)	-1.999	0.001	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C981G:p.H327Q	-0.955	AFR:2(lung),AMR:MU13865040,EAS:0.6995,FIN:0.6181,NFE:0.7429,OTH:0.6620,ASJ:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	300223	.	.	.	.	.	.	.	0.001	4.46	0.000	-0.345	X	1(large_intestine)	0.7494
X	140994280	140994280	A	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs4824884	ENSG00000155495:ENST00000285879:exon4:c.A1090G:p.T364A	MAGEC1:NM_005462:exon4:c.A1090G:p.T364A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2552	0.1684	0.26596	0.1846	0.721	8.961	0.0	.	0.000	.	.	.	MAGEC1:uc022cfi.1:exon1:c.A67G:p.T23A,MAGEC1:uc004fbt.3:exon4:c.A1090G:p.T364A	-0.891	AFR:0.0674,AMR:0.3041,EAS:0.4577,FIN:0.2378,NFE:0.2024,OTH:0.2164,ASJ:0.2109	300223	.	.	.	.	.	.	.	0.414	3.88	0.000	0	X	MU14623882	het
X	140994339	140994339	C	T	MAGEC1	exonic	synonymous SNV	ENSG00000155495	.	ENSG00000155495:ENST00000285879:exon4:c.C1149T:p.S383S	MAGEC1:NM_005462:exon4:c.C1149T:p.S383S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	MAGEC1:uc022cfi.1:exon1:c.C126T:p.S42S,MAGEC1:uc004fbt.3:exon4:c.C1149T:p.S383S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300223	.	.	.	.	.	.	.	.	.	.	.	X	.	het
X	140994407	140994407	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs62611965	ENSG00000155495:ENST00000285879:exon4:c.C1217G:p.S406C	MAGEC1:NM_005462:exon4:c.C1217G:p.S406C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0852	0.0778	0.0749669	0.0681	2.644	20.5	0.0	.	0.001	.	.	.	MAGEC1:uc022cfi.1:exon1:c.C194G:p.S65C,MAGEC1:uc004fbt.3:exon4:c.C1217G:p.S406C	-0.869	AFR:0.0452,AMR:0.0620,EAS:0.0410,FIN:0.0710,NFE:0.0830,OTH:0.0766,ASJ:0.0402	300223	.	.	.	.	.	.	.	0.991	4.23	0.000	0.695	X	.	het
X	140994419	140994419	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs138268726	ENSG00000155495:ENST00000285879:exon4:c.T1229C:p.I410T	MAGEC1:NM_005462:exon4:c.T1229C:p.I410T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0853	0.0781	0.0752318	0.0676	0.558	7.857	0.0	.	0.000	.	.	.	MAGEC1:uc022cfi.1:exon1:c.T206C:p.I69T,MAGEC1:uc004fbt.3:exon4:c.T1229C:p.I410T	-0.913	AFR:0.0459,AMR:0.0655,EAS:0.0390,FIN:0.0712,NFE:0.0820,OTH:0.0692,ASJ:0.0449	300223	.	.	.	.	.	.	.	0.618	3.8	0.000	0.345	X	.	het
X	140994517	140994517	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs62611966	ENSG00000155495:ENST00000285879:exon4:c.C1327G:p.L443V	MAGEC1:NM_005462:exon4:c.C1327G:p.L443V	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0924	0.0819	0.0765563	0.0815	-0.002	2.566	0.0	0.131	0.006	.	.	.	MAGEC1:uc022cfi.1:exon1:c.C304G:p.L102V,MAGEC1:uc004fbt.3:exon4:c.C1327G:p.L443V	-0.852	AFR:0.0551,AMR:0.0641,EAS:0.0419,FIN:0.0873,NFE:0.0999,OTH:0.0842,ASJ:0.0549	300223	.	.	.	.	.	.	.	0.886	4.39	0.000	0.895	X	.	het
X	140995315	140995315	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs56256227	ENSG00000155495:ENST00000285879:exon4:c.C2125T:p.H709Y	MAGEC1:NM_005462:exon4:c.C2125T:p.H709Y	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0937	0.0877	0.0823841	0.0890	-1.245	0.005	0.159	-1.92	0.000	.	.	.	MAGEC1:uc022cfi.1:exon1:c.C1102T:p.H368Y,MAGEC1:uc004fbt.3:exon4:c.C2125T:p.H709Y	-0.925	AFR:0.0734,AMR:0.0743,EAS:0.0470,FIN:0.0910,NFE:0.1027,OTH:0.0942,ASJ:0.0588	300223	.	.	.	.	.	.	.	0.001	4.18	0.000	-0.695	X	.	het
X	141290865	141290865	C	T	MAGEC2	exonic	synonymous SNV	ENSG00000046774	rs3765272	ENSG00000046774:ENST00000247452:exon3:c.G909A:p.P303P	MAGEC2:NM_016249:exon3:c.G909A:p.P303P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7018	0.6634	0.713377	0.6605	.	.	.	.	.	.	.	.	MAGEC2:uc022cfj.1:exon1:c.G909A:p.P303P,MAGEC2:uc004fbu.2:exon3:c.G909A:p.P303P	.	AFR:0.6071,AMR:0.7406,EAS:0.8593,FIN:0.6454,NFE:0.6685,OTH:0.6695,ASJ:0.7111	300468	.	.	.	.	.	.	.	.	.	.	.	X	MU4558141	het
X	147018146	147018146	C	T	FMR1	intronic	.	ENSG00000102081	rs25714	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1639	0.0900	0.261192	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1211,AMR:0.1197,EAS:0.0588,FIN:0.7473,NFE:0.0561,OTH:0.0716,ASJ:0.2570	309550	300623;300624;311360;	449291;908;93256;	449291|-|Unknown|X-linked dominant|Neonatal<br>Infancy<br>Childhood|300624 ~908|FRAXA syndrome<br>FXS<br>FraX syndrome<br>Martin-Bell syndrome|1-5 / 10 000|X-linked dominant|Neonatal<br>Infancy<br>Childhood|300624 ~93256|FXTAS syndrome|1-9 / 100 000|X-linked dominant|Adult|300623 ~	.	.	.	.	.	.	.	.	X	1(lung)	0.1033
X	153218365	153218365	C	A	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs3027878	ENSG00000172534:ENST00000310441:exon19:c.G4542T:p.L1514L,ENSG00000172534:ENST00000369984:exon19:c.G4674T:p.L1558L,ENSG00000172534:ENST00000354233:exon20:c.G4335T:p.L1445L	HCFC1:NM_005334:exon19:c.G4542T:p.L1514L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4065	0.1192	0.383841	MU27601772	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon19:c.G4542T:p.L1514L	.	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.1675,EAS:0.4943,FIN:0.2663,NFE:0.7549,OTH:0.1337,ASJ:0.0704	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.1494
X	153219665	153219665	C	T	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs2071133	ENSG00000172534:ENST00000310441:exon17:c.G4185A:p.A1395A,ENSG00000172534:ENST00000369984:exon17:c.G4185A:p.A1395A,ENSG00000172534:ENST00000354233:exon18:c.G3978A:p.A1326A	HCFC1:NM_005334:exon17:c.G4185A:p.A1395A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3173	0.1513	0.403179	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon17:c.G4185A:p.A1395A	.	AFR:0.2003,AMR:0.1108,EAS:0.2762,FIN:0.7653,NFE:0.1721,OTH:0.1801,ASJ:0.5083	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.2348
X	153220360	153220360	A	G	HCFC1	exonic	nonsynonymous SNV	ENSG00000172534	rs1051152	ENSG00000172534:ENST00000310441:exon17:c.T3490C:p.S1164P,ENSG00000172534:ENST00000369984:exon17:c.T3490C:p.S1164P,ENSG00000172534:ENST00000354233:exon18:c.T3283C:p.S1095P	HCFC1:NM_005334:exon17:c.T3490C:p.S1164P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5008	0.3424	0.58596	1(large_intestine)	-0.925	0.023	1.0	-0.339	0.731	.	.	Immunoglobulin-like fold	HCFC1:uc004fjp.3:exon17:c.T3490C:p.S1164P	-1.026	AFR:1(pancreas),AMR:MU1777482,EAS:0.3640,FIN:0.6809,NFE:0.5435,OTH:0.2841,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	0.0	4.25	0.000	-2.125	X	1(lung)	0.7737
X	153221657	153221657	T	C	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs730106	ENSG00000172534:ENST00000310441:exon16:c.A2841G:p.P947P,ENSG00000172534:ENST00000369984:exon16:c.A2841G:p.P947P,ENSG00000172534:ENST00000354233:exon17:c.A2634G:p.P878P	HCFC1:NM_005334:exon16:c.A2841G:p.P947P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3737	0.3636	0.585166	0.3632	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon16:c.A2841G:p.P947P	.	AFR:0.6821,AMR:0.5468,EAS:0.7704,FIN:0.1785,NFE:0.1877,OTH:0.2744,ASJ:0.3011	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	MU21067151	het
X	153222835	153222835	G	C	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs2071134	ENSG00000172534:ENST00000310441:exon13:c.C2283G:p.T761T,ENSG00000172534:ENST00000369984:exon13:c.C2283G:p.T761T,ENSG00000172534:ENST00000354233:exon14:c.C2076G:p.T692T	HCFC1:NM_005334:exon13:c.C2283G:p.T761T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2882	0.1158	0.384106	LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon13:c.C2283G:p.T761T	.	AFR:0.1662,AMR:0.0685,EAS:0.2637,FIN:0.7525,NFE:0.1326,OTH:0.1498,ASJ:0.4894	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.2090
X	153227770	153227770	G	A	HCFC1	intronic	.	ENSG00000172534	rs59607260	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3419	0.1494	0.404503	0.2011	.	.	.	.	.	.	.	.	.	.	AFR:0.1162,AMR:0.5,EAS:0.7677,FIN:0.1725,NFE:0.1815,OTH:0.2293,ASJ:0.2826	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	MU27601829	het
X	153581932	153581932	A	G	FLNA	exonic	synonymous SNV	ENSG00000196924	rs2070825	ENSG00000196924:ENST00000344736:exon33:c.T5730C:p.A1910A,ENSG00000196924:ENST00000360319:exon34:c.T5826C:p.A1942A,ENSG00000196924:ENST00000422373:exon35:c.T5826C:p.A1942A,ENSG00000196924:ENST00000369850:exon36:c.T5850C:p.A1950A	FLNA:NM_001456:exon35:c.T5826C:p.A1942A,FLNA:NM_001110556:exon36:c.T5850C:p.A1950A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1609	0.2440	0.25404	1(lung)	.	.	.	.	.	.	.	.	FLNA:uc010nuu.1:exon35:c.T5826C:p.A1942A,FLNA:uc004fkk.2:exon36:c.T5850C:p.A1950A	.	AFR:MU770873,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,EAS:0.4881,FIN:0.2175,NFE:0.0484,OTH:0.0735,ASJ:0.2204	300017	300048;300049;300244;300321;304120;305620;309350;311300;314400;	1864;669;90650;2484;1826;669;90652;88630;2149;98892;2301;2978;	1864|-|Unknown|Not applicable|Childhood|314400 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90650|OPD I syndrome<br>OPD syndrome 1<br>Taybi syndrome|-|X-linked dominant|-|311300 ~2484|Melnick-Needles osteodysplasty|<1 / 1 000 000|X-linked dominant|Childhood|309350 ~1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90652|OPD II syndrome<br>OPD syndrome 2|<1 / 1 000 000|X-linked dominant|Neonatal|304120 ~88630|-|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300244 ~2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~2301|-|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|300048 615237 ~2978|CIPO|Unknown|-|All ages|243180 300048 601223 609629 ~	~ko04010 MAPK signaling pathway~ko04510 Focal adhesion~ko05132 Salmonella infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	X	1(large_intestine)	0.1461
X	153596477	153596477	C	T	FLNA	intronic	.	ENSG00000196924	rs2070817	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0505	0.0448	0.0299338	0.0492	.	.	.	.	.	.	.	.	.	.	AFR:0.0098,AMR:0.0228,EAS:0.0118,FIN:0.0991,NFE:0.0632,OTH:0.0642,ASJ:0.0270	300017	300048;300049;300244;300321;304120;305620;309350;311300;314400;	1864;669;90650;2484;1826;669;90652;88630;2149;98892;2301;2978;	1864|-|Unknown|Not applicable|Childhood|314400 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90650|OPD I syndrome<br>OPD syndrome 1<br>Taybi syndrome|-|X-linked dominant|-|311300 ~2484|Melnick-Needles osteodysplasty|<1 / 1 000 000|X-linked dominant|Childhood|309350 ~1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90652|OPD II syndrome<br>OPD syndrome 2|<1 / 1 000 000|X-linked dominant|Neonatal|304120 ~88630|-|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300244 ~2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~2301|-|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|300048 615237 ~2978|CIPO|Unknown|-|All ages|243180 300048 601223 609629 ~	~ko04010 MAPK signaling pathway~ko04510 Focal adhesion~ko05132 Salmonella infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	X	.	het
X	153994596	153994596	G	T	DKC1	exonic	synonymous SNV	ENSG00000130826	rs2728532	ENSG00000130826:ENST00000452771:exon4:c.G327T:p.T109T,ENSG00000130826:ENST00000369550:exon5:c.G369T:p.T123T,ENSG00000130826:ENST00000413910:exon5:c.G369T:p.T123T	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001288747:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9974	0.9919	0.992583	0.9937	.	.	.	.	.	.	.	.	DKC1:uc004fmm.3:exon5:c.G369T:p.T123T,DKC1:uc010nvf.3:exon5:c.G369T:p.T123T	.	AFR:0.9777,AMR:0.9935,EAS:1,FIN:1,NFE:1,OTH:0.9986,ASJ:1	300126	305000;	1775;3322;	1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~	.	.	.	.	.	.	.	.	X	MU82060809	hom
X	154020114	154020114	C	A	MPP1	exonic	synonymous SNV	ENSG00000130830	rs1126762	ENSG00000130830:ENST00000369531:exon3:c.G204T:p.T68T,ENSG00000130830:ENST00000369534:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000393529:exon3:c.G117T:p.T39T,ENSG00000130830:ENST00000393531:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000413259:exon4:c.G165T:p.T55T	MPP1:NM_001166460:exon3:c.G204T:p.T68T,MPP1:NM_001166461:exon3:c.G255T:p.T85T,MPP1:NM_002436:exon3:c.G255T:p.T85T,MPP1:NM_001166462:exon4:c.G165T:p.T55T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6400	0.5528	0.544106	0.5864	.	.	.	.	.	.	.	.	MPP1:uc004fmp.2:exon3:c.G255T:p.T85T,MPP1:uc010nvg.2:exon3:c.G255T:p.T85T,MPP1:uc011mzw.2:exon3:c.G204T:p.T68T,MPP1:uc011mzv.2:exon4:c.G165T:p.T55T	.	AFR:0.2496,AMR:0.5728,EAS:0.7547,FIN:0.7600,NFE:0.7057,OTH:0.7155,ASJ:0.6441	305360	.	.	.	.	.	.	.	.	.	.	.	X	MU13868845	het
